Citrus Sinensis ID: 043388

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850----
Protein Sequence
KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRRV
Secondary Structure (PSIPRED)
cccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccHHHHccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHcccccccEEEccccccccccccccccccccccccccccHHHHHcccccEEEcccccccccccccccccccccEEEccccccccccccccccHHcccccccccEEEcccccccccccHHHHcccccccEEEEEccEEEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccccccccccccccccccccccccccEEEcccccccccccHHHHcccccccHHccccccccccccHHHHcccHHHHccccccEEEcccccccccccHHHHccccccEEEccccccccccHHHHHccccccccccccccccccccccccccccccHHHcccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEEccccEEEEEEEcccccccccHHHHHHHHHHHcccccccccEEEEccccccccccEEEEEEcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccEEcccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHcccccccEEEcccccccccccHHHHHcHHHHcEEEccccccccccEcEcccccccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccccccccHHHcccccccEEEcccccccccccHHHHHcccccEEEEEEEccEEccccHHHHHcccccEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHHcHHHHHcccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEcccccccccccccccccccHHEEcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHccccHHcEEEccccEEEEEEEcccccEEEEEEEEcccccccccHHHHHHHHHHHccHHHHHHHHEEEccccccccccEEEEEEEcccccHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccccccccHHEEEcccccccccEEEEEccccccccHHccccEEcccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHcccccHHEccHHHHccccccccccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHcccc
Coil and Loop (DISEMBL)
knklegqipeEIGSLLNLQTLAIDFnyltgqlpdfVGNLSALGMLLIRWNslggqipttLGLLRNLVYLNVAEnqfsgmfprwicNISSLEFIYLTVNrfsgslpfdilvnlpnlkELYLTFCSLKNLWWLNLEqnnlgmgtassipdslsnasnlerldlsgnqfkgkvsidFSSLKNLWWLNLEqnnlgmgtandLDFVTLLTNCsslkalslcdnqfggelphsIANLSSTMIQFRiggnqisgtipsGIRNLVNLIALTIEVnqlhgiipdgvGELQHLQQLYMFRNflqgsippslgnltKLADLALSFNNlqgnipsslgncqnlkgfdashnkltgaipqqvLSITTLSVYLALAHNLlndslplqvgnlKNLVITCVSLeyldissnsfhgvipfsLGFMKSIKELNvssnnlsgqipEFLQNLSFLEFLNLSYnhlegevptkgvfsnktkiSLQVNVKLcggidelhllscpskgsrkpkltLLKVLIPVVVSCLILSSCLTIVFARRrrsahksvdtspakkqfpmISYAELSKATsefassnmigqgsfgsvykgilgGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLhhhcqppivhgdlkpsnvlldhdmvahqnfslshqldsasktpsssigikgtvgyvapeygmgseasmtgdvYSFGILLLEMftgrrptdaaftegLTLHEFVKMtlpekvieivdPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVlcsmespferMEMRDVVAKLCHTRETFLGRRV
Flexible Loop (DISEMBL)
KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHllscpskgsrkpKLTLLKVLIPVVVSCLILSSCLTIVFARrrrsahksvdtspakkqfpMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLdsasktpsssigiKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHtretflgrrv
Low Complexity Region (SEG)
KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSlknlwwlnleqnnlGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSlknlwwlnleqnnlGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRRV
Disordered region (IsUnstruct)
***********IGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLG************************NQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFAR*******************************************FGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNF****************IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQE*RRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF*****
Disordered Region (DISOPRED)
KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGID********************KVLIPVVVSCLILSSCLTIVFA********************MISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLD***********IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVM**********RARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGR**
Disordered Region (DISEMBL)
KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARR*************KKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLS*************IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRRV
Disordered Region (DISPRO)
*NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRRSA*********KKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMA*******DRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRRV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	854	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.961	0.812	0.417	0.0
C0LGT6	1031	LRR receptor-like serine/	no	no	0.948	0.785	0.401	1e-171
Q9SD62	1025	Putative receptor-like pr	no	no	0.957	0.798	0.422	1e-169
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.949	0.827	0.361	1e-120
Q9FL28	1173	LRR receptor-like serine/	no	no	0.933	0.679	0.318	1e-101
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.930	0.666	0.318	2e-99
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.920	0.713	0.316	4e-99
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.933	0.638	0.314	2e-98
O49318	1124	Probable leucine-rich rep	no	no	0.934	0.709	0.299	4e-97
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.878	0.717	0.319	7e-97

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  636 bits (1640), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/883 (41%), Positives = 539/883 (61%), Gaps = 62/883 (7%)

Query: 2    NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            N+L G +P E+GSL NL  L +  N + G+LP  +GNL+ L  L +  N+L G+IP+ + 
Sbjct: 148  NRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVA 207

Query: 62   LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
             L  +  L +  N FSG+FP  + N+SSL+ + +  N FSG L  D+ + LPNL    L+
Sbjct: 208  QLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNL----LS 263

Query: 122  FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
            F    N +               SIP +LSN S LERL ++ N   G +   F ++ NL 
Sbjct: 264  FNMGGNYF-------------TGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLK 309

Query: 182  WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
             L L  N+LG  ++ DL+F+T LTNC+ L+ L +  N+ GG+LP SIANLS+ ++   +G
Sbjct: 310  LLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLG 369

Query: 242  GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
            G  ISG+IP  I NL+NL  L ++ N L G +P  +G+L +L+ L +F N L G IP  +
Sbjct: 370  GTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFI 429

Query: 302  GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
            GN+T L  L LS N  +G +P+SLGNC +L       NKL G IP +++ I  L + L +
Sbjct: 430  GNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQL-LRLDM 488

Query: 362  AHNLLNDSLPLQVGNLKNL-----------------VITCVSLEYLDISSNSFHGVIPFS 404
            + N L  SLP  +G L+NL                 +  C+++E L +  N F+G IP  
Sbjct: 489  SGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP-D 547

Query: 405  LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQ 464
            L  +  +KE+++S+N+LSG IPE+  + S LE+LNLS+N+LEG+VP KG+F N T +S+ 
Sbjct: 548  LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIV 607

Query: 465  VNVKLCGGIDELHLLSC----PS---KGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFAR 517
             N  LCGGI    L  C    PS   K S + K  ++ V + + +  L+  + +T+++ R
Sbjct: 608  GNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLR 667

Query: 518  RRRSAHKSVDTSPAKKQF--PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMI 575
            +R+   ++ + +P+  +     ISY +L  AT+ F+SSNM+G GSFG+VYK +L  E+ +
Sbjct: 668  KRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKV 727

Query: 576  VAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG 635
            VAVKV+N++++GA +SF+AECE+L++IRHRNL+K++T CSSID +G +F+AL++E+M NG
Sbjct: 728  VAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNG 787

Query: 636  SLEDWLHQSND---HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 692
            SL+ WLH       H     LTL++R+NIAIDVAS ++YLH HC  PI H DLKPSNVLL
Sbjct: 788  SLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLL 847

Query: 693  DHDMVAH-QNFSLSHQL----DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSF 747
            D D+ AH  +F L+  L    + +     SS G++GT+GY APEYG+G + S+ GDVYSF
Sbjct: 848  DDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSF 907

Query: 748  GILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRR 807
            GILLLEMFTG+RPT+  F    TL+ + K  LPE++++IVD S+L   +     + E   
Sbjct: 908  GILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVE--- 964

Query: 808  ARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
                 CL  +   G+ C  ESP  R+    VV +L   RE F 
Sbjct: 965  -----CLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFF 1002

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  602 bits (1552), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 359/894 (40%), Positives = 514/894 (57%), Gaps = 84/894 (9%)

Query: 2    NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            N L   +P E+GSL  L  L +  N LTG  P  +GNL++L  L   +N + G+IP  + 
Sbjct: 155  NHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVA 214

Query: 62   LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
             L  +V+  +A N FSG FP  + NISSLE + L  N FSG+L  D              
Sbjct: 215  RLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRAD-------------- 260

Query: 122  FCSLKNLWWLNLEQNNLGMGT---ASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLK 178
                    +L      L +GT     +IP +L+N S+LER D+S N   G + + F  L+
Sbjct: 261  ------FGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLR 314

Query: 179  NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQF 238
            NLWWL +  N+LG  +++ L+F+  + NC+ L+ L +  N+ GGELP SIANLS+T+   
Sbjct: 315  NLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSL 374

Query: 239  RIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIP 298
             +G N ISGTIP  I NLV+L  L++E N L G +P   G+L +LQ + ++ N + G IP
Sbjct: 375  FLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIP 434

Query: 299  PSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVY 358
               GN+T+L  L L+ N+  G IP SLG C+ L       N+L G IPQ++L I +L+ Y
Sbjct: 435  SYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA-Y 493

Query: 359  LALAHNLLNDSLPLQVGNLKNLV-----------------ITCVSLEYLDISSNSFHGVI 401
            + L++N L    P +VG L+ LV                   C+S+E+L +  NSF G I
Sbjct: 494  IDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAI 553

Query: 402  PFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKI 461
            P  +  + S+K ++ S+NNLSG+IP +L +L  L  LNLS N  EG VPT GVF N T +
Sbjct: 554  P-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAV 612

Query: 462  SLQVNVKLCGGIDELHLLSCPSKGS---RKPKLTLLKVLIPV---VVSCLILSSCLTIVF 515
            S+  N  +CGG+ E+ L  C  + S   RKP     KV+  +   + S L++    ++ +
Sbjct: 613  SVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCW 672

Query: 516  ARRRRSAHKSVDTSPAKKQ-----FPMISYAELSKATSEFASSNMIGQGSFGSVYKGILG 570
              +R+  + + D +P+           +SY EL  ATS F+S+N+IG G+FG+V+KG+LG
Sbjct: 673  FMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLG 732

Query: 571  GEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE 630
             E  +VAVKV+NL + GA +SF+AECE  + IRHRNL+K+IT+CSS+DS+G DF+ALV+E
Sbjct: 733  PENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYE 792

Query: 631  YMENGSLEDWLH-----QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDL 685
            +M  GSL+ WL      + NDH     LT  +++NIAIDVASA+EYLH HC  P+ H D+
Sbjct: 793  FMPKGSLDMWLQLEDLERVNDHSR--SLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDI 850

Query: 686  KPSNVLLDHDMVAH-QNFSLSHQLDSASK----TPSSSIGIKGTVGYVAPEYGMGSEASM 740
            KPSN+LLD D+ AH  +F L+  L    +       SS G++GT+GY APEYGMG + S+
Sbjct: 851  KPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSI 910

Query: 741  TGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNS 800
             GDVYSFGILLLEMF+G++PTD +F     LH + K  L          S       +N+
Sbjct: 911  QGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL----------SGCTSSGGSNA 960

Query: 801  MIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRRV 854
            +          + L  + + G+ CS E P +RM   + V +L   R  F   + 
Sbjct: 961  I---------DEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSKT 1005

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  596 bits (1537), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 376/889 (42%), Positives = 535/889 (60%), Gaps = 71/889 (7%)

Query: 2    NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            N LE  +P E GSL  L  L++  N LTG+ P  +GNL++L ML   +N + G+IP  + 
Sbjct: 163  NHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIA 222

Query: 62   LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
             L+ +++  +A N+F+G+FP  I N+SSL F+ +T N FSG+L  D    LPNL+ LY+ 
Sbjct: 223  RLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMG 282

Query: 122  FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
              S                    +IP++LSN S+L +LD+  N   GK+ + F  L+NL 
Sbjct: 283  INSF-----------------TGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLL 325

Query: 182  WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
             L L  N+LG  ++ DLDF+  LTNCS L+ L++  N+ GG+LP  IANLS+ + +  +G
Sbjct: 326  LLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLG 385

Query: 242  GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
            GN ISG+IP GI NLV+L  L +  N L G +P  +GEL  L+++ ++ N L G IP SL
Sbjct: 386  GNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSL 445

Query: 302  GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
            GN++ L  L L  N+ +G+IPSSLG+C  L   +   NKL G+IP +++ + +L V L +
Sbjct: 446  GNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSL-VVLNV 504

Query: 362  AHNLLNDSLPLQVGNLKNL-----------------VITCVSLEYLDISSNSFHGVIPFS 404
            + NLL   L   +G LK L                 +  C+SLE+L +  NSF G IP  
Sbjct: 505  SFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDI 564

Query: 405  LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQ 464
             G +  ++ L++S NNLSG IPE++ N S L+ LNLS N+ +G VPT+GVF N + +S+ 
Sbjct: 565  RG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVF 623

Query: 465  VNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTI----------- 513
             N+ LCGGI  L L  C  +  R+   + ++ +I + VS ++ +  L             
Sbjct: 624  GNINLCGGIPSLQLQPCSVELPRRH--SSVRKIITICVSAVMAALLLLCLCVVYLCWYKL 681

Query: 514  -VFARRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGE 572
             V + R  +       SP K  +  ISY EL K T  F+SSN+IG G+FG+V+KG LG +
Sbjct: 682  RVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSK 741

Query: 573  EMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM 632
               VA+KV+NL ++GA +SF+AECEAL  IRHRNL+K++TICSS D +G DF+ALV+E+M
Sbjct: 742  NKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFM 801

Query: 633  ENGSLEDWLHQSNDHLEVC-----KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKP 687
             NG+L+ WLH   D +E        L L  R+NIAIDVASA+ YLH +C  PI H D+KP
Sbjct: 802  PNGNLDMWLHP--DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKP 859

Query: 688  SNVLLDHDMVAH-QNFSLSHQLDSASKTP----SSSIGIKGTVGYVAPEYGMGSEASMTG 742
            SN+LLD D+ AH  +F L+  L    +       SS G++GT+GY APEYGMG   S+ G
Sbjct: 860  SNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMG 919

Query: 743  DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK-VIEIVDPSLLMEVMANNSM 801
            DVYSFGI+LLE+FTG+RPT+  F +GLTLH F K  L ++  ++I D ++L    A +  
Sbjct: 920  DVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFN 979

Query: 802  IQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            + E        CL  + R GV CS ESP  R+ M + ++KL   RE+F 
Sbjct: 980  MVE--------CLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFF 1020

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  434 bits (1116), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 330/914 (36%), Positives = 464/914 (50%), Gaps = 103/914 (11%)

Query: 4   LEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNL-SALGMLLIRWNSLGGQIPTTLGL 62
           L G+I   I +L  L  L +  N+  G++P  +G+L   L  L +  N L G IP  LGL
Sbjct: 78  LGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGL 137

Query: 63  LRNLVYLNVAENQFSGMFP-RWICN--ISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY 119
           L  LVYL++  N+ +G  P +  CN   SSL++I L+ N  +G +P +            
Sbjct: 138 LNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNY----------- 186

Query: 120 LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKV-SIDFSSLK 178
              C LK L +L L  N L      ++P SLSN++NL+ +DL  N   G++ S   S + 
Sbjct: 187 --HCHLKELRFLLLWSNKL----TGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMP 240

Query: 179 NLWWLNLEQNNLGMGTAN-DLD-FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMI 236
            L +L L  N+      N +L+ F   L N S L+ L L  N  GGE+  S+ +LS  ++
Sbjct: 241 QLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLV 300

Query: 237 QFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGS 296
           Q  +  N+I G+IP  I NL+NL  L +  N L G IP  + +L  L+++Y+  N L G 
Sbjct: 301 QIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGE 360

Query: 297 IPPSLGNLTKLADLALSFNNLQGNIPSSLGN------------------------CQNLK 332
           IP  LG++ +L  L +S NNL G+IP S GN                        C NL+
Sbjct: 361 IPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLE 420

Query: 333 GFDASHNKLTGAIPQQVLS-ITTLSVYLALAHNLLNDSLPLQV----------------- 374
             D SHN LTG IP +V+S +  L +YL L+ N L+  +PL++                 
Sbjct: 421 ILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELS 480

Query: 375 GNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSF 434
           G +   + +C++LE+L++S N F   +P SLG +  +KEL+VS N L+G IP   Q  S 
Sbjct: 481 GKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSST 540

Query: 435 LEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSCPSKGS-RKPKLTL 493
           L+ LN S+N L G V  KG FS  T  S   +  LCG I  +   +C  K       L +
Sbjct: 541 LKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKKHKYPSVLLPV 598

Query: 494 LKVLIPVVVSCLI---------LSSCLTIVFARRRRSAHKSVDTSPAKKQFPMISYAELS 544
           L  LI   V C+              LT+          K     P   ++P ISY +L 
Sbjct: 599 LLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDP---KYPRISYQQLI 655

Query: 545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIR 603
            AT  F +S++IG G FG VYKG+L      VAVKV++ K    F  SF  EC+ L+  R
Sbjct: 656 AATGGFNASSLIGSGRFGHVYKGVLRNNTK-VAVKVLDPKTALEFSGSFKRECQILKRTR 714

Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           HRNLI+IIT CS        F ALV   M NGSLE  L+          L LIQ VNI  
Sbjct: 715 HRNLIRIITTCSK-----PGFNALVLPLMPNGSLERHLYPG--EYSSKNLDLIQLVNICS 767

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA-HQNFSLSHQLDSASKTPSSSIGIK 722
           DVA  I YLHH+    +VH DLKPSN+LLD +M A   +F +S  +    +T S+   + 
Sbjct: 768 DVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVS 827

Query: 723 ---------GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHE 773
                    G+VGY+APEYGMG  AS  GDVYSFG+LLLE+ +GRRPTD    EG +LHE
Sbjct: 828 FGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHE 887

Query: 774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM 833
           F+K   P+ +  I++ +L            E      ++ +  +   G++C+  +P  R 
Sbjct: 888 FMKSHYPDSLEGIIEQALSRWKPQGKP---EKCEKLWREVILEMIELGLVCTQYNPSTRP 944

Query: 834 EMRDVVAKLCHTRE 847
           +M DV  ++   +E
Sbjct: 945 DMLDVAHEMGRLKE 958

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  371 bits (953), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 297/932 (31%), Positives = 465/932 (49%), Gaps = 135/932 (14%)

Query: 2    NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            N+L G+IP E+G+L+ LQ L I  N LT  +P  +  L+ L  L +  N L G I   +G
Sbjct: 274  NQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIG 333

Query: 62   LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDI--LVNLPNLKELY 119
             L +L  L +  N F+G FP+ I N+ +L  + +  N  SG LP D+  L NL NL    
Sbjct: 334  FLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSA-- 391

Query: 120  LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKN 179
                            +NL  G    IP S+SN + L+ LDLS NQ  G++   F  + N
Sbjct: 392  ---------------HDNLLTG---PIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-N 432

Query: 180  LWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFR 239
            L ++++ +N+      +D+       NCS+L+ LS+ DN   G L   I  L    I  +
Sbjct: 433  LTFISIGRNHFTGEIPDDI------FNCSNLETLSVADNNLTGTLKPLIGKLQKLRI-LQ 485

Query: 240  IGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIP- 298
            +  N ++G IP  I NL +L  L +  N   G IP  +  L  LQ L M+ N L+G IP 
Sbjct: 486  VSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPE 545

Query: 299  ----------------------PSL-GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFD 335
                                  P+L   L  L  L+L  N   G+IP+SL +   L  FD
Sbjct: 546  EMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFD 605

Query: 336  ASHNKLTGAIPQQVL-SITTLSVYLALAHNLLNDSLPLQVGNLK---------NLVITCV 385
             S N LTG IP ++L S+  + +YL  ++NLL  ++P ++G L+         NL    +
Sbjct: 606  ISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSI 665

Query: 386  -----------SLEY----------------------LDISSNSFHGVIPFSLGFMKSIK 412
                       +L++                      L++S NSF G IP S G M  + 
Sbjct: 666  PRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLV 725

Query: 413  ELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGG 472
             L++SSNNL+G+IPE L NLS L+ L L+ N+L+G VP  GVF N     L  N  LCG 
Sbjct: 726  SLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGS 785

Query: 473  IDELHLLSCPSKGSRKPKLTLLKVLI-------PVVVSCLILSSCLTIVFARRRRSAHKS 525
               L   +   K S   K T + ++I        +V+  +++ +C      +   S+  S
Sbjct: 786  KKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESS 845

Query: 526  VDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ 585
            +    +  +       EL +AT  F S+N+IG  S  +VYKG L  +  ++AVKV+NLK+
Sbjct: 846  LPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKE 904

Query: 586  KGAF--RSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ 643
              A   + F  E + L  ++HRNL+KI+        +    KALV  +MENG+LED +H 
Sbjct: 905  FSAESDKWFYTEAKTLSQLKHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHG 960

Query: 644  SNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNF 702
            S   +     +L++++++ + +AS I+YLH     PIVH DLKP+N+LLD D VAH  +F
Sbjct: 961  SAAPIG----SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDF 1016

Query: 703  SLSHQL---DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRR 759
              +  L   +  S T S+S   +GT+GY+APE+    + +   DV+SFGI+++E+ T +R
Sbjct: 1017 GTARILGFREDGSTTASTS-AFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQR 1075

Query: 760  PT--DAAFTEGLTLHEFVKMTL---PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
            PT  +   ++ +TL + V+ ++    + ++ ++D    ME+   +S++   +    +D L
Sbjct: 1076 PTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLD----MEL--GDSIVSLKQEEAIEDFL 1129

Query: 815  NAITRTGVLCSMESPFERMEMRDVVAKLCHTR 846
                +  + C+   P +R +M +++  L   R
Sbjct: 1130 ----KLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  363 bits (933), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 301/944 (31%), Positives = 455/944 (48%), Gaps = 149/944 (15%)

Query: 2    NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            N L G +P E+ S + L T + + N L+G LP ++G    L  LL+  N   G+IP  + 
Sbjct: 292  NSLSGPLPLEL-SEIPLLTFSAERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIE 350

Query: 62   LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
                L +L++A N  SG  PR +C   SLE I L+ N  SG++  ++     +L EL LT
Sbjct: 351  DCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIE-EVFDGCSSLGELLLT 409

Query: 122  FCSL-----KNLWWLNL-------------------EQNNLGMGTASS------IPDSLS 151
               +     ++LW L L                   +  NL   TAS       +P  + 
Sbjct: 410  NNQINGSIPEDLWKLPLMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIG 469

Query: 152  NASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLK 211
            NA++L+RL LS NQ  G++  +   L +L  LNL  N        +L       +C+SL 
Sbjct: 470  NAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELG------DCTSLT 523

Query: 212  ALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALT-------- 263
             L L  N   G++P  I  L+       +  N +SG+IPS      + I +         
Sbjct: 524  TLDLGSNNLQGQIPDKITALAQLQC-LVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHH 582

Query: 264  ----IEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQG 319
                +  N+L G IP+ +GE   L ++ +  N L G IP SL  LT L  L LS N L G
Sbjct: 583  GIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTG 642

Query: 320  NIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKN 379
            +IP  +GN   L+G + ++N+L G IP+    + +L V L L  N L+  +P  +GNLK 
Sbjct: 643  SIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSL-VKLNLTKNKLDGPVPASLGNLKE 701

Query: 380  L-----------------VITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLS 422
            L                 + T   L  L I  N F G IP  LG +  ++ L+VS N LS
Sbjct: 702  LTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLS 761

Query: 423  GQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCG---GIDELHLL 479
            G+IP  +  L  LEFLNL+ N+L GEVP+ GV  + +K  L  N +LCG   G D     
Sbjct: 762  GEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSD----- 816

Query: 480  SCPSKGSR-KPKLTLLKVLIPVVVSCLILSSCLTIVFARRRRSAHKSVDT---------- 528
             C  +G++ +    +  +++   +   +       VF+ RR +  K V            
Sbjct: 817  -CKIEGTKLRSAWGIAGLMLGFTIIVFVF------VFSLRRWAMTKRVKQRDDPERMEES 869

Query: 529  -------------SPAKKQFPM-------------ISYAELSKATSEFASSNMIGQGSFG 562
                         S ++ + P+             +   ++ +AT  F+  N+IG G FG
Sbjct: 870  RLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFG 929

Query: 563  SVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA 622
            +VYK  L GE+ +   K+   K +G  R F+AE E L  ++H NL+ ++  CS      +
Sbjct: 930  TVYKACLPGEKTVAVKKLSEAKTQGN-REFMAEMETLGKVKHPNLVSLLGYCSF-----S 983

Query: 623  DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVH 682
            + K LV+EYM NGSL+ WL      LEV  L   +R+ IA+  A  + +LHH   P I+H
Sbjct: 984  EEKLLVYEYMVNGSLDHWLRNQTGMLEV--LDWSKRLKIAVGAARGLAFLHHGFIPHIIH 1041

Query: 683  GDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMT 741
             D+K SN+LLD D      +F L+ +L SA ++  S++ I GT GY+ PEYG  + A+  
Sbjct: 1042 RDIKASNILLDGDFEPKVADFGLA-RLISACESHVSTV-IAGTFGYIPPEYGQSARATTK 1099

Query: 742  GDVYSFGILLLEMFTGRRPTDAAF--TEGLTLHEFVKMTLPE-KVIEIVDPSLLMEVMAN 798
            GDVYSFG++LLE+ TG+ PT   F  +EG  L  +    + + K ++++DP LL+ V   
Sbjct: 1100 GDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDP-LLVSVALK 1158

Query: 799  NSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL 842
            NS ++             + +  +LC  E+P +R  M DV+  L
Sbjct: 1159 NSQLR-------------LLQIAMLCLAETPAKRPNMLDVLKAL 1189

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  363 bits (931), Expect = 4e-99,   Method: Compositional matrix adjust.
 Identities = 283/893 (31%), Positives = 440/893 (49%), Gaps = 107/893 (11%)

Query: 1    KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
            +N+L G+IP  +G++  L+ LA+  NY TG +P  +G L+ +  L +  N L G+IP  +
Sbjct: 244  QNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREI 303

Query: 61   GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
            G L +   ++ +ENQ +G  P+   +I +L+ ++L  N   G +P +       L EL L
Sbjct: 304  GNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRE-------LGELTL 356

Query: 121  TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
                   L  L+L  N L      +IP  L     L  L L  NQ +GK+        N 
Sbjct: 357  -------LEKLDLSINRLN----GTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNF 405

Query: 181  WWLNLEQNNL-GMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFR 239
              L++  N+L G   A+   F TL+        LSL  N+  G +P  +    S + +  
Sbjct: 406  SVLDMSANSLSGPIPAHFCRFQTLIL-------LSLGSNKLSGNIPRDLKTCKS-LTKLM 457

Query: 240  IGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP 299
            +G NQ++G++P  + NL NL AL +  N L G I   +G+L++L++L +  N   G IPP
Sbjct: 458  LGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPP 517

Query: 300  SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVY- 358
             +GNLTK+    +S N L G+IP  LG+C  ++  D S NK +G I Q++  +  L +  
Sbjct: 518  EIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILR 577

Query: 359  ----------------------LALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNS 396
                                  L L  NLL++++P+++G L +L I+      L+IS N+
Sbjct: 578  LSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQIS------LNISHNN 631

Query: 397  FHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFS 456
              G IP SLG ++ ++ L ++ N LSG+IP  + NL  L   N+S N+L G VP   VF 
Sbjct: 632  LSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQ 691

Query: 457  NKTKISLQVNVKLCGGIDELHLLSCPSKGS----------RKPKLTLLKVLIPVVVSCLI 506
                 +   N  LC           P   S          R+  LT+  ++I  V     
Sbjct: 692  RMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITF 751

Query: 507  LSSCLTIVFARRRRSAHKSVD--TSP---AKKQFPM--ISYAELSKATSEFASSNMIGQG 559
            L  C TI   +RR  A  +++  T P       FP    +Y  L  AT  F+   ++G+G
Sbjct: 752  LGLCWTI---KRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRG 808

Query: 560  SFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITICSSI 617
            + G+VYK  + G E ++AVK +N + +GA    SF AE   L  IRHRN++K+   C   
Sbjct: 809  ACGTVYKAEMSGGE-VIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQ 867

Query: 618  DSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQ 677
            +S       L++EYM  GSL + L +   +   C L    R  IA+  A  + YLHH C+
Sbjct: 868  NS-----NLLLYEYMSKGSLGEQLQRGEKN---CLLDWNARYRIALGAAEGLCYLHHDCR 919

Query: 678  PPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLD-SASKTPSSSIGIKGTVGYVAPEYGMG 735
            P IVH D+K +N+LLD    AH  +F L+  +D S SK+ S+   + G+ GY+APEY   
Sbjct: 920  PQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSA---VAGSYGYIAPEYAYT 976

Query: 736  SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV--IEIVDPSLLM 793
             + +   D+YSFG++LLE+ TG+ P      +G  L  +V+ ++   +  IE+ D  L  
Sbjct: 977  MKVTEKCDIYSFGVVLLELITGKPPVQ-PLEQGGDLVNWVRRSIRNMIPTIEMFDARL-- 1033

Query: 794  EVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR 846
                      +    RT   ++ + +  + C+  SP  R  MR+VVA +   R
Sbjct: 1034 ----------DTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  360 bits (925), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 287/914 (31%), Positives = 436/914 (47%), Gaps = 117/914 (12%)

Query: 2    NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            N L G IPE +  L+ L  L +  N L G L   + NL+ L  L++  N+L G++P  + 
Sbjct: 370  NSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEIS 429

Query: 62   LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
             LR L  L + EN+FSG  P+ I N +SL+ I +  N F G +P  I      LKEL L 
Sbjct: 430  ALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSI----GRLKELNL- 484

Query: 122  FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
                     L+L QN L  G    +P SL N   L  LDL+ NQ  G +   F  LK L 
Sbjct: 485  ---------LHLRQNELVGG----LPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLE 531

Query: 182  WLNLEQNNLGMGTANDLDFVTLLTN---------------CSSLKALS--LCDNQFGGEL 224
             L L  N+L     + L  +  LT                C S   LS  + +N F  E+
Sbjct: 532  QLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEI 591

Query: 225  PHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQ 284
            P  + N S  + + R+G NQ++G IP  +  +  L  L +  N L G IP  +   + L 
Sbjct: 592  PLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLT 650

Query: 285  QLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGA 344
             + +  NFL G IPP LG L++L +L LS N    ++P+ L NC  L       N L G+
Sbjct: 651  HIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGS 710

Query: 345  IPQQVLSITTLSVY-----------------------LALAHNLLNDSLPLQVGNLKNLV 381
            IPQ++ ++  L+V                        L L+ N L   +P+++G L++L 
Sbjct: 711  IPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQ 770

Query: 382  ITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLS 441
                    LD+S N+F G IP ++G +  ++ L++S N L+G++P  + ++  L +LN+S
Sbjct: 771  ------SALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVS 824

Query: 442  YNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVV 501
            +N+L G++  K  FS     S   N  LCG    L   +     +++  L+   V+I   
Sbjct: 825  FNNLGGKL--KKQFSRWPADSFLGNTGLCG--SPLSRCNRVRSNNKQQGLSARSVVIISA 880

Query: 502  VSCLILSSCLTIVFA---RRR---------------------RSAHKSVDTSPAKKQFPM 537
            +S L     + +V A   ++R                     ++ HK +  + A K    
Sbjct: 881  ISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSD-- 938

Query: 538  ISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECE 597
            I + ++ +AT   +   MIG G  G VYK  L   E +   K++      + +SF  E +
Sbjct: 939  IRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVK 998

Query: 598  ALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK--LTL 655
             L  IRHR+L+K++  CS   SK      L++EYM+NGS+ DWLH+    LE  K  L  
Sbjct: 999  TLGRIRHRHLVKLMGYCS---SKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDW 1055

Query: 656  IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQL-DSASK 713
              R+ IA+ +A  +EYLHH C PPIVH D+K SNVLLD +M AH  +F L+  L ++   
Sbjct: 1056 EARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDT 1115

Query: 714  TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHE 773
               S+     + GY+APEY    +A+   DVYS GI+L+E+ TG+ PTD+ F   + +  
Sbjct: 1116 NTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVR 1175

Query: 774  FVKMTLP---EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPF 830
            +V+  L        +++DP L         ++  +  A  Q     +    + C+  SP 
Sbjct: 1176 WVETHLEVAGSARDKLIDPKL-------KPLLPFEEDAACQ-----VLEIALQCTKTSPQ 1223

Query: 831  ERMEMRDVVAKLCH 844
            ER   R     L H
Sbjct: 1224 ERPSSRQACDSLLH 1237

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  356 bits (914), Expect = 4e-97,   Method: Compositional matrix adjust.
 Identities = 274/916 (29%), Positives = 454/916 (49%), Gaps = 118/916 (12%)

Query: 1    KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
            +N + G++P+EIG L+ LQ + +  N  +G +P  +GNL++L  L +  NSL G IP+ +
Sbjct: 238  QNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEI 297

Query: 61   GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
            G +++L  L + +NQ +G  P+ +  +S +  I  + N  SG +P    V L  + EL L
Sbjct: 298  GNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIP----VELSKISELRL 353

Query: 121  TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
             +          L QN L       IP+ LS   NL +LDLS N   G +   F +L ++
Sbjct: 354  LY----------LFQNKL----TGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSM 399

Query: 181  WWLNLEQNNL------GMGTANDLDFVTLLTN----------C--SSLKALSLCDNQFGG 222
              L L  N+L      G+G  + L  V    N          C  S+L  L+L  N+  G
Sbjct: 400  RQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFG 459

Query: 223  ELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQH 282
             +P  +    S ++Q R+ GN+++G  P+ +  LVNL A+ ++ N+  G +P  +G  Q 
Sbjct: 460  NIPPGVLRCKS-LLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQK 518

Query: 283  LQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT 342
            LQ+L++  N    ++P  +  L+ L    +S N+L G IPS + NC+ L+  D S N   
Sbjct: 519  LQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFI 578

Query: 343  GAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNL-------------------VIT 383
            G++P ++ S+  L + L L+ N  + ++P  +GNL +L                   +++
Sbjct: 579  GSLPPELGSLHQLEI-LRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLS 637

Query: 384  CVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYN 443
             + +  +++S N F G IP  +G +  +  L++++N+LSG+IP   +NLS L   N SYN
Sbjct: 638  SLQIA-MNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYN 696

Query: 444  HLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSCPSKGSRKPKLTLLK-------- 495
            +L G++P   +F N T  S   N  LCGG    HL SC    S  P ++ LK        
Sbjct: 697  NLTGQLPHTQIFQNMTLTSFLGNKGLCGG----HLRSCDPSHSSWPHISSLKAGSARRGR 752

Query: 496  --------------VLIPVVVSCLILSSCLTIVFARRRRSAHKSVDTSPAKKQFPMISYA 541
                          +LI +VV  L      T  +   +    +  D     K+    +  
Sbjct: 753  IIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKE--RFTVK 810

Query: 542  ELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKV------INLKQKGAFRSFVAE 595
            ++ +AT  F  S ++G+G+ G+VYK ++   + I   K+       N        SF AE
Sbjct: 811  DILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAE 870

Query: 596  CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL 655
               L  IRHRN++++ + C     +G++   L++EYM  GSL + LH    H     +  
Sbjct: 871  ILTLGKIRHRNIVRLYSFCY---HQGSNSNLLLYEYMSRGSLGELLHGGKSH----SMDW 923

Query: 656  IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSA-SK 713
              R  IA+  A  + YLHH C+P I+H D+K +N+L+D +  AH  +F L+  +D   SK
Sbjct: 924  PTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSK 983

Query: 714  TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHE 773
            + S+   + G+ GY+APEY    + +   D+YSFG++LLE+ TG+ P      +G  L  
Sbjct: 984  SVSA---VAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQ-PLEQGGDLAT 1039

Query: 774  FVKMTLPEKVI--EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFE 831
            + +  + +  +  EI+DP L        + +++D      + +  +T+  VLC+  SP +
Sbjct: 1040 WTRNHIRDHSLTSEILDPYL--------TKVEDD---VILNHMITVTKIAVLCTKSSPSD 1088

Query: 832  RMEMRDVVAKLCHTRE 847
            R  MR+VV  L  + E
Sbjct: 1089 RPTMREVVLMLIESGE 1104

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  355 bits (912), Expect = 7e-97,   Method: Compositional matrix adjust.
 Identities = 271/848 (31%), Positives = 405/848 (47%), Gaps = 98/848 (11%)

Query: 2    NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            N L G IP   G+L  L  L +  N L+G +P  +GNL  L  L +  N+L G+IP++ G
Sbjct: 200  NLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFG 259

Query: 62   LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
             L+N+  LN+ ENQ SG  P  I N+++L+ + L  N+ +G +P               T
Sbjct: 260  NLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPS--------------T 305

Query: 122  FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
              ++K L  L+L  N L      SIP  L    ++  L++S N+  G V   F  L  L 
Sbjct: 306  LGNIKTLAVLHLYLNQLN----GSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALE 361

Query: 182  WLNLEQNNL------GMGTANDLDFVTLLTN----------C--SSLKALSLCDNQFGGE 223
            WL L  N L      G+  + +L  + L TN          C    L+ L+L DN F G 
Sbjct: 362  WLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGP 421

Query: 224  LPHSIANLSSTMIQFRIGGNQISGTIPS--GIRNLVNLIALTIEVNQLHGIIPDGVGELQ 281
            +P S+ +  S +I+ R  GN  SG I    G+   +N I L+   N  HG +     + Q
Sbjct: 422  VPKSLRDCKS-LIRVRFKGNSFSGDISEAFGVYPTLNFIDLS--NNNFHGQLSANWEQSQ 478

Query: 282  HLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKL 341
             L    +  N + G+IPP + N+T+L+ L LS N + G +P S+ N   +     + N+L
Sbjct: 479  KLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRL 538

Query: 342  TGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVS--------------- 386
            +G IP  +  +T L  YL L+ N  +  +P  + NL  L    +S               
Sbjct: 539  SGKIPSGIRLLTNLE-YLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKL 597

Query: 387  --LEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNH 444
              L+ LD+S N   G I      +++++ L++S NNLSGQIP   +++  L  +++S+N+
Sbjct: 598  SQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNN 657

Query: 445  LEGEVPTKGVFSNKTKISLQVNVKLCGGIDELH-LLSC---PSKGSRKPKLTLLKVLIPV 500
            L+G +P    F N    + + N  LCG ++    L  C    SK S K +  ++ +L+P+
Sbjct: 658  LQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPI 717

Query: 501  VVSCLILSSC--LTIVFARRRRSAHKSVDTSPAKKQFPMIS------YAELSKATSEFAS 552
            + + +ILS C  + I F +R +   +  D+    +   + S      Y E+ KAT EF  
Sbjct: 718  IGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDP 777

Query: 553  SNMIGQGSFGSVYKGILGGEEMIVAVKVIN------LKQKGAFRSFVAECEALRNIRHRN 606
              +IG G  G VYK  L     I+AVK +N      +      + F+ E  AL  IRHRN
Sbjct: 778  KYLIGTGGHGKVYKAKL--PNAIMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRN 835

Query: 607  LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
            ++K+   CS    +   F  LV+EYME GSL   L   +   E  KL   +R+N+   VA
Sbjct: 836  VVKLFGFCS---HRRNTF--LVYEYMERGSLRKVLENDD---EAKKLDWGKRINVVKGVA 887

Query: 667  SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTV 725
             A+ Y+HH   P IVH D+   N+LL  D  A   +F  +  L   S   S+   + GT 
Sbjct: 888  HALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSA---VAGTY 944

Query: 726  GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFT-------EGLTLHEFVKMT 778
            GYVAPE     + +   DVYSFG+L LE+  G  P D   T         L+L       
Sbjct: 945  GYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHR 1004

Query: 779  LPEKVIEI 786
            LPE   EI
Sbjct: 1005 LPEPTPEI 1012

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	854
359482058	1040	PREDICTED: probable LRR receptor-like se	0.973	0.799	0.474	0.0
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.973	0.436	0.471	0.0
357484501	1006	Kinase-like protein [Medicago truncatula	0.969	0.823	0.479	0.0
357497603	1027	CCP [Medicago truncatula] gi|355494105|g	0.971	0.808	0.477	0.0
224081190	1011	predicted protein [Populus trichocarpa]	0.969	0.818	0.465	0.0
357484499	1121	Receptor kinase-like protein [Medicago t	0.969	0.738	0.470	0.0
357484467	1030	Kinase-like protein [Medicago truncatula	0.968	0.802	0.457	0.0
357484491	1746	Kinase-like protein [Medicago truncatula	0.966	0.472	0.465	0.0
224127492	1022	predicted protein [Populus trichocarpa]	0.976	0.816	0.452	0.0
357487613	1033	Kinase-like protein [Medicago truncatula	0.969	0.801	0.461	0.0

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  751 bits (1939), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/893 (47%), Positives = 567/893 (63%), Gaps = 62/893 (6%)

Query: 2    NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            N L G+IP  +GS   +  + + +N LTG +PD +GNL+++  L    N L G IP  LG
Sbjct: 163  NNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALG 222

Query: 62   LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
             L+ L ++ +  N FSG+ P  + N+SSLE   L  N+  GSLP+D+   LPNL+     
Sbjct: 223  QLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQ----- 277

Query: 122  FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
                     LN+  N+       S+P SLSNASNL   D++ + F GKVSIDF  + NLW
Sbjct: 278  --------VLNIGNNDF----TGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLW 325

Query: 182  WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
             L L  N LG G A+DL F+  L  C +LK L L  +QFGG LP+SIANLS+ +++ ++ 
Sbjct: 326  GLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLD 385

Query: 242  GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
             NQ+SGTIP GI NLVNL  L +  N   G IP  +G LQ L ++ + RN L G IP SL
Sbjct: 386  NNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSL 445

Query: 302  GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
            GN+T+L  L L  N+L G IPSS GN   L+  D S+N L G IP++V+ + +L++ L L
Sbjct: 446  GNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNL 505

Query: 362  AHNLLNDSLPLQVGNLKNL-----------------VITCVSLEYLDISSNSFHGVIPFS 404
            A N L   LP +V  LKNL                 + +C++LE+L +  N F G IP S
Sbjct: 506  ARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPS 565

Query: 405  LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQ 464
               ++ + +L++S NNLSGQIPEFLQ LS L  LNLS+N+ EG++PTKGVF+N T  S+ 
Sbjct: 566  FISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVA 624

Query: 465  VNVKLCGGIDELHLLSC----PSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRR 520
             N KLCGGI ELHL +C    P  G  K  L L+  L+   +  +++ S L  V  R RR
Sbjct: 625  GNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLL--VINRLRR 682

Query: 521  SAHKSVDTSPAKKQFPM-ISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVK 579
               +   TS + K   + +SY  L KAT  F+S+N+IG G FGSVYKGILG +E +VAVK
Sbjct: 683  VKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVK 742

Query: 580  VINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLED 639
            VI L Q+GA +SF AECEALRNIRHRNL+K++T CSS+D +G DFKALV+E+M NGSLE+
Sbjct: 743  VIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLEN 802

Query: 640  WLH------QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD 693
            WLH      + ND L +  L+L QR+NIAIDVASA++YLHHHC  PIVH DLKPSN+LLD
Sbjct: 803  WLHPVPTPDEINDVLRI--LSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLD 860

Query: 694  HDMVAH-QNFSLSHQLDSAS----KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFG 748
            +DM AH  +F L+  +  A+     + SSSIG+KGT+GY APEYGMG++ S  GD YS+G
Sbjct: 861  NDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYG 920

Query: 749  ILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLME-------VMANNSM 801
            ILLLEMFTG+RPT++ F++ L LH FVKM LPE++ +I+DP  L           A++S 
Sbjct: 921  ILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSN 980

Query: 802  IQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRRV 854
            +   +R +  +CL +I R GV CS+ESP ERM + + + +L   R+  LG  V
Sbjct: 981  LAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLGNGV 1033

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  744 bits (1921), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/893 (47%), Positives = 565/893 (63%), Gaps = 62/893 (6%)

Query: 2    NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            N L G+IP  +GS   +  + + +N LTG +PD +GNL+++  L    N L G IP  LG
Sbjct: 194  NNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALG 253

Query: 62   LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
             L+ L ++ +  N FSG+ P  + N+SSLE   L  N+  GSLP+D+   LPNL+ L   
Sbjct: 254  QLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVL--- 310

Query: 122  FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
                      N+  N+        +P SLSNASNL   D++ + F GKVSIDF  + NLW
Sbjct: 311  ----------NIGNNDF----TGPLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLW 356

Query: 182  WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
             L L  N LG G A+DL F+  L  C +LK L L  +QFGG LP+SIANLS+ +++ ++ 
Sbjct: 357  GLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLD 416

Query: 242  GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
             NQ+SGTIP GI NLVNL  L +  N   G IP  +G LQ L ++ + RN L G IP SL
Sbjct: 417  NNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSL 476

Query: 302  GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
            GN+T+L  L L  N+L G IPSS GN   L+  D S+N L G IP++V+ + +L++ L L
Sbjct: 477  GNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNL 536

Query: 362  AHNLLNDSLPLQVGNLKNL-----------------VITCVSLEYLDISSNSFHGVIPFS 404
            A N L   LP +V  LKNL                 + +C++LE+L +  N F G IP S
Sbjct: 537  ARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPS 596

Query: 405  LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQ 464
               ++ + +L++S NNLSGQIPEFLQ LS L  LNLS+N+ EG++PTKGVF+N T  S+ 
Sbjct: 597  FISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVA 655

Query: 465  VNVKLCGGIDELHLLSC----PSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRR 520
             N KLCGGI ELHL +C    P  G  K  L L+  L+   +  +++ S L  V  R RR
Sbjct: 656  GNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLL--VINRLRR 713

Query: 521  SAHKSVDTSPAKKQFPM-ISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVK 579
               +   TS + K   + +SY  L KAT  F+S+N+IG G FGSVYKG LG +E +VAVK
Sbjct: 714  VKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVK 773

Query: 580  VINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLED 639
            VI L Q+GA +SF AECEALRNIRHRNL+K++T CSS+D +G DFKALV+E+M NGSLE+
Sbjct: 774  VIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLEN 833

Query: 640  WLH------QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD 693
            WLH      + ND L +  L+L QR+NIAIDVASA++YLHHHC  PIVH DLKPSN+LLD
Sbjct: 834  WLHPVPTPDEINDVLRI--LSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLD 891

Query: 694  HDMVAH-QNFSLSHQLDSAS----KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFG 748
            +DM AH  +F L+  +  A+     + SSSIG+KGT+GY APEYGMG++ S  GD YS+G
Sbjct: 892  NDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYG 951

Query: 749  ILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLME-------VMANNSM 801
            ILLLEMFTG+RPT++ F++ L LH FVKM LPE++ +I+DP  L           A++S 
Sbjct: 952  ILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSN 1011

Query: 802  IQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRRV 854
            +   +R +  +CL +I R GV CS+ESP ERM + + + +L   R+  LG  +
Sbjct: 1012 LAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLGNGI 1064

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357484501|ref|XP_003612538.1| Kinase-like protein [Medicago truncatula] gi|355513873|gb|AES95496.1| Kinase-like protein [Medicago truncatula]

 Score =  742 bits (1915), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 418/872 (47%), Positives = 558/872 (63%), Gaps = 44/872 (5%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N + G+IP EIGSL  LQ + +  N LTG  P F+GNLS+L  + + +N+L G+IP  + 
Sbjct: 142 NNVIGKIPIEIGSLKKLQLINVWGNNLTGGFPSFIGNLSSLIGIAVTYNNLKGEIPQEIC 201

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
            L+N+  L+V EN  SGMFP  + NISSL  + LT N+F GSLP ++   LPNL    + 
Sbjct: 202 NLKNIRRLHVGENNLSGMFPSCLYNISSLTQLSLTENKFIGSLPSNLFNTLPNLNMFQIG 261

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
               KN ++              S+P S+ NAS+L+ LDL+ N   G+V      L++L+
Sbjct: 262 ----KNQFF-------------GSMPISIVNASSLQLLDLAQNYLVGQVP-SLEKLQDLY 303

Query: 182 WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
           WLNLE N  G  +  DL+F+  LTNCS L+ +S+C+N+FGG LP+SI +LS+ + +  +G
Sbjct: 304 WLNLEDNYFGNNSTIDLEFLKYLTNCSKLEVVSICNNKFGGSLPNSIGSLSTQLTELCLG 363

Query: 242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
           GN ISG IP  I NLV LI L I+ N   GIIP   G+ Q +Q L +  N L G IPP +
Sbjct: 364 GNLISGKIPVEIGNLVELILLAIDFNHFEGIIPTSFGKFQKMQYLALSGNKLSGYIPPFI 423

Query: 302 GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
           GNL++L  L L  N  QGNIP S+ NCQ L+  D SHNKL+G IP ++  I +LS  L L
Sbjct: 424 GNLSQLFKLDLYRNMFQGNIPPSIENCQKLQYLDLSHNKLSGTIPSEIFHIFSLSNLLNL 483

Query: 362 AHNLLNDSLPLQVGNLKNL-----------------VITCVSLEYLDISSNSFHGVIPFS 404
           +HN L+ SLP +VG LKN+                 +  C +LEYL +  NSF+G IP S
Sbjct: 484 SHNFLSGSLPREVGLLKNIDWLDVSENHLSGDIPTTIGDCTALEYLHLQGNSFNGTIPSS 543

Query: 405 LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQ 464
           L  ++ ++ L++S N LSG IP+ +QN+S LE+LN+S+N LEGEVP  GVF N TK+ L 
Sbjct: 544 LASLEGLQHLDLSRNRLSGSIPDVMQNISVLEYLNVSFNMLEGEVPKNGVFGNVTKVELI 603

Query: 465 VNVKLCGGIDELHLLSCPSKG---SRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRRS 521
            N KLCGGI  LHL  CP KG   ++  K  L+ V++ VV   LILS  +TI + R+R +
Sbjct: 604 GNNKLCGGILLLHLPPCPIKGRKDTKHHKFMLVAVIVSVVFFLLILSFIITIYWVRKRNN 663

Query: 522 AHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI 581
             +S+D SP   Q   +SY +L   T+ F+S N+IG GSFGSVYKG L  E   VAVKV+
Sbjct: 664 K-RSID-SPTIDQLATVSYQDLHHGTNGFSSRNLIGSGSFGSVYKGNLVSENNAVAVKVL 721

Query: 582 NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL 641
           NL++KGA +SF+ EC  L+NIRHRNL+KI+T CSSID K  +FKALVF Y++NGSLE WL
Sbjct: 722 NLQKKGAHKSFIVECNVLKNIRHRNLVKILTCCSSIDYKVQEFKALVFYYIKNGSLEQWL 781

Query: 642 HQSNDHLEVCK-LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH- 699
           H    + E  K L L  R+NI IDVAS + YLH  C+  ++H DLKPSNVLLD DMVAH 
Sbjct: 782 HPEFLNEEHPKTLDLGHRLNIIIDVASTLHYLHQECEQLVIHCDLKPSNVLLDDDMVAHV 841

Query: 700 QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRR 759
            +F ++ +L SA+   +S+IGIKGTVGY  PEYGMGSE S  GD+YSFGIL+LEM TGRR
Sbjct: 842 TDFGIA-KLVSATSGNTSTIGIKGTVGYAPPEYGMGSEVSTYGDMYSFGILMLEMLTGRR 900

Query: 760 PTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITR 819
           PTD  F +G  LH FV ++ P+ +I I+DP LL      +    E+     ++CL ++ R
Sbjct: 901 PTDEVFEDGQNLHNFVAISFPDNLINILDPHLLSRDAVEDGN-NENLIPTVKECLVSLFR 959

Query: 820 TGVLCSMESPFERMEMRDVVAKLCHTRETFLG 851
            G++C++ESP ERM   DV  +L   R+ FL 
Sbjct: 960 IGLICTIESPKERMNTVDVTRELNIIRKAFLA 991

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357497603|ref|XP_003619090.1| CCP [Medicago truncatula] gi|355494105|gb|AES75308.1| CCP [Medicago truncatula]

 Score =  740 bits (1910), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 419/878 (47%), Positives = 559/878 (63%), Gaps = 48/878 (5%)

Query: 2    NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            N L G+IP EIGSL  LQ +++  N+LT  +P F+GNLS L  L +  N+  G+IP  + 
Sbjct: 166  NHLNGKIPIEIGSLKKLQAISVGNNHLTEGIPSFIGNLSCLTRLNLGENNFSGKIPQEIC 225

Query: 62   LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
             L++L  L V+EN  SG  P  + NISSL  + +T N   GS P ++   LPN++     
Sbjct: 226  FLKHLTILGVSENNLSGKIPSCLYNISSLISLTVTQNHLHGSFPPNMFHTLPNIQ----I 281

Query: 122  FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGN-QFKGKVSIDFSSLKNL 180
            F    N +             +  IP S++NAS L+ LDL  N    G+V     +L++L
Sbjct: 282  FAFAANQF-------------SGPIPTSIANASALQILDLGNNMNLVGQVP-SLRNLQDL 327

Query: 181  WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
             +L+LE NNLG  +  DL+F+  LTNCS L  LS+  N FGG LP+SI NLS+ + +  +
Sbjct: 328  SFLSLEVNNLGNNSTMDLEFLKYLTNCSKLYVLSISYNNFGGHLPNSIGNLSTELPELYM 387

Query: 241  GGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS 300
            GGN ISG IP+ +  LV LI LT+E N   GIIP   G+ Q +Q L +  N L G IPP 
Sbjct: 388  GGNMISGKIPAELGRLVGLILLTMESNCFEGIIPTNFGKFQKMQVLSLRENKLSGGIPPF 447

Query: 301  LGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLA 360
            +GNL++L  L L+ N  QG+IP S+GNCQNL+  D SHNKL G IP +VL++ +LS+ L 
Sbjct: 448  IGNLSQLYYLELNHNMFQGSIPPSIGNCQNLQSLDLSHNKLRGTIPVEVLNLFSLSILLN 507

Query: 361  LAHNLLNDSLPLQVGNLKNL-----------------VITCVSLEYLDISSNSFHGVIPF 403
            L+HN L+ SLP +VG LKN+                 +  C SLEY+ +  NSF+G IP 
Sbjct: 508  LSHNSLSGSLPREVGMLKNIEALDVSENHLSGDIPREIGECTSLEYIHLQRNSFNGTIPS 567

Query: 404  SLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISL 463
            SL F+K ++ L++S N LSG IP+ +QN+S LE+LN+S+N LEGEVPT GVF N T+I L
Sbjct: 568  SLTFLKGLRYLDLSRNQLSGSIPDGMQNISVLEYLNVSFNMLEGEVPTNGVFGNATQIDL 627

Query: 464  QVNVKLCGGIDELHLLSCPSKG---SRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRR 520
              N KLCGGI  LHL  CP KG   +++ K  L+ VL+ VV   LILS  +TI +  R+R
Sbjct: 628  IGNKKLCGGISHLHLPPCPIKGRKHAKQHKFRLIAVLVSVVSFILILSFIITI-YMMRKR 686

Query: 521  SAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKV 580
            +  +S D SP   Q   +SY EL   T  F++ NMIG GSFGSVYKG +  E+ +VAVKV
Sbjct: 687  NQKRSFD-SPTIDQLAKVSYQELHVGTDGFSNRNMIGSGSFGSVYKGNIVSEDNVVAVKV 745

Query: 581  INLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDW 640
            +NL++KGA +SF+ EC AL+NIRHRNL+K++T CSS + KG +FKALVFEYM+NGSLE W
Sbjct: 746  LNLQKKGAHKSFIVECNALKNIRHRNLVKVLTCCSSTNYKGQEFKALVFEYMKNGSLEQW 805

Query: 641  LH-QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 699
            LH ++ +      L L  R+NI IDVASA+ YLH  C+  I+H DLKPSNVLLD DMVAH
Sbjct: 806  LHPETLNANPPTTLNLGHRLNIIIDVASALHYLHRECEQLILHCDLKPSNVLLDDDMVAH 865

Query: 700  -QNFSLSHQLDSASKTP---SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMF 755
              +F ++  + + S T    +S+IG+KGTVGY  PEYGMGSE S  GD+YSFGIL+LEM 
Sbjct: 866  VSDFGIARLVSTISGTSNKNTSTIGVKGTVGYAPPEYGMGSEVSTCGDMYSFGILMLEML 925

Query: 756  TGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLL--MEVMANNSMIQEDRRARTQDC 813
            TGRRPTD  F +G  LH FV ++ P+ +I+I+DP LL   E  A      E      +DC
Sbjct: 926  TGRRPTDELFEDGQNLHNFVTISFPDNLIKILDPHLLPRAEEGAIEDGNHEIHIPTIEDC 985

Query: 814  LNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLG 851
              ++ R  +LCS+ESP ERM + DV  +L   ++ FL 
Sbjct: 986  FVSLLRIALLCSLESPKERMNIVDVTRELTTIQKVFLA 1023

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa]

 Score =  724 bits (1870), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 409/879 (46%), Positives = 546/879 (62%), Gaps = 51/879 (5%)

Query: 2    NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            N L G+IP ++GSL  L    +  N L G +P   GNLS++       N L G IP +LG
Sbjct: 156  NNLTGKIPAQLGSLSKLGAFVLQGNNLVGDIPSSFGNLSSVQNFFWTKNYLRGGIPESLG 215

Query: 62   LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
             L+ L Y  VAEN  SG  P  ICNISSL ++ L  N+  GSLP D+ +NLPNL  L + 
Sbjct: 216  NLKRLKYFAVAENDLSGTIPSSICNISSLAYVSLGQNQLHGSLPPDLGLNLPNLAYLVIN 275

Query: 122  FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
            F  L                    IP +LSNAS +  +DLS N   GK+  D +SL +L 
Sbjct: 276  FNHLN-----------------GPIPATLSNASKIFLVDLSYNNLTGKIP-DLASLPDLQ 317

Query: 182  WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
             L +  N+LG G  +DL F+  L N ++L++L + DN FGG LP  ++N S+ +     G
Sbjct: 318  KLLVHHNDLGNGEEDDLSFLYTLANSTNLESLGINDNNFGGVLPEIVSNFSTNLKGITFG 377

Query: 242  GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
             NQI G+IP+ I NL++L  L++E NQLHGIIP  +G+LQ+L  LY+  N + GSIP SL
Sbjct: 378  RNQIHGSIPTEIGNLISLDTLSLETNQLHGIIPSSIGKLQNLAALYLNENKISGSIPSSL 437

Query: 302  GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
            GN+T L +++ + NNLQG IP+SLGN   L   D S N L+G IP++VL I++LSV L L
Sbjct: 438  GNITSLVEVSFAQNNLQGTIPASLGNWHKLLILDLSQNNLSGPIPKEVLGISSLSVLLYL 497

Query: 362  AHNLLNDSLPLQVGNLKNL-----------------VITCVSLEYLDISSNSFHGVIPFS 404
              N L  SLP +VG L NL                 + +C SLE LD+  N F G +P  
Sbjct: 498  HDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEIPKSLDSCKSLEGLDLGGNFFEGPVP-D 556

Query: 405  LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQ 464
            L  +++++ L +S NNLSGQIP+FL++   LE L+LSYN  EGEVP +GVF N ++IS+Q
Sbjct: 557  LSSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDLSYNDFEGEVPEQGVFENTSRISVQ 616

Query: 465  VNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFA--RRRRSA 522
             N KLCGGI +L L  C S    +PK +  K+++ + + C  L   L   F     R++ 
Sbjct: 617  GNKKLCGGIPQLDLPKCTSNEPARPK-SHTKLILIIAIPCGFLGIVLMTSFLLFYSRKTK 675

Query: 523  HKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN 582
             +       +  F  ++Y +L +AT  F+SSN++G G+FGSVY+G L  +  +VAVKV+N
Sbjct: 676  DEPASGPSWESSFQRLTYQDLLQATDGFSSSNLVGAGAFGSVYRGTLTSDGAVVAVKVLN 735

Query: 583  LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            L +KGA +SF+AEC AL NIRHRNL+K+IT CSS D +G DFKALV+E+M NGSLE+WLH
Sbjct: 736  LLRKGASKSFMAECAALINIRHRNLVKVITACSSNDFQGNDFKALVYEFMVNGSLEEWLH 795

Query: 643  Q---SNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 699
                S+   E   L L+QR+NIAIDVASA++YLH+HCQ P+VH DLKPSNVLL  DM A 
Sbjct: 796  PVHISDVTPETRNLDLVQRLNIAIDVASALDYLHNHCQVPVVHCDLKPSNVLLGDDMTAC 855

Query: 700  -QNFSLSHQLDSASK----TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
              +F L+  L  AS       SSS+G+KGT+GY APEYGMGSE S  GDVYS+GILLLEM
Sbjct: 856  VGDFGLARFLPEASNQLPADESSSVGLKGTIGYAAPEYGMGSEVSTYGDVYSYGILLLEM 915

Query: 755  FTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
            FTGRRPTD  F +G  LH + KM LP+ V+E VDP+L      +  M   D   +  +C+
Sbjct: 916  FTGRRPTDGMFKDGHNLHNYAKMVLPDNVLEFVDPTL----REHEEMNHNDDSHKVMECM 971

Query: 815  NAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRR 853
             +I + G+ CS E P ERM + +VV +L   RE   GR+
Sbjct: 972  VSIIKVGLACSAELPGERMGIANVVVELHRIREMLDGRK 1010

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357484499|ref|XP_003612537.1| Receptor kinase-like protein [Medicago truncatula] gi|355513872|gb|AES95495.1| Receptor kinase-like protein [Medicago truncatula]

 Score =  717 bits (1851), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 416/884 (47%), Positives = 558/884 (63%), Gaps = 56/884 (6%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           NKL G+IP EIG L  LQ+L++  N LTG +   +GNLS+L +  +  N+L G IP  + 
Sbjct: 135 NKLIGKIPIEIGYLKKLQSLSVWNNNLTGGISSSIGNLSSLMLFSVPSNNLEGDIPQEIC 194

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
            L+NL  L +  N  SGM P  I N+S L  + L +N F+GSLPF++  NLPNL      
Sbjct: 195 RLKNLRGLYMGVNYLSGMVPSCIYNMSLLTELSLVMNNFNGSLPFNMFHNLPNLI----- 249

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSG-NQFKGKVSIDFSSLKNL 180
                 ++   + Q          IP S++NAS L+ LDL   N   G+V  +   L++L
Sbjct: 250 ------IFEFGVNQ------FTGPIPISIANASALQSLDLGDQNNLVGQVP-NLGKLQDL 296

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
             LNL+ NNLG  +A DL F+  LTNC+ LK  S+  N FGG  P+SI NLS+ + Q  I
Sbjct: 297 QRLNLQSNNLGNNSAIDLMFLRYLTNCTKLKLFSIAGNNFGGNFPNSIGNLSAELKQLYI 356

Query: 241 GGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS 300
           G NQISG IP+ + +LV LI L +  N   GIIP   G+ Q +Q L +  N L G IPP 
Sbjct: 357 GENQISGKIPAELGHLVGLILLAMNFNHFEGIIPTTFGKFQKMQVLILSGNKLSGDIPPF 416

Query: 301 LGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLA 360
           +GNL++L DL L+FN  QGNIP ++GNCQNL+  D S+NK  G+IP +V S+++LS  L 
Sbjct: 417 IGNLSQLFDLELNFNMFQGNIPPTIGNCQNLQVLDLSYNKFNGSIPLEVFSLSSLSNLLD 476

Query: 361 LAHNLLNDSLPLQVGNLKNL-----------------VITCVSLEYLDISSNSFHGVIPF 403
           L+HN L+ S+P +VG LKN+                 +  C +LEYL +  NSF G IP 
Sbjct: 477 LSHNTLSGSIPREVGMLKNIDMLDLSENRLSGDIPRTIGECTTLEYLQLQGNSFSGTIPS 536

Query: 404 SLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISL 463
           S+  +K ++ L++S N LSG IP+ ++++S LE+LN+S+N LEGEVPT GVF N ++I +
Sbjct: 537 SMASLKGLQSLDLSRNQLSGSIPDVMKSISGLEYLNVSFNLLEGEVPTNGVFGNVSQIEV 596

Query: 464 QVNVKLCGGIDELHLLSCP---SKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRR 520
             N KLCGGI ELHL SCP   SK ++K    L+ V++ V+   LILS  ++I +  R+R
Sbjct: 597 IGNKKLCGGISELHLPSCPIKDSKHAKKHNFKLIAVIVSVISFLLILSFVISICWM-RKR 655

Query: 521 SAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKV 580
           + + S D SP   Q   +SY +L + T  F+  N+IG GSFGSVYKG L  E+ +VAVKV
Sbjct: 656 NQNPSFD-SPTIDQLAKVSYQDLHRGTDGFSERNLIGSGSFGSVYKGNLVTEDNVVAVKV 714

Query: 581 INLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDW 640
           +NLK+KGA +SF+ EC AL+NIRHRNL+KI+T CSS D KG  FKALVF+YM+NGSLE W
Sbjct: 715 LNLKKKGAHKSFIVECNALKNIRHRNLVKILTCCSSTDYKGQTFKALVFDYMKNGSLEQW 774

Query: 641 LH---QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 697
           LH    + DH     L L  R+NI  DVA+A+ YLH  C+  ++H DLKPSNVLLD DMV
Sbjct: 775 LHLEILNADHPRT--LDLGHRLNIMNDVATALHYLHQECEQLVLHCDLKPSNVLLDDDMV 832

Query: 698 AH-QNFSLSH---QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLE 753
           AH  +F ++     +D  S   +S+IGIKGTVGY  PEYGMGSE S +GD+YSFGIL+LE
Sbjct: 833 AHVSDFGIARLVSAIDDTSHKETSTIGIKGTVGYAPPEYGMGSEVSTSGDMYSFGILMLE 892

Query: 754 MFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRA----R 809
           + TGRRPTD  F +G  LH FV  + P  +IEI+DP L  E       IQ+  RA     
Sbjct: 893 ILTGRRPTDEVFQDGQNLHNFVATSFPGNIIEILDPHL--EARDVEVTIQDGNRAILVPG 950

Query: 810 TQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRR 853
            ++ L ++ R G++CSMESP ERM + DV  +L   R+ FL  +
Sbjct: 951 VEESLVSLFRIGLICSMESPKERMNIMDVNQELNTIRKAFLAEK 994

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357484467|ref|XP_003612521.1| Kinase-like protein [Medicago truncatula] gi|355513856|gb|AES95479.1| Kinase-like protein [Medicago truncatula]

 Score =  715 bits (1845), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 402/878 (45%), Positives = 551/878 (62%), Gaps = 51/878 (5%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N L G+IP EIGSL  LQ + I  N LTG +P FVGNLS L    +  N+L G IP    
Sbjct: 141 NNLIGKIPIEIGSLKKLQYVTIWKNKLTGGIPSFVGNLSCLTRFSVTSNNLEGDIPQETC 200

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
            L+NL  L +  N  SGM P  + NIS+L  + LT+NRF+GSLP ++   LPNLK     
Sbjct: 201 RLKNLRGLFMGVNYLSGMIPSCLYNISALTELSLTMNRFNGSLPPNMFYTLPNLKSFEPG 260

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
                            G   +  IP S++NAS+L+ +DL  N   G+V      L +L+
Sbjct: 261 -----------------GNQFSGPIPVSIANASSLQIIDLGQNNLVGQVP-SLEKLPDLY 302

Query: 182 WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
           WL+LE N  G  +  DL+F+  LTNCS L+ LS+ +N+FGG LP+ I NLS+ + Q  +G
Sbjct: 303 WLSLEYNYFGNNSTIDLEFLKYLTNCSKLEKLSISNNKFGGSLPNFIGNLSTHLRQLYLG 362

Query: 242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
           GN I+G IP  I NLV L  L++E+NQ  GI+P  +G+ Q++Q L +  N L G IPP +
Sbjct: 363 GNMITGKIPMEIGNLVGLTLLSMELNQFDGIVPSTLGKFQNMQILDLSENKLSGYIPPFI 422

Query: 302 GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
           GNL++L  LA+  N  QGNIP S+GNCQ L+  D SHNKL+G+IP ++ ++  LS  L L
Sbjct: 423 GNLSQLFRLAVHSNMFQGNIPPSIGNCQKLQYLDLSHNKLSGSIPLEIFNLFYLSNLLNL 482

Query: 362 AHNLLNDSLPLQVGNLKNL-----------------VITCVSLEYLDISSNSFHGVIPFS 404
           +HN L+ SLP +VG LKN+                 V  C+SLEYL +  NSF+G IP S
Sbjct: 483 SHNSLSGSLPREVGMLKNINMLDVSENQLSSYLPRTVGECISLEYLLLQGNSFNGTIPSS 542

Query: 405 LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQ 464
           L  +K ++ L++S+N LSG IP+ +Q++S LE LN+S+N LEGEVPT GVF N +K+++ 
Sbjct: 543 LASLKGLRYLDLSTNQLSGSIPDVMQDISCLEHLNVSFNMLEGEVPTNGVFRNASKVAMI 602

Query: 465 VNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVV--VSCLILSSCLTIVFARRRRSA 522
            N KLCGGI +LHL  CP KG + PK  + +++  +V  VS L++   +  ++  R+ + 
Sbjct: 603 GNNKLCGGISQLHLAPCPIKGRKHPKHHIFRLIAVIVSMVSFLLIFLFIITIYWVRKINQ 662

Query: 523 HKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN 582
            +S D SP   Q   +S+ +L + T  F+  N+IG GSFG VY+G L  E+ +VA+KV N
Sbjct: 663 KRSFD-SPPNDQEAKVSFRDLYQGTDGFSDRNLIGSGSFGDVYRGNLVSEDNVVAIKVFN 721

Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           L+  GA +SF+ EC AL+ IRHRNL+KI+T CSS D KG +FKALVF+YM+NGSLE WLH
Sbjct: 722 LQNNGAHKSFIVECNALKFIRHRNLVKILTCCSSTDYKGQEFKALVFDYMKNGSLEQWLH 781

Query: 643 QSNDHLE-VCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-Q 700
               + E    L L  R+NI +DV SA+ YLH+ C+  ++H D+KPSNVLLD DMVAH  
Sbjct: 782 PKVLNEEHTATLDLSHRLNIIMDVGSALHYLHNECEQLVLHCDIKPSNVLLDDDMVAHVS 841

Query: 701 NFSLSH---QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTG 757
           +F ++     +  +S   + +IGIKGTVGY  PEYGMG+E S  GD+YSFGIL+LEM TG
Sbjct: 842 DFGIARLVSAIGGSSHKNTKTIGIKGTVGYAPPEYGMGAEVSTCGDMYSFGILMLEMLTG 901

Query: 758 RRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLL-----MEVMANNSMIQEDRRARTQD 812
           RRPTD AF +   LH FV    P  +I+I+DP L+     +E+    S   E+     ++
Sbjct: 902 RRPTDEAFEDDQNLHNFVATLFPANLIKILDPHLVSKYAEVEIQDGKS---ENLIPSLKE 958

Query: 813 CLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
           CL ++ R G+LCSMESP ERM + DV  +L    + FL
Sbjct: 959 CLVSLFRIGLLCSMESPKERMNIVDVTRELNTIHKAFL 996

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357484491|ref|XP_003612533.1| Kinase-like protein [Medicago truncatula] gi|355513868|gb|AES95491.1| Kinase-like protein [Medicago truncatula]

 Score =  714 bits (1842), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 401/862 (46%), Positives = 540/862 (62%), Gaps = 37/862 (4%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           NKL G++P E+GSL  LQ LAI  N LTG +P F+GNLS L  L + +N+L G IP  + 
Sbjct: 114 NKLIGKLPVEVGSLKRLQILAIGKNNLTGGIPSFMGNLSCLWGLSVPYNNLDGVIPPEIC 173

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
            L+NL  L    N  SG+ P    NISSL  + LT N+  GSLP ++             
Sbjct: 174 RLKNLTILYADPNNLSGIIPSCFYNISSLIKLSLTSNKILGSLPSNM------------- 220

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
           F +L NL ++ + +N +    +  IP S+  A  L  +D   N   G+V      L+NL 
Sbjct: 221 FHTLFNLQYIAIGRNQI----SGPIPISIEKAHGLTLVDFGTNNLVGQVP-SIGELQNLR 275

Query: 182 WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
           +LNL+ NNLG  +  +L F+  L NC+ L+ +S+ +N FGG  P+S+ NLS+      +G
Sbjct: 276 FLNLQSNNLGENSTKELVFLNSLANCTKLELISIYNNSFGGNFPNSLGNLSTQFSVLDLG 335

Query: 242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
            N ISG IP+ +  LV L  L++  N   GIIP   G  Q +Q+L +  N L G +PP +
Sbjct: 336 VNHISGKIPAELGYLVGLTVLSMGFNHFEGIIPTTFGNFQKMQKLLLGGNKLSGDMPPFI 395

Query: 302 GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
           GNL++L DL L  N  QGNIP S+GNCQNL+  D SHN+ +G IP +V ++  LS  L L
Sbjct: 396 GNLSQLFDLRLELNMFQGNIPPSIGNCQNLQYLDLSHNRFSGTIPVEVFNLFYLSKILDL 455

Query: 362 AHNLLNDSLPLQVGNLKNLVIT---CVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSS 418
           +HN L+ SLP +V  LKN+  T   C+SLEYL +  NS +G IP SL  +K+++ L++S 
Sbjct: 456 SHNSLSGSLPREVSMLKNIPGTIGECMSLEYLHLEGNSINGTIPSSLASLKALRYLDLSR 515

Query: 419 NNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHL 478
           N L G IP+ +Q +  LE LN+S+N LEGEVPT GVF+N + I +  N KLCGGI ELHL
Sbjct: 516 NQLYGPIPDVMQKIYGLEHLNVSFNMLEGEVPTDGVFANASHIDMIGNYKLCGGISELHL 575

Query: 479 LSCPSKGSRKPK---LTLLKVLIPVVVSCLILSSCLTIVFARRRRSAHKSVDTSPAKKQF 535
            SCP KGS+  K     L+ V+  V+   LILS  ++I + R+R    K    SP   Q 
Sbjct: 576 PSCPIKGSKSAKKHNFKLIAVIFSVIFFLLILSFVISICWMRKRN--QKPSFDSPTIDQL 633

Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAE 595
             +SY +L + T  F+  N+IG GSFGSVYKG L  E+ +VAVKV+NLK+KGA +SF+ E
Sbjct: 634 AKVSYQDLHRGTDGFSERNLIGSGSFGSVYKGNLVSEDNVVAVKVLNLKKKGAHKSFIVE 693

Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH---QSNDHLEVCK 652
           C AL+NIRHRNL+KI+T CSS D KG  FKALVF+YM+NGSLE WLH    + DH     
Sbjct: 694 CNALKNIRHRNLVKILTCCSSTDYKGQTFKALVFDYMKNGSLEQWLHLEILNADHPRT-- 751

Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDS- 710
           L L  R+NI IDVA+A+ YLH  C+  I+H DLKPSNVLLD DMVAH  +F ++  +   
Sbjct: 752 LDLGHRLNIMIDVATALHYLHQECEQLIIHCDLKPSNVLLDDDMVAHVTDFGIAKLVSDI 811

Query: 711 --ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG 768
              S   +S++GIKG++GY  PEYGMGSE S  GD+YSFGIL+LEM TGRRPTD  F +G
Sbjct: 812 GITSDKDTSTVGIKGSIGYAPPEYGMGSEVSTCGDMYSFGILMLEMLTGRRPTDEFFQDG 871

Query: 769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMES 828
             LH FV  + P+ +I+I+DP L+     + S+  E+      +CL ++ R G++C+MES
Sbjct: 872 QNLHNFVASSFPDNLIKILDPHLVSRDAEDGSI--ENLIPAVNECLVSLFRIGLVCTMES 929

Query: 829 PFERMEMRDVVAKLCHTRETFL 850
           P ERM + DV  +L   R+TFL
Sbjct: 930 PIERMNIMDVTRELNIIRKTFL 951

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa]

 Score =  713 bits (1840), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 400/884 (45%), Positives = 553/884 (62%), Gaps = 50/884 (5%)

Query: 1    KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
            +  L G++P E+G L  LQ L I+ N   G++P   GNLSA+  +    N+L G IP   
Sbjct: 157  RGNLTGKLPAELGLLSKLQVLTIELNNFVGEIPYSFGNLSAINAIYGSINNLEGSIPNVF 216

Query: 61   GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
            G L+ L  L++  N  SGM P  I N+SSL  +   VN+  GSLP  + + LPNL+    
Sbjct: 217  GQLKRLKILSLGANNLSGMIPPSIFNLSSLTLLSFPVNQLYGSLPHTLGLTLPNLQ---- 272

Query: 121  TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
                       N+  N  G      IP + SNASNL    +  N F GKV    SS  +L
Sbjct: 273  ---------VFNIHTNQFG----GLIPATFSNASNLLSFQIGSNNFNGKVP-PLSSSHDL 318

Query: 181  WWLNLEQNNLGMGTANDLDFV-TLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFR 239
              L +  NNLG G  NDL+FV  L  N +SL+AL   DN FGG LP  ++N S+ +++  
Sbjct: 319  QVLGVGDNNLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSNFSTKLMKMT 378

Query: 240  IGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP 299
               NQI G+IP+ I NL+NL AL +E NQL G+IP  +G+LQ L  L++  N + G IP 
Sbjct: 379  FARNQIRGSIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNGNKISGMIPS 438

Query: 300  SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYL 359
            S+GN+T L  + +  NNL+G+IP SLGN Q L     S N L+G IP++++SI +LS+YL
Sbjct: 439  SMGNMTSLGRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELVSIPSLSMYL 498

Query: 360  ALAHNLLNDSLPLQVGNLKNL-----------------VITCVSLEYLDISSNSFHGVIP 402
             L+ N L  SLP+++  L NL                 + +CVSLE L +  N   G IP
Sbjct: 499  VLSENELTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEENFLQGPIP 558

Query: 403  FSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKIS 462
             +L  +++I+ELN+S NNL+GQIPEFL++   LE LNLS+N  EGEVP +G F N + IS
Sbjct: 559  ITLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQNTSAIS 618

Query: 463  LQVNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTI---VFARRR 519
            +  N KLCGGI +L+L  CPS      K +  K++  +   C  L   L I   +F   R
Sbjct: 619  IFGNKKLCGGIPQLNLTRCPSSEPTNSK-SPTKLIWIIGSVCGFLGVILIISFLLFYCFR 677

Query: 520  RSAHKSVDTSPA-KKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAV 578
            +   K   + P+ +  FP ++Y +L  AT  F+S+N+IG+GSFGSV+KGILG ++++VAV
Sbjct: 678  KKKDKPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAV 737

Query: 579  KVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLE 638
            KV+NL +KGA +SF+AECEAL++IRHRNL+K++T CSSID +G DFKALV+E+M NG+LE
Sbjct: 738  KVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLE 797

Query: 639  DWLH--QSNDHLEVCK-LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 695
            +WLH  Q++D     K L L+ R+NIAI +ASA+ YLHH CQ PI+H DLKPSN+LLD +
Sbjct: 798  EWLHPVQTSDEANGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTN 857

Query: 696  MVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
            M AH  +F L+ +  S +   +SS+G+KGT+GY APEYG+G + S  GDVYS+GILLLEM
Sbjct: 858  MTAHVGDFGLA-RFHSEASNQTSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGILLLEM 916

Query: 755  FTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRR----ART 810
            FTG+RP D  F +GL LH + KM LP++++E+VDP L+ E+ + NS  +           
Sbjct: 917  FTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIGPHEI 976

Query: 811  QDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRRV 854
              CL  I + GV CS+E P ERM++ DVV +L   ++T LG R+
Sbjct: 977  SACLMTIIKMGVACSVELPRERMDIGDVVTELNRIKDTLLGTRM 1020

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357487613|ref|XP_003614094.1| Kinase-like protein [Medicago truncatula] gi|355515429|gb|AES97052.1| Kinase-like protein [Medicago truncatula]

 Score =  713 bits (1840), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 405/877 (46%), Positives = 550/877 (62%), Gaps = 49/877 (5%)

Query: 2    NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            N L G+IP EI SL  LQ L I  N LTG +  F+GNLS+L  L I +N+L G IP  + 
Sbjct: 166  NNLIGKIPIEITSLQKLQVLNIRNNKLTGSVSSFIGNLSSLISLSIGYNNLEGNIPKEVC 225

Query: 62   LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
             L+NL  + +  N+ SG FP  + N+SSL  I    N F+GSLP ++             
Sbjct: 226  RLKNLTGIIMFHNKLSGTFPSCLFNMSSLTMISAAANHFNGSLPHNM------------- 272

Query: 122  FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
            F +L+NL  L +  N +    +  IP S++N S+L    +S N F G V      L++LW
Sbjct: 273  FNTLRNLQTLAIGGNQI----SGPIPTSITNGSSLTSFVISENYFVGHVP-SLGKLQDLW 327

Query: 182  WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
             +N+ QNNLG  +  DL+F+  L NCS L A+S+  N FGG LP+SI NLS+ + Q  +G
Sbjct: 328  MINVGQNNLGKNSTKDLEFLESLKNCSKLIAVSIAYNNFGGSLPNSIGNLSTQLSQLYLG 387

Query: 242  GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
            GN ISG IP  I NLV L  LTIE+NQL GIIP   G+ Q++Q L + RN L G IP +L
Sbjct: 388  GNIISGKIPMEIGNLVGLTLLTIELNQLDGIIPSSFGKFQNMQLLDLSRNKLSGVIPTTL 447

Query: 302  GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
            GNL++L  L L  N LQGNIPSS+GNCQ L+      N L+G IP +V  +++LS+ L L
Sbjct: 448  GNLSQLYYLGLGENMLQGNIPSSIGNCQKLQSIVLFQNNLSGTIPLEVFRLSSLSILLDL 507

Query: 362  AHNLLNDSLPLQV-----------------GNLKNLVITCVSLEYLDISSNSFHGVIPFS 404
            + N  + +LP +V                 GN+   +  C+SLEYL    NSFHG+IP S
Sbjct: 508  SKNSFSGNLPKEVSMLTTIDTLDVSDNQLSGNISETIGECISLEYLYFQGNSFHGIIPSS 567

Query: 405  LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQ 464
            L  ++ ++ L++S N L+G IP  LQN+S LE+LN+S+N L+GEVP +GVF N + +++ 
Sbjct: 568  LASLRGLRYLDLSRNRLTGSIPSVLQNISVLEYLNVSFNMLDGEVPKEGVFGNASALAVT 627

Query: 465  VNVKLCGGIDELHLLSCPSKGSRKPKLT--LLKVLIPVVVSCLILSSCLTIVFARRRRSA 522
             N KLCGGI  LHL  C  K  +K K    LL  +I  V+S +I+   +  ++ RR+R+ 
Sbjct: 628  GNNKLCGGISHLHLPPCRVKRMKKKKHRNFLLMAVIVSVISFVIIMLLIVAIYLRRKRNK 687

Query: 523  HKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN 582
              S D SP   Q PM+SY +L +AT  F+  N+IG G FGSVYKG L  E+ ++AVKV+N
Sbjct: 688  KPSSD-SPTIDQLPMVSYQDLYQATDGFSDRNLIGSGGFGSVYKGNLMSEDKVIAVKVLN 746

Query: 583  LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            L++KGA +SF+ EC AL+NIRHRNL+KI+T CSSID+KG +FKALVFEYM NGSLE WLH
Sbjct: 747  LEKKGAHKSFITECNALKNIRHRNLVKILTCCSSIDNKGLEFKALVFEYMRNGSLEQWLH 806

Query: 643  QSN---DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 699
                  DH    K    QR+NI +DV+SA+ YLHH C+  ++H DLKPSNVL+D D+VAH
Sbjct: 807  PGTMNADHPRTLKFE--QRLNILVDVSSALHYLHHECEQLVLHCDLKPSNVLIDDDIVAH 864

Query: 700  -QNFSLSHQLDSA---SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMF 755
              +F ++  + SA   S   +S+IGIKGT+GY  PEYGM SE S  GD+YSFG+L+LEM 
Sbjct: 865  VSDFGIARLVSSADNNSCQETSTIGIKGTIGYAPPEYGMSSEVSTHGDMYSFGMLILEML 924

Query: 756  TGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRR--ARTQDC 813
            TGRRPTD  FT+G  L  +V+++ P+ +++I+DP ++  V         +R   +    C
Sbjct: 925  TGRRPTDDMFTDGQNLRLYVEISFPDNIMKILDPCIVPRVEEATIDDGSNRHLISTMDKC 984

Query: 814  LNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
              +I R G+ CSMESP ERM + D   +L   R+TFL
Sbjct: 985  FVSIFRIGLACSMESPKERMNIEDATRELNIIRKTFL 1021

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	854
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.967	0.817	0.392	3e-149
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.971	0.822	0.390	3.8e-149
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.966	0.804	0.395	2.8e-146
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.974	0.822	0.378	5.7e-146
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.975	0.812	0.393	1.6e-141
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.960	0.795	0.377	2.8e-137
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.756	0.794	0.384	2.3e-110
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.947	0.825	0.345	2.1e-109
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.933	0.679	0.304	7e-93
UNIPROTKB|P93194	1109	INRPK1 "Receptor-like protein	0.936	0.721	0.310	2.7e-91

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1457 (517.9 bits), Expect = 3.0e-149, P = 3.0e-149
 Identities = 344/876 (39%), Positives = 501/876 (57%)

Query:     2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
             N+L G +P E+GSL NL  L +  N + G+LP  +GNL+ L  L +  N+L G+IP+ + 
Sbjct:   148 NRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVA 207

Query:    62 LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKEL--- 118
              L  +  L +  N FSG+FP  + N+SSL+ + +  N FSG L  D+ + LPNL      
Sbjct:   208 QLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMG 267

Query:   119 --YLTFCSXXXXXXXXXXXXXXGMGT---ASSIPDSLSNASNLERLDLSGNQFKGKVSID 173
               Y T  S              GM       SIP +  N  NL+ L L  N      S D
Sbjct:   268 GNYFTG-SIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSRD 325

Query:   174 FSSXXXXXXXXXXXXXXGMGTANDL--DFVTLLTNCSS-LKALSLCDNQFGGELPHSIAN 230
                              G+G  N L  D    + N S+ L  L L      G +P+ I N
Sbjct:   326 LE-FLTSLTNCTQLETLGIGR-NRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGN 383

Query:   231 LSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFR 290
             L +   +  +  N +SG +P+ +  L+NL  L++  N+L G IP  +G +  L+ L +  
Sbjct:   384 LINLQ-KLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSN 442

Query:   291 NFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVL 350
             N  +G +P SLGN + L +L +  N L G IP  +   Q L   D S N L G++PQ + 
Sbjct:   443 NGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIG 502

Query:   351 SITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKS 410
             ++  L   L+L  N L+  LP  +GN       C+++E L +  N F+G IP   G +  
Sbjct:   503 ALQNLGT-LSLGDNKLSGKLPQTLGN-------CLTMESLFLEGNLFYGDIPDLKGLV-G 553

Query:   411 IKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLC 470
             +KE+++S+N+LSG IPE+  + S LE+LNLS+N+LEG+VP KG+F N T +S+  N  LC
Sbjct:   554 VKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLC 613

Query:   471 GGIDELHLLSC----PS---KGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRRSAH 523
             GGI    L  C    PS   K S + K  ++ V + + +  L+  + +T+++ R+R+   
Sbjct:   614 GGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNK 673

Query:   524 KSVDTSPAKKQF--PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI 581
             ++ + +P+  +     ISY +L  AT+ F+SSNM+G GSFG+VYK +L  E+ +VAVKV+
Sbjct:   674 ETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVL 733

Query:   582 NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL 641
             N++++GA +SF+AECE+L++IRHRNL+K++T CSSID +G +F+AL++E+M NGSL+ WL
Sbjct:   734 NMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWL 793

Query:   642 HQSND---HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 698
             H       H     LTL++R+NIAIDVAS ++YLH HC  PI H DLKPSNVLLD D+ A
Sbjct:   794 HPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTA 853

Query:   699 H-QNFSLSHQL---DSASK-TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLE 753
             H  +F L+  L   D  S     SS G++GT+GY APEYG+G + S+ GDVYSFGILLLE
Sbjct:   854 HVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLE 913

Query:   754 MFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDC 813
             MFTG+RPT+  F    TL+ + K  LPE++++IVD S+L   +     + E        C
Sbjct:   914 MFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVE--------C 965

Query:   814 LNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF 849
             L  +   G+ C  ESP  R+    VV +L   RE F
Sbjct:   966 LTMVFEVGLRCCEESPMNRLATSIVVKELISIRERF 1001

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1456 (517.6 bits), Expect = 3.8e-149, P = 3.8e-149
 Identities = 343/879 (39%), Positives = 493/879 (56%)

Query:     2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
             N L   +P E+GSL  L  L +  N L G+ P F+ NL++L +L + +N L G+IP  + 
Sbjct:   148 NNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGEIPDDIA 207

Query:    62 LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL- 120
             +L  +V L +  N FSG+FP    N+SSLE +YL  N FSG+L  D    LPN+ EL L 
Sbjct:   208 MLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLH 267

Query:   121 -TFCSXX--XXXXXXXXXXXXGMGT---ASSIPDSLSNASNLERLDLSGNQFKGKVSIDF 174
               F +                G+G      SI  +     NL  L+L+ N   G  S  F
Sbjct:   268 GNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSL-GSYS--F 324

Query:   175 SSXXXXXXXXXXXXXXGMGTA-NDLD--FVTLLTNCSS-LKALSLCDNQFGGELPHSIAN 230
                             G+  + N L     T + N S+ L  L+L  N   G +PH I N
Sbjct:   325 GDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGN 384

Query:   231 LSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFR 290
             L        +  N ++G +P+ + NLV L  L +  N+  G IP  +G L  L +LY+  
Sbjct:   385 LIGLQ-SLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSN 443

Query:   291 NFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVL 350
             N  +G +PPSLG+ + + DL + +N L G IP  +     L   +   N L+G++P  + 
Sbjct:   444 NSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPNDIG 503

Query:   351 SITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKS 410
              +  L V L L +N L+  LP  +G        C+S+E + +  N F G IP   G M  
Sbjct:   504 RLQNL-VELLLGNNNLSGHLPQTLGK-------CLSMEVIYLQENHFDGTIPDIKGLM-G 554

Query:   411 IKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLC 470
             +K +++S+NNLSG I E+ +N S LE+LNLS N+ EG VPT+G+F N T +S+  N  LC
Sbjct:   555 VKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLC 614

Query:   471 GGIDELHLLSC----PSKGSRKPKLTLLKVLIPVVV--SCLILSSCLTIVFARRRRSAHK 524
             G I EL L  C    P   +R P L L KV I V V  + L+L   +++ + ++R++  K
Sbjct:   615 GSIKELKLKPCIAQAPPVETRHPSL-LKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQK 673

Query:   525 SVDTSPAKKQF--PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN 582
               +++P   +     +SY +L  AT  F+SSN++G GSFG+V+K +L  E  IVAVKV+N
Sbjct:   674 INNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLN 733

Query:   583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
             ++++GA +SF+AECE+L++IRHRNL+K++T C+SID +G +F+AL++E+M NGSL+ WLH
Sbjct:   734 MQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLH 793

Query:   643 QSND---HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 699
                    H     LTL++R+NIAIDVAS ++YLH HC  PI H DLKPSN+LLD D+ AH
Sbjct:   794 PEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAH 853

Query:   700 -QNFSLSHQL---DSASK-TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
               +F L+  L   D  S     SS G++GT+GY APEYGMG + S+ GDVYSFG+L+LEM
Sbjct:   854 VSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEM 913

Query:   755 FTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
             FTG+RPT+  F    TL+ + K  LPE+V++I D S+L   +     + E        CL
Sbjct:   914 FTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRVGFPVLE--------CL 965

Query:   815 NAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRR 853
               I   G+ C  ESP  R+   +   +L   RE F   R
Sbjct:   966 KGILDVGLRCCEESPLNRLATSEAAKELISIRERFFKTR 1004

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1429 (508.1 bits), Expect = 2.8e-146, P = 2.8e-146
 Identities = 348/880 (39%), Positives = 491/880 (55%)

Query:     2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
             N LE  +P E GSL  L  L++  N LTG+ P  +GNL++L ML   +N + G+IP  + 
Sbjct:   163 NHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIA 222

Query:    62 LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
              L+ +++  +A N+F+G+FP  I N+SSL F+ +T N FSG+L  D    LPNL+ LY+ 
Sbjct:   223 RLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMG 282

Query:   122 FCSXXXXX--XXXXXXXXXGMGTASS-----IPDSLSNASNLERLDLSGNQFKGKVSIDF 174
               S                 +   S+     IP S     NL  L L+ N   G  S   
Sbjct:   283 INSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSL-GNYSSGD 341

Query:   175 SSXXXXXXXXXXXXXXGMGTANDL--DFVTLLTNCSS-LKALSLCDNQFGGELPHSIANL 231
                              +G  N L       + N S+ L  LSL  N   G +PH I NL
Sbjct:   342 LDFLGALTNCSQLQYLNVGF-NKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNL 400

Query:   232 SSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRN 291
              S      +G N ++G +P  +  L  L  + +  N L G IP  +G +  L  LY+  N
Sbjct:   401 VSLQT-LDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNN 459

Query:   292 FLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLS 351
               +GSIP SLG+ + L DL L  N L G+IP  L    +L   + S N L G + Q +  
Sbjct:   460 SFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGK 519

Query:   352 ITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSI 411
             +  L + L +++N L+  +P  + N       C+SLE+L +  NSF G IP   G +  +
Sbjct:   520 LKFL-LALDVSYNKLSGQIPQTLAN-------CLSLEFLLLQGNSFVGPIPDIRG-LTGL 570

Query:   412 KELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCG 471
             + L++S NNLSG IPE++ N S L+ LNLS N+ +G VPT+GVF N + +S+  N+ LCG
Sbjct:   571 RFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCG 630

Query:   472 GIDELHLLSCPSKGSRKPKLT--LLKVLIPVVVSCLILSSCLTIVFARRRRSAHKSVDT- 528
             GI  L L  C  +  R+      ++ + +  V++ L+L  CL +V+    +   KSV   
Sbjct:   631 GIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLL-CLCVVYLCWYKLRVKSVRAN 689

Query:   529 --------SPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKV 580
                     SP K  +  ISY EL K T  F+SSN+IG G+FG+V+KG LG +   VA+KV
Sbjct:   690 NNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKV 749

Query:   581 INLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDW 640
             +NL ++GA +SF+AECEAL  IRHRNL+K++TICSS D +G DF+ALV+E+M NG+L+ W
Sbjct:   750 LNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMW 809

Query:   641 LHQSNDHLEVC-----KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 695
             LH   D +E        L L  R+NIAIDVASA+ YLH +C  PI H D+KPSN+LLD D
Sbjct:   810 LHP--DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKD 867

Query:   696 MVAH-QNFSLSHQLDSASKTPS----SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGIL 750
             + AH  +F L+  L    +       SS G++GT+GY APEYGMG   S+ GDVYSFGI+
Sbjct:   868 LTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIV 927

Query:   751 LLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK-VIEIVDPSLLMEVMANNSMIQEDRRAR 809
             LLE+FTG+RPT+  F +GLTLH F K  L ++  ++I D ++L    A +  + E     
Sbjct:   928 LLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVE----- 982

Query:   810 TQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF 849
                CL  + R GV CS ESP  R+ M + ++KL   RE+F
Sbjct:   983 ---CLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESF 1019

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1426 (507.0 bits), Expect = 5.7e-146, P = 5.7e-146
 Identities = 333/879 (37%), Positives = 493/879 (56%)

Query:     2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
             N L   +P E+GSL  L  L +  N L G+LP  +GNL++L  L    N++ G++P  L 
Sbjct:   148 NPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGEVPDELA 207

Query:    62 LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL- 120
              L  +V L ++ N+F G+FP  I N+S+LE ++L  + FSGSL  D    LPN++EL L 
Sbjct:   208 RLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLG 267

Query:   121 ---TFCSXXXXXXXXXXXXXXGMGT---ASSIPDSLSNASNLERLDLSGNQFKGKVSIDF 174
                   +              G+        I  +     +L+ LDLS N   G  +   
Sbjct:   268 ENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPL-GSYTFGD 326

Query:   175 SSXXXXXXXXXXXXXXGMG-TANDLDFVTLLTNCSS-LKALSLCDNQFGGELPHSIANLS 232
                              +G T       T + N S+ L +L+L  N F G +P  I NL 
Sbjct:   327 LEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNLI 386

Query:   233 STMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNF 292
                 + ++G N ++G +P+ +  L+ L  L++  N++ G IP  +G L  L+ LY+  N 
Sbjct:   387 GLQ-RLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNS 445

Query:   293 LQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSI 352
              +G +PPSLG  + + DL + +N L G IP  +     L       N L+G++P  + S+
Sbjct:   446 FEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSL 505

Query:   353 TTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIK 412
               L V L+L +N  +  LP  +GN       C+++E L +  NSF G IP   G M  ++
Sbjct:   506 QNL-VKLSLENNKFSGHLPQTLGN-------CLAMEQLFLQGNSFDGAIPNIRGLM-GVR 556

Query:   413 ELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGG 472
              +++S+N+LSG IPE+  N S LE+LNLS N+  G+VP+KG F N T + +  N  LCGG
Sbjct:   557 RVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGG 616

Query:   473 IDELHLLSC-----PSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFA--RRRRSAHKS 525
             I +L L  C     P +      L  + +L+ + ++ L+L    ++V    R+RR   ++
Sbjct:   617 IKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQT 676

Query:   526 VDTSPAKKQF--PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL 583
              +  P+K +     ISY +L  AT+ F+SSNM+G GSFG+V+K +L  E  IVAVKV+N+
Sbjct:   677 NNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNM 736

Query:   584 KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ 643
             +++GA +SF+AECE+L++ RHRNL+K++T C+S D +G +F+AL++EY+ NGS++ WLH 
Sbjct:   737 QRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHP 796

Query:   644 SNDHLEVCK----LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 699
                  E+ +    LTL++R+NI IDVAS ++YLH HC  PI H DLKPSNVLL+ D+ AH
Sbjct:   797 EEVE-EIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAH 855

Query:   700 -QNFSLSHQL---DSAS-KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
               +F L+  L   D  S     SS G++GT+GY APEYGMG + S+ GDVYSFG+LLLEM
Sbjct:   856 VSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEM 915

Query:   755 FTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
             FTG+RPTD  F   LTLH + K+ LPEKV EI D ++L  +             RT +CL
Sbjct:   916 FTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAIL-HIGLRVGF-------RTAECL 967

Query:   815 NAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRR 853
               +   G+ C  E P  R+   +V  +L   RE F   R
Sbjct:   968 TLVLEVGLRCCEEYPTNRLATSEVAKELISIRERFFKTR 1006

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1384 (492.3 bits), Expect = 1.6e-141, P = 1.6e-141
 Identities = 342/870 (39%), Positives = 488/870 (56%)

Query:     2 NKLEGQIPEEIG-SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
             N+L G IP EIG SL +L  L +  N L+G++P  +GNL++L    + +N L G IP++L
Sbjct:   161 NQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSL 220

Query:    61 GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
             G L +L+ +N+ +N  SGM P  I N+SSL    +  N+  G +P +    L  L+ + +
Sbjct:   221 GQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDM 280

Query:   121 -------TFCSXXXXXXXXXXXXXXGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID 173
                       +              G   +  I        NL  L L  N F+ +   D
Sbjct:   281 GTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDD 340

Query:   174 FSSXXXXXXXXXXXXXXGMGTANDLDFV--TLLTNCS-SLKALSLCDNQFGGELPHSIAN 230
             +                 +G  N+L  V     +N S SL  L+L  N+  G +P  I N
Sbjct:   341 WG-FISDLTNCSKLQTLNLGE-NNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGN 398

Query:   231 LSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFR 290
             L      + +  N   G++PS +  L NL  L    N L G IP  +G L  L  L +  
Sbjct:   399 LIGLQHLY-LCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGT 457

Query:   291 NFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLK-GFDASHNKLTGAIPQQV 349
             N   G IP +L NLT L  L LS NNL G IPS L N Q L    + S N L G+IPQ++
Sbjct:   458 NKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEI 517

Query:   350 LSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMK 409
               +  L  + A + N L+  +P  +G+       C  L YL + +N   G IP +LG +K
Sbjct:   518 GHLKNLVEFHAES-NRLSGKIPNTLGD-------CQLLRYLYLQNNLLSGSIPSALGQLK 569

Query:   410 SIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKL 469
              ++ L++SSNNLSGQIP  L +++ L  LNLS+N   GEVPT G F+  + IS+Q N KL
Sbjct:   570 GLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKL 629

Query:   470 CGGIDELHL-LSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRRSAHKSVDT 528
             CGGI +LHL   CP   +RK    +L + + +  +  ILSS   ++   +R    K   +
Sbjct:   630 CGGIPDLHLPRCCPLLENRK-HFPVLPISVSLAAALAILSSLYLLITWHKRTK--KGAPS 686

Query:   529 SPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA 588
               + K  P++SY++L KAT  FA +N++G GSFGSVYKG L  ++  VAVKV+ L+   A
Sbjct:   687 RTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDH-VAVKVLKLENPKA 745

Query:   589 FRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH-QSNDH 647
              +SF AECEALRN+RHRNL+KI+TICSSID++G DFKA+V+++M NGSLEDW+H ++ND 
Sbjct:   746 LKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQ 805

Query:   648 LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH 706
              +   L L +RV I +DVA A++YLH H   P+VH D+K SNVLLD DMVAH  +F L+ 
Sbjct:   806 ADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLAR 865

Query:   707 QL-DSAS--KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
              L D  S  +  +SS+G  GT+GY APEYG+G  AS  GD+YS+GIL+LE+ TG+RPTD+
Sbjct:   866 ILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDS 925

Query:   764 AFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMAN--NSMIQEDRRARTQDCLNAITRTG 821
              F   L L ++V++ L  +V ++VD  L+++   N  NS      R R  +C+  + R G
Sbjct:   926 TFRPDLGLRQYVELGLHGRVTDVVDTKLILD-SENWLNSTNNSPCR-RITECIVWLLRLG 983

Query:   822 VLCSMESPFERMEMRDVVAKLCHTRETFLG 851
             + CS E P  R    D++ +L   ++   G
Sbjct:   984 LSCSQELPSSRTPTGDIIDELNAIKQNLSG 1013

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1344 (478.2 bits), Expect = 2.8e-137, P = 2.8e-137
 Identities = 333/882 (37%), Positives = 471/882 (53%)

Query:     2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
             N L   +P E+GSL  L  L +  N LTG  P  +GNL++L  L   +N + G+IP  + 
Sbjct:   155 NHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVA 214

Query:    62 LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL- 120
              L  +V+  +A N FSG FP  + NISSLE + L  N FSG+L  D    LPNL+ L L 
Sbjct:   215 RLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLG 274

Query:   121 --TFCSXXXXXXXXXXXXX----XGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS--I 172
                F                        + SIP S     NL  L +  N      S  +
Sbjct:   275 TNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGL 334

Query:   173 DFSSXXXXXXXXXXXXXXGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLS 232
             +F                      +L   ++    ++L +L L  N   G +PH I NL 
Sbjct:   335 EFIGAVANCTQLEYLDVGYNRLGGELP-ASIANLSTTLTSLFLGQNLISGTIPHDIGNLV 393

Query:   233 STMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNF 292
             S   +  +  N +SG +P     L+NL  + +  N + G IP   G +  LQ+L++  N 
Sbjct:   394 SLQ-ELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNS 452

Query:   293 LQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSI 352
               G IP SLG    L DL +  N L G IP  +    +L   D S+N LTG  P++V  +
Sbjct:   453 FHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKL 512

Query:   353 TTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIK 412
               L V L  ++N L+  +P  +G        C+S+E+L +  NSF G IP  +  + S+K
Sbjct:   513 ELL-VGLGASYNKLSGKMPQAIGG-------CLSMEFLFMQGNSFDGAIP-DISRLVSLK 563

Query:   413 ELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGG 472
              ++ S+NNLSG+IP +L +L  L  LNLS N  EG VPT GVF N T +S+  N  +CGG
Sbjct:   564 NVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGG 623

Query:   473 IDELHLLSCPSKGS---RKPKLTLLKVLIPV---VVSCLILSSCLTIVFARRRRSAHKSV 526
             + E+ L  C  + S   RKP     KV+  +   + S L++    ++ +  +R+  + + 
Sbjct:   624 VREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNAS 683

Query:   527 DTSPAKK----QF-PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI 581
             D +P+       F   +SY EL  ATS F+S+N+IG G+FG+V+KG+LG E  +VAVKV+
Sbjct:   684 DGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVL 743

Query:   582 NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL 641
             NL + GA +SF+AECE  + IRHRNL+K+IT+CSS+DS+G DF+ALV+E+M  GSL+ WL
Sbjct:   744 NLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWL 803

Query:   642 H-----QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 696
                   + NDH     LT  +++NIAIDVASA+EYLH HC  P+ H D+KPSN+LLD D+
Sbjct:   804 QLEDLERVNDHSR--SLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDL 861

Query:   697 VAH-QNFSLSHQL---DSAS-KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILL 751
              AH  +F L+  L   D  S     SS G++GT+GY APEYGMG + S+ GDVYSFGILL
Sbjct:   862 TAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILL 921

Query:   752 LEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQ 811
             LEMF+G++PTD +F     LH + K  L          S       +N+ I E       
Sbjct:   922 LEMFSGKKPTDESFAGDYNLHSYTKSIL----------SGCTSSGGSNA-IDEG------ 964

Query:   812 DCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRR 853
               L  + + G+ CS E P +RM   + V +L   R  F   +
Sbjct:   965 --LRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSK 1004

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1090 (388.8 bits), Expect = 2.3e-110, P = 2.3e-110
 Identities = 260/677 (38%), Positives = 386/677 (57%)

Query:     2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
             N L G+IP  +G+L +L  L +  N L+G +P  +G L+ L  L +  N+L G IP++ G
Sbjct:   136 NSLSGEIPAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFG 195

Query:    62 LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
              LR L +L++A N  SG  P  I NISSL    +  N+ SG+LP +   NLP+L+E+Y+ 
Sbjct:   196 QLRRLSFLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMY 255

Query:   122 F------CSXXXXXXXXXXXXXXGMGTASSI-PDSLSNASNLERLDLSGNQFKGKVSID- 173
             +                      G+ + S + P  +    NL+RL+L     + + + D 
Sbjct:   256 YNQFHGRIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDW 315

Query:   174 -FSSXXXXXXXXXXXXXXGMGTANDL-DFVTLLTNCSSLKALSLCDNQFGGELPHSIANL 231
              F +              G      L D V+ L+  SSL +LS+ DN+  G LP  I NL
Sbjct:   316 KFMTALTNCSNLQEVELGGCKFGGVLPDSVSNLS--SSLVSLSIRDNKISGSLPRDIGNL 373

Query:   232 SSTMIQF-RIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFR 290
              +  +Q+  +  N ++G++PS    L NL  LT++ N+L G +P  +G L  L  + +  
Sbjct:   374 VN--LQYLSLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQF 431

Query:   291 NFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGF-DASHNKLTGAIPQQV 349
             N   G+IP +LGNLTKL  + L  NN  G IP  + +   L    D SHN L G+IP+++
Sbjct:   432 NAFGGTIPSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEI 491

Query:   350 LSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMK 409
               +  +  + A ++ L  ++ P  +G        C  L++L + +N  +G IP +L  +K
Sbjct:   492 GKLKNIVEFHADSNKLSGEN-PSTIGE-------CQLLQHLFLQNNFLNGSIPIALTQLK 543

Query:   410 SIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKL 469
              +  L++S NNLSGQIP  L ++  L  LNLS+N   GEVPT GVF+N ++I +Q N  +
Sbjct:   544 GLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHI 603

Query:   470 CGGIDELHLLSCPSKGSRKPK-LTLLKVLIPVVVSCLILSSCLTIVFARRRRSAHKSVDT 528
             CGGI ELHL +C  K  +K K   LL V++  +VS L + S L ++    +R   K V  
Sbjct:   604 CGGIPELHLPTCSLKSRKKKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRK-KEVPA 662

Query:   529 SPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEE----MIVAVKVINLK 584
             + + +  PMI+Y +L KAT  F+SS+++G GSFGSVYKG    ++     +VAV+V+ L+
Sbjct:   663 TTSMQGHPMITYKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLE 722

Query:   585 QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH-Q 643
                A +SF AECE LRN RHRNL+KI+TICSSID++G DFKA+V+++M NGSLEDWLH +
Sbjct:   723 TPKALKSFTAECETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPE 782

Query:   644 SNDHLEVCKLTLIQRVN 660
             +ND  E   LTL QRV+
Sbjct:   783 TNDQAEQRHLTLHQRVS 799

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 1081 (385.6 bits), Expect = 2.1e-109, P = 2.1e-109
 Identities = 302/873 (34%), Positives = 450/873 (51%)

Query:     1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFV---GNLSALGMLLIRWNSLGGQIP 57
             +N L G IP+E+G L  L  L +  N L G +P  +   G+ S+L  + +  NSL G+IP
Sbjct:   124 ENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIP 183

Query:    58 TTLGL-LRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK 116
                   L+ L +L +  N+ +G  P  + N ++L+++ L  N  SG LP  ++  +P L+
Sbjct:   184 LNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQ 243

Query:   117 ELYLTFCSXXXXXXXXXXXXXXGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS 176
              LYL++                          SL+N+S+L+ L+L+GN   G+++     
Sbjct:   244 FLYLSYNHFVSHNNNTNLEPFFA---------SLANSSDLQELELAGNSLGGEITSSVRH 294

Query:   177 XXXXXXXXXXXXXXGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMI 236
                             G+         ++N  +L  L+L  N   G +P  +  LS  + 
Sbjct:   295 LSVNLVQIHLDQNRIHGS-----IPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSK-LE 348

Query:   237 QFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGS 296
             +  +  N ++G IP  + ++  L  L +  N L G IPD  G L  L++L ++ N L G+
Sbjct:   349 RVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGT 408

Query:   297 IPPSLGNLTKLADLALSFNNLQGNIPSSL-GNCQNLKGF-DASHNKLTGAIPQQVLSITT 354
             +P SLG    L  L LS NNL G IP  +  N +NLK + + S N L+G IP + LS   
Sbjct:   409 VPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLE-LSKMD 467

Query:   355 LSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKEL 414
             + + + L+ N L+  +P Q+G+       C++LE+L++S N F   +P SLG +  +KEL
Sbjct:   468 MVLSVDLSSNELSGKIPPQLGS-------CIALEHLNLSRNGFSSTLPSSLGQLPYLKEL 520

Query:   415 NVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGID 474
             +VS N L+G IP   Q  S L+ LN S+N L G V  KG FS  T  S   +  LCG I 
Sbjct:   521 DVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK 580

Query:   475 ELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARR---RRSAHKSVDTSPA 531
              +   +C  K  + P + LL VL+ ++ + ++      +V   R     + +   +    
Sbjct:   581 GMQ--ACKKK-HKYPSV-LLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDE 636

Query:   532 KKQ------FPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ 585
             +KQ      +P ISY +L  AT  F +S++IG G FG VYKG+L      VAVKV++ K 
Sbjct:   637 EKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTK-VAVKVLDPKT 695

Query:   586 KGAFR-SFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS 644
                F  SF  EC+ L+  RHRNLI+IIT CS     G  F ALV   M NGSLE  L+  
Sbjct:   696 ALEFSGSFKRECQILKRTRHRNLIRIITTCSK---PG--FNALVLPLMPNGSLERHLYPG 750

Query:   645 NDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFS 703
                 +   L LIQ VNI  DVA  I YLHH+    +VH DLKPSN+LLD +M A   +F 
Sbjct:   751 EYSSK--NLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFG 808

Query:   704 LSHQLDSASKTPSS----SIG-----IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
             +S  +    +T S+    S G     + G+VGY+APEYGMG  AS  GDVYSFG+LLLE+
Sbjct:   809 ISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEI 868

Query:   755 FTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
              +GRRPTD    EG +LHEF+K   P+ +  I++ +L            E      ++ +
Sbjct:   869 VSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKP---EKCEKLWREVI 925

Query:   815 NAITRTGVLCSMESPFERMEMRDVVAKLCHTRE 847
               +   G++C+  +P  R +M DV  ++   +E
Sbjct:   926 LEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKE 958

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 925 (330.7 bits), Expect = 7.0e-93, P = 7.0e-93
 Identities = 270/886 (30%), Positives = 442/886 (49%)

Query:     1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
             +N L G I EEIG L +L+ L +  N  TG+ P  + NL  L +L + +N++ G++P  L
Sbjct:   321 ENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADL 380

Query:    61 GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
             GLL NL  L+  +N  +G  P  I N + L+ + L+ N+ +G +P            + L
Sbjct:   381 GLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIP-------RGFGRMNL 433

Query:   121 TFCSXXXXXXXXXXXXXXGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS-IDFSSXXX 179
             TF S                     IPD + N SNLE L ++ N   G +  +       
Sbjct:   434 TFISIGRNHFT------------GEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKL 481

Query:   180 XXXXXXXXXXXG-----MGTANDLDFVTL------------LTNCSSLKALSLCDNQFGG 222
                        G     +G   DL+ + L            ++N + L+ L +  N   G
Sbjct:   482 RILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEG 541

Query:   223 ELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQH 282
              +P  + ++    +   +  N+ SG IP+    L +L  L+++ N+ +G IP  +  L  
Sbjct:   542 PIPEEMFDMKLLSV-LDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSL 600

Query:   283 LQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNN--LQGNIPSSLGNCQNLKGFDASHNK 340
             L    +  N L G+IP  L    K   L L+F+N  L G IP  LG  + ++  D S+N 
Sbjct:   601 LNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNL 660

Query:   341 LTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGV 400
              +G+IP+ + +   +   L  + N L+  +P +V    +++I+      L++S NSF G 
Sbjct:   661 FSGSIPRSLQACKNVFT-LDFSQNNLSGHIPDEVFQGMDMIIS------LNLSRNSFSGE 713

Query:   401 IPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTK 460
             IP S G M  +  L++SSNNL+G+IPE L NLS L+ L L+ N+L+G VP  GVF N   
Sbjct:   714 IPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINA 773

Query:   461 ISLQVNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRR 520
               L  N  LCG    L   +   K S   K T + ++I    + L+L   L ++    ++
Sbjct:   774 SDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKK 833

Query:   521 SAHKSVDTSPAKKQFPMISYA---------ELSKATSEFASSNMIGQGSFGSVYKGILGG 571
                K ++ S ++   P +  A         EL +AT  F S+N+IG  S  +VYKG L  
Sbjct:   834 K-EKKIENS-SESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLE- 890

Query:   572 EEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF 629
             +  ++AVKV+NLK+  A     F  E + L  ++HRNL+KI+        +    KALV 
Sbjct:   891 DGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAW----ESGKTKALVL 946

Query:   630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSN 689
              +MENG+LED +H S   +     +L++++++ + +AS I+YLH     PIVH DLKP+N
Sbjct:   947 PFMENGNLEDTIHGSAAPIG----SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPAN 1002

Query:   690 VLLDHDMVAH-QNFSLSHQL---DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVY 745
             +LLD D VAH  +F  +  L   +  S T S+S   +GT+GY+APE+    + +   DV+
Sbjct:  1003 ILLDSDRVAHVSDFGTARILGFREDGSTTASTS-AFEGTIGYLAPEFAYMRKVTTKADVF 1061

Query:   746 SFGILLLEMFTGRRPTDA--AFTEGLTLHEFVKMTLP---EKVIEIVDPSLLMEVMANNS 800
             SFGI+++E+ T +RPT      ++ +TL + V+ ++    + ++ ++D    ME+   +S
Sbjct:  1062 SFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLD----MEL--GDS 1115

Query:   801 MIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR 846
             ++   +    +D L       + C+   P +R +M +++  L   R
Sbjct:  1116 IVSLKQEEAIEDFLKLC----LFCTSSRPEDRPDMNEILTHLMKLR 1157

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)]

 Score = 910 (325.4 bits), Expect = 2.7e-91, P = 2.7e-91
 Identities = 268/864 (31%), Positives = 418/864 (48%)

Query:     2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
             N+  G +P  +G+  +L+        L+G +P   G L+ L  L +  N   G+IP  LG
Sbjct:   270 NQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFSGRIPPELG 329

Query:    62 LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDI--LVNLPNLKELY 119
               ++++ L + +NQ  G  P  +  +S L++++L  N  SG +P  I  + +L +L +LY
Sbjct:   330 KCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWKIQSLQSL-QLY 388

Query:   120 LTFCSXXXXXXXXXXXXXXGMGTASS-----IPDSLSNASNLERLDLSGNQFKGKVSIDF 174
                 S               +    +     IP  L   S+LE LDL+ N F G +  + 
Sbjct:   389 QNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRNMFTGHIPPNL 448

Query:   175 SSXXXXXXXXXXXXXXGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSST 234
              S                   +DL        CS+L+ L L +N   G LP  +      
Sbjct:   449 CSQKKLKRLLLGYNYLEGSVPSDLG------GCSTLERLILEENNLRGGLPDFVEK--QN 500

Query:   235 MIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQ 294
             ++ F + GN  +G IP  + NL N+ A+ +  NQL G IP  +G L  L+ L +  N L+
Sbjct:   501 LLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNILK 560

Query:   295 GSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITT 354
             G +P  L N  KL++L  S N L G+IPS+LG+   L       N  +G IP  +     
Sbjct:   561 GILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSNK 620

Query:   355 LSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKEL 414
             L + L L  NLL   +P  VG L+       +L  L++SSN  +G +P  LG +K ++EL
Sbjct:   621 L-LNLQLGGNLLAGDIP-PVGALQ-------ALRSLNLSSNKLNGQLPIDLGKLKMLEEL 671

Query:   415 NVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGV-FSNKTKISLQVNVKLCGGI 473
             +VS NNLSG +   L  +  L F+N+S+N   G VP     F N +  S   N  LC   
Sbjct:   672 DVSHNNLSGTL-RVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCINC 730

Query:   474 DELHLLSCPSKGSRKP--------K--LTLLKVLIPVVVSCLILSSCLTIVFARRRRSAH 523
                  L+CP     +P        K  L+ L + + +V+  L+   CL +  A       
Sbjct:   731 PA-DGLACPESSILRPCNMQSNTGKGGLSTLGIAM-IVLGALLFIICLFLFSAFLFLHCK 788

Query:   524 KSVDTSPAKKQFPMISYA-ELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN 582
             KSV       Q    S   ++ +AT       +IG+G+ G++YK  L  +++    K++ 
Sbjct:   789 KSVQEIAISAQEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKLVF 848

Query:   583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
                K    S V E E +  +RHRNLIK+            ++  +++ YMENGSL D LH
Sbjct:   849 TGIKNGSVSMVREIETIGKVRHRNLIKLEEFWLR-----KEYGLILYTYMENGSLHDILH 903

Query:   643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
             ++N    +   T   R NIA+  A  + YLH  C P IVH D+KP N+LLD D+  H  +
Sbjct:   904 ETNPPKPLDWST---RHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISD 960

Query:   702 FSLSHQLD-SASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             F ++  LD SA+  PS+++  +GT+GY+APE    +  S   DVYS+G++LLE+ T ++ 
Sbjct:   961 FGIAKLLDQSATSIPSNTV--QGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKA 1018

Query:   761 TDAAFTEGLTLHEFVKM--TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAIT 818
              D +F     +  +V+   T   ++ +IVDPSLL E++  +S + E    +  + L+   
Sbjct:  1019 LDPSFNGETDIVGWVRSVWTQTGEIQKIVDPSLLDELI--DSSVME----QVTEALSLAL 1072

Query:   819 RTGVLCSMESPFERMEMRDVVAKL 842
             R    C+ +   +R  MRDVV +L
Sbjct:  1073 R----CAEKEVDKRPTMRDVVKQL 1092

GO:0005524 "ATP binding" evidence=NAS

GO:0005576 "extracellular region" evidence=NAS

GO:0005886 "plasma membrane" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0019199 "transmembrane receptor protein kinase activity" evidence=NAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGP4	Y3475_ARATH	2, ., 7, ., 1, 1, ., 1	0.4178	0.9613	0.8128	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	854
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-85
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-49
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-45
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-42
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-42
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-38
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-35
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-35
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-34
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-19
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-18
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-13
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-13
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-11
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-11
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-10
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	9e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-09
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-07
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-04
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.001
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.002
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.002
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.002
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.003
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.003
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  291 bits (746), Expect = 7e-85
 Identities = 236/811 (29%), Positives = 390/811 (48%), Gaps = 70/811 (8%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N L G+IP  + +L +L+ L +  N L GQ+P  +G + +L  + + +N+L G+IP  +G
Sbjct: 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG 233

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
            L +L +L++  N  +G  P  + N+ +L++++L  N+ SG +P  I             
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF------------ 281

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
             SL+ L  L+L  N+L    +  IP+ +    NLE L L  N F GK+ +  +SL  L 
Sbjct: 282 --SLQKLISLDLSDNSL----SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQ 335

Query: 182 WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
            L L  N        +L         ++L  L L  N   GE+P  + + S  + +  + 
Sbjct: 336 VLQLWSNKFSGEIPKNLG------KHNNLTVLDLSTNNLTGEIPEGLCS-SGNLFKLILF 388

Query: 242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
            N + G IP  +    +L  + ++ N   G +P    +L  +  L +  N LQG I    
Sbjct: 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448

Query: 302 GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
            ++  L  L+L+ N   G +P S G+ + L+  D S N+ +GA+P+++ S++ L + L L
Sbjct: 449 WDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSEL-MQLKL 506

Query: 362 AHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNL 421
           + N L+  +P ++ + K LV        LD+S N   G IP S   M  + +L++S N L
Sbjct: 507 SENKLSGEIPDELSSCKKLV-------SLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQL 559

Query: 422 SGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSC 481
           SG+IP+ L N+  L  +N+S+NHL G +P+ G F      ++  N+ LCGG     L  C
Sbjct: 560 SGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC 619

Query: 482 PSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRRSAH-KSVDTSPA--KKQFPMI 538
             K  RK       +   +    ++       VF R R +   K V+      + QF   
Sbjct: 620 --KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQF-FD 676

Query: 539 SYAELSKATSEFASS----NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA 594
           S    S   ++  SS    N+I +G  G+ YKG      M   VK IN        S +A
Sbjct: 677 SKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIA 735

Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLT 654
           +   +  ++H N++K+I +C S   KGA    L+ EY+E  +L + L           L+
Sbjct: 736 D---MGKLQHPNIVKLIGLCRS--EKGA---YLIHEYIEGKNLSEVLRN---------LS 778

Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKT 714
             +R  IAI +A A+ +LH  C P +V G+L P  +++D     H   SL   L + +K 
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKC 838

Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEF 774
             SS        YVAPE     + +   D+Y FG++L+E+ TG+ P DA F    ++ E+
Sbjct: 839 FISS-------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891

Query: 775 VKMTLPEKVIEI-VDPSLLMEVMANNSMIQE 804
            +    +  +++ +DPS+  +V  N + I E
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE 922

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  186 bits (475), Expect = 7e-49
 Identities = 147/466 (31%), Positives = 220/466 (47%), Gaps = 59/466 (12%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
           KN + G+I   I  L  +QT+ +  N L+G +PD +   S+                   
Sbjct: 79  KN-ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSS------------------- 118

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
               +L YLN++ N F+G  PR   +I +LE + L+ N  SG +P DI            
Sbjct: 119 ----SLRYLNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDI------------ 160

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
              S  +L  L+L  N L       IP+SL+N ++LE L L+ NQ  G++  +   +K+L
Sbjct: 161 --GSFSSLKVLDLGGNVL----VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSL 214

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
            W+ L  NNL      ++  +T      SL  L L  N   G +P S+ NL +    F +
Sbjct: 215 KWIYLGYNNLSGEIPYEIGGLT------SLNHLDLVYNNLTGPIPSSLGNLKNLQYLF-L 267

Query: 241 GGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS 300
             N++SG IP  I +L  LI+L +  N L G IP+ V +LQ+L+ L++F N   G IP +
Sbjct: 268 YQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA 327

Query: 301 LGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLA 360
           L +L +L  L L  N   G IP +LG   NL   D S N LTG IP+ + S   L   L 
Sbjct: 328 LTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF-KLI 386

Query: 361 LAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNN 420
           L  N L   +P  +G        C SL  + +  NSF G +P     +  +  L++S+NN
Sbjct: 387 LFSNSLEGEIPKSLG-------ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439

Query: 421 LSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVN 466
           L G+I     ++  L+ L+L+ N   G +P          + L  N
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRN 485

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  175 bits (445), Expect = 3e-45
 Identities = 131/404 (32%), Positives = 198/404 (49%), Gaps = 44/404 (10%)

Query: 66  LVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSL 125
           +V ++++    SG     I  +  ++ I L+ N+ SG +P DI             F + 
Sbjct: 71  VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDI-------------FTTS 117

Query: 126 KNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNL 185
            +L +LNL  NN       SIP    +  NLE LDLS N   G++  D  S  +L  L+L
Sbjct: 118 SSLRYLNLSNNNF----TGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDL 171

Query: 186 EQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQI 245
             N L     N       LTN +SL+ L+L  NQ  G++P  +  + S    + +G N +
Sbjct: 172 GGNVLVGKIPNS------LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY-LGYNNL 224

Query: 246 SGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLT 305
           SG IP  I  L +L  L +  N L G IP  +G L++LQ L++++N L G IPPS+ +L 
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQ 284

Query: 306 KLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNL 365
           KL  L LS N+L G IP  +   QNL+      N  TG IP  + S+  L V L L  N 
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV-LQLWSNK 343

Query: 366 LNDSLPLQVGNLKNLVITCVS-----------------LEYLDISSNSFHGVIPFSLGFM 408
            +  +P  +G   NL +  +S                 L  L + SNS  G IP SLG  
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403

Query: 409 KSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTK 452
           +S++ + +  N+ SG++P     L  + FL++S N+L+G + ++
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR 447

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  167 bits (424), Expect = 1e-42
 Identities = 119/321 (37%), Positives = 171/321 (53%), Gaps = 34/321 (10%)

Query: 151 SNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSL 210
           +N+S +  +DLSG    GK+S     L  +  +NL  N L     +D+      T  SSL
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDI-----FTTSSSL 120

Query: 211 KALSLCDNQFGGELPH-SIANL-----SSTMIQFRI---------------GGNQISGTI 249
           + L+L +N F G +P  SI NL     S+ M+   I               GGN + G I
Sbjct: 121 RYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180

Query: 250 PSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLAD 309
           P+ + NL +L  LT+  NQL G IP  +G+++ L+ +Y+  N L G IP  +G LT L  
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240

Query: 310 LALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDS 369
           L L +NNL G IPSSLGN +NL+      NKL+G IP  + S+  L + L L+ N L+  
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKL-ISLDLSDNSLSGE 299

Query: 370 LPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFL 429
           +P  V  L+N       LE L + SN+F G IP +L  +  ++ L + SN  SG+IP+ L
Sbjct: 300 IPELVIQLQN-------LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352

Query: 430 QNLSFLEFLNLSYNHLEGEVP 450
              + L  L+LS N+L GE+P
Sbjct: 353 GKHNNLTVLDLSTNNLTGEIP 373

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  153 bits (388), Expect = 3e-42
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLIKIITIC 614
           +G+G FG+VY          VA+K+I  +   +     + E E L+ + H N++K+  + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                   +   LV EY E GSL+D L ++       KL+  + + I + +   +EYLH 
Sbjct: 61  EDE-----NHLYLVMEYCEGGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHS 110

Query: 675 HCQPPIVHGDLKPSNVLLDHD--MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
           +    I+H DLKP N+LLD D   V   +F LS  L S      +   I GT  Y+APE 
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT---IVGTPAYMAPEV 164

Query: 733 GMG-SEASMTGDVYSFGILLLEM 754
            +G    S   D++S G++L E+
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  143 bits (362), Expect = 3e-38
 Identities = 69/209 (33%), Positives = 102/209 (48%), Gaps = 24/209 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+GSFG VY         +VA+KVI   K K      + E + L+ ++H N   I+ + 
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPN---IVRLY 63

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
              + +   +  LV EY E G L D L +        +L+  +       + SA+EYLH 
Sbjct: 64  DVFEDEDKLY--LVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQILSALEYLHS 115

Query: 675 HCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
                IVH DLKP N+LLD D    +A  +F L+ QLD   K  +      GT  Y+APE
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLA--DFGLARQLDPGEKLTT----FVGTPEYMAPE 166

Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +G       D++S G++L E+ TG+ P
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  142 bits (359), Expect = 7e-38
 Identities = 69/209 (33%), Positives = 106/209 (50%), Gaps = 21/209 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           +G GSFG+VYK    G   IVAVK++  +       ++   E   LR + H N++++I  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
               D    D   LV EY E G L D+L +         L+  +   IA+ +   +EYLH
Sbjct: 67  F--EDK---DHLYLVMEYCEGGDLFDYLSRGG------PLSEDEAKKIALQILRGLEYLH 115

Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE- 731
            +    I+H DLKP N+LLD + V    +F L+ +L  +S + ++     GT  Y+APE 
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT---FVGTPWYMAPEV 169

Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              G+      DV+S G++L E+ TG+ P
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  137 bits (348), Expect = 2e-36
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 36/234 (15%)

Query: 556 IGQGSFGSVYKGIL----GGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G+FG VYKG L     G E  VAVK +     +     F+ E   ++ + H N++++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           + +C+    +G     +V EYM  G L D+L +  +     KLTL   + +A+ +A  +E
Sbjct: 67  LGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHGE-----KLTLKDLLQMALQIAKGME 116

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           YL        VH DL   N L+  ++   ++  +F LS  +           G K  + +
Sbjct: 117 YLESK---NFVHRDLAARNCLVTENLVVKIS--DFGLSRDIYEDDYYRKRGGG-KLPIKW 170

Query: 728 VAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKM 777
           +APE    G  +  S   DV+SFG+LL E+FT G +P       G++  E +++
Sbjct: 171 MAPESLKDGKFTSKS---DVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEL 216

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  135 bits (342), Expect = 1e-35
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 28/216 (12%)

Query: 555 MIGQGSFGSVYKGIL----GGEEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIK 609
            +G+G+FG VYKG L    G +++ VAVK +     +     F+ E   +R + H N++K
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           ++ +C+  +        +V EYME G L  +L ++       KL+L   ++ A+ +A  +
Sbjct: 66  LLGVCTEEEPL-----YIVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQIARGM 115

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           EYL        +H DL   N L+  ++V    +F LS  L           G K  + ++
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR--GGKLPIRWM 170

Query: 729 APE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           APE    G  +  S   DV+SFG+LL E+FT G +P
Sbjct: 171 APESLKEGKFTSKS---DVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  134 bits (340), Expect = 3e-35
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 27/216 (12%)

Query: 555 MIGQGSFGSVYKGIL----GGEEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIK 609
            +G+G+FG VYKG L     G+E+ VAVK +     +     F+ E   +R + H N++K
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           ++ +C+  +        +V EYM  G L D+L ++       +L+L   ++ A+ +A  +
Sbjct: 66  LLGVCTEEEPL-----MIVMEYMPGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGM 116

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           EYL        +H DL   N L+  ++V    +F LS  L           G K  + ++
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK--GGKLPIRWM 171

Query: 729 APE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           APE    G  +  S   DV+SFG+LL E+FT G  P
Sbjct: 172 APESLKEGKFTSKS---DVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  131 bits (331), Expect = 4e-34
 Identities = 67/224 (29%), Positives = 109/224 (48%), Gaps = 34/224 (15%)

Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIK 609
             +G+G+FG VYKG L    G+   VAVK +     +   + F+ E   ++ + H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK---LTLIQRVNIAIDVA 666
           ++ +C+  +        LV EYME G L D+L +S       +   L+L   ++ AI +A
Sbjct: 61  LLGVCTEEEPL-----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIG--- 720
             +EYL        VH DL   N L+  D+   ++  +F LS  +         + G   
Sbjct: 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKIS--DFGLSRDVYDDDYYRKKTGGKLP 170

Query: 721 IKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           I+    ++APE    G+ +  S   DV+SFG+LL E+FT G  P
Sbjct: 171 IR----WMAPESLKDGIFTSKS---DVWSFGVLLWEIFTLGATP 207

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  121 bits (306), Expect = 1e-30
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 16/210 (7%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKII 611
            ++G+GSFGSVY  +      ++AVK + L         +   E   L +++H N+++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
                 +    +   +  EY+  GSL   L      L      +I++      +   + Y
Sbjct: 66  GSERDEEKNTLN---IFLEYVSGGSLSSLLK-KFGKLP---EPVIRKY--TRQILEGLAY 116

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           LH +    IVH D+K +N+L+D D V    +F  + +L        +   ++GT  ++AP
Sbjct: 117 LHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG-SVRGTPYWMAP 172

Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           E   G E     D++S G  ++EM TG+ P
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (286), Expect = 4e-28
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 23/207 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+G FG V  G   G++  VAVK +      A ++F+AE   +  +RH NL++++ +  
Sbjct: 14  IGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVV- 69

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
            +         +V EYM  GSL D+L      +    +TL Q++  A+DV   +EYL   
Sbjct: 70  -LQGNPL---YIVTEYMAKGSLVDYLRSRGRAV----ITLAQQLGFALDVCEGMEYLE-- 119

Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            +   VH DL   NVL+  D+VA   +F L+   +++    S  + +K T    APE   
Sbjct: 120 -EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPVKWT----APEALR 172

Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
             + S   DV+SFGILL E+++ GR P
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  111 bits (280), Expect = 2e-27
 Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 18/207 (8%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
            IG+G FG VYK         VA+KVI L+ K      + E + L+  +H N++K     
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-- 64

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            S   K  D   +V E+   GSL+D L  +N       LT  Q   +  ++   +EYLH 
Sbjct: 65  -SYLKK--DELWIVMEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHS 116

Query: 675 HCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
           +    I+H D+K +N+LL  D  V   +F LS QL S +K  ++ +   GT  ++APE  
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMV---GTPYWMAPEVI 169

Query: 734 MGSEASMTGDVYSFGILLLEMFTGRRP 760
            G       D++S GI  +E+  G+ P
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  109 bits (276), Expect = 8e-27
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 34/215 (15%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKIITIC 614
           +GQGS G VYK        I A+K I++     FR   + E + LR+     ++K     
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----- 63

Query: 615 SSIDSKGADFK----ALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDVASA 668
                 GA +K    ++V EYM+ GSL D L +    +   V          IA  +   
Sbjct: 64  ----CYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAY-------IARQILKG 111

Query: 669 IEYLH--HHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
           ++YLH   H    I+H D+KPSN+L++    V   +F +S  L++     ++ +   GTV
Sbjct: 112 LDYLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV---GTV 164

Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            Y++PE   G   S   D++S G+ LLE   G+ P
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (260), Expect = 1e-24
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 23/216 (10%)

Query: 553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKI 610
            N IG G+FG VY  +      ++AVK I ++       +    E + L  ++H NL+K 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 611 ITICSSIDSKGADFKALVF-EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
             +      +    K  +F EY   G+LE+ L     H  +    +I+     + +   +
Sbjct: 65  YGV------EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRV--YTLQLLEGL 112

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSI-GIKGTVGY 727
            YLH H    IVH D+KP+N+ LDH  ++   +F  + +L + + T    +  + GT  Y
Sbjct: 113 AYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169

Query: 728 VAPEYGMGSEASMTG---DVYSFGILLLEMFTGRRP 760
           +APE   G +    G   D++S G ++LEM TG+RP
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  102 bits (258), Expect = 2e-24
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 31/214 (14%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G+GSFG V          + A+KV+    + ++      + E   L  I H  ++K+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASAI 669
              +  ++   +  LV EY   G L  + H S +     E  +         A ++  A+
Sbjct: 60  --YAFQTEEKLY--LVLEYAPGGEL--FSHLSKEGRFSEERARF-------YAAEIVLAL 106

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAH---QNFSLSHQLDSASKTPSSSIGIKGTVG 726
           EYLH      I++ DLKP N+LLD D   H    +F L+ +L S     ++  G   T  
Sbjct: 107 EYLHSL---GIIYRDLKPENILLDADG--HIKLTDFGLAKELSSEGSRTNTFCG---TPE 158

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           Y+APE  +G       D +S G+LL EM TG+ P
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 3e-24
 Identities = 66/216 (30%), Positives = 114/216 (52%), Gaps = 22/216 (10%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHRN 606
            +   ++IG+G+FG VYKG+       VA+K I+L   ++ A +S + E + L+N++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE-VCKLTLIQRVNIAIDV 665
           ++K I    SI++   D   ++ EY ENGSL   + +     E +  + + Q       V
Sbjct: 61  IVKYIG---SIETS--DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------V 108

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGT 724
              + YLH   +  ++H D+K +N+L   D V    +F ++ +L+  SK  +S +G   T
Sbjct: 109 LQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVG---T 162

Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             ++APE    S AS   D++S G  ++E+ TG  P
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  103 bits (256), Expect = 2e-23
 Identities = 73/220 (33%), Positives = 109/220 (49%), Gaps = 26/220 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRH-RNLIKII 611
           +G+GSFG VY      +  +VA+KV+  K   +      F+ E + L ++ H  N++K+ 
Sbjct: 8   LGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
                  S       LV EY++ GSLED L +         L+  + + I   + SA+EY
Sbjct: 65  DFFQDEGSL-----YLVMEYVDGGSLEDLLKKIGRKG---PLSESEALFILAQILSALEY 116

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD--MVAHQNFSLSHQL---DSASKTPSSSIGIKGTVG 726
           LH      I+H D+KP N+LLD D  +V   +F L+  L    S S  P+      GT G
Sbjct: 117 LHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173

Query: 727 YVAPEYGMGSE---ASMTGDVYSFGILLLEMFTGRRPTDA 763
           Y+APE  +G     AS + D++S GI L E+ TG  P + 
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 99.0 bits (247), Expect = 5e-23
 Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 25/229 (10%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            EF     +G G FG V++G L    + VA+K++        + F  E +AL+ +RH++L
Sbjct: 6   EEFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           I +  +CS       +   ++ E ME GSL  +L       E   L +   +++A  VA 
Sbjct: 65  ISLFAVCS-----VGEPVYIITELMEKGSLLAFLRSP----EGQVLPVASLIDMACQVAE 115

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQL-DSASKTPSSSIGIKGTV 725
            + YL        +H DL   N+L+  D+V    +F L+  + +    +    I  K T 
Sbjct: 116 GMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT- 171

Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHE 773
              APE       S   DV+SFGILL EMFT G+ P       G+  HE
Sbjct: 172 ---APEAASHGTFSTKSDVWSFGILLYEMFTYGQVP-----YPGMNNHE 212

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 99.1 bits (247), Expect = 8e-23
 Identities = 69/229 (30%), Positives = 110/229 (48%), Gaps = 41/229 (17%)

Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 607
           +G+G+FG V+ G         ++ +VAVK   LK+     A + F  E E L N +H N+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQHENI 70

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK--------LTLIQRV 659
           +K   +C+  D        +VFEYME+G L  +L          K        LTL Q +
Sbjct: 71  VKFYGVCTEGDPP-----IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 660 NIAIDVASAIEYL--HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPS 716
            IA+ +AS + YL   H      VH DL   N L+ +D+V    +F +S  + +     +
Sbjct: 126 QIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT-----T 175

Query: 717 SSIGIKGT----VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
               + G     + ++ PE  M  + +   DV+SFG++L E+FT G++P
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 22/209 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITI 613
           +G G FG V+ G   G    VAVK   LK  G     +F+ E + ++ +RH  L+++  +
Sbjct: 14  LGAGQFGEVWMGTWNGT-TKVAVKT--LKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
           CS       +   +V EYM  GSL D+L          KL L Q V++A  +A  + YL 
Sbjct: 70  CS-----EEEPIYIVTEYMSKGSLLDFLKSGEGK----KLRLPQLVDMAAQIAEGMAYLE 120

Query: 674 HHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
                  +H DL   N+L+ ++ +    +F L+  ++    T     G K  + + APE 
Sbjct: 121 ---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE--GAKFPIKWTAPEA 175

Query: 733 GMGSEASMTGDVYSFGILLLEMFT-GRRP 760
                 ++  DV+SFGILL E+ T GR P
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 29/221 (13%)

Query: 553 SNMIGQGSFGSVYKGIL----GGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNL 607
              +G+G FG V               VAVK +N   +   RS F  E E LR + H N+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           +K   +C   +  G     L+ EY+ +GSL D+L +  D     ++ L + +  +  +  
Sbjct: 69  VKYKGVC---EKPGGRSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICK 120

Query: 668 AIEYLH-HHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSAS-----KTPSSSIG 720
            ++YL         +H DL   N+L++ + +V   +F L+  L         K P  S  
Sbjct: 121 GMDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES-- 174

Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPT 761
               + + APE    S+ S   DV+SFG+ L E+FT   P+
Sbjct: 175 ---PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 68/218 (31%), Positives = 112/218 (51%), Gaps = 30/218 (13%)

Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNL 607
            +IG G FG V +G L   G +E+ VA+K   LK          F+ E   +    H N+
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           I++  + +   S+      ++ EYMENGSL+ +L +++      K T+ Q V +   +AS
Sbjct: 68  IRLEGVVTK--SRPV---MIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIAS 117

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVG 726
            ++YL        VH DL   N+L++ ++V    +F LS +L+ +  T ++  G K  + 
Sbjct: 118 GMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGG-KIPIR 173

Query: 727 YVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           + APE   Y   + AS   DV+SFGI++ E+ + G RP
Sbjct: 174 WTAPEAIAYRKFTSAS---DVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 70/215 (32%), Positives = 107/215 (49%), Gaps = 39/215 (18%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVK------VINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           IG+G+FG VYKG+L G    VAVK        +LK+K     F+ E E L+   H N++K
Sbjct: 3   IGKGNFGDVYKGVLKGN-TEVAVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVK 56

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +I +C            +V E +  GSL  +L +  + L V KL     + +++D A+ +
Sbjct: 57  LIGVCVQKQPI-----YIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGM 106

Query: 670 EYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS---SIGIKGTV 725
           EYL        +H DL   N L+ +++++   +F +S + +    T S     I IK T 
Sbjct: 107 EYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT- 162

Query: 726 GYVAPE---YGMGSEASMTGDVYSFGILLLEMFTG 757
              APE   YG  +  S   DV+S+GILL E F+ 
Sbjct: 163 ---APEALNYGRYTSES---DVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 23/224 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G FG V++G+       VAVK +        + F+AE + ++ +RH  LI++  +C+
Sbjct: 14  LGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
             +        +V E M+ GSL ++L           L L Q +++A  VAS + YL   
Sbjct: 72  LEEPI-----YIVTELMKYGSLLEYLQ----GGAGRALKLPQLIDMAAQVASGMAYLEAQ 122

Query: 676 CQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                +H DL   NVL+ ++++    +F L+  +           G K  + + APE  +
Sbjct: 123 ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE--GAKFPIKWTAPEAAL 177

Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKM 777
            +  S+  DV+SFGILL E+ T GR P       G+T  E ++ 
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMP-----YPGMTNAEVLQQ 216

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 94.1 bits (235), Expect = 4e-21
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 24/210 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 613
           IG+G++G VYK        +VA+K I ++ +  G   + + E + L+ +RH N++++  I
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 614 CSSIDSKGADFKALVFEYME---NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
            +S   KG+ +  +VFEYM+    G     L  S +     K T  Q       +   ++
Sbjct: 67  VTS-KGKGSIY--MVFEYMDHDLTG-----LLDSPEV----KFTESQIKCYMKQLLEGLQ 114

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           YLH +    I+H D+K SN+L+++D ++   +F L+      +    ++  I  T+ Y  
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRP 169

Query: 730 PEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
           PE  +G+       D++S G +L E+F G+
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 71/207 (34%), Positives = 104/207 (50%), Gaps = 23/207 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+G FG V  G   G +  VAVK I  K     ++F+AE   +  +RH NL++++ +  
Sbjct: 14  IGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 68

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
            ++ KG  +  +V EYM  GSL D+L      +    L     +  ++DV  A+EYL  +
Sbjct: 69  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEAN 121

Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL   NVL+  D VA   +F L+ +  S   T       K  V + APE   
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG------KLPVKWTAPEALR 172

Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
             + S   DV+SFGILL E+++ GR P
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 90.7 bits (225), Expect = 4e-20
 Identities = 59/211 (27%), Positives = 110/211 (52%), Gaps = 18/211 (8%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRN 606
           ++    + +G G +G VY+G+     + VAVK   LK+       F+ E   ++ I+H N
Sbjct: 6   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPN 63

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           L++++ +C+    +   F  ++ E+M  G+L D+L +  +  EV  + L+    +A  ++
Sbjct: 64  LVQLLGVCT----REPPF-YIITEFMTYGNLLDYL-RECNRQEVNAVVLLY---MATQIS 114

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
           SA+EYL        +H DL   N L+ ++ +V   +F LS  +   + T  +  G K  +
Sbjct: 115 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAKFPI 169

Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 74/241 (30%), Positives = 116/241 (48%), Gaps = 39/241 (16%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+G FG+V +G   G++  VAVK  N+K     ++F+ E   +  + H+NL++++ +  
Sbjct: 14  IGEGEFGAVLQGEYTGQK--VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV-- 67

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
            I   G     +V E M  G+L ++L      L    +++IQ +  ++DVA  +EYL   
Sbjct: 68  -ILHNGL---YIVMELMSKGNLVNFLRTRGRAL----VSVIQLLQFSLDVAEGMEYLE-- 117

Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               +VH DL   N+L+  D VA   +F L      A          K  V + APE   
Sbjct: 118 -SKKLVHRDLAARNILVSEDGVAKVSDFGL------ARVGSMGVDNSKLPVKWTAPEALK 170

Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLM 793
             + S   DV+S+G+LL E+F+ GR P             + KM+L E V E V+    M
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAP-------------YPKMSLKE-VKECVEKGYRM 216

Query: 794 E 794
           E
Sbjct: 217 E 217

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 21/208 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA-FRSFVAECEALRNIRHRNLIKIITIC 614
           +G G+ G V K +      I+AVK I L+   A  +  + E + L          I+   
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY---IVGFY 65

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            +  + G     +  EYM+ GSL+  L +    +    L       IA+ V   + YLH 
Sbjct: 66  GAFYNNGDIS--ICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE 118

Query: 675 HCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQL-DSASKTPSSSIGIKGTVGYVAPEY 732
             +  I+H D+KPSN+L++    +   +F +S QL +S +KT        GT  Y+APE 
Sbjct: 119 --KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT------FVGTSSYMAPER 170

Query: 733 GMGSEASMTGDVYSFGILLLEMFTGRRP 760
             G++ S+  D++S G+ L+E+ TGR P
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 88.0 bits (219), Expect = 4e-19
 Identities = 65/247 (26%), Positives = 99/247 (40%), Gaps = 45/247 (18%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINL-------KQKGAFRSFVAECEAL-RNIRHRNL 607
           IG+GSF +V            A+K+++        K K        E E L R   H  +
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI----EKEVLTRLNGHPGI 64

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           IK+    +  D +   F   V EY  NG L  ++ +         L        A ++  
Sbjct: 65  IKLY--YTFQDEENLYF---VLEYAPNGELLQYIRK------YGSLDEKCTRFYAAEILL 113

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDM---------VAHQNFSLSHQLDSASKTPSSS 718
           A+EYLH      I+H DLKP N+LLD DM             + + S + +    T   S
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 719 IGIK---------GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL 769
              K         GT  YV+PE      A  + D+++ G ++ +M TG+ P   +  E L
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS-NEYL 229

Query: 770 TLHEFVK 776
           T  + +K
Sbjct: 230 TFQKILK 236

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 89.1 bits (221), Expect = 5e-19
 Identities = 72/243 (29%), Positives = 113/243 (46%), Gaps = 28/243 (11%)

Query: 525 SVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK 584
           S  +S +       S    +K+ SE    N IG G+ G+VYK I      + A+KVI   
Sbjct: 51  SSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN 110

Query: 585 QKGAFRSFVA-ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ 643
            +   R  +  E E LR++ H N++K    C  +     + + L+ E+M+ GSLE     
Sbjct: 111 HEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEG--TH 163

Query: 644 SNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNF 702
             D   +         ++A  + S I YLH      IVH D+KPSN+L++    V   +F
Sbjct: 164 IADEQFLA--------DVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADF 212

Query: 703 SLSHQLDSASKTPSSSIGIKGTVGYVAPE-----YGMGSEASMTGDVYSFGILLLEMFTG 757
            +S  L       +SS+   GT+ Y++PE        G+     GD++S G+ +LE + G
Sbjct: 213 GVSRILAQTMDPCNSSV---GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269

Query: 758 RRP 760
           R P
Sbjct: 270 RFP 272

Length = 353

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 31/216 (14%)

Query: 556 IGQGSFGSVYKGIL---GGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FGSV KG+     G+E+ VAVK   LKQ       + F+ E   +  + H  +++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKT--LKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +I +C     KG     LV E    G L  +L +    + V  L  +     A  VA  +
Sbjct: 61  LIGVC-----KGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDLKEL-----AHQVAMGM 108

Query: 670 EYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            YL        VH DL   NVLL +       +F +S  L + S    ++   +  + + 
Sbjct: 109 AYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY 165

Query: 729 APE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           APE   YG  S  S   DV+S+G+ L E F+ G +P
Sbjct: 166 APECINYGKFSSKS---DVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 87.3 bits (217), Expect = 9e-19
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 24/210 (11%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
            IG+G+ G VYK         VA+K + L+++      + E   +++ +H N      I 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPN------IV 78

Query: 615 SSIDS-KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVNIAIDVASAIEY 671
              DS    D   +V EYM+ GSL D + Q         + +   Q   +  +V   +EY
Sbjct: 79  DYYDSYLVGDELWVVMEYMDGGSLTDIITQ-------NFVRMNEPQIAYVCREVLQGLEY 131

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           LH      ++H D+K  N+LL  D  V   +F  + QL       +S   + GT  ++AP
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS---VVGTPYWMAP 185

Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           E     +     D++S GI+ +EM  G  P
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 67/221 (30%), Positives = 112/221 (50%), Gaps = 35/221 (15%)

Query: 555 MIGQGSFGSVYKGIL---GGEEMIVAVKVINLKQKGAF-----RSFVAECEALRNIRHRN 606
           +IG G FG V +G L   G  E+ VA+K +    K  +     R F++E   +    H N
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTL----KSGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 607 LIK---IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +I    ++T    +         ++ E+MENG+L+ +L Q ND     + T+IQ V +  
Sbjct: 67  IIHLEGVVTKSRPV--------MIITEFMENGALDSFLRQ-NDG----QFTVIQLVGMLR 113

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTP--SSSIG 720
            +A+ ++YL    +   VH DL   N+L++ ++V    +F LS  L+  +  P  +SS+G
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170

Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLE-MFTGRRP 760
            K  + + APE     + +   DV+S+GI++ E M  G RP
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 85.6 bits (213), Expect = 2e-18
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 52/231 (22%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINL-KQKGAFRSFV-AECEALRNIRHRNLIKII 611
             IG+GSFG VY      +  +  +K I+L       R     E + L+ + H N+IK  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 612 TICSSIDSKGADFKA-----LVFEYMENGSLEDWLHQ---SNDHL---EVCKLTLIQRVN 660
                       F+      +V EY + G L   + +           ++     +Q   
Sbjct: 66  ----------ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-FVQ--- 111

Query: 661 IAIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSS 718
               +  A++YLH       I+H D+KP N+ L  + +    +F +S  L S      + 
Sbjct: 112 ----LCLALKYLHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV 163

Query: 719 IGIKGTVGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           +   GT  Y++PE      Y   +  S   D++S G +L E+ T + P + 
Sbjct: 164 V---GTPYYLSPELCQNKPY---NYKS---DIWSLGCVLYELCTLKHPFEG 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 86.0 bits (214), Expect = 2e-18
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 29/211 (13%)

Query: 556 IGQGSFGSVYKGI--LGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKII 611
           +G+G++G VYK      GE  IVA+K I L  +  G   + + E   L+ ++H N++K++
Sbjct: 7   LGEGTYGVVYKARDKKTGE--IVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +  +          LVFEY +   L+ +L +    L      LI+   I   +   + Y
Sbjct: 65  DVIHTERKL-----YLVFEYCDM-DLKKYLDKRPGPLS---PNLIKS--IMYQLLRGLAY 113

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMV---AHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            H H    I+H DLKP N+L++ D V   A  +F L+       +T +  +    T+ Y 
Sbjct: 114 CHSHR---ILHRDLKPQNILINRDGVLKLA--DFGLARAFGIPLRTYTHEV---VTLWYR 165

Query: 729 APEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
           APE  +GS+   T  D++S G +  EM TG+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 25/220 (11%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHR 605
           SE      +G G FG V+ G   G+ + VA+K+I    +GA     F+ E + +  + H 
Sbjct: 4   SELTFLKELGSGQFGVVHLGKWRGK-IDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHP 59

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           NL+++  +C+    +   F  +V EYM NG L ++L +        +  L    ++  DV
Sbjct: 60  NLVQLYGVCTK---QRPIF--IVTEYMANGCLLNYL-RERKGKLGTEWLL----DMCSDV 109

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS-HQLDSASKTPSSSIGIKG 723
             A+EYL  +     +H DL   N L+  D V    +F L+ + LD      +SS G K 
Sbjct: 110 CEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKF 163

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
            V +  PE    S  S   DV+SFG+L+ E+F+ G+ P +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 84.6 bits (209), Expect = 5e-18
 Identities = 73/285 (25%), Positives = 135/285 (47%), Gaps = 36/285 (12%)

Query: 548 SEFASSNMIGQGSFGSVYKGIL---GGEEMIVAVKVINL----KQKGAFRSFVAECEALR 600
           S      +IG G FG V++GIL   G +E+ VA+K +      KQ+   + F++E   + 
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMG 61

Query: 601 NIRHRNLIKIITICSSIDSKGADFK--ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
              H N+I++  + +        FK   ++ EYMENG+L+ +L   +      + +  Q 
Sbjct: 62  QFSHHNIIRLEGVVTK-------FKPAMIITEYMENGALDKYLRDHDG-----EFSSYQL 109

Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSS 717
           V +   +A+ ++YL        VH DL   N+L++ ++     +F LS  L+   +   +
Sbjct: 110 VGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166

Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPT-DAAFTEGL-TLHEF 774
           + G K  + + APE     + +   DV+SFGI++ E+ + G RP  D +  E +  +++ 
Sbjct: 167 TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG 226

Query: 775 VKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITR 819
            ++  P        PS + ++M         RR R  D +N + +
Sbjct: 227 FRLPAPMDC-----PSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 23/209 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITI 613
           +GQG FG V+ G   G    VA+K +   + G     +F+ E + ++ +RH  L+++  +
Sbjct: 14  LGQGCFGEVWMGTWNGTTR-VAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            S       +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+ 
Sbjct: 70  VSE------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 119

Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
              +   VH DL+ +N+L+  ++V    +F L+  ++    T     G K  + + APE 
Sbjct: 120 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFPIKWTAPEA 174

Query: 733 GMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            +    ++  DV+SFGILL E+ T GR P
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 84.2 bits (208), Expect = 8e-18
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 31/218 (14%)

Query: 555 MIGQGSFGSVYKGIL---GGEEMIVAVKVINL----KQKGAFRSFVAECEALRNIRHRNL 607
           +IG G FG V  G L   G  E+ VA+K +      KQ+   R F++E   +    H N+
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR---RDFLSEASIMGQFDHPNI 67

Query: 608 IK---IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
           I    ++T    +         +V EYMENGSL+ +L + +        T+IQ V +   
Sbjct: 68  IHLEGVVTKSKPV--------MIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRG 114

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKG 723
           +AS ++YL        VH DL   N+L++ ++V    +F LS  L+   +   ++ G K 
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLE-MFTGRRP 760
            + + APE     + +   DV+S+GI++ E M  G RP
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 84.4 bits (209), Expect = 8e-18
 Identities = 64/240 (26%), Positives = 116/240 (48%), Gaps = 35/240 (14%)

Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGIL---GGEEMIVAVKVINLKQK--GAFRS-FVAE 595
           E+  +   F     +G+G+FG VYKG L          +V +  LK+      +  F  E
Sbjct: 1   EIPLSAVRF--LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC---- 651
            E + +++H N++ ++ +C+           ++FEY+ +G L ++L +++ H +V     
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPT-----CMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 652 ------KLTLIQRVNIAIDVASAIEYLH-HHCQPPIVHGDLKPSNVLL-DHDMVAHQNFS 703
                  L     ++IAI +A+ +EYL  HH     VH DL   N L+ +   V   +F 
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFG 169

Query: 704 LSHQLDSAS--KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           LS  + SA   +  S S+     V ++ PE  +  + +   D++SFG++L E+F+ G +P
Sbjct: 170 LSRDIYSADYYRVQSKSLL---PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 48/223 (21%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG G++G VYK   I  GE  +VA+KVI L+    F     E   L+  RH N++     
Sbjct: 11  IGSGTYGDVYKARDIATGE--LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF-- 66

Query: 614 CSSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLE------VCKLTLIQRVNIAI 663
                  G+  +     +V EY   GSL+D    +   L       VC+ TL        
Sbjct: 67  -------GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-------- 111

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIK 722
                + YLH   +   +H D+K +N+LL +   V   +F +S QL +      S I   
Sbjct: 112 ---KGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI--- 162

Query: 723 GTVGYVAPEYGMGSEASMTG-----DVYSFGILLLEMFTGRRP 760
           GT  ++APE  + +     G     D+++ GI  +E+   + P
Sbjct: 163 GTPYWMAPE--VAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 33/213 (15%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G+GS+GSVYK I      +VA+KV+ +  +   +  + E   L+      ++K      
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKY----- 63

Query: 616 SIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVASA 668
                G+ FK     +V EY   GS+       +D +++   TL +   IA         
Sbjct: 64  ----YGSYFKNTDLWIVMEYCGAGSV-------SDIMKITNKTLTEE-EIAAILYQTLKG 111

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +EYLH +     +H D+K  N+LL+ +  A   +F +S QL       ++ I   GT  +
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI---GTPFW 165

Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +APE       +   D++S GI  +EM  G+ P
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 81.6 bits (201), Expect = 6e-17
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 29/223 (13%)

Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G+FG V+       +   ++M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWL--HQSNDHL-------EVCKLTLIQRVNI 661
             +C+           +VFEYM +G L  +L  H  +  +          +LTL Q + I
Sbjct: 73  YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIG 720
           A  +AS + YL        VH DL   N L+   +V    +F +S  + S   T    +G
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS---TDYYRVG 181

Query: 721 IKGT--VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            +    + ++ PE  +  + +   D++SFG++L E+FT G++P
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 25/212 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 613
           +G G FG V  G   G+   VA+K+I   ++G+     F+ E + +  + H  L+++  +
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
           C+    +   +  +V EYM NG L ++L +     +  +L     + +  DV   + YL 
Sbjct: 68  CTK---QRPIY--IVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLE 117

Query: 674 HHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLS-HQLDSASKTPSSSIGIKGTVGYVAPE 731
                  +H DL   N L+D    V   +F LS + LD      +SS+G K  V +  PE
Sbjct: 118 SK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPE 171

Query: 732 YGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
             + S+ S   DV++FG+L+ E+++ G+ P +
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 80.8 bits (199), Expect = 7e-17
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 31/223 (13%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 605
           SE      IG G FG V+ G    E+  VA+K I   ++GA     F+ E + +  + H 
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHP 59

Query: 606 NLIKIITIC---SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            L+++  +C   S I         LVFE+ME+G L D+L          + TL+    + 
Sbjct: 60  KLVQLYGVCTERSPI--------CLVFEFMEHGCLSDYLRAQRGKFS--QETLLG---MC 106

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSH-QLDSASKTPSSSIG 720
           +DV   + YL       ++H DL   N L+  + V    +F ++   LD      +SS G
Sbjct: 107 LDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY---TSSTG 160

Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
            K  V + +PE    S+ S   DV+SFG+L+ E+F+ G+ P +
Sbjct: 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 23/214 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           I +G++G V+         I A+KVI    + +K      + E + L   +      ++ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS---PYVVK 57

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +  S   K   +  LV EY+  G L   L       E      + R+ IA ++  A+EYL
Sbjct: 58  LYYSFQGKKNLY--LVMEYLPGGDLASLLENVGSLDED-----VARIYIA-EIVLALEYL 109

Query: 673 HHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSH-----QLDSASKTPSSSIGIKGTVG 726
           H +    I+H DLKP N+L+D +  +   +F LS      +  + +        I GT  
Sbjct: 110 HSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           Y+APE  +G   S T D +S G +L E   G  P
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 78/284 (27%), Positives = 130/284 (45%), Gaps = 57/284 (20%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITI 613
           +G G FG V+ G   G    VA+K  +LKQ G+    +F+AE   ++ ++H  L+++  +
Sbjct: 14  LGAGQFGEVWMGYYNGHTK-VAIK--SLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +       +   ++ EYMENGSL D+L          KLT+ + +++A  +A  + ++ 
Sbjct: 70  VTQ------EPIYIITEYMENGSLVDFLKTPEGI----KLTINKLIDMAAQIAEGMAFIE 119

Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE- 731
              +   +H DL+ +N+L+   +     +F L+  ++    T     G K  + + APE 
Sbjct: 120 ---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEA 174

Query: 732 --YGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD 788
             YG  +  S   DV+SFGILL E+ T GR P             +  MT PE VI+ ++
Sbjct: 175 INYGTFTIKS---DVWSFGILLTEIVTYGRIP-------------YPGMTNPE-VIQNLE 217

Query: 789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFER 832
                         +  R  R  +C   +     LC  E P ER
Sbjct: 218 --------------RGYRMPRPDNCPEELYELMRLCWKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 25/214 (11%)

Query: 556 IGQGSFGSVYKGI---LGGEEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G GSFG V +G     GG+ + VAVK + + K       F+ E   + ++ H NLI++ 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +  +          +V E    GSL D L +  D L    ++ +   + A+ +A+ + Y
Sbjct: 63  GVVLTHPLM------MVTELAPLGSLLDRLRK--DALGHFLISTL--CDYAVQIANGMRY 112

Query: 672 LHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+LL   D V   +F L   L            +K    + AP
Sbjct: 113 LE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Query: 731 E---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           E       S AS   DV+ FG+ L EMFT G  P
Sbjct: 170 ESLRTRTFSHAS---DVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 23/209 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITI 613
           +G G FG V+ G   G    VAVK +   + G     SF+ E + ++ +RH  L+++  +
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-VAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            S       +   +V EYM  GSL D+L           L L   V++A  VA+ + Y+ 
Sbjct: 70  VSE------EPIYIVTEYMSKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYIE 119

Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
              +   +H DL+ +N+L+   +V    +F L+  ++    T     G K  + + APE 
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ--GAKFPIKWTAPEA 174

Query: 733 GMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            +    ++  DV+SFGILL E+ T GR P
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 12/214 (5%)

Query: 555 MIGQGSFGSVYKGILGGEEMI---VAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIK 609
           ++G+G FGSV +G L  ++     VAVK + L          F++E   +++  H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 610 IITICSSIDSKGADFKALV-FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           +I +C    S     K +V   +M++G L  +L  S       KL L   +   +D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +EYL +      +H DL   N +L  DM V   +F LS ++ S        I  K  V +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA-KMPVKW 181

Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           +A E       +   DV++FG+ + E+ T G+ P
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 78.2 bits (192), Expect = 7e-16
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 23/209 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITI 613
           +GQG FG V+ G   G    VA+K +   + G     +F+ E + ++ +RH  L+ +  +
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            S       +   +V E+M  GSL D+L + +       L L Q V++A  +A  + Y+ 
Sbjct: 70  VSE------EPIYIVTEFMGKGSLLDFLKEGDGK----YLKLPQLVDMAAQIADGMAYIE 119

Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
              +   +H DL+ +N+L+  ++V    +F L+  ++    T     G K  + + APE 
Sbjct: 120 ---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ--GAKFPIKWTAPEA 174

Query: 733 GMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            +    ++  DV+SFGILL E+ T GR P
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 73/256 (28%), Positives = 106/256 (41%), Gaps = 43/256 (16%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-----QKGAFRSFVAECEALRNIR 603
           +    + +G+G+ GSV K  L    MI A+K I        QK   R    E E  ++ +
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR----ELEINKSCK 57

Query: 604 HRNLIKIITIC-----SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI-- 656
              ++K          SSI         +  EY E GSL+          +V K      
Sbjct: 58  SPYIVKYYGAFLDESSSSI--------GIAMEYCEGGSLDSIYK------KVKKRGGRIG 103

Query: 657 QRV--NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQL-DSAS 712
           ++V   IA  V   + YLH      I+H D+KPSN+LL     V   +F +S +L +S +
Sbjct: 104 EKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160

Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH 772
            T        GT  Y+APE   G   S+T DV+S G+ LLE+   R P        L   
Sbjct: 161 GT------FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI 214

Query: 773 EFVKMTLPEKVIEIVD 788
           E +   +     E+ D
Sbjct: 215 ELLSYIVNMPNPELKD 230

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 56/222 (25%), Positives = 105/222 (47%), Gaps = 22/222 (9%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGE----EMIVAVKVINLKQ-KGAFRSFVAECEALRNI 602
           +E     ++G G+FG+VYKG+   E    ++ VA+KV+  +    A +  + E   + ++
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66

Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            H ++++++ IC S          L+ + M  G L D++    D++    L     +N  
Sbjct: 67  DHPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYL-----LNWC 115

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  LD   K   +  G 
Sbjct: 116 VQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG- 171

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P +
Sbjct: 172 KVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 40/225 (17%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
             F     IG+GSFG VYK I      +VA+KVI+L+            EA   I   ++
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE------------EAEDEIE--DI 46

Query: 608 IKIITICSSIDS-----------KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
            + I   S   S           KG+    ++ EY   GS  D L       +  KL   
Sbjct: 47  QQEIQFLSQCRSPYITKYYGSFLKGSKL-WIIMEYCGGGSCLDLL-------KPGKLDET 98

Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTP 715
               I  +V   +EYLH   +  I H D+K +N+LL +   V   +F +S QL S     
Sbjct: 99  YIAFILREVLLGLEYLH--EEGKI-HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155

Query: 716 SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++ +G   T  ++APE    S      D++S GI  +E+  G  P
Sbjct: 156 NTFVG---TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 30/210 (14%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVI--NLKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           ++G+G+FG V+KG L  ++  VAVK    +L Q+   + F++E   L+   H N++K+I 
Sbjct: 2   LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +C+           +V E +  G    +L +  D L+  +L     V  A+D A+ + YL
Sbjct: 60  VCTQRQPI-----YIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYL 109

Query: 673 H-HHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT-VGYVA 729
              +C    +H DL   N L+ +++++   +F +S Q D       SS G+K   + + A
Sbjct: 110 ESKNC----IHRDLAARNCLVGENNVLKISDFGMSRQEDDGI---YSSSGLKQIPIKWTA 162

Query: 730 PE---YGMGSEASMTGDVYSFGILLLEMFT 756
           PE   YG  S  S   DV+S+GILL E F+
Sbjct: 163 PEALNYGRYSSES---DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 36/213 (16%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           IG+G+FG V+ G L  +   VAVK        +LK K     F+ E   L+   H N+++
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +I +C+    K   +  +V E ++ G    +L      L+V    LIQ V    + A+ +
Sbjct: 58  LIGVCTQ---KQPIY--IVMELVQGGDFLTFLRTEGPRLKV--KELIQMVE---NAAAGM 107

Query: 670 EYLH-HHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT-VG 726
           EYL   HC    +H DL   N L+ + +++   +F +S +        +S+ G+K   V 
Sbjct: 108 EYLESKHC----IHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVK 161

Query: 727 YVAPE---YGMGSEASMTGDVYSFGILLLEMFT 756
           + APE   YG  S  S   DV+SFGILL E F+
Sbjct: 162 WTAPEALNYGRYSSES---DVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 29/216 (13%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLIKIITIC 614
           IG G+   VY  I       VA+K I+L++       +  E +A+    H N++K     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--YYT 66

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVASAIEY 671
           S +     D   LV  Y+  GSL D +  S           +    IA    +V   +EY
Sbjct: 67  SFVVG---DELWLVMPYLSGGSLLDIMKSSY------PRGGLDEAIIATVLKEVLKGLEY 117

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQL-DSASKTPSSSIGIKGTVGYVA 729
           LH + Q   +H D+K  N+LL  D  V   +F +S  L D   +T        GT  ++A
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 730 PE-----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE     +G   +A    D++SFGI  +E+ TG  P
Sbjct: 175 PEVMEQVHGYDFKA----DIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 30/228 (13%)

Query: 554 NMIGQGSFGSVYKGIL------GGEEMIVAVKVINLKQKGA----FRSFVAECEALRNIR 603
           N +G G+FG VY+G        G   + VAVK +   +KGA     + F+ E   + N  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57

Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN-DHLEVCKLTLIQRVNIA 662
           H N++K++ +C   + +      ++ E ME G L  +L  +  +      LTL + ++I 
Sbjct: 58  HPNIVKLLGVCLLNEPQ-----YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPS 716
           +DVA    YL    Q   +H DL   N L+         +V   +F L+  +  +     
Sbjct: 113 LDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169

Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDA 763
              G    V ++APE  +  + +   DV+SFG+L+ E+ T G++P  A
Sbjct: 170 EGEG-LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 20/221 (9%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIIT 612
           ++G+G+FG V+      ++ +V +K I ++Q  K    +   EC+ L+ + H N+I+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
             + ++ K      +V EY   G+L +++ +  + L      L   V I +        L
Sbjct: 67  --NFLEDKAL---MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA-------L 114

Query: 673 HHHCQPPIVHGDLKPSNVLLD-HDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           HH     I+H DLK  N+LLD H MV    +F +S  L S SK  +    + GT  Y++P
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT----VVGTPCYISP 170

Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
           E   G   +   D+++ G +L E+ + +R  +AA    L L
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 36/223 (16%)

Query: 555 MIGQGSFGSVYKG--ILGGEEMIVAVKVINL----------KQKGAFRSFVAECEALRNI 602
           +IG+G++G VY    +  GE M  AVK + L          +QK   ++  +E E L+++
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMM--AVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            H N+++ +           ++ ++  EY+  GS+   L       E       ++V   
Sbjct: 66  DHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV--- 117

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGI 721
                 + YLH      I+H DLK  N+L+D D +    +F +S + D        ++ +
Sbjct: 118 ---LEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN-DQNMSM 170

Query: 722 KGTVGYVAPE----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +G+V ++APE    Y  G  A +  D++S G ++LEMF GRRP
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 28/214 (13%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK----GAFRSFVAECEALRNIRHRNLIK 609
            +IG+G+FG V        + + A+K +N KQK    G+ R+ + E   L+ + H  L+ 
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNHPFLVN 64

Query: 610 IITICSSI-DSKGADFKALVFEYMENGSLEDWLHQSNDHLE-VCKLTLIQRVNIAIDVAS 667
           +     S  D    +   LV + +  G L   L Q     E   K           ++  
Sbjct: 65  L---WYSFQDE---ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVL 111

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVG 726
           A+EYLH      I+H D+KP N+LLD     H  +F+++ ++   + T S+S    GT G
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS----GTPG 164

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           Y+APE       S+  D +S G+   E   G+RP
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.9 bits (187), Expect = 7e-15
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 37/225 (16%)

Query: 555 MIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGA---FRSFVAECEALRNI-RHR 605
            +G+G+FG V K    G     E   VAVK+  LK           V+E E ++ I +H+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ----------SNDHLEVCKLTL 655
           N+I ++ +C+    +G  +  +V EY  +G+L D+L             +       LT 
Sbjct: 77  NIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 656 IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSA 711
              V+ A  VA  +E+L        +H DL   NVL+  D V    +F L+   H +D  
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188

Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+LL E+FT
Sbjct: 189 RKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 75.3 bits (185), Expect = 8e-15
 Identities = 62/219 (28%), Positives = 113/219 (51%), Gaps = 27/219 (12%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINL---------KQKGAFRSFVAECEALRNIRHR 605
           +IG GSFGSVY G+      ++AVK + L         +++    +   E   L+ ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N+++ +   SS+D   AD   +  EY+  GS+   L+      E    TL++  N    +
Sbjct: 67  NIVQYLG--SSLD---ADHLNIFLEYVPGGSVAALLNNYGAFEE----TLVR--NFVRQI 115

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSAS---KTPSSSIGI 721
              + YLH+     I+H D+K +N+L+D+   +   +F +S +L++ S   KT  +   +
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +G+V ++APE    +  +   D++S G L++EM TG+ P
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 58/237 (24%), Positives = 102/237 (43%), Gaps = 29/237 (12%)

Query: 553 SNMIGQGSFGSVYKGILGGEEMIVAVK--VINLKQKGAFRSFVAECEALRNIR---HRNL 607
              IG+G++G+VYK         VA+K   + L ++G   S + E   L+ +    H N+
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDH-----LEVCKLTLIQRVNIA 662
           ++++ +C    +       LVFE+++    +D L           L    +      ++ 
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIK-----DLM 113

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGI 721
             +   +++LH H    IVH DLKP N+L+  D  V   +F L+          S  +  
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-- 168

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT 778
             T+ Y APE  + S  +   D++S G +  E+F  RRP     +E   L +   + 
Sbjct: 169 --TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIFDVI 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 26/214 (12%)

Query: 555 MIGQGSFGSVYKGI---LGGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 610
            IG+G FG VY+G+      E++ VAVK        + R  F+ E   +R   H +++K+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           I + +       +   +V E    G L  +L  +   L++  L L      +  +++A+ 
Sbjct: 73  IGVITE------NPVWIVMELAPLGELRSYLQVNKYSLDLASLIL-----YSYQLSTALA 121

Query: 671 YLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSAS--KTPSSSIGIKGTVGY 727
           YL        VH D+   NVL+   D V   +F LS  L+  S  K     + IK    +
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----W 174

Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           +APE       +   DV+ FG+ + E+   G +P
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 34/226 (15%)

Query: 556 IGQGSFGSV-----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G+FG V     Y      ++M+VAVK +      A + F  E E L N++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWL--HQSNDHLEV--------CKLTLIQRVN 660
             +C        D   +VFEYM++G L  +L  H  +  + V         +L L Q ++
Sbjct: 73  YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSI 719
           IA  +AS + YL        VH DL   N L+  + +V   +F +S  + S     +   
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS-----TDYY 179

Query: 720 GIKG----TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            + G     + ++ PE  M  + +   DV+SFG++L E+FT G++P
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 68/258 (26%), Positives = 117/258 (45%), Gaps = 34/258 (13%)

Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLIK 609
           +GQGSFG VY+G+      G  E  VA+K +N       R  F+ E   ++     ++++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 610 IITICSSIDSKGADFKALV-FEYMENGSLEDWLHQSN-DHLEVCKL---TLIQRVNIAID 664
           ++ +     S G     LV  E M  G L+ +L     +      L   TL + + +A +
Sbjct: 74  LLGVV----STGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKG 723
           +A  + YL        VH DL   N ++  D+ V   +F ++  +    +T     G KG
Sbjct: 128 IADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI---YETDYYRKGGKG 181

Query: 724 T--VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
              V ++APE       +   DV+SFG++L EM T   +P      +GL+  E +K  + 
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP-----YQGLSNEEVLKFVID 236

Query: 781 EKVIEIVD--PSLLMEVM 796
              +++ +  P  L+E+M
Sbjct: 237 GGHLDLPENCPDKLLELM 254

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.4 bits (188), Expect = 3e-14
 Identities = 35/84 (41%), Positives = 56/84 (66%), Gaps = 1/84 (1%)

Query: 267 NQ-LHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSL 325
           NQ L G IP+ + +L+HLQ + +  N ++G+IPPSLG++T L  L LS+N+  G+IP SL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 326 GNCQNLKGFDASHNKLTGAIPQQV 349
           G   +L+  + + N L+G +P  +
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 73.3 bits (181), Expect = 4e-14
 Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 44/219 (20%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVK------VINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G GSFG V      G     A+K      ++ LKQ       + E   L++IRH  L+ 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ---VEHVLNEKRILQSIRHPFLVN 65

Query: 610 IITICSSIDSKGA--DFKAL--VFEYMENGSLEDWLHQSND-HLEVCKLTLIQRVNIAID 664
           +          G+  D   L  V EY+  G L   L +S      V +         A  
Sbjct: 66  LY---------GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF-------YAAQ 109

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH---QNFSLSHQLDSASKTPSSSIGI 721
           V  A+EYLH      IV+ DLKP N+LLD D   +    +F  + ++   + T      +
Sbjct: 110 VVLALEYLHS-LD--IVYRDLKPENLLLDSD--GYIKITDFGFAKRVKGRTYT------L 158

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE  +        D ++ GIL+ EM  G  P
Sbjct: 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 73.5 bits (181), Expect = 4e-14
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 22/208 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 613
           IG+G+ G V+K         VA+K + L++   G     + E +AL+  +H  ++K++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL-- 65

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
              +   G+ F  LV EYM    L + L           L   Q  +    +   + Y+H
Sbjct: 66  --DVFPHGSGF-VLVMEYMP-SDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMH 116

Query: 674 HHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDS-ASKTPSSSIGIKGTVGYVAPE 731
                 I+H DLKP+N+L+    ++   +F L+        +  S  +    T  Y APE
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV---ATRWYRAPE 170

Query: 732 YGMGSEASMTG-DVYSFGILLLEMFTGR 758
              G+     G D+++ G +  E+  G 
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.0 bits (179), Expect = 5e-14
 Identities = 73/294 (24%), Positives = 134/294 (45%), Gaps = 36/294 (12%)

Query: 556 IGQGSFGSVY------KGILGGEEMIVAVKVINLKQKGA-FRSFVAECEALRNIRHRNLI 608
           +G+G FG V       +G   GE+  VAVK +  +  G        E E LRN+ H N++
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQ--VAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           K   IC+  +  G   K L+ E++ +GSL+++L ++ + +      L Q++  A+ +   
Sbjct: 70  KYKGICT--EDGGNGIK-LIMEFLPSGSLKEYLPRNKNKI-----NLKQQLKYAVQICKG 121

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           ++YL        VH DL   NVL++ +  V   +F L+  +++  +  +    +   V +
Sbjct: 122 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178

Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV 787
            APE  + S+  +  DV+SFG+ L E+ T         +E   +  F+KM  P       
Sbjct: 179 YAPECLIQSKFYIASDVWSFGVTLYELLT------YCDSESSPMTLFLKMIGPTHG---- 228

Query: 788 DPSLLMEVMANNSMIQEDRR-ARTQDCLNAITRTGVLCSMESPFERMEMRDVVA 840
                M V     +++E +R  R  +C   + +    C    P +R   ++++ 
Sbjct: 229 ----QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.4 bits (177), Expect = 7e-14
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 15/214 (7%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS----FVAECEALRNIRHRNLIKII 611
           +G+G FGSV +G L  ++ I+ V V  +K     RS    F++E   ++   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 612 TIC-SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR--VNIAIDVASA 668
            +C  +++S+G     ++  +M++G L  +L  S   L  C   L  +  V    D+AS 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS--RLGDCPQYLPTQMLVKFMTDIASG 124

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +EYL        +H DL   N +L+ +M V   +F LS ++ +        I  K  V +
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA-KMPVKW 180

Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           +A E       +   DV+SFG+ + E+ T G+ P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 72.3 bits (177), Expect = 8e-14
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 35/285 (12%)

Query: 547 TSEFASSNMIGQGSFGSVYKGILGGE----EMIVAVKVI-NLKQKGAFRSFVAECEALRN 601
            +E     ++G G FG+V+KGI   E    ++ VA+K I +   +  F+       A+ +
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + H  +++++ IC      GA  + LV +    GSL D + Q  D L+  +L     +N 
Sbjct: 66  LDHAYIVRLLGICP-----GASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRL-----LNW 114

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIG 720
            + +A  + YL  H    +VH +L   N+LL  D +    +F ++  L    K    S  
Sbjct: 115 CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS-E 170

Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKM-- 777
            K  + ++A E  +    +   DV+S+G+ + EM + G  P       G+  HE   +  
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP-----YAGMRPHEVPDLLE 225

Query: 778 ---TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITR 819
               L +  I  +D  +   VM    MI E+ R   ++  N  TR
Sbjct: 226 KGERLAQPQICTIDVYM---VMVKCWMIDENVRPTFKELANEFTR 267

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 64/261 (24%), Positives = 114/261 (43%), Gaps = 39/261 (14%)

Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G+G FG V+          G E +V VK +   K +     F  E +  R + H+N+++
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK---LTLIQRVNIAIDVA 666
           ++ +C     + A+   ++ EY + G L+ +L  +    E  K   L+  Q+V +   +A
Sbjct: 73  LLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSS-----IGI 721
             +++L +      VH DL   N L+           +   L S SK   +S        
Sbjct: 128 LGMDHLSNA---RFVHRDLAARNCLVSSQ------REVKVSLLSLSKDVYNSEYYKLRNA 178

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP----TDAAFTEGLTLHEFVK 776
              + ++APE     + S   DV+SFG+L+ E+FT G  P    +D      L   + ++
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-LE 237

Query: 777 MTLPEKVIEIVDPSLLMEVMA 797
           + +PE       PS L ++M 
Sbjct: 238 LPVPEGC-----PSRLYKLMT 253

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 21/232 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G+G FG V    +     + A K ++   LK++   +  + E + L  +  R    I++
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF---IVS 57

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +  + ++K  D   LV   M  G L+  ++   +          + +  A  +   +E+L
Sbjct: 58  LAYAFETK--DDLCLVMTLMNGGDLKYHIYNVGEP----GFPEARAIFYAAQIICGLEHL 111

Query: 673 HHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H   Q  IV+ DLKP NVLLD H  V   +  L+ +L    K    +    GT GY+APE
Sbjct: 112 H---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA----GTPGYMAPE 164

Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV 783
              G     + D ++ G  L EM  GR P      E +   E  + TL   V
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFR-QRKEKVEKEELKRRTLEMAV 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 56/216 (25%), Positives = 105/216 (48%), Gaps = 20/216 (9%)

Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRH 604
           A + + +   +G+GS+ +VYKGI      +VA+KVI++K ++G   + + E   L+ ++H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
            N++ +  I  + ++        VFEYM    L  ++ Q    L    + L         
Sbjct: 63  ANIVLLHDIIHTKET-----LTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFM-----FQ 111

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKG 723
           +   + Y+H      I+H DLKP N+L+ +   +   +F L+      S+T SS +    
Sbjct: 112 LLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEV---V 165

Query: 724 TVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           T+ Y  P+  +G+ + S   D++  G + +EM  G+
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 32/223 (14%)

Query: 550 FASSNMIGQGSFGSVYKGIL----GGEEMIVAVK-VINLKQKGAFRSFVAECEALRNIRH 604
              S+++ +G+FG ++ GIL     G+E  V VK V +   +      + E   L  + H
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67

Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR--VNIA 662
           +N++ I+ +C        +   +++ YM  G+L+ +L Q           L  +  V++A
Sbjct: 68  QNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLS--------HQLDSASK 713
           I +A  + YLH      ++H D+   N ++D ++ V   + +LS        H L     
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180

Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            P         V ++A E  +  E S   DV+SFG+LL E+ T
Sbjct: 181 RP---------VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 57/230 (24%), Positives = 88/230 (38%), Gaps = 45/230 (19%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLIKI 610
           IG+GSFG+V K     +  I+  K I+      K+K      V+E   LR ++H N   I
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL---VSEVNILRELKHPN---I 61

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR------------ 658
           +     I  +      +V EY E G L                 LIQ+            
Sbjct: 62  VRYYDRIIDRSNQTLYIVMEYCEGGDLA---------------QLIQKCKKERKYIEEEF 106

Query: 659 -VNIAIDVASAIEYLHH--HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKT 714
              I   +  A+   H+       ++H DLKP+N+ LD +      +F L+  L   S  
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166

Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA 764
             + +   GT  Y++PE           D++S G L+ E+     P  A 
Sbjct: 167 AKTYV---GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 62/209 (29%), Positives = 91/209 (43%), Gaps = 22/209 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G G FG V    +  +    A+K +  +   + G      +E E L    H  ++K+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
             +  D K   +  ++ EY   G L   L       +        R  IA  V  A EYL
Sbjct: 60  -RTFKDKK---YIYMLMEYCLGGELWTILR-DRGLFD----EYTARFYIAC-VVLAFEYL 109

Query: 673 HHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H+     I++ DLKP N+LLD +  V   +F  + +L S  KT +      GT  YVAPE
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT----FCGTPEYVAPE 162

Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +      + D +S GILL E+ TGR P
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 27/219 (12%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHR 605
           +EF   N IG+G++G VY+        IVA+K + +  +  G   S + E   L N+RH 
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMEN--GSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           N++++  +   +  K  D   LV EY E    SL D +            +  Q   + +
Sbjct: 67  NIVELKEV---VVGKHLDSIFLVMEYCEQDLASLLDNMP--------TPFSESQVKCLML 115

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLS--HQLDSASKTPSSSIG 720
            +   ++YLH +    I+H DLK SN+LL D   +   +F L+  + L +   TP     
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-- 170

Query: 721 IKGTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
              T+ Y APE  +G     T  D+++ G +L E+   +
Sbjct: 171 ---TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 18/206 (8%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++ +VYKG       IVA+K I+L  ++G   + + E   ++ ++H N++++  + 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            + ++K      LVFEYM+     D     + H     L      +    +   I + H 
Sbjct: 68  HT-ENK----LMLVFEYMDK----DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 675 HCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
           +    ++H DLKP N+L++    +   +F L+        T S+ +    T+ Y AP+  
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEV---VTLWYRAPDVL 172

Query: 734 MGSEASMTG-DVYSFGILLLEMFTGR 758
           +GS    T  D++S G ++ EM TGR
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 62/234 (26%), Positives = 108/234 (46%), Gaps = 43/234 (18%)

Query: 556 IGQGSFGSVYK----GILGGEE-MIVAVKVINLKQKGAF---RSFVAECEALRNIRHRNL 607
           IGQG+FG V++    G+L  E   +VAVK+  LK++ +      F  E   +    H N+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLED--------WLHQ-SNDHLEV-------C 651
           +K++ +C+           L+FEYM  G L +             S+             
Sbjct: 71  VKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDS 710
            L+  +++ IA  VA+ + YL    +   VH DL   N L+  +MV    +F LS  + S
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 711 AS---KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           A     + + +I I+    ++ PE    +  +   DV+++G++L E+F+ G +P
Sbjct: 183 ADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 31/231 (13%)

Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFR-SFVAECEALRN 601
            +   +F     IG+G++G VYK        +VA+K + L  +K  F  + + E + LR 
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 602 IRHRNLIKIITICSSIDSKGADFKA------LVFEYMEN---GSLEDWL-HQSNDHLEVC 651
           + HRN++ +  I +       DFK       LVFEYM++   G LE  L H S DH++  
Sbjct: 63  LNHRNIVNLKEIVTD-KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121

Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDS 710
              L++           + Y H   +   +H D+K SN+LL++   +   +F L+   +S
Sbjct: 122 MKQLLE----------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168

Query: 711 ASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRP 760
               P ++  I  T+ Y  PE  +G E      DV+S G +L E+FT ++P
Sbjct: 169 EESRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 46/302 (15%)

Query: 555 MIGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
            +G+G+FGSV    Y  +      +VAVK +        R F  E E L++++H N++K 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
             +C S   +      LV EY+  GSL D+L +  + L+  KL L      A  +   +E
Sbjct: 71  KGVCYSAGRRNL---RLVMEYLPYGSLRDYLQKHRERLDHRKLLLY-----ASQICKGME 122

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSAS-----KTPSSSIGIKGT 724
           YL        VH DL   N+L++ +  V   +F L+  L         + P  S      
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES-----P 174

Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT----GRRPTDAAFTEGLTLHEFVKMTLP 780
           + + APE    S+ S+  DV+SFG++L E+FT       P            EF++M   
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA----------EFMRMMGN 224

Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA 840
           +K  +++   L+ E++ NN      R      C   I      C    P +R    ++  
Sbjct: 225 DKQGQMIVYHLI-ELLKNNG-----RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278

Query: 841 KL 842
           ++
Sbjct: 279 QV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 74/240 (30%), Positives = 107/240 (44%), Gaps = 48/240 (20%)

Query: 539 SYAEL-SKATSE--FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA---FRSF 592
             AEL SK   E  F     IG GSFG+VY         +VA+K ++   K +   ++  
Sbjct: 3   EIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI 62

Query: 593 VAECEALRNIRHRNLIKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHL 648
           + E   L+ +RH N         +I+ KG   +     LV EY         L  ++D L
Sbjct: 63  IKEVRFLQQLRHPN---------TIEYKGCYLREHTAWLVMEYC--------LGSASDIL 105

Query: 649 EVCKLTLIQRVNIAI---DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSL 704
           EV K  L Q V IA         + YLH H +   +H D+K  N+LL +   V   +F  
Sbjct: 106 EVHKKPL-QEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG- 160

Query: 705 SHQLDSAS-KTPSSSIGIKGTVGYVAPEYGMG-SEASMTG--DVYSFGILLLEMFTGRRP 760
                SAS  +P++S    GT  ++APE  +   E    G  DV+S GI  +E+   R+P
Sbjct: 161 -----SASLVSPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 25/218 (11%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 605
           SE      +G G FG V+ G    + + VA+K IN   +GA     F+ E + +  + H 
Sbjct: 4   SELTFMKELGSGQFGVVHLGKWRAQ-IKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHP 59

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
            L+++  +C     K      +V E+MENG L ++L Q    L    L     +++  DV
Sbjct: 60  KLVQLYGVC--TQQKPL---YIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDV 109

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLS-HQLDSASKTPSSSIGIKG 723
              +EYL    +   +H DL   N L+    +V   +F ++ + LD      +SS G K 
Sbjct: 110 CEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY---TSSSGAKF 163

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            V +  PE    S+ S   DV+SFG+L+ E+FT G+ P
Sbjct: 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 4e-13
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 37/215 (17%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR------HRNL 607
           IG+G++G VYK    L GE  IVA+K I L+    F S      ALR I+      H N+
Sbjct: 7   IGEGTYGVVYKARDKLTGE--IVAIKKIKLR----FESEGIPKTALREIKLLKELNHPNI 60

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDV 665
           IK++ +      KG D   LVFE+M+   L   +      L   + K  L Q       +
Sbjct: 61  IKLLDV---FRHKG-DL-YLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ-------L 107

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    I+H DLKP N+L++   ++   +F L+    S  +  +  +    T
Sbjct: 108 LQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV---VT 161

Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
             Y APE  +G +   T  D++S G +  E+ + R
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 18/216 (8%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA-ECEALRNIRHRN 606
           S +    +IG+G++G+VY+G       +VA+K+INL       S +  E   L  +R   
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
              I     S   KG     ++ EY E GS+   L ++    E   +++I R     +V 
Sbjct: 61  PPNITKYYGSY-LKGPRL-WIIMEYAEGGSVRT-LMKAGPIAEKY-ISVIIR-----EVL 111

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
            A++Y+H      ++H D+K +N+L+ +   V   +F ++  L+  S   S+ +G   T 
Sbjct: 112 VALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVG---TP 165

Query: 726 GYVAPEYGM-GSEASMTGDVYSFGILLLEMFTGRRP 760
            ++APE    G       D++S GI + EM TG  P
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 75/297 (25%), Positives = 119/297 (40%), Gaps = 40/297 (13%)

Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 610
           +G+G FG V    Y     G   +VAVK +  +      S +  E   L+ + H N++K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
              CS    KG     L+ EY+  GSL D+L +         L L Q +  A  +   + 
Sbjct: 72  KGCCSEQGGKGL---QLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQICEGMA 121

Query: 671 YLH--HHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           YLH  H+     +H DL   NVLLD+D +V   +F L+  +    +           V +
Sbjct: 122 YLHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176

Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV 787
            A E    ++ S   DV+SFG+ L E+ T               H   K + P+K  E++
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT---------------HCDSKQSPPKKFEEMI 221

Query: 788 DP-SLLMEVMANNSMIQEDRR-ARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL 842
            P    M V+    +++   R    ++C   +      C       R   R ++  L
Sbjct: 222 GPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 70.3 bits (172), Expect = 5e-13
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 27/210 (12%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IGQG+ G+VY  I       VA+K +NL+Q+      + E   +R  +H N      I +
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPN------IVN 80

Query: 616 SIDSK-GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVASAIEY 671
            +DS    D   +V EY+  GSL D          V   T +    IA    +   A+E+
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTD----------VVTETCMDEGQIAAVCRECLQALEF 130

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           LH +    ++H D+K  N+LL  D  V   +F    Q+       S+ +   GT  ++AP
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAP 184

Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           E           D++S GI+ +EM  G  P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 6e-13
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 36/216 (16%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF------RSFVAECEALRNIRHRNLI 608
           ++G+G++G V K        IVA+K    K K +       ++ + E + LR +RH N++
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDVA 666
            +         KG  +  LVFEY+E   LE  L  S   L  +  +  + Q +       
Sbjct: 64  NLKEAFRR---KGRLY--LVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQ------ 111

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTV 725
            AI Y H H    I+H D+KP N+L+    V    +F  +  L +   +P +      T 
Sbjct: 112 -AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD--YVATR 165

Query: 726 GYVAPEYGMGSEASMTG---DVYSFGILLLEMFTGR 758
            Y APE  +G   +  G   DV++ G ++ E+  G 
Sbjct: 166 WYRAPELLVGD--TNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 38/222 (17%)

Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           F     IG+GSFG V+KGI    + +VA+K+I+L++        AE E + +I+      
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDE-IEDIQQE---- 52

Query: 610 IITICSSIDSK------GADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            IT+ S  DS       G+  K     ++ EY+  GS       + D LE   L   Q  
Sbjct: 53  -ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIA 104

Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
            I  ++   ++YLH   +   +H D+K +NVLL +H  V   +F ++ QL   + T    
Sbjct: 105 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKR 158

Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
               GT  ++APE    S      D++S GI  +E+  G  P
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 38/222 (17%)

Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           F     IG+GSFG VYKGI    + +VA+K+I+L++        AE E + +I+      
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDE-IEDIQQE---- 52

Query: 610 IITICSSIDSK------GADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            IT+ S  DS       G+  K     ++ EY+  GS  D L      LE   +  I R 
Sbjct: 53  -ITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILR- 108

Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
               ++   ++YLH   +   +H D+K +NVLL +   V   +F ++ QL       ++ 
Sbjct: 109 ----EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161

Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +   GT  ++APE    S      D++S GI  +E+  G  P
Sbjct: 162 V---GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 43/283 (15%)

Query: 556 IGQGSFGSV-----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G+FG V     Y      ++++VAVK +      A + F  E E L N++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWL--HQSNDHLEV-----CKLTLIQRVNIAI 663
             +C        D   +VFEYM++G L  +L  H  +  L        +LT  Q ++IA 
Sbjct: 73  YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIK 722
            +A+ + YL        VH DL   N L+  +++    +F +S  + S   T    +G  
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS---TDYYRVGGH 181

Query: 723 GT--VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP--------TDAAFTEGLTL 771
               + ++ PE  M  + +   DV+S G++L E+FT G++P             T+G  L
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241

Query: 772 HEFVKMTLPEKVIEIV------DPSLLMEVMANNSMIQEDRRA 808
                 T P++V +++      +P + + +   +S++Q   +A
Sbjct: 242 QR--PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 40/223 (17%)

Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           F     IG+GSFG V+KGI    + +VA+K+I+L++        AE E + +I+      
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDE-IEDIQQE---- 52

Query: 610 IITICSSIDSK------GADFKA----LVFEYMENGSLEDWLHQSN-DHLEVCKLTLIQR 658
            IT+ S  DS       G+  K     ++ EY+  GS  D L     D  ++   T+++ 
Sbjct: 53  -ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLK- 108

Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
                ++   ++YLH   +   +H D+K +NVLL +   V   +F ++ QL       ++
Sbjct: 109 -----EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160

Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            +   GT  ++APE    S      D++S GI  +E+  G  P
Sbjct: 161 FV---GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 69.5 bits (171), Expect = 1e-12
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 58/229 (25%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLIK 609
           IG G++G V   +       VA+K I+      +  K   R    E + LR++RH N+I 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENIIG 63

Query: 610 IITICSSIDSKGADFKAL--VFEYMENGSLEDWLHQ--------SNDHLEVCKLTLIQRV 659
           ++ I         DF  +  V E ME     D LH+        ++DH    +  L Q  
Sbjct: 64  LLDI--LRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLTDDH---IQYFLYQ-- 111

Query: 660 NIAIDVASAIEYLH--HHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPS 716
                +   ++YLH  +     ++H DLKPSN+L++ +  +   +F L+  +D       
Sbjct: 112 -----ILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Query: 717 SSIGIKGTVGYV------APEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
                     YV      APE  + S       D++S G +  E+ T +
Sbjct: 162 ------FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 72/279 (25%), Positives = 132/279 (47%), Gaps = 25/279 (8%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGE----EMIVAVKVIN-LKQKGAFRSFVAECEALRNI 602
           +E     ++G G+FG+VYKGI   E    ++ VA+K++N      A   F+ E   + ++
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66

Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            H +L++++ +C S   +      LV + M +G L D++H+  D++    L     +N  
Sbjct: 67  DHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWC 115

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL    +  +VH DL   NVL+   + V   +F L+  L+   K  ++  G 
Sbjct: 116 VQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD-GG 171

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E     + +   DV+S+G+ + E+ T G +P D   T  +         LP
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 231

Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITR 819
           +  I  +D  +   VM    MI  D R + ++     +R
Sbjct: 232 QPPICTIDVYM---VMVKCWMIDADSRPKFKELAAEFSR 267

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 37/223 (16%)

Query: 554 NMIGQGSFGSVYKGIL--GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNI-RHRNLIK 609
           ++IG+G+FG V + ++   G +M  A+K++     +   R F  E E L  +  H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQS----------NDHLEVCKLTLIQRV 659
           ++  C   +++G  + A+  EY   G+L D+L +S           +H     LT  Q +
Sbjct: 68  LLGAC---ENRGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSS 718
             A DVA+ ++YL    +   +H DL   NVL+  ++ +   +F LS             
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---------GEE 170

Query: 719 IGIKGTVG-----YVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           + +K T+G     ++A E    S  +   DV+SFG+LL E+ +
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 25/213 (11%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF-RSFVAECEA----LRNIRHRNLIK 609
           ++G GSFGSVY+G+   +    AVK ++L   G   +  V + E     L  ++H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
            +      D+       +  E +  GSL   L +     E     +I+       +   +
Sbjct: 67  YLGTEREEDN-----LYIFLELVPGGSLAKLLKKYGSFPE----PVIR--LYTRQILLGL 115

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           EYLH       VH D+K +N+L+D + +V   +F ++ Q+   S   S     KG+  ++
Sbjct: 116 EYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS----FKGSPYWM 168

Query: 729 APEYGMGSEA-SMTGDVYSFGILLLEMFTGRRP 760
           APE         +  D++S G  +LEM TG+ P
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 32/221 (14%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVK------VINLKQKGAFRSFVAECEALRN 601
            +      +G G+FG V+       E   A+K      VI LKQ+    +   E   L+ 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKE 57

Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + H  +I++    +  D +   F  ++ EY+  G L  +L  S       + +    +  
Sbjct: 58  VSHPFIIRLF--WTEHDQR---FLYMLMEYVPGGELFSYLRNSG------RFSNSTGLFY 106

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
           A ++  A+EYLH      IV+ DLKP N+LLD +  +   +F  + +L   + T      
Sbjct: 107 ASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT------ 157

Query: 721 IKGTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRRP 760
           + GT  Y+APE  + S+      D ++ GIL+ EM  G  P
Sbjct: 158 LCGTPEYLAPEV-IQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 39/226 (17%)

Query: 556 IGQGSFGSVYKGILGGEE-------MIVAVKVINLKQKGA---FRSFVAECEALRNI-RH 604
           +G+G FG V      G +       + VAVK+  LK           V+E E ++ I +H
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS-----NDHLEVCK-----LT 654
           +N+I ++  C+    +      LV EY   G+L ++L        +   + CK     LT
Sbjct: 78  KNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132

Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDS 710
               V+ A  VA  +EYL        +H DL   NVL+  D V    +F L+   H +D 
Sbjct: 133 FKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189

Query: 711 ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             KT +  + +K    ++APE       +   DV+SFG+LL E+FT
Sbjct: 190 YKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.8 bits (171), Expect = 3e-12
 Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 14/157 (8%)

Query: 387 LEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLE 446
           L+ +++S NS  G IP SLG + S++ L++S N+ +G IPE L  L+ L  LNL+ N L 
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503

Query: 447 GEVPTK--GVFSNKTKISLQVNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSC 504
           G VP    G   ++   +   N  LC GI  L   +C    S   K+    +   V V+ 
Sbjct: 504 GRVPAALGGRLLHRASFNFTDNAGLC-GIPGLR--ACGPHLSVGAKIG---IAFGVSVAF 557

Query: 505 LILSSCLTIVFARR------RRSAHKSVDTSPAKKQF 535
           L L  C    + RR      +R A +    + A+  F
Sbjct: 558 LFLVICAMCWWKRRQNILRAQRIAAREAPYAKARTHF 594

Length = 623

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 74/245 (30%), Positives = 109/245 (44%), Gaps = 40/245 (16%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+G+FG VY+        I A+KV++ K+       VA+ E    I  RN    I + +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE------IVAKKEVAHTIGERN----ILVRT 50

Query: 616 SIDSK----GADFK-------ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI- 663
            +D      G  F         LV +YM  G L  W  Q              R    I 
Sbjct: 51  LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRFSE------DRAKFYIA 103

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++  A+E+LH +    IV+ DLKP N+LLD    +A  +F LS    + +KT ++     
Sbjct: 104 ELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FC 157

Query: 723 GTVGYVAPEYGMGSEASMTG--DVYSFGILLLEMFTGRRPTDAAFTEGL-TLHEFVKMTL 779
           GT  Y+APE  +  E   T   D +S G+L+ EM  G  P  A  T+ +     F K+  
Sbjct: 158 GTTEYLAPEV-LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF 216

Query: 780 PEKVI 784
           P+ V+
Sbjct: 217 PKNVL 221

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 19/210 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G+G FG V    +     + A K +N   LK++  +   + E   L  +  R    I++
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF---IVS 57

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +  +  +K  D   LV   M  G L    H  N   E       +       + S +E+L
Sbjct: 58  LAYAFQTK-TDL-CLVMTIMNGGDLR--YHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 673 HHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQL-DSASKTPSSSIGIKGTVGYVAP 730
           H      I++ DLKP NVLLD+D  V   +  L+ +L D  SKT     G  GT G++AP
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK----GYAGTPGFMAP 166

Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           E   G E   + D ++ G+ L EM   R P
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.4 bits (168), Expect = 3e-12
 Identities = 75/251 (29%), Positives = 120/251 (47%), Gaps = 51/251 (20%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR----------HR 605
           +G+G++G V+K I    + +VA+K    K   AFR+     +A R  R          H 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALK----KIFDAFRN---ATDAQRTFREIMFLQELGDHP 67

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN---IA 662
           N++K++ +  + + K  D   LVFEYME     D LH       V +  +++ V+   I 
Sbjct: 68  NIVKLLNVIKAENDK--DI-YLVFEYMET----D-LHA------VIRANILEDVHKRYIM 113

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGI 721
             +  A++Y+H      ++H DLKPSN+LL+ D  V   +F L+  L    + P + +  
Sbjct: 114 YQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170

Query: 722 K--GTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT 778
               T  Y APE  +GS     G D++S G +L EM  G+      F    TL++     
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK----PLFPGTSTLNQL---- 222

Query: 779 LPEKVIEIVDP 789
             EK+IE++ P
Sbjct: 223 --EKIIEVIGP 231

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 23/216 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITIC 614
           IG+G++G VYK        +VA+K++++  +        E   LR    H N+       
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 615 SSIDSKGADFKA-LVFEYMENGSLEDW---LHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
              +  G D +  LV E    GS+ D    L +    L+   +  I R     +    + 
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGLA 127

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           YLH +    ++H D+K  N+LL  +  V   +F +S QLDS     ++ I   GT  ++A
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWMA 181

Query: 730 PEYGMGSEA-----SMTGDVYSFGILLLEMFTGRRP 760
           PE     E          DV+S GI  +E+  G+ P
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 66/212 (31%), Positives = 93/212 (43%), Gaps = 26/212 (12%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN----LKQKGAFRSFVAECEAL-RNIRHRNLIKI 610
           IG+GSFG V       +    AVKV+     LK+K   +  +AE   L +N++H  L+ +
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ-KHIMAERNVLLKNVKHPFLVGL 61

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAI 669
                    + AD    V +Y+  G L   L +     E        R    A ++ASA+
Sbjct: 62  -----HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-------RARFYAAEIASAL 109

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            YLH      I++ DLKP N+LLD    V   +F L  +    SKT S+     GT  Y+
Sbjct: 110 GYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST---FCGTPEYL 163

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           APE         T D +  G +L EM  G  P
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 37/220 (16%)

Query: 555 MIGQGSFGSVYKGIL---GGEEMIVAVKVI----NLKQKGAFRSFVAECEALRNIRHRNL 607
           ++G G FG + +G L      E+ VA+  +    + KQ+   R F+AE   L    H N+
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR---RGFLAEALTLGQFDHSNI 68

Query: 608 IK---IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
           ++   +IT  +++         +V EYM NG+L+ +L +        +L   Q + +   
Sbjct: 69  VRLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPG 115

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
           +AS ++YL    +   VH  L    VL++ D+V   +     Q D  S+   +++  K  
Sbjct: 116 LASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK-SEAIYTTMSGKSP 171

Query: 725 VGYVAPE---YGMGSEASMTGDVYSFGILLLE-MFTGRRP 760
           V + APE   Y   S AS   DV+SFGI++ E M  G RP
Sbjct: 172 VLWAAPEAIQYHHFSSAS---DVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 24/208 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++ +V+KG     E +VA+K I L+ ++GA  + + E   L+N++H N++ +  I 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC-KLTLIQRVNIAI-DVASAIEYL 672
            +          LVFEY+++      L Q  D+   C  L  +  V I +  +   + Y 
Sbjct: 73  HTERC-----LTLVFEYLDSD-----LKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYC 119

Query: 673 HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H      I+H DLKP N+L+ +   +   +F L+      +KT S+ +    T+ Y  P+
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV---VTLWYRPPD 173

Query: 732 YGMGS-EASMTGDVYSFGILLLEMFTGR 758
             +GS E S   D++  G +L EM TGR
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 67.3 bits (164), Expect = 6e-12
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)

Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 606
           +G+G FG V +    G      +  V V V  LK           ++E E ++ I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS-----NDHLEVCK-----LTLI 656
           +I ++ +C+    +G  +  ++ EY   G+L ++L        +   ++ K     L+  
Sbjct: 80  IINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134

Query: 657 QRVNIAIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSA 711
             V+ A  VA  +EYL    C    +H DL   NVL+  D V    +F L+   H +D  
Sbjct: 135 DLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190

Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFGIL+ E+FT
Sbjct: 191 KKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.5 bits (162), Expect = 7e-12
 Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 28/227 (12%)

Query: 550 FASSNMIGQGSFGSVYKGILGGEE---MIVAVKVI--NLKQKGAFRSFVAECEALRNIRH 604
           F    M+G+G FGSV +  L  E+     VAVK++  ++        F+ E   ++   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 605 RNLIKIITICSSIDSKGA-DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
            N+IK+I +     +KG      ++  +M++G L  +L  S    E   L L   V   I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS--------ASKT 714
           D+AS +EYL        +H DL   N +L+ +M V   +F LS ++ S        ASK 
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           P         V ++A E    +  +   DV++FG+ + E+ T G+ P
Sbjct: 178 P---------VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 18/209 (8%)

Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLIK 609
            +IG+G FG VY G L    G+++  AVK +N +        F+ E   +++  H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  +
Sbjct: 61  LLGIC--LPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGM 111

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQ-LDSASKTPSSSIGIKGTVGY 727
           EYL        VH DL   N +LD    V   +F L+    D    +  +  G K  V +
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168

Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           +A E     + +   DV+SFG+LL E+ T
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 45/219 (20%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF-RSFVAECEALRNIRHRNLIKI-- 610
            ++G G+ G+VYK        I+AVKVI L       +  ++E E L       +I    
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 611 -------ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
                  I+IC+              E+M+ GSL D   +  +H+       + R  IA+
Sbjct: 67  AFFVENRISICT--------------EFMDGGSL-DVYRKIPEHV-------LGR--IAV 102

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGI 721
            V   + YL       I+H D+KPSN+L++    V   +F +S QL +S +KT       
Sbjct: 103 AVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT------Y 153

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE   G +  +  DV+S GI  +E+  GR P
Sbjct: 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+GS+ +VYKG       +VA+K I L+  +GA  + + E   L++++H N   I+T+ 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN---IVTLH 69

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWL--HQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
             I +K      LVFEY++   L+ ++        +   +L L Q       +   + Y 
Sbjct: 70  DIIHTKKT--LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ-------LLRGLAYC 119

Query: 673 HHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H      ++H DLKP N+L+     +   +F L+      SKT S+ +    T+ Y  P+
Sbjct: 120 HQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEV---VTLWYRPPD 173

Query: 732 YGMGS-EASMTGDVYSFGILLLEMFTGR 758
             +GS E S + D++  G +  EM TGR
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 58/224 (25%), Positives = 87/224 (38%), Gaps = 48/224 (21%)

Query: 556 IGQGSFGSVY--KGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHR-NLIK 609
           I +G+FGSVY  K    G+    A+KV+   ++  K    +  AE   +        + K
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYF--AIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV---------N 660
           +     S  SK  D+  LV EY+  G                  +LI+ +          
Sbjct: 62  LY---YSFQSK--DYLYLVMEYLNGGDCA---------------SLIKTLGGLPEDWAKQ 101

Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSI 719
              +V   +E LH   Q  I+H D+KP N+L+D    +   +F LS       K      
Sbjct: 102 YIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------ 152

Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
              GT  Y+APE  +G       D +S G ++ E   G  P  A
Sbjct: 153 -FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 24/208 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++ +VYKG     + +VA+K I L+ ++GA  + + E   L++++H N++ +  I 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSND--HLEVCKLTLIQRVNIAIDVASAIEYL 672
            +  S       LVFEY++   L+ +L    +  ++   KL L Q       +   + Y 
Sbjct: 74  HTEKS-----LTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ-------LLRGLNYC 120

Query: 673 HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H      ++H DLKP N+L+ +   +   +F L+      +KT S+ +    T+ Y  P+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV---VTLWYRPPD 174

Query: 732 YGMGS-EASMTGDVYSFGILLLEMFTGR 758
             +GS + S   D++  G +  EM TGR
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 24/214 (11%)

Query: 555 MIGQGSFGSVY--KGILGGEEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNL 607
           ++GQG+FG VY    +  G E  +AVK +         K    +   E + L+N++H  +
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRE--LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           ++    C   D   + F     EYM  GS++D L       E    T+ ++    I    
Sbjct: 67  VQYYG-CLRDDETLSIF----MEYMPGGSVKDQLKAYGALTE----TVTRKYTRQI--LE 115

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
            +EYLH +    IVH D+K +N+L D    V   +F  S +L +   + +    + GT  
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +++PE   G       DV+S G  ++EM T + P
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 41/109 (37%), Positives = 62/109 (56%), Gaps = 15/109 (13%)

Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQL-DSASKTPSSS 718
           IA+ +  A+EYLH   +  ++H D+KPSNVL++ +  V   +F +S  L DS +KT  + 
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA- 164

Query: 719 IGIKGTVGYVAPEYGMGSEASMTG-----DVYSFGILLLEMFTGRRPTD 762
               G   Y+APE  +  E +  G     DV+S GI ++E+ TGR P D
Sbjct: 165 ----GCKPYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 40/229 (17%)

Query: 556 IGQGSFGSVYKGI---LGGEEMIVAVKVINLKQKGA---FRSFVAECEALRNIRHRNLIK 609
           +G+G FG V K     L G      V V  LK+  +    R  ++E   L+ + H ++IK
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN------------------DHLEVC 651
           +   CS     G     L+ EY + GSL  +L +S                   D+ +  
Sbjct: 68  LYGACS---QDGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLS---HQ 707
            LT+   ++ A  ++  ++YL    +  +VH DL   NVL+ +   +   +F LS   ++
Sbjct: 123 ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 708 LDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            DS  K     I +K    ++A E       +   DV+SFG+LL E+ T
Sbjct: 180 EDSYVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 65.7 bits (161), Expect = 2e-11
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 45/222 (20%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G++  VYK        IVA+K I L      + G   + + E + L+ ++H N+I +
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVAS 667
           + +             LVFE+ME            D LE     +I+  +I +   D+ S
Sbjct: 68  LDVFGH-----KSNINLVFEFMET-----------D-LEK----VIKDKSIVLTPADIKS 106

Query: 668 -------AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSI 719
                   +EYLH +    I+H DLKP+N+L+  D V    +F L+    S ++  +  +
Sbjct: 107 YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV 163

Query: 720 GIKGTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRRP 760
               T  Y APE   G+     G D++S G +  E+   R P
Sbjct: 164 ---VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 22/211 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+FG VYK       +  A K+I ++ +     F+ E + L   +H N++ +     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA-Y 71

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
             ++K      ++ E+ + G+L+  +      LE   LT  Q   +   +  A+ +LH H
Sbjct: 72  FYENK----LWILIEFCDGGALDSIM----LELER-GLTEPQIRYVCRQMLEALNFLHSH 122

Query: 676 CQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               ++H DLK  N+LL     V   +F +S +  S  +   + I   GT  ++APE   
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVA 176

Query: 735 GSEASMT-----GDVYSFGILLLEMFTGRRP 760
                        D++S GI L+E+     P
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 20/214 (9%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +F   + +G G+ G V+K       +I+A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 63

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            I+    +  S G    ++  E+M+ GSL+  L ++    E     ++ +V+IA  V   
Sbjct: 64  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 115

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           + YL    +  I+H D+KPSN+L++    +   +F +S QL DS + +        GT  
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRS 167

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           Y++PE   G+  S+  D++S G+ L+EM  GR P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 21/211 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           IG+G F  VYK I   +  +VA+K +    +    A +  + E + L+ + H N+IK + 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV--NIAIDVASAIE 670
             S I++   +   +V E  + G L   +     H +  K  + +R      + + SA+E
Sbjct: 70  --SFIENNELN---IVLELADAGDLSRMI----KHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           ++H      I+H D+KP+NV +    +V   +  L     S +    S +   GT  Y++
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMS 174

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE    +  +   D++S G LL EM   + P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 32/224 (14%)

Query: 549 EFASSNMIGQGSFGSVYK-GILGGEEMIVAVKVINLKQ----KGA------FRSFVAECE 597
           E+A    +G G+FG VYK       + ++A+K IN+      K            V+E  
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 598 ALR-NIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDW---LHQSNDHLEVCKL 653
            ++  +RH N+++             D   +V + +E   L +    L +        ++
Sbjct: 61  IIKEQLRHPNIVRYYKTFLE-----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI 115

Query: 654 TLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSAS 712
                 NI + +  A+ YLH   +  IVH DL P+N++L + D V   +F L+ Q    S
Sbjct: 116 W-----NIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES 168

Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           K  S    + GT+ Y  PE           DV++FG +L +M T
Sbjct: 169 KLTS----VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G FG V+ G        VAVK +      + ++F+ E   ++ ++H  L+++  + +
Sbjct: 14  LGAGQFGEVWMGYYNNSTK-VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
             +        ++ EYM  GSL D+L       E  K+ L + ++ +  +A  + Y+   
Sbjct: 72  KEEPI-----YIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE-- 120

Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            +   +H DL+ +NVL+   ++    +F L+  ++    T     G K  + + APE   
Sbjct: 121 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAIN 177

Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T G+ P
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.5 bits (159), Expect = 3e-11
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 20/214 (9%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +F   + +G G+ G V K       +I+A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 63

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            I+    +  S G    ++  E+M+ GSL+  L ++    E     ++ +V+IA  V   
Sbjct: 64  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKRIPE----EILGKVSIA--VLRG 115

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           + YL    Q  I+H D+KPSN+L++    +   +F +S QL DS + +        GT  
Sbjct: 116 LAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRS 167

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           Y++PE   G+  S+  D++S G+ L+E+  GR P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.4 bits (162), Expect = 4e-11
 Identities = 34/85 (40%), Positives = 50/85 (58%), Gaps = 1/85 (1%)

Query: 243 NQ-ISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
           NQ + G IP+ I  L +L ++ +  N + G IP  +G +  L+ L +  N   GSIP SL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 302 GNLTKLADLALSFNNLQGNIPSSLG 326
           G LT L  L L+ N+L G +P++LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 29/223 (13%)

Query: 549 EFASSN---MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR 605
           E+  +    ++G+G++G VY       ++ +A+K I  +     +    E      ++HR
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N+++ +      DS+   FK +  E +  GSL   L      L+  + T+I        +
Sbjct: 66  NIVQYL----GSDSENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK---QI 117

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDMVAHQNFSLSHQLDSASKTPSSSIGIKG 723
              ++YLH +    IVH D+K  NVL++    +V   +F  S +L  A   P +     G
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTET-FTG 171

Query: 724 TVGYVAPEY------GMGSEASMTGDVYSFGILLLEMFTGRRP 760
           T+ Y+APE       G G+ A    D++S G  ++EM TG+ P
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPA----DIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 22/220 (10%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAEC--EA--LRNIRH 604
           +F   N IG+GSFG V+K +   ++ + A+K I+L      R    E   EA  L  +  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL--SKMNRREREEAIDEARVLAKLDS 58

Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
             +I+      S   KG     +V EY ENG L   L           L   Q     I 
Sbjct: 59  SYIIRYY---ESFLDKGK--LNIVMEYAENGDLHKLLKMQRGR----PLPEDQVWRFFIQ 109

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKG 723
           +   + +LH      I+H D+K  N+ LD +D V   +  ++  L   +   ++   I G
Sbjct: 110 ILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT---IVG 163

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           T  Y++PE       +   DV++ G++L E  TG+ P DA
Sbjct: 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 9e-11
 Identities = 64/240 (26%), Positives = 94/240 (39%), Gaps = 52/240 (21%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G+G  G V+   L G   + A+KV++ K   ++   +  + E E L  + H     + T
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP---FLPT 65

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASAI 669
           + +S  +    +  LV +Y   G L   L +        EV +         A +V  A+
Sbjct: 66  LYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF-------YAAEVLLAL 116

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDS--------ASKTPSSS 718
           EYLH      IV+ DLKP N+LL      M++  +F LS Q D           K    S
Sbjct: 117 EYLH--LLG-IVYRDLKPENILLHESGHIMLS--DFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 719 IGIK------------------GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                                 GT  Y+APE   G       D ++ GILL EM  G  P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 79/316 (25%), Positives = 132/316 (41%), Gaps = 58/316 (18%)

Query: 548 SEFASSNMIGQGSFGSVYKGIL--GGEEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-R 603
           ++    ++IG+G+FG V K  +   G  M  A+K +     K   R F  E E L  +  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKL 653
           H N+I ++  C   + +G  +  L  EY  +G+L D+L +S            +     L
Sbjct: 67  HPNIINLLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121

Query: 654 TLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSAS 712
           +  Q ++ A DVA  ++YL    Q   +H DL   N+L+  + VA   +F LS       
Sbjct: 122 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------ 172

Query: 713 KTPSSSIGIKGTVG-----YVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP----TD 762
                 + +K T+G     ++A E    S  +   DV+S+G+LL E+ + G  P    T 
Sbjct: 173 ---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229

Query: 763 AAFTEGLTL--------------HEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRA 808
           A   E L                ++ ++    EK  E   PS    +++ N M++E +  
Sbjct: 230 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYE--RPSFAQILVSLNRMLEERKTY 287

Query: 809 RTQDCLNAITRTGVLC 824
                    T  G+ C
Sbjct: 288 VNTTLYEKFTYAGIDC 303

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 1e-10
 Identities = 30/81 (37%), Positives = 46/81 (56%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
           +NKL G+IP+E+ S   L +L +  N L+GQ+P     +  L  L +  N L G+IP  L
Sbjct: 508 ENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567

Query: 61  GLLRNLVYLNVAENQFSGMFP 81
           G + +LV +N++ N   G  P
Sbjct: 568 GNVESLVQVNISHNHLHGSLP 588

Length = 968

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 33/221 (14%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
           S   +   IG+GS G V           VAVK ++L+++        E   +R+ +H N+
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 608 IKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           +++        S    D   +V E++E G+L D +  +  + E       Q   + + V 
Sbjct: 79  VEMY------SSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLAVL 125

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
            A+ +LH      ++H D+K  ++LL  D  V   +F    Q+   SK       + GT 
Sbjct: 126 KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGTP 179

Query: 726 GYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            ++APE      YG  +E     D++S GI+++EM  G  P
Sbjct: 180 YWMAPEVISRLPYG--TEV----DIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 63.5 bits (155), Expect = 1e-10
 Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 40/226 (17%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVK-VINLKQK-----GAFRSFVAECEALRNIRHRNLIK 609
           +G+G+FG VYK        +VA+K ++   +K      A R    E + L+ ++H N++ 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71

Query: 610 IITICSSIDSKGADFKA---LVFEYMENGSLEDWLHQSNDHLEVC--KLTLIQRVNIAID 664
           +I +      K    +    +V  YM++  L   L   +  L     K  ++Q       
Sbjct: 72  LIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQ------- 123

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTPSSSIGI 721
           +   I YLH   +  I+H D+K +N+L+D+     +A  +F L+   D     P    G 
Sbjct: 124 LLEGINYLH---ENHILHRDIKAANILIDNQGILKIA--DFGLARPYDGPPPNPKGGGGG 178

Query: 722 KG--------TVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
                     T  Y  PE  +G     T  D++  G +  EMFT R
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 33/217 (15%)

Query: 555 MIGQGSFGSVY--KGILGGEE-MIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLI 608
           ++GQGSFG V+  + I G +   + A+KV+    LK +   R+ + E + L  + H  ++
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDV 665
           K+     +  ++G  +  L+ +++  G L   L  S + +   E  K  L +       +
Sbjct: 62  KL---HYAFQTEGKLY--LILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAE-------L 107

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSSIGIKG 723
           A A+++LH      I++ DLKP N+LLD +  +   +F LS + +D   K  S      G
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS----FCG 160

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           TV Y+APE       + + D +SFG+L+ EM TG  P
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 24/207 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+GS+ +VYKG       +VA+KVI L+ ++G   + + E   L+ ++H N++ +  I 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWL--HQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
            + ++       LVFEY+    L  ++  H    H E  KL L Q       +   + Y+
Sbjct: 73  HTKET-----LTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQ-------LLRGLSYI 119

Query: 673 HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H   Q  I+H DLKP N+L+ D   +   +F L+      S T S+ +    T+ Y  P+
Sbjct: 120 H---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEV---VTLWYRPPD 173

Query: 732 YGMGS-EASMTGDVYSFGILLLEMFTG 757
             +GS E S   D++  G + +EM  G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 27/211 (12%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 613
           IG+G++G VYK         +A+K I L+Q+  G   + + E   L+ ++H N++++  +
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSND---HLEVCKLTLIQRVNIAIDVASAIE 670
             S + +      LVFEY++   L+  +  S D   +  + K  L Q       +   I 
Sbjct: 70  VHS-EKR----LYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQ-------ILRGIA 116

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDH--DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           Y H H    ++H DLKP N+L+D   + +   +F L+       +T +  +    T+ Y 
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEV---VTLWYR 170

Query: 729 APEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
           APE  +GS    T  D++S G +  EM   +
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 31/212 (14%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLI 608
           ++G+GS+G V K        IVA+K         + +K A R    E   L+ +RH NL+
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR----EIRMLKQLRHENLV 63

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSND-HLEVCKLTLIQRVNIAIDVAS 667
            +I +      +      LVFE++++  L+D     N       +  L Q       +  
Sbjct: 64  NLIEVF-----RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQ-------ILR 111

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
            IE+ H H    I+H D+KP N+L+    +V   +F  +  L +  +  +  +    T  
Sbjct: 112 GIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV---ATRW 165

Query: 727 YVAPEYGMG-SEASMTGDVYSFGILLLEMFTG 757
           Y APE  +G ++     D+++ G L+ EM TG
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 59/226 (26%), Positives = 108/226 (47%), Gaps = 33/226 (14%)

Query: 556 IGQGSFGSVYKG--ILGGEE--MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+ +FG +YKG   L G +   +VA+K + ++     +  F  E   +  + H N++ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEV-----------CKLTLIQRV 659
           + + +           ++FEY+  G L ++L   + H +V             L     +
Sbjct: 73  LGVVTQEQPV-----CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASK---TP 715
           +IAI +A+ +EYL  H     VH DL   N+L+   + V   +  LS ++ SA      P
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 716 SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            S + I+    ++ PE  M  + S   D++SFG++L E+F+ G +P
Sbjct: 185 KSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 35/224 (15%)

Query: 556 IGQGSFGSVYKGILGGEEM-----IVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 606
           +G+G FG V      G +      +  V V  LK           ++E E ++ I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L                +   +L+  
Sbjct: 86  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSAS 712
             V+ A  VA  +EYL        +H DL   NVL+  D V    +F L+   H +D   
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197

Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           KT +  + +K    ++APE       +   DV+SFG+LL E+FT
Sbjct: 198 KTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 22/230 (9%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVK-VINLKQKGAFRSFVA--ECEALRNIRH 604
           S++     IGQG+FG V+K      + IVA+K V+   +K  F    A  E + L+ ++H
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF-PITALREIKILQLLKH 70

Query: 605 RNLIKIITICSSIDSKGADFKA---LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            N++ +I IC +  +    +K    LVFE+ E+  L   L   N      K TL +   +
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-----VKFTLSEIKKV 124

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSS-- 718
              + + + Y+H +    I+H D+K +N+L+  D +    +F L+    S SK    +  
Sbjct: 125 MKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAF-SLSKNSKPNRY 180

Query: 719 IGIKGTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRRPTDAAFTE 767
                T+ Y  PE  +G        D++  G ++ EM+T R P     TE
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTE 229

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 556 IGQGSFGSVYKGILGGE--EMIVAVKVI-NLKQKGAFR-SFVAECEALRNIRHRNLIKII 611
           +G G+FG+V KG+   +  E  VAVK++ N     A +   + E   ++ + +  ++++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLT-LIQRVNIAIDVASAIE 670
            IC       A+   LV E  E G L  +L Q N H+    +T L+ +V++ +      +
Sbjct: 63  GICE------AESWMLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGM------K 109

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           YL        VH DL   NVLL     A   +F LS  L +      +    K  V + A
Sbjct: 110 YLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           PE     + S   DV+SFG+L+ E F+ G++P
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 71/226 (31%), Positives = 105/226 (46%), Gaps = 45/226 (19%)

Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 606
           F   + IG GSFG+VY         +VAVK ++   K     ++  + E + L+ ++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 607 LIKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
                    +I+ KG   K     LV EY         L  ++D LEV K  L Q V IA
Sbjct: 83  ---------TIEYKGCYLKEHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 124

Query: 663 IDVASAIE---YLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASK-TPSS 717
                A++   YLH H    ++H D+K  N+LL +   V   +F       SASK +P++
Sbjct: 125 AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG------SASKSSPAN 175

Query: 718 SIGIKGTVGYVAPEYGMG-SEASMTG--DVYSFGILLLEMFTGRRP 760
           S    GT  ++APE  +   E    G  DV+S GI  +E+   R+P
Sbjct: 176 S--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 34/214 (15%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+ G V K +     +I+A K+I+L+ K           A+RN   R L K++  C+
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIK----------PAIRNQIIREL-KVLHECN 57

Query: 616 S---IDSKGADFK----ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           S   +   GA +     ++  E+M+ GSL+  L ++    E     ++ +++IA  V   
Sbjct: 58  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----NILGKISIA--VLRG 111

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           + YL    +  I+H D+KPSN+L++    +   +F +S QL DS + +        GT  
Sbjct: 112 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRS 163

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           Y++PE   G+  ++  D++S G+ L+EM  GR P
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G FG V+      +   VAVK +      +  +F+AE   ++ ++H  L+K+  + +
Sbjct: 14  LGAGQFGEVWMATYN-KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 72  K------EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 119

Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            Q   +H DL+ +N+L+   +V    +F L+  ++    T     G K  + + APE   
Sbjct: 120 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAIN 176

Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL+E+ T GR P
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 63/240 (26%), Positives = 108/240 (45%), Gaps = 25/240 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 84

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  D   +V E++E G+L D +  +  + E       Q   + + V  A+  LH  
Sbjct: 85  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLKALSVLHAQ 135

Query: 676 CQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               ++H D+K  ++LL HD  V   +F    Q+   SK       + GT  ++APE   
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELIS 189

Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE-GLTLHEFVKMTLPEKV--IEIVDPSL 791
                   D++S GI+++EM  G  P    F E  L   + ++  LP K+  +  V PSL
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPPY---FNEPPLKAMKMIRDNLPPKLKNLHKVSPSL 246

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 43/229 (18%)

Query: 556 IGQGSFGSVY----KGIL----------GGEEMIVAVKVINLK-QKGAFRSFVAECEALR 600
           +G+G FG V+    +G+            G+ ++VAVK++     K A   F+ E + + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 601 NIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
            +++ N+I+++ +C S D        ++ EYMENG L  +L Q            I  V+
Sbjct: 73  RLKNPNIIRLLGVCVSDDPL-----CMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 661 I------AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASK 713
           I      A+ +AS ++YL        VH DL   N L+  H  +   +F +S  L S   
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS--- 181

Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTG------DVYSFGILLLEMFT 756
                  I+G    V P   M  E+ + G      DV++FG+ L EMFT
Sbjct: 182 --GDYYRIQGRA--VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 54/224 (24%), Positives = 106/224 (47%), Gaps = 29/224 (12%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA------FRSFVAECEALRNI 602
           E+    ++G+G++G+VY G+    ++I AVK + L           +     E + L+++
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLTNQGQLI-AVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEV--CKLTLIQRVN 660
           +H N+++ +  C   ++      ++  E++  GS+   L++     E   CK T      
Sbjct: 60  KHVNIVQYLGTCLDDNTI-----SIFMEFVPGGSISSILNRFGPLPEPVFCKYTK----- 109

Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSI 719
               +   + YLH++C   +VH D+K +NV+L  + ++   +F  + +L       + S 
Sbjct: 110 ---QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163

Query: 720 GIK---GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            +K   GT  ++APE    S      D++S G  + EM TG+ P
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 48/234 (20%)

Query: 550 FASSNM-----IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH 604
           F + ++     IG+G+FG+V K +      I+AVK I        RS V E E  R +  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI--------RSTVDEKEQKRLLMD 52

Query: 605 RNLIKIITICSSI-DSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            +++   + C  I    GA F+     +  E M+  SL+ +     + L+     + + +
Sbjct: 53  LDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSV---IPEEI 108

Query: 660 --NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTP 715
              IA+    A+ YL    +  I+H D+KPSN+LLD +  +   +F +S QL DS +KT 
Sbjct: 109 LGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR 166

Query: 716 SSSIGIKGTVGYVAPE---------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            +     G   Y+APE         Y + S      DV+S GI L E+ TG+ P
Sbjct: 167 DA-----GCRPYMAPERIDPSARDGYDVRS------DVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 20/207 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG+G++G VYK        +VA+K I L  + +G   + + E   L+ + H N++K++ +
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
              I ++   +  LVFE++ +  L+ ++  S   L    L LI+  +    +   + + H
Sbjct: 68  ---IHTENKLY--LVFEFL-HQDLKKFMDASP--LSGIPLPLIK--SYLFQLLQGLAFCH 117

Query: 674 HHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
            H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T+ Y APE 
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VTLWYRAPEI 171

Query: 733 GMGSEASMTG-DVYSFGILLLEMFTGR 758
            +G +   T  D++S G +  EM T R
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 37/223 (16%)

Query: 554 NMIGQGSFGSVYKGIL--GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNI-RHRNLIK 609
           ++IG+G+FG V K  +   G  M  A+K +     K   R F  E E L  +  H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLIQRV 659
           ++  C   + +G  + A+  EY  +G+L D+L +S            +     L+  Q +
Sbjct: 61  LLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSS 718
           + A DVA  ++YL    Q   +H DL   N+L+  + VA   +F LS             
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQE 163

Query: 719 IGIKGTVG-----YVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           + +K T+G     ++A E    S  +   DV+S+G+LL E+ +
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 62/239 (25%), Positives = 114/239 (47%), Gaps = 33/239 (13%)

Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQKGAFRS-FVAE 595
           E++ +T  F     +G+  FG VYKG L     G +   VA+K +  K +G  R  F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEV----- 650
                 ++H N++ ++ + +          +++F Y  +  L ++L   + H +V     
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPL-----SMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 651 ---CKLTL--IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSL 704
               K TL     V+I   +A+ +E+L  H    +VH DL   NVL+ D   V   +  L
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL 170

Query: 705 SHQLDSAS--KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
             ++ +A   K   +S+     + +++PE  M  + S+  D++S+G++L E+F+ G +P
Sbjct: 171 FREVYAADYYKLMGNSLL---PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 61.5 bits (149), Expect = 5e-10
 Identities = 55/208 (26%), Positives = 105/208 (50%), Gaps = 24/208 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++ +V+KG     E +VA+K I L+ ++GA  + + E   L++++H N++ +  I 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEV--CKLTLIQRVNIAIDVASAIEYL 672
            +  S       LVFEY++   L+ ++    + + +   K+ L Q       +   + Y 
Sbjct: 74  HTDKS-----LTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ-------ILRGLAYC 120

Query: 673 HHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H      ++H DLKP N+L++    +   +F L+      +KT S+ +    T+ Y  P+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV---VTLWYRPPD 174

Query: 732 YGMG-SEASMTGDVYSFGILLLEMFTGR 758
             +G SE S   D++  G +  EM +GR
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 61.3 bits (148), Expect = 5e-10
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 28/238 (11%)

Query: 527 DTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLK 584
           D    +K   ++S  +  K  + F     IGQG+ G+VY    I  G+E  VA+K +NL+
Sbjct: 1   DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQE--VAIKQMNLQ 55

Query: 585 QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQ 643
           Q+      + E   +R  ++ N++      + +DS    D   +V EY+  GSL D +  
Sbjct: 56  QQPKKELIINEILVMRENKNPNIV------NYLDSYLVGDELWVVMEYLAGGSLTDVV-- 107

Query: 644 SNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNF 702
                E C +   Q   +  +   A+++LH +    ++H D+K  N+LL  D  V   +F
Sbjct: 108 ----TETC-MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF 159

Query: 703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
               Q+       S+ +   GT  ++APE           D++S GI+ +EM  G  P
Sbjct: 160 GFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 33/218 (15%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++GSVYK +     + +A+K I L+  +  F   + E + L    H+ +   I   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61

Query: 615 SSIDSKGADF-KALVF---EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
             +D  GA F +  V+   EYM+ GSL D L+      E     +++R  I   V   ++
Sbjct: 62  --VDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLK 116

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLD-SASKTPSSSIGIKGTVGYV 728
           +L       I+H D+KP+NVL++ +  V   +F +S  L  S +KT   +IG +    Y+
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT---NIGCQS---YM 168

Query: 729 APEY----GMGSEASMT--GDVYSFGILLLEMFTGRRP 760
           APE     G     + T   DV+S G+ +LEM  GR P
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 60.9 bits (147), Expect = 7e-10
 Identities = 61/236 (25%), Positives = 105/236 (44%), Gaps = 24/236 (10%)

Query: 527 DTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK 586
           D    +K   ++S  +  K  + F     IGQG+ G+VY  +       VA++ +NL+Q+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58

Query: 587 GAFRSFVAECEALRNIRHRNLIKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQSN 645
                 + E   +R  ++ N++      + +DS    D   +V EY+  GSL D +    
Sbjct: 59  PKKELIINEILVMRENKNPNIV------NYLDSYLVGDELWVVMEYLAGGSLTDVV---- 108

Query: 646 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSL 704
              E C +   Q   +  +   A+E+LH +    ++H D+K  N+LL  D  V   +F  
Sbjct: 109 --TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162

Query: 705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             Q+       S+ +   GT  ++APE           D++S GI+ +EM  G  P
Sbjct: 163 CAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 27/222 (12%)

Query: 554 NMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNL 607
             +G G+FG VY+G+  G      E+ VAVK +         S F+ E   +    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE-VCKLTLIQRVNIAIDVA 666
           +++I +           + ++ E M  G L+ +L ++    E    LT+   +  A DVA
Sbjct: 72  VRLIGVSFERLP-----RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAH-QNFSLSHQLDSAS---KTPSSSI 719
              +YL    +   +H D+   N LL       VA   +F ++  +  AS   K   + +
Sbjct: 127 KGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183

Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            IK    ++ PE  +    +   DV+SFG+LL E+F+ G  P
Sbjct: 184 PIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 556 IGQGSFGSVYKGI--LGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLIKIIT 612
           +G G+FG V KG+  +  +++ VA+KV+  + + + R   + E E +  + +  ++++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +C       A+   LV E    G L  +L    D + V  +     V +   V+  ++YL
Sbjct: 63  VCE------AEALMLVMEMASGGPLNKFLSGKKDEITVSNV-----VELMHQVSMGMKYL 111

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
                   VH DL   NVLL +   A   +F LS  L +      +    K  + + APE
Sbjct: 112 E---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168

Query: 732 YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
                + S   DV+S+GI + E F+ G++P
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.1 bits (151), Expect = 9e-10
 Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 38/233 (16%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLIKII 611
           +IG+G  G VY          VA+K I  +L +    +  F+ E +   ++ H  ++ + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 612 TICSSIDS--------KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +ICS  D         +G   K+L+    +  SL      S +  E  K ++   ++I  
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL------SKELAE--KTSVGAFLSIFH 120

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLL---------DHDMVAHQNFSLSHQLDSASKT 714
            + + IEY+H      ++H DLKP N+LL         D      +       LD     
Sbjct: 121 KICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 715 PSSSIG-------IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            +           I GT  Y+APE  +G  AS + D+Y+ G++L +M T   P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 37/225 (16%)

Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI--NLKQKGAFRSFVAECEALRNI-RHR 605
           +G+G FG V      G       E + VAVK++  +  +K      V+E E ++ I +H+
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHK 81

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ--------SNDHLEVC--KLTL 655
           N+I ++  C+    +      +V EY   G+L ++L          S D   V   ++T 
Sbjct: 82  NIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136

Query: 656 IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLS---HQLDSA 711
              V+    VA  +EYL        +H DL   NVL+ +++++   +F L+   + +D  
Sbjct: 137 KDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193

Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 194 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 60.2 bits (147), Expect = 1e-09
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 29/146 (19%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-------HRN 606
           +G G+FGSVY       GE  +VA+K    K K  F S+  EC  LR ++       H N
Sbjct: 7   LGDGTFGSVYLARNKETGE--LVAIK----KMKKKFYSW-EECMNLREVKSLRKLNEHPN 59

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           ++K+  +    ++    F   VFEYME       L+Q     +    +     +I   + 
Sbjct: 60  IVKLKEVF--RENDELYF---VFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQIL 109

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLL 692
             + ++H H      H DLKP N+L+
Sbjct: 110 QGLAHIHKH---GFFHRDLKPENLLV 132

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 27/215 (12%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIR---HRNLIKI 610
           IG G++G+VYK         VA+K + ++  + G   S V E   L+ +    H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           + +C++  +       LVFE+++   L  +L    D +    L      ++       ++
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL----DKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 671 YLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSL----SHQLDSASKTPSSSIGIKGTV 725
           +LH +C   IVH DLKP N+L+     V   +F L    S Q+   + TP     +  T+
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTP-----VVVTL 171

Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            Y APE  + S  +   D++S G +  EMF  R+P
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 67/286 (23%), Positives = 131/286 (45%), Gaps = 39/286 (13%)

Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 603 RHRNLIKIITIC--SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
            + ++ +++ IC  S++         L+ + M  G L D++ +  D+  +    L+   N
Sbjct: 67  DNPHVCRLLGICLTSTVQ--------LITQLMPFGCLLDYVREHKDN--IGSQYLL---N 113

Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSI 719
             + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  
Sbjct: 114 WCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE- 169

Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKM- 777
           G K  + ++A E  +    +   DV+S+G+ + E+ T G +P D     G+   E   + 
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-----GIPASEISSIL 224

Query: 778 ----TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITR 819
                LP+  I  +D  +   +M    MI  D R + ++ +   ++
Sbjct: 225 EKGERLPQPPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFSK 267

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 26/215 (12%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+GS+GSVYK     +    A+K ++L     K++      V E   L ++ H N+I  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER---EDAVNEIRILASVNHPNIISY 64

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
               + +D        +V EY   G L   + +     ++     I R  I I +   ++
Sbjct: 65  KE--AFLDGNKL---CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--IFIQLLRGLQ 117

Query: 671 YLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDS-ASKTPSSSIGIKGTVGYV 728
            LH      I+H DLK +N+LL  +D+V   +  +S  L    +KT        GT  Y+
Sbjct: 118 ALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI------GTPHYM 168

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           APE   G   S   D++S G LL EM T   P +A
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 22/211 (10%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +IG+GSFG V       EE   AVKV+     LK+K            L+N++H  L+ +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
                    + AD    V +Y+  G L   L +     E C L    R   A ++ASA+ 
Sbjct: 62  -----HFSFQTADKLYFVLDYINGGELFYHLQR-----ERCFLEPRARF-YAAEIASALG 110

Query: 671 YLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           YLH      IV+ DLKP N+LLD    +   +F L  +    + T S+     GT  Y+A
Sbjct: 111 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST---FCGTPEYLA 164

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE         T D +  G +L EM  G  P
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 29/78 (37%), Positives = 47/78 (60%)

Query: 4   LEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLL 63
           L G IP +I  L +LQ++ +  N + G +P  +G++++L +L + +NS  G IP +LG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 64  RNLVYLNVAENQFSGMFP 81
            +L  LN+  N  SG  P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 31/83 (37%), Positives = 50/83 (60%), Gaps = 1/83 (1%)

Query: 293 LQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSI 352
           L+G IP  +  L  L  + LS N+++GNIP SLG+  +L+  D S+N   G+IP+ +  +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 353 TTLSVYLALAHNLLNDSLPLQVG 375
           T+L + L L  N L+  +P  +G
Sbjct: 490 TSLRI-LNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 22/214 (10%)

Query: 555 MIGQGSFGSVY--KGILGGEEMIVAVKVINLKQKGAFRS---FVAECEA--LRNIRHRNL 607
           ++GQG+FG VY    +  G E+  A K +    +    S      ECE   L+N++H   
Sbjct: 9   LLGQGAFGRVYLCYDVDTGREL--AAKQVQFDPESPETSKEVSALECEIQLLKNLQHE-- 64

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
            +I+     +  +      +  EYM  GS++D L       E       +++        
Sbjct: 65  -RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LE 117

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
            + YLH +    IVH D+K +N+L D    V   +F  S +L +   + +    + GT  
Sbjct: 118 GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +++PE   G       DV+S G  ++EM T + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 26/215 (12%)

Query: 556 IGQGSFGSVYKGI-LGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIR---HRNLIK 609
           IG+G++G V+K   L      VA+K + ++  ++G   S + E   LR++    H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDH---LEVCKLTLIQRVNIAIDVA 666
           +  +C+   +       LVFE+++   L  +L +  +     E  K  + Q       + 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ-------LL 120

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
             +++LH H    +VH DLKP N+L+     +   +F L+          S  +    T+
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV----TL 173

Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            Y APE  + S  +   D++S G +  EMF  R+P
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 30/215 (13%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRN------IRHRNLI 608
           M+G+GSFG V+   L G     A+K   LK+         EC  +          H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC-KLTLIQRVNIAIDVAS 667
            +     +  +K   F   V EY+  G L         H++ C K  L +    A ++  
Sbjct: 60  HLYC---TFQTKENLF--FVMEYLNGGDLMF-------HIQSCHKFDLPRATFYAAEIIC 107

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSSIGIKGTV 725
            +++LH      IV+ DLK  N+LLD D  +   +F +  + +   +KT +      GT 
Sbjct: 108 GLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT----FCGTP 160

Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            Y+APE  +G + + + D +SFG+LL EM  G+ P
Sbjct: 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 59.4 bits (143), Expect = 2e-09
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 27/210 (12%)

Query: 556 IGQGSFGSVYKGI---LGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           IGQG+ G+V+  I    G E   VA+K INL+++      + E   ++ +++ N++  + 
Sbjct: 27  IGQGASGTVFTAIDVATGQE---VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFL- 82

Query: 613 ICSSIDSK-GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
                DS    D   +V EY+  GSL D +       E C +   Q   +  +   A+E+
Sbjct: 83  -----DSFLVGDELFVVMEYLAGGSLTDVV------TETC-MDEAQIAAVCRECLQALEF 130

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           LH +    ++H D+K  NVLL  D  V   +F    Q+       S+ +G   T  ++AP
Sbjct: 131 LHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG---TPYWMAP 184

Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           E           D++S GI+ +EM  G  P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 28/217 (12%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECE-------ALRNIRHRNL 607
           ++G+GSFG V    L G + + AVKV  LK+    +    EC        AL   +H  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
            ++    S   +K   F   V EY+  G L   + +S       +    +    A ++  
Sbjct: 59  TQLH---SCFQTKDRLF--FVMEYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVL 107

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
            +++LH      I++ DLK  NVLLD +  +   +F +  +      T S+     GT  
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST---FCGTPD 161

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           Y+APE           D ++ G+LL EM  G+ P + 
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 72/285 (25%), Positives = 132/285 (46%), Gaps = 37/285 (12%)

Query: 548 SEFASSNMIGQGSFGSVYKGIL--GGE--EMIVAVKVI--NLKQKGAFRSFVAECEALRN 601
           +E     ++G G+FG+VYKGI    GE  ++ VA+KV+  N   K A +  + E   +  
Sbjct: 7   TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAG 65

Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           +    + +++ IC +   +      LV + M  G L D++ ++ D +    L     +N 
Sbjct: 66  VGSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNW 114

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIG 720
            + +A  + YL    +  +VH DL   NVL+   + V   +F L+  LD   +T   + G
Sbjct: 115 CVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHADG 170

Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKM-- 777
            K  + ++A E  +    +   DV+S+G+ + E+ T G +P D     G+   E   +  
Sbjct: 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-----GIPAREIPDLLE 225

Query: 778 ---TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITR 819
               LP+  I  +D  +   +M    MI  + R R ++ ++  +R
Sbjct: 226 KGERLPQPPICTIDVYM---IMVKCWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 60/224 (26%), Positives = 90/224 (40%), Gaps = 38/224 (16%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVK------VINLKQKGAFRSFVAECEALRN 601
           S+F     +G GSFG V      G     A+K      ++ +KQ    +    E   L  
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ---VQHVAQEKSILME 74

Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS----NDHLEVCKLTLIQ 657
           + H  ++ ++  CS  D     F   + E++  G L   L ++    ND   V K     
Sbjct: 75  LSHPFIVNMM--CSFQDENRVYF---LLEFVVGGELFTHLRKAGRFPND---VAKF---- 122

Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPS 716
                 ++  A EYLH      I++ DLKP N+LLD+   V   +F        A K P 
Sbjct: 123 ---YHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGF------AKKVPD 170

Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            +  + GT  Y+APE           D ++ G+LL E   G  P
Sbjct: 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 28/215 (13%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLIKIITIC 614
           +G G+ GSV K        ++A KV+++  K + R   + E + +   R      I++  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY---IVSFY 69

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSND-HLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +  ++      +  E+M+ GSL+    +     +E+          IA+ V   + YL+
Sbjct: 70  GAFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILG-------KIAVAVVEGLTYLY 120

Query: 674 --HHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTVGYVA 729
             H     I+H D+KPSN+L++    +   +F +S +L +S + T        GT  Y++
Sbjct: 121 NVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT------FVGTSTYMS 170

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA 764
           PE   G + ++  DV+S GI ++E+  G+ P   +
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 61/259 (23%), Positives = 119/259 (45%), Gaps = 36/259 (13%)

Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR---SFVAECEALRNIRHRNL 607
           +GQGSFG VY+GI  G      E  VA+K +N  +  + R    F+ E   ++     ++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHV 71

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VCKLTLIQRVNIAI 663
           ++++ + S           ++ E M  G L+ +L      +E        +L + + +A 
Sbjct: 72  VRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++A  + YL+ +     VH DL   N ++  D  V   +F ++  +    +T     G K
Sbjct: 127 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRKGGK 180

Query: 723 G--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTL 779
           G   V +++PE       +   DV+SFG++L E+ T   +P      +G++  + ++  +
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQGMSNEQVLRFVM 235

Query: 780 PEKVIEIVD--PSLLMEVM 796
              +++  D  P +L E+M
Sbjct: 236 EGGLLDKPDNCPDMLFELM 254

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 64/262 (24%), Positives = 114/262 (43%), Gaps = 24/262 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GS G V           VAVK ++L+++        E   +R+  H N++ +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN--- 86

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  D   +V E++E G+L D +  +  + E       Q   + + V  A+ YLH+ 
Sbjct: 87  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQ 137

Query: 676 CQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               ++H D+K  ++LL  D  +   +F    Q+   SK       + GT  ++APE   
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVIS 191

Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE-GLTLHEFVKMTLPEKVIEIVDPSLLM 793
                   D++S GI+++EM  G  P    F E  L     ++  LP +V +    S ++
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPPY---FNEPPLQAMRRIRDNLPPRVKDSHKVSSVL 248

Query: 794 EVMANNSMIQE-DRRARTQDCL 814
               +  +++E  +RA  Q+ L
Sbjct: 249 RGFLDLMLVREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.8 bits (142), Expect = 6e-09
 Identities = 75/310 (24%), Positives = 131/310 (42%), Gaps = 48/310 (15%)

Query: 131 LNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNL 190
           L+L+  +    ++    ++L N   L  LDL+ N+ +     + S L  L          
Sbjct: 70  LSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRS----NISELLEL---------- 115

Query: 191 GMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIP 250
                            ++L +L L +N    ++P  I  L S + +  +  N+I  ++P
Sbjct: 116 -----------------TNLTSLDLDNNNI-TDIPPLIGLLKSNLKELDLSDNKIE-SLP 156

Query: 251 SGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADL 310
           S +RNL NL  L +  N L   +P  +  L +L  L +  N +   +PP +  L+ L +L
Sbjct: 157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEEL 214

Query: 311 ALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSL 370
            LS N++   + SSL N +NL G + S+NKL      + +   +    L L++N ++   
Sbjct: 215 DLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLP--ESIGNLSNLETLDLSNNQISSIS 271

Query: 371 PLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFS-LGFMKSIKELNVSSNNLSGQIPEFL 429
            L  G+L N       L  LD+S NS    +P   L  +     LN+     + ++    
Sbjct: 272 SL--GSLTN-------LRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNS 322

Query: 430 QNLSFLEFLN 439
             L+     N
Sbjct: 323 ILLNNNILSN 332

Length = 394

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 22/216 (10%)

Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRN 606
           F    ++G+G FG V    +     + A K +    +K++      + E + L  +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
              ++++  + ++K  D   LV   M  G L+  ++    H+        + V  A ++ 
Sbjct: 62  ---VVSLAYAYETK--DALCLVLTLMNGGDLKFHIY----HMGEAGFEEGRAVFYAAEIC 112

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSI--GIKGT 724
             +E LH   Q  IV+ DLKP N+LLD     H   S    L  A   P      G  GT
Sbjct: 113 CGLEDLH---QERIVYRDLKPENILLDDH--GHIRIS---DLGLAVHVPEGQTIKGRVGT 164

Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           VGY+APE       + + D ++ G LL EM  G+ P
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 6e-09
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 33/215 (15%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G++G VYK    L GE  IVA+K I L+   +G   + + E   L+ + H N+++++
Sbjct: 7   IGEGTYGVVYKARDKLTGE--IVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWL----HQSNDHLEVCKLTLIQRVNIAIDVAS 667
            +  S ++K      LVFE++ +  L+ ++        D   + K  L Q +        
Sbjct: 65  DVVHS-ENK----LYLVFEFL-DLDLKKYMDSSPLTGLD-PPLIKSYLYQLL-------Q 110

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVG 726
            I Y H H    ++H DLKP N+L+D +      +F L+       +T +  +    T+ 
Sbjct: 111 GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV---VTLW 164

Query: 727 YVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRRP 760
           Y APE  +GS    T  D++S G +  EM   RRP
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 28/220 (12%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRN 606
           ++     IG+G++G VYKG       IVA+K I L+  ++G   + + E   L+ ++H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ--SNDHL--EVCKLTLIQRVNIA 662
           ++ +  +    +S+      L+FE++    L+ +L       ++  E+ K  L Q     
Sbjct: 61  IVCLQDVLMQ-ESR----LYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQ----- 109

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGI 721
             +   I + H      ++H DLKP N+L+D+  ++   +F L+       +  +  +  
Sbjct: 110 --ILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV-- 162

Query: 722 KGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRP 760
             T+ Y APE  +GS   S   D++S G +  EM T ++P
Sbjct: 163 -VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 59.5 bits (144), Expect = 7e-09
 Identities = 36/106 (33%), Positives = 60/106 (56%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
           +N+  G +P ++GSL  L  L +  N L+G++PD + +   L  L +  N L GQIP + 
Sbjct: 484 RNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASF 543

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPF 106
             +  L  L++++NQ SG  P+ + N+ SL  + ++ N   GSLP 
Sbjct: 544 SEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589

Length = 968

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 50/219 (22%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK------ 609
           +G G+FG VYK       ++ A KVI+ K +     ++ E + L +  H N++K      
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 610 -------IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
                  +I  C+     G    A++ E      LE  L +    + VCK TL       
Sbjct: 73  YENNLWILIEFCA-----GGAVDAVMLE------LERPLTEPQIRV-VCKQTL------- 113

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVL--LDHDMVAHQNFSLSHQLDSASKTPSSSIG 720
                A+ YLH   +  I+H DLK  N+L  LD D +   +F +S +     +   S I 
Sbjct: 114 ----EALNYLH---ENKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFI- 164

Query: 721 IKGTVGYVAPEYGMGSEAS-----MTGDVYSFGILLLEM 754
             GT  ++APE  M   +         DV+S GI L+EM
Sbjct: 165 --GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.2 bits (138), Expect = 8e-09
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 47/224 (20%)

Query: 556 IGQGSFGSVYKGIL-----GGE--EMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +GQG+F  ++KGI       GE  +  V +KV++   +    SF      +  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
               +C        D   +V EY++ GSL+ +L ++ +      + +  ++ +A  +A A
Sbjct: 63  LNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWA 112

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS----SSIGIKGT 724
           + +L       + HG++   NVL            L  + D  +  P     S  GI  T
Sbjct: 113 LHFLE---DKGLTHGNVCAKNVL------------LIREEDRKTGNPPFIKLSDPGISIT 157

Query: 725 V----------GYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTG 757
           V           +V PE     +  S+  D +SFG  L E+F+G
Sbjct: 158 VLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 57.7 bits (139), Expect = 8e-09
 Identities = 65/211 (30%), Positives = 91/211 (43%), Gaps = 22/211 (10%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +IG+GSFG V       +    AVKV+     LK+K            L+N++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
                    + A+    V +Y+  G L  + H      E C L    R   A +VASAI 
Sbjct: 62  -----HYSFQTAEKLYFVLDYVNGGEL--FFHLQR---ERCFLEPRARF-YAAEVASAIG 110

Query: 671 YLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           YLH      I++ DLKP N+LLD    V   +F L  +     +T S+     GT  Y+A
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST---FCGTPEYLA 164

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE         T D +  G +L EM  G  P
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 1e-08
 Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 52/247 (21%)

Query: 548 SEFASSNMIGQGSFGSVY--KGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNI 602
            +F    +IG+G+FG V+  +    G+  + A+KV+    + ++       AE + L + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQ--VYAMKVLRKSDMIKRNQIAHVRAERDILADA 58

Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
               ++K+    S  D    +   LV EYM  G L + L + +   E  +     R  IA
Sbjct: 59  DSPWIVKLY--YSFQDE---EHLYLVMEYMPGGDLMNLLIRKDVFPE--ETA---RFYIA 108

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH---QNFSLSHQLDSASKTPSSSI 719
            ++  A++ +H   +   +H D+KP N+L+D D   H    +F L  +++ A        
Sbjct: 109 -ELVLALDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLN 162

Query: 720 GIK--------------------------GTVGYVAPEYGMGSEASMTGDVYSFGILLLE 753
                                        GT  Y+APE   G+   +  D +S G++L E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Query: 754 MFTGRRP 760
           M  G  P
Sbjct: 223 MLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 31/238 (13%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIIT-- 612
           +IG+G FG VY         + A+K ++ K     R  + + E L  +  R ++ +++  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETLA-LNERIMLSLVSTG 54

Query: 613 -----ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
                +C +      D    + + M  G L   L Q     E       +    A ++  
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK------EMRFYATEIIL 108

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
            +E++H+     +V+ DLKP+N+LLD H  V   +  L+   D + K P +S+   GT G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV---GTHG 160

Query: 727 YVAPE-YGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV 783
           Y+APE    G+    + D +S G +L ++  G  P     T+    HE  +MTL   V
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTVNV 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 19/206 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GS G V           VAVK+++L+++        E   +R+ +H+N++++    S
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK--S 86

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
            +   G +   L+ E+++ G+L D + Q+       +L   Q   +   V  A+ YLH  
Sbjct: 87  YL--VGEELWVLM-EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ 136

Query: 676 CQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               ++H D+K  ++LL  D  V   +F    Q+   SK       + GT  ++APE   
Sbjct: 137 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVIS 190

Query: 735 GSEASMTGDVYSFGILLLEMFTGRRP 760
            +      D++S GI+++EM  G  P
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 2e-08
 Identities = 45/194 (23%), Positives = 85/194 (43%), Gaps = 24/194 (12%)

Query: 556 IGQGSFGSVYKGIL--GGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           IG+G++G VYK     G +    A+K       +  G  +S   E   LR ++H N++ +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV---NIAIDVAS 667
           + +      K      L+F+Y E+    D       H +  K   I      ++   + +
Sbjct: 68  VEVFLEHADKSV---YLLFDYAEH----DLWQIIKFHRQA-KRVSIPPSMVKSLLWQILN 119

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHQNFSLSHQLDSASKTPSSSIGIK 722
            + YLH +    ++H DLKP+N+L+     +  +V   +  L+   ++  K  +    + 
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 723 GTVGYVAPEYGMGS 736
            T+ Y APE  +G+
Sbjct: 177 VTIWYRAPELLLGA 190

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 21/219 (9%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVK---VINLKQKGAFRSFVAECEALRNIRH 604
           + F     IG+G F  VY+     + + VA+K   + +L    A    + E + L+ + H
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV--NIA 662
            N+IK     S I+    +   +V E  + G L   +     H +  K  + ++      
Sbjct: 62  PNVIKYYA--SFIEDNELN---IVLELADAGDLSRMIK----HFKKQKRLIPEKTVWKYF 112

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGI 721
           + + SA+E++H      ++H D+KP+NV +    +V   +  L     S +    S +G 
Sbjct: 113 VQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG- 168

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             T  Y++PE    +  +   D++S G LL EM   + P
Sbjct: 169 --TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 10/101 (9%)

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSI-- 719
           A ++   +E LH   +   V+ DLKP N+LLD     H   S    L  A K P      
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDY--GHIRIS---DLGLAVKIPEGESIR 159

Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           G  GTVGY+APE       +++ D +  G L+ EM  G+ P
Sbjct: 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 30/209 (14%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+FG VYK        + A KVI  K +     ++ E E L    H  ++K++    
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL---- 75

Query: 616 SIDSKGADFK----ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
                GA +      ++ E+   G+++  + + +  L   ++ +I R      +  A++Y
Sbjct: 76  -----GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR-----QMLEALQY 125

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           LH      I+H DLK  NVLL  D  +   +F +S +     KT        GT  ++AP
Sbjct: 126 LH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK---NVKTLQRRDSFIGTPYWMAP 179

Query: 731 EYGM-----GSEASMTGDVYSFGILLLEM 754
           E  M      +      D++S GI L+EM
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 44/230 (19%)

Query: 556 IGQGSFGSVY----KGIL------------GGEEMIVAVKVINLK-QKGAFRSFVAECEA 598
           +G+G FG V+    +G+             G + ++VAVK++     K A   F+ E + 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL--HQSNDHLEVCKLTLI 656
           +  ++  N+I+++ +C  I S   D   ++ EYMENG L  +L  H+  +  E   +  I
Sbjct: 73  MSRLKDPNIIRLLAVC--ITS---DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 657 QR---VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSAS 712
                + +A  +AS ++YL        VH DL   N L+  +  +   +F +S  L S  
Sbjct: 128 SYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184

Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEA------SMTGDVYSFGILLLEMFT 756
                   I+G    V P   M  E+      +   DV++FG+ L E+ T
Sbjct: 185 -----YYRIQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 24/214 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA--ECEALRNIRHRNLIKIITI 613
           +G+G+FG         ++ +V  K +NL +        A  E   L  ++H N   II  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN---IIAY 64

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASAIE 670
            +           +  EY   G+L D + +    L   E+    L Q       + SA+ 
Sbjct: 65  YNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-------IVSAVS 115

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           Y+H   +  I+H D+K  N+ L    ++   +F +S  L S      + +G   T  Y++
Sbjct: 116 YIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVG---TPYYMS 169

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           PE   G + +   D+++ G +L E+ T +R  DA
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 55.5 bits (133), Expect = 5e-08
 Identities = 69/226 (30%), Positives = 103/226 (45%), Gaps = 44/226 (19%)

Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 606
           F     IG GSFG+VY         +VA+K ++   K +   ++  + E + L+ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 607 LIKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
                    SI+ KG   +     LV EY         L  ++D LEV K  L Q V IA
Sbjct: 87  ---------SIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 128

Query: 663 IDVASAIE---YLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSAS-KTPSS 717
                A++   YLH H    ++H D+K  N+LL +   V   +F       SAS  +P++
Sbjct: 129 AITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG------SASIASPAN 179

Query: 718 SIGIKGTVGYVAPEYGMG-SEASMTG--DVYSFGILLLEMFTGRRP 760
           S    GT  ++APE  +   E    G  DV+S GI  +E+   + P
Sbjct: 180 S--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 26/216 (12%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK----I 610
           ++G+GSFG V    L G + + A+KV  LK+    +    +C  +   R   L      +
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDC-TMTEKRILALAAKHPFL 58

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
             +     +K   F   V EY+  G L   + +S       K    +    A +V  A+ 
Sbjct: 59  TALHCCFQTKDRLF--FVMEYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALM 110

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMVAH---QNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +LH H    +++ DLK  N+LLD +   H    +F +  +      T ++     GT  Y
Sbjct: 111 FLHRH---GVIYRDLKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTT---FCGTPDY 162

Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           +APE     E   + D ++ G+L+ EM  G+ P +A
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 59/216 (27%), Positives = 107/216 (49%), Gaps = 28/216 (12%)

Query: 556 IGQGSFGSVYKG----ILGGE-EMIVAVKVINLKQKGAFR---SFVAECEALRNIRHRNL 607
           +GQGSFG VY+G    I+ GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 71

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLH----QSNDHLEVCKLTLIQRVNIAI 663
           ++++ +     SKG     +V E M +G L+ +L     ++ ++      TL + + +A 
Sbjct: 72  VRLLGVV----SKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++A  + YL+       VH DL   N ++ HD  V   +F ++  +    +T     G K
Sbjct: 127 EIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI---YETDYYRKGGK 180

Query: 723 G--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           G   V ++APE       + + D++SFG++L E+ +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 55.2 bits (133), Expect = 6e-08
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 26/213 (12%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           ++G+GSFG V    L G     A+K   LK+         EC  +     R ++ +    
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVE----RRVLALAWEH 55

Query: 615 SSIDSKGADFKA-----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASA 668
             +      F+       V EY+  G   D +     H++        R    A ++   
Sbjct: 56  PFLTHLFCTFQTKEHLFFVMEYLNGG---DLMF----HIQSSGRFDEARARFYAAEIICG 108

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +++LH      I++ DLK  NVLLD D  +   +F +  +  +     S+     GT  Y
Sbjct: 109 LQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST---FCGTPDY 162

Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +APE   G + + + D +SFG+LL EM  G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 25/211 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG+G++G+V+K        IVA+K + L    +G   S + E   L+ ++H+N++++  +
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE--VCKLTLIQRVNIAIDVASAIEY 671
             S D K      LVFEY +   L+ +    N  ++  + K  + Q       +   + +
Sbjct: 68  LHS-DKK----LTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQ-------LLKGLAF 114

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H H    ++H DLKP N+L++ +  +   +F L+       +  S+ +    T+ Y  P
Sbjct: 115 CHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV---VTLWYRPP 168

Query: 731 EYGMGSEASMTG-DVYSFGILLLEMFTGRRP 760
           +   G++   T  D++S G +  E+    RP
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 40/127 (31%), Positives = 62/127 (48%), Gaps = 13/127 (10%)

Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQL-DSASKTPSSS 718
           + + +  A+ YL       ++H D+KPSN+LLD    V   +F +S +L DS +KT S  
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-- 174

Query: 719 IGIKGTVGYVAPEY----GMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEF 774
               G   Y+APE         +  +  DV+S GI L+E+ TG+ P     TE   L + 
Sbjct: 175 ---AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231

Query: 775 VKMTLPE 781
           ++   P 
Sbjct: 232 LQEEPPS 238

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 56.4 bits (136), Expect = 7e-08
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 38/202 (18%)

Query: 576 VAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS--KGADFKAL 627
           VA+K++         Q+  FR   A C  L    H N++ ++      DS          
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLY---HPNIVALL------DSGEAPPGLLFA 56

Query: 628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKP 687
           VFEY+   +L + L  + D      L   +   + + V  A+   H+     IVH DLKP
Sbjct: 57  VFEYVPGRTLREVL--AADGA----LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKP 107

Query: 688 SNVLLD------HDMVAHQNFSLSHQL----DSASKTPSSSIGIKGTVGYVAPEYGMGSE 737
            N+++       H  V   +F +   L    D+   T + +  + GT  Y APE   G  
Sbjct: 108 QNIMVSQTGVRPHAKVL--DFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP 165

Query: 738 ASMTGDVYSFGILLLEMFTGRR 759
            +   D+Y++G++ LE  TG+R
Sbjct: 166 VTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 31/238 (13%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIIT-- 612
           +IG+G FG VY         + A+K ++ K     R  + + E L  +  R ++ +++  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETLA-LNERIMLSLVSTG 54

Query: 613 -----ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
                +C S      D  + + + M  G L   L Q     E       +    A ++  
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA------EMRFYAAEIIL 108

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFS-LSHQLDSASKTPSSSIGIKGTVG 726
            +E++H+     +V+ DLKP+N+LLD     H   S L    D + K P +S+   GT G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASV---GTHG 160

Query: 727 YVAPE-YGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV 783
           Y+APE    G     + D +S G +L ++  G  P     T+    HE  +MTL   V
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTMAV 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 23/233 (9%)

Query: 538 ISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECE 597
           I  + L      F    ++G G++G VYKG       + A+KV+++ +         E  
Sbjct: 6   IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEIN 64

Query: 598 ALRNI-RHRNLIKIITICSSIDSKGADFKA-LVFEYMENGSLEDWLHQS--NDHLEVCKL 653
            L+    HRN+             G D +  LV E+   GS+ D +  +  N   E   +
Sbjct: 65  MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW-I 123

Query: 654 TLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSAS 712
             I R     ++   + +LH H    ++H D+K  NVLL  +  V   +F +S QLD   
Sbjct: 124 AYICR-----EILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175

Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEA-----SMTGDVYSFGILLLEMFTGRRP 760
              ++ I   GT  ++APE     E          D++S GI  +EM  G  P
Sbjct: 176 GRRNTFI---GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 54.3 bits (130), Expect = 9e-08
 Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 48/228 (21%)

Query: 550 FASSNMIGQGSFGSVY--KGILGGEEMIVAVKVINLKQKGA---FRSFVAECEALRNIRH 604
           F+    IG GSFG+VY  + +   E  +VA+K ++   K +   ++  + E   L+ +RH
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSE--VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 605 RNLIKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
            N         +I  +G   +     LV EY         L  ++D LEV K  L Q V 
Sbjct: 75  PN---------TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVE 116

Query: 661 IAIDVASAIE---YLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSAS-KTP 715
           IA     A++   YLH H    ++H D+K  N+LL +  +V   +F       SAS   P
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG------SASIMAP 167

Query: 716 SSSIGIKGTVGYVAPEYGMG-SEASMTG--DVYSFGILLLEMFTGRRP 760
           ++     GT  ++APE  +   E    G  DV+S GI  +E+   + P
Sbjct: 168 ANX--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.2 bits (133), Expect = 1e-07
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 212 ALSLCDNQ-FGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLH 270
            L L DNQ   G +P+ I+ L   +    + GN I G IP  + ++ +L  L +  N  +
Sbjct: 422 GLGL-DNQGLRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 271 GIIPDGVGELQHLQQLYMFRNFLQGSIPPSLG 302
           G IP+ +G+L  L+ L +  N L G +P +LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 54.6 bits (132), Expect = 1e-07
 Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 53/228 (23%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF-------RSFVAECEALRNIRHRNLI 608
           IG G++G V   I       VA+K    K   AF       R+   E + LR+ +H N+I
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTL-RELKILRHFKHDNII 67

Query: 609 KIITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ--------SNDHLEVCKLTLIQR 658
            I  I   +   GADFK   +V + ME+      LH         + +H+      L++ 
Sbjct: 68  AIRDI---LRPPGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRYFLYQLLR- 118

Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTP 715
                     ++Y+H      ++H DLKPSN+L++ D    +   +F ++  L S+    
Sbjct: 119 ---------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIG--DFGMARGLSSSPTEH 164

Query: 716 SSSIG-IKGTVGYVAPEYGMGS--EASMTGDVYSFGILLLEMFTGRRP 760
              +     T  Y APE  + S  E +   D++S G +  EM  GRR 
Sbjct: 165 KYFMTEYVATRWYRAPEL-LLSLPEYTTAIDMWSVGCIFAEML-GRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 22/220 (10%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEAL--RNIRHRN 606
           +F    ++G+GSFG V      G + + A+K+  LK+    +    EC  +  R +  ++
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQD 58

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
               +T   S   +  D    V EY+  G L   + Q      V K    Q V  A +++
Sbjct: 59  KPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPQAVFYAAEIS 111

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSASKTPSSSIGIKG 723
             + +LH   +  I++ DLK  NV+LD   H  +A       H +D  +          G
Sbjct: 112 VGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-----FCG 163

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           T  Y+APE         + D +++G+LL EM  G+ P D 
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 21/232 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G+G FG V    +     + A K ++   LK+K   +  + E E L  +   N   I+ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +  + +SK      LV   M  G L+  ++    ++    L + + ++ +  +   I +L
Sbjct: 58  LAYAFESK--THLCLVMSLMNGGDLKYHIY----NVGERGLEMERVIHYSAQITCGILHL 111

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H      IV+ D+KP NVLLD        +  L+ +L         +    GT GY+APE
Sbjct: 112 H---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA----GTNGYMAPE 164

Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV 783
                  S   D ++ G  + EM  GR P      E +   E  + TL ++V
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTPF-KDHKEKVAKEELKRRTLEDEV 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 44/230 (19%)

Query: 549 EFASSNM-----IGQGSFGSVYKGI---LGGEEMIVAVKVINLKQKGAFRSFVAECEALR 600
           EF  +N+     +G G+FG V +     L   + ++ V V  LK   A  S   E EAL 
Sbjct: 31  EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSS---EREALM 86

Query: 601 NI--------RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK 652
           +          H N++ ++  C+     G     ++ EY   G L ++L +  +      
Sbjct: 87  SELKIMSHLGNHENIVNLLGACT----IGGPI-LVITEYCCYGDLLNFLRRKRESF---- 137

Query: 653 LTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDS 710
           LTL   ++ +  VA  + +L   +C    +H DL   NVLL H  +    +F L+  + +
Sbjct: 138 LTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMN 193

Query: 711 ASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
                 S+  +KG     V ++APE       +   DV+S+GILL E+F+
Sbjct: 194 -----DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 22/214 (10%)

Query: 555 MIGQGSFGSVY--KGILGGEEMIVAVKVINLKQKGAFRSFVA-ECEA--LRNIRHRNLIK 609
           ++GQG+FG VY       G E+ V     + +     +   A ECE   L+N+ H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN--IAIDVAS 667
                     +     ++  E+M  GS++D L             L + V       +  
Sbjct: 69  YYGCLRDPMERTL---SIFMEHMPGGSIKDQLKSYG--------ALTENVTRKYTRQILE 117

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
            + YLH +    IVH D+K +N+L D    V   +F  S +L +   + +    + GT  
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +++PE   G       D++S G  ++EM T + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 48/222 (21%), Positives = 96/222 (43%), Gaps = 31/222 (13%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINL------KQKGAFRSFVAECEALRNIRHRNLI 608
            +G G+F S Y+        ++AVK +        +Q+    +   E   +  + H ++I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           +          + + F   V E+M  GS+   L +     E   +   +++         
Sbjct: 67  R----MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRG 115

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIG-------I 721
           + YLH +    I+H D+K +N+L+D      Q   ++    +A++  +   G       +
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDS---TGQRLRIA-DFGAAARLAAKGTGAGEFQGQL 168

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
            GT+ ++APE   G +   + DV+S G +++EM T + P +A
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 30/221 (13%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF---RSFVAECEALRNIRHRNLIKIIT 612
           IG G FG V  G +        V V  L+   +      F+ E +  R+++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLH-QSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            C+ +         LV E+   G L+ +L       L     T +QR  +A ++A  + +
Sbjct: 63  QCTEVTP-----YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLH 115

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSH---QLDSASKTPSSSIGIKGTVGY 727
           LH +     +H DL   N LL  D+ V   ++ LSH   + D         + ++    +
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----W 168

Query: 728 VAPE-----YG--MGSEASMTGDVYSFGILLLEMFT-GRRP 760
           +APE     +G  +  + +   +V+S G+ + E+F  G +P
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.4 bits (131), Expect = 2e-07
 Identities = 22/60 (36%), Positives = 38/60 (63%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N + G IP  +GS+ +L+ L + +N   G +P+ +G L++L +L +  NSL G++P  LG
Sbjct: 452 NSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 2e-07
 Identities = 56/230 (24%), Positives = 90/230 (39%), Gaps = 44/230 (19%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRH 604
            +F     +GQG +G V+         IVA+K +    L +    R  + E + L   + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 605 RNLIKIITICSSIDSK----------GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLT 654
             L+K++   +  D +          G DF+ L+      G L      S DH       
Sbjct: 61  EWLVKLLY--AFQDDEYLYLAMEYVPGGDFRTLL---NNLGVL------SEDH------- 102

Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASK 713
              R  +A ++  A++ LH   +   +H DLKP N L+D    +   +F LS        
Sbjct: 103 --ARFYMA-EMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLS------KG 150

Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
             + +  + G+  Y+APE   G     T D +S G +L E   G  P   
Sbjct: 151 IVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 2e-07
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 38/226 (16%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
             + + + IG+G++G V         + VA+K I+    Q    R+ + E + LR  +H 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHE 63

Query: 606 NLIKI--ITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------SNDHLEVCKLT 654
           N+I I  I    S +S    F    +V E ME       L++       SNDH    +  
Sbjct: 64  NIIGILDIIRPPSFES----FNDVYIVQELMETD-----LYKLIKTQHLSNDH---IQYF 111

Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASK 713
           L Q       +   ++Y+H      ++H DLKPSN+LL+ +  +   +F L+   D    
Sbjct: 112 LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161

Query: 714 TPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                     T  Y APE  + S   +   D++S G +L EM + R
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 53.8 bits (130), Expect = 2e-07
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 50/222 (22%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G++G V           VA+K ++      +  K  +R    E   L+++ H N+I 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHMDHENVIG 78

Query: 610 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ---SNDHLEVCKLTLIQRVNIAID 664
           ++ + +   S   DF+   LV   M    L + +     S+DH++           +   
Sbjct: 79  LLDVFTP-ASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQF----------LVYQ 126

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKG 723
           +   ++Y+H      I+H DLKPSN+ ++ D  +   +F L+   D          G   
Sbjct: 127 ILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD------DEMTGYVA 177

Query: 724 TVGYVAPE-------YGMGSEASMTGDVYSFGILLLEMFTGR 758
           T  Y APE       Y      + T D++S G ++ E+ TG+
Sbjct: 178 TRWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 64/253 (25%), Positives = 106/253 (41%), Gaps = 33/253 (13%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHR 605
           +F    +IG+G+FG V    +     + A+K++N   + ++     F  E + L N   R
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAI 663
               I  +  +   +  +   LV +Y   G L   L +  D L  ++ +  L + V +AI
Sbjct: 62  ---WITNLHYAFQDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-LAI 115

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIK 722
           D    + Y         VH D+KP NVLLD +  +   +F    +L  A  T  S++ + 
Sbjct: 116 DSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLL-ADGTVQSNVAV- 164

Query: 723 GTVGYVAPEY------GMGSEASMTGDVYSFGILLLEMFTGRRPTDA---AFTEGLTLHE 773
           GT  Y++PE       G G       D +S G+ + EM  G  P  A     T G  ++ 
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPEC-DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223

Query: 774 FVKMTLPEKVIEI 786
                 P  V ++
Sbjct: 224 KEHFQFPPDVTDV 236

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 26/222 (11%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +F    +IG+G+FG V    +   E I A+K++N K +   R+  A     RN+      
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-KWEMLKRAETACFREERNVLVNGDC 60

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDVA 666
           + IT       +  ++  LV +Y   G L   L +  D L  ++ +  + + V +AI   
Sbjct: 61  QWITTLHYA-FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMV-LAIH-- 116

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSASKTPSSSIGIKG 723
            +I  LH+      VH D+KP NVLLD   H  +A     L    D    T  SS+ + G
Sbjct: 117 -SIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG---TVQSSVAV-G 165

Query: 724 TVGYVAPEYGMGSEASMTG-----DVYSFGILLLEMFTGRRP 760
           T  Y++PE     E  M       D +S G+ + EM  G  P
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 18/185 (9%)

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKG 723
           +++ A+ YLH   +  I++ DLK  NVLLD +   H   +         +   ++    G
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCG 158

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTD---AAFTEGLTLHEFVKMTLP 780
           T  Y+APE   G +   + D ++ G+L+ EM  GR P D   ++        +++   + 
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 218

Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFER------ME 834
           EK I I     +       S + +D + R    L    +TG       PF R      ME
Sbjct: 219 EKQIRIPRSLSVKAASVLKSFLNKDPKER----LGCHPQTGFADIQGHPFFRNVDWDLME 274

Query: 835 MRDVV 839
            + VV
Sbjct: 275 QKQVV 279

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 57/263 (21%), Positives = 109/263 (41%), Gaps = 35/263 (13%)

Query: 563 SVYKGILGGEEMIV-AVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI----ITICSSI 617
           S+YKGI   +E+I+   K  +   K        E + LR I   N++KI    I I   +
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 618 DSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQ 677
                   +L+ EY   G L + L +  D      L+   ++++AID    +  L+ +  
Sbjct: 95  PRL-----SLILEYCTRGYLREVLDKEKD------LSFKTKLDMAIDCCKGLYNLYKYTN 143

Query: 678 PPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDS-ASKTPSSSIGIKGTVGYVAPEY--GM 734
            P  + +L   + L+  +        + H L+   S  P  ++     + Y + +    +
Sbjct: 144 KP--YKNLTSVSFLVTENYKLK---IICHGLEKILSSPPFKNVN---FMVYFSYKMLNDI 195

Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD---PSL 791
            SE ++  D+YS G++L E+FTG+ P      E LT  E   + + +     +    P  
Sbjct: 196 FSEYTIKDDIYSLGVVLWEIFTGKIP-----FENLTTKEIYDLIINKNNSLKLPLDCPLE 250

Query: 792 LMEVMANNSMIQEDRRARTQDCL 814
           +  ++   +     +R   ++ L
Sbjct: 251 IKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 67/230 (29%), Positives = 100/230 (43%), Gaps = 29/230 (12%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNL 607
           +F   +++G+G FG V          I A+KV+      A +  V+  E  R+I    N 
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA-QETVSFFEEERDILSISNS 60

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
             I  +  +   K  D   LV EY   G L   L++  D  +     + Q       +A 
Sbjct: 61  PWIPQLQYAFQDK--DNLYLVMEYQPGGDLLSLLNRYEDQFDE---DMAQ-----FYLAE 110

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +  +H   Q   VH D+KP NVL+D   H  +A  +F  + +L  A+K  +S + + GT
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLA--DFGSAARLT-ANKMVNSKLPV-GT 166

Query: 725 VGYVAPEY--GM-GSEASMTG---DVYSFGILLLEMFTGRRPTDAAFTEG 768
             Y+APE    M G      G   D +S G++  EM  GR P    F EG
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP----FHEG 212

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 23/220 (10%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVK---VINLKQKGAFRSFVAECEALRNIRH 604
           + F     IG+G F  VY+     +   VA+K   +  +    A +  V E + L+ + H
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 605 RNLIKIITICSSIDSKGADFKA-LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV--NI 661
            N+IK +      DS   D +  +V E  + G L     Q   + +  K  + +R     
Sbjct: 62  PNVIKYL------DSFIEDNELNIVLELADAGDLS----QMIKYFKKQKRLIPERTVWKY 111

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
            + + SA+E++H      ++H D+KP+NV +    +V   +  L     S +    S +G
Sbjct: 112 FVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              T  Y++PE    +  +   D++S G LL EM   + P
Sbjct: 169 ---TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 23/221 (10%)

Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLI 608
           F    ++G G++G VYKG       + A+KV+++           E   L+    HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 609 KIITICSSIDSKGADFKA-LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR--VNIAIDV 665
                    +  G D +  LV E+   GS+ D +  +  +      TL +     I  ++
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN------TLKEEWIAYICREI 120

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + +LH H    ++H D+K  NVLL  +  V   +F +S QLD      ++ I   GT
Sbjct: 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GT 174

Query: 725 VGYVAPEYGMGSEA-----SMTGDVYSFGILLLEMFTGRRP 760
             ++APE     E          D++S GI  +EM  G  P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 50/226 (22%)

Query: 556 IGQGSFGSVYKGIL----------GGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRH 604
           +GQG+F ++YKG+L           G+E+ V +KV  L        +F      +  + H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV--LGSDHRDSLAFFETASLMSQLSH 60

Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEV-CKLTLIQRVNIAI 663
           ++L+K+  +C        D   +V EY++ G L+ +LH+  +++ +  KL + ++     
Sbjct: 61  KHLVKLYGVCV------RDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQ----- 109

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKG 723
            +ASA+ YL       +VHG++   N+L     VA    +  +        P    GI  
Sbjct: 110 -LASALHYLEDK---KLVHGNVCGKNIL-----VARYGLNEGYVPFIKLSDP----GIPI 156

Query: 724 TVG----------YVAPEYGMGSEASMT--GDVYSFGILLLEMFTG 757
           TV           ++APE     +AS+T   D +SFG  LLE+ + 
Sbjct: 157 TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 42/137 (30%), Positives = 62/137 (45%), Gaps = 13/137 (9%)

Query: 627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLK 686
           LV EY+  G L    H         KL        A ++  A+ +LH   +  I++ DLK
Sbjct: 73  LVIEYVNGGDL--MFHMQRQR----KLPEEHARFYAAEICIALNFLH---ERGIIYRDLK 123

Query: 687 PSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVY 745
             NVLLD D  +   ++ +  +      T S+     GT  Y+APE   G E   + D +
Sbjct: 124 LDNVLLDADGHIKLTDYGMCKEGLGPGDTTST---FCGTPNYIAPEILRGEEYGFSVDWW 180

Query: 746 SFGILLLEMFTGRRPTD 762
           + G+L+ EM  GR P D
Sbjct: 181 ALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 17/207 (8%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR-NLIKIITIC 614
           IG+GSFG V +      + I A+K I  K     RS V    A R +  + N   I+ + 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            S  S    +  LV  ++  G L   L +     E        R   A ++  A+E LH 
Sbjct: 60  FSFQSPEKLY--LVLAFINGGELFHHLQR-----EGRFDLSRARFYTA-ELLCALENLH- 110

Query: 675 HCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +  +++ DLKP N+LLD+   +A  +F L  +L+      +++    GT  Y+APE  
Sbjct: 111 --KFNVIYRDLKPENILLDYQGHIALCDFGLC-KLNMKDDDKTNTFC--GTPEYLAPELL 165

Query: 734 MGSEASMTGDVYSFGILLLEMFTGRRP 760
           +G   +   D ++ G+LL EM TG  P
Sbjct: 166 LGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 30/227 (13%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLIKI 610
           IG+GSFG +Y      +     +K I+L     K+K A +    E   L  ++H N   I
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPN---I 61

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           +T  +S    G  F  +V EY + G L   +++    L      L   V I++     ++
Sbjct: 62  VTFFASFQENGRLF--IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL----GLK 115

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           ++H      I+H D+K  N+ L  + MVA   +F ++ QL+ + +   + +   GT  Y+
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV---GTPYYL 169

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV 775
           +PE       +   D++S G +L E+ T + P      EG  LH+ V
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHP-----FEGNNLHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 52.2 bits (126), Expect = 4e-07
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 30/156 (19%)

Query: 549 EFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKG------AFRSFVAECEALR 600
           E+   N I +G++G VY+      GE  IVA+K + ++++       + R    E   L 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGE--IVALKKLKMEKEKEGFPITSLR----EINILL 59

Query: 601 NIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCKLTLIQR 658
            ++H N   I+T+   +     D   +V EY+E+   SL + + Q     EV K  ++Q 
Sbjct: 60  KLQHPN---IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEV-KCLMLQ- 114

Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH 694
                 + S + +LH +    I+H DLK SN+LL++
Sbjct: 115 ------LLSGVAHLHDNW---ILHRDLKTSNLLLNN 141

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)

Query: 555 MIGQGSFGSVY--KGILGGEEMIVAVKVINLK---QKGAFRSFVAECEA--LRNIRHRNL 607
           ++G+G+FG VY       G E+  AVK +      Q+ +      ECE   L+N+RH  +
Sbjct: 9   LLGRGAFGEVYLCYDADTGREL--AVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66

Query: 608 IKIITICSSIDSKGADFKALVF-EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           ++        + K    K  +F EYM  GS++D L       E     + +R    I   
Sbjct: 67  VQYYGCLRDPEEK----KLSIFVEYMPGGSIKDQLKAYGALTE----NVTRRYTRQI--L 116

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
             + YLH +    IVH D+K +N+L D    V   +F  S ++ +   + +    + GT 
Sbjct: 117 QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            +++PE   G       DV+S    ++EM T + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 51.9 bits (124), Expect = 6e-07
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 24/212 (11%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRN----IRHRNLIKI 610
           ++G+GSFG V    L G+    AVK   LK+         EC  +      +   N    
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLH-QSNDHLEVCKLTLIQRVNIAIDVASAI 669
              C+   +K   F   V E++  G L    H Q     ++ + T       A ++   +
Sbjct: 60  HLYCT-FQTKEHLF--FVMEFLNGGDL--MFHIQDKGRFDLYRATFY-----AAEIVCGL 109

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           ++LH      I++ DLK  NV+LD D  +   +F +  +        S+     GT  Y+
Sbjct: 110 QFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST---FCGTPDYI 163

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           APE   G + + + D +SFG+LL EM  G+ P
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.4 bits (123), Expect = 6e-07
 Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 30/249 (12%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR---SFVAECEALRNIRHRNLIKIIT 612
           IG G FG V    +  +  +  V V  LK   + +    F+ + +  R ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
            C       A    LVFEY E G L+ +L Q   H    +L L+QR  +A ++A+ + ++
Sbjct: 63  QCVE-----AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHM 115

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           H H     +H DL   N  L  D+   V       S   +   +T          + ++A
Sbjct: 116 HKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKC---VPLRWLA 169

Query: 730 PEYG-------MGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK 782
           PE         + +E +   +V++ G+ L E+F       +  ++   L+  +K    ++
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK----DQ 225

Query: 783 VIEIVDPSL 791
            +++  P L
Sbjct: 226 QVKLFKPQL 234

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 28/237 (11%)

Query: 537 MISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAEC 596
           M+    L   T  +     IG+G++G VYK     +  + AVK+++            E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEI 65

Query: 597 EALRNI-----RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC 651
           EA  NI      H N++K   +    D        LV E    GS+ + +      L +C
Sbjct: 66  EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG----LLIC 121

Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDS 710
              L     I+  +  A+  L H     I+H D+K +N+LL  +  V   +F +S QL S
Sbjct: 122 GQRL-DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180

Query: 711 ASKTPSSSIGIKGTVGYVAPE-------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                ++S+   GT  ++APE       Y    +A    DV+S GI  +E+  G  P
Sbjct: 181 TRLRRNTSV---GTPFWMAPEVIACEQQYDYSYDARC--DVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 25/212 (11%)

Query: 549 EFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN 606
           +F     IG G++G VYK   +  GE  + A+KVI L+    F     E   +++ +H N
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGE--LAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
              I+    S   +  D   +  E+   GSL+D  H +        L+  Q   ++ +  
Sbjct: 68  ---IVAYFGSYLRR--DKLWICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETL 116

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
             + YLH   +   +H D+K +N+LL D+  V   +F +S Q+ +      S I   GT 
Sbjct: 117 QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI---GTP 170

Query: 726 GYVAPEYGMGSEA---SMTGDVYSFGILLLEM 754
            ++APE          +   D+++ GI  +E+
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 42/137 (30%), Positives = 69/137 (50%), Gaps = 14/137 (10%)

Query: 627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLK 686
           L+ +Y+  G L   L+Q  +H    ++    RV IA ++  A+++LH   Q  I++ D+K
Sbjct: 82  LILDYVNGGELFTHLYQR-EHFTESEV----RVYIA-EIVLALDHLH---QLGIIYRDIK 132

Query: 687 PSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA--SMTGD 743
             N+LLD +  V   +F LS +  +  +  + S    GT+ Y+APE   G         D
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC--GTIEYMAPEVIRGGSGGHDKAVD 190

Query: 744 VYSFGILLLEMFTGRRP 760
            +S G+L  E+ TG  P
Sbjct: 191 WWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 51.5 bits (123), Expect = 7e-07
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 27/217 (12%)

Query: 555 MIGQGSFGSVY--KGILGGEE-MIVAVKVI---NLKQKGAFRSFV-AECEALRNIRHRNL 607
           ++G G++G V+  + + G +   + A+KV+    + QK         E + L +IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI-DVA 666
           +  +      D+K      L+ +Y+  G L   L Q     E       Q V I   ++ 
Sbjct: 67  LVTLHYAFQTDTK----LHLILDYINGGELFTHLSQRERFKE-------QEVQIYSGEIV 115

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
            A+E+LH   +  I++ D+K  N+LLD +  V   +F LS +        + S    GT+
Sbjct: 116 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC--GTI 170

Query: 726 GYVAPEYGMGSEASMTG--DVYSFGILLLEMFTGRRP 760
            Y+AP+   G +       D +S G+L+ E+ TG  P
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 52.2 bits (125), Expect = 9e-07
 Identities = 36/111 (32%), Positives = 54/111 (48%), Gaps = 11/111 (9%)

Query: 672 LHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIG--IKGTVGYV 728
           +HH     ++H D+K +N+LL  + +V   +F  S      + T S  +G    GT  YV
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY---AATVSDDVGRTFCGTPYYV 212

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL 779
           APE       S   D++S G+LL E+ T +RP D     G  + E +  TL
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GENMEEVMHKTL 258

Length = 496

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 51.6 bits (123), Expect = 9e-07
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 21/210 (10%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 611
           ++G+G+FG V            A+K++    +  K      + E   L+N RH  L    
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT--- 58

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
           ++  S  +K  D    V EY+  G L  + H S + +     T         ++ SA++Y
Sbjct: 59  SLKYSFQTK--DRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRF----YGAEIVSALDY 110

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           LH      IV+ DLK  N++LD D  +   +F L  +  + + T  +     GT  Y+AP
Sbjct: 111 LH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT---FCGTPEYLAP 164

Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           E    ++     D +  G+++ EM  GR P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 27/213 (12%)

Query: 555 MIGQGSFGSVYKGILGGEE---MIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLI 608
           ++G+G+FG V   IL  E+      A+K++    +  K      V E   L+N RH  L 
Sbjct: 2   LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            +         +  D    V EY   G L  + H S + +     T  +      ++ SA
Sbjct: 59  AL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEIVSA 107

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +EYLH      +V+ D+K  N++LD D  +   +F L  +  S   T  +     GT  Y
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEY 161

Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +APE    ++     D +  G+++ EM  GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.0 bits (110), Expect = 1e-06
 Identities = 20/60 (33%), Positives = 34/60 (56%)

Query: 386 SLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHL 445
           +L+ LD+S+N    +   +   + ++K L++S NNL+   PE    L  L  L+LS N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 5/101 (4%)

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           + +++ A+ +LH   +  I++ DLK  NVLLD +   H   +         +   ++   
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTF 156

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
            GT  Y+APE   G +   + D ++ G+L+ EM  GR P D
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 35/101 (34%), Positives = 47/101 (46%), Gaps = 10/101 (9%)

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSI-- 719
           A ++   +E LH      IV+ DLKP N+LLD     H   S    L  A + P      
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDD--YGHIRIS---DLGLAVEIPEGETIR 159

Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           G  GTVGY+APE       + + D +  G L+ EM  G+ P
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 75/266 (28%), Positives = 112/266 (42%), Gaps = 47/266 (17%)

Query: 86  NISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASS 145
            ISSL+     +N         + +NL  L+        L NL  L+L+ NN+     + 
Sbjct: 79  GISSLDGSENLLNLLPLP---SLDLNLNRLRSNISELLELTNLTSLDLDNNNI-----TD 130

Query: 146 IPDSLSN-ASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLL 204
           IP  +    SNL+ LDLS N+ +  +     +L NL  L+L  N+L        D   LL
Sbjct: 131 IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL-------SDLPKLL 182

Query: 205 TNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTI 264
           +N S+L  L L  N+           L S + +  +  N I   + S + NL NL  L +
Sbjct: 183 SNLSNLNNLDLSGNKI--SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLEL 239

Query: 265 EVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSS 324
             N+L   +P+ +G L +L+ L +  N  Q S   SLG+LT L +L              
Sbjct: 240 SNNKL-EDLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLREL-------------- 282

Query: 325 LGNCQNLKGFDASHNKLTGAIPQQVL 350
                     D S N L+ A+P   L
Sbjct: 283 ----------DLSGNSLSNALPLIAL 298

Length = 394

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 25/205 (12%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           +G G++G VYK   +  GE  + AVK+I L+    F     E   ++  +H N   I+  
Sbjct: 17  VGSGTYGDVYKARNLHTGE--LAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN---IVAY 71

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
             S  S+   +  +  EY   GSL+D  H +   L   ++  + R     +    + YLH
Sbjct: 72  FGSYLSREKLW--ICMEYCGGGSLQDIYHVTGP-LSELQIAYVCR-----ETLQGLAYLH 123

Query: 674 HHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
              +   +H D+K +N+LL D+  V   +F ++ ++ +      S I   GT  ++APE 
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI---GTPYWMAPEV 177

Query: 733 GMGSEA---SMTGDVYSFGILLLEM 754
               +    +   D+++ GI  +E+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 31/217 (14%)

Query: 555 MIGQGSFGSVY--KGILGGE-EMIVAVKVINLKQKGAFRSF--VAECEALRNIRHRNLIK 609
           ++G+G +G V+  + + G +   I A+KV  LK+    R+    A  +A RNI     +K
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEA--VK 58

Query: 610 IITICSSIDSKGADFKA-LVFEYMENGSLEDWLHQSNDHLE-VCKLTLIQRVNIAIDVAS 667
              I   I +     K  L+ EY+  G L   L +    +E      L +       ++ 
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-------ISL 111

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSL---SHQLDSASKTPSSSIGIKG 723
           A+E+LH      I++ DLKP N+LLD    V   +F L   S    + + T        G
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT------FCG 162

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           T+ Y+APE  M S      D +S G L+ +M TG  P
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 66/254 (25%), Positives = 111/254 (43%), Gaps = 35/254 (13%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHR 605
           +F    +IG+G+FG V    L   + + A+K++N   + ++     F  E + L N  ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAI 663
               I T+  +   +   +  LV +Y   G L   L +  D L  ++ +  L + V IAI
Sbjct: 62  ---WITTLHYAFQDENNLY--LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAI 115

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSASKTPSSSIG 720
           D   ++  LH+      VH D+KP N+L+D   H  +A     L    D    T  SS+ 
Sbjct: 116 D---SVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---TVQSSVA 163

Query: 721 IKGTVGYVAPEYGMGSEASM-----TGDVYSFGILLLEMFTGRRPTDAAF---TEGLTLH 772
           + GT  Y++PE     E          D +S G+ + EM  G  P  A     T G  ++
Sbjct: 164 V-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Query: 773 EFVKMTLPEKVIEI 786
              +   P +V ++
Sbjct: 223 HKERFQFPAQVTDV 236

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 57/238 (23%), Positives = 89/238 (37%), Gaps = 34/238 (14%)

Query: 557 GQGSFGSVYKGILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
                  + K        +VAVK INL    K   +    E    R ++H N++  +T  
Sbjct: 11  EDLMIVHLAKHKPTNT--LVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT-S 67

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
             +DS+      +V   M  GS ED L       E      I    I  DV +A++Y+H 
Sbjct: 68  FIVDSE----LYVVSPLMAYGSCEDLL--KTHFPEGLPELAI--AFILKDVLNALDYIHS 119

Query: 675 -HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTP----SSSIGIKGTVGYV 728
                  +H  +K S++LL  D          S  +    K               + ++
Sbjct: 120 KGF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 729 APEYGMGSEASMTG-----DVYSFGILLLEMFTGRRP-TDAAFTEGLTLHEFVKMTLP 780
           +PE     + ++ G     D+YS GI   E+  G  P  D   T+ L   E V+ T+P
Sbjct: 176 SPEV---LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVP 228

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 17/138 (12%)

Query: 627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI-DVASAIEYLHHHCQPPIVHGDL 685
           L+ +Y+  G +   L+Q ++  E         V     ++  A+E+LH   +  IV+ D+
Sbjct: 82  LILDYVSGGEMFTHLYQRDNFSE-------DEVRFYSGEIILALEHLH---KLGIVYRDI 131

Query: 686 KPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY--GMGSEASMTG 742
           K  N+LLD +  V   +F LS +  S  K  + S    GT+ Y+APE   G G       
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC--GTIEYMAPEIIRGKGGHGKAV- 188

Query: 743 DVYSFGILLLEMFTGRRP 760
           D +S GIL+ E+ TG  P
Sbjct: 189 DWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 50.6 bits (121), Expect = 3e-06
 Identities = 27/85 (31%), Positives = 46/85 (54%)

Query: 21  LAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF 80
           L +D   L G +P+ +  L  L  + +  NS+ G IP +LG + +L  L+++ N F+G  
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 81  PRWICNISSLEFIYLTVNRFSGSLP 105
           P  +  ++SL  + L  N  SG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 24/212 (11%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEAL-RNIRHRNLIKI 610
           +IG+GSFG V       +    AVKV+  K    +   +  +AE   L +N++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAI 669
                    +  +    V +++  G L   L +     E        R    A ++ASA+
Sbjct: 62  -----HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE-------PRARFYAAEIASAL 109

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            YLH      IV+ DLKP N+LLD    V   +F L  +  + S T ++     GT  Y+
Sbjct: 110 GYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT---FCGTPEYL 163

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           APE         T D +  G +L EM  G  P
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 49.0 bits (117), Expect = 5e-06
 Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 42/232 (18%)

Query: 554 NMIGQGSFGSVYKG---ILGGEEMIVAVKVINLK-QKGAFRSFVAEC----------EAL 599
             +G+G++G V K    + G    I  VK+I +       R  V  C          + +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 600 RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
             I+H N++ ++ +         DF  LV + M    L+  + +        +LT  Q  
Sbjct: 75  NEIKHENIMGLVDVYVE-----GDFINLVMDIMA-SDLKKVVDRK------IRLTESQVK 122

Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQL--DSASKTPS 716
            I + + + +  LH       +H DL P+N+ ++   +    +F L+ +      S T S
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 717 SSIGIKG---------TVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
               ++          T+ Y APE  MG+E      D++S G +  E+ TG+
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 49.0 bits (117), Expect = 5e-06
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 18/211 (8%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           ++G+GSFG V      G + + A+K+  LK+    +    EC  +   R   L       
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVEC-TMVEKRVLALPGKPPFL 63

Query: 615 SSIDS--KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           + + S  +  D    V EY+  G L   + Q      V K      V  A ++A  + +L
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPHAVFYAAEIAIGLFFL 117

Query: 673 HHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H      I++ DLK  NV+LD +  +   +F +  +     KT  +     GT  Y+APE
Sbjct: 118 HSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCGTPDYIAPE 171

Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
                    + D ++FG+LL EM  G+ P D
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.8 bits (116), Expect = 6e-06
 Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 51/301 (16%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHR 605
           ++F    ++G+G++G V K      + IVA+K     ++      + + E + LR ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAID 664
           N   I+ +  +   +G  +  LVFEY+E   LE      N    E  +  + Q +     
Sbjct: 61  N---IVELKEAFRRRGKLY--LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK---- 111

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKG 723
              AI + H +    IVH D+KP N+L+ H D++   +F  +  L   S    +      
Sbjct: 112 ---AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE--YVA 163

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLE------MFTGRRPTDAAFTEGLTL----HE 773
           T  Y +PE  +G+      D++S G +L E      +F G    D  FT    L     E
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE 223

Query: 774 FVKM-------------------TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
            +K+                   +L  + + I+   +L+++M N   +    R  T+ CL
Sbjct: 224 QMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILS-GVLLDLMKNLLKLNPTDRYLTEQCL 282

Query: 815 N 815
           N
Sbjct: 283 N 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 23/214 (10%)

Query: 556 IGQGSFGSV--YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA--LRNIRHRNLIKII 611
           +G+GS+G V   +    G++ ++  K +NL+         AE EA  L  ++H N   I+
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVI--KKLNLRNASRRERKAAEQEAQLLSQLKHPN---IV 62

Query: 612 TICSSIDSKGAD-FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
               S +  G D    +V  + E G L   L +    L    L   Q V   + +A A++
Sbjct: 63  AYRESWE--GEDGLLYIVMGFCEGGDLYHKLKEQKGKL----LPENQVVEWFVQIAMALQ 116

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           YLH   +  I+H DLK  NV L   +++   +  ++  L++     S+ IG   T  Y++
Sbjct: 117 YLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIG---TPYYMS 170

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           PE       +   DV++ G  + EM T +   +A
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 48.3 bits (115), Expect = 8e-06
 Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 18/210 (8%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLI-KIIT 612
           IG+G++G VYK        +VA+K   L+  ++G   + + E   L+ +     I +++ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWL--HQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           +    +  G     LVFEY+++  L+ ++  +       +     I+  +    +   + 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPA-KTIK--SFMYQLLKGVA 124

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD--MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           + H H    ++H DLKP N+L+D    ++   +  L        K+ +  I    T+ Y 
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI---VTLWYR 178

Query: 729 APEYGMGSEA-SMTGDVYSFGILLLEMFTG 757
           APE  +GS   S   D++S G +  EM   
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.1 bits (114), Expect = 8e-06
 Identities = 34/101 (33%), Positives = 48/101 (47%), Gaps = 10/101 (9%)

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSI-- 719
           A ++   +E L    +  IV+ DLKP N+LLD     H   S    L  A + P      
Sbjct: 108 AAELCCGLEDLQ---RERIVYRDLKPENILLDDR--GHIRIS---DLGLAVQIPEGETVR 159

Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           G  GTVGY+APE     + + + D +  G L+ EM  G+ P
Sbjct: 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.1 bits (114), Expect = 8e-06
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 30/219 (13%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-----RHRNLIKI 610
           IG+G++G V+K +        AVK+++            E EA  NI      H N++K 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN---IAIDVAS 667
             +    D K  D   LV E    GS+ D        L    L   +R+    IA  +  
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTD--------LVKGFLKRGERMEEPIIAYILHE 132

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           A+  L H      +H D+K +N+LL  +  V   +F +S QL S     ++S+   GT  
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---GTPF 189

Query: 727 YVAPEY-----GMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++APE       + S      DV+S GI  +E+  G  P
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 48.4 bits (115), Expect = 9e-06
 Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 36/215 (16%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G++G+V   +       VA+K +       L  K A+R    E   L++++H N+I 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78

Query: 610 IITICSSIDS--KGADFKALVFEYM--ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           ++ + +   S  +  DF  LV  +M  + G L      S D ++           +   +
Sbjct: 79  LLDVFTPDLSLDRFHDF-YLVMPFMGTDLGKLMKHEKLSEDRIQF----------LVYQM 127

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              ++Y+H      I+H DLKP N+ ++ D  +   +F L+ Q DS         G   T
Sbjct: 128 LKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS------EMTGYVVT 178

Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE  +     + T D++S G ++ EM TG+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 48.3 bits (115), Expect = 9e-06
 Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 29/214 (13%)

Query: 555 MIGQGSFGSVYKGILGGEEM---IVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLI 608
           ++G+G+FG V   IL  E+      A+K++    +  K      + E   L+N RH  L 
Sbjct: 2   LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVAS 667
            +         +  D    V EY   G L         HL   ++    R      ++ S
Sbjct: 59  AL-----KYSFQTHDRLCFVMEYANGGEL-------FFHLSRERVFSEDRARFYGAEIVS 106

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           A+ YLH      +V+ DLK  N++LD D  +   +F L  +  S   T  +     GT  
Sbjct: 107 ALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPE 160

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 48.7 bits (116), Expect = 1e-05
 Identities = 20/61 (32%), Positives = 36/61 (59%)

Query: 390 LDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEV 449
           L + +    G IP  +  ++ ++ +N+S N++ G IP  L +++ LE L+LSYN   G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 450 P 450
           P
Sbjct: 483 P 483

Length = 623

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 26/216 (12%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 611
           ++G+GSFG V    L     + AVKV+    + Q       + E   L   R+   +  +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAIE 670
             C     +  D    V E++  G L         H++  +     R    A ++ SA+ 
Sbjct: 62  YCCF----QTPDRLFFVMEFVNGGDLMF-------HIQKSRRFDEARARFYAAEITSALM 110

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMVAH---QNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +LH      I++ DLK  NVLLDH+   H    +F +  +     KT S+     GT  Y
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTST---FCGTPDY 162

Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           +APE         + D ++ G+LL EM  G  P +A
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 32/216 (14%)

Query: 555 MIGQGSFGSVYKGILGGEEM--------IVAVKVINLKQKGAFRSFVAECEALRNIRHRN 606
           ++G+G+FG V   IL  E+         I+  +VI  K + A    + E   L+N RH  
Sbjct: 2   LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHT--LTENRVLQNSRHPF 56

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDV 665
           L  +         +  D    V EY   G L  + H S +     ++    R      ++
Sbjct: 57  LTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRE-----RVFSEDRARFYGAEI 104

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            SA++YLH   +  +V+ DLK  N++LD D  +   +F L  +     K  ++     GT
Sbjct: 105 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKTFCGT 159

Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 28/211 (13%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFV------AECEALRNIRHRNLIK 609
           +G G++GSV         + VAVK    K    F+S +       E   L++++H N+I 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           ++ + +   S        +  ++    L       N+ ++  KLT      +   +   +
Sbjct: 81  LLDVFTPARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLIYQILRGL 133

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           +Y+H      I+H DLKPSN+ ++ D  +   +F L      A  T     G   T  Y 
Sbjct: 134 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL------ARHTDDEMTGYVATRWYR 184

Query: 729 APEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
           APE  +     + T D++S G ++ E+ TGR
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 29/204 (14%)

Query: 571 GEEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF 629
              ++VAVKV+       A   F+ E + L  +   N+ +++ +C+           ++ 
Sbjct: 44  DAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPL-----CMIM 98

Query: 630 EYMENGSLEDWL--HQSNDHLEVCKLTLIQR---VNIAIDVASAIEYLHHHCQPPIVHGD 684
           EYMENG L  +L  H +      C    +     + +A  +AS + YL        VH D
Sbjct: 99  EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155

Query: 685 LKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG- 742
           L   N L+  +  +   +F +S  L S     S    ++G      P   M  E+ + G 
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYS-----SDYYRVQGRA--PLPIRWMAWESVLLGK 208

Query: 743 -----DVYSFGILLLEMFT-GRRP 760
                DV++FG+ L E+ T  R  
Sbjct: 209 FTTKSDVWAFGVTLWEILTLCREQ 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 2e-05
 Identities = 23/77 (29%), Positives = 29/77 (37%), Gaps = 17/77 (22%)

Query: 114 NLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID 173
           NLK L L+   L  +                    +     NL+ LDLSGN         
Sbjct: 1   NLKSLDLSNNRLTVI-----------------PDGAFKGLPNLKVLDLSGNNLTSISPEA 43

Query: 174 FSSLKNLWWLNLEQNNL 190
           FS L +L  L+L  NNL
Sbjct: 44  FSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.3 bits (115), Expect = 2e-05
 Identities = 48/150 (32%), Positives = 69/150 (46%), Gaps = 23/150 (15%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHR 605
           EF     I +G+FG VY G       + AVKV+   ++  K       AE +AL      
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA----- 59

Query: 606 NLIK---IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            L K   I+ +  S+ S  A+   LV EY+  G ++  LH      E   +  I      
Sbjct: 60  -LSKSPFIVHLYYSLQS--ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----- 111

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL 692
            +VA A++YLH H    I+H DLKP N+L+
Sbjct: 112 -EVALALDYLHRH---GIIHRDLKPDNMLI 137

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 24/215 (11%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           ++G+GSFG V      G + + A+K+  LK+    +    EC  +   R   L       
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEK-RVLALSGKPPFL 63

Query: 615 SSIDS--KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           + + S  +  D    V EY+  G L   + Q      V +      V  A ++A  + +L
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ------VGRFKEPHAVFYAAEIAIGLFFL 117

Query: 673 HHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDS-ASKTPSSSIGIKGTVGYV 728
           H      I++ DLK  NV+LD   H  +A       +  D   +KT        GT  Y+
Sbjct: 118 H---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT------FCGTPDYI 168

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           APE         + D ++FG+LL EM  G+ P + 
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 38/249 (15%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G GS G V+  +    +  VAVK I L    + +  + E + +R + H N++K+  +  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 616 SIDSK-GADFKAL--------VFEYMENGSLEDWLHQ---SNDHLEVCKLTLIQRVNIAI 663
              S    D  +L        V EYME   L + L Q   S +H  +    L++      
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLR------ 125

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD--MVAHQNFSLSHQLDSA-SKTPSSSIG 720
                ++Y+H      ++H DLKP+NV ++ +  ++   +F L+  +D   S     S G
Sbjct: 126 ----GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 721 IKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL 779
           +  T  Y +P   +  +  +   D+++ G +  EM TG+     A       HE  +M L
Sbjct: 179 LV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA-------HELEQMQL 230

Query: 780 PEKVIEIVD 788
             + + +V 
Sbjct: 231 ILESVPVVR 239

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 37/220 (16%)

Query: 555 MIGQGSFGSVYKGI--LGGEEMIVAVKVIN--LKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +IG+GS+G V   I    GE+  VA+K IN   +        + E + LR +RH ++++I
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEK--VAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64

Query: 611 ITICSSIDSKGADFKAL--VFEYMENGSLEDWLHQ---SNDHL--EVCKLTLIQRVNIAI 663
             I      +  +FK +  VFE ME+      LHQ   +ND L  E  +  L Q      
Sbjct: 65  KHIMLPPSRR--EFKDIYVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQ------ 111

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIK 722
            +  A++Y+H      + H DLKP N+L + D  +   +F L+    + + TP++     
Sbjct: 112 -LLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARV--AFNDTPTAIFWTD 165

Query: 723 --GTVGYVAPEY--GMGSEASMTGDVYSFGILLLEMFTGR 758
              T  Y APE      S+ +   D++S G +  E+ TG+
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 40/154 (25%)

Query: 556 IGQGSFGSV--YKGILGGEEMIVAVKVINLKQKGAFRSFV------AECEALRNIRHRNL 607
           IG+G++G V   K     E+  VA+K I      AF + +       E + LR++ H N+
Sbjct: 13  IGRGAYGIVCSAKNSETNEK--VAIKKIA----NAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ--------SNDHLEVCKLTLIQRV 659
           I I  I      +  +   +V+E M+       LHQ        S+DH   C+  L Q  
Sbjct: 67  IAIKDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDH---CQYFLYQ-- 116

Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD 693
                +   ++Y+H      ++H DLKPSN+LL+
Sbjct: 117 -----LLRGLKYIH---SANVLHRDLKPSNLLLN 142

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 42/152 (27%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVK---------VINLKQKGAFRSFVAECEALRNIRHRN 606
           IG+GS+G V+K        IVA+K         VI   +K A R    E   L+ ++H N
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVI---KKIALR----EIRMLKQLKHPN 61

Query: 607 LIKIITICSSIDSKGADFKA-----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           L+ +I +          F+      LVFEY ++ ++   L++   +       LI++  I
Sbjct: 62  LVNLIEV----------FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKK--I 105

Query: 662 AIDVASAIEYLH-HHCQPPIVHGDLKPSNVLL 692
                 A+ + H H+C    +H D+KP N+L+
Sbjct: 106 IWQTLQAVNFCHKHNC----IHRDVKPENILI 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 45.6 bits (109), Expect = 4e-05
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 23/170 (13%)

Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEV--CKLTLIQRVNI 661
           + N IK+    +++         L+ +Y+++G L D L +    L     K  + Q V  
Sbjct: 68  NPNFIKLYYSVTTLKGH-----VLIMDYIKDGDLFDLL-KKEGKLSEAEVKKIIRQLVE- 120

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
                 A+  LH H    I+H D+K  NVL D      + +   + L     TPS     
Sbjct: 121 ------ALNDLHKH---NIIHNDIKLENVLYDRAK--DRIYLCDYGLCKIIGTPSC---Y 166

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
            GT+ Y +PE   G    ++ D ++ G+L  E+ TG+ P      E L L
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216

Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.5 bits (110), Expect = 5e-05
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 17/149 (11%)

Query: 618 DSKGADFKALVFEYMENGSLEDWLHQS-NDHLEVCKLTLIQRVNIAI---DVASAIEYLH 673
           D K  D   L+ EY   G L   + Q   +HL        Q   + +    +  A++ +H
Sbjct: 133 DFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP------FQEYEVGLLFYQIVLALDEVH 186

Query: 674 HHCQPPIVHGDLKPSNV-LLDHDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTVGYVAPE 731
                 ++H DLK +N+ L+   ++   +F  S Q  DS S   +SS    GT  Y+APE
Sbjct: 187 SRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC--GTPYYLAPE 241

Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                  S   D++S G++L E+ T  RP
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 6e-05
 Identities = 43/174 (24%), Positives = 70/174 (40%), Gaps = 31/174 (17%)

Query: 595 ECEALRNIRHRNLIKII-------TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDH 647
           E + L+ I HR +I +I       T+C  +      +K  +F Y++              
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPK----YKCDLFTYVDRSG----------- 180

Query: 648 LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSH 706
                L L Q + I   +  A+ YLH      I+H D+K  N+ LD  +     +F  + 
Sbjct: 181 ----PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAAC 233

Query: 707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +LD+   TP    G  GT+   +PE           D++S G++L EM      
Sbjct: 234 KLDAHPDTP-QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 31/200 (15%)

Query: 559 GSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSID 618
           GS G V+     G+   V +K+    QKG   + + E   L+N+ H ++I++     ++ 
Sbjct: 77  GSEGRVFVATKPGQPDPVVLKI---GQKG---TTLIEAMLLQNVNHPSVIRMK---DTLV 127

Query: 619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQP 678
           S       +V  +  +  L  +L + +  L + +  +I++      +   + YLH     
Sbjct: 128 SGAI--TCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEK-----QILEGLRYLHAQ--- 176

Query: 679 PIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS---IGIKGTVGYVAPEYGM 734
            I+H D+K  N+ + D D V   +         A++ P  +   +G+ GTV   APE   
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLG-------AAQFPVVAPAFLGLAGTVETNAPEVLA 229

Query: 735 GSEASMTGDVYSFGILLLEM 754
             + +   D++S GI+L EM
Sbjct: 230 RDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 36/215 (16%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFV------AECEALRNIRHRNLIK 609
           +G G++GSV           VAVK    K    F+S +       E   L++++H N+I 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78

Query: 610 IITICSSIDSKGADFKA--LVFEYM--ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           ++ + +   S   +F    LV   M  +  ++      S++H++     L++        
Sbjct: 79  LLDVFTPATS-IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR-------- 129

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              ++Y+H      I+H DLKPSNV ++ D  +   +F L+ Q D          G   T
Sbjct: 130 --GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD------DEMTGYVAT 178

Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE  +     + T D++S G ++ E+  G+
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 52/237 (21%)

Query: 556 IGQGSFGSVYK----------------GILGGEEMIVAVKVINLK-QKGAFRSFVAECEA 598
           +G+G FG V+                  +  G  ++VAVK++     K A   F+ E + 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL--HQSNDHLEVCKLTLI 656
           L  ++  N+I+++ +C   D        ++ EYMENG L  +L  H  +D  E     + 
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPL-----CMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 657 QR-----------VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSL 704
                        +++A+ +AS ++YL        VH DL   N L+  ++ +   +F +
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGM 184

Query: 705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG------DVYSFGILLLEMF 755
           S  L +          I+G    V P   M  E  + G      DV++FG+ L E+ 
Sbjct: 185 SRNLYAG-----DYYRIQGRA--VLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.1 bits (106), Expect = 1e-04
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 556 IGQGSFGSVYKGIL--GGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           +G+G++G VYK     G +E   A+K I  +  G   S   E   LR ++H N+I +  +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 614 CSSIDSKGADFKA-LVFEYMENG--SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
             S     +D K  L+F+Y E+    +  +   S  + +  +L      ++   +   I 
Sbjct: 67  FLS----HSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 671 YLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
           YLH +    ++H DLKP+N+L+     +   V   +   +   +S  K  +    +  T 
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 726 GYVAPEYGMGSEASMTG-DVYSFGILLLEMFT 756
            Y APE  +G+       D+++ G +  E+ T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 37/221 (16%)

Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------LKQKGAFRSFVAECEALRNIR 603
           + S   +G G++GSV   I       VA+K ++      +  K A+R    E   L++++
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQ 72

Query: 604 HRNLIKIITICSSIDSKGADFKA--LVFEYMENGSLED--WLHQSNDHLEVCKLTLIQRV 659
           H N+I ++ + +S  S G +F+   LV  YM+   L+       S D ++          
Sbjct: 73  HENVIGLLDVFTSAVS-GDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY--------- 121

Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSS 718
            +   +   ++Y+H      I+H DLKP N+ ++ D  +   +F L+   D A  T    
Sbjct: 122 -LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMT---- 172

Query: 719 IGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
            G   T  Y APE  +     + T D++S G ++ EM TG+
Sbjct: 173 -GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 556 IGQGSFGSVYKGIL--GGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           +G+G++G VYK     G ++   A+K I  +  G   S   E   LR ++H N+I +  +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 614 CSSIDSKGADFKA-LVFEYMENG--SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
             S     AD K  L+F+Y E+    +  +   S  + +  +L      ++   +   I 
Sbjct: 67  FLS----HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 671 YLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
           YLH +    ++H DLKP+N+L+     +   V   +   +   +S  K  +    +  T 
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 726 GYVAPEYGMGSEASMTG-DVYSFGILLLEMFT 756
            Y APE  +G+       D+++ G +  E+ T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 52/238 (21%)

Query: 556 IGQGSFGSVYKGIL------------------------GGEEMIVAVKVINLKQKGAFRS 591
           +GQG+  ++Y G L                         G E+ V +KV++   +    +
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 592 FVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC 651
           F      +  + H +L  +  +C     +G++   +V E++E+G L+  L +    + V 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCV----RGSE-NIMVEEFVEHGPLDVCLRKEKGRVPVA 117

Query: 652 -KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDS 710
            K+T+ Q+      +ASA+ YL       +VHG++   N+LL    +A          D 
Sbjct: 118 WKITVAQQ------LASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSD- 167

Query: 711 ASKTPSSSIGIKG------TVGYVAPE-YGMGSEASMTGDVYSFGILLLEM-FTGRRP 760
               P  S            + ++APE    G+  S   D +SFG  LLE+ F G  P
Sbjct: 168 ----PGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 34/227 (14%)

Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINL-----KQKGAFRSFVAECEALRNIRHR 605
           IG+GSFG   K IL      G++ ++  K IN+     K++   R    E   L N++H 
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVI--KEINISKMSPKEREESRK---EVAVLSNMKHP 59

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N   I+    S +  G  +  +V +Y E G L   ++     L        Q ++  + +
Sbjct: 60  N---IVQYQESFEENGNLY--IVMDYCEGGDLYKKINAQRGVL----FPEDQILDWFVQI 110

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
             A++++H      I+H D+K  N+ L  D  +   +F ++  L+S  +   + I   GT
Sbjct: 111 CLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI---GT 164

Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
             Y++PE       +   D+++ G +L EM T +   +A   + L L
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 7/106 (6%)

Query: 148 DSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNC 207
           DS      ++ L L     +G +  D S L++L  +NL  N++       L       + 
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG------SI 465

Query: 208 SSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI 253
           +SL+ L L  N F G +P S+  L+S  I   + GN +SG +P+ +
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRI-LNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 74/327 (22%), Positives = 131/327 (40%), Gaps = 41/327 (12%)

Query: 140 MGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD 199
               + +  +LS+ +  E L  +      +         NL  + + +  L + +   L 
Sbjct: 2   TPAENLLKSALSSNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLL 61

Query: 200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNL 259
             + L+   SL  LS                    +    +  N++   I S +  L NL
Sbjct: 62  LPSSLSRLLSLDLLSPSGISSLDGS--ENLLNLLPLPSLDLNLNRLRSNI-SELLELTNL 118

Query: 260 IALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQG 319
            +L ++ N +  I P       +L++L +  N ++ S+P  L NL  L +L LSFN+L  
Sbjct: 119 TSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS- 176

Query: 320 NIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKN 379
           ++P  L N  NL   D S NK++  +P ++  ++ L       ++++   L   + NLKN
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII--ELLSSLSNLKN 233

Query: 380 LVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLN 439
           L         L++S                         NN    +PE + NLS LE L+
Sbjct: 234 L-------SGLELS-------------------------NNKLEDLPESIGNLSNLETLD 261

Query: 440 LSYNHLEGEVPTKGVFSNKTKISLQVN 466
           LS N +   + + G  +N  ++ L  N
Sbjct: 262 LSNNQIS-SISSLGSLTNLRELDLSGN 287

Length = 394

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.6 bits (105), Expect = 2e-04
 Identities = 59/250 (23%), Positives = 96/250 (38%), Gaps = 54/250 (21%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +F S  +IG+G+FG V          I A+K++  K     +  VA   A R+I    L+
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDI----LV 56

Query: 609 K-----IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +     ++ +  S   K   +  L+ E++  G +   L + +   E      I    +AI
Sbjct: 57  EADGAWVVKMFYSFQDKRNLY--LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAI 114

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKT-------- 714
           D    + ++H          D+KP N+LLD    V   +F L   L  A +T        
Sbjct: 115 DAIHQLGFIHR---------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165

Query: 715 -PSSSIGIK-----------------------GTVGYVAPEYGMGSEASMTGDVYSFGIL 750
            P S    +                       GT  Y+APE  M +  +   D +S G++
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225

Query: 751 LLEMFTGRRP 760
           + EM  G  P
Sbjct: 226 MYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 41/132 (31%), Positives = 63/132 (47%), Gaps = 14/132 (10%)

Query: 627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLK 686
           LV ++ E G L  W H S   L + +   ++R   A ++  A++ LH   +  IV  DL 
Sbjct: 62  LVLQHAEGGKL--WSHISK-FLNIPE-ECVKR--WAAEMVVALDALH---REGIVCRDLN 112

Query: 687 PSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYS 746
           P+N+LLD       +  L++     S+   S  G      Y APE G  SE +   D +S
Sbjct: 113 PNNILLDD----RGHIQLTY-FSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWS 167

Query: 747 FGILLLEMFTGR 758
            G +L E+ TG+
Sbjct: 168 LGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 43.8 bits (103), Expect = 3e-04
 Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 7/82 (8%)

Query: 680 IVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA 738
           IV+ DLKP N+LLD D  +   +F  +  +D+ + T      + GT  Y+APE  +    
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT------LCGTPEYIAPEILLNVGH 205

Query: 739 SMTGDVYSFGILLLEMFTGRRP 760
               D ++ GI + E+  G  P
Sbjct: 206 GKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 24/212 (11%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI--- 610
           N+IG GSFG VY+ I       VA+K   + Q   +++   E   ++N+ H N+I +   
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN--RELLIMKNLNHINIIFLKDY 127

Query: 611 -ITICSSIDSKGADFKALVFEYMENGSLEDWLHQS-NDHLEVCKLTLIQRVNIAIDVASA 668
             T C   + K   F  +V E++     +   H + N+H     L L      +  +  A
Sbjct: 128 YYTECFKKNEKNI-FLNVVMEFIPQTVHKYMKHYARNNH----ALPLFLVKLYSYQLCRA 182

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGTVG 726
           + Y+H      I H DLKP N+L+D +    +  +F  +  L +  +    S+    +  
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR----SVSYICSRF 235

Query: 727 YVAPEYGMGSEASMTG-DVYSFGILLLEMFTG 757
           Y APE  +G+    T  D++S G ++ EM  G
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 17/127 (13%)

Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSA 711
           L L Q   +A  + SAI+Y+H   +  I+H D+K  NVL++  + +   +F  +     +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH--GEG-IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313

Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLE-------MFTG-----RR 759
             TP    GI GTV   APE   G   + + D++S G+++ E       +F+      RR
Sbjct: 314 WSTPFH-YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR 372

Query: 760 PTDAAFT 766
           P DA   
Sbjct: 373 PYDAQIL 379

Length = 461

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 43.3 bits (102), Expect = 5e-04
 Identities = 30/108 (27%), Positives = 53/108 (49%), Gaps = 9/108 (8%)

Query: 122 FCSLKNLWWLN-LEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
           F S K  W+++ L  +N G+     IP+ +S   +L+ ++LSGN  +G +     S+ +L
Sbjct: 411 FDSTKGKWFIDGLGLDNQGL--RGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL 468

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSI 228
             L+L  N+        L  +T      SL+ L+L  N   G +P ++
Sbjct: 469 EVLDLSYNSFNGSIPESLGQLT------SLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 42.6 bits (100), Expect = 5e-04
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 20/205 (9%)

Query: 556 IGQGSFGSVY----KGILGGEEMIV--AVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G+GSFG+VY    K  +  E + V   + V  L      ++   E + L  + H  ++K
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLDHPAIVK 66

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
                S ++    D   ++ EY E   L+  L +     +   L+  Q     I +   +
Sbjct: 67  FHA--SFLER---DAFCIITEYCEGRDLDCKLEELKHTGK--TLSENQVCEWFIQLLLGV 119

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
            Y+H   Q  I+H DLK  N+ L ++++   +F +S  L  +    ++     GT  Y++
Sbjct: 120 HYMH---QRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATT---FTGTPYYMS 173

Query: 730 PEYGMGSEASMTGDVYSFGILLLEM 754
           PE           D++S G +L EM
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.8 bits (101), Expect = 5e-04
 Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 30/179 (16%)

Query: 586 KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ 643
           K A+R  V     ++ + H+N+I ++    +      +F+   LV E M+  +L   +  
Sbjct: 60  KRAYRELVL----MKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM 113

Query: 644 SNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNF 702
             DH  +  L L Q       +   I++LH      I+H DLKPSN+++  D      +F
Sbjct: 114 DLDHERMSYL-LYQ-------MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 162

Query: 703 SLSHQL-DSASKTPSSSIGIKGTVGYVAPE--YGMGSEASMTGDVYSFGILLLEMFTGR 758
            L+     S   TP        T  Y APE   GMG + ++  D++S G ++ EM  G 
Sbjct: 163 GLARTAGTSFMMTPYVV-----TRYYRAPEVILGMGYKENV--DIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 31/113 (27%), Positives = 50/113 (44%), Gaps = 13/113 (11%)

Query: 648 LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH--DMVAHQNFSLS 705
           + +C +  I+R      V  AI+YLH +    I+H D+K  N+ ++H  D+      +  
Sbjct: 179 IAICDILAIER-----SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230

Query: 706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGR 758
             +D      +   G  GT+   APE           D++S GI+L EM T  
Sbjct: 231 FPVDI---NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 42.3 bits (99), Expect = 7e-04
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 42/217 (19%)

Query: 556 IGQGSFG---SVYKGILGGEEMIVAVKVI------NLKQKGAFRSFVAECEALRNIRHRN 606
           IG G+ G   + +  +LG   + VAVK +          K A+R  V     L+ + H+N
Sbjct: 29  IGSGAQGIVCAAFDTVLG---INVAVKKLSRPFQNQTHAKRAYRELVL----LKCVNHKN 81

Query: 607 LIKIITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
           +I ++ + +   S   +F+   LV E M+  +L   +H   DH  +  L L Q       
Sbjct: 82  IISLLNVFTPQKSL-EEFQDVYLVMELMD-ANLCQVIHMELDHERMSYL-LYQ------- 131

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKG 723
           +   I++LH      I+H DLKPSN+++  D      +F L       ++T  ++  +  
Sbjct: 132 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL-------ARTACTNFMMTP 181

Query: 724 TV---GYVAPEYGMGSEASMTGDVYSFGILLLEMFTG 757
            V    Y APE  +G       D++S G ++ E+  G
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.0 bits (98), Expect = 0.001
 Identities = 56/246 (22%), Positives = 94/246 (38%), Gaps = 46/246 (18%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNL 607
           +F S  +IG+G+FG V          + A+K++  K     +  V    A R+I    + 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEADS 60

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           + ++ +  S   K   +  L+ E++  G +   L + +   E      I    +AID   
Sbjct: 61  LWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH 118

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKT----------PS 716
            + ++H          D+KP N+LLD    V   +F L   L  A +T          PS
Sbjct: 119 QLGFIHR---------DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169

Query: 717 S----------------------SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
                                  +    GT  Y+APE  M +  +   D +S G+++ EM
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 755 FTGRRP 760
             G  P
Sbjct: 230 LIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.1 bits (99), Expect = 0.001
 Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 45/144 (31%)

Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-------------------HDMVA 698
           R  IA ++  AIE +H   +   +H D+KP N+L+D                   HD   
Sbjct: 104 RFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 699 HQ--------NFSLSHQLDSASKTPSSSIGIK--------------GTVGYVAPEYGMGS 736
           +Q        +   S +     +     +  +              GT  Y+APE  + +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219

Query: 737 EASMTGDVYSFGILLLEMFTGRRP 760
             +   D +S G++L EM  G+ P
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 41.6 bits (98), Expect = 0.001
 Identities = 39/125 (31%), Positives = 51/125 (40%), Gaps = 20/125 (16%)

Query: 113 PNLKELYLTFCSLKN---------------LWWLNLEQNNLGMGTASSIPDSLSNASNLE 157
           P L++L L    L+                L  LNL  N +G     ++ + L    NLE
Sbjct: 137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE 196

Query: 158 RLDLSGNQFK----GKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKAL 213
            LDL+ N         ++   +SLK+L  LNL  NNL    A  L    L  N  SL  L
Sbjct: 197 VLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNI-SLLTL 255

Query: 214 SLCDN 218
           SL  N
Sbjct: 256 SLSCN 260

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 49/170 (28%), Positives = 73/170 (42%), Gaps = 33/170 (19%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           NK+E  +P  + +L NL+ L + FN L+  LP  + NLS L  L +  N +   +P  + 
Sbjct: 150 NKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI-SDLPPEIE 206

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLE----FIYLTVNRFSGSLPFDILVNLPNLKE 117
           LL  L  L+++ N         I  +SSL        L ++        + + NL NL+ 
Sbjct: 207 LLSALEELDLSNN-------SIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLET 259

Query: 118 LYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFK 167
           L L+              NN       S   SL + +NL  LDLSGN   
Sbjct: 260 LDLS--------------NNQI-----SSISSLGSLTNLRELDLSGNSLS 290

Length = 394

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 36/227 (15%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMI---VAVKVINLKQKGAFRSFVAECEALRNIRHR 605
           E+    +IG G FG VY+     +  I      K+ NL+ +    + V E     NI   
Sbjct: 13  EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDI 68

Query: 606 NLIKIITICSSIDSKG-------ADFKALVFEYMENGSLEDWLHQSNDHLEVCKL---TL 655
           + I +     +ID  G         FK     Y     LE  +  + +  +  K     L
Sbjct: 69  DKIALWKNIHNIDHLGIPKYYGCGSFKRCRM-YYRFILLEKLVENTKEIFKRIKCKNKKL 127

Query: 656 IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV---------LLDHDMVAHQNFSLSH 706
           I+  NI  D+ + +EY+H H    I HGD+KP N+         ++D+ + +H  F +  
Sbjct: 128 IK--NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASH--FIIHG 180

Query: 707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLE 753
           +    SK        +GT+ Y   +   G+  +  GD+ S G  +L+
Sbjct: 181 KHIEYSK--EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 28/120 (23%), Positives = 55/120 (45%), Gaps = 22/120 (18%)

Query: 576 VAVKVINLKQKGAFRSFVAECEALRNIRHRNLI--KIITICSSIDSKGADFKALVFEYME 633
             +K+   ++KGA R    E   L+ +  + L   K++      +S G  +  L+ E++E
Sbjct: 24  YVLKINPSREKGADR--EREVAILQLLARKGLPVPKVLASG---ESDGWSY--LLMEWIE 76

Query: 634 NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD 693
             +L+             +++  ++ +IA  +A  +  LH      + HGDL P N+L+D
Sbjct: 77  GETLD-------------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD 123

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 52/219 (23%), Positives = 89/219 (40%), Gaps = 17/219 (7%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           ++G+GSFG          +   A+K I L K   A      E   L  ++H N   I+  
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN---IVAF 63

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
             S ++ G  +  +V EY + G L   +      L      L   V + +     ++++H
Sbjct: 64  KESFEADGHLY--IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL----GVQHIH 117

Query: 674 HHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
              +  ++H D+K  N+ L  +  V   +F  +  L S      + +G   T  YV PE 
Sbjct: 118 ---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG---TPYYVPPEI 171

Query: 733 GMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
                 +   D++S G +L E+ T + P  A   + L L
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 28/150 (18%)

Query: 659 VNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPS 716
           ++ +  VA  + +L   +C    +H DL   N+LL H  +    +F L+  +    +  S
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI----RNDS 268

Query: 717 SSIGIKGT----VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT------GRRPTDAAFT 766
           + + +KG     V ++APE       +   DV+S+GILL E+F+         P D+ F 
Sbjct: 269 NYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327

Query: 767 EGLTLHEFVKMTLPEKVIEIVDPSLLMEVM 796
           +   + E  +M  PE       PS + ++M
Sbjct: 328 K--MIKEGYRMLSPE-----CAPSEMYDIM 350

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 35/110 (31%), Positives = 54/110 (49%), Gaps = 15/110 (13%)

Query: 653 LTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDS 710
           LT +  ++    VA  +E+L   +C    VH DL   NVLL    +V   +F L+  +  
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMH 289

Query: 711 ASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            S   S     KG+    V ++APE    +  +   DV+S+GILL E+F+
Sbjct: 290 DSNYVS-----KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.4 bits (95), Expect = 0.003
 Identities = 59/254 (23%), Positives = 96/254 (37%), Gaps = 57/254 (22%)

Query: 548 SEFASSNMIGQGSFGSV--YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--- 602
            +F S  +IG+G+FG V   +    G   I A+K +  K +   +  VA   A R+I   
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGH--IYAMKKL-RKSEMLEKEQVAHVRAERDILAE 57

Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
                + +    S  D    ++  L+ EY+  G +   L + +   E  + T   R  IA
Sbjct: 58  ADNPWV-VKLYYSFQDE---NYLYLIMEYLPGGDMMTLLMKKDTFTE--EET---RFYIA 108

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-------------------HDMVAHQNF- 702
            +   AI+ +H       +H D+KP N+LLD                   H    ++   
Sbjct: 109 -ETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164

Query: 703 -SLSHQLDSASKTPSSSIG---------------IKGTVGYVAPEYGMGSEASMTGDVYS 746
            +L          P SS                   GT  Y+APE  + +  +   D +S
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224

Query: 747 FGILLLEMFTGRRP 760
            G+++ EM  G  P
Sbjct: 225 LGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 25/165 (15%)

Query: 631 YMENGSLEDWLHQSNDHLEVCK--LTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKP 687
           ++E  SL D   +  +  ++ K  LTL   +  +  VA  +E+L    C    +H DL  
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC----IHRDLAA 207

Query: 688 SNVLL-DHDMVAHQNFSLSHQL----DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG 742
            N+LL ++++V   +F L+  +    D   K  +     +  + ++APE       ++  
Sbjct: 208 RNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-----RLPLKWMAPETIFDRVYTIQS 262

Query: 743 DVYSFGILLLEMFT-GRRP-----TDAAFTEGLTLHEFVKMTLPE 781
           DV+SFG+LL E+F+ G  P      D  F     L E  +M  P+
Sbjct: 263 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--RLKEGTRMRAPD 305

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	854
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.78
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
PRK10345	210	hypothetical protein; Provisional	99.76
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.75
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.74
smart00090	237	RIO RIO-like kinase.	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.62
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.57
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.57
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.53
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.51
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.5
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.48
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.42
PLN03150	623	hypothetical protein; Provisional	99.41
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.4
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.4
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.36
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.33
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.33
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.3
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.29
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.28
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.27
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.27
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.23
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.22
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.22
KOG1243	690	consensus Protein kinase [General function predict	99.22
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.22
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.21
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.19
PLN03150	623	hypothetical protein; Provisional	99.13
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.1
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.08
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.99
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.96
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.96
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.95
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.92
KOG3087	229	consensus Serine/threonine protein kinase [General	98.9
COG4248	637	Uncharacterized protein with protein kinase and he	98.82
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.81
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.81
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.76
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.73
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.7
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.64
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.6
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.57
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.56
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.51
PRK09902	216	hypothetical protein; Provisional	98.46
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.45
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.41

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-97  Score=919.36  Aligned_cols=782  Identities=30%  Similarity=0.462  Sum_probs=605.1

Q ss_pred             CcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccCh
Q 043388            2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFP   81 (854)
Q Consensus         2 n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p   81 (854)
                      |++++.+|..|+.+++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..|+.+++|++|+|++|++++.+|
T Consensus       150 n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p  229 (968)
T PLN00113        150 NMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP  229 (968)
T ss_pred             CcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCC
Confidence            66777788888888888888888888877788888888888888888888887788888888888888888888887788


Q ss_pred             hhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCC-----------CCCceeeccCccCCCCCCCCCCccc
Q 043388           82 RWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSL-----------KNLWWLNLEQNNLGMGTASSIPDSL  150 (854)
Q Consensus        82 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l-----------~~L~~L~L~~N~l~~~~~~~~p~~~  150 (854)
                      ..|+++++|++|+|++|++++.+|. .|.++++|++|+++.|++           ++|+.|+|++|.+.    +.+|..+
T Consensus       230 ~~l~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~----~~~p~~~  304 (968)
T PLN00113        230 YEIGGLTSLNHLDLVYNNLTGPIPS-SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS----GEIPELV  304 (968)
T ss_pred             hhHhcCCCCCEEECcCceeccccCh-hHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeec----cCCChhH
Confidence            8888888888888888888766654 467788888888877653           46778888888773    4567778


Q ss_pred             cCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhh
Q 043388          151 SNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIAN  230 (854)
Q Consensus       151 ~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  230 (854)
                      .++++|++|++++|++++..|..|..+++|+.|+|++|.+...      .+..+..+++|+.|++++|++++.+|..+..
T Consensus       305 ~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~------~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~  378 (968)
T PLN00113        305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE------IPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS  378 (968)
T ss_pred             cCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCc------CChHHhCCCCCcEEECCCCeeEeeCChhHhC
Confidence            8888888888888888888888888888888888888887532      2335677788888888888888888888877


Q ss_pred             hcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchh
Q 043388          231 LSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADL  310 (854)
Q Consensus       231 l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  310 (854)
                      +. .++.|++++|.+.+.+|..+..+++|+.|++++|++++..|..|..+++|+.|++++|.+++.+|..+..+++|+.|
T Consensus       379 ~~-~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  457 (968)
T PLN00113        379 SG-NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQML  457 (968)
T ss_pred             cC-CCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEE
Confidence            65 68888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             ccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCcccccccccccccccccee
Q 043388          311 ALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYL  390 (854)
Q Consensus       311 ~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L  390 (854)
                      +|++|++.+.+|..+ ..++|+.|++++|++++.+|..+..+..+.. +++++|.+.+.+|..+++       +.+|++|
T Consensus       458 ~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~-------l~~L~~L  528 (968)
T PLN00113        458 SLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQ-LKLSENKLSGEIPDELSS-------CKKLVSL  528 (968)
T ss_pred             ECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCE-EECcCCcceeeCChHHcC-------ccCCCEE
Confidence            888888888777765 4578899999999998888888877777655 899999999999988877       4579999


Q ss_pred             eccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCCCccccCccccccccccccc
Q 043388          391 DISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLC  470 (854)
Q Consensus       391 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c  470 (854)
                      +|++|.+++.+|..|..+++|+.|+|++|++++.+|..+.++++|+.|++++|+++|.+|..+.|......++.+|+.+|
T Consensus       529 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc  608 (968)
T PLN00113        529 DLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC  608 (968)
T ss_pred             ECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCCCcceEEEEehhhHHHHHHHHHHHHHHHHhhhcccC--CCCCC-Cc-ccc------cCCcccH
Q 043388          471 GGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVFARRRRSAH--KSVDT-SP-AKK------QFPMISY  540 (854)
Q Consensus       471 ~~~~~~~~~~c~~~~~~~~~~~~~~i~i~~~~~~~~~~~~~~~~~~~rrr~~~--~~~~~-~~-~~~------~~~~~~~  540 (854)
                      ++........|....  + ...+..+++.++++++++++++++++++++|+..  +.... .. ...      ....+++
T Consensus       609 ~~~~~~~~~~c~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  685 (968)
T PLN00113        609 GGDTTSGLPPCKRVR--K-TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI  685 (968)
T ss_pred             CCccccCCCCCcccc--c-cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhH
Confidence            976544344564321  1 1122222222222222222222222222222211  11110 00 000      0111233


Q ss_pred             HHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          541 AELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       541 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      ++   ....|...++||+|+||.||+|++..++..||||+++.....    ...|++.+++++|||||+++++|.+.+  
T Consensus       686 ~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~--  756 (968)
T PLN00113        686 ND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK--  756 (968)
T ss_pred             HH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC--
Confidence            33   345677889999999999999999889999999998643321    235688999999999999999997655  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                         ..++||||+++|+|.++++         .++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.+...++
T Consensus       757 ---~~~lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~  824 (968)
T PLN00113        757 ---GAYLIHEYIEGKNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL  824 (968)
T ss_pred             ---CCEEEEeCCCCCcHHHHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence               5799999999999999985         4689999999999999999999776679999999999999999888777


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      +||.+.......       ...||+.|+|||++.+..++.|+|||||||++|||+||+.||+..........+|.+....
T Consensus       825 ~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  897 (968)
T PLN00113        825 RLSLPGLLCTDT-------KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS  897 (968)
T ss_pred             EeccccccccCC-------CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC
Confidence            777654432211       1258899999999999999999999999999999999999997655445556666554332


Q ss_pred             cc-cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          781 EK-VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       781 ~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                      .. ....+|+.....            .....+...++.+++.+||+.||++||||+||+++|+++.+
T Consensus       898 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        898 DCHLDMWIDPSIRGD------------VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccchhheeCccccCC------------CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            22 223334332110            01112335568899999999999999999999999998865

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-51  Score=509.01  Aligned_cols=448  Identities=32%  Similarity=0.495  Sum_probs=302.5

Q ss_pred             CCcccccCchhhh-cCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCccc
Q 043388            1 KNKLEGQIPEEIG-SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGM   79 (854)
Q Consensus         1 ~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~   79 (854)
                      .|+++|.+|..+. .+++|++|+|++|.+++.+|.  +.+++|++|+|++|.+++.+|..|+.+++|++|+|++|.+.+.
T Consensus       102 ~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  179 (968)
T PLN00113        102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK  179 (968)
T ss_pred             CCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccccc
Confidence            4778888887765 888888888888888776664  4467777777777777777777777777777777777777777


Q ss_pred             ChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCC-----------CCCceeeccCccCCCCCCCCCCc
Q 043388           80 FPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSL-----------KNLWWLNLEQNNLGMGTASSIPD  148 (854)
Q Consensus        80 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l-----------~~L~~L~L~~N~l~~~~~~~~p~  148 (854)
                      +|.+|+++++|++|+|++|++++.+|. .|.++++|++|++++|++           ++|+.|+|++|.+.    +.+|.
T Consensus       180 ~p~~~~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~----~~~p~  254 (968)
T PLN00113        180 IPNSLTNLTSLEFLTLASNQLVGQIPR-ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT----GPIPS  254 (968)
T ss_pred             CChhhhhCcCCCeeeccCCCCcCcCCh-HHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceec----cccCh
Confidence            777777777777777777777655553 356777777777766543           46677777777663    34566


Q ss_pred             cccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhh
Q 043388          149 SLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSI  228 (854)
Q Consensus       149 ~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  228 (854)
                      .|+++++|++|+|++|++.+..|..|..+++|++|+|++|.+....      +..+.++++|+.|++++|.+++.+|..+
T Consensus       255 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~------p~~~~~l~~L~~L~l~~n~~~~~~~~~~  328 (968)
T PLN00113        255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI------PELVIQLQNLEILHLFSNNFTGKIPVAL  328 (968)
T ss_pred             hHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCC------ChhHcCCCCCcEEECCCCccCCcCChhH
Confidence            6677777777777777776666666666677777777766664221      2234445555555555555555555554


Q ss_pred             hhhcccccEEEccCCcccccCCccccccccCCeeeccccccc------------------------cCCCCCccCcccCc
Q 043388          229 ANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLH------------------------GIIPDGVGELQHLQ  284 (854)
Q Consensus       229 ~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~------------------------~~~~~~~~~l~~L~  284 (854)
                      ..++ .|+.|++++|.+++.+|..++.+++|+.|++++|+++                        +..|..+..+++|+
T Consensus       329 ~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~  407 (968)
T PLN00113        329 TSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLR  407 (968)
T ss_pred             hcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCC
Confidence            4443 4555555555555445555555555555555555544                        44444555555555


Q ss_pred             eeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcC
Q 043388          285 QLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHN  364 (854)
Q Consensus       285 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n  364 (854)
                      .|++++|++++.+|..|..++.|+.|++++|.+++.+|..+..+++|+.|++++|++.+.+|..+. ...+. .+++++|
T Consensus       408 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~-~L~ls~n  485 (968)
T PLN00113        408 RVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLE-NLDLSRN  485 (968)
T ss_pred             EEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccce-EEECcCC
Confidence            555555555555555555555555555555555555555555555566666666665555554332 23332 3677777


Q ss_pred             CCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeeccccc
Q 043388          365 LLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNH  444 (854)
Q Consensus       365 ~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~  444 (854)
                      .+++.+|..+.+       +.+|+.|+|++|++.+.+|..++.+++|++|+|++|.+++.+|..|..+++|+.|||++|+
T Consensus       486 ~l~~~~~~~~~~-------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  558 (968)
T PLN00113        486 QFSGAVPRKLGS-------LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ  558 (968)
T ss_pred             ccCCccChhhhh-------hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCc
Confidence            777777776666       4579999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcccCCCC-ccccCcccccccccccccC
Q 043388          445 LEGEVPTK-GVFSNKTKISLQVNVKLCG  471 (854)
Q Consensus       445 l~~~~p~~-~~~~~~~~~~~~~n~~~c~  471 (854)
                      ++|.+|.. ..+.....+++.+|...+.
T Consensus       559 l~~~~p~~l~~l~~L~~l~ls~N~l~~~  586 (968)
T PLN00113        559 LSGEIPKNLGNVESLVQVNISHNHLHGS  586 (968)
T ss_pred             ccccCChhHhcCcccCEEeccCCcceee
Confidence            99999874 3355667778888876543

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-50  Score=428.45  Aligned_cols=288  Identities=40%  Similarity=0.659  Sum_probs=241.9

Q ss_pred             cCCcccHHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEE
Q 043388          534 QFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI  613 (854)
Q Consensus       534 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  613 (854)
                      ....|+++++..||++|...++||+|+||.||+|... ++..||||++........++|.+|++++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            4567999999999999999999999999999999998 558999998876544314569999999999999999999999


Q ss_pred             eeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec
Q 043388          614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD  693 (854)
Q Consensus       614 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  693 (854)
                      |.+.++    ..++|||||++|+|.++++.....    .++|.+|++||.++|+||+|||+.+.|+||||||||+|||+|
T Consensus       140 C~e~~~----~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD  211 (361)
T KOG1187|consen  140 CLEGGE----HRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD  211 (361)
T ss_pred             EecCCc----eEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence            987662    479999999999999999986532    789999999999999999999999999999999999999999


Q ss_pred             CCccccc-cccccccccc-CCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcc-cCCch
Q 043388          694 HDMVAHQ-NFSLSHQLDS-ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF-TEGLT  770 (854)
Q Consensus       694 ~~~~~~~-Dfg~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~-~~~~~  770 (854)
                      +++.+++ |||+|+.... .......   ..||.+|+|||+...+..+.|+|||||||+++|++||+.|.+... .....
T Consensus       212 ~~~~aKlsDFGLa~~~~~~~~~~~~~---~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~  288 (361)
T KOG1187|consen  212 EDFNAKLSDFGLAKLGPEGDTSVSTT---VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS  288 (361)
T ss_pred             CCCCEEccCccCcccCCccccceeee---cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence            9999998 9999966554 2211110   069999999999999999999999999999999999999988654 23344


Q ss_pred             HhHHhhhcCCc-ccccccCchhhH-HHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          771 LHEFVKMTLPE-KVIEIVDPSLLM-EVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       771 ~~~~~~~~~~~-~~~~~~d~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                      +.+|....+.. .+.+++||.+.. ..             ...++...+.+++.+|++.+|.+||+|.||+++|+.+.
T Consensus       289 l~~w~~~~~~~~~~~eiiD~~l~~~~~-------------~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  289 LVEWAKPLLEEGKLREIVDPRLKEGEY-------------PDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHHHHHHCcchhheeCCCccCCCC-------------ChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            77777655554 578888988742 11             00134667899999999999999999999999996654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6e-47  Score=378.09  Aligned_cols=253  Identities=26%  Similarity=0.363  Sum_probs=209.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++.+..+.||+|..|+||+++++.+++.+|+|++... +....+++.+|++++++.+||+||.+||.|.....    .++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence            3555678899999999999999999999999999644 34446789999999999999999999999987652    489


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      |+||||++|||++++...+      ++++...-+|+.+|++||.|||+ +   +||||||||+|||++..+.+|+ |||.
T Consensus       155 I~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             eehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccc
Confidence            9999999999999998765      78999999999999999999996 5   9999999999999999888777 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +..+.....     ..++||..|||||.+.+..|+.++||||||++++|+.+|+.||...........+.......+.. 
T Consensus       226 S~~lvnS~a-----~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp-  299 (364)
T KOG0581|consen  226 SGILVNSIA-----NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP-  299 (364)
T ss_pred             cHHhhhhhc-----ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC-
Confidence            998876622     23679999999999999999999999999999999999999998652222222222221111110 


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHH-HHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQ-DCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                            +..+. .+..++..++..|+++||.+|||++|+++.
T Consensus       300 ----------------------P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  300 ----------------------PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             ----------------------CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                                  01111 357789999999999999999999999764

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=388.35  Aligned_cols=261  Identities=31%  Similarity=0.467  Sum_probs=209.7

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccc--hHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++...+.||+|+||+||+|.+.+. ..||||++.......  .++|.+|+.+|.+++|||||+++|+|.+...    ..+
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~  116 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLC  116 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceE
Confidence            344456699999999999999833 239999997543222  5689999999999999999999999987542    479


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeecCCCCceEecCCc-cccc-ccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP-IVHGDLKPSNVLLDHDM-VAHQ-NFS  703 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~~~-Dfg  703 (854)
                      +||||+++|+|.++++...    ...+++..+++||.|||+||.|||++   + ||||||||+|||++.+. ..|+ |||
T Consensus       117 iVtEy~~~GsL~~~l~~~~----~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKR----KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCc
Confidence            9999999999999998841    12899999999999999999999999   7 99999999999999996 7777 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccC--CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGM--GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      +++........   .....||+.|||||++.  ...|+.|+|||||||++|||+||+.||..... .......+..    
T Consensus       190 lsr~~~~~~~~---~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~----  261 (362)
T KOG0192|consen  190 LSREKVISKTS---MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVG----  261 (362)
T ss_pred             cceeecccccc---ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhc----
Confidence            99887654311   12246999999999999  56899999999999999999999999986533 1111111111    


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhc
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLG  851 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  851 (854)
                                            ..+...+..|+..+..++.+||+.||+.||++.|++..|+.+......
T Consensus       262 ----------------------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  262 ----------------------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             ----------------------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence                                  111112223577889999999999999999999999999999876654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-46  Score=374.49  Aligned_cols=202  Identities=31%  Similarity=0.527  Sum_probs=181.5

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ...+|...+.||+|+||+||+|+++.++..||||.+...  .....+.+..|+++++.++|||||++++++...+     
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~-----   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD-----   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-----
Confidence            356889999999999999999999999999999999765  4445677889999999999999999999998776     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC------cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD------MV  697 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~  697 (854)
                      +.|+|||||.||+|.+|++..+      .+++..++.++.|+|.||++||++   +||||||||+|||++..      -.
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~  153 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRG------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPV  153 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCce
Confidence            8999999999999999999876      789999999999999999999999   99999999999999875      33


Q ss_pred             ccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          698 AHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      .|| |||+|+.........    ..+|++-|||||+++..+|+.|+|+||.|+++|++++|++||+...
T Consensus       154 LKIADFGfAR~L~~~~~a~----tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  154 LKIADFGFARFLQPGSMAE----TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             EEecccchhhhCCchhHHH----HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            455 999999988554332    3689999999999999999999999999999999999999998654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-46  Score=373.71  Aligned_cols=253  Identities=24%  Similarity=0.313  Sum_probs=202.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-------ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-------KGAFRSFVAECEALRNIRHRNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  619 (854)
                      -+.|.+.+.+|+|+||.|-+|..+.+++.||||++....       ........+|+++|++++|||||++++++...+ 
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d-  249 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD-  249 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC-
Confidence            356888999999999999999999999999999996432       112344679999999999999999999998877 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC---c
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---M  696 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~  696 (854)
                          ..||||||++||+|.+++-.++      .+.+..-..+++|++.|+.|||++   ||+||||||+|||+..+   .
T Consensus       250 ----s~YmVlE~v~GGeLfd~vv~nk------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~  316 (475)
T KOG0615|consen  250 ----SSYMVLEYVEGGELFDKVVANK------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDC  316 (475)
T ss_pred             ----ceEEEEEEecCccHHHHHHhcc------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcce
Confidence                6799999999999999998876      566667788999999999999999   99999999999999766   5


Q ss_pred             cccc-ccccccccccCCCCCCcccccCCcccccCccccCCCC---CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh
Q 043388          697 VAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE---ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH  772 (854)
Q Consensus       697 ~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~  772 (854)
                      ..++ |||+|+..+....    ....+||+.|.|||++.+..   +..|+|+||+|||+|-+++|.+||.+...+.....
T Consensus       317 llKItDFGlAK~~g~~sf----m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e  392 (475)
T KOG0615|consen  317 LLKITDFGLAKVSGEGSF----MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE  392 (475)
T ss_pred             EEEecccchhhcccccee----hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH
Confidence            5566 9999998864332    23468999999999987754   34488999999999999999999986543322223


Q ss_pred             HHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ++.+..+...                        .....+..++..+++.+||..||++|||+.|+++.
T Consensus       393 QI~~G~y~f~------------------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  393 QILKGRYAFG------------------------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             HHhcCccccc------------------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            3222222111                        01122336667899999999999999999999763

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=384.68  Aligned_cols=258  Identities=29%  Similarity=0.445  Sum_probs=215.7

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +.+...+.||+|-||+||.|.++ ....||+|.++.... ..++|.+|+++|++|+|++||+++|+|...+     .+||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyI  278 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYI  278 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEE
Confidence            34556788999999999999998 444799999986532 3478999999999999999999999998755     5899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      |||||+.|+|.+||+...+    ..+...+.+.++.|||.||+||+++   ++|||||.++||||+++.++|| |||+|+
T Consensus       279 VtE~m~~GsLl~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREG----GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             EEEecccCcHHHHhhhcCC----CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence            9999999999999998432    2788999999999999999999999   9999999999999999999999 999999


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ...+......  .+..-+..|.|||.+..+.++.|||||||||+|||++| |+.||....     ..+.+..        
T Consensus       352 ~~~d~~Y~~~--~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----n~ev~~~--------  416 (468)
T KOG0197|consen  352 LIGDDEYTAS--EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----NEEVLEL--------  416 (468)
T ss_pred             ccCCCceeec--CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----HHHHHHH--------
Confidence            6554433222  22345778999999999999999999999999999999 999987542     2222111        


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                                     .....|.+.++.|+.++.++|..||+.+|++|||++.+...++++...-
T Consensus       417 ---------------le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  417 ---------------LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             ---------------HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence                           1123455667788999999999999999999999999999999887654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-45  Score=383.40  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=209.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ..|...+.||+|||+.||++++..+|..||+|++...   .....+...+|+++.+.|+|||||+++++|++.+     +
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~-----n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN-----N   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-----c
Confidence            5699999999999999999999889999999999753   3455678999999999999999999999998877     8


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      +|||.|+|+.++|.++++..+      ++++.+++.+..||+.||.|||+.   +|+|||||..|+|+++++.+|| |||
T Consensus        93 VYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence            999999999999999999554      899999999999999999999999   9999999999999999988888 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +|..+.......   ...+|||.|.|||++.....+..+||||+|||+|-|++|++||+...     +.+......... 
T Consensus       164 LAt~le~~~Erk---~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~Ik~~~-  234 (592)
T KOG0575|consen  164 LATQLEYDGERK---KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNKIKLNE-  234 (592)
T ss_pred             eeeeecCccccc---ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHHHHhcC-
Confidence            999987653322   34789999999999999999999999999999999999999998542     111111110000 


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                             ...+.....+..++|..+|+.||.+|||+++|+..
T Consensus       235 -----------------------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  235 -----------------------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -----------------------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                                   00111224456789999999999999999999864

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-46  Score=353.95  Aligned_cols=264  Identities=22%  Similarity=0.302  Sum_probs=210.6

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ...+|.+.++||+|+||+||+++...+|..||.|.++..  +....++...|+.++++++|||||+++++-...+   ..
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~---~e   93 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED---NE   93 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc---ch
Confidence            356899999999999999999999999999999998743  3445677899999999999999999998533322   22


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeecCCCCceEecCCccccc-c
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQP-PIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ..+||||||.+|+|.++++..+..  ...+++..+++++.|++.||.++|+..++ -|+||||||.||+++.++++++ |
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD  171 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD  171 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence            479999999999999999876533  33799999999999999999999995332 2899999999999999999998 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||+++.+.......   ...+|||.||+||.+.+..|+.||||||+||++|||..-++||.+.     .+.+........
T Consensus       172 fGL~r~l~s~~tfA---~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qg  243 (375)
T KOG0591|consen  172 FGLGRFLSSKTTFA---HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQG  243 (375)
T ss_pred             chhHhHhcchhHHH---HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcC
Confidence            99999987654432   3468999999999999999999999999999999999999999864     222222211111


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                      ......|                      +-++..+.+++..|+..||+.||+...++..+..
T Consensus       244 d~~~~p~----------------------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  244 DYPPLPD----------------------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             CCCCCcH----------------------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            1111111                      2336678899999999999999996555555443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-46  Score=385.08  Aligned_cols=404  Identities=20%  Similarity=0.213  Sum_probs=349.8

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      .-++||+|+|+|...-+..|.++++|+.++|..|.++ .+|.......+|+.|+|.+|.|+++..+.++.++.|+.||||
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            4567999999999888889999999999999999999 889888888889999999999999999999999999999999


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccc
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS  176 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~  176 (854)
                      .|.|+ .+|...|..-.++++|+|++|+++.++                 .+.|.++.+|.+|.|++|+|+.+++..|..
T Consensus       158 rN~is-~i~~~sfp~~~ni~~L~La~N~It~l~-----------------~~~F~~lnsL~tlkLsrNrittLp~r~Fk~  219 (873)
T KOG4194|consen  158 RNLIS-EIPKPSFPAKVNIKKLNLASNRITTLE-----------------TGHFDSLNSLLTLKLSRNRITTLPQRSFKR  219 (873)
T ss_pred             hchhh-cccCCCCCCCCCceEEeeccccccccc-----------------cccccccchheeeecccCcccccCHHHhhh
Confidence            99998 999999988899999999999988774                 367889999999999999999999999999


Q ss_pred             cCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccccc
Q 043388          177 LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNL  256 (854)
Q Consensus       177 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l  256 (854)
                      +++|+.|+|..|+|..+..-      .|.++++|+.|.|..|.|...-...|..+. +++.|+|+.|+++..-..++.+|
T Consensus       220 L~~L~~LdLnrN~irive~l------tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~-kme~l~L~~N~l~~vn~g~lfgL  292 (873)
T KOG4194|consen  220 LPKLESLDLNRNRIRIVEGL------TFQGLPSLQNLKLQRNDISKLDDGAFYGLE-KMEHLNLETNRLQAVNEGWLFGL  292 (873)
T ss_pred             cchhhhhhccccceeeehhh------hhcCchhhhhhhhhhcCcccccCcceeeec-ccceeecccchhhhhhccccccc
Confidence            99999999999999765433      689999999999999999966666677775 89999999999998889999999


Q ss_pred             ccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCccccc
Q 043388          257 VNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDA  336 (854)
Q Consensus       257 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  336 (854)
                      +.|+.|+||+|.|..+.+++....++|++|+|++|+|+...+..|..|..|+.|+|++|+++.....+|..+++|+.|||
T Consensus       293 t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdL  372 (873)
T KOG4194|consen  293 TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDL  372 (873)
T ss_pred             chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcC
Confidence            99999999999999999999999999999999999999888899999999999999999999888889999999999999


Q ss_pred             CCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEc
Q 043388          337 SHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNV  416 (854)
Q Consensus       337 s~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  416 (854)
                      ++|.+++.+.+....                      |..       +++|+.|+|.+|+|..+...+|..+..|+.|||
T Consensus       373 r~N~ls~~IEDaa~~----------------------f~g-------l~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL  423 (873)
T KOG4194|consen  373 RSNELSWCIEDAAVA----------------------FNG-------LPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDL  423 (873)
T ss_pred             cCCeEEEEEecchhh----------------------hcc-------chhhhheeecCceeeecchhhhccCcccceecC
Confidence            999998776653221                      111       457999999999999777789999999999999


Q ss_pred             cCcccccccchhhcCccCCCeeecccccCcccCCCCccccCccccccccc-ccccCCcccc
Q 043388          417 SSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVN-VKLCGGIDEL  476 (854)
Q Consensus       417 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n-~~~c~~~~~~  476 (854)
                      .+|.|..+-|++|..+ .|+.|-+..-.+-|.+--.|..+....-.++.. ...|+.|..+
T Consensus       424 ~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~qWl~~~~lq~sv~a~CayPe~L  483 (873)
T KOG4194|consen  424 GDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQWLYRRKLQSSVIAKCAYPEPL  483 (873)
T ss_pred             CCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHHHHHhcccccceeeeccCCccc
Confidence            9999999999999999 999998887777777665554443333222221 1347766554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.6e-44  Score=343.81  Aligned_cols=276  Identities=19%  Similarity=0.259  Sum_probs=204.7

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +.|+...++|+|+||+||+++++.+|+.||||++....+  ...+-..||++++++++|+|+|.++.+|....     ..
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-----kl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-----KL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc-----ee
Confidence            467888999999999999999999999999999964433  23455789999999999999999999986544     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++|+|||+. ++.+-+.....     .++...+.++++|+++|+.|+|++   ++|||||||+|||++..++.++ |||+
T Consensus        77 hLVFE~~dh-TvL~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   77 HLVFEYCDH-TVLHELERYPN-----GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             EEEeeecch-HHHHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence            999999988 66565665543     678889999999999999999999   9999999999999999988886 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh-HHhhhcCCcc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH-EFVKMTLPEK  782 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~  782 (854)
                      |+....+...   .+.++.|.+|+|||.+.| .+|+..+||||.||++.||++|.+.|.+..+-+..+. ...-......
T Consensus       148 AR~L~~pgd~---YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr  224 (396)
T KOG0593|consen  148 ARTLSAPGDN---YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR  224 (396)
T ss_pred             hHhhcCCcch---hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH
Confidence            9988753332   234679999999999888 6799999999999999999999999987654321111 1111111111


Q ss_pred             cccccCchhhHHHhhc-cchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMAN-NSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      -..+...........- ...-.+.-+.........+.+++..|++.||++|++.+|++.
T Consensus       225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111100000000000 000001111223344567889999999999999999999874

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.6e-43  Score=330.32  Aligned_cols=273  Identities=21%  Similarity=0.283  Sum_probs=214.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .+|...+++|+|.||.||+|++..+|+.||||+++...  ++......||++.++.++|+||+.++++|...+     ..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-----~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-----NL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-----ce
Confidence            46888899999999999999999999999999998653  233456789999999999999999999997766     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      .+|+|||+. +|+..++....     .++..++..++.++++|++|+|++   .|+||||||.|+|++++++.|+ |||+
T Consensus        77 ~lVfEfm~t-dLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             EEEEEeccc-cHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence            899999987 99999987653     789999999999999999999999   9999999999999999999888 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh---cCC
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM---TLP  780 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~---~~~  780 (854)
                      |+.+.........   .+-|.+|+|||.+.|. .|+..+||||.||++.||+-|.+-|.+..+- .++..+.+.   ..+
T Consensus       148 Ar~f~~p~~~~~~---~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~LGTP~~  223 (318)
T KOG0659|consen  148 ARFFGSPNRIQTH---QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRALGTPTP  223 (318)
T ss_pred             hhccCCCCccccc---ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHcCCCCc
Confidence            9999876654432   2679999999999885 5999999999999999999998877765332 222222222   222


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +.|.++..   ..++........+.....+..+.....+++..++..||.+|+|++|++++
T Consensus       224 ~~WP~~~~---lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  224 DQWPEMTS---LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccCccccc---cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            33332211   11111111011111122344556677999999999999999999999875

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.8e-43  Score=384.45  Aligned_cols=264  Identities=26%  Similarity=0.453  Sum_probs=219.0

Q ss_pred             hhccccCccCCCcceEEEEeEEC-----CCceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILG-----GEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      .+....+.||+|.||+||+|+..     ++...||||.++..... ...+|+||+++++.++|||||+++|+|...+   
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~---  562 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD---  562 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC---
Confidence            45566789999999999999874     34578999999876655 6789999999999999999999999998877   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCccc--------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLE--------VCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD  693 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  693 (854)
                        -.++|+|||..|||.+||........        ..+++..+.+.||.|||.||+||-++   .+|||||..+|+||.
T Consensus       563 --P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  563 --PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG  637 (774)
T ss_pred             --eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence              57999999999999999987543211        23488999999999999999999999   999999999999999


Q ss_pred             CCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchH
Q 043388          694 HDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTL  771 (854)
Q Consensus       694 ~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~  771 (854)
                      ++.++|| |||+++.+........... ..-+..|||||.++.+++|.+||||||||||||+++ |+.||.+...++  .
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~-t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--V  714 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGN-TLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--V  714 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCC-ceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--H
Confidence            9999999 9999998877655443211 234789999999999999999999999999999999 999998653321  1


Q ss_pred             hHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          772 HEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       772 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      .+.++   ..                       .-.+.++.|+.++.+||..||+.+|.+||+++||-..|....+.
T Consensus       715 Ie~i~---~g-----------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  715 IECIR---AG-----------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHH---cC-----------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            11111   11                       11234677899999999999999999999999999999887654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-42  Score=357.87  Aligned_cols=278  Identities=24%  Similarity=0.310  Sum_probs=214.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .+.|+..++||+|.||.||+|++..+|+.||+|+++...  .+...-..||+.||++++||||+++.+...+..   ...
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~---~~s  192 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL---SGS  192 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---Cce
Confidence            467888899999999999999999999999999998654  444566789999999999999999999987762   226


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      +|+|+|||+. +|..++....-     .++..++..+++|++.||+|+|++   +|+|||||.+|||||.+++.++ |||
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~v-----kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGV-----KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCc-----ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccc
Confidence            8999999988 99998887543     799999999999999999999999   9999999999999999999998 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC--C
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL--P  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~--~  780 (854)
                      +|+.+.......  .+..+-|.+|+|||.+.|. .|+.++|+||.|||+.||++|++.|.+..+- ..+..+.+..-  .
T Consensus       264 LAr~y~~~~~~~--~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcGSP~  340 (560)
T KOG0600|consen  264 LARFYTPSGSAP--YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCGSPT  340 (560)
T ss_pred             ceeeccCCCCcc--cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhCCCC
Confidence            999887665433  2345689999999999885 5999999999999999999999999875332 22333222211  1


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +..+...+-... ............-++.....+....+++..+|..||.+|.||.++++
T Consensus       341 e~~W~~~kLP~~-~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  341 EDYWPVSKLPHA-TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             hhccccccCCcc-cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            122221110000 00000001111112234445677889999999999999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=359.31  Aligned_cols=276  Identities=20%  Similarity=0.230  Sum_probs=210.0

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccch-HHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF-RSFVAECEALRNIR-HRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  623 (854)
                      ..++|.+.++||.|.||.||+|+...++..||||.++.+-.... -.-.||++.+++++ |||||++.+++.+.+.    
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~----   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR----   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc----
Confidence            35789999999999999999999999999999999975433322 23468999999998 9999999999876552    


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++|||||+. +|+++++.+++     .+++.+++.|+.||++||+|+|.+   |+.|||+||+|||+....+.|| ||
T Consensus        84 ~L~fVfE~Md~-NLYqLmK~R~r-----~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   84 ILYFVFEFMDC-NLYQLMKDRNR-----LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             eEeeeHHhhhh-hHHHHHhhcCC-----cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence            68999999977 99999998743     899999999999999999999999   9999999999999996666666 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh---hc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK---MT  778 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~---~~  778 (854)
                      |+|+.+.......    .++.|++|+|||++.. +.|+.+.||||+|||++|+.+-++.|.+..+-+ .+..+..   ..
T Consensus       155 GLARev~SkpPYT----eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~KIc~VLGtP  229 (538)
T KOG0661|consen  155 GLAREVRSKPPYT----EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYKICEVLGTP  229 (538)
T ss_pred             ccccccccCCCcc----hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHHHHHHhCCC
Confidence            9999987654432    3678999999998665 669999999999999999999999998764322 1222221   11


Q ss_pred             CCcccccccCchhhHHHhh-ccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMA-NNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..+.+.+.  ..+...+.- -....+..-......+..+..+++.+|++|||.+||||+|.++.
T Consensus       230 ~~~~~~eg--~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  230 DKDSWPEG--YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             ccccchhH--HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11111111  011100000 00011111112223457788999999999999999999999875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=346.21  Aligned_cols=242  Identities=28%  Similarity=0.371  Sum_probs=200.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|++.++||+|+||.||.++.+.+++.+|+|+++..   .....+...+|..++.+++||.||+++..|.+.+     
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~-----   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE-----   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC-----
Confidence            57899999999999999999999999999999999643   2344577889999999999999999999988766     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+|+||+.||.|...|.+.+      .+++..++-++.+|+.||.|||++   +|||||+||+|||+|.++..++ ||
T Consensus        99 kLylVld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF  169 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF  169 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence            7999999999999999999876      789999999999999999999999   9999999999999999998887 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+|+.........   ..++||+.|||||++.+..|+.++|.||+||++|||++|.+||....     ..++........
T Consensus       170 gL~k~~~~~~~~t---~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~k  241 (357)
T KOG0598|consen  170 GLCKEDLKDGDAT---RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKGK  241 (357)
T ss_pred             ccchhcccCCCcc---ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcCc
Confidence            9999665443332   23789999999999999999999999999999999999999998542     222222222211


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM  833 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  833 (854)
                      ..  .-|.                     -...+..+++...+..||++|.
T Consensus       242 ~~--~~p~---------------------~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 LP--LPPG---------------------YLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CC--CCCc---------------------cCCHHHHHHHHHHhccCHHHhc
Confidence            00  0000                     0134456888889999999996

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-43  Score=365.67  Aligned_cols=263  Identities=27%  Similarity=0.421  Sum_probs=210.2

Q ss_pred             HHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       544 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      ..-.+++.+.+.||+|+||+||+|+|.++   ||||++....  +...+.|++|+.++++-+|.||+-+.|||..+.   
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---  461 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---  461 (678)
T ss_pred             ccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---
Confidence            33456677889999999999999999864   9999998654  345688999999999999999999999998765   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                         ..||+.+|+|.+|+.+++..+.     .+...+.+.||+|||+||.|||.+   +|||||||..||++.++..++| 
T Consensus       462 ---~AIiTqwCeGsSLY~hlHv~et-----kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIg  530 (678)
T KOG0193|consen  462 ---LAIITQWCEGSSLYTHLHVQET-----KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIG  530 (678)
T ss_pred             ---eeeeehhccCchhhhhccchhh-----hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEe
Confidence               4999999999999999998753     789999999999999999999999   9999999999999999887777 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCC---CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS---EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                      |||++..-..-.. ........|...|||||+++..   +|++.+||||||+|+|||+||..||.....+     +++.+
T Consensus       531 DFGLatvk~~w~g-~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-----qIifm  604 (678)
T KOG0193|consen  531 DFGLATVKTRWSG-EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-----QIIFM  604 (678)
T ss_pred             cccceeeeeeecc-ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-----heEEE
Confidence            9999875433211 1111123488999999998753   5899999999999999999999999732211     11111


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      .-...    ..               ++.......|++++.+|+..||..+|++||.+.+|+.+|+++..+
T Consensus       605 VGrG~----l~---------------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  605 VGRGY----LM---------------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ecccc----cC---------------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            11110    00               111122346688999999999999999999999999999988764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-42  Score=352.34  Aligned_cols=260  Identities=27%  Similarity=0.405  Sum_probs=204.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..++...+.||+|+||+||++....+|...|||.+...+....+.+.+|+.+|.+++|||||+++|.....+.   ...+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence            3457778999999999999999998899999999976644446778999999999999999999997544332   3579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC-Cccccc-cccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQ-NFSL  704 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~~~-Dfg~  704 (854)
                      +.|||+++|+|.+++...+.     .+++..++.++.||++||+|||++   +||||||||+|||++. ++..++ |||.
T Consensus        93 i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence            99999999999999998753     589999999999999999999999   9999999999999999 566666 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      ++..............+.||+.|||||++..+ ...+++||||+||++.||+||++||.........+......   ...
T Consensus       165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---~~~  241 (313)
T KOG0198|consen  165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---DSL  241 (313)
T ss_pred             ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---CCC
Confidence            98877522222333346799999999999853 34569999999999999999999998531111111111100   000


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      ..                       .+...+....+++..|++.||++||||.++++.--
T Consensus       242 P~-----------------------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  242 PE-----------------------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             CC-----------------------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            00                       11122455778999999999999999999988643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-42  Score=356.08  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=209.9

Q ss_pred             HHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCC
Q 043388          544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDS  619 (854)
Q Consensus       544 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  619 (854)
                      .+...+|..++.||+|+|++||+|+.+.+++.||||++...   .....+-+.+|-++|.+| .||.|++++..|.+.. 
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-  147 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-  147 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-
Confidence            34457899999999999999999999999999999999643   233345677899999999 8999999999988766 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~  699 (854)
                          ..|.|+||+++|+|.++|++.+      .+++..++.+|.+|+.||+|||+.   |||||||||+|||+|.|+..+
T Consensus       148 ----sLYFvLe~A~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  148 ----SLYFVLEYAPNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             ----ceEEEEEecCCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence                6899999999999999999886      789999999999999999999999   999999999999999999999


Q ss_pred             c-ccccccccccCCCC----------CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC
Q 043388          700 Q-NFSLSHQLDSASKT----------PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG  768 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~  768 (854)
                      | |||.|+.+......          ......++||..|.+||++.+...++.+|+|+|||++|+|+.|++||.+.. +.
T Consensus       215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-ey  293 (604)
T KOG0592|consen  215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-EY  293 (604)
T ss_pred             EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-HH
Confidence            8 99999988654322          111134789999999999999999999999999999999999999998642 22


Q ss_pred             chHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       769 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..+..++...+                            +.++..++.+.+|+.+.|..||.+|+|++++.+.
T Consensus       294 liFqkI~~l~y----------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  294 LIFQKIQALDY----------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHHHHhcc----------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            22222222111                            0111224456788899999999999999887653

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-43  Score=375.17  Aligned_cols=273  Identities=27%  Similarity=0.443  Sum_probs=230.3

Q ss_pred             CCcccHHHHHHHHhhc---------cccCccCCCcceEEEEeEECCCc---eEEEEEEeeccc-ccchHHHHHHHHHHHh
Q 043388          535 FPMISYAELSKATSEF---------ASSNMIGQGSFGSVYKGILGGEE---MIVAVKVINLKQ-KGAFRSFVAECEALRN  601 (854)
Q Consensus       535 ~~~~~~~~~~~~~~~~---------~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~  601 (854)
                      ...++|++-.+|..+|         .+.++||.|.||+||+|+++..+   ..||||.++... .....+|..|+.||.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            3456777766666665         45789999999999999997544   579999998653 4456789999999999


Q ss_pred             ccCCCeeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 043388          602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIV  681 (854)
Q Consensus       602 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~iv  681 (854)
                      ++||||+++.|+.....     -++||+|||++|+|+.||+.+.+     .+++.+..-+.++||.||.||-+.   ++|
T Consensus       687 FdHPNIIrLEGVVTks~-----PvMIiTEyMENGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLsdm---~YV  753 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSK-----PVMIITEYMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLSDM---NYV  753 (996)
T ss_pred             CCCCcEEEEEEEEecCc-----eeEEEhhhhhCCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHhhc---Cch
Confidence            99999999999987665     58999999999999999998864     689999999999999999999999   999


Q ss_pred             eecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCC
Q 043388          682 HGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRR  759 (854)
Q Consensus       682 H~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~  759 (854)
                      ||||.++||||+.+.++|+ |||+++...+.......+.+-.-+..|.|||.+...+++.+||||||||||||.++ |..
T Consensus       754 HRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGER  833 (996)
T KOG0196|consen  754 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER  833 (996)
T ss_pred             hhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCC
Confidence            9999999999999999999 99999988776644444444455789999999999999999999999999999888 999


Q ss_pred             CCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 043388          760 PTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVV  839 (854)
Q Consensus       760 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  839 (854)
                      ||.....++     .++                       ...+..|.+.+.+|+..+.+||..||++|-.+||++.+++
T Consensus       834 PYWdmSNQd-----VIk-----------------------aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV  885 (996)
T KOG0196|consen  834 PYWDMSNQD-----VIK-----------------------AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIV  885 (996)
T ss_pred             cccccchHH-----HHH-----------------------HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHH
Confidence            987543321     111                       1123455566778999999999999999999999999999


Q ss_pred             HHHHhhhhh
Q 043388          840 AKLCHTRET  848 (854)
Q Consensus       840 ~~L~~~~~~  848 (854)
                      ..|.++...
T Consensus       886 ~~lDklIrn  894 (996)
T KOG0196|consen  886 STLDKLIRN  894 (996)
T ss_pred             HHHHHHhcC
Confidence            999887643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=339.85  Aligned_cols=264  Identities=22%  Similarity=0.320  Sum_probs=210.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ..+|...++||.|..++||+|+....+..||||++..... ...+.+.+|+..|+.++||||++++..|....     ..
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-----~L   99 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS-----EL   99 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-----ee
Confidence            4689999999999999999999988999999999986543 33588999999999999999999999998766     79


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      |+||+||.+||+.++++..-..    .+++..+..|.+++++||.|||.+   |.||||||+.||||+.++.+++ |||.
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~----Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPD----GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccc----cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence            9999999999999999986533    689999999999999999999999   9999999999999999998888 9999


Q ss_pred             ccccccCCCCCCcc-cccCCcccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          705 SHQLDSASKTPSSS-IGIKGTVGYVAPEYGMG--SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      +..+.......... ..++||+.|||||+++.  ..|+.|+||||||++..|+.+|..||...-.-...+.. .+...+.
T Consensus       173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-Lqn~pp~  251 (516)
T KOG0582|consen  173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-LQNDPPT  251 (516)
T ss_pred             eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-hcCCCCC
Confidence            87776544322222 45689999999999544  45999999999999999999999999753221111111 1111111


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      -.....|.+                  +.......+.+++..|++.||.+|||++++++.
T Consensus       252 ~~t~~~~~d------------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  252 LLTSGLDKD------------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cccccCChH------------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            111111111                  111224468899999999999999999999764

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.3e-41  Score=328.37  Aligned_cols=278  Identities=22%  Similarity=0.280  Sum_probs=212.6

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ..++|...+.|++|+||.||+|+++.+++.||+|+++....  +..-...||+.++.+.+|||||.+..+.....   -+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d  150 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MD  150 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cc
Confidence            46789999999999999999999999999999999976542  33345689999999999999999999876554   23


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      .+|||||||+. +|..++...+.     ++...++.-+..|+++|++|||..   .|+||||||+|+|+...+..++ ||
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDF  221 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADF  221 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEeccc
Confidence            68999999998 99999998763     788999999999999999999999   8999999999999999998888 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh--cC
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM--TL  779 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~--~~  779 (854)
                      |+|+.++.+....+   ..+-|.+|+|||.+.+. .|+.+.|+||+|||+.|++++++.|.+...-+ .+..+...  ..
T Consensus       222 GLAR~ygsp~k~~T---~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-Ql~~If~llGtP  297 (419)
T KOG0663|consen  222 GLAREYGSPLKPYT---PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-QLDKIFKLLGTP  297 (419)
T ss_pred             chhhhhcCCcccCc---ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-HHHHHHHHhCCC
Confidence            99999988755443   35689999999998885 49999999999999999999999998764322 22222222  12


Q ss_pred             Cccccccc-CchhhHHHhhccchhhHhhhhhHHH--HHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          780 PEKVIEIV-DPSLLMEVMANNSMIQEDRRARTQD--CLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       780 ~~~~~~~~-d~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .+.++.-+ ....+..+.......... +..+..  ..+.-.+++...+..||.+|.|+.|.++
T Consensus       298 te~iwpg~~~lp~~k~~~f~~~pyn~l-r~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  298 SEAIWPGYSELPAVKKMTFSEHPYNNL-RKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccccCCCccccchhhccccCCCCchhh-hhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            22222222 111111110000000001 111111  2356678999999999999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=355.27  Aligned_cols=250  Identities=23%  Similarity=0.348  Sum_probs=210.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ..|....+||+|+.|.||.|....++..||||++........+-+.+|+.+|+..+|+|||++++.|...+     ..|+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-----eLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-----ELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-----eeEE
Confidence            45777789999999999999999999999999999888777788999999999999999999999887654     6899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      |||||+||+|.+.+...       .+++.++..|+.++++||+|||.+   +|+|||||.+|||++.++..++ |||+|.
T Consensus       348 VMEym~ggsLTDvVt~~-------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT-------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA  417 (550)
T ss_pred             EEeecCCCchhhhhhcc-------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence            99999999999998865       689999999999999999999999   9999999999999999988887 999999


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .+........   ..+||+.|||||+.....|++|+||||||++++||+-|++||-...    .+.......- ...   
T Consensus       418 qi~~~~~KR~---TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~----PlrAlyLIa~-ng~---  486 (550)
T KOG0578|consen  418 QISEEQSKRS---TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN----PLRALYLIAT-NGT---  486 (550)
T ss_pred             ccccccCccc---cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC----hHHHHHHHhh-cCC---
Confidence            9877654332   3579999999999999999999999999999999999999986421    1111111000 000   


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                        .+....+....++.+++.+||+.||++||++.|+++.
T Consensus       487 ------------------P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  487 ------------------PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ------------------CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence                              0111223336678899999999999999999999864

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-43  Score=361.82  Aligned_cols=362  Identities=23%  Similarity=0.259  Sum_probs=329.2

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      +|+|...-++.|.++++|+++.+..|.++ .+|...+...+|+.|+|.+|.|+.+..+.+..++.|+.||||.|.|+.+.
T Consensus        87 nNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~  165 (873)
T KOG4194|consen   87 NNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIP  165 (873)
T ss_pred             ccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhccc
Confidence            58899899999999999999999999999 89998888899999999999999999999999999999999999999887


Q ss_pred             hhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEe
Q 043388           81 PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLD  160 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~  160 (854)
                      -..|..-.++++|+|++|+|+ .+..+.|.++.+|..|.|+.|+++.|                 -+..|++|++|+.|+
T Consensus       166 ~~sfp~~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlkLsrNrittL-----------------p~r~Fk~L~~L~~Ld  227 (873)
T KOG4194|consen  166 KPSFPAKVNIKKLNLASNRIT-TLETGHFDSLNSLLTLKLSRNRITTL-----------------PQRSFKRLPKLESLD  227 (873)
T ss_pred             CCCCCCCCCceEEeecccccc-ccccccccccchheeeecccCccccc-----------------CHHHhhhcchhhhhh
Confidence            788988899999999999999 99999999999988888888888655                 246789999999999


Q ss_pred             cCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEc
Q 043388          161 LSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI  240 (854)
Q Consensus       161 Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l  240 (854)
                      |..|+|.-+.-..|.++++|+.|.|..|.|..+..+      +|.+|.++++|+|..|++...--.++++++ .|+.|+|
T Consensus       228 LnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG------~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt-~L~~L~l  300 (873)
T KOG4194|consen  228 LNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDG------AFYGLEKMEHLNLETNRLQAVNEGWLFGLT-SLEQLDL  300 (873)
T ss_pred             ccccceeeehhhhhcCchhhhhhhhhhcCcccccCc------ceeeecccceeecccchhhhhhcccccccc-hhhhhcc
Confidence            999999977688999999999999999999988876      789999999999999999977778888987 7999999


Q ss_pred             cCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceeccc
Q 043388          241 GGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGN  320 (854)
Q Consensus       241 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  320 (854)
                      +.|.|..+.++++.-..+|++|+|++|+|+...+++|..|..|++|+|++|.|+..-..+|..+.+|+.|||++|.|+..
T Consensus       301 S~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~  380 (873)
T KOG4194|consen  301 SYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWC  380 (873)
T ss_pred             chhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEE
Confidence            99999999999999999999999999999999999999999999999999999977778899999999999999999976


Q ss_pred             CC---CCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCccc
Q 043388          321 IP---SSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSF  397 (854)
Q Consensus       321 ~~---~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l  397 (854)
                      +-   ..|.++++|+.|++.+|++. .+|...                        |..       +..|++|||.+|.|
T Consensus       381 IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krA------------------------fsg-------l~~LE~LdL~~Nai  428 (873)
T KOG4194|consen  381 IEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRA------------------------FSG-------LEALEHLDLGDNAI  428 (873)
T ss_pred             EecchhhhccchhhhheeecCceee-ecchhh------------------------hcc-------CcccceecCCCCcc
Confidence            54   46888999999999999998 555432                        222       45699999999999


Q ss_pred             ccCCCcccccCCCCCEEEccCccc
Q 043388          398 HGVIPFSLGFMKSIKELNVSSNNL  421 (854)
Q Consensus       398 ~~~~p~~~~~l~~L~~L~Ls~N~l  421 (854)
                      ..+-|.+|..+ .|++|.++.-.+
T Consensus       429 aSIq~nAFe~m-~Lk~Lv~nSssf  451 (873)
T KOG4194|consen  429 ASIQPNAFEPM-ELKELVMNSSSF  451 (873)
T ss_pred             eeecccccccc-hhhhhhhcccce
Confidence            99999999999 999998765443

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=349.40  Aligned_cols=242  Identities=26%  Similarity=0.409  Sum_probs=201.1

Q ss_pred             ccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEee
Q 043388          552 SSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEY  631 (854)
Q Consensus       552 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  631 (854)
                      ..+.||+|+.|.||+|+.+  ++.||||+++.-       -..+++-|++|+||||+.+.|+|....     .+||||||
T Consensus       128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsP-----cyCIiMEf  193 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSP-----CYCIIMEF  193 (904)
T ss_pred             hhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCc-----eeEEeeec
Confidence            3578999999999999997  667999987422       235778899999999999999998765     88999999


Q ss_pred             ccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccccc
Q 043388          632 MENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDS  710 (854)
Q Consensus       632 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~  710 (854)
                      |+.|-|.+.|+..+      +++....+.|..+||.||.|||.+   .|||||||.-||||..+.++|| |||.++....
T Consensus       194 Ca~GqL~~VLka~~------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  194 CAQGQLYEVLKAGR------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             cccccHHHHHhccC------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            99999999999876      788889999999999999999999   9999999999999999988888 9999988765


Q ss_pred             CCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCch
Q 043388          711 ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS  790 (854)
Q Consensus       711 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  790 (854)
                      ..    +...++||..|||||++...+.++|+||||||||||||+||..||......     .+++.....         
T Consensus       265 ~S----TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIwGVGsN---------  326 (904)
T KOG4721|consen  265 KS----TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIWGVGSN---------  326 (904)
T ss_pred             hh----hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeEEeccCC---------
Confidence            42    334578999999999999999999999999999999999999998743111     111111100         


Q ss_pred             hhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                                   ....+.+..|++.+.-++++||+-.|..||++++++..|+-...
T Consensus       327 -------------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  327 -------------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             -------------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence                         01123445678889999999999999999999999988765443

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=317.14  Aligned_cols=270  Identities=20%  Similarity=0.259  Sum_probs=216.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      .+|++.+.+|+|||+.||.++...++..||+|++.....++.+..++|++..++++||||+++++++......+....||
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            57999999999999999999998899999999998777777889999999999999999999999987766556778999


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      +++|...|||.+.+......  +..+++.++++|+.+|++||.+||+. .|+++||||||.||++.+++.+++ |||.+.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~k--g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIK--GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EeehhccccHHHHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999876543  23789999999999999999999998 346999999999999999777776 999998


Q ss_pred             ccccCCCCCCc------ccccCCcccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          707 QLDSASKTPSS------SIGIKGTVGYVAPEYGM---GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       707 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                      ...-.-.....      ...-..|..|+|||.+.   +...++++|||||||++|+|+.|..||+.....+..+.-.+..
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n  257 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN  257 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence            76433221110      11123789999999875   3557999999999999999999999998654444333221111


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                 ++.         ..+     .....++.+.+++..|++.||.+||++.+++..+..+
T Consensus       258 -----------~q~---------s~P-----~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  258 -----------AQI---------SIP-----NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -----------ccc---------ccC-----CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                       000         000     0011366789999999999999999999999998765

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.8e-41  Score=348.13  Aligned_cols=246  Identities=29%  Similarity=0.440  Sum_probs=208.7

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|.+.+.||+|+||.||||+.+.+.+.||+|.+....  ..+.+.+.+|+++++.++|||||.++++|+...     +.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~-----~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA-----HL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-----eE
Confidence            57889999999999999999999999999999996543  345677999999999999999999999998766     79


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      |+|.||+.| +|..++...+      .++++.++.|+.|++.||.|||+.   +|.|||+||.||+++.++..|. |||+
T Consensus        77 ~vVte~a~g-~L~~il~~d~------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQDG------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             EEEehhhhh-hHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence            999999977 9999999876      799999999999999999999999   9999999999999999988886 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      |+.+.....   ....+.|||.|||||+..+..|+..+|+||+||++||+++|++||...     .+.+.++....+...
T Consensus       147 Ar~m~~~t~---vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v~  218 (808)
T KOG0597|consen  147 ARAMSTNTS---VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPVK  218 (808)
T ss_pred             hhhcccCce---eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCCC
Confidence            998876433   223467999999999999999999999999999999999999999743     344444443333211


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..                        ......+..++...+.+||.+|.|..+++.
T Consensus       219 ~p------------------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 PP------------------------STASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             Cc------------------------ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            10                        122445678888899999999999998865

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=352.03  Aligned_cols=251  Identities=25%  Similarity=0.336  Sum_probs=201.3

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc----cc-cchHHHHHHHHHHHhcc-CCCeeeEEEEeeccC
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK----QK-GAFRSFVAECEALRNIR-HRNLIKIITICSSID  618 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  618 (854)
                      ...+.|.+.+.||+|+||.|+.|.+..++..||+|+++..    .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999999989999999977543    11 23456778999999998 999999999998776


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-cc
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MV  697 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~  697 (854)
                           ..++||||+.||+|.+++...+      ++.+.+++.++.|++.|++|+|++   +|+||||||+||+++.+ +.
T Consensus        94 -----~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~  159 (370)
T KOG0583|consen   94 -----KIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN  159 (370)
T ss_pred             -----eEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence                 6899999999999999999854      788899999999999999999999   99999999999999998 66


Q ss_pred             ccc-ccccccccccCCCCCCcccccCCcccccCccccCCCC-CC-ccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHH
Q 043388          698 AHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-AS-MTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEF  774 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~  774 (854)
                      .++ |||++.....   ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..... ..+..+
T Consensus       160 ~Kl~DFG~s~~~~~---~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-~l~~ki  235 (370)
T KOG0583|consen  160 LKLSDFGLSAISPG---EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-NLYRKI  235 (370)
T ss_pred             EEEeccccccccCC---CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-HHHHHH
Confidence            665 9999998841   111223368999999999999976 74 7899999999999999999999863211 111111


Q ss_pred             hhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          775 VKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       775 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ....+  .+...++                         ..++..++.+|+..||.+|+|+.|+++
T Consensus       236 ~~~~~--~~p~~~~-------------------------S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  236 RKGEF--KIPSYLL-------------------------SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             hcCCc--cCCCCcC-------------------------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            11100  0111110                         344678999999999999999999983

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-41  Score=333.16  Aligned_cols=284  Identities=23%  Similarity=0.256  Sum_probs=215.3

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEee--cccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN--LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ....|...+.||+|+||.|+.|.+..+++.||||++.  .......++..||+++++.++|+||+.+++++.........
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3455666789999999999999999999999999986  44555567889999999999999999999998774444555


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      .+|+|+|+|+. +|.+.++...      .++...+..+.+|+++||.|+|+.   +|+|||+||+|++++.+...++ ||
T Consensus       100 DvYiV~elMet-DL~~iik~~~------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen  100 DVYLVFELMET-DLHQIIKSQQ------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             eeEEehhHHhh-HHHHHHHcCc------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence            78999999965 9999999875      589999999999999999999999   9999999999999999876676 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh--hcC
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK--MTL  779 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~--~~~  779 (854)
                      |+|+..... ......+.++.|.+|+|||++.. ..|+.+.||||.||++.||++|++.|.+...- ..+..+..  ...
T Consensus       170 GLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-~Ql~lI~~~lGtP  247 (359)
T KOG0660|consen  170 GLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-HQLQLILELLGTP  247 (359)
T ss_pred             cceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH-HHHHHHHHhcCCC
Confidence            999998765 33333456789999999998655 56999999999999999999999999875321 11111111  111


Q ss_pred             CcccccccCchhhHHHhhccchhhH-hhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQE-DRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ++.....+...-...+.......++ .-...+..+.....+++.+|+..||.+|+|++|.++.
T Consensus       248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            2222222222222223222111111 1112223345567899999999999999999998763

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.1e-44  Score=356.76  Aligned_cols=410  Identities=33%  Similarity=0.429  Sum_probs=330.8

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      +|+++ .+-+++.+|..|++|++++|+++ ..|.+++.+.+++.|+.++|+++ .+|..++.+.+|..|+.++|.+. ..
T Consensus        54 ~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el  129 (565)
T KOG0472|consen   54 HNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-EL  129 (565)
T ss_pred             cCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ec
Confidence            35666 56677999999999999999999 79999999999999999999999 89999999999999999999999 67


Q ss_pred             hhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCC----------CCceeeccCccCCCCCCCCCCccc
Q 043388           81 PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLK----------NLWWLNLEQNNLGMGTASSIPDSL  150 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~----------~L~~L~L~~N~l~~~~~~~~p~~~  150 (854)
                      |+.++.+..|+.|+..+|+|+ ++|.+. .++.+|..|++.+|+++          .|+.||...|-+     +.+|..+
T Consensus       130 ~~~i~~~~~l~dl~~~~N~i~-slp~~~-~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L-----~tlP~~l  202 (565)
T KOG0472|consen  130 PDSIGRLLDLEDLDATNNQIS-SLPEDM-VNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLL-----ETLPPEL  202 (565)
T ss_pred             CchHHHHhhhhhhhccccccc-cCchHH-HHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhh-----hcCChhh
Confidence            788999999999999999998 898764 57788888888888764          568999999999     7899999


Q ss_pred             cCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhh
Q 043388          151 SNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIAN  230 (854)
Q Consensus       151 ~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  230 (854)
                      +.|.+|+.|||.+|+|... | .|.++..|.+|+++.|.|..++++      ...++++|.+|||.+|+++ +.|+.+..
T Consensus       203 g~l~~L~~LyL~~Nki~~l-P-ef~gcs~L~Elh~g~N~i~~lpae------~~~~L~~l~vLDLRdNklk-e~Pde~cl  273 (565)
T KOG0472|consen  203 GGLESLELLYLRRNKIRFL-P-EFPGCSLLKELHVGENQIEMLPAE------HLKHLNSLLVLDLRDNKLK-EVPDEICL  273 (565)
T ss_pred             cchhhhHHHHhhhcccccC-C-CCCccHHHHHHHhcccHHHhhHHH------Hhcccccceeeeccccccc-cCchHHHH
Confidence            9999999999999999855 4 899999999999999999988775      5779999999999999999 89999999


Q ss_pred             hcccccEEEccCCcccccCCccccccccCCeeeccccccccC--------------------------------------
Q 043388          231 LSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGI--------------------------------------  272 (854)
Q Consensus       231 l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--------------------------------------  272 (854)
                      +. +|.+||+++|.|+ ..|.+++++ .|+.|-+.+|.+..+                                      
T Consensus       274 Lr-sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~  350 (565)
T KOG0472|consen  274 LR-SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTL  350 (565)
T ss_pred             hh-hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCC
Confidence            86 7999999999999 678899999 999999999988633                                      


Q ss_pred             CCCCc---cCcccCceee--------------------------CccccccccCCccccCccccc-hhccccceecccCC
Q 043388          273 IPDGV---GELQHLQQLY--------------------------MFRNFLQGSIPPSLGNLTKLA-DLALSFNNLQGNIP  322 (854)
Q Consensus       273 ~~~~~---~~l~~L~~L~--------------------------L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~  322 (854)
                      .+..|   ..+.+.+.|+                          ++.|++. .+|..+..+..+. .+.+++|.+. .+|
T Consensus       351 ~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~  428 (565)
T KOG0472|consen  351 PSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVP  428 (565)
T ss_pred             CCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cch
Confidence            01111   1223344444                          4445554 4444444444433 3444555554 677


Q ss_pred             CCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCC
Q 043388          323 SSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIP  402 (854)
Q Consensus       323 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p  402 (854)
                      ..++.+++|..|+|++|.+. .+|.+++++..+.. +++++|.+. .+|..+-.       ...|+.+-.++|++..+.|
T Consensus       429 ~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~-LnlS~NrFr-~lP~~~y~-------lq~lEtllas~nqi~~vd~  498 (565)
T KOG0472|consen  429 LELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQT-LNLSFNRFR-MLPECLYE-------LQTLETLLASNNQIGSVDP  498 (565)
T ss_pred             HHHHhhhcceeeecccchhh-hcchhhhhhhhhhe-ecccccccc-cchHHHhh-------HHHHHHHHhccccccccCh
Confidence            77777888888888888776 78888887777554 888888663 44544433       3346667777788887777


Q ss_pred             cccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCc
Q 043388          403 FSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLE  446 (854)
Q Consensus       403 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  446 (854)
                      ..+.+|.+|..|||.+|.|. .+|..+++|.+|++|++++|++.
T Consensus       499 ~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  499 SGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            77888888888888888888 78888888888888888888887

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=380.20  Aligned_cols=266  Identities=25%  Similarity=0.423  Sum_probs=216.7

Q ss_pred             hccccCccCCCcceEEEEeEECCC-----ceEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGE-----EMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .-+..+.||+|.||.||+|...+.     ...||||.++.. +.+...+|.+|+.+|++++|||||+++|+|.+..    
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~----  768 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG----  768 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC----
Confidence            345568999999999999998532     234899988644 4556788999999999999999999999998855    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCc-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                       ..+|++|||++|+|..||++.+.. .....++..+.+.++.|||+|+.||+++   ++|||||.++|+|++...++|| 
T Consensus       769 -~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  769 -PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             -CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence             579999999999999999987321 2234789999999999999999999999   9999999999999999999988 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      |||+|+.+........... -.-+..|||||.+.++.++.|+|||||||++||++| |..||......+ .+..+     
T Consensus       845 DFGlArDiy~~~yyr~~~~-a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-v~~~~-----  917 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGE-AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-VLLDV-----  917 (1025)
T ss_pred             ccchhHhhhhchheeccCc-cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-HHHHH-----
Confidence            9999996655443322111 134578999999999999999999999999999999 999997543221 11111     


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhc
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLG  851 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  851 (854)
                                            ...+|.+.+..|+..+.++|..||+.+|++||++..+++++..+.....+
T Consensus       918 ----------------------~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  918 ----------------------LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             ----------------------HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence                                  11224455667899999999999999999999999999999998877654

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-39  Score=354.58  Aligned_cols=266  Identities=21%  Similarity=0.356  Sum_probs=203.2

Q ss_pred             HhhccccCccCCCcceEEEEeEEC-----CCceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILG-----GEEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  619 (854)
                      .++|++.++||+|+||.||+|.+.     .++..||||+++... ....+.+.+|+.++.++ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN-   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC-
Confidence            367999999999999999999852     345689999987433 23346789999999999 8999999999886543 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcc---------------------------------------------------
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHL---------------------------------------------------  648 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------  648 (854)
                         ...++||||+++|+|.+++.......                                                   
T Consensus        85 ---~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          85 ---GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             ---CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence               25789999999999999997642110                                                   


Q ss_pred             -----cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccCCCCCCcccccC
Q 043388          649 -----EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIK  722 (854)
Q Consensus       649 -----~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~  722 (854)
                           ....+++.++..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||+++......... ......
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~  237 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGSAR  237 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchh-cccCCC
Confidence                 012478889999999999999999999   9999999999999998887776 999998764332211 111234


Q ss_pred             CcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccch
Q 043388          723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSM  801 (854)
Q Consensus       723 gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  801 (854)
                      +++.|+|||++.+..++.++|||||||++|||++ |..||....... ........   ....                 
T Consensus       238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~---~~~~-----------------  296 (338)
T cd05102         238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKD---GTRM-----------------  296 (338)
T ss_pred             CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhc---CCCC-----------------
Confidence            6788999999998899999999999999999997 999997542211 11111100   0000                 


Q ss_pred             hhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          802 IQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       802 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                            .....++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       297 ------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         297 ------RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                  0011224568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=316.34  Aligned_cols=199  Identities=26%  Similarity=0.370  Sum_probs=180.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|+..+.||.|+||+|.+++.+.++..+|+|+++....   ...+...+|..+++.+.||.++++++.|.+..     
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-----  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-----  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-----
Confidence            5688999999999999999999999999999999975432   23456778999999999999999999987766     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      +.||||||++||.|..+++..+      ++++..++-+|.||+.||+|||+.   +|++||+||+|||+|.++..++ ||
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence            8999999999999999999877      789999999999999999999999   9999999999999999998887 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      |+|+.....      +...+|||.|+|||++....+..++|-|||||++|||+.|.+||....
T Consensus       189 GFAK~v~~r------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~  245 (355)
T KOG0616|consen  189 GFAKRVSGR------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN  245 (355)
T ss_pred             cceEEecCc------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence            999988654      334789999999999999999999999999999999999999998653

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-40  Score=332.07  Aligned_cols=277  Identities=23%  Similarity=0.295  Sum_probs=205.1

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      .|...+++|.|+||.||+|+...++..||||+.-...+.    --+|+++|+.++|||||++.-+|....+.+..+..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            467789999999999999999989999999988544321    2479999999999999999999987765544567899


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-ccccc-cccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQ-NFSLSH  706 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~~~-Dfg~~~  706 (854)
                      |||||. +|.++++.....  ...++...++-+..||.+||+|||+.   +|+||||||.|+|+|.+ +..|+ |||.|+
T Consensus       101 leymP~-tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHhchH-HHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            999987 999999863111  12677788889999999999999998   99999999999999987 66666 999999


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc--c
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK--V  783 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~  783 (854)
                      .........    .+..|+.|+|||.+.|. .|+.+.||||.|||+.||+-|++-|.+.. ....+.++++......  -
T Consensus       175 ~L~~~epni----SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  175 VLVKGEPNI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             eeccCCCce----eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHH
Confidence            987665443    24579999999999885 59999999999999999999999998743 2334444444322111  1


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...+.+... +............+-.......+..+++.++++++|.+|.++.|++..
T Consensus       250 I~~mn~~y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  250 IKSMNPNYT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             HhhcCcccc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            111111100 000000000000011112235667899999999999999999998754

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=337.88  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=205.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..|+..++||+|+||.||+|.+..+++.||+|++.... ....+++.+|+.++..++++||.++|+.|....     ..+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cHH
Confidence            35777799999999999999999999999999998654 445688999999999999999999999887655     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      ++||||.||++.+.++...      .+.+..+.-|.+++..|+.|||++   +.+|||||+.||++..++.+++ |||.+
T Consensus        88 iiMey~~gGsv~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa  158 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGN------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA  158 (467)
T ss_pred             HHHHHhcCcchhhhhccCC------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence            9999999999999998765      446677778899999999999999   9999999999999998866665 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ..........   ..++||+.|||||++.+..|+.|+||||+|++.+||.+|.+|+.......      +...++.....
T Consensus       159 ~ql~~~~~rr---~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr------vlflIpk~~PP  229 (467)
T KOG0201|consen  159 GQLTNTVKRR---KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR------VLFLIPKSAPP  229 (467)
T ss_pred             eeeechhhcc---ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce------EEEeccCCCCC
Confidence            8887655443   34689999999999998899999999999999999999999987543210      00111111111


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .++                      ..+...+.+++..|+..||+.||||.++++.
T Consensus       230 ~L~----------------------~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  230 RLD----------------------GDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccc----------------------cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            111                      1335668899999999999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-40  Score=307.67  Aligned_cols=250  Identities=23%  Similarity=0.349  Sum_probs=209.4

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      +.++|.+++.||+|.||.||.|+.+.++..||+|++...+   .....++.+|++|-+.|+||||+++|+||.+..    
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~----   95 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK----   95 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc----
Confidence            4678999999999999999999999999999999996442   334567899999999999999999999998876    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       .+|+++||.++|++...+...+..    .+++.....+..|+|.|+.|+|..   +|+||||||+|+|++..+..++ |
T Consensus        96 -riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAd  167 (281)
T KOG0580|consen   96 -RIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIAD  167 (281)
T ss_pred             -eeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccC
Confidence             789999999999999999965432    678888899999999999999999   9999999999999999988887 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.+........     ...+||..|.|||...+..++.++|+|++||+.||++.|.+||.... .+..+.++.+..   
T Consensus       168 fGwsV~~p~~kR-----~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~---  238 (281)
T KOG0580|consen  168 FGWSVHAPSNKR-----KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD---  238 (281)
T ss_pred             CCceeecCCCCc-----eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc---
Confidence            999876653222     23689999999999999999999999999999999999999998654 333333333221   


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                          ..+|                     ........+++.+|+..+|.+|.+..||++.
T Consensus       239 ----~~~p---------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  239 ----LKFP---------------------STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----ccCC---------------------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                1111                     1124456789999999999999999999864

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.1e-39  Score=337.67  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=198.2

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecccccc---hHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA---FRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ...||+|++|.||+|.+  +++.||||+++......   .+.+.+|+.++++++||||+++++++.+.. .+....++||
T Consensus        25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~  101 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLIL  101 (283)
T ss_pred             CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEE
Confidence            36799999999999998  47899999997543332   467889999999999999999999987622 1123579999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||+..  +++||||||+||+++.++..++ |||+++..
T Consensus       102 Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988        102 EYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             EeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            9999999999998654      6789999999999999999999742  7889999999999999887776 99998866


Q ss_pred             ccCCCCCCcccccCCcccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMG--SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .....      ...|+..|+|||++.+  ..++.++|||||||++|||++|+.||......     +...........  
T Consensus       174 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~--  240 (283)
T PHA02988        174 SSPPF------KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-----EIYDLIINKNNS--  240 (283)
T ss_pred             ccccc------cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhcCCC--
Confidence            43321      2358899999999876  67999999999999999999999999754211     111111000000  


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                                          ......++..+.+++.+||+.||++|||++|+++.|+....
T Consensus       241 --------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        241 --------------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             --------------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                                00011235678899999999999999999999999988753

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=331.63  Aligned_cols=270  Identities=26%  Similarity=0.366  Sum_probs=200.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHh--ccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ......++||+|+||.||||+..  ++.||||++....   .+.|.+|-+|.+-  ++|+||++++++-...... ....
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey  283 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY  283 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence            34455678999999999999997  5889999997554   3567788877765  4899999999975443322 3367


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC------CCCeEeecCCCCceEecCCcccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC------QPPIVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~~  699 (854)
                      +||+||.+.|+|.+||+.+       .++|.+..+|+..+++||+|||+..      +|+|+|||||++||||..|....
T Consensus       284 wLVt~fh~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc  356 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC  356 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence            9999999999999999987       7899999999999999999999753      67899999999999999999888


Q ss_pred             c-ccccccccccCCCCCCcccccCCcccccCccccCCCC------CCccchhHHHHHHHHHHHhCCCCCCC-cccC----
Q 043388          700 Q-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE------ASMTGDVYSFGILLLEMFTGRRPTDA-AFTE----  767 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slGvvl~elltg~~pf~~-~~~~----  767 (854)
                      | |||+|..+...... ....+.+||..|||||++.+..      .-.+.||||+|.|+|||+++..-++. ...+    
T Consensus       357 IaDFGLAl~~~p~~~~-~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp  435 (534)
T KOG3653|consen  357 IADFGLALRLEPGKPQ-GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP  435 (534)
T ss_pred             eeccceeEEecCCCCC-cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence            8 99999998855433 3344578999999999987743      22468999999999999997655431 1111    


Q ss_pred             -------CchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          768 -------GLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       768 -------~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                             ...+.++....+.++.+..+...+               ..  -.....+.+.+..||+.||+.|.|+.=|.+
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W---------------~~--h~~~~~l~et~EeCWDhDaeARLTA~Cv~e  498 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAW---------------RK--HAGMAVLCETIEECWDHDAEARLTAGCVEE  498 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCChhhh---------------hc--CccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence                   111111111111111111110000               00  012566889999999999999999999999


Q ss_pred             HHHhhhhh
Q 043388          841 KLCHTRET  848 (854)
Q Consensus       841 ~L~~~~~~  848 (854)
                      ++.++..-
T Consensus       499 R~~~l~~~  506 (534)
T KOG3653|consen  499 RMAELMML  506 (534)
T ss_pred             HHHHHhcc
Confidence            98887643

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=348.17  Aligned_cols=257  Identities=25%  Similarity=0.384  Sum_probs=205.6

Q ss_pred             ccccCccCCCcceEEEEeEECCCc----eEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEE----MIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      -...++||+|+||.||+|+....+    ..||||..+..   ......++.+|+++|++++|||||++||++....    
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~----  234 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE----  234 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC----
Confidence            344589999999999999986432    23899998752   3556788999999999999999999999998776    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       -.++|||+|+||+|.++++..+.     .++..++..++.+.|.||+|||++   +++||||.++|+|++.+.+++| |
T Consensus       235 -Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  235 -PLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             -ccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence             57999999999999999998763     589999999999999999999999   9999999999999999988777 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||+++..........   ...-+..|+|||.+..+.+++++|||||||++||+++ |..||.+....  ....++   ..
T Consensus       306 FGLs~~~~~~~~~~~---~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI---~~  377 (474)
T KOG0194|consen  306 FGLSRAGSQYVMKKF---LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKI---VK  377 (474)
T ss_pred             cccccCCcceeeccc---cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHH---Hh
Confidence            999887652211110   1135789999999999999999999999999999999 89999864322  111111   01


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ...                      +.......+..+..++.+||..+|++||||.++.+.++.+....
T Consensus       378 ~~~----------------------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  378 NGY----------------------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             cCc----------------------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence            111                      11111123667888999999999999999999999999887653

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-39  Score=327.12  Aligned_cols=259  Identities=23%  Similarity=0.334  Sum_probs=201.0

Q ss_pred             HHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--------------ccchHHHHHHHHHHHhccCCCeee
Q 043388          544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--------------KGAFRSFVAECEALRNIRHRNLIK  609 (854)
Q Consensus       544 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~  609 (854)
                      ....++|++.+.||+|.||.|-+|....+++.||||++....              ....+...+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            345688999999999999999999999999999999995321              122468899999999999999999


Q ss_pred             EEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCc
Q 043388          610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSN  689 (854)
Q Consensus       610 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  689 (854)
                      ++.+..+..   .+..|||+|||..|.+...=....      .++..++++++.++..||+|||.+   +||||||||+|
T Consensus       173 LiEvLDDP~---s~~~YlVley~s~G~v~w~p~d~~------els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsN  240 (576)
T KOG0585|consen  173 LIEVLDDPE---SDKLYLVLEYCSKGEVKWCPPDKP------ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSN  240 (576)
T ss_pred             EEEeecCcc---cCceEEEEEeccCCccccCCCCcc------cccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhh
Confidence            999987655   347999999999888754322211      389999999999999999999999   99999999999


Q ss_pred             eEecCCccccc-ccccccccccCCCCC--CcccccCCcccccCccccCCCC----CCccchhHHHHHHHHHHHhCCCCCC
Q 043388          690 VLLDHDMVAHQ-NFSLSHQLDSASKTP--SSSIGIKGTVGYVAPEYGMGSE----ASMTGDVYSFGILLLEMFTGRRPTD  762 (854)
Q Consensus       690 Ill~~~~~~~~-Dfg~~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~slGvvl~elltg~~pf~  762 (854)
                      +|+++++.+|| |||.+..........  ......+|||.|+|||...++.    .+.+.||||+||+||.++.|+.||.
T Consensus       241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            99999999998 999998774432211  1112357999999999877733    4678899999999999999999997


Q ss_pred             CcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          763 AAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       763 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +.+.- ..+..++.....                          .+...+..+.+.+++.++|.+||++|.+..+|...
T Consensus       321 ~~~~~-~l~~KIvn~pL~--------------------------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  321 DDFEL-ELFDKIVNDPLE--------------------------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             cchHH-HHHHHHhcCccc--------------------------CCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            53211 111111111110                          01111235568899999999999999999998654

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.8e-39  Score=350.88  Aligned_cols=280  Identities=21%  Similarity=0.238  Sum_probs=201.9

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.++||+|+||.||+|++..++..||||+++..  .......+.+|++++++++||||+++++++...........|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478899999999999999999989999999998643  223345688999999999999999999998765544444689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||++ ++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++
T Consensus        81 lv~e~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          81 VVFELME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence            9999995 59999987654      688999999999999999999999   9999999999999999987776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC---C
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMG--SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL---P  780 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~---~  780 (854)
                      +................||+.|+|||++.+  ..++.++|||||||++|||++|++||......  .....+....   +
T Consensus       151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~  228 (338)
T cd07859         151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPS  228 (338)
T ss_pred             cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCC
Confidence            865433222222233569999999999866  57899999999999999999999999754211  1111111000   0


Q ss_pred             cc-cccccCchhhHHHhhccc-hhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EK-VIEIVDPSLLMEVMANNS-MIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~-~~~~~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .. ...+..... ........ ..+.........+...+.+++.+||+.||++|||++|+++.
T Consensus       229 ~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         229 PETISRVRNEKA-RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHHhhhhhH-HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00 000000000 00000000 00000000111224567899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-39  Score=342.79  Aligned_cols=248  Identities=21%  Similarity=0.299  Sum_probs=205.8

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .+-|+.++.||.|+.|.|-.|++..+|+.+|||++...   .......+.+|+.+|+-+.||||+++|++|+...     
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~-----   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ-----   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-----
Confidence            45688899999999999999999999999999999654   2233456789999999999999999999998776     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      +.|+|.||+++|-|.+++...+      ++++.++.+++.||..|+.|+|..   +|+|||+||+|+|+|.....+| ||
T Consensus        86 ~lylvlEyv~gGELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF  156 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKG------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF  156 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence            7999999999999999999887      789999999999999999999999   9999999999999998877777 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |+|..-....--.    ..||++.|.|||++.|..| +.++||||.|||||.++||+.||++.     .+.........+
T Consensus       157 GMAsLe~~gklLe----TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLlKV~~G  227 (786)
T KOG0588|consen  157 GMASLEVPGKLLE----TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLLKVQRG  227 (786)
T ss_pred             ceeecccCCcccc----ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHHHHHcC
Confidence            9997654443322    2589999999999999886 67999999999999999999999832     222222111111


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .                        ...+...+.+..+++.+|+..||+.|.|++||++.
T Consensus       228 ~------------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  228 V------------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             c------------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            1                        11112235567899999999999999999999874

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.4e-39  Score=334.76  Aligned_cols=206  Identities=26%  Similarity=0.386  Sum_probs=181.4

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ..++|.....||+|+||+||+|+-+.+|..+|+|+++..   .....+.++.|-.+|...++|.||++|..|.+.+    
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~----  214 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE----  214 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC----
Confidence            567899999999999999999999999999999999754   3455677889999999999999999999998776    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       +.||||||++||++..+|...+      .+++..++.++.+++.|++.+|..   |||||||||+|+|||..+..++ |
T Consensus       215 -~LYLiMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD  284 (550)
T KOG0605|consen  215 -YLYLIMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD  284 (550)
T ss_pred             -eeEEEEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence             8999999999999999999876      899999999999999999999999   9999999999999999998888 9


Q ss_pred             cccccccccCC----------------------CC----CCc------------------ccccCCcccccCccccCCCC
Q 043388          702 FSLSHQLDSAS----------------------KT----PSS------------------SIGIKGTVGYVAPEYGMGSE  737 (854)
Q Consensus       702 fg~~~~~~~~~----------------------~~----~~~------------------~~~~~gt~~y~aPE~~~~~~  737 (854)
                      ||+|.......                      ..    ...                  ....+|||.|+|||++.+..
T Consensus       285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg  364 (550)
T KOG0605|consen  285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG  364 (550)
T ss_pred             ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence            99996543210                      00    000                  12357999999999999999


Q ss_pred             CCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          738 ASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       738 ~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      |+..+|.||+|||+|||+.|.+||....
T Consensus       365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~t  392 (550)
T KOG0605|consen  365 YGKECDWWSLGCIMYEMLVGYPPFCSET  392 (550)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999998654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=319.37  Aligned_cols=273  Identities=24%  Similarity=0.370  Sum_probs=216.3

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc--cCCCeeeEEEEeeccCCCCCc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ..++....+.||+|.||+||+|.|+  |+.||||++...+   .+.+.+|.+|.+.+  +|+||+.+++.-.... ....
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~T  282 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWT  282 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceE
Confidence            3456778899999999999999998  6679999997554   36788999998875  9999999998754433 3445


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeecCCCCceEecCCccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH-----CQPPIVHGDLKPSNVLLDHDMVA  698 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~  698 (854)
                      ..++|++|.+.|||+|||...       .++....++++..+|.||+|||..     .+|.|+|||||+.||||..++..
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence            689999999999999999975       789999999999999999999953     57899999999999999999988


Q ss_pred             cc-ccccccccccCCC-CCCcccccCCcccccCccccCCCC------CCccchhHHHHHHHHHHHhC----------CCC
Q 043388          699 HQ-NFSLSHQLDSASK-TPSSSIGIKGTVGYVAPEYGMGSE------ASMTGDVYSFGILLLEMFTG----------RRP  760 (854)
Q Consensus       699 ~~-Dfg~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slGvvl~elltg----------~~p  760 (854)
                      -| |+|+|........ -.......+||..|||||++...-      .-..+||||||.|+||+..+          +.|
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            88 9999988766532 233344568999999999986532      23468999999999999853          356


Q ss_pred             CCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          761 TDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       761 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      |.+....+..+.++.....-++....++..+                 ...++...+.++|+.||..+|..|-|+-.+-+
T Consensus       436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW-----------------~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW-----------------KSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             cccCCCCCCCHHHHhcceeecccCCCCCccc-----------------ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            6655555555555555444444444443333                 23455778999999999999999999999999


Q ss_pred             HHHhhhhh
Q 043388          841 KLCHTRET  848 (854)
Q Consensus       841 ~L~~~~~~  848 (854)
                      .+.++.+.
T Consensus       499 tl~~l~~~  506 (513)
T KOG2052|consen  499 TLAKLSNS  506 (513)
T ss_pred             HHHHHhcC
Confidence            99888754

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.6e-38  Score=346.06  Aligned_cols=263  Identities=21%  Similarity=0.358  Sum_probs=201.9

Q ss_pred             HhhccccCccCCCcceEEEEeEE-----CCCceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  619 (854)
                      .++|++.++||+|+||.||+|++     ..++..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.+ 
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~-  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG-  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence            35789999999999999999975     3356789999996433 23346788999999999 8999999999997665 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCc----------------------------------------------------
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDH----------------------------------------------------  647 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------  647 (854)
                          ..++||||+++|+|.+++......                                                    
T Consensus       113 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         113 ----PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ----cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence                679999999999999999754210                                                    


Q ss_pred             -----------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccc
Q 043388          648 -----------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLD  709 (854)
Q Consensus       648 -----------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~  709 (854)
                                       .....+++..+..++.||+.||+|||+.   +|+||||||+||+++.+...++ |||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                             0012578899999999999999999999   9999999999999998887766 999998765


Q ss_pred             cCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          710 SASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       710 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      ...... ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ...++........      
T Consensus       266 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~------  337 (375)
T cd05104         266 NDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRML------  337 (375)
T ss_pred             Cccccc-ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccCC------
Confidence            432211 1111235678999999999999999999999999999998 888986532211 1111111110000      


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                          .....+.++.+++.+||+.||++|||+.||+++|++.
T Consensus       338 --------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 --------------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             --------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                                0011144688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.6e-38  Score=333.77  Aligned_cols=250  Identities=22%  Similarity=0.303  Sum_probs=197.1

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      |+..+.||+|+||.||+|.+..+++.||+|++....   ......+.+|++++++++|++|+++++++.+.+     ..+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-----~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-----ALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-----eEE
Confidence            677899999999999999998899999999986432   223346788999999999999999999987655     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++.....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++
T Consensus        77 lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~  149 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA  149 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            99999999999988865432    1688999999999999999999999   9999999999999998877776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........    ....||..|+|||++.+..++.++|||||||++|||++|+.||....... ........ .....  
T Consensus       150 ~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~-~~~~~--  221 (285)
T cd05631         150 VQIPEGETV----RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDRR-VKEDQ--  221 (285)
T ss_pred             EEcCCCCee----cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHHHHH-hhccc--
Confidence            876432221    23468999999999999999999999999999999999999998543211 11111110 00000  


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-----HHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-----MRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  840 (854)
                                           ..........+.+++.+||+.||++||+     ++|+++
T Consensus       222 ---------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 ---------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ---------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                                 0001112456789999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.8e-38  Score=339.35  Aligned_cols=199  Identities=26%  Similarity=0.384  Sum_probs=173.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|++.+.||+|+||.||+|++..++..||+|+++.... ...+.+.+|++++++++||||+++++++...+     ..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   79 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EIS   79 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----EEE
Confidence            579999999999999999999999999999999975432 33467899999999999999999999987655     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++....      .+++..+..++.|++.||+|||+..  +|+||||||+||+++.++..++ |||++
T Consensus        80 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  151 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVS  151 (331)
T ss_pred             EEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccc
Confidence            9999999999999998654      6788999999999999999999862  6999999999999998887776 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ........     ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       152 ~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         152 GQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             cccccccc-----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            76643221     2246899999999999989999999999999999999999999754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.9e-39  Score=319.13  Aligned_cols=246  Identities=23%  Similarity=0.331  Sum_probs=206.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .+|++.+.||+|.||.|-+|.....|+.||||.++..   +..+.-.+++|++||+.++||||+.+|.+|+..+     .
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd-----K  127 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD-----K  127 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc-----e
Confidence            4788889999999999999999889999999999644   3444556889999999999999999999997766     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      +.|||||..+|.|++|+.+.+      .+++.++++++.||..|+.|+|.+   +++|||+|.+|||+|.+...+| |||
T Consensus       128 IvivMEYaS~GeLYDYiSer~------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISERG------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             EEEEEEecCCccHHHHHHHhc------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence            899999999999999999876      799999999999999999999999   9999999999999999998888 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      ++..+.....-    ..++|++.|.+||++.|.+| ++.+|-||+||++|-++.|..||++.     +....++......
T Consensus       199 LSNly~~~kfL----qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs~Ga  269 (668)
T KOG0611|consen  199 LSNLYADKKFL----QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQISRGA  269 (668)
T ss_pred             hhhhhccccHH----HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhhccc
Confidence            99887654432    24789999999999999886 67899999999999999999999864     3333333332222


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..+.-.                         +....-+|++|+..+|++|.|+.+|...
T Consensus       270 YrEP~~-------------------------PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  270 YREPET-------------------------PSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ccCCCC-------------------------CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            222221                         1223467888999999999999988754

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-38  Score=316.21  Aligned_cols=283  Identities=21%  Similarity=0.289  Sum_probs=210.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCC-eeeEEEEeeccCC-CCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRN-LIKIITICSSIDS-KGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~-~~~  622 (854)
                      ...|...++||+|+||+||+|+.+.+|+.||+|+++....  +......+|+.++++++|+| ||++++++.+... .+.
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            5667788899999999999999999999999999986543  45567789999999999999 9999999987652 233


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++||||++. +|.+++.......  ..++...++.++.||++||+|||++   +|+||||||.||+|++++..++ |
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence            357899999976 9999998865321  2466688999999999999999999   9999999999999999988887 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh---h
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK---M  777 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~---~  777 (854)
                      ||+|+...-+.....   ..++|.+|+|||++.+. .|+...||||+||+++||+++++.|.+..+.+ .+..+.+   .
T Consensus       164 FGlAra~~ip~~~yt---~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-ql~~If~~lGt  239 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYT---PEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-QLFRIFRLLGT  239 (323)
T ss_pred             cchHHHhcCCccccc---ccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHHcCC
Confidence            999997765544322   24689999999999987 69999999999999999999999998765422 2222222   1


Q ss_pred             cCCcccccccC-chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          778 TLPEKVIEIVD-PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       778 ~~~~~~~~~~d-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...+.|..... |.....+...  ..+..-............+++..|++.+|.+|.|++.+++.
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~--~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKW--PGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccCCCCccccccccccCcCC--CCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11122222211 1111000000  00000000000111356789999999999999999999875

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.7e-38  Score=344.68  Aligned_cols=264  Identities=22%  Similarity=0.367  Sum_probs=202.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECC-----CceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  619 (854)
                      .++|.+.+.||+|+||.||+|++..     ++..||+|+++... ......+.+|+++++.+ +|+||++++++|.... 
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~-  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG-  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC-
Confidence            3589999999999999999998643     33579999997543 23345688999999999 8999999999987655 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCc----------------------------------------------------
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDH----------------------------------------------------  647 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------  647 (854)
                          ..++||||+++|+|.+++......                                                    
T Consensus       116 ----~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         116 ----PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             ----CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence                689999999999999998653210                                                    


Q ss_pred             ------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccCCCC
Q 043388          648 ------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKT  714 (854)
Q Consensus       648 ------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~  714 (854)
                                  .....+++.++++++.||+.||+|||+.   +|+||||||+||+++.+...++ |||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                        0112578899999999999999999999   9999999999999998887776 99999876443221


Q ss_pred             CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccccccCchhhH
Q 043388          715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLM  793 (854)
Q Consensus       715 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  793 (854)
                      . ......++..|+|||++.+..++.++|||||||++|||++ |+.||....... .............     .+    
T Consensus       269 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~-----~~----  337 (374)
T cd05106         269 V-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMS-----RP----  337 (374)
T ss_pred             e-eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCcc-----CC----
Confidence            1 1111235678999999988899999999999999999997 999997542221 1111111100000     00    


Q ss_pred             HHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          794 EVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                                       ...+.++.+++.+||+.||++|||+.+|+++|+++.
T Consensus       338 -----------------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 -----------------DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             -----------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                             011456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.5e-38  Score=336.64  Aligned_cols=267  Identities=22%  Similarity=0.344  Sum_probs=199.3

Q ss_pred             hhccccCccCCCcceEEEEeEECC----------------CceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG----------------EEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKI  610 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~  610 (854)
                      ++|.+.++||+|+||.||+|.+..                ++..||+|++.... .....++.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999998632                34579999987543 2234578999999999999999999


Q ss_pred             EEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCc-------------ccccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 043388          611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDH-------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQ  677 (854)
Q Consensus       611 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~  677 (854)
                      ++++.+.+     ..++||||+++|+|.+++......             .....+++.++..++.||+.||+|||+.  
T Consensus        85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--  157 (304)
T cd05096          85 LGVCVDED-----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--  157 (304)
T ss_pred             EEEEecCC-----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence            99997654     579999999999999998754211             1112578889999999999999999999  


Q ss_pred             CCeEeecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh
Q 043388          678 PPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT  756 (854)
Q Consensus       678 ~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt  756 (854)
                       +|+||||||+||+++.++..++ |||+++......... ......++..|+|||++.+..++.++|||||||++|||++
T Consensus       158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             -CccccCcchhheEEcCCccEEECCCccceecccCceeE-ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence             9999999999999999887766 999998664432211 1112346789999999988889999999999999999987


Q ss_pred             --CCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC
Q 043388          757 --GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME  834 (854)
Q Consensus       757 --g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs  834 (854)
                        +..||......  ..................                   ......++..+.+++.+||+.||++|||
T Consensus       236 ~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~li~~cl~~~p~~RPs  294 (304)
T cd05096         236 LCKEQPYGELTDE--QVIENAGEFFRDQGRQVY-------------------LFRPPPCPQGLYELMLQCWSRDCRERPS  294 (304)
T ss_pred             ccCCCCCCcCCHH--HHHHHHHHHhhhcccccc-------------------ccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence              55677643211  111111110000000000                   0011123567889999999999999999


Q ss_pred             HHHHHHHHHh
Q 043388          835 MRDVVAKLCH  844 (854)
Q Consensus       835 ~~evl~~L~~  844 (854)
                      +.||.+.|++
T Consensus       295 ~~~i~~~l~~  304 (304)
T cd05096         295 FSDIHAFLTE  304 (304)
T ss_pred             HHHHHHHHhC
Confidence            9999988763

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.6e-38  Score=332.84  Aligned_cols=275  Identities=22%  Similarity=0.310  Sum_probs=199.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|.+.++||+|+||.||+|....++..||+|+++... ......+.+|+.++++++||||+++++++...+     ..
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER-----CL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC-----eE
Confidence            357999999999999999999999899999999997543 233456789999999999999999999986644     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++ +|.+++.....     .+++..+..++.||+.||+|||++   +|+||||||+||+++.++..++ |||+
T Consensus        79 ~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~  149 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGL  149 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcc
Confidence            999999975 99998876432     578889999999999999999999   9999999999999998877776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh---cCC
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM---TLP  780 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~---~~~  780 (854)
                      ++.........   ....|++.|+|||++.+ ..++.++||||+||++|||+||++||....... .+......   ...
T Consensus       150 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  225 (288)
T cd07871         150 ARAKSVPTKTY---SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTE  225 (288)
T ss_pred             eeeccCCCccc---cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence            87654332221   22358999999998876 458999999999999999999999997543211 11111111   111


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +.+....+................. .........+..+++.+|++.||.+|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         226 ETWPGITSNEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             HHhhccccchhhhccccCccCCCch-HHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1111111111000000000000000 0000112345779999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=337.29  Aligned_cols=245  Identities=23%  Similarity=0.296  Sum_probs=197.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|++++++++||||+++++++.+..     .
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR-----F   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-----e
Confidence            36888999999999999999999899999999996432   223456889999999999999999998876544     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++...+      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence            899999999999999998654      678899999999999999999999   9999999999999998877776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      ++........      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......     ...........
T Consensus       147 ~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~  215 (291)
T cd05612         147 FAKKLRDRTW------TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKILAGKL  215 (291)
T ss_pred             cchhccCCcc------cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCc
Confidence            9887643221      246899999999999888999999999999999999999999753211     11111000000


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-----HHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-----MRDVVAK  841 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  841 (854)
                                              .........+.+++.+||+.||.+||+     ++|+++.
T Consensus       216 ------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 ------------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ------------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                                    000111345778999999999999995     7777654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.4e-38  Score=338.45  Aligned_cols=200  Identities=27%  Similarity=0.398  Sum_probs=173.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|++.++||+|+||.||+|.+..++..+|+|+++.... .....+.+|++++++++||||++++++|.+.+     +.
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC-----EE
Confidence            3689999999999999999999998999999999875432 33467899999999999999999999998755     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++|+|.+++....      .+++..+..++.|++.||+|||+..  +|+||||||+||+++.++..++ |||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~  150 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV  150 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence            99999999999999997654      5788889999999999999999752  7999999999999998876666 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      +........     ....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       151 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         151 SGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             chhhhhhcc-----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            876643222     1246899999999999888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-37  Score=326.62  Aligned_cols=256  Identities=24%  Similarity=0.368  Sum_probs=201.2

Q ss_pred             HhhccccCccCCCcceEEEEeEEC---CCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILG---GEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ..+|++.+.||+|+||.||+|.+.   ..+..||+|+++.... ...+.+.+|+.++++++||||+++++++...+    
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   79 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN----   79 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC----
Confidence            357899999999999999999874   3567899999875432 33457889999999999999999999987654    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++|+|.+++.....     .+++.+++.++.|++.||+|||+.   +++||||||+||+++.++..++ |
T Consensus        80 -~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d  150 (266)
T cd05064          80 -TMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG  150 (266)
T ss_pred             -CcEEEEEeCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence             68999999999999999976432     688999999999999999999999   9999999999999999887777 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||.+.........  ......++..|+|||.+.+..++.++|||||||++||+++ |+.||......  ...+.......
T Consensus       151 fg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~  226 (266)
T cd05064         151 FRRLQEDKSEAIY--TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDGFR  226 (266)
T ss_pred             Ccccccccccchh--cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCCC
Confidence            9987654322211  1112235678999999998899999999999999999875 99999753211  11111110000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                                .+....++..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus       227 --------------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 --------------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                                      001122356688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.1e-38  Score=340.30  Aligned_cols=241  Identities=24%  Similarity=0.311  Sum_probs=193.1

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      +.||+|+||.||+|+...+++.||+|+++...   ......+.+|++++++++||||+++++++...+     ..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD-----RLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC-----EEEEEEe
Confidence            46999999999999999899999999997532   233456788999999999999999999987655     7899999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccc
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLD  709 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~  709 (854)
                      |+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||+++...
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            999999999998654      688999999999999999999999   9999999999999998887776 999987543


Q ss_pred             cCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCc
Q 043388          710 SASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDP  789 (854)
Q Consensus       710 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~  789 (854)
                      .....   .....||+.|+|||++.+..++.++||||+||++|||++|+.||......  ......   ..... .    
T Consensus       147 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~---~~~~~-~----  213 (323)
T cd05571         147 SDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELI---LMEEI-R----  213 (323)
T ss_pred             cCCCc---ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHH---HcCCC-C----
Confidence            22211   12346999999999999989999999999999999999999999743211  111111   00000 0    


Q ss_pred             hhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          790 SLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                                         ........+.+++.+||+.||++||     ++.++++
T Consensus       214 -------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         214 -------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -------------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                               0011245577899999999999999     7888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.3e-38  Score=334.11  Aligned_cols=275  Identities=21%  Similarity=0.274  Sum_probs=200.1

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.+.||+|+||.||+|++..+++.||+|+++...  ....+.+.+|++++++++||||+++++++...+     ..+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-----KLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC-----EEE
Confidence            6889999999999999999999899999999997542  233467889999999999999999999987654     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||++++.+..+.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++
T Consensus        77 lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~  147 (287)
T cd07848          77 LVFEYVEKNMLELLEEMPN------GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFA  147 (287)
T ss_pred             EEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence            9999999877765543322      688899999999999999999999   9999999999999999887776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh--cCCccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM--TLPEKV  783 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~  783 (854)
                      ..........  .....||+.|+|||++.+..++.++||||+||++|||++|++||......+ ........  ..+...
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~  224 (287)
T cd07848         148 RNLSEGSNAN--YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQ  224 (287)
T ss_pred             cccccccccc--ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHH
Confidence            8764432221  123468999999999998889999999999999999999999997543211 11111110  011000


Q ss_pred             ccc--cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEI--VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~--~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...  .++.......................++..+.+++.+|++.||++|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000  000000000000000000001111224567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-38  Score=341.20  Aligned_cols=245  Identities=21%  Similarity=0.290  Sum_probs=198.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.++++++||||+++++++.+.+     
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN-----   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-----
Confidence            468999999999999999999999899999999997432   233467889999999999999999999987655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Df  162 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDF  162 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeec
Confidence            7899999999999999998654      678888999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |++........      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+.........
T Consensus       163 g~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~~~  231 (329)
T PTZ00263        163 GFAKKVPDRTF------TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEKILAGR  231 (329)
T ss_pred             cCceEcCCCcc------eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHHHhcCC
Confidence            99987644322      24699999999999998899999999999999999999999964321     11111100000


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-----HHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-----MRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  840 (854)
                      . . . +                     ..+...+.+++.+||+.||.+||+     ++|+++
T Consensus       232 ~-~-~-p---------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        232 L-K-F-P---------------------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             c-C-C-C---------------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            0 0 0 0                     001344678999999999999997     577664

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=331.81  Aligned_cols=255  Identities=25%  Similarity=0.419  Sum_probs=214.5

Q ss_pred             hccccCccCCCcceEEEEeEEC----CCceEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          549 EFASSNMIGQGSFGSVYKGILG----GEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .....++||+|.||.||+|.+.    +..-.||||..+.. ..+..+.|..|+.+|++++|||||+++|+|.+..     
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-----  464 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-----  464 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-----
Confidence            3455689999999999999984    23456899998764 3445688999999999999999999999998754     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                       .|||||.++-|.|.+|+.....     .++......++.||+.||+|||+.   .+|||||..+|||+.....+++ ||
T Consensus       465 -~WivmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  465 -MWIVMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             -eeEEEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence             7999999999999999998764     788889999999999999999999   9999999999999998877776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |+++.+..........  ..-+..|||||.+.-.+++.+||||.|||.+||+++ |..||.+-...+...          
T Consensus       536 GLSR~~ed~~yYkaS~--~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----------  603 (974)
T KOG4257|consen  536 GLSRYLEDDAYYKASR--GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----------  603 (974)
T ss_pred             chhhhccccchhhccc--cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE----------
Confidence            9999998776554332  235778999999999999999999999999999998 999998653321100          


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                                        ......|.+.++.|+..+..++.+||++||.+||++.|+.+.|.++.+
T Consensus       604 ------------------~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  604 ------------------HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ------------------EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                              011234556667889999999999999999999999999999988876

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-38  Score=332.15  Aligned_cols=253  Identities=20%  Similarity=0.289  Sum_probs=211.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|...+++|+|+||.++.++++.++..||+|.+....  ....+...+|+.++++++|||||.+.+.|...+    ..
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~~   78 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----QL   78 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----ce
Confidence            357889999999999999999999999999999997543  333457889999999999999999999998765    14


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .+|||+||+||++.+.+.+.++    ..++++.+..++.|++.|+.|||+.   .|+|||||+.|||++.+..+++ |||
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfG  151 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFG  151 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchh
Confidence            8999999999999999998763    2789999999999999999999998   9999999999999998877777 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +|+.+......   ...++||+.||.||.+.+.+|..|+||||+||++|||++-+++|.......     .+....... 
T Consensus       152 laK~l~~~~~~---a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----Li~ki~~~~-  222 (426)
T KOG0589|consen  152 LAKILNPEDSL---ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----LILKINRGL-  222 (426)
T ss_pred             hhhhcCCchhh---hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----HHHHHhhcc-
Confidence            99999876522   223679999999999999999999999999999999999999998653321     111111111 


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                         .+                   +....+..++..++..|++.+|+.||++.+++.+
T Consensus       223 ---~~-------------------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 ---YS-------------------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---CC-------------------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence               00                   1112235678899999999999999999999887

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=304.21  Aligned_cols=251  Identities=21%  Similarity=0.324  Sum_probs=201.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|.|+.||++....+|+.+|+|++...  .....+++.+|+.|.+.++||||+++.+.+.+..     +
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~-----~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----F   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc-----e
Confidence            56788889999999999999999999999999988532  2336788999999999999999999999876655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC----ccccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQ  700 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~~~  700 (854)
                      .|+|+|+|+|++|..-|....      .+++..+-..++||+.||+|+|..   +|||||+||+|+++...    .+++.
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R~------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~  155 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLA  155 (355)
T ss_pred             eEEEEecccchHHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeec
Confidence            899999999999987666542      778889999999999999999999   99999999999999542    34555


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |||+|.......    ...+.+|||+|||||++...+|+..+|||+.||++|-++.|.+||.+.... ..+.++....+.
T Consensus       156 ~FGvAi~l~~g~----~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I~~g~yd  230 (355)
T KOG0033|consen  156 DFGLAIEVNDGE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQIKAGAYD  230 (355)
T ss_pred             ccceEEEeCCcc----ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhccccC
Confidence            999999988332    334578999999999999999999999999999999999999999863221 122222222111


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                           ...|.+                   ....++..+++++|+..||.+|.|+.|.+.
T Consensus       231 -----~~~~~w-------------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  231 -----YPSPEW-------------------DTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             -----CCCccc-------------------CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                 001111                   112344678999999999999999998864

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=348.58  Aligned_cols=265  Identities=21%  Similarity=0.265  Sum_probs=211.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-CCCeeeEEE-EeeccCCCC-Cce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIIT-ICSSIDSKG-ADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~-~~~~~~~~~-~~~  624 (854)
                      .++++.+.|.+|||+.||.|++.+.+..||+|++-..+....+.+.+|+++|+.|. |+|||.+++ ........+ ...
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            35677899999999999999999777999999997777788889999999999995 999999999 433332333 467


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc-cccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~-~Dfg  703 (854)
                      ++|.||||+||.|-+++......    .+++.++++|+.|+++|+++||.. +|+|||||||-+|||++.++..+ +|||
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~----~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQT----RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhc----cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence            89999999999999999976432    699999999999999999999987 67899999999999999988555 5999


Q ss_pred             cccccccCCCCCCc------ccccCCcccccCcccc---CCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHH
Q 043388          704 LSHQLDSASKTPSS------SIGIKGTVGYVAPEYG---MGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEF  774 (854)
Q Consensus       704 ~~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~  774 (854)
                      .+............      .....-|+.|+|||++   .+...++|+||||+||+||-|+....||+....-       
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------  264 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------  264 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence            98766444321110      1112379999999975   4567899999999999999999999999853111       


Q ss_pred             hhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          775 VKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       775 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                                .+++..              +..+....+...+.+||..||+.||++||++-+|++.+.++...
T Consensus       265 ----------aIlng~--------------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  265 ----------AILNGN--------------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ----------eEEecc--------------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                      011100              01111123367799999999999999999999999999888764

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=340.58  Aligned_cols=252  Identities=21%  Similarity=0.276  Sum_probs=200.6

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +|.+.+.||+|+||.||+|++..+++.||+|+++...   ......+.+|++++..++||||+++++++...+     ..
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE-----YL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-----EE
Confidence            6889999999999999999999889999999997542   233466889999999999999999999987655     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      |+||||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||+
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~  147 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGL  147 (333)
T ss_pred             EEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcC
Confidence            99999999999999997654      678899999999999999999999   9999999999999999887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +......      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...............
T Consensus       148 a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  220 (333)
T cd05600         148 SKGIVTY------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKYWKETLQRP  220 (333)
T ss_pred             Ccccccc------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHhccccccCC
Confidence            9866541      123469999999999999899999999999999999999999997542211 011110000000000


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...++.                    ..+..++.+++.+|+..+|.+||++.|+++.
T Consensus       221 ~~~~~~--------------------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         221 VYDDPR--------------------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCccc--------------------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000000                    1124567889999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.5e-37  Score=330.47  Aligned_cols=275  Identities=20%  Similarity=0.306  Sum_probs=198.2

Q ss_pred             hccccCccCCCcceEEEEeEECC-CceEEEEEEeeccc--ccchHHHHHHHHHHHhc---cCCCeeeEEEEeeccCCCCC
Q 043388          549 EFASSNMIGQGSFGSVYKGILGG-EEMIVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~  622 (854)
                      +|++.+.||+|+||.||+|++.. ++..||+|+++...  ......+.+|+.+++.+   +||||++++++|........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            68899999999999999999853 56889999987432  22334567788877766   69999999999865433334


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++||||++ ++|.+++......    .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence            46899999996 5999998765322    578999999999999999999999   9999999999999998877776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc---
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT---  778 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~---  778 (854)
                      ||.+........    .....||+.|+|||++.+..++.++|||||||++|||++|++||......+ .+.......   
T Consensus       154 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~  228 (290)
T cd07862         154 FGLARIYSFQMA----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLP  228 (290)
T ss_pred             ccceEeccCCcc----cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCC
Confidence            999987654321    123468999999999988889999999999999999999999998643221 111211111   


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .+..+.....  .........  ..........++...+.+++.+|++.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~--~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         229 GEEDWPRDVA--LPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             Chhhchhhhc--ccchhccCC--CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            1111100000  000000000  000000011123556789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=331.78  Aligned_cols=258  Identities=24%  Similarity=0.420  Sum_probs=218.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+....++||-|.||.||.|.|+.....||||.++.. ....++|.+|+.+|+.++|||+|+++|+|....     -.|
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PFY  339 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PFY  339 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----CeE
Confidence            34567789999999999999999999999999999754 345689999999999999999999999998755     469


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      ||+|||..|+|.+|+++..+.    .++....+.+|.||+.||+||..+   ++|||||.++|.|+.++.++++ |||++
T Consensus       340 IiTEfM~yGNLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             EEEecccCccHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence            999999999999999987643    677778899999999999999999   9999999999999999998888 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +.+.....+...  +..-+..|.|||-+....++.|+|||+|||+|||+.| |..||.+.     ++.+...        
T Consensus       413 RlMtgDTYTAHA--GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqVY~--------  477 (1157)
T KOG4278|consen  413 RLMTGDTYTAHA--GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYG--------  477 (1157)
T ss_pred             hhhcCCceeccc--CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHHH--------
Confidence            999776554332  2335678999999999999999999999999999999 99998753     2222211        


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                                     ......|...++.|++.+.++|+.||+++|.+||+++|+-+.++.+..
T Consensus       478 ---------------LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  478 ---------------LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             ---------------HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence                           111234555677889999999999999999999999999999887653

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-37  Score=335.79  Aligned_cols=241  Identities=24%  Similarity=0.301  Sum_probs=192.5

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      +.||+|+||.||+|+...++..||+|+++..   .......+.+|++++++++||||+++++++...+     ..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----RLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----EEEEEEe
Confidence            4699999999999999989999999999753   2233456788999999999999999999987655     7899999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccc
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLD  709 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~  709 (854)
                      |+++|+|.+++....      .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++..++ |||++....
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          76 YANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            999999999887654      688999999999999999999999   9999999999999998877776 999987543


Q ss_pred             cCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCc
Q 043388          710 SASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDP  789 (854)
Q Consensus       710 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~  789 (854)
                      .....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......    .... .    
T Consensus       147 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~----~~~~-~----  213 (323)
T cd05595         147 SDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELIL----MEEI-R----  213 (323)
T ss_pred             CCCCc---cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHh----cCCC-C----
Confidence            22211   12346999999999999989999999999999999999999999743211 0111110    0000 0    


Q ss_pred             hhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          790 SLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                                         ....+...+.+++.+||+.||++||     ++.++++
T Consensus       214 -------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         214 -------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -------------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                               0011245577899999999999998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-38  Score=335.45  Aligned_cols=243  Identities=23%  Similarity=0.323  Sum_probs=200.2

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  621 (854)
                      ..++|...++||+|+||.|++|..+++++.+|||+++..   ..++.+..+.|.+|+... +||.++.++.+|.+.+   
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~---  442 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE---  442 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC---
Confidence            457899999999999999999999999999999999855   355677888999988877 5999999999998877   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                        +.|.||||+.||++..+.+..       .+++..++-+|..|+.||+|||++   +|||||||.+|||+|.++.+++ 
T Consensus       443 --~l~fvmey~~Ggdm~~~~~~~-------~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiA  510 (694)
T KOG0694|consen  443 --HLFFVMEYVAGGDLMHHIHTD-------VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIA  510 (694)
T ss_pred             --eEEEEEEecCCCcEEEEEecc-------cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEec
Confidence              899999999999955444432       789999999999999999999999   9999999999999999998888 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |||+++..-....   .+..++||+.|||||++.+..|+.++|.|||||+||||+.|..||.+...+ ..+..++...+ 
T Consensus       511 DFGlcKe~m~~g~---~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-e~FdsI~~d~~-  585 (694)
T KOG0694|consen  511 DFGLCKEGMGQGD---RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-EVFDSIVNDEV-  585 (694)
T ss_pred             ccccccccCCCCC---ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCC-
Confidence            9999986543222   334579999999999999999999999999999999999999999865322 11111111110 


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM  835 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  835 (854)
                            .-|                     .-++.+...++.+++..+|++|--+
T Consensus       586 ------~yP---------------------~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 ------RYP---------------------RFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ------CCC---------------------CcccHHHHHHHHHHhccCcccccCC
Confidence                  111                     1125567789999999999999876

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-37  Score=332.28  Aligned_cols=275  Identities=21%  Similarity=0.299  Sum_probs=197.8

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|.+.+.||+|+||.||+|+...+++.||+|+++.... .....+.+|+.++++++||||+++++++.+.+     ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-----TL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC-----eE
Confidence            4689999999999999999999998999999999874432 23346788999999999999999999987654     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||++ ++|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||+
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~  149 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL  149 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence            99999996 588888875432     578889999999999999999999   9999999999999998877666 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC--Cc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL--PE  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~  781 (854)
                      +..........   ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+....+........  ..
T Consensus       150 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (303)
T cd07869         150 ARAKSVPSHTY---SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNE  226 (303)
T ss_pred             ceeccCCCccC---CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCCh
Confidence            87654322211   22458999999998876 45889999999999999999999999864322122222111100  00


Q ss_pred             c-ccccc-CchhhHHHhhccchhhHhhhh--hHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 K-VIEIV-DPSLLMEVMANNSMIQEDRRA--RTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~-~~~~~-d~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      . +.... .+....+....  ..+.....  ........+.+++..|++.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         227 DTWPGVHSLPHFKPERFTL--YSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhccchhhccccccccccc--cCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0 00000 00000000000  00000000  00011345778999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.6e-37  Score=321.62  Aligned_cols=255  Identities=24%  Similarity=0.429  Sum_probs=204.0

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      .+|.+.+.||+|+||.||+|.+..++..||+|+++... ...+.+.+|++++++++|+||+++++++...+     ..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC-----CcEE
Confidence            56888999999999999999998889999999986432 33567899999999999999999999987654     5799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|.+++.....    ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+.
T Consensus        80 v~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence            9999999999999976432    2688999999999999999999999   9999999999999998887776 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ..........  ....++..|+|||...+..++.++|||||||++|||++ |..||.....+  ...........     
T Consensus       153 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~-----  223 (263)
T cd05052         153 LMTGDTYTAH--AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKGYR-----  223 (263)
T ss_pred             ccccceeecc--CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCC-----
Confidence            7654332211  11234678999999988899999999999999999998 99998643211  11111110000     


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                           ......++.++.+++.+||+.+|++|||+.+++++|+++
T Consensus       224 ---------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 ---------------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                                 001112356688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.4e-37  Score=339.98  Aligned_cols=265  Identities=24%  Similarity=0.374  Sum_probs=203.8

Q ss_pred             HhhccccCccCCCcceEEEEeEECC-----CceEEEEEEeecccc-cchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQK-GAFRSFVAECEALRNIR-HRNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  619 (854)
                      .++|.+.++||+|+||.||+|++..     .+..||||+++.... ...+.+.+|+++++++. ||||++++++|.+.+ 
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~-  114 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG-  114 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-
Confidence            4578899999999999999998743     235799999965432 33467899999999996 999999999997654 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcc---------------------------------------------------
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHL---------------------------------------------------  648 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------  648 (854)
                          ..++|||||++|+|.+++.......                                                   
T Consensus       115 ----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         115 ----PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ----ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence                6899999999999999987642100                                                   


Q ss_pred             ---------------------------------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCc
Q 043388          649 ---------------------------------------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSN  689 (854)
Q Consensus       649 ---------------------------------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  689 (854)
                                                             ....+++.++..++.|++.||+|||+.   +|+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence                                                   012478888999999999999999999   99999999999


Q ss_pred             eEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccC
Q 043388          690 VLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE  767 (854)
Q Consensus       690 Ill~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~  767 (854)
                      |+++.+...++ |||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....+
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYV-SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             EEEeCCCEEEEEeCCcceecccccccc-ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            99999887776 999998764432211 1122347788999999998889999999999999999997 99998753221


Q ss_pred             CchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          768 GLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       768 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                      .. .........                          +......++..+.+++.+||+.||++|||+.+|.++|+++.+
T Consensus       347 ~~-~~~~~~~~~--------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 ST-FYNKIKSGY--------------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HH-HHHHHhcCC--------------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            11 111111000                          000112235668899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-38  Score=334.78  Aligned_cols=239  Identities=23%  Similarity=0.309  Sum_probs=190.1

Q ss_pred             cCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeec
Q 043388          556 IGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM  632 (854)
Q Consensus       556 lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  632 (854)
                      ||+|+||.||+|++..+++.||+|+++..   .......+.+|+.++++++||||+++++++...+     ..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE-----KLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC-----eEEEEEcCC
Confidence            79999999999999989999999999643   2334466789999999999999999999987654     789999999


Q ss_pred             cCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccC
Q 043388          633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSA  711 (854)
Q Consensus       633 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~  711 (854)
                      ++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||+++.....
T Consensus        76 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          76 NGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            9999999997654      688999999999999999999999   9999999999999998887776 99998754332


Q ss_pred             CCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchh
Q 043388          712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL  791 (854)
Q Consensus       712 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  791 (854)
                      ...   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .+..........        
T Consensus       147 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~~--------  210 (312)
T cd05585         147 DDK---TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEPL--------  210 (312)
T ss_pred             CCc---cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCC--------
Confidence            211   1235699999999999998999999999999999999999999974321     111111111100        


Q ss_pred             hHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC---HHHHHH
Q 043388          792 LMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME---MRDVVA  840 (854)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~  840 (854)
                                      .....+...+.+++.+||+.||++||+   +.|++.
T Consensus       211 ----------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         211 ----------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             ----------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence                            000112455778999999999999986   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.8e-38  Score=298.73  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=207.5

Q ss_pred             HHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--------cchHHHHHHHHHHHhc-cCCCeeeEEE
Q 043388          542 ELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--------GAFRSFVAECEALRNI-RHRNLIKIIT  612 (854)
Q Consensus       542 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~  612 (854)
                      .-......|...+.+|.|..++|-++..+.++..+|+|++.....        ...++-.+|+.|++++ .||+|+.+.+
T Consensus        11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D   90 (411)
T KOG0599|consen   11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD   90 (411)
T ss_pred             hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence            344556778889999999999999999999999999999964321        1234567899999998 7999999999


Q ss_pred             EeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe
Q 043388          613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL  692 (854)
Q Consensus       613 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  692 (854)
                      +|++..     +.++|+|.|+.|.|.+++...-      .+++.+.++|+.|+..|++|||..   .|||||+||+|||+
T Consensus        91 ~yes~s-----F~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILl  156 (411)
T KOG0599|consen   91 VYESDA-----FVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILL  156 (411)
T ss_pred             eccCcc-----hhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheee
Confidence            998766     8899999999999999999765      889999999999999999999999   99999999999999


Q ss_pred             cCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCC------CCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          693 DHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG------SEASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       693 ~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      |++...++ |||+|+.+.....-.    ..+|||+|.|||.+.-      ..|+..+|+||.||++|.++.|.+||....
T Consensus       157 ddn~~i~isDFGFa~~l~~GekLr----elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk  232 (411)
T KOG0599|consen  157 DDNMNIKISDFGFACQLEPGEKLR----ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK  232 (411)
T ss_pred             ccccceEEeccceeeccCCchhHH----HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH
Confidence            99988888 999999987765432    3689999999997643      348889999999999999999999997421


Q ss_pred             cCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          766 TEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       766 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                        ...+   .+. +.+.-.+.-.                   +...+......+++.+|++.||.+|.|++|+++.
T Consensus       233 --QmlM---LR~-ImeGkyqF~s-------------------peWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  233 --QMLM---LRM-IMEGKYQFRS-------------------PEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             --HHHH---HHH-HHhcccccCC-------------------cchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence              1111   111 1111111111                   2223446678899999999999999999999764

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-37  Score=337.37  Aligned_cols=246  Identities=22%  Similarity=0.295  Sum_probs=197.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCc-eEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEE-MIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|.+.+.||+|+||.||+|.+..++ ..||+|++...   .....+.+.+|+++++.++||||+++++++.+..    
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----  104 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES----  104 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC----
Confidence            468999999999999999999876544 68999998643   2234567889999999999999999999987655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++..++ |
T Consensus       105 -~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~D  174 (340)
T PTZ00426        105 -YLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTD  174 (340)
T ss_pred             -EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEec
Confidence             7899999999999999998654      678999999999999999999999   9999999999999998887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||++.......      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........    
T Consensus       175 FG~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~~~----  243 (340)
T PTZ00426        175 FGFAKVVDTRT------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKILEG----  243 (340)
T ss_pred             CCCCeecCCCc------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHHhcC----
Confidence            99998764322      2246999999999999888999999999999999999999999753211 001111110    


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  841 (854)
                      .. . ..                      ......+.+++.+|++.||++|+     +++|+++.
T Consensus       244 ~~-~-~p----------------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        244 II-Y-FP----------------------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CC-C-CC----------------------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            00 0 00                      01133467899999999999995     88888754

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.5e-37  Score=326.59  Aligned_cols=275  Identities=25%  Similarity=0.371  Sum_probs=204.1

Q ss_pred             hhccccCccCCCcceEEEEeEE----CCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGIL----GGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .+|++.+.||+|+||.||+|..    ..++..||+|+++.......+.+.+|++++++++||||+++++++...+   ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CC
Confidence            4688899999999999999985    3467899999987665555678899999999999999999999876543   22


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df  152 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF  152 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence            57999999999999999976432     588999999999999999999999   9999999999999998887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |++.................++..|+|||+..+..++.++|||||||++|||++|..|+.....      .+........
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~  226 (284)
T cd05081         153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA------EFMRMMGNDK  226 (284)
T ss_pred             cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch------hhhhhccccc
Confidence            9998765433221111112345569999999888899999999999999999998877643211      1111000000


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ........+.. ....     ..+.+....++..+.+++.+||+.+|++||||.||++.|+.+
T Consensus       227 ~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         227 QGQMIVYHLIE-LLKN-----NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             ccccchHHHHH-HHhc-----CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00001111100 0000     001111223456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.6e-37  Score=318.68  Aligned_cols=251  Identities=27%  Similarity=0.403  Sum_probs=198.0

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      .+|++.+.||+|+||.||+|.++ ++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+     ..++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-----PLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC-----CEEE
Confidence            57889999999999999999987 55679999886432 23467889999999999999999999987654     6799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++|+|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.++
T Consensus        77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence            9999999999999876432     578999999999999999999999   9999999999999999887776 999988


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........  .....++..|+|||++.+..++.++||||||+++|||++ |+.||......  ........   ..  .
T Consensus       149 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~---~~--~  219 (256)
T cd05114         149 YVLDDEYTS--SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISR---GF--R  219 (256)
T ss_pred             ccCCCceec--cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC---CC--C
Confidence            664332211  112345678999999988889999999999999999999 89998643211  11111111   00  0


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      ...+.                     ..+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       220 ~~~~~---------------------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         220 LYRPK---------------------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCC---------------------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            00010                     11345789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-37  Score=337.95  Aligned_cols=270  Identities=18%  Similarity=0.179  Sum_probs=197.8

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|...      ...+.+|++++++++||||+++++++....     ..++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~l  160 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNK-----FTCL  160 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC-----eeEE
Confidence            56999999999999999999999999999999653      235678999999999999999999987654     6899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      |||++. ++|.+++....      .+++.+++.|+.||+.||+|||++   +|+||||||+||+++.++..++ |||+++
T Consensus       161 v~e~~~-~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~  230 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC  230 (391)
T ss_pred             EEecCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence            999995 68998887654      678999999999999999999999   9999999999999998876666 999997


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC------CchHhHHhhhcC-
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE------GLTLHEFVKMTL-  779 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~------~~~~~~~~~~~~-  779 (854)
                      ........  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ...+........ 
T Consensus       231 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~  308 (391)
T PHA03212        231 FPVDINAN--KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT  308 (391)
T ss_pred             cccccccc--ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence            54332211  122357999999999999989999999999999999999999887543211      111222221111 


Q ss_pred             -CcccccccCchhhHHH---hhccchhhHhh--hhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          780 -PEKVIEIVDPSLLMEV---MANNSMIQEDR--RARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       780 -~~~~~~~~d~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       +..............+   .......+..+  .......+..+.+++.+||+.||++|||++|+++
T Consensus       309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             1111000000000000   00000000000  0112234567889999999999999999999985

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2e-37  Score=334.30  Aligned_cols=242  Identities=23%  Similarity=0.320  Sum_probs=193.4

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      +.||+|+||.||+|+...+++.||+|++...   .......+.+|+++++.++||||+++++++...+     ..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD-----RLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----EEEEEEe
Confidence            4689999999999999989999999999743   2234467789999999999999999999987655     7899999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccc
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLD  709 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~  709 (854)
                      |+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||+++...
T Consensus        76 y~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          76 YVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             CCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            999999999887654      688999999999999999999999   9999999999999998877776 999987543


Q ss_pred             cCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCc
Q 043388          710 SASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDP  789 (854)
Q Consensus       710 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~  789 (854)
                      .....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+.......... . +  
T Consensus       147 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~-~-~--  214 (328)
T cd05593         147 TDAAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEDI-K-F--  214 (328)
T ss_pred             Ccccc---cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCCc-c-C--
Confidence            22211   1234699999999999988999999999999999999999999974321     111111110000 0 0  


Q ss_pred             hhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHHH
Q 043388          790 SLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVAK  841 (854)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  841 (854)
                                          +......+.+++.+|++.||++||     ++.|+++.
T Consensus       215 --------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 --------------------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --------------------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                                011234577899999999999997     88888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.2e-37  Score=326.63  Aligned_cols=271  Identities=24%  Similarity=0.341  Sum_probs=202.1

Q ss_pred             ccccCccCCCcceEEEEeEE----CCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          550 FASSNMIGQGSFGSVYKGIL----GGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      |.+.+.||+|+||+||++..    ..++..||+|+++.... ...+.+.+|++++++++||||+++++++....   ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG---GKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---Cce
Confidence            48889999999999988654    34678899999875432 23567889999999999999999999886543   225


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++...       .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence            78999999999999999753       589999999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      ++.................++..|+|||...+..++.++|||||||++|||+||+.||......   ..+.......   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~---  226 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQG---  226 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhccccc---
Confidence            9987654332211111223567899999998888999999999999999999999998643221   1111110000   


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                       ........ +.....     ........++.++.+++.+||+.+|++|||+++|++.|+++.
T Consensus       227 -~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         227 -QMTVVRLI-ELLERG-----MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             -ccchhhhh-hhhhcC-----CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence             00000000 000000     000111234567899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5e-37  Score=322.30  Aligned_cols=261  Identities=21%  Similarity=0.301  Sum_probs=205.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||.||+|+...+++.||||.++...   ......+.+|++++++++||||+++++++...+     .
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-----E   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-----e
Confidence            57899999999999999999998899999999886432   233456889999999999999999999987654     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++......  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++..++ |||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence            79999999999999988653221  12578889999999999999999999   9999999999999998876666 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      .+..........   ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+.....   . 
T Consensus       152 ~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~-  224 (267)
T cd08228         152 LGRFFSSKTTAA---HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC---D-  224 (267)
T ss_pred             cceeccchhHHH---hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC---C-
Confidence            988765432211   123588999999999888899999999999999999999999864322211111111100   0 


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                          .+.                 .....+...+.+++.+||+.+|++||++.+|++.+++++
T Consensus       225 ----~~~-----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 ----YPP-----------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ----CCC-----------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                000                 001123456889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=334.14  Aligned_cols=247  Identities=23%  Similarity=0.344  Sum_probs=200.4

Q ss_pred             ccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeeccC
Q 043388          555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMEN  634 (854)
Q Consensus       555 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  634 (854)
                      ++|+|.||+||-|++..+...+|||.+..++....+-+..|+.+.++++|.|||+++|.|.+.+     +.-|.||.++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-----f~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-----FFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-----eEEEEeecCCC
Confidence            7999999999999999999999999998777777778899999999999999999999986655     78899999999


Q ss_pred             CCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC-Cccccc-ccccccccccCC
Q 043388          635 GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQ-NFSLSHQLDSAS  712 (854)
Q Consensus       635 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~~~-Dfg~~~~~~~~~  712 (854)
                      |||.++++...++.   .-.+.++-.+.+||+.||.|||+.   .|||||||-+||||+. .++.+| |||.++....-.
T Consensus       657 GSLSsLLrskWGPl---KDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPL---KDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             CcHHHHHHhccCCC---ccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            99999999876422   226777788999999999999999   9999999999999975 578888 999999876533


Q ss_pred             CCCCcccccCCcccccCccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCch
Q 043388          713 KTPSSSIGIKGTVGYVAPEYGMGSE--ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS  790 (854)
Q Consensus       713 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  790 (854)
                      ...   ..+.||..|||||++..++  |+.++|||||||++.||.||++||.........+.+. .      +.      
T Consensus       731 P~T---ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-G------my------  794 (1226)
T KOG4279|consen  731 PCT---ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-G------MY------  794 (1226)
T ss_pred             ccc---cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-c------ce------
Confidence            222   2256999999999998754  8999999999999999999999997543221111110 0      00      


Q ss_pred             hhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                   ...++.+++...+...++.+|..+||.+||+++++++.
T Consensus       795 -------------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  795 -------------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             -------------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence                         01112234446677889999999999999999999864

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.4e-38  Score=335.34  Aligned_cols=197  Identities=27%  Similarity=0.379  Sum_probs=174.4

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-C-----CCeeeEEEEeeccCCCCC
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-H-----RNLIKIITICSSIDSKGA  622 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~  622 (854)
                      +|.+.+.||+|+||.|.+|.+.++++.||||+++.... ...+...|+.+|..++ |     -|+|++++||...+    
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~----  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN----  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc----
Confidence            89999999999999999999999999999999976543 3456678999999996 4     38999999998776    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC---Ccccc
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAH  699 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~~  699 (854)
                       +.|||+|.++. +|.++++.+...    .++...++.|+.||+.||.+||+.   +|||+||||+|||+.+   ..+++
T Consensus       262 -HlciVfELL~~-NLYellK~n~f~----Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV  332 (586)
T KOG0667|consen  262 -HLCIVFELLST-NLYELLKNNKFR----GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV  332 (586)
T ss_pred             -ceeeeehhhhh-hHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence             89999999966 999999988643    789999999999999999999999   9999999999999965   35667


Q ss_pred             cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          700 QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       700 ~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      ||||.|+.......+      +..++.|+|||++.|.+|+.+.||||||||++||++|.+.|.+..
T Consensus       333 IDFGSSc~~~q~vyt------YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  333 IDFGSSCFESQRVYT------YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             EecccccccCCccee------eeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            799999987765442      468999999999999999999999999999999999988887653

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.1e-37  Score=323.69  Aligned_cols=261  Identities=26%  Similarity=0.468  Sum_probs=204.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCc-----eEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEE-----MIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|++.+.||+|+||.||+|.....+     ..||+|.++.... .....+.+|++++++++||||+++++++...+  
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--   81 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ--   81 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC--
Confidence            357899999999999999999986544     6899999864432 23456889999999999999999999987654  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCccc----------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCce
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLE----------VCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV  690 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  690 (854)
                         ..+++|||+++|+|.+++........          ...+++.++..++.|++.||+|||+.   +++||||||+||
T Consensus        82 ---~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Ni  155 (283)
T cd05048          82 ---PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNC  155 (283)
T ss_pred             ---ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceE
Confidence               57999999999999999986532111          13678899999999999999999999   999999999999


Q ss_pred             EecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCC
Q 043388          691 LLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEG  768 (854)
Q Consensus       691 ll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~  768 (854)
                      +++.++..++ |||++.......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... 
T Consensus       156 l~~~~~~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-  233 (283)
T cd05048         156 LVGEGLTVKISDFGLSRDIYSADYYR-VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-  233 (283)
T ss_pred             EEcCCCcEEECCCcceeecccccccc-ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            9999887776 999998664432211 1122346889999999988889999999999999999998 99998753221 


Q ss_pred             chHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       769 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                       ...+.+..   ...                       ......++.++.+++.+||+.||++||+++||++.|+.
T Consensus       234 -~~~~~i~~---~~~-----------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 -EVIEMIRS---RQL-----------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHHHc---CCc-----------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             11111110   000                       01122346778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.1e-36  Score=323.10  Aligned_cols=264  Identities=24%  Similarity=0.429  Sum_probs=206.2

Q ss_pred             hhccccCccCCCcceEEEEeEE-----CCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .+|.+.+.||+|+||.||++..     ..++..+|+|.+........+.+.+|++++++++||||+++++++...+    
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD----   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence            5788999999999999999985     2345679999987655555678999999999999999999999987654    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCc-------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDH-------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD  695 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  695 (854)
                       ..++||||+++++|.+++......       .....+++.+++.++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~  156 (288)
T cd05093          81 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  156 (288)
T ss_pred             -ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence             689999999999999999754310       1122589999999999999999999999   99999999999999998


Q ss_pred             ccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhH
Q 043388          696 MVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHE  773 (854)
Q Consensus       696 ~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~  773 (854)
                      +..++ |||.+.......... ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ....
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~  234 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIEC  234 (288)
T ss_pred             CcEEeccCCccccccCCceee-cCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH
Confidence            87776 999998664332211 1112236788999999998889999999999999999998 999986542211 1111


Q ss_pred             HhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       774 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ...    .....                       ....++.++.+++.+||+.+|.+|||+.||.+.|+++..+
T Consensus       235 i~~----~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 ITQ----GRVLQ-----------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHc----CCcCC-----------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            111    00000                       0011245688999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.1e-37  Score=331.39  Aligned_cols=265  Identities=22%  Similarity=0.352  Sum_probs=202.8

Q ss_pred             hhccccCccCCCcceEEEEeEECC-----CceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSK  620 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  620 (854)
                      ++|++.+.||+|+||.||+|...+     +++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|...+  
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~--   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG--   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC--
Confidence            479999999999999999997543     35789999987432 22345678899999999 8999999999886543  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCc-----------------------------------------------------
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDH-----------------------------------------------------  647 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------------  647 (854)
                        ...+++|||+++|+|.+++......                                                     
T Consensus        85 --~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          85 --GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             --CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence              2578999999999999998653210                                                     


Q ss_pred             --ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCc
Q 043388          648 --LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGT  724 (854)
Q Consensus       648 --~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt  724 (854)
                        .....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||++..+........ .....++
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~-~~~~~~~  238 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDARLP  238 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhh-ccCCCCC
Confidence              0012688999999999999999999999   9999999999999998876666 9999987644322111 1123467


Q ss_pred             ccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhh
Q 043388          725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQ  803 (854)
Q Consensus       725 ~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  803 (854)
                      ..|+|||++.+..++.++|||||||++|||++ |+.||....... .+........    ...                 
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~----~~~-----------------  296 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGT----RMR-----------------  296 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccC----CCC-----------------
Confidence            88999999999999999999999999999998 999987532211 1111111000    000                 


Q ss_pred             HhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          804 EDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       804 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                           ....+..++.+++.+||+.+|++||++.|+++.|+++.+
T Consensus       297 -----~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         297 -----APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             -----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                 001124557899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.8e-37  Score=318.90  Aligned_cols=254  Identities=23%  Similarity=0.413  Sum_probs=201.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.++||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.++++++|+||+++++++...+     ..+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   77 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEE-----PIY   77 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-----CcE
Confidence            468999999999999999999976 566799998864332 3468899999999999999999999886544     579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++.....    ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+
T Consensus        78 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence            99999999999999976432    2678889999999999999999999   9999999999999999887776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      ..........  .....++..|+|||+..+..++.++|||||||++|||+| |+.||......  ............   
T Consensus       151 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~---  223 (261)
T cd05072         151 RVIEDNEYTA--REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYRM---  223 (261)
T ss_pred             eecCCCceec--cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCC---
Confidence            8765432221  112346778999999988889999999999999999998 99998643211  111111111000   


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                                             +....++.++.+++.+|+..+|++||+++++.+.|++
T Consensus       224 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 -----------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                                   0011124567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.3e-37  Score=334.44  Aligned_cols=249  Identities=26%  Similarity=0.362  Sum_probs=191.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ..+|...++||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++|+||+++++++...+     ..
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~  147 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-----EI  147 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-----eE
Confidence            3567778999999999999999998999999999865432 23467889999999999999999999987654     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++|+|.+..          ...+..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||+
T Consensus       148 ~lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~  214 (353)
T PLN00034        148 QVLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGV  214 (353)
T ss_pred             EEEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccccc
Confidence            9999999999986531          345667788999999999999999   9999999999999999887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-----SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      ++........   .....||..|+|||++..     ...+.++|||||||++|||++|+.||......  ..........
T Consensus       215 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~  289 (353)
T PLN00034        215 SRILAQTMDP---CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAIC  289 (353)
T ss_pred             ceeccccccc---ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHh
Confidence            9876543221   122469999999998743     23457899999999999999999999732211  1111111000


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...                       .......+..++.+++.+||+.||++|||+.|+++.
T Consensus       290 ~~~-----------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 MSQ-----------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ccC-----------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000                       000011224568899999999999999999999874

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.4e-37  Score=330.69  Aligned_cols=259  Identities=22%  Similarity=0.372  Sum_probs=202.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCce----EEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEM----IVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .+|+..+.||+|+||.||+|++..++.    .||+|+++... ....+++.+|+.+++.++||||++++++|...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            579999999999999999999865554    48999986443 33456788999999999999999999998653     


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++|+||+++|+|.+++.....     .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D  152 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD  152 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence             35799999999999999987542     578889999999999999999999   9999999999999998877776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||+++.......... .....++..|+|||++.+..++.++|||||||++||+++ |+.||......  .+.........
T Consensus       153 fG~a~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~  229 (316)
T cd05108         153 FGLAKLLGADEKEYH-AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGER  229 (316)
T ss_pred             ccccccccCCCccee-ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCCC
Confidence            999987754332211 112235678999999999899999999999999999998 99998743211  11111111000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                        .                        +....+...+.+++.+||+.+|++||++.+++..+..+..+.
T Consensus       230 --~------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         230 --L------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             --C------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence              0                        000112345778999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5e-37  Score=347.06  Aligned_cols=253  Identities=20%  Similarity=0.259  Sum_probs=200.4

Q ss_pred             hccccCccCCCcceEEEEeEECCC-ceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGE-EMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      .|.+.+.||+|+||.||+|....+ +..||+|.+..........+.+|+.+++.++|||||++++++...+     ..++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD-----KLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC-----EEEE
Confidence            489999999999999999998766 7889999876555444566788999999999999999999997765     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++|+|.+++.....  ....+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||+++
T Consensus       143 v~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~  217 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK  217 (478)
T ss_pred             EEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence            9999999999998865321  122688999999999999999999999   9999999999999998887776 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      ........ ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+..........   
T Consensus       218 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~~---  288 (478)
T PTZ00267        218 QYSDSVSL-DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGKY---  288 (478)
T ss_pred             ecCCcccc-ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCC---
Confidence            76543221 112235699999999999998999999999999999999999999974321     111111000000   


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       ++                   ....+...+.+++..||+.||++||++.+++.
T Consensus       289 -~~-------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 -DP-------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CC-------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             00                   00112455789999999999999999999875

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.7e-37  Score=338.77  Aligned_cols=202  Identities=23%  Similarity=0.351  Sum_probs=172.1

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .|.+.+.||+|+||+||+|++..+++.||+|+++...   ....+.+.+|++++++++||||+++++++.+.+     ..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-----NL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-----EE
Confidence            5888999999999999999999999999999997532   233467889999999999999999999997655     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence            99999999999999998654      678888999999999999999999   9999999999999998887776 9999


Q ss_pred             ccccccCCCC--------------------------------------------CCcccccCCcccccCccccCCCCCCc
Q 043388          705 SHQLDSASKT--------------------------------------------PSSSIGIKGTVGYVAPEYGMGSEASM  740 (854)
Q Consensus       705 ~~~~~~~~~~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~  740 (854)
                      +..+......                                            .......+||+.|+|||++.+..++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            7643211000                                            00012356999999999999888999


Q ss_pred             cchhHHHHHHHHHHHhCCCCCCCc
Q 043388          741 TGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       741 ~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ++|||||||++|||++|+.||...
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~  251 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAP  251 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCC
Confidence            999999999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-36  Score=319.86  Aligned_cols=264  Identities=23%  Similarity=0.406  Sum_probs=200.5

Q ss_pred             ccccCccCCCcceEEEEeEECCCce--EEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCce
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEM--IVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGADF  624 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  624 (854)
                      |.+.++||+|+||.||+|++..++.  .||+|.++..  .....+.+.+|+++++.++|+||+++++++..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999876654  6899988653  23345678899999999999999999998754332 12235


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++...........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            789999999999999886443222223689999999999999999999999   9999999999999998877766 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      +++.......... .....+++.|+|||+..+..++.++|||||||++|||++ |+.||.....  ....+.....   .
T Consensus       158 ~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~---~  231 (272)
T cd05075         158 LSKKIYNGDYYRQ-GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQG---N  231 (272)
T ss_pred             cccccCcccceec-CCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcC---C
Confidence            9987654332111 112246778999999998889999999999999999999 8899864321  1111111110   0


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ..                       .....++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       232 ~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RL-----------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC-----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00                       00011245578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-37  Score=322.77  Aligned_cols=250  Identities=33%  Similarity=0.513  Sum_probs=190.5

Q ss_pred             ccCccCCCcceEEEEeEEC----CCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          552 SSNMIGQGSFGSVYKGILG----GEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       552 ~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +.+.||.|.||.||+|.+.    ..+..|+||+++.... ...+.+.+|++.+++++||||++++|++...+     ..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----ccc
Confidence            4578999999999999997    4567899999965433 33678999999999999999999999998444     479


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++.....    ..+++.++..|+.||+.||+|||+.   +++|+||+++||+++.++..++ |||++
T Consensus        78 lv~e~~~~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~  150 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS  150 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred             cccccccccccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence            99999999999999998722    2789999999999999999999999   9999999999999999888887 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      ......... .......+...|+|||.+.+..++.++||||||+++||+++ |+.||.....  ....+....   ... 
T Consensus       151 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~~---~~~-  223 (259)
T PF07714_consen  151 RPISEKSKY-KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLKQ---GQR-  223 (259)
T ss_dssp             EETTTSSSE-EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHHT---TEE-
T ss_pred             ccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc---ccc-
Confidence            877332221 11112347789999999998889999999999999999999 7888764311  111111110   000 


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                                            ......++..+.+++..||+.||++|||++++++.|
T Consensus       224 ----------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 ----------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                                  011112355688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.9e-36  Score=319.60  Aligned_cols=258  Identities=24%  Similarity=0.375  Sum_probs=199.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCce----EEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEM----IVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .+|++.+.||+|+||.||+|.+..++.    .||+|.+.... .....++..|+..+++++||||+++++++...     
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~-----   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA-----   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-----
Confidence            578899999999999999999976665    47777775332 22346678888899999999999999987532     


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++++||+++|+|.+++.....     .+++..+..|+.||+.||+|||+.   +++||||||+||+++.++..++ |
T Consensus        82 -~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D  152 (279)
T cd05111          82 -SLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD  152 (279)
T ss_pred             -ccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence             36789999999999999986532     688999999999999999999999   9999999999999999887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||.++......... ......++..|+|||+..+..++.++|||||||++||+++ |+.||......  ...+.......
T Consensus       153 fg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~  229 (279)
T cd05111         153 FGVADLLYPDDKKY-FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEKGER  229 (279)
T ss_pred             CccceeccCCCccc-ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCc
Confidence            99998764432211 1122457789999999988889999999999999999998 99998753211  11111111000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                           ...+                     ..+...+.+++.+||..+|++|||+.|+++.|..+..+
T Consensus       230 -----~~~~---------------------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         230 -----LAQP---------------------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             -----CCCC---------------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                 0000                     11234467889999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-36  Score=321.99  Aligned_cols=261  Identities=28%  Similarity=0.478  Sum_probs=204.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECC-----CceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|.+.+.||+|+||.||+|....     ++..||+|+++..... ..+.+.+|++++++++|+||+++++++....  
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD--   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC--
Confidence            4578889999999999999998742     3578999999755433 4568999999999999999999999987654  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCC--------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSND--------HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL  692 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  692 (854)
                         ..++||||+++++|.+++...+.        ......+++.++..++.|++.|++|||+.   +++||||||+||++
T Consensus        82 ---~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili  155 (280)
T cd05049          82 ---PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV  155 (280)
T ss_pred             ---CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence               68999999999999999986532        11223688999999999999999999999   99999999999999


Q ss_pred             cCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCch
Q 043388          693 DHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLT  770 (854)
Q Consensus       693 ~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~  770 (854)
                      +.++..++ |||.+.......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......  .
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~  232 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--E  232 (280)
T ss_pred             cCCCeEEECCcccceecccCccee-cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--H
Confidence            99887776 999987654322111 1112246788999999999999999999999999999999 99998653221  1


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                      ..+....   .....                       ....++..+.+++.+||+.||++||++.||++.|++
T Consensus       233 ~~~~~~~---~~~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         233 VIECITQ---GRLLQ-----------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHHc---CCcCC-----------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1111110   00000                       001224568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=324.34  Aligned_cols=263  Identities=24%  Similarity=0.342  Sum_probs=210.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +...+.++||+|.||+|.+++.. .+..||||.++..... ...+|.+|+++|.+++|||||+++|+|...+     ..+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chH
Confidence            34567899999999999999998 4789999999866543 4588999999999999999999999998877     579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +++|||++|+|.+|+..+...    ........+|+.|||.||+||.+.   ++||||+.++|+|+|.++..|| |||++
T Consensus       612 mI~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms  684 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS  684 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence            999999999999999988532    234555678999999999999999   9999999999999999998888 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh--CCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT--GRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +........... ...+-+..|||||.+.-++++.+||||+|||++||+++  ...||....+++  ..+-.....+.+-
T Consensus       685 R~lysg~yy~vq-gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~  761 (807)
T KOG1094|consen  685 RNLYSGDYYRVQ-GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQG  761 (807)
T ss_pred             cccccCCceeee-cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCC
Confidence            977655443211 12346789999999999999999999999999999875  888987654331  1221111121111


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ...+                   ..++..|+..+.+++.+||..|-++||+++++...|.+.
T Consensus       762 ~~~~-------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 RQVV-------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ccee-------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1111                   123345688899999999999999999999999888764

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.4e-36  Score=322.95  Aligned_cols=264  Identities=26%  Similarity=0.436  Sum_probs=206.6

Q ss_pred             hhccccCccCCCcceEEEEeEEC-----CCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILG-----GEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ++|.+.+.||+|+||.||+|++.     .++..+|+|.++.......+.+.+|++++++++|+||+++++++...+    
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD----   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC----
Confidence            57888999999999999999864     245679999987655555577899999999999999999999987654    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL  692 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  692 (854)
                       ..++||||+++++|.+++......          .....+++..++.++.|++.|++|||++   +|+||||||+||++
T Consensus        81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~  156 (291)
T cd05094          81 -PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV  156 (291)
T ss_pred             -ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence             679999999999999999764311          0112588999999999999999999999   99999999999999


Q ss_pred             cCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCch
Q 043388          693 DHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLT  770 (854)
Q Consensus       693 ~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~  770 (854)
                      +.++..++ |||.+.......... ......++..|+|||++.+..++.++|||||||++|||+| |+.||......  .
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~  233 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--E  233 (291)
T ss_pred             ccCCcEEECCCCcccccCCCceee-cCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence            99887776 999997665432211 1112346889999999998899999999999999999999 99998653221  1


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ..+....   .....                       ....++..+.+++.+||+.+|++|||+++|+++|+++.+.
T Consensus       234 ~~~~~~~---~~~~~-----------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         234 VIECITQ---GRVLE-----------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHHHhC---CCCCC-----------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            1111110   00000                       0011245688999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.8e-37  Score=320.68  Aligned_cols=256  Identities=27%  Similarity=0.447  Sum_probs=207.1

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ...+|++.++||+|+||.||+|.+.. +..+|+|++..........+.+|+.+++.++|+||+++++++...+     ..
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-----PV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-----Ce
Confidence            45689999999999999999999986 8899999997665545678899999999999999999999987655     67


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++++|.+++.....    ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++..++ |||.
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~  150 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL  150 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence            999999999999999986532    2689999999999999999999999   9999999999999999887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +...........   ...++..|+|||...+..++.++||||||+++|+|++ |+.||......  ...........   
T Consensus       151 ~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~---  222 (261)
T cd05148         151 ARLIKEDVYLSS---DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITAGYR---  222 (261)
T ss_pred             hhhcCCcccccc---CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHhCCc---
Confidence            987654322221   2346788999999988889999999999999999998 89998653211  11111110000   


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                             ......++..+.+++.+||+.||++|||++++++.|+.+
T Consensus       223 -----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 -----------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                                   001112245688999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.3e-37  Score=307.53  Aligned_cols=254  Identities=26%  Similarity=0.348  Sum_probs=205.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .+.|+..+.||+|.-|+||+++..+++..+|+|++....   .....+...|.+||+.++||.++.+|+.+++..     
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~-----  150 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK-----  150 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc-----
Confidence            467888899999999999999999999999999997542   344567788999999999999999999998876     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      +.|+|||||+||+|....+.+...    .+++..++-+|.+|+-||+|||-.   |||+|||||+||||.+++...+ ||
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~----~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF  223 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGK----RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF  223 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCC----ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence            899999999999999998887643    899999999999999999999999   9999999999999999988877 99


Q ss_pred             ccccccccCC---------------------------------C--------------------CCCcccccCCcccccC
Q 043388          703 SLSHQLDSAS---------------------------------K--------------------TPSSSIGIKGTVGYVA  729 (854)
Q Consensus       703 g~~~~~~~~~---------------------------------~--------------------~~~~~~~~~gt~~y~a  729 (854)
                      .++.......                                 .                    ....+..++||-.|.|
T Consensus       224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA  303 (459)
T KOG0610|consen  224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA  303 (459)
T ss_pred             cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence            8876542100                                 0                    0012234679999999


Q ss_pred             ccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhh
Q 043388          730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRAR  809 (854)
Q Consensus       730 PE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~  809 (854)
                      ||++.|...+.++|.|+|||++|||+.|+.||.+...+ ..+..++.....-.                          .
T Consensus       304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv~~~l~Fp--------------------------~  356 (459)
T KOG0610|consen  304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIVGQPLKFP--------------------------E  356 (459)
T ss_pred             ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHhcCCCcCC--------------------------C
Confidence            99999999999999999999999999999999876433 23333332211100                          0


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCC----HHHHH
Q 043388          810 TQDCLNAITRTGVLCSMESPFERME----MRDVV  839 (854)
Q Consensus       810 ~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl  839 (854)
                      .........++|++.|.+||.+|..    +.||-
T Consensus       357 ~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  357 EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            0012456789999999999999998    66654

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-36  Score=318.53  Aligned_cols=264  Identities=24%  Similarity=0.403  Sum_probs=202.8

Q ss_pred             ccccCccCCCcceEEEEeEECCC---ceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCc
Q 043388          550 FASSNMIGQGSFGSVYKGILGGE---EMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGAD  623 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  623 (854)
                      |.+.+.||+|+||.||+|....+   +..||+|+++...  ......+.+|++.++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56789999999999999998643   4789999987543  2334678999999999999999999998866543 2333


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++...........+++..+..++.|++.||+|||+.   +++||||||+||++++++..++ ||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence            5799999999999999986653222233689999999999999999999999   9999999999999999877666 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |.++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......  ...+........
T Consensus       158 g~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~  234 (273)
T cd05035         158 GLSKKIYSGDYYRQ-GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGNRL  234 (273)
T ss_pred             cceeeccccccccc-cccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC
Confidence            99987654432211 111235678999999988889999999999999999999 88998643211  111111110000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                                .....++..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus       235 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         235 --------------------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             --------------------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                                      00112345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7e-37  Score=345.62  Aligned_cols=263  Identities=21%  Similarity=0.259  Sum_probs=204.9

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC--
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK--  620 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--  620 (854)
                      ....+|.+.+.||+|+||+||+|++..+++.||||+++...  ......+.+|+.++..++|+|++++.+.+...+..  
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34569999999999999999999998899999999997542  23345678999999999999999998877544321  


Q ss_pred             -CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc
Q 043388          621 -GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       621 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~  699 (854)
                       .....++||||+++|+|.+++......  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence             122468999999999999999764321  22688999999999999999999999   999999999999999888777


Q ss_pred             c-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          700 Q-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                      + |||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..+.....
T Consensus       184 L~DFGls~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~  257 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDD-VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKT  257 (496)
T ss_pred             EEecccCeecccccccc-ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHH
Confidence            6 999998765432221 1123569999999999999899999999999999999999999997432     11221111


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...... .                      ....++.++.+++..||+.||.+||++.++++.
T Consensus       258 ~~~~~~-~----------------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 LAGRYD-P----------------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             hcCCCC-C----------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            111000 0                      011224568899999999999999999999764

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.8e-37  Score=329.07  Aligned_cols=240  Identities=23%  Similarity=0.345  Sum_probs=187.4

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ++||+|+||.||+|++..+++.||+|+++...   ....+.+..|..++... +||||+++++++...+     ..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-----~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE-----HLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEE
Confidence            46999999999999999899999999997532   23344566777777654 8999999999987654     789999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||+++..
T Consensus        76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            9999999999987654      678899999999999999999999   9999999999999998877666 99999765


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......     +.........  ... 
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~~~~--~~~-  215 (316)
T cd05592         147 MNGEG---KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFDSILNDR--PHF-  215 (316)
T ss_pred             CCCCC---ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHcCC--CCC-
Confidence            33221   122356999999999999988999999999999999999999999754221     1111100000  000 


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHH-HHH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR-DVV  839 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl  839 (854)
                                           ...+...+.+++..||+.||++||++. ++.
T Consensus       216 ---------------------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         216 ---------------------PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ---------------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                                 011134567899999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=338.68  Aligned_cols=253  Identities=21%  Similarity=0.308  Sum_probs=196.7

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||.||+|++..+++.||||+++...   ......+.+|++++..++||||+++++++.+.+     +
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN-----Y   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----e
Confidence            36889999999999999999999899999999997432   233456788999999999999999999987755     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++..++ |||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence            899999999999999998654      689999999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCCCC-----------------------------------CcccccCCcccccCccccCCCCCCccchhHHHH
Q 043388          704 LSHQLDSASKTP-----------------------------------SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFG  748 (854)
Q Consensus       704 ~~~~~~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG  748 (854)
                      ++..+.......                                   ......+||+.|+|||++.+..++.++||||||
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  226 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG  226 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence            987653221100                                   001124699999999999988899999999999


Q ss_pred             HHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCC
Q 043388          749 ILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMES  828 (854)
Q Consensus       749 vvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d  828 (854)
                      |++|||++|+.||....... .......  ..... .... .                    ..+...+.+++.+|+. +
T Consensus       227 ~il~el~~G~~Pf~~~~~~~-~~~~i~~--~~~~~-~~~~-~--------------------~~~s~~~~~li~~ll~-~  280 (364)
T cd05599         227 VIMYEMLVGYPPFCSDNPQE-TYRKIIN--WKETL-QFPD-E--------------------VPLSPEAKDLIKRLCC-E  280 (364)
T ss_pred             hHHHHhhcCCCCCCCCCHHH-HHHHHHc--CCCcc-CCCC-C--------------------CCCCHHHHHHHHHHcc-C
Confidence            99999999999997542110 1111110  00000 0000 0                    0113446678888886 9


Q ss_pred             CCCCCC---HHHHHH
Q 043388          829 PFERME---MRDVVA  840 (854)
Q Consensus       829 P~~RPs---~~evl~  840 (854)
                      |.+|++   +.|+++
T Consensus       281 p~~R~~~~~~~~ll~  295 (364)
T cd05599         281 AERRLGNNGVNEIKS  295 (364)
T ss_pred             HhhcCCCCCHHHHhc
Confidence            999998   888866

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.5e-37  Score=320.53  Aligned_cols=254  Identities=20%  Similarity=0.303  Sum_probs=199.8

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+|++.+.||+|+||.||+|+...+++.||+|+++.........+.+|+.++++++||||+++++++...+     ..+
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-----~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-----KLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-----EEE
Confidence            357999999999999999999998899999999997665555567889999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +|+|||+||+||+++.++..++ |||.+
T Consensus        83 iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~  153 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA  153 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence            9999999999999987543      678999999999999999999999   9999999999999998876666 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGM---GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      .........   .....|+..|+|||.+.   ...++.++|||||||++|||++|+.||........ ...+......  
T Consensus       154 ~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~--  227 (267)
T cd06646         154 AKITATIAK---RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNFQ--  227 (267)
T ss_pred             eeecccccc---cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCCC--
Confidence            876433221   12245889999999874   34578899999999999999999999864321110 0000000000  


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                           .+..                .....++..+.+++.+||+.+|++|||++++++.
T Consensus       228 -----~~~~----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         228 -----PPKL----------------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             -----CCCC----------------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence                 0000                0001124567899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.5e-36  Score=317.02  Aligned_cols=261  Identities=21%  Similarity=0.291  Sum_probs=206.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||.||+|....+++.||+|.++..   .....+.+.+|++++++++|+|++++++++...+     .
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~-----~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN-----E   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-----e
Confidence            5789999999999999999999989999999988642   2233567889999999999999999999987654     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++......  ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhccc--CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence            79999999999999998753221  12678999999999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      .+..........   ....++..|+|||...+..++.++|||||||++|+|++|+.||.....   ...+..........
T Consensus       152 ~~~~~~~~~~~~---~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~  225 (267)
T cd08224         152 LGRFFSSKTTAA---HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEKCDY  225 (267)
T ss_pred             eeeeccCCCccc---ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhhcCCC
Confidence            987664432211   123588999999999888899999999999999999999999864321   11111111000000


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                      ...                      ....++..+.+++.+||..+|++|||+.+|+++++++.
T Consensus       226 ~~~----------------------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         226 PPL----------------------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCC----------------------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            000                      00123456889999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.5e-37  Score=343.28  Aligned_cols=279  Identities=19%  Similarity=0.279  Sum_probs=194.8

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccC---CCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSID---SKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~  623 (854)
                      ..+|.+.++||+|+||.||+|....+++.||||++....    ....+|+.+++.++||||+++++++....   .....
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            357999999999999999999998889999999885332    23457999999999999999999875432   11223


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc-cc-ccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VA-HQN  701 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~-~~D  701 (854)
                      +.++||||+++ ++.+++......  ...+++..++.++.||+.||+|||+.   +|+||||||+||+++.+. .. ++|
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARN--NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence            56799999975 787777643211  12688999999999999999999999   999999999999998654 34 459


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||+|+........    ....||+.|+|||++.+. .++.++|||||||++|||++|++||...... ..+.........
T Consensus       215 FGla~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~  289 (440)
T PTZ00036        215 FGSAKNLLAGQRS----VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGT  289 (440)
T ss_pred             cccchhccCCCCc----ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence            9999876543222    234689999999998764 6899999999999999999999999754321 111222111100


Q ss_pred             --cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 --EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 --~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                        ........+.... ...........+.......+.++.+++.+||+.||.+|||+.|+++.
T Consensus       290 p~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        290 PTEDQLKEMNPNYAD-IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCHHHHHHhchhhhc-ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence              0000000000000 00000000000011111234568899999999999999999999754

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.4e-36  Score=318.97  Aligned_cols=258  Identities=25%  Similarity=0.437  Sum_probs=202.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCc---eEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEE---MIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ..+|+..+.||+|+||.||+|+...++   ..+|+|.++... ....+.+.+|++++++++|+|++++.+++...+    
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   79 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK----   79 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC----
Confidence            457888999999999999999986544   379999986542 333567889999999999999999999987655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++++|.+++.....     .+++.++..++.|++.|++|||+.   +++||||||+||+++.+...++ |
T Consensus        80 -~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d  150 (268)
T cd05063          80 -PAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSD  150 (268)
T ss_pred             -CcEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECC
Confidence             67999999999999999976432     688999999999999999999999   9999999999999999887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||++..................+..|+|||++.+..++.++|||||||++||+++ |+.||......  .....+.... 
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~~~-  227 (268)
T cd05063         151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAINDGF-  227 (268)
T ss_pred             CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhcCC-
Confidence            9999876543322211122234567999999988889999999999999999998 99998643211  1111111000 


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                               +.+...+++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus       228 -------------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 -------------------------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                                     0001112355688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=329.93  Aligned_cols=253  Identities=25%  Similarity=0.379  Sum_probs=207.2

Q ss_pred             hccccCccCCCcceEEEEeEECC---CceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          549 EFASSNMIGQGSFGSVYKGILGG---EEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      +....++||+|.||.|++|.|..   +...||||.++..... ...+|.+|+.+|.+|+|+|++++||+.-+.      -
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------P  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------h
Confidence            34445789999999999999953   3457899999866544 678999999999999999999999998653      3


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++|||.++.|||.+.|+....    ..+-......++.|||.||.||.++   +.||||+..+|+++-....+|| |||
T Consensus       185 ~mMV~ELaplGSLldrLrka~~----~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFG  257 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKK----AILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFG  257 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccc----cceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccc
Confidence            6899999999999999998332    2788888999999999999999999   9999999999999977666665 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      +.+.++.............-...|+|||.+....++.+||||+|||++|||+| |..||.+....  .+.          
T Consensus       258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--qIL----------  325 (1039)
T KOG0199|consen  258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--QIL----------  325 (1039)
T ss_pred             ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--HHH----------
Confidence            99988776554433333445778999999999999999999999999999999 99998764211  111          


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                        +.+|              ...+..+.+.|++.++++++.||..+|++|||+..+.+.+
T Consensus       326 --~~iD--------------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  326 --KNID--------------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             --Hhcc--------------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence              1111              1234456678899999999999999999999999998654

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.9e-37  Score=330.82  Aligned_cols=242  Identities=24%  Similarity=0.332  Sum_probs=191.3

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ++||+|+||.||+|++..+++.||+|+++..   .....+.+..|.+++..+ +||||+++++++...+     ..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~-----~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD-----RLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----eEEEEE
Confidence            4699999999999999989999999999743   233445677899998876 7999999999987655     689999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|..++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++...
T Consensus        76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999987654      678899999999999999999999   9999999999999999887776 99998764


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     ...........   ..
T Consensus       147 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~i~~~~~---~~  215 (321)
T cd05591         147 ILNGVT---TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDDV---LY  215 (321)
T ss_pred             ccCCcc---ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCC---CC
Confidence            332221   12346899999999999889999999999999999999999999754221     11111100000   00


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-------CHHHHHHH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-------EMRDVVAK  841 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~evl~~  841 (854)
                      |                     ..+..++.+++..|++.||++||       ++.++++.
T Consensus       216 p---------------------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         216 P---------------------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             C---------------------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            0                     01134577899999999999999       77777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.5e-37  Score=333.69  Aligned_cols=242  Identities=23%  Similarity=0.301  Sum_probs=192.1

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      +.||+|+||.||+|.+..+++.||+|+++...   ......+.+|++++..++||||+++++++...+     ..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~-----~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-----RLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC-----EEEEEEe
Confidence            46999999999999999899999999997532   233456788999999999999999999887655     7899999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      |+++|+|.+++....      .+++.++..++.||+.||+|||+ .   +|+||||||+||+++.++..++ |||+++..
T Consensus        76 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            999999999887654      68899999999999999999997 6   9999999999999999887776 99998754


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     ........... .   
T Consensus       147 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i~~~~~-~---  214 (325)
T cd05594         147 IKDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEEI-R---  214 (325)
T ss_pred             CCCCcc---cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHHhcCCC-C---
Confidence            322211   12246999999999999989999999999999999999999999743211     11111000000 0   


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHHH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVAK  841 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  841 (854)
                                          ........+.+++.+|++.||++|+     ++.++++.
T Consensus       215 --------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         215 --------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             --------------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                                0001134577899999999999997     89988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.7e-37  Score=327.04  Aligned_cols=274  Identities=20%  Similarity=0.302  Sum_probs=199.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|.+.+.||+|+||.||+|++..++..||+|+++... ......+.+|+.++++++||||+++++++...+     ..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-----SLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-----eEE
Confidence            57899999999999999999999899999999987543 233356788999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++ +|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~  151 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA  151 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence            99999975 89888876532     578889999999999999999999   9999999999999998877776 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC--Ccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL--PEK  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~  782 (854)
                      ..........   ....+|+.|+|||++.+ ..++.++||||+||++|||+||+.||......+ ..........  ...
T Consensus       152 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~  227 (309)
T cd07872         152 RAKSVPTKTY---SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEE  227 (309)
T ss_pred             eecCCCcccc---ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHH
Confidence            7654332221   12357899999998865 458999999999999999999999997543221 1111111110  011


Q ss_pred             -cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 -VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 -~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       +....+............. +.........+..++.+++.+|++.||.+|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         228 TWPGISSNDEFKNYNFPKYK-PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HHhhhcchhhhhhhhcCccC-CCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             1111110000000000000 00000111123456789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.1e-37  Score=330.11  Aligned_cols=236  Identities=26%  Similarity=0.335  Sum_probs=188.2

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||.||+|++..+++.||+|+++..   .....+.+.+|..++..+ +||||+++++++...+     ..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-----~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD-----RLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-----EEEEEE
Confidence            4699999999999999989999999999743   233456677888888877 7999999999987655     789999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++...
T Consensus        76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            9999999999987654      688999999999999999999999   9999999999999999887776 99998764


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     +..........   ..
T Consensus       147 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~---~~  215 (320)
T cd05590         147 IFNGKT---TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDEV---VY  215 (320)
T ss_pred             CcCCCc---ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcCCC---CC
Confidence            322211   12346999999999999888999999999999999999999999753211     11111111000   00


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM  835 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  835 (854)
                      +                     ..+...+.+++.+|++.||++||++
T Consensus       216 ~---------------------~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 P---------------------TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             C---------------------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            0                     0113457789999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-36  Score=319.02  Aligned_cols=261  Identities=21%  Similarity=0.290  Sum_probs=205.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|.+.+.||+|+||.||+|+...++..||||.+....   .....++.+|+.+++.++||||+++++++...+     .
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-----E   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-----e
Confidence            47888999999999999999998899999999886432   223457889999999999999999999987654     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++++|.+++......  ...+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++..++ |||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence            89999999999999998753211  12689999999999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      .+..........   ....|+..|+|||+..+..++.++||||||+++|||++|..||.....+   ...+........ 
T Consensus       152 ~~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-  224 (267)
T cd08229         152 LGRFFSSKTTAA---HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQCD-  224 (267)
T ss_pred             hhhccccCCccc---ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhhcCC-
Confidence            987765433211   1245889999999998888999999999999999999999998643221   111111000000 


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                          .+.                 .....+..++.+++.+||+.+|++||||.+|++.++++.
T Consensus       225 ----~~~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         225 ----YPP-----------------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ----CCC-----------------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                000                 001123556889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9e-37  Score=351.66  Aligned_cols=266  Identities=22%  Similarity=0.295  Sum_probs=203.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.++||+|+||.||+|++..+++.||+|+++...   ....+++.+|++++++++||||+++++++.+.+     .
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~-----~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD-----P   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-----E
Confidence            57999999999999999999999899999999986432   223457899999999999999999999987655     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCc-----ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDH-----LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~  699 (854)
                      .++||||++||+|.+++......     ......++..++.++.||+.||+|||+.   +|+||||||+||+++.++..+
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence            89999999999999998753211     0112467788899999999999999999   999999999999999887777


Q ss_pred             c-ccccccccccCCC---------------CCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 043388          700 Q-NFSLSHQLDSASK---------------TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA  763 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~  763 (854)
                      + |||+++.......               ........+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            6 9999987622110               00111124699999999999999999999999999999999999999975


Q ss_pred             cccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-CHHHHHHHH
Q 043388          764 AFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-EMRDVVAKL  842 (854)
Q Consensus       764 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L  842 (854)
                      ..........    .       ..++..               .....+++..+.+++.+|++.||++|| +++++.+.|
T Consensus       234 ~~~~ki~~~~----~-------i~~P~~---------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L  287 (932)
T PRK13184        234 KKGRKISYRD----V-------ILSPIE---------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL  287 (932)
T ss_pred             cchhhhhhhh----h-------ccChhh---------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            3211110000    0       000000               000112355678899999999999996 567777777


Q ss_pred             Hhhhh
Q 043388          843 CHTRE  847 (854)
Q Consensus       843 ~~~~~  847 (854)
                      +...+
T Consensus       288 e~~lq  292 (932)
T PRK13184        288 EPHLQ  292 (932)
T ss_pred             HHHHh
Confidence            76644

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.9e-37  Score=335.28  Aligned_cols=203  Identities=25%  Similarity=0.356  Sum_probs=174.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||+||+|+...+++.||+|+++...   ......+.+|+.++.+++|+||+++++++.+..     .
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-----~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-----N   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----e
Confidence            37889999999999999999999899999999997432   233456788999999999999999999987655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+||||+++|+|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++..++ |||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence            899999999999999998654      688999999999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCCC--------------------------------CCcccccCCcccccCccccCCCCCCccchhHHHHHHH
Q 043388          704 LSHQLDSASKT--------------------------------PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILL  751 (854)
Q Consensus       704 ~~~~~~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl  751 (854)
                      +++........                                .......+||+.|+|||++.+..++.++|||||||++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil  226 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence            98765432110                                0011235799999999999998999999999999999


Q ss_pred             HHHHhCCCCCCCc
Q 043388          752 LEMFTGRRPTDAA  764 (854)
Q Consensus       752 ~elltg~~pf~~~  764 (854)
                      |||++|+.||...
T Consensus       227 ~ell~G~~Pf~~~  239 (363)
T cd05628         227 YEMLIGYPPFCSE  239 (363)
T ss_pred             HHHHhCCCCCCCC
Confidence            9999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.7e-37  Score=330.21  Aligned_cols=241  Identities=23%  Similarity=0.309  Sum_probs=190.3

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCC-CeeeEEEEeeccCCCCCce
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHR-NLIKIITICSSIDSKGADF  624 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~  624 (854)
                      +|++.+.||+|+||.||+|++..+++.||+|+++..   .....+.+..|.+++..++|+ +|+++++++...+     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-----R   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----E
Confidence            578899999999999999999989999999999743   233456778899999999765 5888888876654     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+||||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+|||++.++..++ |||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence            899999999999999997654      678899999999999999999999   9999999999999998877766 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      ++.........   .....||+.|+|||++.+..++.++||||+||++|||+||+.||...... ..........  ...
T Consensus       147 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~~~~--~~~  220 (324)
T cd05587         147 MCKENIFGGKT---TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQSIMEHN--VSY  220 (324)
T ss_pred             cceecCCCCCc---eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCC--CCC
Confidence            98754322211   12346999999999999989999999999999999999999999753211 0111110000  000


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM  835 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  835 (854)
                                                .......+.+++.+|++.||.+||+.
T Consensus       221 --------------------------~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         221 --------------------------PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --------------------------CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                                      00113456789999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-36  Score=322.56  Aligned_cols=250  Identities=22%  Similarity=0.296  Sum_probs=201.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      .+|++.+.||+|+||.||+|....++..||+|.+........+.+.+|+.+++.++|+||+++++++....     ..++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-----~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-----EEEE
Confidence            47888999999999999999998889999999998665555678899999999999999999999987644     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|.+++...       .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+.
T Consensus        95 v~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          95 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             eecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence            99999999999998643       568889999999999999999999   9999999999999999887777 999988


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .........   ....|++.|+|||.+.+..++.++|||||||++|||++|+.||........ .......    .....
T Consensus       165 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~----~~~~~  236 (296)
T cd06654         165 QITPEQSKR---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATN----GTPEL  236 (296)
T ss_pred             hcccccccc---CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcC----CCCCC
Confidence            654332211   123588999999999888899999999999999999999999975422111 1111100    00000


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..                     .......+.+++.+||..+|++|||+.|+++.
T Consensus       237 ~~---------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         237 QN---------------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CC---------------------ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            00                     11124457789999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-39  Score=307.89  Aligned_cols=250  Identities=22%  Similarity=0.327  Sum_probs=209.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +-|.+.++||+|+||.||+|.++.+|..+|+|.+....  +.+++.+|+.+|++++.|+||++||.|....     ..||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DLWI  105 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DLWI  105 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ceEe
Confidence            34777889999999999999999999999999886543  4678999999999999999999999876655     5899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      |||||..|++.+.++..+.     ++++.++..++...++||+|||..   .-+|||||+.|||++.++.+++ |||.|.
T Consensus       106 VMEYCGAGSiSDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAG  177 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARRK-----PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAG  177 (502)
T ss_pred             ehhhcCCCcHHHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccc
Confidence            9999999999999987654     899999999999999999999999   8999999999999999999998 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .+.+.....   ..+.||+.|||||++..-.|..++||||+|++..||..|++||.....-..     +. .++.     
T Consensus       178 QLTDTMAKR---NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-----IF-MIPT-----  243 (502)
T KOG0574|consen  178 QLTDTMAKR---NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-----IF-MIPT-----  243 (502)
T ss_pred             hhhhhHHhh---CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-----eE-eccC-----
Confidence            886654433   236799999999999999999999999999999999999999874321100     00 0000     


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                     .++.....++.+..++.++++.|+-..|++|-|+-++++.
T Consensus       244 ---------------~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  244 ---------------KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ---------------CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence                           0111223456678889999999999999999999988764

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-36  Score=315.86  Aligned_cols=257  Identities=28%  Similarity=0.419  Sum_probs=202.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCC---ceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGE---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|++.+.||+|+||.||+|.+..+   ...||+|+++... ......+.+|+.++++++||||+++++++...+    
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   78 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR----   78 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC----
Confidence            35789999999999999999998643   5689999987543 233467889999999999999999999986654    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++++|.+++.....     .+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++..++ |
T Consensus        79 -~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~d  149 (266)
T cd05033          79 -PVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD  149 (266)
T ss_pred             -ceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECc
Confidence             67999999999999999976542     688999999999999999999999   9999999999999999887666 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||.+.......... ......++..|+|||...+..++.++||||||+++||+++ |..||......  ...........
T Consensus       150 fg~~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~  226 (266)
T cd05033         150 FGLSRRLEDSEATY-TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGYR  226 (266)
T ss_pred             cchhhcccccccce-eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC
Confidence            99998875322211 1112345678999999998889999999999999999998 99998643211  11111111000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      .                          +....++..+.+++.+||+.+|++||++.||++.|+++
T Consensus       227 ~--------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 L--------------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C--------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0                          00112245688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.9e-37  Score=329.63  Aligned_cols=244  Identities=23%  Similarity=0.305  Sum_probs=190.0

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHH---HhccCCCeeeEEEEeeccCCCCCc
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEAL---RNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      |++.+.||+|+||.||+|.+..+++.||||+++...   ....+.+.+|++++   +.++||||+++++++...+     
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~-----   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED-----   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-----
Confidence            667889999999999999999899999999997432   23345666776665   4568999999999987655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+||||+++|+|..++...       .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence            789999999999999888643       689999999999999999999999   9999999999999998877766 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |++.........   .....|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..........   
T Consensus       146 g~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-~~~~i~~~~~---  218 (324)
T cd05589         146 GLCKEGMGFGDR---TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-VFDSIVNDEV---  218 (324)
T ss_pred             cCCccCCCCCCc---ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCC---
Confidence            998754332211   123569999999999999899999999999999999999999997532110 0111110000   


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-----HHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-----MRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  840 (854)
                                               ..+..++..+.+++.+||+.||.+||+     +.++++
T Consensus       219 -------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 -------------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                                     000112455778999999999999994     555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.4e-36  Score=318.89  Aligned_cols=262  Identities=22%  Similarity=0.385  Sum_probs=200.2

Q ss_pred             HHhhccccCccCCCcceEEEEeEECC-----CceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDS  619 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  619 (854)
                      ..++|++.+.||+|+||.||+|.+.+     ++..||+|++.... .....++.+|+.+++.++||||+++++++.... 
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence            45789999999999999999998742     35679999986432 223456889999999999999999999986554 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcc----cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHL----EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD  695 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  695 (854)
                          ..++||||+++|+|.+++.......    ....+++..+..++.|++.||+|||+.   +++||||||+||+++++
T Consensus        83 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          83 ----PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             ----CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence                6799999999999999997643211    112467888999999999999999998   99999999999999998


Q ss_pred             ccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhH
Q 043388          696 MVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHE  773 (854)
Q Consensus       696 ~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~  773 (854)
                      +..++ |||++............ ....+++.|+|||++.+..++.++|||||||++|||++ |..||......  ...+
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~  232 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKG-GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLR  232 (277)
T ss_pred             CCEEECCCCCccccCCcceeecC-CCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH
Confidence            87776 99998765443221111 11245788999999998889999999999999999999 78888643211  1111


Q ss_pred             HhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       774 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                      ...   ......                       ....++..+.+++.+|++.+|++|||+.|+++.|++
T Consensus       233 ~~~---~~~~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         233 FVM---EGGLLD-----------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHH---cCCcCC-----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            110   000000                       011124568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.5e-36  Score=313.80  Aligned_cols=248  Identities=26%  Similarity=0.373  Sum_probs=194.4

Q ss_pred             ccCCCcceEEEEeEE--CCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          555 MIGQGSFGSVYKGIL--GGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       555 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      .||+|+||.||+|.+  ..++..||+|+++....  ...+.+.+|+.+++.++||||+++++++...      ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE------SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC------CcEEEEe
Confidence            589999999999975  45678999999864432  2356788999999999999999999987532      4689999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccc
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLD  709 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~  709 (854)
                      |+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+....
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~  146 (257)
T cd05116          76 LAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG  146 (257)
T ss_pred             cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence            999999999997653      678999999999999999999999   9999999999999999886666 999998765


Q ss_pred             cCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          710 SASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       710 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      .............++..|+|||.+....++.++|||||||++|||++ |+.||.....  ....+.......   ..   
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~~~---~~---  218 (257)
T cd05116         147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESGER---ME---  218 (257)
T ss_pred             CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC---CC---
Confidence            44322111222335689999999988889999999999999999998 9999975321  112221111000   00   


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                          ....++..+.+++.+||+.||++||++++|.+.|++.
T Consensus       219 --------------------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 --------------------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --------------------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                                0112255688999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-36  Score=314.43  Aligned_cols=254  Identities=27%  Similarity=0.428  Sum_probs=201.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|++|.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++||||+++++++...+     ..+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE-----PIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCC-----Cee
Confidence            457899999999999999999986 557899999875432 3467899999999999999999999987654     579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....    ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        78 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAG----RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             eeeecccCCcHHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence            99999999999999976531    2689999999999999999999999   9999999999999998886665 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      ..........  ..+...+..|+|||+..+..++.++||||||+++|||++ |+.||......  .....+......   
T Consensus       151 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~---  223 (261)
T cd05068         151 RVIKEDIYEA--REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGYRM---  223 (261)
T ss_pred             EEccCCcccc--cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCC---
Confidence            8776332211  112234568999999998889999999999999999999 99998743211  111111110000   


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                                             .....++..+.+++.+|++.+|.+||++.++.+.|++
T Consensus       224 -----------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 -----------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -----------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                                   0011124568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=336.34  Aligned_cols=254  Identities=22%  Similarity=0.326  Sum_probs=201.0

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|.+.+.||+|+||.||+|++..+++.||+|+++...   ......+.+|++++..++||||+++++++.+.+     +
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-----H   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-----e
Confidence            36889999999999999999999899999999997432   244567889999999999999999999887654     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence            899999999999999998763      688999999999999999999998   9999999999999999887776 999


Q ss_pred             cccccccCCC--------------------------CCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhC
Q 043388          704 LSHQLDSASK--------------------------TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTG  757 (854)
Q Consensus       704 ~~~~~~~~~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg  757 (854)
                      ++........                          .........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence            9987654430                          00112234699999999999999999999999999999999999


Q ss_pred             CCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-HH
Q 043388          758 RRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-MR  836 (854)
Q Consensus       758 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~  836 (854)
                      +.||...... ........  +......   +                   ....++..+.+++..|+. ||.+||+ +.
T Consensus       227 ~~Pf~~~~~~-~~~~~i~~--~~~~~~~---p-------------------~~~~~~~~~~~li~~ll~-dp~~R~~s~~  280 (350)
T cd05573         227 FPPFYSDTLQ-ETYNKIIN--WKESLRF---P-------------------PDPPVSPEAIDLICRLLC-DPEDRLGSFE  280 (350)
T ss_pred             CCCCCCCCHH-HHHHHHhc--cCCcccC---C-------------------CCCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence            9999754311 01111110  0000000   0                   000024557788999997 9999999 99


Q ss_pred             HHHHH
Q 043388          837 DVVAK  841 (854)
Q Consensus       837 evl~~  841 (854)
                      |+++.
T Consensus       281 ~ll~h  285 (350)
T cd05573         281 EIKSH  285 (350)
T ss_pred             HHhcC
Confidence            99864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.2e-36  Score=328.63  Aligned_cols=247  Identities=22%  Similarity=0.304  Sum_probs=191.1

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ++||+|+||.||+|++..+++.||+|+++..   .....+.+.+|..++.++ +||||+++++++.+..     ..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~-----~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES-----RLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-----EEEEEE
Confidence            4689999999999999989999999999753   223345678899999998 7999999999987655     689999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||+++..
T Consensus        76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            9999999999887654      689999999999999999999999   9999999999999998876666 99998753


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC---chHhHHhhhcCCccccc
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG---LTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~  785 (854)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||+......   .....+.........  
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--  221 (329)
T cd05588         147 IRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--  221 (329)
T ss_pred             ccCCC---ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--
Confidence            22211   1223569999999999999899999999999999999999999997432111   111111110000000  


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC------HHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME------MRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~  840 (854)
                                           ...+..+...+.+++.+|++.||.+||+      +.|+++
T Consensus       222 ---------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         222 ---------------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence                                 0001112445788999999999999998      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.5e-37  Score=327.42  Aligned_cols=240  Identities=23%  Similarity=0.351  Sum_probs=188.7

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ++||+|+||.||+|++..++..||+|+++...   .........|..++... +||||+++++++.+.+     +.|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE-----HLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC-----EEEEEE
Confidence            46999999999999999999999999997532   23345667788888765 8999999999987655     789999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||+++..
T Consensus        76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            9999999999987654      678899999999999999999999   9999999999999998877766 99998754


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      .....   ......||+.|+|||++.+..++.++||||+||++|||++|+.||......  ...+......+ ..     
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~~~-~~-----  215 (316)
T cd05620         147 VFGDN---RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVDTP-HY-----  215 (316)
T ss_pred             ccCCC---ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC-CC-----
Confidence            32211   122356999999999999989999999999999999999999999743211  11111110000 00     


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHH-HHH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR-DVV  839 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl  839 (854)
                      +                     ..+..++.+++.+|++.||++||++. ++.
T Consensus       216 ~---------------------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 P---------------------RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             C---------------------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            0                     01134567899999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-36  Score=326.58  Aligned_cols=240  Identities=25%  Similarity=0.381  Sum_probs=188.7

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+.+..|..++... +||||+++++++.+.+     ..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE-----NLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-----EEEEEE
Confidence            46999999999999999899999999997542   23345667788888764 9999999999987655     689999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++...
T Consensus        76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            9999999999997653      678899999999999999999999   9999999999999998877766 99998754


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...+.+....+     ...
T Consensus       147 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~~-----~~~  216 (316)
T cd05619         147 MLGDAK---TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMDNP-----CYP  216 (316)
T ss_pred             CCCCCc---eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC-----CCC
Confidence            322211   12346899999999999988999999999999999999999999753211  11111110000     000


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHH-HHH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR-DVV  839 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl  839 (854)
                                            ..+...+.+++.+|++.||++||++. ++.
T Consensus       217 ----------------------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         217 ----------------------RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ----------------------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                                  01134567899999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-36  Score=318.60  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=191.6

Q ss_pred             cCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeec
Q 043388          556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM  632 (854)
Q Consensus       556 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  632 (854)
                      ||+|+||.||+++...+++.||+|++....   ......+..|++++++++||||+++++++....     +.++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~-----~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT-----HLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC-----eEEEEEecC
Confidence            799999999999999899999999986422   222345567999999999999999999887654     789999999


Q ss_pred             cCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccC
Q 043388          633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSA  711 (854)
Q Consensus       633 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~  711 (854)
                      ++|+|.+++.....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++......
T Consensus        76 ~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          76 NGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             CCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            99999998865432    2578999999999999999999999   9999999999999998877666 99998876543


Q ss_pred             CCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchh
Q 043388          712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL  791 (854)
Q Consensus       712 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  791 (854)
                      ...    ....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ...+...........       
T Consensus       149 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~-------  216 (277)
T cd05607         149 KTI----TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDEVK-------  216 (277)
T ss_pred             cee----eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccccc-------
Confidence            221    12358999999999998889999999999999999999999997432211 111111111110000       


Q ss_pred             hHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          792 LMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                                      .....+..++.+++..||+.||++||++.|+++.+
T Consensus       217 ----------------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         217 ----------------FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ----------------cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence                            00011245578999999999999999998776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.2e-36  Score=312.91  Aligned_cols=249  Identities=24%  Similarity=0.366  Sum_probs=193.6

Q ss_pred             ccCCCcceEEEEeEEC--CCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEee
Q 043388          555 MIGQGSFGSVYKGILG--GEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEY  631 (854)
Q Consensus       555 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  631 (854)
                      .||+|+||.||+|.+.  +++..||+|++..... ...+.+.+|+.++++++||||+++++++...      ..++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~------~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE------ALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC------CeEEEEEe
Confidence            3899999999999874  4566799999875433 2345688999999999999999999987532      46899999


Q ss_pred             ccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccccc
Q 043388          632 MENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDS  710 (854)
Q Consensus       632 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~  710 (854)
                      +++|+|.+++.....     .+++.++++++.|++.||+|||++   +++||||||+||+++.+...++ |||.+.....
T Consensus        76 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          76 ASGGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             CCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence            999999999875432     688999999999999999999999   9999999999999998887776 9999986644


Q ss_pred             CCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccccccCc
Q 043388          711 ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDP  789 (854)
Q Consensus       711 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~  789 (854)
                      ............++..|+|||++.+..++.++|||||||++||+++ |+.||......  .....+.....         
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~---------  216 (257)
T cd05115         148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGKR---------  216 (257)
T ss_pred             CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCCC---------
Confidence            3322211122234678999999988889999999999999999996 99998753211  11111111000         


Q ss_pred             hhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          790 SLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                       ......++.++.+++.+||..+|++||++.+|.+.|+..
T Consensus       217 -----------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 -----------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                             000112356688999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-36  Score=313.40  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=197.4

Q ss_pred             CccCCCcceEEEEeEECCCc---eEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEE---MIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ++||+|+||.||+|.+...+   ..||+|.++.... ...+.+.+|+++++++.|+||+++++++...      ..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE------PLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC------ceEEEE
Confidence            47999999999999875444   7899999875433 2456788999999999999999999987532      468999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++..++ |||.++..
T Consensus        75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~  145 (257)
T cd05060          75 ELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL  145 (257)
T ss_pred             EeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence            9999999999998654      678999999999999999999999   9999999999999999887766 99999877


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccccc
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV  787 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  787 (854)
                      ..............++..|+|||...+..++.++|||||||++||+++ |+.||.....  .....+.....+.      
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~------  217 (257)
T cd05060         146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERL------  217 (257)
T ss_pred             ecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcC------
Confidence            544332222222234578999999988889999999999999999998 9999875321  1222222111000      


Q ss_pred             CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       788 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                                          .....++..+.+++.+||..+|++||++.++++.|+++.
T Consensus       218 --------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 --------------------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                                011122456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.4e-36  Score=319.01  Aligned_cols=247  Identities=23%  Similarity=0.327  Sum_probs=191.5

Q ss_pred             cCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeec
Q 043388          556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM  632 (854)
Q Consensus       556 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  632 (854)
                      ||+|+||+||++.+..+++.||+|++....   ....+.+..|++++++++|+||+++.+++....     ..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT-----DLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC-----eEEEEEeCC
Confidence            799999999999999899999999986432   223456788999999999999999999887654     689999999


Q ss_pred             cCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccC
Q 043388          633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSA  711 (854)
Q Consensus       633 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~  711 (854)
                      ++|+|.+++......  ...+++..++.++.||+.||+|||+.   +|+||||||+||+++.++..++ |||.+......
T Consensus        76 ~~g~L~~~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          76 NGGDLRYHIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             CCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            999999888643211  12689999999999999999999999   9999999999999998877666 99999776543


Q ss_pred             CCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchh
Q 043388          712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL  791 (854)
Q Consensus       712 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  791 (854)
                      ...   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..............        
T Consensus       151 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~--------  218 (280)
T cd05608         151 QSK---TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILNDSV--------  218 (280)
T ss_pred             Ccc---ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccCC--------
Confidence            322   123468999999999999999999999999999999999999997532211 11111111110000        


Q ss_pred             hHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          792 LMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                                      .....++..+.+++.+||+.||++||     +++++++
T Consensus       219 ----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 ----------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ----------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence                            00112245678999999999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-36  Score=328.59  Aligned_cols=242  Identities=24%  Similarity=0.318  Sum_probs=187.8

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||.||+|++..+++.||+|+++..   .....+.+.+|+.++.++ +||||+++++++....     ..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-----RLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC-----EEEEEE
Confidence            4699999999999999989999999999753   223345677899888877 8999999999987655     789999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|..++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||+++..
T Consensus        76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            9999999999887654      688999999999999999999999   9999999999999999887776 99998754


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC---chHhHHhhhcCCccccc
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG---LTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~  785 (854)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....+.......... 
T Consensus       147 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-  222 (329)
T cd05618         147 LRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-  222 (329)
T ss_pred             cCCCCc---cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-
Confidence            322211   123569999999999999999999999999999999999999996421111   1111111100000000 


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM  835 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  835 (854)
                                            ..+..+...+.+++.+||+.||++||++
T Consensus       223 ----------------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 ----------------------RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                                  0011124457789999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.6e-36  Score=312.88  Aligned_cols=248  Identities=25%  Similarity=0.377  Sum_probs=193.9

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeec
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM  632 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  632 (854)
                      +.||+|+||.||+|++..+++.||+|.+.... ......+.+|++++++++||||+++++++....     ..++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-----CeEEEEeec
Confidence            46999999999999998889999999886432 233467899999999999999999999987654     679999999


Q ss_pred             cCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccC
Q 043388          633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSA  711 (854)
Q Consensus       633 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~  711 (854)
                      ++++|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+......
T Consensus        76 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  147 (252)
T cd05084          76 QGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG  147 (252)
T ss_pred             cCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence            99999999975432     578999999999999999999999   9999999999999998886666 99998765432


Q ss_pred             CCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccccccCch
Q 043388          712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS  790 (854)
Q Consensus       712 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  790 (854)
                      ..... .....++..|+|||.+.++.++.++|||||||++|||++ |..||......  ..........+.         
T Consensus       148 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~~~---------  215 (252)
T cd05084         148 VYAST-GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGVRL---------  215 (252)
T ss_pred             ccccc-CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCC---------
Confidence            21111 111123567999999998889999999999999999998 88888643211  111111100000         


Q ss_pred             hhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                                       .....++..+.+++.+|++.+|++|||+.||.++|.
T Consensus       216 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         216 -----------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             -----------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                             001122456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-36  Score=322.15  Aligned_cols=275  Identities=20%  Similarity=0.276  Sum_probs=198.8

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhc---cCCCeeeEEEEeeccCCCCCc
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~  623 (854)
                      +|++.+.||+|+||.||+|++..+++.||+|.++...  ......+.+|+.+++++   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999999999999999987532  22234566788777766   699999999998765444445


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++ +|.+++......    .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPP----GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            68999999975 899988765321    589999999999999999999999   9999999999999998877766 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc---C
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT---L  779 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~---~  779 (854)
                      |++.........    ....||..|+|||++.+..++.++||||+||++|||++|++||...... ..+.......   .
T Consensus       153 g~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~  227 (288)
T cd07863         153 GLARIYSCQMAL----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPP  227 (288)
T ss_pred             CccccccCcccC----CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCC
Confidence            999876533221    1245899999999999888999999999999999999999999654221 1111111110   0


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...+.....  ........  ............+...+.+++.+|++.||++|||+.|++.
T Consensus       228 ~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         228 EDDWPRDVT--LPRGAFSP--RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hhhCccccc--ccccccCC--CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000100000  00000000  0000000111123556789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=314.85  Aligned_cols=253  Identities=21%  Similarity=0.302  Sum_probs=200.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-----cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-----GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ++|.+.+.||+|++|.||+|....+++.||+|++.....     ...+.+.+|++++++++||||+++++++...+    
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   77 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE----   77 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC----
Confidence            468889999999999999999988899999999864321     12356889999999999999999999987655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        78 -~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          78 -TLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             -eEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence             7899999999999999998654      678889999999999999999999   9999999999999999877776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.+.................|+..|+|||++.+..++.++||||+|+++||+++|+.||......    ..........
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~  223 (263)
T cd06625         148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIATQP  223 (263)
T ss_pred             cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHHHhccC
Confidence            999876654322221112345888999999999988999999999999999999999998643111    1111100000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..                       ......+...+.+++.+||..+|.+|||+.|+++.
T Consensus       224 ~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 TN-----------------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CC-----------------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            00                       00011224557889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.1e-36  Score=317.94  Aligned_cols=260  Identities=23%  Similarity=0.372  Sum_probs=200.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECC-----CceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|.+.+.||+|+||.||+|.+..     .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+  
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL--   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--
Confidence            5679999999999999999999976     67889999886443 223456899999999999999999999887654  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCc-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc---
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---  696 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---  696 (854)
                         ..++||||+++++|.+++...... .....+++.+++.++.||+.||+|||+.   +++||||||+||+++.++   
T Consensus        83 ---~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          83 ---PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             ---CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCc
Confidence               568999999999999999875421 1123589999999999999999999999   999999999999998653   


Q ss_pred             -ccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHH
Q 043388          697 -VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEF  774 (854)
Q Consensus       697 -~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~  774 (854)
                       .+++|||+++.......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||......  .....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~  233 (277)
T cd05036         157 VAKIADFGMARDIYRASYYRK-GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEF  233 (277)
T ss_pred             ceEeccCccccccCCccceec-CCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence             34459999987643222111 111234578999999998899999999999999999997 99998754221  11111


Q ss_pred             hhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          775 VKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       775 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      +......                          .....++..+.+++.+|++.+|++|||+.+|++.|.
T Consensus       234 ~~~~~~~--------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VTGGGRL--------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHcCCcC--------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1110000                          001112456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.6e-36  Score=317.87  Aligned_cols=257  Identities=22%  Similarity=0.328  Sum_probs=200.4

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCC-Cc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKG-AD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~-~~  623 (854)
                      +.+.|++.+.||+|+||.||+|....+++.||+|++..... ....+.+|+.++.++ +|+||+++++++...+..+ ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            56788999999999999999999998999999999975533 346788999999998 7999999999987654322 24


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++.....    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++..++ ||
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence            68999999999999999986432    2688999999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM-----GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                      |++.........   .....|+..|+|||++.     +..++.++|||||||++|||++|+.||......    ......
T Consensus       156 g~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~~~  228 (272)
T cd06637         156 GVSAQLDRTVGR---RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLI  228 (272)
T ss_pred             CCceeccccccc---CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHHHH
Confidence            998866433221   12346899999999876     345788999999999999999999998643211    111000


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       .........                      ...++..+.+++.+||..+|.+|||+.|+++
T Consensus       229 -~~~~~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 -PRNPAPRLK----------------------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -hcCCCCCCC----------------------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             000000000                      0112455789999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=322.19  Aligned_cols=252  Identities=23%  Similarity=0.315  Sum_probs=197.3

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .|++.++||+|+||.||++.+..+++.||+|++....   ......+.+|+.++++++||||+++++++...+     ..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-----AL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-----eE
Confidence            4778899999999999999998889999999986432   222345778999999999999999999987654     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++|+|.+++.....    ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++..++ |||+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999999998865432    1689999999999999999999999   9999999999999998877766 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +.........    ....|+..|+|||++.+..++.++||||+||++||+++|+.||...... ....++... ....  
T Consensus       149 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~-~~~~--  220 (285)
T cd05605         149 AVEIPEGETI----RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERR-VKED--  220 (285)
T ss_pred             ceecCCCCcc----ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHH-hhhc--
Confidence            8876432221    1246899999999999888999999999999999999999999753221 111111110 0000  


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVAK  841 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  841 (854)
                                           ........+..+.+++.+||+.||++||     +++++++.
T Consensus       221 ---------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         221 ---------------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ---------------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                                 0000112245678999999999999999     78888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-36  Score=327.10  Aligned_cols=241  Identities=24%  Similarity=0.328  Sum_probs=192.0

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||.||+|.+..++..||+|+++..   .......+.+|.+++..+ +||||+++++++...+     ..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~-----~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD-----RLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEE
Confidence            4699999999999999988999999999743   233455677899999888 7999999999987655     789999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++...
T Consensus        76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            9999999999987654      689999999999999999999999   9999999999999999887776 99998753


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     ...........   . 
T Consensus       147 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~~~~i~~~~~---~-  214 (318)
T cd05570         147 ILGGVT---TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELFQSILEDEV---R-  214 (318)
T ss_pred             CcCCCc---ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HHHHHHHcCCC---C-
Confidence            322211   12246899999999999999999999999999999999999999743211     11111000000   0 


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH-----HHHHH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM-----RDVVA  840 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~  840 (854)
                                          ....++..+.+++.+||+.||.+|||+     .++++
T Consensus       215 --------------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 --------------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             --------------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                                001124457899999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.8e-37  Score=334.83  Aligned_cols=254  Identities=19%  Similarity=0.263  Sum_probs=198.0

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ..++|++.+.||+|+||.||+|+...++..||+|+++..   .....+.+.+|+.+++.++||||+++++++.+..    
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~----  116 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK----  116 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence            467899999999999999999999989999999999642   2233355788999999999999999999887655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       +.++||||+++|+|.+++...       .++...+..++.|++.||+|||+.   +|+||||||+|||++.++..++ |
T Consensus       117 -~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D  185 (370)
T cd05596         117 -YLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD  185 (370)
T ss_pred             -EEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence             789999999999999998753       467788889999999999999999   9999999999999999887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCC----CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS----EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                      ||.+..........  .....||+.|+|||++.+.    .++.++|||||||++|||++|+.||...... ..+......
T Consensus       186 fG~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~  262 (370)
T cd05596         186 FGTCMKMDANGMVR--CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMDH  262 (370)
T ss_pred             ccceeeccCCCccc--CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHcC
Confidence            99998765432211  1234699999999988653    4789999999999999999999999753211 111111110


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCC--CCCHHHHHHH
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFE--RMEMRDVVAK  841 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  841 (854)
                      ..  .. ..  +                   ....++.++.+++..|++.+|.+  |||+.|+++.
T Consensus       263 ~~--~~-~~--~-------------------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         263 KN--SL-TF--P-------------------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CC--cC-CC--C-------------------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            00  00 00  0                   00012455778999999999987  9999999754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-37  Score=336.63  Aligned_cols=203  Identities=22%  Similarity=0.328  Sum_probs=171.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|.+.++||+|+||.||+|+...+++.||||++....   ....+.+.+|++++++++||||+++++++.+..     +
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-----Y   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----e
Confidence            36889999999999999999999999999999986432   233466888999999999999999999987655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+||||+++|+|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence            899999999999999997654      678889999999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCCC------------C--------------------------------CcccccCCcccccCccccCCCCCC
Q 043388          704 LSHQLDSASKT------------P--------------------------------SSSIGIKGTVGYVAPEYGMGSEAS  739 (854)
Q Consensus       704 ~~~~~~~~~~~------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~  739 (854)
                      +++.+......            .                                ......+||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  226 (377)
T cd05629         147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG  226 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence            98643221000            0                                000124699999999999988999


Q ss_pred             ccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          740 MTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       740 ~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      .++|||||||++|||++|+.||...
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~~  251 (377)
T cd05629         227 QECDWWSLGAIMFECLIGWPPFCSE  251 (377)
T ss_pred             CceeeEecchhhhhhhcCCCCCCCC
Confidence            9999999999999999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.8e-36  Score=314.17  Aligned_cols=251  Identities=25%  Similarity=0.383  Sum_probs=197.5

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|++.+.||+|+||.||+|.+. ++..||+|.++... ...+.+.+|+.++++++||||+++++++...+     ..++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-----PIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-----CcEE
Confidence            57889999999999999999887 34569999886433 23467899999999999999999999986654     5799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++|+|.+++.....     .+++.+++.++.||+.||+|||+.   +++|+||||+||+++.++..++ |||.++
T Consensus        77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence            9999999999999976432     578999999999999999999999   9999999999999998887766 999988


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ........  ......++..|+|||+..+..++.++|||||||++|||++ |+.||......  .............   
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~---  221 (256)
T cd05113         149 YVLDDEYT--SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLRLY---  221 (256)
T ss_pred             ecCCCcee--ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCCCC---
Confidence            66443221  1122346778999999988889999999999999999999 99998643211  1111111000000   


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                                             .....+..+.+++.+||+.+|++||++.++++.++
T Consensus       222 -----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 -----------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                                   00011456789999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=323.72  Aligned_cols=251  Identities=24%  Similarity=0.305  Sum_probs=206.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  622 (854)
                      ...|.+.+.||+|.||.||+++.+.+|+.+|+|++.....   ...+.+.+|+.+|+++. |||||.++++|++..    
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~----  109 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD----  109 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC----
Confidence            4578888999999999999999999999999999975433   24568999999999998 999999999998877    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-----cc
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-----MV  697 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~  697 (854)
                       ..++|||+|.||.|.+.+...       .+++.++..++.|++.|++|||+.   ||+|||+||+|+|+...     .+
T Consensus       110 -~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~i  178 (382)
T KOG0032|consen  110 -SVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRI  178 (382)
T ss_pred             -eEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcE
Confidence             789999999999999999875       278999999999999999999999   99999999999999654     24


Q ss_pred             cccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          698 AHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       698 ~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                      +.+|||++......    .....++||+.|+|||++.+..|+.++||||+||++|.|++|.+||.......... .....
T Consensus       179 k~~DFGla~~~~~~----~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~~  253 (382)
T KOG0032|consen  179 KLIDFGLAKFIKPG----ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILRG  253 (382)
T ss_pred             EEeeCCCceEccCC----ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHcC
Confidence            44599999988772    22334689999999999999999999999999999999999999998764332221 22221


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .+     +..+                   +..+.......+++..|+..||.+|+|+.++++.
T Consensus       254 ~~-----~f~~-------------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 DF-----DFTS-------------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CC-----CCCC-------------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            11     1111                   1112235567889999999999999999999883

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.1e-37  Score=337.30  Aligned_cols=203  Identities=24%  Similarity=0.326  Sum_probs=172.0

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||.||+|+...+++.||+|++....   ......+.+|++++++++|+||+++++++.+.+     .
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-----N   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----E
Confidence            36899999999999999999999899999999986432   233466889999999999999999999987655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence            899999999999999997654      678888899999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCC----------------------------------------CCCcccccCCcccccCccccCCCCCCccch
Q 043388          704 LSHQLDSASK----------------------------------------TPSSSIGIKGTVGYVAPEYGMGSEASMTGD  743 (854)
Q Consensus       704 ~~~~~~~~~~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  743 (854)
                      +|..+.....                                        ........+||+.|+|||++.+..++.++|
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  226 (376)
T cd05598         147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  226 (376)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence            9754321000                                        000112357999999999999989999999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCc
Q 043388          744 VYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       744 v~slGvvl~elltg~~pf~~~  764 (854)
                      ||||||++|||++|+.||...
T Consensus       227 iwSlGvilyell~G~~Pf~~~  247 (376)
T cd05598         227 WWSVGVILYEMLVGQPPFLAD  247 (376)
T ss_pred             eeeccceeeehhhCCCCCCCC
Confidence            999999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.4e-36  Score=327.63  Aligned_cols=241  Identities=22%  Similarity=0.297  Sum_probs=190.9

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCce
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      +|.+.+.||+|+||.||+|++..+++.||+|+++...   ....+.+..|..++..+ +|++|+++++++.+.+     .
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD-----R   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-----E
Confidence            5788999999999999999999899999999997432   22334567788888877 5889999999887655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence            899999999999999987654      678899999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +++........   .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.....  . 
T Consensus       147 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~--~-  219 (323)
T cd05616         147 MCKENMWDGVT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNV--A-  219 (323)
T ss_pred             CceecCCCCCc---cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC--C-
Confidence            98754332211   12346999999999999999999999999999999999999999754221 11111111000  0 


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM  835 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  835 (854)
                         .                      +.....++.+++.+|++.||++|+++
T Consensus       220 ---~----------------------p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 ---Y----------------------PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---C----------------------CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence               0                      01123457789999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.1e-36  Score=316.22  Aligned_cols=253  Identities=22%  Similarity=0.315  Sum_probs=199.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++...+     ..+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~-----~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD-----KLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----EEE
Confidence            357888999999999999999999899999999998665555567889999999999999999999987655     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++....      .+++.++..++.|++.|++|||+.   +++|+||||+||+++.++..++ |||.+
T Consensus        83 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVS  153 (267)
T ss_pred             EEEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceee
Confidence            9999999999999987654      688999999999999999999999   9999999999999998876666 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGM---GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      .........   .....|+..|+|||++.   ...++.++||||+||++|||++|+.||....... ............ 
T Consensus       154 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~-  228 (267)
T cd06645         154 AQITATIAK---RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTKSNFQP-  228 (267)
T ss_pred             eEccCcccc---cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhccCCCC-
Confidence            766433221   12346899999999874   4558899999999999999999999986432111 111110000000 


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                            +..                .....++..+.+++.+|++.+|++||+++++++
T Consensus       229 ------~~~----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         229 ------PKL----------------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ------Ccc----------------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                  000                000012345778999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.3e-36  Score=329.69  Aligned_cols=264  Identities=24%  Similarity=0.346  Sum_probs=202.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECC-----CceEEEEEEeecccc-cchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQK-GAFRSFVAECEALRNIR-HRNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  619 (854)
                      .++|.+.++||+|+||.||+|++.+     .+..||+|+++.... ...+.+.+|++++.++. ||||++++++|.... 
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~-  114 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG-  114 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC-
Confidence            4578889999999999999999642     456899999975432 22457889999999997 999999999987654 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCc----------------------------------------------------
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDH----------------------------------------------------  647 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------  647 (854)
                          ..++||||+++|+|.++++..+..                                                    
T Consensus       115 ----~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         115 ----PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ----CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence                679999999999999999764310                                                    


Q ss_pred             ----------------------------------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 043388          648 ----------------------------------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKP  687 (854)
Q Consensus       648 ----------------------------------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  687 (854)
                                                              .....+++.+++.++.|++.||+|||+.   +|+||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence                                                    0112467888899999999999999998   999999999


Q ss_pred             CceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcc
Q 043388          688 SNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAF  765 (854)
Q Consensus       688 ~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~  765 (854)
                      +||+++.+...++ |||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999998887776 999998654322111 1112347889999999988889999999999999999998 899986432


Q ss_pred             cCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          766 TEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       766 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ... ...........                          ...+..+..++.+++.+||+.+|++||+++||++.|+++
T Consensus       347 ~~~-~~~~~~~~~~~--------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         347 MNE-QFYNAIKRGYR--------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             chH-HHHHHHHcCCC--------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111 11111110000                          000111245688999999999999999999999999886


Q ss_pred             h
Q 043388          846 R  846 (854)
Q Consensus       846 ~  846 (854)
                      .
T Consensus       400 ~  400 (401)
T cd05107         400 L  400 (401)
T ss_pred             h
Confidence            4

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-36  Score=326.61  Aligned_cols=241  Identities=23%  Similarity=0.309  Sum_probs=189.7

Q ss_pred             CccCCCcceEEEEeEEC---CCceEEEEEEeecc----cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          554 NMIGQGSFGSVYKGILG---GEEMIVAVKVINLK----QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +.||+|+||.||+++..   .+++.||+|+++..    .......+.+|+++++.++||||+++++++...+     ..|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG-----KLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC-----eEE
Confidence            67999999999999873   46789999999743    2223456788999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++....      .+.+..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++
T Consensus        77 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  147 (323)
T cd05584          77 LILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC  147 (323)
T ss_pred             EEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence            9999999999999997654      677888899999999999999999   9999999999999998887776 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      +........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     ........... .
T Consensus       148 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~~~~-~  218 (323)
T cd05584         148 KESIHEGTV---THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILKGKL-N  218 (323)
T ss_pred             eecccCCCc---ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCC-C
Confidence            754332221   12346999999999999888999999999999999999999999753211     11111100000 0


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                       +                      ...+...+.+++.+|++.||++||     ++.++++
T Consensus       219 -~----------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 -L----------------------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -C----------------------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence             0                      011134577899999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-36  Score=336.11  Aligned_cols=202  Identities=22%  Similarity=0.338  Sum_probs=171.7

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .|.+.++||+|+||.||+|+...+++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+     ..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-----~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----NL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-----EE
Confidence            5888999999999999999999899999999996432   233457889999999999999999999987655     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++..++ |||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence            99999999999999997654      678888999999999999999999   9999999999999999887776 9999


Q ss_pred             ccccccCCC--------------------------------------------CCCcccccCCcccccCccccCCCCCCc
Q 043388          705 SHQLDSASK--------------------------------------------TPSSSIGIKGTVGYVAPEYGMGSEASM  740 (854)
Q Consensus       705 ~~~~~~~~~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~  740 (854)
                      +..+.....                                            ........+||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            754321000                                            000112346999999999999989999


Q ss_pred             cchhHHHHHHHHHHHhCCCCCCCc
Q 043388          741 TGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       741 ~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ++||||+||++|||++|+.||...
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCC
Confidence            999999999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2e-36  Score=328.08  Aligned_cols=251  Identities=22%  Similarity=0.276  Sum_probs=193.4

Q ss_pred             hccccCccCCCcceEEEEeEEC---CCceEEEEEEeecc----cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCC
Q 043388          549 EFASSNMIGQGSFGSVYKGILG---GEEMIVAVKVINLK----QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSK  620 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  620 (854)
                      +|++.+.||+|+||.||+|+..   .+++.||+|+++..    .....+.+.+|+.++.++ +|++|+++++++...+  
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA--   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--
Confidence            4788999999999999999874   46889999999642    222345678899999999 5999999999886654  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                         ..++||||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+|||++.++..++
T Consensus        79 ---~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl  146 (332)
T cd05614          79 ---KLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL  146 (332)
T ss_pred             ---EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence               6899999999999999997654      688999999999999999999999   9999999999999998877776


Q ss_pred             -ccccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                       |||+++.........  .....||+.|+|||++.+. .++.++|||||||++|||+||+.||....... ....+....
T Consensus       147 ~DfG~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~  223 (332)
T cd05614         147 TDFGLSKEFLSEEKER--TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVSRRI  223 (332)
T ss_pred             eeCcCCccccccCCCc--cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHHHHH
Confidence             999998654332221  2235699999999998875 47899999999999999999999997432211 111111110


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                      ...      ++.                  ........+.+++.+||+.||++||     +++++++
T Consensus       224 ~~~------~~~------------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         224 LKC------DPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             hcC------CCC------------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            000      000                  0011244577899999999999999     6677764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.9e-36  Score=312.70  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=201.4

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|.+.+.||+|++|.||+|....++..||+|.+...  .....+.+.+|++++++++|||++++++++...+     ..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-----KLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC-----EEE
Confidence            477889999999999999999989999999998643  2344567889999999999999999999987654     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++..++ |||.+
T Consensus        76 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence            99999999999999987532    2688999999999999999999999   9999999999999999877776 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ..........   ....|++.|+|||+..+..++.++|||||||++|||++|+.||......     ...........  
T Consensus       149 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--  218 (256)
T cd08529         149 KLLSDNTNFA---NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----ALILKIIRGVF--  218 (256)
T ss_pred             eeccCccchh---hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHcCCC--
Confidence            8765433221   1245889999999999988999999999999999999999999754211     11111000000  


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                           ......+...+.+++.+||+.+|++||++.++++.
T Consensus       219 ---------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 ---------------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---------------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                                 00011224568899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.5e-36  Score=343.45  Aligned_cols=202  Identities=23%  Similarity=0.367  Sum_probs=165.6

Q ss_pred             HHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccC------CCeeeEEEEeec
Q 043388          543 LSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH------RNLIKIITICSS  616 (854)
Q Consensus       543 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~  616 (854)
                      +....++|++.++||+|+||.||+|.+..+++.||||+++.... ..+....|+.+++.++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            34456789999999999999999999988899999999964322 23456678888887755      458899998865


Q ss_pred             cCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc
Q 043388          617 IDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM  696 (854)
Q Consensus       617 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  696 (854)
                      ..    .+.|+|||++ +++|.+++....      .+++.++..|+.||+.||+|||+++  +||||||||+|||++.++
T Consensus       203 ~~----~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        203 ET----GHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSD  269 (467)
T ss_pred             CC----ceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCC
Confidence            33    2689999998 779999887654      6889999999999999999999732  899999999999998754


Q ss_pred             -----------------ccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCC
Q 043388          697 -----------------VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRR  759 (854)
Q Consensus       697 -----------------~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~  759 (854)
                                       ++++|||.+......      ....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~  343 (467)
T PTZ00284        270 TVVDPVTNRALPPDPCRVRICDLGGCCDERHS------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL  343 (467)
T ss_pred             cccccccccccCCCCceEEECCCCccccCccc------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence                             344599987643222      123579999999999999999999999999999999999999


Q ss_pred             CCCCc
Q 043388          760 PTDAA  764 (854)
Q Consensus       760 pf~~~  764 (854)
                      ||+..
T Consensus       344 pf~~~  348 (467)
T PTZ00284        344 LYDTH  348 (467)
T ss_pred             CCCCC
Confidence            99754

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.5e-36  Score=317.28  Aligned_cols=274  Identities=23%  Similarity=0.385  Sum_probs=203.2

Q ss_pred             hhccccCccCCCcceEEEEeEE----CCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGIL----GGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .-|++.+.||+|+||.||+|++    ..++..||+|.++... ....+.+.+|++++++++|||++++++++...+   .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---G   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---C
Confidence            3578889999999999999985    3467889999987543 333467899999999999999999999987642   2


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++||||+++++|.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~d  152 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD  152 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECC
Confidence            257999999999999999976432     578999999999999999999999   9999999999999998887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.+.................++..|+|||+..+..++.++|||||||++||+++++.|+......   ........ ..
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~~-~~  228 (284)
T cd05079         153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGPT-HG  228 (284)
T ss_pred             CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcccc-cc
Confidence            999987654332211122345778899999998888999999999999999999988775432110   00000000 00


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      .   ....... .....     ..+.+....++..+.+++.+||+.+|++|||+.++++.++++
T Consensus       229 ~---~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         229 Q---MTVTRLV-RVLEE-----GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             c---ccHHHHH-HHHHc-----CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0   0000000 00000     000111123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.1e-36  Score=326.43  Aligned_cols=266  Identities=21%  Similarity=0.343  Sum_probs=201.3

Q ss_pred             hhccccCccCCCcceEEEEeEEC-----CCceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILG-----GEEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSK  620 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  620 (854)
                      ++|++.+.||+|+||.||+|.+.     .+++.||||+++... ......+.+|+.++.++ +||||++++++|...+  
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--   84 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG--   84 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC--
Confidence            57999999999999999999853     357889999997543 23345788999999999 6899999999886543  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcc----------------------------------------------------
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHL----------------------------------------------------  648 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------------------------  648 (854)
                        ...++||||+++|+|.+++.......                                                    
T Consensus        85 --~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          85 --GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             --CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence              25789999999999999987532100                                                    


Q ss_pred             ---------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccCCCCCCcc
Q 043388          649 ---------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSS  718 (854)
Q Consensus       649 ---------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~  718 (854)
                               ....+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++.......... ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~  238 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RK  238 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchh-hc
Confidence                     012478888999999999999999999   9999999999999998877776 999998764322211 11


Q ss_pred             cccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhh
Q 043388          719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMA  797 (854)
Q Consensus       719 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  797 (854)
                      ....++..|+|||...+..++.++|||||||++|||++ |..||....... ..............              
T Consensus       239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~--------------  303 (343)
T cd05103         239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMRA--------------  303 (343)
T ss_pred             CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCCCCC--------------
Confidence            12235678999999988889999999999999999997 999986532211 11111100000000              


Q ss_pred             ccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          798 NNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                                  ...+..++.+++..||+.||++|||+.||++.|+.+.++
T Consensus       304 ------------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         304 ------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             ------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                        001134578899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.3e-36  Score=313.27  Aligned_cols=253  Identities=28%  Similarity=0.447  Sum_probs=199.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|++.++||+|+||.||+|++.++ ..||+|+++.... ..+.+.+|++++++++||||+++++++...      ..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~l   77 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIYI   77 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCC------CcEE
Confidence            5799999999999999999998755 4699999875332 346789999999999999999999986432      4689


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++|+|.+++.....    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+.
T Consensus        78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~  150 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR  150 (262)
T ss_pred             EEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCcee
Confidence            9999999999999976432    1578999999999999999999999   9999999999999999887766 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........  .....++..|+|||+..+..++.++|||||||++||++| |+.||....... .... ......     
T Consensus       151 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~~~-~~~~~~-----  221 (262)
T cd05071         151 LIEDNEYTA--RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQ-VERGYR-----  221 (262)
T ss_pred             ecccccccc--ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HHHH-HhcCCC-----
Confidence            765433221  112346778999999988889999999999999999999 888886432111 0110 000000     


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                           ......++..+.+++.+|++.+|++||++.++.+.|++.
T Consensus       222 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 ---------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ---------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                                 000112355688999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9e-36  Score=311.36  Aligned_cols=252  Identities=28%  Similarity=0.440  Sum_probs=198.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|++.++||+|+||.||+|... ++..||+|.++.... ..+++.+|+.++++++|+|++++++++...      ..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~l   77 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEE------PIYI   77 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCC------CcEE
Confidence            57889999999999999999887 566799999875433 346789999999999999999999987432      4689


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|.+++.....    ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+.
T Consensus        78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             EEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeee
Confidence            9999999999999976432    1578999999999999999999999   9999999999999999887766 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........  .....++..|+|||+..+..++.++||||||+++||+++ |+.||.....  ....+........    
T Consensus       151 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~----  222 (260)
T cd05070         151 LIEDNEYTA--RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVERGYRM----  222 (260)
T ss_pred             eccCccccc--ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCC----
Confidence            765432211  112235678999999988889999999999999999999 8999864321  1111111110000    


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                                            +....++..+.+++.+|+..+|++|||++++.+.|++
T Consensus       223 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 ----------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                                  0011224568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.1e-36  Score=317.43  Aligned_cols=258  Identities=27%  Similarity=0.423  Sum_probs=201.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCC---ceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGE---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|++.+.||+|+||.||+|++..+   +..+|+|.++... ....+.+.+|+.++++++||||+++++++...+    
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   78 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK----   78 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence            36789999999999999999988533   4479999886432 233467899999999999999999999986544    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++++|.+++.....     .+++.++..++.|++.|++|||+.   +++||||||+||+++.++..++ |
T Consensus        79 -~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~d  149 (267)
T cd05066          79 -PVMIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSD  149 (267)
T ss_pred             -ccEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCC
Confidence             67999999999999999976532     578999999999999999999999   9999999999999998887766 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||.+.................++..|+|||++.+..++.++|||||||++||+++ |+.||......  ...........
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~  227 (267)
T cd05066         150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGYR  227 (267)
T ss_pred             CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCCc
Confidence            9999877543322211122234678999999998889999999999999999887 99998643211  11111111000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                                .+....++..+.+++.+|++.+|.+||+|.++++.|.++
T Consensus       228 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 --------------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                                      000112245678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.2e-36  Score=317.91  Aligned_cols=262  Identities=25%  Similarity=0.371  Sum_probs=201.6

Q ss_pred             hccccCccCCCcceEEEEeEECC-----CceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          549 EFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      +|++.+.||+|+||.||+|+...     ....+|+|.+..... ...+++.+|+.+++.++||||+++++.+...+    
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG----   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC----
Confidence            47788999999999999998742     235789998864432 33467889999999999999999999987654    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCc------------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDH------------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGD  684 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  684 (854)
                       ..++||||+++|+|.+++......                  .....+++.+++.++.|++.||+|||+.   +|+|||
T Consensus        77 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d  152 (290)
T cd05045          77 -PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD  152 (290)
T ss_pred             -CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence             579999999999999998753211                  0113588999999999999999999999   999999


Q ss_pred             CCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 043388          685 LKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD  762 (854)
Q Consensus       685 lkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~  762 (854)
                      |||+||++++++..++ |||+++......... ......++..|+|||+..+..++.++||||||+++|||++ |+.||.
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  231 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  231 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccchh-cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence            9999999998887776 999998664332211 1112346778999999988889999999999999999999 999986


Q ss_pred             CcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          763 AAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       763 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                      .....  ...+.......                          ......++..+.+++..||+.+|++||+++|+++.|
T Consensus       232 ~~~~~--~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l  283 (290)
T cd05045         232 GIAPE--RLFNLLKTGYR--------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL  283 (290)
T ss_pred             CCCHH--HHHHHHhCCCC--------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence            43211  11111111000                          000112245688999999999999999999999999


Q ss_pred             Hhhhh
Q 043388          843 CHTRE  847 (854)
Q Consensus       843 ~~~~~  847 (854)
                      +++..
T Consensus       284 ~~~~~  288 (290)
T cd05045         284 EKMMV  288 (290)
T ss_pred             HHHHh
Confidence            98865

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-37  Score=327.36  Aligned_cols=248  Identities=22%  Similarity=0.405  Sum_probs=205.4

Q ss_pred             cccCccCCCcceEEEEeEECCCceEEE---EEEeec-ccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          551 ASSNMIGQGSFGSVYKGILGGEEMIVA---VKVINL-KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       551 ~~~~~lg~G~~g~V~~~~~~~~~~~va---vK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +...+||+|+|-+||+|.+..+|..||   ||.-+. ......++|..|+.+++.|+|||||++|++|.+...   ....
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            335789999999999999998888776   333222 234446889999999999999999999999988764   3678


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-ccccc-cccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQ-NFSL  704 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~~~-Dfg~  704 (854)
                      +|+|.+..|+|..|.++.+      .++...+..|++||++||.|||++ .|+|||||||.+||||+.+ +.+|| |+|+
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             eeeecccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence            9999999999999999887      778889999999999999999998 6799999999999999875 55666 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      |..........     +.|||.|||||+.. ..|.+.+||||||+.++||+|+..||..+......+........|..+.
T Consensus       193 Atl~r~s~aks-----vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~  266 (632)
T KOG0584|consen  193 ATLLRKSHAKS-----VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS  266 (632)
T ss_pred             HHHhhccccce-----eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh
Confidence            99887655432     57999999999977 6799999999999999999999999998765544444444444444454


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .+-||.                          +.++|.+|+.. .++|||+.|+++.
T Consensus       267 kV~dPe--------------------------vr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  267 KVKDPE--------------------------VREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ccCCHH--------------------------HHHHHHHHhcC-chhccCHHHHhhC
Confidence            444433                          67899999999 9999999999864

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2e-40  Score=330.46  Aligned_cols=403  Identities=28%  Similarity=0.402  Sum_probs=325.0

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      +|+++ ++|++++.+..++.|+.++|+++ .+|.+++.+..|..|++++|++. ..|+.++.+-.|..|+..+|+++ ..
T Consensus        77 ~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-sl  152 (565)
T KOG0472|consen   77 DNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SL  152 (565)
T ss_pred             cchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cC
Confidence            47777 78889999999999999999999 89999999999999999999999 78888999999999999999999 68


Q ss_pred             hhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCC----------CCCCceeeccCccCCCCCCCCCCccc
Q 043388           81 PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCS----------LKNLWWLNLEQNNLGMGTASSIPDSL  150 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~----------l~~L~~L~L~~N~l~~~~~~~~p~~~  150 (854)
                      |+++.++.+|..|++.+|+++ .+|++... ++.|++|+...|-          +++|+.|+|.+|+|     ..+| .|
T Consensus       153 p~~~~~~~~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki-----~~lP-ef  224 (565)
T KOG0472|consen  153 PEDMVNLSKLSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKI-----RFLP-EF  224 (565)
T ss_pred             chHHHHHHHHHHhhccccchh-hCCHHHHH-HHHHHhcccchhhhhcCChhhcchhhhHHHHhhhccc-----ccCC-CC
Confidence            888999999999999999999 78877655 8999999998775          45678899999999     5677 78


Q ss_pred             cCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhh
Q 043388          151 SNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIAN  230 (854)
Q Consensus       151 ~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  230 (854)
                      .+++.|++|+++.|+|.-++.....++.+|..|||..|++...+.+       +.-+++|..||+++|.|+ .+|.++++
T Consensus       225 ~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pde-------~clLrsL~rLDlSNN~is-~Lp~sLgn  296 (565)
T KOG0472|consen  225 PGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPDE-------ICLLRSLERLDLSNNDIS-SLPYSLGN  296 (565)
T ss_pred             CccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCchH-------HHHhhhhhhhcccCCccc-cCCccccc
Confidence            8899999999999999866666677999999999999999877654       667788999999999998 78888888


Q ss_pred             hcccccEEEccCCccccc--------------------------------------CCccc---cccccC----------
Q 043388          231 LSSTMIQFRIGGNQISGT--------------------------------------IPSGI---RNLVNL----------  259 (854)
Q Consensus       231 l~~~L~~L~l~~N~l~~~--------------------------------------~~~~~---~~l~~L----------  259 (854)
                      +  .|+.|-+.+|.+..+                                      .+..|   ..+.+.          
T Consensus       297 l--hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~ql  374 (565)
T KOG0472|consen  297 L--HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQL  374 (565)
T ss_pred             c--eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccc
Confidence            8  688888888855311                                      00001   112233          


Q ss_pred             ----------------CeeeccccccccCCCCCccCcccCce-eeCccccccccCCccccCccccchhccccceecccCC
Q 043388          260 ----------------IALTIEVNQLHGIIPDGVGELQHLQQ-LYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIP  322 (854)
Q Consensus       260 ----------------~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  322 (854)
                                      +..+++.|++. ..|..+..++.+++ +.+++|.+. .+|..++.+++|..|+|++|.+. .+|
T Consensus       375 t~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP  451 (565)
T KOG0472|consen  375 TLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLP  451 (565)
T ss_pred             ccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcc
Confidence                            34555555555 34555555555544 456666665 89999999999999999999998 799


Q ss_pred             CCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCC
Q 043388          323 SSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIP  402 (854)
Q Consensus       323 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p  402 (854)
                      ..++.+..|+.||+|.|++. .+|..+..+..+.. +-.++|++....|..+++       +.+|..|||.+|.+. .+|
T Consensus       452 ~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEt-llas~nqi~~vd~~~l~n-------m~nL~tLDL~nNdlq-~IP  521 (565)
T KOG0472|consen  452 EEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLET-LLASNNQIGSVDPSGLKN-------MRNLTTLDLQNNDLQ-QIP  521 (565)
T ss_pred             hhhhhhhhhheecccccccc-cchHHHhhHHHHHH-HHhccccccccChHHhhh-------hhhcceeccCCCchh-hCC
Confidence            99999999999999999998 88887776666543 556678888777766777       457999999999999 788


Q ss_pred             cccccCCCCCEEEccCcccccccchhhcCccCCCeee
Q 043388          403 FSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLN  439 (854)
Q Consensus       403 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  439 (854)
                      ..+++|.+|++|+|++|.++ .++..+-.......|.
T Consensus       522 p~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~  557 (565)
T KOG0472|consen  522 PILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAILS  557 (565)
T ss_pred             hhhccccceeEEEecCCccC-CCHHHHhccChHHHHH
Confidence            89999999999999999999 5555443333333333

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.3e-36  Score=318.78  Aligned_cols=262  Identities=25%  Similarity=0.399  Sum_probs=200.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCce--EEEEEEeecc-cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEM--IVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ++|++.+.||+|+||.||+|....++.  .+|+|.++.. .....+.+.+|++++.++ +||||+++++++....     
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-----   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG-----   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-----
Confidence            478899999999999999999876654  4788888642 233446788999999999 7999999999987654     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcc----------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHL----------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD  693 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  693 (854)
                      ..++||||+++|+|.+++.......          ....+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence            6799999999999999997643110          112588999999999999999999999   999999999999999


Q ss_pred             CCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchH
Q 043388          694 HDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTL  771 (854)
Q Consensus       694 ~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~  771 (854)
                      .+...++ |||++..........    ....+..|+|||+..+..++.++|||||||++|||++ |..||......    
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~----  225 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYVKKT----MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA----  225 (297)
T ss_pred             CCCeEEECCcCCCccccceeccC----CCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence            8876666 999986433211111    1123567999999988889999999999999999998 99999643211    


Q ss_pred             hHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          772 HEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       772 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                       +...... ....                      ......++..+.+++.+||+.+|.+|||+.++++.|+.+.++.
T Consensus       226 -~~~~~~~-~~~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         226 -ELYEKLP-QGYR----------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             -HHHHHHh-cCCC----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence             1111100 0000                      0001112456789999999999999999999999999888755

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.4e-36  Score=315.96  Aligned_cols=260  Identities=23%  Similarity=0.361  Sum_probs=202.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCce----EEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEM----IVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      ..+|++.++||+|+||+||+|++..++.    .||+|+++... ....+.+.+|+.+++.++|+||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence            4678999999999999999999865654    48999986543 23356788999999999999999999998643    


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                        ..+++|||+++|+|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ 
T Consensus        82 --~~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~  151 (279)
T cd05109          82 --TVQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKIT  151 (279)
T ss_pred             --CcEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence              36799999999999999976432     688999999999999999999999   9999999999999988776665 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      |||+++.......... .....++..|+|||...+..++.++|||||||++||+++ |..||.....  .....+.....
T Consensus       152 dfG~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~  228 (279)
T cd05109         152 DFGLARLLDIDETEYH-ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGE  228 (279)
T ss_pred             CCCceeecccccceee-cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCC
Confidence            9999987754322211 111235678999999988889999999999999999998 9999864321  11112111100


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ...                          ....++..+.+++..||+.||++||++.|+++.++.+..+.
T Consensus       229 ~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         229 RLP--------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             cCC--------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            000                          00112445788999999999999999999999998886654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.8e-36  Score=318.96  Aligned_cols=259  Identities=22%  Similarity=0.381  Sum_probs=201.6

Q ss_pred             HhhccccCccCCCcceEEEEeEE-----CCCceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  619 (854)
                      .++|.+.+.||+|+||.||+|..     ..++..||+|+++... ....+.+.+|+++++++ +||||+++++++...+ 
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG-  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC-
Confidence            35799999999999999999975     3346689999987543 23346788999999999 7999999999987655 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~  699 (854)
                          ..++||||+++|+|.+++......    .+++.++..++.|++.||+|||+.   +|+|+||||+||+++.+...+
T Consensus       113 ----~~~lv~e~~~~~~L~~~i~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~  181 (302)
T cd05055         113 ----PILVITEYCCYGDLLNFLRRKRES----FLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK  181 (302)
T ss_pred             ----ceEEEEEcCCCCcHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEE
Confidence                579999999999999999764321    489999999999999999999999   999999999999999888776


Q ss_pred             c-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhh
Q 043388          700 Q-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~  777 (854)
                      + |||.+.......... ......++..|+|||.+.+..++.++||||+||++|||++ |+.||....... ........
T Consensus       182 l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~  259 (302)
T cd05055         182 ICDFGLARDIMNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKE  259 (302)
T ss_pred             ECCCcccccccCCCcee-ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHc
Confidence            6 999998664432211 1112346788999999998889999999999999999998 999987542211 11111111


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      .....                          .......++.+++.+|+..+|++|||+.|+++.|++.
T Consensus       260 ~~~~~--------------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         260 GYRMA--------------------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCcCC--------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            00000                          0001134578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.8e-36  Score=320.43  Aligned_cols=263  Identities=27%  Similarity=0.394  Sum_probs=200.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCce--EEEEEEeecc-cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEM--IVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|++.+.||+|+||.||+|.+..++.  .+|+|.++.. .....+.+.+|++++.++ +||||+++++++...+    
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~----   81 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----   81 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC----
Confidence            4678999999999999999999876664  4577776532 223346788999999999 8999999999987654    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcc----------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHL----------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL  692 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  692 (854)
                       ..++||||+++|+|.+++.......          ....+++.+++.++.|++.|++|||+.   +|+||||||+||++
T Consensus        82 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili  157 (303)
T cd05088          82 -YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV  157 (303)
T ss_pred             -CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence             6899999999999999997653210          112578999999999999999999999   99999999999999


Q ss_pred             cCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCch
Q 043388          693 DHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLT  770 (854)
Q Consensus       693 ~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~  770 (854)
                      +.++..++ |||++.........    ....++..|+|||++.+..++.++|||||||++|||+| |..||......  .
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~  231 (303)
T cd05088         158 GENYVAKIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--E  231 (303)
T ss_pred             cCCCcEEeCccccCcccchhhhc----ccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--H
Confidence            98877766 99998643221111    11224678999999988889999999999999999998 99998643211  1


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ..+........   .                       ....++..+.+++.+||+.+|++||++.++++.++++.+..
T Consensus       232 ~~~~~~~~~~~---~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         232 LYEKLPQGYRL---E-----------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             HHHHHhcCCcC---C-----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11111000000   0                       00112345789999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-36  Score=312.43  Aligned_cols=251  Identities=28%  Similarity=0.406  Sum_probs=197.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|++++++++||||+++++++...+     ..++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l   76 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR-----PIFI   76 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-----ceEE
Confidence            46888999999999999999987 566899999864322 3457889999999999999999999986554     6799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|.+++.....     .+++..++.++.|++.|++|||+.   +|+||||||+||+++.++..++ |||.++
T Consensus        77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~  148 (256)
T cd05059          77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR  148 (256)
T ss_pred             EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence            9999999999999976532     678999999999999999999999   9999999999999999887776 999987


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........  .....++..|+|||...+..++.++|||||||++||+++ |+.||......  ............    
T Consensus       149 ~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~----  220 (256)
T cd05059         149 YVLDDQYTS--SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGYRL----  220 (256)
T ss_pred             ecccccccc--cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcCCcC----
Confidence            664332211  111234568999999998889999999999999999999 89998643211  111111100000    


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                                            .....++.++.+++.+||..+|++|||+.|+++.|.
T Consensus       221 ----------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         221 ----------------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence                                  000112556889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.4e-36  Score=316.59  Aligned_cols=239  Identities=23%  Similarity=0.370  Sum_probs=183.2

Q ss_pred             ccCCCcceEEEEeEECC------------------------CceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeE
Q 043388          555 MIGQGSFGSVYKGILGG------------------------EEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI  610 (854)
Q Consensus       555 ~lg~G~~g~V~~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  610 (854)
                      .||+|+||.||+|....                        ....||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998531                        124689998875544445678889999999999999999


Q ss_pred             EEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCce
Q 043388          611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV  690 (854)
Q Consensus       611 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  690 (854)
                      +++|....     ..++||||+++|+|..++.....     .+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        82 ~~~~~~~~-----~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni  148 (274)
T cd05076          82 HGVCVRGS-----ENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI  148 (274)
T ss_pred             EEEEEeCC-----ceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence            99997655     67999999999999999876432     678899999999999999999999   999999999999


Q ss_pred             EecCCc--------ccccccccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHH-hCCCC
Q 043388          691 LLDHDM--------VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMF-TGRRP  760 (854)
Q Consensus       691 ll~~~~--------~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~ell-tg~~p  760 (854)
                      +++..+        .+..|||.+.......       ...++..|+|||.+.+ ..++.++|||||||++||++ +|+.|
T Consensus       149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~~-------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  221 (274)
T cd05076         149 LLARLGLAEGTSPFIKLSDPGVSFTALSRE-------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP  221 (274)
T ss_pred             EEeccCcccCccceeeecCCcccccccccc-------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            997643        2334999876443221       1247888999998865 56899999999999999985 69999


Q ss_pred             CCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          761 TDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       761 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      |.......  ...+......  .                          .+.....+.+++.+||+.+|++|||+.+|++
T Consensus       222 ~~~~~~~~--~~~~~~~~~~--~--------------------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~  271 (274)
T cd05076         222 LKERTPSE--KERFYEKKHR--L--------------------------PEPSCKELATLISQCLTYEPTQRPSFRTILR  271 (274)
T ss_pred             ccccChHH--HHHHHHhccC--C--------------------------CCCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence            87532211  1111110000  0                          0001234778999999999999999999998


Q ss_pred             HHH
Q 043388          841 KLC  843 (854)
Q Consensus       841 ~L~  843 (854)
                      .|+
T Consensus       272 ~L~  274 (274)
T cd05076         272 DLT  274 (274)
T ss_pred             hhC
Confidence            863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.3e-36  Score=316.23  Aligned_cols=260  Identities=25%  Similarity=0.396  Sum_probs=199.9

Q ss_pred             hhccccCccCCCcceEEEEeEE----CCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGIL----GGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .+|++.+.||+|+||.||+|.+    ..++..||+|.+.... ......+.+|++++++++||||+++++++....    
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----   80 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ----   80 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----
Confidence            5788899999999999999986    2356789999987433 233467889999999999999999999987654    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCc-----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceE
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDH-----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVL  691 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl  691 (854)
                       ..++||||+++++|.+++......           .....+++.++..++.|++.||+|||+.   +|+||||||+||+
T Consensus        81 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil  156 (283)
T cd05090          81 -PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL  156 (283)
T ss_pred             -ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence             679999999999999998643210           0112578899999999999999999999   9999999999999


Q ss_pred             ecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCc
Q 043388          692 LDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGL  769 (854)
Q Consensus       692 l~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~  769 (854)
                      ++.+...++ |||++........... .....++..|+|||+..+..++.++|||||||++|||++ |..||.....  .
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~  233 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRV-QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--Q  233 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceec-ccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--H
Confidence            999887776 9999987644322111 112346778999999988889999999999999999998 9999864321  1


Q ss_pred             hHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          770 TLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                      ...+.........                          ....++.++.+++.+||+.||++||++.+|.++|..
T Consensus       234 ~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         234 EVIEMVRKRQLLP--------------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHcCCcCC--------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1122111110000                          001124567889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.4e-36  Score=328.76  Aligned_cols=203  Identities=23%  Similarity=0.279  Sum_probs=169.8

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC-CC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK-GA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~  622 (854)
                      ..++|.+.+.||+|+||.||+|.+..++..||+|++...  .......+.+|+.+++.++||||+++++++...... ..
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999999989999999998643  233356778999999999999999999998654321 12


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...|+||||+++ ++.+.+..        .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D  166 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  166 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence            347999999976 67666642        467888899999999999999999   9999999999999999887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ||+++.......    .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       167 fg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         167 FGLARTACTNFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             CCCccccccCcc----CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            999976543221    12246899999999999989999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2e-36  Score=332.96  Aligned_cols=280  Identities=18%  Similarity=0.196  Sum_probs=200.0

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+++++.++|+||+++++++...+.......|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999999889999999998643  223346788999999999999999999998765533334689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+. ++|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||++
T Consensus        81 lv~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence            9999996 58888886543      688999999999999999999999   9999999999999999887776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +.........  .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+.............
T Consensus       151 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~  227 (372)
T cd07853         151 RVEEPDESKH--MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLE  227 (372)
T ss_pred             eecccCcccc--CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHH
Confidence            8654332211  1223588999999998874 4789999999999999999999999754321 1111111110000000


Q ss_pred             cc--cCchhhHHHhhccchhhH--hhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          785 EI--VDPSLLMEVMANNSMIQE--DRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       785 ~~--~d~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +.  ................+.  ...........++.+++.+|++.||++|||+.|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            00  000000000000000000  0000011224567899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.5e-36  Score=319.29  Aligned_cols=271  Identities=23%  Similarity=0.334  Sum_probs=201.5

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +|++.+.||+|+||.||+|.+..++..||+|.++.... ....++.+|++++++++||||+++++++...+     +.++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-----EISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----EEEE
Confidence            68899999999999999999998999999999875432 23456889999999999999999999997655     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|.+++....      .+++..+..++.|++.||+|||+.+  +++||||||+||+++.++..++ |||.+.
T Consensus        77 v~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (308)
T cd06615          77 CMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG  148 (308)
T ss_pred             EeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcc
Confidence            999999999999998654      6788999999999999999999732  8999999999999998887776 999987


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc--
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI--  784 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--  784 (854)
                      .......     ....|+..|+|||+..+..++.++|||||||++|||++|+.||......  ....+..........  
T Consensus       149 ~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~  221 (308)
T cd06615         149 QLIDSMA-----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKE  221 (308)
T ss_pred             ccccccc-----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccC
Confidence            6543221     1246899999999998888999999999999999999999999754311  111111111000000  


Q ss_pred             --------cccCchhh--HHHhhccchhhHhhhhh-HHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          785 --------EIVDPSLL--MEVMANNSMIQEDRRAR-TQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       785 --------~~~d~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                              ...++...  .+.....  ........ ...+...+.+++.+||..+|++|||+.||++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         222 SHRPVSGHPPDSPRPMAIFELLDYI--VNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CcccccCCCCCccchhhHHHHHHHH--hcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    00000000  0000000  00000000 01134568899999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2e-36  Score=331.08  Aligned_cols=203  Identities=21%  Similarity=0.327  Sum_probs=172.5

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++...+   
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~---  116 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK---  116 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC---
Confidence            3457899999999999999999999989999999998642   2223456788999999999999999999987655   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                        ..|+||||+++|+|.+++...       .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++..++ 
T Consensus       117 --~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~  184 (370)
T cd05621         117 --YLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLA  184 (370)
T ss_pred             --EEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEE
Confidence              789999999999999999653       467888999999999999999999   9999999999999998887776 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCC----CCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS----EASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      |||++.........  ......||+.|+|||++.+.    .++.++||||+||++|||++|+.||...
T Consensus       185 DFG~a~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         185 DFGTCMKMDETGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             ecccceecccCCce--ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            99999876543221  11235699999999998653    3788999999999999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.7e-36  Score=314.76  Aligned_cols=248  Identities=25%  Similarity=0.339  Sum_probs=194.8

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +|++.++||+|+||.||+|.+..++..||+|++.... ......+.+|++++++++||||+++++++...+     ..++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-----RISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-----EEEE
Confidence            6788899999999999999998899999999986542 233457889999999999999999999998765     6789


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|..+.          .+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++..++ |||++.
T Consensus        77 v~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~  143 (279)
T cd06619          77 CTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVST  143 (279)
T ss_pred             EEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence            99999999997542          457788889999999999999999   9999999999999999887777 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch--HhHHhhhcCCcccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT--LHEFVKMTLPEKVI  784 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~  784 (854)
                      .......     ....||..|+|||++.+..++.++|||||||++|+|++|+.||.........  ............  
T Consensus       144 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--  216 (279)
T cd06619         144 QLVNSIA-----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--  216 (279)
T ss_pred             ecccccc-----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--
Confidence            6644322     1246899999999999888999999999999999999999999753221111  001110000000  


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                         .+..                 .......++.+++.+|++.+|++||+++|+++.
T Consensus       217 ---~~~~-----------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         217 ---PPVL-----------------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ---CCCC-----------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence               0000                 001113457889999999999999999999765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.1e-36  Score=318.64  Aligned_cols=250  Identities=22%  Similarity=0.287  Sum_probs=201.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+|++.+.||+|+||.||+|....++..||+|.+........+.+.+|+.+++.++|+||+++++++...+     ..+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----EEE
Confidence            368999999999999999999998889999999997665555677889999999999999999999987654     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++...       .+++.++..++.|++.||.|||+.   +++||||||+||+++.++..++ |||.+
T Consensus        93 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~  162 (297)
T cd06656          93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (297)
T ss_pred             EeecccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccc
Confidence            999999999999998653       568889999999999999999999   9999999999999998877776 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ..........   ....+++.|+|||...+..++.++|||||||++|++++|+.||............ ..    .....
T Consensus       163 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-~~----~~~~~  234 (297)
T cd06656         163 AQITPEQSKR---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-AT----NGTPE  234 (297)
T ss_pred             eEccCCccCc---CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-cc----CCCCC
Confidence            7654432211   1235889999999999888999999999999999999999999754221110000 00    00000


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..                     ........+.+++.+||+.+|++||++.++++
T Consensus       235 ~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 LQ---------------------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CC---------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00                     01112445778999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.2e-36  Score=329.48  Aligned_cols=251  Identities=22%  Similarity=0.271  Sum_probs=196.7

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +|.+.+.||+|+||.||+|+...+++.||+|+++...   ....+.+.+|+.+++.++|+||+++++++.+.+     ..
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~-----~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD-----NL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----eE
Confidence            6889999999999999999999899999999997532   234456889999999999999999999887654     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++|+|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||+
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~  148 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGS  148 (330)
T ss_pred             EEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCC
Confidence            999999999999999987532     688999999999999999999999   9999999999999999887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccC------CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGM------GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                      +.........  ......||+.|+|||++.      +..++.++|||||||++|||++|+.||...... ..+...... 
T Consensus       149 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~~~-  224 (330)
T cd05601         149 AARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNNIMNF-  224 (330)
T ss_pred             CeECCCCCce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHHHHcC-
Confidence            9876543322  112246899999999986      456789999999999999999999999753211 011111110 


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                        .......+                     .......+.+++..|++ +|++|||+.++++
T Consensus       225 --~~~~~~~~---------------------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         225 --QRFLKFPE---------------------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             --CCccCCCC---------------------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence              00000000                     00113457788889997 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.6e-36  Score=322.08  Aligned_cols=203  Identities=23%  Similarity=0.306  Sum_probs=162.4

Q ss_pred             cCccCCCcceEEEEeEEC--CCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          553 SNMIGQGSFGSVYKGILG--GEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      .++||+|+||+||+|++.  .+++.||+|.++...  ....+.+|++++++++||||+++++++.....   ...++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHAD---RKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCC---cEEEEEEe
Confidence            468999999999999975  366889999986432  23567899999999999999999998865432   36899999


Q ss_pred             eccCCCHHHHhhhcCCc---ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec----CCccccc-cc
Q 043388          631 YMENGSLEDWLHQSNDH---LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD----HDMVAHQ-NF  702 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~----~~~~~~~-Df  702 (854)
                      |+++ +|.+++......   .....+++..+..++.||+.||+|||+.   +|+||||||+|||++    .++..++ ||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            9965 898887643211   1122588999999999999999999999   999999999999994    3344554 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      |+++................||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9998776543332233345789999999998774 5899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.4e-36  Score=315.40  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=200.8

Q ss_pred             hhccccCccCCCcceEEEEeEECCCce---EEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .+|++.+.||+|+||.||+|.+..++.   .||+|+++.. .......+.+|+.++++++||||+++++++....     
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR-----   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC-----
Confidence            568899999999999999999876553   6999998754 2334567999999999999999999999986554     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++.....     .+++.+++.++.|++.||+|||+.   +++||||||+||+++.+...++ ||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df  150 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF  150 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence            67999999999999999976532     678999999999999999999999   9999999999999998877766 99


Q ss_pred             ccccccccCCCCCCcc--cccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcC
Q 043388          703 SLSHQLDSASKTPSSS--IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      |.+.............  .+...+..|+|||++.+..++.++|||||||++||+++ |..||......  .....+....
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~  228 (269)
T cd05065         151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDY  228 (269)
T ss_pred             ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCC
Confidence            9987664432221111  11112457999999998899999999999999999887 99998643211  1111111100


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      .                          .+...+++..+.+++.+||+.+|.+||++.+|+..|+++
T Consensus       229 ~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 R--------------------------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             c--------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0                          001122345678999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.4e-36  Score=324.76  Aligned_cols=243  Identities=24%  Similarity=0.317  Sum_probs=188.9

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||.||+|+...+++.||+|+++...   ....+.+.+|+.++.++ +||+|+++++++....     ..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS-----RLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-----EEEEEE
Confidence            46999999999999999899999999997532   23345678899999888 6999999999987655     689999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||+++..
T Consensus        76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            9999999999887654      689999999999999999999999   9999999999999998877776 99998754


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC-CchHhHHhhhcCCccccccc
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE-GLTLHEFVKMTLPEKVIEIV  787 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  787 (854)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....++..........   
T Consensus       147 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---  220 (327)
T cd05617         147 LGPGDT---TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI---  220 (327)
T ss_pred             cCCCCc---eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---
Confidence            322211   12356999999999999999999999999999999999999999753221 11111111110000000   


Q ss_pred             CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHH
Q 043388          788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR  836 (854)
Q Consensus       788 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  836 (854)
                                          ..+...+..+.+++.+|++.||++||++.
T Consensus       221 --------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         221 --------------------RIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence                                00011134567899999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.1e-36  Score=311.61  Aligned_cols=239  Identities=23%  Similarity=0.387  Sum_probs=184.5

Q ss_pred             CccCCCcceEEEEeEECC------------CceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          554 NMIGQGSFGSVYKGILGG------------EEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      +.||+|+||.||+|....            ....||+|++..........+.+|+.+++.++||||+++++++....   
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~---   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV---   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            468999999999998642            23368999887665555567889999999999999999999987654   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc-----
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-----  696 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----  696 (854)
                        ..++||||+++|+|..++.....     .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++     
T Consensus        78 --~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~  147 (262)
T cd05077          78 --ENIMVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC  147 (262)
T ss_pred             --CCEEEEecccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCC
Confidence              56899999999999998875432     688999999999999999999999   999999999999998654     


Q ss_pred             ---ccccccccccccccCCCCCCcccccCCcccccCccccC-CCCCCccchhHHHHHHHHHHH-hCCCCCCCcccCCchH
Q 043388          697 ---VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM-GSEASMTGDVYSFGILLLEMF-TGRRPTDAAFTEGLTL  771 (854)
Q Consensus       697 ---~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvvl~ell-tg~~pf~~~~~~~~~~  771 (854)
                         ++..|||.+.......       ...++..|+|||++. +..++.++|||||||++|||+ +|+.||......  ..
T Consensus       148 ~~~~~l~d~g~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~  218 (262)
T cd05077         148 GPFIKLSDPGIPITVLSRQ-------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--EK  218 (262)
T ss_pred             CceeEeCCCCCCccccCcc-------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--HH
Confidence               2344999886553321       234788999999886 456899999999999999998 588887643211  01


Q ss_pred             hHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          772 HEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       772 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                      ..+.....     ....                       .....+.+++.+||+.||.+||++.++++.+
T Consensus       219 ~~~~~~~~-----~~~~-----------------------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         219 ERFYEGQC-----MLVT-----------------------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHHhcCc-----cCCC-----------------------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            11100000     0000                       0134578899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.7e-36  Score=315.11  Aligned_cols=251  Identities=22%  Similarity=0.314  Sum_probs=197.8

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      .|++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++||||+++++++....     ..++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-----EEEEE
Confidence            3678899999999999999999899999999997665555678899999999999999999999987654     68999


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQ  707 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~  707 (854)
                      |||+++++|..++.....     .+++..+..++.|++.||+|||+.   +++||||||+||+++.++..++ |||++..
T Consensus        81 ~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~  152 (282)
T cd06643          81 IEFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK  152 (282)
T ss_pred             EEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccc
Confidence            999999999998865332     689999999999999999999999   9999999999999998887776 9999876


Q ss_pred             cccCCCCCCcccccCCcccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          708 LDSASKTPSSSIGIKGTVGYVAPEYGM-----GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       708 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      .......   .....++..|+|||++.     +..++.++|||||||++|||++|++||...... ...........+  
T Consensus       153 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~--  226 (282)
T cd06643         153 NTRTIQR---RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPP--  226 (282)
T ss_pred             ccccccc---cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-HHHHHHhhcCCC--
Confidence            5432221   12245899999999874     345788999999999999999999998753211 111111110000  


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                        ...                     ....++..+.+++.+||+.||.+||++.++++.
T Consensus       227 --~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         227 --TLA---------------------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             --CCC---------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              000                     011124567899999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7e-36  Score=316.90  Aligned_cols=274  Identities=22%  Similarity=0.285  Sum_probs=197.6

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.+.||+|++|.||+|+...++..||+|+++...  ....+.+.+|+.++++++||||+++++++....     ..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-----RLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-----eEE
Confidence            5788899999999999999998889999999986432  233467889999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||++ ++|.+++.....   ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  148 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA  148 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence            9999997 589888865432   12688999999999999999999999   9999999999999999887776 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc--CCcc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LPEK  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~  782 (854)
                      ..........   ....+++.|+|||++.+. .++.++|||||||++|||+||++||........ ........  ....
T Consensus       149 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~  224 (285)
T cd07861         149 RAFGIPVRVY---THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTED  224 (285)
T ss_pred             eecCCCcccc---cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChh
Confidence            7654432211   123478899999987664 478999999999999999999999975422111 11111100  0000


Q ss_pred             cccccCchhhHHHhh-ccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMA-NNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .+.... . ...... ...............+..++.+++.+||+.||++|||+.+|++
T Consensus       225 ~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         225 VWPGVT-S-LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhcch-h-hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000 0 000000 0000000000111123567789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.5e-36  Score=348.00  Aligned_cols=258  Identities=20%  Similarity=0.291  Sum_probs=197.7

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ...+|.+.+.||+|+||+||+|.+..++..||+|++....  ......+.+|+.++++++|||||+++++|.....   .
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~---~   87 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN---Q   87 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC---C
Confidence            4578999999999999999999999899999999987542  2335678899999999999999999998865432   2


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCC----CCeEeecCCCCceEecCC----
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQ----PPIVHGDLKPSNVLLDHD----  695 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~Dlkp~NIll~~~----  695 (854)
                      ..|+||||+++|+|.+++......  ...+++..++.|+.||+.||+|||+...    .+||||||||+|||++.+    
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            689999999999999999764211  1268999999999999999999998521    259999999999999643    


Q ss_pred             -------------c-ccccccccccccccCCCCCCcccccCCcccccCccccCC--CCCCccchhHHHHHHHHHHHhCCC
Q 043388          696 -------------M-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG--SEASMTGDVYSFGILLLEMFTGRR  759 (854)
Q Consensus       696 -------------~-~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~  759 (854)
                                   . ++++|||++.........    ....||+.|+|||++.+  ..++.++|||||||++|||+||+.
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~----~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~  241 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMA----HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT  241 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccc----cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence                         2 344599999876443221    22469999999999864  458899999999999999999999


Q ss_pred             CCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 043388          760 PTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVV  839 (854)
Q Consensus       760 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  839 (854)
                      ||.....    ...+........     +  .                 .....+..+.+++..||+.+|.+||++.|++
T Consensus       242 PF~~~~~----~~qli~~lk~~p-----~--l-----------------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL  293 (1021)
T PTZ00266        242 PFHKANN----FSQLISELKRGP-----D--L-----------------PIKGKSKELNILIKNLLNLSAKERPSALQCL  293 (1021)
T ss_pred             CCCcCCc----HHHHHHHHhcCC-----C--C-----------------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence            9974321    111111100000     0  0                 0011145578899999999999999999998


Q ss_pred             H
Q 043388          840 A  840 (854)
Q Consensus       840 ~  840 (854)
                      .
T Consensus       294 ~  294 (1021)
T PTZ00266        294 G  294 (1021)
T ss_pred             c
Confidence            4

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.8e-36  Score=315.75  Aligned_cols=259  Identities=25%  Similarity=0.413  Sum_probs=201.2

Q ss_pred             hhccccCccCCCcceEEEEeEEC-----CCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILG-----GEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .+|...++||+|+||.||+|...     .++..+|+|.+..........+.+|++++++++|+||+++++++....    
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR----   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC----
Confidence            56788899999999999999752     356789999987665555678999999999999999999999987654    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDH---------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD  693 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  693 (854)
                       ..++||||+++|+|.+++......         .....+++.+++.++.|++.|++|||+.   +++||||||+||+++
T Consensus        81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~  156 (280)
T cd05092          81 -PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG  156 (280)
T ss_pred             -ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence             579999999999999999865321         0112578999999999999999999999   999999999999999


Q ss_pred             CCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchH
Q 043388          694 HDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTL  771 (854)
Q Consensus       694 ~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~  771 (854)
                      +++..++ |||++.......... ......+++.|+|||+..+..++.++|||||||++|||++ |++||......  ..
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~  233 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYR-VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EA  233 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceee-cCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HH
Confidence            8887776 999987654322111 1112235788999999998889999999999999999998 99998643211  11


Q ss_pred             hHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          772 HEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       772 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      ..........                          .....++..+.+++.+||+.||.+||++.||.+.|+
T Consensus       234 ~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 IECITQGREL--------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHcCccC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1111000000                          001122456789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.8e-36  Score=318.30  Aligned_cols=269  Identities=22%  Similarity=0.271  Sum_probs=205.2

Q ss_pred             ccHHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeec
Q 043388          538 ISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSS  616 (854)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  616 (854)
                      +.++.+..+.++|++.+.||+|+||.||+|.+..+++.||+|+++.... ....+.+|+.+++++ +||||+++++++..
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            4445666678899999999999999999999998999999998864322 235678899999999 69999999999865


Q ss_pred             cCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc
Q 043388          617 IDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM  696 (854)
Q Consensus       617 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  696 (854)
                      .........++||||+++++|.+++......  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~  161 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG  161 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence            4434445789999999999999988643211  12678889999999999999999999   999999999999999988


Q ss_pred             cccc-ccccccccccCCCCCCcccccCCcccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch
Q 043388          697 VAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-----SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT  770 (854)
Q Consensus       697 ~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~  770 (854)
                      ..++ |||++..........   ....|++.|+|||++..     ..++.++||||+||++|||++|+.||......   
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---  235 (286)
T cd06638         162 GVKLVDFGVSAQLTSTRLRR---NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---  235 (286)
T ss_pred             CEEEccCCceeecccCCCcc---ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---
Confidence            7766 999988764432211   12358999999998753     44788999999999999999999998743211   


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                       ....... ........++                     ..+...+.+++.+||+.||++|||+.|+++.
T Consensus       236 -~~~~~~~-~~~~~~~~~~---------------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         236 -RALFKIP-RNPPPTLHQP---------------------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -HHHhhcc-ccCCCcccCC---------------------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence             1111000 0000000011                     1113457889999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-36  Score=325.55  Aligned_cols=237  Identities=27%  Similarity=0.317  Sum_probs=185.0

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHH-HHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECE-ALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||+||+|++..+++.||+|++....   ......+.+|.. +++.++||||+++++++...+     ..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~-----~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD-----KLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC-----EEEEEE
Confidence            46999999999999999899999999996432   222344555554 467789999999999987655     689999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||++...
T Consensus        76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            9999999999987654      678899999999999999999999   9999999999999998877776 99998754


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+.......... . ..
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~-~-~~  216 (323)
T cd05575         147 IEHSK---TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNKPL-R-LK  216 (323)
T ss_pred             ccCCC---ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCCC-C-CC
Confidence            32221   12234699999999999998999999999999999999999999975321     111111110000 0 00


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR  836 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  836 (854)
                                            ...+..+.+++.+|++.||.+||++.
T Consensus       217 ----------------------~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 ----------------------PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ----------------------CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                                  01144577899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.1e-36  Score=316.28  Aligned_cols=274  Identities=24%  Similarity=0.378  Sum_probs=206.6

Q ss_pred             hhccccCccCCCcceEEEEeEECC----CceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG----EEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ++|...+.||+|+||.||+|++..    ++..||+|+++..... ..+.+.+|++++++++|+||+++++++...+   .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~---~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPG---G   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCC---C
Confidence            467788999999999999999753    4789999999755443 4578999999999999999999999886533   2


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++||||+++++|.+++.....     .+++..+..++.|++.||+|||+.   +++||||||+||+++.++..++ |
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  152 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD  152 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence            367999999999999999986542     589999999999999999999999   9999999999999999887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.+.................++..|+|||...+..++.++||||||+++|||++|+.|+.........   +.......
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~  229 (284)
T cd05038         153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQ  229 (284)
T ss_pred             cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---cccccccc
Confidence            999988764332221121234567799999998888999999999999999999999998653221100   00000000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      .    ..+.... ....     ..+......++.++.+++.+||+.+|++||||.||+++|+++
T Consensus       230 ~----~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         230 M----IVTRLLE-LLKE-----GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             c----cHHHHHH-HHHc-----CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            0    0000000 0000     001111223456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-35  Score=311.08  Aligned_cols=252  Identities=21%  Similarity=0.330  Sum_probs=194.2

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-----ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      +|...+.||+|+||.||+|....++..||+|++....     ....+.+.+|+.++++++||||+++++++....   ..
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA---EK   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC---CC
Confidence            6888999999999999999998889999999886432     123456888999999999999999999876532   12


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..+++|||+++++|.+++....      .+++...+.++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~df  150 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDF  150 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence            6789999999999999997654      578888999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |++.................++..|+|||++.+..++.++|||||||++||+++|+.||.....    ......... ..
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~~~~-~~  225 (266)
T cd06651         151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIAT-QP  225 (266)
T ss_pred             CCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHHHhc-CC
Confidence            9988664432222222234588999999999988899999999999999999999999974311    111110000 00


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                          ..+..                  ...+...+.+++ .||..+|++||+++||++
T Consensus       226 ----~~~~~------------------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 ----TNPQL------------------PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ----CCCCC------------------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                00000                  111133455565 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-36  Score=317.96  Aligned_cols=267  Identities=24%  Similarity=0.342  Sum_probs=197.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCC--------------ceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGE--------------EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIIT  612 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~  612 (854)
                      ++|++.+.||+|+||.||+|...+.              ...||+|.++... ......+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5789999999999999999987532              3358999986542 233457889999999999999999999


Q ss_pred             EeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCc------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 043388          613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDH------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLK  686 (854)
Q Consensus       613 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  686 (854)
                      ++....     ..++||||+++++|.+++......      .....+++..++.++.|++.||+|||+.   +++|||||
T Consensus        85 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk  156 (295)
T cd05097          85 VCVSDD-----PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA  156 (295)
T ss_pred             EEcCCC-----ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence            987654     679999999999999999654210      0112468889999999999999999999   99999999


Q ss_pred             CCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh--CCCCCCC
Q 043388          687 PSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT--GRRPTDA  763 (854)
Q Consensus       687 p~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt--g~~pf~~  763 (854)
                      |+||+++.++..++ |||++.......... ......++..|+|||+..+..++.++|||||||++|||++  |..||..
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCccee-ccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            99999998876666 999997654332111 1112345788999999988889999999999999999998  6667764


Q ss_pred             cccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          764 AFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       764 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      ....  ...................                   .....++..+.+++.+||+.||++|||+++|++.|.
T Consensus       236 ~~~~--~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         236 LSDE--QVIENTGEFFRNQGRQIYL-------------------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             cChH--HHHHHHHHhhhhccccccC-------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            3211  1111000000000000000                   000112456889999999999999999999999886


Q ss_pred             h
Q 043388          844 H  844 (854)
Q Consensus       844 ~  844 (854)
                      +
T Consensus       295 ~  295 (295)
T cd05097         295 E  295 (295)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-37  Score=318.76  Aligned_cols=244  Identities=25%  Similarity=0.339  Sum_probs=197.2

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc---chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      |.-.+.||.|+||.||-|++..+...||||.+....+.   ...++.+|+..+.+++|||+|.+.|+|-...     ..|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-----TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-----TAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-----hHH
Confidence            44456799999999999999999999999999755433   3567899999999999999999999986544     679


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +|||||-| |-.+++.-.+.     ++.+.++..|+.+.++||+|||+.   +.||||||+.|||+++.+++++ |||.|
T Consensus       103 LVMEYClG-SAsDlleVhkK-----plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSA  173 (948)
T KOG0577|consen  103 LVMEYCLG-SASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSA  173 (948)
T ss_pred             HHHHHHhc-cHHHHHHHHhc-----cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccch
Confidence            99999954 99998887654     788899999999999999999999   9999999999999999998887 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGM---GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      ....+..       .++|||.|||||++.   .+.|+-|+||||+|+++.|+.-.++|+.....- ..+..+.....   
T Consensus       174 si~~PAn-------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIAQNes---  242 (948)
T KOG0577|consen  174 SIMAPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNES---  242 (948)
T ss_pred             hhcCchh-------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHHhcCC---
Confidence            8776543       257999999999865   478999999999999999999999997643211 01111111100   


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                            |.+                 ...++...+..++..|++.-|.+|||..+++..
T Consensus       243 ------PtL-----------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  243 ------PTL-----------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ------CCC-----------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                  000                 112346678899999999999999999988754

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1e-35  Score=316.56  Aligned_cols=250  Identities=22%  Similarity=0.306  Sum_probs=201.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|||++++++++...+     ..++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD-----ELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc-----eEEE
Confidence            35889999999999999999998899999999997665555678899999999999999999999987654     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|.+++...       .+++.++..++.|++.|++|||+.   +++||||||+||+++.++..++ |||++.
T Consensus        94 v~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          94 VMEYLAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             EEEecCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence            99999999999988643       578999999999999999999999   9999999999999998877776 999988


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .........   ....|+..|+|||.+.+..++.++|||||||++|++++|+.||....... ........ ....   .
T Consensus       164 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-~~~~~~~~-~~~~---~  235 (296)
T cd06655         164 QITPEQSKR---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATN-GTPE---L  235 (296)
T ss_pred             hcccccccC---CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc-CCcc---c
Confidence            664432211   12358899999999988889999999999999999999999997542211 11111000 0000   0


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                           .....+...+.+++.+||..||++|||+.++++.
T Consensus       236 ---------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         236 ---------------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ---------------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                                 0011124457789999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.4e-35  Score=309.81  Aligned_cols=252  Identities=25%  Similarity=0.441  Sum_probs=199.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|.+.++||+|+||.||+|... ++..||+|.+..... ..+++.+|+.++++++|+||+++++++.. +     ..++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-----~~~~   77 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-E-----PIYI   77 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-C-----CcEE
Confidence            57889999999999999999976 677899999875433 34678999999999999999999998642 2     4799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|.+++......    .+++.++..++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+.
T Consensus        78 v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  150 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGI----KLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLAR  150 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCccee
Confidence            99999999999998765322    688999999999999999999999   9999999999999999887776 999997


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........  .....++..|+|||++.+..++.++|||||||++||+++ |+.||......  ...+.........   
T Consensus       151 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~---  223 (260)
T cd05067         151 LIEDNEYTA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYRMP---  223 (260)
T ss_pred             ecCCCCccc--ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCCCC---
Confidence            765322211  112346788999999988889999999999999999999 99999754211  1111111100000   


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                                             ....++.++.+++.+|++.+|++|||++++.+.|+.
T Consensus       224 -----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 -----------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                                   001124568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.8e-36  Score=315.32  Aligned_cols=261  Identities=24%  Similarity=0.382  Sum_probs=200.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECC-----CceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      ..+|.+.+.||+|+||.||+|.+..     ++..||+|+++..... ..+.+.+|+.++..++||||+++++++....  
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--   81 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ--   81 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--
Confidence            3568888999999999999998753     3578999999754332 2456889999999999999999999987655  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCce
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV  690 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  690 (854)
                         ..++++||+++++|.+++......          .....+++..+..++.|++.||+|+|+.   +|+||||||+||
T Consensus        82 ---~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Ni  155 (283)
T cd05091          82 ---PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNV  155 (283)
T ss_pred             ---ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhhe
Confidence               579999999999999998643210          1122578889999999999999999999   999999999999


Q ss_pred             EecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCC
Q 043388          691 LLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEG  768 (854)
Q Consensus       691 ll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~  768 (854)
                      +++++...++ |||+++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... 
T Consensus       156 l~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-  233 (283)
T cd05091         156 LVFDKLNVKISDLGLFREVYAADYYK-LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-  233 (283)
T ss_pred             EecCCCceEecccccccccccchhee-eccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            9998876665 999988764432211 1112346789999999988889999999999999999998 88888643211 


Q ss_pred             chHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       769 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                       ...+.+.   .....                       ....+++..+.+++..||+.+|++||+++||++.|+.
T Consensus       234 -~~~~~i~---~~~~~-----------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 -DVIEMIR---NRQVL-----------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HHHHHHH---cCCcC-----------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             1111111   10000                       0112335668899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-35  Score=313.79  Aligned_cols=261  Identities=23%  Similarity=0.377  Sum_probs=202.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCC-----ceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGE-----EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|.+.+.||+|+||.||+|.+...     +..||+|.+.... ......+.+|+.+++.++||||+++++++....  
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ--   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC--
Confidence            35889999999999999999998643     4789999986443 233457889999999999999999999987654  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcc----cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHL----EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM  696 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  696 (854)
                         ..++||||+++|+|.+++.......    ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        83 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~  156 (277)
T cd05032          83 ---PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             ---CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence               6899999999999999997643211    122578899999999999999999999   999999999999999998


Q ss_pred             cccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHH
Q 043388          697 VAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEF  774 (854)
Q Consensus       697 ~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~  774 (854)
                      ..++ |||.++......... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||......  .....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~  233 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKF  233 (277)
T ss_pred             CEEECCcccchhhccCcccc-cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHH
Confidence            8877 999988665433211 1112346789999999988889999999999999999998 99998643211  11111


Q ss_pred             hhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          775 VKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       775 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                      ...   .....                       .+..++..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       234 ~~~---~~~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         234 VID---GGHLD-----------------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             Hhc---CCCCC-----------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            110   00000                       011124568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-35  Score=310.54  Aligned_cols=254  Identities=23%  Similarity=0.416  Sum_probs=192.2

Q ss_pred             CccCCCcceEEEEeEECC---CceEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGG---EEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||.||+|.+..   ....||+|.+... .....+.+.+|+.+++.++||||+++++++...+.    ..++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG----SPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC----CcEEEE
Confidence            468999999999998742   3567999988543 23345678899999999999999999998764331    468999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++.....     ..++..+..++.|++.||+|||+.   +++||||||+||+++.++..++ |||.++..
T Consensus        77 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~  148 (262)
T cd05058          77 PYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI  148 (262)
T ss_pred             ecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence            99999999999976432     457778889999999999999999   9999999999999999887776 99999765


Q ss_pred             ccCCCC-CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhC-CCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          709 DSASKT-PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTG-RRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       709 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      ...... ........++..|+|||+..+..++.++|||||||++|||++| .+||....  ..........   ...   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~---~~~---  220 (262)
T cd05058         149 YDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQ---GRR---  220 (262)
T ss_pred             cCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhc---CCC---
Confidence            432211 1111123467889999999888899999999999999999995 55554321  1111111110   000   


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                                          ......++..+.+++..||+.+|++||++.||++.|+++..
T Consensus       221 --------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         221 --------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             --------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                                00001124568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-36  Score=315.47  Aligned_cols=240  Identities=23%  Similarity=0.360  Sum_probs=185.5

Q ss_pred             CccCCCcceEEEEeEECCCce-------EEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          554 NMIGQGSFGSVYKGILGGEEM-------IVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +.||+|+||.||+|.....+.       .||+|.+........+.+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence            469999999999999865443       48888886555555567889999999999999999999987654     579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc---------
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV---------  697 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---------  697 (854)
                      +||||+++|+|.+++.....     .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.         
T Consensus        76 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~  147 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI  147 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceE
Confidence            99999999999999986542     578899999999999999999999   9999999999999987653         


Q ss_pred             cccccccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCC-CCCCCcccCCchHhHHh
Q 043388          698 AHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR-RPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       698 ~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~-~pf~~~~~~~~~~~~~~  775 (854)
                      ++.|||.+.......       ...++..|+|||++.+. .++.++|||||||++||+++|. .||......  ......
T Consensus       148 ~l~d~g~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~~~~  218 (258)
T cd05078         148 KLSDPGISITVLPKE-------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKLQFY  218 (258)
T ss_pred             EecccccccccCCch-------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHHHHH
Confidence            334999876553321       13578899999998874 5799999999999999999985 555422111  000110


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      ...  .   .                       .+.....++.+++.+||+.||++|||++++++.|+
T Consensus       219 ~~~--~---~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         219 EDR--H---Q-----------------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             Hcc--c---c-----------------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000  0   0                       00011345789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8e-36  Score=310.83  Aligned_cols=250  Identities=18%  Similarity=0.243  Sum_probs=199.4

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +|++.+.||+|+||.||++++..++..||+|.++.. .....+.+.+|+.+++.++|+||+++++++.+..     ..++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-----HLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EEEE
Confidence            478889999999999999999989999999998643 2334567889999999999999999999987655     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++|+|.+++......    .++...++.++.|++.||+|||+.   +|+|+||||+||+++.++..++ |||.+.
T Consensus        76 v~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRGK----LFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             EEeeCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence            99999999999998754321    578899999999999999999999   9999999999999998877776 999987


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .........   ....|+..|+|||++.+..++.++||||||+++|+|++|+.||.....     ............ ..
T Consensus       149 ~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~-~~  219 (255)
T cd08219         149 LLTSPGAYA---CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVCQGSY-KP  219 (255)
T ss_pred             eeccccccc---ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHhcCCC-CC
Confidence            665432211   124588999999999888899999999999999999999999974321     111111000000 00


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +                      ...+...+.+++.+||+.||++|||+.|++.+
T Consensus       220 ~----------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 L----------------------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             C----------------------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0                      01123457789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-35  Score=312.54  Aligned_cols=254  Identities=22%  Similarity=0.292  Sum_probs=195.9

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .+++.+.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.++++++|+||+++++++...+     .
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~   79 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG-----F   79 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC-----E
Confidence            34556666678999999999999998889999999987665555678899999999999999999999987654     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCccccccc--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC-Cccccc-
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKL--TLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQ-  700 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~~~-  700 (854)
                      .++||||+++++|.+++.....     .+  ++..+..++.|++.||+|||+.   +|+||||||+||+++. ++..++ 
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~  151 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKIS  151 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhcc-----cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEe
Confidence            8999999999999999986432     33  7788889999999999999999   9999999999999976 444554 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE--ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                      |||.+..........   ....|+..|+|||++.+..  ++.++|||||||++|++++|+.||.........  .+....
T Consensus       152 dfg~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~  226 (268)
T cd06624         152 DFGTSKRLAGINPCT---ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGM  226 (268)
T ss_pred             cchhheecccCCCcc---ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhh
Confidence            999987664322211   1235889999999986643  788999999999999999999998643211110  000000


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      . ..     .                  ......+...+.+++.+||+.+|.+|||+.|+++
T Consensus       227 ~-~~-----~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         227 F-KI-----H------------------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             h-cc-----C------------------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            0 00     0                  0001122455788999999999999999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-35  Score=316.22  Aligned_cols=264  Identities=27%  Similarity=0.419  Sum_probs=203.5

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCC-----ceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGE-----EMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSID  618 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  618 (854)
                      ..++|++.+.||+|+||.||+|.....     ...||+|++.... ......+.+|++++.++ +|+||+++++++...+
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            346799999999999999999998633     3789999987532 23345688999999999 8999999999987654


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPS  688 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~  688 (854)
                           ..++||||+++|+|.+++......          .....+++..++.++.|++.||+|||+.   +|+||||||+
T Consensus        90 -----~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~  161 (293)
T cd05053          90 -----PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR  161 (293)
T ss_pred             -----CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence                 579999999999999999753210          1123689999999999999999999999   9999999999


Q ss_pred             ceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCccc
Q 043388          689 NVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFT  766 (854)
Q Consensus       689 NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~  766 (854)
                      ||+++.++..++ |||.++.......... .....++..|+|||+..+..++.++|||||||++||+++ |..||.....
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHIDYYRK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             eEEEcCCCeEEeCccccccccccccceec-cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            999998887776 9999987654322111 111235678999999988889999999999999999998 9999864321


Q ss_pred             CCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          767 EGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       767 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                      .  ...........   .                       .....+...+.+++.+||..+|++|||+.|+++.|+++.
T Consensus       241 ~--~~~~~~~~~~~---~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 E--ELFKLLKEGYR---M-----------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             H--HHHHHHHcCCc---C-----------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1  11111110000   0                       001122456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-35  Score=316.07  Aligned_cols=266  Identities=24%  Similarity=0.388  Sum_probs=205.4

Q ss_pred             HHhhccccCccCCCcceEEEEeEEC-------CCceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeec
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILG-------GEEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSS  616 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  616 (854)
                      ...+|.+.+.||+|+||.||+|+..       .++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3578999999999999999999752       234579999986432 33456789999999999 89999999999876


Q ss_pred             cCCCCCceeeEEEeeccCCCHHHHhhhcCCcc----------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 043388          617 IDSKGADFKALVFEYMENGSLEDWLHQSNDHL----------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLK  686 (854)
Q Consensus       617 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  686 (854)
                      ..     ..++||||+++|+|.+++.......          ....+++.++..++.||+.||+|||+.   +|+|||||
T Consensus        93 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlk  164 (304)
T cd05101          93 DG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLA  164 (304)
T ss_pred             CC-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence            54     6799999999999999998653210          112578899999999999999999999   99999999


Q ss_pred             CCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCc
Q 043388          687 PSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAA  764 (854)
Q Consensus       687 p~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~  764 (854)
                      |+||+++.++..++ |||.++.......... .....+++.|+|||++.+..++.++|||||||++||+++ |..||...
T Consensus       165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         165 ARNVLVTENNVMKIADFGLARDVNNIDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             cceEEEcCCCcEEECCCccceeccccccccc-ccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999998887776 9999987754332211 112346778999999988889999999999999999998 78888643


Q ss_pred             ccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          765 FTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       765 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                      .     ..++........                       +......++..+.+++.+||+.+|.+|||+.|+++.|.+
T Consensus       244 ~-----~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         244 P-----VEELFKLLKEGH-----------------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             C-----HHHHHHHHHcCC-----------------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            2     111111110000                       000111235668899999999999999999999999998


Q ss_pred             hhhh
Q 043388          845 TRET  848 (854)
Q Consensus       845 ~~~~  848 (854)
                      +..-
T Consensus       296 ~~~~  299 (304)
T cd05101         296 ILTL  299 (304)
T ss_pred             HHHh
Confidence            8653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.5e-35  Score=307.89  Aligned_cols=252  Identities=27%  Similarity=0.451  Sum_probs=197.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|.+.+.||+|++|.||+|.+..+ ..||+|.+..... ..+.+.+|++++++++|+|++++++++...      ..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSEE------PIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcCC------CcEE
Confidence            5688999999999999999998744 4699998864432 346788999999999999999999987432      4689


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++|+|.+++.....    ..+++..+..++.|++.||+|||+.   +++||||||+||++++++..++ |||.+.
T Consensus        78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence            9999999999999976432    2578999999999999999999999   9999999999999999887776 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........  .....++..|+|||+..+..++.++|||||||++|||++ |+.||......  ...+........    
T Consensus       151 ~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~----  222 (260)
T cd05069         151 LIEDNEYTA--RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYRM----  222 (260)
T ss_pred             EccCCcccc--cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC----
Confidence            764432221  112346778999999988889999999999999999999 99998753221  111111110000    


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                                            ......+..+.+++.+||+.||++||++++|.+.|++
T Consensus       223 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 ----------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                                  0011224568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.9e-35  Score=316.71  Aligned_cols=266  Identities=25%  Similarity=0.385  Sum_probs=204.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECC-------CceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeecc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG-------EEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSI  617 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  617 (854)
                      .++|.+.+.||+|+||.||+|++.+       +...||+|.++... ......+.+|+++++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3689999999999999999998743       23569999997542 23345688899999999 799999999998765


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCcc----------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDHL----------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKP  687 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  687 (854)
                      +     ..++||||+++|+|.+++.......          ....+++.+++.++.|++.||+|||+.   +++||||||
T Consensus        97 ~-----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  168 (307)
T cd05098          97 G-----PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA  168 (307)
T ss_pred             C-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence            4     6799999999999999998653210          112588999999999999999999999   999999999


Q ss_pred             CceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcc
Q 043388          688 SNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAF  765 (854)
Q Consensus       688 ~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~  765 (854)
                      +||+++.++..++ |||.+........... .....++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKK-TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhc-cccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            9999998887776 9999876643221111 111234578999999988889999999999999999998 888886431


Q ss_pred             cCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          766 TEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       766 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ..  ...........                          ......+..++.+++.+||+.+|.+|||+.||++.|.++
T Consensus       248 ~~--~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         248 VE--ELFKLLKEGHR--------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HH--HHHHHHHcCCC--------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            11  11111111000                          001112245688899999999999999999999999998


Q ss_pred             hhhh
Q 043388          846 RETF  849 (854)
Q Consensus       846 ~~~~  849 (854)
                      .+..
T Consensus       300 ~~~~  303 (307)
T cd05098         300 LALT  303 (307)
T ss_pred             HHHh
Confidence            8754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.5e-36  Score=313.81  Aligned_cols=252  Identities=27%  Similarity=0.450  Sum_probs=196.1

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchH--HHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR--SFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      |++.+.||+|+||+||+|+...+++.||+|++.........  ...+|+.++++++||||+++++++....     ..++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN-----YLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS-----EEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc-----cccc
Confidence            67889999999999999999999999999999866433222  3456999999999999999999998754     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+.
T Consensus        76 v~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             EEEEETTEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             cccccccccccccccccc------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence            999999999999998433      789999999999999999999999   9999999999999998776665 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccC-CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGM-GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ......   .......++..|+|||+.. +..++.++||||+|+++|+|++|..||......  ...........     
T Consensus       147 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~-----  216 (260)
T PF00069_consen  147 KLSENN---ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILK-----  216 (260)
T ss_dssp             ESTSTT---SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHH-----
T ss_pred             cccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhccc-----
Confidence            652111   1222346899999999998 788999999999999999999999999854110  00000000000     


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                         +..            .............+.+++..||+.||++|||+.++++
T Consensus       217 ---~~~------------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  217 ---RPL------------PSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ---THH------------HHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ---ccc------------cccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000            0000000001267889999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.9e-35  Score=308.06  Aligned_cols=250  Identities=30%  Similarity=0.395  Sum_probs=197.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+|.+.+.||+|+||.||+|...  +..||+|.++...  ..+.+.+|+.++++++|+|++++++++...+    ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   76 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC----CceE
Confidence            357899999999999999999876  6679999886432  3467899999999999999999999865432    2579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++......    .+++..++.++.|++.||+|||++   +++||||||+||+++.++..++ |||++
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~  149 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  149 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccc
Confidence            999999999999999865421    578999999999999999999999   9999999999999998887776 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      .........      ..++..|+|||+..+..++.++|||||||++|||++ |+.||......  ............   
T Consensus       150 ~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~---  218 (256)
T cd05082         150 KEASSTQDT------GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKM---  218 (256)
T ss_pred             eeccccCCC------CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCCC---
Confidence            765433221      235678999999988889999999999999999998 99998643111  111111110000   


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                             .....++..+.+++.+|++.+|++|||+.++++.|+++
T Consensus       219 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 -----------------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                                   00112355688999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.3e-36  Score=319.60  Aligned_cols=275  Identities=21%  Similarity=0.303  Sum_probs=199.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|.+.+.||+|+||.||+|.+..++..||+|.++... ......+.+|+.++++++||||+++++++....     ..
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-----~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC-----eE
Confidence            357999999999999999999999889999999987443 233456788999999999999999999987654     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||++ ++|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~  150 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGL  150 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcc
Confidence            99999997 599998876432     578899999999999999999999   9999999999999999877776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh---cCC
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM---TLP  780 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~---~~~  780 (854)
                      +..........   ....+++.|+|||++.+. .++.++|||||||++|||++|++||....... ........   ...
T Consensus       151 ~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~  226 (301)
T cd07873         151 ARAKSIPTKTY---SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRILGTPTE  226 (301)
T ss_pred             hhccCCCCCcc---cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCh
Confidence            87654332221   123478999999987664 47889999999999999999999997543211 11111110   011


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..+....+........... ............+...+.+++.+|++.||.+|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         227 ETWPGILSNEEFKSYNYPK-YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hhchhhhccccccccccCc-cccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1111111100000000000 0000000111123456789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-35  Score=308.92  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=197.3

Q ss_pred             CccCCCcceEEEEeEECC-C--ceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGG-E--EMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~-~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ++||+|++|.||+|.+.. .  ...||+|.+..... ...+.+.+|+.++++++||||+++++++.. .     ..++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-----~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H-----PLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C-----eEEEEE
Confidence            468999999999999854 2  33699999976554 556789999999999999999999999875 2     679999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+...
T Consensus        75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~  147 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL  147 (257)
T ss_pred             EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence            99999999999987542    2689999999999999999999999   9999999999999998887776 99999887


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccccc
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV  787 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  787 (854)
                      ..............++..|+|||++.+..++.++|||||||++|||++ |+.||......  ...+..... ....    
T Consensus       148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~-~~~~----  220 (257)
T cd05040         148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKE-GERL----  220 (257)
T ss_pred             cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhc-CCcC----
Confidence            553322222223457889999999988889999999999999999999 99998643211  111111100 0000    


Q ss_pred             CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       788 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                                          .....++..+.+++.+|++.+|++|||+.|+++.|.
T Consensus       221 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 --------------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --------------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                                001122456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.2e-36  Score=327.82  Aligned_cols=204  Identities=22%  Similarity=0.271  Sum_probs=170.8

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CC
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KG  621 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~  621 (854)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++..... ..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3567899999999999999999999888999999998643  22334677899999999999999999998865432 12


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                      ....++||||+++ ++.+.+..        .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ 
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence            2357999999976 77776643        467888999999999999999999   9999999999999998887776 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      |||+++........    ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       162 Dfg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         162 DFGLARTAGTSFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             eCcccccCCCcccc----CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999865443221    2246899999999999988999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-36  Score=325.41  Aligned_cols=279  Identities=20%  Similarity=0.254  Sum_probs=199.7

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CC
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KG  621 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~  621 (854)
                      ...++|.+.+.||+|+||.||+|.+..++..||||++....  ....+.+.+|++++++++||||+++++++..... ..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999998899999999986432  2234567789999999999999999998764322 12


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                      ....+++||++ +++|.+++...       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ 
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence            23478999998 77999887643       688999999999999999999999   9999999999999999887776 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc-
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT-  778 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-  778 (854)
                      |||+++......      ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+.... 
T Consensus       161 Dfg~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~  233 (343)
T cd07878         161 DFGLARQADDEM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVG  233 (343)
T ss_pred             CCccceecCCCc------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhC
Confidence            999998764422      22468999999999877 56899999999999999999999999753211 1111111110 


Q ss_pred             -CCcccccccCchhhHHHhhccchh-hHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          779 -LPEKVIEIVDPSLLMEVMANNSMI-QEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       779 -~~~~~~~~~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                       ........+............... ..............+.+++.+|++.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             000011111111111100000000 000000111123457799999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.3e-36  Score=322.67  Aligned_cols=241  Identities=22%  Similarity=0.312  Sum_probs=189.9

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCce
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  624 (854)
                      +|...+.||+|+||.||+|++..+++.||+|+++..   .....+.+..|..++..+. |++|+++++++.+.+     .
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD-----R   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-----E
Confidence            467789999999999999999989999999999743   2333456788999988885 567888888876654     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence            899999999999999987654      688999999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +++........   .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........  . 
T Consensus       147 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~~~~~--~-  219 (323)
T cd05615         147 MCKEHMVDGVT---TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-ELFQSIMEHNV--S-  219 (323)
T ss_pred             cccccCCCCcc---ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC--C-
Confidence            98764332211   12346899999999999888999999999999999999999999754211 01111111000  0 


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM  835 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  835 (854)
                                               .+..+...+.+++.+|++.+|.+|++.
T Consensus       220 -------------------------~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 -------------------------YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -------------------------CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                                     001123456789999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.4e-36  Score=315.94  Aligned_cols=250  Identities=23%  Similarity=0.327  Sum_probs=196.2

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      |+..+.||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.++++++|++++++++.+.+.+     ..+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-----ALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-----EEE
Confidence            6777899999999999999999999999999864322   22345778999999999999999999987654     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....    ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++
T Consensus        77 lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA  149 (285)
T ss_pred             EEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccce
Confidence            99999999999999865432    2588999999999999999999999   9999999999999998877766 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........    ....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ..... ..... ..  
T Consensus       150 ~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~-~~~~~-~~--  220 (285)
T cd05630         150 VHVPEGQTI----KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV-ERLVK-EV--  220 (285)
T ss_pred             eecCCCccc----cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH-Hhhhh-hh--
Confidence            765432221    12468999999999998889999999999999999999999997532211 00000 00000 00  


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-----HHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-----MRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  840 (854)
                                          .......+...+.+++..||+.||++|||     +.|+++
T Consensus       221 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         221 --------------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             --------------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                                00011122455789999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-35  Score=307.64  Aligned_cols=250  Identities=30%  Similarity=0.448  Sum_probs=201.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+|++.+.||+|+||.||+|...  ++.||+|.++.... ..+++.+|+.++++++|+||+++++++....     ..+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN-----PLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC-----CeE
Confidence            457889999999999999999886  67899999975544 4578899999999999999999999987643     679


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++......    .+++..+..++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRA----VITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence            999999999999999765421    589999999999999999999999   9999999999999998887776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      ........      ...++..|+|||++.+..++.++||||||+++||+++ |+.||......  ............   
T Consensus       150 ~~~~~~~~------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~---  218 (256)
T cd05039         150 KEASQGQD------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEKGYRM---  218 (256)
T ss_pred             cccccccc------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhcCCCC---
Confidence            87743222      1235678999999988889999999999999999997 99998643211  111111110000   


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                                             .....++..+.+++.+||..+|++|||+.|++++|+++
T Consensus       219 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 -----------------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -----------------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                                   00112245688999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-35  Score=315.67  Aligned_cols=267  Identities=22%  Similarity=0.365  Sum_probs=198.8

Q ss_pred             hhccccCccCCCcceEEEEeEECC----------------CceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG----------------EEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKI  610 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~  610 (854)
                      ++|++.++||+|+||.||+|.+..                ++..||+|+++... .....++.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            468999999999999999986432                34579999987543 2334678999999999999999999


Q ss_pred             EEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcc-----cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 043388          611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-----EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDL  685 (854)
Q Consensus       611 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  685 (854)
                      ++++...+     ..++||||+++|+|.+++.......     ....+++.++..++.|++.||+|||+.   +++||||
T Consensus        85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl  156 (296)
T cd05095          85 LAVCITSD-----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL  156 (296)
T ss_pred             EEEEecCC-----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence            99987655     5799999999999999998653211     123578889999999999999999999   9999999


Q ss_pred             CCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh--CCCCCC
Q 043388          686 KPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT--GRRPTD  762 (854)
Q Consensus       686 kp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt--g~~pf~  762 (854)
                      ||+||+++.++..++ |||.+..+....... ......++..|+|||...++.++.++|||||||++|||++  |..||.
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence            999999998876665 999998664432211 1111235678999999888889999999999999999998  778876


Q ss_pred             CcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          763 AAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       763 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                      ......  .................                   .+....++..+.+++.+||+.||.+||++.||.+.|
T Consensus       236 ~~~~~~--~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l  294 (296)
T cd05095         236 QLSDEQ--VIENTGEFFRDQGRQVY-------------------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL  294 (296)
T ss_pred             ccChHH--HHHHHHHHHhhcccccc-------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            432211  10000000000000000                   000112346688999999999999999999999988


Q ss_pred             Hh
Q 043388          843 CH  844 (854)
Q Consensus       843 ~~  844 (854)
                      ++
T Consensus       295 ~~  296 (296)
T cd05095         295 LE  296 (296)
T ss_pred             hC
Confidence            63

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.4e-36  Score=322.69  Aligned_cols=276  Identities=17%  Similarity=0.165  Sum_probs=193.4

Q ss_pred             ccCccCCC--cceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          552 SSNMIGQG--SFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       552 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +.++||+|  +||+||++....+++.||+|+++...  ....+.+.+|+++++.++||||+++++++...+     ..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-----ELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----EEEE
Confidence            35789999  78999999999999999999997542  223456778999999999999999999997765     6899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++|+|.+++......    .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++..++ ||+.+.
T Consensus        77 v~e~~~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             EEeccCCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence            99999999999999764321    578999999999999999999999   9999999999999998876665 887654


Q ss_pred             ccccCCCCC----CcccccCCcccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          707 QLDSASKTP----SSSIGIKGTVGYVAPEYGMG--SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       707 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      .........    .......++..|+|||++.+  ..++.++|||||||++|||++|+.||........ .........+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~  228 (327)
T cd08227         150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVP  228 (327)
T ss_pred             ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCcc
Confidence            432211100    01112347788999999876  4589999999999999999999999975422211 1111111111


Q ss_pred             cccc---------------cccCchhhHHHh---hccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVI---------------EIVDPSLLMEVM---ANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~---------------~~~d~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ....               ...+........   ...........+....+...+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            0000               000000000000   00000000000111233567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-35  Score=309.74  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=193.3

Q ss_pred             CccCCCcceEEEEeEECCCce--EEEEEEeecc-cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEM--IVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||.||+|++..++.  .+|+|.++.. .....+.+.+|++++.++ +||||+++++++....     ..++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-----~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----YLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-----CceEEE
Confidence            469999999999999977664  4688888643 233446788999999999 8999999999987654     679999


Q ss_pred             eeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc
Q 043388          630 EYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~  699 (854)
                      ||+++|+|.+++......          .....+++.+++.++.|++.|++|||+.   +++||||||+||+++.++..+
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence            999999999999764311          1112578999999999999999999998   999999999999999888777


Q ss_pred             c-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhh
Q 043388          700 Q-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~  777 (854)
                      + |||++.........    .....+..|+|||+..+..++.++|||||||++|||++ |..||......     .....
T Consensus       153 l~dfgl~~~~~~~~~~----~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~  223 (270)
T cd05047         153 IADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEK  223 (270)
T ss_pred             ECCCCCccccchhhhc----cCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHH
Confidence            6 99998643221111    11224667999999988889999999999999999997 99998643211     11111


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                      .......                       .....+...+.+++.+||+.+|.+|||+.|+++.|.++.
T Consensus       224 ~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         224 LPQGYRL-----------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HhCCCCC-----------------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            0000000                       000112445789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-36  Score=327.35  Aligned_cols=238  Identities=25%  Similarity=0.304  Sum_probs=188.1

Q ss_pred             CccCCCcceEEEEeEE---CCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEE
Q 043388          554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      +.||+|+||.||+++.   ..+++.||+|+++...  ......+.+|++++++++||||+++++++...+     ..|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG-----KLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----EEEEE
Confidence            6799999999999886   3468899999997532  223345778999999999999999999987654     78999


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQ  707 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~  707 (854)
                      |||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||++..
T Consensus        77 ~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  147 (318)
T cd05582          77 LDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  147 (318)
T ss_pred             EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence            99999999999987653      689999999999999999999999   9999999999999998877766 9999876


Q ss_pred             cccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccccc
Q 043388          708 LDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV  787 (854)
Q Consensus       708 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  787 (854)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......     +.......... .  
T Consensus       148 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~i~~~~~-~--  216 (318)
T cd05582         148 SIDHEK---KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMTMILKAKL-G--  216 (318)
T ss_pred             cCCCCC---ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHHHHHcCCC-C--
Confidence            543321   122356999999999999888999999999999999999999999753211     11111000000 0  


Q ss_pred             CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHH
Q 043388          788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRD  837 (854)
Q Consensus       788 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e  837 (854)
                                           ....+...+.+++.+||+.||++||++.+
T Consensus       217 ---------------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 ---------------------MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ---------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                                 00112345778999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.8e-36  Score=323.70  Aligned_cols=242  Identities=26%  Similarity=0.318  Sum_probs=186.3

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHH-HHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECE-ALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||.||+|++..+++.||+|++....   ......+.+|.. +++.++||||+++++++...+     ..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~-----~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-----KLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-----eEEEEE
Confidence            46999999999999999899999999997432   122234444544 467789999999999987655     689999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+.+..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||+++..
T Consensus        76 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          76 DYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            9999999999997654      577888889999999999999999   9999999999999998877666 99998754


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      .....   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+........  .    ..
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~--~----~~  216 (325)
T cd05602         147 IEHNG---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILNKPL--Q----LK  216 (325)
T ss_pred             ccCCC---CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-HHHHHHHhCCc--C----CC
Confidence            33221   122356999999999999989999999999999999999999999743211 01111110000  0    00


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                            ......+.+++.+|++.||.+||++.+.+..
T Consensus       217 ----------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         217 ----------------------PNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             ----------------------CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence                                  0124457789999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.4e-35  Score=309.13  Aligned_cols=253  Identities=20%  Similarity=0.278  Sum_probs=195.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-----ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+....     ....+.+.+|+.++++++||||+++++++.+...   
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME---   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC---
Confidence            46889999999999999999999899999999886432     1224578889999999999999999998765431   


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++..++ |
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence            25789999999999999987654      578888999999999999999999   9999999999999999887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.+.................|+..|+|||.+.+..++.++|||||||++||+++|+.||......    ........ .
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~-~  224 (265)
T cd06652         150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIAT-Q  224 (265)
T ss_pred             CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHHHhc-C
Confidence            999886644322222222345899999999998888999999999999999999999998643111    11111000 0


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..    .+                  ..+......+.+++.+|+. +|++||+++|+++
T Consensus       225 ~~----~~------------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 PT----NP------------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CC----CC------------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            00    00                  0011223456678888884 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.6e-35  Score=315.56  Aligned_cols=267  Identities=24%  Similarity=0.406  Sum_probs=203.7

Q ss_pred             HhhccccCccCCCcceEEEEeEEC-------CCceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeecc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILG-------GEEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSI  617 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  617 (854)
                      .++|.+.+.||+|+||.||+|+..       .....||+|+++... ......+.+|+++++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            368899999999999999999863       234579999987432 23346788999999999 699999999998754


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKP  687 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  687 (854)
                      .     ..++||||+++|+|.+++......          .....+++.++..++.|++.||+|||+.   +|+||||||
T Consensus        91 ~-----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  162 (314)
T cd05099          91 G-----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA  162 (314)
T ss_pred             C-----ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence            4     679999999999999999764321          0113588999999999999999999999   999999999


Q ss_pred             CceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcc
Q 043388          688 SNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAF  765 (854)
Q Consensus       688 ~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~  765 (854)
                      +||+++.++..++ |||.++............ ...++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTS-NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccc-cCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            9999998886665 999998765432211111 1234568999999988889999999999999999999 889986432


Q ss_pred             cCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          766 TEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       766 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ..  ........   ....                       .....++.++.+++.+||+.+|++|||+.|+++.|.++
T Consensus       242 ~~--~~~~~~~~---~~~~-----------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         242 VE--ELFKLLRE---GHRM-----------------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HH--HHHHHHHc---CCCC-----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            11  11111110   0000                       00112245677899999999999999999999999998


Q ss_pred             hhhhh
Q 043388          846 RETFL  850 (854)
Q Consensus       846 ~~~~~  850 (854)
                      .....
T Consensus       294 ~~~~~  298 (314)
T cd05099         294 LAAVS  298 (314)
T ss_pred             HHHhc
Confidence            76543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=308.42  Aligned_cols=247  Identities=22%  Similarity=0.328  Sum_probs=201.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc--chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .-|...+.||+|.|+.|-+|++.-+|..||||+++...-+  ....+.+|++.|+-++|||||++|.+.....     ..
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-----Kl   92 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-----KL   92 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc-----eE
Confidence            4577789999999999999999999999999999765432  3456889999999999999999999986655     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-c-ccccccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-M-VAHQNFS  703 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~-~~~~Dfg  703 (854)
                      |+|+|.-++|+|++||-++..     .+.+.-+.+++.||+.|+.|+|+.   .+||||+||+||.+-+. + +++.|||
T Consensus        93 yLiLELGD~GDl~DyImKHe~-----Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEE-----GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhc-----cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence            999999999999999988764     688899999999999999999999   99999999999988553 4 4445999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      ++-.+.+...-.    ..+|+..|-|||++.|..| .+++||||+||++|.+++|++||+...+.+. +.          
T Consensus       165 FSNkf~PG~kL~----TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-LT----------  229 (864)
T KOG4717|consen  165 FSNKFQPGKKLT----TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-LT----------  229 (864)
T ss_pred             ccccCCCcchhh----cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-hh----------
Confidence            998887665433    3589999999999999876 4678999999999999999999987644321 11          


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                        .++|...                ..+.....+..++|..|+..||.+|.+.+||+.
T Consensus       230 --mImDCKY----------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  230 --MIMDCKY----------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             --hhhcccc----------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence              1222111                011223556789999999999999999999865

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.3e-35  Score=311.94  Aligned_cols=257  Identities=22%  Similarity=0.346  Sum_probs=201.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCC---ceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGE---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .+|.+.+.||+|+||.||+|.+...   ...||+|...... ....+.+.+|+.++++++||||+++++++...      
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN------   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC------
Confidence            4688889999999999999987533   4578999886554 33456789999999999999999999988642      


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +++||||||+||+++.++..++ ||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~  151 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDF  151 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccC
Confidence            36899999999999999976432     578999999999999999999999   9999999999999998877766 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |++...........  ....++..|+|||.+....++.++|||||||++||+++ |+.||.......  ........  .
T Consensus       152 g~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~--~  225 (270)
T cd05056         152 GLSRYLEDESYYKA--SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENG--E  225 (270)
T ss_pred             ceeeecccccceec--CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcC--C
Confidence            99887654422111  12235678999999888889999999999999999996 999997543211  11111000  0


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      .                        ......++..+.+++.+|+..+|++|||+.++++.|+++...
T Consensus       226 ~------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         226 R------------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             c------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            0                        001112345688999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-37  Score=329.42  Aligned_cols=257  Identities=25%  Similarity=0.402  Sum_probs=211.3

Q ss_pred             hccccCccCCCcceEEEEeEECCCc----eEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEE----MIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      +.+..++||+|+||+||+|.|.-.+    .+||+|++... ......++..|+-+|.+++|||++|++|+|....     
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence            3455689999999999999995444    36899988643 4455688999999999999999999999997654     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                       ..||++|++.|+|.++++.++.     .+.....+.|..|||+||.|||++   ++|||||.++||||.....++| ||
T Consensus       772 -~qlvtq~mP~G~LlDyvr~hr~-----~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdf  842 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREHRD-----NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDF  842 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHhhc-----cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEec
Confidence             6899999999999999998765     678889999999999999999999   9999999999999998887777 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |+++............ +..-.+.|||-|.+....++.++|||||||++||++| |..|++....+  .+.+..      
T Consensus       843 gla~ll~~d~~ey~~~-~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--eI~dll------  913 (1177)
T KOG1025|consen  843 GLAKLLAPDEKEYSAP-GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--EIPDLL------  913 (1177)
T ss_pred             chhhccCccccccccc-ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--HhhHHH------
Confidence            9999887765543322 2345678999999999999999999999999999999 99998754221  111111      


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                                          ..+.|.+.++.|...+..++.+||..|+..||+++++.+.+.++...
T Consensus       914 --------------------e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  914 --------------------EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             --------------------hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence                                11223445566778899999999999999999999999999887653

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=314.31  Aligned_cols=253  Identities=22%  Similarity=0.350  Sum_probs=201.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||.||+|.+..++..||+|+++.......+.+.+|++++++++||||+++++++....     ..+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN-----KLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC-----eEE
Confidence            357999999999999999999998889999999998766556678899999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....     .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        79 lv~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~  150 (280)
T cd06611          79 ILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS  150 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence            99999999999999876532     688999999999999999999999   9999999999999998887776 99988


Q ss_pred             cccccCCCCCCcccccCCcccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGM-----GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ..........   ....|++.|+|||.+.     +..++.++|||||||++|||++|+.||...... .....+.....+
T Consensus       151 ~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~  226 (280)
T cd06611         151 AKNKSTLQKR---DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKSEPP  226 (280)
T ss_pred             hhhccccccc---ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcCCCC
Confidence            7654432221   2245899999999874     344778999999999999999999999753211 111111110000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                           .++                    ....+...+.+++..||+.+|.+||++.++++.
T Consensus       227 -----~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 -----TLD--------------------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -----CcC--------------------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                 000                    011224457789999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.2e-35  Score=314.07  Aligned_cols=251  Identities=23%  Similarity=0.290  Sum_probs=198.0

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +.|++.++||+|+||.||+|++..++..||+|++........+.+.+|++++++++||||+++++++....     ..++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG-----KLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC-----eEEE
Confidence            56889999999999999999999889999999998766666678899999999999999999999987654     6899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|..++.....     .+++..+..++.|++.|++|||+.   +++||||||+||+++.++..++ |||.+.
T Consensus        87 v~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             EEecCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999988765432     688999999999999999999999   9999999999999998776666 999987


Q ss_pred             ccccCCCCCCcccccCCcccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGM-----GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      .........   ....++..|+|||++.     ...++.++|||||||++|||++|+.||...... .....+.....+ 
T Consensus       159 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~-  233 (292)
T cd06644         159 KNVKTLQRR---DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPP-  233 (292)
T ss_pred             ecccccccc---ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcCCCc-
Confidence            643322211   1245889999999874     345788999999999999999999998643211 111111110000 


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                         ...                     ....+...+.+++.+||..+|++||++.|+++
T Consensus       234 ---~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 ---TLS---------------------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ---cCC---------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               000                     01112345778999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-35  Score=313.84  Aligned_cols=256  Identities=21%  Similarity=0.316  Sum_probs=202.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|++.+.||+|+||+||+|.+..++..||+|++.... ....+.+.+|+++++.++||||+++++++....     ..
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~   78 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-----NI   78 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC-----EE
Confidence            367889999999999999999999889999999986543 334567899999999999999999999987764     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++++|.+++...+      .+++..+..++.+++.||.|||+..  +++||||||+||+++.++..++ |||+
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl  150 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGV  150 (284)
T ss_pred             EEEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCc
Confidence            99999999999999987654      6789999999999999999999732  8999999999999998887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCc------hHhHHhhhc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL------TLHEFVKMT  778 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~------~~~~~~~~~  778 (854)
                      +........     ....|+..|+|||++.+..++.++|||||||++||+++|+.||........      ....+....
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd06620         151 SGELINSIA-----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI  225 (284)
T ss_pred             ccchhhhcc-----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence            865533221     124689999999999888899999999999999999999999985432210      001111100


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                      ..+.                      .......+++..+.+++.+|++.||++|||+.|+++..
T Consensus       226 ~~~~----------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         226 VQEP----------------------PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             hhcc----------------------CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0000                      00000112356688999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.7e-35  Score=313.24  Aligned_cols=250  Identities=21%  Similarity=0.301  Sum_probs=194.8

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      |+..+.||+|+||+||+|.+..+++.||+|.+....   ......+.+|++++++++|+||+++.+++...+     ..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-----ALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-----EEE
Confidence            667789999999999999999899999999986432   222345788999999999999999999887654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++..++ |||++
T Consensus        77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             EEEEeccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence            99999999999998875432    1689999999999999999999999   9999999999999998877766 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........    ....|+..|+|||++.+..++.++|||||||++||+++|+.||....... ....+... ..... .
T Consensus       150 ~~~~~~~~~----~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~-~~~~~-~  222 (285)
T cd05632         150 VKIPEGESI----RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRR-VLETE-E  222 (285)
T ss_pred             eecCCCCcc----cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-hhccc-c
Confidence            765432211    22468999999999988889999999999999999999999997532110 11111110 00000 0


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-----HHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-----MRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  840 (854)
                      .                      ....+...+.+++..|++.||++||+     ++++++
T Consensus       223 ~----------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 V----------------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             c----------------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            0                      00112445778999999999999999     566655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.3e-36  Score=328.80  Aligned_cols=208  Identities=21%  Similarity=0.310  Sum_probs=175.1

Q ss_pred             HHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeec
Q 043388          540 YAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSS  616 (854)
Q Consensus       540 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  616 (854)
                      ..++....++|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            334555668999999999999999999999999999999998642   22234557889999999999999999999876


Q ss_pred             cCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc
Q 043388          617 IDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM  696 (854)
Q Consensus       617 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  696 (854)
                      ..     +.++||||+++|+|.+++...       .++...+..++.||+.||+|||+.   +|+||||||+||+++.++
T Consensus       115 ~~-----~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~  179 (371)
T cd05622         115 DR-----YLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG  179 (371)
T ss_pred             CC-----EEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCC
Confidence            54     789999999999999998753       467888899999999999999999   999999999999999888


Q ss_pred             cccc-ccccccccccCCCCCCcccccCCcccccCccccCCC----CCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          697 VAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS----EASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       697 ~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ..++ |||++..........  .....||+.|+|||++.+.    .++.++|||||||++|||++|+.||...
T Consensus       180 ~ikL~DfG~a~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         180 HLKLADFGTCMKMNKEGMVR--CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             CEEEEeCCceeEcCcCCccc--ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence            7776 999998765432211  1235699999999998653    3789999999999999999999999753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.4e-35  Score=311.82  Aligned_cols=266  Identities=24%  Similarity=0.363  Sum_probs=206.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECC----CceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG----EEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      .++|.+.+.||+|+||.||+|.+..    .+..||+|++.... ....+.+.+|+.++++++|+||+++++++...+   
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG---   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC---
Confidence            4689999999999999999999874    26789999886432 233567889999999999999999999886542   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCc--ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDH--LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~  699 (854)
                       ...++++||+++|+|.+++......  .....+++.+++.++.|++.||+|||+.   +++||||||+||+++.++..+
T Consensus        82 -~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          82 -EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             -CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence             2578999999999999999765321  1113689999999999999999999999   999999999999999888777


Q ss_pred             c-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhh
Q 043388          700 Q-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~  777 (854)
                      + |||+++.+........ .....++..|+|||++.+..++.++|||||||++||+++ |+.||.....  ..+..+...
T Consensus       158 l~d~g~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~  234 (280)
T cd05043         158 ITDNALSRDLFPMDYHCL-GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKD  234 (280)
T ss_pred             ECCCCCcccccCCceEEe-CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHc
Confidence            6 9999986644322111 111246778999999988889999999999999999999 9999874321  112221111


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ....                          .....++.++.+++.+||..||++|||+.|+++.|+++.++
T Consensus       235 ~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         235 GYRL--------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCC--------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            1000                          00112245688999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.1e-35  Score=314.98  Aligned_cols=268  Identities=22%  Similarity=0.338  Sum_probs=201.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCC----------------ceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGE----------------EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIK  609 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  609 (854)
                      .++|++.+.||+|+||.||+|.+...                +..||+|++.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            46789999999999999999987643                3568999987543 234567889999999999999999


Q ss_pred             EEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcc-----cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 043388          610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-----EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGD  684 (854)
Q Consensus       610 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  684 (854)
                      +++++...+     ..++||||+++++|.+++.......     ....+++..++.++.|++.||+|||+.   +|+|||
T Consensus        84 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d  155 (296)
T cd05051          84 LLGVCTVDP-----PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD  155 (296)
T ss_pred             EEEEEecCC-----CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            999987654     6799999999999999997654210     112588999999999999999999999   999999


Q ss_pred             CCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh--CCCCC
Q 043388          685 LKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT--GRRPT  761 (854)
Q Consensus       685 lkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt--g~~pf  761 (854)
                      |||+||+++.++..++ |||.+.......... ......++..|+|||++.+..++.++|||||||++|||++  |..||
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  234 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYR-VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY  234 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCccee-ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence            9999999999877776 999987654432211 1112346789999999988889999999999999999998  67777


Q ss_pred             CCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          762 DAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       762 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ......  ..................                   ......++.++.+++.+||+.||++|||+.||++.
T Consensus       235 ~~~~~~--~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~  293 (296)
T cd05051         235 EHLTDQ--QVIENAGHFFRDDGRQIY-------------------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLF  293 (296)
T ss_pred             CCcChH--HHHHHHHhcccccccccc-------------------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHH
Confidence            543211  111111111000000000                   00011224568899999999999999999999998


Q ss_pred             HHh
Q 043388          842 LCH  844 (854)
Q Consensus       842 L~~  844 (854)
                      |++
T Consensus       294 L~~  296 (296)
T cd05051         294 LQR  296 (296)
T ss_pred             hcC
Confidence            863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.3e-36  Score=324.95  Aligned_cols=242  Identities=25%  Similarity=0.291  Sum_probs=187.2

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHH-HHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECE-ALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||.||+|++..+++.||+|++....   ......+.+|.. +++.++||||+++++++...+     ..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~-----~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE-----KLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-----EEEEEE
Confidence            46999999999999999899999999996432   223345556655 467789999999999987655     789999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|..++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||+++..
T Consensus        76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          76 DFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            9999999999887654      688999999999999999999999   9999999999999998887776 99998754


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+..........  ...
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~~~~~~~--~~~  216 (325)
T cd05604         147 IAQSD---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMYDNILHKPL--VLR  216 (325)
T ss_pred             CCCCC---CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHHHHHHcCCc--cCC
Confidence            32221   12235699999999999998999999999999999999999999975321     111111110000  000


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +                      .....+.+++.+|++.+|.+||++++.++.
T Consensus       217 ~----------------------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         217 P----------------------GASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             C----------------------CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            0                      113446788999999999999998644433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.6e-36  Score=329.43  Aligned_cols=203  Identities=25%  Similarity=0.358  Sum_probs=173.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|+..+.||+|+||.||+|+...+++.||+|+++..   .......+.+|+.++..++||+|+++++++.+.+     .
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR-----N   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----E
Confidence            3688899999999999999999989999999999743   2334567888999999999999999999987655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence            899999999999999997654      688999999999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCCC--------------------------------CCcccccCCcccccCccccCCCCCCccchhHHHHHHH
Q 043388          704 LSHQLDSASKT--------------------------------PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILL  751 (854)
Q Consensus       704 ~~~~~~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl  751 (854)
                      ++.........                                .......+||+.|+|||++.+..++.++|||||||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  226 (360)
T cd05627         147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (360)
T ss_pred             CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence            98755322100                                0011235699999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCc
Q 043388          752 LEMFTGRRPTDAA  764 (854)
Q Consensus       752 ~elltg~~pf~~~  764 (854)
                      |||++|+.||...
T Consensus       227 yel~tG~~Pf~~~  239 (360)
T cd05627         227 YEMLIGYPPFCSE  239 (360)
T ss_pred             eecccCCCCCCCC
Confidence            9999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.1e-35  Score=312.03  Aligned_cols=264  Identities=22%  Similarity=0.357  Sum_probs=201.0

Q ss_pred             HHhhccccCccCCCcceEEEEeEECC-----CceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDS  619 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  619 (854)
                      ..++|++.++||+|+||.||+|..+.     .+..||+|.++.... .....+.+|+.++++++||||+++++++.... 
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence            35789999999999999999997642     356899998864332 22346788999999999999999999986654 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcc----cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHL----EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD  695 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  695 (854)
                          ..++||||+++|+|.+++.......    .....++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        83 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~  155 (288)
T cd05061          83 ----PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD  155 (288)
T ss_pred             ----CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence                5799999999999999997643211    112457788899999999999999999   99999999999999998


Q ss_pred             ccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhH
Q 043388          696 MVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHE  773 (854)
Q Consensus       696 ~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~  773 (854)
                      +..++ |||+++........... ....++..|+|||.+.+..++.++|||||||++|||++ |..||......     +
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~  229 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKG-GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----Q  229 (288)
T ss_pred             CcEEECcCCcccccccccccccc-CCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----H
Confidence            87776 99998865443221111 11235778999999988889999999999999999999 78888643211     1


Q ss_pred             HhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       774 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                      +..........                       .....++..+.+++.+|++.||++|||+.++++.+.+..
T Consensus       230 ~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         230 VLKFVMDGGYL-----------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHHHcCCCC-----------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11111100000                       001122456889999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=308.36  Aligned_cols=253  Identities=24%  Similarity=0.331  Sum_probs=202.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|.+.+.||+|+||.||+|....++..+|+|++........+.+.+|++++++++||||+++++++....     ..++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD-----KLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC-----EEEE
Confidence            57889999999999999999998888999999998766556788999999999999999999999987654     6899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      +|||+++++|.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+.
T Consensus        78 ~~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  149 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA  149 (262)
T ss_pred             EEeCCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence            9999999999999876522     688999999999999999999999   9999999999999999887776 999988


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCC---CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGS---EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      .........   ....++..|+|||...+.   .++.++|||||||++|||++|+.||........ ...........  
T Consensus       150 ~~~~~~~~~---~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~~~~--  223 (262)
T cd06613         150 QLTATIAKR---KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSNFPP--  223 (262)
T ss_pred             hhhhhhhcc---ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCCC--
Confidence            765432111   124588899999998776   789999999999999999999999975321111 11100000000  


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                           +.                .......+.++.+++.+||..+|.+|||+.+|+.
T Consensus       224 -----~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         224 -----PK----------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -----cc----------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 00                0011122456889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1e-35  Score=326.55  Aligned_cols=279  Identities=17%  Similarity=0.193  Sum_probs=200.0

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~  622 (854)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.+++.++||||+++++++..... ...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999999889999999998643  23334678899999999999999999998765432 122


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...|+||||+++ ++.+++..        .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence            357999999975 78777643        467888999999999999999999   9999999999999998887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC-
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP-  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~-  780 (854)
                      ||+++........    ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ 
T Consensus       170 fG~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~  244 (364)
T cd07875         170 FGLARTAGTSFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTP  244 (364)
T ss_pred             CCCccccCCCCcc----cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCC
Confidence            9999866443221    2246899999999999989999999999999999999999999754321 111111111000 


Q ss_pred             -cccccccCchhhHHHhhccc----h--------hhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 -EKVIEIVDPSLLMEVMANNS----M--------IQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 -~~~~~~~d~~~~~~~~~~~~----~--------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                       ......+.+...........    .        ...............+.+++.+|++.||.+|||+.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             00111111110000000000    0        0000000001113467899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.8e-35  Score=312.58  Aligned_cols=261  Identities=26%  Similarity=0.418  Sum_probs=200.8

Q ss_pred             HhhccccCccCCCcceEEEEeEECC-----CceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      ..+|++.+.||+|+||.||+|.+.+     ++..||+|+++.... .....+.+|+.++++++||||+++++++...+  
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~--   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK--   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--
Confidence            4679999999999999999998753     578899999875432 23466889999999999999999999987654  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCc----------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDH----------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGD  684 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  684 (854)
                         ..++||||+++|+|.+++......                .....+++.+++.++.|++.||+|||+.   +++|||
T Consensus        82 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d  155 (288)
T cd05050          82 ---PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD  155 (288)
T ss_pred             ---ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence               579999999999999999754211                1112578889999999999999999999   999999


Q ss_pred             CCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 043388          685 LKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD  762 (854)
Q Consensus       685 lkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~  762 (854)
                      |||+||+++.++..++ |||.+........... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKA-SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCccccc-cCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999998887776 9999876543322111 111235678999999988889999999999999999998 888886


Q ss_pred             CcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          763 AAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       763 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                      .....     +............                       ....++.++.+++.+||+.+|++|||+.|+++.|
T Consensus       235 ~~~~~-----~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l  286 (288)
T cd05050         235 GMAHE-----EVIYYVRDGNVLS-----------------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL  286 (288)
T ss_pred             CCCHH-----HHHHHHhcCCCCC-----------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence            43211     1111111110000                       0011245688999999999999999999999988


Q ss_pred             Hh
Q 043388          843 CH  844 (854)
Q Consensus       843 ~~  844 (854)
                      ++
T Consensus       287 ~~  288 (288)
T cd05050         287 QR  288 (288)
T ss_pred             hC
Confidence            64

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.6e-36  Score=322.75  Aligned_cols=237  Identities=26%  Similarity=0.299  Sum_probs=184.1

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHH-HHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECE-ALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ++||+|+||.||+|++..+++.||+|++....   ......+.+|.. +++.++||||+++++++.+.+     ..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~-----~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE-----KLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----EEEEEE
Confidence            46999999999999999899999999996432   222344555554 578889999999999887655     689999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||+++..
T Consensus        76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          76 DYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            9999999998887643      678888999999999999999999   9999999999999999887776 99998754


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+.......... . + 
T Consensus       147 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~-~-~-  215 (321)
T cd05603         147 VEPEE---TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHKPL-Q-L-  215 (321)
T ss_pred             CCCCC---ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcCCC-C-C-
Confidence            32221   12234689999999999988899999999999999999999999975321     111111110000 0 0 


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR  836 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  836 (854)
                                           .......+.+++.+|++.||.+||++.
T Consensus       216 ---------------------~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 ---------------------PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ---------------------CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                                 001134577899999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.9e-35  Score=308.25  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=200.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|+..+.||+|+||.||+|.+..++..||+|.+.....  .+.+.+|++++++++|+||+++++++....     ..++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT-----DLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----cEEE
Confidence            578899999999999999999998889999999875433  578999999999999999999999987654     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      +|||+++++|.+++.....     .+++..+..++.|++.||+|||+.   +++||||+|+||+++.++..++ |||.+.
T Consensus        76 ~~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNK-----TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             EEecCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence            9999999999999975432     689999999999999999999999   9999999999999999887776 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .........   ....|+..|+|||++.+..++.++|||||||++|+|++|+.||......... .. .......     
T Consensus       148 ~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-~~-~~~~~~~-----  217 (256)
T cd06612         148 QLTDTMAKR---NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FM-IPNKPPP-----  217 (256)
T ss_pred             hcccCcccc---ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-hh-hccCCCC-----
Confidence            775543211   1234789999999998888999999999999999999999998753221100 00 0000000     


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                         .                ......+...+.+++.+||+.+|++|||+.||++
T Consensus       218 ---~----------------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         218 ---T----------------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             ---C----------------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence               0                0011122456788999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.3e-35  Score=315.78  Aligned_cols=267  Identities=21%  Similarity=0.251  Sum_probs=204.7

Q ss_pred             cHHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeecc
Q 043388          539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSI  617 (854)
Q Consensus       539 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  617 (854)
                      ..+++..++++|.+.+.||+|+||.||+|....+++.+|+|++..... ....+.+|+.+++++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            345555668899999999999999999999988999999999864322 235678899999999 899999999998765


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV  697 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  697 (854)
                      +.......++||||+++|+|.++++.....  ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence            543444689999999999999998753211  12688999999999999999999999   9999999999999998876


Q ss_pred             ccc-ccccccccccCCCCCCcccccCCcccccCccccCCC-----CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchH
Q 043388          698 AHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-----EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL  771 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~  771 (854)
                      .++ |||.+..........   ....|+..|+|||++...     .++.++|||||||++|||++|+.||...... ...
T Consensus       167 ~kl~dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~  242 (291)
T cd06639         167 VKLVDFGVSAQLTSTRLRR---NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTL  242 (291)
T ss_pred             EEEeecccchhcccccccc---cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHH
Confidence            666 999988765432211   123588999999987543     3688999999999999999999998743211 111


Q ss_pred             hHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          772 HEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       772 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..+....    .....+                     .+.....+.+++.+||+.+|++||++.|+++
T Consensus       243 ~~~~~~~----~~~~~~---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         243 FKIPRNP----PPTLLH---------------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHhcCC----CCCCCc---------------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1111100    000000                     1112345889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-35  Score=310.49  Aligned_cols=258  Identities=23%  Similarity=0.384  Sum_probs=202.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCce----EEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEM----IVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .+|++.+.||+|+||.||+|.+..++.    .||+|+...... .....+.+|+.++++++||||+++++++.. .    
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~----   81 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S----   81 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C----
Confidence            578899999999999999999865553    689998865432 334678899999999999999999999875 2    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++|+|.+++.....     .+++..+..++.|++.||+|||+.   +++||||||+||+++.++..++ |
T Consensus        82 -~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d  152 (279)
T cd05057          82 -QVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD  152 (279)
T ss_pred             -ceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence             57999999999999999986542     588999999999999999999998   9999999999999998877776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||.++.......... .....++..|+|||......++.++|||||||++||+++ |+.||......  ...+.+.....
T Consensus       153 fg~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~  229 (279)
T cd05057         153 FGLAKLLDVDEKEYH-AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGER  229 (279)
T ss_pred             CcccccccCccccee-cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCCC
Confidence            999987654322211 111234678999999988889999999999999999999 99998754211  11111111000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      .     .                     ....+...+.+++.+||..+|.+||++.++++.|.++..+
T Consensus       230 ~-----~---------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         230 L-----P---------------------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             C-----C---------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            0     0                     0011134577889999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.9e-35  Score=308.18  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=187.9

Q ss_pred             CccCCCcceEEEEeEECC--CceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          554 NMIGQGSFGSVYKGILGG--EEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      +.||+|+||.||+|.+..  ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+..     ..++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-----PYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-----CcEEEEE
Confidence            468999999999998753  456799998865432 23357889999999999999999999987654     5799999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccc
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLD  709 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~  709 (854)
                      |+++|+|.+++...... .....++..+..++.|++.|++|||+.   +++||||||+||+++.++..++ |||.+....
T Consensus        76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999999999764321 112467778889999999999999999   9999999999999999877776 999987544


Q ss_pred             cCCCCCCcccccCCcccccCccccCCC-------CCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          710 SASKTPSSSIGIKGTVGYVAPEYGMGS-------EASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       710 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ...... ......++..|+|||++.+.       .++.++|||||||++|||++ |+.||.......  ...+.   ...
T Consensus       152 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~---~~~  225 (269)
T cd05087         152 KEDYYV-TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYT---VRE  225 (269)
T ss_pred             Ccceee-cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH---hhc
Confidence            322211 11224578899999987642       35789999999999999996 999997542221  11110   111


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      ......++...                  ......+.+++..|| .+|++|||++||+..|+
T Consensus       226 ~~~~~~~~~~~------------------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 QQLKLPKPRLK------------------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ccCCCCCCccC------------------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            10111111110                  011344677888998 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-35  Score=328.37  Aligned_cols=274  Identities=20%  Similarity=0.213  Sum_probs=196.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ...|.+.+.||+|+||.||+|.+..+++.||||...      ...+.+|++++++++|+|||++++++...+     ..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-----~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGG-----LTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC-----EEE
Confidence            346999999999999999999999899999999642      234578999999999999999999987655     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +|||++. ++|.+++.....     .+++.+++.|+.|++.||+|||+.   +|+||||||+|||++.++..++ |||++
T Consensus       237 lv~e~~~-~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence            9999995 699988875432     689999999999999999999999   9999999999999998876666 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC---C---chHhHHhhhc-
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE---G---LTLHEFVKMT-  778 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~---~---~~~~~~~~~~-  778 (854)
                      +......... ......||+.|+|||++.+..++.++|||||||++|||++|..|+......   .   ..+...+... 
T Consensus       308 ~~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~  386 (461)
T PHA03211        308 CFARGSWSTP-FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ  386 (461)
T ss_pred             eecccccccc-cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc
Confidence            8764332211 122356999999999999999999999999999999999988765432111   0   1111221110 


Q ss_pred             C-CcccccccCchhhHHHhhccc--hhhHhhhh---hHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          779 L-PEKVIEIVDPSLLMEVMANNS--MIQEDRRA---RTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       779 ~-~~~~~~~~d~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      . ...........+.........  ........   ........+.+++.+||+.||.+|||+.|+++.
T Consensus       387 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        387 VHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0 001111111111111110000  00000000   001123357789999999999999999999874

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.4e-35  Score=313.98  Aligned_cols=260  Identities=25%  Similarity=0.397  Sum_probs=200.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCce----EEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEM----IVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      ..+|+..+.||+|+||.||+|++..++.    .||+|.+..... .....+.+|+.++++++||||++++++|...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence            3578889999999999999999865554    578888864432 2234688999999999999999999998643    


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                        ..++|+||+++|+|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ 
T Consensus        82 --~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~  151 (303)
T cd05110          82 --TIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT  151 (303)
T ss_pred             --CceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEc
Confidence              25799999999999999876532     578889999999999999999999   9999999999999988776665 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      |||.++......... ......++..|+|||++.+..++.++|||||||++||+++ |+.||.....  ....++.....
T Consensus       152 Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~  228 (303)
T cd05110         152 DFGLARLLEGDEKEY-NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGE  228 (303)
T ss_pred             cccccccccCccccc-ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCC
Confidence            999998765432211 1122346788999999988889999999999999999997 9999864321  11122211100


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      .  .   .                     ....+...+.+++..||..+|++||+++++++.+.++.+..
T Consensus       229 ~--~---~---------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         229 R--L---P---------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             C--C---C---------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            0  0   0                     00112345778999999999999999999999999887554

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-36  Score=323.16  Aligned_cols=283  Identities=19%  Similarity=0.212  Sum_probs=203.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|.+.+.||+|+||.||+|++..++..||+|++.... ......+.+|+.++++++|+||+++++++...........
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999999899999999986432 3344668889999999999999999998876554444568


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++ ++.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||+
T Consensus        84 ~lv~e~~~~-~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             EEEehhccc-CHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence            999999975 888877543       688999999999999999999999   9999999999999999877776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh---hcCC
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK---MTLP  780 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~---~~~~  780 (854)
                      +.................||..|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+..   ....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~~~~~~  231 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVLGTPSQ  231 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCH
Confidence            9876543332222233568999999998655 46899999999999999999999999753211 01111111   0111


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +.+..+.+...........................++.+++.+||+.+|++|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1111111111100000000000000000111225668899999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.3e-35  Score=308.75  Aligned_cols=256  Identities=21%  Similarity=0.302  Sum_probs=185.6

Q ss_pred             CccCCCcceEEEEeEECC--CceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          554 NMIGQGSFGSVYKGILGG--EEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      +.||+|+||.||+|....  ....+|+|.+.... ......+.+|+.+++.++||||+++++++....     ..++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-----~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-----PYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-----ceEEEEE
Confidence            369999999999997642  34578888875433 223456889999999999999999999987654     6799999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccc
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLD  709 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~  709 (854)
                      |+++|+|.+++....... ....++.....++.||+.||+|||+.   +|+||||||+||+++.++..++ |||.+....
T Consensus        76 ~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             eCCCCcHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence            999999999998754321 12456778899999999999999999   9999999999999999887776 999987543


Q ss_pred             cCCCCCCcccccCCcccccCccccCC-------CCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          710 SASKTPSSSIGIKGTVGYVAPEYGMG-------SEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       710 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ...... ......++..|+|||+...       ..++.++|||||||++|||++ |..||....... ........    
T Consensus       152 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~----  225 (269)
T cd05042         152 PEDYYI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVRE----  225 (269)
T ss_pred             cchhee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhc----
Confidence            322111 1122346778999998642       357889999999999999999 788886432111 11111111    


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      ......++..                  ...+...+.+++..|| .||++|||++||++.|.
T Consensus       226 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         226 QDIKLPKPQL------------------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cCccCCCCcc------------------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111111110                  0112445667888888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=308.79  Aligned_cols=248  Identities=26%  Similarity=0.343  Sum_probs=200.1

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +|.+.+.||.|++|.||+|++..++..||+|++.... ......+.+|+++++.++|+||+++++++.+..     ..++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-----KLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-----eEEE
Confidence            6888899999999999999999899999999987543 344567889999999999999999999987654     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      |+||+++++|.+++...       .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++..++ |||.+.
T Consensus        77 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  146 (274)
T cd06609          77 IMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSG  146 (274)
T ss_pred             EEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccce
Confidence            99999999999998754       678999999999999999999999   9999999999999999887776 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .........   ....|+..|+|||++.+..++.++|||||||++|||+||+.||......  ..........+....  
T Consensus       147 ~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~--  219 (274)
T cd06609         147 QLTSTMSKR---NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLFLIPKNNPPSLE--  219 (274)
T ss_pred             eeccccccc---ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHHHhhhcCCCCCc--
Confidence            876543211   2245888999999999888999999999999999999999999743211  111101100000000  


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                       +                      ..++..+.+++.+||..+|++|||++++++.
T Consensus       220 -~----------------------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         220 -G----------------------NKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -c----------------------cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             0                      0024457789999999999999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.3e-35  Score=302.63  Aligned_cols=246  Identities=27%  Similarity=0.414  Sum_probs=192.3

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeec
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM  632 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  632 (854)
                      ++||+|+||.||+|... ++..||+|+++.... .....+.+|++++++++||||+++++++....     ..++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-----PIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-----ccEEEEECC
Confidence            46999999999999876 678899999865432 22346889999999999999999999987654     579999999


Q ss_pred             cCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccC
Q 043388          633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSA  711 (854)
Q Consensus       633 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~  711 (854)
                      ++++|.+++.....     .+++..+..++.|++.||.|+|+.   +++||||||+||+++.++..++ |||++......
T Consensus        75 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          75 PGGDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence            99999999875432     578999999999999999999999   9999999999999998887666 99998765433


Q ss_pred             CCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccccccCch
Q 043388          712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS  790 (854)
Q Consensus       712 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  790 (854)
                      .....  ....++..|+|||+..+..++.++|||||||++||+++ |..||......  ............         
T Consensus       147 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~---------  213 (250)
T cd05085         147 IYSSS--GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKGYRM---------  213 (250)
T ss_pred             ccccC--CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCCC---------
Confidence            22111  11235678999999988889999999999999999998 99998743211  111111110000         


Q ss_pred             hhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                                       .....++..+.+++.+|++.+|++||++.|+++.|.
T Consensus       214 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         214 -----------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                             000112456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-35  Score=305.61  Aligned_cols=253  Identities=30%  Similarity=0.510  Sum_probs=199.8

Q ss_pred             CccCCCcceEEEEeEECCC---ceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGE---EMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||.||+|.....   +..||+|+++..... ..+.+.+|++.+..++|+|++++++++....     ..++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE-----PLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC-----ceEEEE
Confidence            4799999999999999865   889999999765433 3678899999999999999999999987643     689999


Q ss_pred             eeccCCCHHHHhhhcCCc---ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          630 EYMENGSLEDWLHQSNDH---LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      ||+++++|.+++......   .....+++.+++.++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence            999999999999875210   0012789999999999999999999999   9999999999999999877776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      ......... .......++..|+|||.+.+..++.++||||+||++|||++ |..||......  ...+....   ..  
T Consensus       153 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~---~~--  224 (262)
T cd00192         153 RDVYDDDYY-RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLRK---GY--  224 (262)
T ss_pred             ccccccccc-ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc---CC--
Confidence            887654321 11223457889999999988889999999999999999999 69998754211  11111110   00  


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                                           +......++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       225 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ---------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                                 00011222566889999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4e-35  Score=316.19  Aligned_cols=203  Identities=23%  Similarity=0.315  Sum_probs=161.6

Q ss_pred             cCccCCCcceEEEEeEECC--CceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          553 SNMIGQGSFGSVYKGILGG--EEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      ..+||+|+||.||+|+...  ++..||+|.++...  ....+.+|++++++++||||+++++++.....   ...++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSD---RKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCC---CeEEEEEe
Confidence            4689999999999999753  56789999886433  23567899999999999999999999865432   26799999


Q ss_pred             eccCCCHHHHhhhcCCc---ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec----CCccccc-cc
Q 043388          631 YMENGSLEDWLHQSNDH---LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD----HDMVAHQ-NF  702 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~----~~~~~~~-Df  702 (854)
                      |+++ +|.+++......   .....+++..+..++.|++.||+|||+.   +|+||||||+||++.    .++..++ ||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9975 888887643211   1123588999999999999999999999   999999999999993    3444555 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      |+++................||+.|+|||++.+. .++.++|||||||++|||+||++||...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9998776544332233345689999999998764 5899999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.1e-35  Score=309.38  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=200.0

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..|+..+.||+|+||.||+|.+..++..||+|+++... ......+.+|++++++++||||+++++++.+..     ..+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-----KLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----EEE
Confidence            46778899999999999999998889999999987543 334567889999999999999999999987655     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++...       .+++.++..++.|++.||+|||+.   +++|+||+|+||+++.++..++ |||.+
T Consensus        79 lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~  148 (277)
T cd06640          79 IIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             EEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence            999999999999998653       578888999999999999999999   9999999999999998887776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........   .....++..|+|||++.+..++.++|||||||++|||++|+.||.......  ......    ...  
T Consensus       149 ~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~----~~~--  217 (277)
T cd06640         149 GQLTDTQIK---RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--VLFLIP----KNN--  217 (277)
T ss_pred             eeccCCccc---cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--Hhhhhh----cCC--
Confidence            776543321   112357889999999988889999999999999999999999987432111  000000    000  


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                          .......++..+.+++.+||+.+|++||++.++++.
T Consensus       218 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 --------------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             --------------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                                001112345668899999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.5e-35  Score=306.80  Aligned_cols=250  Identities=22%  Similarity=0.378  Sum_probs=197.2

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc---------chHHHHHHHHHHHhccCCCeeeEEEEeeccCC
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---------AFRSFVAECEALRNIRHRNLIKIITICSSIDS  619 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  619 (854)
                      +|.+...||+|++|.||+|.+..++..||+|.+......         ..+.+.+|+.++++++||||+++++++...+ 
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD-   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence            367788999999999999999888899999988643221         2256789999999999999999999987654 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~  699 (854)
                          ..++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++..+
T Consensus        80 ----~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          80 ----HLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             ----ccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence                6799999999999999997654      678889999999999999999999   999999999999999888777


Q ss_pred             c-ccccccccccCCCCC---CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          700 Q-NFSLSHQLDSASKTP---SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                      + |||.++.........   .......|+..|+|||.+.+..++.++||||+||++|+|++|+.||...... .......
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~  225 (267)
T cd06628         147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-QAIFKIG  225 (267)
T ss_pred             ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-HHHHHHh
Confidence            6 999998775322111   1111245889999999998888999999999999999999999999753211 0111000


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      . ..        .+.                  ....++..+.+++.+||+.||.+||++.|+++
T Consensus       226 ~-~~--------~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 E-NA--------SPE------------------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             c-cC--------CCc------------------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            0 00        000                  01122456788999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.2e-35  Score=311.21  Aligned_cols=265  Identities=22%  Similarity=0.323  Sum_probs=203.9

Q ss_pred             ccHHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeec
Q 043388          538 ISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSS  616 (854)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  616 (854)
                      .+..++....+.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+..|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            3455556677899999999999999999999988999999999865432 335678899999998 79999999999864


Q ss_pred             cCC-CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC
Q 043388          617 IDS-KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD  695 (854)
Q Consensus       617 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  695 (854)
                      ... ......++||||+++|+|.+++......    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~  157 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN----ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            322 1234689999999999999999765422    577888899999999999999999   99999999999999988


Q ss_pred             ccccc-ccccccccccCCCCCCcccccCCcccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCc
Q 043388          696 MVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM-----GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL  769 (854)
Q Consensus       696 ~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~  769 (854)
                      +..++ |||.+.........   .....|+..|+|||.+.     +..++.++|||||||++|||++|+.||....... 
T Consensus       158 ~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-  233 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-  233 (282)
T ss_pred             CCEEEeeCcchhhhhccccC---CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-
Confidence            87776 99998766432221   12245899999999875     3457889999999999999999999996432110 


Q ss_pred             hHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          770 TLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ........ .        .+.                 .....++..+.+++.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~-~--------~~~-----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         234 ALFLIPRN-P--------PPK-----------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhhhHhhC-C--------CCC-----------------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            00000000 0        000                 001123456889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.6e-35  Score=316.24  Aligned_cols=263  Identities=25%  Similarity=0.411  Sum_probs=202.5

Q ss_pred             hhccccCccCCCcceEEEEeEECC-------CceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG-------EEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSID  618 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  618 (854)
                      .+|.+.+.||+|+||.||+|++.+       .+..||+|+++... ....+.+.+|+++++++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            478999999999999999998642       23468999887432 23356789999999999 8999999999987654


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPS  688 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~  688 (854)
                           ..++||||+++|+|.+++......          .....+++.+++.++.|++.||+|||+.   +|+||||||+
T Consensus        92 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          92 -----PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             -----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence                 679999999999999999764311          1123588999999999999999999999   9999999999


Q ss_pred             ceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCccc
Q 043388          689 NVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFT  766 (854)
Q Consensus       689 NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~  766 (854)
                      ||+++.++..++ |||.++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccc-cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999998887776 999998765432211 1112235678999999999889999999999999999998 8888864321


Q ss_pred             CCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          767 EGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       767 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                           .++..........                       .....++.++.+++.+||+.+|++|||+.|+++.|+++.
T Consensus       243 -----~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         243 -----EELFKLLKEGHRM-----------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             -----HHHHHHHHcCCCC-----------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence                 1111111000000                       001122456889999999999999999999999999887


Q ss_pred             h
Q 043388          847 E  847 (854)
Q Consensus       847 ~  847 (854)
                      .
T Consensus       295 ~  295 (334)
T cd05100         295 T  295 (334)
T ss_pred             h
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-35  Score=326.72  Aligned_cols=273  Identities=20%  Similarity=0.220  Sum_probs=197.3

Q ss_pred             hhccccCccCCCcceEEEEeEECC--CceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG--EEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .+|.+.+.||+|+||.||+|...+  .+..||+|.+...     +...+|++++++++||||+++++++....     ..
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~~  161 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS-----TV  161 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC-----EE
Confidence            479999999999999999998643  4678999987533     23568999999999999999999887654     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+. ++|.+++....      .+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++..++ |||+
T Consensus       162 ~lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~  231 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGA  231 (392)
T ss_pred             EEEehhcC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcc
Confidence            99999996 58999885433      789999999999999999999999   9999999999999998877776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC--chHhHHhhhcCCc-
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG--LTLHEFVKMTLPE-  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~--~~~~~~~~~~~~~-  781 (854)
                      ++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+.......... 
T Consensus       232 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~  310 (392)
T PHA03207        232 ACKLDAHPDTP-QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP  310 (392)
T ss_pred             ccccCcccccc-cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence            98765543221 1224579999999999999899999999999999999999999997653321  1122222111100 


Q ss_pred             -ccccccCchhhHHHhhccch-hhHhhhh---hHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 -KVIEIVDPSLLMEVMANNSM-IQEDRRA---RTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 -~~~~~~d~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                       .........+...+...... .+....+   .-......+.+++.+|+..||++|||+.|++..
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence             00000000111111000000 0000000   001123457789999999999999999999875

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7e-35  Score=303.96  Aligned_cols=250  Identities=20%  Similarity=0.286  Sum_probs=201.5

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|+..+.||+|+||.||.++...++..+|+|.+....  ....+++.+|++++++++|+||+++++++.+.+     ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-----TLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC-----eEE
Confidence            4788999999999999999999899999999986542  344567889999999999999999999997654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++.....    ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             EEEEecCCCcHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence            99999999999999986532    2688999999999999999999999   9999999999999999887776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........   .....|++.|+|||+..+..++.++||||||+++|||++|+.||.....     .+............
T Consensus       149 ~~~~~~~~~---~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~  220 (256)
T cd08221         149 KILGSEYSM---AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQGNYTP  220 (256)
T ss_pred             EEccccccc---ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCCCC
Confidence            876544321   1224589999999999888899999999999999999999999864321     11111111110000


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                             ....++..+.+++.+||..+|++||++.|+++.
T Consensus       221 -----------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         221 -----------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -----------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                                   001224557889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.1e-35  Score=304.12  Aligned_cols=251  Identities=21%  Similarity=0.303  Sum_probs=198.3

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.+.||+|++|.||+|.+..+++.||+|++....  ....+.+.+|++++++++|+|++++++.+...+    ...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEE
Confidence            4788999999999999999998889999999986543  234467889999999999999999998765322    2578


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....    ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        77 lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~  149 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA  149 (257)
T ss_pred             EEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence            99999999999999986432    1689999999999999999999999   9999999999999998887766 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........   .....|++.|+|||+..+..++.++||||+||++||+++|+.||......     .............
T Consensus       150 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~  221 (257)
T cd08223         150 RVLENQCDM---ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRIIEGKLPP  221 (257)
T ss_pred             EEecccCCc---cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHhcCCCC
Confidence            876443221   12245889999999999988999999999999999999999998743211     1111100000000


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                             ........+.+++.+|++.+|++|||+.++++.
T Consensus       222 -----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         222 -----------------------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -----------------------CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                                   001124567899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-35  Score=305.92  Aligned_cols=254  Identities=28%  Similarity=0.453  Sum_probs=200.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|.+.++||+|+||.||+|... ++..||||.+..... ..+++.+|+.++++++|+||+++++++....     ..+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   77 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE-----PIY   77 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCC-----ceE
Confidence            468999999999999999999987 557899999875433 3467899999999999999999999986544     579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....    ..+++.++..++.|++.|++|||+.   +++|+||||+||+++.++..++ |||.+
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~  150 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLA  150 (261)
T ss_pred             EEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccc
Confidence            99999999999999987532    2689999999999999999999999   9999999999999998887766 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      ..........  .....++..|+|||.+.+..++.++||||+||++||+++ |+.||...... ........ ....   
T Consensus       151 ~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~-~~~~---  223 (261)
T cd05034         151 RLIEDDEYTA--REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVER-GYRM---  223 (261)
T ss_pred             eeccchhhhh--hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc-CCCC---
Confidence            8765422111  111235678999999998889999999999999999999 99998643211 11111111 0000   


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                                             .....++..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       224 -----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 -----------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                                   0001124567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=6.9e-38  Score=327.39  Aligned_cols=365  Identities=26%  Similarity=0.385  Sum_probs=234.8

Q ss_pred             eccccccc-ccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCC
Q 043388           46 LIRWNSLG-GQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCS  124 (854)
Q Consensus        46 ~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~  124 (854)
                      |+++|.++ +..|.....|+.++.|.|...++. .+|+.++.+.+|++|.+++|++. ++.- -+..||.|+.+.+..|+
T Consensus        13 DfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhG-ELs~Lp~LRsv~~R~N~   89 (1255)
T KOG0444|consen   13 DFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHG-ELSDLPRLRSVIVRDNN   89 (1255)
T ss_pred             cccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhh-hhccchhhHHHhhhccc
Confidence            34444443 234444444555555555555544 34455555555555555555544 3321 12344444444444444


Q ss_pred             CCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhc
Q 043388          125 LKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLL  204 (854)
Q Consensus       125 l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~  204 (854)
                      |++                ..+|+.+..|..|+.||||+|+++ ..|..+...+++-.|+||+|+|.+++..      .|
T Consensus        90 LKn----------------sGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~------lf  146 (1255)
T KOG0444|consen   90 LKN----------------SGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNS------LF  146 (1255)
T ss_pred             ccc----------------CCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCch------HH
Confidence            432                234555555555555555555555 3344555555555555555555555543      34


Q ss_pred             cCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccc-cCCCCCccCcccC
Q 043388          205 TNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLH-GIIPDGVGELQHL  283 (854)
Q Consensus       205 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L  283 (854)
                      -++..|-.||||+|++. .+|..+..+. .|++|.|++|.+....-..+..+++|..|.+++.+=+ .-+|.++..+.+|
T Consensus       147 inLtDLLfLDLS~NrLe-~LPPQ~RRL~-~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL  224 (1255)
T KOG0444|consen  147 INLTDLLFLDLSNNRLE-MLPPQIRRLS-MLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNL  224 (1255)
T ss_pred             HhhHhHhhhccccchhh-hcCHHHHHHh-hhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhh
Confidence            45555555566666555 5555555554 5666666666555443444555666777777766533 2356677777777


Q ss_pred             ceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhc
Q 043388          284 QQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAH  363 (854)
Q Consensus       284 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~  363 (854)
                      ..++|+.|.+. .+|+.+.++.+|+.|+||+|+|+ .+....+.+.+|++|+||.|+++ .+|..++.++.+.. |.+.+
T Consensus       225 ~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k-Ly~n~  300 (1255)
T KOG0444|consen  225 RDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK-LYANN  300 (1255)
T ss_pred             hhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH-HHhcc
Confidence            77777777777 77777777777777777777777 45555666777777777777777 67777777777766 77777


Q ss_pred             CCCC-CCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeeccc
Q 043388          364 NLLN-DSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSY  442 (854)
Q Consensus       364 n~l~-~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  442 (854)
                      |+++ ..+|..+|.       +.+|+.+..++|.+. ..|..+..+.+|+.|.|++|++- .+|+.+.-++.|+.|||..
T Consensus       301 NkL~FeGiPSGIGK-------L~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlre  371 (1255)
T KOG0444|consen  301 NKLTFEGIPSGIGK-------LIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRE  371 (1255)
T ss_pred             CcccccCCccchhh-------hhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccC
Confidence            7766 567888888       456899999999998 88999999999999999999998 7999999999999999999


Q ss_pred             ccCcccCCC
Q 043388          443 NHLEGEVPT  451 (854)
Q Consensus       443 N~l~~~~p~  451 (854)
                      |+=---+|.
T Consensus       372 NpnLVMPPK  380 (1255)
T KOG0444|consen  372 NPNLVMPPK  380 (1255)
T ss_pred             CcCccCCCC
Confidence            985544443

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3e-35  Score=312.21  Aligned_cols=274  Identities=20%  Similarity=0.287  Sum_probs=199.1

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++|+|++++++++....     ..+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-----KLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-----EEE
Confidence            6888999999999999999999889999999986432  223456789999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||++++++..++....      .+++.+++.++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+
T Consensus        77 ~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (286)
T cd07847          77 LVFEYCDHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFA  147 (286)
T ss_pred             EEEeccCccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccc
Confidence            9999999988888766443      689999999999999999999999   9999999999999998887776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh--cCCcc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM--TLPEK  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~  782 (854)
                      .........   .....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+. .......  .....
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~  223 (286)
T cd07847         148 RILTGPGDD---YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPR  223 (286)
T ss_pred             eecCCCccc---ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChH
Confidence            877554321   112357889999999876 4578999999999999999999999975432211 1111100  00000


Q ss_pred             cccccCchhhHH-HhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLME-VMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..+..++..... ...................+..+.+++.+||+.+|++|||+.|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            000000000000 0000000000001111223566889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=319.39  Aligned_cols=201  Identities=26%  Similarity=0.334  Sum_probs=170.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||.||+|+...+++.||+|++...   .....+.+.+|+.++..++|+||+++++++.+.+     +
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN-----N   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-----e
Confidence            3688999999999999999999989999999999642   2233456888999999999999999999987655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+||||+++|+|.+++.....     .+++..+..++.||+.||+|||++   +|+||||||+||+++.++..++ |||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence            8999999999999999976432     678899999999999999999999   9999999999999998887666 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-----SEASMTGDVYSFGILLLEMFTGRRPTDA  763 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~pf~~  763 (854)
                      ++..........  .....||+.|+|||++..     ..++.++||||+||++|||++|+.||..
T Consensus       148 ~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         148 SCLRLLADGTVQ--SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             ceeecCCCCCcc--ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            987665432211  112358999999999863     4578899999999999999999999974

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.4e-35  Score=311.28  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=197.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..|+..+.||+|+||.||+|.+..++..||+|.++... ....+.+.+|++++++++||||+++++++....     ..+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   78 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-----KLW   78 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-----ceE
Confidence            35677788999999999999998889999999987443 334567889999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++...       .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++..++ |||++
T Consensus        79 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06642          79 IIMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             EEEEccCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccc
Confidence            999999999999988642       578899999999999999999999   9999999999999998887776 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ..........   ....|+..|+|||++.+..++.++|||||||++|||++|+.||.......  ......    ...  
T Consensus       149 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~----~~~--  217 (277)
T cd06642         149 GQLTDTQIKR---NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIP----KNS--  217 (277)
T ss_pred             ccccCcchhh---hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhh----cCC--
Confidence            7765432211   12358899999999998889999999999999999999999986432111  000000    000  


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                        .+.                  ....++..+.+++.+||+.+|++||++.||++.
T Consensus       218 --~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         218 --PPT------------------LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --CCC------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              000                  001224567899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.5e-35  Score=305.88  Aligned_cols=251  Identities=20%  Similarity=0.359  Sum_probs=195.6

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccc------cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      +|++.+.||+|+||.||+|... ++..+|+|.++....      .....+.+|++++++++|+||+++++++.+..    
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   75 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN----   75 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC----
Confidence            4788899999999999999875 788999999864321      22356889999999999999999999987654    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++..++ |
T Consensus        76 -~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          76 -TISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             -eEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence             7899999999999999997653      578889999999999999999999   9999999999999998887776 9


Q ss_pred             cccccccccCCCC---CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          702 FSLSHQLDSASKT---PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       702 fg~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                      ||.+.........   ........|+..|+|||+..+..++.++|||||||++||+++|+.||....... .......  
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~--  222 (265)
T cd06631         146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGA--  222 (265)
T ss_pred             chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhh--
Confidence            9998865332111   111123458999999999998889999999999999999999999997432111 0100000  


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       .......+.                      ..+..++.+++.+||+.+|++||++.|+++
T Consensus       223 -~~~~~~~~~----------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 -HRGLMPRLP----------------------DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -ccCCCCCCC----------------------CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             000000000                      112455788999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-35  Score=322.23  Aligned_cols=193  Identities=22%  Similarity=0.311  Sum_probs=163.2

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ....+|.+.+.||+|+||.||+|++..++..||+|+....      ....|+.++++++||||+++++++....     .
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~  131 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGA-----I  131 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCC-----e
Confidence            3445799999999999999999999988999999975322      2356999999999999999999987655     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+. ++|.+++.....     .+++.+++.|+.||+.||+|||++   +|+||||||+||+++.++..++ |||
T Consensus       132 ~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        132 TCMVLPHYS-SDLYTYLTKRSR-----PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             eEEEEEccC-CcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCc
Confidence            799999995 589988875432     689999999999999999999999   9999999999999998877666 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPT  761 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf  761 (854)
                      .++.......    .....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       203 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        203 AAQFPVVAPA----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccCcc----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            9875432211    12346999999999999989999999999999999999965554

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.8e-35  Score=305.80  Aligned_cols=238  Identities=24%  Similarity=0.439  Sum_probs=187.0

Q ss_pred             CccCCCcceEEEEeEECCCc----------eEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          554 NMIGQGSFGSVYKGILGGEE----------MIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      +.||+|+||.||+|.+..++          ..|++|++...... ...+.+|+.++++++||||+++++++.. .     
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D-----   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-C-----
Confidence            46999999999999997665          45788887654433 5788999999999999999999999876 3     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc-------
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-------  696 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------  696 (854)
                      ..++||||+++|+|.+++.....     .+++..+..++.||+.||+|||++   +|+||||||+||+++.++       
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~  145 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP  145 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence            46899999999999999987542     578899999999999999999999   999999999999999876       


Q ss_pred             -ccccccccccccccCCCCCCcccccCCcccccCccccCCC--CCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHh
Q 043388          697 -VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS--EASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLH  772 (854)
Q Consensus       697 -~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~  772 (854)
                       .+++|||.+.......       ...++..|+|||++.+.  .++.++|||||||++||+++ |..||......  ...
T Consensus       146 ~~kl~Dfg~a~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~  216 (259)
T cd05037         146 FIKLSDPGIPITVLSRE-------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKE  216 (259)
T ss_pred             eEEeCCCCccccccccc-------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHH
Confidence             4445999988765411       12467889999998876  78999999999999999999 57777543211  111


Q ss_pred             HHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      .+...   .....  .+                   .    ...+.+++.+||..+|.+|||+.||++.|+
T Consensus       217 ~~~~~---~~~~~--~~-------------------~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         217 RFYQD---QHRLP--MP-------------------D----CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHhc---CCCCC--CC-------------------C----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11110   00000  00                   0    145789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.2e-35  Score=308.11  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=194.1

Q ss_pred             CccCCCcceEEEEeEECCCc------eEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          554 NMIGQGSFGSVYKGILGGEE------MIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +.||+|+||.||+|++....      ..||+|.+.... ......+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-----PQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-----CeE
Confidence            46999999999999986433      689999886432 234567899999999999999999999987654     579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc-----cccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-----VAHQ  700 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~~~  700 (854)
                      +||||+++++|.+++....... ....+++.+++.++.|++.||+|||+.   +++|+||||+||+++.+.     ..++
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence            9999999999999997643211 223578999999999999999999998   999999999999998876     4454


Q ss_pred             -ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhc
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~  778 (854)
                       |||++........... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......  ........ 
T Consensus       153 ~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~-  228 (269)
T cd05044         153 GDFGLARDIYKSDYYRK-EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTA-  228 (269)
T ss_pred             CCccccccccccccccc-CcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHhc-
Confidence             9999986644322111 112245788999999999899999999999999999998 99998643211  11111110 


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                        ..                       +......++..+.+++.+||..+|.+||+++++.+.|++
T Consensus       229 --~~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         229 --GG-----------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             --CC-----------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence              00                       000111225568899999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-36  Score=310.37  Aligned_cols=254  Identities=22%  Similarity=0.331  Sum_probs=194.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeec--ccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  623 (854)
                      -..|++.++||+||.+.||++...+ .+.||+|++..  .+......|.+|+..|.++ .|.+||++++|-...+     
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~-----  433 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG-----  433 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc-----
Confidence            3578999999999999999999874 45566665542  3344567899999999999 5999999999966544     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccccccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFS  703 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg  703 (854)
                      +.||||||-+. +|.++|++....    ...| .++.+..|++.|+.++|.+   ||||.||||.|+++-.+..++||||
T Consensus       434 ~lYmvmE~Gd~-DL~kiL~k~~~~----~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG~LKLIDFG  504 (677)
T KOG0596|consen  434 YLYMVMECGDI-DLNKILKKKKSI----DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKGRLKLIDFG  504 (677)
T ss_pred             eEEEEeecccc-cHHHHHHhccCC----CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEeeeEEeeeec
Confidence            89999998765 999999987642    2234 6788999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCC-----------CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-----------EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH  772 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~  772 (854)
                      .|..+......- .....+||+.|||||.+...           +.+++|||||+||+||+|+.|++||.....      
T Consensus       505 IA~aI~~DTTsI-~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------  577 (677)
T KOG0596|consen  505 IANAIQPDTTSI-VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------  577 (677)
T ss_pred             hhcccCccccce-eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------
Confidence            999887654332 22335799999999987532           257899999999999999999999973211      


Q ss_pred             HHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .|.+      +..+.||...-++..-           .+  ..++.++++.||++||.+|||+.|+++.
T Consensus       578 ~~aK------l~aI~~P~~~Iefp~~-----------~~--~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  578 QIAK------LHAITDPNHEIEFPDI-----------PE--NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HHHH------HHhhcCCCccccccCC-----------CC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            1111      1122233211111000           00  2237899999999999999999999863

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.7e-35  Score=313.75  Aligned_cols=270  Identities=19%  Similarity=0.282  Sum_probs=195.3

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.+.||+|+||.||+|++..+|..||+|+++...  ......+.+|++++++++||||+++++++.+..     ..+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK-----KLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC-----ceE
Confidence            4778899999999999999999899999999986432  223356788999999999999999999986554     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +|+||+++ +|.+++.....     .+++..++.++.||++||+|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        76 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~  146 (284)
T cd07839          76 LVFEYCDQ-DLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA  146 (284)
T ss_pred             EEEecCCC-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence            99999975 88888765432     689999999999999999999999   9999999999999998877776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc--
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK--  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--  782 (854)
                      ..........   ....++..|+|||++.+.. ++.++|||||||++|||+||+.|+.........+...........  
T Consensus       147 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd07839         147 RAFGIPVRCY---SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE  223 (284)
T ss_pred             hccCCCCCCc---CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChH
Confidence            8664432221   1235789999999887754 789999999999999999999986543222111111111100000  


Q ss_pred             -cc---cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 -VI---EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 -~~---~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       +.   ...+...   ....  ...............++.+++.+||+.||.+|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         224 SWPGVSKLPDYKP---YPMY--PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HhHHhhhcccccc---cCCC--CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence             00   0000000   0000  0000000111123566789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.3e-35  Score=310.62  Aligned_cols=272  Identities=22%  Similarity=0.313  Sum_probs=197.1

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|+..+.||+|++|.||+|++..++..||||+++...  ......+.+|++++++++||||+++++++.+.+     ..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC-----cEE
Confidence            4788899999999999999999899999999986432  223457889999999999999999999986544     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+. ++|.+++......    .+++..+..++.|++.||+|||+.   +++||||+|+||+++.++..++ |||.+
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPLS----GIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence            9999996 5899988765322    688999999999999999999999   9999999999999999887776 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC-Ccc-
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL-PEK-  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~-  782 (854)
                      ..........   ....++..|+|||+..+.. ++.++|||||||++|||+||+.||....... ...+...... +.. 
T Consensus       148 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~  223 (284)
T cd07860         148 RAFGVPVRTY---THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEV  223 (284)
T ss_pred             hhcccCcccc---ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChh
Confidence            7664432221   1224788999999887644 6889999999999999999999997543211 1111111110 100 


Q ss_pred             cccccC--chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVD--PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ......  +.....+....   ..............+.+++.+|++.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         224 VWPGVTSLPDYKPSFPKWA---RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhhhHHHHHHhhccccc---ccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000000  00000000000   00000001122455788999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-34  Score=302.36  Aligned_cols=251  Identities=27%  Similarity=0.448  Sum_probs=196.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|.++.... ....+.+|++++++++|||++++++++....     ..+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS-----PIC   75 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC-----ceE
Confidence            357888999999999999999986 466899998864332 3467899999999999999999999986654     679


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....     .+++..+..++.|++.|++|||+.   +++||||||+||+++.++..++ |||.+
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~  147 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMT  147 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcce
Confidence            99999999999999876532     578899999999999999999999   9999999999999998876665 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      .........  ......++..|+|||+..+..++.++|||||||++||+++ |+.||......  ...+......     
T Consensus       148 ~~~~~~~~~--~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~-----  218 (256)
T cd05112         148 RFVLDDQYT--SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAGF-----  218 (256)
T ss_pred             eecccCccc--ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCCC-----
Confidence            766433221  1112235678999999988889999999999999999998 99998643211  1111110000     


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                      ....+.                     ..+.++.+++.+||+.+|++|||+.|++++|
T Consensus       219 ~~~~~~---------------------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         219 RLYKPR---------------------LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCC---------------------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            000011                     0145688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-34  Score=303.20  Aligned_cols=253  Identities=23%  Similarity=0.422  Sum_probs=199.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|.+.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. .     ..+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~-----~~~   76 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E-----PIY   76 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C-----CeE
Confidence            357889999999999999999876 55679999886432 234678899999999999999999998865 2     479


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....    ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence            99999999999999976432    2678889999999999999999998   9999999999999999888877 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      ..........  .....++..|+|||++.+..++.++|||||||++|++++ |+.||......  ...+........   
T Consensus       150 ~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~---  222 (260)
T cd05073         150 RVIEDNEYTA--REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRM---  222 (260)
T ss_pred             eeccCCCccc--ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCCC---
Confidence            7664432211  112346678999999988889999999999999999999 99998743211  111111111000   


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                                             +.....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus       223 -----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 -----------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -----------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                                   0011124568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.7e-35  Score=306.73  Aligned_cols=259  Identities=23%  Similarity=0.381  Sum_probs=199.9

Q ss_pred             hhccccCccCCCcceEEEEeEECC-----CceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      ++|++.+.||+|+||.||+|+.+.     +...||+|.+...... ..+.+.+|++++++++|+||+++++++.+.+   
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE---   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC---
Confidence            578889999999999999999753     3467999988654433 4567899999999999999999999986654   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcc---cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccc
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA  698 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  698 (854)
                        ..++||||+++|+|.+++.......   ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..
T Consensus        82 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          82 --PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             --cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence              6799999999999999998654211   112589999999999999999999999   99999999999999998877


Q ss_pred             cc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhh
Q 043388          699 HQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVK  776 (854)
Q Consensus       699 ~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~  776 (854)
                      ++ |||++.........  ......++..|+|||.+.+..++.++|||||||++|++++ |..||......  .......
T Consensus       157 ~l~~~~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~  232 (275)
T cd05046         157 KVSLLSLSKDVYNSEYY--KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQ  232 (275)
T ss_pred             EEcccccccccCccccc--ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHH
Confidence            76 99988755332211  1112346788999999988889999999999999999999 88888643221  1111111


Q ss_pred             hcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       777 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                         .......                      ....++..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       233 ---~~~~~~~----------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 ---AGKLELP----------------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ---cCCcCCC----------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence               0000000                      00112456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-36  Score=319.89  Aligned_cols=286  Identities=23%  Similarity=0.288  Sum_probs=204.8

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccC-CCCCceeeE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSID-SKGADFKAL  627 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l  627 (854)
                      +...+.||+|+||.||+|+++.+|+.||||.++... ....+...+|+++|++++|||||+++++-++.. ..-.....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            444678999999999999999999999999997543 344577889999999999999999998744332 111345789


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC----ccccc-cc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQ-NF  702 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~~~-Df  702 (854)
                      |||||.||||+..+....   ..+.+++.+.+.+..+++.||.|||++   +||||||||.||++-.+    .+.|+ ||
T Consensus        95 vmEyC~gGsL~~~L~~PE---N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPE---NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             EEeecCCCcHHHHhcCcc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence            999999999999998754   345899999999999999999999999   99999999999998432    24444 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch--HhHHhhhcC
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT--LHEFVKMTL  779 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~--~~~~~~~~~  779 (854)
                      |.|+..++...    ...++||..|.+||+... ..|+..+|.|||||++|++.||..||.........  .........
T Consensus       169 G~Arel~d~s~----~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk  244 (732)
T KOG4250|consen  169 GAARELDDNSL----FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK  244 (732)
T ss_pred             cccccCCCCCe----eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence            99999887652    334689999999999984 78999999999999999999999999754332211  111111111


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC--CHHHHHHHHHhhhh
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM--EMRDVVAKLCHTRE  847 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP--s~~evl~~L~~~~~  847 (854)
                      +....-..++...+.+...... +. .-.........+..++..++..+|.+|.  ...+....+..++.
T Consensus       245 p~~v~i~~~~~eNgpv~~s~~l-P~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  245 PSGVAIGAQEEENGPVEWSSTL-PQ-PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             CCceeEeeecccCCceeeeccC-CC-cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            2222111111111111100000 00 0011112234466777778889999998  77777766666653

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.6e-35  Score=307.89  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=201.2

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++....     ..++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-----DISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC-----EEEE
Confidence            5778899999999999999999899999999987553 234567889999999999999999999987654     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      |+||+++++|.+++....     ..+++..+..++.|++.|++|||+ .   +++||||||+||+++.++..++ |||.+
T Consensus        77 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~  148 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVS  148 (265)
T ss_pred             EEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999998753     178889999999999999999999 7   9999999999999999877666 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ..........     ..++..|+|||+..+..++.++||||||+++|++++|+.||...........+..........  
T Consensus       149 ~~~~~~~~~~-----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  221 (265)
T cd06605         149 GQLVNSLAKT-----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--  221 (265)
T ss_pred             hhhHHHHhhc-----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--
Confidence            7664332211     458899999999999899999999999999999999999997543221122221111111000  


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                         +..                 ....+...+.+++.+||..+|++|||+.|++..
T Consensus       222 ---~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 ---PRL-----------------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ---CCC-----------------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence               000                 000135568899999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-34  Score=306.73  Aligned_cols=260  Identities=24%  Similarity=0.304  Sum_probs=200.5

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +|...+.||.|++|.||+|.+..+++.||+|.+..... .....+.+|++++++++||||++++++|....   ....++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEEE
Confidence            67888999999999999999988899999999875432 34567899999999999999999999986543   225799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|.+++......  ...++...+..++.|++.||+|||+.   +++|+||+|+||+++.++..++ |||++.
T Consensus        79 v~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKR--GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            99999999999987653221  12678889999999999999999999   9999999999999998887776 999987


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC---chHhHHhhhcCCccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG---LTLHEFVKMTLPEKV  783 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~---~~~~~~~~~~~~~~~  783 (854)
                      ........     ...++..|+|||.+.+..++.++||||+||++|||++|+.||.......   .....+.........
T Consensus       154 ~~~~~~~~-----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd06621         154 ELVNSLAG-----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL  228 (287)
T ss_pred             cccccccc-----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence            65433221     2347889999999988889999999999999999999999998552211   111111111000000


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...                    ..........+.+++.+||+.+|++|||+.|+++.
T Consensus       229 ~~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         229 KDE--------------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             ccC--------------------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            000                    00001124568899999999999999999999873

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.3e-35  Score=306.19  Aligned_cols=264  Identities=26%  Similarity=0.416  Sum_probs=199.8

Q ss_pred             ccccCccCCCcceEEEEeEEC---CCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC-c
Q 043388          550 FASSNMIGQGSFGSVYKGILG---GEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA-D  623 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~-~  623 (854)
                      |.+.+.||+|+||.||+|.+.   +++..||||++...  .....+++.+|++++++++||||+++++++......+. .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999864   35789999998643  23345678899999999999999999998866443221 2


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++++||+++|+|.+++...........+++..++.++.|++.||+|||+.   +|+||||||+||+++.+...++ ||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            3578999999999999886543222223578899999999999999999999   9999999999999998877776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |.++........... ....+++.|++||...+..++.++|||||||++|||++ |++||.....  .....+....  .
T Consensus       158 g~~~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~--~  232 (273)
T cd05074         158 GLSKKIYSGDYYRQG-CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKG--N  232 (273)
T ss_pred             cccccccCCcceecC-CCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcC--C
Confidence            999876443221111 12245678999999988889999999999999999999 8888864321  1111111110  0


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ...                        ....++..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       233 ~~~------------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 RLK------------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cCC------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            000                        0011245688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=316.00  Aligned_cols=251  Identities=23%  Similarity=0.355  Sum_probs=204.3

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      -|.++..||.|+||.||+|+.+.++...|-|++........++|.-|++|++.++||+||++++.|...+     ..+|.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-----kLwil  107 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-----KLWIL  107 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-----ceEEE
Confidence            4566778999999999999999888888999999888888899999999999999999999999876655     58999


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQ  707 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~  707 (854)
                      .|||.||-++.++-+-+.     .+++.++..+++|++.||.|||++   .|||||||+.|||++-++..++ |||.+..
T Consensus       108 iEFC~GGAVDaimlEL~r-----~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK  179 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGR-----VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK  179 (1187)
T ss_pred             EeecCCchHhHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence            999999999998887653     799999999999999999999999   9999999999999999887776 9999876


Q ss_pred             cccCCCCCCcccccCCcccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          708 LDSASKTPSSSIGIKGTVGYVAPEYGM-----GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       708 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      .......   ...+.|||.|||||+.+     +.+|++++||||||++|.||..+.+|......    +.-.......+ 
T Consensus       180 n~~t~qk---RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----MRVllKiaKSe-  251 (1187)
T KOG0579|consen  180 NKSTRQK---RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKSE-  251 (1187)
T ss_pred             chhHHhh---hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----HHHHHHHhhcC-
Confidence            5443322   22367999999999854     46799999999999999999999999764311    11111111111 


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..-.+                     .+..+...+.+++.+|+..+|..||++.++++.
T Consensus       252 PPTLl---------------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  252 PPTLL---------------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CCccc---------------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            00111                     223346678899999999999999999998763

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.3e-35  Score=309.67  Aligned_cols=251  Identities=23%  Similarity=0.303  Sum_probs=200.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+|.+.+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++||||+++++++...+     ..+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-----ELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-----cEE
Confidence            368899999999999999999998788999999987655555677899999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +|+||+++++|.+++...       .+++.++..++.|++.||+|||+.   +++||||||+||+++.++..++ |||++
T Consensus        93 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~  162 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (293)
T ss_pred             EEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcce
Confidence            999999999999998753       567889999999999999999999   9999999999999998887776 99988


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ..........   ....|++.|+|||...+..++.++|||||||++|++++|+.||........ ......  ....  .
T Consensus       163 ~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~--~~~~--~  234 (293)
T cd06647         163 AQITPEQSKR---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIAT--NGTP--E  234 (293)
T ss_pred             eccccccccc---ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehhc--CCCC--C
Confidence            7665433221   123588999999999888899999999999999999999999975422110 000000  0000  0


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                       .                    .........+.+++.+||+.+|++||++.+++..
T Consensus       235 -~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 -L--------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -C--------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0                    0011124457789999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.6e-35  Score=311.77  Aligned_cols=249  Identities=22%  Similarity=0.324  Sum_probs=196.4

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      .|.....||+|+||.||++....++..||||++........+.+.+|+.++++++|+||+++++.+...+     ..++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-----ELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC-----eEEEE
Confidence            3444577999999999999998889999999987655555677899999999999999999999887654     68999


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQ  707 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~  707 (854)
                      |||+++++|.+++...       .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||++..
T Consensus        98 ~e~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~  167 (292)
T cd06658          98 MEFLEGGALTDIVTHT-------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQ  167 (292)
T ss_pred             EeCCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence            9999999999988543       578889999999999999999999   9999999999999998877776 9999876


Q ss_pred             cccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccccc
Q 043388          708 LDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV  787 (854)
Q Consensus       708 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  787 (854)
                      ........   ....|+..|+|||...+..++.++|||||||++||+++|+.||......  ..........+....   
T Consensus       168 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~---  239 (292)
T cd06658         168 VSKEVPKR---KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDNLPPRVK---  239 (292)
T ss_pred             cccccccC---ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCccc---
Confidence            54332211   2245899999999998888999999999999999999999998743211  000001110100000   


Q ss_pred             CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       788 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                           ........+.+++..|+..||.+|||+.|+++.
T Consensus       240 ---------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         240 ---------------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ---------------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                                 001123457788999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.2e-34  Score=304.61  Aligned_cols=255  Identities=24%  Similarity=0.350  Sum_probs=196.7

Q ss_pred             hccccCccCCCcceEEEEeEECC-CceEEEEEEeeccc----------ccchHHHHHHHHHHHh-ccCCCeeeEEEEeec
Q 043388          549 EFASSNMIGQGSFGSVYKGILGG-EEMIVAVKVINLKQ----------KGAFRSFVAECEALRN-IRHRNLIKIITICSS  616 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~  616 (854)
                      +|++.+.||+|+||.||+|.+.. .++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999986 67889999885321          2234557788888865 699999999999876


Q ss_pred             cCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc
Q 043388          617 IDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM  696 (854)
Q Consensus       617 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  696 (854)
                      .+     ..++||||+++++|.+++......  ...+++..++.++.|++.||.|||+..  +++||||||+||+++.++
T Consensus        81 ~~-----~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~  151 (269)
T cd08528          81 ND-----RLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDD  151 (269)
T ss_pred             CC-----eEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCC
Confidence            54     789999999999999988653211  126888999999999999999999631  899999999999999988


Q ss_pred             cccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          697 VAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       697 ~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                      ..++ |||.+.......    ......|+..|+|||+..+..++.++||||||+++||+++|+.||.....     ....
T Consensus       152 ~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~  222 (269)
T cd08528         152 KVTITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLA  222 (269)
T ss_pred             cEEEecccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHH
Confidence            7776 999998765443    11234589999999999988899999999999999999999999864311     1111


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      ............                      ...+...+.+++.+||+.||++||++.||.++++
T Consensus       223 ~~~~~~~~~~~~----------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         223 TKIVEAVYEPLP----------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHhhccCCcCC----------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            110000000000                      0012455788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.8e-35  Score=305.78  Aligned_cols=254  Identities=23%  Similarity=0.414  Sum_probs=195.4

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccc----------cchHHHHHHHHHHHhccCCCeeeEEEEeeccC
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK----------GAFRSFVAECEALRNIRHRNLIKIITICSSID  618 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  618 (854)
                      +|.+.+.||+|+||.||+|....+++.||+|.++....          ...+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            47788999999999999999988899999998863211          11346788999999999999999999987654


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccc
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA  698 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  698 (854)
                           ..++||||+++++|.+++....      .+++..+..++.|++.||.|||+.   +++||||||+||+++.++..
T Consensus        82 -----~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~  147 (272)
T cd06629          82 -----YLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC  147 (272)
T ss_pred             -----ceEEEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence                 6899999999999999998753      688899999999999999999999   99999999999999988877


Q ss_pred             cc-ccccccccccCCCCCCcccccCCcccccCccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          699 HQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE--ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       699 ~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                      ++ |||.+.......... ......|+..|+|||......  ++.++||||||+++||+++|+.||.....    .....
T Consensus       148 ~l~d~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~  222 (272)
T cd06629         148 KISDFGISKKSDDIYDND-QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMF  222 (272)
T ss_pred             EEeecccccccccccccc-ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHH
Confidence            76 999987654322111 112345889999999987654  78999999999999999999999863211    11111


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .... .......++.                  ....++..+.+++..||+.+|++|||+.||++
T Consensus       223 ~~~~-~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         223 KLGN-KRSAPPIPPD------------------VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             Hhhc-cccCCcCCcc------------------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1000 0000000000                  00122456888999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.9e-35  Score=317.40  Aligned_cols=202  Identities=25%  Similarity=0.332  Sum_probs=170.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|.+.++||+|+||.||+++...+++.||+|++...   .......+.+|+.++..++|++|+++++++.+.+     .
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN-----N   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-----E
Confidence            3688999999999999999999989999999998642   2223345788999999999999999999987655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence            8999999999999999986432     678889999999999999999999   9999999999999998877776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGM-----GSEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ++.........  ......||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       148 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         148 SCLKLMEDGTV--QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             hheecccCCcc--eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            98765432221  112246999999999886     345889999999999999999999999743

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.6e-34  Score=302.86  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=200.0

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc--chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|...+.||+|+||.||+|....+++.||+|+++.....  ..+.+.+|+.++++++|+||+++++++...+     ..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-----KVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC-----EEE
Confidence            478889999999999999999888999999999765443  5678899999999999999999999876554     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +|+||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+|+||+|+||+++.++..++ |||.+
T Consensus        76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~  146 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA  146 (264)
T ss_pred             EEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence            9999999999999998653      578889999999999999999999   9999999999999999887776 99999


Q ss_pred             cccccCCCCCCc-ccccCCcccccCccccCCCC---CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          706 HQLDSASKTPSS-SIGIKGTVGYVAPEYGMGSE---ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       706 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ............ .....++..|+|||++.+..   ++.++||||||+++||+++|+.||....... ............
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~  225 (264)
T cd06626         147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGAGHKP  225 (264)
T ss_pred             cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhcCCCC
Confidence            877554332222 22345889999999988766   8899999999999999999999997542111 111101100000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...                        ....+...+.+++.+||+.+|.+|||+.|++.
T Consensus       226 ~~~------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 PIP------------------------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCC------------------------cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000                        00112445678999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.8e-35  Score=308.66  Aligned_cols=275  Identities=20%  Similarity=0.215  Sum_probs=200.6

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.+.||+|+||.||+|.+..++..||+|++....  ....+.+.+|+.++++++||||+++++++....     ..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-----GFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC-----eeE
Confidence            4788899999999999999998889999999997554  333567899999999999999999999987644     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+ +++|.+++.....     .+++.+++.++.||+.||+|||+.   +++|+||||+||+++.++..++ |||.+
T Consensus        76 ~v~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~  146 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA  146 (286)
T ss_pred             EEeccc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence            999999 9999999876542     689999999999999999999999   9999999999999998877666 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC---Cc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL---PE  781 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~---~~  781 (854)
                      .........  ......|+..|+|||++.+. .++.++||||+||++|||++|++||...... ...........   ..
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~  223 (286)
T cd07832         147 RLFSEEEPR--LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEE  223 (286)
T ss_pred             ccccCCCCC--ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChH
Confidence            877554321  11123589999999998664 4689999999999999999998887643221 11111111100   00


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .+.+..+........... ...........+....+.+++.+|++.+|++|||++++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         224 TWPGLTSLPDYNKITFPE-SKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHhhccCcchhhcccCCC-CCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            011100000000000000 00000001112234678899999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.2e-35  Score=317.81  Aligned_cols=202  Identities=26%  Similarity=0.344  Sum_probs=171.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|.+.+.||+|+||.||++++..+++.||+|++...   .......+.+|..++..++|++|+++++++.+.+     +
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~-----~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN-----Y   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----E
Confidence            3688999999999999999999989999999998642   2223455788999999999999999999987655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+||||+++|+|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence            8999999999999999986432     678889999999999999999999   9999999999999998877666 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-----SEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ++..........  .....||+.|+|||++.+     +.++.++|||||||++|||++|+.||...
T Consensus       148 ~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         148 SCLKMNQDGTVQ--SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             ceeeccCCCcee--eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            998765432211  112469999999998875     45788999999999999999999999743

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.2e-34  Score=301.60  Aligned_cols=247  Identities=27%  Similarity=0.427  Sum_probs=195.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+|++.+.||+|+||.||+|..  +++.||+|.++...  ..+.+.+|+.++++++|||++++++++...      ..+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~   74 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLY   74 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcE
Confidence            36789999999999999999975  56779999986432  346788999999999999999999998543      358


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++......    .+++..+..++.|++.|++|||+.   +++||||||+||+++.++..++ |||.+
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~  147 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRA----LVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLA  147 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccc
Confidence            999999999999999765321    578999999999999999999998   9999999999999998887766 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      ........      ....+..|+|||++.+..++.++|||||||++|||++ |+.||......  ...+........   
T Consensus       148 ~~~~~~~~------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~---  216 (254)
T cd05083         148 RVGSMGVD------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVEKGYRM---  216 (254)
T ss_pred             eeccccCC------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhCCCCC---
Confidence            76543211      1234678999999988889999999999999999998 99998743221  111111100000   


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                                             .....++..+.+++.+||+.+|++||+++++++.|++
T Consensus       217 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 -----------------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -----------------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                                   0011224567899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-35  Score=309.90  Aligned_cols=276  Identities=21%  Similarity=0.307  Sum_probs=196.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|++.+.||+|++|.||+|....+++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+     +.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~   78 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK-----TL   78 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC-----eE
Confidence            3678999999999999999999988899999999865432 22345678999999999999999999987654     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++ +|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.
T Consensus        79 ~lv~e~~~~-~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~  149 (291)
T cd07844          79 TLVFEYLDT-DLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGL  149 (291)
T ss_pred             EEEEecCCC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccc
Confidence            999999975 99998876542     678899999999999999999999   9999999999999999887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC---C
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL---P  780 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~---~  780 (854)
                      ++.........   ....++..|+|||+..+ ..++.++||||+||++|||++|+.||..................   +
T Consensus       150 ~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (291)
T cd07844         150 ARAKSVPSKTY---SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTE  226 (291)
T ss_pred             ccccCCCCccc---cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCCh
Confidence            87654322211   11246889999998876 45889999999999999999999999754321111111111100   0


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHH--HHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDC--LNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..+....+...... ..................  ...+.+++.+|++.+|++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         227 ETWPGVSSNPEFKP-YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhhhcccccc-ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000000000000 000000000000000011  255778999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.1e-35  Score=313.39  Aligned_cols=274  Identities=23%  Similarity=0.322  Sum_probs=198.7

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.++||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|+++++.++||||+++++++....     ..+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK-----RLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC-----eEE
Confidence            68889999999999999999988899999998854322  23457889999999999999999999986544     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||++++++.++.....      .+++.++..++.|++.||+|||+.   +++||||+|+||++++++..++ |||++
T Consensus        77 lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~  147 (286)
T cd07846          77 LVFEFVDHTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA  147 (286)
T ss_pred             EEEecCCccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeee
Confidence            9999999999988776543      578999999999999999999999   9999999999999999887776 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh--cCCcc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM--TLPEK  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~  782 (854)
                      .........   .....++..|+|||+..+ ..++.++|||||||++|||++|++||...... .........  .....
T Consensus       148 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~  223 (286)
T cd07846         148 RTLAAPGEV---YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPR  223 (286)
T ss_pred             eeccCCccc---cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchh
Confidence            876543321   122458899999999876 34788999999999999999999998643211 011111100  00000


Q ss_pred             cccccCchhhHHHhh-ccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMA-NNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .....+......... ...............++..+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            001111000000000 0000000001111234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.4e-34  Score=303.28  Aligned_cols=254  Identities=22%  Similarity=0.261  Sum_probs=200.6

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|.+.+.||+|+||.||+|.+..++..||+|++....  ....+.+.+|++++++++||||+++++++....   ....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS---NQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC---CCEEE
Confidence            4788899999999999999998899999999986432  233456888999999999999999999876533   22579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEeecCCCCceEecCCccccc-
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH-----HHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                      ++|||+++++|.+++......  ...+++..++.++.|++.||+|||     +.   +++|+||||+||+++.++..++ 
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKE--RKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence            999999999999999764221  227899999999999999999999     66   9999999999999999887776 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |||.+..........   ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....  ....+.......
T Consensus       153 d~g~~~~~~~~~~~~---~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~  227 (265)
T cd08217         153 DFGLAKILGHDSSFA---KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKEGKF  227 (265)
T ss_pred             cccccccccCCcccc---cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhcCCC
Confidence            999998775543211   124589999999999988899999999999999999999999975421  111111111000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                          ..                      .....+..+.+++.+|++.+|++||++.+|++.
T Consensus       228 ----~~----------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 ----RR----------------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CC----------------------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                00                      011224567899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-34  Score=302.29  Aligned_cols=250  Identities=19%  Similarity=0.268  Sum_probs=199.1

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.+.||+|+||.||++....+++.||+|++....  ....+++.+|+.++++++||||+++++++...+     +.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG-----NLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC-----eEE
Confidence            4788999999999999999998899999999986432  233467899999999999999999999986654     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++......    .+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++..++ |||.+
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRGV----LFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             EEEecCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence            999999999999998764321    578889999999999999999999   9999999999999998877766 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ..........   ....|+..|+|||+..+..++.++|||||||++|++++|+.||.....     .+........... 
T Consensus       149 ~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~-  219 (256)
T cd08218         149 RVLNSTVELA---RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGSYP-  219 (256)
T ss_pred             eecCcchhhh---hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCCCC-
Confidence            8765432211   123588899999999888899999999999999999999999864311     1111111100000 


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                            .....+...+.+++.+||+.+|++||++.||++.
T Consensus       220 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 ----------------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ----------------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                                  0011224568899999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.9e-35  Score=311.32  Aligned_cols=275  Identities=21%  Similarity=0.256  Sum_probs=198.8

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc-----chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      +|...+.||+|+||.||+|.+..+++.||+|.++.....     ....+..|++++++++|+||+++++++.+.+     
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS-----   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC-----
Confidence            477889999999999999999888999999999754322     2345678999999999999999999987744     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+ +|+|.+++....     ..+++..++.++.||++||+|||++   +|+||||||+||+++.++..++ ||
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence            789999999 889999997653     1689999999999999999999999   9999999999999999887777 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |.+...........   ...+++.|+|||.+.+ ..++.++|||||||++|||++|.+||...... .............
T Consensus       147 g~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~  222 (298)
T cd07841         147 GLARSFGSPNRKMT---HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTP  222 (298)
T ss_pred             eeeeeccCCCcccc---ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCC
Confidence            99987755432211   1246888999998865 45789999999999999999998887653221 1111111110000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ......+............................+.+++.+||+.||++|||+.|+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            000000000000000000000000011112335678899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=312.65  Aligned_cols=253  Identities=26%  Similarity=0.336  Sum_probs=198.0

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc---chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +|+..+.||+|+||.||+|....+++.||+|.+......   ..+.+.+|+++++.++|+||+++++++....     ..
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET-----YL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-----EE
Confidence            688899999999999999999988999999999754322   3457889999999999999999999986654     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++++|.+++.....    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++..++ |||+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecch
Confidence            999999999999999875432    2688999999999999999999999   9999999999999998877666 9999


Q ss_pred             ccccccCCCCC--------------------------CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCC
Q 043388          705 SHQLDSASKTP--------------------------SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGR  758 (854)
Q Consensus       705 ~~~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~  758 (854)
                      +..........                          .......||..|+|||++.+..++.++|||||||++|+|++|+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~  229 (316)
T cd05574         150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT  229 (316)
T ss_pred             hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence            87654322110                          0111246889999999999888999999999999999999999


Q ss_pred             CCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC----
Q 043388          759 RPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME----  834 (854)
Q Consensus       759 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----  834 (854)
                      .||...... ..+.........  .                        ......+..+.+++.+||+.||++|||    
T Consensus       230 ~pf~~~~~~-~~~~~~~~~~~~--~------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~  282 (316)
T cd05574         230 TPFKGSNRD-ETFSNILKKEVT--F------------------------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRG  282 (316)
T ss_pred             CCCCCCchH-HHHHHHhcCCcc--C------------------------CCccccCHHHHHHHHHHccCCHhHCCCchhh
Confidence            999754221 111111110000  0                        000012566889999999999999999    


Q ss_pred             HHHHHH
Q 043388          835 MRDVVA  840 (854)
Q Consensus       835 ~~evl~  840 (854)
                      +.|+++
T Consensus       283 ~~~ll~  288 (316)
T cd05574         283 AAEIKQ  288 (316)
T ss_pred             HHHHHc
Confidence            555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.5e-35  Score=308.27  Aligned_cols=254  Identities=21%  Similarity=0.306  Sum_probs=196.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|++.+.||+|+||.||+|.+..++..||+|.++.. .......+.+|++++++++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-----AVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-----eEE
Confidence            3688899999999999999999989999999998754 2333467889999999999999999999887654     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....   ...+++..+..++.|++.||.|||+.+  +|+||||||+||+++.++..++ |||.+
T Consensus        76 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~  150 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS  150 (286)
T ss_pred             EEEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence            99999999999999876421   126899999999999999999999742  8999999999999998877666 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCC------CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE------ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      .........     ...++..|+|||.+.+..      ++.++|||||||++|||++|+.||.......  .........
T Consensus       151 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~  223 (286)
T cd06622         151 GNLVASLAK-----TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSAIV  223 (286)
T ss_pred             ccccCCccc-----cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHHHh
Confidence            766433221     235788999999875543      5889999999999999999999996432111  111000000


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...                       ......++...+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         224 DGD-----------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             hcC-----------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            000                       000111235567889999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-34  Score=302.26  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=196.7

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-----ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      +|+..+.||+|+||.||+|....++..||+|.+....     ....+.+.+|++++++++|+||+++++++....     
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-----   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC-----
Confidence            4677899999999999999998889999999986543     224567889999999999999999999987654     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++++|.+++....      .+++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++..++ ||
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence            6899999999999999997653      578999999999999999999999   9999999999999998887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |.+........    .....|+..|+|||.+.... ++.++|+|||||++|++++|+.||...... .........   .
T Consensus       147 ~~~~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~---~  218 (258)
T cd06632         147 GMAKQVVEFSF----AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-AAVFKIGRS---K  218 (258)
T ss_pred             ccceecccccc----ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-HHHHHHHhc---c
Confidence            99887644331    12245889999999987766 899999999999999999999998753211 000000000   0


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .. .                      .....+...+.+++.+||+.+|++||++.++++
T Consensus       219 ~~-~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 EL-P----------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cC-C----------------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            00 0                      001112455778999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-34  Score=301.01  Aligned_cols=248  Identities=23%  Similarity=0.357  Sum_probs=197.3

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|+..+.||+|+||.||+|....++..+|+|++....  ......+.+|++++++++||||+++++.+...+     ..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-----ALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC-----EEE
Confidence            4788899999999999999998899999999986542  234567889999999999999999999876544     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc-ccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAH-QNFSL  704 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~~-~Dfg~  704 (854)
                      +||||+++++|.+++.....    ..+++..+..++.|++.|++|||+.   +++||||||+||+++.+. ..+ .|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence            99999999999999986532    1578999999999999999999999   999999999999998654 444 49999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +.........    ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .......    ....
T Consensus       149 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~----~~~~  219 (256)
T cd08220         149 SKILSSKSKA----YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMS----GTFA  219 (256)
T ss_pred             ceecCCCccc----cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-HHHHHHh----cCCC
Confidence            9877543322    12458899999999998889999999999999999999999986532111 1111100    0000


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .                       ....+...+.+++.+||+.+|++|||+.|+++
T Consensus       220 ~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         220 P-----------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             C-----------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0                       00112456789999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.3e-34  Score=301.92  Aligned_cols=255  Identities=22%  Similarity=0.333  Sum_probs=183.8

Q ss_pred             CccCCCcceEEEEeEECCC--ceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          554 NMIGQGSFGSVYKGILGGE--EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      +.||+|+||.||+|....+  ...+++|.++... ....+.+.+|+.+++.++||||++++++|....     ..++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-----PYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-----ccEEEEe
Confidence            3699999999999976432  3456677765433 234568899999999999999999999987654     6799999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccc
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLD  709 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~  709 (854)
                      |+++|+|.+++......  ....++..+..++.||+.||+|||+.   +++||||||+||+++.++..++ |||.+....
T Consensus        76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~  150 (268)
T cd05086          76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY  150 (268)
T ss_pred             cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccC
Confidence            99999999999865322  12466777889999999999999999   9999999999999998887776 999876432


Q ss_pred             cCCCCCCcccccCCcccccCccccCC-------CCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          710 SASKTPSSSIGIKGTVGYVAPEYGMG-------SEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       710 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ..... .......++..|+|||+...       ..++.++|||||||++|||++ |..||...... ..+...    ..+
T Consensus       151 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~----~~~  224 (268)
T cd05086         151 KEDYI-ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHV----IKD  224 (268)
T ss_pred             cchhh-hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH----Hhh
Confidence            22111 11123458899999998743       245789999999999999997 56777543211 111111    111


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      ......++...                  ......+.+++..|| .+|++||+++||++.|.
T Consensus       225 ~~~~~~~~~~~------------------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         225 QQVKLFKPQLE------------------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cccccCCCccC------------------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11111222110                  011345677888899 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=298.98  Aligned_cols=247  Identities=29%  Similarity=0.440  Sum_probs=194.1

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeec
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM  632 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  632 (854)
                      ++||+|+||.||+|.+.. ++.||+|.+...... ..+.+.+|++++++++|+||+++++++....     ..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-----PIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----CeEEEEEcC
Confidence            479999999999999986 899999998754433 4567899999999999999999999987655     689999999


Q ss_pred             cCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccC
Q 043388          633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSA  711 (854)
Q Consensus       633 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~  711 (854)
                      ++++|.+++.....     .+++..+..++.+++.|++|||+.   +++||||||+||+++.++..++ |||.+......
T Consensus        75 ~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          75 PGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            99999999976432     578889999999999999999999   9999999999999998876666 99998866432


Q ss_pred             CCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccccccCch
Q 043388          712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS  790 (854)
Q Consensus       712 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  790 (854)
                      ..... .....++..|+|||.+.+..++.++|||||||++|||+| |..||......  ............         
T Consensus       147 ~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~~~---------  214 (251)
T cd05041         147 IYTVS-DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGYRM---------  214 (251)
T ss_pred             cceec-cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCCCC---------
Confidence            21111 111234677999999988889999999999999999999 88888643211  111111110000         


Q ss_pred             hhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                                       .....++..+.+++.+|+..+|.+|||+.|+++.|.
T Consensus       215 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         215 -----------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -----------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                             001122456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7e-35  Score=310.33  Aligned_cols=248  Identities=21%  Similarity=0.305  Sum_probs=196.7

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      |.....||+|+||.||+|....++..||+|++........+.+.+|+.+++.++||||+++++++...+     ..++||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE-----ELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC-----eEEEEE
Confidence            344567999999999999998889999999997655555677889999999999999999999887654     689999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++++|.+++...       .+++.++..++.|++.||+|||+.   +++||||||+||+++.++..++ |||++...
T Consensus        98 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~  167 (297)
T cd06659          98 EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI  167 (297)
T ss_pred             ecCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence            999999999987542       578999999999999999999999   9999999999999999887776 99998765


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      .......   ....|+..|+|||++.+..++.++|||||||++|||++|+.||......  ...............    
T Consensus       168 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~----  238 (297)
T cd06659         168 SKDVPKR---KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSPPPKLK----  238 (297)
T ss_pred             ccccccc---cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCCCcc----
Confidence            4432211   2245899999999998888999999999999999999999999743211  111111110000000    


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                          ........+.+++.+|++.+|++||++.|+++.
T Consensus       239 --------------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 --------------------NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             --------------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                                001113457789999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-35  Score=318.42  Aligned_cols=240  Identities=25%  Similarity=0.274  Sum_probs=183.1

Q ss_pred             cCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhc---cCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI---RHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       556 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ||+|+||.||+|++..+++.||+|++....   ......+.+|..++...   +||||+++++++....     ..++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~-----~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS-----DLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-----eEEEEE
Confidence            799999999999999899999999986432   22233455677777665   6999999999987655     689999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||++...
T Consensus        76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          76 DYMSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             cCCCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            9999999999987654      688999999999999999999999   9999999999999998877766 99998764


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccccc
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV  787 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  787 (854)
                      ......   .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.....     .+.......... ...
T Consensus       147 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~-~~~  217 (330)
T cd05586         147 LTDNKT---TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFGKV-RFP  217 (330)
T ss_pred             CCCCCC---ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcCCC-CCC
Confidence            332221   1235699999999998764 489999999999999999999999975321     111111100000 000


Q ss_pred             CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC----HHHHHH
Q 043388          788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME----MRDVVA  840 (854)
Q Consensus       788 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl~  840 (854)
                      .                      ......+.+++.+||+.||.+||+    +.|+++
T Consensus       218 ~----------------------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 K----------------------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             C----------------------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0                      011345678999999999999995    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-34  Score=303.83  Aligned_cols=254  Identities=20%  Similarity=0.326  Sum_probs=197.9

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccc------cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      +|+..+.||+|+||.||+|....++..||+|++.....      ...+.+.+|++++++++|+||+++++++.+.+    
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   76 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS----   76 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC----
Confidence            47788999999999999999988999999999874331      13467889999999999999999999987655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc--cccc
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM--VAHQ  700 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~~~  700 (854)
                       ..++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++  .+++
T Consensus        77 -~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          77 -HFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             -eEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence             6899999999999999997654      678899999999999999999999   999999999999998764  3445


Q ss_pred             ccccccccccCCCCCC-cccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          701 NFSLSHQLDSASKTPS-SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      |||.+........... ......|+..|+|||.+.+..++.++||||+|+++|++++|+.||.......  .........
T Consensus       147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~  224 (268)
T cd06630         147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFKIA  224 (268)
T ss_pred             ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHHHHHh
Confidence            9999987755422111 1122458899999999988889999999999999999999999986432111  111110000


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .....                      ..........+.+++.+|+..+|++||++.|+++
T Consensus       225 ~~~~~----------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 SATTA----------------------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ccCCC----------------------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            00000                      0011123456788999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=344.37  Aligned_cols=257  Identities=26%  Similarity=0.392  Sum_probs=204.0

Q ss_pred             HHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       544 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      ...+-++....+||.|.||.||-|....+|...|+|.++..  .........+|..++..++|||+|++||+-...+   
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe--- 1307 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE--- 1307 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH---
Confidence            34455677889999999999999999999999999988643  2444567889999999999999999999866555   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                        ..+|.||||++|+|.+.+...+      ..++.....+..|++.|++|||++   |||||||||.||+++.++..|. 
T Consensus      1308 --kv~IFMEyC~~GsLa~ll~~gr------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1308 --KVYIFMEYCEGGSLASLLEHGR------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred             --HHHHHHHHhccCcHHHHHHhcc------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEee
Confidence              6899999999999999998765      456666677899999999999999   9999999999999999987776 


Q ss_pred             ccccccccccCCCC-CCcccccCCcccccCccccCCCC---CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh
Q 043388          701 NFSLSHQLDSASKT-PSSSIGIKGTVGYVAPEYGMGSE---ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK  776 (854)
Q Consensus       701 Dfg~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~  776 (854)
                      |||.|..+.....+ ........||+.|||||++.+..   ...++||||+|||+.||+||+.||...+.+-.-+.....
T Consensus      1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA 1456 (1509)
T ss_pred             cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc
Confidence            99999988766422 22233567999999999987743   677899999999999999999999865333111111111


Q ss_pred             hcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       777 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...|                           +.++....+-.+++.+|++.||++|+++.|+++.
T Consensus      1457 gh~P---------------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GHKP---------------------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             cCCC---------------------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            1111                           1122235556788999999999999999988764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.9e-35  Score=333.02  Aligned_cols=262  Identities=24%  Similarity=0.353  Sum_probs=196.4

Q ss_pred             HHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC---
Q 043388          544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS---  619 (854)
Q Consensus       544 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  619 (854)
                      .+...+|++.+.||+||||.||+++.+-+|+.||||++... +......+.+|+..+++++|||||+++..|.+...   
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            57888999999999999999999999999999999999755 34445678999999999999999999865422110   


Q ss_pred             -------------------------------------------------C------------------------------
Q 043388          620 -------------------------------------------------K------------------------------  620 (854)
Q Consensus       620 -------------------------------------------------~------------------------------  620 (854)
                                                                       .                              
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0                              


Q ss_pred             --------------------------------CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHH
Q 043388          621 --------------------------------GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA  668 (854)
Q Consensus       621 --------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~  668 (854)
                                                      .....||-||||+.-.++++++.+...     -.....++++.+|+.|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEG  709 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHH
Confidence                                            003458999999997788887765421     1356788999999999


Q ss_pred             HHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccccc---------------CCCCCCcccccCCcccccCccc
Q 043388          669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDS---------------ASKTPSSSIGIKGTVGYVAPEY  732 (854)
Q Consensus       669 L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~---------------~~~~~~~~~~~~gt~~y~aPE~  732 (854)
                      |+|+|++   |||||||||.||++|++..++| |||+|+....               ........++.+||.-|+|||+
T Consensus       710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            9999999   9999999999999999877777 9999998320               0111123456789999999999


Q ss_pred             cCCC---CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhh
Q 043388          733 GMGS---EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRAR  809 (854)
Q Consensus       733 ~~~~---~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~  809 (854)
                      +.+.   .|+.|+|+||+|||++||+.   ||.........+.......++.. .+..+++                   
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~-------------------  843 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPE-------------------  843 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccccc-------------------
Confidence            8774   49999999999999999984   56644322222222222222222 1222222                   


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          810 TQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       810 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                          ...=.+++.++++.||.+||||.|++.
T Consensus       844 ----~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  844 ----HPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ----chHHHHHHHHHhcCCCccCCCHHHHhh
Confidence                122357889999999999999999975

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-34  Score=310.21  Aligned_cols=256  Identities=22%  Similarity=0.278  Sum_probs=197.7

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+++++.++||||+++++++...+     +.
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR-----HL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-----EE
Confidence            6888999999999999999999899999999986543   233456789999999999999999999987654     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++..++ |||.
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~  147 (305)
T cd05609          77 CMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGL  147 (305)
T ss_pred             EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCC
Confidence            99999999999999997654      678899999999999999999999   9999999999999999887776 9998


Q ss_pred             ccccccCCCC------------CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh
Q 043388          705 SHQLDSASKT------------PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH  772 (854)
Q Consensus       705 ~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~  772 (854)
                      ++........            ........|+..|+|||.+.+..++.++|||||||++||+++|+.||.....     .
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~  222 (305)
T cd05609         148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----E  222 (305)
T ss_pred             ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H
Confidence            8642211100            0011124578899999999888899999999999999999999999964321     1


Q ss_pred             HHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                      +..........   ..+.                  ....++..+.+++.+||+.+|++||++.++.+.++.
T Consensus       223 ~~~~~~~~~~~---~~~~------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         223 ELFGQVISDDI---EWPE------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHHHHhccc---CCCC------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            11111100000   0000                  000124557899999999999999997666665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-34  Score=308.24  Aligned_cols=278  Identities=23%  Similarity=0.303  Sum_probs=196.1

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++.+|.+.+.||+|+||.||+|....++..||+|++..... .....+.+|+.+++.++|+||+++++++...+     .
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE-----T   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-----e
Confidence            45789999999999999999999988899999999865432 23346789999999999999999999987544     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||++ +++.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg  148 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG  148 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence            899999996 688777754422     567888899999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc-CCc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT-LPE  781 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~  781 (854)
                      .++.........   ....++..|+|||++.+. .++.++|||||||++|||++|+.||.........+.+..... .+.
T Consensus       149 ~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  225 (291)
T cd07870         149 LARAKSIPSQTY---SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT  225 (291)
T ss_pred             cccccCCCCCCC---CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCC
Confidence            987654332221   123478999999998764 478899999999999999999999975433211121111100 000


Q ss_pred             c-ccccc--CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 K-VIEIV--DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~-~~~~~--d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      . .....  -+...........................+.+++.+|++.||++|||+.|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0 00000  00000000000000000000000001345778999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.7e-34  Score=301.65  Aligned_cols=259  Identities=24%  Similarity=0.324  Sum_probs=202.8

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|++.+.||.|+||+||+|....++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+     ..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-----ELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-----EEE
Confidence            36889999999999999999998889999999986433 234577899999999999999999999887654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++..++ |||++
T Consensus        76 iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~  149 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS  149 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence            99999999999999976432   12688999999999999999999999   9999999999999998877666 99999


Q ss_pred             cccccCCCCC-CcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          706 HQLDSASKTP-SSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       706 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      .......... .......|+..|+|||++... .++.++|||||||++|||++|+.||....... ......... +...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~-~~~~  227 (267)
T cd06610         150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQND-PPSL  227 (267)
T ss_pred             HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCC-CCCc
Confidence            8776544331 112234689999999998776 78999999999999999999999997542211 111111110 0000


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...                     .....++..+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 ETG---------------------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCc---------------------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000                     001123566789999999999999999999976

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.7e-34  Score=300.00  Aligned_cols=251  Identities=29%  Similarity=0.532  Sum_probs=198.6

Q ss_pred             ccccCccCCCcceEEEEeEECCCc----eEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEE----MIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      +++.+.||+|+||.||+|++...+    ..||+|+++..... ..+.+.+|++.+.+++|+||+++++++.+.+     .
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE-----P   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-----e
Confidence            356789999999999999998665    88999999755433 5678899999999999999999999987654     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .+++|||+++++|.+++......    .+++.++..++.|++.||+|||+.   +++||||||+||+++.++..++ |||
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg  148 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG  148 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence            89999999999999999875421    289999999999999999999999   9999999999999999986665 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      .+............  ...++..|+|||...+..++.++||||+|+++|||++ |+.||.....  ....+........ 
T Consensus       149 ~~~~~~~~~~~~~~--~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~-  223 (258)
T smart00219      149 LSRDLYDDDYYKKK--GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGYRL-  223 (258)
T ss_pred             Cceecccccccccc--cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCC-
Confidence            99877654322211  1237789999999988889999999999999999998 8888864211  1111111110000 


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                                               .....++.++.+++.+|+..+|++|||+.|+++.|
T Consensus       224 -------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 -------------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                                     00011255688999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.6e-34  Score=306.23  Aligned_cols=253  Identities=23%  Similarity=0.289  Sum_probs=191.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHH-HHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEA-LRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++.... .....+..|+.+ ++..+||||+++++++....     ..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-----~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-----DV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-----cE
Confidence            368889999999999999999998999999999875432 223455667665 55668999999999987654     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||++ |+|.+++......  ...+++..++.++.|++.||+|||+++  +++||||||+||+++.++..++ |||.
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~  150 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI  150 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999997 5898888754321  136899999999999999999999854  8999999999999999887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCC----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMG----SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      +.........    ....|+..|+|||.+.+    ..++.++|||||||++|||++|+.||.................. 
T Consensus       151 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  225 (283)
T cd06617         151 SGYLVDSVAK----TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS-  225 (283)
T ss_pred             cccccccccc----ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC-
Confidence            8876432211    12358899999998765    44688999999999999999999998642211111111111000 


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                              +..                 ....++..+.+++.+||..+|++||++.++++
T Consensus       226 --------~~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 --------PQL-----------------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --------CCC-----------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    000                 00112456889999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-34  Score=300.05  Aligned_cols=253  Identities=20%  Similarity=0.290  Sum_probs=197.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc-----cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .+|++.+.||+|+||.||+|.+..++..||+|++...     .......+.+|++++++++|+||+++++++.+.+.   
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~---   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE---   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC---
Confidence            4688999999999999999999889999999987532     12334578899999999999999999999865432   


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++||||+++++|.+++....      .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++..++ |
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence            25789999999999999987653      578888999999999999999999   9999999999999998887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.++................|+..|+|||++.+..++.++|||||||++||+++|+.||.....    ....... ...
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~  224 (264)
T cd06653         150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFKI-ATQ  224 (264)
T ss_pred             cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHHH-HcC
Confidence            99998764432222222234689999999999888899999999999999999999999864311    1111111 000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .....+                      .....+++.+++.+|+. +|..||++.+++.
T Consensus       225 ~~~~~~----------------------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         225 PTKPML----------------------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCCC----------------------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            000001                      11224567889999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.3e-34  Score=306.80  Aligned_cols=280  Identities=19%  Similarity=0.236  Sum_probs=199.9

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCcee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +|++.+.||+|+||.||+|.+..+++.||+|+.+...  ......+.+|+.+++++. ||||+++++++...+..+....
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6888999999999999999999899999999986432  223467888999999995 6999999999877654344457


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC-Cccccc-ccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQ-NFS  703 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~~~-Dfg  703 (854)
                      ++||||+++ +|.+++...... ....+++..++.++.||+.||+|||+.   +|+||||||+||+++. ++..++ |||
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            999999986 899988764321 122689999999999999999999999   9999999999999998 666666 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc-CCc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT-LPE  781 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~  781 (854)
                      .+..........   ....+++.|+|||++.+ ..++.++|||||||++|||++|..||....... ....+.... .+.
T Consensus       157 ~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVKSY---THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPT  232 (295)
T ss_pred             cceecCCCcccc---CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence            988664432211   11246889999998765 457899999999999999999999997532211 111111100 000


Q ss_pred             c--cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 K--VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~--~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .  +....+...   ........+............++.+++.+||+.||.+||++.|++.
T Consensus       233 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRD---WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccc---hhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0  000000000   0000000001111112234667889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=284.59  Aligned_cols=257  Identities=22%  Similarity=0.281  Sum_probs=201.4

Q ss_pred             HHhhcccc-CccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCc
Q 043388          546 ATSEFASS-NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       546 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .+++|++. ++||-|-.|.|..+..+.+++.+|+|++...     ...++|++..-.. .|||||+++++|.... .+..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSY-QGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCce
Confidence            46677764 6899999999999999999999999998543     4457898876665 7999999999987654 3455


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC---ccccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQ  700 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~~~  700 (854)
                      ...+|||.|+||.|.+.+.+.+..    .+++.++..|+.||+.|++|||+.   +|+||||||+|+|....   -+.++
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~----afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQ----AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccc----cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence            788999999999999999988643    799999999999999999999999   99999999999999653   34444


Q ss_pred             -ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                       |||+|+.-.....-.    ..+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.....  ..+..-.+..+
T Consensus       206 tDfGFAK~t~~~~~L~----TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI  279 (400)
T KOG0604|consen  206 TDFGFAKETQEPGDLM----TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRI  279 (400)
T ss_pred             cccccccccCCCcccc----CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHh
Confidence             999998766432222    24679999999999999999999999999999999999999975321  11111111111


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...-.+..++                   .....+++..++++.++..+|.+|.|+.|+++
T Consensus       280 ~~gqy~FP~p-------------------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  280 RTGQYEFPEP-------------------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             hccCccCCCh-------------------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            1111122222                   22344677889999999999999999999875

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=305.52  Aligned_cols=260  Identities=23%  Similarity=0.323  Sum_probs=201.5

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCC-CCCc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDS-KGAD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~  623 (854)
                      .+++|++.+.||+|++|.||+|.+..+++.||+|++..... ..+.+.+|+.+++++ +|+||+++++++..... ....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            46889999999999999999999988899999999875543 346789999999999 79999999999876553 2344


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++++|.+++......  ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++..++ ||
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence            689999999999999998764311  12688999999999999999999999   9999999999999998876665 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-----SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                      |.+..........   ....|+..|+|||++..     ..++.++|||||||++|++++|+.||...... ....+....
T Consensus       158 ~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~  233 (275)
T cd06608         158 GVSAQLDSTLGRR---NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPRN  233 (275)
T ss_pred             ccceecccchhhh---cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhcc
Confidence            9987664432211   12458999999998753     34678999999999999999999999643111 111111110


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..         +..                .....+...+.+++.+||..||++|||+.|+++
T Consensus       234 ~~---------~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         234 PP---------PTL----------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             CC---------CCC----------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00         000                011123556889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.6e-34  Score=300.11  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=203.4

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +|.+.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|+..+.+++|+|++++++++....     ..++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-----EISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-----eEEE
Confidence            68889999999999999999998899999999876543 34578899999999999999999999987654     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      ||||+++++|.+++....      .+++..+..++.|++.|++|||+ .   +++||||+|+||+++.++..++ |||.+
T Consensus        77 v~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~  147 (264)
T cd06623          77 VLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGIS  147 (264)
T ss_pred             EEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccc
Confidence            999999999999998653      78999999999999999999999 8   9999999999999998887766 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ..........   ....++..|+|||...+..++.++||||||+++|+|++|+.||......  ...+.......... .
T Consensus       148 ~~~~~~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~-~  221 (264)
T cd06623         148 KVLENTLDQC---NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICDGPP-P  221 (264)
T ss_pred             eecccCCCcc---cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhcCCC-C
Confidence            8775443322   1235889999999999888999999999999999999999999755321  11111111110000 0


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHH-HHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQD-CLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..                      ... ++..+.+++..|+..+|++|||+.|+++.
T Consensus       222 ~~----------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         222 SL----------------------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CC----------------------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00                      011 24568899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.6e-35  Score=316.06  Aligned_cols=281  Identities=20%  Similarity=0.215  Sum_probs=203.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ..+|.+.+.||+|+||+||+|++..++..||||.++..  .......+.+|+.+++.++|+||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35789999999999999999999989999999998643  2233456778999999999999999999887654333346


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+. ++|.+++....      .+++..+..++.|++.||.|||+.   +++||||||+||+++.++..++ |||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence            899999996 68999887654      688999999999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh---HHhhhcC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH---EFVKMTL  779 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~---~~~~~~~  779 (854)
                      ++.........   .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ....   .......
T Consensus       154 ~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~  229 (337)
T cd07858         154 LARTTSEKGDF---MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPS  229 (337)
T ss_pred             cccccCCCccc---ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCC
Confidence            99876543211   122357899999998765 46899999999999999999999999754211 0111   1111111


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ++......+.......................++...+.+++.+||+.+|++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            11111111111111100000000000111122346778899999999999999999999876

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.6e-34  Score=307.60  Aligned_cols=277  Identities=20%  Similarity=0.254  Sum_probs=199.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.++....  .....+.+|+.++++++||||+++++++...+   ...
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~   80 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK   80 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence            4689999999999999999999998899999999975432  22345678999999999999999999987652   137


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++ +|.+++.....     .+++.+++.++.|++.||+|||+.   +++||||||+||+++.++..++ |||
T Consensus        81 ~~lv~e~~~~-~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g  151 (293)
T cd07843          81 IYMVMEYVEH-DLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFG  151 (293)
T ss_pred             EEEEehhcCc-CHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecC
Confidence            8999999975 99998876542     589999999999999999999999   9999999999999999887777 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC---
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL---  779 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~---  779 (854)
                      .+..........   ....+++.|+|||.+.+.. ++.++||||+||++|||++|++||....... ..........   
T Consensus       152 ~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~  227 (293)
T cd07843         152 LAREYGSPLKPY---TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPT  227 (293)
T ss_pred             ceeeccCCcccc---ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCc
Confidence            998776543221   1234788999999887644 6899999999999999999999997543211 1111111000   


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHH--HHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQD--CLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...+....+-.......... ............  ..+.+.+++.+||+.+|++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         228 EKIWPGFSELPGAKKKTFTK-YPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hHHHHHhhccchhccccccc-ccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00000000000000000000 000000001111  2556789999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.4e-35  Score=284.98  Aligned_cols=211  Identities=25%  Similarity=0.348  Sum_probs=180.4

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCc----eEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccC
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEE----MIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSID  618 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  618 (854)
                      .....|.....||+|.||.||+|...++.    +.+|+|.++...  .+......+|+.+++.++||||+.+..++...+
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            34568999999999999999999765432    378999997542  234467789999999999999999999987653


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC---
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---  695 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---  695 (854)
                          ..+++++||.+. +|.+.|+-++.... ..++...+..|+.||+.|+.|||+.   =|+|||+||.|||+..+   
T Consensus       101 ----~~v~l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgpe  171 (438)
T KOG0666|consen  101 ----KKVWLLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPE  171 (438)
T ss_pred             ----ceEEEEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCc
Confidence                268999999998 99999987754433 4789999999999999999999999   79999999999999776   


Q ss_pred             -ccccc-ccccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          696 -MVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       696 -~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                       +.++| |+|+++.+..+-.+......++-|.+|+|||.+.|. .||++.||||.||++.||+|-++.|.+.
T Consensus       172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence             77777 999999998887776666678899999999999885 4899999999999999999999988764

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.4e-34  Score=297.56  Aligned_cols=251  Identities=23%  Similarity=0.315  Sum_probs=194.4

Q ss_pred             cHHHHHHHHhhccccCcc--CCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEee
Q 043388          539 SYAELSKATSEFASSNMI--GQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICS  615 (854)
Q Consensus       539 ~~~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  615 (854)
                      +..+.....++|.+.+.+  |+|+||.||++....++..+|+|++........     |+.....+ +||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence            345556667788888887  999999999999998999999999865432211     22222222 7999999999987


Q ss_pred             ccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC
Q 043388          616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD  695 (854)
Q Consensus       616 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  695 (854)
                      ..+     ..++||||+++|+|.+++....      .+++.++..++.|+++||+|||+.   +++||||||+||+++.+
T Consensus        80 ~~~-----~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~  145 (267)
T PHA03390         80 TLK-----GHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRA  145 (267)
T ss_pred             cCC-----eeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCC
Confidence            755     6899999999999999998654      689999999999999999999999   99999999999999988


Q ss_pred             c-cccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhH
Q 043388          696 M-VAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHE  773 (854)
Q Consensus       696 ~-~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~  773 (854)
                      + ..++ |||.+........       ..|+..|+|||++.+..++.++||||+||++|||++|+.||............
T Consensus       146 ~~~~~l~dfg~~~~~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~  218 (267)
T PHA03390        146 KDRIYLCDYGLCKIIGTPSC-------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES  218 (267)
T ss_pred             CCeEEEecCccceecCCCcc-------CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHH
Confidence            7 5554 9999876643321       35889999999999888999999999999999999999999854333222222


Q ss_pred             HhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-HHHHHH
Q 043388          774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-MRDVVA  840 (854)
Q Consensus       774 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~  840 (854)
                      +.... ....                        .....+...+.+++.+||+.+|.+||+ ++|+++
T Consensus       219 ~~~~~-~~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        219 LLKRQ-QKKL------------------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHhh-cccC------------------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            22211 0000                        001123456789999999999999996 588874

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-34  Score=301.50  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=195.9

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhcc---CCCeeeEEEEeeccCCCCCce
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIR---HRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .|+..+.||+|+||.||+|.+..++..||+|+++... ......+.+|+.++++++   |||++++++++....     .
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~-----~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP-----R   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-----E
Confidence            4777899999999999999998899999999986542 334567889999999996   999999999987544     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++++|.+++...       .+++..+..++.|++.||+|||+.   +|+||||+|+||+++.++..++ |||
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence            89999999999999998643       678999999999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      .+..........   ....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||......     ......... 
T Consensus       147 ~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~~-  217 (277)
T cd06917         147 VAALLNQNSSKR---STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIPKS-  217 (277)
T ss_pred             ceeecCCCcccc---ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhccccC-
Confidence            998775543221   224589999999988654 4789999999999999999999999743211     111000000 


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                          ..+.+.                 ...++.++.+++.+||+.||++||++.|+++.
T Consensus       218 ----~~~~~~-----------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         218 ----KPPRLE-----------------DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ----CCCCCC-----------------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                000000                 00124567889999999999999999999764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4e-34  Score=303.29  Aligned_cols=273  Identities=22%  Similarity=0.308  Sum_probs=199.9

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +|++.++||+|++|.||+|++..++..||+|+++.... ...+.+.+|++++++++|+||+++++++.+.+     ..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-----KLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-----cEEE
Confidence            48889999999999999999998999999999975432 33466788999999999999999999987755     6799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++ +|.+++.....   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+.
T Consensus        76 v~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~  148 (284)
T cd07836          76 VFEYMDK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR  148 (284)
T ss_pred             EEecCCc-cHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence            9999985 89998876432   12689999999999999999999999   9999999999999998877776 999997


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh---cCCcc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM---TLPEK  782 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~  782 (854)
                      .........   ....++..|+|||++.+. .++.++|||||||++||+++|+.||......+ ........   .....
T Consensus       149 ~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~  224 (284)
T cd07836         149 AFGIPVNTF---SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTEST  224 (284)
T ss_pred             hhcCCcccc---ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhh
Confidence            654432211   123478899999987664 47889999999999999999999997653221 11111111   00000


Q ss_pred             cccccC-chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVD-PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +....+ +........   ............+...+.+++.+|++.||.+||++.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         225 WPGISQLPEYKPTFPR---YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHHhcCchhcccccC---CChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000 000000000   0001111112234567889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=305.39  Aligned_cols=271  Identities=23%  Similarity=0.309  Sum_probs=196.9

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      |++.+.||+|++|.||+|.+..++..||+|++....  ....+.+.+|++++++++|||++++++++.+.+     ..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~-----~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN-----KLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC-----eEEE
Confidence            567789999999999999998899999999987543  233457889999999999999999999987654     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||++ ++|.+++.....    ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++..++ |||.+.
T Consensus        76 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          76 VFEFLD-LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             EEeccC-cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            999995 599999876542    2689999999999999999999999   9999999999999999887776 999997


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC-Ccc-c
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL-PEK-V  783 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~-~  783 (854)
                      .........   ....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ....+..... +.. .
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~  223 (283)
T cd07835         148 AFGVPVRTY---THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDV  223 (283)
T ss_pred             ccCCCcccc---CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHH
Confidence            654332211   112468899999987664 47899999999999999999999997542211 1111111110 000 0


Q ss_pred             c-c-ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 I-E-IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~-~-~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      . . ...+..........   ..............+.+++.+|++.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         224 WPGVTSLPDYKPTFPKWA---RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhchhhhhhccccc---ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0 0 00000000000000   00000111122456889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=307.02  Aligned_cols=275  Identities=23%  Similarity=0.314  Sum_probs=200.2

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++...  ....+.+.+|++++++++|+||+++++++...+     ..+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-----RLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC-----EEE
Confidence            6888999999999999999999889999999986432  334567899999999999999999999987644     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||++++.+..+.....      .+++.++..++.||+.||+|||+.   +++||||+|+||+++.++..++ |||.+
T Consensus        77 iv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~  147 (288)
T cd07833          77 LVFEYVERTLLELLEASPG------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFA  147 (288)
T ss_pred             EEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecc
Confidence            9999999877766554432      578999999999999999999999   9999999999999999887776 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh--hcCCcc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK--MTLPEK  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~  782 (854)
                      ..........  .....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+ .......  ...+..
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~  224 (288)
T cd07833         148 RALRARPASP--LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPS  224 (288)
T ss_pred             cccCCCcccc--ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHH
Confidence            8776544311  1224588999999999887 78999999999999999999999997542211 1111000  000000


Q ss_pred             ccccc--CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIV--DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~--d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .....  ++.......................++.++.+++.+||..+|++|||++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00000  00000000000000000000111123677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.7e-34  Score=299.74  Aligned_cols=249  Identities=20%  Similarity=0.314  Sum_probs=197.0

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|.+.+.||+|+||.||+|....++..||+|.+....  ....+.+.+|++++++++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-----~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-----RLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC-----eEE
Confidence            4778899999999999999999899999999986542  233467889999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc-c-ccccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-V-AHQNFSL  704 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~-~~~Dfg~  704 (854)
                      +||||+++++|.+++......    .+++..+..++.|++.||+|||+.   +++|+||||+||+++++. . ++.|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGV----LFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence            999999999999999764321    578999999999999999999999   999999999999998875 3 3449999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +..........   ....|++.|+|||+..+..++.++|||||||++||+++|+.||.....     .+...........
T Consensus       149 ~~~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~  220 (257)
T cd08225         149 ARQLNDSMELA---YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQGYFA  220 (257)
T ss_pred             chhccCCcccc---cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhcccCC
Confidence            88765432211   123589999999999888899999999999999999999999864321     1111111111110


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      . ..+                      .....+.+++.+||+.+|++|||+.|+++
T Consensus       221 ~-~~~----------------------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         221 P-ISP----------------------NFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             C-CCC----------------------CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0 000                      11345788999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-34  Score=308.26  Aligned_cols=209  Identities=21%  Similarity=0.331  Sum_probs=171.4

Q ss_pred             hccccCccCCCcceEEEEeEECC--CceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          549 EFASSNMIGQGSFGSVYKGILGG--EEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .|.+.++||+|+||.||+|.+..  ++..||+|.+....   ....+.+.+|+.++++++||||+++++++....   ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA---DK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC---Cc
Confidence            47788999999999999999987  78999999997632   444567889999999999999999999997652   22


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC----Ccccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH----DMVAH  699 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~~  699 (854)
                      ..++||||+++ ++.+++....... ...++...+..++.|++.||+|||+.   +|+||||||+||+++.    ++..+
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence            68999999975 7877776443211 12678899999999999999999999   9999999999999998    67666


Q ss_pred             c-ccccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          700 Q-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      + |||++.................++..|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus       153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            6 999998775544322223345689999999987764 57899999999999999999999997653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.8e-34  Score=301.21  Aligned_cols=248  Identities=23%  Similarity=0.345  Sum_probs=197.5

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +-|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++||||+++++++....     ..+
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~   78 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLW   78 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-----eEE
Confidence            34777889999999999999998889999999986433 233467889999999999999999999987655     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++...       .+++..+..++.|++.|++|||+.   +++|+||||+||+++.++..++ |||++
T Consensus        79 lv~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~  148 (277)
T cd06641          79 IIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA  148 (277)
T ss_pred             EEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccc
Confidence            999999999999998643       578999999999999999999999   9999999999999999887766 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ..........   ....++..|+|||...+..++.++|||||||++|+|++|..||......  ...........    .
T Consensus       149 ~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~----~  219 (277)
T cd06641         149 GQLTDTQIKR---NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPKNNP----P  219 (277)
T ss_pred             eecccchhhh---ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhcCCC----C
Confidence            7664432211   1235788999999998888999999999999999999999998643211  11111100000    0


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .+                      ...++..+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 TL----------------------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CC----------------------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00                      11224557789999999999999999999884

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.6e-34  Score=300.06  Aligned_cols=242  Identities=21%  Similarity=0.264  Sum_probs=183.9

Q ss_pred             ccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHh---ccCCCeeeEEEEeeccCCCCCceeeEE
Q 043388          555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRN---IRHRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       555 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      .||+|+||.||+|....+++.||+|.+.....   .....+.+|..+++.   .+||||+.+++++...+     ..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD-----KLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC-----eEEEE
Confidence            48999999999999988899999999864321   112233445443333   47999999999887654     68999


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQ  707 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~  707 (854)
                      |||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++..
T Consensus        76 ~e~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          76 LDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             EecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            99999999999987654      689999999999999999999999   9999999999999998877766 9999876


Q ss_pred             cccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          708 LDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       708 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .......     ...|+..|+|||...+ ..++.++||||+||++|||++|+.||.........  .........     
T Consensus       147 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~-----  214 (279)
T cd05633         147 FSKKKPH-----ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTV-----  214 (279)
T ss_pred             ccccCcc-----CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHHhhcC-----
Confidence            5433221     2358999999998864 55899999999999999999999999754322111  111100000     


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVAK  841 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  841 (854)
                       ..                  ...+.++..+.+++.+|++.||++||     |++|+++.
T Consensus       215 -~~------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         215 -NV------------------ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -Cc------------------CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             00                  01112245678899999999999999     59888774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.2e-34  Score=304.04  Aligned_cols=246  Identities=24%  Similarity=0.340  Sum_probs=193.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ..|...+.||+|+||.||+|....+++.||+|++.....   ...+++.+|+++++.++||||++++++|...+     .
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-----~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-----T   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-----e
Confidence            458888999999999999999988899999999864322   23356889999999999999999999997655     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||++ |++.+++.....     .+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++..++ |||
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence            799999997 588777765432     688999999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGM---GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      .+.......       ...++..|+|||++.   ...++.++|||||||++|||++|+.||........ ... ...   
T Consensus       161 ~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~~~-~~~---  228 (307)
T cd06607         161 SASLVSPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYH-IAQ---  228 (307)
T ss_pred             cceecCCCC-------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-HHH-Hhc---
Confidence            987654321       235788999999874   35688999999999999999999999864321100 000 000   


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...     +..                 ....+...+.+++.+||+.+|++||++.+|+..
T Consensus       229 ~~~-----~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         229 NDS-----PTL-----------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCC-----CCC-----------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000     000                 011235568899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.1e-34  Score=304.88  Aligned_cols=264  Identities=19%  Similarity=0.252  Sum_probs=188.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCC---ceEEEEEEeecccccch-----------HHHHHHHHHHHhccCCCeeeEEEE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGE---EMIVAVKVINLKQKGAF-----------RSFVAECEALRNIRHRNLIKIITI  613 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~~  613 (854)
                      .+|.+.++||+|+||.||+|.+..+   +..+|+|+.........           .....+...+..++|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5799999999999999999999876   66778886543322110           111233344556689999999997


Q ss_pred             eeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec
Q 043388          614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD  693 (854)
Q Consensus       614 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  693 (854)
                      +..... ...+.++++|++.. ++.+.+....      ..++..+..|+.|++.||+|||+.   +|+||||||+|||++
T Consensus        92 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~  160 (294)
T PHA02882         92 GSFKRC-RMYYRFILLEKLVE-NTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD  160 (294)
T ss_pred             eeEecC-CceEEEEEEehhcc-CHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            654432 22345788888744 7777665432      356778899999999999999999   999999999999999


Q ss_pred             CCccccc-ccccccccccCCCCC----CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC
Q 043388          694 HDMVAHQ-NFSLSHQLDSASKTP----SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG  768 (854)
Q Consensus       694 ~~~~~~~-Dfg~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~  768 (854)
                      .++..++ |||+|+.+.......    .......||+.|+|||+..+..++.++|||||||++|||++|+.||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            8877666 999998764322111    11123469999999999999999999999999999999999999997653221


Q ss_pred             chHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       769 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      ..... ....+...   +..                 .......++..+.+++..|+..+|++||++.++.+.++
T Consensus       241 ~~~~~-~~~~~~~~---~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        241 NLIHA-AKCDFIKR---LHE-----------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHH-hHHHHHHH---hhh-----------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            11111 10000000   000                 00011233567889999999999999999999998763

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.4e-34  Score=304.42  Aligned_cols=244  Identities=25%  Similarity=0.302  Sum_probs=196.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|++++++++||||+++++++....     .
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-----N   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----e
Confidence            36888999999999999999999889999999986432   233567889999999999999999999987654     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||+|+||+++.++..++ |||
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence            899999999999999998764      688999999999999999999999   9999999999999998877776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      ++.......      ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ........    ...
T Consensus       147 ~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~----~~~  215 (290)
T cd05580         147 FAKRVKGRT------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILE----GKV  215 (290)
T ss_pred             CccccCCCC------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhc----CCc
Confidence            988765441      1245899999999998888899999999999999999999998753211 00111110    000


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                        .+                      .......+.+++.+||+.||.+||     +++|+++
T Consensus       216 --~~----------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 --RF----------------------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --cC----------------------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              00                      001134577899999999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=307.10  Aligned_cols=250  Identities=24%  Similarity=0.301  Sum_probs=204.5

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc--chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ..+..|.+.+.||+|.|+.|..|++.-++..||+|.++...-.  ....+.+|+++|..++|||||+++.+.+...    
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~----  128 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA----  128 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc----
Confidence            3457899999999999999999999999999999999765433  3356889999999999999999999998766    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..|+||||+.+|.+++++...+      ......+..++.|+.+|++|+|++   .|||||||++||+++.+++.+| |
T Consensus       129 -~lylV~eya~~ge~~~yl~~~g------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaD  198 (596)
T KOG0586|consen  129 -TLYLVMEYASGGELFDYLVKHG------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIAD  198 (596)
T ss_pred             -eeEEEEEeccCchhHHHHHhcc------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeec
Confidence             7899999999999999999887      445588899999999999999999   9999999999999999997776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||++..+.......    .++|++.|.|||++.+..| ++++|+||+||++|-++.|..||++..-...     ....+.
T Consensus       199 fgfS~~~~~~~~lq----t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----r~rvl~  269 (596)
T KOG0586|consen  199 FGFSTFFDYGLMLQ----TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----RPRVLR  269 (596)
T ss_pred             cccceeeccccccc----ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----cchhee
Confidence            99999987554433    3689999999999999764 7899999999999999999999986432211     111111


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..+.                      -+  .-...+..+++++++..+|.+|++++++.+.
T Consensus       270 gk~r----------------------Ip--~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  270 GKYR----------------------IP--FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             eeec----------------------cc--ceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            1100                      00  0002335678888999999999999999765

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.4e-34  Score=300.81  Aligned_cols=248  Identities=21%  Similarity=0.304  Sum_probs=196.8

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      +|...+.||+|++|.||+|....+++.||+|+++.......+.+.+|+.+++.++||||+++++++...+     ..++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-----~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-----ELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC-----eEEEE
Confidence            3555679999999999999998889999999987655555567889999999999999999999987654     68999


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQ  707 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~  707 (854)
                      +||+++++|.+++...       .+++.++..++.|++.||+|||+.   +++||||||+||+++.++..++ |||.+..
T Consensus        95 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648          95 MEFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             EeccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence            9999999999998762       578899999999999999999999   9999999999999998877766 9998876


Q ss_pred             cccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccccc
Q 043388          708 LDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV  787 (854)
Q Consensus       708 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  787 (854)
                      ........   ....|+..|+|||...+..++.++|||||||++|||++|+.||......  ..........+....   
T Consensus       165 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~---  236 (285)
T cd06648         165 VSKEVPRR---KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKRIRDNLPPKLK---  236 (285)
T ss_pred             hccCCccc---ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHhcCCCCCc---
Confidence            54332211   1245899999999998888999999999999999999999998642110  011111100000000   


Q ss_pred             CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       788 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                                           ....++..+.+++.+||+.+|++|||+.++++
T Consensus       237 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 ---------------------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ---------------------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence                                 00112456889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4e-34  Score=306.89  Aligned_cols=278  Identities=23%  Similarity=0.299  Sum_probs=198.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||.||+|.+..++..||+|+++....  .....+.+|+.++++++|+||+++++++....   ...
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence            4689999999999999999999998999999999975432  22345678999999999999999999986543   125


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++ +|.+++....     ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++..++ |||
T Consensus        83 ~~lv~e~~~~-~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          83 IFLVMEYCEQ-DLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             EEEEEecCCC-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence            7999999975 8988887643     2689999999999999999999999   9999999999999998877776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC-C-
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL-P-  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-~-  780 (854)
                      .+..........   ....++..|+|||.+.+ ..++.++||||+||++|||++|++||...... ..+........ + 
T Consensus       154 ~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~~~~~~  229 (309)
T cd07845         154 LARTYGLPAKPM---TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQLLGTPN  229 (309)
T ss_pred             eeeecCCccCCC---CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence            998776543221   12246788999999876 45789999999999999999999999754321 11111111100 0 


Q ss_pred             cccc-cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVI-EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~-~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...+ ...+............... ............+.+++.+|++.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         230 ESIWPGFSDLPLVGKFTLPKQPYN-NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhchhhhcccccccccccCCCCC-chHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000 0000000000000000000 0000111124567889999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-34  Score=313.19  Aligned_cols=279  Identities=20%  Similarity=0.263  Sum_probs=197.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC------
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG------  621 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~------  621 (854)
                      .+|.+.+.||+|+||.||+|....++..||+|++........+.+.+|++++++++||||+++++++.......      
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57999999999999999999999899999999997766666678899999999999999999998776543211      


Q ss_pred             ---CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-cc
Q 043388          622 ---ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MV  697 (854)
Q Consensus       622 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~  697 (854)
                         ....++||||++ ++|.+++...       .+++..++.++.||+.||+|||+.   +|+||||||+||+++.+ ..
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~  153 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence               135789999997 4898887643       578899999999999999999999   99999999999999754 44


Q ss_pred             cc-cccccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          698 AH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       698 ~~-~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                      .+ +|||.+.................++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~  232 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLIL  232 (342)
T ss_pred             EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence            44 499999866433222211122357889999997654 558889999999999999999999997542211 111111


Q ss_pred             hhcCCcccccccCchhhH---HHhh-ccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          776 KMTLPEKVIEIVDPSLLM---EVMA-NNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .. .+....+.. .....   .... ..................++.+++..|++.||++|||+.|+++
T Consensus       233 ~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         233 ES-VPVVREEDR-NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             Hh-cCCCChHHh-hhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            11 000000000 00000   0000 0000000000111123456789999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-34  Score=301.05  Aligned_cols=275  Identities=22%  Similarity=0.309  Sum_probs=200.6

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      |.+.+.||+|+||.||+|+...++..||+|++....  ......+.+|++++++++|+|++++++++...+   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            567889999999999999999889999999997653  334467889999999999999999999987652   226899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++ +|.+++....     ..+++.+++.++.|++.||+|||+.   +++|+||||+||++++++..++ |||.+.
T Consensus        78 v~e~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             Eeccccc-cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence            9999975 8998887653     1688999999999999999999999   9999999999999999888777 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc---CCcc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT---LPEK  782 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~---~~~~  782 (854)
                      .........  .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..........   ....
T Consensus       149 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~  225 (287)
T cd07840         149 PYTKRNSAD--YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDEN  225 (287)
T ss_pred             eccCCCccc--ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhh
Confidence            776543211  122347889999998765 45789999999999999999999999754321 1111111110   0111


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHH-HHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQD-CLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +....+.... .........+......... ++..+.+++.+||..+|++||++.++++
T Consensus       226 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         226 WPGVSKLPWF-ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccccchhh-hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1111000000 0000000011111111222 2677899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.3e-34  Score=307.27  Aligned_cols=275  Identities=19%  Similarity=0.246  Sum_probs=192.5

Q ss_pred             CccCCC--cceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQG--SFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ..||+|  +||+||+|++..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+     ..++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-----WLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-----ceEEEE
Confidence            356666  99999999998899999999987543  233467889999999999999999999997655     689999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||++++++.+++......    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ ||+.+...
T Consensus        79 e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          79 PFMAYGSANSLLKTYFPE----GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             ecccCCCHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            999999999998875421    578899999999999999999999   9999999999999998877666 88765433


Q ss_pred             ccCCCCC----CcccccCCcccccCccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          709 DSASKTP----SSSIGIKGTVGYVAPEYGMGS--EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       709 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      .......    .......++..|+|||++.+.  .++.++|||||||++|||++|+.||........ ............
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~  230 (328)
T cd08226         152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSP  230 (328)
T ss_pred             hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCC
Confidence            2211111    001112356779999998763  478999999999999999999999975432211 111111100000


Q ss_pred             cccccCchhhH---------------HHhh----ccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLM---------------EVMA----NNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~---------------~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ......+....               ....    ........+......+...+.+++.+||+.||++|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            00000000000               0000    00000011112233456788999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-34  Score=310.55  Aligned_cols=282  Identities=20%  Similarity=0.230  Sum_probs=206.6

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|.+.+.||+|++|.||+|+...++..||+|++....  ....+.+.+|+++++.++|+||+++++++......+....|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788999999999999999998889999999987543  34456789999999999999999999998776533444689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++ +|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        81 lv~e~~~~-~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             EEecchhh-hHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence            99999975 8999887654      789999999999999999999999   9999999999999999877776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc--CCcc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LPEK  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~  782 (854)
                      .................++..|+|||++.+. .++.++||||+|+++|+|++|+.||....... .........  ....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  229 (330)
T cd07834         151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEVLGTPSEE  229 (330)
T ss_pred             EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHhcCCCChh
Confidence            8876654211122234588999999999887 78999999999999999999999997653211 111111100  0111


Q ss_pred             cccccCchhhHHHhhc-cchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMAN-NSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .....+.......... ...............+..+.+++.+||+.+|++|||+.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0110111111111100 0000000011112235678899999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.6e-34  Score=310.48  Aligned_cols=283  Identities=21%  Similarity=0.246  Sum_probs=203.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||.||+|....++..||+|++....  ....+.+.+|+.++++++||||+++++++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            378999999999999999999999899999999986432  233466788999999999999999999876544 23346


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+. |+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence            899999996 59999887544      689999999999999999999999   9999999999999999987776 999


Q ss_pred             cccccccCCCCC-CcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh--cC
Q 043388          704 LSHQLDSASKTP-SSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM--TL  779 (854)
Q Consensus       704 ~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~--~~  779 (854)
                      .+.......... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+......  ..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~g~~  231 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSVLGSP  231 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHHhCCC
Confidence            998765433221 11123468999999998765 45899999999999999999999999753211 011111110  00


Q ss_pred             CcccccccCchhhHHHhhccchhhHhh-hhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDR-RARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +....+..................... .......+..+.+++.+|++.+|++|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            111100000000000000000000000 00112235678999999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3e-34  Score=299.53  Aligned_cols=247  Identities=24%  Similarity=0.325  Sum_probs=198.4

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +|.+.+.||+|+||.||+|.+..++..||+|++....   ....+.+.+|++++++++||||+++++++....     ..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-----NM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC-----eE
Confidence            4788899999999999999998889999999997432   234578899999999999999999999886544     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +++|+||||+||+++.++..++ |||.
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence            99999999999999997653      678899999999999999999999   9999999999999999887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +........    .....|+..|+|||+..+..++.++||||+|+++|+|++|+.||......  ....+...... . .
T Consensus       147 ~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~-~-~  218 (258)
T cd05578         147 ATKVTPDTL----TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET-A-D  218 (258)
T ss_pred             ccccCCCcc----ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc-c-c
Confidence            887654321    12245889999999998888999999999999999999999999854322  11111111110 0 0


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH--HHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM--RDVV  839 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl  839 (854)
                                            ...+...+..+.+++.+||+.||.+||++  +|++
T Consensus       219 ----------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 ----------------------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ----------------------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                                  00111224567899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.5e-34  Score=303.46  Aligned_cols=258  Identities=22%  Similarity=0.287  Sum_probs=191.7

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|...+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. |+||+++++++....     ..
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-----~~   78 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-----DC   78 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-----cE
Confidence            45667789999999999999999899999999986443 233457889999999996 999999999887644     57


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      +++|||++. ++.++....... ....+++..+..++.|++.||+|||+..  +++||||||+||+++.++..++ |||+
T Consensus        79 ~~~~e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~  154 (288)
T cd06616          79 WICMELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGI  154 (288)
T ss_pred             EEEEecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecch
Confidence            899999864 665543321000 0126889999999999999999999743  8999999999999998876666 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCC---CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS---EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      +.........    ....|+..|+|||++.+.   .++.++|||||||++|||++|+.||....    ...+........
T Consensus       155 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~  226 (288)
T cd06616         155 SGQLVDSIAK----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKG  226 (288)
T ss_pred             hHHhccCCcc----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCC
Confidence            9766443221    123588999999998776   68999999999999999999999997432    111111111100


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..     +...              ......++.++.+++.+||+.+|++|||+.||++.
T Consensus       227 ~~-----~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         227 DP-----PILS--------------NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CC-----CcCC--------------CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00     0000              00001235568899999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-33  Score=300.14  Aligned_cols=253  Identities=23%  Similarity=0.325  Sum_probs=202.2

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ....|.+.+.||+|++|.||+|.+..++..||+|+++.... ..+.+.+|++.++.++|+|++++++++....     ..
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD-----EL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-----EE
Confidence            45568888999999999999999988899999999976544 4567889999999999999999999987764     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++|+||+++++|.+++....     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++..++ |||.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccch
Confidence            99999999999999998764     1689999999999999999999998   9999999999999998877766 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +..........   ....++..|+|||++.+..++.++|||||||++|+|++|+.||...... ...........    .
T Consensus       163 ~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~~~~----~  234 (286)
T cd06614         163 AAQLTKEKSKR---NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITTKGI----P  234 (286)
T ss_pred             hhhhccchhhh---ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCC----C
Confidence            87654432211   1234788999999998888999999999999999999999998643111 01111100000    0


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .                     ......++..+.+++.+|++.+|.+|||+.++++.
T Consensus       235 ~---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         235 P---------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             C---------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            0                     00111234568899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.6e-34  Score=310.81  Aligned_cols=279  Identities=18%  Similarity=0.212  Sum_probs=200.1

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~  622 (854)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.++++++||||+++++++..... .+.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999999989999999998632  22334567789999999999999999998865432 122


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...|+||||+++ +|.+.+..        .++..++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence            357999999965 88887753        367888899999999999999999   9999999999999999887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc--C
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--L  779 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~  779 (854)
                      ||.+........    .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..........  .
T Consensus       162 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~  236 (353)
T cd07850         162 FGLARTAGTSFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTP  236 (353)
T ss_pred             CccceeCCCCCC----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCC
Confidence            999987654322    12235889999999999989999999999999999999999999754211 1111111100  0


Q ss_pred             CcccccccCchhhHHHhhcc-------------chhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANN-------------SMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +..+.+.+++..........             ...+.............+.+++.+|++.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00111111111100000000             000000000011224567899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.4e-34  Score=309.12  Aligned_cols=281  Identities=21%  Similarity=0.309  Sum_probs=200.5

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  622 (854)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++...  .......+.+|+.+++++ +||||+++++++...+.   
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~---   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND---   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC---
Confidence            457899999999999999999999888999999988532  223345677899999999 99999999999865432   


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++||||+++ +|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        82 ~~~~lv~e~~~~-~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          82 KDIYLVFEYMET-DLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             ceEEEEeccccc-CHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence            257999999974 999988653       567888899999999999999999   9999999999999999987777 9


Q ss_pred             cccccccccCCCC--CCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          702 FSLSHQLDSASKT--PSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       702 fg~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                      ||.+.........  ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .........
T Consensus       151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~  229 (337)
T cd07852         151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVI  229 (337)
T ss_pred             ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence            9999876543321  112223468999999998765 457899999999999999999999997542211 111111110


Q ss_pred             --CCcccccccCchhhHHHhhccc-hhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          779 --LPEKVIEIVDPSLLMEVMANNS-MIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       779 --~~~~~~~~~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                        ........+............. ............++.++.+++.+||+.||++|||+.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence              0000000000000000000000 00000001111235678999999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.3e-33  Score=303.36  Aligned_cols=286  Identities=22%  Similarity=0.295  Sum_probs=199.5

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC---
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK---  620 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---  620 (854)
                      ..++|.+.++||+|+||.||+|+...++..||||.+....  ......+.+|++++++++||||++++++|...+..   
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            4568999999999999999999999899999999986432  22234567899999999999999999998765421   


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                      .....++||||+++ ++.+++.....     .+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++..++
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNV-----KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence            22356999999965 88888765432     678999999999999999999999   9999999999999999887776


Q ss_pred             -ccccccccccCCCCC-CcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCC-chHhHHhh
Q 043388          701 -NFSLSHQLDSASKTP-SSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEG-LTLHEFVK  776 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~-~~~~~~~~  776 (854)
                       |||.+.......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||....... ........
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence             999998765433221 111234578899999987664 37889999999999999999999987542211 01111111


Q ss_pred             hcCCccccccc-CchhhHHHhhc-cchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          777 MTLPEKVIEIV-DPSLLMEVMAN-NSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       777 ~~~~~~~~~~~-d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...+....... +.......... ..................+.+++.+||..||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            11111111000 00000000000 000000000000001345678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.3e-33  Score=301.84  Aligned_cols=246  Identities=23%  Similarity=0.315  Sum_probs=192.7

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .|...+.||+|+||.||+|++..++..||+|++....   ......+.+|++++++++|||++++++++....     ..
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-----TA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-----eE
Confidence            3677889999999999999998889999999986432   223457889999999999999999999987655     67


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++ ++.+++.....     .+++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++..++ |||.
T Consensus       101 ~lv~e~~~g-~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~  171 (317)
T cd06635         101 WLVMEYCLG-SASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS  171 (317)
T ss_pred             EEEEeCCCC-CHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence            999999975 88887765432     688999999999999999999999   9999999999999998887776 9998


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGM---GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      +.......       ...|+..|+|||++.   ++.++.++|||||||++|||++|+.||...... .....+.....+.
T Consensus       172 ~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~~  243 (317)
T cd06635         172 ASIASPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPT  243 (317)
T ss_pred             ccccCCcc-------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCCC
Confidence            86543321       235889999999874   456899999999999999999999998643111 1111111110000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                                                .....+...+.+++.+||+.+|.+||++.++++..
T Consensus       244 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         244 --------------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             --------------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                                      00112245678999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=5.8e-37  Score=320.48  Aligned_cols=311  Identities=26%  Similarity=0.430  Sum_probs=156.7

Q ss_pred             cCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccc-cCCcCccCCCCCcEEecccccCcccChhhhc
Q 043388            7 QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGG-QIPTTLGLLRNLVYLNVAENQFSGMFPRWIC   85 (854)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~   85 (854)
                      .+|++++.|.+|++|.+++|++. .+...++.|+.|+.+++++|++.. -+|..+-.+..|+.||||+|+++ ..|..+.
T Consensus        46 ~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE  123 (1255)
T KOG0444|consen   46 QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLE  123 (1255)
T ss_pred             hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhh
Confidence            34555555555555555555555 444455555555555555555532 24444445555555555555555 4555555


Q ss_pred             CCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCc
Q 043388           86 NISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ  165 (854)
Q Consensus        86 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~  165 (854)
                      ..+++-.|+||+|+|. +||..+|.+|+.|-.|||+.|+|.                  .+|+.+..+..|++|+||+|.
T Consensus       124 ~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe------------------~LPPQ~RRL~~LqtL~Ls~NP  184 (1255)
T KOG0444|consen  124 YAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE------------------MLPPQIRRLSMLQTLKLSNNP  184 (1255)
T ss_pred             hhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh------------------hcCHHHHHHhhhhhhhcCCCh
Confidence            5555555555555554 555555555554444444444443                  234555555555555555555


Q ss_pred             CcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcc
Q 043388          166 FKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQI  245 (854)
Q Consensus       166 i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l  245 (854)
                      +....-..+..+++|+.|++++-+=+.     ..+|+.+.++.+|..+|||.|.+. .+|+.+.++. +|+.|+|++|+|
T Consensus       185 L~hfQLrQLPsmtsL~vLhms~TqRTl-----~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~-~LrrLNLS~N~i  257 (1255)
T KOG0444|consen  185 LNHFQLRQLPSMTSLSVLHMSNTQRTL-----DNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLR-NLRRLNLSGNKI  257 (1255)
T ss_pred             hhHHHHhcCccchhhhhhhcccccchh-----hcCCCchhhhhhhhhccccccCCC-cchHHHhhhh-hhheeccCcCce
Confidence            554444444445555555555443221     112334445555555555555555 4555555554 455555555555


Q ss_pred             cccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCcccccc-ccCCccccCccccchhccccceecccCCCC
Q 043388          246 SGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQ-GSIPPSLGNLTKLADLALSFNNLQGNIPSS  324 (854)
Q Consensus       246 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  324 (854)
                      + .+.-..+...+|++|+||.|+++ ..|+++..+++|+.|++.+|+++ .-+|..++.|.+|+.+..++|.+. ..|+.
T Consensus       258 t-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEg  334 (1255)
T KOG0444|consen  258 T-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEG  334 (1255)
T ss_pred             e-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchh
Confidence            5 33333444445555555555555 34555555555555555555543 124445555555555555555554 45555


Q ss_pred             CcCCCCCcccccCCCcccCccchhh
Q 043388          325 LGNCQNLKGFDASHNKLTGAIPQQV  349 (854)
Q Consensus       325 ~~~l~~L~~L~ls~N~l~~~~p~~~  349 (854)
                      ++.|..|+.|.|+.|++. .+|..+
T Consensus       335 lcRC~kL~kL~L~~NrLi-TLPeaI  358 (1255)
T KOG0444|consen  335 LCRCVKLQKLKLDHNRLI-TLPEAI  358 (1255)
T ss_pred             hhhhHHHHHhccccccee-echhhh
Confidence            555555555555555554 344443

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=9.3e-34  Score=301.91  Aligned_cols=274  Identities=23%  Similarity=0.295  Sum_probs=194.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.++...  ....+.+.+|++++++++||||+++++++....     ..
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-----RL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-----eE
Confidence            47889999999999999999999899999999986432  233457889999999999999999999987654     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-cc-cccccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MV-AHQNFS  703 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~-~~~Dfg  703 (854)
                      ++||||++ +++.+++......    .+++..+..++.||+.||+|||+.   +++||||||+||+++.+ .. ++.|||
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSPDF----AKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCCCC----CcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence            99999996 4888887654321    467888889999999999999999   99999999999999854 33 445999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC--C
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL--P  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~--~  780 (854)
                      ++..........   ....+++.|+|||++.+. .++.++||||+||++|+|+||+.||......+ ...+......  .
T Consensus       149 ~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~  224 (294)
T PLN00009        149 LARAFGIPVRTF---THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGTPN  224 (294)
T ss_pred             cccccCCCcccc---ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence            997654432211   123578899999988664 57899999999999999999999997542211 1111111000  0


Q ss_pred             ccccc-ccC-chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIE-IVD-PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~-~~d-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...+. ..+ +.........   ...............+.+++.+|++.+|++||++.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        225 EETWPGVTSLPDYKSAFPKW---PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhccccccchhhhhhcccC---CCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000 000 0000000000   0000000011224557889999999999999999999863

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.8e-34  Score=300.32  Aligned_cols=271  Identities=18%  Similarity=0.190  Sum_probs=192.1

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCceeeE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      |++.+.||+|+||.||+|+...++..||+|+++... ........+|+.++.++. |+|++++++++.+..   ....++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence            567889999999999999998899999999986532 222234567899999885 999999999987652   126799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++ ++.+++.....     .+++.++..++.|++.||+|||+.   +++||||||+||+++. +..++ |||.+.
T Consensus        78 v~e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          78 VFELMDM-NLYELIKGRKR-----PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             EEecCCc-cHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence            9999974 88888876432     689999999999999999999999   9999999999999999 55555 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC---Ccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL---PEK  782 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~---~~~  782 (854)
                      .........    ...++..|+|||++.. ..++.++||||+||++|||++|+.||......+  .........   ++.
T Consensus       148 ~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~  221 (282)
T cd07831         148 GIYSKPPYT----EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAE  221 (282)
T ss_pred             ccccCCCcC----CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHH
Confidence            765432211    2357899999997654 557899999999999999999999997542211  111111000   000


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +............. ........-......++..+.+++.+||+.+|++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         222 VLKKFRKSRHMNYN-FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHhhccccccccc-CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000000000000 0000000001111234677899999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-33  Score=292.73  Aligned_cols=249  Identities=27%  Similarity=0.365  Sum_probs=201.1

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      +|+..+.||+|++|.||+|.+..++..||+|++........+.+.+|++++++++|++++++++++....     ..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-----ELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eEEEE
Confidence            4778899999999999999998889999999997665555678999999999999999999999987654     68999


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQ  707 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~  707 (854)
                      +||+++++|.+++....     ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++..++ |||.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             EecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence            99999999999988753     1689999999999999999999998   9999999999999998876666 9999887


Q ss_pred             cccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccccc
Q 043388          708 LDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV  787 (854)
Q Consensus       708 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  787 (854)
                      ......    .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......  ........   .......
T Consensus       148 ~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~---~~~~~~~  218 (253)
T cd05122         148 LSDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIAT---NGPPGLR  218 (253)
T ss_pred             cccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHh---cCCCCcC
Confidence            765432    12245889999999998888999999999999999999999998743211  00010110   0000000


Q ss_pred             CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       788 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +                     ...++..+.+++.+||+.||++|||+.|+++
T Consensus       219 ~---------------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 N---------------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             c---------------------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0                     0011455789999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=272.98  Aligned_cols=252  Identities=19%  Similarity=0.276  Sum_probs=198.7

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc-cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .+......||.|+.|.||+++.+.+|...|||.+... .....+++...++++..- ++|.||+.+|||....     .+
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV  166 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DV  166 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hH
Confidence            4455567799999999999999999999999999654 344556777888877766 4899999999998765     57


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      +|.||.|.- ..+.+++....     ++++..+-++...+.+||.||.+++  +|+|||+||+|||+|+.++.++ |||.
T Consensus       167 ~IcMelMs~-C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGI  238 (391)
T KOG0983|consen  167 FICMELMST-CAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGI  238 (391)
T ss_pred             HHHHHHHHH-HHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccc
Confidence            899999844 67777776543     6788888899999999999999986  9999999999999999887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMG---SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      +..+-+......    ..|.+.|||||.+.-   ..|+.++||||||++++|+.||+.||.....+-..+........  
T Consensus       239 sGrlvdSkAhtr----sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP--  312 (391)
T KOG0983|consen  239 SGRLVDSKAHTR----SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP--  312 (391)
T ss_pred             cceeeccccccc----ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC--
Confidence            988876654432    359999999998764   35889999999999999999999999986555433433333111  


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                         ..+++..                    .....+.+++..|+..|+.+||...++++.
T Consensus       313 ---P~L~~~~--------------------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  313 ---PLLPGHM--------------------GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ---CCCCccc--------------------CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence               1111110                    125567889999999999999999998764

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-33  Score=302.38  Aligned_cols=283  Identities=22%  Similarity=0.290  Sum_probs=201.5

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC---
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDS---  619 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  619 (854)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|++++++++||||+++++++.+..+   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45688999999999999999999999889999999997543  2334567889999999999999999999866441   


Q ss_pred             --CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc
Q 043388          620 --KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV  697 (854)
Q Consensus       620 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  697 (854)
                        ......++||||+++ ++.+++....     ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~  154 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ  154 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence              112368999999976 7777776542     1689999999999999999999999   9999999999999999887


Q ss_pred             ccc-ccccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          698 AHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                      .++ |||.+..........  .....++..|+|||.+.+ ..++.++|||||||++|||++|++||...... ..+....
T Consensus       155 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~  231 (302)
T cd07864         155 IKLADFGLARLYNSEESRP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELIS  231 (302)
T ss_pred             EEeCcccccccccCCcccc--cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence            777 999998765443211  112246788999998765 35789999999999999999999999753211 1111111


Q ss_pred             h---hcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          776 K---MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       776 ~---~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .   ...+..+........... .................++..+.+++.+||+.+|.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         232 RLCGSPCPAVWPDVIKLPYFNT-MKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHhCCCChhhcccccccccccc-cccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1   111111111100000000 000000000001111223567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=277.56  Aligned_cols=263  Identities=22%  Similarity=0.311  Sum_probs=200.4

Q ss_pred             HHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccC
Q 043388          540 YAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSID  618 (854)
Q Consensus       540 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  618 (854)
                      +++.-+-++     +.||+|+|+.|--++...++..||||++.........++.+|++++.+. .|+||+++++||++..
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            455555554     6799999999999999989999999999877666677899999999999 6999999999998766


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC---
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---  695 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---  695 (854)
                           ..|+|||-|.||+|.+.|.+..      .+++.++.++.++||.||.|||.+   ||+|||+||+|||-...   
T Consensus       150 -----~FYLVfEKm~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~v  215 (463)
T KOG0607|consen  150 -----RFYLVFEKMRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKV  215 (463)
T ss_pred             -----eEEEEEecccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCc
Confidence                 6799999999999999999876      789999999999999999999999   99999999999999654   


Q ss_pred             -cccccccccccccccCCC----CCCcccccCCcccccCccccC---C--CCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          696 -MVAHQNFSLSHQLDSASK----TPSSSIGIKGTVGYVAPEYGM---G--SEASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       696 -~~~~~Dfg~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                       .++++||.++..+.....    ........+|+..|||||+..   +  ..|+.++|.||+|||+|-|++|.+||.+.-
T Consensus       216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C  295 (463)
T KOG0607|consen  216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC  295 (463)
T ss_pred             CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence             355568877665433211    111223467999999999743   2  348999999999999999999999997642


Q ss_pred             cC------CchH---hHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHH
Q 043388          766 TE------GLTL---HEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR  836 (854)
Q Consensus       766 ~~------~~~~---~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  836 (854)
                      ..      +..-   .+..-..+.+...+..|..|                   ..++.+-.+++...+..||.+|-++.
T Consensus       296 g~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW-------------------ahIS~eakdlisnLlvrda~~rlsa~  356 (463)
T KOG0607|consen  296 GADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW-------------------AHISSEAKDLISNLLVRDAKQRLSAA  356 (463)
T ss_pred             CCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh-------------------HHhhHHHHHHHHHHHhccHHhhhhhh
Confidence            21      1111   01111111111222222222                   23355567788888889999999998


Q ss_pred             HHHH
Q 043388          837 DVVA  840 (854)
Q Consensus       837 evl~  840 (854)
                      +++.
T Consensus       357 ~vln  360 (463)
T KOG0607|consen  357 QVLN  360 (463)
T ss_pred             hccC
Confidence            8876

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4e-33  Score=291.24  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=202.3

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|+..+.||+|++|.||+|....+++.|++|++.....  ...+.+.+|++++++++|+||+++++++....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            47788999999999999999998899999999975542  44678899999999999999999999987652   12689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +++|+||+|+||+++.++..++ |||.+
T Consensus        78 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence            9999999999999998754      789999999999999999999998   9999999999999998776666 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .......... ......++..|+|||...+..++.++||||||+++|++++|+.||.....   ............... 
T Consensus       149 ~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~-  223 (260)
T cd06606         149 KRLGDIETGE-GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYKIGSSGEPP-  223 (260)
T ss_pred             Eecccccccc-cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHhccccCCCc-
Confidence            8876654310 11124588999999999888899999999999999999999999975431   111111100000000 


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                                            ......+..+.+++.+|++.+|++||++.|++.
T Consensus       224 ----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         224 ----------------------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ----------------------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                                  011122456889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=296.55  Aligned_cols=275  Identities=20%  Similarity=0.266  Sum_probs=199.6

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhc---cCCCeeeEEEEeeccCCCCCce
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNI---RHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      |++.+.||+|+||.||+|++..++..||+|+++....  .....+.+|+.+++++   +|+|++++++++...+..+...
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999999988899999999974322  2234567788877766   5999999999998766434445


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .+++|||+++ +|.+++......    .+++..++.++.|++.||+|||+.   +++|+||||+||+++.++..++ |||
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKP----GLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence            8999999975 899988765421    589999999999999999999999   9999999999999999987776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC-cc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP-EK  782 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~  782 (854)
                      .+.........    ....++..|+|||++.+..++.++|||||||++|||++|++||...... .....+...... ..
T Consensus       153 ~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  227 (287)
T cd07838         153 LARIYSFEMAL----TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSE  227 (287)
T ss_pred             cceeccCCccc----ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCCh
Confidence            98876543221    1234788999999999888999999999999999999999998754321 122222211111 00


Q ss_pred             cccccCchh-hHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSL-LMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ......... .......   ..........+....+.+++.+||+.||.+||++.|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         228 EEWPRNVSLPRSSFPSY---TPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HhcCCCcccchhhcccc---cccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000000000 0000000   000001112233567789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.2e-33  Score=294.89  Aligned_cols=244  Identities=24%  Similarity=0.314  Sum_probs=189.8

Q ss_pred             cCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeec
Q 043388          556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM  632 (854)
Q Consensus       556 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  632 (854)
                      ||+|+||+||+|....+++.||+|++....   ......+.+|++++++++||||+++++++...+     ..|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD-----DLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC-----eEEEEEecC
Confidence            699999999999999899999999986432   223456678999999999999999999987654     689999999


Q ss_pred             cCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccC
Q 043388          633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSA  711 (854)
Q Consensus       633 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~  711 (854)
                      ++++|.+++.....    ..+++.++..++.|++.||.|||+.   +++||||+|+||+++.++..++ |||.+......
T Consensus        76 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          76 NGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             CCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            99999999976543    2688999999999999999999999   9999999999999999877766 99998766432


Q ss_pred             CCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchh
Q 043388          712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL  791 (854)
Q Consensus       712 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  791 (854)
                      ...    ....++..|+|||+..+..++.++||||+||++|+|++|+.||....... ...+.........         
T Consensus       149 ~~~----~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~---------  214 (277)
T cd05577         149 KKI----KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTLEMA---------  214 (277)
T ss_pred             Ccc----ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhcccccc---------
Confidence            211    12357889999999988889999999999999999999999997543211 1111111100000         


Q ss_pred             hHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          792 LMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                                     ......+...+.+++.+||+.+|++||     ++.++++
T Consensus       215 ---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         215 ---------------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ---------------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence                           000111245578999999999999999     5665654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-33  Score=306.88  Aligned_cols=279  Identities=20%  Similarity=0.259  Sum_probs=196.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  624 (854)
                      .+|.+.+.||+|+||.||+|++..++..||+|++...  .......+.+|+.++++++||||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            7899999999999999999999888999999998643  22234567899999999999999999999865432 12234


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++|+||+.. ++.++...        .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        95 ~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMGH--------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             EEEEeccccc-CHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence            6899999965 77766421        578889999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc-CC-
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT-LP-  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~-  780 (854)
                      +++......      ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+....... .+ 
T Consensus       163 ~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~  235 (342)
T cd07879         163 LARHADAEM------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPG  235 (342)
T ss_pred             CCcCCCCCC------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence            987653321      12457889999999876 45889999999999999999999999753211 1111111100 00 


Q ss_pred             cccccccCchhhHHHhhcc-chhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH--HHhh
Q 043388          781 EKVIEIVDPSLLMEVMANN-SMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK--LCHT  845 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~  845 (854)
                      ....+..+........... .................+.+++.+||+.||++||+++|++..  ++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            0011111100000000000 000000000111234567899999999999999999999854  4443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.7e-33  Score=298.68  Aligned_cols=245  Identities=22%  Similarity=0.328  Sum_probs=194.3

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeec
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM  632 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  632 (854)
                      ..+||+|+||.||+|....++..||+|++..........+.+|+.+++.++|+|++++++++...+     ..++||||+
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~   99 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWVVMEFL   99 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC-----EEEEEEecC
Confidence            357999999999999998899999999986555445567889999999999999999999987655     789999999


Q ss_pred             cCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccC
Q 043388          633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSA  711 (854)
Q Consensus       633 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~  711 (854)
                      ++++|.+++...       .+++..+..++.|++.|++|||+.   +++||||||+||+++.++..++ |||.+......
T Consensus       100 ~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~  169 (292)
T cd06657         100 EGGALTDIVTHT-------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  169 (292)
T ss_pred             CCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence            999999987543       578889999999999999999999   9999999999999998876666 99998766433


Q ss_pred             CCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchh
Q 043388          712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL  791 (854)
Q Consensus       712 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  791 (854)
                      ...   .....|++.|+|||+..+..++.++||||+||++|||++|+.||......  ..........+....       
T Consensus       170 ~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~-------  237 (292)
T cd06657         170 VPR---RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPKLK-------  237 (292)
T ss_pred             ccc---ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCcccC-------
Confidence            221   12245889999999988888999999999999999999999998643111  111111111111100       


Q ss_pred             hHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          792 LMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                       ....+...+.+++.+||+.+|.+||++.++++.
T Consensus       238 -----------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         238 -----------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             -----------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence                             001123456788999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.1e-33  Score=302.17  Aligned_cols=274  Identities=21%  Similarity=0.204  Sum_probs=189.1

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      .+.+|.|  |.||.++...+++.||||++...  .....+.+.+|++++++++|+||+++++++...+     ..+++||
T Consensus         7 ~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~-----~~~~~~e   79 (314)
T cd08216           7 GKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-----ELYVVSP   79 (314)
T ss_pred             hHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC-----eEEEEEe
Confidence            3344444  45555555557899999999754  3344568999999999999999999999987655     6899999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccc
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLD  709 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~  709 (854)
                      |+++|+|.+++......    .+++..+..++.|++.||+|||++   +|+||||||+||+++.++..++ |||.+....
T Consensus        80 ~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          80 LMAYGSCEDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             ccCCCCHHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeec
Confidence            99999999999865322    578889999999999999999999   9999999999999998877777 999887654


Q ss_pred             cCCCC----CCcccccCCcccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          710 SASKT----PSSSIGIKGTVGYVAPEYGMG--SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       710 ~~~~~----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      .....    ........++..|+|||++.+  ..++.++|||||||++|||++|+.||........ ..+......+..+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~  231 (314)
T cd08216         153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLL  231 (314)
T ss_pred             cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCcccc
Confidence            32221    111122457889999999876  3588999999999999999999999975422111 1111111111000


Q ss_pred             c----cccCchhhHH--HhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          784 I----EIVDPSLLME--VMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       784 ~----~~~d~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .    ..........  ......................+.+++.+||+.||++|||++|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0    0000000000  00000000001111122334568899999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.5e-33  Score=292.19  Aligned_cols=242  Identities=26%  Similarity=0.341  Sum_probs=191.9

Q ss_pred             cCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeec
Q 043388          556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM  632 (854)
Q Consensus       556 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  632 (854)
                      ||.|++|.||+|++..++..||+|++....   ....+.+.+|++++++++||||+++++++.+..     ..++||||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK-----YIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC-----ccEEEEecC
Confidence            699999999999999889999999996432   233467899999999999999999999987654     689999999


Q ss_pred             cCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccC
Q 043388          633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSA  711 (854)
Q Consensus       633 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~  711 (854)
                      ++++|.+++....      .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++..++ |||.+......
T Consensus        76 ~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          76 LGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             CCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            9999999998754      578899999999999999999998   9999999999999998887776 99999877554


Q ss_pred             CCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchh
Q 043388          712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL  791 (854)
Q Consensus       712 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  791 (854)
                      ..    .....|+..|+|||.+.+..++.++|+||+|+++|++++|+.||.....+..   +..........        
T Consensus       147 ~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~--------  211 (262)
T cd05572         147 QK----TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---EIYNDILKGNG--------  211 (262)
T ss_pred             cc----cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---HHHHHHhccCC--------
Confidence            31    1224588999999999888899999999999999999999999975432111   11110000000        


Q ss_pred             hHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-----HHHHHH
Q 043388          792 LMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-----MRDVVA  840 (854)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  840 (854)
                                    ....+..+...+.+++.+||+.+|++||+     +.|+++
T Consensus       212 --------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         212 --------------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             --------------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence                          00001111456889999999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-35  Score=277.03  Aligned_cols=284  Identities=20%  Similarity=0.329  Sum_probs=206.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeec--ccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC---CC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS---KG  621 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  621 (854)
                      .+.|....+||+|.||+||+|+.+.+++.||+|++-.  ...+......+|++++..++|+|++.++.+|.....   +.
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            3456677899999999999999999999999987633  334445677899999999999999999988855432   23


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                      ....|+||++|+. +|..++.....     +++..++.+++.++..||.|+|+.   .|+|||+||+|++|+.+++.++ 
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~v-----r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKV-----RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccc-----cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence            3357999999988 99999887642     789999999999999999999999   9999999999999999998887 


Q ss_pred             ccccccccccCCCCC-CcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCC-ch-HhHHhh
Q 043388          701 NFSLSHQLDSASKTP-SSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEG-LT-LHEFVK  776 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~-~~-~~~~~~  776 (854)
                      |||+++.+....... ...+..+-|.+|++||.+.|. .|+++.|||+.||++.||+||.+-+.+..... .. +.....
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            999998775543322 223345679999999998875 59999999999999999999999988654321 11 111112


Q ss_pred             hcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHH------HHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL------NAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       777 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~------~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..-++.|..+..-.+...+....  .+.......++..      ++..+++..++..||.+|+++++++..
T Consensus       247 s~tkevWP~~d~lpL~~sie~eP--l~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEP--LPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCC--CCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            22222232222222222211110  1111111112212      246788999999999999999998754

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.1e-33  Score=292.65  Aligned_cols=242  Identities=21%  Similarity=0.257  Sum_probs=183.7

Q ss_pred             ccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHH---HHHhccCCCeeeEEEEeeccCCCCCceeeEE
Q 043388          555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECE---ALRNIRHRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       555 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      .||+|+||.||+|....+++.||+|.+.....   .....+..|..   .++...||+|+++++++...+     ..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-----KLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----EEEEE
Confidence            48999999999999988899999999864321   11122334443   344457999999999887655     68999


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQ  707 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~  707 (854)
                      |||+++|+|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+..
T Consensus        76 ~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          76 LDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            99999999999887543      689999999999999999999999   9999999999999998887776 9999876


Q ss_pred             cccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          708 LDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       708 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      ......     ....|+..|+|||++.++ .++.++||||+||++|||++|+.||.........  .........     
T Consensus       147 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~-----  214 (278)
T cd05606         147 FSKKKP-----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTM-----  214 (278)
T ss_pred             cCccCC-----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHHhhcc-----
Confidence            543221     123589999999998754 5899999999999999999999999754221111  100000000     


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVAK  841 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  841 (854)
                       ++.                  ....++..+.+++.+|+..+|++||     ++.|+++.
T Consensus       215 -~~~------------------~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         215 -AVE------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             -CCC------------------CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence             000                  0011245678899999999999999     99999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-35  Score=290.01  Aligned_cols=273  Identities=21%  Similarity=0.270  Sum_probs=205.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccC--C----CeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH--R----NLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~~~~~~~~~~~~  620 (854)
                      +.+|.+...+|+|.||.|-++.+...+..||||+++.... ..++.+-|+++++++.+  |    -+|.+.+||...+  
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg--  164 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG--  164 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC--
Confidence            6789999999999999999999998899999999975543 33567789999999942  2    3788888887666  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-----
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-----  695 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----  695 (854)
                         +.|||+|.+ |.|+.+++..+...    +++..+++.|++|++++++|||+.   +++|-|+||+||++...     
T Consensus       165 ---hiCivfell-G~S~~dFlk~N~y~----~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  165 ---HICIVFELL-GLSTFDFLKENNYI----PFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             ---ceEEEEecc-ChhHHHHhccCCcc----ccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence               799999998 66999999986532    889999999999999999999999   99999999999999421     


Q ss_pred             ----------------cccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCC
Q 043388          696 ----------------MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRR  759 (854)
Q Consensus       696 ----------------~~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~  759 (854)
                                      .++++|||.|........      .++.|..|+|||++.+-.++.++||||+||||+|+.||..
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs------~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS------TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccCcc------eeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence                            244569999987655442      3578999999999999999999999999999999999999


Q ss_pred             CCCCccc-CCchHhHHhhhcCCccccccc-----------C------chhhHHHhhccchhhHhhhhhHHHHHHHHHHHh
Q 043388          760 PTDAAFT-EGLTLHEFVKMTLPEKVIEIV-----------D------PSLLMEVMANNSMIQEDRRARTQDCLNAITRTG  821 (854)
Q Consensus       760 pf~~~~~-~~~~~~~~~~~~~~~~~~~~~-----------d------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  821 (854)
                      .|....+ +...+.+.+-.++|..+..-.           |      +.-...+...+......... .+....++.+++
T Consensus       308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~-~d~e~~~LfDLl  386 (415)
T KOG0671|consen  308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ-DDLEHVQLFDLL  386 (415)
T ss_pred             ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc-CcHHHhHHHHHH
Confidence            9987542 222233333334443322111           0      00001111111111111111 123356799999


Q ss_pred             hcccCCCCCCCCCHHHHHH
Q 043388          822 VLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       822 ~~cl~~dP~~RPs~~evl~  840 (854)
                      ..|+..||.+|+|++|++.
T Consensus       387 ~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHccCccccccHHHHhc
Confidence            9999999999999999875

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.6e-33  Score=303.00  Aligned_cols=282  Identities=22%  Similarity=0.299  Sum_probs=198.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCC---CC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDS---KG  621 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  621 (854)
                      +++|++.++||+|+||.||+|++..++..||+|++.....  .....+.+|++++++++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            5789999999999999999999998999999999864322  223467889999999999999999998755432   12


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                      ....++||||+++ ++.+.+.....     .+++.++..++.|+++||+|||+.   +|+||||||+||+++.++..++ 
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSV-----KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence            3357999999975 77777765321     689999999999999999999999   9999999999999999887776 


Q ss_pred             ccccccccccCCCCCC--------cccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchH
Q 043388          701 NFSLSHQLDSASKTPS--------SSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL  771 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~  771 (854)
                      |||++...........        ......+++.|+|||.+.+. .++.++|||||||++|||++|++||....... ..
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~  236 (311)
T cd07866         158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QL  236 (311)
T ss_pred             cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence            9999986654322111        11234578899999987654 58899999999999999999999997543211 11


Q ss_pred             hHHhhhc---CCcccccccC-chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          772 HEFVKMT---LPEKVIEIVD-PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       772 ~~~~~~~---~~~~~~~~~d-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .......   .+..+....+ +.....  ......+.............+.+++.+|++.||++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGV--HSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhccccccc--ccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1111110   0000000000 000000  00000000001111223456889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-33  Score=297.06  Aligned_cols=272  Identities=22%  Similarity=0.280  Sum_probs=200.0

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      |.+.+.||+|++|.||+|....++..+|+|+++....  .....+.+|++++++++|+||+++++++....     ..++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG-----DLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC-----CEEE
Confidence            5677899999999999999988899999999865432  24567889999999999999999999987654     6899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++ ++.+++.....     .+++.++..++.|++.||+|||+.   +|+|+||||+||+++.++..++ |||.+.
T Consensus        76 v~e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          76 VFEFMDT-DLYKLIKDRQR-----GLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             EEeccCC-CHHHHHHhhcc-----cCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            9999976 89888876432     689999999999999999999999   9999999999999998877766 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh---cCCcc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM---TLPEK  782 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~  782 (854)
                      .........   ....++..|+|||.+.+. .++.++||||+|+++|+++||+.||......+ ........   ..+..
T Consensus       147 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~  222 (283)
T cd05118         147 SFGSPVRPY---THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEV  222 (283)
T ss_pred             ecCCCcccc---cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHh
Confidence            776543111   123578899999998776 78999999999999999999999997543211 11111111   00111


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +....+......... .............++..++.+++.+||+.||.+||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         223 WPKFTSLARNYKFSF-PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cccchhhhhhhhhhh-ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111111000000000 000000001122345778999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.8e-33  Score=303.60  Aligned_cols=277  Identities=21%  Similarity=0.237  Sum_probs=198.1

Q ss_pred             HHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          543 LSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       543 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      +...+++|++.+.||+|+||.||+|....++..||+|++...  .....+.+.+|++++++++||||+++++++....  
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--   82 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL--   82 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC--
Confidence            344678899999999999999999999989999999988532  2233467889999999999999999999886533  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                        ...++||||+ +++|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++
T Consensus        83 --~~~~lv~e~~-~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l  149 (328)
T cd07856          83 --EDIYFVTELL-GTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKI  149 (328)
T ss_pred             --CcEEEEeehh-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEe
Confidence              1578999999 56999888643       567788889999999999999999   9999999999999998876666


Q ss_pred             -ccccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh-
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM-  777 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~-  777 (854)
                       |||.+.......      ....++..|+|||.+.+ ..++.++|||||||++||+++|+.||....... ....+... 
T Consensus       150 ~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~  222 (328)
T cd07856         150 CDFGLARIQDPQM------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLL  222 (328)
T ss_pred             CccccccccCCCc------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence             999987543321      12357889999998766 568999999999999999999999997542210 00000100 


Q ss_pred             -cCCcccc-cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          778 -TLPEKVI-EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       778 -~~~~~~~-~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                       ..++++. ...+........................+...+.+++.+|++.+|++|||+.+++..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         223 GTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0111111 111111000000000000000001111234678899999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-34  Score=253.14  Aligned_cols=202  Identities=24%  Similarity=0.405  Sum_probs=173.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .+|...++||+|.||+||+|+...+++.||+|+++..+  ++......+|+-+++.++|.|||+++++..+..     ..
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk-----kl   76 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL   76 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc-----ee
Confidence            35677789999999999999999999999999997543  444677899999999999999999999987655     57


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      -+|+|||.. +|..+...-.+     .++.+.++.++.|+++||.|+|++   ++.|||+||.|.+++.++..++ |||+
T Consensus        77 tlvfe~cdq-dlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgl  147 (292)
T KOG0662|consen   77 TLVFEFCDQ-DLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGL  147 (292)
T ss_pred             EEeHHHhhH-HHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccch
Confidence            899999966 99998877654     688899999999999999999999   9999999999999999998887 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCC-CCccchhHHHHHHHHHHHh-CCCCCCCccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-ASMTGDVYSFGILLLEMFT-GRRPTDAAFT  766 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~ellt-g~~pf~~~~~  766 (854)
                      ++.++-+......   -+-|.+|++|.++.+.+ |+...|+||.||++.|+.. |++.|.+...
T Consensus       148 arafgipvrcysa---evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv  208 (292)
T KOG0662|consen  148 ARAFGIPVRCYSA---EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV  208 (292)
T ss_pred             hhhcCCceEeeec---eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence            9988766543322   24799999999999865 8889999999999999997 7777776543

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-33  Score=290.78  Aligned_cols=244  Identities=22%  Similarity=0.274  Sum_probs=186.9

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHH-hccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALR-NIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||.||+|....+++.||+|+++....   .....+..|..++. ..+|+|++++++++...+     ..++||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD-----YLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC-----eEEEEE
Confidence            569999999999999988899999999864321   22234455555443 448999999999987654     789999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++++|.+++....      .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++..++ |||++...
T Consensus        77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            9999999999997654      678899999999999999999999   9999999999999998877776 99988765


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD  788 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d  788 (854)
                      ...       ....|+..|+|||...+..++.++||||||+++||+++|..||....... ...........  .     
T Consensus       148 ~~~-------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~--~-----  212 (260)
T cd05611         148 LEN-------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRRIN--W-----  212 (260)
T ss_pred             ccc-------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcccC--C-----
Confidence            431       12358899999999988888999999999999999999999997432210 11111000000  0     


Q ss_pred             chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                                       .......++..+.+++.+||+.+|++||++.++.+.+.
T Consensus       213 -----------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         213 -----------------PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             -----------------CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence                             00011123566889999999999999998876655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.9e-33  Score=302.84  Aligned_cols=274  Identities=19%  Similarity=0.290  Sum_probs=194.7

Q ss_pred             hhcc-ccCccCCCcceEEEEeEECCCceEEEEEEeecccccc--------------hHHHHHHHHHHHhccCCCeeeEEE
Q 043388          548 SEFA-SSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--------------FRSFVAECEALRNIRHRNLIKIIT  612 (854)
Q Consensus       548 ~~~~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~  612 (854)
                      ++|. +.+.||+|+||.||+|.+..+++.||+|+++......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3554 4577999999999999998889999999986432211              125778999999999999999999


Q ss_pred             EeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe
Q 043388          613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL  692 (854)
Q Consensus       613 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  692 (854)
                      ++...+     +.++||||++ |+|.+++....      .+++.....++.|++.||+|||+.   +|+||||||+||++
T Consensus        88 ~~~~~~-----~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill  152 (335)
T PTZ00024         88 VYVEGD-----FINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI  152 (335)
T ss_pred             EEecCC-----cEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence            987654     7899999997 59999987543      678899999999999999999999   99999999999999


Q ss_pred             cCCccccc-ccccccccccCCC-----------CCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCC
Q 043388          693 DHDMVAHQ-NFSLSHQLDSASK-----------TPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRR  759 (854)
Q Consensus       693 ~~~~~~~~-Dfg~~~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~  759 (854)
                      +.++..++ |||.+........           .........++..|+|||++.+. .++.++||||+||++|||++|+.
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~  232 (335)
T PTZ00024        153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP  232 (335)
T ss_pred             CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99887776 9999987652110           01111123468899999998764 46899999999999999999999


Q ss_pred             CCCCcccCCchHhHHhh---hcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHH
Q 043388          760 PTDAAFTEGLTLHEFVK---MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR  836 (854)
Q Consensus       760 pf~~~~~~~~~~~~~~~---~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  836 (854)
                      ||......+ .+.....   ......+....+-......   ....+.........+...+.+++.+|++.+|++|||+.
T Consensus       233 p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~  308 (335)
T PTZ00024        233 LFPGENEID-QLGRIFELLGTPNEDNWPQAKKLPLYTEF---TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK  308 (335)
T ss_pred             CCCCCCHHH-HHHHHHHHhCCCchhhCcchhhccccccc---CcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence            997543211 1111111   1100001000000000000   00000000011122355688999999999999999999


Q ss_pred             HHHH
Q 043388          837 DVVA  840 (854)
Q Consensus       837 evl~  840 (854)
                      |++.
T Consensus       309 ~~l~  312 (335)
T PTZ00024        309 EALK  312 (335)
T ss_pred             HHhc
Confidence            9986

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.1e-33  Score=289.16  Aligned_cols=251  Identities=23%  Similarity=0.356  Sum_probs=201.2

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.+.||+|+||.||+|.+..++..||+|++.....  ...+.+.+|+++++.++|+|++++++.+...+     ..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~-----~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG-----KLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC-----EEE
Confidence            47888999999999999999998899999999975533  44567889999999999999999999887653     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +|+||+++++|.+++.....  ....+++.++..++.+++.||+|||+.   +++|+||+|+||+++.++..++ |||.+
T Consensus        76 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~  150 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS  150 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence            99999999999999987531  112789999999999999999999999   9999999999999998777766 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........   .....|++.|+|||...+..++.++||||+|+++|+|++|+.||....     ..+............
T Consensus       151 ~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~  222 (258)
T cd08215         151 KVLSSTVDL---AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQYPP  222 (258)
T ss_pred             eecccCcce---ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCCCCC
Confidence            876554311   112358899999999988889999999999999999999999986432     111111111110000


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       +                      ...+...+.+++.+||..+|++|||+.|+++
T Consensus       223 -~----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 -I----------------------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -C----------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             0                      0122456788999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-33  Score=288.67  Aligned_cols=247  Identities=26%  Similarity=0.430  Sum_probs=199.9

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.+.||+|++|.||+|+...+++.||+|.+.....  ...+.+.+|++++++++|+|++++++++.+..     ..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-----SLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-----EEE
Confidence            47888999999999999999988899999999976543  34567899999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++....      .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        76 ~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  146 (254)
T cd06627          76 IILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA  146 (254)
T ss_pred             EEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence            9999999999999997653      789999999999999999999999   9999999999999999877776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........   .....++..|+|||...+..++.++||||+|+++|+|++|+.||.....    ........ ..... 
T Consensus       147 ~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~-  217 (254)
T cd06627         147 TKLNDVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIV-QDDHP-  217 (254)
T ss_pred             eecCCCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh-ccCCC-
Confidence            877654432   1224588999999998887889999999999999999999999874321    11111100 00000 


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .+                      .......+.+++.+||..+|++|||+.|++.
T Consensus       218 ~~----------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PL----------------------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CC----------------------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            00                      0112455778999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=292.03  Aligned_cols=249  Identities=23%  Similarity=0.311  Sum_probs=200.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ...|+.-++||+||||.||-++.+.+|+.||.|.+..+   .........+|-.++.+++.+.||.+-..|++.+     
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd-----  258 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD-----  258 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-----
Confidence            34678889999999999999999999999999988543   2333456788999999999999999988887766     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+|+..|.||+|.-+|...+..    .+++..++-+|.+|+.||++||..   +||+||+||+|||+|+.+.+.| |.
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~~----gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGNP----GFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCCC----CCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence            789999999999999999887643    789999999999999999999999   9999999999999999999998 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+|..+.......    +.+||.+|||||++....|+...|.||+||++|||+.|+.||....... ...          
T Consensus       332 GLAvei~~g~~~~----~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-k~e----------  396 (591)
T KOG0986|consen  332 GLAVEIPEGKPIR----GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-KRE----------  396 (591)
T ss_pred             ceEEecCCCCccc----cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-hHH----------
Confidence            9999987655433    3479999999999999999999999999999999999999997532110 000          


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR  836 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  836 (854)
                         .+|....           .+...-.+...++..++....++.||++|-..+
T Consensus       397 ---Evdrr~~-----------~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  397 ---EVDRRTL-----------EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ---HHHHHHh-----------cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence               1111110           001111233355667777888999999987544

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.4e-33  Score=297.03  Aligned_cols=247  Identities=23%  Similarity=0.311  Sum_probs=192.5

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ..|...+.||+|+||.||+|+...++..||+|.+...   .....+++.+|+++++.++|+|++++++++....     .
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----e
Confidence            4477788999999999999999888999999998642   2233456788999999999999999999987654     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+. |++.+++.....     .+++.++..++.|++.|+.|||+.   +++||||||+||+++.++..++ |||
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  160 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence            799999996 588887765432     578899999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGM---GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      .+.......       ...|+..|+|||.+.   ...++.++|||||||++|||++|+.||...... .....+.....+
T Consensus       161 ~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~  232 (308)
T cd06634         161 SASIMAPAN-------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP  232 (308)
T ss_pred             cceeecCcc-------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhcCCC
Confidence            987654321       235889999999874   356788999999999999999999998643111 001111110000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                      .                          .....+...+.+++.+||+.+|++||++.++++.-
T Consensus       233 ~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         233 A--------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             C--------------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            0                          00112245578999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.6e-33  Score=293.74  Aligned_cols=247  Identities=24%  Similarity=0.325  Sum_probs=193.0

Q ss_pred             cCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeec
Q 043388          556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM  632 (854)
Q Consensus       556 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  632 (854)
                      ||+|+||.||+|++..+++.||+|++.....   ...+.+.+|++++++++||||+++++.+....     ..|+||||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK-----NLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc-----EEEEEEecC
Confidence            6899999999999998899999999865432   34567889999999999999999998876544     689999999


Q ss_pred             cCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccC
Q 043388          633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSA  711 (854)
Q Consensus       633 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~  711 (854)
                      ++++|.+++....      .+++..+..++.|++.||+|||+.   +++||||+|+||+++.++..++ |||++......
T Consensus        76 ~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          76 PGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            9999999998654      678999999999999999999999   9999999999999999887776 99998765443


Q ss_pred             CCC-----CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          712 SKT-----PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       712 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      ...     ........++..|+|||...+..++.++||||||+++||+++|+.||......     +..........   
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~---  218 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILNGKI---  218 (265)
T ss_pred             cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCc---
Confidence            221     11122345888999999998888999999999999999999999999743211     11111000000   


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                       .                  .+.....+..+.+++.+||+.+|++|||+.++.+.++
T Consensus       219 -~------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 -E------------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -C------------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence             0                  0000001456789999999999999999966665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.2e-33  Score=301.83  Aligned_cols=280  Identities=19%  Similarity=0.225  Sum_probs=196.5

Q ss_pred             hccccCccCCCcceEEEEeEECCC--ceEEEEEEeecc--cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCc
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGE--EMIVAVKVINLK--QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  623 (854)
                      +|++.+.||+|+||.||+|+...+  +..||+|++...  .....+.+.+|+++++++ +||||+++++++.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            477889999999999999999877  889999998643  222345678899999999 5999999999765432 2233


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++++||+. ++|.+++....      .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence            5789999986 59999987543      688999999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCC-CcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC-
Q 043388          703 SLSHQLDSASKTP-SSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL-  779 (854)
Q Consensus       703 g~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-  779 (854)
                      |.+.......... .......||..|+|||+..+ ..++.++||||+||++|++++|++||....... .......... 
T Consensus       150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~  228 (332)
T cd07857         150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGT  228 (332)
T ss_pred             CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCC
Confidence            9998765432211 11223568999999998766 468999999999999999999999987532211 1111111100 


Q ss_pred             -Ccc-cccccCchhhHHHhhccchhhHhh-hhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 -PEK-VIEIVDPSLLMEVMANNSMIQEDR-RARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 -~~~-~~~~~d~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                       ... .....++... .........+... ......+...+.+++.+|++.||++|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         229 PDEETLSRIGSPKAQ-NYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CCHHHHHhhhhhhHH-HHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             000 1111111000 0000000000000 00001124568899999999999999999998653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-33  Score=303.23  Aligned_cols=277  Identities=20%  Similarity=0.250  Sum_probs=199.3

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC-CC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK-GA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~  622 (854)
                      ..++|++.+.||+|+||.||+|....++..||||++....  ....+.+.+|++++++++||||+++++++...... ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4568999999999999999999999899999999985432  22345678999999999999999999988654321 12


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++||||+ +++|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            2468999999 77999888642       678999999999999999999999   9999999999999998877766 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC-
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL-  779 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~-  779 (854)
                      ||.+........      ...+++.|+|||.+.+ ..++.++||||+||++|++++|+.||...... ........... 
T Consensus       162 fg~~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~  234 (343)
T cd07880         162 FGLARQTDSEMT------GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGT  234 (343)
T ss_pred             cccccccccCcc------ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCC
Confidence            999886543221      2357899999998876 45889999999999999999999999754221 11111111111 


Q ss_pred             -CcccccccCchhhHHHhhccchh-hHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          780 -PEKVIEIVDPSLLMEVMANNSMI-QEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       780 -~~~~~~~~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       +..+...+............... +.........+...+.+++.+|++.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             11111111111111111000000 00001111233556889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.7e-33  Score=295.95  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=192.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||.||+|.+..++..||||+++... ......+.+|+.++.+. .||||+++++++.+..     .
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-----D   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-----e
Confidence            467889999999999999999999889999999997543 22345567788777777 4999999999987655     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++ ++.+++.....     .+++..+..++.|++.||+|||+..  +|+||||+|+||+++.++..++ |||
T Consensus        89 ~~~v~e~~~~-~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          89 VFICMELMST-CLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             EEEEeeccCc-CHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccc
Confidence            8999999854 78877765332     6889999999999999999999732  8999999999999998887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCC----CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE----ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      .+..........    ...++..|+|||.+.+..    ++.++||||||+++|||++|+.||.........+......  
T Consensus       161 ~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--  234 (296)
T cd06618         161 ISGRLVDSKAKT----RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE--  234 (296)
T ss_pred             cchhccCCCccc----CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC--
Confidence            987764432221    234788999999987653    7889999999999999999999996432111111111111  


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                        .......                     ...+..++.+++.+||+.||.+||++.++++.
T Consensus       235 --~~~~~~~---------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         235 --EPPSLPP---------------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             --CCCCCCC---------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              0000000                     00124567899999999999999999999765

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.2e-32  Score=295.60  Aligned_cols=244  Identities=24%  Similarity=0.348  Sum_probs=189.6

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      |...+.||+|+||.||+|++..++..||+|++.....   ...+.+.+|+++++.++|||++++++++.+..     ..+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-----TAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEE
Confidence            5556789999999999999988899999999864322   23456788999999999999999999987755     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+. |++.+++.....     .+++.++..++.|++.|++|||+.   +++||||||+||+++.++..++ |||.+
T Consensus        98 lv~e~~~-~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence            9999996 588888765432     688999999999999999999999   9999999999999998877766 99987


Q ss_pred             cccccCCCCCCcccccCCcccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGM---GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      ......       ....|+..|+|||++.   ...++.++|||||||++|||++|..||....... ..........+. 
T Consensus       169 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~~-  239 (313)
T cd06633         169 SKSSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNDSPT-  239 (313)
T ss_pred             cccCCC-------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCC-
Confidence            643221       1245889999999974   4568899999999999999999999986532110 111111000000 


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                         ..                      ...+...+.+++.+||+.+|.+||++.+++..
T Consensus       240 ---~~----------------------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 ---LQ----------------------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---CC----------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00                      01123457789999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.3e-33  Score=302.34  Aligned_cols=284  Identities=19%  Similarity=0.234  Sum_probs=202.7

Q ss_pred             HHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeecc
Q 043388          540 YAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSI  617 (854)
Q Consensus       540 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  617 (854)
                      -.++....++|.+.+.||+|+||.||+|.+..++..||+|+++...  ....+.+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3456667889999999999999999999998899999999986432  22345678899999999999999999988643


Q ss_pred             CC-CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc
Q 043388          618 DS-KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM  696 (854)
Q Consensus       618 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  696 (854)
                      .. ......+++++++ +++|.+++...       .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence            32 1223468888887 77998887643       578899999999999999999999   999999999999999988


Q ss_pred             cccc-ccccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHH
Q 043388          697 VAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEF  774 (854)
Q Consensus       697 ~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~  774 (854)
                      ..++ |||++.......      ....++..|+|||...+ ..++.++|||||||++|||++|+.||...... ......
T Consensus       158 ~~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~  230 (345)
T cd07877         158 ELKILDFGLARHTDDEM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLI  230 (345)
T ss_pred             CEEEecccccccccccc------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence            7776 999987654322      22458899999998766 46889999999999999999999999643221 111111


Q ss_pred             hhhc--CCcccccccCchhhHHHhhccchhhHhh-hhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          775 VKMT--LPEKVIEIVDPSLLMEVMANNSMIQEDR-RARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       775 ~~~~--~~~~~~~~~d~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ....  .+......+.......+.......+... ..........+.+++.+|++.||.+||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            1111  1111111111111111110000000000 00001124567899999999999999999998764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-33  Score=316.59  Aligned_cols=283  Identities=19%  Similarity=0.173  Sum_probs=187.5

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCc-eEEEEEEe--------------e---cccccchHHHHHHHHHHHhccCCCe
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEE-MIVAVKVI--------------N---LKQKGAFRSFVAECEALRNIRHRNL  607 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~ni  607 (854)
                      ..++|++.+.||+|+||+||++..+... ..++.|.+              .   .........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4578999999999999999998764322 22222211              0   0111223567899999999999999


Q ss_pred             eeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 043388          608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKP  687 (854)
Q Consensus       608 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  687 (854)
                      +++++++...+     ..|+|+|++. +++.+++........ ......++..|+.|++.||+|||++   +||||||||
T Consensus       226 v~l~~~~~~~~-----~~~lv~e~~~-~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP  295 (501)
T PHA03210        226 LKIEEILRSEA-----NTYMITQKYD-FDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL  295 (501)
T ss_pred             CcEeEEEEECC-----eeEEEEeccc-cCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            99999997765     6799999995 488887765432111 1334567788999999999999999   999999999


Q ss_pred             CceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCccc
Q 043388          688 SNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFT  766 (854)
Q Consensus       688 ~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~  766 (854)
                      +|||++.++..++ |||+++.+.......  .....||..|+|||++.+..++.++|||||||++|||++|..++.....
T Consensus       296 ~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~  373 (501)
T PHA03210        296 ENIFLNCDGKIVLGDFGTAMPFEKEREAF--DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG  373 (501)
T ss_pred             HHEEECCCCCEEEEeCCCceecCcccccc--cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC
Confidence            9999998877776 999998775433221  2235699999999999998999999999999999999998764432211


Q ss_pred             --CCchHhHHhhhcCCcccccccCc--hhhHHHhhccchh-hHhhhhhH--HHHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 043388          767 --EGLTLHEFVKMTLPEKVIEIVDP--SLLMEVMANNSMI-QEDRRART--QDCLNAITRTGVLCSMESPFERMEMRDVV  839 (854)
Q Consensus       767 --~~~~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~-~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPs~~evl  839 (854)
                        ....+.+...... ....+..++  .+...+....... ........  ......+.+++.+|++.||.+|||+.|++
T Consensus       374 ~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL  452 (501)
T PHA03210        374 GKPGKQLLKIIDSLS-VCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL  452 (501)
T ss_pred             CCHHHHHHHHHHhcc-cChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence              1112222221110 000011111  0000000000000 00000000  01234567788999999999999999998


Q ss_pred             HH
Q 043388          840 AK  841 (854)
Q Consensus       840 ~~  841 (854)
                      +.
T Consensus       453 ~h  454 (501)
T PHA03210        453 AL  454 (501)
T ss_pred             hC
Confidence            64

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-33  Score=321.71  Aligned_cols=265  Identities=26%  Similarity=0.405  Sum_probs=209.1

Q ss_pred             hhccccCccCCCcceEEEEeEECC-------CceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG-------EEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSID  618 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  618 (854)
                      ++..+.+.+|+|.||.||+|...+       ....||||..+... ..+.+.+..|+++|+.+ +|+||+.++|+|...+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            344556699999999999997631       15679999997443 34567899999999999 6999999999998733


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcC---------Ccccc-cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSN---------DHLEV-CKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPS  688 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~-~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~  688 (854)
                           ..++|+||++.|+|.++++..+         ..... ..++..+.+.++.|||.|++||++.   ++||||+.++
T Consensus       376 -----~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  376 -----PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             -----ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence                 6899999999999999999876         11000 1489999999999999999999999   9999999999


Q ss_pred             ceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCccc
Q 043388          689 NVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFT  766 (854)
Q Consensus       689 NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~  766 (854)
                      |||+..+.+++| |||+|+................-+..|||||.+....++.|+|||||||++||++| |..||.+...
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            999999988888 99999976655443211111012456999999999999999999999999999999 9999875210


Q ss_pred             CCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          767 EGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       767 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                      . ..+.++.                          .+..+.+.++.|..++.++|+.||+.+|++||++.|+.+.++...
T Consensus       528 ~-~~l~~~l--------------------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  528 T-EELLEFL--------------------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             H-HHHHHHH--------------------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            1 1111111                          122334556667888999999999999999999999999999864


Q ss_pred             h
Q 043388          847 E  847 (854)
Q Consensus       847 ~  847 (854)
                      .
T Consensus       581 ~  581 (609)
T KOG0200|consen  581 Q  581 (609)
T ss_pred             H
Confidence            3

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5e-33  Score=289.98  Aligned_cols=249  Identities=24%  Similarity=0.279  Sum_probs=199.2

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +|++.++||+|+||.||++++..++..+|+|++....  ......+.+|++++++++|+||+++++++....     ..+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN-----KLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC-----EEE
Confidence            4788899999999999999999899999999987542  233457788999999999999999999887654     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++......  ...+++..++.++.|++.||+|||+.   +++||||+|+||+++.++..++ |||.+
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~  150 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS  150 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence            999999999999998764321  12688999999999999999999999   9999999999999998876666 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........     ...++..|+|||...+..++.++|+||+|+++||+++|+.||......  ........   .... 
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~---~~~~-  219 (256)
T cd08530         151 KVLKKNMAK-----TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR---GKYP-  219 (256)
T ss_pred             hhhccCCcc-----cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc---CCCC-
Confidence            877654211     234789999999999888999999999999999999999999754211  11111110   0000 


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                                            .....+...+.+++.+|++.+|++||++.|+++
T Consensus       220 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         220 ----------------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ----------------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                                  001123456889999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=277.28  Aligned_cols=202  Identities=26%  Similarity=0.346  Sum_probs=176.3

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ..++|...++||+|.||.|.+++-+.+++.+|+|+++..-   ++....-..|-++++..+||.+..+-..|...+    
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d----  241 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD----  241 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc----
Confidence            4578999999999999999999999999999999997542   233344567889999999999998877776655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..|.||||+.||.|.-++...+      .+++...+-+...|+.||.|||++   +||+||+|.+|.|+|.|+..+| |
T Consensus       242 -rlCFVMeyanGGeLf~HLsrer------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitD  311 (516)
T KOG0690|consen  242 -RLCFVMEYANGGELFFHLSRER------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITD  311 (516)
T ss_pred             -eEEEEEEEccCceEeeehhhhh------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeee
Confidence             7899999999999998888765      788888889999999999999999   9999999999999999999998 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ||+++.--....+   ...++|||.|.|||++.+..|+.++|.|.+|||+|||++|+.||...
T Consensus       312 FGLCKE~I~~g~t---~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  312 FGLCKEEIKYGDT---TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             cccchhcccccce---eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence            9999865443322   23478999999999999999999999999999999999999999754

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.2e-33  Score=289.03  Aligned_cols=251  Identities=20%  Similarity=0.247  Sum_probs=193.1

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecc-----cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      +|.+.+.||+|+||.||+|.+...+..+++|+.+..     .......+.+|+.++++++||||+++++++.+..     
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-----   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-----
Confidence            478889999999999999999866666777766532     1223345678999999999999999999886544     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccccccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFS  703 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg  703 (854)
                      ..++||||+++++|.+++......  ...+++.+++.++.|++.||+|||+.   +++|+||||+||+++.+..+++|||
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~~~~~l~d~g  150 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNLLKIGDFG  150 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeecCCEeecccC
Confidence            579999999999999998753211  12689999999999999999999999   9999999999999998776666999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      .+..........   ....|+..|+|||...+..++.++||||||+++|++++|..||....     ............ 
T Consensus       151 ~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~-  221 (260)
T cd08222         151 VSRLLMGSCDLA---TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVEGP-  221 (260)
T ss_pred             ceeecCCCcccc---cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHcCC-
Confidence            987764432211   12358889999999888888999999999999999999999986321     111111100000 


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                          .+                  .....++.++.+++.+||..+|++||++.|+++
T Consensus       222 ----~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 ----TP------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ----CC------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                00                  011223556789999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-33  Score=292.90  Aligned_cols=270  Identities=20%  Similarity=0.237  Sum_probs=194.2

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCceeeE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      |.+.+.||+|++|.||+|+...+++.||+|++..... .......+|+..+++++ |+|++++++++...+     ..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~-----~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND-----ELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC-----cEEE
Confidence            5678899999999999999988899999999864432 22234567999999998 999999999987644     6899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+ +|+|.+++.....    ..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++..++ |||.+.
T Consensus        76 v~e~~-~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             EEecC-CCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence            99999 7799998876542    2679999999999999999999999   9999999999999999877776 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh---hcCCcc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK---MTLPEK  782 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~---~~~~~~  782 (854)
                      ........    ....++..|+|||++.+ ..++.++||||||+++|||++|++||......+ .......   ......
T Consensus       148 ~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~  222 (283)
T cd07830         148 EIRSRPPY----TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQD  222 (283)
T ss_pred             eccCCCCc----CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhh
Confidence            76543221    12358899999998754 457899999999999999999999997542211 1111111   000000


Q ss_pred             cccc--cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEI--VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~--~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +.+.  .+..........   ...............+.+++.+||+.+|++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         223 WPEGYKLASKLGFRFPQF---APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhHhhhhcccccccccc---ccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000  000000000000   000000011111456889999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-33  Score=302.09  Aligned_cols=277  Identities=19%  Similarity=0.262  Sum_probs=199.2

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~  622 (854)
                      ..++|.+.+.||+|++|.||+|++..++..||+|++...  .....+.+.+|+.++++++|||++++.+++...+. ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            456899999999999999999999988999999998643  22234567789999999999999999987765442 222


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++|+||+ +++|.+++...       .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence            3479999999 66999988752       688999999999999999999999   9999999999999998877776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc--
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--  778 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--  778 (854)
                      ||.+.......      ....++..|+|||...+ ..++.++|||||||++||+++|+.||...... ..+.......  
T Consensus       162 fg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~  234 (343)
T cd07851         162 FGLARHTDDEM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGT  234 (343)
T ss_pred             ccccccccccc------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCC
Confidence            99998764432      12357889999998765 36789999999999999999999999753221 1111111110  


Q ss_pred             CCcccccccCchhhHHHhhccchhhH-hhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQE-DRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .++.+...+.......+......... .-......+..++.+++.+|++.+|++|||+.||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            01111111111111111110000000 000111123567889999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.8e-33  Score=292.76  Aligned_cols=249  Identities=25%  Similarity=0.384  Sum_probs=198.0

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCce
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  624 (854)
                      +|.+.+.||+|+||.||+|+...++..||+|++...   .....+.+.+|++++++++ ||||+++++++...+     .
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE-----N   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc-----e
Confidence            688899999999999999999989999999998643   2233467889999999998 999999999876544     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++..++ |||
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~  147 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFG  147 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCc
Confidence            899999999999999998754      789999999999999999999999   9999999999999998876665 999


Q ss_pred             cccccccCCCC-----------------CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCccc
Q 043388          704 LSHQLDSASKT-----------------PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFT  766 (854)
Q Consensus       704 ~~~~~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~  766 (854)
                      .+.........                 ........|+..|+|||...+..++.++||||||++++++++|+.||.....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  227 (280)
T cd05581         148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE  227 (280)
T ss_pred             cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence            99876543321                 0112234578999999999888899999999999999999999999975421


Q ss_pred             CCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH----HHHHH
Q 043388          767 EGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM----RDVVA  840 (854)
Q Consensus       767 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~  840 (854)
                      . ..........  .                          ......+..+.+++.+||+.+|.+|||+    +|+++
T Consensus       228 ~-~~~~~~~~~~--~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 Y-LTFQKILKLE--Y--------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             H-HHHHHHHhcC--C--------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1 1111111000  0                          0001114557899999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=292.25  Aligned_cols=270  Identities=23%  Similarity=0.311  Sum_probs=197.9

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      |+..+.||+|++|.||+|+...+++.||+|++....  ....+.+.+|+.++++++|+|++++++++.+.+     ..++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER-----KLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC-----ceEE
Confidence            566788999999999999999889999999997653  334567889999999999999999999987654     6899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||++ ++|.+++....     ..+++.++..++.|++.||+|||+.   +|+||||+|+||+++.++..++ |||.+.
T Consensus        76 v~e~~~-~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             EecCcC-cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence            999997 49999998753     1688999999999999999999999   9999999999999999877776 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh---cCCcc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM---TLPEK  782 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~  782 (854)
                      .........   ....++..|+|||.+.+. .++.++|||||||++||+++|+.||......+ ........   .....
T Consensus       147 ~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  222 (282)
T cd07829         147 AFGIPLRTY---THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIFQILGTPTEES  222 (282)
T ss_pred             ccCCCcccc---CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHHHhCCCcHHH
Confidence            765433221   123467889999998776 78999999999999999999999997543211 11111110   00000


Q ss_pred             cccccCch-hhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPS-LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +....+-. .........   ..............+.+++.+||+.+|++||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         223 WPGVTKLPDYKPTFPKFP---PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHhhcccccccccccccC---ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000000 000000000   00000111122456899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.9e-32  Score=290.86  Aligned_cols=256  Identities=21%  Similarity=0.257  Sum_probs=195.3

Q ss_pred             hccccCccCCCcceEEEEeEEC---CCceEEEEEEeeccc----ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCC
Q 043388          549 EFASSNMIGQGSFGSVYKGILG---GEEMIVAVKVINLKQ----KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSK  620 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  620 (854)
                      +|++.+.||+|+||.||+|+..   .++..||||+++...    ....+.+.+|++++.++ +||||+++++++....  
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~--   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT--   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--
Confidence            4778899999999999999864   356889999986432    22345678999999999 6999999998876544  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                         ..++||||+++|+|.+++....      .+++..+..++.|+++||+|||+.   +++||||||+||+++.++..++
T Consensus        79 ---~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l  146 (288)
T cd05583          79 ---KLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL  146 (288)
T ss_pred             ---EEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence               6899999999999999987643      678889999999999999999998   9999999999999998877666


Q ss_pred             -ccccccccccCCCCCCcccccCCcccccCccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE--ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                       |||++..........  .....|+..|+|||...+..  .+.++||||||+++|||++|+.||...... ....++...
T Consensus       147 ~dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~  223 (288)
T cd05583         147 TDFGLSKEFLAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRR  223 (288)
T ss_pred             EECccccccccccccc--cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHH
Confidence             999987765432211  12245899999999987655  788999999999999999999998642111 111111111


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      .....                        ......+...+.+++.+||+.||++|||+.++.+.++..
T Consensus       224 ~~~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         224 ILKSK------------------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HHccC------------------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            00000                        000111234577899999999999999999888776553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.1e-32  Score=287.87  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=192.0

Q ss_pred             hccccCccCCCcceEEEEeEEC---CCceEEEEEEeeccc----ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCC
Q 043388          549 EFASSNMIGQGSFGSVYKGILG---GEEMIVAVKVINLKQ----KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSK  620 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  620 (854)
                      +|++.+.||+|+||.||+|...   .++..||+|+++...    ....+.+.+|++++.++ +|+||+++++++....  
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT--   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--
Confidence            4778899999999999999874   368899999986432    22346678899999999 6999999998886544  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                         ..++||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +++||||||+||+++.++..++
T Consensus        79 ---~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl  146 (290)
T cd05613          79 ---KLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL  146 (290)
T ss_pred             ---eEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence               6799999999999999998654      678889999999999999999999   9999999999999999887776


Q ss_pred             -ccccccccccCCCCCCcccccCCcccccCccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS--EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                       |||++.........  ......|+..|+|||...+.  .++.++||||||+++|+|++|+.||...... .....+...
T Consensus       147 ~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~  223 (290)
T cd05613         147 TDFGLSKEFHEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRR  223 (290)
T ss_pred             eeCccceeccccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHH
Confidence             99998876443221  11234589999999998753  4678999999999999999999998643211 111111111


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHHH
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVAK  841 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  841 (854)
                      .....                        .+....+...+.+++.+||+.||++||     ++.++++.
T Consensus       224 ~~~~~------------------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         224 ILKSE------------------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             hhccC------------------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            10000                        000011244577899999999999997     66776553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=275.06  Aligned_cols=254  Identities=23%  Similarity=0.260  Sum_probs=190.2

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHh-ccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRN-IRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      ...||.|+||+|+|-.++..|+..|||+++.... ...+++..|.+...+ -+.||||++||.+...+     ..||.||
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-----dcWiCME  143 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-----DCWICME  143 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-----ceeeeHH
Confidence            4569999999999999999999999999986544 456778888876544 48999999999987765     5799999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccc
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLD  709 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~  709 (854)
                      .|.- |++.+-+.-.. .....+++.-.-+|+...+.||.||-+..  .|||||+||+|||++..+.+++ |||.+....
T Consensus       144 LMd~-SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHhh-hHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            9965 77766543211 11236788888889999999999999876  8999999999999998876665 999998776


Q ss_pred             cCCCCCCcccccCCcccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccccc
Q 043388          710 SASKTPSSSIGIKGTVGYVAPEYGMG--SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV  787 (854)
Q Consensus       710 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  787 (854)
                      .+-...    .-.|...|||||.+..  ..|+.+|||||+|+++||+.||+.|+..-...-..+.+.+....+.-..   
T Consensus       220 ~SiAkT----~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~---  292 (361)
T KOG1006|consen  220 DSIAKT----VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF---  292 (361)
T ss_pred             HHHHhh----hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC---
Confidence            543322    2358999999998765  3489999999999999999999999875432111122222211111000   


Q ss_pred             CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       788 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +..                   .-.....+..++..|+.+|-.+||+..++.+.
T Consensus       293 ~~~-------------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 DKE-------------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ccc-------------------ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            000                   01124557889999999999999999998764

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=282.77  Aligned_cols=259  Identities=24%  Similarity=0.342  Sum_probs=196.0

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-------cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-------GAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .+|-..++||+|||++||+|.+....++||||+-.....       ...+...+|.+|.+.++||.||++|+|+.-..  
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt--  540 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT--  540 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc--
Confidence            568888999999999999999998899999998753321       12344678999999999999999999986544  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC---cc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MV  697 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~  697 (854)
                        +..|-|+|||+|-+|+-|++.++      .+++.+++.|+.||+.||.||.+. +|+|||-||||.|||+..+   +.
T Consensus       541 --dsFCTVLEYceGNDLDFYLKQhk------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  541 --DSFCTVLEYCEGNDLDFYLKQHK------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             --ccceeeeeecCCCchhHHHHhhh------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccce
Confidence              25789999999999999999887      789999999999999999999987 6799999999999999654   55


Q ss_pred             ccc-ccccccccccCCCCC----CcccccCCcccccCccccCCC----CCCccchhHHHHHHHHHHHhCCCCCCCcccCC
Q 043388          698 AHQ-NFSLSHQLDSASKTP----SSSIGIKGTVGYVAPEYGMGS----EASMTGDVYSFGILLLEMFTGRRPTDAAFTEG  768 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvvl~elltg~~pf~~~~~~~  768 (854)
                      .+| |||+++.++......    .-+....||.+|.+||.+.-+    ..+.|+||||.||++|.++.|+.||.......
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ  691 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ  691 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence            566 999999997765431    222345799999999986543    36889999999999999999999997543221


Q ss_pred             chHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       769 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..+.+ -.......+.-...                      .....+...+|++|+++--++|....++..
T Consensus       692 dILqe-NTIlkAtEVqFP~K----------------------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  692 DILQE-NTILKATEVQFPPK----------------------PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             HHHhh-hchhcceeccCCCC----------------------CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            11111 00000000000000                      011344567888899888888887777643

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=5.1e-32  Score=316.54  Aligned_cols=146  Identities=31%  Similarity=0.445  Sum_probs=128.8

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|.+.++||+|+||.||+|.+..+++.||||+++...   ......+.+|+.++..++||||+++++++....     
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-----   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN-----   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-----
Confidence            468999999999999999999999899999999996432   223467889999999999999999999886654     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      +.|+||||+++++|.+++....      .+++..++.|+.||+.||+|||+.   +|+||||||+|||++.++..++ ||
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DF  148 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDF  148 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeC
Confidence            7899999999999999997654      578888999999999999999999   9999999999999998877766 99


Q ss_pred             cccc
Q 043388          703 SLSH  706 (854)
Q Consensus       703 g~~~  706 (854)
                      |+++
T Consensus       149 Gls~  152 (669)
T cd05610         149 GLSK  152 (669)
T ss_pred             CCCc
Confidence            9886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-31  Score=278.84  Aligned_cols=236  Identities=27%  Similarity=0.339  Sum_probs=189.1

Q ss_pred             cCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeec
Q 043388          556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM  632 (854)
Q Consensus       556 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  632 (854)
                      ||+|+||.||++....+++.||+|+++....   ...+.+..|++++++++|+||+++++.+....     ..++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE-----KLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC-----eeEEEEecC
Confidence            6999999999999988899999999875432   24567889999999999999999999876544     789999999


Q ss_pred             cCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccC
Q 043388          633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSA  711 (854)
Q Consensus       633 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~  711 (854)
                      ++++|.+++....      .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++..++ |||.+......
T Consensus        76 ~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          76 PGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            9999999998764      678999999999999999999998   9999999999999999887776 99998876544


Q ss_pred             CCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchh
Q 043388          712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL  791 (854)
Q Consensus       712 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  791 (854)
                      ...   .....++..|+|||...+...+.++|+||||+++||+++|+.||.....     .+..........        
T Consensus       147 ~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--------  210 (250)
T cd05123         147 GSR---TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDPL--------  210 (250)
T ss_pred             CCc---ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCCC--------
Confidence            211   1234588999999999888899999999999999999999999964321     111111110000        


Q ss_pred             hHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHH
Q 043388          792 LMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRD  837 (854)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e  837 (854)
                                      ......+..+.+++.+||..||++||++.+
T Consensus       211 ----------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 ----------------RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence                            000111445778999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=3.7e-32  Score=270.49  Aligned_cols=272  Identities=24%  Similarity=0.338  Sum_probs=212.2

Q ss_pred             HHHHHHhhccccCccCCCcceEEEEeEECCCc-----eEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEee
Q 043388          542 ELSKATSEFASSNMIGQGSFGSVYKGILGGEE-----MIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICS  615 (854)
Q Consensus       542 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  615 (854)
                      ++.....+++...++-+|.||+||+|.|....     +.|-+|.++.. +.-....+..|.-.+..+.|||+.++.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            44444556777889999999999999886432     34556666433 2233456788988899999999999999987


Q ss_pred             ccCCCCCceeeEEEeeccCCCHHHHhhhcC--CcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec
Q 043388          616 SIDSKGADFKALVFEYMENGSLEDWLHQSN--DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD  693 (854)
Q Consensus       616 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  693 (854)
                      +..    ...+..+.++.-|+|..|+...+  +......++..+...+|.|++.|++|||++   +|||.||.++|.+||
T Consensus       358 e~~----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  358 EDY----ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID  430 (563)
T ss_pred             ecc----CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence            644    26789999999999999998433  122234678888999999999999999999   999999999999999


Q ss_pred             CCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchH
Q 043388          694 HDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTL  771 (854)
Q Consensus       694 ~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~  771 (854)
                      +...+++ |=.+++...+.....-.. .-..+..||+||.+....|+.++|||||||++|||+| |+.|+...       
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGD-nEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI-------  502 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGD-NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI-------  502 (563)
T ss_pred             hheeEEeccchhccccCcccccccCC-CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc-------
Confidence            9977776 999999887665432111 1235778999999999999999999999999999999 99998643       


Q ss_pred             hHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          772 HEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       772 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                                      ||.-...+.     ..+.|...+-.|+.++..+|.-||+.+|++||+++|++.-|.+....+
T Consensus       503 ----------------DPfEm~~yl-----kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  503 ----------------DPFEMEHYL-----KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             ----------------CHHHHHHHH-----hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence                            222111111     123445566678999999999999999999999999999999876554

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=5.2e-33  Score=285.69  Aligned_cols=196  Identities=26%  Similarity=0.383  Sum_probs=168.5

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      .++||+|.||+||-|+++.+|+.||||+++...  ......+++|+.|++++.||.||.+...|++.+     .+++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-----rvFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-----RVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-----eEEEEeh
Confidence            589999999999999999999999999996432  233477899999999999999999999998877     7899999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC----ccccccccccc
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSH  706 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~~~Dfg~~~  706 (854)
                      -+.| +..++|-.....    ++++..-.-+..||+.||+|||.+   +|+|+|+||+|||+...    .++++|||+|+
T Consensus       644 Kl~G-DMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  644 KLHG-DMLEMILSSEKG----RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             hhcc-hHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence            9965 666665544322    788888888899999999999999   99999999999999653    46667999999


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      .++...-..    .++||+.|.|||++....|...-|+||.||++|.-++|..||....
T Consensus       716 iIgEksFRr----sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE  770 (888)
T KOG4236|consen  716 IIGEKSFRR----SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE  770 (888)
T ss_pred             ecchhhhhh----hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence            998765433    3689999999999999999999999999999999999999997543

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.98  E-value=4.6e-34  Score=313.41  Aligned_cols=390  Identities=29%  Similarity=0.348  Sum_probs=250.2

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeee
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYL   95 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L   95 (854)
                      -.|+.||+++|++. ..|..+..+.+|++|+++.|-|. ..|.....+++|++|+|.+|++. ..|..+..+.+|++|++
T Consensus        45 v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~Ldl  121 (1081)
T KOG0618|consen   45 VKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDL  121 (1081)
T ss_pred             eeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhccccccc
Confidence            33666666666666 56666666666666666666666 55666666666666666666666 56666666666666666


Q ss_pred             cccccccccCcccccCCCC-------------------CcEEEcccCCC--------CCCce-eeccCccCCCCCCCCCC
Q 043388           96 TVNRFSGSLPFDILVNLPN-------------------LKELYLTFCSL--------KNLWW-LNLEQNNLGMGTASSIP  147 (854)
Q Consensus        96 ~~N~l~~~~~~~~~~~l~~-------------------L~~L~l~~n~l--------~~L~~-L~L~~N~l~~~~~~~~p  147 (854)
                      +.|++. .+|.-+ ..++.                   .+.+++..|.+        .+++. |+|++|++.       -
T Consensus       122 S~N~f~-~~Pl~i-~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~-------~  192 (1081)
T KOG0618|consen  122 SFNHFG-PIPLVI-EVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEME-------V  192 (1081)
T ss_pred             chhccC-CCchhH-HhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhh-------h
Confidence            666665 555322 11222                   44455544433        23444 888888873       1


Q ss_pred             ccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChh
Q 043388          148 DSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHS  227 (854)
Q Consensus       148 ~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  227 (854)
                      -.+.++.+|+.|....|++..+.-    .-++|+.|+.++|.+.....        -.-..+|+++++++|+++ .+|++
T Consensus       193 ~dls~~~~l~~l~c~rn~ls~l~~----~g~~l~~L~a~~n~l~~~~~--------~p~p~nl~~~dis~n~l~-~lp~w  259 (1081)
T KOG0618|consen  193 LDLSNLANLEVLHCERNQLSELEI----SGPSLTALYADHNPLTTLDV--------HPVPLNLQYLDISHNNLS-NLPEW  259 (1081)
T ss_pred             hhhhhccchhhhhhhhcccceEEe----cCcchheeeeccCcceeecc--------ccccccceeeecchhhhh-cchHH
Confidence            235566777777777777764331    23455666666665542211        112245556666666655 45555


Q ss_pred             hhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCcc-------
Q 043388          228 IANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS-------  300 (854)
Q Consensus       228 ~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------  300 (854)
                      +..+. +++.++..+|+++ .+|..+...++|+.|++.+|++.. +|....+++.|++|+|..|+|. ..|+.       
T Consensus       260 i~~~~-nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~y-ip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~  335 (1081)
T KOG0618|consen  260 IGACA-NLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEY-IPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNA  335 (1081)
T ss_pred             HHhcc-cceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhh-CCCcccccceeeeeeehhcccc-ccchHHHhhhhH
Confidence            55554 5555666666654 455555555555555555555552 3344455555555555555554 22221       


Q ss_pred             -------------------ccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHh
Q 043388          301 -------------------LGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL  361 (854)
Q Consensus       301 -------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l  361 (854)
                                         =..++.|+.|++.+|.++...-..+.++++|+.|+|++|++. .+|+...........|+|
T Consensus       336 ~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~L  414 (1081)
T KOG0618|consen  336 SLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNL  414 (1081)
T ss_pred             HHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhc
Confidence                               122456888999999998777778888999999999999997 788776665555566999


Q ss_pred             hcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecc
Q 043388          362 AHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLS  441 (854)
Q Consensus       362 ~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls  441 (854)
                      |+|+++ .+|..+.+       +..|++|...+|++. ..| .+..++.|+.+|||.|+|+...-..-..+++|++|||+
T Consensus       415 SGNkL~-~Lp~tva~-------~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlS  484 (1081)
T KOG0618|consen  415 SGNKLT-TLPDTVAN-------LGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLS  484 (1081)
T ss_pred             ccchhh-hhhHHHHh-------hhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeecc
Confidence            999986 45666666       667899999999998 566 88899999999999999984333333344899999999


Q ss_pred             cccC
Q 043388          442 YNHL  445 (854)
Q Consensus       442 ~N~l  445 (854)
                      +|..
T Consensus       485 GN~~  488 (1081)
T KOG0618|consen  485 GNTR  488 (1081)
T ss_pred             CCcc
Confidence            9984

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3e-32  Score=290.53  Aligned_cols=240  Identities=25%  Similarity=0.277  Sum_probs=191.1

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCce
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .+++|.....+|.|+|+.|-.+.+..+++..+||++....    .+-.+|+.++... +||||+++.+.+.+..     +
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~-----~  390 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGK-----E  390 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCc-----e
Confidence            3567888888999999999999999999999999996552    2234677666666 7999999999987765     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe-cCCc-cccccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDM-VAHQNF  702 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~-~~~~Df  702 (854)
                      .|+|||.+.||-+.+.+...+      .+. .++..|+.+|+.|+.|||++   ||||||+||+|||+ +..+ +.++||
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~------~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyF  460 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKP------EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYF  460 (612)
T ss_pred             eeeeehhccccHHHHHHHhcc------hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEe
Confidence            899999999998888777654      233 67788999999999999999   99999999999999 4666 444599


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |.++.......+      .+-|..|.|||+.....|++++|+||||++||+|++|+.||...-.+    .+...+.....
T Consensus       461 G~a~~~~~~~~t------p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~~~  530 (612)
T KOG0603|consen  461 GFWSELERSCDT------PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQMPK  530 (612)
T ss_pred             chhhhCchhhcc------cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcCCc
Confidence            999988765222      24688999999999989999999999999999999999999865333    11111111111


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..                          +..+.+..+++..||+.||.+||+|+++..
T Consensus       531 ~s--------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  531 FS--------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             cc--------------------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            10                          223556789999999999999999999864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.5e-31  Score=274.85  Aligned_cols=221  Identities=20%  Similarity=0.186  Sum_probs=174.0

Q ss_pred             CcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeeccCCCHH
Q 043388          559 GSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLE  638 (854)
Q Consensus       559 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  638 (854)
                      |.+|.||++++..+++.||+|+++...     .+.+|...+....||||+++++++...+     ..++||||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED-----SVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC-----eEEEEEecCCCCCHH
Confidence            899999999999999999999986543     2334555556668999999999887654     689999999999999


Q ss_pred             HHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccCCCCCCc
Q 043388          639 DWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSS  717 (854)
Q Consensus       639 ~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~  717 (854)
                      +++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+........    
T Consensus        74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~----  140 (237)
T cd05576          74 SHISKFL------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD----  140 (237)
T ss_pred             HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccccc----
Confidence            9987654      588999999999999999999999   9999999999999998877666 9998766544321    


Q ss_pred             ccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhh
Q 043388          718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMA  797 (854)
Q Consensus       718 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  797 (854)
                        ...++..|+|||...+..++.++||||+||++|||++|+.|+.......       .    ... .. +         
T Consensus       141 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~----~~~-~~-~---------  196 (237)
T cd05576         141 --GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------N----THT-TL-N---------  196 (237)
T ss_pred             --cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------c----ccc-cc-C---------
Confidence              1246778999999988889999999999999999999998875321100       0    000 00 0         


Q ss_pred             ccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHH
Q 043388          798 NNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRD  837 (854)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e  837 (854)
                                 ....+...+.+++.+|++.||++||++.+
T Consensus       197 -----------~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         197 -----------IPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             -----------CcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence                       00011345778999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-32  Score=295.10  Aligned_cols=264  Identities=22%  Similarity=0.329  Sum_probs=213.2

Q ss_pred             HHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccC
Q 043388          540 YAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSID  618 (854)
Q Consensus       540 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  618 (854)
                      ++.+..-+..|.+.++||.|.+|.||+++...+++.+|+|+.......+ +++..|.++++.. .|||++.++|++...+
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            3334444567889999999999999999999999999999987665443 6677888888887 7999999999998888


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccc
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA  698 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  698 (854)
                      ....+..|+|||||.+||.-++++...+    ..+.|..+..|++.++.|+.|||..   .++|||||-.|||++.++.+
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g----~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKG----NRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcc----cchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence            8888899999999999999999998763    2889999999999999999999999   99999999999999987655


Q ss_pred             c-cccccccccccCCCCCCcccccCCcccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh
Q 043388          699 H-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-----SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH  772 (854)
Q Consensus       699 ~-~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~  772 (854)
                      + +|||.+...........   ...||+.|||||++..     ..|+.++|+||+|++..||.-|.+|+.....-    .
T Consensus       163 KLvDFGvSaQldsT~grRn---T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----r  235 (953)
T KOG0587|consen  163 KLVDFGVSAQLDSTVGRRN---TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----R  235 (953)
T ss_pred             EEeeeeeeeeeeccccccc---CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh----h
Confidence            5 59999998876554332   3579999999998754     34778999999999999999999998643211    0


Q ss_pred             HHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ....  ++.                    .++....+++.+.+++.++|..|+..|-++||++.++++
T Consensus       236 aLF~--IpR--------------------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  236 ALFL--IPR--------------------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hhcc--CCC--------------------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            0000  000                    111122234556788999999999999999999998875

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=307.53  Aligned_cols=208  Identities=25%  Similarity=0.350  Sum_probs=180.2

Q ss_pred             HHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeecc
Q 043388          541 AELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSI  617 (854)
Q Consensus       541 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  617 (854)
                      .++.-..++|.+.++||+|+||.|..++.+.+++.||+|++...   ......-|..|-++|..-+.+=|+++...|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            44555678999999999999999999999999999999999642   234446688899999998999999998887766


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV  697 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  697 (854)
                      .     +.|+|||||+||+|-.++....      ++++..++-++..|+-||.-+|+.   |+|||||||+|||+|..|.
T Consensus       148 ~-----~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GH  213 (1317)
T KOG0612|consen  148 R-----YLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGH  213 (1317)
T ss_pred             c-----ceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCc
Confidence            5     8999999999999999998765      688888999999999999999999   9999999999999999998


Q ss_pred             ccc-ccccccccccCCCCCCcccccCCcccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          698 AHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-----SEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      .++ |||.|..+........  ...+|||.|.+||++..     +.|++.+|.||+||++|||+.|..||...
T Consensus       214 ikLADFGsClkm~~dG~V~s--~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  214 IKLADFGSCLKMDADGTVRS--SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD  284 (1317)
T ss_pred             EeeccchhHHhcCCCCcEEe--ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence            887 9999998875544332  23579999999998752     56999999999999999999999999753

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-34  Score=311.96  Aligned_cols=425  Identities=30%  Similarity=0.336  Sum_probs=287.9

Q ss_pred             cCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcC
Q 043388            7 QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICN   86 (854)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~   86 (854)
                      .||..+-.-..++.|++++|-+....-+.+..--.|++|+|++|++. ..|..+..+.+|+.|+++.|.|. ..|.+..+
T Consensus        12 ~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~   89 (1081)
T KOG0618|consen   12 LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSN   89 (1081)
T ss_pred             ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhh
Confidence            68888888888999999999998433334444455999999999998 89999999999999999999999 68899999


Q ss_pred             CCCCceeeecccccccccCcccccCCCCCcEEEcccCCC----------CCCceeeccCc-------------------c
Q 043388           87 ISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSL----------KNLWWLNLEQN-------------------N  137 (854)
Q Consensus        87 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l----------~~L~~L~L~~N-------------------~  137 (854)
                      +.+|++|.|.+|++. .+|.+ +..+.+|+.|++++|..          +.++++..++|                   .
T Consensus        90 ~~~l~~lnL~~n~l~-~lP~~-~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~  167 (1081)
T KOG0618|consen   90 MRNLQYLNLKNNRLQ-SLPAS-ISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNV  167 (1081)
T ss_pred             hhcchhheeccchhh-cCchh-HHhhhcccccccchhccCCCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhh
Confidence            999999999999998 88865 68999999999999864          23345555555                   2


Q ss_pred             CCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEccc
Q 043388          138 LGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCD  217 (854)
Q Consensus       138 l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~  217 (854)
                      ++    +.++..+..++.  .|+|++|.+.   ...+..+.+|+.|+...|++..+..          ..++|+.|+.++
T Consensus       168 l~----~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~----------~g~~l~~L~a~~  228 (1081)
T KOG0618|consen  168 LG----GSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI----------SGPSLTALYADH  228 (1081)
T ss_pred             cc----cchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEe----------cCcchheeeecc
Confidence            21    222333333333  3566666554   2234555556666666666554332          235677777777


Q ss_pred             CcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccC
Q 043388          218 NQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSI  297 (854)
Q Consensus       218 N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  297 (854)
                      |.++...+.   ..+.+|+++++++|+++ .+|+++..+.+|+.|+..+|+++ ..|..+..+++|+.|....|.+. -+
T Consensus       229 n~l~~~~~~---p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yi  302 (1081)
T KOG0618|consen  229 NPLTTLDVH---PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YI  302 (1081)
T ss_pred             Ccceeeccc---cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hC
Confidence            777622221   12236777777777777 45577777777777777777775 56666777777777777777777 66


Q ss_pred             CccccCccccchhccccceecccCCCCCcCCCC-CcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccc
Q 043388          298 PPSLGNLTKLADLALSFNNLQGNIPSSLGNCQN-LKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGN  376 (854)
Q Consensus       298 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~  376 (854)
                      |+...+++.|+.|+|..|+|....+..|.-... |+.|+.+.|++. ..|..-.........|.+.+|.+++..-..+-+
T Consensus       303 p~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~  381 (1081)
T KOG0618|consen  303 PPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVN  381 (1081)
T ss_pred             CCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhcc
Confidence            666777777777777777777333333333332 566666666665 344222222233345777778777654444444


Q ss_pred             cccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccch----------------------hhcCccC
Q 043388          377 LKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPE----------------------FLQNLSF  434 (854)
Q Consensus       377 l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~----------------------~~~~l~~  434 (854)
                             ...|+.|+|++|+|...+...+.++..|++|+||+|+|+ .+|+                      .+.+++.
T Consensus       382 -------~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~q  453 (1081)
T KOG0618|consen  382 -------FKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQ  453 (1081)
T ss_pred             -------ccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhcCc
Confidence                   345777777777777544455677777777777777776 3433                      5566788


Q ss_pred             CCeeecccccCccc-CCCCccccCcccccccccccc
Q 043388          435 LEFLNLSYNHLEGE-VPTKGVFSNKTKISLQVNVKL  469 (854)
Q Consensus       435 L~~L~ls~N~l~~~-~p~~~~~~~~~~~~~~~n~~~  469 (854)
                      |+.+|+|.|+|+-. +|..--..+...+++.||.++
T Consensus       454 L~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  454 LKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             ceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            88888888888753 233222366778889999874

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3e-32  Score=252.40  Aligned_cols=272  Identities=19%  Similarity=0.257  Sum_probs=206.4

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCce
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ..++|++.+++|+|.|++||.|....+.+.++||++++..   .+.+.+|+++++.+. ||||++++++..++...   .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk---t  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESK---T  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCcccc---C
Confidence            4578999999999999999999998888999999997654   367889999999996 99999999998776643   5


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccc--cccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA--HQNF  702 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~--~~Df  702 (854)
                      ..+|+||+++.+...+..         .++..+++..+.+++.||.|+|++   ||+|||+||.|+|+|....+  +||+
T Consensus       110 paLiFE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             chhHhhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence            689999999987776543         677788899999999999999999   99999999999999987544  4699


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |+|.++.+.....    ..+.+..|.-||.+... .|+..-|+|||||++..|+..+.||....+....+..+.+....+
T Consensus       178 GLAEFYHp~~eYn----VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~  253 (338)
T KOG0668|consen  178 GLAEFYHPGKEYN----VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD  253 (338)
T ss_pred             chHhhcCCCceee----eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence            9999987765433    23578889999988774 478889999999999999999999987655555555554433322


Q ss_pred             cc-------ccccCchhhHHH---hhccchhhHhhhhhHH-HHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KV-------IEIVDPSLLMEV---MANNSMIQEDRRARTQ-DCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~-------~~~~d~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .+       .-.+||+.-.-.   .+..+.  ........ -...+..+++...+..|-.+|||++|.++.
T Consensus       254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~--~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWS--RFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHHHHccCCChhHhhHhhccccccHH--HhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            21       112344432211   111000  00000000 013567789999999999999999998753

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-32  Score=272.16  Aligned_cols=202  Identities=26%  Similarity=0.368  Sum_probs=173.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  622 (854)
                      ..+|....+||+|+||.|.+|..+++.+.+|||+++..   +.++.+--+.|-++++-. +-|.++++..++.+.+    
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD----  423 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD----  423 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh----
Confidence            45788899999999999999999999999999999743   233334445666676655 5678899998887776    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..|.||||+.||+|--.+++-+      .+.+..+.-+|.+||-||-|||++   +|++||||.+|||+|.++..+| |
T Consensus       424 -RLyFVMEyvnGGDLMyhiQQ~G------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~D  493 (683)
T KOG0696|consen  424 -RLYFVMEYVNGGDLMYHIQQVG------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIAD  493 (683)
T ss_pred             -heeeEEEEecCchhhhHHHHhc------ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeee
Confidence             6899999999999999988876      667778889999999999999999   9999999999999999998888 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      ||+++.--....+   +..++||+.|+|||++...+|+..+|.|||||+||||+.|++||++..
T Consensus       494 FGmcKEni~~~~T---TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD  554 (683)
T KOG0696|consen  494 FGMCKENIFDGVT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  554 (683)
T ss_pred             cccccccccCCcc---eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999865443332   334789999999999999999999999999999999999999998753

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.5e-30  Score=296.07  Aligned_cols=276  Identities=18%  Similarity=0.158  Sum_probs=168.9

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCC----ceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccC-CC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGE----EMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSID-SK  620 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~  620 (854)
                      ..++|.+.++||+|+||.||+|++..+    +..||+|++.....  .+....|  .+....+.++..++..+.... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            567899999999999999999999888    88999998753321  1111111  122222223322222211111 12


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcc--------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHL--------------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLK  686 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  686 (854)
                      .....++||||+++++|.+++.......              .........+..++.|++.||+|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            2336899999999999999987543110              000112344667999999999999999   99999999


Q ss_pred             CCceEecC-Cccccc-ccccccccccCCCCCCcccccCCcccccCccccCCC----------------------CCCccc
Q 043388          687 PSNVLLDH-DMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS----------------------EASMTG  742 (854)
Q Consensus       687 p~NIll~~-~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~s  742 (854)
                      |+|||++. ++..++ |||+|+.........  .....+|+.|+|||.+...                      .++.++
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~--~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccC--CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            99999986 344554 999998664432221  1235689999999965322                      234567


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc-CC-cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHH
Q 043388          743 DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT-LP-EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRT  820 (854)
Q Consensus       743 Dv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~-~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  820 (854)
                      |||||||++|||+++..|++...   ..+....... .. ..+.....+....+...        .....+.......++
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~d~~~~~~~dL  429 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRR--------GFEVLDLDGGAGWEL  429 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhh--------hhhhccccchHHHHH
Confidence            99999999999999776654210   0111111000 00 00111111100000000        000001112345689


Q ss_pred             hhcccCCCCCCCCCHHHHHHH
Q 043388          821 GVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       821 ~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +.+|++.||++|||++|+++.
T Consensus       430 i~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        430 LKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HHHHccCCcccCCCHHHHhCC
Confidence            999999999999999999874

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-31  Score=268.53  Aligned_cols=136  Identities=27%  Similarity=0.445  Sum_probs=119.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-----C---CCeeeEEEEeeccCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-----H---RNLIKIITICSSIDS  619 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~~~  619 (854)
                      .+|.+.++||.|.|++||+|.+....+.||+|+.+..+. ..+....|++++++++     |   ..||+++++|...+.
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            689999999999999999999999999999999975543 3356788999999983     3   369999999988776


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL  692 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  692 (854)
                      .+. ++|||+|++ |.+|..+|....-    ..++...+.+|++||+.||.|||.+|  +|||-||||+|||+
T Consensus       157 NG~-HVCMVfEvL-GdnLLklI~~s~Y----rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQ-HVCMVFEVL-GDNLLKLIKYSNY----RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCc-EEEEEehhh-hhHHHHHHHHhCC----CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            554 899999999 6699999987643    27899999999999999999999999  99999999999999

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=279.78  Aligned_cols=201  Identities=24%  Similarity=0.353  Sum_probs=177.4

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ...++..+..||-||||.|-++........+|+|.++..   +....+.+..|-.+|...+.|.||++|..|.+..    
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k----  493 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK----  493 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch----
Confidence            345667778899999999999999866666899888643   3444567788999999999999999999887655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ++|+.||-|-||.+...++..+      .++...++-++..++.|++|||++   +||+|||||+|.++|.++..++ |
T Consensus       494 -yvYmLmEaClGGElWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVD  563 (732)
T KOG0614|consen  494 -YVYMLMEACLGGELWTILRDRG------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVD  563 (732)
T ss_pred             -hhhhhHHhhcCchhhhhhhhcC------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEee
Confidence             8999999999999999999876      678888899999999999999999   9999999999999999988776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ||+|+.+.....+.    .++||+.|.|||++.....+.++|.||+|+++||+++|.+||.+.
T Consensus       564 FGFAKki~~g~KTw----TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~  622 (732)
T KOG0614|consen  564 FGFAKKIGSGRKTW----TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV  622 (732)
T ss_pred             hhhHHHhccCCcee----eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999998876654    478999999999999999999999999999999999999999865

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-31  Score=242.42  Aligned_cols=217  Identities=23%  Similarity=0.270  Sum_probs=173.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++......||+|+||.|-+-++..+|...|+|.++..- .+..++..+|+++..+. .+|.+|.+||.+....     .
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-----d  119 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG-----D  119 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc-----c
Confidence            344555678999999999999999999999999997553 33446678888876554 7999999999776544     5


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .+|.||.|.. ||+.+-++.-..  ...+++...-+||..+.+||.|||++.  .++|||+||+|||++.++.+++ |||
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~--g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKK--GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhc--CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence            8999999966 888876654221  227888889999999999999999986  8999999999999999988887 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG----SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                      .+-...++.....    ..|...|||||.+..    ..|+.||||||+|+++.||.+++.||+.-...-..+.+.+..
T Consensus       195 IsG~L~dSiAkt~----daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  195 ISGYLVDSIAKTM----DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             cceeehhhhHHHH----hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            9988766543321    248889999998754    368999999999999999999999998655444444444443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=8e-30  Score=263.36  Aligned_cols=238  Identities=29%  Similarity=0.402  Sum_probs=190.5

Q ss_pred             cceEEEEeEECCCceEEEEEEeecccccc-hHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeeccCCCHH
Q 043388          560 SFGSVYKGILGGEEMIVAVKVINLKQKGA-FRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLE  638 (854)
Q Consensus       560 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  638 (854)
                      +||.||+|+..++++.+|+|++....... .+.+.+|++.+++++|+|++++++++....     ..+++|||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED-----KLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC-----EEEEEEeCCCCCCHH
Confidence            58999999999889999999997655444 678999999999999999999999987654     689999999999999


Q ss_pred             HHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccCCCCCCc
Q 043388          639 DWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSS  717 (854)
Q Consensus       639 ~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~  717 (854)
                      +++....      .+++..+..++.+++.|++|||+.   +++|+||+|+||+++.++..++ |||.+.........   
T Consensus        76 ~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---  143 (244)
T smart00220       76 DLLKKRG------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLL---  143 (244)
T ss_pred             HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccccc---
Confidence            9987654      378899999999999999999999   9999999999999999877766 99999887654311   


Q ss_pred             ccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhh
Q 043388          718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMA  797 (854)
Q Consensus       718 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  797 (854)
                       ....++..|+|||...+..++.++||||+|+++|++++|..||...... ....+.........    ..         
T Consensus       144 -~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~----~~---------  208 (244)
T smart00220      144 -TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPKPPF----PP---------  208 (244)
T ss_pred             -ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCC----cc---------
Confidence             1245888999999998888999999999999999999999998753111 11111111100000    00         


Q ss_pred             ccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          798 NNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                                 ....++.++.+++.+|+..+|++||++.++++
T Consensus       209 -----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      209 -----------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             -----------ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence                       00002456889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-31  Score=288.38  Aligned_cols=245  Identities=26%  Similarity=0.359  Sum_probs=185.5

Q ss_pred             ccCccCCCcce-EEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          552 SSNMIGQGSFG-SVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       552 ~~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ..+++|.|+.| .||+|...  ++.||||++-..   ..+-..+|+..++.- +||||||+++.-.+     ..+.||..
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d-----~qF~YIal  582 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQD-----RQFLYIAL  582 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccC-----CceEEEEe
Confidence            34678999887 57999996  779999988533   234567999999888 69999999886433     33899999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC---C--ccccc-ccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---D--MVAHQ-NFS  703 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~~~-Dfg  703 (854)
                      |.|.. +|.+++......  .........+.+..|++.||+|||+.   +||||||||.||||+.   +  ..++| |||
T Consensus       583 ELC~~-sL~dlie~~~~d--~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  583 ELCAC-SLQDLIESSGLD--VEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             hHhhh-hHHHHHhccccc--hhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccc
Confidence            99977 999999985211  11122245677899999999999998   9999999999999976   2  34556 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      +++.............+..||-+|+|||++.....+.++||||+|||+|+.++ |.+||......+..+   .....  .
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI---l~~~~--~  731 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI---LTGNY--T  731 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh---hcCcc--c
Confidence            99999887776666667789999999999999888899999999999999999 599997542221111   10000  0


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ... +                    ....+|  +..++|.+|++++|..||++.+|+.
T Consensus       732 L~~-L--------------------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  732 LVH-L--------------------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eee-e--------------------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            000 0                    001111  4568999999999999999999963

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.8e-29  Score=279.15  Aligned_cols=267  Identities=17%  Similarity=0.193  Sum_probs=180.3

Q ss_pred             HHhhccccCccCCCcceEEEEeEEC----------------CCceEEEEEEeecccccchHH--------------HHHH
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILG----------------GEEMIVAVKVINLKQKGAFRS--------------FVAE  595 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E  595 (854)
                      ..++|.+.++||+|+||.||+|.+.                ..++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3568999999999999999999752                245679999987543332233              3346


Q ss_pred             HHHHHhccCCC-----eeeEEEEeeccCCC---CCceeeEEEeeccCCCHHHHhhhcCCc------------------cc
Q 043388          596 CEALRNIRHRN-----LIKIITICSSIDSK---GADFKALVFEYMENGSLEDWLHQSNDH------------------LE  649 (854)
Q Consensus       596 ~~~l~~l~h~n-----iv~~~~~~~~~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~  649 (854)
                      +..+.+++|.+     +++++++|......   .....++||||+++|+|.++++.....                  ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            77777776654     47788887653211   123579999999999999999753211                  01


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCccccc
Q 043388          650 VCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYV  728 (854)
Q Consensus       650 ~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~  728 (854)
                      ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++..........  .....+|+.|+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~  377 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYS  377 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCccee
Confidence            12356788899999999999999999   9999999999999998887776 999997654432211  11123588999


Q ss_pred             CccccCCCC----------------------CCccchhHHHHHHHHHHHhCCC-CCCCcccCC-------chHhHHhhhc
Q 043388          729 APEYGMGSE----------------------ASMTGDVYSFGILLLEMFTGRR-PTDAAFTEG-------LTLHEFVKMT  778 (854)
Q Consensus       729 aPE~~~~~~----------------------~~~~sDv~slGvvl~elltg~~-pf~~~~~~~-------~~~~~~~~~~  778 (854)
                      |||.+....                      ...+.||||+||++|||++|.. ||.......       .....|... 
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-  456 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-  456 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-
Confidence            999875422                      1234799999999999999875 665321110       011111100 


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCC---CCCCCHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESP---FERMEMRDVVA  840 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~  840 (854)
                       ...   ..+                  ............+++.+++..+|   .+|+|++|+++
T Consensus       457 -~~~---~~~------------------~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 -KGQ---KYD------------------FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -ccc---CCC------------------cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence             000   000                  00111224557788888998766   68999999975

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.7e-30  Score=249.09  Aligned_cols=201  Identities=24%  Similarity=0.369  Sum_probs=174.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|...++||+|+|+.|..++++++.+.||+|+++..   +..+++=.+.|-.+..+. +||.+|-+..+|.+..    
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes----  324 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES----  324 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc----
Confidence            46899999999999999999999999999999999743   344445566777777666 7999999999887655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..+.|.||++||+|--.+.+.+      .++++.++-+..+|.-||.|||++   ||++||+|.+||++|..+..++ |
T Consensus       325 -rlffvieyv~ggdlmfhmqrqr------klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltd  394 (593)
T KOG0695|consen  325 -RLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTD  394 (593)
T ss_pred             -eEEEEEEEecCcceeeehhhhh------cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecc
Confidence             6899999999999987776654      799999999999999999999999   9999999999999999988887 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      +|+++.--.+..   .+..++||+.|.|||++.+..|+..+|.|++||+++||+.|+.||+.-
T Consensus       395 ygmcke~l~~gd---~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  395 YGMCKEGLGPGD---TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             cchhhcCCCCCc---ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence            999986544333   233478999999999999999999999999999999999999999853

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.96  E-value=5.2e-32  Score=270.48  Aligned_cols=300  Identities=19%  Similarity=0.192  Sum_probs=224.6

Q ss_pred             EEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecc-c
Q 043388           20 TLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTV-N   98 (854)
Q Consensus        20 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N   98 (854)
                      ..|.++-.++ .+|..+.  .....++|..|+|+.+.|.+|+.+++|+.||||+|+|+.|-|++|.++.+|..|-+.+ |
T Consensus        50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N  126 (498)
T KOG4237|consen   50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN  126 (498)
T ss_pred             eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence            4566777777 6777766  4678889999999988888999999999999999999999999999999988777766 8


Q ss_pred             ccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccC
Q 043388           99 RFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLK  178 (854)
Q Consensus        99 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~  178 (854)
                      +|+ .+|.++|.+|..|+-|.+.-|++..+                 ..+.|..|++|..|.|.+|.+..+....|..+.
T Consensus       127 kI~-~l~k~~F~gL~slqrLllNan~i~Ci-----------------r~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~  188 (498)
T KOG4237|consen  127 KIT-DLPKGAFGGLSSLQRLLLNANHINCI-----------------RQDALRDLPSLSLLSLYDNKIQSICKGTFQGLA  188 (498)
T ss_pred             chh-hhhhhHhhhHHHHHHHhcChhhhcch-----------------hHHHHHHhhhcchhcccchhhhhhccccccchh
Confidence            998 89999999888888888877777654                 357788899999999999999888777999999


Q ss_pred             CCCeEecccccccCC------CCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhccccc-EEEccCCcccccCC-
Q 043388          179 NLWWLNLEQNNLGMG------TANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMI-QFRIGGNQISGTIP-  250 (854)
Q Consensus       179 ~L~~L~L~~N~l~~~------~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~-~L~l~~N~l~~~~~-  250 (854)
                      .++.+++..|.+...      .......+..+++..-..-..+.++++..+-+..|......+. .+....+.. ++-| 
T Consensus       189 ~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d-~~cP~  267 (498)
T KOG4237|consen  189 AIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPD-SICPA  267 (498)
T ss_pred             ccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcC-CcChH
Confidence            999999998873211      0001112333455555555566666666444444433211121 122222223 2444 


Q ss_pred             ccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCC
Q 043388          251 SGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQN  330 (854)
Q Consensus       251 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  330 (854)
                      ..|..|++|+.|+|++|+|+.+.+.+|.++..++.|+|..|+|..+-...|.++..|+.|+|++|+|+...|.+|..+..
T Consensus       268 ~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~  347 (498)
T KOG4237|consen  268 KCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS  347 (498)
T ss_pred             HHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence            45888888888888888888888888888888888888888888777778888888888888888888888888888888


Q ss_pred             CcccccCCCcc
Q 043388          331 LKGFDASHNKL  341 (854)
Q Consensus       331 L~~L~ls~N~l  341 (854)
                      |..|+|-.|.+
T Consensus       348 l~~l~l~~Np~  358 (498)
T KOG4237|consen  348 LSTLNLLSNPF  358 (498)
T ss_pred             eeeeehccCcc
Confidence            88888877765

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-31  Score=252.03  Aligned_cols=203  Identities=23%  Similarity=0.317  Sum_probs=166.9

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      .+..+.||.|+||.||.+++..+|+.||+|++...  .-...+++.+|++.+..++|.||+..+++..-....-....|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            44568899999999999999999999999988533  2233577899999999999999999888764433221224688


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ++|.|.. +|..++....      .++...+.-+.+||++||.|||+.   +|.||||||.|.+++.+-+.+| |||+++
T Consensus       135 ~TELmQS-DLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR  204 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR  204 (449)
T ss_pred             HHHHHHh-hhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence            9999955 8988887654      788888999999999999999999   9999999999999999998887 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ..........  +.-+-|..|+|||+++|. .|+.+.||||.||++.|++.++..|...
T Consensus       205 vee~d~~~hM--TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq  261 (449)
T KOG0664|consen  205 TWDQRDRLNM--THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA  261 (449)
T ss_pred             ccchhhhhhh--HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence            7765433221  112468899999999985 5999999999999999999998888754

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.5e-29  Score=261.44  Aligned_cols=206  Identities=23%  Similarity=0.312  Sum_probs=175.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .-|..++.||-|+||+|.++.-.++...||+|.++..+   ......++.|-+||...+.+=||++|..|.+.+     .
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-----n  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----N  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-----c
Confidence            45888999999999999999998888899999987543   223445778999999999999999999887766     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|.||||++||++-.+|-+.+      .+.+.-++-++.++..|+++.|..   |+|||||||+|||||.++..++ |||
T Consensus       704 LYFVMdYIPGGDmMSLLIrmg------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence            899999999999999998876      678888888999999999999999   9999999999999999998888 999


Q ss_pred             cccccccCCC---------CC------------------------------CcccccCCcccccCccccCCCCCCccchh
Q 043388          704 LSHQLDSASK---------TP------------------------------SSSIGIKGTVGYVAPEYGMGSEASMTGDV  744 (854)
Q Consensus       704 ~~~~~~~~~~---------~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv  744 (854)
                      +|.-+.-...         ..                              ......+||+.|+|||++....++.-+|.
T Consensus       775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw  854 (1034)
T KOG0608|consen  775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW  854 (1034)
T ss_pred             ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence            9976522100         00                              00123569999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCcccC
Q 043388          745 YSFGILLLEMFTGRRPTDAAFTE  767 (854)
Q Consensus       745 ~slGvvl~elltg~~pf~~~~~~  767 (854)
                      ||.|||||||+.|++||......
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPG  877 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCC
Confidence            99999999999999999876544

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-29  Score=260.81  Aligned_cols=200  Identities=25%  Similarity=0.362  Sum_probs=171.2

Q ss_pred             HHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--------ccchHHHHHHHHHHHhcc---CCCeeeEEE
Q 043388          544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--------KGAFRSFVAECEALRNIR---HRNLIKIIT  612 (854)
Q Consensus       544 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~  612 (854)
                      .....+|...+.+|+|+||.|+.|.++.+...|+||.+....        +.....+.-|+.||..++   |+||+++++
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            344567999999999999999999999888899999885432        122234567999999997   999999999


Q ss_pred             EeeccCCCCCceeeEEEeec-cCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceE
Q 043388          613 ICSSIDSKGADFKALVFEYM-ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVL  691 (854)
Q Consensus       613 ~~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl  691 (854)
                      +|++.+     +.||+||-. +|-+|.++|..+.      .+++.++..|++||+.|+++||++   +|||||||-+||.
T Consensus       637 fFEddd-----~yyl~te~hg~gIDLFd~IE~kp------~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvi  702 (772)
T KOG1152|consen  637 FFEDDD-----YYYLETEVHGEGIDLFDFIEFKP------RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVI  702 (772)
T ss_pred             eeecCC-----eeEEEecCCCCCcchhhhhhccC------ccchHHHHHHHHHHHhcccccccc---CceecccccccEE
Confidence            998877     789999975 5569999998876      789999999999999999999999   9999999999999


Q ss_pred             ecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 043388          692 LDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTD  762 (854)
Q Consensus       692 l~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~  762 (854)
                      ++.++.+++ |||.|.......-.     .++||..|.|||++.|..| +..-|||++|+++|.++....||.
T Consensus       703 vd~~g~~klidfgsaa~~ksgpfd-----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  703 VDSNGFVKLIDFGSAAYTKSGPFD-----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EecCCeEEEeeccchhhhcCCCcc-----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999876665 99999877654432     3679999999999999876 566899999999999999999875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=8.8e-29  Score=251.20  Aligned_cols=280  Identities=25%  Similarity=0.324  Sum_probs=203.5

Q ss_pred             HHHHHhhccccCccCCCcceEEEEeEECC---CceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccC
Q 043388          543 LSKATSEFASSNMIGQGSFGSVYKGILGG---EEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSID  618 (854)
Q Consensus       543 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  618 (854)
                      +......|..+++||+|.|++||+|.+..   ..+.||+|.+...+..  .++.+|++.|..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            33445678999999999999999999876   6789999999766543  5688999999999 5899999999876555


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc-
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV-  697 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-  697 (854)
                           ...+|+||++.....++..         .++..++..+++.+..||+|+|+.   |||||||||+|++.+.... 
T Consensus       109 -----~v~ivlp~~~H~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~r  171 (418)
T KOG1167|consen  109 -----QVAIVLPYFEHDRFRDLYR---------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQR  171 (418)
T ss_pred             -----eeEEEecccCccCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCC
Confidence                 7899999999998888876         466788999999999999999999   9999999999999987643 


Q ss_pred             -cccccccccccccCC-----------------------------------------CCCCcccccCCcccccCccccCC
Q 043388          698 -AHQNFSLSHQLDSAS-----------------------------------------KTPSSSIGIKGTVGYVAPEYGMG  735 (854)
Q Consensus       698 -~~~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~  735 (854)
                       .++|||+|.......                                         ..........||++|+|||++..
T Consensus       172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k  251 (418)
T KOG1167|consen  172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR  251 (418)
T ss_pred             ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence             445999998321100                                         00001123569999999999877


Q ss_pred             C-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc------------cccc----cCchhhHHHhhc
Q 043388          736 S-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK------------VIEI----VDPSLLMEVMAN  798 (854)
Q Consensus       736 ~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------------~~~~----~d~~~~~~~~~~  798 (854)
                      . ..++++||||.||+++-+++++.||....++-..+.+.+.......            +++.    ..++....+..-
T Consensus       252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~  331 (418)
T KOG1167|consen  252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL  331 (418)
T ss_pred             ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence            4 4799999999999999999999999887666555555443222211            1110    011111111110


Q ss_pred             -cchhhH-----hhhhhHHHH-HHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          799 -NSMIQE-----DRRARTQDC-LNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       799 -~~~~~~-----~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                       .....+     ..+....++ +..+.+++.+|+..||.+|.|++|.++.
T Consensus       332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence             000000     111112222 3478899999999999999999998763

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=1e-28  Score=254.24  Aligned_cols=203  Identities=21%  Similarity=0.298  Sum_probs=172.8

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc------CCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR------HRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~  620 (854)
                      -.+|.+....|+|-|++|.+|.+...|..||||+++.... ..+.=.+|+++|++|+      -.|+++++..|....  
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn--  507 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN--  507 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc--
Confidence            4679999999999999999999988889999999975532 2345578999999995      348899888877665  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc--cc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM--VA  698 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~  698 (854)
                         +.|||||.+. .+|.++++..+..   ..+....+..++.|+.-||..|-..   +|+|.||||+||||++..  .+
T Consensus       508 ---HLClVFE~Ls-lNLRevLKKyG~n---vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  508 ---HLCLVFEPLS-LNLREVLKKYGRN---VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             ---eeEEEehhhh-chHHHHHHHhCcc---cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceee
Confidence               8999999984 4999999987643   3788889999999999999999998   999999999999998864  34


Q ss_pred             ccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC
Q 043388          699 HQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE  767 (854)
Q Consensus       699 ~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~  767 (854)
                      ++|||.|........++     +.-+..|.|||++.|..|+...|+||.||+|||+.||+..|.+....
T Consensus       578 LCDfGSA~~~~eneitP-----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN  641 (752)
T KOG0670|consen  578 LCDFGSASFASENEITP-----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN  641 (752)
T ss_pred             eccCccccccccccccH-----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence            45999998887765543     34578899999999999999999999999999999999999886543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-28  Score=236.75  Aligned_cols=268  Identities=19%  Similarity=0.228  Sum_probs=194.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  624 (854)
                      .+|.-.+.+|.|.- .|-.|.+.-.++.||+|+....  .....++..+|...+..++|+||++++.++.-... .....
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            35666788999988 7888888778899999987432  23344677899999999999999999998853321 11224


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+|||||.. +|.+.+..        .++-.++..|..|++.|++|||+.   +|+||||||+||++..+...++ |||
T Consensus        96 ~y~v~e~m~~-nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILM--------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence            7999999965 99998883        456678889999999999999999   9999999999999999988888 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +|+..+..    ...+.++.|..|+|||++.+..+.+.+||||.||++.||++|+..|.+.    ..+.+|.+..-   .
T Consensus       164 ~ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~---~  232 (369)
T KOG0665|consen  164 LARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIE---Q  232 (369)
T ss_pred             hhcccCcc----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHH---H
Confidence            99877654    1223467899999999999988999999999999999999999998743    22233332110   0


Q ss_pred             ccccCchhhHHHhhccc----hhhH-----------------hhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNS----MIQE-----------------DRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~----~~~~-----------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .+..|++...+......    ..+.                 .......+ .....+++.+||..+|++|.++++++.
T Consensus       233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~-~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLD-CSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccc-hHHHHHHHHHhhccChhhcccHHHHhc
Confidence            01112221111100000    0000                 00000011 344678899999999999999999875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.2e-26  Score=234.00  Aligned_cols=210  Identities=30%  Similarity=0.498  Sum_probs=178.7

Q ss_pred             cCCCcceEEEEeEECCCceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeeccC
Q 043388          556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMEN  634 (854)
Q Consensus       556 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  634 (854)
                      ||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.+.|++++++++++....     ..+++|||+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN-----HLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-----eEEEEEecCCC
Confidence            68999999999999878999999999765432 3467899999999999999999999987653     68999999999


Q ss_pred             CCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC-Ccccc-cccccccccccCC
Q 043388          635 GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAH-QNFSLSHQLDSAS  712 (854)
Q Consensus       635 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~~-~Dfg~~~~~~~~~  712 (854)
                      ++|.+++....     ..+++..+..++.+++++++|||+.   +++|+||+|+||+++. +...+ +|||.+.......
T Consensus        76 ~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          76 GSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            99999988653     1678999999999999999999999   9999999999999998 55555 4999998776543


Q ss_pred             CCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchh
Q 043388          713 KTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL  791 (854)
Q Consensus       713 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  791 (854)
                      .   ......+...|++||..... .++.++|+|++|++++++                                     
T Consensus       148 ~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------  187 (215)
T cd00180         148 S---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------  187 (215)
T ss_pred             c---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------
Confidence            2   11123478899999998887 788999999999999999                                     


Q ss_pred             hHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          792 LMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                             ..+.+++..|++.+|++||++.++++.
T Consensus       188 -----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -----------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -----------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                                   125678889999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=227.91  Aligned_cols=254  Identities=19%  Similarity=0.252  Sum_probs=188.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .+.|.+.+.+|+|.||.+-+++++++...+|+|-+..... ..++|.+|..---.| .|.||+.-|+......    ++.
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----d~Y   97 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----DAY   97 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcC----ceE
Confidence            4679999999999999999999999999999998865433 357889998765555 5899998887643322    267


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec-CC--ccccccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HD--MVAHQNF  702 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~--~~~~~Df  702 (854)
                      +.++||++.|+|.+-+...       .+.+....+++.|+++|+.|||++   ++||||||.+||||- .|  .++++||
T Consensus        98 vF~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             EEeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence            8999999999999887764       466777889999999999999999   999999999999993 23  4555699


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCC-----CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-----EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                      |.++..+......      .-+-.|.|||.....     ...+.+|||.||+++|.++||+.||+.....+..+.+|...
T Consensus       168 G~t~k~g~tV~~~------~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w  241 (378)
T KOG1345|consen  168 GLTRKVGTTVKYL------EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW  241 (378)
T ss_pred             ccccccCceehhh------hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH
Confidence            9998776544332      246679999975432     35778999999999999999999999766666555555443


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                      ......      .+               +..+....+...++.++-+..+|++|-...++.++-
T Consensus       242 ~~rk~~------~~---------------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  242 LKRKNP------AL---------------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             hcccCc------cC---------------chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            221110      00               001111234455667778888999886655555543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-28  Score=258.75  Aligned_cols=252  Identities=22%  Similarity=0.314  Sum_probs=200.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|....++|+|.||.||||+++.+++..|+|+++......+.-..+|+-+++..+|||||.++|-|...+     ..++
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klwi   89 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLWI   89 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcEE
Confidence            57888899999999999999999999999999999888778888899999999999999999999886655     5799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      +||||.+|+|.+.-+..+      ++++.++..+++...+|++|||+.   +-+|||||-.||++++.+.++. |||.+.
T Consensus        90 cMEycgggslQdiy~~Tg------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsa  160 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSA  160 (829)
T ss_pred             EEEecCCCcccceeeecc------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchh
Confidence            999999999999877665      789999999999999999999999   8999999999999988877666 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCcccc---CCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYG---MGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      .+...-....   .+.||+.|||||+.   ..+.|..++|||+.|+...|+---++|.....    .+....-+..    
T Consensus       161 qitati~Krk---sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh----pmr~l~LmTk----  229 (829)
T KOG0576|consen  161 QITATIAKRK---SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH----PMRALFLMTK----  229 (829)
T ss_pred             hhhhhhhhhh---cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc----hHHHHHHhhc----
Confidence            8866443322   35799999999975   34668999999999999999988777743211    1111000000    


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       ...+|               ........+.+.+-++++.|+..+|.+|||+..++.
T Consensus       230 -S~~qp---------------p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  230 -SGFQP---------------PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -cCCCC---------------CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence             00000               011111223556788999999999999999987654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=3.2e-26  Score=233.47  Aligned_cols=199  Identities=31%  Similarity=0.488  Sum_probs=170.2

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      |.+.+.||+|++|.||+|...+++..+|+|.+...... ..+.+.+|++.+++++|+|++++++++....     ..+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE-----PLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC-----ceEEE
Confidence            56678999999999999999987899999999765544 5678899999999999999999999986654     67999


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQ  707 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~  707 (854)
                      +||+++++|.+++.....     .+++..+..++.+++.++.|||+.   +++|+|++|+||+++.+...++ |||.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~  147 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGG-----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF  147 (225)
T ss_pred             EeccCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence            999999999999987541     178899999999999999999999   9999999999999998766665 9999988


Q ss_pred             cccCCCCCCcccccCCcccccCcccc-CCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 043388          708 LDSASKTPSSSIGIKGTVGYVAPEYG-MGSEASMTGDVYSFGILLLEMFTGRRPTDA  763 (854)
Q Consensus       708 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvvl~elltg~~pf~~  763 (854)
                      .......  ......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       148 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      148 IHRDLAA--LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ecCcccc--cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            7654311  11224578899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=6.1e-29  Score=248.56  Aligned_cols=395  Identities=19%  Similarity=0.230  Sum_probs=250.8

Q ss_pred             cCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEeccc-ccCcccChhhhc
Q 043388            7 QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAE-NQFSGMFPRWIC   85 (854)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~   85 (854)
                      .+|.++..  ....++|..|+|+.+.|.+|+.+++|++|||++|+|+.+-|++|.++++|..|-+.+ |+|+.+..++|+
T Consensus        60 eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~  137 (498)
T KOG4237|consen   60 EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG  137 (498)
T ss_pred             cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence            46666665  778899999999977778999999999999999999999999999999988887777 999988888999


Q ss_pred             CCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCc-cccCCCCCCEEecCCC
Q 043388           86 NISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPD-SLSNASNLERLDLSGN  164 (854)
Q Consensus        86 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~-~~~~l~~L~~L~Ls~N  164 (854)
                      +|.+|+.|.+.-|++. .++.++|+.+++|..|.+-.|.++.+                  +. +|..+..++++++..|
T Consensus       138 gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i------------------~~~tf~~l~~i~tlhlA~n  198 (498)
T KOG4237|consen  138 GLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSI------------------CKGTFQGLAAIKTLHLAQN  198 (498)
T ss_pred             hHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhh------------------ccccccchhccchHhhhcC
Confidence            9999999999999998 89999999999998888877766543                  33 5677777777777777


Q ss_pred             c------------CcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChh-hhhh
Q 043388          165 Q------------FKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHS-IANL  231 (854)
Q Consensus       165 ~------------i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l  231 (854)
                      .            +....|..+++..-..-..|.++++..+.+..+  .   ..+.++..=..+.....++.|.. |..+
T Consensus       199 p~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf--~---c~~esl~s~~~~~d~~d~~cP~~cf~~L  273 (498)
T KOG4237|consen  199 PFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKF--L---CSLESLPSRLSSEDFPDSICPAKCFKKL  273 (498)
T ss_pred             ccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhh--h---hhHHhHHHhhccccCcCCcChHHHHhhc
Confidence            6            333445566666666666666666655544321  0   00111111011111122233332 2233


Q ss_pred             cccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhc
Q 043388          232 SSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLA  311 (854)
Q Consensus       232 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  311 (854)
                       ++|+.|+|++|+|+.+-+.+|.++..+++|.|..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+..|..|+
T Consensus       274 -~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~  352 (498)
T KOG4237|consen  274 -PNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN  352 (498)
T ss_pred             -ccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeee
Confidence             2555555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             cccceecc-----------------cCCCCCcCCCCCcccccCCCccc---Cccchhh---------cchhhhHHHHHhh
Q 043388          312 LSFNNLQG-----------------NIPSSLGNCQNLKGFDASHNKLT---GAIPQQV---------LSITTLSVYLALA  362 (854)
Q Consensus       312 L~~N~l~~-----------------~~~~~~~~l~~L~~L~ls~N~l~---~~~p~~~---------~~~~~l~~~l~l~  362 (854)
                      |-.|.+.-                 ..|.. ++-..++.+.++.+.+.   -..|.+.         ...+-+.+...-|
T Consensus       353 l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcS  431 (498)
T KOG4237|consen  353 LLSNPFNCNCRLAWLGEWLRKKSVVGNPRC-QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCS  431 (498)
T ss_pred             hccCcccCccchHHHHHHHhhCCCCCCCCC-CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhc
Confidence            55554320                 00100 01122444444444332   1111111         1112222223333


Q ss_pred             cCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeeccc
Q 043388          363 HNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSY  442 (854)
Q Consensus       363 ~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  442 (854)
                       |+....+|..+..         .-..|++.+|.++ .+|..  .+.+| .+||++|+|+..--..|.++++|.+|-||+
T Consensus       432 -nk~lk~lp~~iP~---------d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsy  497 (498)
T KOG4237|consen  432 -NKLLKLLPRGIPV---------DVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSY  497 (498)
T ss_pred             -ccchhhcCCCCCc---------hhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEec
Confidence             3444455655543         4567999999999 56665  67788 999999999977777899999999999998


Q ss_pred             c
Q 043388          443 N  443 (854)
Q Consensus       443 N  443 (854)
                      |
T Consensus       498 n  498 (498)
T KOG4237|consen  498 N  498 (498)
T ss_pred             C
Confidence            7

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=7.4e-25  Score=213.97  Aligned_cols=170  Identities=18%  Similarity=0.172  Sum_probs=128.6

Q ss_pred             CCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccccccccccccccCCCC
Q 043388          635 GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKT  714 (854)
Q Consensus       635 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg~~~~~~~~~~~  714 (854)
                      |+|.+++...+.     .+++.+++.|+.|++.||+|||++   +      ||+||+++.++..++ ||.+.......  
T Consensus         1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~-fG~~~~~~~~~--   63 (176)
T smart00750        1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL-DGSVAFKTPEQ--   63 (176)
T ss_pred             CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee-ccceEeecccc--
Confidence            689999986432     689999999999999999999998   5      999999999988888 99988765422  


Q ss_pred             CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHH
Q 043388          715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLME  794 (854)
Q Consensus       715 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  794 (854)
                            ..||+.|+|||++.+..++.++|||||||++|||+||+.||............+..........          
T Consensus        64 ------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------  127 (176)
T smart00750       64 ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR----------  127 (176)
T ss_pred             ------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc----------
Confidence                  1488999999999999999999999999999999999999975432222222222111110000          


Q ss_pred             HhhccchhhHhhhhhHHHHH--HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          795 VMANNSMIQEDRRARTQDCL--NAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                                 .+.......  ..+.+++.+||+.+|++||++.|+++.+..+...
T Consensus       128 -----------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      128 -----------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             -----------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence                       000111112  2588999999999999999999999998776543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.92  E-value=8.2e-25  Score=250.05  Aligned_cols=265  Identities=25%  Similarity=0.279  Sum_probs=209.7

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeee
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYL   95 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L   95 (854)
                      ..-..|+|++|.|+ .+|..+.  ++|+.|++.+|+|+ .+|..   +++|++|+|++|+|+. +|..   .++|+.|+|
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L  269 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSI  269 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence            45778999999999 7888776  48999999999999 56753   5899999999999995 5643   468999999


Q ss_pred             cccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcc
Q 043388           96 TVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS  175 (854)
Q Consensus        96 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~  175 (854)
                      ++|.|+ .+|. .   .++|+.|++++|+++.                  +|..   +++|+.|+|++|+|+++++ .  
T Consensus       270 s~N~L~-~Lp~-l---p~~L~~L~Ls~N~Lt~------------------LP~~---p~~L~~LdLS~N~L~~Lp~-l--  320 (788)
T PRK15387        270 FSNPLT-HLPA-L---PSGLCKLWIFGNQLTS------------------LPVL---PPGLQELSVSDNQLASLPA-L--  320 (788)
T ss_pred             cCCchh-hhhh-c---hhhcCEEECcCCcccc------------------cccc---ccccceeECCCCccccCCC-C--
Confidence            999998 7774 2   2456666666666543                  3442   4689999999999997643 2  


Q ss_pred             ccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccc
Q 043388          176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRN  255 (854)
Q Consensus       176 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~  255 (854)
                       ..+|+.|++++|+|+.++.-          ..+|+.|+|++|+|+ .+|..    ++.|..|++++|+|+. +|..   
T Consensus       321 -p~~L~~L~Ls~N~L~~LP~l----------p~~Lq~LdLS~N~Ls-~LP~l----p~~L~~L~Ls~N~L~~-LP~l---  380 (788)
T PRK15387        321 -PSELCKLWAYNNQLTSLPTL----------PSGLQELSVSDNQLA-SLPTL----PSELYKLWAYNNRLTS-LPAL---  380 (788)
T ss_pred             -cccccccccccCcccccccc----------ccccceEecCCCccC-CCCCC----Ccccceehhhcccccc-Cccc---
Confidence             34688899999999865531          257999999999999 56653    3468889999999994 5653   


Q ss_pred             cccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccc
Q 043388          256 LVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFD  335 (854)
Q Consensus       256 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  335 (854)
                      ..+|+.|+|++|+|+++ |..   .++|+.|++++|++++ +|..+   .+|+.|++++|+|+ .+|..+.++++|+.|+
T Consensus       381 ~~~L~~LdLs~N~Lt~L-P~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~Ld  451 (788)
T PRK15387        381 PSGLKELIVSGNRLTSL-PVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVN  451 (788)
T ss_pred             ccccceEEecCCcccCC-CCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEE
Confidence            35799999999999964 433   3679999999999994 66543   46889999999999 6899999999999999


Q ss_pred             cCCCcccCccchhh
Q 043388          336 ASHNKLTGAIPQQV  349 (854)
Q Consensus       336 ls~N~l~~~~p~~~  349 (854)
                      |++|++++..|..+
T Consensus       452 Ls~N~Ls~~~~~~L  465 (788)
T PRK15387        452 LEGNPLSERTLQAL  465 (788)
T ss_pred             CCCCCCCchHHHHH
Confidence            99999998766644

>PLN03210 Resistant to P

Probab=99.92  E-value=5.5e-24  Score=263.23  Aligned_cols=338  Identities=21%  Similarity=0.241  Sum_probs=226.9

Q ss_pred             CccccCcCCCCeeeccccc------ccccCCcCccCCC-CCcEEecccccCcccChhhhcCCCCCceeeecccccccccC
Q 043388           33 PDFVGNLSALGMLLIRWNS------LGGQIPTTLGLLR-NLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLP  105 (854)
Q Consensus        33 ~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  105 (854)
                      +.+|..+.+|+.|.+..+.      +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|+++ .+|
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~  627 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW  627 (1153)
T ss_pred             HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence            4456677777777775543      3334566666553 5777777777776 456655 4567777777777776 666


Q ss_pred             cccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEec
Q 043388          106 FDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNL  185 (854)
Q Consensus       106 ~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L  185 (854)
                      .+ +..+++|+.|+|+.+..            +     +.+|+ ++.+++|++|+|++|......|..+..+++|+.|++
T Consensus       628 ~~-~~~l~~Lk~L~Ls~~~~------------l-----~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L  688 (1153)
T PLN03210        628 DG-VHSLTGLRNIDLRGSKN------------L-----KEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM  688 (1153)
T ss_pred             cc-cccCCCCCEEECCCCCC------------c-----CcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence            54 35566666666655421            1     23343 666777777777777655566677777777777777


Q ss_pred             ccc-cccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeec
Q 043388          186 EQN-NLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTI  264 (854)
Q Consensus       186 ~~N-~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  264 (854)
                      ++| .++.++..        .++++|+.|++++|...+.+|..    ..+|+.|++++|.++ .+|..+ .+++|+.|++
T Consensus       689 ~~c~~L~~Lp~~--------i~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l  754 (1153)
T PLN03210        689 SRCENLEILPTG--------INLKSLYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENLDELIL  754 (1153)
T ss_pred             CCCCCcCccCCc--------CCCCCCCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-cccccccccc
Confidence            774 34444332        25677788888777655455532    236777888888876 455544 5677887777


Q ss_pred             ccccc-------ccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccC
Q 043388          265 EVNQL-------HGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDAS  337 (854)
Q Consensus       265 ~~N~l-------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls  337 (854)
                      .++..       ....+..+...++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|+++
T Consensus       755 ~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls  833 (1153)
T PLN03210        755 CEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLS  833 (1153)
T ss_pred             cccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECC
Confidence            76432       22222233445688888888887777788888888888888888875444667665 67888888888


Q ss_pred             CCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEcc
Q 043388          338 HNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVS  417 (854)
Q Consensus       338 ~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  417 (854)
                      +|.....+|.                         .          ..+|+.|+|++|.++ .+|.++..+++|+.|+|+
T Consensus       834 ~c~~L~~~p~-------------------------~----------~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~  877 (1153)
T PLN03210        834 GCSRLRTFPD-------------------------I----------STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMN  877 (1153)
T ss_pred             CCCccccccc-------------------------c----------ccccCEeECCCCCCc-cChHHHhcCCCCCEEECC
Confidence            8754322221                         1          135788999999998 578888899999999998


Q ss_pred             C-cccccccchhhcCccCCCeeeccccc
Q 043388          418 S-NNLSGQIPEFLQNLSFLEFLNLSYNH  444 (854)
Q Consensus       418 ~-N~l~~~~p~~~~~l~~L~~L~ls~N~  444 (854)
                      + |+++ .+|..+..+++|+.++++++.
T Consensus       878 ~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        878 GCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCcC-ccCcccccccCCCeeecCCCc
Confidence            8 5565 577778888899999988874

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=2.2e-24  Score=246.51  Aligned_cols=60  Identities=30%  Similarity=0.358  Sum_probs=34.5

Q ss_pred             cceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCC
Q 043388          387 LEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPT  451 (854)
Q Consensus       387 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  451 (854)
                      |+.|++++|+|++ +|..   ..+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|.
T Consensus       404 L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        404 LKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             CCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            5556666666653 3432   234556666666665 4566666666666666666666655443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=4.4e-25  Score=265.30  Aligned_cols=201  Identities=18%  Similarity=0.269  Sum_probs=139.3

Q ss_pred             hccC-CCeeeEEEEeeccCCCC--CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 043388          601 NIRH-RNLIKIITICSSIDSKG--ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQ  677 (854)
Q Consensus       601 ~l~h-~niv~~~~~~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~  677 (854)
                      .++| +||++++++|......+  ....+.+|||+ +++|.+++....     ..+++.+++.++.||++||+|||++  
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~--   99 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQ--   99 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhC--
Confidence            4456 58888888874333222  22467788988 559999997542     2689999999999999999999999  


Q ss_pred             CCeEeecCCCCceEecC-------------------Cccccc-ccccccccccCCC-------------CCCcccccCCc
Q 043388          678 PPIVHGDLKPSNVLLDH-------------------DMVAHQ-NFSLSHQLDSASK-------------TPSSSIGIKGT  724 (854)
Q Consensus       678 ~~ivH~Dlkp~NIll~~-------------------~~~~~~-Dfg~~~~~~~~~~-------------~~~~~~~~~gt  724 (854)
                       +|+||||||+|||++.                   +...++ |||+++.......             .........||
T Consensus       100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181        100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence             9999999999999953                   333344 8888765321100             00011124589


Q ss_pred             ccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhH
Q 043388          725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQE  804 (854)
Q Consensus       725 ~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  804 (854)
                      +.|||||++.+..++.++|||||||++|||++|.+|+....   ...........        .+..             
T Consensus       179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~--------~~~~-------------  234 (793)
T PLN00181        179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVL--------PPQI-------------  234 (793)
T ss_pred             cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhc--------Chhh-------------
Confidence            99999999999999999999999999999999988865321   01111111000        0000             


Q ss_pred             hhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          805 DRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       805 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                            .........++.+||+.+|.+||+|.|+++
T Consensus       235 ------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        235 ------LLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             ------hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence                  000223456778899999999999999975

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-22  Score=216.54  Aligned_cols=264  Identities=20%  Similarity=0.253  Sum_probs=193.2

Q ss_pred             hccccCccCCCcceEEEEeEECCCc-eEEEEEEeecccccchHHHHHHHHHHHhccC----CCeeeEEEEeeccCCCCCc
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEE-MIVAVKVINLKQKGAFRSFVAECEALRNIRH----RNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~  623 (854)
                      +|.+.++||+|+||.||.|....++ ..+|+|+...........+..|..++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999997664 6789998876543333367889999999863    58888888763    1222


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc------c
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM------V  697 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~------~  697 (854)
                      +.++||+.+ |.+|.++......    ..++..++.+|+.|++.+|+++|+.   |++||||||+|+++....      +
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~----~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPP----GRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCC----CCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence            679999988 7799998866542    2799999999999999999999999   999999999999997642      4


Q ss_pred             cccccccccccc--cCC----CCCCc-ccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch
Q 043388          698 AHQNFSLSHQLD--SAS----KTPSS-SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT  770 (854)
Q Consensus       698 ~~~Dfg~~~~~~--~~~----~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~  770 (854)
                      .++|||+++.+.  ...    ..... .....||..|+++....+...+.+.|+||++.++.|++.|..||........ 
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-  245 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-  245 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-
Confidence            456999999332  221    11111 2345699999999999999999999999999999999999999965432111 


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ..++...........                       .....+.++.++...+-..+..++|....+.+.+......
T Consensus       246 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  246 KSKFEKDPRKLLTDR-----------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHHHHHhhhhcccc-----------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            111111000000000                       0001134455555556668999999999999988777654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.1e-24  Score=205.33  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=186.5

Q ss_pred             ccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          552 SSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       552 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ...+|.+...|+.|+|+|.++.  +++|++...+  ....++|..|.-.++-+.||||..++|.|..+.     ...++.
T Consensus       194 l~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nlv~is  266 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NLVIIS  266 (448)
T ss_pred             hhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----CceEee
Confidence            3456888999999999998554  6777775443  223467889999999999999999999998765     688999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccccccccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLD  709 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg~~~~~~  709 (854)
                      .||+.|||+..+++...    ...+-.++.++|.++|+|++|||+.. |-|.---+.+..|++|++..+++..+-+++-.
T Consensus       267 q~mp~gslynvlhe~t~----vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf  341 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTS----VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF  341 (448)
T ss_pred             eeccchHHHHHHhcCcc----EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee
Confidence            99999999999998753    26788899999999999999999973 33444568999999999988887554443322


Q ss_pred             cCCCCCCcccccCCcccccCccccCCCCC---CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          710 SASKTPSSSIGIKGTVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       710 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      ...       +..-.+.||+||.++..+-   -.++|+|||++++||+.|...||..-..-+.-+.-     .-+.+...
T Consensus       342 qe~-------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-----aleglrv~  409 (448)
T KOG0195|consen  342 QEV-------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-----ALEGLRVH  409 (448)
T ss_pred             ecc-------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-----hhcccccc
Confidence            221       1235789999999887653   45789999999999999999999754322111110     00111111


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                      +.|                      .....+.+++.-|+..||.+||.++.|+-.|+++.
T Consensus       410 ipp----------------------gis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  410 IPP----------------------GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCC----------------------CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            222                      22455778889999999999999999998888753

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=9.3e-23  Score=200.03  Aligned_cols=264  Identities=17%  Similarity=0.257  Sum_probs=197.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      -.|+++++||+|+||+++.|+..-++++||||.-..+++.  .++..|.+..+.| ..+.|..+|-|-....     +-.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~-----~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGK-----YNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccc-----hhh
Confidence            3699999999999999999999889999999976544332  4567788888887 5688888876643322     568


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC------ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD------MVAHQ  700 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~~~  700 (854)
                      +|+|.+ |.||++++.-.++     .++..++..||.|+..-++|+|++   .+|.|||||+|+||...      .+.+|
T Consensus       101 LVidLL-GPSLEDLFD~CgR-----~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihii  171 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGR-----RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHII  171 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcC-----cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEE
Confidence            999998 7899999987654     899999999999999999999999   99999999999999643      45556


Q ss_pred             ccccccccccCCCCC----CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh
Q 043388          701 NFSLSHQLDSASKTP----SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK  776 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~  776 (854)
                      |||+|+.+.++....    .......||..||+-....|...+.+.|+-|+|-|+++.+-|..||.+...+... ..+.+
T Consensus       172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-~kYeK  250 (449)
T KOG1165|consen  172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-EKYEK  250 (449)
T ss_pred             eccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-HHHHH
Confidence            999999987765432    2233456999999999999999999999999999999999999999875322111 11100


Q ss_pred             hcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       777 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                               +-+..-.           .......+..+.++...+...-..+-++-|..+-+...+..+.+.
T Consensus       251 ---------IGe~Kr~-----------T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  251 ---------IGETKRS-----------TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             ---------hcccccc-----------CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence                     0000000           000111223355666666666667888888888777777666543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=2.8e-23  Score=194.71  Aligned_cols=203  Identities=25%  Similarity=0.371  Sum_probs=167.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccC-CCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH-RNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ...|.++++||+|+||.+|.|....+|..||||+-.....  ...+..|.++.+.++| ..|..+..|..+..     +-
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~-----yn   86 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKD-----YN   86 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccc-----cc
Confidence            4689999999999999999999999999999998754433  2457789999999975 45555555544433     67


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC----cccccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQN  701 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~~~D  701 (854)
                      .+|||.. |.||++++.-..+     .++..+++.+|-|++.-++|+|.+   ++|||||||+|+|..-+    ...+||
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R-----~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSR-----RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhh-----hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence            8999998 7899999876543     789999999999999999999999   99999999999999654    345579


Q ss_pred             cccccccccCCCC----CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          702 FSLSHQLDSASKT----PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       702 fg~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      ||+|+.+.+....    ........||..|.+-....+...+.+.|+-|+|.++....-|..||++..
T Consensus       158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            9999988664332    222334679999999988888888999999999999999999999998753

>PLN03210 Resistant to P

Probab=99.89  E-value=1.9e-22  Score=249.68  Aligned_cols=336  Identities=21%  Similarity=0.272  Sum_probs=229.4

Q ss_pred             cCCcCccCCCCCcEEeccccc------CcccChhhhcCCC-CCceeeecccccccccCcccccCCCCCcEEEcccCCCCC
Q 043388           55 QIPTTLGLLRNLVYLNVAENQ------FSGMFPRWICNIS-SLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKN  127 (854)
Q Consensus        55 ~~~~~~~~l~~L~~L~Ls~N~------l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~  127 (854)
                      ..+.+|.+|++|+.|.+..+.      +...+|+.|..++ +|+.|++.+|.++ .+|...  ...+|++|++..|+++.
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~~  625 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLEK  625 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCccccc
Confidence            445678888888888886654      3334667777664 5888888888887 777653  34556666655555543


Q ss_pred             CceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEeccccc-ccCCCCCChhhhhhccC
Q 043388          128 LWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNN-LGMGTANDLDFVTLLTN  206 (854)
Q Consensus       128 L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~~~~  206 (854)
                                        +|..+..+++|+.|+|++|......| .++.+++|++|+|++|. +..       ++..+..
T Consensus       626 ------------------L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~-------lp~si~~  679 (1153)
T PLN03210        626 ------------------LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVE-------LPSSIQY  679 (1153)
T ss_pred             ------------------cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccc-------cchhhhc
Confidence                              45667778888888888875443444 47788888888888864 332       3345778


Q ss_pred             CCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCcee
Q 043388          207 CSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQL  286 (854)
Q Consensus       207 l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  286 (854)
                      +++|+.|++++|...+.+|..+ ++. +|+.|++++|.....+|..   .++|+.|+|++|.++. .|..+ .+++|+.|
T Consensus       680 L~~L~~L~L~~c~~L~~Lp~~i-~l~-sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L  752 (1153)
T PLN03210        680 LNKLEDLDMSRCENLEILPTGI-NLK-SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDEL  752 (1153)
T ss_pred             cCCCCEEeCCCCCCcCccCCcC-CCC-CCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccccc
Confidence            8888888888865444677655 443 6888888888665555543   3577888888888874 44444 57778888


Q ss_pred             eCcccccc-------ccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHH
Q 043388          287 YMFRNFLQ-------GSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYL  359 (854)
Q Consensus       287 ~L~~N~l~-------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l  359 (854)
                      ++.++...       ...+..+...++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|.            
T Consensus       753 ~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~------------  820 (1153)
T PLN03210        753 ILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT------------  820 (1153)
T ss_pred             cccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC------------
Confidence            77764322       11222233346788888888876667788888888888888887654334442            


Q ss_pred             HhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeee
Q 043388          360 ALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLN  439 (854)
Q Consensus       360 ~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  439 (854)
                                   .+ +       +.+|+.|+|++|..-..+|..   ..+|+.|+|++|.++ .+|.++..+++|+.|+
T Consensus       821 -------------~~-~-------L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~  875 (1153)
T PLN03210        821 -------------GI-N-------LESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLD  875 (1153)
T ss_pred             -------------CC-C-------ccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEE
Confidence                         21 1       456999999998655455543   468999999999998 7899999999999999


Q ss_pred             ccc-ccCcccCCCCccccCcccccc
Q 043388          440 LSY-NHLEGEVPTKGVFSNKTKISL  463 (854)
Q Consensus       440 ls~-N~l~~~~p~~~~~~~~~~~~~  463 (854)
                      |++ |+|.+..+....+.....+.+
T Consensus       876 L~~C~~L~~l~~~~~~L~~L~~L~l  900 (1153)
T PLN03210        876 MNGCNNLQRVSLNISKLKHLETVDF  900 (1153)
T ss_pred             CCCCCCcCccCcccccccCCCeeec
Confidence            998 667664443333444444443

syringae 6; Provisional

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=5.9e-23  Score=217.84  Aligned_cols=167  Identities=20%  Similarity=0.180  Sum_probs=127.0

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECC-CceEEEEEEeecc-----cccchHHHHHHHHHHHhccCCCeeeEEEEeeccC
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGG-EEMIVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLIKIITICSSID  618 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  618 (854)
                      ....+|.+.+.||+|+||+||+|.+.. +++.||||++...     .....+.+.+|++++++++|+|+++.+..+   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            345689999999999999999999875 6778899987532     122345689999999999999998533221   1


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC-CCCceEecCCcc
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDL-KPSNVLLDHDMV  697 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~  697 (854)
                           ..++||||++|++|... ...         .   ...++.|+++||+|||+.   +|+|||| ||+|||++.++.
T Consensus        92 -----~~~LVmE~~~G~~L~~~-~~~---------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~  150 (365)
T PRK09188         92 -----KDGLVRGWTEGVPLHLA-RPH---------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGE  150 (365)
T ss_pred             -----CcEEEEEccCCCCHHHh-Ccc---------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCC
Confidence                 36999999999999732 110         1   135788999999999999   9999999 999999987765


Q ss_pred             cc-cccccccccccCCCCCC-----cccccCCcccccCccccCC
Q 043388          698 AH-QNFSLSHQLDSASKTPS-----SSIGIKGTVGYVAPEYGMG  735 (854)
Q Consensus       698 ~~-~Dfg~~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~  735 (854)
                      .+ +|||+|+.+........     ......+++.|+|||++..
T Consensus       151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            55 49999998765432111     1134568899999998764

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=3.9e-22  Score=230.08  Aligned_cols=265  Identities=23%  Similarity=0.365  Sum_probs=192.5

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeee
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYL   95 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L   95 (854)
                      .+.++|+++++.++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|++ +|..+.  .+|+.|+|
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~L  248 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMEL  248 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEEC
Confidence            46789999999999 6787665  58999999999999 5676554  589999999999994 566553  47999999


Q ss_pred             cccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcc
Q 043388           96 TVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS  175 (854)
Q Consensus        96 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~  175 (854)
                      ++|+|+ .+|..+.   .+|+.|+++.|+|+                  .+|+.+.  ++|+.|+|++|+|+.++. .+.
T Consensus       249 s~N~L~-~LP~~l~---s~L~~L~Ls~N~L~------------------~LP~~l~--~sL~~L~Ls~N~Lt~LP~-~lp  303 (754)
T PRK15370        249 SINRIT-ELPERLP---SALQSLDLFHNKIS------------------CLPENLP--EELRYLSVYDNSIRTLPA-HLP  303 (754)
T ss_pred             cCCccC-cCChhHh---CCCCEEECcCCccC------------------ccccccC--CCCcEEECCCCccccCcc-cch
Confidence            999998 8886543   34555555555443                  3455442  478999999999986543 332


Q ss_pred             ccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccc
Q 043388          176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRN  255 (854)
Q Consensus       176 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~  255 (854)
                        ++|+.|++++|+++.++..         -.++|+.|++++|.++ .+|..+.   +.|+.|++++|+|+ .+|..+. 
T Consensus       304 --~sL~~L~Ls~N~Lt~LP~~---------l~~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~L~-~LP~~lp-  366 (754)
T PRK15370        304 --SGITHLNVQSNSLTALPET---------LPPGLKTLEAGENALT-SLPASLP---PELQVLDVSKNQIT-VLPETLP-  366 (754)
T ss_pred             --hhHHHHHhcCCccccCCcc---------ccccceeccccCCccc-cCChhhc---CcccEEECCCCCCC-cCChhhc-
Confidence              4788889999988765432         1257889999999988 5776554   47889999999988 4666553 


Q ss_pred             cccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccc----cCccccchhccccceecccCCCCCcCCCCC
Q 043388          256 LVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL----GNLTKLADLALSFNNLQGNIPSSLGNCQNL  331 (854)
Q Consensus       256 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  331 (854)
                       ++|+.|+|++|+|+.+ |..+.  ..|+.|++++|++. .+|..+    +.++.+..|++.+|.++.      ..+.+|
T Consensus       367 -~~L~~LdLs~N~Lt~L-P~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L  435 (754)
T PRK15370        367 -PTITTLDVSRNALTNL-PENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNM  435 (754)
T ss_pred             -CCcCEEECCCCcCCCC-CHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHH
Confidence             5889999999999854 44443  36888999999988 555544    345778889999998862      344555


Q ss_pred             cccccCCCcccC
Q 043388          332 KGFDASHNKLTG  343 (854)
Q Consensus       332 ~~L~ls~N~l~~  343 (854)
                      +.| ++.+.+.|
T Consensus       436 ~~L-l~s~~~~g  446 (754)
T PRK15370        436 QRL-MSSVGYQG  446 (754)
T ss_pred             HHh-hhcccccC
Confidence            555 34444443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=6.8e-22  Score=228.06  Aligned_cols=118  Identities=28%  Similarity=0.449  Sum_probs=53.7

Q ss_pred             CCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeC
Q 043388          209 SLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYM  288 (854)
Q Consensus       209 ~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  288 (854)
                      +|+.|+|++|+++ .+|..+.   +.|+.|++++|+++. +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++
T Consensus       284 sL~~L~Ls~N~Lt-~LP~~lp---~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~L  353 (754)
T PRK15370        284 ELRYLSVYDNSIR-TLPAHLP---SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDV  353 (754)
T ss_pred             CCcEEECCCCccc-cCcccch---hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEEC
Confidence            3444444444444 2333221   234445555555542 232221  345555555555553 233222  45555555


Q ss_pred             ccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCccc
Q 043388          289 FRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT  342 (854)
Q Consensus       289 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  342 (854)
                      ++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ..|+.|++++|+++
T Consensus       354 s~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~  401 (754)
T PRK15370        354 SKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV  401 (754)
T ss_pred             CCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc
Confidence            555555 3443332  35555555555555 2333332  24555555555554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.4e-22  Score=229.67  Aligned_cols=255  Identities=21%  Similarity=0.254  Sum_probs=187.9

Q ss_pred             ccCccCCCcceEEEEeEECCCceEEEEEEeecc--ccc----chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          552 SSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKG----AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       552 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ..+++|.|++|.|+.+........++.|.++..  ...    ....+..|+.+-..+.|+|++..+..+.+...     .
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----~  396 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----I  396 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----c
Confidence            357899999998888887666655666654321  111    11225567777788899999887776655442     2


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      .-+||||++ +|..++....      .++..++..+++|+..|++|+|+.   ||.|||+|++|++++.+++.++ |||.
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~  466 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGA  466 (601)
T ss_pred             hhhhhcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCc
Confidence            334999999 9999998763      678888999999999999999999   9999999999999999987776 9999


Q ss_pred             ccccccCCCC-CCcccccCCcccccCccccCCCCCCc-cchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          705 SHQLDSASKT-PSSSIGIKGTVGYVAPEYGMGSEASM-TGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       705 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      +..+..+... .....+++|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+..+.+..   ...+
T Consensus       467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~---~~~~  543 (601)
T KOG0590|consen  467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN---YSDQ  543 (601)
T ss_pred             ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc---cccc
Confidence            9877655432 23445688999999999999988866 57999999999999999999987654433321100   0000


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      . .                ............+.+...++.+|+++||.+|.|+.+|++.
T Consensus       544 ~-~----------------~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  544 R-N----------------IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             c-c----------------cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            0 0                0111122223446667789999999999999999999864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=6.3e-20  Score=199.88  Aligned_cols=260  Identities=29%  Similarity=0.415  Sum_probs=192.3

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc---chHHHHHHHHHHHhccCC-CeeeEEEEeeccCCCCCcee
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFRSFVAECEALRNIRHR-NLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~  625 (854)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+......   ....+.+|+.+++.+.|+ +++++++++....     ..
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-----SL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-----EE
Confidence            667789999999999999998   67899998654332   367899999999999988 7999999984433     37


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc--ccccccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM--VAHQNFS  703 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~~~Dfg  703 (854)
                      +++++|+.++++.+++......   ..++......++.|++.++.|+|+.   +++|||+||+||+++...  .+.+|||
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence            9999999999999777765321   2578889999999999999999999   999999999999999887  3445999


Q ss_pred             cccccccCCCCCC---cccccCCcccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccC--CchHhHHh
Q 043388          704 LSHQLDSASKTPS---SSIGIKGTVGYVAPEYGMG---SEASMTGDVYSFGILLLEMFTGRRPTDAAFTE--GLTLHEFV  775 (854)
Q Consensus       704 ~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~pf~~~~~~--~~~~~~~~  775 (854)
                      .+...........   ......||..|+|||...+   ..++...|+||+|++++++++|..||......  ........
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  227 (384)
T COG0515         148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII  227 (384)
T ss_pred             cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH
Confidence            9986655433221   2234679999999999987   57889999999999999999999997654321  11111111


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .............+..               .   ......+.+++..|+..+|..|.++.+....
T Consensus       228 ~~~~~~~~~~~~~~~~---------------~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         228 LELPTPSLASPLSPSN---------------P---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HhcCCcccccccCccc---------------c---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111110000000000               0   1113456788888999999999999887664

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=6.5e-21  Score=186.28  Aligned_cols=141  Identities=17%  Similarity=0.150  Sum_probs=108.4

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeeccccc--c-------hHH-----------------HHHHHHHHHhccCCC
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--A-------FRS-----------------FVAECEALRNIRHRN  606 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~n  606 (854)
                      ...||+|+||.||+|.+. +|+.||||+++.....  .       ...                 ..+|++++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999754211  0       011                 234999999998877


Q ss_pred             eeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeecC
Q 043388          607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDL  685 (854)
Q Consensus       607 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dl  685 (854)
                      +.....+..  .     ..++||||++++++........      .++..++..++.|++.+|+|+ |+.   +|+||||
T Consensus        81 v~~p~~~~~--~-----~~~iVmE~i~g~~l~~~~~~~~------~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl  144 (190)
T cd05147          81 IPCPEPILL--K-----SHVLVMEFIGDDGWAAPRLKDA------PLSESKARELYLQVIQIMRILYQDC---RLVHADL  144 (190)
T ss_pred             CCCCcEEEe--c-----CCEEEEEEeCCCCCcchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence            643332211  1     2389999999987765433222      678899999999999999999 687   9999999


Q ss_pred             CCCceEecCCccccccccccccccc
Q 043388          686 KPSNVLLDHDMVAHQNFSLSHQLDS  710 (854)
Q Consensus       686 kp~NIll~~~~~~~~Dfg~~~~~~~  710 (854)
                      ||+||+++.+.++++|||+|.....
T Consensus       145 kP~NIli~~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         145 SEYNLLYHDGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CHHHEEEECCcEEEEEccccccCCC
Confidence            9999999977777789999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=1.3e-21  Score=219.30  Aligned_cols=249  Identities=22%  Similarity=0.281  Sum_probs=175.9

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHH--HHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEA--LRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +|...+.+|++.|=.|.+|+++ .|. |+||++-... .-..+.|.++++-  ...++|||++++.-+.....     ..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~k-----AA   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDK-----AA   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhH-----HH
Confidence            6777899999999999999998 454 9999996544 2233444444433  44458999999887754433     57


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      |||-+|+.+ +|+|.+..+.      .+...+.+.|+.|++.||..+|..   ||+|||||.+||||+.-.-..+ ||..
T Consensus        97 ylvRqyvkh-nLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAs  166 (1431)
T KOG1240|consen   97 YLVRQYVKH-NLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFAS  166 (1431)
T ss_pred             HHHHHHHhh-hhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccc
Confidence            899999977 9999998765      678888999999999999999999   9999999999999988654444 9976


Q ss_pred             ccccccCCCCCCccccc----CCcccccCccccCCC----------C-CCccchhHHHHHHHHHHHh-CCCCCCCcccCC
Q 043388          705 SHQLDSASKTPSSSIGI----KGTVGYVAPEYGMGS----------E-ASMTGDVYSFGILLLEMFT-GRRPTDAAFTEG  768 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~----~gt~~y~aPE~~~~~----------~-~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~  768 (854)
                      -+...-+...+.....+    ..-..|.|||.+...          . .+++.||||+|||++|+++ |++||.-.    
T Consensus       167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----  242 (1431)
T KOG1240|consen  167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----  242 (1431)
T ss_pred             cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----
Confidence            55432222222111111    123469999976431          1 5788999999999999999 89998632    


Q ss_pred             chHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       769 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                       .+..|...       ...|++...+              .+++  ..+..++..|++.||++|.++++.++.-
T Consensus       243 -QL~aYr~~-------~~~~~e~~Le--------------~Ied--~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  243 -QLLAYRSG-------NADDPEQLLE--------------KIED--VSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             -HHHhHhcc-------CccCHHHHHH--------------hCcC--ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence             12222111       0112111111              1111  2367889999999999999999999873

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=2.5e-21  Score=190.17  Aligned_cols=175  Identities=17%  Similarity=0.174  Sum_probs=132.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchH---H------HHHHHHHHHhccCCCeeeEEEEeecc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR---S------FVAECEALRNIRHRNLIKIITICSSI  617 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~~~~~~~~~  617 (854)
                      ..+|++.+++|.|+||.||.+..  ++..+|+|+++........   .      +.+|+..+.++.|++|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            46899999999999999999765  3557999999754333222   2      67999999999999999999986654


Q ss_pred             CCCC---CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC
Q 043388          618 DSKG---ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH  694 (854)
Q Consensus       618 ~~~~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~  694 (854)
                      ....   ....++||||++|.+|.++..          ++.    ....+++.++..+|+.   |++|||+||+||+++.
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~  170 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK  170 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence            3111   224789999999999988732          222    2456999999999999   9999999999999999


Q ss_pred             CcccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHH
Q 043388          695 DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMF  755 (854)
Q Consensus       695 ~~~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ell  755 (854)
                      +++.++|||...........               ..+.....+..++|+|||||++....
T Consensus       171 ~gi~liDfg~~~~~~e~~a~---------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NGLRIIDLSGKRCTAQRKAK---------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCEEEEECCCcccccchhhH---------------HHHHHHhHhcccccccceeEeehHHH
Confidence            88766799987655322111               11344455678999999999987554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.9e-20  Score=187.98  Aligned_cols=202  Identities=20%  Similarity=0.240  Sum_probs=140.5

Q ss_pred             cCCCeeeEEEEeeccCC----------------------CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHH
Q 043388          603 RHRNLIKIITICSSIDS----------------------KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN  660 (854)
Q Consensus       603 ~h~niv~~~~~~~~~~~----------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~  660 (854)
                      +|||||++.++|.+.-.                      ......|+||..++. +|.+++...       ..+...+..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-------~~s~r~~~~  345 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-------HRSYRTGRV  345 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-------CCchHHHHH
Confidence            59999999988754321                      123347899999877 999999876       345667778


Q ss_pred             HHHHHHHHHHHHHhcCCCCeEeecCCCCceEe--cCCcccc--c-ccccccccccCC---CCCCcccccCCcccccCccc
Q 043388          661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL--DHDMVAH--Q-NFSLSHQLDSAS---KTPSSSIGIKGTVGYVAPEY  732 (854)
Q Consensus       661 i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~~--~-Dfg~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~  732 (854)
                      |+.|++.|+.|||.+   ||.|||+|++||++  |+|..+.  + |||++--.+...   ...+......|...-||||+
T Consensus       346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            999999999999999   99999999999999  4444333  3 999875443311   11112223457888999998


Q ss_pred             cCCCC------CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhh
Q 043388          733 GMGSE------ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDR  806 (854)
Q Consensus       733 ~~~~~------~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~  806 (854)
                      ....+      --.|+|.|+.|.+.||+++...||........+...|.+...                           
T Consensus       423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL---------------------------  475 (598)
T KOG4158|consen  423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL---------------------------  475 (598)
T ss_pred             hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC---------------------------
Confidence            75422      245899999999999999999999753211111111111111                           


Q ss_pred             hhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          807 RARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       807 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                      +..++.|+..+.+++...++.||.+|++..-....+
T Consensus       476 Palp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  476 PALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             CCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence            112334466678899999999999999976554443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=2.3e-19  Score=176.37  Aligned_cols=141  Identities=20%  Similarity=0.195  Sum_probs=108.5

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecccccc--------------------------hHHHHHHHHHHHhccCCC
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--------------------------FRSFVAECEALRNIRHRN  606 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n  606 (854)
                      ...||+|++|.||+|.+. +|+.||||+++......                          ...+.+|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999988 89999999997542110                          112357899999999998


Q ss_pred             eeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecC
Q 043388          607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPIVHGDL  685 (854)
Q Consensus       607 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dl  685 (854)
                      +.....+...       ..++||||++|+++........      .++..++..++.|++.++.|+|+ .   ||+||||
T Consensus        81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~------~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDl  144 (190)
T cd05145          81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDV------PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDL  144 (190)
T ss_pred             CCCceEEEec-------CCEEEEEEecCCCchhhhhhhc------cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCC
Confidence            7544443322       2389999999886544322221      56778899999999999999999 8   9999999


Q ss_pred             CCCceEecCCccccccccccccccc
Q 043388          686 KPSNVLLDHDMVAHQNFSLSHQLDS  710 (854)
Q Consensus       686 kp~NIll~~~~~~~~Dfg~~~~~~~  710 (854)
                      ||+||+++.+.++++|||++.....
T Consensus       145 kP~NIll~~~~~~liDFG~a~~~~~  169 (190)
T cd05145         145 SEYNILYHDGKPYIIDVSQAVELDH  169 (190)
T ss_pred             ChhhEEEECCCEEEEEcccceecCC
Confidence            9999999955555669999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=1.9e-19  Score=182.45  Aligned_cols=239  Identities=20%  Similarity=0.286  Sum_probs=152.3

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhcc----------CCCeeeEEEEee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIR----------HRNLIKIITICS  615 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~~~~~~~  615 (854)
                      .+...+.||.|+++.||.+++..+++.+|||++....   ....+++++|.-....+.          |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4566789999999999999999999999999996443   234566666665444432          112222122211


Q ss_pred             ccC---------CCCCc---eeeEEEeeccCCCHHHHhhh---cCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 043388          616 SID---------SKGAD---FKALVFEYMENGSLEDWLHQ---SNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPI  680 (854)
Q Consensus       616 ~~~---------~~~~~---~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~i  680 (854)
                      ...         .....   ..+++|+-+.+ +|.+++..   ....  ........+..+..|+++.+++||+.   |+
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl  166 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSY---GL  166 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence            110         00001   23678888854 88888654   2111  12455566677889999999999999   99


Q ss_pred             EeecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCC--------CCCCccchhHHHHHHH
Q 043388          681 VHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG--------SEASMTGDVYSFGILL  751 (854)
Q Consensus       681 vH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~slGvvl  751 (854)
                      +|+||||+|++++.++...+ ||+.....+.....      ...+..|.|||....        ..++.+.|.|++|+++
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l  240 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL  240 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceeec------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence            99999999999999998888 99887766553322      124578999997533        2478899999999999


Q ss_pred             HHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCC
Q 043388          752 LEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFE  831 (854)
Q Consensus       752 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~  831 (854)
                      |.|+||+.||+...........+                      ..|           .+.++.+..++..+++.+|++
T Consensus       241 y~lWC~~lPf~~~~~~~~~~~~f----------------------~~C-----------~~~Pe~v~~LI~~lL~~~~~~  287 (288)
T PF14531_consen  241 YSLWCGRLPFGLSSPEADPEWDF----------------------SRC-----------RDMPEPVQFLIRGLLQRNPED  287 (288)
T ss_dssp             HHHHHSS-STCCCGGGSTSGGGG----------------------TTS-----------S---HHHHHHHHHHT-SSGGG
T ss_pred             HHHHHccCCCCCCCccccccccc----------------------hhc-----------CCcCHHHHHHHHHHccCCccc
Confidence            99999999998553321111000                      000           133677899999999999998


Q ss_pred             C
Q 043388          832 R  832 (854)
Q Consensus       832 R  832 (854)
                      |
T Consensus       288 R  288 (288)
T PF14531_consen  288 R  288 (288)
T ss_dssp             S
T ss_pred             C
Confidence            8

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.78  E-value=1.2e-20  Score=203.45  Aligned_cols=274  Identities=21%  Similarity=0.229  Sum_probs=128.6

Q ss_pred             cCchhhhcCCCCCEEecccccccc----cCCccccCcCCCCeeeccccccc------ccCCcCccCCCCCcEEecccccC
Q 043388            7 QIPEEIGSLLNLQTLAIDFNYLTG----QLPDFVGNLSALGMLLIRWNSLG------GQIPTTLGLLRNLVYLNVAENQF   76 (854)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~------~~~~~~~~~l~~L~~L~Ls~N~l   76 (854)
                      ..+..|..+.+|++|+|++|.++.    .++..+...+.|++|+++++.+.      ..++..|..+++|++|+|++|.+
T Consensus        14 ~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~   93 (319)
T cd00116          14 RATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNAL   93 (319)
T ss_pred             chHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCC
Confidence            344555555566666666666532    23444555555666666666554      12233445555666666666666


Q ss_pred             cccChhhhcCCCC---CceeeecccccccccCc----ccccCC-CCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCc
Q 043388           77 SGMFPRWICNISS---LEFIYLTVNRFSGSLPF----DILVNL-PNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPD  148 (854)
Q Consensus        77 ~~~~p~~~~~l~~---L~~L~L~~N~l~~~~~~----~~~~~l-~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~  148 (854)
                      .+..+..+..+.+   |++|++++|++++ .+.    ..+..+ ++|++|+++.|.++             ......++.
T Consensus        94 ~~~~~~~~~~l~~~~~L~~L~ls~~~~~~-~~~~~l~~~l~~~~~~L~~L~L~~n~l~-------------~~~~~~~~~  159 (319)
T cd00116          94 GPDGCGVLESLLRSSSLQELKLNNNGLGD-RGLRLLAKGLKDLPPALEKLVLGRNRLE-------------GASCEALAK  159 (319)
T ss_pred             ChhHHHHHHHHhccCcccEEEeeCCccch-HHHHHHHHHHHhCCCCceEEEcCCCcCC-------------chHHHHHHH
Confidence            5445555544444   6666666665541 100    111222 33333333333322             111112333


Q ss_pred             cccCCCCCCEEecCCCcCccc----CCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccC
Q 043388          149 SLSNASNLERLDLSGNQFKGK----VSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGEL  224 (854)
Q Consensus       149 ~~~~l~~L~~L~Ls~N~i~~~----~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  224 (854)
                      .+..+++|++|+|++|.+++.    .+..+..+++|++|+|++|.++.....  .+...+..+++|++|++++|.+++..
T Consensus       160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--~l~~~~~~~~~L~~L~ls~n~l~~~~  237 (319)
T cd00116         160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--ALAETLASLKSLEVLNLGDNNLTDAG  237 (319)
T ss_pred             HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH--HHHHHhcccCCCCEEecCCCcCchHH
Confidence            444555555666655555521    112233334555555555555422211  22233444555555555555554322


Q ss_pred             ChhhhhhcccccEEEccCCcccccCCccccccccCCeeecccccccc----CCCCCccCcccCceeeCcccccccc----
Q 043388          225 PHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHG----IIPDGVGELQHLQQLYMFRNFLQGS----  296 (854)
Q Consensus       225 p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----  296 (854)
                      ...+....                    ....+.|++|++++|.++.    .....+..+++|+++++++|.+...    
T Consensus       238 ~~~l~~~~--------------------~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~  297 (319)
T cd00116         238 AAALASAL--------------------LSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQL  297 (319)
T ss_pred             HHHHHHHH--------------------hccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHH
Confidence            22221110                    0012456666666666641    1122344456677777777776633    


Q ss_pred             CCccccCc-cccchhccccce
Q 043388          297 IPPSLGNL-TKLADLALSFNN  316 (854)
Q Consensus       297 ~~~~~~~l-~~L~~L~L~~N~  316 (854)
                      ....+... +.|+.|++.+|.
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         298 LAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHHHhhcCCchhhcccCCCC
Confidence            23333333 566777766664

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=9.9e-19  Score=201.30  Aligned_cols=199  Identities=22%  Similarity=0.274  Sum_probs=154.6

Q ss_pred             HHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc---CCCeeeEEEEeeccCC
Q 043388          543 LSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR---HRNLIKIITICSSIDS  619 (854)
Q Consensus       543 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~  619 (854)
                      ....-..|.+.+.||+|+||.||+|.... |+.||+|+-+......   |.-=.+++.+|+   -+-|+.+...+...+ 
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~-  767 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN-  767 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC-
Confidence            33445678999999999999999999985 9999999987654332   111223344444   123333333333333 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC-----
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-----  694 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----  694 (854)
                          .-++|+||.+.|+|.+++...+      .++|.-.+.++.|+++-+++||..   +|||+||||+|.|+..     
T Consensus       768 ----~S~lv~ey~~~Gtlld~~N~~~------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~  834 (974)
T KOG1166|consen  768 ----ASVLVSEYSPYGTLLDLINTNK------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICAD  834 (974)
T ss_pred             ----cceeeeeccccccHHHhhccCC------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCC
Confidence                3589999999999999999554      788999999999999999999999   9999999999999943     


Q ss_pred             ---CcccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 043388          695 ---DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP  760 (854)
Q Consensus       695 ---~~~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p  760 (854)
                         .+.++||||.+..+.--... ....+.++|-.+-.+|+..|..+++.+|-|.++.+++.|+.|+.-
T Consensus       835 ~~~~~l~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  835 SDSKGLYLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             CcccceEEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence               25667799999877554333 233456789999999999999999999999999999999999753

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=1.9e-18  Score=165.66  Aligned_cols=187  Identities=14%  Similarity=0.083  Sum_probs=135.8

Q ss_pred             cccCccCCCcceEEEEeEECCCceEEEEEEeeccccc----chHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCcee
Q 043388          551 ASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG----AFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       551 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .+...|++|+||+||.+..  .+..++.+.+.....-    ....+.+|+++|+++. |+++++++++.         ..
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence            4567899999999997766  4667777766543321    1225789999999995 58899998862         35


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC-CCCceEecCCcccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDL-KPSNVLLDHDMVAH-QNFS  703 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~~-~Dfg  703 (854)
                      +++|||++|.+|.+....             ....++.|++.+|+++|+.   ||+|||| ||+||+++.++..+ +|||
T Consensus        74 ~lvmeyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             EEEEeeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence            899999999998754321             0134678999999999999   9999999 79999998776544 5999


Q ss_pred             cccccccCCCC----C-Cc-----ccccCCcccccCccccCCC-CCC-ccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          704 LSHQLDSASKT----P-SS-----SIGIKGTVGYVAPEYGMGS-EAS-MTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       704 ~~~~~~~~~~~----~-~~-----~~~~~gt~~y~aPE~~~~~-~~~-~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ++.........    . ..     ......++.|++|+...-. ..+ .+.+.++-|+-+|.++||..|+...
T Consensus       138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            99865543310    0 00     0112367788888754332 233 5679999999999999999987654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=1.3e-18  Score=187.55  Aligned_cols=215  Identities=27%  Similarity=0.384  Sum_probs=160.5

Q ss_pred             HHhccCCCeeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCC
Q 043388          599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQP  678 (854)
Q Consensus       599 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~  678 (854)
                      |+.+.|.|+.+++|.+....     ..++|.+||..|+|.+.+.....     .+++.-...+.++|+.||+|+|+.   
T Consensus         1 l~~l~h~n~~~f~g~~~~~~-----~~~~i~~~c~rGsl~D~i~~~~~-----~~d~~F~~s~~rdi~~Gl~ylh~s---   67 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGP-----EMIVIWEYCSRGSLLDILSNEDI-----KLDYFFILSFIRDISKGLAYLHNS---   67 (484)
T ss_pred             CcccchhhhhhheeeEecCC-----ceEEEEeeecCccHHhHHhcccc-----CccHHHHHHHHHHHHHHHHHHhcC---
Confidence            35678999999999998764     68999999999999999987432     788888999999999999999998   


Q ss_pred             Ce-EeecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCC-------CCCccchhHHHHH
Q 043388          679 PI-VHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-------EASMTGDVYSFGI  749 (854)
Q Consensus       679 ~i-vH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~slGv  749 (854)
                      +| .|+.+++.|.++|...+.++ |||+.......... .......-...|.|||.+.+.       ..+.+.||||||+
T Consensus        68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~-~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~i  146 (484)
T KOG1023|consen   68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEP-EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGI  146 (484)
T ss_pred             cceeeeeeccccceeeeeEEEEechhhhcccccccccc-cccchhHHHHhccCHHHhcccccccccccccccCCeehHHH
Confidence            55 99999999999999999998 99998777531111 111112245679999998763       1467899999999


Q ss_pred             HHHHHHhCCCCCCCcccCCch--HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCC
Q 043388          750 LLLEMFTGRRPTDAAFTEGLT--LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSME  827 (854)
Q Consensus       750 vl~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  827 (854)
                      +++|+++.+.||+........  ....+..    ......-|....                ..+..+++..++.+||..
T Consensus       147 i~~ei~~r~~~~~~~~~~~~~~eii~~~~~----~~~~~~rP~i~~----------------~~e~~~~l~~l~~~cw~e  206 (484)
T KOG1023|consen  147 IMYEILFRSGPFDLRNLVEDPDEIILRVKK----GGSNPFRPSIEL----------------LNELPPELLLLVARCWEE  206 (484)
T ss_pred             HHHHHHhccCccccccccCChHHHHHHHHh----cCCCCcCcchhh----------------hhhcchHHHHHHHHhccc
Confidence            999999999999875433221  2222221    011111111100                012344688999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhhh
Q 043388          828 SPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       828 dP~~RPs~~evl~~L~~~~~  847 (854)
                      +|++||++++|-..++.+..
T Consensus       207 ~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  207 IPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ChhhCccHHHHHhhhhhhcc
Confidence            99999999999988877655

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=1.8e-20  Score=202.09  Aligned_cols=284  Identities=20%  Similarity=0.214  Sum_probs=156.4

Q ss_pred             EEeccccccc-ccCCccccCcCCCCeeecccccccc----cCCcCccCCCCCcEEecccccCcc------cChhhhcCCC
Q 043388           20 TLAIDFNYLT-GQLPDFVGNLSALGMLLIRWNSLGG----QIPTTLGLLRNLVYLNVAENQFSG------MFPRWICNIS   88 (854)
Q Consensus        20 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~   88 (854)
                      .|+|..+.++ +.....+..+.+|+.|++++|.++.    .++..+...++|++|++++|.+.+      .++.++..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            5778888887 3455567777788888888888843    245556677778888888887762      3445667777


Q ss_pred             CCceeeecccccccccCcccccCCCC---CcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCC-CCCCEEecCCC
Q 043388           89 SLEFIYLTVNRFSGSLPFDILVNLPN---LKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNA-SNLERLDLSGN  164 (854)
Q Consensus        89 ~L~~L~L~~N~l~~~~~~~~~~~l~~---L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l-~~L~~L~Ls~N  164 (854)
                      +|+.|+|++|.+.+ .....|..+.+   |++|+++.|++.             ......+...+..+ ++|+.|+|++|
T Consensus        82 ~L~~L~l~~~~~~~-~~~~~~~~l~~~~~L~~L~ls~~~~~-------------~~~~~~l~~~l~~~~~~L~~L~L~~n  147 (319)
T cd00116          82 GLQELDLSDNALGP-DGCGVLESLLRSSSLQELKLNNNGLG-------------DRGLRLLAKGLKDLPPALEKLVLGRN  147 (319)
T ss_pred             ceeEEEccCCCCCh-hHHHHHHHHhccCcccEEEeeCCccc-------------hHHHHHHHHHHHhCCCCceEEEcCCC
Confidence            88888888887762 22223333322   444444433332             11111222334444 56666666666


Q ss_pred             cCccc----CCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEc
Q 043388          165 QFKGK----VSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI  240 (854)
Q Consensus       165 ~i~~~----~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l  240 (854)
                      .+++.    .+..|..+++|++|++++|.++....  ..+...+..+++|++|+|++|.+++..+.              
T Consensus       148 ~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~--~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--------------  211 (319)
T cd00116         148 RLEGASCEALAKALRANRDLKELNLANNGIGDAGI--RALAEGLKANCNLEVLDLNNNGLTDEGAS--------------  211 (319)
T ss_pred             cCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHH--HHHHHHHHhCCCCCEEeccCCccChHHHH--------------
Confidence            66521    12233344445555555554432100  01122233334444444444444321111              


Q ss_pred             cCCcccccCCccccccccCCeeeccccccccCCCCCcc-----CcccCceeeCccccccc----cCCccccCccccchhc
Q 043388          241 GGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVG-----ELQHLQQLYMFRNFLQG----SIPPSLGNLTKLADLA  311 (854)
Q Consensus       241 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~  311 (854)
                             .++..+..+++|++|++++|++++.....+.     ..+.|++|++++|.++.    .+...+..+++|+.++
T Consensus       212 -------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~  284 (319)
T cd00116         212 -------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELD  284 (319)
T ss_pred             -------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEE
Confidence                   1223345567788888888877643222221     23678888888887761    2334455567778888


Q ss_pred             cccceeccc----CCCCCcCC-CCCcccccCCCc
Q 043388          312 LSFNNLQGN----IPSSLGNC-QNLKGFDASHNK  340 (854)
Q Consensus       312 L~~N~l~~~----~~~~~~~l-~~L~~L~ls~N~  340 (854)
                      +++|.++..    ....+... +.|+.+++.+|.
T Consensus       285 l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         285 LRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             CCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence            888887743    33333334 567777777665

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=4.9e-18  Score=167.09  Aligned_cols=138  Identities=13%  Similarity=0.195  Sum_probs=105.4

Q ss_pred             cccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-----cCCCeeeEEEEeeccCCCCCce-
Q 043388          551 ASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-----RHRNLIKIITICSSIDSKGADF-  624 (854)
Q Consensus       551 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~-  624 (854)
                      ...+.||+|+||.||.  +..++.. +||++........+.+.+|+.+++.+     .||||++++|++.+..+  ... 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g--~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG--TGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC--CeEE
Confidence            4467899999999995  6555554 69988765555567899999999999     57999999999987542  223 


Q ss_pred             eeEEEee--ccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeecCCCCceEecCC-----c
Q 043388          625 KALVFEY--MENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI-EYLHHHCQPPIVHGDLKPSNVLLDHD-----M  696 (854)
Q Consensus       625 ~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlkp~NIll~~~-----~  696 (854)
                      ..+||||  +++|+|.+++.+.       .+++.  ..++.|++.++ +|||++   +|+||||||+||+++..     .
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence            3478999  6679999999653       23433  35677888777 999999   99999999999999742     3


Q ss_pred             ccccccccc
Q 043388          697 VAHQNFSLS  705 (854)
Q Consensus       697 ~~~~Dfg~~  705 (854)
                      .+++||+.+
T Consensus       148 ~~LiDg~G~  156 (210)
T PRK10345        148 PVVCDNIGE  156 (210)
T ss_pred             EEEEECCCC
Confidence            445585433

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.75  E-value=6.2e-20  Score=163.28  Aligned_cols=165  Identities=30%  Similarity=0.537  Sum_probs=108.2

Q ss_pred             ccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCc
Q 043388          253 IRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLK  332 (854)
Q Consensus       253 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  332 (854)
                      +..+++++.|.||+|+++ .+|..+..+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. +.|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            445667777777777777 44555777777777777777777 67777777777777777777776 6777777777777


Q ss_pred             ccccCCCcccC-ccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCC
Q 043388          333 GFDASHNKLTG-AIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSI  411 (854)
Q Consensus       333 ~L~ls~N~l~~-~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L  411 (854)
                      +|||++|++.. .+|..|+.++++.. +.++.|.+. .+|..++++       .+|+.|.+..|.+- ..|..++.+.+|
T Consensus       106 vldltynnl~e~~lpgnff~m~tlra-lyl~dndfe-~lp~dvg~l-------t~lqil~lrdndll-~lpkeig~lt~l  175 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRA-LYLGDNDFE-ILPPDVGKL-------TNLQILSLRDNDLL-SLPKEIGDLTRL  175 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHH-HHhcCCCcc-cCChhhhhh-------cceeEEeeccCchh-hCcHHHHHHHHH
Confidence            77777777753 45666666555544 555555542 455555553       34566666666665 456666666666


Q ss_pred             CEEEccCcccccccchhhcC
Q 043388          412 KELNVSSNNLSGQIPEFLQN  431 (854)
Q Consensus       412 ~~L~Ls~N~l~~~~p~~~~~  431 (854)
                      ++|++.+|+++ .+|..+++
T Consensus       176 relhiqgnrl~-vlppel~~  194 (264)
T KOG0617|consen  176 RELHIQGNRLT-VLPPELAN  194 (264)
T ss_pred             HHHhcccceee-ecChhhhh
Confidence            66666666666 44444443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.74  E-value=2.3e-20  Score=166.02  Aligned_cols=166  Identities=29%  Similarity=0.429  Sum_probs=95.2

Q ss_pred             hcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCce
Q 043388           13 GSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEF   92 (854)
Q Consensus        13 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~   92 (854)
                      .++.+++.|.||+|+++ .+|..+.++.+|++|++.+|+|. .+|..++.+++|+.|+++-|++. +.|..|+.++.|+.
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence            34455666666666666 55556666666666666666666 55666666666666666666666 56666666666666


Q ss_pred             eeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCc
Q 043388           93 IYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSI  172 (854)
Q Consensus        93 L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~  172 (854)
                      |||+.|++..                                         ..+|..|..|+.|+-|+|++|.+. +.|.
T Consensus       107 ldltynnl~e-----------------------------------------~~lpgnff~m~tlralyl~dndfe-~lp~  144 (264)
T KOG0617|consen  107 LDLTYNNLNE-----------------------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPP  144 (264)
T ss_pred             hhcccccccc-----------------------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCCh
Confidence            6666665542                                         223555555555555555555554 4444


Q ss_pred             CccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhh
Q 043388          173 DFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANL  231 (854)
Q Consensus       173 ~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  231 (854)
                      ..+.+++|+.|.+..|.+-+++       ..+..+..|+.|++.+|+++ .+|..++++
T Consensus       145 dvg~lt~lqil~lrdndll~lp-------keig~lt~lrelhiqgnrl~-vlppel~~l  195 (264)
T KOG0617|consen  145 DVGKLTNLQILSLRDNDLLSLP-------KEIGDLTRLRELHIQGNRLT-VLPPELANL  195 (264)
T ss_pred             hhhhhcceeEEeeccCchhhCc-------HHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence            5555555555555555553322       23445555556666666665 555554443

>smart00090 RIO RIO-like kinase

Probab=99.73  E-value=1.8e-17  Score=167.61  Aligned_cols=144  Identities=22%  Similarity=0.203  Sum_probs=109.9

Q ss_pred             hccccCccCCCcceEEEEeE-ECCCceEEEEEEeeccccc------------------------chHHHHHHHHHHHhcc
Q 043388          549 EFASSNMIGQGSFGSVYKGI-LGGEEMIVAVKVINLKQKG------------------------AFRSFVAECEALRNIR  603 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  603 (854)
                      -|.+.+.||+|++|.||+|. +..+|+.||+|+++.....                        ....+.+|++++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 5568999999999753210                        0123568999999997


Q ss_pred             CC--CeeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC-e
Q 043388          604 HR--NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP-I  680 (854)
Q Consensus       604 h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~-i  680 (854)
                      +.  .+.+++++.         ..++||||++++++..+.....      .....+...++.|++.+++|||+.   + |
T Consensus       109 ~~~i~~p~~~~~~---------~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---g~i  170 (237)
T smart00090      109 EAGVPVPKPIAWR---------RNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYKE---GEL  170 (237)
T ss_pred             hcCCCCCeeeEec---------CceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHhc---CCE
Confidence            53  344555431         2479999999988877653322      345566788999999999999999   8 9


Q ss_pred             EeecCCCCceEecCCccccccccccccccc
Q 043388          681 VHGDLKPSNVLLDHDMVAHQNFSLSHQLDS  710 (854)
Q Consensus       681 vH~Dlkp~NIll~~~~~~~~Dfg~~~~~~~  710 (854)
                      +||||||+||+++.+..+++|||.+.....
T Consensus       171 iH~Dikp~NIli~~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      171 VHGDLSEYNILVHDGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EeCCCChhhEEEECCCEEEEEChhhhccCC
Confidence            999999999999955556669998875443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=6.9e-19  Score=188.83  Aligned_cols=186  Identities=25%  Similarity=0.283  Sum_probs=153.3

Q ss_pred             ccCCCcceEEEEeEE---CCCceEEEEEEeeccccc--chHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCceeeEE
Q 043388          555 MIGQGSFGSVYKGIL---GGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       555 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      ++|+|.||.|+.+.-   ...+..+|+|+.+.....  .......|..++...+ ||.+|++...+....     ..+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-----kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-----KLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-----chhHh
Confidence            479999999987643   335677899988643211  1124556778888886 999999988876655     57899


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQ  707 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~  707 (854)
                      ++|..||.+...+....      .+++.........+|-|++++|+.   +|+|||+|++||+++.++..+. |||.++.
T Consensus        76 ld~~rgg~lft~l~~~~------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske  146 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEV------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE  146 (612)
T ss_pred             hhhcccchhhhccccCC------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence            99999999998887765      677778888889999999999999   9999999999999999996666 9999987


Q ss_pred             cccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 043388          708 LDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA  763 (854)
Q Consensus       708 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~  763 (854)
                      .-.....       +||..|||||++.  ....++|-||||++++||+||..||..
T Consensus       147 ~v~~~~~-------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  147 AVKEKIA-------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hHhhhhc-------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            7654433       6999999999988  467789999999999999999999975

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=1.1e-18  Score=183.56  Aligned_cols=124  Identities=29%  Similarity=0.497  Sum_probs=105.9

Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      +.||.|++|+..+|.+|+...+..   ...++.....++.|++.|++|   +   +.+|||+||.||++..+...+| ||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~---e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTG---EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcc---cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhh
Confidence            578999999999999999865432   366788899999999999999   6   8999999999999988887777 99


Q ss_pred             ccccccccCCC---CCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh
Q 043388          703 SLSHQLDSASK---TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT  756 (854)
Q Consensus       703 g~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt  756 (854)
                      |+.........   .....+...||..||+||.+.+..|+.|+||||+|++++|++.
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            99887765541   1223344679999999999999999999999999999999997

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=8.4e-17  Score=162.00  Aligned_cols=134  Identities=19%  Similarity=0.301  Sum_probs=107.6

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccccc--------chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--------AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +.||+|++|.||+|.+  .+..|++|+.......        ....+.+|++++..+.|+++.....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5799999999999988  4566889986533211        1235778999999999998876666654433     46


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccccccccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLS  705 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg~~  705 (854)
                      ++||||++|++|.+++....         + ++..++.+++.+|+++|+.   +++|||++|+||+++.+.+.++|||.+
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~~~~~~liDf~~a  141 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG---------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILSGGKIYLIDFGLA  141 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEECCCEEEEECCcc
Confidence            89999999999999986432         1 7788999999999999999   999999999999999666666799987


Q ss_pred             cc
Q 043388          706 HQ  707 (854)
Q Consensus       706 ~~  707 (854)
                      ..
T Consensus       142 ~~  143 (211)
T PRK14879        142 EF  143 (211)
T ss_pred             cC
Confidence            64

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=2.7e-16  Score=180.13  Aligned_cols=146  Identities=22%  Similarity=0.291  Sum_probs=111.8

Q ss_pred             cHHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEe--ecccc------cchHHHHHHHHHHHhccCCCeeeE
Q 043388          539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI--NLKQK------GAFRSFVAECEALRNIRHRNLIKI  610 (854)
Q Consensus       539 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~--~~~~~------~~~~~~~~E~~~l~~l~h~niv~~  610 (854)
                      ++.........|...+.||+|+||.||+|.+.+..  +++|+.  +....      ...+++.+|++++.+++|++++..
T Consensus       324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p  401 (535)
T PRK09605        324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP  401 (535)
T ss_pred             eeccccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence            34444444555677899999999999999987443  344432  21111      123568899999999999999887


Q ss_pred             EEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCce
Q 043388          611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV  690 (854)
Q Consensus       611 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  690 (854)
                      ..++....     ..++||||+++++|.+++.              ....++.+++.+|.|||+.   +++|||+||+||
T Consensus       402 ~~~~~~~~-----~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NI  459 (535)
T PRK09605        402 VIYDVDPE-----EKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNF  459 (535)
T ss_pred             EEEEEeCC-----CCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHE
Confidence            77665533     4589999999999998875              2457899999999999999   999999999999


Q ss_pred             EecCCccccccccccccc
Q 043388          691 LLDHDMVAHQNFSLSHQL  708 (854)
Q Consensus       691 ll~~~~~~~~Dfg~~~~~  708 (854)
                      +++.+.++++|||+++..
T Consensus       460 Ll~~~~~~liDFGla~~~  477 (535)
T PRK09605        460 IVRDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEECCcEEEEeCcccccC
Confidence            997666676799998653

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=3.6e-16  Score=155.76  Aligned_cols=130  Identities=24%  Similarity=0.340  Sum_probs=100.3

Q ss_pred             ccCCCcceEEEEeEECCCceEEEEEEeeccc--cc------chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KG------AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       555 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .||+|+||.||+|.+.  +..|++|+.....  ..      ...++.+|++++..+.|+++.....++....     ..+
T Consensus         1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT   73 (199)
T ss_pred             CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence            4899999999999964  5679999864321  11      1245778999999998876544333333322     358


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccccccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSH  706 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg~~~  706 (854)
                      +||||++|++|.+++....      .       .++.+++.+|+++|+.   +++|||++|+||+++.+.+..+|||.+.
T Consensus        74 lv~e~~~g~~l~~~~~~~~------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~~~~~~liDfg~a~  137 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVRDDKLYLIDFGLGK  137 (199)
T ss_pred             EEEEEECCccHHHHHhhcH------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEECCcEEEEECCCCc
Confidence            9999999999998875431      1       7899999999999999   9999999999999996566667999876


Q ss_pred             c
Q 043388          707 Q  707 (854)
Q Consensus       707 ~  707 (854)
                      .
T Consensus       138 ~  138 (199)
T TIGR03724       138 Y  138 (199)
T ss_pred             C
Confidence            5

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.65  E-value=8.4e-16  Score=152.60  Aligned_cols=144  Identities=24%  Similarity=0.218  Sum_probs=109.0

Q ss_pred             HHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc----------------------chHHHHHHHHHH
Q 043388          542 ELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG----------------------AFRSFVAECEAL  599 (854)
Q Consensus       542 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l  599 (854)
                      ++...-..|.+.+.||+|+||.||+|... +++.||||+++.....                      ....+.+|+.++
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            33333344788899999999999999886 7899999987643210                      012357789999


Q ss_pred             HhccCC--CeeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 043388          600 RNIRHR--NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQ  677 (854)
Q Consensus       600 ~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~  677 (854)
                      .++.|+  .+.+.++..         ..++||||++|++|.+....            .....++.+++.++.++|+.  
T Consensus        88 ~~l~~~~i~v~~~~~~~---------~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~--  144 (198)
T cd05144          88 KALYEEGFPVPKPIDWN---------RHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH--  144 (198)
T ss_pred             HHHHHcCCCCCceeecC---------CceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC--
Confidence            999887  455554421         35899999999998765321            23457889999999999998  


Q ss_pred             CCeEeecCCCCceEecCCccccc-cccccccccc
Q 043388          678 PPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDS  710 (854)
Q Consensus       678 ~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~  710 (854)
                       +|+||||||+||++++++..++ |||.+.....
T Consensus       145 -gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         145 -GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             -CCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence             9999999999999998776665 9999865544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.62  E-value=3e-16  Score=176.80  Aligned_cols=168  Identities=29%  Similarity=0.383  Sum_probs=122.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+|..++.|..|+||.||.++++.+.+.+|+|+-+..      .      +++     ||..+-+           ..+
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------l------ilR-----nilt~a~-----------npf  133 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------L------ILR-----NILTFAG-----------NPF  133 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc------h------hhh-----ccccccC-----------Ccc
Confidence            35788899999999999999999988889999543211      0      111     1222211           122


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      .|      |+=...++..+      .++.        +++.+++|+|+.   +|+|||+||+|.+|+.-+..+. |||++
T Consensus       134 vv------gDc~tllk~~g------~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLs  190 (1205)
T KOG0606|consen  134 VV------GDCATLLKNIG------PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLS  190 (1205)
T ss_pred             ee------chhhhhcccCC------CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhh
Confidence            22      34344444432      2222        227899999999   9999999999999999887777 99999


Q ss_pred             cccccCCCC------------CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          706 HQLDSASKT------------PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       706 ~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      +..-....+            ......++||+.|+|||++....|+..+|.|++|+++||.+.|..||++..
T Consensus       191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt  262 (1205)
T KOG0606|consen  191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT  262 (1205)
T ss_pred             hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence            866432211            111234689999999999999999999999999999999999999998753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=3.2e-16  Score=178.07  Aligned_cols=254  Identities=23%  Similarity=0.267  Sum_probs=187.3

Q ss_pred             hhccccCccCCCcceEEEEeEEC-CCceEEEEEEeeccc--ccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILG-GEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  623 (854)
                      ..|...+.||+|+|+.|-.+... .....+|+|.+....  ....+....|..+-..+. |+|++.+++.....+     
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-----   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-----   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-----
Confidence            45777788999999999888774 344567777765443  233344556777777776 999999999876655     


Q ss_pred             eeeEEEeeccCCCHHHHhh-hcCCcccccccCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeecCCCCceEecCCc-cccc
Q 043388          624 FKALVFEYMENGSLEDWLH-QSNDHLEVCKLTLIQRVNIAIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDM-VAHQ  700 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~~~  700 (854)
                      ..++++||.+++++.+.+. ....     ..+...+-.+..|+..|+.|+| ..   ++.|||+||+|.+++..+ ..++
T Consensus        95 ~~~~~~~~s~g~~~f~~i~~~~~~-----~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~  166 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKISHPDST-----GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKI  166 (601)
T ss_pred             ccccccCcccccccccccccCCcc-----CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccC
Confidence            6899999999999998883 3221     3455566778999999999999 77   999999999999999988 5665


Q ss_pred             -ccccccccccCCCCCCcccccCC-cccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKG-TVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                       |||+|..+.............+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........+..|...
T Consensus       167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~  246 (601)
T KOG0590|consen  167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN  246 (601)
T ss_pred             CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc
Confidence             99999988773333334444678 9999999998884 56788999999999999999999998776555444444332


Q ss_pred             cCC--cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          778 TLP--EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       778 ~~~--~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...  ...+.-+                          .....++...++..+|..|.+.+++..
T Consensus       247 ~~~~~~~~~~~~--------------------------~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  247 KGRFTQLPWNSI--------------------------SDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ccccccCccccC--------------------------ChhhhhcccccccCCchhccccccccc
Confidence            211  1111111                          223456777788899999998887643

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.57  E-value=9.7e-15  Score=143.88  Aligned_cols=137  Identities=22%  Similarity=0.286  Sum_probs=96.9

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeeccccc--chHH----------------------HHHHHHHHHhccCC--C
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRS----------------------FVAECEALRNIRHR--N  606 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--n  606 (854)
                      .+.||+|+||+||+|.+. +++.||||+++.....  ....                      ...|...+.++.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            468999999999999987 7889999998753211  1111                      13566666666443  3


Q ss_pred             eeeEEEEeeccCCCCCceeeEEEeeccCCCHHHH-hhhcCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeec
Q 043388          607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDW-LHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPIVHGD  684 (854)
Q Consensus       607 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~D  684 (854)
                      +.+.+++.         ..++||||++++++... +...       ... .++..++.+++.++.++|. .   +|+|||
T Consensus        81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D  140 (187)
T cd05119          81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLYREA---GLVHGD  140 (187)
T ss_pred             CCceEecC---------CCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence            45555431         35899999999654321 1111       111 5677899999999999999 7   999999


Q ss_pred             CCCCceEecCCccccccccccccccc
Q 043388          685 LKPSNVLLDHDMVAHQNFSLSHQLDS  710 (854)
Q Consensus       685 lkp~NIll~~~~~~~~Dfg~~~~~~~  710 (854)
                      |||+||+++.+..+++|||.+.....
T Consensus       141 l~p~Nili~~~~~~liDfg~a~~~~~  166 (187)
T cd05119         141 LSEYNILVDDGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CChhhEEEECCcEEEEECcccccccC
Confidence            99999999954555569999876544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.53  E-value=1.1e-15  Score=161.09  Aligned_cols=196  Identities=30%  Similarity=0.462  Sum_probs=163.0

Q ss_pred             CCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCce
Q 043388          206 NCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQ  285 (854)
Q Consensus       206 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  285 (854)
                      .+.--...||+.|++. ++|..+..+. .|+.+.|.+|.|. .+|..+.++..|++|||+.|+++ ..|..+..|+ |+.
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~-~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv  147 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFV-SLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV  147 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHH-HHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence            3444566789999998 8898888876 6888999999998 88999999999999999999999 5777788887 999


Q ss_pred             eeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCC
Q 043388          286 LYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNL  365 (854)
Q Consensus       286 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~  365 (854)
                      |.+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|.+..               
T Consensus       148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~---------------  209 (722)
T KOG0532|consen  148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC---------------  209 (722)
T ss_pred             EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh---------------
Confidence            999999998 78888998899999999999998 78888999999999999999887 4554432               


Q ss_pred             CCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccC---CCeeeccc
Q 043388          366 LNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSF---LEFLNLSY  442 (854)
Q Consensus       366 l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~ls~  442 (854)
                                .|        .|..||+|.|+++ .+|..|..|+.|++|-|.+|.|+ .+|..+...-.   .++|+..-
T Consensus       210 ----------~L--------pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA  269 (722)
T KOG0532|consen  210 ----------SL--------PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQA  269 (722)
T ss_pred             ----------CC--------ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchh
Confidence                      22        3889999999999 88999999999999999999999 67776644332   35666666


Q ss_pred             cc
Q 043388          443 NH  444 (854)
Q Consensus       443 N~  444 (854)
                      .+
T Consensus       270 ~q  271 (722)
T KOG0532|consen  270 CQ  271 (722)
T ss_pred             cc
Confidence            54

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.51  E-value=1.1e-13  Score=131.25  Aligned_cols=134  Identities=20%  Similarity=0.246  Sum_probs=107.1

Q ss_pred             ccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccC--CCeeeEEEEeeccCCCCCceeeEEE
Q 043388          552 SSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH--RNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       552 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.+.||+|.++.||++...+  ..+++|.......  ...+.+|+.+++.++|  ..+++++++....+     ..+++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~-----~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDG-----WSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-----ccEEEE
Confidence            35789999999999999864  6799998865433  4678899999999976  58899888775442     579999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQ  707 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~-~Dfg~~~~  707 (854)
                      ||++++++..+             +......++.+++++++++|.....+++|+|++|+||+++.++..+ +|||.+..
T Consensus        73 e~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          73 EWIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99998777643             3445667899999999999986444799999999999999855444 59998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.50  E-value=1.7e-13  Score=139.05  Aligned_cols=138  Identities=17%  Similarity=0.121  Sum_probs=102.1

Q ss_pred             cCccC-CCcceEEEEeEECCCceEEEEEEeeccc-------------ccchHHHHHHHHHHHhccCCCe--eeEEEEeec
Q 043388          553 SNMIG-QGSFGSVYKGILGGEEMIVAVKVINLKQ-------------KGAFRSFVAECEALRNIRHRNL--IKIITICSS  616 (854)
Q Consensus       553 ~~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~  616 (854)
                      ...|| .||.|+||.+...  +..+|||.+....             ......+.+|++++.++.|+++  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35687 8899999999885  5678999885311             1223567889999999998874  677776543


Q ss_pred             cCCCCCceeeEEEeeccC-CCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC
Q 043388          617 IDSKGADFKALVFEYMEN-GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD  695 (854)
Q Consensus       617 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  695 (854)
                      ... .....++||||++| .+|.+++...       .++..    .+.+++.++++||+.   ||+||||||+|||++.+
T Consensus       114 ~~~-~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~  178 (239)
T PRK01723        114 RHG-LFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPD  178 (239)
T ss_pred             ecC-cceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC
Confidence            221 12234699999997 6999888643       33332    356899999999999   99999999999999876


Q ss_pred             c-ccccccccccc
Q 043388          696 M-VAHQNFSLSHQ  707 (854)
Q Consensus       696 ~-~~~~Dfg~~~~  707 (854)
                      + +.++|||.+..
T Consensus       179 ~~v~LIDfg~~~~  191 (239)
T PRK01723        179 GKFWLIDFDRGEL  191 (239)
T ss_pred             CCEEEEECCCccc
Confidence            6 45569998764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=5e-14  Score=139.05  Aligned_cols=161  Identities=23%  Similarity=0.378  Sum_probs=125.9

Q ss_pred             HHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC
Q 043388          597 EALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC  676 (854)
Q Consensus       597 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~  676 (854)
                      .-+-++.|.|+|++..|+.+....+......+.|||+.|++.++|++....  ...+......+|+.||..||.|||+. 
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~--~~a~~~~~wkkw~tqIlsal~yLhs~-  195 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN--QKALFQKAWKKWCTQILSALSYLHSC-  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh--hhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence            345566899999999999888766666788999999999999999987543  23677777889999999999999996 


Q ss_pred             CCCeEeecCCCCceEecCCcccccccccccccccCCCCC--CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHH
Q 043388          677 QPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTP--SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEM  754 (854)
Q Consensus       677 ~~~ivH~Dlkp~NIll~~~~~~~~Dfg~~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~el  754 (854)
                      .|+|+|+++..+-|++..++..++|-+.-..........  .....-.+-++|.|||+-.....+.++|||+||+...||
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            789999999999999999988888655433332211110  011112367899999998777788899999999999999


Q ss_pred             HhCCCC
Q 043388          755 FTGRRP  760 (854)
Q Consensus       755 ltg~~p  760 (854)
                      ..+..-
T Consensus       276 ailEiq  281 (458)
T KOG1266|consen  276 AILEIQ  281 (458)
T ss_pred             HHheec
Confidence            887653

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.42  E-value=6.5e-15  Score=155.24  Aligned_cols=104  Identities=25%  Similarity=0.448  Sum_probs=49.3

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeee
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYL   95 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L   95 (854)
                      ..-...||+.|++. .+|..++.+..|+.|.|.+|.+. .+|..+..+..|++|||+.|+++ .+|..++.| -|+.|-+
T Consensus        75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli~  150 (722)
T KOG0532|consen   75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLIV  150 (722)
T ss_pred             cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEEE
Confidence            33444455555554 45555544455555555555554 44555555555555555555555 344444443 2445555


Q ss_pred             cccccccccCcccccCCCCCcEEEcccCCC
Q 043388           96 TVNRFSGSLPFDILVNLPNLKELYLTFCSL  125 (854)
Q Consensus        96 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l  125 (854)
                      ++|+++ .+|.++= .++.|.+|+.+.|.+
T Consensus       151 sNNkl~-~lp~~ig-~~~tl~~ld~s~nei  178 (722)
T KOG0532|consen  151 SNNKLT-SLPEEIG-LLPTLAHLDVSKNEI  178 (722)
T ss_pred             ecCccc-cCCcccc-cchhHHHhhhhhhhh
Confidence            555554 4444432 333444444433333

>PLN03150 hypothetical protein; Provisional

Probab=99.41  E-value=4.4e-13  Score=155.14  Aligned_cols=114  Identities=35%  Similarity=0.555  Sum_probs=97.6

Q ss_pred             HHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCee
Q 043388          359 LALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFL  438 (854)
Q Consensus       359 l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  438 (854)
                      |+|++|.+.+.+|..++.       +.+|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|
T Consensus       423 L~L~~n~L~g~ip~~i~~-------L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L  495 (623)
T PLN03150        423 LGLDNQGLRGFIPNDISK-------LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRIL  495 (623)
T ss_pred             EECCCCCccccCCHHHhC-------CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEE
Confidence            677788888888887777       4569999999999999999999999999999999999999999999999999999


Q ss_pred             ecccccCcccCCCC--ccccCcccccccccccccCCccccccccCC
Q 043388          439 NLSYNHLEGEVPTK--GVFSNKTKISLQVNVKLCGGIDELHLLSCP  482 (854)
Q Consensus       439 ~ls~N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~~~~~~~~~~c~  482 (854)
                      +|++|+++|.+|..  ..+.+...+++.+|+.+|+.+.   ...|.
T Consensus       496 ~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~  538 (623)
T PLN03150        496 NLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACG  538 (623)
T ss_pred             ECcCCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCc
Confidence            99999999999974  2233445678899999998653   24564

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.40  E-value=3e-13  Score=150.01  Aligned_cols=261  Identities=28%  Similarity=0.335  Sum_probs=155.9

Q ss_pred             EEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCC-CCcEEecccccCcccChhhhcCCCCCceeeeccc
Q 043388           20 TLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLR-NLVYLNVAENQFSGMFPRWICNISSLEFIYLTVN   98 (854)
Q Consensus        20 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N   98 (854)
                      .|+++.|.+. .....+..++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..+..++.|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            5777777775 34445555677888888888887 6666666664 8888888888887 45566778888888888888


Q ss_pred             ccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccC
Q 043388           99 RFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLK  178 (854)
Q Consensus        99 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~  178 (854)
                      +++ .+|... ..+++|+.|+++.|+++.                  +|.....+..|++|++++|++. ..+..+..+.
T Consensus       174 ~l~-~l~~~~-~~~~~L~~L~ls~N~i~~------------------l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~  232 (394)
T COG4886         174 DLS-DLPKLL-SNLSNLNNLDLSGNKISD------------------LPPEIELLSALEELDLSNNSII-ELLSSLSNLK  232 (394)
T ss_pred             hhh-hhhhhh-hhhhhhhheeccCCcccc------------------CchhhhhhhhhhhhhhcCCcce-ecchhhhhcc
Confidence            887 666432 145555555555555433                  3454445556777777777543 3345566777


Q ss_pred             CCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccccccc
Q 043388          179 NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVN  258 (854)
Q Consensus       179 ~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~  258 (854)
                      ++..|.+.+|++...       +..+..++++++|++++|.++ .++. +..+. .++.|++++|.++...|........
T Consensus       233 ~l~~l~l~~n~~~~~-------~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~-~l~~L~~s~n~~~~~~~~~~~~~~~  302 (394)
T COG4886         233 NLSGLELSNNKLEDL-------PESIGNLSNLETLDLSNNQIS-SISS-LGSLT-NLRELDLSGNSLSNALPLIALLLLL  302 (394)
T ss_pred             cccccccCCceeeec-------cchhccccccceecccccccc-cccc-ccccC-ccCEEeccCccccccchhhhccchh
Confidence            777777777776542       224566677777777777777 4443 55554 6777777777777555544433222


Q ss_pred             CCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceec
Q 043388          259 LIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ  318 (854)
Q Consensus       259 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  318 (854)
                      ...+..  +.+. ..+..+.....+....+..+... ..+..+.....+..++...+...
T Consensus       303 ~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  358 (394)
T COG4886         303 LELLLN--LLLT-LKALELKLNSILLNNNILSNGET-SSPEALSILESLNNLWTLDNALD  358 (394)
T ss_pred             HHhhhh--hhhh-ccccccccccccccccccccccc-ccchhhcccccccCceecccccc
Confidence            221111  2222 12222233333444444455544 45555555555555555555544

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.40  E-value=3.7e-13  Score=149.29  Aligned_cols=200  Identities=30%  Similarity=0.380  Sum_probs=129.6

Q ss_pred             EEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCC-CCCcEEEcccCCCCCCceeeccCccCCCCCCCCC
Q 043388           68 YLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNL-PNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSI  146 (854)
Q Consensus        68 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l-~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~  146 (854)
                      .|+++.|++. .....+..++.++.|++.+|.++ .+|... ..+ ++|+.|++++|+++                  .+
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~-~~~~~nL~~L~l~~N~i~------------------~l  155 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLI-GLLKSNLKELDLSDNKIE------------------SL  155 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCcccc-ccchhhcccccccccchh------------------hh
Confidence            5777777764 23334555567777777777776 565432 122 14444444444443                  33


Q ss_pred             CccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCCh
Q 043388          147 PDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPH  226 (854)
Q Consensus       147 p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  226 (854)
                      |..+..+++|+.|++++|+++.+++ ....+++|+.|++++|++..++..       ...+..|++|.+++|.+. ..+.
T Consensus       156 ~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~~~~L~~L~ls~N~i~~l~~~-------~~~~~~L~~l~~~~N~~~-~~~~  226 (394)
T COG4886         156 PSPLRNLPNLKNLDLSFNDLSDLPK-LLSNLSNLNNLDLSGNKISDLPPE-------IELLSALEELDLSNNSII-ELLS  226 (394)
T ss_pred             hhhhhccccccccccCCchhhhhhh-hhhhhhhhhheeccCCccccCchh-------hhhhhhhhhhhhcCCcce-ecch
Confidence            4556677777777777777775443 333667777777777777766542       223455777788877544 4566


Q ss_pred             hhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccc
Q 043388          227 SIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL  301 (854)
Q Consensus       227 ~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  301 (854)
                      .+..+. .+..+.+.+|++. ..+..+..+++++.|++++|+++.+.+  ++.+.+|+.|++++|.+....|...
T Consensus       227 ~~~~~~-~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         227 SLSNLK-NLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             hhhhcc-cccccccCCceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence            666665 5777777777776 346777888888888888888886544  7788888888888888876555433

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.36  E-value=2.8e-12  Score=141.79  Aligned_cols=142  Identities=18%  Similarity=0.214  Sum_probs=98.5

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecccccc----------------------------------------hHHH
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA----------------------------------------FRSF  592 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~  592 (854)
                      .+.||.|++|.||+|+.. +|+.||||+.+......                                        .-+|
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            367999999999999997 78999999986432100                                        0125


Q ss_pred             HHHHHHHHhcc----CCCeeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHH-
Q 043388          593 VAECEALRNIR----HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS-  667 (854)
Q Consensus       593 ~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~-  667 (854)
                      .+|++.+.++.    |.+-+.+-.+|.+..    ...++||||++|++|.++......     ..   .+.+++.+++. 
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~-----~~---~~~~ia~~~~~~  268 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEA-----GL---DRKALAENLARS  268 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhc-----CC---CHHHHHHHHHHH
Confidence            55666666652    333334333333221    135899999999999987654321     11   23456777666 


Q ss_pred             HHHHHHhcCCCCeEeecCCCCceEecCCcccc-ccccccccccc
Q 043388          668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDS  710 (854)
Q Consensus       668 ~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~-~Dfg~~~~~~~  710 (854)
                      .+.++|..   |++|+|+||.||+++.++..+ +|||++..+..
T Consensus       269 ~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       269 FLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            47889988   999999999999998876555 59999877754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.33  E-value=9.3e-13  Score=124.37  Aligned_cols=123  Identities=31%  Similarity=0.416  Sum_probs=35.5

Q ss_pred             cccccccccCCccccCcCCCCeeecccccccccCCcCcc-CCCCCcEEecccccCcccChhhhcCCCCCceeeecccccc
Q 043388           23 IDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG-LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFS  101 (854)
Q Consensus        23 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  101 (854)
                      |..+.|. .+|. +.+...++.|+|++|+|+. +. .++ .+.+|+.|+|++|.|+.+.  .+..++.|++|++++|+|+
T Consensus         4 lt~~~i~-~~~~-~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~   77 (175)
T PF14580_consen    4 LTANMIE-QIAQ-YNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRIS   77 (175)
T ss_dssp             ------------------------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---
T ss_pred             ccccccc-cccc-ccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCC
Confidence            3444444 3333 3333456777777777763 32 344 4677777777777777432  3666777777777777776


Q ss_pred             cccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcc
Q 043388          102 GSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKG  168 (854)
Q Consensus       102 ~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~  168 (854)
                       +++......+|+|++|++++|++.++.               .+ ..++.+++|++|+|.+|.++.
T Consensus        78 -~i~~~l~~~lp~L~~L~L~~N~I~~l~---------------~l-~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   78 -SISEGLDKNLPNLQELYLSNNKISDLN---------------EL-EPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             -S-CHHHHHH-TT--EEE-TTS---SCC---------------CC-GGGGG-TT--EEE-TT-GGGG
T ss_pred             -ccccchHHhCCcCCEEECcCCcCCChH---------------Hh-HHHHcCCCcceeeccCCcccc
Confidence             665443345667777777766666552               12 345567777777777777763

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.33  E-value=1.5e-12  Score=140.78  Aligned_cols=251  Identities=22%  Similarity=0.231  Sum_probs=176.8

Q ss_pred             hhccccCccCC--CcceEEEEeEE--CCCceEEEEEEeecccc--cchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCC
Q 043388          548 SEFASSNMIGQ--GSFGSVYKGIL--GGEEMIVAVKVINLKQK--GAFRSFVAECEALRNI-RHRNLIKIITICSSIDSK  620 (854)
Q Consensus       548 ~~~~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  620 (854)
                      ..|.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+....  ....+-.+|+...+++ .|++.++.+..+.+.+  
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~--  191 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG--  191 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC--
Confidence            34566788999  99999999998  77888999998543222  2223345677766666 5999999777766554  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeecCCCCceEecCC-
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS----AIEYLHHHCQPPIVHGDLKPSNVLLDHD-  695 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-  695 (854)
                         ..++-+|++. .++.++.+....     .++....+.+..+..+    |+.++|+.   +++|-|+||+||+...+ 
T Consensus       192 ---~lfiqtE~~~-~sl~~~~~~~~~-----~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  192 ---ILFIQTELCG-ESLQSYCHTPCN-----FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDW  259 (524)
T ss_pred             ---cceeeecccc-chhHHhhhcccc-----cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccc
Confidence               6789999985 688888776542     3556666777777777    99999999   99999999999999988 


Q ss_pred             ccccc-ccccccccccCCCCCCcc--cccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh
Q 043388          696 MVAHQ-NFSLSHQLDSASKTPSSS--IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH  772 (854)
Q Consensus       696 ~~~~~-Dfg~~~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~  772 (854)
                      ...+. |||+...+..........  ....|...|++||...+ .++.++|+||+|.++.+..++..++......  ...
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W~  336 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS--SWS  336 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC--Ccc
Confidence            66665 999998887765322111  12257889999999765 5788999999999999999988776532111  111


Q ss_pred             HHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +.-....+.+..+..                          ..++...+..|++.+|-.|++++++...
T Consensus       337 ~~r~~~ip~e~~~~~--------------------------s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  337 QLRQGYIPLEFCEGG--------------------------SSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ccccccCchhhhcCc--------------------------chhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            111111111111100                          2234447778999999999988877653

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.30  E-value=1.1e-11  Score=138.20  Aligned_cols=150  Identities=15%  Similarity=0.148  Sum_probs=95.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc----------------------------------ch---
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG----------------------------------AF---  589 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------~~---  589 (854)
                      ..+|+. +.||+|++|.||+|+.+.+|+.||||+.++....                                  ..   
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            445776 7899999999999999967999999999743110                                  00   


Q ss_pred             ---HHHHHHHHHHHhcc----CCCeeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHH
Q 043388          590 ---RSFVAECEALRNIR----HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA  662 (854)
Q Consensus       590 ---~~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~  662 (854)
                         -++.+|+..+.++.    +...+.+-.++.+..    ...++||||++|+++.++-.-.........+....+..++
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~  273 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF  273 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence               12455655555552    444444444443221    1468999999999998753211111011123333333334


Q ss_pred             HHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc-----ccccccccccccccC
Q 043388          663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-----VAHQNFSLSHQLDSA  711 (854)
Q Consensus       663 ~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~~~Dfg~~~~~~~~  711 (854)
                      .|+       +..   |++|+|+||.||+++.++     .+.+|||+...+...
T Consensus       274 ~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        274 TQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            443       345   999999999999999876     444599999887553

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.29  E-value=3.2e-13  Score=149.79  Aligned_cols=178  Identities=25%  Similarity=0.267  Sum_probs=92.6

Q ss_pred             CCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhc
Q 043388          153 ASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLS  232 (854)
Q Consensus       153 l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  232 (854)
                      ++.|+.|++++|.|+.+.  .|..+++|+.+++++|.+..+...     . ...+.+++.+++.+|.+...-  .+..+.
T Consensus       139 l~~L~~L~l~~N~i~~~~--~~~~l~~L~~l~l~~n~i~~ie~~-----~-~~~~~~l~~l~l~~n~i~~i~--~~~~~~  208 (414)
T KOG0531|consen  139 LTLLKELNLSGNLISDIS--GLESLKSLKLLDLSYNRIVDIEND-----E-LSELISLEELDLGGNSIREIE--GLDLLK  208 (414)
T ss_pred             ccchhhheeccCcchhcc--CCccchhhhcccCCcchhhhhhhh-----h-hhhccchHHHhccCCchhccc--chHHHH
Confidence            344555555555554332  233355555555555555433321     0 234455555555555554211  111111


Q ss_pred             ccccEEEccCCcccccCCccccccc--cCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchh
Q 043388          233 STMIQFRIGGNQISGTIPSGIRNLV--NLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADL  310 (854)
Q Consensus       233 ~~L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  310 (854)
                       .+..+++..|.++...+  +..+.  .|+.+++++|++.. .+..+..+.++..|++.+|++...-  .+.....+..+
T Consensus       209 -~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~  282 (414)
T KOG0531|consen  209 -KLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSEL  282 (414)
T ss_pred             -HHHHhhcccccceeccC--cccchhHHHHHHhcccCcccc-ccccccccccccccchhhccccccc--cccccchHHHh
Confidence             23333555565553222  12222  36777777777763 2255666777777777777776332  24455666777


Q ss_pred             ccccceeccc---CCCC-CcCCCCCcccccCCCcccCccc
Q 043388          311 ALSFNNLQGN---IPSS-LGNCQNLKGFDASHNKLTGAIP  346 (854)
Q Consensus       311 ~L~~N~l~~~---~~~~-~~~l~~L~~L~ls~N~l~~~~p  346 (854)
                      .+..|.+...   .... ....+.++.+.+..|.+....+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  283 WLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             ccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            7777776522   1111 4556778888888887765443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.28  E-value=4.9e-11  Score=115.11  Aligned_cols=139  Identities=19%  Similarity=0.203  Sum_probs=100.9

Q ss_pred             cCccCCCcceEEEEeEECC------CceEEEEEEeeccc------------c----------cchHHHH----HHHHHHH
Q 043388          553 SNMIGQGSFGSVYKGILGG------EEMIVAVKVINLKQ------------K----------GAFRSFV----AECEALR  600 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~------------~----------~~~~~~~----~E~~~l~  600 (854)
                      ...||.|.-+.||.|....      .+..+|||+.+...            +          ...+.+.    +|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998653      35789999985211            0          0122333    8999999


Q ss_pred             hccC--CCeeeEEEEeeccCCCCCceeeEEEeeccCCCHHH-HhhhcCCcccccccCHHHHHHHHHHHHHHHHHH-HhcC
Q 043388          601 NIRH--RNLIKIITICSSIDSKGADFKALVFEYMENGSLED-WLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL-HHHC  676 (854)
Q Consensus       601 ~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~L-H~~~  676 (854)
                      ++..  -++.+.+++.         ..++||||+.++.+.. .++..       .++..+...+..+++.+|.++ |.. 
T Consensus        82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~-------~~~~~~~~~i~~~i~~~l~~l~H~~-  144 (197)
T cd05146          82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDA-------KLNDEEMKNAYYQVLSMMKQLYKEC-  144 (197)
T ss_pred             HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhcc-------ccCHHHHHHHHHHHHHHHHHHHHhC-
Confidence            9953  5677777651         3489999997654422 22211       334456677889999999999 777 


Q ss_pred             CCCeEeecCCCCceEecCCccccccccccccccc
Q 043388          677 QPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDS  710 (854)
Q Consensus       677 ~~~ivH~Dlkp~NIll~~~~~~~~Dfg~~~~~~~  710 (854)
                        +|||+|+++.||+++++.+.+||||.+.....
T Consensus       145 --glVHGDLs~~NIL~~~~~v~iIDF~qav~~~h  176 (197)
T cd05146         145 --NLVHADLSEYNMLWHDGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             --CeecCCCCHHHEEEECCcEEEEECCCceeCCC
Confidence              99999999999999988888889998876643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.27  E-value=1.7e-13  Score=136.96  Aligned_cols=256  Identities=19%  Similarity=0.253  Sum_probs=143.3

Q ss_pred             CccCCCCCcEEecccccCccc----ChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeecc
Q 043388           59 TLGLLRNLVYLNVAENQFSGM----FPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLE  134 (854)
Q Consensus        59 ~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~  134 (854)
                      ....+..+++|+||+|.|...    +...+.+.++|+..++|+= ++|.+-..+.   ..|+.|.-.--....|++||||
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~---e~L~~l~~aL~~~~~L~~ldLS  100 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIP---EALKMLSKALLGCPKLQKLDLS  100 (382)
T ss_pred             HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHH---HHHHHHHHHHhcCCceeEeecc
Confidence            345567788888888888643    3344566777777777743 2222211111   1111111111111256666677


Q ss_pred             CccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCc-------------CccccCCCCeEecccccccCCCCCChhhh
Q 043388          135 QNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSI-------------DFSSLKNLWWLNLEQNNLGMGTANDLDFV  201 (854)
Q Consensus       135 ~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~-------------~f~~l~~L~~L~L~~N~l~~~~~~~~~~~  201 (854)
                      +|.++......+-+-++.++.|++|+|.+|-+...-..             ...+-++|++++..+|++...+..  ...
T Consensus       101 DNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~--~~A  178 (382)
T KOG1909|consen  101 DNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGAT--ALA  178 (382)
T ss_pred             ccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHH--HHH
Confidence            77776655555556677788888888888877532222             234456777777777777655543  344


Q ss_pred             hhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccC----CCCCc
Q 043388          202 TLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGI----IPDGV  277 (854)
Q Consensus       202 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~  277 (854)
                      ..|...+.|+.+.+..|.|..   ..+.                  .....|..+++|+.|||.+|-++..    ...++
T Consensus       179 ~~~~~~~~leevr~~qN~I~~---eG~~------------------al~eal~~~~~LevLdl~DNtft~egs~~LakaL  237 (382)
T KOG1909|consen  179 EAFQSHPTLEEVRLSQNGIRP---EGVT------------------ALAEALEHCPHLEVLDLRDNTFTLEGSVALAKAL  237 (382)
T ss_pred             HHHHhccccceEEEecccccC---chhH------------------HHHHHHHhCCcceeeecccchhhhHHHHHHHHHh
Confidence            566667777777777777651   1110                  1123345555666666666655422    22344


Q ss_pred             cCcccCceeeCccccccccCCccc-----cCccccchhccccceeccc----CCCCCcCCCCCcccccCCCcc
Q 043388          278 GELQHLQQLYMFRNFLQGSIPPSL-----GNLTKLADLALSFNNLQGN----IPSSLGNCQNLKGFDASHNKL  341 (854)
Q Consensus       278 ~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~ls~N~l  341 (854)
                      ..+++|+.|++++|.+...-..+|     ...++|+.|.|.+|.|+..    +..++...+.|+.|+|++|++
T Consensus       238 ~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  238 SSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             cccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            555566666666666553332222     1245666777777766521    223344466777777777777

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.27  E-value=2.5e-12  Score=121.47  Aligned_cols=132  Identities=23%  Similarity=0.252  Sum_probs=51.9

Q ss_pred             hhcCCCCCEEecccccccccCCcccc-CcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCC
Q 043388           12 IGSLLNLQTLAIDFNYLTGQLPDFVG-NLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSL   90 (854)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L   90 (854)
                      +.+...+++|+|++|.|+ .+. .++ .+.+|+.|+|++|.|+. ++ .+..+++|++|+|++|+|+.+.+.....+++|
T Consensus        15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L   90 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNL   90 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred             cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence            455667899999999999 454 465 68899999999999994 43 58889999999999999996544333579999


Q ss_pred             ceeeecccccccccC-cccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecC
Q 043388           91 EFIYLTVNRFSGSLP-FDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLS  162 (854)
Q Consensus        91 ~~L~L~~N~l~~~~~-~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls  162 (854)
                      ++|+|++|+|. .+. -..+..+++|+.|++.+|.+.+..              ..-...+..+|+|+.||-.
T Consensus        91 ~~L~L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~~~~--------------~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen   91 QELYLSNNKIS-DLNELEPLSSLPKLRVLSLEGNPVCEKK--------------NYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             -EEE-TTS----SCCCCGGGGG-TT--EEE-TT-GGGGST--------------THHHHHHHH-TT-SEETTE
T ss_pred             CEEECcCCcCC-ChHHhHHHHcCCCcceeeccCCcccchh--------------hHHHHHHHHcChhheeCCE
Confidence            99999999998 443 345677888888888877765321              1112345677888887753

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.23  E-value=4.1e-13  Score=134.27  Aligned_cols=257  Identities=20%  Similarity=0.186  Sum_probs=151.1

Q ss_pred             hhhhcCCCCCEEecccccccc----cCCccccCcCCCCeeecccc---cccccCCc-------CccCCCCCcEEeccccc
Q 043388           10 EEIGSLLNLQTLAIDFNYLTG----QLPDFVGNLSALGMLLIRWN---SLGGQIPT-------TLGLLRNLVYLNVAENQ   75 (854)
Q Consensus        10 ~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~l~~n---~l~~~~~~-------~~~~l~~L~~L~Ls~N~   75 (854)
                      +.+..+..++.|+||+|.+..    .+.+.+.+.++|+.-++++-   ++...+|.       ++...++|++||||.|.
T Consensus        24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA  103 (382)
T KOG1909|consen   24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA  103 (382)
T ss_pred             HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence            345567788889999998853    24445666677777777754   22223333       33445577777777777


Q ss_pred             CcccChhh----hcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCcccc
Q 043388           76 FSGMFPRW----ICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLS  151 (854)
Q Consensus        76 l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~  151 (854)
                      |....+..    +..+++|++|+|.+|.+. ...-..++.  .|.+|.               .|           .-..
T Consensus       104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~~--al~~l~---------------~~-----------kk~~  154 (382)
T KOG1909|consen  104 FGPKGIRGLEELLSSCTDLEELYLNNCGLG-PEAGGRLGR--ALFELA---------------VN-----------KKAA  154 (382)
T ss_pred             cCccchHHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHHH--HHHHHH---------------HH-----------hccC
Confidence            76444433    345666777777777654 221111110  011111               11           1112


Q ss_pred             CCCCCCEEecCCCcCcccCC----cCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChh
Q 043388          152 NASNLERLDLSGNQFKGKVS----IDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHS  227 (854)
Q Consensus       152 ~l~~L~~L~Ls~N~i~~~~~----~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  227 (854)
                      .-++|+++...+|++..-..    ..|...+.|+.+.++.|.|..-..  .-...+|..+++|++|||.+|-++......
T Consensus       155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~--~al~eal~~~~~LevLdl~DNtft~egs~~  232 (382)
T KOG1909|consen  155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGV--TALAEALEHCPHLEVLDLRDNTFTLEGSVA  232 (382)
T ss_pred             CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchh--HHHHHHHHhCCcceeeecccchhhhHHHHH
Confidence            24567777777777654322    345666777777777777753332  234557888999999999999888433222


Q ss_pred             hhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCc-----cCcccCceeeCcccccccc----CC
Q 043388          228 IANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGV-----GELQHLQQLYMFRNFLQGS----IP  298 (854)
Q Consensus       228 ~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~~  298 (854)
                      +                     ...+..+++|++|++++|.+..-...+|     ...++|+.|.|.+|.|+..    +.
T Consensus       233 L---------------------akaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la  291 (382)
T KOG1909|consen  233 L---------------------AKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALA  291 (382)
T ss_pred             H---------------------HHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHH
Confidence            2                     2234445566777777776654433332     2367788888888877632    23


Q ss_pred             ccccCccccchhccccceec
Q 043388          299 PSLGNLTKLADLALSFNNLQ  318 (854)
Q Consensus       299 ~~~~~l~~L~~L~L~~N~l~  318 (854)
                      ......+.|..|+|++|.+.
T Consensus       292 ~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  292 ACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHhcchhhHHhcCCccccc
Confidence            34555778888888888883

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.22  E-value=4e-11  Score=116.06  Aligned_cols=130  Identities=16%  Similarity=0.133  Sum_probs=94.6

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCee-eEEEEeeccCCCCCceeeEEEee
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI-KIITICSSIDSKGADFKALVFEY  631 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~  631 (854)
                      .+.++.|.++.||+++..  +..|++|+...... ....+.+|+++++.+.+.+++ +++.+...       ..++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~-------~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPE-------TGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCC-------CCeEEEEe
Confidence            356899999999999875  66799998764432 123567899999998665544 45544321       24799999


Q ss_pred             ccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeecCCCCceEecCCccccccccccc
Q 043388          632 MENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC--QPPIVHGDLKPSNVLLDHDMVAHQNFSLSH  706 (854)
Q Consensus       632 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~~~Dfg~~~  706 (854)
                      ++|.++.+.    .      ..    ...++.+++++|+.||+..  ..+++|+|++|.||+++.+...++||+.+.
T Consensus        73 i~G~~l~~~----~------~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~  135 (170)
T cd05151          73 IEGSELLTE----D------FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAG  135 (170)
T ss_pred             cCCCccccc----c------cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEeccccc
Confidence            999887643    0      01    1245678999999999982  123599999999999997767777999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.22  E-value=1.6e-12  Score=133.54  Aligned_cols=234  Identities=23%  Similarity=0.212  Sum_probs=154.9

Q ss_pred             EEecccccccccCCcc----ccCcCCCCeeecccccccccCC--cCccCCCCCcEEecccccCcccCh--hhhcCCCCCc
Q 043388           20 TLAIDFNYLTGQLPDF----VGNLSALGMLLIRWNSLGGQIP--TTLGLLRNLVYLNVAENQFSGMFP--RWICNISSLE   91 (854)
Q Consensus        20 ~L~L~~n~l~~~~~~~----~~~l~~L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~   91 (854)
                      .+.+++-++...--+.    =+++..|+...|.+..+. ..+  .....+++++.||||.|-+....|  .....|++|+
T Consensus        97 ~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le  175 (505)
T KOG3207|consen   97 VLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLE  175 (505)
T ss_pred             HhhhcCceeEEecHHHHHHHhhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccch
Confidence            3444555544332222    256778999999999887 444  467889999999999999885544  3456899999


Q ss_pred             eeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCC
Q 043388           92 FIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS  171 (854)
Q Consensus        92 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~  171 (854)
                      .|+|+.|++.--.....-..+++|+.|.|+.|++.             .   ..+-......|+|+.|+|..|....+..
T Consensus       176 ~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls-------------~---k~V~~~~~~fPsl~~L~L~~N~~~~~~~  239 (505)
T KOG3207|consen  176 NLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLS-------------W---KDVQWILLTFPSLEVLYLEANEIILIKA  239 (505)
T ss_pred             hcccccccccCCccccchhhhhhhheEEeccCCCC-------------H---HHHHHHHHhCCcHHHhhhhcccccceec
Confidence            99999999862222222234566777777766654             1   2233345567889999999997555666


Q ss_pred             cCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCccc-CChhhhhhcccccEEEccCCcccccCC
Q 043388          172 IDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE-LPHSIANLSSTMIQFRIGGNQISGTIP  250 (854)
Q Consensus       172 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~~L~~L~l~~N~l~~~~~  250 (854)
                      ..+.-+..|++|||++|++-..+.     ......++.|+.|+++.+.+... +|+.                    ..-
T Consensus       240 ~~~~i~~~L~~LdLs~N~li~~~~-----~~~~~~l~~L~~Lnls~tgi~si~~~d~--------------------~s~  294 (505)
T KOG3207|consen  240 TSTKILQTLQELDLSNNNLIDFDQ-----GYKVGTLPGLNQLNLSSTGIASIAEPDV--------------------ESL  294 (505)
T ss_pred             chhhhhhHHhhccccCCccccccc-----ccccccccchhhhhccccCcchhcCCCc--------------------cch
Confidence            777788899999999998864332     23566778888888888877621 1110                    001


Q ss_pred             ccccccccCCeeeccccccccCC-CCCccCcccCceeeCccccccc
Q 043388          251 SGIRNLVNLIALTIEVNQLHGII-PDGVGELQHLQQLYMFRNFLQG  295 (854)
Q Consensus       251 ~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~  295 (854)
                      +-...+++|++|+++.|+|.... -..+..+++|+.|....|.+..
T Consensus       295 ~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  295 DKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             hhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            11234567888888888875321 1234566777888888888873

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.22  E-value=1.3e-10  Score=126.94  Aligned_cols=170  Identities=19%  Similarity=0.233  Sum_probs=129.9

Q ss_pred             EeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcC
Q 043388          566 KGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN  645 (854)
Q Consensus       566 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  645 (854)
                      .|..+.++.+|.|++.+.......+...+-++.++.++||+|+++++.++..+     ..|+|+|.+.  .|..++++. 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-----~~ylvTErV~--Pl~~~lk~l-  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-----TLYLVTERVR--PLETVLKEL-  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-----ceEEEeeccc--cHHHHHHHh-
Confidence            57777789999999998666545566778889999999999999999887655     7899999984  577777753 


Q ss_pred             CcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCc
Q 043388          646 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGT  724 (854)
Q Consensus       646 ~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt  724 (854)
                              ........+.||+.||.|||..|  +++|++|.-+.|+|++.+..++ +|..+...........   ...--
T Consensus       102 --------~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~---~~~~~  168 (690)
T KOG1243|consen  102 --------GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK---SLYLI  168 (690)
T ss_pred             --------HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc---cchhh
Confidence                    34556678899999999999877  9999999999999999998887 8877655543332111   01122


Q ss_pred             ccccCccccCCCCCCccchhHHHHHHHHHHHhCC
Q 043388          725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGR  758 (854)
Q Consensus       725 ~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~  758 (854)
                      -.|..|+.+....  -..|.|.|||+++|++.|.
T Consensus       169 ~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  169 ESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             hcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence            3466666544333  3469999999999999993

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.22  E-value=2e-12  Score=125.97  Aligned_cols=187  Identities=20%  Similarity=0.220  Sum_probs=108.5

Q ss_pred             cccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccc---cCCc--------------------Ccc
Q 043388            5 EGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGG---QIPT--------------------TLG   61 (854)
Q Consensus         5 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---~~~~--------------------~~~   61 (854)
                      ...+|=++.-+++|..+.+|++.=. -+-+-...-+.|+++...+..++.   ..|.                    ...
T Consensus       203 ~~~l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~d  281 (490)
T KOG1259|consen  203 PNRLSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSAD  281 (490)
T ss_pred             ccccccchHHhhhhheeeeeccchh-heeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecc
Confidence            3345556677778888888877654 333333344567777776665541   0111                    111


Q ss_pred             CCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCC
Q 043388           62 LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMG  141 (854)
Q Consensus        62 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~  141 (854)
                      .-+.|++||||+|.|+ .+.++..-++.++.|++|.|+|. .+..  ++.+++|++|||++|.|.++             
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n--La~L~~L~~LDLS~N~Ls~~-------------  344 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN--LAELPQLQLLDLSGNLLAEC-------------  344 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh--hhhcccceEeecccchhHhh-------------
Confidence            1235666677777666 45555666666666777776665 4443  45556666666665555433             


Q ss_pred             CCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCc
Q 043388          142 TASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFG  221 (854)
Q Consensus       142 ~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  221 (854)
                           ..+-.++.+.++|.|++|.|..+  ..+..+-+|..||+++|+|...     +-...+++++-|+.|.|.+|.+.
T Consensus       345 -----~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~l-----deV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  345 -----VGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEEL-----DEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             -----hhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhH-----HHhcccccccHHHHHhhcCCCcc
Confidence                 23334566667777777766533  2455566667777777776533     22345666677777777777776

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.21  E-value=1e-12  Score=127.89  Aligned_cols=136  Identities=24%  Similarity=0.227  Sum_probs=67.9

Q ss_pred             cccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCC
Q 043388           35 FVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPN  114 (854)
Q Consensus        35 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~  114 (854)
                      .+..+..|+.|||++|.|+ .+..+..-+++++.|++|+|.|..+.  .++.|++|+.||||+|.++ ++. ++-..+-+
T Consensus       279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~-Gwh~KLGN  353 (490)
T KOG1259|consen  279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECV-GWHLKLGN  353 (490)
T ss_pred             ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhh-hhHhhhcC
Confidence            3344445555555555555 44555555555555555555555322  2555555555555555554 221 12222333


Q ss_pred             CcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCC-cCccccCCCCeEecccccccCC
Q 043388          115 LKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS-IDFSSLKNLWWLNLEQNNLGMG  193 (854)
Q Consensus       115 L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~-~~f~~l~~L~~L~L~~N~l~~~  193 (854)
                      .++|.|+.|.++.|                   ..+.++.+|..||+++|+|..... ..+++++-|+.|.|.+|.|..+
T Consensus       354 IKtL~La~N~iE~L-------------------SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  354 IKTLKLAQNKIETL-------------------SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             EeeeehhhhhHhhh-------------------hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            33333333333322                   234555666666666666654432 3456666666666666666544


Q ss_pred             C
Q 043388          194 T  194 (854)
Q Consensus       194 ~  194 (854)
                      .
T Consensus       415 v  415 (490)
T KOG1259|consen  415 V  415 (490)
T ss_pred             c
Confidence            3

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.19  E-value=2.3e-12  Score=142.92  Aligned_cols=269  Identities=26%  Similarity=0.305  Sum_probs=177.1

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      .++.++..++.+.+.--. ...+..++.++++.|.|. .+-..+..+++|+.|++.+|+|..+.. .+..+++|++|+|+
T Consensus        50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls  126 (414)
T KOG0531|consen   50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLS  126 (414)
T ss_pred             hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhccc-chhhhhcchheecc
Confidence            444555555544321111 145566777777777777 344556777778888888888774333 26667778888888


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCC-cCcc
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS-IDFS  175 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~-~~f~  175 (854)
                      +|+|+ .+..  +..++.|+.|++++|.+..+                   ..+..+++|+.+++++|++..+.+ . ..
T Consensus       127 ~N~I~-~i~~--l~~l~~L~~L~l~~N~i~~~-------------------~~~~~l~~L~~l~l~~n~i~~ie~~~-~~  183 (414)
T KOG0531|consen  127 FNKIT-KLEG--LSTLTLLKELNLSGNLISDI-------------------SGLESLKSLKLLDLSYNRIVDIENDE-LS  183 (414)
T ss_pred             ccccc-cccc--hhhccchhhheeccCcchhc-------------------cCCccchhhhcccCCcchhhhhhhhh-hh
Confidence            88777 4332  33444455555555555433                   234557888888888888886665 3 57


Q ss_pred             ccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccc
Q 043388          176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRN  255 (854)
Q Consensus       176 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~  255 (854)
                      .+.+|+.+++.+|.+..+..        +..+..+..+++..|.++..-+....... .|+.+++++|.+. ..+..+..
T Consensus       184 ~~~~l~~l~l~~n~i~~i~~--------~~~~~~l~~~~l~~n~i~~~~~l~~~~~~-~L~~l~l~~n~i~-~~~~~~~~  253 (414)
T KOG0531|consen  184 ELISLEELDLGGNSIREIEG--------LDLLKKLVLLSLLDNKISKLEGLNELVML-HLRELYLSGNRIS-RSPEGLEN  253 (414)
T ss_pred             hccchHHHhccCCchhcccc--------hHHHHHHHHhhcccccceeccCcccchhH-HHHHHhcccCccc-cccccccc
Confidence            78888888888888875543        23344555568888888733221111110 2778899999988 44467888


Q ss_pred             cccCCeeeccccccccCCCCCccCcccCceeeCcccccccc---CCcc-ccCccccchhccccceecccCCC
Q 043388          256 LVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGS---IPPS-LGNLTKLADLALSFNNLQGNIPS  323 (854)
Q Consensus       256 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~-~~~l~~L~~L~L~~N~l~~~~~~  323 (854)
                      +.++..|++.+|++...  ..+.....+..+.+..|.+...   .... ....+.++.+.+.+|.+....+.
T Consensus       254 ~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
T KOG0531|consen  254 LKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSL  323 (414)
T ss_pred             cccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccccc
Confidence            89999999999999854  3356777888889999987632   2222 56678899999999998865543

>PLN03150 hypothetical protein; Provisional

Probab=99.13  E-value=6.2e-11  Score=137.41  Aligned_cols=107  Identities=27%  Similarity=0.408  Sum_probs=94.9

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      .++.|+|++|.++|.+|..++.+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|+.++++++|++|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCcccccCCCCCcEEEcccC
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFC  123 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n  123 (854)
                      +|+++|.+|..+...+.++..+++..|
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N  525 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDN  525 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCC
Confidence            999999999765333344455555444

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.13  E-value=1e-11  Score=127.68  Aligned_cols=185  Identities=24%  Similarity=0.199  Sum_probs=99.5

Q ss_pred             CCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCC--cCccccCCCCeEecccccccCCCCCChhhh
Q 043388          124 SLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS--IDFSSLKNLWWLNLEQNNLGMGTANDLDFV  201 (854)
Q Consensus       124 ~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~--~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~  201 (854)
                      ++++|+...|.+...++....   .....+++++.||||+|-+....+  .-...+++|+.|+|+.|++.....+     
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~---~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s-----  190 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIE---EYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISS-----  190 (505)
T ss_pred             hHHhhhheeecCccccccchh---hhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccc-----
Confidence            345555555555555322211   234456666666666665553322  1233455555555555555432222     


Q ss_pred             hhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCC-ccccccccCCeeeccccccccCCCCCccCc
Q 043388          202 TLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIP-SGIRNLVNLIALTIEVNQLHGIIPDGVGEL  280 (854)
Q Consensus       202 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  280 (854)
                                               ......+.++.|.|+.|.++...- .....+++|+.|+|+.|..-.+......-+
T Consensus       191 -------------------------~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~  245 (505)
T KOG3207|consen  191 -------------------------NTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKIL  245 (505)
T ss_pred             -------------------------cchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhh
Confidence                                     111222345555555555553221 123456677777777775333444445566


Q ss_pred             ccCceeeCccccccccCC--ccccCccccchhccccceecccC-CCC-----CcCCCCCcccccCCCccc
Q 043388          281 QHLQQLYMFRNFLQGSIP--PSLGNLTKLADLALSFNNLQGNI-PSS-----LGNCQNLKGFDASHNKLT  342 (854)
Q Consensus       281 ~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~-~~~-----~~~l~~L~~L~ls~N~l~  342 (854)
                      +.|+.|+|++|++. ..+  ...+.++.|..|+++.+.+..+. |+.     ...+++|+.|+++.|++.
T Consensus       246 ~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  246 QTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             hHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            67777777777766 333  34566777777777777776432 222     245677777777777775

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.10  E-value=5.5e-11  Score=128.84  Aligned_cols=199  Identities=22%  Similarity=0.202  Sum_probs=145.9

Q ss_pred             HHHHHhhccccCccCCCcceEEEEeEEC-CCceEEEEEEeecccccchH--HHHHHHHHHHhc-cCCCeeeEEEEeeccC
Q 043388          543 LSKATSEFASSNMIGQGSFGSVYKGILG-GEEMIVAVKVINLKQKGAFR--SFVAECEALRNI-RHRNLIKIITICSSID  618 (854)
Q Consensus       543 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~~~~~~~~~~  618 (854)
                      ......+|..+..||.|.|+.|++.... .++..|++|...........  .-..|+.+...+ .|.++++.+..|....
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            4455678999999999999999998765 57788999977543222212  224566555555 5888888776665444


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-cc
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MV  697 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~  697 (854)
                           ..|+--|||++++....+.-..      .++...++++..|++.++.++|+.   .++|+|+||+||++..+ +.
T Consensus       340 -----~~~ip~e~~~~~s~~l~~~~~~------~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~  405 (524)
T KOG0601|consen  340 -----QGYIPLEFCEGGSSSLRSVTSQ------MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFF  405 (524)
T ss_pred             -----cccCchhhhcCcchhhhhHHHH------hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhh
Confidence                 4578999999998887663322      677778889999999999999999   99999999999999886 55


Q ss_pred             ccc-ccccccccccCCCCCCcccccCCcccc-cCccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 043388          698 AHQ-NFSLSHQLDSASKTPSSSIGIKGTVGY-VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP  760 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p  760 (854)
                      ... |||.+..+.......     ..++..| .+|+......+..+.|+||||..+.|.+++..-
T Consensus       406 ~~~~~~~~~t~~~~~~~~~-----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  406 SKLGDFGCWTRLAFSSGVF-----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             hhccccccccccceecccc-----cccccccccchhhccccccccccccccccccccccccCccc
Confidence            555 999887533222111     1133444 355566667788999999999999999998764

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.08  E-value=1.2e-09  Score=101.05  Aligned_cols=128  Identities=25%  Similarity=0.311  Sum_probs=95.1

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecc--ccc------chHHHHHHHHHHHhccCC--CeeeEEEEeeccCCCCCc
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKG------AFRSFVAECEALRNIRHR--NLIKIITICSSIDSKGAD  623 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~------~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~  623 (854)
                      ..+++|+-+.+|.+.+.  |..+++|.-..+  ...      ..++-.+|++++.+++-.  ++..++++.  .+     
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~-----   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PD-----   72 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CC-----
Confidence            46889999999999885  334666654222  111      124567899999998644  444455543  22     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccccccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFS  703 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg  703 (854)
                      ...|+|||++|..|.+++....             ..++..+-.-+.-||..   +|||+|+.++||++..+.+..||||
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~~-------------~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~i~~IDfG  136 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEAR-------------PDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGRIYFIDFG  136 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhcc-------------hHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCcEEEEECC
Confidence            4579999999999998887641             34566777778889999   9999999999999999999999999


Q ss_pred             ccc
Q 043388          704 LSH  706 (854)
Q Consensus       704 ~~~  706 (854)
                      ++.
T Consensus       137 Lg~  139 (204)
T COG3642         137 LGE  139 (204)
T ss_pred             ccc
Confidence            986

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.99  E-value=2.1e-10  Score=130.43  Aligned_cols=207  Identities=23%  Similarity=0.300  Sum_probs=145.6

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ..+.+.+.+-+-+|.++.++.+.-...+...+.|+....   ...+.+....+-.+.-...||-+++...-+.     ..
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-----~r  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-----CR  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-----CC
Confidence            456677788899999999999888777755666554321   1112233333333333344566665443311     12


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++|++|+.+++|...++..+      ..+..-++.....+.++.+|||+.   .+.|||++|.|++...++.... |
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~  947 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSG------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTD  947 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCC------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCc
Confidence            24689999999999999988765      344444556677788999999998   7999999999999988876666 8


Q ss_pred             cccccccccC---------------------CC-------CCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHH
Q 043388          702 FSLSHQLDSA---------------------SK-------TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLE  753 (854)
Q Consensus       702 fg~~~~~~~~---------------------~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~e  753 (854)
                      ||.....+..                     ..       .........||+.|.|||...+.....++|.|+.|++++|
T Consensus       948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen  948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred             cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence            8743322111                     00       0011234669999999999999999999999999999999


Q ss_pred             HHhCCCCCCCccc
Q 043388          754 MFTGRRPTDAAFT  766 (854)
Q Consensus       754 lltg~~pf~~~~~  766 (854)
                      .++|.+||.....
T Consensus      1028 ~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETP 1040 (1205)
T ss_pred             hhcCCCCCCCcch
Confidence            9999999986543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.96  E-value=4.3e-10  Score=87.37  Aligned_cols=59  Identities=25%  Similarity=0.365  Sum_probs=30.6

Q ss_pred             CCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccc
Q 043388           41 ALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNR   99 (854)
Q Consensus        41 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~   99 (854)
                      +|++|++++|+|+.+.++.|..+++|++|++++|.|+.+.|++|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            44555555555554444455555555555555555554444555555555555555554

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.96  E-value=4.8e-10  Score=87.07  Aligned_cols=59  Identities=34%  Similarity=0.507  Sum_probs=33.3

Q ss_pred             CCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCC
Q 043388           65 NLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCS  124 (854)
Q Consensus        65 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~  124 (854)
                      +|++|+|++|+|+.+.+++|.++++|++|++++|+|+ .++.++|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSES-EEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCCc
Confidence            4555555555555555555555555555555555555 5555555555555555555554

...

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.95  E-value=5.3e-09  Score=106.16  Aligned_cols=144  Identities=21%  Similarity=0.259  Sum_probs=106.2

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccC--CCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRH--RNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      +.||.|.++.||++... +|..+++|+...... .....+.+|+++++.+.+  ..+.+++.+.....  .....++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            56899999999999886 467899998764332 134578899999999975  34677777765432  1124589999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC----------------------------------  676 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~----------------------------------  676 (854)
                      |++|.++.+.+.. .      .++..+...++.+++++|++||+..                                  
T Consensus        81 ~i~G~~l~~~~~~-~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          81 RVDGRVLRDRLLR-P------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EeCCEecCCCCCC-C------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            9999888775532 1      4567777888888888888888531                                  


Q ss_pred             -------------------CCCeEeecCCCCceEecC--Ccc-cccccccccc
Q 043388          677 -------------------QPPIVHGDLKPSNVLLDH--DMV-AHQNFSLSHQ  707 (854)
Q Consensus       677 -------------------~~~ivH~Dlkp~NIll~~--~~~-~~~Dfg~~~~  707 (854)
                                         ...++|+|++|.||+++.  +.. .+|||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               246899999999999988  453 4569987653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.92  E-value=1.1e-08  Score=98.60  Aligned_cols=126  Identities=22%  Similarity=0.233  Sum_probs=82.8

Q ss_pred             EEEEeEECCCceEEEEEEeeccc-------------cc-------------chHHHHHHHHHHHhccCC--CeeeEEEEe
Q 043388          563 SVYKGILGGEEMIVAVKVINLKQ-------------KG-------------AFRSFVAECEALRNIRHR--NLIKIITIC  614 (854)
Q Consensus       563 ~V~~~~~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~E~~~l~~l~h~--niv~~~~~~  614 (854)
                      .||.|... ++..+|||+.+...             ..             ......+|.+.|.++...  ++.+.+++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999887 67899999985321             00             023457899999999755  567777652


Q ss_pred             eccCCCCCceeeEEEeecc--CCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeecCCCCceE
Q 043388          615 SSIDSKGADFKALVFEYME--NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVL  691 (854)
Q Consensus       615 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlkp~NIl  691 (854)
                               ..++||||++  |..+..+....        ++......++.+++..+..+ |..   ||+|+|+.+.||+
T Consensus        80 ---------~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl  139 (188)
T PF01163_consen   80 ---------RNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL  139 (188)
T ss_dssp             ---------TTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred             ---------CCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence                     2379999998  65554433221        11234456778888866665 677   9999999999999


Q ss_pred             ecCCcccccccccccccc
Q 043388          692 LDHDMVAHQNFSLSHQLD  709 (854)
Q Consensus       692 l~~~~~~~~Dfg~~~~~~  709 (854)
                      ++++.+.+||||.+....
T Consensus       140 v~~~~~~iIDf~qav~~~  157 (188)
T PF01163_consen  140 VDDGKVYIIDFGQAVDSS  157 (188)
T ss_dssp             EETTCEEE--GTTEEETT
T ss_pred             eecceEEEEecCcceecC
Confidence            999988888999886554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.90  E-value=1.3e-08  Score=93.55  Aligned_cols=142  Identities=23%  Similarity=0.247  Sum_probs=98.5

Q ss_pred             ccCccCCCcceEEEEeEECCCceEEEEEEeecc--c------ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          552 SSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--Q------KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       552 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ....+-+|+-+.|+++.+.  |+.+.||.-..+  .      .-..++..+|++++.++.--.|.-..-++.+..     
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~-----   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY-----   83 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence            4567889999999999996  666667643211  1      112346788999999986444332222232322     


Q ss_pred             eeeEEEeeccC-CCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc----c
Q 043388          624 FKALVFEYMEN-GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV----A  698 (854)
Q Consensus       624 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~----~  698 (854)
                      .-.|+|||++| .++.+++......    .........++.+|-+.+.-||..   +|||+||..+||++..++.    .
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMED----ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccC----cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence            24799999977 5888888775432    222233367889999999999999   9999999999999977653    3


Q ss_pred             ccccccccc
Q 043388          699 HQNFSLSHQ  707 (854)
Q Consensus       699 ~~Dfg~~~~  707 (854)
                      .||||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            459998753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.82  E-value=6.9e-08  Score=99.59  Aligned_cols=270  Identities=15%  Similarity=0.148  Sum_probs=155.9

Q ss_pred             ccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeec--cCCCCCceeeEE
Q 043388          552 SSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSS--IDSKGADFKALV  628 (854)
Q Consensus       552 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~~~~~~lv  628 (854)
                      .++.||+|+-+.+|-.-.-.+   .+-|++.........+   .+..|.+. .||-+-.-+.|=..  .+.++.....+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchhhc---hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            457899999999997544322   3457776544332222   12223333 56644331221100  011222236778


Q ss_pred             EeeccCC-CHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc-cc---cc
Q 043388          629 FEYMENG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN---FS  703 (854)
Q Consensus       629 ~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~-~D---fg  703 (854)
                      |+.+++. ....+.....+........|.-.++.+..+|.+.+.||..   |.+-+|+.++|+|++++..+. +|   |-
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            8887764 2333333222111223578999999999999999999999   999999999999998876544 44   33


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccC-----CCCCCccchhHHHHHHHHHHHhC-CCCCCCcccC---CchHh-H
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGM-----GSEASMTGDVYSFGILLLEMFTG-RRPTDAAFTE---GLTLH-E  773 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg-~~pf~~~~~~---~~~~~-~  773 (854)
                      +.   .    ........+|...|.+||...     +...+...|-|.+||++++++.| ++||.+..-.   ..... .
T Consensus       166 i~---~----ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         166 IN---A----NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             ec---c----CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            22   1    111222346899999999754     34457789999999999999985 9999864211   11111 1


Q ss_pred             HhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCC--CCCCCCCHHHHHHHHHhhhhhh
Q 043388          774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSME--SPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       774 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      +....+-..    -|        ...-..+..+....+-.+..+..+..+|...  .|.-|||++..+..|.++...+
T Consensus       239 Ia~g~f~ya----~~--------~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         239 IAHGRFAYA----SD--------QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             hhcceeeec----hh--------ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            111110000    00        0000001111112223345566666777754  3568999999999888877655

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.81  E-value=1.3e-07  Score=100.30  Aligned_cols=177  Identities=16%  Similarity=0.156  Sum_probs=129.3

Q ss_pred             cceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEeeccC-CCHH
Q 043388          560 SFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMEN-GSLE  638 (854)
Q Consensus       560 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~  638 (854)
                      .-.+.|++...-+|..|++|+++..+.........-++.++++.|+|||++.+++.... .+....++||+|+++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence            34678999999999999999995444333333445678899999999999999987433 344568999999986 4777


Q ss_pred             HHhhhcCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          639 DWLHQSNDH---------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       639 ~~l~~~~~~---------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      +.-......         ......++...|.++.|+..||.++|+.   |+.-+-+.|.+|+++.+...++ ..|.....
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            655433221         2234678889999999999999999999   9999999999999999864444 44443333


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP  760 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p  760 (854)
                      .....                 |-+.   --.+-|.=.||.+++-+.||..-
T Consensus       444 ~~d~~-----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  444 QEDPT-----------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cCCCC-----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            32220                 1111   12356999999999999999654

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.81  E-value=2e-09  Score=127.30  Aligned_cols=104  Identities=24%  Similarity=0.231  Sum_probs=60.9

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeeccccc--ccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCcee
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNS--LGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFI   93 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L   93 (854)
                      ...+...+.+|.+. .++....+- .|++|-+..|.  +..+.++.|..++.|+.|||++|.=-+.+|+.+++|-+|++|
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~~~-~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL  600 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSENP-KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL  600 (889)
T ss_pred             hheeEEEEeccchh-hccCCCCCC-ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence            45556666666665 444444332 56666666664  443444456666666666666665545666666666666666


Q ss_pred             eecccccccccCcccccCCCCCcEEEcccC
Q 043388           94 YLTVNRFSGSLPFDILVNLPNLKELYLTFC  123 (854)
Q Consensus        94 ~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n  123 (854)
                      +|++..++ .+|.+ +.+|.+|.+|++.++
T Consensus       601 ~L~~t~I~-~LP~~-l~~Lk~L~~Lnl~~~  628 (889)
T KOG4658|consen  601 DLSDTGIS-HLPSG-LGNLKKLIYLNLEVT  628 (889)
T ss_pred             cccCCCcc-ccchH-HHHHHhhheeccccc
Confidence            66666665 55544 345555555555443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.76  E-value=1.2e-07  Score=97.40  Aligned_cols=144  Identities=13%  Similarity=0.037  Sum_probs=97.6

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeeccccc-----------chHHHHHHHHHHHhccCC--CeeeEEEEeeccCCC
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-----------AFRSFVAECEALRNIRHR--NLIKIITICSSIDSK  620 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~  620 (854)
                      +.+-+.....|+++...  |+.|.||........           ....+.+|...+.++...  .+++.+++.......
T Consensus        28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            34444444557777664  668999977432211           112478999999888433  344555555432222


Q ss_pred             CCceeeEEEeeccCC-CHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC----
Q 043388          621 GADFKALVFEYMENG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----  695 (854)
Q Consensus       621 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----  695 (854)
                      .....++|||++++- +|.+++.....    ...+...+..++.+++..++-||..   ||+|+|++++|||++.+    
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence            123468999999886 89998864211    1445667778999999999999999   99999999999999751    


Q ss_pred             ----ccccccccccc
Q 043388          696 ----MVAHQNFSLSH  706 (854)
Q Consensus       696 ----~~~~~Dfg~~~  706 (854)
                          ...+|||+.+.
T Consensus       179 ~~~~~~~LIDl~r~~  193 (268)
T PRK15123        179 EEDLKLSVIDLHRAQ  193 (268)
T ss_pred             CCCceEEEEECCccc
Confidence                34456998765

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.73  E-value=2.1e-08  Score=118.85  Aligned_cols=131  Identities=19%  Similarity=0.190  Sum_probs=82.5

Q ss_pred             CcCCCCeeecccccccccCCcCccCCCCCcEEeccccc--CcccChhhhcCCCCCceeeecccccccccCcccccCCCCC
Q 043388           38 NLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQ--FSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL  115 (854)
Q Consensus        38 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  115 (854)
                      +....++..+-+|.+. .++..... ++|++|-+..|.  +..+.++.|..++.|..|||++|.=-+.+|..+ +.|-+|
T Consensus       521 ~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I-~~Li~L  597 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSI-GELVHL  597 (889)
T ss_pred             chhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHH-hhhhhh
Confidence            3356677777777776 45555443 367777777775  554555567777777777777664333556443 455555


Q ss_pred             cEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEeccccc
Q 043388          116 KELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNN  189 (854)
Q Consensus       116 ~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~  189 (854)
                      ++|+++...++                  .+|..++++.+|.+|++.++.-...++.....+.+|++|.+..-.
T Consensus       598 ryL~L~~t~I~------------------~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  598 RYLDLSDTGIS------------------HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             hcccccCCCcc------------------ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            55555555443                  347777777777777777776555556666667777777776554

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.70  E-value=1.7e-10  Score=125.48  Aligned_cols=182  Identities=25%  Similarity=0.269  Sum_probs=123.8

Q ss_pred             chhhhcCCCCCEEecccccccccCCccccCcCCCCeeeccccccc---ccCCcCccC------CCCCcEEecccccCccc
Q 043388            9 PEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLG---GQIPTTLGL------LRNLVYLNVAENQFSGM   79 (854)
Q Consensus         9 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~---~~~~~~~~~------l~~L~~L~Ls~N~l~~~   79 (854)
                      |-.|.-+++|++|.|.++.|.. ...-.+--+.|+.|... |.++   .++....+.      -..|...+.+.|++. .
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~-~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~  178 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST-AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-L  178 (1096)
T ss_pred             CceeccccceeeEEecCcchhh-hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-h
Confidence            5566777788888888887762 22212222345555332 3322   111111111      136888899999998 6


Q ss_pred             ChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEE
Q 043388           80 FPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERL  159 (854)
Q Consensus        80 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L  159 (854)
                      ...++.-++.|+.|+|++|+++ .+.  .+..+++|++|||++|.|+.+..+...                 + -+|..|
T Consensus       179 mD~SLqll~ale~LnLshNk~~-~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~-----------------g-c~L~~L  237 (1096)
T KOG1859|consen  179 MDESLQLLPALESLNLSHNKFT-KVD--NLRRLPKLKHLDLSYNCLRHVPQLSMV-----------------G-CKLQLL  237 (1096)
T ss_pred             HHHHHHHHHHhhhhccchhhhh-hhH--HHHhcccccccccccchhccccccchh-----------------h-hhheee
Confidence            7788999999999999999998 665  578899999999999988766322221                 1 238888


Q ss_pred             ecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCc
Q 043388          160 DLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFG  221 (854)
Q Consensus       160 ~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  221 (854)
                      .|++|.++.+.  .+.++++|+.|||++|-|..-..     ...+..+..|+.|+|.+|.+-
T Consensus       238 ~lrnN~l~tL~--gie~LksL~~LDlsyNll~~hse-----L~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  238 NLRNNALTTLR--GIENLKSLYGLDLSYNLLSEHSE-----LEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             eecccHHHhhh--hHHhhhhhhccchhHhhhhcchh-----hhHHHHHHHHHHHhhcCCccc
Confidence            89999887543  56788888889999988864322     234556778888888888876

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.64  E-value=1.3e-07  Score=93.13  Aligned_cols=134  Identities=26%  Similarity=0.238  Sum_probs=94.8

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccc----------------------ccchHHHHHHHHHHHhccCC--
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ----------------------KGAFRSFVAECEALRNIRHR--  605 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--  605 (854)
                      ..++..||-|.-|.||.|... .|.++|||.-+...                      .-......+|.++|.++...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            345688999999999999998 78899999654211                      01133467899999999644  


Q ss_pred             CeeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 043388          606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDL  685 (854)
Q Consensus       606 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  685 (854)
                      .|.+.+++-         ..++||||++|-.|...-           ++....-.|+..|+.-+...-..   ||||+|+
T Consensus       172 ~VP~P~~~n---------RHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~~---GiVHGDl  228 (304)
T COG0478         172 KVPKPIAWN---------RHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYRR---GIVHGDL  228 (304)
T ss_pred             CCCCccccc---------cceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHHc---CccccCC
Confidence            777777651         458999999996665432           12233334555555555555566   9999999


Q ss_pred             CCCceEecCC-cccccccccccc
Q 043388          686 KPSNVLLDHD-MVAHQNFSLSHQ  707 (854)
Q Consensus       686 kp~NIll~~~-~~~~~Dfg~~~~  707 (854)
                      .+=||+++++ ....|||-.+..
T Consensus       229 SefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         229 SEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             chheEEEecCCCEEEEeCccccc
Confidence            9999999998 555669965543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.60  E-value=5e-07  Score=89.83  Aligned_cols=110  Identities=25%  Similarity=0.249  Sum_probs=85.0

Q ss_pred             hHHHHHHHHHHHhcc--CCCeeeEEEEeeccCCCCCceeeEEEeeccCC-CHHHHhhhcCCcccccccCHHHHHHHHHHH
Q 043388          589 FRSFVAECEALRNIR--HRNLIKIITICSSIDSKGADFKALVFEYMENG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDV  665 (854)
Q Consensus       589 ~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~i  665 (854)
                      .....+|...+.++.  .-.+.+.+++........ ...++|+|++++- +|.+++....      ..+......++.++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l  127 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRAL  127 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHH
Confidence            346788999888884  334566777765544322 4568999999884 8999988643      24556678899999


Q ss_pred             HHHHHHHHhcCCCCeEeecCCCCceEecCCc----cccccccccccc
Q 043388          666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQL  708 (854)
Q Consensus       666 a~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~~~Dfg~~~~~  708 (854)
                      +..++-||..   ||+|+|+++.|||++.+.    ...|||+.++..
T Consensus       128 ~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  128 ARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999   999999999999999886    666799876643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.57  E-value=7.6e-09  Score=100.11  Aligned_cols=256  Identities=18%  Similarity=0.213  Sum_probs=137.6

Q ss_pred             cCCCCCcEEecccccCcccChhhh----cCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCc
Q 043388           61 GLLRNLVYLNVAENQFSGMFPRWI----CNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQN  136 (854)
Q Consensus        61 ~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N  136 (854)
                      ..+..++.++||+|.|.+.-.+++    .+-.+|+..++++--. |..-..+..   +|+.|--.--++..|+..+||+|
T Consensus        27 ~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ft-gr~kde~~~---~L~~Ll~aLlkcp~l~~v~LSDN  102 (388)
T COG5238          27 EMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFT-GRDKDELYS---NLVMLLKALLKCPRLQKVDLSDN  102 (388)
T ss_pred             HhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhh-cccHHHHHH---HHHHHHHHHhcCCcceeeecccc
Confidence            446778888888888876544444    4456677777665422 222221111   11222112223445566666666


Q ss_pred             cCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCc-------------cccCCCCeEecccccccCCCCCChhhhhh
Q 043388          137 NLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDF-------------SSLKNLWWLNLEQNNLGMGTANDLDFVTL  203 (854)
Q Consensus       137 ~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f-------------~~l~~L~~L~L~~N~l~~~~~~~~~~~~~  203 (854)
                      .++......+-+.++.-+.|++|.|++|.+..+...-+             .+-+.|++.+...|++...+...  +...
T Consensus       103 Afg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~--~a~~  180 (388)
T COG5238         103 AFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKEL--SAAL  180 (388)
T ss_pred             ccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHH--HHHH
Confidence            66655545555667788888888888887753332222             34566778888888776655531  2223


Q ss_pred             ccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccC----CCCCccC
Q 043388          204 LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGI----IPDGVGE  279 (854)
Q Consensus       204 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~  279 (854)
                      |..-..|+++.+..|.|.   |..+..+.                 -..+..+.+|+.|||..|-++..    ..+++..
T Consensus       181 l~sh~~lk~vki~qNgIr---pegv~~L~-----------------~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~  240 (388)
T COG5238         181 LESHENLKEVKIQQNGIR---PEGVTMLA-----------------FLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCE  240 (388)
T ss_pred             HHhhcCceeEEeeecCcC---cchhHHHH-----------------HHHHHHhCcceeeeccccchhhhhHHHHHHHhcc
Confidence            344457777777777765   44333221                 01123344555566665555422    2223334


Q ss_pred             cccCceeeCccccccccCCcc----cc--CccccchhccccceecccCCCC-----C--cCCCCCcccccCCCccc
Q 043388          280 LQHLQQLYMFRNFLQGSIPPS----LG--NLTKLADLALSFNNLQGNIPSS-----L--GNCQNLKGFDASHNKLT  342 (854)
Q Consensus       280 l~~L~~L~L~~N~l~~~~~~~----~~--~l~~L~~L~L~~N~l~~~~~~~-----~--~~l~~L~~L~ls~N~l~  342 (854)
                      .+.|+.|.+..|-++..-..+    |.  ..++|..|-..+|.+.+.+-..     |  ..++-|..|-+.+|++.
T Consensus       241 W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~  316 (388)
T COG5238         241 WNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIK  316 (388)
T ss_pred             cchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcch
Confidence            445566666666555332221    11  1355666666666655322111     1  24666777777777775

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.56  E-value=8.7e-09  Score=89.41  Aligned_cols=116  Identities=23%  Similarity=0.270  Sum_probs=77.6

Q ss_pred             hccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCccc
Q 043388          203 LLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQH  282 (854)
Q Consensus       203 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  282 (854)
                      .+.....|+..+|++|.+. ..|+.|....+.++.|+|++|.|+ .+|..+..++.|+.|+++.|.+. ..|..+..|.+
T Consensus        48 ~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~  124 (177)
T KOG4579|consen   48 MLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIK  124 (177)
T ss_pred             HHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHh
Confidence            4455566777788888887 677777666667778888888887 66766888888888888888877 45666666777


Q ss_pred             CceeeCccccccccCCccccCccccchhccccceecccCC
Q 043388          283 LQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIP  322 (854)
Q Consensus       283 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  322 (854)
                      |-.|+..+|.+. .+|..+..-+..-..++.++.+.+.-+
T Consensus       125 l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~  163 (177)
T KOG4579|consen  125 LDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK  163 (177)
T ss_pred             HHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence            777887777776 444333322333344445555554433

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.51  E-value=3.8e-08  Score=108.36  Aligned_cols=99  Identities=22%  Similarity=0.517  Sum_probs=75.6

Q ss_pred             HHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccCCCCCC------cccccCCcccccCccccC
Q 043388          662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPS------SSIGIKGTVGYVAPEYGM  734 (854)
Q Consensus       662 ~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~  734 (854)
                      +.+++.|+.|+|...  ++||++|.|++|.++..+..++ .|+++...........      ...-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            345569999999885  9999999999999999987777 8887765544222111      111123456799999999


Q ss_pred             CCCCCccchhHHHHHHHHHHH-hCCCCCC
Q 043388          735 GSEASMTGDVYSFGILLLEMF-TGRRPTD  762 (854)
Q Consensus       735 ~~~~~~~sDv~slGvvl~ell-tg~~pf~  762 (854)
                      +...+.++|+||+||++|.+. .|+.-+.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~  211 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIA  211 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhh
Confidence            988999999999999999999 4555554

>PRK09902 hypothetical protein; Provisional

Probab=98.46  E-value=2.7e-06  Score=82.39  Aligned_cols=142  Identities=18%  Similarity=0.160  Sum_probs=101.7

Q ss_pred             cCCCcceEEEEeEECCCceEEEEEEeecc-----c-ccchHHHHHHHHHHHhccC--CCeeeEEEEeeccCCCCCceeeE
Q 043388          556 IGQGSFGSVYKGILGGEEMIVAVKVINLK-----Q-KGAFRSFVAECEALRNIRH--RNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       556 lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      -|+||.+-|++....+.  .+=+|.-...     . +-....|.+|...+.++..  -.+.+.. ++...........+|
T Consensus        26 ~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            46799999999887633  5777876411     0 2345689999999999943  3355555 443333333445789


Q ss_pred             EEeeccC-CCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc---ccccccc
Q 043388          628 VFEYMEN-GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFS  703 (854)
Q Consensus       628 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~~~Dfg  703 (854)
                      |+|-+++ .||.+++......    +.+...+..+..++++.++-||..   |+.|+|+-+.||+++.++   +..|||.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~----~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVS----PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcC----CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            9998763 4899988654321    557777889999999999999999   999999999999998433   4556887


Q ss_pred             cccc
Q 043388          704 LSHQ  707 (854)
Q Consensus       704 ~~~~  707 (854)
                      -++.
T Consensus       176 k~r~  179 (216)
T PRK09902        176 KSRR  179 (216)
T ss_pred             ccch
Confidence            5543

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.45  E-value=2e-08  Score=97.32  Aligned_cols=209  Identities=19%  Similarity=0.175  Sum_probs=121.6

Q ss_pred             hhhhcCCCCCEEecccccccccC----CccccCcCCCCeeeccccccc---c-------cCCcCccCCCCCcEEeccccc
Q 043388           10 EEIGSLLNLQTLAIDFNYLTGQL----PDFVGNLSALGMLLIRWNSLG---G-------QIPTTLGLLRNLVYLNVAENQ   75 (854)
Q Consensus        10 ~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~---~-------~~~~~~~~l~~L~~L~Ls~N~   75 (854)
                      +.+..+..++.+|||+|.|....    ...+.+-.+|+..++++--..   .       .+..++.+++.|+..+||.|.
T Consensus        24 eel~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNA  103 (388)
T COG5238          24 EELEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNA  103 (388)
T ss_pred             HHHHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccc
Confidence            35566889999999999996543    344566678888888765221   1       223355678999999999999


Q ss_pred             CcccChh----hhcCCCCCceeeecccccccccCccc-------------ccCCCCCcEEEcccCCCC------------
Q 043388           76 FSGMFPR----WICNISSLEFIYLTVNRFSGSLPFDI-------------LVNLPNLKELYLTFCSLK------------  126 (854)
Q Consensus        76 l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~~~~~-------------~~~l~~L~~L~l~~n~l~------------  126 (854)
                      |....|+    .++.-+.|.+|.|++|.+- .+.-+-             -++-|.|+......|++.            
T Consensus       104 fg~~~~e~L~d~is~~t~l~HL~l~NnGlG-p~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~  182 (388)
T COG5238         104 FGSEFPEELGDLISSSTDLVHLKLNNNGLG-PIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLE  182 (388)
T ss_pred             cCcccchHHHHHHhcCCCceeEEeecCCCC-ccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHH
Confidence            9866554    5667788999999999874 332211             124567777777766653            


Q ss_pred             ---CCceeeccCccCCCCCCCCCC-ccccCCCCCCEEecCCCcCcccCC----cCccccCCCCeEecccccccCCCCCCh
Q 043388          127 ---NLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLSGNQFKGKVS----IDFSSLKNLWWLNLEQNNLGMGTANDL  198 (854)
Q Consensus       127 ---~L~~L~L~~N~l~~~~~~~~p-~~~~~l~~L~~L~Ls~N~i~~~~~----~~f~~l~~L~~L~L~~N~l~~~~~~~~  198 (854)
                         .|+.+.+.+|.|.-.+++.+- ..+..+.+|+.|||..|-++....    .++...+.|++|.+..|-++.-...  
T Consensus       183 sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~--  260 (388)
T COG5238         183 SHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVK--  260 (388)
T ss_pred             hhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHH--
Confidence               455555566655322111110 122334556666666665553222    2334455556666665555433322  


Q ss_pred             hhhhhcc--CCCCCcEEEcccCcCc
Q 043388          199 DFVTLLT--NCSSLKALSLCDNQFG  221 (854)
Q Consensus       199 ~~~~~~~--~l~~L~~L~L~~N~l~  221 (854)
                      .+...|.  ..++|..|-..+|.+.
T Consensus       261 ~v~~~f~e~~~p~l~~L~~~Yne~~  285 (388)
T COG5238         261 SVLRRFNEKFVPNLMPLPGDYNERR  285 (388)
T ss_pred             HHHHHhhhhcCCCccccccchhhhc
Confidence            1112221  1245555555555554

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.41  E-value=3e-08  Score=97.35  Aligned_cols=84  Identities=18%  Similarity=0.201  Sum_probs=52.4

Q ss_pred             ccCCeeeccccccccCC-CCCccCcccCceeeCccccccccC-CccccCccccchhccccceecccCCC------CCcCC
Q 043388          257 VNLIALTIEVNQLHGII-PDGVGELQHLQQLYMFRNFLQGSI-PPSLGNLTKLADLALSFNNLQGNIPS------SLGNC  328 (854)
Q Consensus       257 ~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~------~~~~l  328 (854)
                      +++..+.+..|.|.... ...+..++.+..|+|+.|+|.... -+++.++++|..|.+++|.+...+..      -++.+
T Consensus       199 pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL  278 (418)
T KOG2982|consen  199 PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARL  278 (418)
T ss_pred             ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeec
Confidence            45666667777665332 234566677777778777776321 23567777888888888877643322      24567


Q ss_pred             CCCcccccCCCccc
Q 043388          329 QNLKGFDASHNKLT  342 (854)
Q Consensus       329 ~~L~~L~ls~N~l~  342 (854)
                      ++++.|+=+  +++
T Consensus       279 ~~v~vLNGs--kIs  290 (418)
T KOG2982|consen  279 TKVQVLNGS--KIS  290 (418)
T ss_pred             cceEEecCc--ccc
Confidence            888887644  554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	854
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		9e-37
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		4e-13
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		9e-37
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		4e-13
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-35
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-34
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-23
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-23
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-19
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-18
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-17
3iok_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-13
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-13
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-13
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-13
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-13
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-13
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-07
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		4e-07
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		4e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-07
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		4e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
3soa_A	444	Full-Length Human Camkii Length = 444		5e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		9e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-07
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		9e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-07
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		1e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		2e-06
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		2e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		8e-05
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		8e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-05
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		1e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		2e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		2e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		3e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-04
3rfj_A	279	Design Of A Binding Scaffold Based On Variable Lymp		7e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		7e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-04
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		8e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  136 bits (342), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 142/523 (27%), Positives = 226/523 (43%), Gaps = 110/523 (21%)
Query: 1   KNKLEGQIPEEI-GSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIP-T 58
           +NK  G+IP+ + G+   L  L +  N+  G +P F G+ S L  L +  N+  G++P  
Sbjct: 275 ENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD 334
Query: 59  TLGLLRNLVYLNVAENQFSGMFPRWICNIS-SLEFIYLTVNRFSGSLPFDILVNLPN-LK 116
           TL  +R L  L+++ N+FSG  P  + N+S SL  + L+ N FSG +  ++  N  N L+
Sbjct: 335 TLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ 394
Query: 117 ELYLTFCSXXXXXXXXXXXXXXGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS 176
           ELYL                    G    IP +LSN S L  L LS N   G +     S
Sbjct: 395 ELYLQ-----------------NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 437
Query: 177 XXXXXXXXXXXXXXGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHS---IANLSS 233
                                          S L+ L L  N   GE+P     +  L +
Sbjct: 438 L------------------------------SKLRDLKLWLNMLEGEIPQELMYVKTLET 467
Query: 234 TMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFL 293
            ++ F    N ++G IPSG+ N  NL  +++  N+L G IP  +G L++L  L +  N  
Sbjct: 468 LILDF----NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 523
Query: 294 QGSIPPSLGNLTKLADLALSFNNLQGNIPSSL---------------------------- 325
            G+IP  LG+   L  L L+ N   G IP+++                            
Sbjct: 524 SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKE 583
Query: 326 ----GNCQNLKGFDASH-NKLTGAIPQQVLSITTLS------------VYLALAHNLLND 368
               GN    +G  +   N+L+   P  + S                 ++L +++N+L+ 
Sbjct: 584 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG 643
Query: 369 SLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEF 428
            +P ++G++  L I       L++  N   G IP  +G ++ +  L++SSN L G+IP+ 
Sbjct: 644 YIPKEIGSMPYLFI-------LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 696
Query: 429 LQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCG 471
           +  L+ L  ++LS N+L G +P  G F          N  LCG
Sbjct: 697 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 739

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 127/276 (46%), Gaps = 45/276 (16%)
Query: 207 CS-SLKALSLCDNQFGGELPHSIANLSSTMIQF-RIGGNQIS--GTIPSGIRNLVNLIAL 262
           CS SL +L L  N   G +    +  S + ++F  +  N +   G +  G++ L +L  L
Sbjct: 95  CSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK-LNSLEVL 153
Query: 263 TIEVNQLHG------IIPDGVGELQHLQQLYMFRNFLQGSIP------------------ 298
            +  N + G      ++ DG GEL+HL    +  N + G +                   
Sbjct: 154 DLSANSISGANVVGWVLSDGCGELKHLA---ISGNKISGDVDVSRCVNLEFLDVSSNNFS 210
Query: 299 ---PSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTL 355
              P LG+ + L  L +S N L G+   ++  C  LK  + S N+  G IP   L + +L
Sbjct: 211 TGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSL 268
Query: 356 SVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELN 415
             YL+LA N     +P        L   C +L  LD+S N F+G +P   G    ++ L 
Sbjct: 269 Q-YLSLAENKFTGEIP------DFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLA 321
Query: 416 VSSNNLSGQIP-EFLQNLSFLEFLNLSYNHLEGEVP 450
           +SSNN SG++P + L  +  L+ L+LS+N   GE+P
Sbjct: 322 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 357

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  152 bits (383), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 135/457 (29%), Positives = 208/457 (45%), Gaps = 91/457 (19%)
Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           NK+ G +  ++   +NL+ L +  N  +  +P F+G+ SAL  L I  N L G     + 
Sbjct: 188 NKISGDV--DVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAIS 244
Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
               L  LN++ NQF G  P     + SL+++ L  N+F+G                   
Sbjct: 245 TCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGE------------------ 284
Query: 122 FCSXXXXXXXXXXXXXXGMGTASSIPDSLSNASN-LERLDLSGNQFKGKVSIDFSSXXXX 180
                                   IPD LS A + L  LDLSGN F G V   F S    
Sbjct: 285 ------------------------IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320
Query: 181 XXXXXXXXXXGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
                         + +L   TLL     LK L L  N+F GELP S+ NLS++++   +
Sbjct: 321 ESLALSSNNF----SGELPMDTLLK-MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 241 GGNQISG--------------------------TIPSGIRNLVNLIALTIEVNQLHGIIP 274
             N  SG                           IP  + N   L++L +  N L G IP
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
Query: 275 DGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGF 334
             +G L  L+ L ++ N L+G IP  L  +  L  L L FN+L G IPS L NC NL   
Sbjct: 436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 335 DASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISS 394
             S+N+LTG IP+ +  +  L++ L L++N  + ++P ++G+       C SL +LD+++
Sbjct: 496 SLSNNRLTGEIPKWIGRLENLAI-LKLSNNSFSGNIPAELGD-------CRSLIWLDLNT 547
Query: 395 NSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQN 431
           N F+G IP ++ F +S K   +++N ++G+   +++N
Sbjct: 548 NLFNGTIPAAM-FKQSGK---IAANFIAGKRYVYIKN 580

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 127/276 (46%), Gaps = 45/276 (16%)
Query: 207 CS-SLKALSLCDNQFGGELPHSIANLSSTMIQF-RIGGNQIS--GTIPSGIRNLVNLIAL 262
           CS SL +L L  N   G +    +  S + ++F  +  N +   G +  G++ L +L  L
Sbjct: 98  CSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK-LNSLEVL 156
Query: 263 TIEVNQLHG------IIPDGVGELQHLQQLYMFRNFLQGSIP------------------ 298
            +  N + G      ++ DG GEL+HL    +  N + G +                   
Sbjct: 157 DLSANSISGANVVGWVLSDGCGELKHLA---ISGNKISGDVDVSRCVNLEFLDVSSNNFS 213
Query: 299 ---PSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTL 355
              P LG+ + L  L +S N L G+   ++  C  LK  + S N+  G IP   L + +L
Sbjct: 214 TGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSL 271
Query: 356 SVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELN 415
             YL+LA N     +P        L   C +L  LD+S N F+G +P   G    ++ L 
Sbjct: 272 Q-YLSLAENKFTGEIP------DFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLA 324
Query: 416 VSSNNLSGQIP-EFLQNLSFLEFLNLSYNHLEGEVP 450
           +SSNN SG++P + L  +  L+ L+LS+N   GE+P
Sbjct: 325 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  145 bits (367), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 100/336 (29%), Positives = 165/336 (49%), Gaps = 33/336 (9%)
Query: 518 RRRSAHKSVDTSPAKK-------QFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILG 570
           RR+         PA++       Q    S  EL  A+  F++ N++G+G FG VYKG L 
Sbjct: 1   RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 571 GEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE 630
              ++   ++   + +G    F  E E +    HRNL+++   C +        + LV+ 
Sbjct: 61  DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-----RLLVYP 115
Query: 631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV 690
           YM NGS+   L +  +      L   +R  IA+  A  + YLH HC P I+H D+K +N+
Sbjct: 116 YMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 173
Query: 691 LLDHDMVA-HQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGI 749
           LLD +  A   +F L+  +D   K       ++GT+G++APEY    ++S   DV+ +G+
Sbjct: 174 LLDEEFEAVVGDFGLAKLMD--YKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 231
Query: 750 LLLEMFTGRRPTDAAF---TEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDR 806
           +LLE+ TG+R  D A     + + L ++VK  L EK +E      L++V    +   E+ 
Sbjct: 232 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA-----LVDVDLQGNYKDEE- 285
Query: 807 RARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL 842
                  +  + +  +LC+  SP ER +M +VV  L
Sbjct: 286 -------VEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 156/313 (49%), Gaps = 26/313 (8%)
Query: 534 QFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFV 593
           Q    S  EL  A+  F + N++G+G FG VYKG L    ++   ++   + +G    F 
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 594 AECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKL 653
            E E +    HRNL+++   C +        + LV+ YM NGS+   L +  +      L
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPES--QPPL 128
Query: 654 TLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA-HQNFSLSHQLDSAS 712
              +R  IA+  A  + YLH HC P I+H D+K +N+LLD +  A   +F L+  +D   
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--Y 186
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF---TEGL 769
           K       ++G +G++APEY    ++S   DV+ +G++LLE+ TG+R  D A     + +
Sbjct: 187 KDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 770 TLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESP 829
            L ++VK  L EK +E      L++V    +   E+        +  + +  +LC+  SP
Sbjct: 247 MLLDWVKGLLKEKKLEA-----LVDVDLQGNYKDEE--------VEQLIQVALLCTQSSP 293
Query: 830 FERMEMRDVVAKL 842
            ER +M +VV  L
Sbjct: 294 MERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 96/314 (30%), Positives = 147/314 (46%), Gaps = 33/314 (10%)
Query: 536 PMISY----AELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS 591
           P  SY     +L +AT+ F    +IG G FG VYKG+L  +   VA+K    +       
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEE 81
Query: 592 FVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC 651
           F  E E L   RH +L+ +I  C   +        L+++YMENG+L+  L+ S+  L   
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHLYGSD--LPTM 134
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDS 710
            ++  QR+ I I  A  + YLH      I+H D+K  N+LLD + V    +F +S +   
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191
Query: 711 ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF-TEGL 769
             +T    + +KGT+GY+ PEY +    +   DVYSFG++L E+   R     +   E +
Sbjct: 192 LDQTHLXXV-VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250
Query: 770 TLHEFVKMTLPEKVIE-IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMES 828
            L E+   +     +E IVDP+L  ++                + L     T V C   S
Sbjct: 251 NLAEWAVESHNNGQLEQIVDPNLADKIRP--------------ESLRKFGDTAVKCLALS 296
Query: 829 PFERMEMRDVVAKL 842
             +R  M DV+ KL
Sbjct: 297 SEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 96/314 (30%), Positives = 147/314 (46%), Gaps = 33/314 (10%)
Query: 536 PMISY----AELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS 591
           P  SY     +L +AT+ F    +IG G FG VYKG+L  +   VA+K    +       
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEE 81
Query: 592 FVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC 651
           F  E E L   RH +L+ +I  C   +        L+++YMENG+L+  L+ S+  L   
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHLYGSD--LPTM 134
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDS 710
            ++  QR+ I I  A  + YLH      I+H D+K  N+LLD + V    +F +S +   
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191
Query: 711 ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF-TEGL 769
             +T    + +KGT+GY+ PEY +    +   DVYSFG++L E+   R     +   E +
Sbjct: 192 LGQTHLXXV-VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250
Query: 770 TLHEFVKMTLPEKVIE-IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMES 828
            L E+   +     +E IVDP+L  ++                + L     T V C   S
Sbjct: 251 NLAEWAVESHNNGQLEQIVDPNLADKIRP--------------ESLRKFGDTAVKCLALS 296
Query: 829 PFERMEMRDVVAKL 842
             +R  M DV+ KL
Sbjct: 297 SEDRPSMGDVLWKL 310

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 115/248 (46%), Gaps = 34/248 (13%)
Query: 249 IPSGIRNLVNLIALTIE-VNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKL 307
           IPS + NL  L  L I  +N L G IP  + +L  L  LY+    + G+IP  L  +  L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 308 ADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLN 367
             L  S+N L G +P S+ +  NL G     N+++GAIP    S + L   + ++ N L 
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 368 DSLPLQVGNLKNLVITCVSLEYLDISSNSFHG--------------------VIPFSL-- 405
             +P    NL        +L ++D+S N   G                     + F L  
Sbjct: 188 GKIPPTFANL--------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 406 -GFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQ 464
            G  K++  L++ +N + G +P+ L  L FL  LN+S+N+L GE+P  G    +  +S  
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ-RFDVSAY 298
Query: 465 VNVK-LCG 471
            N K LCG
Sbjct: 299 ANNKCLCG 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 123/252 (48%), Gaps = 32/252 (12%)
Query: 524 KSVDTSPAKKQFPMISYAELSKATSEF------ASSNMIGQGSFGSVYKGILGGEEMIVA 577
           KS++ S  +  F   S+ EL   T+ F         N +G+G FG VYKG +      VA
Sbjct: 3   KSLEVSDTR--FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVA 58
Query: 578 VK----VINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYME 633
           VK    ++++  +   + F  E + +   +H NL++++       S G D   LV+ YM 
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMP 113
Query: 634 NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH--HHCQPPIVHGDLKPSNVL 691
           NGSL D L   +       L+   R  IA   A+ I +LH  HH     +H D+K +N+L
Sbjct: 114 NGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANIL 165
Query: 692 LDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGIL 750
           LD    A   +F L+   +  ++T   S  I GT  Y+APE  +  E +   D+YSFG++
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMXS-RIVGTTAYMAPE-ALRGEITPKSDIYSFGVV 223
Query: 751 LLEMFTGRRPTD 762
           LLE+ TG    D
Sbjct: 224 LLEIITGLPAVD 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 122/252 (48%), Gaps = 32/252 (12%)
Query: 524 KSVDTSPAKKQFPMISYAELSKATSEF------ASSNMIGQGSFGSVYKGILGGEEMIVA 577
           KS++ S  +  F   S+ EL   T+ F         N +G+G FG VYKG +      VA
Sbjct: 3   KSLEVSDTR--FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVA 58
Query: 578 VK----VINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYME 633
           VK    ++++  +   + F  E + +   +H NL++++       S G D   LV+ YM 
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMP 113
Query: 634 NGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH--HHCQPPIVHGDLKPSNVL 691
           NGSL D L   +       L+   R  IA   A+ I +LH  HH     +H D+K +N+L
Sbjct: 114 NGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANIL 165
Query: 692 LDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGIL 750
           LD    A   +F L+   +  ++T      I GT  Y+APE  +  E +   D+YSFG++
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMXX-RIVGTTAYMAPE-ALRGEITPKSDIYSFGVV 223
Query: 751 LLEMFTGRRPTD 762
           LLE+ TG    D
Sbjct: 224 LLEIITGLPAVD 235

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 17/208 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR--SFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+V++    G +  VAVK++  +   A R   F+ E   ++ +RH N++  +  
Sbjct: 45  IGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +   +      ++V EY+  GSL   LH+S    +   L   +R+++A DVA  + YLH
Sbjct: 103 VTQPPNL-----SIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDVAKGMNYLH 154
Query: 674 HHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
           +   PPIVH +LK  N+L+D    V   +F LS      + T  SS    GT  ++APE 
Sbjct: 155 NR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEV 210
Query: 733 GMGSEASMTGDVYSFGILLLEMFTGRRP 760
                ++   DVYSFG++L E+ T ++P
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 111/208 (53%), Gaps = 17/208 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR--SFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+V++    G +  VAVK++  +   A R   F+ E   ++ +RH N++  +  
Sbjct: 45  IGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +   +      ++V EY+  GSL   LH+S    +   L   +R+++A DVA  + YLH
Sbjct: 103 VTQPPNL-----SIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDVAKGMNYLH 154
Query: 674 HHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
           +   PPIVH DLK  N+L+D    V   +F LS +L ++    S      GT  ++APE 
Sbjct: 155 NR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLS-RLKASXFLXSKXAA--GTPEWMAPEV 210
Query: 733 GMGSEASMTGDVYSFGILLLEMFTGRRP 760
                ++   DVYSFG++L E+ T ++P
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 116/242 (47%), Gaps = 30/242 (12%)
Query: 534 QFPMISYAELSKATSEF------ASSNMIGQGSFGSVYKGILGGEEMIVAVK----VINL 583
           +F   S+ EL   T+ F         N +G+G FG VYKG +      VAVK    ++++
Sbjct: 5   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDI 62
Query: 584 KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ 643
             +   + F  E + +   +H NL++++       S G D   LV+ YM NGSL D L  
Sbjct: 63  TTEELKQQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGSLLDRLSC 117
Query: 644 SNDHLEVCKLTLIQRVNIAIDVASAIEYLH--HHCQPPIVHGDLKPSNVLLDHDMVAH-Q 700
            +       L+   R  IA   A+ I +LH  HH     +H D+K +N+LLD    A   
Sbjct: 118 LDG---TPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKIS 169
Query: 701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +F L+   +  ++       I GT  Y+APE  +  E +   D+YSFG++LLE+ TG   
Sbjct: 170 DFGLARASEKFAQXVMXX-RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPA 227
Query: 761 TD 762
            D
Sbjct: 228 VD 229

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 133/278 (47%), Gaps = 33/278 (11%)
Query: 554 NMIGQGSFGSVYKGIL----GGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLI 608
            +IG G FG VYKG+L    G +E+ VA+K +        R  F+ E   +    H N+I
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           ++  + S           ++ EYMENG+L+ +L + +    V +L  + R      +A+ 
Sbjct: 110 RLEGVISKYKPM-----MIITEYMENGALDKFLREKDGEFSVLQLVGMLR-----GIAAG 159
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           ++YL +      VH DL   N+L++ ++V    +F LS  L+   +   ++ G K  + +
Sbjct: 160 MKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVK-----MTLPE 781
            APE     + +   DV+SFGI++ E+ T G RP    + E L+ HE +K       LP 
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP----YWE-LSNHEVMKAINDGFRLP- 270
Query: 782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITR 819
               +  PS + ++M      +  RR +  D ++ + +
Sbjct: 271 --TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 113/242 (46%), Gaps = 30/242 (12%)
Query: 534 QFPMISYAELSKATSEF------ASSNMIGQGSFGSVYKGILGGEEMIVAVK----VINL 583
           +F   S+ EL   T+ F         N  G+G FG VYKG +      VAVK    ++++
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN--TTVAVKKLAAMVDI 59
Query: 584 KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ 643
             +   + F  E +     +H NL++++       S G D   LV+ Y  NGSL D L  
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELL----GFSSDGDDL-CLVYVYXPNGSLLDRLSC 114
Query: 644 SNDHLEVCKLTLIQRVNIAIDVASAIEYLH--HHCQPPIVHGDLKPSNVLLDHDMVAH-Q 700
            +       L+   R  IA   A+ I +LH  HH     +H D+K +N+LLD    A   
Sbjct: 115 LDG---TPPLSWHXRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKIS 166
Query: 701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +F L+   +  ++    S  I GT  Y APE  +  E +   D+YSFG++LLE+ TG   
Sbjct: 167 DFGLARASEKFAQXVXXS-RIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPA 224
Query: 761 TD 762
            D
Sbjct: 225 VD 226

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+G FG V  G   G +  VAVK I  K     ++F+AE   +  +RH NL++++ +  
Sbjct: 14  IGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 68
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
            ++ KG  +  +V EYM  GSL D+L      +      L      ++DV  A+EYL  +
Sbjct: 69  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLL----KFSLDVCEAMEYLEGN 121
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL   NVL+  D VA   +F L+ +  S   T       K  V + APE   
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG------KLPVKWTAPEALR 172
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
             + S   DV+SFGILL E+++ GR P
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 117/247 (47%), Gaps = 30/247 (12%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+G FG V  G   G +  VAVK I  K     ++F+AE   +  +RH NL++++ +  
Sbjct: 20  IGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 74
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
            ++ KG  +  +V EYM  GSL D+L      +      L      ++DV  A+EYL  +
Sbjct: 75  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLL----KFSLDVCEAMEYLEGN 127
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL   NVL+  D VA   +F L+ +  S   T       K  V + APE   
Sbjct: 128 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG------KLPVKWTAPEALR 178
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLT--LHEFVKMTLPEKVIEIVDPSL 791
            +  S   DV+SFGILL E+++ GR P      + +   + +  KM  P+       P  
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-----PPA 233
Query: 792 LMEVMAN 798
           + EVM N
Sbjct: 234 VYEVMKN 240

>pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 96  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 147
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 148 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 257
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 258 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 312
Query: 851 G 851
           G
Sbjct: 313 G 313

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+G FG V  G   G +  VAVK I  K     ++F+AE   +  +RH NL++++ +  
Sbjct: 29  IGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 83
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
            ++ KG  +  +V EYM  GSL D+L      +      L      ++DV  A+EYL  +
Sbjct: 84  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLL----KFSLDVCEAMEYLEGN 136
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL   NVL+  D VA   +F L+ +  S   T       K  V + APE   
Sbjct: 137 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG------KLPVKWTAPEALR 187
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
             + S   DV+SFGILL E+++ GR P
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 129
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 239
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 240 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
Query: 851 G 851
           G
Sbjct: 295 G 295

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +      A   A+V ++ E  SL   LH S    E+ KL     ++IA   A  ++YLH
Sbjct: 89  ST------APQLAIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 137
Query: 674 HHCQPPIVHGDLKPSNVLLDHD----------MVAHQNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D                +S SHQ +  S          G
Sbjct: 138 AKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS----------G 184
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     ++   S   DVY+FGI+L E+ TG+ P
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 82  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 133
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 134 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 190
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 243
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 244 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 298
Query: 851 G 851
           G
Sbjct: 299 G 299

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 83  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 134
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 135 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 191
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 192 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 244
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 245 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 299
Query: 851 G 851
           G
Sbjct: 300 G 300

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 129
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 239
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 240 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
Query: 851 G 851
           G
Sbjct: 295 G 295

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 81  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 132
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 133 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 242
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 243 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297
Query: 851 G 851
           G
Sbjct: 298 G 298

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 85  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 136
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 137 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 193
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 194 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 246
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 247 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 301
Query: 851 G 851
           G
Sbjct: 302 G 302

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 76  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 127
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 128 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 184
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 185 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 237
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 238 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 292
Query: 851 G 851
           G
Sbjct: 293 G 293

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 160
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 161 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 217
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 270
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 271 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
Query: 851 G 851
           G
Sbjct: 326 G 326

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 84  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 135
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 136 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 192
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 193 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 245
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 246 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 300
Query: 851 G 851
           G
Sbjct: 301 G 301

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+G FG V  G   G +  VAVK I  K     ++F+AE   +  +RH NL++++ +  
Sbjct: 201 IGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 255
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
            ++ KG  +  +V EYM  GSL D+L      +      L      ++DV  A+EYL  +
Sbjct: 256 -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLL----KFSLDVCEAMEYLEGN 308
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL   NVL+  D VA   +F L+ +  S   T       K  V + APE   
Sbjct: 309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG------KLPVKWTAPEALR 359
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
             + S   DV+SFGILL E+++ GR P
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +          A+V ++ E  SL   LH S    E+ KL     ++IA   A  ++YLH
Sbjct: 77  STKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 125
Query: 674 HHCQPPIVHGDLKPSNVLLDHD----------MVAHQNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D                +S SHQ +  S          G
Sbjct: 126 AKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLS----------G 172
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     ++   S   DVY+FGI+L E+ TG+ P
Sbjct: 173 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 114/222 (51%), Gaps = 16/222 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAE 595
           P  +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 60
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL 655
              ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L
Sbjct: 61  AAVMKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ-EVNAVVL 114
Query: 656 IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKT 714
           +    +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T
Sbjct: 115 LY---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDT 166
Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            ++  G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 167 XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +          A+V ++ E  SL   LH S    E+ KL     ++IA   A  ++YLH
Sbjct: 89  STKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 137
Query: 674 HHCQPPIVHGDLKPSNVLLDHD----------MVAHQNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D                +S SHQ +  S          G
Sbjct: 138 AKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS----------G 184
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     ++   S   DVY+FGI+L E+ TG+ P
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 129
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 239
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 240 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
Query: 851 G 851
           G
Sbjct: 295 G 295

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 45/279 (16%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G FG VY+G+     + VAVK +  +       F+ E   ++ I+H NL++++ +C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
               +   F  ++ E+M  G+L D+L + N   EV  + L+    +A  ++SA+EYL   
Sbjct: 78  ----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVSAVVLLY---MATQISSAMEYLE-- 126
Query: 676 CQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            +   +H DL   N L+ ++ +V   +F LS  +     T ++  G K  + + APE   
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTXTAHAGAKFPIKWTAPESLA 183
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLM 793
            ++ S+  DV++FG+LL E+ T G  P                          +DPS + 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPG-----------------------IDPSQVY 220
Query: 794 EVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFER 832
           E++  +      R  R + C   +      C   +P +R
Sbjct: 221 ELLEKDY-----RMERPEGCPEKVYELMRACWQWNPSDR 254

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +      A   A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 73  ST------APQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 121
Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH----------QNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D+               +S SHQ +  S          G
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----------G 168
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 135/297 (45%), Gaps = 28/297 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 96  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 147
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 148 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 257
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE 847
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+
Sbjct: 258 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 309

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVIEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL+ +N+L+  ++V    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT--ARQGAKFPIKWTAPEAAL 188
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ IRH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL+ +N+L+  ++V    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAAL 188
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 135/297 (45%), Gaps = 28/297 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 77  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 128
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 129 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 185
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 186 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 238
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE 847
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+
Sbjct: 239 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 290

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 540 YAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEAL 599
           Y E+    SE   S  IG GSFG+VYKG   G+  +  +KV++   +  F++F  E   L
Sbjct: 30  YWEIE--ASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPE-QFQAFRNEVAVL 86
Query: 600 RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
           R  RH N++  +   +       D  A+V ++ E  SL   L     H++  K  + Q +
Sbjct: 87  RKTRHVNILLFMGYMTK------DNLAIVTQWCEGSSLYKHL-----HVQETKFQMFQLI 135
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSS 718
           +IA   A  ++YLH      I+H D+K +N+ L   + V   +F L+    +     S S
Sbjct: 136 DIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLA----TVKSRWSGS 188
Query: 719 IGIK---GTVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
             ++   G+V ++APE     +    S   DVYS+GI+L E+ TG  P
Sbjct: 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLY- 115
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 116 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 168
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/315 (25%), Positives = 128/315 (40%), Gaps = 51/315 (16%)
Query: 537 MISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAEC 596
           MI Y E+           ++G+G+FG V K     ++  VA+K I  + +   ++F+ E 
Sbjct: 4   MIDYKEIE-------VEEVVGRGAFGVVCKAKWRAKD--VAIKQI--ESESERKAFIVEL 52
Query: 597 EALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
             L  + H N++K+   C        +   LV EY E GSL + LH +     +   T  
Sbjct: 53  RQLSRVNHPNIVKLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEP---LPYYTAA 102
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS 716
             ++  +  +  + YLH      ++H DLKP N+LL    VA           +A    +
Sbjct: 103 HAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL----VAGGTVLKICDFGTACDIQT 158
Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK 776
                KG+  ++APE   GS  S   DV+S+GI+L E+ T R+P D              
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD-------------- 204
Query: 777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR 836
                   EI  P+  +    +N      R    ++    I      C  + P +R  M 
Sbjct: 205 --------EIGGPAFRIMWAVHNGT----RPPLIKNLPKPIESLMTRCWSKDPSQRPSME 252
Query: 837 DVVAKLCHTRETFLG 851
           ++V  + H    F G
Sbjct: 253 EIVKIMTHLMRYFPG 267

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVIEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL+ +N+L+  ++V    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAAL 188
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 51/315 (16%)
Query: 537 MISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAEC 596
           MI Y E+           ++G+G+FG V K     ++  VA+K   ++ +   ++F+ E 
Sbjct: 5   MIDYKEIE-------VEEVVGRGAFGVVCKAKWRAKD--VAIK--QIESESERKAFIVEL 53
Query: 597 EALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
             L  + H N++K+   C        +   LV EY E GSL + LH +     +   T  
Sbjct: 54  RQLSRVNHPNIVKLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEP---LPYYTAA 103
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS 716
             ++  +  +  + YLH      ++H DLKP N+LL    VA           +A    +
Sbjct: 104 HAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL----VAGGTVLKICDFGTACDIQT 159
Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK 776
                KG+  ++APE   GS  S   DV+S+GI+L E+ T R+P D              
Sbjct: 160 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD-------------- 205
Query: 777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR 836
                   EI  P+  +    +N      R    ++    I      C  + P +R  M 
Sbjct: 206 --------EIGGPAFRIMWAVHNGT----RPPLIKNLPKPIESLMTRCWSKDPSQRPSME 253
Query: 837 DVVAKLCHTRETFLG 851
           ++V  + H    F G
Sbjct: 254 EIVKIMTHLMRYFPG 268

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 250 E------EPIYIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 299
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL+ +N+L+  ++V    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 300 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAAL 354
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 135/301 (44%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L    + ++  KL     +     +   +EY
Sbjct: 81  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQAHAERIDHIKL-----LQYTSQICKGMEY 132
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 133 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 242
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 243 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297
Query: 851 G 851
           G
Sbjct: 298 G 298

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 250 E------EPIYIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 299
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL+ +N+L+  ++V    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 300 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAAL 354
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 118/243 (48%), Gaps = 40/243 (16%)
Query: 539 SYAELSKATSEFASS---------NMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           ++ + ++A  EFA            +IG G FG V  G L   G  E+ VA+K +     
Sbjct: 11  TFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT 70
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIK---IITICSSIDSKGADFKALVFEYMENGSLED 639
            KQ+   R F++E   +    H N+I    ++T C  +         ++ EYMENGSL+ 
Sbjct: 71  DKQR---RDFLSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDA 119
Query: 640 WLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 699
           +L +++      + T+IQ V +   + S ++YL        VH DL   N+L++ ++V  
Sbjct: 120 FLRKNDG-----RFTVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCK 171
Query: 700 -QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-G 757
             +F +S  L+   +   ++ G K  + + APE     + +   DV+S+GI++ E+ + G
Sbjct: 172 VSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 231
Query: 758 RRP 760
            RP
Sbjct: 232 ERP 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 73  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 121
Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH----------QNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D+               +S SHQ +  S          G
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS----------G 168
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 78  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 126
Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH----------QNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D+               +S SHQ +  S          G
Sbjct: 127 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----------G 173
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 174 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 73  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 121
Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH----------QNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D+               +S SHQ +  S          G
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----------G 168
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 93  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 141
Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH----------QNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D+               +S SHQ +  S          G
Sbjct: 142 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS----------G 188
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 189 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 333 E------EPIYIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 382
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL+ +N+L+  ++V    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 383 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAAL 437
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 143/318 (44%), Gaps = 33/318 (10%)
Query: 544 SKATSEFASSNM-----IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVA 594
           S+  ++F   ++     +G+G+FGSV    Y  +      +VAVK +    +   R F  
Sbjct: 2   SRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 61
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLT 654
           E E L++++H N++K   +C S   +      L+ EY+  GSL D+L +  + ++  KL 
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL- 117
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASK 713
               +     +   +EYL        +H +L   N+L++++  V   +F L+  L    +
Sbjct: 118 ----LQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE 170
Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHE 773
                   +  + + APE    S+ S+  DV+SFG++L E+FT    + +         E
Sbjct: 171 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------E 224
Query: 774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM 833
           F++M   +K  +++    L+E++ NN      R  R   C + I      C   +  +R 
Sbjct: 225 FMRMIGNDKQGQMI-VFHLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRP 278
Query: 834 EMRDVVAKLCHTRETFLG 851
             RD+  ++   R+   G
Sbjct: 279 SFRDLALRVDQIRDNMAG 296

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 75  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 123
Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH----------QNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D+               +S SHQ +  S          G
Sbjct: 124 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----------G 170
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 171 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 250 E------EPIYIVGEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 299
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL+ +N+L+  ++V    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 300 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAAL 354
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
           ++    + +G G +G VY+G+     + VAVK +  +       F+ E   ++ I+H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           ++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+    +A  ++S
Sbjct: 70  VQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLY---MATQISS 120
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           A+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++  G K  + 
Sbjct: 121 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTXTAHAGAKFPIK 175
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVSAVVLLY- 120
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 121 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 173
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 100 STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 148
Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH----------QNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D+               +S SHQ +  S          G
Sbjct: 149 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----------G 195
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 196 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 101 STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 149
Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH----------QNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D+               +S SHQ +  S          G
Sbjct: 150 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----------G 196
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 197 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVSAVVLLY- 115
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 116 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 168
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLY- 115
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 116 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 168
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL+ +N+L+  ++V    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAAL 188
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 101 STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 149
Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH----------QNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D+               +S SHQ +  S          G
Sbjct: 150 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS----------G 196
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 197 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 42/220 (19%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 78  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 126
Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH----------QNFSLSHQLDSASKTPSSSIGIKG 723
                 I+H DLK +N+ L  D+               +S SHQ +  S          G
Sbjct: 127 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----------G 173
Query: 724 TVGYVAPEYGMGSEA---SMTGDVYSFGILLLEMFTGRRP 760
           ++ ++APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 174 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVCEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL+ +N+L+  ++V    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAAL 188
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 63
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 64  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 116
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 117 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 169
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 170 PAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 60/222 (27%), Positives = 114/222 (51%), Gaps = 16/222 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAE 595
           P  +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 63
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL 655
              ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L
Sbjct: 64  AAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVL 117
Query: 656 IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKT 714
           +    +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T
Sbjct: 118 LY---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDT 169
Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            ++  G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 16  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 74  E------EPIXIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVE-- 121
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            +   VH DL+ +N+L+  ++V    +F L+  ++    T     G K  + + APE  +
Sbjct: 122 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ--GAKFPIKWTAPEAAL 178
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 179 YGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 65  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 117
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 118 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 170
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 171 PAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 75
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 76  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 128
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 129 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 181
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 182 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 128/279 (45%), Gaps = 45/279 (16%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G +G VY+G+     + VAVK +  +       F+ E   ++ I+H NL++++ +C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
               +   F  ++ E+M  G+L D+L + N   EV  + L+    +A  ++SA+EYL   
Sbjct: 78  ----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVSAVVLLY---MATQISSAMEYLE-- 126
Query: 676 CQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            +   +H DL   N L+ ++ +V   +F LS  +     T ++  G K  + + APE   
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTFTAHAGAKFPIKWTAPESLA 183
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLM 793
            ++ S+  DV++FG+LL E+ T G  P                          +DPS + 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPG-----------------------IDPSQVY 220
Query: 794 EVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFER 832
           E++  +      R  R + C   +      C   +P +R
Sbjct: 221 ELLEKDY-----RMERPEGCPEKVYELMRACWQWNPSDR 254

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 123/245 (50%), Gaps = 42/245 (17%)
Query: 539 SYAELSKATSEFASS---------NMIGQGSFGSVYKGIL---GGEEMIVAVKVIN---- 582
           ++ + ++A  EFA            +IG G FG V  G L   G  E+ VA+K +     
Sbjct: 15  TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 74
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIK---IITICSSIDSKGADFKALVFEYMENGSLED 639
            KQ+   R F++E   +    H N+I    ++T  + +         ++ E+MENGSL+ 
Sbjct: 75  EKQR---RDFLSEASIMGQFDHPNVIHLEGVVTKSTPV--------MIITEFMENGSLDS 123
Query: 640 WLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 699
           +L Q++      + T+IQ V +   +A+ ++YL        VH DL   N+L++ ++V  
Sbjct: 124 FLRQNDG-----QFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCK 175
Query: 700 -QNFSLSHQL--DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             +F LS  L  D++  T +S++G K  + + APE     + +   DV+S+GI++ E+ +
Sbjct: 176 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235
Query: 757 -GRRP 760
            G RP
Sbjct: 236 YGERP 240

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 65  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 117
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 118 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 170
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 171 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 65  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 117
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 118 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 170
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 171 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 120
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 121 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 173
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 120
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 121 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 173
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVSAVVLLY- 115
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 116 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 168
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 193 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGNMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 251 E------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 300
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL+ +N+L+  ++V    +F L   ++    T  +  G K  + + APE  +
Sbjct: 301 N---YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYT--ARQGAKFPIKWTAPEAAL 355
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 356 YGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 120
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 121 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTXTA 173
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  G L D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVMEYMSKGCLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL+ +N+L+  ++V    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAAL 188
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ E++  GSL ++L +  + ++  KL     +     +   +EY
Sbjct: 81  GVCYSAGRRNL---KLIMEFLPYGSLREYLQKHKERIDHIKL-----LQYTSQICKGMEY 132
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        +H DL   N+L++++  V   +F L+  L    +        +  + + AP
Sbjct: 133 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E    S+ S+  DV+SFG++L E+FT    + +         EF++M   +K  +++   
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMI-VF 242
Query: 791 LLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL 850
            L+E++ NN      R  R   C + I      C   +  +R   RD+  ++   R+   
Sbjct: 243 HLIELLKNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297
Query: 851 G 851
           G
Sbjct: 298 G 298

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 119/240 (49%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFASS---------NMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           +Y + ++A  EFA            +IG G FG V  G L   G  E+ VA+K + +   
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            KQ+   R F+ E   +    H N+I +  + +   SK      +V EYMENGSL+ +L 
Sbjct: 64  EKQR---RDFLGEASIMGQFDHPNIIHLEGVVTK--SKPV---MIVTEYMENGSLDTFLK 115
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
           +++      + T+IQ V +   +++ ++YL        VH DL   N+L++ ++V    +
Sbjct: 116 KNDG-----QFTVIQLVGMLRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 167
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F LS  L+   +   ++ G K  + + APE     + +   DV+S+GI++ E+ + G RP
Sbjct: 168 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL  +N+L+  ++V    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 134 N---YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAAL 188
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 115/238 (48%), Gaps = 40/238 (16%)
Query: 544 SKATSEFASS---------NMIGQGSFGSVYKGIL---GGEEMIVAVKVINL----KQKG 587
           ++A  EFA            +IG G FG V  G L   G  E+ VA+K +      KQ+ 
Sbjct: 1   NQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR- 59
Query: 588 AFRSFVAECEALRNIRHRNLIK---IITICSSIDSKGADFKALVFEYMENGSLEDWLHQS 644
             R F++E   +    H N+I    ++T C  +         ++ EYMENGSL+ +L ++
Sbjct: 60  --RDFLSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKN 109
Query: 645 NDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFS 703
           +      + T+IQ V +   + S ++YL        VH DL   N+L++ ++V    +F 
Sbjct: 110 DG-----RFTVIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFG 161
Query: 704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           +S  L+   +   ++ G K  + + APE     + +   DV+S+GI++ E+ + G RP
Sbjct: 162 MSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 118/240 (49%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFAS---------SNMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           +Y + ++   EFA            ++G G FG V  G L     +E+ VA+K + +   
Sbjct: 25  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 84
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            KQ+   R F+ E   +    H N+I++  + +   SK      +V EYMENGSL+ +L 
Sbjct: 85  EKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSFLR 136
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
           + +      + T+IQ V +   +AS ++YL        VH DL   N+L++ ++V    +
Sbjct: 137 KHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 188
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F LS  L+   +   ++ G K  + + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 189 FGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 118/240 (49%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFAS---------SNMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           +Y + ++   EFA            ++G G FG V  G L     +E+ VA+K + +   
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            KQ+   R F+ E   +    H N+I++  + +   SK      +V EYMENGSL+ +L 
Sbjct: 87  EKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSFLR 138
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
           + +      + T+IQ V +   +AS ++YL        VH DL   N+L++ ++V    +
Sbjct: 139 KHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F LS  L+   +   ++ G K  + + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 191 FGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 19  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 77  E------EPIYIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVE-- 124
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            +   VH DL+ +N+L+  ++V    +F L+  ++    T     G K  + + APE  +
Sbjct: 125 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFPIKWTAPEAAL 181
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 120
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 121 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 173
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 174 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 115
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 116 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 168
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 115
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H DL   N L+ ++ +V   +F LS  +     T ++
Sbjct: 116 --MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 168
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 118/240 (49%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFAS---------SNMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           +Y + ++   EFA            ++G G FG V  G L     +E+ VA+K + +   
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            KQ+   R F+ E   +    H N+I++  + +   SK      +V EYMENGSL+ +L 
Sbjct: 87  EKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSFLR 138
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
           + +      + T+IQ V +   +AS ++YL        VH DL   N+L++ ++V    +
Sbjct: 139 KHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F LS  L+   +   ++ G K  + + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 191 FGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  G L D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVTEYMSKGCLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL+ +N+L+  ++V    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAAL 188
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 15  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK-LTLIQRVNIAIDVASAIEYLHH 674
                  +   +V EYM  GSL D+L       E+ K L L Q V++A  +AS + Y+  
Sbjct: 73  E------EPIYIVTEYMSKGSLLDFLKG-----EMGKYLRLPQLVDMAAQIASGMAYVE- 120
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +   VH DL+ +N+L+  ++V    +F L+  ++    T     G K  + + APE  
Sbjct: 121 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFPIKWTAPEAA 176
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRP 760
           +    ++  DV+SFGILL E+ T GR P
Sbjct: 177 LYGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 17  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK-LTLIQRVNIAIDVASAIEYLHH 674
                  +   +V EYM  GSL D+L       E+ K L L Q V++A  +AS + Y+  
Sbjct: 75  E------EPIYIVTEYMSKGSLLDFLKG-----EMGKYLRLPQLVDMAAQIASGMAYVE- 122
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +   VH DL+ +N+L+  ++V    +F L+  ++    T     G K  + + APE  
Sbjct: 123 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFPIKWTAPEAA 178
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRP 760
           +    ++  DV+SFGILL E+ T GR P
Sbjct: 179 LYGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 31/219 (14%)
Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVINL----KQKGAFRSFVAECEALRNIRHRN 606
            +IG G FG V  G L   G  E+ VA+K +      KQ+   R F++E   +    H N
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR---RDFLSEASIMGQFDHPN 70
Query: 607 LIK---IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +I    ++T C  +         ++ EYMENGSL+ +L +++      + T+IQ V +  
Sbjct: 71  IIHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG-----RFTVIQLVGMLR 117
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIK 722
            + S ++YL        VH DL   N+L++ ++V    +F +S  L+   +   ++ G K
Sbjct: 118 GIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 174
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
             + + APE     + +   DV+S+GI++ E+ + G RP
Sbjct: 175 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 118/240 (49%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFAS---------SNMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           ++ + ++   EFA            ++G G FG V  G L     +E+ VA+K + +   
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            KQ+   R F+ E   +    H N+I++  + +   SK      +V EYMENGSL+ +L 
Sbjct: 87  EKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSFLR 138
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
           + +      + T+IQ V +   +AS ++YL        VH DL   N+L++ ++V    +
Sbjct: 139 KHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSD 190
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F LS  L+   +   ++ G K  + + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 191 FGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 269
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 270 MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVSAVVLLY- 322
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H +L   N L+ ++ +V   +F LS  +     T ++
Sbjct: 323 --MATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 375
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V+++  +AS + Y+   
Sbjct: 81  E------EPIYIVTEYMNKGSLLDFLKGETGKY----LRLPQLVDMSAQIASGMAYVE-- 128
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            +   VH DL+ +N+L+  ++V    +F L+  ++    T     G K  + + APE  +
Sbjct: 129 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFPIKWTAPEAAL 185
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVINL----KQKGAFRSFVAECEALRNIRHRN 606
            ++G G FG V  G L     +E+ VA+K + +    KQ+   R F+ E   +    H N
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPN 95
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           +I++  + +   SK      +V EYMENGSL+ +L + +      + T+IQ V +   +A
Sbjct: 96  IIRLEGVVTK--SKPV---MIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIA 145
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTV 725
           S ++YL        VH DL   N+L++ ++V    +F LS  L+   +   ++ G K  +
Sbjct: 146 SGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 202
Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 116/239 (48%), Gaps = 40/239 (16%)
Query: 544 SKATSEFASS---------NMIGQGSFGSVYKGIL---GGEEMIVAVKVINLKQKGAF-- 589
           ++A  EFA            +IG G FG V +G L   G +E  VA+K +    KG +  
Sbjct: 3   NEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTE 58
Query: 590 ---RSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF-EYMENGSLEDWLHQSN 645
              R F++E   +    H N+I++  + ++          ++  E+MENG+L+ +L    
Sbjct: 59  RQRREFLSEASIMGQFEHPNIIRLEGVVTN------SMPVMILTEFMENGALDSFLR--- 109
Query: 646 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSL 704
             L   + T+IQ V +   +AS + YL        VH DL   N+L++ ++V    +F L
Sbjct: 110 --LNDGQFTVIQLVGMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGL 164
Query: 705 SHQLDSASKTPS--SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           S  L+  S  P+  SS+G K  + + APE     + +   D +S+GI++ E+ + G RP
Sbjct: 165 SRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 118/240 (49%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFAS---------SNMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           ++ + ++   EFA            ++G G FG V  G L     +E+ VA+K + +   
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            KQ+   R F+ E   +    H N+I++  + +   SK      +V EYMENGSL+ +L 
Sbjct: 87  EKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSFLR 138
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
           + +      + T+IQ V +   +AS ++YL        VH DL   N+L++ ++V    +
Sbjct: 139 KHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F LS  L+   +   ++ G K  + + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 191 FGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +GQG FG V+ G   G    VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L           L L Q V+++  +AS + Y+   
Sbjct: 81  E------EPIYIVTEYMNKGSLLDFLKGETGKY----LRLPQLVDMSAQIASGMAYVE-- 128
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            +   VH DL+ +N+L+  ++V    +F L+  ++    T     G K  + + APE  +
Sbjct: 129 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQ--GAKFPIKWTAPEAAL 185
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVINL----KQKGAFRSFVAECEALRNIRHRN 606
            ++G G FG V  G L     +E+ VA+K + +    KQ+   R F+ E   +    H N
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPN 78
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           +I++  + +   SK      +V EYMENGSL+ +L + +      + T+IQ V +   +A
Sbjct: 79  IIRLEGVVTK--SKPV---MIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIA 128
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTV 725
           S ++YL        VH DL   N+L++ ++V    +F LS  L+   +   ++ G K  +
Sbjct: 129 SGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 118/240 (49%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFAS---------SNMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           ++ + ++   EFA            ++G G FG V  G L     +E+ VA+K + +   
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            KQ+   R F+ E   +    H N+I++  + +   SK      +V EYMENGSL+ +L 
Sbjct: 87  EKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSFLR 138
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
           + +      + T+IQ V +   +AS ++YL        VH DL   N+L++ ++V    +
Sbjct: 139 KHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F LS  L+   +   ++ G K  + + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 191 FGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G +G VY G+     + VAVK +  +       F+ E   ++ I+H NL++++ +C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                      +V EYM  G+L D+L + N      ++T +  + +A  ++SA+EYL   
Sbjct: 99  LEPPF-----YIVTEYMPYGNLLDYLRECNRE----EVTAVVLLYMATQISSAMEYLE-- 147
Query: 676 CQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            +   +H DL   N L+ ++ +V   +F LS  +     T ++  G K  + + APE   
Sbjct: 148 -KKNFIHRDLAARNCLVGENHVVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLA 204
Query: 735 GSEASMTGDVYSFGILLLEMFT 756
            +  S+  DV++FG+LL E+ T
Sbjct: 205 YNTFSIKSDVWAFGVLLWEIAT 226

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 31/220 (14%)
Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVINLKQKGAF-----RSFVAECEALRNIRHR 605
            +IG G FG V +G L   G +E  VA+K +    KG +     R F++E   +    H 
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTERQRREFLSEASIMGQFEHP 75
Query: 606 NLIKIITICSSIDSKGADFKALVF-EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
           N+I++  + ++          ++  E+MENG+L+ +L      L   + T+IQ V +   
Sbjct: 76  NIIRLEGVVTN------SMPVMILTEFMENGALDSFLR-----LNDGQFTVIQLVGMLRG 124
Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPS--SSIGI 721
           +AS + YL        VH DL   N+L++ ++V    +F LS  L+  S  P+  SS+G 
Sbjct: 125 IASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGG 181
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           K  + + APE     + +   D +S+GI++ E+ + G RP
Sbjct: 182 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 113/219 (51%), Gaps = 16/219 (7%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 308
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 309 MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 361
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +A  ++SA+EYL    +   +H +L   N L+ ++ +V   +F LS  +     T ++
Sbjct: 362 --MATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTA 414
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             G K  + + APE    ++ S+  DV++FG+LL E+ T
Sbjct: 415 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 118/240 (49%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFAS---------SNMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           ++ + ++   EFA            ++G G FG V  G L     +E+ VA+K + +   
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            KQ+   R F+ E   +    H N+I++  + +   SK      +V EYMENGSL+ +L 
Sbjct: 87  EKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSFLR 138
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
           + +      + T+IQ V +   +AS ++YL        VH DL   N+L++ ++V    +
Sbjct: 139 KHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F L+  L+   +   ++ G K  + + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 191 FGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 117/240 (48%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFAS---------SNMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           ++ + ++   EFA            ++G G FG V  G L     +E+ VA+K + +   
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            KQ+   R F+ E   +    H N+I++  + +   SK      +V EYMENGSL+ +L 
Sbjct: 87  EKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSFLR 138
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
           + +      + T+IQ V +   +AS ++YL        VH DL   N+L++ ++V    +
Sbjct: 139 KHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F L   L+   +   ++ G K  + + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 117/240 (48%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFAS---------SNMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           +Y + ++   EFA            ++G G FG V  G L     +E+ VA+K + +   
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            KQ+   R F+ E   +    H N+I++  + +   SK      +V E MENGSL+ +L 
Sbjct: 87  EKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEXMENGSLDSFLR 138
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
           + +      + T+IQ V +   +AS ++YL        VH DL   N+L++ ++V    +
Sbjct: 139 KHD-----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F LS  L+   +   ++ G K  + + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 191 FGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 118/257 (45%), Gaps = 41/257 (15%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA-------FRSFVAECEA 598
           A +E      IG+G FG V+KG L  ++ +VA+K + L            F+ F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           + N+ H N++K+  +  +          +V E++  G L    H+  D     K ++  +
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR-------MVMEFVPCGDL---YHRLLDKAHPIKWSV--K 124
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVL---LDHDM---VAHQNFSLSHQLDSAS 712
           + + +D+A  IEY+ +   PPIVH DL+  N+    LD +        +FSLS Q     
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ----- 178
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMT--GDVYSFGILLLEMFTGRRPTDAAFTEG-- 768
            +  S  G+ G   ++APE     E S T   D YSF ++L  + TG  P D  ++ G  
Sbjct: 179 -SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKI 236
Query: 769 ----LTLHEFVKMTLPE 781
               +   E ++ T+PE
Sbjct: 237 KFINMIREEGLRPTIPE 253

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G FG V+ G   G    VA+K +         SF+ E + ++ ++H  L+++  + S
Sbjct: 17  LGNGQFGEVWMGTWNGNTK-VAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +V EYM  GSL D+L       E   L L   V++A  VA+ + Y+   
Sbjct: 75  E------EPIYIVTEYMNKGSLLDFLKDG----EGRALKLPNLVDMAAQVAAGMAYIERM 124
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                +H DL+ +N+L+ + ++    +F L+  ++    T  +  G K  + + APE  +
Sbjct: 125 N---YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXT--ARQGAKFPIKWTAPEAAL 179
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL E+ T GR P
Sbjct: 180 YGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 113/221 (51%), Gaps = 33/221 (14%)
Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRN 606
            +IG G FG V  G L   G  E+ VA+K +      KQ+   R F++E   +    H N
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPN 69
Query: 607 LIK---IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +I    ++T  + +         ++ E+MENGSL+ +L Q++      + T+IQ V +  
Sbjct: 70  VIHLEGVVTKSTPV--------MIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLR 116
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQL--DSASKTPSSSIG 720
            +A+ ++YL        VH  L   N+L++ ++V    +F LS  L  D++  T +S++G
Sbjct: 117 GIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            K  + + APE     + +   DV+S+GI++ E+ + G RP
Sbjct: 174 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 49/280 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G      V V +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 30  LGAGQFGEVWMGYYNGH---TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 87  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 136
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                 +H DL+ +N+L+   +     +F L+  ++    T  +  G K  + + APE  
Sbjct: 137 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT--AREGAKFPIKWTAPEAI 191
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLL 792
                ++  DV+SFGILL E+ T GR P             +  MT PE +         
Sbjct: 192 NYGTFTIKSDVWSFGILLTEIVTHGRIP-------------YPGMTNPEVI--------- 229
Query: 793 MEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFER 832
                  ++ +  R  R  +C   + +   LC  E P +R
Sbjct: 230 ------QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 263

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 49/280 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G      V V +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 29  LGAGQFGEVWMGYYNGH---TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 86  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 135
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                 +H DL+ +N+L+   +     +F L+  ++    T  +  G K  + + APE  
Sbjct: 136 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT--AREGAKFPIKWTAPEAI 190
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLL 792
                ++  DV+SFGILL E+ T GR P             +  MT PE VI+ ++    
Sbjct: 191 NYGTFTIKSDVWSFGILLTEIVTHGRIP-------------YPGMTNPE-VIQNLERGYR 236
Query: 793 MEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFER 832
           M               R  +C   + +   LC  E P +R
Sbjct: 237 M--------------VRPDNCPEELYQLMRLCWKERPEDR 262

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 49/280 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G      V V +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 27  LGAGQFGEVWMGYYNGH---TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 84  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 133
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                 +H DL+ +N+L+   +     +F L+  ++    T  +  G K  + + APE  
Sbjct: 134 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT--AREGAKFPIKWTAPEAI 188
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLL 792
                ++  DV+SFGILL E+ T GR P             +  MT PE VI+ ++    
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGRIP-------------YPGMTNPE-VIQNLERGYR 234
Query: 793 MEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFER 832
           M               R  +C   + +   LC  E P +R
Sbjct: 235 M--------------VRPDNCPEELYQLMRLCWKERPEDR 260

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 32/226 (14%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA----ECEALRNIR 603
           +E     +IG G FG VY+    G+E  VAVK             +     E +    ++
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N+I +  +C    +       LV E+   G L       N  L   ++     VN A+
Sbjct: 65  HPNIIALRGVCLKEPNL-----CLVMEFARGGPL-------NRVLSGKRIPPDILVNWAV 112
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVL---------LDHDMVAHQNFSLSHQLDSASKT 714
            +A  + YLH     PI+H DLK SN+L         L + ++   +F L+ +    +K 
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172
Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            ++     G   ++APE    S  S   DV+S+G+LL E+ TG  P
Sbjct: 173 SAA-----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 117/240 (48%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFASS---------NMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           +Y + ++A  +FA            +IG G FG V  G L   G  ++ VA+K + +   
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            KQ+   R F+ E   +    H N++ +      + ++G     +V E+MENG+L+ +L 
Sbjct: 85  EKQR---RDFLCEASIMGQFDHPNVVHL----EGVVTRGKPV-MIVIEFMENGALDAFLR 136
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
           + +      + T+IQ V +   +A+ + YL        VH DL   N+L++ ++V    +
Sbjct: 137 KHDG-----QFTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSD 188
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F LS  ++   +   ++ G K  V + APE     + +   DV+S+GI++ E+ + G RP
Sbjct: 189 FGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 117/240 (48%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFAS---------SNMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           ++ + ++   EFA            ++G G FG V  G L     +E+ VA+K + +   
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            KQ+   R F+ E   +    H N+I++  + +   SK      +V E MENGSL+ +L 
Sbjct: 87  EKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEXMENGSLDSFLR 138
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
           + +      + T+IQ V +   +AS ++YL        VH DL   N+L++ ++V    +
Sbjct: 139 KHD-----AQFTVIQLVGMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSD 190
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F LS  L+   +   ++ G K  + + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 191 FGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 25/216 (11%)
Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVINL----KQKGAFRSFVAECEALRNIRHRN 606
            ++G G FG V  G L     +E+ VA+K + +    KQ+   R F+ E   +    H N
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPN 78
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           +I++  + +   SK      +V E MENGSL+ +L + +      + T+IQ V +   +A
Sbjct: 79  IIRLEGVVTK--SKPV---MIVTEXMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIA 128
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTV 725
           S ++YL        VH DL   N+L++ ++V    +F LS  L+   +   ++ G K  +
Sbjct: 129 SGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            + +PE     + +   DV+S+GI+L E+ + G RP
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 35/223 (15%)
Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLIKIIT 612
           +IG+G +G+VYKG L  +E  VAVKV +   +   ++F+ E    R   + H N+ + I 
Sbjct: 20  LIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIV 74
Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLH-QSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
               + + G     LV EY  NGSL  +L   ++D +  C+L        A  V   + Y
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL--------AHSVTRGLAY 126
Query: 672 LH------HHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLD-----SASKTPSSSI 719
           LH       H +P I H DL   NVL+ +D      +F LS +L         +  +++I
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 720 GIKGTVGYVAPEYGMGS------EASMTG-DVYSFGILLLEMF 755
              GT+ Y+APE   G+      E+++   D+Y+ G++  E+F
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 556 IGQGSFGSVY------KGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLI 608
           +G+G FG V       +G   GE+  VAVK +  +  G        E E LRN+ H N++
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQ--VAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           K   IC+     G +   L+ E++ +GSL+++L ++ +     K+ L Q++  A+ +   
Sbjct: 75  KYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKG 126
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           ++YL        VH DL   NVL++ +  V   +F L+  +++  +  +        V +
Sbjct: 127 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 183
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            APE  M S+  +  DV+SFG+ L E+ T
Sbjct: 184 YAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 49/280 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G      V V +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 31  LGAGQFGEVWMGYYNGH---TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 88  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 137
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                 +H DL+ +N+L+   +     +F L+  ++    T  +  G K  + + APE  
Sbjct: 138 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT--AREGAKFPIKWTAPEAI 192
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLL 792
                ++  DV+SFGILL E+ T GR P             +  MT PE VI+ ++    
Sbjct: 193 NYGTFTIKSDVWSFGILLTEIVTHGRIP-------------YPGMTNPE-VIQNLERGYR 238
Query: 793 MEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFER 832
           M               R  +C   + +   LC  E P +R
Sbjct: 239 M--------------VRPDNCPEELYQLMRLCWKERPEDR 264

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 556 IGQGSFGSVY------KGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLI 608
           +G+G FG V       +G   GE+  VAVK +  +  G        E E LRN+ H N++
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQ--VAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           K   IC+     G +   L+ E++ +GSL+++L ++ +     K+ L Q++  A+ +   
Sbjct: 87  KYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKG 138
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           ++YL        VH DL   NVL++ +  V   +F L+  +++  +  +        V +
Sbjct: 139 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 195
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            APE  M S+  +  DV+SFG+ L E+ T
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 35/217 (16%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 613
           +G G FG V  G   G+   VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 32  LGTGQFGVVKYGKWRGQ-YDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLH------QSNDHLEVCKLTLIQRVNIAIDVAS 667
           C+    +   F  ++ EYM NG L ++L       Q+   LE+CK           DV  
Sbjct: 88  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCK-----------DVCE 131
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           A+EYL        +H DL   N L+ D  +V   +F LS  +    +T  SS+G K  V 
Sbjct: 132 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEET--SSVGSKFPVR 186
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           +  PE  M S+ S   D+++FG+L+ E+++ G+ P +
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 117/257 (45%), Gaps = 41/257 (15%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA-------FRSFVAECEA 598
           A +E      IG+G FG V+KG L  ++ +VA+K + L            F+ F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           + N+ H N++K+  +  +          +V E++  G L    H+  D     K ++  +
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR-------MVMEFVPCGDL---YHRLLDKAHPIKWSV--K 124
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVL---LDHDM---VAHQNFSLSHQLDSAS 712
           + + +D+A  IEY+ +   PPIVH DL+  N+    LD +        +F LS Q     
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----- 178
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMT--GDVYSFGILLLEMFTGRRPTDAAFTEG-- 768
            +  S  G+ G   ++APE     E S T   D YSF ++L  + TG  P D  ++ G  
Sbjct: 179 -SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKI 236
Query: 769 ----LTLHEFVKMTLPE 781
               +   E ++ T+PE
Sbjct: 237 KFINMIREEGLRPTIPE 253

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 23/219 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 605
           SE      IG G FG V+ G    ++  VA+K I   ++GA     F+ E E +  + H 
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTI---REGAMSEEDFIEEAEVMMKLSHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
            L+++  +C            LVFE+ME+G L D+L           L     + + +DV
Sbjct: 63  KLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 112
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + YL   C   ++H DL   N L+ ++ ++   +F ++  +     T  SS G K  
Sbjct: 113 CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFP 167
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           V + +PE    S  S   DV+SFG+L+ E+F+ G+ P +
Sbjct: 168 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 206

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 23/219 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 605
           SE      IG G FG V+ G    ++  VA+K I   ++GA     F+ E E +  + H 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTI---REGAMSEEDFIEEAEVMMKLSHP 60
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
            L+++  +C            LVFE+ME+G L D+L           L     + + +DV
Sbjct: 61  KLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 110
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + YL   C   ++H DL   N L+ ++ ++   +F ++  +     T  SS G K  
Sbjct: 111 CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFP 165
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           V + +PE    S  S   DV+SFG+L+ E+F+ G+ P +
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 121/286 (42%), Gaps = 39/286 (13%)
Query: 554 NMIGQGSFGSVYKGILGGEE---MIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLI 608
            ++G+G FGSV +G L  E+   + VAVK + L    +     F++E   +++  H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           +++ +C  + S+G     ++  +M+ G L  +L  S        + L   +   +D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +EYL +      +H DL   N +L  DM V   +F LS ++ S        I  K  V +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA-KMPVKW 215
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEI 786
           +A E       +   DV++FG+ + E+ T G  P       G+  HE             
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP-----YPGVQNHEMY----------- 259
Query: 787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFER 832
                       + ++   R  + +DCL+ +      C    P +R
Sbjct: 260 ------------DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 23/219 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 605
           SE      IG G FG V+ G    ++  VA+K I   ++GA     F+ E E +  + H 
Sbjct: 10  SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTI---REGAMSEEDFIEEAEVMMKLSHP 65
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
            L+++  +C            LVFE+ME+G L D+L           L     + + +DV
Sbjct: 66  KLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 115
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + YL   C   ++H DL   N L+ ++ ++   +F ++  +     T  SS G K  
Sbjct: 116 CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFP 170
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           V + +PE    S  S   DV+SFG+L+ E+F+ G+ P +
Sbjct: 171 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 209

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 34/214 (15%)
Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNL 607
             IG+G+FG V+ G L  +  +VAVK        +LK K     F+ E   L+   H N+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNI 174
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           +++I +C+           +V E ++ G    +L      L V   TL+Q V    D A+
Sbjct: 175 VRLIGVCTQKQP-----IYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVG---DAAA 224
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT-V 725
            +EYL   C    +H DL   N L+ + +++   +F +S   + A    ++S G++   V
Sbjct: 225 GMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVXAASGGLRQVPV 279
Query: 726 GYVAPE---YGMGSEASMTGDVYSFGILLLEMFT 756
            + APE   YG  S  S   DV+SFGILL E F+
Sbjct: 280 KWTAPEALNYGRYSSES---DVWSFGILLWETFS 310

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 35/217 (16%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 613
           +G G FG V  G   G+   VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 17  LGTGQFGVVKYGKWRGQ-YDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLH------QSNDHLEVCKLTLIQRVNIAIDVAS 667
           C+    +   F  ++ EYM NG L ++L       Q+   LE+CK           DV  
Sbjct: 73  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCK-----------DVCE 116
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           A+EYL        +H DL   N L+ D  +V   +F LS  +     T  SS+G K  V 
Sbjct: 117 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVR 171
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           +  PE  M S+ S   D+++FG+L+ E+++ G+ P +
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 35/217 (16%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 613
           +G G FG V  G   G+   VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 12  LGTGQFGVVKYGKWRGQ-YDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLH------QSNDHLEVCKLTLIQRVNIAIDVAS 667
           C+    +   F  ++ EYM NG L ++L       Q+   LE+CK           DV  
Sbjct: 68  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCK-----------DVCE 111
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           A+EYL        +H DL   N L+ D  +V   +F LS  +     T  SS+G K  V 
Sbjct: 112 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVR 166
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           +  PE  M S+ S   D+++FG+L+ E+++ G+ P +
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 35/217 (16%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 613
           +G G FG V  G   G+   VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 32  LGTGQFGVVKYGKWRGQ-YDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLH------QSNDHLEVCKLTLIQRVNIAIDVAS 667
           C+    +   F  ++ EYM NG L ++L       Q+   LE+CK           DV  
Sbjct: 88  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCK-----------DVCE 131
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           A+EYL        +H DL   N L+ D  +V   +F LS  +     T  SS+G K  V 
Sbjct: 132 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVR 186
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           +  PE  M S+ S   D+++FG+L+ E+++ G+ P +
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G    VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-VAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 78  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE- 126
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +   +H DL+ +N+L+   +     +F L+  ++    T     G K  + + APE  
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE--GAKFPIKWTAPEAI 182
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRP 760
                ++  DV+SFGILL E+ T GR P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G    VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-VAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 78  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE- 126
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +   +H DL+ +N+L+   +     +F L+  ++    T     G K  + + APE  
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE--GAKFPIKWTAPEAI 182
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRP 760
                ++  DV+SFGILL E+ T GR P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 114/251 (45%), Gaps = 29/251 (11%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA-------FRSFVAECEA 598
           A +E      IG+G FG V+KG L  ++ +VA+K + L            F+ F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           + N+ H N++K+  +  +          +V E++  G L    H+  D     K ++  +
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR-------MVMEFVPCGDL---YHRLLDKAHPIKWSV--K 124
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSS 718
           + + +D+A  IEY+ +   PPIVH DL+  N+ L          +      ++ ++  S 
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSV 183
Query: 719 IGIKGTVGYVAPEYGMGSEASMT--GDVYSFGILLLEMFTGRRPTDAAFTEG------LT 770
            G+ G   ++APE     E S T   D YSF ++L  + TG  P D  ++ G      + 
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFINMI 242
Query: 771 LHEFVKMTLPE 781
             E ++ T+PE
Sbjct: 243 REEGLRPTIPE 253

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G    VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTK-VAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 79  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE- 127
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +   +H DL+ +N+L+   +     +F L+  ++    T     G K  + + APE  
Sbjct: 128 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE--GAKFPIKWTAPEAI 183
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRP 760
                ++  DV+SFGILL E+ T GR P
Sbjct: 184 NYGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G    VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTK-VAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 80  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE- 128
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +   +H DL+ +N+L+   +     +F L+  ++    T     G K  + + APE  
Sbjct: 129 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE--GAKFPIKWTAPEAI 184
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRP 760
                ++  DV+SFGILL E+ T GR P
Sbjct: 185 NYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 35/217 (16%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 613
           +G G FG V  G   G+   VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 23  LGTGQFGVVKYGKWRGQ-YDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLH------QSNDHLEVCKLTLIQRVNIAIDVAS 667
           C+    +   F  ++ EYM NG L ++L       Q+   LE+CK           DV  
Sbjct: 79  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCK-----------DVCE 122
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           A+EYL        +H DL   N L+ D  +V   +F LS  +     T  SS+G K  V 
Sbjct: 123 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVR 177
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           +  PE  M S+ S   D+++FG+L+ E+++ G+ P +
Sbjct: 178 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 34/214 (15%)
Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNL 607
             IG+G+FG V+ G L  +  +VAVK        +LK K     F+ E   L+   H N+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNI 174
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           +++I +C+           +V E ++ G    +L      L V   TL+Q V    D A+
Sbjct: 175 VRLIGVCTQKQP-----IYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVG---DAAA 224
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT-V 725
            +EYL   C    +H DL   N L+ + +++   +F +S   + A    ++S G++   V
Sbjct: 225 GMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPV 279
Query: 726 GYVAPE---YGMGSEASMTGDVYSFGILLLEMFT 756
            + APE   YG  S  S   DV+SFGILL E F+
Sbjct: 280 KWTAPEALNYGRYSSES---DVWSFGILLWETFS 310

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G    VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-VAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 84  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE- 132
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +   +H DL+ +N+L+   +     +F L+  ++    T     G K  + + APE  
Sbjct: 133 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAI 188
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRP 760
                ++  DV+SFGILL E+ T GR P
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G    VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-VAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 78  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE- 126
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +   +H DL+ +N+L+   +     +F L+  ++    T     G K  + + APE  
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAI 182
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRP 760
                ++  DV+SFGILL E+ T GR P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G    VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTK-VAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 73  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE- 121
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +   +H DL+ +N+L+   +     +F L+  ++    T     G K  + + APE  
Sbjct: 122 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAI 177
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRP 760
                ++  DV+SFGILL E+ T GR P
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVTHGRIP 205

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G    VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTK-VAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 83  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE- 131
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +   +H DL+ +N+L+   +     +F L+  ++    T     G K  + + APE  
Sbjct: 132 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAI 187
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRP 760
                ++  DV+SFGILL E+ T GR P
Sbjct: 188 NYGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 38/219 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 613
           IG+G FG V++G   GEE  VAVK+ + +++   RS+  E E  + +  RH N++  I  
Sbjct: 37  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 90
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
             + D+       LV +Y E+GSL D+L++         +T+   + +A+  AS + +LH
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLH 143
Query: 674 HHC-----QPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKT----PSSSIGI 721
                   +P I H DLK  N+L+  +    +A    ++ H  DSA+ T    P+  +G 
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH--DSATDTIDIAPNHRVGT 201
Query: 722 KGTVGYVAPEYGMGS------EASMTGDVYSFGILLLEM 754
           K    Y+APE    S      E+    D+Y+ G++  E+
Sbjct: 202 K---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 38/219 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 613
           IG+G FG V++G   GEE  VAVK+ + +++   RS+  E E  + +  RH N++  I  
Sbjct: 50  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 103
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
             + D+       LV +Y E+GSL D+L++         +T+   + +A+  AS + +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLH 156
Query: 674 HHC-----QPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKT----PSSSIGI 721
                   +P I H DLK  N+L+  +    +A    ++ H  DSA+ T    P+  +G 
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH--DSATDTIDIAPNHRVGT 214
Query: 722 KGTVGYVAPEYGMGS------EASMTGDVYSFGILLLEM 754
           K    Y+APE    S      E+    D+Y+ G++  E+
Sbjct: 215 K---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 35/215 (16%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 613
           +G G FG V  G   G+   VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 16  LGTGQFGVVKYGKWRGQ-YDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLH------QSNDHLEVCKLTLIQRVNIAIDVAS 667
           C+    +   F  ++ EYM NG L ++L       Q+   LE+CK           DV  
Sbjct: 72  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCK-----------DVCE 115
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           A+EYL        +H DL   N L+ D  +V   +F LS  +     T  SS+G K  V 
Sbjct: 116 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVR 170
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           +  PE  M S+ S   D+++FG+L+ E+++ G+ P
Sbjct: 171 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 205

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 94  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 144
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           ++YL        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 145 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVK 201
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 202 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFASS---------NMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           +Y E  +A   F             +IG G  G V  G L   G  ++ VA+K +     
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            +Q+   R F++E   +    H N+I++  + +           +V EYMENGSL+ +L 
Sbjct: 91  ERQR---RDFLSEASIMGQFDHPNIIRLEGVVTR-----GRLAMIVTEYMENGSLDTFLR 142
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
             +      + T++Q V +   V + + YL        VH DL   NVL+D ++V    +
Sbjct: 143 THDG-----QFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSD 194
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F LS  L+       ++ G K  + + APE       S   DV+SFG+++ E+   G RP
Sbjct: 195 FGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 23/219 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHR 605
           SE      IG G FG V+ G    ++  VA+K I   ++G+     F+ E E +  + H 
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTI---KEGSMSEDDFIEEAEVMMKLSHP 82
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
            L+++  +C            LVFE+ME+G L D+L           L     + + +DV
Sbjct: 83  KLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 132
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + YL   C   ++H DL   N L+ ++ ++   +F ++  +     T  SS G K  
Sbjct: 133 CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFP 187
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           V + +PE    S  S   DV+SFG+L+ E+F+ G+ P +
Sbjct: 188 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 226

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 38/219 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 613
           IG+G FG V++G   GEE  VAVK+ + +++   RS+  E E  + +  RH N++  I  
Sbjct: 12  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 65
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
             + D+       LV +Y E+GSL D+L++         +T+   + +A+  AS + +LH
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLH 118
Query: 674 HHC-----QPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKT----PSSSIGI 721
                   +P I H DLK  N+L+  +    +A    ++ H  DSA+ T    P+  +G 
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH--DSATDTIDIAPNHRVGT 176
Query: 722 KGTVGYVAPEYGMGS------EASMTGDVYSFGILLLEM 754
           K    Y+APE    S      E+    D+Y+ G++  E+
Sbjct: 177 K---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G  G V+ G   G    VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTK-VAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 78  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE- 126
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +   +H DL+ +N+L+   +     +F L+  ++ A  T     G K  + + APE  
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTARE--GAKFPIKWTAPEAI 182
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRP 760
                ++  DV+SFGILL E+ T GR P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 38/219 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 613
           IG+G FG V++G   GEE  VAVK+ + +++   RS+  E E  + +  RH N++  I  
Sbjct: 17  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 70
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
             + D+       LV +Y E+GSL D+L++         +T+   + +A+  AS + +LH
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLH 123
Query: 674 HHC-----QPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKT----PSSSIGI 721
                   +P I H DLK  N+L+  +    +A    ++ H  DSA+ T    P+  +G 
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH--DSATDTIDIAPNHRVGT 181
Query: 722 KGTVGYVAPEYGMGS------EASMTGDVYSFGILLLEM 754
           K    Y+APE    S      E+    D+Y+ G++  E+
Sbjct: 182 K---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 113 SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 163
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           ++YL        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 164 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 220
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 221 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 38/219 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 613
           IG+G FG V++G   GEE  VAVK+ + +++   RS+  E E  + +  RH N++  I  
Sbjct: 11  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 64
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
             + D+       LV +Y E+GSL D+L++         +T+   + +A+  AS + +LH
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLH 117
Query: 674 HHC-----QPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKT----PSSSIGI 721
                   +P I H DLK  N+L+  +    +A    ++ H  DSA+ T    P+  +G 
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH--DSATDTIDIAPNHRVGT 175
Query: 722 KGTVGYVAPEYGMGS------EASMTGDVYSFGILLLEM 754
           K    Y+APE    S      E+    D+Y+ G++  E+
Sbjct: 176 K---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 95  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 145
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           ++YL        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 146 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 202
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 26/275 (9%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 87  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 137
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           ++YL        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 138 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 194
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLH--EFVKMTLPEKV 783
           ++A E     + +   DV+SFG+LL E+ T G  P     T  +T++  +  ++  PE  
Sbjct: 195 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 254
Query: 784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAIT 818
                P  L EVM      + + R    + ++ I+
Sbjct: 255 -----PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 284

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 114 SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 164
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           ++YL        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 165 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 221
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 222 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 38/219 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 613
           IG+G FG V++G   GEE  VAVK+ + +++   RS+  E E  + +  RH N++  I  
Sbjct: 14  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 67
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
             + D+       LV +Y E+GSL D+L++         +T+   + +A+  AS + +LH
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLH 120
Query: 674 HHC-----QPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKT----PSSSIGI 721
                   +P I H DLK  N+L+  +    +A    ++ H  DSA+ T    P+  +G 
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH--DSATDTIDIAPNHRVGT 178
Query: 722 KGTVGYVAPEYGMGS------EASMTGDVYSFGILLLEM 754
           K    Y+APE    S      E+    D+Y+ G++  E+
Sbjct: 179 K---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 539 SYAELSKATSEFASS---------NMIGQGSFGSVYKGIL---GGEEMIVAVKVINL--- 583
           +Y E  +A   F             +IG G  G V  G L   G  ++ VA+K +     
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 584 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
            +Q+   R F++E   +    H N+I++  + +           +V EYMENGSL+ +L 
Sbjct: 91  ERQR---RDFLSEASIMGQFDHPNIIRLEGVVTR-----GRLAMIVTEYMENGSLDTFLR 142
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
             +      + T++Q V +   V + + YL        VH DL   NVL+D ++V    +
Sbjct: 143 THDG-----QFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSD 194
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F LS  L+       ++ G K  + + APE       S   DV+SFG+++ E+   G RP
Sbjct: 195 FGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 92  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 142
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           ++YL        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 143 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 199
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 95  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 145
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           ++YL        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 146 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 202
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 93  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 143
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           ++YL        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 144 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 200
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 90  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 140
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           ++YL        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 141 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 94  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 144
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           ++YL        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 145 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 201
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 202 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 139/299 (46%), Gaps = 32/299 (10%)
Query: 528 TSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGE----EMIVAVKVIN- 582
           T+P + Q  ++   EL +         ++G G+FG+VYKGI   E    ++ VA+K++N 
Sbjct: 25  TAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE 77
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
                A   F+ E   + ++ H +L++++ +C S   +      LV + M +G L +++H
Sbjct: 78  TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVH 131
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQN 701
           +  D++    L     +N  + +A  + YL       +VH DL   NVL+   + V   +
Sbjct: 132 EHKDNIGSQLL-----LNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITD 183
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F L+  L+   K  ++  G K  + ++A E     + +   DV+S+G+ + E+ T G +P
Sbjct: 184 FGLARLLEGDEKEYNAD-GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 242
Query: 761 TDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITR 819
            D   T  +         LP+  I  +D   +  VM    MI  D R + ++     +R
Sbjct: 243 YDGIPTREIPDLLEKGERLPQPPICTID---VYMVMVKCWMIDADSRPKFKELAAEFSR 298

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 35/217 (16%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 613
           +G G FG V  G   G+   VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 17  LGTGQFGVVKYGKWRGQ-YDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLH------QSNDHLEVCKLTLIQRVNIAIDVAS 667
           C+    +   F  ++ EYM NG L ++L       Q+   LE+CK           DV  
Sbjct: 73  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQLLEMCK-----------DVCE 116
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           A+EYL        +H DL   N L+ D  +V   +F LS  +     T  SS G K  V 
Sbjct: 117 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSRGSKFPVR 171
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           +  PE  M S+ S   D+++FG+L+ E+++ G+ P +
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 23/219 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 605
           SE      IG G FG V+ G    ++  VA+K I   ++GA     F+ E E +  + H 
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTI---REGAMSEEDFIEEAEVMMKLSHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
            L+++  +C            LVFE+ME+G L D+L           L     + + +DV
Sbjct: 63  KLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 112
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + YL    +  ++H DL   N L+ ++ ++   +F ++  +     T  SS G K  
Sbjct: 113 CEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFP 167
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           V + +PE    S  S   DV+SFG+L+ E+F+ G+ P +
Sbjct: 168 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 206

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 96  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 146
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQ-LDSASKTPSSSIGIKGTVG 726
           +++L        VH DL   N +LD    V   +F L+   LD    +  +  G K  V 
Sbjct: 147 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVK 203
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 139/299 (46%), Gaps = 32/299 (10%)
Query: 528 TSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGE----EMIVAVKVIN- 582
           T+P + Q  ++   EL +         ++G G+FG+VYKGI   E    ++ VA+K++N 
Sbjct: 2   TAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE 54
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
                A   F+ E   + ++ H +L++++ +C S   +      LV + M +G L +++H
Sbjct: 55  TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVH 108
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQN 701
           +  D++    L     +N  + +A  + YL       +VH DL   NVL+   + V   +
Sbjct: 109 EHKDNIGSQLL-----LNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITD 160
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           F L+  L+   K  ++  G K  + ++A E     + +   DV+S+G+ + E+ T G +P
Sbjct: 161 FGLARLLEGDEKEYNAD-GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 219
Query: 761 TDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITR 819
            D   T  +         LP+  I  +D  +   VM    MI  D R + ++     +R
Sbjct: 220 YDGIPTREIPDLLEKGERLPQPPICTIDVYM---VMVKCWMIDADSRPKFKELAAEFSR 275

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G FG V+ G   G    VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTK-VAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
           +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++  
Sbjct: 74  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE- 122
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
             +   +H +L+ +N+L+   +     +F L+  ++    T     G K  + + APE  
Sbjct: 123 --ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAI 178
Query: 734 MGSEASMTGDVYSFGILLLEMFT-GRRP 760
                ++  DV+SFGILL E+ T GR P
Sbjct: 179 NYGTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 605
           SE      IG G FG V+ G    ++  VA+K I   ++GA     F+ E E +  + H 
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTI---REGAMSEEDFIEEAEVMMKLSHP 63
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
            L+++  +C            LV E+ME+G L D+L           L     + + +DV
Sbjct: 64  KLVQLYGVCLEQAPI-----CLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 113
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + YL   C   ++H DL   N L+ ++ ++   +F ++  +     T  SS G K  
Sbjct: 114 CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFP 168
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           V + +PE    S  S   DV+SFG+L+ E+F+ G+ P +
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 207

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 556 IGQGSFGSV-----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G+FG V     Y      ++M+VAVK +      A + F  E E L N++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC----------KLTLIQRVN 660
             +C        D   +VFEYM++G L  +L        +           +L L Q ++
Sbjct: 83  YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSI 719
           IA  +AS + YL        VH DL   N L+  + +V   +F +S  + S   T    +
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS---TDYYRV 191
Query: 720 GIKGT--VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           G      + ++ PE  M  + +   DV+SFG++L E+FT G++P
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 613
           +G G FG V  G   G+   VAVK+I   ++G+     F  E + +  + H  L+K   +
Sbjct: 16  LGSGQFGVVKLGKWKGQ-YDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 614 CSSIDSKGADFKA-LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           CS       ++   +V EY+ NG L ++L      LE  +L     + +  DV   + +L
Sbjct: 72  CSK------EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFL 120
Query: 673 HHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLS-HQLDSASKTPSSSIGIKGTVGYVAP 730
             H     +H DL   N L+D D+ V   +F ++ + LD       SS+G K  V + AP
Sbjct: 121 ESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAP 174
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
           E     + S   DV++FGIL+ E+F+ G+ P D
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 93  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 143
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           +++L        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 144 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 200
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 96  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 146
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           +++L        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 147 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 203
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 100 SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 150
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           +++L        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 151 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 207
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 208 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 95  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 145
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           +++L        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 146 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 95  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 145
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           +++L        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 146 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++A E     + +   DV+SFG+LL E+ T   P
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G+GSFG V        +  VA+K I+   LK+         E   L+ +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           + ++      D   +V EY   G L D++      +E  ++T  +       +  AIEY 
Sbjct: 77  VITT----PTDI-VMVIEYA-GGELFDYI------VEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 673 HHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H H    IVH DLKP N+LLD ++ V   +F LS+ +   +   +S     G+  Y APE
Sbjct: 125 HRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPE 177
Query: 732 YGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL 769
              G   A    DV+S GI+L  M  GR P D  F   L
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 119/253 (47%), Gaps = 26/253 (10%)
Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++       E    T+   +   + VA  
Sbjct: 154 SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 204
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           +++L        VH DL   N +LD    V   +F L+  + D    +  +  G K  V 
Sbjct: 205 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLH--EFVKMTLPEKV 783
           ++A E     + +   DV+SFG+LL E+ T G  P     T  +T++  +  ++  PE  
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 321
Query: 784 IEIVDPSLLMEVM 796
                P  L EVM
Sbjct: 322 -----PDPLYEVM 329

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVA-ECEALRNIRHRNLIKIIT 612
           +G+GSFG V           VA+K+IN K   K   +  +  E   LR +RH ++IK+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +  S D        +V EY  N  L D++ Q +   E       Q++       SA+EY 
Sbjct: 72  VIKSKDEI-----IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQI------ISAVEYC 119
Query: 673 HHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H H    IVH DLKP N+LLD H  V   +F LS+ +   +   +S     G+  Y APE
Sbjct: 120 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPE 172
Query: 732 YGMGS-EASMTGDVYSFGILLLEMFTGRRPTD 762
              G   A    DV+S G++L  M   R P D
Sbjct: 173 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVA-ECEALRNIRHRNLIKIIT 612
           +G+GSFG V           VA+K+IN K   K   +  +  E   LR +RH ++IK+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +  S D        +V EY  N  L D++ Q +   E       Q++       SA+EY 
Sbjct: 81  VIKSKDEI-----IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQI------ISAVEYC 128
Query: 673 HHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H H    IVH DLKP N+LLD H  V   +F LS+ +   +   +S     G+  Y APE
Sbjct: 129 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPE 181
Query: 732 YGMGS-EASMTGDVYSFGILLLEMFTGRRPTD 762
              G   A    DV+S G++L  M   R P D
Sbjct: 182 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVA-ECEALRNIRHRNLIKIIT 612
           +G+GSFG V           VA+K+IN K   K   +  +  E   LR +RH ++IK+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +  S D        +V EY  N  L D++ Q +   E       Q++       SA+EY 
Sbjct: 76  VIKSKDEI-----IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQI------ISAVEYC 123
Query: 673 HHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H H    IVH DLKP N+LLD H  V   +F LS+ +   +   +S     G+  Y APE
Sbjct: 124 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPE 176
Query: 732 YGMGS-EASMTGDVYSFGILLLEMFTGRRPTD 762
              G   A    DV+S G++L  M   R P D
Sbjct: 177 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVA-ECEALRNIRHRNLIKIIT 612
           +G+GSFG V           VA+K+IN K   K   +  +  E   LR +RH ++IK+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +  S D        +V EY  N  L D++ Q +   E       Q++       SA+EY 
Sbjct: 82  VIKSKDEI-----IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQI------ISAVEYC 129
Query: 673 HHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H H    IVH DLKP N+LLD H  V   +F LS+ +   +   +S     G+  Y APE
Sbjct: 130 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPE 182
Query: 732 YGMGS-EASMTGDVYSFGILLLEMFTGRRPTD 762
              G   A    DV+S G++L  M   R P D
Sbjct: 183 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 24/221 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILG--GEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
           +     +G G FG V + I    GE++ +      L  K   R +  E + ++ + H N+
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNV 74
Query: 608 IKIITICSSIDSKGA-DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           +    +   +      D   L  EY E G L  +L+Q  +    C L       +  D++
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDIS 131
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLD-------HDMVAHQNFSLSHQLDSASKTPSSSI 719
           SA+ YLH +    I+H DLKP N++L        H ++   +   + +LD          
Sbjct: 132 SALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII---DLGYAKELDQGE----LCT 181
Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              GT+ Y+APE     + ++T D +SFG L  E  TG RP
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 24/221 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILG--GEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
           +     +G G FG V + I    GE++ +      L  K   R +  E + ++ + H N+
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNV 75
Query: 608 IKIITICSSIDSKGA-DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           +    +   +      D   L  EY E G L  +L+Q  +    C L       +  D++
Sbjct: 76  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDIS 132
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLD-------HDMVAHQNFSLSHQLDSASKTPSSSI 719
           SA+ YLH +    I+H DLKP N++L        H ++   +   + +LD          
Sbjct: 133 SALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII---DLGYAKELDQGE----LCT 182
Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              GT+ Y+APE     + ++T D +SFG L  E  TG RP
Sbjct: 183 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA----ECEALRNIRH 604
            +   + +G G+FG V  G        VAVK++N +QK      V     E + L+  RH
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
            ++IK+  + S+      DF  +V EY+  G L D++ +     E+    L Q++     
Sbjct: 71  PHIIKLYQVIST----PTDF-FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI----- 120
Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKG 723
             SA++Y H H    +VH DLKP NVLLD  M A   +F LS+ +       +S     G
Sbjct: 121 -LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----G 172
Query: 724 TVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTD 762
           +  Y APE   G   A    D++S G++L  +  G  P D
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 25/220 (11%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA----ECEALRNIRH 604
            +   + +G G+FG V  G        VAVK++N +QK      V     E + L+  RH
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
            ++IK+  + S+      DF  +V EY+  G L D++ +     E+    L Q++     
Sbjct: 71  PHIIKLYQVIST----PTDF-FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI----- 120
Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKG 723
             SA++Y H H    +VH DLKP NVLLD  M A   +F LS+ +        S     G
Sbjct: 121 -LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC----G 172
Query: 724 TVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTD 762
           +  Y APE   G   A    D++S G++L  +  G  P D
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 119/256 (46%), Gaps = 37/256 (14%)
Query: 556 IGQGSFGSV-----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G+FG V     Y      ++++VAVK +      A + F  E E L N++H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWL--HQSNDHLEV-----CKLTLIQRVNIAI 663
             +C        D   +VFEYM++G L  +L  H  +  L        +LT  Q ++IA 
Sbjct: 81  YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIK 722
            +A+ + YL        VH DL   N L+  + +V   +F +S  + S   T    +G  
Sbjct: 136 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS---TDYYRVGGH 189
Query: 723 GT--VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP--------TDAAFTEGLTL 771
               + ++ PE  M  + +   DV+S G++L E+FT G++P             T+G  L
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249
Query: 772 HEFVKMTLPEKVIEIV 787
                 T P++V E++
Sbjct: 250 QR--PRTCPQEVYELM 263

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 32/228 (14%)
Query: 557 GQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSS 616
            +G FG V+K  L  +   VAVK+  L+ K +++S   E  +   ++H NL++ I    +
Sbjct: 24  ARGRFGCVWKAQLMND--FVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFI----A 76
Query: 617 IDSKGADFKA---LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            + +G++ +    L+  + + GSL        D+L+   +T  +  ++A  ++  + YLH
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSL-------TDYLKGNIITWNELCHVAETMSRGLSYLH 129
Query: 674 HHC--------QPPIVHGDLKPSNVLLDHDMVA-HQNFSLSHQLDSASKTPSSSIGIKGT 724
                      +P I H D K  NVLL  D+ A   +F L+ + +   K P  + G  GT
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPG-KPPGDTHGQVGT 188
Query: 725 VGYVAPEYGMGS-----EASMTGDVYSFGILLLEMFTGRRPTDAAFTE 767
             Y+APE   G+     +A +  D+Y+ G++L E+ +  +  D    E
Sbjct: 189 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDE 236

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEA-LRNIR 603
           S+F    +IG+GSFG V       EE+  AVKV+  K   +K   +  ++E    L+N++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H  L+ +         + AD    V +Y+  G L   L +     E C L    R   A 
Sbjct: 98  HPFLVGL-----HFSFQTADKLYFVLDYINGGELFYHLQR-----ERCFLEPRARF-YAA 146
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ASA+ YLH      IV+ DLKP N+LLD    +   +F L  +    + T S+     
Sbjct: 147 EIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST---FC 200
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           GT  Y+APE         T D +  G +L EM  G  P
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 554 NMIGQGSFGSVY---KGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           + +G G   +VY     IL  +  I A+ +   +++   + F  E      + H+N++ +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           I +      +  D   LV EY+E  +L +++           L++   +N    +   I+
Sbjct: 77  IDV-----DEEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIK 125
Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           + H      IVH D+KP N+L+D +      +F ++  L   S T ++ +   GTV Y +
Sbjct: 126 HAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV--LGTVQYFS 180
Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE   G       D+YS GI+L EM  G  P
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 68  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 113
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   NF  S    S+ +T    
Sbjct: 114 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT---- 166
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 167 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 225
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 226 TFPDFVTE 233

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 69  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   NF  S    S+ +T    
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT---- 167
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 168 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 226
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 227 TFPDFVTE 234

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 556 IGQGSFGSVYKGIL---GGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G GSFG V +G      G+ + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +  +   K      +V E    GSL D L +   H  +  L+       A+ VA  +
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 134
Query: 670 EYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            YL        +H DL   N+LL   D+V   +F L   L             K    + 
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           APE       S   D + FG+ L EMFT G+ P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 30/227 (13%)
Query: 547 TSEFASSNMIGQGSFGSVY--KGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRN 601
           +  +    ++G+GSFG V   K  + G+E   AVKVI+   +KQK    S + E + L+ 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQE--CAVKVISKRQVKQKTDKESLLREVQLLKQ 88
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + H N++K+       + KG  +  LV E    G L D +       EV    +I++V  
Sbjct: 89  LDHPNIMKLYEF---FEDKGYFY--LVGEVYTGGELFDEIISRKRFSEVDAARIIRQV-- 141
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTPSS 717
                S I Y+H +    IVH DLKP N+LL+       +   +F LS   + ASK    
Sbjct: 142 ----LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKD 193
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA 764
            I   GT  Y+APE   G+      DV+S G++L  + +G  P + A
Sbjct: 194 KI---GTAYYIAPEVLHGTYDEKC-DVWSTGVILYILLSGCPPFNGA 236

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 108/218 (49%), Gaps = 19/218 (8%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRH 604
           ++S+F     +G G++ +VYKG+     + VA+K + L  ++G   + + E   ++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN--DHLEVCKLTLIQRVNIA 662
            N++++  +  + +        LVFE+M+N  L+ ++      +     +L L++     
Sbjct: 63  ENIVRLYDVIHTENK-----LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           +     + + H +    I+H DLKP N+L++    +   +F L+        T SS +  
Sbjct: 117 L--LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV-- 169
Query: 722 KGTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
             T+ Y AP+  MGS    T  D++S G +L EM TG+
Sbjct: 170 -VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 610
           +G+G FG V    Y     G   +VAVK +        RS +  E + LR + H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
              C   +  GA    LV EY+  GSL D+L + +       + L Q +  A  +   + 
Sbjct: 99  KGCC---EDAGAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 148
Query: 671 YLH--HHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           YLH  H+     +H DL   NVLLD+D +V   +F L+  +    +           V +
Sbjct: 149 YLHAQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFW 203
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            APE     +     DV+SFG+ L E+ T
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 38/272 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS----FVAECEALRNIRHRNLIKII 611
           IG+GSF +VYKG+    E  V V    L+ +   +S    F  E E L+ ++H N+++  
Sbjct: 34  IGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
               S   KG     LV E   +G+L+ +L +     +V K+ +++  +    +   +++
Sbjct: 92  DSWEST-VKGKKCIVLVTELXTSGTLKTYLKR----FKVXKIKVLR--SWCRQILKGLQF 144
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           LH    PPI+H DLK  N+ +     + +   L     +  K  S +  + GT  + APE
Sbjct: 145 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL---ATLKRASFAKAVIGTPEFXAPE 200
Query: 732 -YGMGSEASMTGDVYSFGILLLEMFTGRRP----TDAA-----FTEGLTLHEFVKMTLPE 781
            Y    + S+  DVY+FG   LE  T   P     +AA      T G+    F K+ +PE
Sbjct: 201 XYEEKYDESV--DVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258
Query: 782 KVIEIV--------DPSLLMEVMANNSMIQED 805
            V EI+        D    ++ + N++  QE+
Sbjct: 259 -VKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
            ++     +G+G++G VYK     +  IVA+K I L  + +G   + + E   L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++ +I +  S          LVFE+ME   L+  L ++         T +Q   I I +
Sbjct: 80  NIVSLIDVIHS-----ERCLTLVFEFMEK-DLKKVLDENK--------TGLQDSQIKIYL 125
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              +  + H  Q  I+H DLKP N+L++ D  +   +F L+       ++ +  +    T
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV---VT 182
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
           + Y AP+  MGS+   T  D++S G +  EM TG+
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 107/227 (47%), Gaps = 30/227 (13%)
Query: 547 TSEFASSNMIGQGSFGSVY--KGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRN 601
           +  +    ++G+GSFG V   K  + G+E   AVKVI+   +KQK    S + E + L+ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQE--CAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + H N++K+       + KG  +  LV E    G L D +       EV    +I++V  
Sbjct: 83  LDHPNIMKLYEF---FEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV-- 135
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ----NFSLSHQLDSASKTPSS 717
                S I Y+H +    IVH DLKP N+LL+           +F LS   + ASK    
Sbjct: 136 ----LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKD 187
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA 764
            I   GT  Y+APE   G+      DV+S G++L  + +G  P + A
Sbjct: 188 KI---GTAYYIAPEVLHGTYDEKC-DVWSTGVILYILLSGCPPFNGA 230

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
            ++     +G+G++G VYK     +  IVA+K I L  + +G   + + E   L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++ +I +  S          LVFE+ME   L+  L ++         T +Q   I I +
Sbjct: 80  NIVSLIDVIHS-----ERCLTLVFEFMEK-DLKKVLDENK--------TGLQDSQIKIYL 125
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              +  + H  Q  I+H DLKP N+L++ D  +   +F L+       ++ +  +    T
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV---VT 182
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
           + Y AP+  MGS+   T  D++S G +  EM TG+
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 556 IGQGSFGSVYKGIL---GGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G GSFG V +G      G+ + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +  +   K      +V E    GSL D L +   H  +  L+       A+ VA  +
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 128
Query: 670 EYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            YL        +H DL   N+LL   D+V   +F L   L             K    + 
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           APE       S   D + FG+ L EMFT G+ P
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 67  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 112
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 113 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT---- 165
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 166 -TLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 224
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 225 TFPDFVTE 232

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 556 IGQGSFGSVYKGIL---GGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G GSFG V +G      G+ + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +  +   K      +V E    GSL D L +   H  +  L+       A+ VA  +
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 134
Query: 670 EYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            YL        +H DL   N+LL   D+V   +F L   L             K    + 
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           APE       S   D + FG+ L EMFT G+ P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 106/245 (43%), Gaps = 24/245 (9%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           RH N++++           A    L+ EY   G +   L + +   E    T I      
Sbjct: 71  RHPNILRLYGYFHD-----ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI------ 119
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
            ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T      +
Sbjct: 120 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----TL 171
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKMTLP 780
            GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ T P
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 231
Query: 781 EKVIE 785
           + V E
Sbjct: 232 DFVTE 236

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 107/227 (47%), Gaps = 30/227 (13%)
Query: 547 TSEFASSNMIGQGSFGSVY--KGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRN 601
           +  +    ++G+GSFG V   K  + G+E   AVKVI+   +KQK    S + E + L+ 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQE--CAVKVISKRQVKQKTDKESLLREVQLLKQ 105
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + H N++K+       + KG  +  LV E    G L D +       EV    +I++V  
Sbjct: 106 LDHPNIMKLYEF---FEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV-- 158
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ----NFSLSHQLDSASKTPSS 717
                S I Y+H +    IVH DLKP N+LL+           +F LS   + ASK    
Sbjct: 159 ----LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKD 210
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA 764
            I   GT  Y+APE   G+      DV+S G++L  + +G  P + A
Sbjct: 211 KI---GTAYYIAPEVLHGTYDEKC-DVWSTGVILYILLSGCPPFNGA 253

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 107/227 (47%), Gaps = 30/227 (13%)
Query: 547 TSEFASSNMIGQGSFGSVY--KGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRN 601
           +  +    ++G+GSFG V   K  + G+E   AVKVI+   +KQK    S + E + L+ 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQE--CAVKVISKRQVKQKTDKESLLREVQLLKQ 106
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + H N++K+       + KG  +  LV E    G L D +       EV    +I++V  
Sbjct: 107 LDHPNIMKLYEF---FEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV-- 159
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ----NFSLSHQLDSASKTPSS 717
                S I Y+H +    IVH DLKP N+LL+           +F LS   + ASK    
Sbjct: 160 ----LSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKD 211
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA 764
            I   GT  Y+APE   G+      DV+S G++L  + +G  P + A
Sbjct: 212 KI---GTAYYIAPEVLHGTYDEKC-DVWSTGVILYILLSGCPPFNGA 254

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 32  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 85
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 139
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 195
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   EGL   + +K+    P
Sbjct: 196 GTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAG-NEGLIFAKIIKLEYDFP 254
Query: 781 EK 782
           EK
Sbjct: 255 EK 256

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 107/243 (44%), Gaps = 26/243 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRH 604
            +F    ++G+GSF +V            A+K++  +   ++        E + +  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 605 RNLIKIITICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
              +K+   C   D K      L F   Y +NG L  ++ +     E C      R   A
Sbjct: 97  PFFVKLY-FCFQDDEK------LYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA 144
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
            ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  +
Sbjct: 145 -EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 200
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--L 779
            GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    
Sbjct: 201 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDF 258
Query: 780 PEK 782
           PEK
Sbjct: 259 PEK 261

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 556 IGQGSFGSVY--KGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G+F  V   + IL G+E  VAVK+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +   I+++   +  LV EY   G + D+L       E       +++       SA++Y
Sbjct: 80  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI------VSAVQY 128
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H   Q  IVH DLK  N+LLD DM +   +F  S++    +K  +      G+  Y AP
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAP 181
Query: 731 EYGMGSEASMTG-DVYSFGILLLEMFTGRRPTDA 763
           E   G +      DV+S G++L  + +G  P D 
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 556 IGQGSFGSVY--KGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G+F  V   + IL G+E  VAVK+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +   I+++   +  LV EY   G + D+L       E       +++       SA++Y
Sbjct: 80  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI------VSAVQY 128
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H   Q  IVH DLK  N+LLD DM +   +F  S++    +K  +      G+  Y AP
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAP 181
Query: 731 EYGMGSEASMTG-DVYSFGILLLEMFTGRRPTDA 763
           E   G +      DV+S G++L  + +G  P D 
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 109/246 (44%), Gaps = 24/246 (9%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR 603
            K   +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R
Sbjct: 6   KKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTR 59
Query: 604 HRNLIKII--TICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            R+++  +       +     D + L F   Y +NG L  ++ +     E C      R 
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRF 114
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSS 718
             A ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++
Sbjct: 115 YTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 170
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT 778
             + GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+ 
Sbjct: 171 XFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLE 228
Query: 779 --LPEK 782
              PEK
Sbjct: 229 YDFPEK 234

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           F     IG+GSFG V+KGI    + +VA+K+I+L++       + +              
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE------------- 55
Query: 610 IITICSSIDSK------GADFK----ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            IT+ S  DS       G+  K     ++ EY+  GS       + D LE   L   Q  
Sbjct: 56  -ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIA 107
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
            I  ++   ++YLH   +   +H D+K +NVLL +H  V   +F ++ QL       ++ 
Sbjct: 108 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 164
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +   GT  ++APE    S      D++S GI  +E+  G  P
Sbjct: 165 V---GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 164
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 165 -DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 223
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 224 TFPDFVTE 231

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 71  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 116
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 117 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 169
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 170 -TLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 228
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 229 TFPDFVTE 236

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           F     IG+GSFG V+KGI    + +VA+K+I+L++       + +              
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE------------- 75
Query: 610 IITICSSIDSK------GADFK----ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            IT+ S  DS       G+  K     ++ EY+  GS       + D LE   L   Q  
Sbjct: 76  -ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIA 127
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
            I  ++   ++YLH   +   +H D+K +NVLL +H  V   +F ++ QL       ++ 
Sbjct: 128 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 184
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +   GT  ++APE    S      D++S GI  +E+  G  P
Sbjct: 185 V---GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 32  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 85
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 139
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 195
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   EGL   + +K+    P
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEGLIFAKIIKLEYDFP 254
Query: 781 EK 782
           EK
Sbjct: 255 EK 256

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 109/246 (44%), Gaps = 24/246 (9%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR 603
            K   +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R
Sbjct: 3   KKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTR 56
Query: 604 HRNLIKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            R+++  +       +     D + L F   Y +NG L  ++ +     E C      R 
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRF 111
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSS 718
             A ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++
Sbjct: 112 YTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 167
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT 778
             + GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+ 
Sbjct: 168 XFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLE 225
Query: 779 --LPEK 782
              PEK
Sbjct: 226 YDFPEK 231

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 67  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 112
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 113 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 165
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 166 -DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 224
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 225 TFPDFVTE 232

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 164
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 165 -DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 223
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 224 TFPDFVTE 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 109/246 (44%), Gaps = 24/246 (9%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR 603
            K   +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R
Sbjct: 5   KKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTR 58
Query: 604 HRNLIKII--TICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            R+++  +       +     D + L F   Y +NG L  ++ +     E C      R 
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRF 113
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSS 718
             A ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++
Sbjct: 114 YTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 169
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT 778
             + GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+ 
Sbjct: 170 XFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLE 227
Query: 779 --LPEK 782
              PEK
Sbjct: 228 YDFPEK 233

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 109/246 (44%), Gaps = 24/246 (9%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR 603
            K   +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R
Sbjct: 4   KKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTR 57
Query: 604 HRNLIKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            R+++  +       +     D + L F   Y +NG L  ++ +     E C      R 
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRF 112
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSS 718
             A ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++
Sbjct: 113 YTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT 778
             + GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+ 
Sbjct: 169 XFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLE 226
Query: 779 --LPEK 782
              PEK
Sbjct: 227 YDFPEK 232

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 556 IGQGSFGSVYKG---ILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G GSFG V +G      G+ + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +  +   K      +V E    GSL D L +   H  +  L+       A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 670 EYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            YL        +H DL   N+LL   D+V   +F L   L             K    + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           APE       S   D + FG+ L EMFT G+ P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 92  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 137
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 138 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 190
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 191 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 249
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 250 TFPDFVTE 257

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 69  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 167
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 168 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 226
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 227 TFPDFVTE 234

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 71  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 116
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 117 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 169
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 170 -DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 228
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 229 TFPDFVTE 236

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 164
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 165 -ELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 223
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 224 TFPDFVTE 231

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 164
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 165 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 223
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 224 TFPDFVTE 231

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 556 IGQGSFGSVY--KGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G+F  V   + IL G+E  VAVK+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 15  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +   I+++   +  LV EY   G + D+L       E       +++       SA++Y
Sbjct: 73  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGWMKEKEARAKFRQI------VSAVQY 121
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H   Q  IVH DLK  N+LLD DM +   +F  S++    +K  +      G+  Y AP
Sbjct: 122 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAP 174
Query: 731 EYGMGSEASMTG-DVYSFGILLLEMFTGRRPTDA 763
           E   G +      DV+S G++L  + +G  P D 
Sbjct: 175 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 208

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 556 IGQGSFGSVY--KGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G+F  V   + IL G+E  VAVK+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +   I+++   +  LV EY   G + D+L       E       +++       SA++Y
Sbjct: 80  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI------VSAVQY 128
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H   Q  IVH DLK  N+LLD DM +   +F  S++    +K  +      G   Y AP
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFC----GAPPYAAP 181
Query: 731 EYGMGSEASMTG-DVYSFGILLLEMFTGRRPTDA 763
           E   G +      DV+S G++L  + +G  P D 
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 71  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 116
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 117 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 169
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 170 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 228
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 229 TFPDFVTE 236

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 36/227 (15%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-----GAFRSFVAEC 596
           ++      +   + +G+G F +VYK        IVA+K I L  +     G  R+ + E 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 597 EALRNIRHRNLIKIITICSSIDSKGADFK-ALVFEYMENGSLEDWLHQSN-----DHLEV 650
           + L+ + H N+I +      +D+ G     +LVF++ME   LE  +  ++      H++ 
Sbjct: 64  KLLQELSHPNIIGL------LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKA 116
Query: 651 CKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLD 709
             L  +Q           +EYLH H    I+H DLKP+N+LLD + V    +F L+    
Sbjct: 117 YMLMTLQ----------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163
Query: 710 SASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMF 755
           S ++     +    T  Y APE   G+     G D+++ G +L E+ 
Sbjct: 164 SPNRAYXHQV---VTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 70  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 115
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 116 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 168
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 169 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 227
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 228 TFPDFVTE 235

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 83  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 128
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T    
Sbjct: 129 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 181
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 182 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 240
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 241 TFPDFVTE 248

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           F     IG+GSFG V+KGI    + +VA+K+I+L++       + +              
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE------------- 55
Query: 610 IITICSSIDSK------GADFK----ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            IT+ S  DS       G+  K     ++ EY+  GS       + D LE   L   Q  
Sbjct: 56  -ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIA 107
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
            I  ++   ++YLH   +   +H D+K +NVLL +H  V   +F ++ QL       +  
Sbjct: 108 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXF 164
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +   GT  ++APE    S      D++S GI  +E+  G  P
Sbjct: 165 V---GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 556 IGQGSFGSVYKG---ILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G GSFG V +G      G+ + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +  +   K      +V E    GSL D L +   H  +  L+       A+ VA  +
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 128
Query: 670 EYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            YL        +H DL   N+LL   D+V   +F L   L             K    + 
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           APE       S   D + FG+ L EMFT G+ P
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 556 IGQGSFGSVYKG---ILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G GSFG V +G      G+ + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +  +   K      +V E    GSL D L +   H  +  L+       A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 670 EYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            YL        +H DL   N+LL   D+V   +F L   L             K    + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           APE       S   D + FG+ L EMFT G+ P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 556 IGQGSFGSVYKG---ILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G GSFG V +G      G+ + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +  +   K      +V E    GSL D L +   H  +  L+       A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 670 EYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            YL        +H DL   N+LL   D+V   +F L   L             K    + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           APE       S   D + FG+ L EMFT G+ P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 556 IGQGSFGSVY--KGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G+F  V   + IL G+E  VAV++I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +   I+++   +  LV EY   G + D+L       E       +++       SA++Y
Sbjct: 80  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI------VSAVQY 128
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H   Q  IVH DLK  N+LLD DM +   +F  S++    +K  +      G+  Y AP
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAP 181
Query: 731 EYGMGSEASMTG-DVYSFGILLLEMFTGRRPTDA 763
           E   G +      DV+S G++L  + +G  P D 
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           F     IG+GSFG V+KGI    + +VA+K+I+L++       + +              
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE------------- 70
Query: 610 IITICSSIDSK------GADFK----ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            IT+ S  DS       G+  K     ++ EY+  GS       + D LE   L   Q  
Sbjct: 71  -ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIA 122
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
            I  ++   ++YLH   +   +H D+K +NVLL +H  V   +F ++ QL   + T    
Sbjct: 123 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKR 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
               GT  ++APE    S      D++S GI  +E+  G  P
Sbjct: 177 NXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/340 (22%), Positives = 145/340 (42%), Gaps = 55/340 (16%)
Query: 523 HKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN 582
           ++ V  +P    +P++ + ++          ++IG+G+FG V K  +  + + +   +  
Sbjct: 4   NRKVKNNPDPTIYPVLDWNDIK-------FQDVIGEGNFGQVLKARIKKDGLRMDAAIKR 56
Query: 583 LKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLE 638
           +K+   K   R F  E E L  +  H N+I ++  C   + +G  +  L  EY  +G+L 
Sbjct: 57  MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRG--YLYLAIEYAPHGNLL 111
Query: 639 DWLHQSN----------DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPS 688
           D+L +S            +     L+  Q ++ A DVA  ++YL    Q   +H +L   
Sbjct: 112 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAAR 168
Query: 689 NVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSF 747
           N+L+  + VA   +F LS   +   K     + ++    ++A E    S  +   DV+S+
Sbjct: 169 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSY 224
Query: 748 GILLLEMFT-GRRP----TDAAFTEGL--------------TLHEFVKMTLPEKVIEIVD 788
           G+LL E+ + G  P    T A   E L               +++ ++    EK  E   
Sbjct: 225 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYE--R 282
Query: 789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMES 828
           PS    +++ N M++E +           T  G+ CS E 
Sbjct: 283 PSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEE 322

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 105/245 (42%), Gaps = 24/245 (9%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           RH N++++           A    L+ EY   G +   L + +   E    T I      
Sbjct: 71  RHPNILRLYGYFHD-----ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI------ 119
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
            ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +       +
Sbjct: 120 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX-----XL 171
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKMTLP 780
            GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ T P
Sbjct: 172 XGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 231
Query: 781 EKVIE 785
           + V E
Sbjct: 232 DFVTE 236

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G+FG V+       +   ++M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQ---------SNDHLEVCKLTLIQRVNI 661
             +C    ++G     +VFEYM +G L  +L             + +    L L Q + +
Sbjct: 109 FGVC----TEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIG 720
           A  VA+ + YL        VH DL   N L+   +V    +F +S  + S   T    +G
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS---TDYYRVG 217
Query: 721 IKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP------TDA--AFTEGL 769
            +    + ++ PE  +  + +   DV+SFG++L E+FT G++P      T+A    T+G 
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277
Query: 770 TLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNA 816
            L        P +V  I+      E    +S+  +D  AR Q    A
Sbjct: 278 ELER--PRACPPEVYAIMRGCWQREPQQRHSI--KDVHARLQALAQA 320

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-------GAFRSFVAECEALRNIRHRN 606
           + +G G+FG V  G        VAVK++N +QK       G  R    E + L+  RH +
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRR---EIQNLKLFRHPH 77
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           +IK+  + S+     +D   +V EY+  G L D++ ++    E     L Q++       
Sbjct: 78  IIKLYQVIST----PSDI-FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------L 126
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTV 725
           S ++Y H H    +VH DLKP NVLLD  M A   +F LS+ +        S     G+ 
Sbjct: 127 SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC----GSP 179
Query: 726 GYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTD 762
            Y APE   G   A    D++S G++L  +  G  P D
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 134/314 (42%), Gaps = 58/314 (18%)
Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIK 609
           ++IG+G+FG V K  +  + + +   +  +K+   K   R F  E E L  +  H N+I 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLIQRV 659
           ++  C   + +G  +  L  EY  +G+L D+L +S            +     L+  Q +
Sbjct: 81  LLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSS 718
           + A DVA  ++YL    Q   +H DL   N+L+  + VA   +F LS             
Sbjct: 136 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQE 183
Query: 719 IGIKGTVG-----YVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP----TDAAFTEG 768
           + +K T+G     ++A E    S  +   DV+S+G+LL E+ + G  P    T A   E 
Sbjct: 184 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 243
Query: 769 L--------------TLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           L               +++ ++    EK  E   PS    +++ N M++E +        
Sbjct: 244 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYE--RPSFAQILVSLNRMLEERKTYVNTTLY 301
Query: 815 NAITRTGVLCSMES 828
              T  G+ CS E 
Sbjct: 302 EKFTYAGIDCSAEE 315

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 556 IGQGSFGSVY--KGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G+F  V   + IL G E  VA+K+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 20  IGKGNFAKVKLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +   I+++   +  L+ EY   G + D+L       E    +  +++       SA++Y
Sbjct: 78  EV---IETEKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQY 126
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H   Q  IVH DLK  N+LLD DM +   +F  S++     K  +      G+  Y AP
Sbjct: 127 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC----GSPPYAAP 179
Query: 731 EYGMGSEASMTG-DVYSFGILLLEMFTGRRPTDA 763
           E   G +      DV+S G++L  + +G  P D 
Sbjct: 180 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 213

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 134/314 (42%), Gaps = 58/314 (18%)
Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIK 609
           ++IG+G+FG V K  +  + + +   +  +K+   K   R F  E E L  +  H N+I 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLIQRV 659
           ++  C   + +G  +  L  EY  +G+L D+L +S            +     L+  Q +
Sbjct: 91  LLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSS 718
           + A DVA  ++YL    Q   +H DL   N+L+  + VA   +F LS             
Sbjct: 146 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQE 193
Query: 719 IGIKGTVG-----YVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP----TDAAFTEG 768
           + +K T+G     ++A E    S  +   DV+S+G+LL E+ + G  P    T A   E 
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 769 L--------------TLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           L               +++ ++    EK  E   PS    +++ N M++E +        
Sbjct: 254 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYE--RPSFAQILVSLNRMLEERKTYVNTTLY 311
Query: 815 NAITRTGVLCSMES 828
              T  G+ CS E 
Sbjct: 312 EKFTYAGIDCSAEE 325

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 556 IGQGSFGSVY--KGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G+F  V   + IL G E  VA+K+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 23  IGKGNFAKVKLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +   I+++   +  L+ EY   G + D+L       E    +  +++       SA++Y
Sbjct: 81  EV---IETEKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQY 129
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H   Q  IVH DLK  N+LLD DM +   +F  S++     K  +      G   Y AP
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAAP 182
Query: 731 EYGMGSEASMTG-DVYSFGILLLEMFTGRRPTDA 763
           E   G +      DV+S G++L  + +G  P D 
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 108/223 (48%), Gaps = 29/223 (13%)
Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G+FG V+       +   ++M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQ---------SNDHLEVCKLTLIQRVNI 661
             +C    ++G     +VFEYM +G L  +L             + +    L L Q + +
Sbjct: 80  FGVC----TEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIG 720
           A  VA+ + YL        VH DL   N L+   +V    +F +S  + S   T    +G
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS---TDYYRVG 188
Query: 721 IKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            +    + ++ PE  +  + +   DV+SFG++L E+FT G++P
Sbjct: 189 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 105/227 (46%), Gaps = 30/227 (13%)
Query: 547 TSEFASSNMIGQGSFGSVY--KGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRN 601
           +  +    ++G+GSFG V   K  + G+E   AVKVI+   +KQK    S + E + L+ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQE--CAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + H N+ K+       + KG  +  LV E    G L D +       EV    +I++V  
Sbjct: 83  LDHPNIXKLYEF---FEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV-- 135
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ----NFSLSHQLDSASKTPSS 717
                S I Y H +    IVH DLKP N+LL+           +F LS   + ASK    
Sbjct: 136 ----LSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKXKD 187
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA 764
            I   GT  Y+APE   G+      DV+S G++L  + +G  P + A
Sbjct: 188 KI---GTAYYIAPEVLHGTYDEKC-DVWSTGVILYILLSGCPPFNGA 230

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 126/293 (43%), Gaps = 38/293 (12%)
Query: 543 LSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEAL 599
           + +   +F   N++G+GSF  VY+       + VA+K+I+ K   + G  +    E +  
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 600 RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
             ++H +++++         + +++  LV E   NG +  +L        V   +  +  
Sbjct: 66  CQLKHPSILELYNYF-----EDSNYVYLVLEMCHNGEMNRYLKN-----RVKPFSENEAR 115
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSS 718
           +    + + + YLH H    I+H DL  SN+LL  +M +   +F L+ QL    K P   
Sbjct: 116 HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL----KMPHEK 168
Query: 719 -IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM 777
              + GT  Y++PE    S   +  DV+S G +   +  GR P D          + VK 
Sbjct: 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT---------DTVKN 219
Query: 778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPF 830
           TL + V+   +    + + A + + Q  RR       N   R  +   ++ PF
Sbjct: 220 TLNKVVLADYEMPSFLSIEAKDLIHQLLRR-------NPADRLSLSSVLDHPF 265

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 108/223 (48%), Gaps = 29/223 (13%)
Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G+FG V+       +   ++M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQ---------SNDHLEVCKLTLIQRVNI 661
             +C    ++G     +VFEYM +G L  +L             + +    L L Q + +
Sbjct: 86  FGVC----TEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIG 720
           A  VA+ + YL        VH DL   N L+   +V    +F +S  + S   T    +G
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS---TDYYRVG 194
Query: 721 IKGT--VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            +    + ++ PE  +  + +   DV+SFG++L E+FT G++P
Sbjct: 195 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 556 IGQGSFGSVY--KGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G+F  V   + IL G+E  VAV++I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +   I+++   +  LV EY   G + D+L       E       +++       SA++Y
Sbjct: 80  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI------VSAVQY 128
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H   Q  IVH DLK  N+LLD DM +   +F  S++    +K         G+  Y AP
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC----GSPPYAAP 181
Query: 731 EYGMGSEASMTG-DVYSFGILLLEMFTGRRPTDA 763
           E   G +      DV+S G++L  + +G  P D 
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G FG V+      +   VAVK +      +  +F+AE   ++ ++H  L+K+  + +
Sbjct: 23  LGAGQFGEVWMATYN-KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 81  K------EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 128
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            Q   +H DL+ +N+L+   +V    +F L+  ++    T     G K  + + APE   
Sbjct: 129 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAIN 185
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL+E+ T GR P
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 25/224 (11%)
Query: 557 GQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSS 616
            +G FG V+K  L  E   VAVK+  ++ K ++++   E  +L  ++H N+++ I     
Sbjct: 33  ARGRFGCVWKAQLLNE--YVAVKIFPIQDKQSWQNEY-EVYSLPGMKHENILQFIGAEKR 89
Query: 617 IDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC 676
             S   D   L+  + E GSL       +D L+   ++  +  +IA  +A  + YLH   
Sbjct: 90  GTSVDVDL-WLITAFHEKGSL-------SDFLKANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 677 -------QPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
                  +P I H D+K  NVLL +++ A   +F L+ + + A K+   + G  GT  Y+
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE-AGKSAGDTHGQVGTRRYM 200
Query: 729 APEYGMGS-----EASMTGDVYSFGILLLEMFTGRRPTDAAFTE 767
           APE   G+     +A +  D+Y+ G++L E+ +     D    E
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 32  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 85
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC-----TRFYTA- 139
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV- 195
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      AS + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 196 GTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 254
Query: 781 EK 782
           EK
Sbjct: 255 EK 256

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 69  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +     
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA---- 167
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 168 -ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 226
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 227 TFPDFVTE 234

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +F   + +G G+ G V+K       +++A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 126
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            I+    +  S G    ++  E+M+ GSL+  L ++    E     ++ +V+IA  V   
Sbjct: 127 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 178
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           + YL    +  I+H D+KPSN+L++    +   +F +S QL DS + +        GT  
Sbjct: 179 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRS 230
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
           Y++PE   G+  S+  D++S G+ L+EM  GR P      + L L
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 275

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 29  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 82
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 136
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 192
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 251
Query: 781 EK 782
           EK
Sbjct: 252 EK 253

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 556 IGQGSFGSVY--KGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G+F  V   + +L G E  VAVK+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 23  IGKGNFAKVKLARHVLTGRE--VAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +   I+++   +  LV EY   G + D+L       E       +++       SA++Y
Sbjct: 81  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI------VSAVQY 129
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H   Q  IVH DLK  N+LLD DM +   +F  S++    +K  +      G+  Y AP
Sbjct: 130 CH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC----GSPPYAAP 182
Query: 731 EYGMGSEASMTG-DVYSFGILLLEMFTGRRPTDA 763
           E   G +      DV+S G++L  + +G  P D 
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 537 MISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAEC 596
           ++S  +  K  + F     IGQG+ G+VY  +       VA++ +NL+Q+      + E 
Sbjct: 12  IVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 597 EALRNIRHRNLIKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL 655
             +R  ++ N++      + +DS    D   +V EY+  GSL D +       E C +  
Sbjct: 69  LVMRENKNPNIV------NYLDSYLVGDELWVVMEYLAGGSLTDVV------TETC-MDE 115
Query: 656 IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKT 714
            Q   +  +   A+E+LH +    ++H D+K  N+LL  D  V   +F    Q+      
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            S+ +   GT  ++APE           D++S GI+ +EM  G  P
Sbjct: 173 RSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 14  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 67
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 68  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 122 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 177
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 178 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 236
Query: 781 EK 782
           EK
Sbjct: 237 EK 238

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 548 SEFASSNMIGQGSFGSVY--KGILGGE-EMIVAVKVIN---LKQKGAFRSFVAECEALRN 601
           S+F    ++GQGSFG V+  K I G +   + A+KV+    LK +   R+ + E + L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + H  ++K+     +  ++G  +  L+ +++  G L            + K  +    ++
Sbjct: 83  VNHPFIVKL---HYAFQTEGKLY--LILDFLRGGDL---------FTRLSKEVMFTEEDV 128
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSSI 719
              +A     L H     I++ DLKP N+LLD +  +   +F LS + +D   K  S   
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC- 187
Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              GTV Y+APE       + + D +SFG+L+ EM TG  P
Sbjct: 188 ---GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 92  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 137
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +     
Sbjct: 138 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD---- 190
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 191 -DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 249
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 250 TFPDFVTE 257

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 112/226 (49%), Gaps = 20/226 (8%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F   + +G G+ G V+K       +++A K+I+L+ K A R+ +     L+ +   N 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNS 63
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
             I+    +  S G    ++  E+M+ GSL+  L ++    E     ++ +V+IA  V  
Sbjct: 64  PYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIK 115
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTV 725
            + YL    +  I+H D+KPSN+L++    +   +F +S QL DS + +        GT 
Sbjct: 116 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTR 167
Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
            Y++PE   G+  S+  D++S G+ L+EM  GR P      + L L
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 112/226 (49%), Gaps = 20/226 (8%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F   + +G G+ G V+K       +++A K+I+L+ K A R+ +     L+ +   N 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNS 63
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
             I+    +  S G    ++  E+M+ GSL+  L ++    E     ++ +V+IA  V  
Sbjct: 64  PYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIK 115
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTV 725
            + YL    +  I+H D+KPSN+L++    +   +F +S QL DS + +        GT 
Sbjct: 116 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTR 167
Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
            Y++PE   G+  S+  D++S G+ L+EM  GR P      + L L
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 32  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 85
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 139
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 195
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 254
Query: 781 EK 782
           EK
Sbjct: 255 EK 256

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +F   + +G G+ G V+K       +++A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 64
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            I+    +  S G    ++  E+M+ GSL+  L ++    E     ++ +V+IA  V   
Sbjct: 65  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 116
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           + YL    +  I+H D+KPSN+L++    +   +F +S QL DS + +        GT  
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRS 168
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
           Y++PE   G+  S+  D++S G+ L+EM  GR P      + L L
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 548 SEFASSNMIGQGSFGSVY--KGILGGE-EMIVAVKVIN---LKQKGAFRSFVAECEALRN 601
           S+F    ++GQGSFG V+  K I G +   + A+KV+    LK +   R+ + E + L  
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 83
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + H  ++K+     +  ++G  +  L+ +++  G L            + K  +    ++
Sbjct: 84  VNHPFIVKL---HYAFQTEGKLY--LILDFLRGGDL---------FTRLSKEVMFTEEDV 129
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSSI 719
              +A     L H     I++ DLKP N+LLD +  +   +F LS + +D   K  S   
Sbjct: 130 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC- 188
Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              GTV Y+APE       + + D +SFG+L+ EM TG  P
Sbjct: 189 ---GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 112/253 (44%), Gaps = 30/253 (11%)
Query: 541 AELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECE 597
           A+   A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 598 ALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI- 656
              ++RH N++++       DS       L+ EY   G++         + E+ KL+   
Sbjct: 61  IQSHLRHPNILRLYGYFH--DSTRV---YLILEYAPLGTV---------YRELQKLSKFD 106
Query: 657 -QRVNIAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASK 713
            QR    I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +
Sbjct: 107 EQRTATYITELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 163
Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLH 772
                  + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + +     
Sbjct: 164 A-----ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRI 218
Query: 773 EFVKMTLPEKVIE 785
             V+ T P+ V E
Sbjct: 219 SRVEFTFPDFVTE 231

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +F   + +G G+ G V+K       +++A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 64
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            I+    +  S G    ++  E+M+ GSL+  L ++    E     ++ +V+IA  V   
Sbjct: 65  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 116
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           + YL    +  I+H D+KPSN+L++    +   +F +S QL DS + +        GT  
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRS 168
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
           Y++PE   G+  S+  D++S G+ L+EM  GR P      + L L
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 30  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 83
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 137
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 193
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 252
Query: 781 EK 782
           EK
Sbjct: 253 EK 254

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 32  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 85
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 139
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 195
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 254
Query: 781 EK 782
           EK
Sbjct: 255 EK 256

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 30  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 83
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 137
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV- 193
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 252
Query: 781 EK 782
           EK
Sbjct: 253 EK 254

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 88/189 (46%), Gaps = 14/189 (7%)
Query: 576 VAVKVI--NLKQKGAFR-SFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM 632
           VAVKV+  +L +  +F   F  E +    + H  ++ +     + ++       +V EY+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEA-ETPAGPLPYIVMEYV 98
Query: 633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 692
           +  +L D +H          +T  + + +  D   A+ + H +    I+H D+KP+N+++
Sbjct: 99  DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 693 DH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILL 751
              + V   +F ++  +  +  + + +  + GT  Y++PE   G       DVYS G +L
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 752 LEMFTGRRP 760
            E+ TG  P
Sbjct: 210 YEVLTGEPP 218

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 109/214 (50%), Gaps = 20/214 (9%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +F   + +G G+ G V+K       +++A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 64
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            I+    +  S G    ++  E+M+ GSL+  L ++    E     ++ +V+IA  V   
Sbjct: 65  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 116
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           + YL    +  I+H D+KPSN+L++    +   +F +S QL DS + +        GT  
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRS 168
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           Y++PE   G+  S+  D++S G+ L+EM  GR P
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 610
           +G+G FG V    Y     G   +VAVK +        RS +  E + LR + H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
              C   + +G     LV EY+  GSL D+L + +       + L Q +  A  +   + 
Sbjct: 82  KGCC---EDQGEKSLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 131
Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           YLH       +H +L   NVLLD+D +V   +F L+  +    +           V + A
Sbjct: 132 YLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFT 756
           PE     +     DV+SFG+ L E+ T
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 69  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +     
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD---- 167
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 168 -DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 226
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 227 TFPDFVTE 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 33  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 86
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 140
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 141 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 196
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 197 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 255
Query: 781 EK 782
           EK
Sbjct: 256 EK 257

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 112/226 (49%), Gaps = 20/226 (8%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F   + +G G+ G V+K       +++A K+I+L+ K A R+ +     L+ +   N 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNS 90
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
             I+    +  S G    ++  E+M+ GSL+  L ++    E     ++ +V+IA  V  
Sbjct: 91  PYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIK 142
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTV 725
            + YL    +  I+H D+KPSN+L++    +   +F +S QL DS + +        GT 
Sbjct: 143 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTR 194
Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
            Y++PE   G+  S+  D++S G+ L+EM  GR P      + L L
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 30  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 83
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 137
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 193
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 252
Query: 781 EK 782
           EK
Sbjct: 253 EK 254

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 24/226 (10%)
Query: 537 MISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAEC 596
           ++S  +  K  + F     IGQG+ G+VY  +       VA++ +NL+Q+      + E 
Sbjct: 12  IVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 597 EALRNIRHRNLIKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL 655
             +R  ++ N++      + +DS    D   +V EY+  GSL D +       E C +  
Sbjct: 69  LVMRENKNPNIV------NYLDSYLVGDELWVVMEYLAGGSLTDVV------TETC-MDE 115
Query: 656 IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKT 714
            Q   +  +   A+E+LH +    ++H D+K  N+LL  D  V   +F    Q+      
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            S  +   GT  ++APE           D++S GI+ +EM  G  P
Sbjct: 173 RSEMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 68  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 113
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +     
Sbjct: 114 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX---- 166
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 167 -XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 225
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 226 TFPDFVTE 233

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 29  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 82
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 136
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV- 192
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 251
Query: 781 EK 782
           EK
Sbjct: 252 EK 253

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 548 SEFASSNMIGQGSFGSVY--KGILGGE-EMIVAVKVIN---LKQKGAFRSFVAECEALRN 601
           S+F    ++GQGSFG V+  K I G +   + A+KV+    LK +   R+ + E + L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + H  ++K+     +  ++G  +  L+ +++  G L            + K  +    ++
Sbjct: 83  VNHPFIVKL---HYAFQTEGKLY--LILDFLRGGDL---------FTRLSKEVMFTEEDV 128
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSSI 719
              +A     L H     I++ DLKP N+LLD +  +   +F LS + +D   K  S   
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC- 187
Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              GTV Y+APE       + + D +SFG+L+ EM TG  P
Sbjct: 188 ---GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 32  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 85
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 139
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 195
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 254
Query: 781 EK 782
           EK
Sbjct: 255 EK 256

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F   + +G G+ G V K       +I+A K+I+L+ K A R+ +     L+ +   N 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQI--IRELQVLHECNS 73
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
             I+    +  S G    ++  E+M+ GSL+  L ++    E     ++ +V+IA  V  
Sbjct: 74  PYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKRIPE----EILGKVSIA--VLR 125
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTV 725
            + YL    Q  I+H D+KPSN+L++    +   +F +S QL DS + +        GT 
Sbjct: 126 GLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTR 177
Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            Y+APE   G+  S+  D++S G+ L+E+  GR P
Sbjct: 178 SYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 30/248 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVN 660
           RH N++++           A    L+ EY   G++         + E+ KL+    QR  
Sbjct: 67  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 112
Query: 661 IAI-DVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
             I ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +     
Sbjct: 113 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD---- 165
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKM 777
             + GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ 
Sbjct: 166 -TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 224
Query: 778 TLPEKVIE 785
           T P+ V E
Sbjct: 225 TFPDFVTE 232

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 81/322 (25%), Positives = 139/322 (43%), Gaps = 56/322 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 613
           IG+G +G V+ G   GE+  VAVKV    ++    S+  E E  + +  RH N++  I  
Sbjct: 45  IGKGRYGEVWMGKWRGEK--VAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIA- 98
Query: 614 CSSIDSKGADFK-ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
            + I   G+  +  L+ +Y ENGSL D+L  +        L     + +A    S + +L
Sbjct: 99  -ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCHL 150
Query: 673 HHHC-----QPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDS--ASKTPSSSIGIK 722
           H        +P I H DLK  N+L+  +    +A    ++    D+      P++ +G K
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 723 GTVGYVAPEYGMGS------EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK 776
               Y+ PE    S      ++ +  D+YSFG++L E+   RR       E        +
Sbjct: 211 ---RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVE--------E 257
Query: 777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDR-----RARTQDCLNAITRTGVLCSMESPFE 831
             LP   +   DPS   E M     I++ R     R  + +CL  + +    C   +P  
Sbjct: 258 YQLPYHDLVPSDPSY--EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315
Query: 832 R---MEMRDVVAKLCHTRETFL 850
           R   + ++  +AK+  +++  L
Sbjct: 316 RLTALRVKKTLAKMSESQDIKL 337

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 610
           +G+G FG V    Y     G   +VAVK +        RS +  E + LR + H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
              C   + +G     LV EY+  GSL D+L + +       + L Q +  A  +   + 
Sbjct: 82  KGCC---EDQGEKSLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 131
Query: 671 YLH--HHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           YLH  H+     +H +L   NVLLD+D +V   +F L+  +    +           V +
Sbjct: 132 YLHAQHY-----IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            APE     +     DV+SFG+ L E+ T
Sbjct: 187 YAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 88/189 (46%), Gaps = 14/189 (7%)
Query: 576 VAVKVI--NLKQKGAFR-SFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM 632
           VAVKV+  +L +  +F   F  E +    + H  ++ +     + ++       +V EY+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYV 98
Query: 633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 692
           +  +L D +H          +T  + + +  D   A+ + H +    I+H D+KP+N+++
Sbjct: 99  DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 693 DH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILL 751
              + V   +F ++  +  +  + + +  + GT  Y++PE   G       DVYS G +L
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 752 LEMFTGRRP 760
            E+ TG  P
Sbjct: 210 YEVLTGEPP 218

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 63/245 (25%), Positives = 107/245 (43%), Gaps = 24/245 (9%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           RH N++++           A    L+ EY   G++   L + +   E    T I      
Sbjct: 63  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 112
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
            ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T      +
Sbjct: 113 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----L 163
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKMTLP 780
            GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ T P
Sbjct: 164 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 223
Query: 781 EKVIE 785
           + V E
Sbjct: 224 DFVTE 228

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 63/245 (25%), Positives = 107/245 (43%), Gaps = 24/245 (9%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           RH N++++           A    L+ EY   G++   L + +   E    T I      
Sbjct: 65  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 114
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
            ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T      +
Sbjct: 115 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----L 165
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKMTLP 780
            GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ T P
Sbjct: 166 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 225
Query: 781 EKVIE 785
           + V E
Sbjct: 226 DFVTE 230

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 63/245 (25%), Positives = 107/245 (43%), Gaps = 24/245 (9%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           RH N++++           A    L+ EY   G++   L + +   E    T I      
Sbjct: 69  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 118
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
            ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T      +
Sbjct: 119 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----L 169
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKMTLP 780
            GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ T P
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229
Query: 781 EKVIE 785
           + V E
Sbjct: 230 DFVTE 234

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 24/226 (10%)
Query: 537 MISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAEC 596
           ++S  +  K  + F     IGQG+ G+VY  +       VA++ +NL+Q+      + E 
Sbjct: 12  IVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 597 EALRNIRHRNLIKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL 655
             +R  ++ N++      + +DS    D   +V EY+  GSL D +       E C +  
Sbjct: 69  LVMRENKNPNIV------NYLDSYLVGDELWVVMEYLAGGSLTDVV------TETC-MDE 115
Query: 656 IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKT 714
            Q   +  +   A+E+LH +    ++H D+K  N+LL  D  V   +F    Q+      
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            S  +   GT  ++APE           D++S GI+ +EM  G  P
Sbjct: 173 RSXMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI------NLKQKGAFRSFVAECEA 598
           ++  ++ +  ++G+GS+G V K        IVA+K         + +K A R    E + 
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDW-LHQSNDHLEVCKLTLIQ 657
           L+ +RH NL+ ++ +C     K      LVFE++++  L+D  L  +    +V +  L Q
Sbjct: 78  LKQLRHENLVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPS 716
            +N        I + H H    I+H D+KP N+L+    +V   +F  +  L +  +   
Sbjct: 133 IIN-------GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 717 SSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTG 757
             +    T  Y APE  +G  +     DV++ G L+ EMF G
Sbjct: 183 DEV---ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 111/250 (44%), Gaps = 36/250 (14%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G FG V+ G        VAVK +      + ++F+ E   ++ ++H  L+++  + +
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
             +        ++ EYM  GSL D+L       E  K+ L + ++ +  +A  + Y+   
Sbjct: 79  REEPI-----YIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIERK 129
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                +H DL+ +NVL+   ++    +F L+  ++    T     G K  + + APE   
Sbjct: 130 N---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAIN 184
Query: 735 GSEASMTGDVYSFGILLLEMFT-------GRRPTD--AAFTEGL----------TLHEFV 775
               ++  DV+SFGILL E+ T       GR   D   A ++G            L++ +
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYDIM 244
Query: 776 KMTLPEKVIE 785
           KM   EK  E
Sbjct: 245 KMCWKEKAEE 254

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 28/228 (12%)
Query: 537 MISYAELSKATSEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVA 594
           ++S  +  K  + F     IGQG+ G+VY    +  G+E  VA++ +NL+Q+      + 
Sbjct: 13  IVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQE--VAIRQMNLQQQPKKELIIN 67
Query: 595 ECEALRNIRHRNLIKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQSNDHLEVCKL 653
           E   +R  ++ N++      + +DS    D   +V EY+  GSL D +       E C +
Sbjct: 68  EILVMRENKNPNIV------NYLDSYLVGDELWVVMEYLAGGSLTDVV------TETC-M 114
Query: 654 TLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSAS 712
              Q   +  +   A+E+LH +    ++H D+K  N+LL  D  V   +F    Q+    
Sbjct: 115 DEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 171
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              S  +   GT  ++APE           D++S GI+ +EM  G  P
Sbjct: 172 SKRSXMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 63/245 (25%), Positives = 107/245 (43%), Gaps = 24/245 (9%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           RH N++++           A    L+ EY   G++   L + +   E    T I      
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 115
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
            ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +T      +
Sbjct: 116 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTX-----L 166
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKMTLP 780
            GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ T P
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226
Query: 781 EKVIE 785
           + V E
Sbjct: 227 DFVTE 231

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G FG V+      +   VAVK +      +  +F+AE   ++ ++H  L+K+  + +
Sbjct: 196 LGAGQFGEVWMATYN-KHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 254 K------EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 301
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            Q   +H DL+ +N+L+   +V    +F L+  ++    T     G K  + + APE   
Sbjct: 302 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAIN 358
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL+E+ T GR P
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 109/214 (50%), Gaps = 20/214 (9%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +F   + +G G+ G V+K       +++A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 83
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            I+    +  S G    ++  E+M+ GSL+  L ++    E     ++ +V+IA  V   
Sbjct: 84  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 135
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           + YL    +  I+H D+KPSN+L++    +   +F +S QL DS + +        GT  
Sbjct: 136 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRS 187
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           Y++PE   G+  S+  D++S G+ L+EM  GR P
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 30/246 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRH 604
            +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVNIA 662
            N++++           A    L+ EY   G++         + E+ KL+    QR    
Sbjct: 72  PNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSRFDEQRTATY 117
Query: 663 I-DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
           I ++A+A+ Y H      ++H D+KP N+LL  +  +   +F  S    S+ +T      
Sbjct: 118 ITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT-----T 169
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKMTL 779
           + GT+ Y+ PE   G       D++S G+L  E   G  P +A  + E       V+ T 
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTF 229
Query: 780 PEKVIE 785
           P+ V E
Sbjct: 230 PDFVTE 235

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 123/271 (45%), Gaps = 32/271 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAE 595
           E   A  +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VC 651
              ++     ++++++ + S           ++ E M  G L+ +L      +E    + 
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS 710
             +L + + +A ++A  + YL+ +     VH DL   N ++  D  V   +F ++  +  
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 173
Query: 711 ASKTPSSSIGIKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE 767
             +T     G KG   V +++PE       +   DV+SFG++L E+ T   +P      +
Sbjct: 174 -XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQ 227
Query: 768 GLTLHEFVKMTLPEKVIEIVD--PSLLMEVM 796
           GL+  + ++  +   +++  D  P +L+E+M
Sbjct: 228 GLSNEQVLRFVMEGGLLDKPDNCPDMLLELM 258

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 88/189 (46%), Gaps = 14/189 (7%)
Query: 576 VAVKVI--NLKQKGAFR-SFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM 632
           VAVKV+  +L +  +F   F  E +    + H  ++ +     + ++       +V EY+
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYV 115
Query: 633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 692
           +  +L D +H          +T  + + +  D   A+ + H   Q  I+H D+KP+N+++
Sbjct: 116 DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMI 166
Query: 693 DH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILL 751
              + V   +F ++  +  +  + + +  + GT  Y++PE   G       DVYS G +L
Sbjct: 167 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 226
Query: 752 LEMFTGRRP 760
            E+ TG  P
Sbjct: 227 YEVLTGEPP 235

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 88/189 (46%), Gaps = 14/189 (7%)
Query: 576 VAVKVI--NLKQKGAFR-SFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM 632
           VAVKV+  +L +  +F   F  E +    + H  ++ +     + ++       +V EY+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYV 98
Query: 633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 692
           +  +L D +H          +T  + + +  D   A+ + H +    I+H D+KP+N+++
Sbjct: 99  DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 693 DH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILL 751
              + V   +F ++  +  +  + + +  + GT  Y++PE   G       DVYS G +L
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 752 LEMFTGRRP 760
            E+ TG  P
Sbjct: 210 YEVLTGEPP 218

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 113/250 (45%), Gaps = 16/250 (6%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEE---MIVAVKVI--NLKQKGAFRSFVAECEALRNIR 603
           +F    M+G+G FGSV +  L  E+   + VAVK++  ++        F+ E   ++   
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 604 HRNLIKIITICSSIDSKGA-DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           H ++ K++ +     +KG      ++  +M++G L  +L  S        L L   V   
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           +D+A  +EYL        +H DL   N +L  DM V   +F LS ++ S           
Sbjct: 144 VDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-RQGCAS 199
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV----KM 777
           K  V ++A E    +  ++  DV++FG+ + E+ T R  T  A  E   ++ ++    ++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT-RGQTPYAGIENAEIYNYLIGGNRL 258
Query: 778 TLPEKVIEIV 787
             P + +E V
Sbjct: 259 KQPPECMEEV 268

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 33  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 86
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 140
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 141 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV- 196
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 197 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 255
Query: 781 EK 782
           EK
Sbjct: 256 EK 257

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 88/189 (46%), Gaps = 14/189 (7%)
Query: 576 VAVKVI--NLKQKGAFR-SFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM 632
           VAVKV+  +L +  +F   F  E +    + H  ++ +     + ++       +V EY+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYV 98
Query: 633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 692
           +  +L D +H          +T  + + +  D   A+ + H +    I+H D+KP+N+++
Sbjct: 99  DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 693 DH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILL 751
              + V   +F ++  +  +  + + +  + GT  Y++PE   G       DVYS G +L
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 752 LEMFTGRRP 760
            E+ TG  P
Sbjct: 210 YEVLTGEPP 218

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQKGAFR---SFVAECEALRNIRHRNL 607
           +GQGSFG VY+G     I G  E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLH----QSNDHLEVCKLTLIQRVNIAI 663
           ++++ +     SKG     +V E M +G L+ +L     ++ ++      TL + + +A 
Sbjct: 83  VRLLGVV----SKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++A  + YL+       VH DL   N ++ HD  V   +F ++  +    +T     G K
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI---XETDXXRKGGK 191
Query: 723 G--TVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
           G   V ++APE       + + D++SFG++L E+
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+D++  S   L    L LI+  +    +
Sbjct: 63  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKDFMDASA--LTGIPLPLIK--SYLFQL 112
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 166
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 224
Query: 782 KVI 784
           +V+
Sbjct: 225 EVV 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQKGAFR---SFVAECEALRNIRHRNL 607
           +GQGSFG VY+G     I G  E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 79
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLH----QSNDHLEVCKLTLIQRVNIAI 663
           ++++ +     SKG     +V E M +G L+ +L     ++ ++      TL + + +A 
Sbjct: 80  VRLLGVV----SKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 134
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++A  + YL+       VH DL   N ++ HD  V   +F ++  +    +T     G K
Sbjct: 135 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI---XETDXXRKGGK 188
Query: 723 G--TVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
           G   V ++APE       + + D++SFG++L E+
Sbjct: 189 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 106/238 (44%), Gaps = 28/238 (11%)
Query: 529 SPAKKQFPMISYAELSKATSE-FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG 587
           +P ++Q   +    L+K   E F     +G+GS+GSVYK I      IVA+K + +  + 
Sbjct: 9   NPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ES 66
Query: 588 AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK----ALVFEYMENGSLEDWLHQ 643
             +  + E   ++     +++K           G+ FK     +V EY   GS+ D +  
Sbjct: 67  DLQEIIKEISIMQQCDSPHVVKYY---------GSYFKNTDLWIVMEYCGAGSVSDIIRL 117
Query: 644 SNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNF 702
            N  L   ++  I +  +       +EYLH   +   +H D+K  N+LL+ +  A   +F
Sbjct: 118 RNKTLTEDEIATILQSTL-----KGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADF 169
Query: 703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            ++ QL       +  I   GT  ++APE       +   D++S GI  +EM  G+ P
Sbjct: 170 GVAGQLTDXMAKRNXVI---GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 33/228 (14%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNI- 602
           ATS +     IG G++G+VYK         VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 603 --RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSND---HLEVCKLTLIQ 657
              H N+++++ +C++  +       LVFE+++   L  +L ++       E  K  + Q
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSL----SHQLDSAS 712
            +         +++LH +C   IVH DLKP N+L+     V   +F L    S+Q+  A 
Sbjct: 121 FLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP 170
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                   +  T+ Y APE  + S  +   D++S G +  EMF  R+P
Sbjct: 171 --------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 209

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 127/274 (46%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V ++ L++     A +  + E   + ++
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 109 DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 157
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 158 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 213
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 214 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 273
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 274 QPPICTIDVYM---IMVKCWMIDADSRPKFRELI 304

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQKGAFR---SFVAECEALRNIRHRNL 607
           +GQGSFG VY+G     I G  E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLH----QSNDHLEVCKLTLIQRVNIAI 663
           ++++ +     SKG     +V E M +G L+ +L     ++ ++      TL + + +A 
Sbjct: 83  VRLLGVV----SKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++A  + YL+       VH DL   N ++ HD  V   +F ++  +    +T     G K
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI---XETDXXRKGGK 191
Query: 723 G--TVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
           G   V ++APE       + + D++SFG++L E+
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 87/189 (46%), Gaps = 14/189 (7%)
Query: 576 VAVKVI--NLKQKGAFR-SFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM 632
           VAVKV+  +L +  +F   F  E +    + H  ++ +     + ++       +V EY+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYV 98
Query: 633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 692
           +  +L D +H          +T  + + +  D   A+ + H +    I+H D+KP+N+L+
Sbjct: 99  DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANILI 149
Query: 693 DH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILL 751
              + V   +F ++  +  +  +   +  + GT  Y++PE   G       DVYS G +L
Sbjct: 150 SATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 752 LEMFTGRRP 760
            E+ TG  P
Sbjct: 210 YEVLTGEPP 218

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIK 609
           +G+  FG VYKG L     G +   VA+K +  K +G  R  F  E      ++H N++ 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEV----------CKLTLIQRV 659
           ++ + +          +++F Y  +G L ++L   + H +V            L     V
Sbjct: 94  LLGVVTKDQPL-----SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTP--- 715
           ++   +A+ +EYL  H    +VH DL   NVL+ D   V   +  L  ++ +A       
Sbjct: 149 HLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 205
Query: 716 SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEF 774
           +S + I+    ++APE  M  + S+  D++S+G++L E+F+ G +P       G +  + 
Sbjct: 206 NSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC-----GYSNQDV 256
Query: 775 VKMTLPEKVIEIVD--PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVL 823
           V+M    +V+   D  P+ +  +M         RR R +D  + +   G L
Sbjct: 257 VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 35/224 (15%)
Query: 556 IGQGSFGSVYKGILGGEE-----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 606
           +G+G+FG V      G +      +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH-QSNDHLEVC---------KLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L  +    LE C         +L+  
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSAS 712
             V+ A  VA  +EYL        +H DL   NVL+  D V    +F L+   H +D   
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           KT +  + +K    ++APE       +   DV+SFG+LL E+FT
Sbjct: 208 KTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 35/224 (15%)
Query: 556 IGQGSFGSVYKGILGGEE-----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 606
           +G+G+FG V      G +      +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH-QSNDHLEVC---------KLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L  +    LE C         +L+  
Sbjct: 81  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSAS 712
             V+ A  VA  +EYL        +H DL   NVL+  D V    +F L+   H +D   
Sbjct: 136 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           KT +  + +K    ++APE       +   DV+SFG+LL E+FT
Sbjct: 193 KTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 130/289 (44%), Gaps = 40/289 (13%)
Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIK 609
           +G+  FG VYKG L     G +   VA+K +  K +G  R  F  E      ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEV----------CKLTLIQRV 659
           ++ + +          +++F Y  +G L ++L   + H +V            L     V
Sbjct: 77  LLGVVTKDQPL-----SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTP--- 715
           ++   +A+ +EYL  H    +VH DL   NVL+ D   V   +  L  ++ +A       
Sbjct: 132 HLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 716 SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEF 774
           +S + I+    ++APE  M  + S+  D++S+G++L E+F+ G +P       G +  + 
Sbjct: 189 NSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC-----GYSNQDV 239
Query: 775 VKMTLPEKVIEIVD--PSLLMEVMANNSMIQEDRRARTQDCLNAITRTG 821
           V+M    +V+   D  P+ +  +M         RR R +D  + +   G
Sbjct: 240 VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           F   + IG+GSFG VYKGI    + +VA+K+I+L++       + +              
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQE------------- 67
Query: 610 IITICSSIDSK------GADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            IT+ S  DS       G+  K+    ++ EY+  GS  D L      LE   +  I R 
Sbjct: 68  -ITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILR- 123
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
               ++   ++YLH   +   +H D+K +NVLL +   V   +F ++ QL       +  
Sbjct: 124 ----EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXF 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +   GT  ++APE    S      D++S GI  +E+  G  P
Sbjct: 177 V---GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 610
           +G+G FG V    Y     G   +VAVK +        RS +  E E LR + H +++K 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
              C   + +G     LV EY+  GSL D+L +         + L Q +  A  +   + 
Sbjct: 76  KGCC---EDQGEKSVQLVMEYVPLGSLRDYLPRHC-------VGLAQLLLFAQQICEGMA 125
Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           YLH       +H  L   NVLLD+D +V   +F L+  +    +           V + A
Sbjct: 126 YLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 182
Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFT 756
           PE     +     DV+SFG+ L E+ T
Sbjct: 183 PECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAE 595
           E   A  +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VC 651
              ++     ++++++ + S           ++ E M  G L+ +L      +E    + 
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS 710
             +L + + +A ++A  + YL+ +     VH DL   N ++  D  V   +F ++  +  
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 182
Query: 711 ASKTPSSSIGIKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE 767
             +T     G KG   V +++PE       +   DV+SFG++L E+ T   +P      +
Sbjct: 183 -XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQ 236
Query: 768 GLTLHEFVKMTLPEKVIEIVD--PSLLMEVM 796
           GL+  + ++  +   +++  D  P +L E+M
Sbjct: 237 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELM 267

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 28/228 (12%)
Query: 537 MISYAELSKATSEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVA 594
           ++S  +  K  + F     IGQG+ G+VY    +  G+E  VA++ +NL+Q+      + 
Sbjct: 13  IVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQE--VAIRQMNLQQQPKKELIIN 67
Query: 595 ECEALRNIRHRNLIKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQSNDHLEVCKL 653
           E   +R  ++ N++      + +DS    D   +V EY+  GSL D +       E C +
Sbjct: 68  EILVMRENKNPNIV------NYLDSYLVGDELWVVMEYLAGGSLTDVV------TETC-M 114
Query: 654 TLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSAS 712
              Q   +  +   A+E+LH +    ++H ++K  N+LL  D  V   +F    Q+    
Sbjct: 115 DEGQIAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQ 171
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              S+ +   GT  ++APE           D++S GI+ +EM  G  P
Sbjct: 172 SKRSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 79  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 127
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 128 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 183
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 243
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 244 QPPICTID---VYMIMVKCWMIDADSRPKFRELI 274

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 24/242 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +    +L  E        I + +K   R  + E +     R R++
Sbjct: 30  EDFKFGKILGEGSFSTT---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 83
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 137
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 193
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP 780
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+    P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFP 252
Query: 781 EK 782
           EK
Sbjct: 253 EK 254

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 22/235 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F    ++G+GSF +V   +L  E        I + +K   R  + E +     R R++
Sbjct: 35  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 88
Query: 608 IKIIT--ICSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           +  +       +     D + L F   Y +NG L  ++ +     E C      R   A 
Sbjct: 89  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 142
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  + 
Sbjct: 143 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 198
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM 777
           GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+
Sbjct: 199 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKL 252

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 117/243 (48%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++ +  L+D++  S   L    L LI+  +    +
Sbjct: 66  NIVKLLDVIHTENKL-----YLVFEFL-SMDLKDFMDASA--LTGIPLPLIK--SYLFQL 115
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 116 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 169
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 227
Query: 782 KVI 784
           +V+
Sbjct: 228 EVV 230

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 556 IGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 610
           +G+G FG V    Y     G   +VAVK +        RS +  E E LR + H +++K 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
              C   + +G     LV EY+  GSL D+L +         + L Q +  A  +   + 
Sbjct: 77  KGCC---EDQGEKSVQLVMEYVPLGSLRDYLPRHC-------VGLAQLLLFAQQICEGMA 126
Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           YLH       +H  L   NVLLD+D +V   +F L+  +    +           V + A
Sbjct: 127 YLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 183
Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFT 756
           PE     +     DV+SFG+ L E+ T
Sbjct: 184 PECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 126
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 182
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 243 QPPICTIDVYM---IMVKCWMIDADSRPKFRELI 273

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 181
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 242 QPPICTIDVYM---IMVKCWMIDADSRPKFRELI 272

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFV-AECEALRNIRHRN 606
           ++F     +G+G FG V++     ++   A+K I L  +   R  V  E +AL  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 607 LIKIIT--ICSSIDSKGADFKALVFEYME-----NGSLEDWLHQSNDHLEVCKLTLIQR- 658
           +++     +  +   K       V+ Y++       +L+DW++        C +   +R 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR------CTIEERERS 118
Query: 659 --VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASK-- 713
             ++I + +A A+E+LH      ++H DLKPSN+     D+V   +F L   +D   +  
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 714 ---TP----SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
              TP    +   G  GT  Y++PE   G+  S   D++S G++L E+
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 179
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 240 QPPICTIDVYM---IMVKCWMIDADSRPKFRELI 270

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 42/230 (18%)
Query: 556 IGQGSFGSVYK----GILGGEEM-IVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIK 609
           IG+G+FG V++    G+L  E   +VAVK++  +     ++ F  E   +    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC------------------ 651
           ++ +C+           L+FEYM  G L ++L   + H  VC                  
Sbjct: 115 LLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPH-TVCSLSHSDLSTRARVSSPGP 168
Query: 652 -KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLD 709
             L+  +++ IA  VA+ + YL        VH DL   N L+  +MV    +F LS  + 
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 710 SASKTPS---SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           SA    +    +I I+    ++ PE    +  +   DV+++G++L E+F+
Sbjct: 226 SADYYKADGNDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 62/245 (25%), Positives = 106/245 (43%), Gaps = 24/245 (9%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           RH N++++           A    L+ EY   G++   L + +   E    T I      
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 115
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
            ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +       +
Sbjct: 116 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA-----AL 166
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKMTLP 780
            GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ T P
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226
Query: 781 EKVIE 785
           + V E
Sbjct: 227 DFVTE 231

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 549 EFASSNMIGQGSFGSVYKG---ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR 605
           +F    +IG G FG V+K    I G   +I  VK  N K +        E +AL  + H 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE-------REVKALAKLDHV 64
Query: 606 NLIKIITI---------CSSIDSKGADFKALV--FEYMENGSLEDWLHQSNDHLEVCKLT 654
           N++               SS +S  +  K L    E+ + G+LE W+ +        KL 
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----KLD 120
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQNFSLSHQLDSASK 713
            +  + +   +   ++Y+H      +++ DLKPSN+ L+D   V   +F L   L +  K
Sbjct: 121 KVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMF 755
              S    KGT+ Y++PE     +     D+Y+ G++L E+ 
Sbjct: 178 RXRS----KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 76  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 124
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 125 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 180
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 240
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 241 QPPICTIDVYM---IMVKCWMIDADSRPKFRELI 271

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIIT 612
           + +G+G++ +VYKG     + +VA+K I L+ ++GA  + + E   L++++H N++ +  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSND--HLEVCKLTLIQRVNIAIDVASAIE 670
           I  +  S       LVFEY++   L+ +L    +  ++   KL L Q       +   + 
Sbjct: 68  IIHTEKS-----LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ-------LLRGLA 114
Query: 671 YLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           Y H   +  ++H DLKP N+L+ +   +   +F L+      +KT  + +    T+ Y  
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV---VTLWYRP 168
Query: 730 PEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           P+  +GS + S   D++  G +  EM TGR
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 117/243 (48%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++ +  L+D++  S   L    L LI+  +    +
Sbjct: 65  NIVKLLDVIHTENKL-----YLVFEFL-SMDLKDFMDASA--LTGIPLPLIK--SYLFQL 114
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 115 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 168
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 226
Query: 782 KVI 784
           +V+
Sbjct: 227 EVV 229

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 76  DNPHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYVREHKDNIGSQYL-----LNWC 124
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 125 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 180
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 240
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 241 QPPICTIDVYM---IMVKCWMIDADSRPKFRELI 271

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNI- 602
           ATS +     IG G++G+VYK         VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 603 --RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
              H N+++++ +C++  +       LVFE+++   L  +L    D      L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKD 116
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSL----SHQLDSASKTP 715
           +       +++LH +C   IVH DLKP N+L+     V   +F L    S+Q+       
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM------- 166
Query: 716 SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            +   +  T+ Y APE  + S  +   D++S G +  EMF  R+P
Sbjct: 167 -ALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 209

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 104/247 (42%), Gaps = 45/247 (18%)
Query: 543 LSKATSEFASSNMI-----GQGSFGSVYKGI---LGGEEMIVAVKVINLKQKGA---FRS 591
           L     EF   N++     G+G FG V K     L G      V V  LK+  +    R 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 592 FVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN------ 645
            ++E   L+ + H ++IK+   CS           L+ EY + GSL  +L +S       
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGP-----LLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 646 ------------DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL- 692
                       DH +   LT+   ++ A  ++  ++YL    +  +VH DL   N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVA 184
Query: 693 DHDMVAHQNFSLS---HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGI 749
           +   +   +F LS   ++ DS  K     I +K    ++A E       +   DV+SFG+
Sbjct: 185 EGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK----WMAIESLFDHIYTTQSDVWSFGV 240
Query: 750 LLLEMFT 756
           LL E+ T
Sbjct: 241 LLWEIVT 247

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 31/241 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
           ++F+   +IG+G FG VY         + A+K ++ K     R  + + E L  +  R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIM 241
Query: 608 IKIIT-------ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
           + +++       +C S      D  + + + M  G L         H  + +  +    +
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL---------HYHLSQHGVFSEAD 292
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSI 719
           +    A  I  L H     +V+ DLKP+N+LLD H  V   +  L+   D + K P +S+
Sbjct: 293 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV 350
Query: 720 GIKGTVGYVAPEY-GMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT 778
              GT GY+APE    G     + D +S G +L ++  G  P     T+    HE  +MT
Sbjct: 351 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMT 405
Query: 779 L 779
           L
Sbjct: 406 L 406

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 104/247 (42%), Gaps = 45/247 (18%)
Query: 543 LSKATSEFASSNMI-----GQGSFGSVYKGI---LGGEEMIVAVKVINLKQKGA---FRS 591
           L     EF   N++     G+G FG V K     L G      V V  LK+  +    R 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 592 FVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN------ 645
            ++E   L+ + H ++IK+   CS           L+ EY + GSL  +L +S       
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGP-----LLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 646 ------------DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL- 692
                       DH +   LT+   ++ A  ++  ++YL    +  +VH DL   N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVA 184
Query: 693 DHDMVAHQNFSLS---HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGI 749
           +   +   +F LS   ++ DS  K     I +K    ++A E       +   DV+SFG+
Sbjct: 185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK----WMAIESLFDHIYTTQSDVWSFGV 240
Query: 750 LLLEMFT 756
           LL E+ T
Sbjct: 241 LLWEIVT 247

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 31/241 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
           ++F+   +IG+G FG VY         + A+K ++ K     R  + + E L  +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIM 242
Query: 608 IKIIT-------ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
           + +++       +C S      D  + + + M  G L         H  + +  +    +
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL---------HYHLSQHGVFSEAD 293
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSI 719
           +    A  I  L H     +V+ DLKP+N+LLD H  V   +  L+   D + K P +S+
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV 351
Query: 720 GIKGTVGYVAPEY-GMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT 778
              GT GY+APE    G     + D +S G +L ++  G  P     T+    HE  +MT
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMT 406
Query: 779 L 779
           L
Sbjct: 407 L 407

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 104/247 (42%), Gaps = 45/247 (18%)
Query: 543 LSKATSEFASSNMI-----GQGSFGSVYKGI---LGGEEMIVAVKVINLKQKGA---FRS 591
           L     EF   N++     G+G FG V K     L G      V V  LK+  +    R 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 592 FVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN------ 645
            ++E   L+ + H ++IK+   CS           L+ EY + GSL  +L +S       
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGP-----LLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 646 ------------DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL- 692
                       DH +   LT+   ++ A  ++  ++YL    +  +VH DL   N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVA 184
Query: 693 DHDMVAHQNFSLS---HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGI 749
           +   +   +F LS   ++ DS  K     I +K    ++A E       +   DV+SFG+
Sbjct: 185 EGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK----WMAIESLFDHIYTTQSDVWSFGV 240
Query: 750 LLLEMFT 756
           LL E+ T
Sbjct: 241 LLWEIVT 247

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQKGAFR---SFVAECEALRNIRHRNL 607
           +GQGSFG VY+G     I G  E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLH----QSNDHLEVCKLTLIQRVNIAI 663
           ++++ +     SKG     +V E M +G L+ +L     ++ ++      TL + + +A 
Sbjct: 83  VRLLGVV----SKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++A  + YL+       VH DL   N ++ HD  V   +F ++  +    +T     G K
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI---YETAYYRKGGK 191
Query: 723 G--TVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
           G   V ++APE       + + D++SFG++L E+
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 37/230 (16%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNI- 602
           ATS +     IG G++G+VYK         VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 603 --RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSND---HLEVCKLTLIQ 657
              H N+++++ +C++  +       LVFE+++   L  +L ++       E  K  + Q
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-------DMVAHQNFSLSHQLDS 710
            +         +++LH +C   IVH DLKP N+L+         D    + +S    LD 
Sbjct: 121 FLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDP 170
Query: 711 ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                     +  T+ Y APE  + S  +   D++S G +  EMF  R+P
Sbjct: 171 ----------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 209

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 31/241 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
           ++F+   +IG+G FG VY         + A+K ++ K     R  + + E L  +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIM 242
Query: 608 IKIIT-------ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
           + +++       +C S      D  + + + M  G L         H  + +  +    +
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL---------HYHLSQHGVFSEAD 293
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSI 719
           +    A  I  L H     +V+ DLKP+N+LLD H  V   +  L+   D + K P +S+
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV 351
Query: 720 GIKGTVGYVAPEY-GMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT 778
              GT GY+APE    G     + D +S G +L ++  G  P     T+    HE  +MT
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMT 406
Query: 779 L 779
           L
Sbjct: 407 L 407

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 31/241 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
           ++F+   +IG+G FG VY         + A+K ++ K     R  + + E L  +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIM 242
Query: 608 IKIIT-------ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
           + +++       +C S      D  + + + M  G L         H  + +  +    +
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL---------HYHLSQHGVFSEAD 293
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSI 719
           +    A  I  L H     +V+ DLKP+N+LLD H  V   +  L+   D + K P +S+
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV 351
Query: 720 GIKGTVGYVAPEY-GMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT 778
              GT GY+APE    G     + D +S G +L ++  G  P     T+    HE  +MT
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMT 406
Query: 779 L 779
           L
Sbjct: 407 L 407

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 22/222 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            +F   + +G G+ G V+K       +++A K+I+L+ K A R+ +     L+ +   N 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNS 66
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
             I+    +  S G    ++  E+M+ GSL+  L ++    E     ++ +V+IA  V  
Sbjct: 67  PYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIK 118
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSSSIGIKGTV 725
            + YL    +  I+H D+KPSN+L++    +   +F +S QL D  +          GT 
Sbjct: 119 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE------FVGTR 170
Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGR--RPTDAAF 765
            Y++PE   G+  S+  D++S G+ L+EM  GR  RP  A F
Sbjct: 171 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIF 212

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQKGAFR---SFVAECEALRNIRHRNL 607
           +GQGSFG VY+G     I G  E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLH----QSNDHLEVCKLTLIQRVNIAI 663
           ++++ +     SKG     +V E M +G L+ +L     ++ ++      TL + + +A 
Sbjct: 83  VRLLGVV----SKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++A  + YL+       VH DL   N ++ HD  V   +F ++  +    +T     G K
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI---YETDYYRKGGK 191
Query: 723 G--TVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
           G   V ++APE       + + D++SFG++L E+
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 126
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 182
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 243 QPPICTIDVYM---IMVKCWMIDADSRPKFRELI 273

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAE 595
           E   A  +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VC 651
              ++     ++++++ + S           ++ E M  G L+ +L      +E    + 
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS 710
             +L + + +A ++A  + YL+ +     VH DL   N ++  D  V   +F ++  +  
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 175
Query: 711 ASKTPSSSIGIKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE 767
             +T     G KG   V +++PE       +   DV+SFG++L E+ T   +P      +
Sbjct: 176 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQ 229
Query: 768 GLTLHEFVKMTLPEKVIEIVD--PSLLMEVM 796
           GL+  + ++  +   +++  D  P +L E+M
Sbjct: 230 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELM 260

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 556 IGQGSFGSVY--KGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G+F  V   + IL G+E  VAVK+I+  Q    + +    E    + + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +   I+++   +  LV EY   G + D+L       E       +++       SA++Y
Sbjct: 80  EV---IETEKTLY--LVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI------VSAVQY 128
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H   Q  IVH DLK  N+LLD D  +   +F  S++    +K  +      G   Y AP
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFC----GAPPYAAP 181
Query: 731 EYGMGSEASMTG-DVYSFGILLLEMFTGRRPTDA 763
           E   G +      DV+S G++L  + +G  P D 
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 111/252 (44%), Gaps = 35/252 (13%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGE--EMIVAVKVINLKQKGAFRSFVAECEALRNIRHR 605
           S+     ++G+G FG   K +   E  E++V  ++I   ++   R+F+ E + +R + H 
Sbjct: 10  SDLIHGEVLGKGCFGQAIK-VTHRETGEVMVMKELIRFDEETQ-RTFLKEVKVMRCLEHP 67
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K I +      K  +F   + EY++ G+L   +   +      +    QRV+ A D+
Sbjct: 68  NVLKFIGVLYK--DKRLNF---ITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDI 117
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIK-- 722
           AS + YLH      I+H DL   N L+ ++  V   +F L+  +      P     +K  
Sbjct: 118 ASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 723 ---------GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE-----G 768
                    G   ++APE   G       DV+SFGI+L E+  GR   D  +       G
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFG 233
Query: 769 LTLHEFVKMTLP 780
           L +  F+    P
Sbjct: 234 LNVRGFLDRYCP 245

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 126
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 182
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 243 QPPICTIDVYM---IMVKCWMIDADSRPKFRELI 273

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAE 595
           E   A  +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VC 651
              ++     ++++++ + S           ++ E M  G L+ +L      +E    + 
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS 710
             +L + + +A ++A  + YL+ +     VH DL   N ++  D  V   +F ++  +  
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 182
Query: 711 ASKTPSSSIGIKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE 767
             +T     G KG   V +++PE       +   DV+SFG++L E+ T   +P      +
Sbjct: 183 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQ 236
Query: 768 GLTLHEFVKMTLPEKVIEIVD--PSLLMEVM 796
           GL+  + ++  +   +++  D  P +L E+M
Sbjct: 237 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELM 267

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 130
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 186
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 247 QPPICTID---VYMIMVKCWMIDADSRPKFRELI 277

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 181
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 242 QPPICTID---VYMIMVKCWMIDADSRPKFRELI 272

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 62/245 (25%), Positives = 106/245 (43%), Gaps = 24/245 (9%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           RH N++++           A    L+ EY   G++   L + +   E    T I      
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 115
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
            ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +       +
Sbjct: 116 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----L 166
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKMTLP 780
            GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ T P
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 226
Query: 781 EKVIE 785
           + V E
Sbjct: 227 DFVTE 231

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 100 DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 148
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 149 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 204
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 205 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 264
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 265 QPPICTID---VYMIMVKCWMIDADSRPKFRELI 295

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQKGAFR---SFVAECEALRNIRHRNL 607
           +GQGSFG VY+G     I G  E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 81
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLH----QSNDHLEVCKLTLIQRVNIAI 663
           ++++ +     SKG     +V E M +G L+ +L     ++ ++      TL + + +A 
Sbjct: 82  VRLLGVV----SKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 136
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++A  + YL+       VH DL   N ++ HD  V   +F ++  +    +T     G K
Sbjct: 137 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI---YETDYYRKGGK 190
Query: 723 G--TVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
           G   V ++APE       + + D++SFG++L E+
Sbjct: 191 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 62/245 (25%), Positives = 106/245 (43%), Gaps = 24/245 (9%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 602
           A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           RH N++++           A    L+ EY   G++   L + +   E    T I      
Sbjct: 69  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 118
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
            ++A+A+ Y H      ++H D+KP N+LL     +   +F  S    S+ +       +
Sbjct: 119 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----L 169
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKMTLP 780
            GT+ Y+ PE   G       D++S G+L  E   G+ P +A  + E       V+ T P
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 229
Query: 781 EKVIE 785
           + V E
Sbjct: 230 DFVTE 234

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAE 595
           E   A  +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 100
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VC 651
              ++     ++++++ + S           ++ E M  G L+ +L      +E    + 
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS 710
             +L + + +A ++A  + YL+ +     VH DL   N ++  D  V   +F ++  +  
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 210
Query: 711 ASKTPSSSIGIKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE 767
             +T     G KG   V +++PE       +   DV+SFG++L E+ T   +P      +
Sbjct: 211 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQ 264
Query: 768 GLTLHEFVKMTLPEKVIEIVD--PSLLMEVM 796
           GL+  + ++  +   +++  D  P +L E+M
Sbjct: 265 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELM 295

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 63  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 112
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 113 LQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 166
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 224
Query: 782 KVI 784
           +V+
Sbjct: 225 EVV 227

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAE 595
           E   A  +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VC 651
              ++     ++++++ + S           ++ E M  G L+ +L      +E    + 
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS 710
             +L + + +A ++A  + YL+ +     VH DL   N ++  D  V   +F ++  +  
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 179
Query: 711 ASKTPSSSIGIKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE 767
             +T     G KG   V +++PE       +   DV+SFG++L E+ T   +P      +
Sbjct: 180 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQ 233
Query: 768 GLTLHEFVKMTLPEKVIEIVD--PSLLMEVM 796
           GL+  + ++  +   +++  D  P +L E+M
Sbjct: 234 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELM 264

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G FG V+      +   VAVK +      +  +F+AE   ++ ++H  L+K+  + +
Sbjct: 190 LGAGQFGEVWMATYN-KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 248 K------EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 295
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            Q   +H DL+ +N+L+   +V    +F L+             +G K  + + APE   
Sbjct: 296 -QRNYIHRDLRAANILVSASLVCKIADFGLAR------------VGAKFPIKWTAPEAIN 342
Query: 735 GSEASMTGDVYSFGILLLEMFT-GRRP 760
               ++  DV+SFGILL+E+ T GR P
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAE 595
           E   A  +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VC 651
              ++     ++++++ + S           ++ E M  G L+ +L      +E    + 
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS 710
             +L + + +A ++A  + YL+ +     VH DL   N ++  D  V   +F ++  +  
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 181
Query: 711 ASKTPSSSIGIKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE 767
             +T     G KG   V +++PE       +   DV+SFG++L E+ T   +P      +
Sbjct: 182 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQ 235
Query: 768 GLTLHEFVKMTLPEKVIEIVD--PSLLMEVM 796
           GL+  + ++  +   +++  D  P +L E+M
Sbjct: 236 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELM 266

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 63  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 112
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 166
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 224
Query: 782 KVI 784
           +V+
Sbjct: 225 EVV 227

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 81  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 129
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 130 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 185
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 186 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 245
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 246 QPPICTID---VYMIMVKCWMIDADSRPKFRELI 276

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 30/246 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRH 604
            +F     +G+G FG+VY       + I+A+KV+    L++ G       E E   ++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI--QRVNIA 662
            N++++           A    L+ EY   G++         + E+ KL+    QR    
Sbjct: 72  PNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSRFDEQRTATY 117
Query: 663 I-DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
           I ++A+A+ Y H      ++H D+KP N+LL  +  +   +F  S    S+ +       
Sbjct: 118 ITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD-----T 169
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA-AFTEGLTLHEFVKMTL 779
           + GT+ Y+ PE   G       D++S G+L  E   G  P +A  + E       V+ T 
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTF 229
Query: 780 PEKVIE 785
           P+ V E
Sbjct: 230 PDFVTE 235

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 70  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 119
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 120 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 173
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 231
Query: 782 KVI 784
           +V+
Sbjct: 232 EVV 234

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 179
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 240 QPPICTID---VYMIMVKCWMIDADSRPKFRELI 270

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 179
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 240 QPPICTIDVYM---IMRKCWMIDADSRPKFRELI 270

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 126
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 182
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 243 QPPICTIDVYM---IMRKCWMIDADSRPKFRELI 273

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 72  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 120
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 121 VQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 176
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 177 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 236
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 237 QPPICTIDVYM---IMVKCWMIDADSRPKFRELI 267

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGXLLDYVREHKDNIGSQYL-----LNWC 123
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 179
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 240 QPPICTID---VYMIMVKCWMIDADSRPKFRELI 270

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 70  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 119
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 120 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 173
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 231
Query: 782 KVI 784
           +V+
Sbjct: 232 EVV 234

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAE 595
           E   A  +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VC 651
              ++     ++++++ + S           ++ E M  G L+ +L      +E    + 
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS 710
             +L + + +A ++A  + YL+ +     VH DL   N ++  D  V   +F ++  +  
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 181
Query: 711 ASKTPSSSIGIKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE 767
             +T     G KG   V +++PE       +   DV+SFG++L E+ T   +P      +
Sbjct: 182 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQ 235
Query: 768 GLTLHEFVKMTLPEKVIEIVD--PSLLMEVM 796
           GL+  + ++  +   +++  D  P +L E+M
Sbjct: 236 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELM 266

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 62  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 111
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 165
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 223
Query: 782 KVI 784
           +V+
Sbjct: 224 EVV 226

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 63  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 112
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 166
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 224
Query: 782 KVI 784
           +V+
Sbjct: 225 EVV 227

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 556 IGQGSFGSVYKGILGGEE-----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 606
           +G+G+FG V      G +      +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L               H    +L+  
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSAS 712
             V+ A  VA  +EYL        +H DL   NVL+  D V    +F L+   H +D   
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXK 207
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           KT +  + +K    ++APE       +   DV+SFG+LL E+FT
Sbjct: 208 KTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAE 595
           E   A  +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VC 651
              ++     ++++++ + S           ++ E M  G L+ +L      +E    + 
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS 710
             +L + + +A ++A  + YL+ +     VH DL   N ++  D  V   +F ++  +  
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 188
Query: 711 ASKTPSSSIGIKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE 767
             +T     G KG   V +++PE       +   DV+SFG++L E+ T   +P      +
Sbjct: 189 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQ 242
Query: 768 GLTLHEFVKMTLPEKVIEIVD--PSLLMEVM 796
           GL+  + ++  +   +++  D  P +L E+M
Sbjct: 243 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELM 273

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 63  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 112
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 166
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 224
Query: 782 KVI 784
           +V+
Sbjct: 225 EVV 227

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 64  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 113
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 114 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 167
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 225
Query: 782 KVI 784
           +V+
Sbjct: 226 EVV 228

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 62  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 111
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 165
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 223
Query: 782 KVI 784
           +V+
Sbjct: 224 EVV 226

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 69  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 117
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 173
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 233
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 234 QPPICTIDVYM---IMVKCWMIDADSRPKFRELI 264

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 53/237 (22%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF---------RSFVAECEALR 600
           +    ++G+G    V + I        AVK+I++   G+F          + + E + LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 601 NIR-HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            +  H N+I++     +       F  LVF+ M+ G L D+L +        K+TL ++ 
Sbjct: 79  KVSGHPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLTE--------KVTLSEKE 125
Query: 660 NIAI-----DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASK 713
              I     +V  A+  L+      IVH DLKP N+LLD DM +   +F  S QLD   K
Sbjct: 126 TRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 714 TPSSSIGIKGTVGYVAPEY----------GMGSEASMTGDVYSFGILLLEMFTGRRP 760
             S    + GT  Y+APE           G G E     D++S G+++  +  G  P
Sbjct: 180 LRS----VCGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 611
           M+G+GSFG V K      +   AVKVIN    K K    + + E E L+ + H N++K+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDHPNIMKLF 87
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            I     S       +V E    G L D + +     E     +I++V       S I Y
Sbjct: 88  EILEDSSSF-----YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV------FSGITY 136
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +H H    IVH DLKP N+LL+       +   +F LS      +K         GT  Y
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----GTAYY 189
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +APE   G+      DV+S G++L  + +G  P
Sbjct: 190 IAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 85  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 133
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 134 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 189
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 190 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 249
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 250 QPPICTIDVYM---IMRKCWMIDADSRPKFRELI 280

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 67  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 116
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 117 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 170
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 228
Query: 782 KVI 784
           +V+
Sbjct: 229 EVV 231

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAE 595
           E   A  +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VC 651
              ++     ++++++ + S           ++ E M  G L+ +L      +E    + 
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS 710
             +L + + +A ++A  + YL+ +     VH DL   N  +  D  V   +F ++  +  
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDI-- 175
Query: 711 ASKTPSSSIGIKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE 767
             +T     G KG   V +++PE       +   DV+SFG++L E+ T   +P      +
Sbjct: 176 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQ 229
Query: 768 GLTLHEFVKMTLPEKVIEIVD--PSLLMEVM 796
           GL+  + ++  +   +++  D  P +L+E+M
Sbjct: 230 GLSNEQVLRFVMEGGLLDKPDNCPDMLLELM 260

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 562 GSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG 621
           G ++KG   G +++V V  +        R F  EC  LR   H N++ ++  C    S  
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ---SPP 80
Query: 622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIV 681
           A    L+  +M  GSL + LH+  + +    +   Q V  A+D+A  + +L H  +P I 
Sbjct: 81  APHPTLITHWMPYGSLYNVLHEGTNFV----VDQSQAVKFALDMARGMAFL-HTLEPLIP 135
Query: 682 HGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASM- 740
              L   +V++D DM A  +        +  K    S G      +VAPE          
Sbjct: 136 RHALNSRSVMIDEDMTARISM-------ADVKFSFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 741 --TGDVYSFGILLLEMFTGRRP 760
             + D++SF +LL E+ T   P
Sbjct: 189 RRSADMWSFAVLLWELVTREVP 210

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 40/223 (17%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           F     IG+GSFG V+KGI    + +VA+K+I+L++       + +              
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQE------------- 71
Query: 610 IITICSSIDS-----------KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
            IT+ S  DS           KG+    ++ EY+  GS       + D L        Q 
Sbjct: 72  -ITVLSQCDSSYVTKYYGSYLKGSKL-WIIMEYLGGGS-------ALDLLRAGPFDEFQI 122
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSS 717
             +  ++   ++YLH   +   +H D+K +NVLL +   V   +F ++ QL       ++
Sbjct: 123 ATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 179
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            +   GT  ++APE    S      D++S GI  +E+  G  P
Sbjct: 180 FV---GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 25/240 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 84
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  D   +V E++E G+L D +  +  + E       Q   + + V  A+  LH  
Sbjct: 85  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 135
Query: 676 CQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               ++H D+K  ++LL HD  V   +F    Q+   SK       + GT  ++APE   
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELIS 189
Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE-GLTLHEFVKMTLPEKV--IEIVDPSL 791
                   D++S GI+++EM  G  P    F E  L   + ++  LP ++  +  V PSL
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPPY---FNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 246

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 25/240 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 93
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  D   +V E++E G+L D +  +  + E       Q   + + V  A+  LH  
Sbjct: 94  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 144
Query: 676 CQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               ++H D+K  ++LL HD  V   +F    Q+   SK       + GT  ++APE   
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELIS 198
Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE-GLTLHEFVKMTLPEKV--IEIVDPSL 791
                   D++S GI+++EM  G  P    F E  L   + ++  LP ++  +  V PSL
Sbjct: 199 RLPYGPEVDIWSLGIMVIEMVDGEPPY---FNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 255

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 25/240 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 95
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  D   +V E++E G+L D +  +  + E       Q   + + V  A+  LH  
Sbjct: 96  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 146
Query: 676 CQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               ++H D+K  ++LL HD  V   +F    Q+   SK       + GT  ++APE   
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELIS 200
Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE-GLTLHEFVKMTLPEKV--IEIVDPSL 791
                   D++S GI+++EM  G  P    F E  L   + ++  LP ++  +  V PSL
Sbjct: 201 RLPYGPEVDIWSLGIMVIEMVDGEPPY---FNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 257

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 36/233 (15%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-----SFVAECEA 598
           S ATS +     IG G++G+VYK         VA+K + +   G        S V E   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 599 LRNI---RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSND---HLEVCK 652
           LR +    H N+++++ +C++  +       LVFE+++   L  +L ++       E  K
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSL----SHQ 707
             + Q +         +++LH +C   IVH DLKP N+L+     V   +F L    S+Q
Sbjct: 124 DLMRQFLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 708 LDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +   + TP     +  T+ Y APE  + S  +   D++S G +  EMF  R+P
Sbjct: 174 M---ALTP-----VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 217

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 46/234 (19%)
Query: 549 EFASSNMIGQGSFGSVYKG---ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR 605
           +F    +IG G FG V+K    I G   +I  VK  N K +        E +AL  + H 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE-------REVKALAKLDHV 65
Query: 606 NLIKIITICSSIDS---------KGADFKA---------------LVFEYMENGSLEDWL 641
           N++         D          + +D+                 +  E+ + G+LE W+
Sbjct: 66  NIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI 125
Query: 642 HQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ 700
            +        KL  +  + +   +   ++Y+H      ++H DLKPSN+ L+D   V   
Sbjct: 126 EKRRGE----KLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIG 178
Query: 701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
           +F L   L +  K   S    KGT+ Y++PE     +     D+Y+ G++L E+
Sbjct: 179 DFGLVTSLKNDGKRTRS----KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 606
           +G+G+FG V      G        +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L               H    +L+  
Sbjct: 137 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSAS 712
             V+ A  VA  +EYL        +H DL   NVL+  D V    +F L+   H +D   
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           KT +  + +K    ++APE       +   DV+SFG+LL E+FT
Sbjct: 249 KTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 66  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 115
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 116 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 169
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 227
Query: 782 KVI 784
           +V+
Sbjct: 228 EVV 230

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 65  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 114
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 115 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 168
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 226
Query: 782 KVI 784
           +V+
Sbjct: 227 EVV 229

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 63  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 112
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 166
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 224
Query: 782 KVI 784
           +V+
Sbjct: 225 EVV 227

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 25/240 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 88
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  D   +V E++E G+L D +  +  + E       Q   + + V  A+  LH  
Sbjct: 89  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 139
Query: 676 CQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               ++H D+K  ++LL HD  V   +F    Q+   SK       + GT  ++APE   
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELIS 193
Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE-GLTLHEFVKMTLPEKV--IEIVDPSL 791
                   D++S GI+++EM  G  P    F E  L   + ++  LP ++  +  V PSL
Sbjct: 194 RLPYGPEVDIWSLGIMVIEMVDGEPPY---FNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 250

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 62  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 111
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 165
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 223
Query: 782 KVI 784
           +V+
Sbjct: 224 EVV 226

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 66  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 115
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 116 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 169
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 227
Query: 782 KVI 784
           +V+
Sbjct: 228 EVV 230

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 33/283 (11%)
Query: 548 SEFASSNMIGQGSFGSVYKGIL--GGEEMIVAVKVINLKQKGAFRSFVAECE---ALRNI 602
           +E     ++G G FG+V+KG+    GE + + V +  ++ K   +SF A  +   A+ ++
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            H ++++++ +C      G+  + LV +Y+  GSL D + Q    L    L     +N  
Sbjct: 73  DHAHIVRLLGLCP-----GSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWG 121
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL  H    +VH +L   NVLL     V   +F ++  L    K    S   
Sbjct: 122 VQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA- 177
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E     + +   DV+S+G+ + E+ T G  P       GL L E   +   
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP-----YAGLRLAEVPDLL-- 230
Query: 781 EKVIEIVDPSL----LMEVMANNSMIQEDRRARTQDCLNAITR 819
           EK   +  P +    +  VM    MI E+ R   ++  N  TR
Sbjct: 231 EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTR 273

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 63  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 112
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 166
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 224
Query: 782 KVI 784
           +V+
Sbjct: 225 EVV 227

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 613
           +G+G +G V++G   GE   VAVK+ + + +   +S+  E E    +  RH N++  I  
Sbjct: 45  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA- 98
Query: 614 CSSIDSKGADFK-ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
            S + S+ +  +  L+  Y E GSL        D+L++  L  +  + I + +AS + +L
Sbjct: 99  -SDMTSRHSSTQLWLITHYHEMGSL-------YDYLQLTTLDTVSCLRIVLSIASGLAHL 150
Query: 673 H-----HHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
           H        +P I H DLK  N+L+  +    +A    ++ H   S ++    +    GT
Sbjct: 151 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS-QSTNQLDVGNNPRVGT 209
Query: 725 VGYVAPEYGMGS------EASMTGDVYSFGILLLEM 754
             Y+APE    +      ++    D+++FG++L E+
Sbjct: 210 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 64  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 113
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 114 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 167
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 225
Query: 782 KVI 784
           +V+
Sbjct: 226 EVV 228

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 67  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 116
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 117 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 170
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 228
Query: 782 KVI 784
           +V+
Sbjct: 229 EVV 231

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 60/250 (24%), Positives = 113/250 (45%), Gaps = 36/250 (14%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G FG V+ G        VAVK +      + ++F+ E   ++ ++H  L+++  + +
Sbjct: 20  LGAGQFGEVWMGYYNNSTK-VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
             +        ++ E+M  GSL D+L       E  K+ L + ++ +  +A  + Y+   
Sbjct: 78  KEEPI-----YIITEFMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE-- 126
Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
            +   +H DL+ +NVL+   ++    +F L+  ++    T     G K  + + APE   
Sbjct: 127 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAIN 183
Query: 735 GSEASMTGDVYSFGILLLEMFT-------GRRPTD--AAFTEGL----------TLHEFV 775
               ++  +V+SFGILL E+ T       GR   D  +A ++G            L++ +
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELYDIM 243
Query: 776 KMTLPEKVIE 785
           KM   EK  E
Sbjct: 244 KMCWKEKAEE 253

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 63  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 112
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 166
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 224
Query: 782 KVI 784
           +V+
Sbjct: 225 EVV 227

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 103/240 (42%), Gaps = 53/240 (22%)
Query: 538 ISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL--KQKGAFRSFVAE 595
           +S A  + +   +     +G+G++G VYK I       VA+K I L  +++G   + + E
Sbjct: 24  VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE 83
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSND-HLEVCKLT 654
              L+ ++HRN+I++ ++             L+FEY EN  L+ ++ ++ D  + V K  
Sbjct: 84  VSLLKELQHRNIIELKSVIHHNHR-----LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF 137
Query: 655 LIQRVNIAIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASK 713
           L Q +N        + + H   C    +H DLKP N+LL               +  AS+
Sbjct: 138 LYQLIN-------GVNFCHSRRC----LHRDLKPQNLLL--------------SVSDASE 172
Query: 714 TPSSSIGIKG-----------------TVGYVAPEYGMGSEASMTG-DVYSFGILLLEMF 755
           TP   IG  G                 T+ Y  PE  +GS    T  D++S   +  EM 
Sbjct: 173 TPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 611
           M+G+GSFG V K      +   AVKVIN    K K    + + E E L+ + H N++K+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDHPNIMKLF 87
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            I     S       +V E    G L D + +     E     +I++V       S I Y
Sbjct: 88  EILEDSSSF-----YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV------FSGITY 136
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +H H    IVH DLKP N+LL+       +   +F LS      +K         GT  Y
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----GTAYY 189
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +APE   G+      DV+S G++L  + +G  P
Sbjct: 190 IAPEVLRGTYDEKC-DVWSAGVILYILLSGTPP 221

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 63  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 112
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 166
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 224
Query: 782 KVI 784
           +V+
Sbjct: 225 EVV 227

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 32/237 (13%)
Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAEC-E 597
            +A   +   ++   ++IG+G    V + +        AVK++ +  +      + E  E
Sbjct: 85  DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 598 ALRNIRH--RNLIKIITICSSIDS-KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLT 654
           A R   H  R +     I + IDS + + F  LVF+ M  G L D+L       E   L+
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL------TEKVALS 198
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASK 713
             +  +I   +  A+ +LH +    IVH DLKP N+LLD +M +   +F  S  L+   K
Sbjct: 199 EKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK 255
Query: 714 TPSSSIGIKGTVGYVAPEY----------GMGSEASMTGDVYSFGILLLEMFTGRRP 760
                  + GT GY+APE           G G E     D+++ G++L  +  G  P
Sbjct: 256 LRE----LCGTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVILFTLLAGSPP 304

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 65  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 114
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 115 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 168
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 226
Query: 782 KVI 784
           +V+
Sbjct: 227 EVV 229

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 62  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 111
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 165
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 223
Query: 782 KVI 784
           +V+
Sbjct: 224 EVV 226

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 611
           M+G+GSFG V K      +   AVKVIN    K K    + + E E L+ + H N++K+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDHPNIMKLF 87
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            I     S       +V E    G L D + +     E     +I++V       S I Y
Sbjct: 88  EILEDSSSF-----YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV------FSGITY 136
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +H H    IVH DLKP N+LL+       +   +F LS      +K         GT  Y
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----GTAYY 189
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +APE   G+      DV+S G++L  + +G  P
Sbjct: 190 IAPEVLRGTYDEKC-DVWSAGVILYILLSGTPP 221

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 613
           +G+G +G V++G   GE   VAVK+ + + +   +S+  E E    +  RH N++  I  
Sbjct: 16  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA- 69
Query: 614 CSSIDSKGADFK-ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
            S + S+ +  +  L+  Y E GSL        D+L++  L  +  + I + +AS + +L
Sbjct: 70  -SDMTSRHSSTQLWLITHYHEMGSL-------YDYLQLTTLDTVSCLRIVLSIASGLAHL 121
Query: 673 H-----HHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
           H        +P I H DLK  N+L+  +    +A    ++ H   S ++    +    GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS-QSTNQLDVGNNPRVGT 180
Query: 725 VGYVAPEYGMGS------EASMTGDVYSFGILLLEM 754
             Y+APE    +      ++    D+++FG++L E+
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 556 IGQGSFGSVYKGILGGEE-----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 606
           +G+G+FG V      G +      +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L               H    +L+  
Sbjct: 85  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSAS 712
             V+ A  VA  +EYL        +H DL   NVL+  D V    +F L+   H +D   
Sbjct: 140 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 196
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           KT +  + +K    ++APE       +   DV+SFG+LL E+FT
Sbjct: 197 KTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 66  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKTFMDASA--LTGIPLPLIK--SYLFQL 115
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 116 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 169
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 227
Query: 782 KVI 784
           +V+
Sbjct: 228 EVV 230

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 556 IGQGSFGSVYKGILGGEE-----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 606
           +G+G+FG V      G +      +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L               H    +L+  
Sbjct: 89  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSAS 712
             V+ A  VA  +EYL        +H DL   NVL+  D V    +F L+   H +D   
Sbjct: 144 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 200
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           KT +  + +K    ++APE       +   DV+SFG+LL E+FT
Sbjct: 201 KTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 556 IGQGSFGSVYKGILGGEE-----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 606
           +G+G+FG V      G +      +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L               H    +L+  
Sbjct: 88  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSAS 712
             V+ A  VA  +EYL        +H DL   NVL+  D V    +F L+   H +D   
Sbjct: 143 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 199
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           KT +  + +K    ++APE       +   DV+SFG+LL E+FT
Sbjct: 200 KTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 556 IGQGSFGSVYKGILGGEE-----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 606
           +G+G+FG V      G +      +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L               H    +L+  
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSAS 712
             V+ A  VA  +EYL        +H DL   NVL+  D V    +F L+   H +D   
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           KT +  + +K    ++APE       +   DV+SFG+LL E+FT
Sbjct: 208 KTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 65  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 114
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 115 LQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 168
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 226
Query: 782 KVI 784
           +V+
Sbjct: 227 EVV 229

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 64  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 113
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 114 LQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 167
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 225
Query: 782 KVI 784
           +V+
Sbjct: 226 EVV 228

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 125/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F  +  L +  K   +  G 
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-GG 181
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 242 QPPICTID---VYMIMVKCWMIDADSRPKFRELI 272

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 33/283 (11%)
Query: 548 SEFASSNMIGQGSFGSVYKGIL--GGEEMIVAVKVINLKQKGAFRSFVAECE---ALRNI 602
           +E     ++G G FG+V+KG+    GE + + V +  ++ K   +SF A  +   A+ ++
Sbjct: 31  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 90
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            H ++++++ +C      G+  + LV +Y+  GSL D + Q    L    L     +N  
Sbjct: 91  DHAHIVRLLGLCP-----GSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWG 139
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL  H    +VH +L   NVLL     V   +F ++  L    K    S   
Sbjct: 140 VQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA- 195
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E     + +   DV+S+G+ + E+ T G  P       GL L E   +   
Sbjct: 196 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP-----YAGLRLAEVPDLL-- 248
Query: 781 EKVIEIVDPSL----LMEVMANNSMIQEDRRARTQDCLNAITR 819
           EK   +  P +    +  VM    MI E+ R   ++  N  TR
Sbjct: 249 EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTR 291

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 53/237 (22%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF---------RSFVAECEALR 600
           +    ++G+G    V + I        AVK+I++   G+F          + + E + LR
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 601 NIR-HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR- 658
            +  H N+I++     +       F  LVF+ M+ G L D+L +        K+TL ++ 
Sbjct: 66  KVSGHPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLTE--------KVTLSEKE 112
Query: 659 ----VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASK 713
               +   ++V  A+  L+      IVH DLKP N+LLD DM +   +F  S QLD   K
Sbjct: 113 TRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 166
Query: 714 TPSSSIGIKGTVGYVAPEY----------GMGSEASMTGDVYSFGILLLEMFTGRRP 760
                  + GT  Y+APE           G G E     D++S G+++  +  G  P
Sbjct: 167 LRE----VCGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 215

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 25/240 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  D   +V E++E G+L D +  +  + E       Q   + + V  A+  LH  
Sbjct: 142 V-----GDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 189
Query: 676 CQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               ++H D+K  ++LL HD  V   +F    Q+   SK       + GT  ++APE   
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELIS 243
Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE-GLTLHEFVKMTLPEKV--IEIVDPSL 791
                   D++S GI+++EM  G  P    F E  L   + ++  LP ++  +  V PSL
Sbjct: 244 RLPYGPEVDIWSLGIMVIEMVDGEPPY---FNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 300

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 613
           +G+G +G V++G   GE   VAVK+ + + +   +S+  E E    +  RH N++  I  
Sbjct: 16  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA- 69
Query: 614 CSSIDSKGADFK-ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
            S + S+ +  +  L+  Y E GSL        D+L++  L  +  + I + +AS + +L
Sbjct: 70  -SDMTSRHSSTQLWLITHYHEMGSL-------YDYLQLTTLDTVSCLRIVLSIASGLAHL 121
Query: 673 H-----HHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
           H        +P I H DLK  N+L+  +    +A    ++ H   S ++    +    GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS-QSTNQLDVGNNPRVGT 180
Query: 725 VGYVAPEYGMGS------EASMTGDVYSFGILLLEM 754
             Y+APE    +      ++    D+++FG++L E+
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 556 IGQGSFGSVYKGILGGEE-----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 606
           +G+G+FG V      G +      +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L               H    +L+  
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSAS 712
             V+ A  VA  +EYL        +H DL   NVL+  D V    +F L+   H +D   
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 713 KTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           KT +  + +K    ++APE       +   DV+SFG+LL E+FT
Sbjct: 208 KTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 64  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 113
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 114 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 167
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 225
Query: 782 KVI 784
           +V+
Sbjct: 226 EVV 228

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 125/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 79  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 127
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F  +  L +  K   +  G 
Sbjct: 128 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-GG 183
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 243
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 244 QPPICTIDVYM---IMVKCWMIDADSRPKFRELI 274

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE+++   L+ ++  S   L    L LI+  +    +
Sbjct: 66  NIVKLLDVIHTENKL-----YLVFEHVDQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 115
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 116 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 169
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 227
Query: 782 KVI 784
           +V+
Sbjct: 228 EVV 230

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++ +  L+ ++  S   L    L LI+  +    +
Sbjct: 66  NIVKLLDVIHTENKL-----YLVFEFL-SMDLKKFMDASA--LTGIPLPLIK--SYLFQL 115
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 116 LQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 169
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 227
Query: 782 KVI 784
           +V+
Sbjct: 228 EVV 230

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 125/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F  +  L +  K   +  G 
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-GG 181
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 242 QPPICTID---VYMIMRKCWMIDADSRPKFRELI 272

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 25/240 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  D   +V E++E G+L D +  +  + E       Q   + + V  A+  LH  
Sbjct: 219 V-----GDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 266
Query: 676 CQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               ++H D+K  ++LL HD  V   +F    Q+   SK       + GT  ++APE   
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELIS 320
Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE-GLTLHEFVKMTLPEKV--IEIVDPSL 791
                   D++S GI+++EM  G  P    F E  L   + ++  LP ++  +  V PSL
Sbjct: 321 RLPYGPEVDIWSLGIMVIEMVDGEPPY---FNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 377

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 125/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++  G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 130
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 186
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D  +   +M    MI  D R + ++ +
Sbjct: 247 QPPICTIDVYM---IMVKCWMIDADSRPKFRELI 277

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++ +  L+ ++  S   L    L LI+  +    +
Sbjct: 64  NIVKLLDVIHTENKL-----YLVFEFL-SMDLKKFMDASA--LTGIPLPLIK--SYLFQL 113
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T    +    T
Sbjct: 114 LQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV---VT 167
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 225
Query: 782 KVI 784
           +V+
Sbjct: 226 EVV 228

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 53/237 (22%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF---------RSFVAECEALR 600
           +    ++G+G    V + I        AVK+I++   G+F          + + E + LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 601 NIR-HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            +  H N+I++     +       F  LVF+ M+ G L D+L +        K+TL ++ 
Sbjct: 79  KVSGHPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLTE--------KVTLSEKE 125
Query: 660 NIAI-----DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASK 713
              I     +V  A+  L+      IVH DLKP N+LLD DM +   +F  S QLD   K
Sbjct: 126 TRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 714 TPSSSIGIKGTVGYVAPEY----------GMGSEASMTGDVYSFGILLLEMFTGRRP 760
                  + GT  Y+APE           G G E     D++S G+++  +  G  P
Sbjct: 180 LRE----VCGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQKGAFR---SFVAECEALRNIRHRNL 607
           +GQGSFG VY+G     I G  E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 83
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLH----QSNDHLEVCKLTLIQRVNIAI 663
           ++++ +     SKG     +V E M +G L+ +L     ++ ++      TL + + +A 
Sbjct: 84  VRLLGVV----SKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 138
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++A  + YL+       VH +L   N ++ HD  V   +F ++  +    +T     G K
Sbjct: 139 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDI---YETDYYRKGGK 192
Query: 723 G--TVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
           G   V ++APE       + + D++SFG++L E+
Sbjct: 193 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 50/219 (22%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK------ 609
           +G G+FG VYK       ++ A KVI+ K +     ++ E + L +  H N++K      
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 610 -------IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
                  +I  C+     G    A++ E      LE  L +S   + VCK TL       
Sbjct: 105 YENNLWILIEFCA-----GGAVDAVMLE------LERPLTESQIQV-VCKQTL------- 145
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVL--LDHDMVAHQNFSLSHQLDSASKTPSSSIG 720
                A+ YLH +    I+H DLK  N+L  LD D +   +F +S +    ++T      
Sbjct: 146 ----DALNYLHDN---KIIHRDLKAGNILFTLDGD-IKLADFGVSAK---NTRTIQRRDS 194
Query: 721 IKGTVGYVAPEYGMGSEA-----SMTGDVYSFGILLLEM 754
             GT  ++APE  M   +         DV+S GI L+EM
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 556 IGQGSFGSVYKG-----ILGGEEMIVAVKVINLKQKGAFR---SFVAECEALRNIRHRNL 607
           +GQGSFG VY+G     I G  E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLH----QSNDHLEVCKLTLIQRVNIAI 663
           ++++ +     SKG     +V E M +G L+ +L     ++ ++      TL + + +A 
Sbjct: 83  VRLLGVV----SKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIK 722
           ++A  + YL+       VH +L   N ++ HD  V   +F ++  +    +T     G K
Sbjct: 138 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDI---YETDYYRKGGK 191
Query: 723 G--TVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
           G   V ++APE       + + D++SFG++L E+
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+K I L  + +G   + + E   L+ + H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE--VVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 62  NIVKLLDVIHTENKL-----YLVFEHVHQ-DLKTFMDASA--LTGIPLPLIK--SYLFQL 111
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 165
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 223
Query: 782 KVI 784
           +V+
Sbjct: 224 EVV 226

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 30/222 (13%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRN------ 601
            +F    M+G+GSFG V+           A+K   LK+         EC  +        
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC-KLTLIQRVN 660
             H  L  +   C+    +   F   V EY+  G L         H++ C K  L +   
Sbjct: 76  WEHPFLTHMF--CTFQTKENLFF---VMEYLNGGDL-------MYHIQSCHKFDLSRATF 123
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSS 718
            A ++   +++LH      IV+ DLK  N+LLD D  +   +F +  + +   +KT    
Sbjct: 124 YAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC 180
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
               GT  Y+APE  +G + + + D +SFG+LL EM  G+ P
Sbjct: 181 ----GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 24/227 (10%)
Query: 543 LSKATSEFASSNMIGQGSFGSVYKGI-LGGEEMIVAVKVINLK--QKGAFRSFVAECEAL 599
           L +A  ++     IG+G++G V+K   L      VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 600 RNIR---HRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCKLT 654
           R++    H N++++  +C+   +       LVFE+++    +  D + +     E  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASK 713
           + Q       +   +++LH H    +VH DLKP N+L+     +   +F L+        
Sbjct: 126 MFQ-------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             S  +    T+ Y APE  + S  +   D++S G +  EMF  R+P
Sbjct: 176 LTSVVV----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 24/227 (10%)
Query: 543 LSKATSEFASSNMIGQGSFGSVYKGI-LGGEEMIVAVKVINLK--QKGAFRSFVAECEAL 599
           L +A  ++     IG+G++G V+K   L      VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 600 RNIR---HRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCKLT 654
           R++    H N++++  +C+   +       LVFE+++    +  D + +     E  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASK 713
           + Q       +   +++LH H    +VH DLKP N+L+     +   +F L+        
Sbjct: 126 MFQ-------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             S  +    T+ Y APE  + S  +   D++S G +  EMF  R+P
Sbjct: 176 LTSVVV----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 37/225 (16%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G+FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L              + +   ++T  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQL---DSA 711
             V+    +A  +EYL    C    +H DL   NVL+ +++++   +F L+  +   D  
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 214 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 24/227 (10%)
Query: 543 LSKATSEFASSNMIGQGSFGSVYKGI-LGGEEMIVAVKVINLK--QKGAFRSFVAECEAL 599
           L +A  ++     IG+G++G V+K   L      VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 600 RNIR---HRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCKLT 654
           R++    H N++++  +C+   +       LVFE+++    +  D + +     E  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASK 713
           + Q       +   +++LH H    +VH DLKP N+L+     +   +F L+        
Sbjct: 126 MFQ-------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             S  +    T+ Y APE  + S  +   D++S G +  EMF  R+P
Sbjct: 176 LTSVVV----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 37/225 (16%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G+FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L              + +   ++T  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQL---DSA 711
             V+    +A  +EYL    C    +H DL   NVL+ +++++   +F L+  +   D  
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 214 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 30/222 (13%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRN------ 601
            +F    M+G+GSFG V+           A+K   LK+         EC  +        
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC-KLTLIQRVN 660
             H  L  +   C+    +   F   V EY+  G L         H++ C K  L +   
Sbjct: 75  WEHPFLTHMF--CTFQTKENLFF---VMEYLNGGDL-------MYHIQSCHKFDLSRATF 122
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSS 718
            A ++   +++LH      IV+ DLK  N+LLD D  +   +F +  + +   +KT    
Sbjct: 123 YAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC 179
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
               GT  Y+APE  +G + + + D +SFG+LL EM  G+ P
Sbjct: 180 ----GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 125/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 130
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F  +  L +  K   +  G 
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-GG 186
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 247 QPPICTID---VYMIMVKCWMIDADSRPKFRELI 277

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 125/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F  +  L +  K   +  G 
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-GG 179
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 240 QPPICTID---VYMIMVKCWMIDADSRPKFRELI 270

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 111/243 (45%), Gaps = 28/243 (11%)
Query: 548 SEFASSNMIGQGSFGSVY---KGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRN 601
           S F    ++GQGSFG V+   K        + A+KV+    LK +   R+ + E + L +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM-ERDILAD 86
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + H  ++K+     +  ++G  +  L+ +++  G L            + K  +    ++
Sbjct: 87  VNHPFVVKL---HYAFQTEGKLY--LILDFLRGGDL---------FTRLSKEVMFTEEDV 132
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSSI 719
              +A     L H     I++ DLKP N+LLD +  +   +F LS + +D   K  S   
Sbjct: 133 KFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC- 191
Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA-FTEGLTLHEFVKMT 778
              GTV Y+APE       S + D +S+G+L+ EM TG  P       E +TL    K+ 
Sbjct: 192 ---GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLG 248
Query: 779 LPE 781
           +P+
Sbjct: 249 MPQ 251

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 125/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++  G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 130
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 186
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 247 QPPICTID---VYMIMVKCWMIDADSRPKFRELI 277

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 42/237 (17%)
Query: 545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH 604
           +  S+F    ++GQG+FG V K     +    A+K I   ++    + ++E   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNH 61
Query: 605 -------------RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC 651
                        RN +K +T   ++  K   F  +  EY ENG+L D +H  N + +  
Sbjct: 62  QYVVRYYAAWLERRNFVKPMT---AVKKKSTLF--IQMEYCENGTLYDLIHSENLNQQRD 116
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSH---- 706
           +   + R      +  A+ Y+H      I+H DLKP N+ +D    V   +F L+     
Sbjct: 117 EYWRLFR-----QILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 707 -----QLDSASKTPSSSIGIKGTVG---YVAPEYGMGS-EASMTGDVYSFGILLLEM 754
                +LDS +  P SS  +   +G   YVA E   G+   +   D+YS GI+  EM
Sbjct: 169 SLDILKLDSQN-LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 50/219 (22%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK------ 609
           +G G+FG VYK       ++ A KVI+ K +     ++ E + L +  H N++K      
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 610 -------IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
                  +I  C+     G    A++ E      LE  L +S   + VCK TL       
Sbjct: 105 YENNLWILIEFCA-----GGAVDAVMLE------LERPLTESQIQV-VCKQTL------- 145
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVL--LDHDMVAHQNFSLSHQLDSASKTPSSSIG 720
                A+ YLH +    I+H DLK  N+L  LD D +   +F +S +     +   S I 
Sbjct: 146 ----DALNYLHDN---KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRXIQRRDSFI- 196
Query: 721 IKGTVGYVAPEYGMGSEA-----SMTGDVYSFGILLLEM 754
             GT  ++APE  M   +         DV+S GI L+EM
Sbjct: 197 --GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 125/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F  +  L +  K   +  G 
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-GG 181
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 242 QPPICTID---VYMIMRKCWMIDADSRPKFRELI 272

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
           ++F    ++G+GSFG V      G E + A+K+  LK+    +    EC  +   R   L
Sbjct: 19  TDFNFLMVLGKGSFGKVMLADRKGTEELYAIKI--LKKDVVIQDDDVECTMVEK-RVLAL 75
Query: 608 IKIITICSSIDS--KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           +      + + S  +  D    V EY+  G L   + Q      V K    Q V  A ++
Sbjct: 76  LDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPQAVFYAAEI 129
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSASKTPSSSIGIK 722
           +  + +LH      I++ DLK  NV+LD   H  +A       H +D  +     +    
Sbjct: 130 SIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT-----TREFC 181
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           GT  Y+APE         + D +++G+LL EM  G+ P D 
Sbjct: 182 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 222

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+  I L  + +G   + + E   L+ + H 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE--VVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 63  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 112
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 166
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 224
Query: 782 KVI 784
           +V+
Sbjct: 225 EVV 227

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 550 FASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
           F     IG+G++G VYK    L GE  +VA+  I L  + +G   + + E   L+ + H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE--VVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++K++ +  + +        LVFE++    L+ ++  S   L    L LI+  +    +
Sbjct: 62  NIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQL 111
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + + H H    ++H DLKP N+L++ +  +   +F L+       +T +  +    T
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV---VT 165
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRR--PTDAAFTEGLTLHEFVKMTLPE 781
           + Y APE  +G +   T  D++S G +  EM T R   P D+   +   +  F  +  P+
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPD 223
Query: 782 KVI 784
           +V+
Sbjct: 224 EVV 226

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 125/274 (45%), Gaps = 25/274 (9%)
Query: 548 SEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI 602
           +EF    ++  G+FG+VYKG  I  GE++ + V +  L++     A +  + E   + ++
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+     V   +F L+  L +  K   +  G 
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 179
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP 780
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D      ++        LP
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCL 814
           +  I  +D   +  +M    MI  D R + ++ +
Sbjct: 240 QPPICTID---VYMIMVKCWMIDADSRPKFRELI 270

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 541 AELSKAT---SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVA 594
           AE+ K      +F     +G+G FG+VY       + I+A+KV+    L+++G       
Sbjct: 5   AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 64
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLT 654
           E E   ++RH N++++       D K      L+ E+   G L   L +     E    T
Sbjct: 65  EIEIQSHLRHPNILRMYNYFH--DRKRI---YLMLEFAPRGELYKELQKHGRFDEQRSAT 119
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASK 713
            ++      ++A A+ Y H   +  ++H D+KP N+L+ +   +   +F  S    S  +
Sbjct: 120 FME------ELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 170
Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
                  + GT+ Y+ PE   G       D++  G+L  E   G  P D+
Sbjct: 171 R-----XMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKG 723
           + S +E+LH   Q  I++ DLKP NVLLD D  V   +  L+ +L +     + + G  G
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAG 351
Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           T G++APE  +G E   + D ++ G+ L EM   R P  A
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKG 723
           + S +E+LH   Q  I++ DLKP NVLLD D  V   +  L+ +L +     + + G  G
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAG 351
Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           T G++APE  +G E   + D ++ G+ L EM   R P  A
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKG 723
           + S +E+LH   Q  I++ DLKP NVLLD D  V   +  L+ +L +     + + G  G
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAG 351
Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           T G++APE  +G E   + D ++ G+ L EM   R P  A
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKG 723
           + S +E+LH   Q  I++ DLKP NVLLD D  V   +  L+ +L +     + + G  G
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAG 351
Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           T G++APE  +G E   + D ++ G+ L EM   R P  A
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 121/271 (44%), Gaps = 32/271 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAE 595
           E   A  +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VC 651
              ++     ++++++ + S           ++ E M  G L+ +L      +     + 
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS 710
             +L + + +A ++A  + YL+ +     VH DL   N ++  D  V   +F ++  +  
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 178
Query: 711 ASKTPSSSIGIKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE 767
             +T     G KG   V +++PE       +   DV+SFG++L E+ T   +P      +
Sbjct: 179 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQ 232
Query: 768 GLTLHEFVKMTLPEKVIEIVD--PSLLMEVM 796
           GL+  + ++  +   +++  D  P +L E+M
Sbjct: 233 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELM 263

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G+FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L              + +   ++T  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQL---DSA 711
             V+    +A  +EYL    C    +H DL   NVL+  + V    +F L+  +   D  
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLARDINNIDYY 213
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 214 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 121/271 (44%), Gaps = 32/271 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAE 595
           E   A  +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VC 651
              ++     ++++++ + S           ++ E M  G L+ +L      +     + 
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDS 710
             +L + + +A ++A  + YL+ +     VH DL   N ++  D  V   +F ++  +  
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 188
Query: 711 ASKTPSSSIGIKG--TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE 767
             +T     G KG   V +++PE       +   DV+SFG++L E+ T   +P      +
Sbjct: 189 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQ 242
Query: 768 GLTLHEFVKMTLPEKVIEIVD--PSLLMEVM 796
           GL+  + ++  +   +++  D  P +L E+M
Sbjct: 243 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELM 273

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 613
           +G+G +G V++G+  GE   VAVK+ + + +   +S+  E E    +  RH N++  I  
Sbjct: 16  VGKGRYGEVWRGLWHGES--VAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIA- 69
Query: 614 CSSIDSKGADFK-ALVFEYMENGSLEDWLHQS--NDHLEVCKLTLIQRVNIAIDVASAIE 670
            S + S+ +  +  L+  Y E+GSL D+L +     HL          + +A+  A  + 
Sbjct: 70  -SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA---------LRLAVSAACGLA 119
Query: 671 YLH-----HHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGIK 722
           +LH        +P I H D K  NVL+  ++   +A    ++ H   S      ++  + 
Sbjct: 120 HLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV- 178
Query: 723 GTVGYVAPEYGMGS------EASMTGDVYSFGILLLEM 754
           GT  Y+APE           E+    D+++FG++L E+
Sbjct: 179 GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L              + +   ++T  
Sbjct: 149 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQL---DSA 711
             V+    +A  +EYL    C    +H DL   NVL+ +++++   +F L+  +   D  
Sbjct: 204 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 260 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 37/225 (16%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G+FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L              + +   ++T  
Sbjct: 103 IITLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQL---DSA 711
             V+    +A  +EYL    C    +H DL   NVL+ +++++   +F L+  +   D  
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 214 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 107/222 (48%), Gaps = 31/222 (13%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G+FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L              + +   ++T  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKT 714
             V+    +A  +EYL    C    +H DL   NVL+ +++++   +F L+  +++    
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            +++ G +  V ++APE       +   DV+SFG+L+ E+FT
Sbjct: 214 KNTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 37/225 (16%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G+FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L              + +   ++T  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQL---DSA 711
             V+    +A  +EYL    C    +H DL   NVL+ +++++   +F L+  +   D  
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 214 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN- 606
            +F     +G GSFG V+           A+KV  LK++   R        L+ + H N 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVR--------LKQVEHTND 55
Query: 607 ---LIKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLE-VCKLTLIQR 658
              ++ I+T    I   G    A    ++ +Y+E G L   L +S      V K      
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF----- 110
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSS 717
              A +V  A+EYLH      I++ DLKP N+LLD +  +   +F        A   P  
Sbjct: 111 --YAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF------AKYVPDV 159
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +  + GT  Y+APE       + + D +SFGIL+ EM  G  P
Sbjct: 160 TYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 37/225 (16%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G+FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L              + +   ++T  
Sbjct: 103 IIHLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQL---DSA 711
             V+    +A  +EYL    C    +H DL   NVL+ +++++   +F L+  +   D  
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 214 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 117/262 (44%), Gaps = 24/262 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GS G V           VAVK ++L+++        E   +R+  H N++ + +   
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS--- 109
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  D   +V E++E G+L D +  +  + E       Q   + + V  A+ YLH+ 
Sbjct: 110 --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQ 160
Query: 676 CQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               ++H D+K  ++LL  D  +   +F    Q+   SK       + GT  ++APE   
Sbjct: 161 G---VIHRDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKXLVGTPYWMAPEVIS 214
Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE-GLTLHEFVKMTLPEKVIEIVDPSLLM 793
                   D++S GI+++EM  G  P    F E  L     ++ +LP +V ++   S ++
Sbjct: 215 RLPYGTEVDIWSLGIMVIEMIDGEPPY---FNEPPLQAMRRIRDSLPPRVKDLHKVSSVL 271
Query: 794 EVMANNSMIQE-DRRARTQDCL 814
               +  +++E  +RA  Q+ L
Sbjct: 272 RGFLDLMLVREPSQRATAQELL 293

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 126/284 (44%), Gaps = 35/284 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGIL--GGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI 602
           +E     ++G G+FG+VYKGI    GE + + V +  L++     A +  + E   +  +
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 76
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
               + +++ IC +   +      LV + M  G L D + ++   L    L     +N  
Sbjct: 77  GSPYVSRLLGICLTSTVQ------LVTQLMPYGCLLDHVRENRGRLGSQDL-----LNWC 125
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+   + V   +F L+  LD   +T   + G 
Sbjct: 126 MQIAKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHADGG 181
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKM--- 777
           K  + ++A E  +    +   DV+S+G+ + E+ T G +P D     G+   E   +   
Sbjct: 182 KVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD-----GIPAREIPDLLEK 236
Query: 778 --TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITR 819
              LP+  I  +D   +  +M    MI  + R R ++ ++  +R
Sbjct: 237 GERLPQPPICTID---VYMIMVKCWMIDSECRPRFRELVSEFSR 277

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIIT 612
           IG+GSFG V        + + A+K +N +   ++   R+   E + ++ + H  L+    
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV---N 79
Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDVASAIE 670
           +  S   +   F  +V + +  G L   L Q N H   E  KL + + V        A++
Sbjct: 80  LWYSFQDEEDMF--MVVDLLLGGDLRYHL-QQNVHFKEETVKLFICELV-------MALD 129
Query: 671 YLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           YL +     I+H D+KP N+LLD H  V   +F+++  L   ++  +    + GT  Y+A
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT----MAGTKPYMA 182
Query: 730 PEY---GMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE      G+  S   D +S G+   E+  GRRP
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L              + +   ++T  
Sbjct: 90  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQL---DSA 711
             V+    +A  +EYL    C    +H DL   NVL+ +++++   +F L+  +   D  
Sbjct: 145 DLVSCTYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLARDINNIDYY 200
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 201 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 31/230 (13%)
Query: 541 AELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEA 598
           A  ++ T ++     +G+G+F  V + +        A K+IN K+  A   +    E   
Sbjct: 24  ATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI 83
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSL-EDWL---HQSNDHLEVCKLT 654
            R ++H N++++     SI  +G  F  LVF+ +  G L ED +   + S      C   
Sbjct: 84  CRLLKHPNIVRLH---DSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQ 138
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDS 710
           +++ VN          ++H H    IVH DLKP N+LL        V   +F L+ ++  
Sbjct: 139 ILESVN----------HIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG 185
Query: 711 ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +   +  G  GT GY++PE           D+++ G++L  +  G  P
Sbjct: 186 EQQ---AWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L              + +   ++T  
Sbjct: 95  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQL---DSA 711
             V+    +A  +EYL    C    +H DL   NVL+ +++++   +F L+  +   D  
Sbjct: 150 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 205
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 206 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFV-AECEALRNIR-HRNLIKI 610
            +++G+G+   V   I        AVK+I  KQ G  RS V  E E L   + HRN++++
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           I      D        LVFE M  GS+   +H+     E+    ++Q      DVASA++
Sbjct: 77  IEFFEEEDRF-----YLVFEKMRGGSILSHIHKRRHFNELEASVVVQ------DVASALD 125
Query: 671 YLHHHCQPPIVHGDLKPSNVLLDH----DMVAHQNFSLSHQL----DSASKTPSSSIGIK 722
           +LH+     I H DLKP N+L +H      V   +F L   +    D +  +    +   
Sbjct: 126 FLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 723 GTVGYVAPEY--GMGSEASMTG---DVYSFGILLLEM------FTGRRPTDAAFTEG 768
           G+  Y+APE       EAS+     D++S G++L  +      F GR  +D  +  G
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++ EY   G+L ++L              + +   ++T  
Sbjct: 92  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQL---DSA 711
             V+    +A  +EYL    C    +H DL   NVL+ +++++   +F L+  +   D  
Sbjct: 147 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 202
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 203 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q  AF++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y+      + +++   H    K TL +  V + +  + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICS 185
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFV-AECEALRNIR-HRNLIKI 610
            +++G+G+   V   I        AVK+I  KQ G  RS V  E E L   + HRN++++
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           I      D        LVFE M  GS+   +H+     E+    ++Q      DVASA++
Sbjct: 77  IEFFEEEDRF-----YLVFEKMRGGSILSHIHKRRHFNELEASVVVQ------DVASALD 125
Query: 671 YLHHHCQPPIVHGDLKPSNVLLDH----DMVAHQNFSLSHQL----DSASKTPSSSIGIK 722
           +LH+     I H DLKP N+L +H      V   +F L   +    D +  +    +   
Sbjct: 126 FLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPC 182
Query: 723 GTVGYVAPEY--GMGSEASMTG---DVYSFGILLLEM------FTGRRPTDAAFTEG 768
           G+  Y+APE       EAS+     D++S G++L  +      F GR  +D  +  G
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 109/232 (46%), Gaps = 24/232 (10%)
Query: 547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRH 604
            S++     IGQG+FG V+K         VA+K + ++  ++G   + + E + L+ ++H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 605 RNLIKIITICSSIDSKGADFKA---LVFEYMEN---GSLEDWLHQSNDHLEVCKLTLIQR 658
            N++ +I IC +  S     KA   LVF++ E+   G L + L          K TL + 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL---------VKFTLSEI 127
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKT-PS 716
             +   + + + Y+H +    I+H D+K +NVL+  D V    +F L+     A  + P+
Sbjct: 128 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 717 SSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTE 767
                  T+ Y  PE  +G  +     D++  G ++ EM+T R P     TE
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTE 235

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 50/219 (22%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK------ 609
           +G G+FG VYK       ++ A KVI+ K +     ++ E + L +  H N++K      
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 610 -------IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
                  +I  C+     G    A++ E      LE  L +S   + VCK TL       
Sbjct: 105 YENNLWILIEFCA-----GGAVDAVMLE------LERPLTESQIQV-VCKQTL------- 145
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVL--LDHDMVAHQNFSLSHQLDSASKTPSSSIG 720
                A+ YLH +    I+H DLK  N+L  LD D +   +F +S +     +     I 
Sbjct: 146 ----DALNYLHDN---KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRXIQRRDXFI- 196
Query: 721 IKGTVGYVAPEYGMGSEA-----SMTGDVYSFGILLLEM 754
             GT  ++APE  M   +         DV+S GI L+EM
Sbjct: 197 --GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 102/238 (42%), Gaps = 31/238 (13%)
Query: 528 TSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-K 586
           +S  KKQ      AE  K   EF  +  +G G+F  V          + AVK I  K  K
Sbjct: 10  SSSWKKQ------AEDIKKIFEFKET--LGTGAFSEVVLAEEKATGKLFAVKCIPKKALK 61
Query: 587 GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSND 646
           G   S   E   LR I+H N++ +  I  S      +   LV + +  G L D + +   
Sbjct: 62  GKESSIENEIAVLRKIKHENIVALEDIYES-----PNHLYLVMQLVSGGELFDRIVEKGF 116
Query: 647 HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNF 702
           + E    TLI++V        A+ YLH   +  IVH DLKP N+L     +   +   +F
Sbjct: 117 YTEKDASTLIRQV------LDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDF 167
Query: 703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            LS +++      S++ G   T GYVAPE       S   D +S G++   +  G  P
Sbjct: 168 GLS-KMEGKGDVMSTACG---TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 556 IGQGSFGSVYKGILGGEE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G FG V++GI    E   M VA+K   N         F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            + +       +   ++ E    G L  +L      L++  L L      A  +++A+ Y
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-----YAYQLSTALAY 126
Query: 672 LHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        VH D+   NVL+  +D V   +F LS  ++ ++   +S    K  + ++AP
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASK--GKLPIKWMAP 181
Query: 731 EYGMGSEASMTGDVYSFGILLLEMF 755
           E       +   DV+ FG+ + E+ 
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q  AF++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y+      + +++   H    K TL +  V + +  + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICS 185
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 554 NMIGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           + +G+G+FGSV    Y  +      +VAVK +        R F  E + L+ +    ++K
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
              +       G     LV EY+ +G L D+L +    L+  +L L      +  +   +
Sbjct: 73  YRGVSYG---PGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SSQICKGM 124
Query: 670 EYL-HHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           EYL    C    VH DL   N+L++ +  V   +F L+  L             +  + +
Sbjct: 125 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            APE    +  S   DV+SFG++L E+FT
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 117/288 (40%), Gaps = 40/288 (13%)
Query: 523 HKSVDTSPAKKQFPMISYAELSKA-----------TSEFASSNMIGQGSFGSVYKGILGG 571
           +   + SP +++  ++ Y E +K              +F    +IG+G+FG V    L  
Sbjct: 38  YDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN 97
Query: 572 EEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEY 631
            + + A+K++N K +   R+  A     R++      K IT          +   LV +Y
Sbjct: 98  ADKVFAMKILN-KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL-YLVMDY 155
Query: 632 MENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSN 689
              G L   L +  D L  E+ +  L + V IAID    + Y         VH D+KP N
Sbjct: 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMV-IAIDSVHQLHY---------VHRDIKPDN 205
Query: 690 VLLD---HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASM-----T 741
           +L+D   H  +A     L    D    T  SS+ + GT  Y++PE     E         
Sbjct: 206 ILMDMNGHIRLADFGSCLKLMEDG---TVQSSVAV-GTPDYISPEILQAMEGGKGRYGPE 261
Query: 742 GDVYSFGILLLEMFTGRRPTDA---AFTEGLTLHEFVKMTLPEKVIEI 786
            D +S G+ + EM  G  P  A     T G  ++   +   P +V ++
Sbjct: 262 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 550 FASSNMIGQGSFGSVY--KGILGGEEMIVAVKVINLKQKGAFR--SFVAECEALRNIRHR 605
           F    ++G G+F  V+  K  L G+  + A+K I  K+  AFR  S   E   L+ I+H 
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGK--LFALKCI--KKSPAFRDSSLENEIAVLKKIKHE 66
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++ +  I  S          LV + +  G L D + +   + E     +IQ+V      
Sbjct: 67  NIVTLEDIYES-----TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV------ 115
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
            SA++YLH +    IVH DLKP N+L     ++  +   +F LS    +   + +     
Sbjct: 116 LSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC---- 168
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT GYVAPE       S   D +S G++   +  G  P
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 36/231 (15%)
Query: 547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHR 605
           +S+F   +++G+G++G V          IVA+K I    K  F    + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ-------SNDHLEVCKLTLIQR 658
           N+I I  I      +  +   ++ E M+       LH+       S+DH++         
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQY-------- 116
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSS 717
                    A++ LH      ++H DLKPSN+L++ +  +   +F L+  +D ++   S 
Sbjct: 117 --FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 718 SIGIK-GTVGYVAPEYGMGSEASMTG-------DVYSFGILLLEMFTGRRP 760
             G + G V +VA  +    E  +T        DV+S G +L E+F  RRP
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP 221

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 36/231 (15%)
Query: 547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHR 605
           +S+F   +++G+G++G V          IVA+K I    K  F    + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ-------SNDHLEVCKLTLIQR 658
           N+I I  I      +  +   ++ E M+       LH+       S+DH++         
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQY-------- 116
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSS 717
                    A++ LH      ++H DLKPSN+L++ +  +   +F L+  +D ++   S 
Sbjct: 117 --FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 718 SIGIK-GTVGYVAPEYGMGSEASMTG-------DVYSFGILLLEMFTGRRP 760
             G + G   YVA  +    E  +T        DV+S G +L E+F  RRP
Sbjct: 172 PTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP 221

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 103/246 (41%), Gaps = 52/246 (21%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---------------------- 585
           +++   + IG+GS+G V       +    A+KV++ K+                      
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 586 ----KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL 641
               +G       E   L+ + H N++K++ +   +D    D   +VFE +  G +    
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPV---- 125
Query: 642 HQSNDHLEVCKLTLIQRVNIAI---DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MV 697
                 +EV  L  +          D+   IEYLH+     I+H D+KPSN+L+  D  +
Sbjct: 126 ------MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHI 176
Query: 698 AHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG---DVYSFGILLLEM 754
              +F +S++   +    S+++   GT  ++APE    +    +G   DV++ G+ L   
Sbjct: 177 KIADFGVSNEFKGSDALLSNTV---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 755 FTGRRP 760
             G+ P
Sbjct: 234 VFGQCP 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q  AF++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y+        +++   H    K TL +  V + +  + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPAT-----VYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSXICS 185
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 556 IGQGSFGSVYKGILGGEE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G FG V++GI    E   M VA+K   N         F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            + +       +   ++ E    G L  +L      L++  L L      A  +++A+ Y
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-----YAYQLSTALAY 126
Query: 672 LHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        VH D+   NVL+  +D V   +F LS  ++ ++   +S    K  + ++AP
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMAP 181
Query: 731 EYGMGSEASMTGDVYSFGILLLEMF 755
           E       +   DV+ FG+ + E+ 
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 611
           +G G+FG+V KG    ++++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            IC       A+   LV E  E G L  +L Q N H++   +     + +   V+  ++Y
Sbjct: 85  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNI-----IELVHQVSMGMKY 132
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L    +   VH DL   NVLL     A   +F LS  L +      +    K  V + AP
Sbjct: 133 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           E     + S   DV+SFG+L+ E F+ G++P
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 111/234 (47%), Gaps = 28/234 (11%)
Query: 547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRH 604
            S++     IGQG+FG V+K         VA+K + ++  ++G   + + E + L+ ++H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 605 RNLIKIITICSSIDS-----KGADFKALVFEYMEN---GSLEDWLHQSNDHLEVCKLTLI 656
            N++ +I IC +  S     KG+ +  LVF++ E+   G L + L          K TL 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIY--LVFDFCEHDLAGLLSNVL---------VKFTLS 124
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKT- 714
           +   +   + + + Y+H +    I+H D+K +NVL+  D V    +F L+     A  + 
Sbjct: 125 EIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 715 PSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTE 767
           P+       T+ Y  PE  +G  +     D++  G ++ EM+T R P     TE
Sbjct: 182 PNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTE 234

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 613
           IG+G++G VYK      E   A+K I L+++  G   + + E   L+ ++H N++K+  +
Sbjct: 10  IGEGTYGVVYKAQNNYGETF-ALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK--LTLIQRVNIAIDVASAIEY 671
             +          LVFE+++              L+VC+  L  +   +  + + + I Y
Sbjct: 69  IHTKKRL-----VLVFEHLD--------QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H      ++H DLKP N+L++ +  +   +F L+       +  +  I    T+ Y AP
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI---VTLWYRAP 169
Query: 731 EYGMGSEA-SMTGDVYSFGILLLEMFTG 757
           +  MGS+  S T D++S G +  EM  G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 111/233 (47%), Gaps = 28/233 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHR 605
           S++     IGQG+FG V+K         VA+K + ++  ++G   + + E + L+ ++H 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 606 NLIKIITICSSIDS-----KGADFKALVFEYMEN---GSLEDWLHQSNDHLEVCKLTLIQ 657
           N++ +I IC +  S     KG+ +  LVF++ E+   G L + L          K TL +
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIY--LVFDFCEHDLAGLLSNVL---------VKFTLSE 126
Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKT-P 715
              +   + + + Y+H +    I+H D+K +NVL+  D V    +F L+     A  + P
Sbjct: 127 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 716 SSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTE 767
           +       T+ Y  PE  +G  +     D++  G ++ EM+T R P     TE
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTE 235

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 611
           +G G+FG+V KG    ++++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            IC       A+   LV E  E G L  +L Q N H++   +     + +   V+  ++Y
Sbjct: 95  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNI-----IELVHQVSMGMKY 142
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L    +   VH DL   NVLL     A   +F LS  L +      +    K  V + AP
Sbjct: 143 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 199
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           E     + S   DV+SFG+L+ E F+ G++P
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 611
           +G G+FG+V KG    ++++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            IC       A+   LV E  E G L  +L Q N H++   +     + +   V+  ++Y
Sbjct: 95  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNI-----IELVHQVSMGMKY 142
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L    +   VH DL   NVLL     A   +F LS  L +      +    K  V + AP
Sbjct: 143 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 199
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           E     + S   DV+SFG+L+ E F+ G++P
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 611
           +G G+FG+V KG    ++++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            IC       A+   LV E  E G L  +L Q N H++   +     + +   V+  ++Y
Sbjct: 93  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNI-----IELVHQVSMGMKY 140
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L    +   VH DL   NVLL     A   +F LS  L +      +    K  V + AP
Sbjct: 141 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 197
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           E     + S   DV+SFG+L+ E F+ G++P
Sbjct: 198 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 111/234 (47%), Gaps = 28/234 (11%)
Query: 547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRH 604
            S++     IGQG+FG V+K         VA+K + ++  ++G   + + E + L+ ++H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 605 RNLIKIITICSSIDS-----KGADFKALVFEYMEN---GSLEDWLHQSNDHLEVCKLTLI 656
            N++ +I IC +  S     KG+ +  LVF++ E+   G L + L          K TL 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIY--LVFDFCEHDLAGLLSNVL---------VKFTLS 125
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKT- 714
           +   +   + + + Y+H +    I+H D+K +NVL+  D V    +F L+     A  + 
Sbjct: 126 EIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182
Query: 715 PSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTE 767
           P+       T+ Y  PE  +G  +     D++  G ++ EM+T R P     TE
Sbjct: 183 PNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTE 235

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 42/237 (17%)
Query: 545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH 604
           +  S+F    ++GQG+FG V K     +    A+K I   ++    + ++E   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNH 61
Query: 605 -------------RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC 651
                        RN +K +T   ++  K   F  +  EY EN +L D +H  N + +  
Sbjct: 62  QYVVRYYAAWLERRNFVKPMT---AVKKKSTLF--IQMEYCENRTLYDLIHSENLNQQRD 116
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSH---- 706
           +   + R      +  A+ Y+H      I+H DLKP N+ +D    V   +F L+     
Sbjct: 117 EYWRLFR-----QILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 707 -----QLDSASKTPSSSIGIKGTVG---YVAPEYGMGS-EASMTGDVYSFGILLLEM 754
                +LDS +  P SS  +   +G   YVA E   G+   +   D+YS GI+  EM
Sbjct: 169 SLDILKLDSQN-LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 24/236 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRH 604
            +F     +G+G FG+VY         IVA+KV+    ++++G       E E   ++ H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
            N++++       D +      L+ EY   G L   L +S      C     +   I  +
Sbjct: 83  PNILRLYNYF--YDRRRI---YLILEYAPRGELYKELQKS------CTFDEQRTATIMEE 131
Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKG 723
           +A A+ Y H      ++H D+KP N+LL         +F  S    S  +       + G
Sbjct: 132 LADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK-----TMCG 183
Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL 779
           T+ Y+ PE   G   +   D++  G+L  E+  G  P ++A +   T    VK+ L
Sbjct: 184 TLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESA-SHNETYRRIVKVDL 238

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 45/253 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRHRNLIKI 610
           IG G    V++ +L  ++ I A+K +NL++       ++R+ +A    L+  +H +  KI
Sbjct: 20  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QHSD--KI 74
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLE--DWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           I +    D +  D    ++  ME G+++   WL +         +   +R +   ++  A
Sbjct: 75  IRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEA 123
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQL--DSASKTPSSSIGIKGTVG 726
           +  +H H    IVH DLKP+N L+   M+   +F +++Q+  D+ S    S +   GTV 
Sbjct: 124 VHTIHQHG---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQV---GTVN 177
Query: 727 YVAPEYGMGSEASMTG-----------DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV 775
           Y+ PE      +S              DV+S G +L  M  G+ P      +   LH  +
Sbjct: 178 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 237
Query: 776 KMTLPEKVIEIVD 788
               P   IE  D
Sbjct: 238 D---PNHEIEFPD 247

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 105/254 (41%), Gaps = 29/254 (11%)
Query: 530 PAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGA 588
           P   + P    AE  +   +F   +++G G+F  V        + +VA+K I  K  +G 
Sbjct: 2   PGAVEGPRWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK 59
Query: 589 FRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL 648
             S   E   L  I+H N++ +  I  S    G     L+ + +  G L D + +   + 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYES----GGHL-YLIMQLVSGGELFDRIVEKGFYT 114
Query: 649 EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVL---LDHD-MVAHQNFSL 704
           E     LI        V  A++YLH      IVH DLKP N+L   LD D  +   +F L
Sbjct: 115 ERDASRLI------FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 165
Query: 705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP---- 760
           S   D  S   ++     GT GYVAPE       S   D +S G++   +  G  P    
Sbjct: 166 SKMEDPGSVLSTAC----GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 221
Query: 761 TDAAFTEGLTLHEF 774
            DA   E +   E+
Sbjct: 222 NDAKLFEQILKAEY 235

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y+      + +++   H    K TL +  V + +  + 
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSXICS 185
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G+FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++  Y   G+L ++L              + +   ++T  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQL---DSA 711
             V+    +A  +EYL    C    +H DL   NVL+ +++++   +F L+  +   D  
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 214 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 78
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y+      + +++   H    K TL +  V + +  + 
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 134 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSXICS 186
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y+      + +++   H    K TL +  V + +  + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICS 185
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y+      + +++   H    K TL +  V + +  + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSXICS 185
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+G++GSV K +      I+AVK I        RS V E E  + +   +++   + C 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI--------RSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV-------NIAIDVASA 668
            I      F   +F   +     + +  S D       +++  V        I +    A
Sbjct: 82  YI----VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQL-DSASKTPSSSIGIKGTVG 726
           + +L  + +  I+H D+KPSN+LLD    +   +F +S QL DS +KT  +     G   
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-----GCRP 190
Query: 727 YVAPEYGMGSEASMTG-----DVYSFGILLLEMFTGRRP 760
           Y+APE  +   AS  G     DV+S GI L E+ TGR P
Sbjct: 191 YMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 611
           +G G+FG+V KG    ++++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            IC       A+   LV E  E G L  +L Q N H++     +I+ V+    V+  ++Y
Sbjct: 79  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVK--DKNIIELVH---QVSMGMKY 126
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L    +   VH DL   NVLL     A   +F LS  L +      +    K  V + AP
Sbjct: 127 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAP 183
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           E     + S   DV+SFG+L+ E F+ G++P
Sbjct: 184 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 36/231 (15%)
Query: 547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHR 605
           +S+F   +++G+G++G V          IVA+K I    K  F    + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ-------SNDHLEVCKLTLIQR 658
           N+I I  I      +  +   ++ E M+       LH+       S+DH++         
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQY-------- 116
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSS 717
                    A++ LH      ++H DLKPSN+L++ +  +   +F L+  +D ++   S 
Sbjct: 117 --FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 718 SIGIK-------GTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRP 760
             G +        T  Y APE  + S + S   DV+S G +L E+F  RRP
Sbjct: 172 PTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP 221

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 613
           IG+G++G VYK      E   A+K I L+++  G   + + E   L+ ++H N++K+  +
Sbjct: 10  IGEGTYGVVYKAQNNYGETF-ALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK--LTLIQRVNIAIDVASAIEY 671
             +          LVFE+++              L+VC+  L  +   +  + + + I Y
Sbjct: 69  IHTKKRL-----VLVFEHLD--------QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H      ++H DLKP N+L++ +  +   +F L+       +  +  +    T+ Y AP
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV---VTLWYRAP 169
Query: 731 EYGMGSEA-SMTGDVYSFGILLLEMFTG 757
           +  MGS+  S T D++S G +  EM  G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 45/253 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRHRNLIKI 610
           IG G    V++ +L  ++ I A+K +NL++       ++R+ +A    L+  +H +  KI
Sbjct: 36  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QHSD--KI 90
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLE--DWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           I +    D +  D    ++  ME G+++   WL +         +   +R +   ++  A
Sbjct: 91  IRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEA 139
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQL--DSASKTPSSSIGIKGTVG 726
           +  +H H    IVH DLKP+N L+   M+   +F +++Q+  D+ S    S +   GTV 
Sbjct: 140 VHTIHQHG---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQV---GTVN 193
Query: 727 YVAPEYGMGSEASMTG-----------DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV 775
           Y+ PE      +S              DV+S G +L  M  G+ P      +   LH  +
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 776 KMTLPEKVIEIVD 788
               P   IE  D
Sbjct: 254 D---PNHEIEFPD 263

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y+      + +++   H    K TL +  V + +  + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSXICS 185
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 23/220 (10%)
Query: 547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRH 604
           T E+     IG+G+F  V + +        A K+IN K+  A   +    E    R ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
            N++++     SI  +G  F  LVF+ +  G L + +     + E      IQ++  A+ 
Sbjct: 63  SNIVRLH---DSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV- 116
Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDSASKTPSSSIG 720
                  LH H Q  +VH DLKP N+LL        V   +F L+ ++    +   +  G
Sbjct: 117 -------LHCH-QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ---AWFG 165
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             GT GY++PE           D+++ G++L  +  G  P
Sbjct: 166 FAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 45/253 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRHRNLIKI 610
           IG G    V++ +L  ++ I A+K +NL++       ++R+ +A    L+  +H +  KI
Sbjct: 16  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QHSD--KI 70
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLE--DWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           I +    D +  D    ++  ME G+++   WL +         +   +R +   ++  A
Sbjct: 71  IRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEA 119
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQL--DSASKTPSSSIGIKGTVG 726
           +  +H H    IVH DLKP+N L+   M+   +F +++Q+  D+ S    S +   GTV 
Sbjct: 120 VHTIHQHG---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQV---GTVN 173
Query: 727 YVAPEYGMGSEASMTG-----------DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV 775
           Y+ PE      +S              DV+S G +L  M  G+ P      +   LH  +
Sbjct: 174 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 233
Query: 776 KMTLPEKVIEIVD 788
               P   IE  D
Sbjct: 234 D---PNHEIEFPD 243

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 90
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y     + + +++   H    K TL +  V + +  + 
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 146 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICS 198
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 199 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 96
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y     + + +++   H    K TL +  V + +  + 
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 152 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSXICS 204
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 205 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 611
           +G G+FG+V KG    ++++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            IC       A+   LV E  E G L  +L Q N H++   +     + +   V+  ++Y
Sbjct: 437 GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNI-----IELVHQVSMGMKY 484
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L    +   VH DL   NVLL     A   +F LS  L +      +    K  V + AP
Sbjct: 485 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 541
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           E     + S   DV+SFG+L+ E F+ G++P
Sbjct: 542 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRN 601
           +K +  +     +G+G+F  V + +     +  A K+IN K+  A  F+    E    R 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           ++H N++++     SI  +   F  LVF+ +  G L + +     + E      IQ++  
Sbjct: 62  LQHPNIVRL---HDSIQEE--SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI-- 114
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTPSS 717
                 +I Y H +    IVH +LKP N+LL        V   +F L+ +++ +     +
Sbjct: 115 ----LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----A 163
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             G  GT GY++PE       S   D+++ G++L  +  G  P
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRN 601
           +K +  +     +G+G+F  V + +     +  A K+IN K+  A  F+    E    R 
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           ++H N++++     SI  +   F  LVF+ +  G L + +     + E      IQ++  
Sbjct: 61  LQHPNIVRL---HDSIQEE--SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI-- 113
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTPSS 717
                 +I Y H +    IVH +LKP N+LL        V   +F L+ +++ +     +
Sbjct: 114 ----LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----A 162
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             G  GT GY++PE       S   D+++ G++L  +  G  P
Sbjct: 163 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRN 601
           +K +  +     +G+G+F  V + +     +  A K+IN K+  A  F+    E    R 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           ++H N++++     SI  +   F  LVF+ +  G L + +     + E      IQ++  
Sbjct: 62  LQHPNIVRL---HDSIQEE--SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI-- 114
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTPSS 717
                 +I Y H +    IVH +LKP N+LL        V   +F L+ +++ +     +
Sbjct: 115 ----LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----A 163
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             G  GT GY++PE       S   D+++ G++L  +  G  P
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 556 IGQGSFGSVYKGILGGEE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G FG V++GI    E   M VA+K   N         F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            + +       +   ++ E    G L  +L      L++  L L      A  +++A+ Y
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-----YAYQLSTALAY 126
Query: 672 LHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        VH D+   NVL+   D V   +F LS  ++ ++   +S    K  + ++AP
Sbjct: 127 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMAP 181
Query: 731 EYGMGSEASMTGDVYSFGILLLEMF 755
           E       +   DV+ FG+ + E+ 
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 613
           IG+G++G VYK      E   A+K I L+++  G   + + E   L+ ++H N++K+  +
Sbjct: 10  IGEGTYGVVYKAQNNYGETF-ALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK--LTLIQRVNIAIDVASAIEY 671
             +          LVFE+++              L+VC+  L  +   +  + + + I Y
Sbjct: 69  IHTKKRL-----VLVFEHLD--------QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H      ++H DLKP N+L++ +  +   +F L+       +  +  +    T+ Y AP
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV---VTLWYRAP 169
Query: 731 EYGMGSEA-SMTGDVYSFGILLLEMFTG 757
           +  MGS+  S T D++S G +  EM  G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 85
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y+      + +++   H    K TL +  V + +  + 
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 141 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSXICS 193
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 194 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 45/253 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRHRNLIKI 610
           IG G    V++ +L  ++ I A+K +NL++       ++R+ +A    L+  +H +  KI
Sbjct: 17  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QHSD--KI 71
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLE--DWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           I +    D +  D    ++  ME G+++   WL +         +   +R +   ++  A
Sbjct: 72  IRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKKS------IDPWERKSYWKNMLEA 120
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQL--DSASKTPSSSIGIKGTVG 726
           +  +H H    IVH DLKP+N L+   M+   +F +++Q+  D+ S    S +   GTV 
Sbjct: 121 VHTIHQHG---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQV---GTVN 174
Query: 727 YVAPEYGMGSEASMTG-----------DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV 775
           Y+ PE      +S              DV+S G +L  M  G+ P      +   LH  +
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234
Query: 776 KMTLPEKVIEIVD 788
               P   IE  D
Sbjct: 235 D---PNHEIEFPD 244

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 89
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y     + + +++   H    K TL +  V + +  + 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSXICS 197
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 81
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y+      + +++   H    K TL +  V + +  + 
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 137 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSXICS 189
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GS G V           VAVK+++L+++        E   +R+ +H N++++     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                G +   L+ E+++ G+L D + Q        +L   Q   +   V  A+ YLH  
Sbjct: 113 V----GEELWVLM-EFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 676 CQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               ++H D+K  ++LL  D  V   +F    Q+   SK       + GT  ++APE   
Sbjct: 161 G---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKXLVGTPYWMAPEVIS 214
Query: 735 GSEASMTGDVYSFGILLLEMFTGRRP 760
            S  +   D++S GI+++EM  G  P
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 611
           +G G+FG+V KG    ++++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            IC       A+   LV E  E G L  +L Q N H++     +I+ V+    V+  ++Y
Sbjct: 75  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVK--DKNIIELVH---QVSMGMKY 122
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L    +   VH DL   NVLL     A   +F LS  L +      +    K  V + AP
Sbjct: 123 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           E     + S   DV+SFG+L+ E F+ G++P
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 611
           +G G+FG+V KG    ++++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            IC       A+   LV E  E G L  +L Q N H++     +I+ V+    V+  ++Y
Sbjct: 79  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVK--DKNIIELVH---QVSMGMKY 126
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L    +   VH DL   NVLL     A   +F LS  L +      +    K  V + AP
Sbjct: 127 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 183
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           E     + S   DV+SFG+L+ E F+ G++P
Sbjct: 184 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 611
           +G G+FG+V KG    ++++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            IC       A+   LV E  E G L  +L Q N H++     +I+ V+    V+  ++Y
Sbjct: 73  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVK--DKNIIELVH---QVSMGMKY 120
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L    +   VH DL   NVLL     A   +F LS  L +      +    K  V + AP
Sbjct: 121 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 177
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           E     + S   DV+SFG+L+ E F+ G++P
Sbjct: 178 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 606
           +G+G+FG V      G       E + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----------DHLEVCKLTLI 656
           +I ++  C+     G  +  ++  Y   G+L ++L              + +   ++T  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQL---DSA 711
             V+    +A  +EYL    C    +H DL   NVL+ +++++   +F L+  +   D  
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            KT +  + +K    ++APE       +   DV+SFG+L+ E+FT
Sbjct: 214 KKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 611
           +G G+FG+V KG    ++++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            IC       A+   LV E  E G L  +L Q N H++   +     + +   V+  ++Y
Sbjct: 438 GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNI-----IELVHQVSMGMKY 485
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L    +   VH DL   NVLL     A   +F LS  L +      +    K  V + AP
Sbjct: 486 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 542
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           E     + S   DV+SFG+L+ E F+ G++P
Sbjct: 543 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 554 NMIGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           + +G+G+FGSV    Y  +      +VAVK +        R F  E + L+ +    ++K
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
              +       G     LV EY+ +G L D+L +    L+  +L L      +  +   +
Sbjct: 77  YRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SSQICKGM 128
Query: 670 EYL-HHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           EYL    C    VH DL   N+L++ +  V   +F L+  L             +  + +
Sbjct: 129 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            APE    +  S   DV+SFG++L E+FT
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 554 NMIGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           + +G+G+FGSV    Y  +      +VAVK +        R F  E + L+ +    ++K
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
              +       G     LV EY+ +G L D+L +    L+  +L L      +  +   +
Sbjct: 76  YRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SSQICKGM 127
Query: 670 EYL-HHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           EYL    C    VH DL   N+L++ +  V   +F L+  L             +  + +
Sbjct: 128 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            APE    +  S   DV+SFG++L E+FT
Sbjct: 184 YAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 82
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y     + + +++   H    K TL +  V + +  + 
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 138 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICS 190
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 191 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 556 IGQGSFGSVYKGILGGEE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G FG V++GI    E   + VA+K   N         F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            + +       +   ++ E    G L  +L      L++  L L      A  +++A+ Y
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-----YAYQLSTALAY 126
Query: 672 LHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        VH D+   NVL+  +D V   +F LS  ++ ++   +S    K  + ++AP
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMAP 181
Query: 731 EYGMGSEASMTGDVYSFGILLLEMF 755
           E       +   DV+ FG+ + E+ 
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 89
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y     + + +++   H    K TL +  V + +  + 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSXICS 197
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 554 NMIGQGSFGSV----YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           + +G+G+FGSV    Y  +      +VAVK +        R F  E + L+ +    ++K
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
              +       G     LV EY+ +G L D+L +    L+  +L L      +  +   +
Sbjct: 89  YRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SSQICKGM 140
Query: 670 EYL-HHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           EYL    C    VH DL   N+L++ +  V   +F L+  L             +  + +
Sbjct: 141 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFT 756
            APE    +  S   DV+SFG++L E+FT
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 111
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y     + + +++   H    K TL +  V + +  + 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICS 219
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           ++++  + ++K  D   LV   M  G L+  ++    H+        + V  A ++   +
Sbjct: 246 VVSLAYAYETK--DALCLVLTLMNGGDLKFHIY----HMGQAGFPEARAVFYAAEICCGL 299
Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSI--GIKGTVGY 727
           E LH      IV+ DLKP N+LLD     H +  +S  L  A   P      G  GTVGY
Sbjct: 300 EDLHRE---RIVYRDLKPENILLDD----HGHIRIS-DLGLAVHVPEGQTIKGRVGTVGY 351
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +APE       + + D ++ G LL EM  G+ P
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           ++++  + ++K  D   LV   M  G L+  ++    H+        + V  A ++   +
Sbjct: 246 VVSLAYAYETK--DALCLVLTLMNGGDLKFHIY----HMGQAGFPEARAVFYAAEICCGL 299
Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSI--GIKGTVGY 727
           E LH      IV+ DLKP N+LLD     H +  +S  L  A   P      G  GTVGY
Sbjct: 300 EDLHRE---RIVYRDLKPENILLDD----HGHIRIS-DLGLAVHVPEGQTIKGRVGTVGY 351
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +APE       + + D ++ G LL EM  G+ P
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 556 IGQGSFGSVYKGILGGEE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G FG V++GI    E   + VA+K   N         F+ E   +R   H +++K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            + +       +   ++ E    G L  +L      L++  L L      A  +++A+ Y
Sbjct: 106 GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-----YAYQLSTALAY 154
Query: 672 LHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        VH D+   NVL+  +D V   +F LS  ++ ++   +S    K  + ++AP
Sbjct: 155 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMAP 209
Query: 731 EYGMGSEASMTGDVYSFGILLLEMF 755
           E       +   DV+ FG+ + E+ 
Sbjct: 210 ESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 111
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y     + + +++   H    K TL +  V + +  + 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSXICS 219
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 113
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y     + + +++   H    K TL +  V + +  + 
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 169 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICS 221
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 222 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRN 601
           +K +  +     +G+G+F  V + +     +  A K+IN K+  A  F+    E    R 
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 84
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           ++H N++++     SI  +   F  LVF+ +  G L + +     + E      IQ++  
Sbjct: 85  LQHPNIVRL---HDSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI-- 137
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTPSS 717
                 +I Y H +    IVH +LKP N+LL        V   +F L+ +++ +     +
Sbjct: 138 ----LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----A 186
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             G  GT GY++PE       S   D+++ G++L  +  G  P
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 105
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y     + + +++   H    K TL +  V + +  + 
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 161 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICS 213
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 214 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 45/253 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRHRNLIKI 610
           IG G    V++ +L  ++ I A+K +NL++       ++R+ +A    L+  +H +  KI
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QHSD--KI 118
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLE--DWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           I +    D +  D    ++  ME G+++   WL +         +   +R +   ++  A
Sbjct: 119 IRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEA 167
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQL--DSASKTPSSSIGIKGTVG 726
           +  +H H    IVH DLKP+N L+   M+   +F +++Q+  D+ S    S +   GTV 
Sbjct: 168 VHTIHQHG---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQV---GTVN 221
Query: 727 YVAPEYGMGSEASMTG-----------DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV 775
           Y+ PE      +S              DV+S G +L  M  G+ P      +   LH  +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
Query: 776 KMTLPEKVIEIVD 788
               P   IE  D
Sbjct: 282 D---PNHEIEFPD 291

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 556 IGQGSFGSVYK--GILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKII 611
           +G+G+F  V +   +L G+E   A K+IN K+  A   +    E    R ++H N++++ 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEY--AAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL- 86
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
               SI  +G  +  L+F+ +  G L + +     + E      IQ++  A+        
Sbjct: 87  --HDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-------- 134
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           LH H Q  +VH DLKP N+LL   +    V   +F L+ +++   +   +  G  GT GY
Sbjct: 135 LHCH-QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ---AWFGFAGTPGY 190
Query: 728 VAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++PE           D+++ G++L  +  G  P
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 115
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y     + + +++   H    K TL +  V + +  + 
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 171 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICS 223
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 224 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 556 IGQGSFGSVYKGILGGEE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G FG V++GI    E   M VA+K   N         F+ E   +R   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            + +       +   ++ E    G L  +L      L++  L L      A  +++A+ Y
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-----YAYQLSTALAY 506
Query: 672 LHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        VH D+   NVL+  +D V   +F LS  ++ ++   +S    K  + ++AP
Sbjct: 507 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMAP 561
Query: 731 EYGMGSEASMTGDVYSFGILLLEM 754
           E       +   DV+ FG+ + E+
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEI 585

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN----LKQKGAFRSFVAECEA 598
           A  +   + ++G+G FG VY+G+     GE++ VAVK       L  K     F++E   
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVI 78
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++N+ H +++K+I I         +   ++ E    G L  +L ++ + L+V  L L   
Sbjct: 79  MKNLDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVL--- 129
Query: 659 VNIAIDVASAIEYLHH-HCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS 716
              ++ +  A+ YL   +C    VH D+   N+L+   + V   +F LS  ++      +
Sbjct: 130 --YSLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 183
Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           S   +   + +++PE       +   DV+ F + + E+ + G++P
Sbjct: 184 SVTRL--PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 156
Query: 610 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     SS + K   +  LV +Y     + + +++   H    K TL +  V + +  + 
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD D    +  +F  + QL         ++    +
Sbjct: 212 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICS 264
Query: 725 VGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGR 758
             Y APE   G ++ + + DV+S G +L E+  G+
Sbjct: 265 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 126/312 (40%), Gaps = 48/312 (15%)
Query: 492 TLLKVLIPVVVSCLILSSCLTIVFARRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFA 551
           TLL VL+ +   C           +  RR  + +     AK    ++   +L +   +F 
Sbjct: 29  TLLDVLVCLYTEC---------SHSALRRDKYVAEFLEWAKPFTQLVKEMQLHR--EDFE 77
Query: 552 SSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
              +IG+G+FG V    +   E I A+K++N K +   R   AE    R  R    + + 
Sbjct: 78  IIKVIGRGAFGEVAVVKMKNTERIYAMKILN-KWEMLKR---AETACFREERD---VLVN 130
Query: 612 TICSSIDSKGADFK-----ALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDV 665
             C  I +    F+      LV +Y   G L   L +  D L E      I  + +AID 
Sbjct: 131 GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID- 189
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSASKTPSSSIGIK 722
             +I  LH+      VH D+KP NVLLD   H  +A     L    D    T  SS+ + 
Sbjct: 190 --SIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG---TVQSSVAV- 237
Query: 723 GTVGYVAPEYGMGSEASM-----TGDVYSFGILLLEMFTGRRPTDA---AFTEGLTLHEF 774
           GT  Y++PE     E  M       D +S G+ + EM  G  P  A     T G  ++  
Sbjct: 238 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 297
Query: 775 VKMTLPEKVIEI 786
            +   P  V ++
Sbjct: 298 ERFQFPSHVTDV 309

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 105/259 (40%), Gaps = 31/259 (11%)
Query: 525 SVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK 584
           S  + P K     I   E      +     +IG+G FG VY G   GE   VA+++I+++
Sbjct: 10  SARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIE 66
Query: 585 Q--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  +   ++F  E  A R  RH N++  +  C S         A++    +  +L   + 
Sbjct: 67  RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PPHLAIITSLCKGRTLYSVVR 121
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN- 701
            +   L+V K        IA ++   + YLH      I+H DLK  NV  D+  V   + 
Sbjct: 122 DAKIVLDVNKTR-----QIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYDNGKVVITDF 173
Query: 702 --FSLSHQLDSASKTPSSSIGIKGTVGYVAPE----YGMGSEA-----SMTGDVYSFGIL 750
             FS+S  L +  +     I   G + ++APE        +E      S   DV++ G +
Sbjct: 174 GLFSISGVLQAGRREDKLRIQ-NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
Query: 751 LLEMFTGRRPTDAAFTEGL 769
             E+     P      E +
Sbjct: 233 WYELHAREWPFKTQPAEAI 251

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 556 IGQGSFGSVYKGILGGEE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G FG V++GI    E   + VA+K   N         F+ E   +R   H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            + +       +   ++ E    G L  +L      L++  L L      A  +++A+ Y
Sbjct: 83  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-----YAYQLSTALAY 131
Query: 672 LHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        VH D+   NVL+  +D V   +F LS  ++ ++   +S    K  + ++AP
Sbjct: 132 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMAP 186
Query: 731 EYGMGSEASMTGDVYSFGILLLEMF 755
           E       +   DV+ FG+ + E+ 
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 126/312 (40%), Gaps = 48/312 (15%)
Query: 492 TLLKVLIPVVVSCLILSSCLTIVFARRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFA 551
           TLL VL+ +   C           +  RR  + +     AK    ++   +L +   +F 
Sbjct: 45  TLLDVLVCLYTEC---------SHSALRRDKYVAEFLEWAKPFTQLVKEMQLHR--EDFE 93
Query: 552 SSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
              +IG+G+FG V    +   E I A+K++N K +   R   AE    R  R    + + 
Sbjct: 94  IIKVIGRGAFGEVAVVKMKNTERIYAMKILN-KWEMLKR---AETACFREERD---VLVN 146
Query: 612 TICSSIDSKGADFK-----ALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDV 665
             C  I +    F+      LV +Y   G L   L +  D L E      I  + +AID 
Sbjct: 147 GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID- 205
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSASKTPSSSIGIK 722
             +I  LH+      VH D+KP NVLLD   H  +A     L    D    T  SS+ + 
Sbjct: 206 --SIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG---TVQSSVAV- 253
Query: 723 GTVGYVAPEYGMGSEASMTG-----DVYSFGILLLEMFTGRRPTDA---AFTEGLTLHEF 774
           GT  Y++PE     E  M       D +S G+ + EM  G  P  A     T G  ++  
Sbjct: 254 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 313
Query: 775 VKMTLPEKVIEI 786
            +   P  V ++
Sbjct: 314 ERFQFPSHVTDV 325

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 556 IGQGSFGSVYKGILGGEE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G FG V++GI    E   + VA+K   N         F+ E   +R   H +++K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            + +       +   ++ E    G L  +L      L++  L L      A  +++A+ Y
Sbjct: 75  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-----YAYQLSTALAY 123
Query: 672 LHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        VH D+   NVL+  +D V   +F LS  ++ ++   +S    K  + ++AP
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMAP 178
Query: 731 EYGMGSEASMTGDVYSFGILLLEMF 755
           E       +   DV+ FG+ + E+ 
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +  + H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 113 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  AS        +   
Sbjct: 168 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-P 223
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
            ++     IG+G++G+V+K        IVA+K + L    +G   S + E   L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAI 663
           N++++  +  S D K      LVFE+ +   L+ +    N  L  E+ K  L Q      
Sbjct: 62  NIVRLHDVLHS-DKK----LTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ------ 109
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIK 722
            +   + + H      ++H DLKP N+L++ +  +   NF L+       +  S+ +   
Sbjct: 110 -LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV--- 162
Query: 723 GTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRRP 760
            T+ Y  P+   G++   T  D++S G +  E+    RP
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 556 IGQGSFGSVYKGILGGEE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G FG V++GI    E   + VA+K   N         F+ E   +R   H +++K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            + +       +   ++ E    G L  +L      L++  L L      A  +++A+ Y
Sbjct: 81  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-----YAYQLSTALAY 129
Query: 672 LHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        VH D+   NVL+  +D V   +F LS  ++ ++   +S    K  + ++AP
Sbjct: 130 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMAP 184
Query: 731 EYGMGSEASMTGDVYSFGILLLEMF 755
           E       +   DV+ FG+ + E+ 
Sbjct: 185 ESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 45/253 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRHRNLIKI 610
           IG G    V++ +L  ++ I A+K +NL++       ++R+ +A    L+  +H +  KI
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QHSD--KI 118
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLE--DWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           I +    D +  D    ++  ME G+++   WL +         +   +R +   ++  A
Sbjct: 119 IRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEA 167
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQL--DSASKTPSSSIGIKGTVG 726
           +  +H H    IVH DLKP+N L+   M+   +F +++Q+  D+ S    S +   GTV 
Sbjct: 168 VHTIHQHG---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQV---GTVN 221
Query: 727 YVAPEYGMGSEASMTG-----------DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV 775
           Y+ PE      +S              DV+S G +L  M  G+ P      +   LH  +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
Query: 776 KMTLPEKVIEIVD 788
               P   IE  D
Sbjct: 282 D---PNHEIEFPD 291

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 556 IGQGSFGSVYKGILGGEE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G FG V++GI    E   + VA+K   N         F+ E   +R   H +++K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            + +       +   ++ E    G L  +L      L++  L L      A  +++A+ Y
Sbjct: 80  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-----YAYQLSTALAY 128
Query: 672 LHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        VH D+   NVL+  +D V   +F LS  ++ ++   +S    K  + ++AP
Sbjct: 129 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMAP 183
Query: 731 EYGMGSEASMTGDVYSFGILLLEMF 755
           E       +   DV+ FG+ + E+ 
Sbjct: 184 ESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +  + H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 99  CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  AS        +   
Sbjct: 154 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-P 209
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 113 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  AS        +   
Sbjct: 168 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-P 223
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 51/233 (21%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR----------HR 605
           +G+G++G V+K I      +VAVK I       F +F    +A R  R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++ ++ +  + + +      LVF+YME       LH     +    L  + +  +   +
Sbjct: 70  NIVNLLNVLRADNDRDV---YLVFDYMETD-----LHAV---IRANILEPVHKQYVVYQL 118
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASK-TPSSSIGIK- 722
              I+YLH      ++H D+KPSN+LL+ +  V   +F LS    +  + T +  + I  
Sbjct: 119 IKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 723 ----------------GTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
                            T  Y APE  +GS     G D++S G +L E+  G+
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 556 IGQGSFGSVYKGILGGEE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G FG V++GI    E   M VA+K   N         F+ E   +R   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            + +       +   ++ E    G L  +L      L++  L L      A  +++A+ Y
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-----YAYQLSTALAY 506
Query: 672 LHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L        VH D+   NVL+   D V   +F LS  ++ ++   +S    K  + ++AP
Sbjct: 507 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK--GKLPIKWMAP 561
Query: 731 EYGMGSEASMTGDVYSFGILLLEM 754
           E       +   DV+ FG+ + E+
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEI 585

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 90  CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 144
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  AS        +   
Sbjct: 145 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-P 200
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 201 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 98  CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  AS        +   
Sbjct: 153 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-P 208
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 99  CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  AS        +   
Sbjct: 154 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML-P 209
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 98  CIGV--SLQSLP---RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  AS        +   
Sbjct: 153 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-P 208
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 115 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 169
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  AS        +   
Sbjct: 170 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-P 225
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 226 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 99  CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  AS        +   
Sbjct: 154 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-P 209
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 105 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 159
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  AS        +   
Sbjct: 160 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-P 215
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 216 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 113 CIGV--SLQSLP---RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  AS        +   
Sbjct: 168 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-P 223
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 103/248 (41%), Gaps = 29/248 (11%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVA 594
           P    AE  +   +F   +++G G+F  V        + +VA+K I  +  +G   S   
Sbjct: 8   PRWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN 65
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLT 654
           E   L  I+H N++ +  I  S    G     L+ + +  G L D + +   + E     
Sbjct: 66  EIAVLHKIKHPNIVALDDIYES----GGHL-YLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVL---LDHD-MVAHQNFSLSHQLDS 710
           LI        V  A++YLH      IVH DLKP N+L   LD D  +   +F LS   D 
Sbjct: 121 LI------FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171
Query: 711 ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP----TDAAFT 766
            S   ++     GT GYVAPE       S   D +S G++   +  G  P     DA   
Sbjct: 172 GSVLSTAC----GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 227
Query: 767 EGLTLHEF 774
           E +   E+
Sbjct: 228 EQILKAEY 235

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 81/319 (25%), Positives = 131/319 (41%), Gaps = 50/319 (15%)
Query: 63  LRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPF---------------- 106
           L NL  +N + NQ + + P  + N++ L  I +  N+ +   P                 
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 119
Query: 107 ---DILVNLPNLKELYLTFCSXXXXXXXXXXXXXXGMGTASSIPD--SLSNASNLERLDL 161
              D L NL NL  L L+  +               +   + + D   L+N + LERLD+
Sbjct: 120 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFGNQVTDLKPLANLTTLERLDI 179
Query: 162 SGNQFKGKVSI-----DFSSXXXXXXXXXXXXXXGMGT--------ANDLDFVTLLTNCS 208
           S N+    +S+     +  S              G+ T         N L  +  L + +
Sbjct: 180 SSNKV-SDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLT 238
Query: 209 SLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIP-SGIRNLVNLIALTIEVN 267
           +L  L L +NQ     P S     + + + ++G NQIS   P +G+  L NL    +  N
Sbjct: 239 NLTDLDLANNQISNLAPLSGL---TKLTELKLGANQISNISPLAGLTALTNL---ELNEN 292
Query: 268 QLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGN 327
           QL  I P  +  L++L  L ++ N +    P S  +LTKL  L   +NN   ++ SSL N
Sbjct: 293 QLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFF-YNNKVSDV-SSLAN 346
Query: 328 CQNLKGFDASHNKLTGAIP 346
             N+    A HN+++   P
Sbjct: 347 LTNINWLSAGHNQISDLTP 365

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 81/319 (25%), Positives = 129/319 (40%), Gaps = 50/319 (15%)
Query: 63  LRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPF---------------- 106
           L NL  +N + NQ + + P  + N++ L  I +  N+ +   P                 
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 119
Query: 107 ---DILVNLPNLKELYLTFCSXXXXXXXXXXXXXXGMGTASSIPD--SLSNASNLERLDL 161
              D L NL NL  L L+  +               +   + + D   L+N + LERLD+
Sbjct: 120 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFGNQVTDLKPLANLTTLERLDI 179
Query: 162 SGNQFKGKVSI-----DFSSXXXXXXXXXXXXXXGMGT--------ANDLDFVTLLTNCS 208
           S N+    +S+     +  S              G+ T         N L  +  L + +
Sbjct: 180 SSNKV-SDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLT 238
Query: 209 SLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIP-SGIRNLVNLIALTIEVN 267
           +L  L L +NQ     P S     + + + ++G NQIS   P +G+  L NL    +  N
Sbjct: 239 NLTDLDLANNQISNLAPLSGL---TKLTELKLGANQISNISPLAGLTALTNL---ELNEN 292
Query: 268 QLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGN 327
           QL  I P  +  L++L  L ++ N +    P S  +LTKL  L  S N +     SSL N
Sbjct: 293 QLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFSNNKVSD--VSSLAN 346
Query: 328 CQNLKGFDASHNKLTGAIP 346
             N+    A HN+++   P
Sbjct: 347 LTNINWLSAGHNQISDLTP 365

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK---QKGAFRSFVAECEALRN 601
           ++F    ++G+G+FG V   IL  E+      A+K++  +    K      V E   L+N
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            RH  L  +     + D         V EY   G L  + H S + +     T  +    
Sbjct: 62  TRHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRERV----FTEERARFY 110
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA+EYLH      +V+ D+K  N++LD D  +   +F L  +  S   T  +  G
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              T  Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 168 ---TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G+G FG+VY       + I+A+KV+    L+++G       E E   ++RH N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
                D K      L+ E+   G L   L +     E    T ++      ++A A+ Y 
Sbjct: 82  YFH--DRKRI---YLMLEFAPRGELYKELQKHGRFDEQRSATFME------ELADALHYC 130
Query: 673 HHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H   +  ++H D+KP N+L+ +   +   +F  S    S  +       + GT+ Y+ PE
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX-----MCGTLDYLPPE 182
Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
              G       D++  G+L  E   G  P D+
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 103/248 (41%), Gaps = 29/248 (11%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVA 594
           P    AE  +   +F   +++G G+F  V        + +VA+K I  +  +G   S   
Sbjct: 8   PRWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN 65
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLT 654
           E   L  I+H N++ +  I  S    G     L+ + +  G L D + +   + E     
Sbjct: 66  EIAVLHKIKHPNIVALDDIYES----GGHL-YLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVL---LDHD-MVAHQNFSLSHQLDS 710
           LI        V  A++YLH      IVH DLKP N+L   LD D  +   +F LS   D 
Sbjct: 121 LI------FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171
Query: 711 ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP----TDAAFT 766
            S   ++     GT GYVAPE       S   D +S G++   +  G  P     DA   
Sbjct: 172 GSVLSTAC----GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 227
Query: 767 EGLTLHEF 774
           E +   E+
Sbjct: 228 EQILKAEY 235

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK---QKGAFRSFVAECEALRN 601
           ++F    ++G+G+FG V   IL  E+      A+K++  +    K      V E   L+N
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            RH  L  +     + D         V EY   G L  + H S + +     T  +    
Sbjct: 62  TRHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRERV----FTEERARFY 110
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA+EYLH      +V+ D+K  N++LD D  +   +F L  +  S   T  +  G
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              T  Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 168 ---TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 81/319 (25%), Positives = 131/319 (41%), Gaps = 50/319 (15%)
Query: 63  LRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPF---------------- 106
           L NL  +N + NQ + + P  + N++ L  I +  N+ +   P                 
Sbjct: 67  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 124
Query: 107 ---DILVNLPNLKELYLTFCSXXXXXXXXXXXXXXGMGTASSIPD--SLSNASNLERLDL 161
              D L NL NL  L L+  +               +   + + D   L+N + LERLD+
Sbjct: 125 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI 184
Query: 162 SGNQFKGKVSI-----DFSSXXXXXXXXXXXXXXGMGT--------ANDLDFVTLLTNCS 208
           S N+    +S+     +  S              G+ T         N L  +  L + +
Sbjct: 185 SSNKV-SDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLT 243
Query: 209 SLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIP-SGIRNLVNLIALTIEVN 267
           +L  L L +NQ     P S     + + + ++G NQIS   P +G+  L NL    +  N
Sbjct: 244 NLTDLDLANNQISNLAPLSGL---TKLTELKLGANQISNISPLAGLTALTNL---ELNEN 297
Query: 268 QLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGN 327
           QL  I P  +  L++L  L ++ N +    P S  +LTKL  L   +NN   ++ SSL N
Sbjct: 298 QLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFF-YNNKVSDV-SSLAN 351
Query: 328 CQNLKGFDASHNKLTGAIP 346
             N+    A HN+++   P
Sbjct: 352 LTNINWLSAGHNQISDLTP 370

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 125 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 179
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  AS        +   
Sbjct: 180 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-P 235
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 236 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K    G     A K I  ++  + R  V+      E   LR IRH N   
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN--- 69
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           IIT+    ++K  D   L+ E +  G L D+L +         LT  +       +   +
Sbjct: 70  IITLHDIFENK-TDV-VLILELVSGGELFDFLAEKES------LTEDEATQFLKQILDGV 121
Query: 670 EYLHHHCQPPIVHGDLKPSNV-LLDHDM----VAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N+ LLD ++    +   +F ++H++++ ++  +    I GT
Sbjct: 122 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN----IFGT 174
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +VAPE        +  D++S G++   + +G  P
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK---QKGAFRSFVAECEALRN 601
           ++F    ++G+G+FG V   IL  E+      A+K++  +    K      V E   L+N
Sbjct: 8   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            RH  L  +     + D         V EY   G L  + H S + +     T  +    
Sbjct: 65  TRHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRERV----FTEERARFY 113
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA+EYLH      +V+ D+K  N++LD D  +   +F L  +  S   T  +  G
Sbjct: 114 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 170
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              T  Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 171 ---TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K    G     A K I  ++  + R  V+      E   LR IRH N   
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN--- 76
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           IIT+    ++K  D   L+ E +  G L D+L +         LT  +       +   +
Sbjct: 77  IITLHDIFENK-TDV-VLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGV 128
Query: 670 EYLHHHCQPPIVHGDLKPSNV-LLDHDM----VAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N+ LLD ++    +   +F ++H++++ ++  +    I GT
Sbjct: 129 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN----IFGT 181
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +VAPE        +  D++S G++   + +G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 99/240 (41%), Gaps = 20/240 (8%)
Query: 529 SPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA 588
           SPA+     I  + L      F    ++G G++G VYKG       + A+KV+++     
Sbjct: 6   SPAR-SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE 64
Query: 589 FRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFK-ALVFEYMENGSLEDWLHQSND 646
                 E   L+    HRN+          +  G D +  LV E+   GS+ D +   N 
Sbjct: 65  -EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNT 121
Query: 647 HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLS 705
                K   I    I  ++   + +LH H    ++H D+K  NVLL  +  V   +F +S
Sbjct: 122 KGNTLKEEWI--AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-----ASMTGDVYSFGILLLEMFTGRRP 760
            QLD      ++ I   GT  ++APE     E          D++S GI  +EM  G  P
Sbjct: 177 AQLDRTVGRRNTFI---GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 605
            ++     IG+G++G+V+K        IVA+K + L    +G   S + E   L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAI 663
           N++++  +  S D K      LVFE+ +   L+ +    N  L  E+ K  L Q      
Sbjct: 62  NIVRLHDVLHS-DKK----LTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ------ 109
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIK 722
            +   + + H      ++H DLKP N+L++ +  +   +F L+       +  S+ +   
Sbjct: 110 -LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV--- 162
Query: 723 GTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRRP 760
            T+ Y  P+   G++   T  D++S G +  E+    RP
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 103/248 (41%), Gaps = 29/248 (11%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVA 594
           P    AE  +   +F   +++G G+F  V        + +VA+K I  +  +G   S   
Sbjct: 8   PRWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN 65
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLT 654
           E   L  I+H N++ +  I  S    G     L+ + +  G L D + +   + E     
Sbjct: 66  EIAVLHKIKHPNIVALDDIYES----GGHL-YLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVL---LDHD-MVAHQNFSLSHQLDS 710
           LI        V  A++YLH      IVH DLKP N+L   LD D  +   +F LS   D 
Sbjct: 121 LI------FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 171
Query: 711 ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP----TDAAFT 766
            S   ++     GT GYVAPE       S   D +S G++   +  G  P     DA   
Sbjct: 172 GSVLSTAC----GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 227
Query: 767 EGLTLHEF 774
           E +   E+
Sbjct: 228 EQILKAEY 235

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 544 SKATSEFASSNMIGQGSFGSVYK--GILGGEEMIVAVKVINLKQKGA--FRSFVAECEAL 599
           ++ T E+     +G+G+F  V +   +L G+E   A  +IN K+  A   +    E    
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEY--AAMIINTKKLSARDHQKLEREARIC 64
Query: 600 RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
           R ++H N++++     SI  +G  +  L+F+ +  G L + +     + E      IQ++
Sbjct: 65  RLLKHPNIVRL---HDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQI 119
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTP 715
             A+        LH H Q  +VH +LKP N+LL   +    V   +F L+ +++   +  
Sbjct: 120 LEAV--------LHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-- 168
Query: 716 SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            +  G  GT GY++PE           D+++ G++L  +  G  P
Sbjct: 169 -AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 25/238 (10%)
Query: 529 SPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVK---VINLKQ 585
            P K   P + Y  L+     F     IG+G F  VY+     + + VA+K   + +L  
Sbjct: 17  QPQKALRPDMGYNTLA----NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD 72
Query: 586 KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN 645
             A    + E + L+ + H N+IK     S I+    +   +V E  + G L   +    
Sbjct: 73  AKARADCIKEIDLLKQLNHPNVIKYYA--SFIEDNELN---IVLELADAGDLSRMI---- 123
Query: 646 DHLEVCKLTLIQRV--NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNF 702
            H +  K  + +R      + + SA+E++H      ++H D+KP+NV +    +V   + 
Sbjct: 124 KHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 180
Query: 703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            L     S +    S +G   T  Y++PE    +  +   D++S G LL EM   + P
Sbjct: 181 GLGRFFSSKTTAAHSLVG---TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 45/253 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRHRNLIKI 610
           IG G    V++ +L  ++ I A+K +NL++       ++R+ +A    L+  +H +  KI
Sbjct: 36  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QHSD--KI 90
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLE--DWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           I +    D +  D    ++  ME G+++   WL +         +   +R +   ++  A
Sbjct: 91  IRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEA 139
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQL--DSASKTPSSSIGIKGTVG 726
           +  +H H    IVH DLKP+N L+   M+   +F +++Q+  D       S +   GTV 
Sbjct: 140 VHTIHQHG---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDXXXVVKDSQV---GTVN 193
Query: 727 YVAPEYGMGSEASMTG-----------DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV 775
           Y+ PE      +S              DV+S G +L  M  G+ P      +   LH  +
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 776 KMTLPEKVIEIVD 788
               P   IE  D
Sbjct: 254 D---PNHEIEFPD 263

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 104/241 (43%), Gaps = 32/241 (13%)
Query: 530 PAKKQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN--- 582
           P  ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++   
Sbjct: 2   PMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 61
Query: 583 ---LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLED 639
              +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L  
Sbjct: 62  QSIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-- 115
Query: 640 WLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VA 698
                N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  + 
Sbjct: 116 -----NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 167
Query: 699 HQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTG 757
             +F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TG
Sbjct: 168 ILDFGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 758 R 758
           R
Sbjct: 222 R 222

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K    G     A K I  ++  + R  V+      E   LR IRH N   
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPN--- 90
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           IIT+    ++K  D   L+ E +  G L D+L +         LT  +       +   +
Sbjct: 91  IITLHDIFENK-TDV-VLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGV 142
Query: 670 EYLHHHCQPPIVHGDLKPSNV-LLDHDM----VAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N+ LLD ++    +   +F ++H++++ ++  +    I GT
Sbjct: 143 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN----IFGT 195
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +VAPE        +  D++S G++   + +G  P
Sbjct: 196 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K       +  A K I  +Q  A R  V+      E   LR + H N   
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN--- 76
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +IT+    +++      L+ E +  G L D+L Q     E    + I+++         +
Sbjct: 77  VITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQI------LDGV 128
Query: 670 EYLHHHCQPPIVHGDLKPSNV-LLDHDM-VAHQ---NFSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N+ LLD ++ + H    +F L+H+++   +  +    I GT
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IFGT 181
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +VAPE        +  D++S G++   + +G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K       +  A K I  +Q  A R  V+      E   LR + H N   
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN--- 76
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +IT+    +++      L+ E +  G L D+L Q     E    + I+++         +
Sbjct: 77  VITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQI------LDGV 128
Query: 670 EYLHHHCQPPIVHGDLKPSNV-LLDHDM-VAHQ---NFSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N+ LLD ++ + H    +F L+H+++   +  +    I GT
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IFGT 181
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +VAPE        +  D++S G++   + +G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 75/317 (23%), Positives = 127/317 (40%), Gaps = 40/317 (12%)
Query: 542 ELSKATS-----EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAEC 596
           E  KA+S     +F    +IG+GS+  V    L   + I A+KV+    K    +   + 
Sbjct: 9   ESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV----KKELVNDDEDI 64
Query: 597 EALRNIRH-----RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC 651
           + ++  +H      N   ++ + S   ++   F   V EY+  G L    H         
Sbjct: 65  DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF--FVIEYVNGGDL--MFHMQRQR---- 116
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSA 711
           KL        + +++ A+ YLH      I++ DLK  NVLLD +   H   +        
Sbjct: 117 KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEG 171
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTD---AAFTEG 768
            +   ++    GT  Y+APE   G +   + D ++ G+L+ EM  GR P D   ++    
Sbjct: 172 LRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 231
Query: 769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMES 828
               +++   + EK I I     +       S + +D + R    L  + +TG       
Sbjct: 232 QNTEDYLFQVILEKQIRIPRSMSVKAASVLKSFLNKDPKER----LGCLPQTGFADIQGH 287
Query: 829 PFER------MEMRDVV 839
           PF R      ME + VV
Sbjct: 288 PFFRNVDWDMMEQKQVV 304

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 53/227 (23%), Positives = 108/227 (47%), Gaps = 34/227 (14%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGIL---GGEEMIVAVK------VINLKQKGAFRSFVAEC 596
           A  +   + ++G+G FG VY+G+     GE++ VAVK       ++ K+K     F++E 
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-----FMSEA 60
Query: 597 EALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
             ++N+ H +++K+I I         +   ++ E    G L  +L ++ + L+V  L L 
Sbjct: 61  VIMKNLDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVL- 113
Query: 657 QRVNIAIDVASAIEYLHH-HCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKT 714
                ++ +  A+ YL   +C    VH D+   N+L+   + V   +F LS  ++     
Sbjct: 114 ----YSLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 165
Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            +S   +   + +++PE       +   DV+ F + + E+ + G++P
Sbjct: 166 KASVTRLP--IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 53/227 (23%), Positives = 108/227 (47%), Gaps = 34/227 (14%)
Query: 546 ATSEFASSNMIGQGSFGSVYKGIL---GGEEMIVAVK------VINLKQKGAFRSFVAEC 596
           A  +   + ++G+G FG VY+G+     GE++ VAVK       ++ K+K     F++E 
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-----FMSEA 64
Query: 597 EALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
             ++N+ H +++K+I I         +   ++ E    G L  +L ++ + L+V  L L 
Sbjct: 65  VIMKNLDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVL- 117
Query: 657 QRVNIAIDVASAIEYLHH-HCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKT 714
                ++ +  A+ YL   +C    VH D+   N+L+   + V   +F LS  ++     
Sbjct: 118 ----YSLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169
Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            +S   +   + +++PE       +   DV+ F + + E+ + G++P
Sbjct: 170 KASVTRLP--IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K       +  A K I  +Q  A R  V+      E   LR + H N   
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN--- 76
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +IT+    +++      L+ E +  G L D+L Q     E    + I+++         +
Sbjct: 77  VITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQI------LDGV 128
Query: 670 EYLHHHCQPPIVHGDLKPSNV-LLDHDM-VAHQ---NFSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N+ LLD ++ + H    +F L+H+++   +  +    I GT
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IFGT 181
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +VAPE        +  D++S G++   + +G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 552 SSNMIGQGSFGSVYKG--ILGGEEMI-VAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 607
           S  +IG+G FG VY G  I   +  I  A+K ++ + +     +F+ E   +R + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           + +I I   +  +G     ++  YM +G L  ++     +  V  L     ++  + VA 
Sbjct: 85  LALIGIM--LPPEG--LPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVAR 135
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQ-LDSASKTPSSSIGIKGTV 725
            +EYL    +   VH DL   N +LD    V   +F L+   LD    +       +  V
Sbjct: 136 GMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            + A E       +   DV+SFG+LL E+ T   P
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K       +  A K I  +Q  A R  V+      E   LR + H N   
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN--- 76
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +IT+    +++      L+ E +  G L D+L Q     E    + I+++         +
Sbjct: 77  VITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQI------LDGV 128
Query: 670 EYLHHHCQPPIVHGDLKPSNV-LLDHDM-VAHQ---NFSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N+ LLD ++ + H    +F L+H+++   +  +    I GT
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IFGT 181
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +VAPE        +  D++S G++   + +G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK---QKGAFRSFVAECEALRN 601
           ++F    ++G+G+FG V   IL  E+      A+K++  +    K      V E   L+N
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            RH  L  +     + D         V EY   G L  + H S + +     T  +    
Sbjct: 62  TRHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRERV----FTEERARFY 110
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA+EYLH      +V+ D+K  N++LD D  +   +F L  +  S   T     G
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              T  Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 168 ---TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK---QKGAFRSFVAECEALRN 601
           ++F    ++G+G+FG V   IL  E+      A+K++  +    K      V E   L+N
Sbjct: 10  NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            RH  L  +     + D         V EY   G L  + H S + +     T  +    
Sbjct: 67  TRHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRERV----FTEERARFY 115
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA+EYLH      +V+ D+K  N++LD D  +   +F L  +  S   T     G
Sbjct: 116 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 172
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              T  Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 173 ---TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 27/222 (12%)
Query: 547 TSEFASSNMIGQGSFGSVYK--GILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNI 602
           T E+     +G+G+F  V +   I  G+E   A K+IN K+  A   +    E    R +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEY--AAKIINTKKLSARDHQKLEREARICRLL 60
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           +H N++++     SI  +G  F  LVF+ +  G L + +     + E      IQ++   
Sbjct: 61  KHPNIVRL---HDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI--- 112
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDSASKTPSSS 718
                 +E ++H     IVH DLKP N+LL        V   +F L+ ++    +   + 
Sbjct: 113 ------LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ---AW 163
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            G  GT GY++PE           D+++ G++L  +  G  P
Sbjct: 164 FGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK---QKGAFRSFVAECEALRN 601
           ++F    ++G+G+FG V   IL  E+      A+K++  +    K      V E   L+N
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            RH  L  +     + D         V EY   G L  + H S + +     T  +    
Sbjct: 62  TRHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRERV----FTEERARFY 110
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA+EYLH      +V+ D+K  N++LD D  +   +F L  +  S   T     G
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              T  Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 168 ---TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           ++G+G++G VY G     ++ +A+K I  +     +    E    ++++H+N+++ +   
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL--- 85
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            S    G  F  +  E +  GSL   L      L+  + T+         +   ++YLH 
Sbjct: 86  GSFSENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK---QILEGLKYLHD 140
Query: 675 HCQPPIVHGDLKPSNVLLD--HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE- 731
           +    IVH D+K  NVL++    ++   +F  S +L  A   P +     GT+ Y+APE 
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTET-FTGTLQYMAPEI 194
Query: 732 -----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                 G G  A    D++S G  ++EM TG+ P
Sbjct: 195 IDKGPRGYGKAA----DIWSLGCTIIEMATGKPP 224

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 31/238 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL-IKIITIC 614
           +G+G++G V K        I+AVK I        R+ V   E  R +   ++ ++ +   
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI--------RATVNSQEQKRLLMDLDISMRTVDCP 110
Query: 615 SSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
            ++   GA F+     +  E M+  SL+ +  Q  D  +     ++ +  IA+ +  A+E
Sbjct: 111 FTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALE 167
Query: 671 YLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLS-HQLDSASKTPSSSIGIKGTVGYV 728
           +LH      ++H D+KPSNVL++    V   +F +S + +DS +KT  +     G   Y+
Sbjct: 168 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA-----GCKPYM 220
Query: 729 APEYGMGSEASMTG-----DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE 781
           APE  +  E +  G     D++S GI ++E+   R P D+  T    L + V+   P+
Sbjct: 221 APER-INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 277

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK---QKGAFRSFVAECEALRN 601
           ++F    ++G+G+FG V   IL  E+      A+K++  +    K      V E   L+N
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            RH  L  +     + D         V EY   G L  + H S + +     T  +    
Sbjct: 62  TRHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRERV----FTEERARFY 110
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA+EYLH      +V+ D+K  N++LD D  +   +F L  +  S   T     G
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              T  Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 168 ---TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 127/304 (41%), Gaps = 59/304 (19%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS---------FVAECEAL 599
           E+  S  +G G+ G V           VA+K+I+ K+K A  S            E E L
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 69
Query: 600 RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE--VCKLTLIQ 657
           + + H  +IKI     + D        +V E ME G L D +   N  L+   CKL   Q
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQ 122
Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDSASK 713
                  +  A++YLH +    I+H DLKP NVLL       ++   +F  S  L   S 
Sbjct: 123 -------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 714 TPSSSIGIKGTVGYVAPE--YGMGSEA-SMTGDVYSFGILLLEMFTGRRP-----TDAAF 765
             +    + GT  Y+APE    +G+   +   D +S G++L    +G  P     T  + 
Sbjct: 173 MRT----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
Query: 766 TEGLTLHEF-----VKMTLPEKVIE------IVDPSLLM---EVMANNSMIQEDRRARTQ 811
            + +T  ++     V   + EK ++      +VDP       E + +  +  ED + + Q
Sbjct: 229 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288
Query: 812 DCLN 815
           D L+
Sbjct: 289 DLLS 292

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 105/240 (43%), Gaps = 32/240 (13%)
Query: 531 AKKQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN---- 582
           + K+ P     EL+K   E    + + + +G G++GSV         + +AVK ++    
Sbjct: 30  SHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQ 89
Query: 583 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDW 640
             +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L   
Sbjct: 90  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADL--- 142
Query: 641 LHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAH 699
               N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +  
Sbjct: 143 ----NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 195
Query: 700 QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
            +F L+   D          G   T  Y APE  +     +MT D++S G ++ E+ TGR
Sbjct: 196 LDFGLARHTD------DEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 45/253 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRHRNLIKI 610
           IG G    V++ +L  ++ I A+K +NL++       ++R+ +A    L+  +H +  KI
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QHSD--KI 118
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLE--DWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           I +    D +  D    ++  ME G+++   WL +         +   +R +   ++  A
Sbjct: 119 IRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEA 167
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQL--DSASKTPSSSIGIKGTVG 726
           +  +H H    IVH DLKP+N L+   M+   +F +++Q+  D+ S    S +   G V 
Sbjct: 168 VHTIHQHG---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQV---GAVN 221
Query: 727 YVAPEYGMGSEASMTG-----------DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV 775
           Y+ PE      +S              DV+S G +L  M  G+ P      +   LH  +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
Query: 776 KMTLPEKVIEIVD 788
               P   IE  D
Sbjct: 282 D---PNHEIEFPD 291

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 139 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  A         +   
Sbjct: 194 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML-P 249
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 26/227 (11%)
Query: 542 ELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRN 601
           E      E     ++G+G++G VY G     ++ +A+K I  +     +    E    ++
Sbjct: 2   EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH 61
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           ++H+N+++ +    S    G  F  +  E +  GSL   L      L+  + T+      
Sbjct: 62  LKHKNIVQYL---GSFSENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK- 115
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDMVAHQNFSLSHQLDSASKTPSSSI 719
              +   ++YLH +    IVH D+K  NVL++    ++   +F  S +L  A   P +  
Sbjct: 116 --QILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTET 168
Query: 720 GIKGTVGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              GT+ Y+APE       G G  A    D++S G  ++EM TG+ P
Sbjct: 169 -FTGTLQYMAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATGKPP 210

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 129/304 (42%), Gaps = 59/304 (19%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS---------FVAECEAL 599
           E+  S  +G G+ G V           VA+K+I+ K+K A  S            E E L
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 68
Query: 600 RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE--VCKLTLIQ 657
           + + H  +IKI     + D        +V E ME G L D +   N  L+   CKL   Q
Sbjct: 69  KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQ 121
Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHD-MVAHQNFSLSHQLDSASK 713
                  +  A++YLH +    I+H DLKP NVLL   + D ++   +F  S  L   S 
Sbjct: 122 -------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 171
Query: 714 TPSSSIGIKGTVGYVAPE--YGMGSEA-SMTGDVYSFGILLLEMFTGRRP-----TDAAF 765
             +    + GT  Y+APE    +G+   +   D +S G++L    +G  P     T  + 
Sbjct: 172 MRT----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 227
Query: 766 TEGLTLHEF-----VKMTLPEKVIE------IVDPSLLM---EVMANNSMIQEDRRARTQ 811
            + +T  ++     V   + EK ++      +VDP       E + +  +  ED + + Q
Sbjct: 228 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 287
Query: 812 DCLN 815
           D L+
Sbjct: 288 DLLS 291

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 27/222 (12%)
Query: 547 TSEFASSNMIGQGSFGSVYK--GILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNI 602
           T E+     +G+G+F  V +   I  G+E   A K+IN K+  A   +    E    R +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEY--AAKIINTKKLSARDHQKLEREARICRLL 60
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           +H N++++     SI  +G  F  LVF+ +  G L + +     + E      IQ++   
Sbjct: 61  KHPNIVRL---HDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI--- 112
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDSASKTPSSS 718
                 +E ++H     IVH DLKP N+LL        V   +F L+ ++    +   + 
Sbjct: 113 ------LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ---AW 163
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            G  GT GY++PE           D+++ G++L  +  G  P
Sbjct: 164 FGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 129/319 (40%), Gaps = 50/319 (15%)
Query: 63  LRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPF---------------- 106
           L NL  +N + NQ + + P  + N++ L  I +  N+ +   P                 
Sbjct: 66  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 123
Query: 107 ---DILVNLPNLKELYLTFCSXXXXXXXXXXXXXXGMGTASSIPD--SLSNASNLERLDL 161
              D L NL NL  L L+  +               +   + + D   L+N + LERLD+
Sbjct: 124 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI 183
Query: 162 SGNQFKGKVSI-----DFSSXXXXXXXXXXXXXXGMGT--------ANDLDFVTLLTNCS 208
           S N+    +S+     +  S              G+ T         N L  +  L + +
Sbjct: 184 SSNKV-SDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLT 242
Query: 209 SLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIP-SGIRNLVNLIALTIEVN 267
           +L  L L +NQ     P S     + + + ++G NQIS   P +G+  L NL    +  N
Sbjct: 243 NLTDLDLANNQISNLAPLSGL---TKLTELKLGANQISNISPLAGLTALTNL---ELNEN 296
Query: 268 QLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGN 327
           QL  I P  +  L++L  L ++ N +    P S  +LTKL  L  + N +     SSL N
Sbjct: 297 QLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLAN 350
Query: 328 CQNLKGFDASHNKLTGAIP 346
             N+    A HN+++   P
Sbjct: 351 LTNINWLSAGHNQISDLTP 369

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 129/304 (42%), Gaps = 59/304 (19%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS---------FVAECEAL 599
           E+  S  +G G+ G V           VA+K+I+ K+K A  S            E E L
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 69
Query: 600 RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE--VCKLTLIQ 657
           + + H  +IKI     + D        +V E ME G L D +   N  L+   CKL   Q
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQ 122
Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHD-MVAHQNFSLSHQLDSASK 713
                  +  A++YLH +    I+H DLKP NVLL   + D ++   +F  S  L   S 
Sbjct: 123 -------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 714 TPSSSIGIKGTVGYVAPE--YGMGSEA-SMTGDVYSFGILLLEMFTGRRP-----TDAAF 765
             +    + GT  Y+APE    +G+   +   D +S G++L    +G  P     T  + 
Sbjct: 173 MRT----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
Query: 766 TEGLTLHEF-----VKMTLPEKVIE------IVDPSLLM---EVMANNSMIQEDRRARTQ 811
            + +T  ++     V   + EK ++      +VDP       E + +  +  ED + + Q
Sbjct: 229 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288
Query: 812 DCLN 815
           D L+
Sbjct: 289 DLLS 292

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K       +  A K I  +Q  A R  V+      E   LR + H N   
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN--- 76
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +IT+    +++      L+ E +  G L D+L Q     E    + I+++         +
Sbjct: 77  VITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQI------LDGV 128
Query: 670 EYLHHHCQPPIVHGDLKPSNV-LLDHDM-VAHQ---NFSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N+ LLD ++ + H    +F L+H+++   +  +    I GT
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IFGT 181
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +VAPE        +  D++S G++   + +G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 89/338 (26%), Positives = 145/338 (42%), Gaps = 77/338 (22%)
Query: 12  IGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNV 71
           + +L NL  L +  N +T   P  + NL+ L  L +  N++     + L  L +L  LN 
Sbjct: 103 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNF 158
Query: 72  AENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSXXXXXXX 131
           + NQ + + P  + N+++LE + ++ N+ S      +L  L NL+ L             
Sbjct: 159 SSNQVTDLKP--LANLTTLERLDISSNKVSD---ISVLAKLTNLESL------------- 200
Query: 132 XXXXXXXGMGTASSIPD--SLSNASNLERLDLSGNQFKGKVSIDFSSXXXXXXXXXXXXX 189
                   + T + I D   L   +NL+ L L+GNQ K                      
Sbjct: 201 --------IATNNQISDITPLGILTNLDELSLNGNQLKD--------------------- 231
Query: 190 XGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTI 249
             +GT         L + ++L  L L +NQ     P S     + + + ++G NQIS   
Sbjct: 232 --IGT---------LASLTNLTDLDLANNQISNLAPLSGL---TKLTELKLGANQISNIS 277
Query: 250 P-SGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLA 308
           P +G+  L NL    +  NQL  I P  +  L++L  L ++ N +    P S  +LTKL 
Sbjct: 278 PLAGLTALTNL---ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKLQ 330
Query: 309 DLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIP 346
            L   +NN   ++ SSL N  N+    A HN+++   P
Sbjct: 331 RLFF-YNNKVSDV-SSLANLTNINWLSAGHNQISDLTP 366

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 105/242 (43%), Gaps = 32/242 (13%)
Query: 529 SPAKKQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-- 582
           S A ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++  
Sbjct: 22  SNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 81
Query: 583 ----LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLE 638
               +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L 
Sbjct: 82  FQSIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL- 136
Query: 639 DWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-V 697
                 N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +
Sbjct: 137 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 187
Query: 698 AHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFT 756
              +F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ T
Sbjct: 188 KILDFGL------ARHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241
Query: 757 GR 758
           GR
Sbjct: 242 GR 243

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 52/205 (25%), Positives = 81/205 (39%), Gaps = 24/205 (11%)
Query: 562 GSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG 621
           G ++KG   G +++V V  +        R F  EC  LR   H N++ ++  C    S  
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ---SPP 80
Query: 622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIV 681
           A    L+  +   GSL + LH+  + +    +   Q V  A+D A    +L H  +P I 
Sbjct: 81  APHPTLITHWXPYGSLYNVLHEGTNFV----VDQSQAVKFALDXARGXAFL-HTLEPLIP 135
Query: 682 HGDLKPSNVLLDHDMVAH---QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA 738
              L   +V +D D  A     +   S Q       P+          +VAPE       
Sbjct: 136 RHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPA----------WVAPEALQKKPE 185
Query: 739 SM---TGDVYSFGILLLEMFTGRRP 760
                + D +SF +LL E+ T   P
Sbjct: 186 DTNRRSADXWSFAVLLWELVTREVP 210

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 127/304 (41%), Gaps = 59/304 (19%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS---------FVAECEAL 599
           E+  S  +G G+ G V           VA+K+I+ K+K A  S            E E L
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 75
Query: 600 RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE--VCKLTLIQ 657
           + + H  +IKI     + D        +V E ME G L D +   N  L+   CKL   Q
Sbjct: 76  KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQ 128
Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDSASK 713
                  +  A++YLH +    I+H DLKP NVLL       ++   +F  S  L   S 
Sbjct: 129 -------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 178
Query: 714 TPSSSIGIKGTVGYVAPE--YGMGSEA-SMTGDVYSFGILLLEMFTGRRP-----TDAAF 765
             +    + GT  Y+APE    +G+   +   D +S G++L    +G  P     T  + 
Sbjct: 179 MRT----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 234
Query: 766 TEGLTLHEF-----VKMTLPEKVIE------IVDPSLLM---EVMANNSMIQEDRRARTQ 811
            + +T  ++     V   + EK ++      +VDP       E + +  +  ED + + Q
Sbjct: 235 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 294
Query: 812 DCLN 815
           D L+
Sbjct: 295 DLLS 298

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 127/305 (41%), Gaps = 59/305 (19%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS---------FVAECEA 598
            E+  S  +G G+ G V           VA+++I+ K+K A  S            E E 
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEI 207
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE--VCKLTLI 656
           L+ + H  +IKI     + D        +V E ME G L D +   N  L+   CKL   
Sbjct: 208 LKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKV-VGNKRLKEATCKLYFY 260
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDSAS 712
           Q       +  A++YLH +    I+H DLKP NVLL       ++   +F  S  L   S
Sbjct: 261 Q-------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 310
Query: 713 KTPSSSIGIKGTVGYVAPE--YGMGSEA-SMTGDVYSFGILLLEMFTGRRP-----TDAA 764
              +    + GT  Y+APE    +G+   +   D +S G++L    +G  P     T  +
Sbjct: 311 LMRT----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 366
Query: 765 FTEGLTLHEF-----VKMTLPEKVIE------IVDPSLLM---EVMANNSMIQEDRRART 810
             + +T  ++     V   + EK ++      +VDP       E + +  +  ED + + 
Sbjct: 367 LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 426
Query: 811 QDCLN 815
           QD L+
Sbjct: 427 QDLLS 431

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G+FG VY+G + G       + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASA 668
            I +  S+ S     + ++ E M  G L+ +L ++     +   L ++  +++A D+A  
Sbjct: 116 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 170
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            +YL  +     +H D+   N LL       +    +F ++  +  A         +   
Sbjct: 171 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML-P 226
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           V ++ PE  M    +   D +SFG+LL E+F+
Sbjct: 227 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 26/221 (11%)
Query: 547 TSEFASSNMIGQGSFGSVY---KGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR 603
           +  +     +G G++G V      + G E  I  +K  ++       + + E   L+ + 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N++K+       D +      LV E    G L D +       EV    ++++V    
Sbjct: 80  HPNIMKLYEFFE--DKRNY---YLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV---- 130
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDSASKTPSSSI 719
              S   YLH H    IVH DLKP N+LL+      ++   +F LS   +   K      
Sbjct: 131 --LSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL- 184
Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              GT  Y+APE  +  +     DV+S G++L  +  G  P
Sbjct: 185 ---GTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/277 (21%), Positives = 111/277 (40%), Gaps = 75/277 (27%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFV-AECEALRNI 602
           S+  ++F     +G+G FG V++     ++   A+K I L  +   R  V  E +AL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 603 RHRNLIKIITIC-----------------------------SSIDSKGADFKAL------ 627
            H  +++                                  S +D+     + +      
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 628 ------------VFEYME-----NGSLEDWLHQSNDHLEVCKLTLIQR---VNIAIDVAS 667
                       V+ Y++       +L+DW+++       C L   +    ++I I +A 
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR------CSLEDREHGVCLHIFIQIAE 175
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASK-----TP----SS 717
           A+E+LH      ++H DLKPSN+     D+V   +F L   +D   +     TP    ++
Sbjct: 176 AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEM 754
             G  GT  Y++PE   G+  S   D++S G++L E+
Sbjct: 233 HXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 128
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 129 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPD 177
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 178 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 129/304 (42%), Gaps = 59/304 (19%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS---------FVAECEAL 599
           E+  S  +G G+ G V           VA+K+I+ K+K A  S            E E L
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 69
Query: 600 RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE--VCKLTLIQ 657
           + + H  +IKI     + D        +V E ME G L D +   N  L+   CKL   Q
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQ 122
Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHD-MVAHQNFSLSHQLDSASK 713
                  +  A++YLH +    I+H DLKP NVLL   + D ++   +F  S  L   S 
Sbjct: 123 -------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 714 TPSSSIGIKGTVGYVAPE--YGMGSEA-SMTGDVYSFGILLLEMFTGRRP-----TDAAF 765
             +    + GT  Y+APE    +G+   +   D +S G++L    +G  P     T  + 
Sbjct: 173 MRT----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
Query: 766 TEGLTLHEF-----VKMTLPEKVIE------IVDPSLLM---EVMANNSMIQEDRRARTQ 811
            + +T  ++     V   + EK ++      +VDP       E + +  +  ED + + Q
Sbjct: 229 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288
Query: 812 DCLN 815
           D L+
Sbjct: 289 DLLS 292

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 42/225 (18%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 606
           F+    IG GSFG+VY         +VA+K ++   K +   ++  + E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 607 LIKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
                    +I  +G   +     LV EY         L  ++D LEV K  L Q V IA
Sbjct: 116 ---------TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 157
Query: 663 IDVASAIE---YLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
                A++   YLH H    ++H D+K  N+LL +  +V   +F       SAS    ++
Sbjct: 158 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG------SASIMAPAN 208
Query: 719 IGIKGTVGYVAPEYGMG-SEASMTG--DVYSFGILLLEMFTGRRP 760
             + GT  ++APE  +   E    G  DV+S GI  +E+   + P
Sbjct: 209 XFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K       +  A K I  +Q  A R  V       E   LR + H N   
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN--- 76
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           IIT+    +++  D   L+ E +  G L D+L Q     E    + I+++         +
Sbjct: 77  IITLHDVYENR-TDV-VLILELVSGGELFDFLAQKESLSEEEATSFIKQI------LDGV 128
Query: 670 EYLHHHCQPPIVHGDLKPSNV-LLDHDM-VAHQ---NFSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N+ LLD ++ + H    +F L+H+++   +  +    I GT
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IFGT 181
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +VAPE        +  D++S G++   + +G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 127/305 (41%), Gaps = 59/305 (19%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS---------FVAECEA 598
            E+  S  +G G+ G V           VA+++I+ K+K A  S            E E 
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEI 193
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE--VCKLTLI 656
           L+ + H  +IKI     + D        +V E ME G L D +   N  L+   CKL   
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKV-VGNKRLKEATCKLYFY 246
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDSAS 712
           Q       +  A++YLH +    I+H DLKP NVLL       ++   +F  S  L   S
Sbjct: 247 Q-------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
Query: 713 KTPSSSIGIKGTVGYVAPE--YGMGSEA-SMTGDVYSFGILLLEMFTGRRP-----TDAA 764
              +    + GT  Y+APE    +G+   +   D +S G++L    +G  P     T  +
Sbjct: 297 LMRT----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 352
Query: 765 FTEGLTLHEF-----VKMTLPEKVIE------IVDPSLLM---EVMANNSMIQEDRRART 810
             + +T  ++     V   + EK ++      +VDP       E + +  +  ED + + 
Sbjct: 353 LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 412
Query: 811 QDCLN 815
           QD L+
Sbjct: 413 QDLLS 417

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 89/339 (26%), Positives = 143/339 (42%), Gaps = 57/339 (16%)
Query: 25  FNYLTGQLPDF--VGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFP- 81
            N+   QL D   + NL+ L  +L+  N +    P  L  L NL  L +  NQ + + P 
Sbjct: 68  INFSNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPL 125
Query: 82  RWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSXXXXXXXXXXXXXXGMG 141
           + + N++ LE    T++  S       L  L +L++L  +F S                 
Sbjct: 126 KNLTNLNRLELSSNTISDISA------LSGLTSLQQL--SFSSNQVTDLK---------- 167
Query: 142 TASSIPDSLSNASNLERLDLSGNQFKGKVSI-----DFSSXXXXXXXXXXXXXXGMGT-- 194
                   L+N + LERLD+S N+    +S+     +  S              G+ T  
Sbjct: 168 -------PLANLTTLERLDISSNKV-SDISVLAKLTNLESLIATNNQISDITPLGILTNL 219
Query: 195 ------ANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGT 248
                  N L  +  L + ++L  L L +NQ     P S     + + + ++G NQIS  
Sbjct: 220 DELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGL---TKLTELKLGANQISNI 276
Query: 249 IP-SGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKL 307
            P +G+  L NL    +  NQL  I P  +  L++L  L ++ N +    P S  +LTKL
Sbjct: 277 SPLAGLTALTNL---ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKL 329
Query: 308 ADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIP 346
             L   +NN   ++ SSL N  N+    A HN+++   P
Sbjct: 330 QRLFF-YNNKVSDV-SSLANLTNINWLSAGHNQISDLTP 366

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 89/339 (26%), Positives = 141/339 (41%), Gaps = 57/339 (16%)
Query: 25  FNYLTGQLPDF--VGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFP- 81
            N+   QL D   + NL+ L  +L+  N +    P  L  L NL  L +  NQ + + P 
Sbjct: 68  INFSNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPL 125
Query: 82  RWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSXXXXXXXXXXXXXXGMG 141
           + + N++ LE    T++  S       L  L +L++L  +F S                 
Sbjct: 126 KNLTNLNRLELSSNTISDISA------LSGLTSLQQL--SFSSNQVTDLK---------- 167
Query: 142 TASSIPDSLSNASNLERLDLSGNQFKGKVSI-----DFSSXXXXXXXXXXXXXXGMGT-- 194
                   L+N + LERLD+S N+    +S+     +  S              G+ T  
Sbjct: 168 -------PLANLTTLERLDISSNKV-SDISVLAKLTNLESLIATNNQISDITPLGILTNL 219
Query: 195 ------ANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGT 248
                  N L  +  L + ++L  L L +NQ     P S     + + + ++G NQIS  
Sbjct: 220 DELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGL---TKLTELKLGANQISNI 276
Query: 249 IP-SGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKL 307
            P +G+  L NL    +  NQL  I P  +  L++L  L ++ N +    P S  +LTKL
Sbjct: 277 SPLAGLTALTNL---ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTKL 329
Query: 308 ADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIP 346
             L  S N +     SSL N  N+    A HN+++   P
Sbjct: 330 QRLFFSNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 366

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 22/220 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH--- 604
            +F    +IG+GS+  V    L   + I A+KV+    K    +   + + ++  +H   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV----KKELVNDDEDIDWVQTEKHVFE 64
Query: 605 --RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
              N   ++ + S   ++   F   V EY+  G L   + +        KL        +
Sbjct: 65  QASNHPFLVGLHSCFQTESRLF--FVIEYVNGGDLMFHMQRQR------KLPEEHARFYS 116
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIK 722
            +++ A+ YLH      I++ DLK  NVLLD +   H   +         +   ++    
Sbjct: 117 AEISLALNYLHERG---IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSXFC 171
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
           GT  Y+APE   G +   + D ++ G+L+ EM  GR P D
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 42/225 (18%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 606
           F+    IG GSFG+VY         +VA+K ++   K +   ++  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 607 LIKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
                    +I  +G   +     LV EY         L  ++D LEV K  L Q V IA
Sbjct: 77  ---------TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 118
Query: 663 IDVASAIE---YLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSS 718
                A++   YLH H    ++H D+K  N+LL +  +V   +F       SAS    ++
Sbjct: 119 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG------SASIMAPAN 169
Query: 719 IGIKGTVGYVAPEYGMG-SEASMTG--DVYSFGILLLEMFTGRRP 760
             + GT  ++APE  +   E    G  DV+S GI  +E+   + P
Sbjct: 170 XFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 102/233 (43%), Gaps = 36/233 (15%)
Query: 545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH 604
           +  S+F    ++GQG+FG V K     +    A+K I   ++    + ++E   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVXLLASLNH 61
Query: 605 RNLIK----------IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLT 654
           + +++           +   +++  K   F  +  EY EN +L D +H  N + +  +  
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLF--IQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSH------- 706
            + R      +  A+ Y+H      I+H +LKP N+ +D    V   +F L+        
Sbjct: 120 RLFR-----QILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 707 --QLDSASKTPSSSIGIK---GTVGYVAPEYGMGS-EASMTGDVYSFGILLLE 753
             +LDS +  P SS  +    GT  YVA E   G+   +   D YS GI+  E
Sbjct: 172 ILKLDSQN-LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 104/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  + +   + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK------LTLIQRVNIA 662
            ++  C+     G     +V E+ + G+L  +L    +     K      LTL   +  +
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS--SSI 719
             VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P      
Sbjct: 151 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDI---YKDPDYVRKG 204
Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 205 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 22/220 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH--- 604
            +F    +IG+GS+  V    L   + I A+KV+    K    +   + + ++  +H   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV----KKELVNDDEDIDWVQTEKHVFE 60
Query: 605 --RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
              N   ++ + S   ++   F   V EY+  G L    H         KL        +
Sbjct: 61  QASNHPFLVGLHSCFQTESRLF--FVIEYVNGGDL--MFHMQRQR----KLPEEHARFYS 112
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIK 722
            +++ A+ YLH      I++ DLK  NVLLD +   H   +         +   ++    
Sbjct: 113 AEISLALNYLHERG---IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSXFC 167
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
           GT  Y+APE   G +   + D ++ G+L+ EM  GR P D
Sbjct: 168 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 554 NMIGQGSFGSVY--KGILGGEE-MIVAVKVINLKQKGAFRSF--VAECEALRNI----RH 604
            ++G+G +G V+  + + G     I A+KV  LK+    R+    A  +A RNI    +H
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNILEEVKH 80
Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
             ++ +I    +  + G  +  L+ EY+  G L   L +    +E      +  +++A  
Sbjct: 81  PFIVDLI---YAFQTGGKLY--LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA-- 133
Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSSIGIK 722
                  L H  Q  I++ DLKP N++L+H   V   +F L  + +   + T +      
Sbjct: 134 -------LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---- 182
Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           GT+ Y+APE  M S  +   D +S G L+ +M TG  P
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + IG G++GSV         + VAVK ++      
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 68  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 118
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 119 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILD 173
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 174 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 554 NMIGQGSFGSVY--KGILGGEE-MIVAVKVINLKQKGAFRSF--VAECEALRNI----RH 604
            ++G+G +G V+  + + G     I A+KV  LK+    R+    A  +A RNI    +H
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNILEEVKH 80
Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
             ++ +I    +  + G  +  L+ EY+  G L   L +    +E      +  +++A  
Sbjct: 81  PFIVDLIY---AFQTGGKLY--LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA-- 133
Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKG 723
                  L H  Q  I++ DLKP N++L+H   V   +F L  +   +    + +    G
Sbjct: 134 -------LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE---SIHDGTVTHXFCG 183
Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           T+ Y+APE  M S  +   D +S G L+ +M TG  P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 128
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 129 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 177
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 178 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 90/222 (40%), Gaps = 31/222 (13%)
Query: 547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN 606
           T  +     IG GS+    + I     M  AVK+I+  +    R    E E L  +R+  
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEIL--LRYGQ 74
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
              IIT+    D     +  +V E M+ G L D +      L     +  +   +   + 
Sbjct: 75  HPNIITLKDVYDD--GKYVYVVTELMKGGELLDKI------LRQKFFSEREASAVLFTIT 126
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHQNFSLSHQLDSAS---KTPSSS 718
             +EYLH      +VH DLKPSN+L      + + +   +F  + QL + +    TP   
Sbjct: 127 KTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY- 182
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                T  +VAPE           D++S G+LL  M TG  P
Sbjct: 183 -----TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 556 IGQGSFGSVYKGI--LGGEEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G G+FGSV +G+  +  +++ VA+KV+    +K      + E + +  + +  ++++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +C       A+   LV E    G L  +L    + + V  +       +   V+  ++YL
Sbjct: 78  VCQ------AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA-----ELLHQVSMGMKYL 126
Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
               +   VH DL   NVLL +   A   +F LS  L +     ++    K  + + APE
Sbjct: 127 E---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 732 YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
                + S   DV+S+G+ + E  + G++P
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 74
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDH--ICY 132
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 133 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 128
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 129 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 177
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 178 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR 74
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 132
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 133 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 181
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 23/223 (10%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNL 607
           ++    +IG G+   V       ++  VA+K INL++ + +    + E +A+    H N 
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN- 69
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ---SNDHLEVCKLTLIQRVNIAI- 663
             I++  +S   K  D   LV + +  GS+ D +       +H    K  ++    IA  
Sbjct: 70  --IVSYYTSFVVK--DELWLVMKLLSGGSVLDIIKHIVAKGEH----KSGVLDESTIATI 121
Query: 664 --DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSI- 719
             +V   +EYLH + Q   +H D+K  N+LL  D  V   +F +S  L +      + + 
Sbjct: 122 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 178
Query: 720 -GIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRP 760
               GT  ++APE            D++SFGI  +E+ TG  P
Sbjct: 179 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA--ECEALRNIRHR 605
            ++     IG+GS+G V+K        IVA+K     +       +A  E   L+ ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           NL+ ++ +      +      LVFEY ++      LH+ + +       L++  +I    
Sbjct: 63  NLVNLLEV-----FRRKRRLHLVFEYCDHTV----LHELDRYQRGVPEHLVK--SITWQT 111
Query: 666 ASAIEYLH-HHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKG 723
             A+ + H H+C    +H D+KP N+L+  H ++   +F  +  L   S      +    
Sbjct: 112 LQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV---A 164
Query: 724 TVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTG 757
           T  Y +PE  +G ++     DV++ G +  E+ +G
Sbjct: 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 72
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 73  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 130
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 131 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 179
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 180 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 19  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 78
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 79  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 136
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 137 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 185
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 186 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 128
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 129 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 177
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 178 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 128
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 129 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 177
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 178 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 31  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 90
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 148
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 149 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 197
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 198 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 74
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 132
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 133 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 181
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 68  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 118
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 119 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILD 173
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 174 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 9   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 68
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 126
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 127 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 175
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 176 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 22/214 (10%)
Query: 551 ASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           + + ++G G FG V+K       + +A K+I  +          E   +  + H NLI++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
                S +        LV EY++ G L D +       E   LT +  +     +   I 
Sbjct: 152 YDAFESKND-----IVLVMEYVDGGELFDRIID-----ESYNLTELDTILFMKQICEGIR 201
Query: 671 YLHHHCQPPIVHGDLKPSNVLL---DHDMVAHQNFSLSHQLDSASKTPSSSIGIK-GTVG 726
           ++H   Q  I+H DLKP N+L    D   +   +F L+ +       P   + +  GT  
Sbjct: 202 HMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY-----KPREKLKVNFGTPE 253
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++APE       S   D++S G++   + +G  P
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 23/223 (10%)
Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNL 607
           ++    +IG G+   V       ++  VA+K INL++ + +    + E +A+    H N 
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN- 74
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ---SNDHLEVCKLTLIQRVNIAI- 663
             I++  +S   K  D   LV + +  GS+ D +       +H    K  ++    IA  
Sbjct: 75  --IVSYYTSFVVK--DELWLVMKLLSGGSVLDIIKHIVAKGEH----KSGVLDESTIATI 126
Query: 664 --DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSI- 719
             +V   +EYLH + Q   +H D+K  N+LL  D  V   +F +S  L +      + + 
Sbjct: 127 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 720 -GIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRP 760
               GT  ++APE            D++SFGI  +E+ TG  P
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKXQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 26/221 (11%)
Query: 547 TSEFASSNMIGQGSFGSV---YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR 603
           +  +     +G G++G V      + G E  I  +K  ++       + + E   L+ + 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N++K+       D +      LV E    G L D +       EV    ++++V    
Sbjct: 63  HPNIMKLYEFFE--DKRNY---YLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV---- 113
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDSASKTPSSSI 719
              S   YLH H    IVH DLKP N+LL+      ++   +F LS   +   K      
Sbjct: 114 --LSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL- 167
Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              GT  Y+APE  +  +     DV+S G++L  +  G  P
Sbjct: 168 ---GTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 44/244 (18%)
Query: 542 ELSKATSEFASSNMIGQGSFGSV-----YKGILGGEEMIVAVKVINLKQKGAFR-SFVAE 595
           E  +   EF    ++G G+FG V     Y     G  + VAVK++  K   + R + ++E
Sbjct: 41  EFPRENLEFG--KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 98
Query: 596 CEALRNI-RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ-----SNDHLE 649
            + +  +  H N++ ++  C+     G  +  L+FEY   G L ++L       S D +E
Sbjct: 99  LKMMTQLGSHENIVNLLGACTL---SGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 650 VCK------------LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 697
                          LT    +  A  VA  +E+L        VH DL   NVL+ H  V
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKV 210
Query: 698 AH-QNFSLSHQLDSASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVYSFGILLL 752
               +F L+  + S      S+  ++G     V ++APE       ++  DV+S+GILL 
Sbjct: 211 VKICDFGLARDIMS-----DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265
Query: 753 EMFT 756
           E+F+
Sbjct: 266 EIFS 269

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 16  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 75
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 133
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 134 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 182
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 183 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 17  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 76
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 77  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 134
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 135 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 183
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 184 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 8   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 67
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 68  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 125
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 126 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 174
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 175 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 74
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 132
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 133 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 68  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 118
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 119 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 173
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 174 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 32/235 (13%)
Query: 536 PMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------LKQ 585
           P     EL+K   E    + + + +G G++GSV         + VAVK ++      +  
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 586 KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN 645
           K  +R    E   L++++H N+I ++ + +   S        +  ++    L       N
Sbjct: 62  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-------N 110
Query: 646 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSL 704
           + ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +F L
Sbjct: 111 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167
Query: 705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                 A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 168 ------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G++G+V   + G     VA+K +       L  K A+R    E   L+++RH N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 610 IITICSSIDSKGADFK--ALVFEYM--ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           ++ + +  D    DF    LV  +M  + G L        D ++     +++        
Sbjct: 89  LLDVFTP-DETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK-------- 139
Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              + Y+H      I+H DLKP N+ ++ D  +   +F L+ Q D      S   G   T
Sbjct: 140 --GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD------SEMXGXVVT 188
Query: 725 VGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
             Y APE  +     + T D++S G ++ EM TG+
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 9   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 68
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 126
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 127 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 175
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 176 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 70  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 120
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 121 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 175
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 176 FGL------ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 70  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 120
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 121 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 175
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 176 FGL------ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 14  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 73
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 74  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 124
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 125 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILD 179
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 180 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 74
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 132
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 133 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 182 HDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 23  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 82
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 83  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 133
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 134 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 188
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 189 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 65  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 115
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 116 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 170
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 171 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 70  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 120
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 121 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 175
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 176 FGL------ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 16  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 75
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 133
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 134 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 182
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 183 HDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 68  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 118
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 119 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 173
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 174 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 2   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 61
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 62  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 112
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 113 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 167
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 168 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 69  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 119
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 120 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 174
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 175 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 542 ELSKATS-----EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAEC 596
           E  KA+S     +F    +IG+GS+  V    L   + I A++V+    K    +   + 
Sbjct: 41  ESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV----KKELVNDDEDI 96
Query: 597 EALRNIRH-----RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC 651
           + ++  +H      N   ++ + S   ++   F   V EY+  G L    H         
Sbjct: 97  DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF--FVIEYVNGGDL--MFHMQRQR---- 148
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSA 711
           KL        + +++ A+ YLH      I++ DLK  NVLLD +   H   +        
Sbjct: 149 KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEG 203
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
            +   ++    GT  Y+APE   G +   + D ++ G+L+ EM  GR P D
Sbjct: 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 32/235 (13%)
Query: 536 PMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------LKQ 585
           P     EL+K   E    + + + +G G++GSV         + VAVK ++      +  
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 62
Query: 586 KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN 645
           K  +R    E   L++++H N+I ++ + +   S        +  ++    L       N
Sbjct: 63  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-------N 111
Query: 646 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSL 704
           + ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +F L
Sbjct: 112 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 168
Query: 705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                 A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 ------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 65  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 115
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 116 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 170
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 171 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 26  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 86  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 136
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 137 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 191
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 192 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 32/235 (13%)
Query: 536 PMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------LKQ 585
           P     EL+K   E    + + + +G G++GSV         + VAVK ++      +  
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 62
Query: 586 KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN 645
           K  +R    E   L++++H N+I ++ + +   S        +  ++    L       N
Sbjct: 63  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-------N 111
Query: 646 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSL 704
           + ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +F L
Sbjct: 112 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 168
Query: 705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                 A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 ------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 70  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 120
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 121 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 175
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 176 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK---QKGAFRSFVAECEALRN 601
           +EF    ++G+G+FG V   IL  E+      A+K++  +    K      + E   L+N
Sbjct: 8   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            RH  L  +         +  D    V EY   G L  + H S + +     +  +    
Sbjct: 65  SRHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFY 113
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA++YLH   +  +V+ DLK  N++LD D  +   +F L  +     K  ++   
Sbjct: 114 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKX 168
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             GT  Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 169 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 22  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 81
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 82  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 132
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 133 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 187
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 188 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 15  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 74
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 75  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 125
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 126 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 180
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 181 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 15  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 74
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 75  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 125
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 126 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 180
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 181 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 550 FASSNMIGQGSFGS-VYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALR-NIRHRNL 607
           F   +++G G+ G+ VY+G+    +  VAVK I L +  +F     E + LR +  H N+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRD--VAVKRI-LPECFSFAD--REVQLLRESDEHPNV 80
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN-DHLEVCKLTLIQRVNIAIDVA 666
           I+    C+  D +   F+ +  E +   +L++++ Q +  HL +  +TL+Q+        
Sbjct: 81  IRYF--CTEKDRQ---FQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTT------ 128
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLD----HDMVAH--QNFSLSHQLDSASKTPSSSIG 720
           S + +LH      IVH DLKP N+L+     H  +     +F L  +L     + S   G
Sbjct: 129 SGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 721 IKGTVGYVAPEYGMGSE-----ASMTGDVYSFGILL 751
           + GT G++APE  M SE      + T D++S G + 
Sbjct: 186 VPGTEGWIAPE--MLSEDCKENPTYTVDIFSAGCVF 219

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKXQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 69  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 119
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 120 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILD 174
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 175 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK---QKGAFRSFVAECEALRN 601
           +EF    ++G+G+FG V   IL  E+      A+K++  +    K      + E   L+N
Sbjct: 10  NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            RH  L  +     + D         V EY   G L  + H S + +     +  +    
Sbjct: 67  SRHPFLTALKYSFQTHDRL-----CFVMEYANGGEL--FFHLSRERV----FSEDRARFY 115
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA++YLH   +  +V+ DLK  N++LD D  +   +F L  +     K  ++   
Sbjct: 116 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKX 170
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             GT  Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 171 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 69  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 119
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 120 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 174
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 175 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 32/235 (13%)
Query: 536 PMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------LKQ 585
           P     EL+K   E    + + + +G G++GSV         + VAVK ++      +  
Sbjct: 4   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 63
Query: 586 KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN 645
           K  +R    E   L++++H N+I ++ + +   S        +  ++    L       N
Sbjct: 64  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-------N 112
Query: 646 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSL 704
           + ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +F L
Sbjct: 113 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 169
Query: 705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                 A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 170 ------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 14  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 73
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 74  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 124
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 125 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 179
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 180 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 72
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 130
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 131 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 179
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 180 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 32/210 (15%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+FG VYK        + A KVI  K +     ++ E E L    H  ++K++    
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL---- 74
Query: 616 SIDSKGADFK----ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
                GA +      ++ E+   G+++  + + +  L   ++ ++ R      +  A+ +
Sbjct: 75  -----GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QMLEALNF 124
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSAS--KTPSSSIGIKGTVGYVA 729
           LH      I+H DLK  NVL    M    +  L+    SA   KT        GT  ++A
Sbjct: 125 LHSKR---IIHRDLKAGNVL----MTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 177
Query: 730 PEYGMGSEASMT-----GDVYSFGILLLEM 754
           PE  M      T      D++S GI L+EM
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK---QKGAFRSFVAECEALRN 601
           +EF    ++G+G+FG V   IL  E+      A+K++  +    K      + E   L+N
Sbjct: 9   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            RH  L  +     + D         V EY   G L  + H S + +     +  +    
Sbjct: 66  SRHPFLTALKYSFQTHDRL-----CFVMEYANGGEL--FFHLSRERV----FSEDRARFY 114
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA++YLH   +  +V+ DLK  N++LD D  +   +F L  +     K  ++   
Sbjct: 115 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKX 169
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             GT  Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 106/235 (45%), Gaps = 28/235 (11%)
Query: 545 KATSEFASSNMIGQGSFGS--VYKGILGGEEMIVAVKVINL-----KQKGAFRSFVAECE 597
           ++  ++     IG+GSFG   + K    G + ++  K IN+     K++   R  VA   
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVI--KEINISRMSSKEREESRREVA--- 75
Query: 598 ALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQ 657
            L N++H N   I+    S +  G+ +  +V +Y E G L   ++     L        Q
Sbjct: 76  VLANMKHPN---IVQYRESFEENGSLY--IVMDYCEGGDLFKRINAQKGVL----FQEDQ 126
Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPS 716
            ++  + +  A++++H      I+H D+K  N+ L  D  V   +F ++  L+S  +   
Sbjct: 127 ILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183
Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
           + IG   T  Y++PE       +   D+++ G +L E+ T +   +A   + L L
Sbjct: 184 ACIG---TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 15  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSI 74
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 75  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 125
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 126 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 180
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 181 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 23/183 (12%)
Query: 586 KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSL--EDWLHQ 643
           K  +  F  E + + +I++   +    I ++ D        +++EYMEN S+   D    
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEV-----YIIYEYMENDSILKFDEYFF 138
Query: 644 SNDHLEVCKLTLIQRVNIAID-VASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQN 701
             D    C    IQ +   I  V ++  Y+H+  +  I H D+KPSN+L+D +  V   +
Sbjct: 139 VLDKNYTC-FIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSD 195
Query: 702 FSLS-HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG---DVYSFGILLLEMFTG 757
           F  S + +D   K      G +GT  ++ PE+   +E+S  G   D++S GI L  MF  
Sbjct: 196 FGESEYMVDKKIK------GSRGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYN 248
Query: 758 RRP 760
             P
Sbjct: 249 VVP 251

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 65  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 115
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 116 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILD 170
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 171 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 536 PMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------LKQ 585
           P     EL+K   E    + + + +G G++GSV           VAVK ++      +  
Sbjct: 2   PTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 586 KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN 645
           K  +R    E   L++++H N+I ++ + +   S        +  ++    L       N
Sbjct: 62  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-------N 110
Query: 646 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSL 704
           + ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +F L
Sbjct: 111 NIVKCAKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167
Query: 705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                 A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 168 ------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 73  HPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAEKES------LTEEEATEFLK 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 177 --IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 32/210 (15%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+FG VYK        + A KVI  K +     ++ E E L    H  ++K++    
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL---- 82
Query: 616 SIDSKGADFK----ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
                GA +      ++ E+   G+++  + + +  L   ++ ++ R      +  A+ +
Sbjct: 83  -----GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QMLEALNF 132
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSAS--KTPSSSIGIKGTVGYVA 729
           LH      I+H DLK  NVL    M    +  L+    SA   KT        GT  ++A
Sbjct: 133 LHSKR---IIHRDLKAGNVL----MTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185
Query: 730 PEYGMGSEASMT-----GDVYSFGILLLEM 754
           PE  M      T      D++S GI L+EM
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 40/224 (17%)
Query: 556 IGQGSFGSVY--KGILGGEEMIVAVKVINLKQ--KGAF-----------RSFVAECEALR 600
           +G G++G V   K   G  E   A+KVI   Q  KG +                E   L+
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEK--AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 601 NIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
           ++ H N+IK+  +    D K   +  LV E+ E G L + +   N H    K       N
Sbjct: 102 SLDHPNIIKLFDVFE--DKK---YFYLVTEFYEGGELFEQI--INRH----KFDECDAAN 150
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDSASKTPS 716
           I   + S I YLH H    IVH D+KP N+LL++      +   +F LS       K   
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                 GT  Y+APE  +  + +   DV+S G+++  +  G  P
Sbjct: 208 RL----GTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK------LTLIQRVNIA 662
            ++  C+     G     +V E+ + G+L  +L    +     K      LTL   +  +
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS--SSI 719
             VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P      
Sbjct: 151 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDI---YKDPDYVRKG 204
Query: 720 GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
             +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 205 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMI---VAVKVINLK---QKGAFRSFVAECEALRN 601
           +EF    ++G+G+FG V   IL  E+      A+K++  +    K      + E   L+N
Sbjct: 148 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            RH  L  +         +  D    V EY   G L  + H S + +     +  +    
Sbjct: 205 SRHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFY 253
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA++YLH   +  +V+ DLK  N++LD D  +   +F L  +     K  ++   
Sbjct: 254 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKT 308
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             GT  Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 25/221 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLIKIITIC 614
           +G+GSFG V++          AVK + L+    FR   +  C  L + R      I+ + 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE---VFRVEELVACAGLSSPR------IVPLY 116
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            ++  +   +  +  E +E GSL   + Q     E   L  + +          +EYLH 
Sbjct: 117 GAV--REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA------LEGLEYLHT 168
Query: 675 HCQPPIVHGDLKPSNVLLDHD--MVAHQNF--SLSHQLDSASKTPSSSIGIKGTVGYVAP 730
                I+HGD+K  NVLL  D    A  +F  +L  Q D   K+  +   I GT  ++AP
Sbjct: 169 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
           E  MG       D++S   ++L M  G  P    F   L L
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 266

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA++ I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR 74
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 132
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 133 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 72
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      +V + ME     L    H SNDH  +C 
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH--ICY 130
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 131 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPD 179
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 180 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK---QKGAFRSFVAECEALRN 601
           +EF    ++G+G+FG V   IL  E+      A+K++  +    K      + E   L+N
Sbjct: 151 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
            RH  L  +         +  D    V EY   G L  + H S + +     +  +    
Sbjct: 208 SRHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFY 256
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA++YLH   +  +V+ DLK  N++LD D  +   +F L  +     K  ++   
Sbjct: 257 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKT 311
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             GT  Y+APE    ++     D +  G+++ EM  GR P
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 25/221 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLIKIITIC 614
           +G+GSFG V++          AVK + L+    FR   +  C  L + R      I+ + 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE---VFRVEELVACAGLSSPR------IVPLY 132
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            ++  +   +  +  E +E GSL   + Q     E   L  + +          +EYLH 
Sbjct: 133 GAV--REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA------LEGLEYLHT 184
Query: 675 HCQPPIVHGDLKPSNVLLDHD--MVAHQNF--SLSHQLDSASKTPSSSIGIKGTVGYVAP 730
                I+HGD+K  NVLL  D    A  +F  +L  Q D   K+  +   I GT  ++AP
Sbjct: 185 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 241
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
           E  MG       D++S   ++L M  G  P    F   L L
Sbjct: 242 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 282

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +    
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILG 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 28/219 (12%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK--------LTLIQRVN 660
            ++  C+     G     +V E+ + G+L  +L    +     K        LTL   + 
Sbjct: 97  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS--S 717
            +  VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P    
Sbjct: 153 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDI---XKDPDXVR 206
Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
               +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 20/216 (9%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLI 608
           F     +G G+FG V+        +   +K IN  + +       AE E L+++ H N+I
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           KI  +     +       +V E  E G L + +  +    +      +    +   + +A
Sbjct: 84  KIFEVFEDYHN-----MYIVMETCEGGELLERIVSAQARGKALSEGYV--AELMKQMMNA 136
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLD----HDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
           + Y H      +VH DLKP N+L      H  +   +F L+       K+   S    GT
Sbjct: 137 LAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF----KSDEHSTNAAGT 189
Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             Y+APE     + +   D++S G+++  + TG  P
Sbjct: 190 ALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 9/202 (4%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG GS+G   K     +  I+  K ++     +   +  V+E   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD- 72
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
              ID        +V EY E G L   + +     +      + RV   + +A    +  
Sbjct: 73  -RIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 674 HHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
                 ++H DLKP+NV LD    V   +F L+  L+  +    + +   GT  Y++PE 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV---GTPYYMSPEQ 187
Query: 733 GMGSEASMTGDVYSFGILLLEM 754
                 +   D++S G LL E+
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 85/202 (42%), Gaps = 9/202 (4%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG GS+G   K     +  I+  K ++     +   +  V+E   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD- 72
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
              ID        +V EY E G L   + +     +      + RV   + +A    +  
Sbjct: 73  -RIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 674 HHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
                 ++H DLKP+NV LD    V   +F L+  L+  +   S +    GT  Y++PE 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT---SFAKAFVGTPYYMSPEQ 187
Query: 733 GMGSEASMTGDVYSFGILLLEM 754
                 +   D++S G LL E+
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYEL 209

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 25/221 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLIKIITIC 614
           +G+GSFG V++          AVK + L+    FR   +  C  L + R      I+ + 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLE---VFRVEELVACAGLSSPR------IVPLY 130
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            ++  +   +  +  E +E GSL   + Q     E   L  + +          +EYLH 
Sbjct: 131 GAV--REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA------LEGLEYLHT 182
Query: 675 HCQPPIVHGDLKPSNVLLDHD--MVAHQNF--SLSHQLDSASKTPSSSIGIKGTVGYVAP 730
                I+HGD+K  NVLL  D    A  +F  +L  Q D   K+  +   I GT  ++AP
Sbjct: 183 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 239
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
           E  MG       D++S   ++L M  G  P    F   L L
Sbjct: 240 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 280

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV           VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 73  HPN---VITLHEVYENKTD--VILILELVAGGELFDFLAEKE------SLTEEEATEFLK 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV           VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           + L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 YGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 109/251 (43%), Gaps = 42/251 (16%)
Query: 525 SVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK 584
           S D+ P K       + ++ K TSE     ++G+G++  V   +        AVK+I  K
Sbjct: 2   STDSLPGK-------FEDMYKLTSE-----LLGEGAYAKVQGAVSLQNGKEYAVKIIE-K 48
Query: 585 QKGAFRSFV-AECEALRNIR-HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           Q G  RS V  E E L   + ++N++++I      D++      LVFE ++ GS+   + 
Sbjct: 49  QAGHSRSRVFREVETLYQCQGNKNILELIEFFED-DTRFY----LVFEKLQGGSILAHI- 102
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNF 702
           Q   H    + + + R     DVA+A+++LH      I H DLKP N+L +         
Sbjct: 103 QKQKHFNEREASRVVR-----DVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVK 154
Query: 703 SLSHQLDSASKTPSSSIGIK--------GTVGYVAPEY-----GMGSEASMTGDVYSFGI 749
                L S  K  +S   I         G+  Y+APE         +      D++S G+
Sbjct: 155 ICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGV 214
Query: 750 LLLEMFTGRRP 760
           +L  M +G  P
Sbjct: 215 VLYIMLSGYPP 225

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 536 PMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------LKQ 585
           P     EL+K   E    + + + +G G++GSV           VAVK ++      +  
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 586 KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN 645
           K  +R    E   L++++H N+I ++ + +   S        +  ++    L       N
Sbjct: 62  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-------N 110
Query: 646 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSL 704
           + ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +F L
Sbjct: 111 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167
Query: 705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                 A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 168 ------ARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 73  HPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAEKES------LTEEEATEFLK 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 73  HPN---VITLHEVYENKTD--VILILELVAGGELFDFLAEKES------LTEEEATEFLK 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV           VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG-- 71
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 121
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMXGTLPYVAPELL 178
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG-- 72
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 122
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMXGTLPYVAPELL 179
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV           VAVK ++      
Sbjct: 23  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 82
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 83  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 133
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 134 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 188
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 189 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK---------LTLIQRV 659
            ++  C+     G     +V E+ + G+L  +L    +     K         LTL   +
Sbjct: 96  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS-- 716
             +  VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P   
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI---XKDPDXV 205
Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
                +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV           VAVK ++      
Sbjct: 22  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 81
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 82  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 132
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 133 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 187
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 188 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV           VAVK ++      
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 68
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 69  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 119
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 120 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 174
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 175 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 73  HPN---VITLHEVYENKTD--VILILELVAGGELFDFLAEKE------SLTEEEATEFLK 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 72  HPN---VITLHEVYENKTD--VILILELVAGGELFDFLAEKE------SLTEEEATEFLK 120
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 121 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 175
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 176 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 536 PMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------LKQ 585
           P     EL+K   E    + + + +G G++GSV           VAVK ++      +  
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 586 KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN 645
           K  +R    E   L++++H N+I ++ + +   S        +  ++    L       N
Sbjct: 62  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-------N 110
Query: 646 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSL 704
           + ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +F L
Sbjct: 111 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167
Query: 705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                 A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 168 ------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV           VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FYL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 72  HPN---VITLHEVYENKTD--VILILELVAGGELFDFLAEKES------LTEEEATEFLK 120
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 121 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 175
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 176 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 73  HPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAEKES------LTEEEATEFLK 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 556 IGQGSFGSVYKGI--LGGEEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G G+FGSV +G+  +  +++ VA+KV+    +K      + E + +  + +  ++++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLT-LIQRVNIAIDVASAIEY 671
           +C       A+   LV E    G L  +L    + + V  +  L+ +V++       ++Y
Sbjct: 404 VCQ------AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM------GMKY 451
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           L    +   VH +L   NVLL +   A   +F LS  L +     ++    K  + + AP
Sbjct: 452 LE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           E     + S   DV+S+G+ + E  + G++P
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV           VAVK ++      
Sbjct: 23  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 82
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 83  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 133
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 134 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 188
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 189 FGL------ARHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 73  HPN---VITLHEVYENKTD--VILILELVAGGELFDFLAEKES------LTEEEATEFLK 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 73  HPN---VITLHEVYENKTD--VILILELVAGGELFDFLAEKES------LTEEEATEFLK 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 102/239 (42%), Gaps = 34/239 (14%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNF 702
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D       
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL---- 164
Query: 703 SLSHQLDS--ASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                LD+  A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 165 ---KILDAGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 114 --NNIVKSQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILD 168
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L    D          G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 169 FGLCRHTD------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 73  HPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAEKES------LTEEEATEFLK 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK----------LTLIQR 658
            ++  C+     G     +V E+ + G+L  +L    +     K          LTL   
Sbjct: 86  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS- 716
           +  +  VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P  
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI---XKDPDX 195
Query: 717 -SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
                 +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK----------LTLIQR 658
            ++  C+     G     +V E+ + G+L  +L    +     K          LTL   
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS- 716
           +  +  VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P  
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI---XKDPDX 204
Query: 717 -SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
                 +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS-----FVAECEALRNIRHRNLIKI 610
           +G G++G V   +L  +++    + I + +K +  +      + E   L+ + H N++K+
Sbjct: 45  LGSGAYGEV---LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
                  D +      LV E  + G L D +       EV    +I++V       S + 
Sbjct: 102 YDFFE--DKRNY---YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV------LSGVT 150
Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           YLH H    IVH DLKP N+LL+      ++   +F LS   ++  K         GT  
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL----GTAY 203
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           Y+APE  +  +     DV+S G++L  +  G  P
Sbjct: 204 YIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 556 IGQGSFGSVYKGI---LGG----EEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +GQG+F  ++KG+   +G      E  V +KV++   +    SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
               +C        D   LV E+++ GSL+ +L ++ +    C + ++ ++ +A  +A+A
Sbjct: 76  LNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNKN----C-INILWKLEVAKQLAAA 125
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
           + +L  +    ++HG++   N+LL    D          LS    S +  P     ++  
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI--LQER 180
Query: 725 VGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTG 757
           + +V PE     +  ++  D +SFG  L E+ +G
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K  D   L+ E +  G L D+L +         LT  +      
Sbjct: 73  HPN---VITLHEVYENK-TDV-ILILELVAGGELFDFLAEKE------SLTEEEATEFLK 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK----------LTLIQR 658
            ++  C+     G     +V E+ + G+L  +L    +     K          LTL   
Sbjct: 132 NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS- 716
           +  +  VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P  
Sbjct: 188 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI---YKDPDY 241
Query: 717 -SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
                 +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 242 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 101/238 (42%), Gaps = 32/238 (13%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + +   +G G++GSV           VAVK ++      
Sbjct: 13  QERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 72
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 73  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 123
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQN 701
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D  +   +
Sbjct: 124 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 178
Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           F L      A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 179 FGL------ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 108/262 (41%), Gaps = 37/262 (14%)
Query: 537 MISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFV 593
           ++   E+     +F    +IG+G+F  V    +     + A+K++N   + ++G    F 
Sbjct: 50  VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 594 AECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVC 651
            E + L N   R + ++         +  ++  LV EY   G L   L +  + +  E+ 
Sbjct: 110 EERDVLVNGDRRWITQL-----HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA 164
Query: 652 KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQL 708
           +  L + V +AID    + Y         VH D+KP N+LLD   H  +A     L  + 
Sbjct: 165 RFYLAEIV-MAIDSVHRLGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214
Query: 709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG-------DVYSFGILLLEMFTGRRPT 761
           D   +    S+   GT  Y++PE                  D ++ G+   EMF G+ P 
Sbjct: 215 DGTVR----SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
Query: 762 DA---AFTEGLTLHEFVKMTLP 780
            A   A T G  +H    ++LP
Sbjct: 271 YADSTAETYGKIVHYKEHLSLP 292

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 102/237 (43%), Gaps = 30/237 (12%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNF 702
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D    +  
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC---ELK 165
Query: 703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
            L   L  A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 166 ILDRGL--ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK----------LTLIQR 658
            ++  C+     G     +V E+ + G+L  +L    +     K          LTL   
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS- 716
           +  +  VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P  
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI---YKDPDY 204
Query: 717 -SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
                 +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 101/239 (42%), Gaps = 34/239 (14%)
Query: 533 KQFPMISYAELSKATSE----FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------ 582
           ++ P     EL+K   E    + + + +G G++GSV         + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 583 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
           +  K  +R    E   L++++H N+I ++ + +   S        +  ++    L     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----- 113
Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNF 702
             N+ ++  KLT      +   +   ++Y+H      I+H DLKPSN+ ++ D       
Sbjct: 114 --NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL---- 164
Query: 703 SLSHQLDS--ASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                LD   A  T     G   T  Y APE  +     + T D++S G ++ E+ TGR
Sbjct: 165 ---KILDGGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK----------LTLIQR 658
            ++  C+     G     +V E+ + G+L  +L    +     K          LTL   
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS- 716
           +  +  VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P  
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI---YKDPDX 204
Query: 717 -SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
                 +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK----------LTLIQR 658
            ++  C+     G     +V E+ + G+L  +L    +     K          LTL   
Sbjct: 97  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS- 716
           +  +  VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P  
Sbjct: 153 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI---YKDPDY 206
Query: 717 -SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
                 +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 207 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 73  HPN---VITLHEVYENKTD--VILILELVAGGELFDFLAEKES------LTEEEATEFLK 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG-- 71
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 121
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 178
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 18/228 (7%)
Query: 536 PMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVA 594
           P +   ++      + + + IG+G++G V        ++ VA+K I+  + +   +  + 
Sbjct: 31  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 90
Query: 595 ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM--ENGSLEDWLHQSNDHLEVCK 652
           E + L   RH N+I I  I  +   +      LV   M  +   L    H SNDH  +C 
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDH--ICY 148
Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSA 711
             L Q       +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D  
Sbjct: 149 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 197
Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                       T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 198 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 121
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMXGTLPYVAPELL 178
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 121
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMXGTLPYVAPELL 178
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 121
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMXGTLPYVAPELL 178
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK----------LTLIQR 658
            ++  C+    K      ++ E+ + G+L  +L    +     K          LTL   
Sbjct: 86  NLLGACT----KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS- 716
           +  +  VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P  
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI---XKDPDX 195
Query: 717 -SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
                 +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 111/238 (46%), Gaps = 31/238 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL-IKIITIC 614
           +G+G++G V K        I+AVK I        R+ V   E  R +   ++ ++ +   
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI--------RATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 615 SSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
            ++   GA F+     +  E M+  SL+ +  Q  D  +     ++ +  IA+ +  A+E
Sbjct: 67  FTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALE 123
Query: 671 YLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLS-HQLDSASKTPSSSIGIKGTVGYV 728
           +LH      ++H D+KPSNVL++    V   +F +S + +D  +K   +     G   Y+
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GCKPYM 176
Query: 729 APEYGMGSEASMTG-----DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE 781
           APE  +  E +  G     D++S GI ++E+   R P D+  T    L + V+   P+
Sbjct: 177 APER-INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLHG 123
Query: 675 HCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 179
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLHG 123
Query: 675 HCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 179
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLHG 123
Query: 675 HCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 179
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 104/250 (41%), Gaps = 21/250 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLHG 123
Query: 675 HCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 179
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTDA---AFTEGLTLHEFVKMTLPEKVIEIVDP 789
              E  +   DV+S GI+L  M  G  P D    +  E     E      P K I+    
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 790 SLLMEVMANN 799
           +LL +++  N
Sbjct: 240 ALLHKILVEN 249

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK----------LTLIQR 658
            ++  C+    K      ++ E+ + G+L  +L    +     K          LTL   
Sbjct: 86  NLLGACT----KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS- 716
           +  +  VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P  
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI---YKDPDY 195
Query: 717 -SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
                 +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 104/250 (41%), Gaps = 21/250 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLHG 122
Query: 675 HCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 178
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTDA---AFTEGLTLHEFVKMTLPEKVIEIVDP 789
              E  +   DV+S GI+L  M  G  P D    +  E     E      P K I+    
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 238
Query: 790 SLLMEVMANN 799
           +LL +++  N
Sbjct: 239 ALLHKILVEN 248

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGA----FRSFVAECEALRNIRHR-NLI 608
           +G+G+FG V +    G +     + + +K  ++GA     R+ ++E + L +I H  N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK----------LTLIQR 658
            ++  C+    K      ++ E+ + G+L  +L    +     K          LTL   
Sbjct: 86  NLLGACT----KPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPS- 716
           +  +  VA  +E+L        +H DL   N+LL + ++V   +F L+  +    K P  
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI---YKDPDY 195
Query: 717 -SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
                 +  + ++APE       ++  DV+SFG+LL E+F+
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI- 602
           S+ T+EF     IG G FGSV+K +   +  I A+K    + K      V E  ALR + 
Sbjct: 3   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 58
Query: 603 ------RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
                 +H ++++  +  +       D   +  EY   GSL D + ++   +   K   +
Sbjct: 59  AHAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 113
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS 716
           +  ++ + V   + Y+H      +VH D+KPSN+ +    + +       + D AS    
Sbjct: 114 K--DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 168
Query: 717 SSIGIKGTVGYV-APEYGMGSEASMTGDV 744
             IG  G V  + +P+   G    +  +V
Sbjct: 169 FKIGDLGHVTRISSPQVEEGDSRFLANEV 197

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 556 IGQGSFGSVYKGI---LGG----EEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +GQG+F  ++KG+   +G      E  V +KV++   +    SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
               +C        D   LV E+++ GSL+ +L ++ +    C + ++ ++ +A  +A A
Sbjct: 76  LNYGVCFC-----GDENILVQEFVKFGSLDTYLKKNKN----C-INILWKLEVAKQLAWA 125
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
           + +L  +    ++HG++   N+LL    D          LS    S +  P     ++  
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI--LQER 180
Query: 725 VGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTG 757
           + +V PE     +  ++  D +SFG  L E+ +G
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI- 602
           S+ T+EF     IG G FGSV+K +   +  I A+K    + K      V E  ALR + 
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 62
Query: 603 ------RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
                 +H ++++  +  +       D   +  EY   GSL D + ++   +   K   +
Sbjct: 63  AHAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS 716
           +  ++ + V   + Y+H      +VH D+KPSN+ +    + +       + D AS    
Sbjct: 118 K--DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 717 SSIGIKGTVGYV-APEYGMGSEASMTGDV 744
             IG  G V  + +P+   G    +  +V
Sbjct: 173 FKIGDLGHVTRISSPQVEEGDSRFLANEV 201

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI- 602
           S+ T+EF     IG G FGSV+K +   +  I A+K    + K      V E  ALR + 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 603 ------RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
                 +H ++++  +  +       D   +  EY   GSL D + ++   +   K   +
Sbjct: 61  AHAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 115
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS 716
           +  ++ + V   + Y+H      +VH D+KPSN+ +    + +       + D AS    
Sbjct: 116 K--DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 170
Query: 717 SSIGIKGTVGYV-APEYGMGSEASMTGDV 744
             IG  G V  + +P+   G    +  +V
Sbjct: 171 FKIGDLGHVTRISSPQVEEGDSRFLANEV 199

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 22/226 (9%)
Query: 556 IGQGSFGSV--YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           +G+G F  V   +G+  G     A+K I   ++        E +  R   H N+++++  
Sbjct: 37  LGEGGFSYVDLVEGLHDGH--FYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 614 CSSIDSKGADFKA-LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           C  +  +GA  +A L+  + + G+L + + +  D      LT  Q + + + +   +E +
Sbjct: 95  C--LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF--LTEDQILWLLLGICRGLEAI 150
Query: 673 HHHCQPPIVHGDLKPSNVLLDH-------DMVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
           H        H DLKP+N+LL         D+ +     +  +    + T       + T+
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 726 GYVAPE-YGMGSEASM--TGDVYSFGILLLEMFTGRRPTDAAFTEG 768
            Y APE + + S   +    DV+S G +L  M  G  P D  F +G
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 87/219 (39%), Gaps = 31/219 (14%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +     IG GS+    + +     M  AVKVI+  +    R    E E L  +R+     
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK----RDPSEEIEIL--LRYGQHPN 82
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           IIT+    D     +  LV E M  G L D + +     E       +   +   +   +
Sbjct: 83  IITLKDVYDDGKHVY--LVTELMRGGELLDKILRQKFFSER------EASFVLHTIGKTV 134
Query: 670 EYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHQNFSLSHQLDSASK---TPSSSIGI 721
           EYLH      +VH DLKPSN+L      + + +   +F  + QL + +    TP      
Sbjct: 135 EYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY---- 187
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             T  +VAPE           D++S GILL  M  G  P
Sbjct: 188 --TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA----L 599
            K    +   ++IG+GSFG V K     E+  VA+K+I  K K AF +  A+ E     L
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLN-QAQIEVRLLEL 106
Query: 600 RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            N +H   +K   +         +   LVFE M + +L D L  +N       L L ++ 
Sbjct: 107 MN-KHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTN--FRGVSLNLTRK- 161
Query: 660 NIAIDVASAIEYLHHHCQPP--IVHGDLKPSNVLL---DHDMVAHQNFSLSHQLDSASKT 714
             A  + +A+ +L     P   I+H DLKP N+LL       +   +F  S QL      
Sbjct: 162 -FAQQMCTALLFL---ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 217
Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTG 757
              S        Y +PE  +G    +  D++S G +L+EM TG
Sbjct: 218 XIQS------RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIR 603
           + +   +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N   +IT+    ++K      L+ E +  G L D+L +         LT  +      
Sbjct: 73  HPN---VITLHEVYENKTD--VILIGELVAGGELFDFLAEKES------LTEEEATEFLK 121
Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNV-LLDHDMVAHQ----NFSLSHQLDSASKTPSSS 718
            + + + YLH      I H DLKP N+ LLD ++   +    +F L+H++D  ++  +  
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             I GT  +VAPE        +  D++S G++   + +G  P
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI- 602
           S+ T+EF     IG G FGSV+K +   +  I A+K    + K      V E  ALR + 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 603 ------RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
                 +H ++++  +  +       D   +  EY   GSL D + ++   +   K   +
Sbjct: 61  AHAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 115
Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS 716
           +  ++ + V   + Y+H      +VH D+KPSN+ +    + +       + D AS    
Sbjct: 116 K--DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 170
Query: 717 SSIGIKGTVGYV-APEYGMGSEASMTGDV 744
             IG  G V  + +P+   G    +  +V
Sbjct: 171 FKIGDLGHVTRISSPQVEEGDSRFLANEV 199

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 113/244 (46%), Gaps = 37/244 (15%)
Query: 534 QFPMISYAELSKATSEFASSNMIGQGSFGSVYKGI---LGGEEMIVAVKVINLKQKGAF- 589
           Q P     E  +   +F  +  +G G+FG V +     LG E+ ++ V V  LK      
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 590 --RSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSND 646
              + ++E + + ++ +H N++ ++  C+     G     ++ EY   G L ++L + + 
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKSR 146
Query: 647 HLE------VCKLTLIQR--VNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMV 697
            LE      +   TL  R  ++ +  VA  + +L   +C    +H D+   NVLL +  V
Sbjct: 147 VLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHV 202
Query: 698 AH-QNFSLSHQLDSASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVYSFGILLL 752
           A   +F L+  + +      S+  +KG     V ++APE       ++  DV+S+GILL 
Sbjct: 203 AKIGDFGLARDIMN-----DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257
Query: 753 EMFT 756
           E+F+
Sbjct: 258 EIFS 261

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 87/219 (39%), Gaps = 31/219 (14%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +     IG GS+    + +     M  AVKVI+  +    R    E E L  +R+     
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK----RDPSEEIEIL--LRYGQHPN 82
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           IIT+    D     +  LV E M  G L D +      L     +  +   +   +   +
Sbjct: 83  IITLKDVYDDGKHVY--LVTELMRGGELLDKI------LRQKFFSEREASFVLHTIGKTV 134
Query: 670 EYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHQNFSLSHQLDSASK---TPSSSIGI 721
           EYLH      +VH DLKPSN+L      + + +   +F  + QL + +    TP      
Sbjct: 135 EYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY---- 187
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             T  +VAPE           D++S GILL  M  G  P
Sbjct: 188 --TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA----L 599
            K    +   ++IG+GSFG V K     E+  VA+K+I  K K AF +  A+ E     L
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLN-QAQIEVRLLEL 106
Query: 600 RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            N +H   +K   +         +   LVFE M + +L D L  +N       L L ++ 
Sbjct: 107 MN-KHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTN--FRGVSLNLTRK- 161
Query: 660 NIAIDVASAIEYLHHHCQPP--IVHGDLKPSNVLL---DHDMVAHQNFSLSHQLDSASKT 714
             A  + +A+ +L     P   I+H DLKP N+LL       +   +F  S QL      
Sbjct: 162 -FAQQMCTALLFL---ATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQ 217
Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTG 757
              S        Y +PE  +G    +  D++S G +L+EM TG
Sbjct: 218 XIQS------RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA----L 599
            K    +   ++IG+GSFG V K     E+  VA+K+I  K K AF +  A+ E     L
Sbjct: 31  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLN-QAQIEVRLLEL 87
Query: 600 RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
            N +H   +K   +         +   LVFE M + +L D L  +N       L L ++ 
Sbjct: 88  MN-KHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTN--FRGVSLNLTRK- 142
Query: 660 NIAIDVASAIEYLHHHCQPP--IVHGDLKPSNVLL---DHDMVAHQNFSLSHQLDSASKT 714
             A  + +A+ +L     P   I+H DLKP N+LL       +   +F  S QL      
Sbjct: 143 -FAQQMCTALLFL---ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 198
Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTG 757
              S        Y +PE  +G    +  D++S G +L+EM TG
Sbjct: 199 XIQS------RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 235

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 70
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 71  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 120
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 177
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 121
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 178
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 121
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 178
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 122
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 179
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 121
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 178
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 121
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 178
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 121
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 178
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        +      + + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMAGVVYLH- 122
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 179
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           +     IG+G++G V        +  VA+K I+  + +   +  + E + L   RH N+I
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ-------SNDHLEVCKLTLIQRVNI 661
            I  I      + +  +A+   Y+    +E  L++       SNDH  +C   L Q    
Sbjct: 105 GIRDIL-----RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDH--ICYF-LYQ---- 152
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIG 720
              +   ++Y+H      ++H DLKPSN+L++    +   +F L+   D           
Sbjct: 153 ---ILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTE 206
Query: 721 IKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
              T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 207 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G+G++G V K        I AVK I        R+ V   E  R +   ++      C 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI--------RATVNSQEQKRLLXDLDISXRTVDCP 93
Query: 616 -SIDSKGADFK---ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            ++   GA F+     +   + + SL+ +  Q  D  +     ++ +  IA+ +  A+E+
Sbjct: 94  FTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEH 151
Query: 672 LHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLS-HQLDSASKTPSSSIGIKGTVGYVA 729
           LH      ++H D+KPSNVL++    V   +F +S + +D  +K   +     G   Y A
Sbjct: 152 LHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA-----GCKPYXA 204
Query: 730 PEYGMGSEASMTG-----DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE 781
           PE  +  E +  G     D++S GI  +E+   R P D+  T    L + V+   P+
Sbjct: 205 PER-INPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 260

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 10/215 (4%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG GS+G   K     +  I+  K ++     +   +  V+E   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY-- 71
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
              I  +      +V EY E G L   + +     +      + RV   + +A    +  
Sbjct: 72  -DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 674 HHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
                 ++H DLKP+NV LD    V   +F L+  L+         +   GT  Y++PE 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV---GTPYYMSPEQ 187
Query: 733 GMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE 767
                 +   D++S G LL E+     P   AF++
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYEL-CALMPPFTAFSQ 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 27/222 (12%)
Query: 550 FASSNMIGQGSFGSVY--KGILGGEE-MIVAVKVIN----LKQKGAFRSFVAECEALRNI 602
           F    ++G G++G V+  + I G +   + A+KV+     +++         E + L +I
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           R    +  +      ++K      L+ +Y+  G L   L Q     E         V I 
Sbjct: 116 RQSPFLVTLHYAFQTETK----LHLILDYINGGELFTHLSQRERFTE-------HEVQIY 164
Query: 663 I-DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
           + ++  A+E+LH   +  I++ D+K  N+LLD +  V   +F LS +    +     +  
Sbjct: 165 VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF--VADETERAYD 219
Query: 721 IKGTVGYVAPEYGMGSEASMTG--DVYSFGILLLEMFTGRRP 760
             GT+ Y+AP+   G ++      D +S G+L+ E+ TG  P
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 110/240 (45%), Gaps = 33/240 (13%)
Query: 534 QFPMISYAELSKATSEFASSNMIGQGSFGSVYKGI---LGGEEMIVAVKVINLKQKG--- 587
           Q P     E  +   +F  +  +G G+FG V +     LG E+ ++ V V  LK      
Sbjct: 26  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 83
Query: 588 AFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN- 645
              + ++E + + ++ +H N++ ++  C+     G     ++ EY   G L ++L +   
Sbjct: 84  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKAE 138
Query: 646 ---DHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-Q 700
              D  +   L L   ++ +  VA  + +L   +C    +H D+   NVLL +  VA   
Sbjct: 139 ADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIG 194
Query: 701 NFSLSHQLDSASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           +F L+  + +      S+  +KG     V ++APE       ++  DV+S+GILL E+F+
Sbjct: 195 DFGLARDIMN-----DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 60/297 (20%)
Query: 534 QFPMISYAELSKATSEFASSNMIGQGSFGSV-----YKGILGGEEMIVAVKVI----NLK 584
           Q P     E  +    F  +  +G G+FG V     Y  I     M VAVK++    +L 
Sbjct: 27  QLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 84
Query: 585 QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS 644
           ++ A  S +     L N  H N++ ++  C+           ++ EY   G L ++L + 
Sbjct: 85  EREALMSELKVLSYLGN--HMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRK 137
Query: 645 NDHLEVCKLT-------------LIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNV 690
            D   +C  T             L   ++ +  VA  + +L   +C    +H DL   N+
Sbjct: 138 RDSF-ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNI 192
Query: 691 LLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVY 745
           LL H  +    +F L+  + +      S+  +KG     V ++APE       +   DV+
Sbjct: 193 LLTHGRITKICDFGLARDIKN-----DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 247
Query: 746 SFGILLLEMFT------GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVM 796
           S+GI L E+F+         P D+ F +   + E  +M  PE       P+ + ++M
Sbjct: 248 SYGIFLWELFSLGSSPYPGMPVDSKFYK--MIKEGFRMLSPEHA-----PAEMYDIM 297

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 25/221 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSF-VAECEALRNIRHRNLIKIITIC 614
           +G+GSFG V++          AVK + L+    FR+  +  C  L + R      I+ + 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLE---VFRAEELMACAGLTSPR------IVPLY 151
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            ++  +   +  +  E +E GSL   + +     E   L  + +          +EYLH 
Sbjct: 152 GAV--REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA------LEGLEYLHS 203
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSH----QLDSASKTPSSSIGIKGTVGYVAP 730
                I+HGD+K  NVLL  D          H    Q D   K+  +   I GT  ++AP
Sbjct: 204 R---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAP 260
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
           E  +G       DV+S   ++L M  G  P    F   L L
Sbjct: 261 EVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCL 301

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 60/297 (20%)
Query: 534 QFPMISYAELSKATSEFASSNMIGQGSFGSV-----YKGILGGEEMIVAVKVI----NLK 584
           Q P     E  +    F  +  +G G+FG V     Y  I     M VAVK++    +L 
Sbjct: 11  QLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 585 QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS 644
           ++ A  S +     L N  H N++ ++  C+           ++ EY   G L ++L + 
Sbjct: 69  EREALMSELKVLSYLGN--HMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRK 121
Query: 645 NDHLEVCKLT-------------LIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNV 690
            D   +C  T             L   ++ +  VA  + +L   +C    +H DL   N+
Sbjct: 122 RDSF-ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNI 176
Query: 691 LLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVY 745
           LL H  +    +F L+  + +      S+  +KG     V ++APE       +   DV+
Sbjct: 177 LLTHGRITKICDFGLARDIKN-----DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 746 SFGILLLEMFT------GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVM 796
           S+GI L E+F+         P D+ F +   + E  +M  PE       P+ + ++M
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYK--MIKEGFRMLSPEHA-----PAEMYDIM 281

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 18/217 (8%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRN 606
           F    ++G+GSFG V    +     + AVKV+    + Q       + E   L   R+  
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
            +  +  C     +  D    V E++  G L   + +S       +    +    A ++ 
Sbjct: 85  FLTQLFCCF----QTPDRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEII 134
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           SA+ +LH      I++ DLK  NVLLDH+   H   +             ++    GT  
Sbjct: 135 SALMFLHDKG---IIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPD 189
Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           Y+APE           D ++ G+LL EM  G  P +A
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 39/245 (15%)
Query: 534 QFPMISYAELSKATSEFASSNMIGQGSFGSVYKGI---LGGEEMIVAVKVINLKQKG--- 587
           Q P     E  +   +F  +  +G G+FG V +     LG E+ ++ V V  LK      
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 588 AFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSND 646
              + ++E + + ++ +H N++ ++  C+     G     ++ EY   G L ++L + + 
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKSR 146
Query: 647 HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP----------IVHGDLKPSNVLLDHDM 696
            LE           IA   AS  + LH   Q             +H D+   NVLL +  
Sbjct: 147 VLETDPA-----FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201
Query: 697 VAH-QNFSLSHQLDSASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVYSFGILL 751
           VA   +F L+  + +      S+  +KG     V ++APE       ++  DV+S+GILL
Sbjct: 202 VAKIGDFGLARDIMN-----DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
Query: 752 LEMFT 756
            E+F+
Sbjct: 257 WEIFS 261

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/249 (22%), Positives = 100/249 (40%), Gaps = 32/249 (12%)
Query: 519 RRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAV 578
           R   +  V+T   ++ +   S+        ++     +G+G +  V++ I       V V
Sbjct: 8   RARVYTDVNTHRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 67
Query: 579 KVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLE 638
           K++   +K   +    E + L N+R      IIT+   +    +   ALVFE++ N   +
Sbjct: 68  KILKPVKKNKIKR---EIKILENLR--GGPNIITLADIVKDPVSRTPALVFEHVNNTDFK 122
Query: 639 DWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 698
             L+Q+        LT         ++  A++Y H      I+H D+KP NV++DH+   
Sbjct: 123 Q-LYQT--------LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHE--- 167
Query: 699 HQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-------ASMTGDVYSFGILL 751
           H+   L     +    P     ++     VA  Y  G E          + D++S G +L
Sbjct: 168 HRKLRLIDWGLAEFYHPGQEYNVR-----VASRYFKGPELLVDYQMYDYSLDMWSLGCML 222
Query: 752 LEMFTGRRP 760
             M   + P
Sbjct: 223 ASMIFRKEP 231

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 110/240 (45%), Gaps = 33/240 (13%)
Query: 534 QFPMISYAELSKATSEFASSNMIGQGSFGSVYKGI---LGGEEMIVAVKVINLKQKG--- 587
           Q P     E  +   +F  +  +G G+FG V +     LG E+ ++ V V  LK      
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 588 AFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN- 645
              + ++E + + ++ +H N++ ++  C+     G     ++ EY   G L ++L +   
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKAE 146
Query: 646 ---DHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-Q 700
              D  +   L L   ++ +  VA  + +L   +C    +H D+   NVLL +  VA   
Sbjct: 147 ADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIG 202
Query: 701 NFSLSHQLDSASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
           +F L+  + +      S+  +KG     V ++APE       ++  DV+S+GILL E+F+
Sbjct: 203 DFGLARDIMN-----DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 46/269 (17%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G+FG V        +   AVKV+ N+K+    RS   E + L+ I++ ++     + 
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT--RSAKIEADILKKIQNDDINNNNIVK 100
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSND---HLEVCKLTLIQRVNIAIDVASAIEY 671
                   D   L+FE +   SL + + ++N    H+E  KL         I++  A+ Y
Sbjct: 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKL-------YCIEILKALNY 152
Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSAS----KTPSSSI-------- 719
           L    +  + H DLKP N+LLD         ++    D       +T S+ I        
Sbjct: 153 LR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 720 --------GIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
                    I  T  Y APE  +     ++ D++SFG +L E++TG        +     
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG--------SLLFRT 261
Query: 772 HEFVK-MTLPEKVIEIVDPSLLMEVMANN 799
           HE ++ + + E +I+ +  ++L E    N
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTN 290

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 78/191 (40%), Gaps = 21/191 (10%)
Query: 220 FGGELPHSIANLS--STMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDG 276
            GG   H I+ L   + +    + GNQ+  ++P+G+   L NL  L +  NQL  + PDG
Sbjct: 70  LGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSL-PDG 127
Query: 277 V-GELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFD 335
           V  +L +L  L +  N LQ         LT L +L LS+N LQ            LK   
Sbjct: 128 VFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLR 187
Query: 336 ASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSN 395
              N+L  ++P  V    T   Y+ L  N  +               TC  + YL    N
Sbjct: 188 LYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWD--------------CTCPGIRYLSEWIN 232
Query: 396 SFHGVIPFSLG 406
              GV+  S G
Sbjct: 233 KHSGVVRNSAG 243

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 60/297 (20%)
Query: 534 QFPMISYAELSKATSEFASSNMIGQGSFGSV-----YKGILGGEEMIVAVKVI----NLK 584
           Q P     E  +    F  +  +G G+FG V     Y  I     M VAVK++    +L 
Sbjct: 34  QLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 91
Query: 585 QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS 644
           ++ A  S +     L N  H N++ ++  C+           ++ EY   G L ++L + 
Sbjct: 92  EREALMSELKVLSYLGN--HMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRK 144
Query: 645 NDHLEVCKLT-------------LIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNV 690
            D   +C  T             L   ++ +  VA  + +L   +C    +H DL   N+
Sbjct: 145 RDSF-ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNI 199
Query: 691 LLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVY 745
           LL H  +    +F L+  + +      S+  +KG     V ++APE       +   DV+
Sbjct: 200 LLTHGRITKICDFGLARHIKN-----DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 254
Query: 746 SFGILLLEMFT------GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVM 796
           S+GI L E+F+         P D+ F +   + E  +M  PE       P+ + ++M
Sbjct: 255 SYGIFLWELFSLGSSPYPGMPVDSKFYK--MIKEGFRMLSPEHA-----PAEMYDIM 304

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 60/297 (20%)
Query: 534 QFPMISYAELSKATSEFASSNMIGQGSFGSV-----YKGILGGEEMIVAVKVI----NLK 584
           Q P     E  +    F  +  +G G+FG V     Y  I     M VAVK++    +L 
Sbjct: 29  QLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 86
Query: 585 QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS 644
           ++ A  S +     L N  H N++ ++  C+           ++ EY   G L ++L + 
Sbjct: 87  EREALMSELKVLSYLGN--HMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRK 139
Query: 645 NDHLEVCKLT-------------LIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNV 690
            D   +C  T             L   ++ +  VA  + +L   +C    +H DL   N+
Sbjct: 140 RDSF-ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNI 194
Query: 691 LLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVY 745
           LL H  +    +F L+  + +      S+  +KG     V ++APE       +   DV+
Sbjct: 195 LLTHGRITKICDFGLARDIKN-----DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 249
Query: 746 SFGILLLEMFT------GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVM 796
           S+GI L E+F+         P D+ F +   + E  +M  PE       P+ + ++M
Sbjct: 250 SYGIFLWELFSLGSSPYPGMPVDSKFYK--MIKEGFRMLSPEHA-----PAEMYDIM 299

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           + +  +IG GSFG V++  L   + +   KV+   Q   F++   E + +R ++H N++ 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL---QDKRFKN--RELQIMRIVKHPNVVD 96
Query: 610 IIT-ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL-IQRVNIAI-DVA 666
           +     S+ D K   F  LV EY     + + +++++ H    K T+ +  + + +  + 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHD--MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            ++ Y+H      I H D+KP N+LLD    ++   +F  +  L +       ++    +
Sbjct: 152 RSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG----EPNVSXICS 204
Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
             Y APE   G+    T  D++S G ++ E+  G+
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 60/297 (20%)
Query: 534 QFPMISYAELSKATSEFASSNMIGQGSFGSV-----YKGILGGEEMIVAVKVI----NLK 584
           Q P     E  +    F  +  +G G+FG V     Y  I     M VAVK++    +L 
Sbjct: 34  QLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 91
Query: 585 QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS 644
           ++ A  S +     L N  H N++ ++  C+           ++ EY   G L ++L + 
Sbjct: 92  EREALMSELKVLSYLGN--HMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRK 144
Query: 645 NDHLEVCKLT-------------LIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNV 690
            D   +C  T             L   ++ +  VA  + +L   +C    +H DL   N+
Sbjct: 145 RDSF-ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNI 199
Query: 691 LLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVY 745
           LL H  +    +F L+  + +      S+  +KG     V ++APE       +   DV+
Sbjct: 200 LLTHGRITKICDFGLARDIKN-----DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 254
Query: 746 SFGILLLEMFT------GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVM 796
           S+GI L E+F+         P D+ F +   + E  +M  PE       P+ + ++M
Sbjct: 255 SYGIFLWELFSLGSSPYPGMPVDSKFYK--MIKEGFRMLSPEHA-----PAEMYDIM 304

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 24/215 (11%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           F   + +G+G+   VY+    G +   A+KV  LK+    +    E   L  + H N+IK
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  I  +         +LV E +  G L D + +   + E      ++++        A+
Sbjct: 113 LKEIFETPTEI-----SLVLELVTGGELFDRIVEKGYYSERDAADAVKQI------LEAV 161
Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
            YLH +    IVH DLKP N+L         +   +F LS  ++      +    + GT 
Sbjct: 162 AYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT----VCGTP 214
Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           GY APE   G       D++S GI+   +  G  P
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 25/221 (11%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSF-VAECEALRNIRHRNLIKIITIC 614
           +G+GSFG V++          AVK + L+    FR+  +  C  L + R      I+ + 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLE---VFRAEELMACAGLTSPR------IVPLY 132
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            ++  +   +  +  E +E GSL   + +     E   L  + +          +EYLH 
Sbjct: 133 GAV--REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA------LEGLEYLHS 184
Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSH----QLDSASKTPSSSIGIKGTVGYVAP 730
                I+HGD+K  NVLL  D          H    Q D   K   +   I GT  ++AP
Sbjct: 185 R---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAP 241
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
           E  +G       DV+S   ++L M  G  P    F   L L
Sbjct: 242 EVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCL 282

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 48/221 (21%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---AFRSFVAECEALRNIRHRN---LIK 609
           +G G++GSV           VAVK ++   +    A R++  E   L++++H N   L+ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGLLD 94
Query: 610 IITICSSIDS----------KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV 659
           + T  +SI+            GAD   +V    ++ +L      S++H++     L++  
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIV----KSQAL------SDEHVQFLVYQLLR-- 142
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSS 718
                    ++Y+H      I+H DLKPSNV ++ D      +F L+ Q D         
Sbjct: 143 --------GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQAD------EEM 185
Query: 719 IGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
            G   T  Y APE  +     + T D++S G ++ E+  G+
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAEC-EALRN-------IRHRNL 607
           +G+G++G V   +    E  VAVK++++K+         +C E ++        + H N+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-------AVDCPENIKKEICINAMLNHENV 67
Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           +K          +  + + L  EY   G L D +       E        +      + +
Sbjct: 68  VKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ------LMA 116
Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
            + YLH      I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ 
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLP 172
Query: 727 YVAPEYGMGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
           YVAPE     E  +   DV+S GI+L  M  G  P D
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 113/271 (41%), Gaps = 28/271 (10%)
Query: 63  LRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT- 121
           L NL YLN+  NQ + + P  + N+  L  +Y+  N+ +       L NL NL+ELYL  
Sbjct: 65  LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD---ISALQNLTNLRELYLNE 119
Query: 122 -FCSXXXXXXXXXXXXXXGMGTASSIPD--SLSNASNLERLDLSGNQFKGKVSI----DF 174
              S               +G   ++ D   LSN + L  L ++ ++ K    I    D 
Sbjct: 120 DNISDISPLANLTKXYSLNLGANHNLSDLSPLSNXTGLNYLTVTESKVKDVTPIANLTDL 179
Query: 175 SSXXXXXXXXXXXXXXGMGTA--------NDLDFVTLLTNCSSLKALSLCDNQFGGELPH 226
            S                 T+        N +  +T + N + L +L + +N+     P 
Sbjct: 180 YSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITPVANXTRLNSLKIGNNKITDLSP- 238
Query: 227 SIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQL 286
            +ANLS  +    IG NQIS    + +++L  L  L +  NQ+  I    +  L  L  L
Sbjct: 239 -LANLSQ-LTWLEIGTNQISDI--NAVKDLTKLKXLNVGSNQISDI--SVLNNLSQLNSL 292
Query: 287 YMFRNFLQGSIPPSLGNLTKLADLALSFNNL 317
           ++  N L       +G LT L  L LS N++
Sbjct: 293 FLNNNQLGNEDXEVIGGLTNLTTLFLSQNHI 323

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 14/108 (12%)
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQL-DSASKTPSS 717
            + + +  A+ YL    +  ++H D+KPSN+LLD    +   +F +S +L D  +K  S+
Sbjct: 128 KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185
Query: 718 SIGIKGTVGYVAPEY-----GMGSEASMTGDVYSFGILLLEMFTGRRP 760
                G   Y+APE          +  +  DV+S GI L+E+ TG+ P
Sbjct: 186 -----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 548 SEFASSNMIGQGSFGSVY--KGILGGEEMIVAV----KVINLKQKGAFRSFVAECEALRN 601
            +F     IG GSFG V   K +  G    + +    KV+ LKQ       + E   L+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           +    L+K+         K      +V EYM  G +   L +      + + +       
Sbjct: 98  VNFPFLVKL-----EFSFKDNSNLYMVMEYMPGGDMFSHLRR------IGRFSEPHARFY 146
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           A  +    EYLH      +++ DLKP N+L+D      Q +        A +    +  +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ-----QGYIKVADFGFAKRVKGRTWXL 198
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 548 SEFASSNMIGQGSFGSVY--KGILGGEEMIVAV----KVINLKQKGAFRSFVAECEALRN 601
            +F     IG GSFG V   K +  G    + +    KV+ LKQ       + E   L+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           +    L+K+         K      +V EYM  G +   L +      + + +       
Sbjct: 98  VNFPFLVKL-----EFSFKDNSNLYMVMEYMPGGDMFSHLRR------IGRFSEPHARFY 146
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           A  +    EYLH      +++ DLKP N+L+D      Q +        A +    +  +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ-----QGYIKVADFGFAKRVKGRTWXL 198
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 23/225 (10%)
Query: 543 LSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALR 600
           L     ++    +IG+G+FG V        + + A+K+++  +  K +  +F  E   + 
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 601 NIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
              +   + +   C+  D K   +  +V EYM  G L + L  + D  E         V 
Sbjct: 130 AFANSPWV-VQLFCAFQDDK---YLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVV 184
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSI 719
           +A+D   ++          ++H D+KP N+LLD H  +   +F    ++D        + 
Sbjct: 185 LALDAIHSM---------GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDT- 234
Query: 720 GIKGTVGYVAPEY----GMGSEASMTGDVYSFGILLLEMFTGRRP 760
              GT  Y++PE     G         D +S G+ L EM  G  P
Sbjct: 235 -AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 46/220 (20%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRN---LIKI 610
           +G G++GSV           VAVK ++   +     R    E   L++++H N   L+ +
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 611 ITICSSIDS----------KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
            T  +SI+            GAD   +V    +  +L      S++H++     L++   
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIV----KCQAL------SDEHVQFLVYQLLR--- 134
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSI 719
                   ++Y+H      I+H DLKPSNV ++ D      +F L+ Q D          
Sbjct: 135 -------GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD------EEMT 178
Query: 720 GIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           G   T  Y APE  +     + T D++S G ++ E+  G+
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           ++G+GSFG V      G + + AVK+  LK+    +    EC  +   R   L       
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEK-RVLALPGKPPFL 83
Query: 615 SSIDS--KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           + + S  +  D    V EY+  G L   + Q      V +      V  A ++A  + +L
Sbjct: 84  TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ------VGRFKEPHAVFYAAEIAIGLFFL 137
Query: 673 HHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
                  I++ DLK  NV+LD   H  +A       +  D  +     +    GT  Y+A
Sbjct: 138 QSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-----TKXFCGTPDYIA 189
Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE         + D ++FG+LL EM  G+ P
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 18/210 (8%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G+ G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 121
Query: 675 HCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD  D +   +F L+      ++    +  + GT+ YVAPE  
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 178
Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTD 762
              E  +   DV+S GI+L  M  G  P D
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 27/226 (11%)
Query: 545 KATSEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI 602
           +  + +     IG GSFG +Y G  I  GEE+ + ++ +  K          E +  + +
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMM 59
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           +    I  I  C +      D+  +V E +   SLED  +  +      K +L   + +A
Sbjct: 60  QGGVGIPTIRWCGA----EGDYNVMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLA 109
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTP--- 715
             + S IEY+H       +H D+KP N L+      ++V   +F L+ +   A       
Sbjct: 110 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166
Query: 716 -SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              +  + GT  Y +    +G E S   D+ S G +L+    G  P
Sbjct: 167 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 212

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 27/226 (11%)
Query: 545 KATSEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI 602
           +  + +     IG GSFG +Y G  I  GEE+ + ++ +  K          E +  + +
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMM 61
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
           +    I  I  C +      D+  +V E +   SLED  +  +      K +L   + +A
Sbjct: 62  QGGVGIPTIRWCGA----EGDYNVMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLA 111
Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTP--- 715
             + S IEY+H       +H D+KP N L+      ++V   +F L+ +   A       
Sbjct: 112 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 168
Query: 716 -SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              +  + GT  Y +    +G E S   D+ S G +L+    G  P
Sbjct: 169 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 46/220 (20%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRN---LIKI 610
           +G G++GSV           VAVK ++   +     R    E   L++++H N   L+ +
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 611 ITICSSIDS----------KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
            T  +SI+            GAD   +V    +  +L      S++H++     L++   
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIV----KCQAL------SDEHVQFLVYQLLR--- 142
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSI 719
                   ++Y+H      I+H DLKPSNV ++ D      +F L+ Q D          
Sbjct: 143 -------GLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQAD------EEMT 186
Query: 720 GIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
           G   T  Y APE  +     + T D++S G ++ E+  G+
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/227 (22%), Positives = 100/227 (44%), Gaps = 25/227 (11%)
Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMI-----VAVKVINLKQKGAFRSFVAECEA 598
           +K   ++   +++G+GS+G V K +L  E +      +  K    +      +   E + 
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL 59
Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           LR +RH+N+I+++ +  + + +      +V EY   G     + +  D +   +  + Q 
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKM---YMVMEYCVCG-----MQEMLDSVPEKRFPVCQA 111
Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTP 715
                 +   +EYLH      IVH D+KP N+LL       ++    + +    +A  T 
Sbjct: 112 HGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 716 SSSIGIKGTVGYVAPEY--GMGSEASMTGDVYSFGILLLEMFTGRRP 760
            +S   +G+  +  PE   G+ + +    D++S G+ L  + TG  P
Sbjct: 169 RTS---QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 31/222 (13%)
Query: 547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN 606
           T  +     IG GS+    + I        AVK+I+  +    R    E E L  +R+  
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK----RDPTEEIEIL--LRYGQ 74
Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
              IIT+    D     +  +V E  + G L D +      L     +  +   +   + 
Sbjct: 75  HPNIITLKDVYDD--GKYVYVVTELXKGGELLDKI------LRQKFFSEREASAVLFTIT 126
Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHQNFSLSHQLDSAS---KTPSSS 718
             +EYLH      +VH DLKPSN+L      + + +   +F  + QL + +    TP   
Sbjct: 127 KTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY- 182
Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                T  +VAPE           D++S G+LL    TG  P
Sbjct: 183 -----TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           ++G+GSFG V      G + + AVK+  LK+    +    EC  +   R   L       
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEK-RVLALPGKPPFL 404
Query: 615 SSIDS--KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           + + S  +  D    V EY+  G L   + Q      V +      V  A ++A  + +L
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ------VGRFKEPHAVFYAAEIAIGLFFL 458
Query: 673 HHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
                  I++ DLK  NV+LD   H  +A       +  D  +     +    GT  Y+A
Sbjct: 459 QSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-----TKXFCGTPDYIA 510
Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE         + D ++FG+LL EM  G+ P
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 31/228 (13%)
Query: 545 KATSEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI 602
           +  +++     IG GSFG +Y G  I  GEE+ + ++ +  K          E +  + +
Sbjct: 6   RVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHP----QLHIESKFYKMM 61
Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC--KLTLIQRVN 660
           +    I  I  C +      D+  +V E +   SLED  +        C  K +L   + 
Sbjct: 62  QGGVGIPSIKWCGA----EGDYNVMVMELL-GPSLEDLFN-------FCSRKFSLKTVLL 109
Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQLDSASKTP- 715
           +A  + S IEY+H       +H D+KP N L+      ++V   +F L+ +   A     
Sbjct: 110 LADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166
Query: 716 ---SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                +  + GT  Y +    +G E S   D+ S G +L+    G  P
Sbjct: 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 548 SEFASSNMIGQGSFGSVY--KGILGGEEMIVAV----KVINLKQKGAFRSFVAECEALRN 601
            +F     IG GSFG V   K +  G    + +    KV+ LKQ       + E   L+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           +    L+K+         K      +V EY+  G +   L +      + + +       
Sbjct: 98  VNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFY 146
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           A  +    EYLH      +++ DLKP N+L+D      Q +        A +    +  +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ-----QGYIKVADFGFAKRVKGRTWXL 198
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G+G++G VYK      +      +  ++  G   S   E   LR ++H N+I +  +  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 616 SIDSKGADFKA-LVFEYMENG--SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           S     AD K  L+F+Y E+    +  +   S  + +  +L      ++   +   I YL
Sbjct: 89  S----HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 673 HHHCQPPIVHGDLKPSNVLL-----DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           H +    ++H DLKP+N+L+     +   V   +   +   +S  K  +    +  T  Y
Sbjct: 145 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 728 VAPEYGMGSEASMTG-DVYSFGILLLEMFT 756
            APE  +G+       D+++ G +  E+ T
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 87/220 (39%), Gaps = 27/220 (12%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +   N IG+GS+G V   +  G  +  A K I          F  E E ++++ H N+I+
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 610 II-TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           +  T   + D        LV E    G     L +   H  V + +   R  I  DV SA
Sbjct: 88  LYETFEDNTDI------YLVMELCTGGE----LFERVVHKRVFRESDAAR--IMKDVLSA 135
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ----NFSLSHQLDSASKTPSSSIGIK-G 723
           + Y H      + H DLKP N L   D         +F L+ +       P   +  K G
Sbjct: 136 VAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-----KPGKMMRTKVG 187
Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           T  YV+P+   G       D +S G+++  +  G  P  A
Sbjct: 188 TPYYVSPQVLEGLYGPEC-DEWSAGVMMYVLLCGYPPFSA 226

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 85/209 (40%), Gaps = 22/209 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+FG V++          A K +    +    +   E + +  +RH  L+ +     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
             +        +++E+M  G L     +  D  E  K++  + V     V   + ++H +
Sbjct: 225 DDNEM-----VMIYEFMSGGEL---FEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 676 CQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSASKTPSSSIGIK-GTVGYVAPE 731
                VH DLKP N++      + +   +F L+  LD     P  S+ +  GT  + APE
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-----PKQSVKVTTGTAEFAAPE 326
Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              G       D++S G+L   + +G  P
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 87/220 (39%), Gaps = 27/220 (12%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +   N IG+GS+G V   +  G  +  A K I          F  E E ++++ H N+I+
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 610 II-TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           +  T   + D        LV E    G     L +   H  V + +   R  I  DV SA
Sbjct: 71  LYETFEDNTDI------YLVMELCTGGE----LFERVVHKRVFRESDAAR--IMKDVLSA 118
Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ----NFSLSHQLDSASKTPSSSIGIK-G 723
           + Y H      + H DLKP N L   D         +F L+ +       P   +  K G
Sbjct: 119 VAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-----KPGKMMRTKVG 170
Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           T  YV+P+   G       D +S G+++  +  G  P  A
Sbjct: 171 TPYYVSPQVLEGLYGPEC-DEWSAGVMMYVLLCGYPPFSA 209

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/255 (21%), Positives = 103/255 (40%), Gaps = 38/255 (14%)
Query: 521 SAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKV 580
           SAH    ++P K + P +      +    +     +G+G F   Y+      + + A KV
Sbjct: 18  SAHVDPKSAPLK-EIPDVLVD--PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 581 INLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS----------KGADFKALVFE 630
                       V +   L+  +   +   I I  S+D+          +  DF  +V E
Sbjct: 75  ------------VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLE 122
Query: 631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV 690
                SL + LH+    +   +     R  I       ++YLH++    ++H DLK  N+
Sbjct: 123 ICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLHNNR---VIHRDLKLGNL 173
Query: 691 LLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGI 749
            L+ DM V   +F L+ +++   +   +   + GT  Y+APE       S   D++S G 
Sbjct: 174 FLNDDMDVKIGDFGLATKIEFDGERKKT---LCGTPNYIAPEVLCKKGHSFEVDIWSLGC 230
Query: 750 LLLEMFTGRRPTDAA 764
           +L  +  G+ P + +
Sbjct: 231 ILYTLLVGKPPFETS 245

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 8/99 (8%)
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           A  +    EYLH      +++ DLKP N+L+D      Q +        A +    +  +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ-----QGYIQVTDFGFAKRVKGRTWXL 198
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 35/231 (15%)
Query: 545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH 604
           +    +     +G+G F   Y+      + + A KV            V +   L+  + 
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV------------VPKSMLLKPHQK 70
Query: 605 RNLIKIITICSSIDS----------KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLT 654
             +   I I  S+D+          +  DF  +V E     SL + LH+    +   +  
Sbjct: 71  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR 129
Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASK 713
              R  I       ++YLH++    ++H DLK  N+ L+ DM V   +F L+ +++   +
Sbjct: 130 YFMRQTI-----QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE 181
Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA 764
                  + GT  Y+APE       S   D++S G +L  +  G+ P + +
Sbjct: 182 RKKD---LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 85/209 (40%), Gaps = 22/209 (10%)
Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+FG V++          A K +    +    +   E + +  +RH  L+ +     
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
             +        +++E+M  G L     +  D  E  K++  + V     V   + ++H +
Sbjct: 119 DDNEM-----VMIYEFMSGGEL---FEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 676 CQPPIVHGDLKPSNVLL---DHDMVAHQNFSLSHQLDSASKTPSSSIGIK-GTVGYVAPE 731
                VH DLKP N++      + +   +F L+  LD     P  S+ +  GT  + APE
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-----PKQSVKVTTGTAEFAAPE 220
Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              G       D++S G+L   + +G  P
Sbjct: 221 VAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 63/139 (45%), Gaps = 18/139 (12%)
Query: 627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLK 686
           ++ E ME G L   + +  D       T  +   I  D+ +AI++LH H    I H D+K
Sbjct: 103 IIMECMEGGELFSRIQERGDQ----AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVK 155
Query: 687 PSNVLL---DHDMVAH-QNFSLSHQL-DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMT 741
           P N+L    + D V    +F  + +   +A +TP        T  YVAPE     +   +
Sbjct: 156 PENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY------TPYYVAPEVLGPEKYDKS 209
Query: 742 GDVYSFGILLLEMFTGRRP 760
            D++S G+++  +  G  P
Sbjct: 210 CDMWSLGVIMYILLCGFPP 228

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 8/99 (8%)
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           A  +    EYLH      +++ DLKP N+L+D      Q +        A +    +  +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ-----QGYIQVTDFGFAKRVKGRTWXL 198
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 548 SEFASSNMIGQGSFGSVY--KGILGGEEMIVAV----KVINLKQKGAFRSFVAECEALRN 601
            +F     +G GSFG V   K +  G    + +    KV+ LKQ       + E   L+ 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 83
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           +    L+K+         K      +V EY+  G +   L +      + + +       
Sbjct: 84  VNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFY 132
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           A  +    EYLH      +++ DLKP N+L+D      Q +        A +    +  +
Sbjct: 133 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ-----QGYIQVTDFGFAKRVKGRTWTL 184
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 185 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 37/221 (16%)
Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------LKQKGAFRSFVAECEALRNIR 603
           + S   +G G++GSV   I       VA+K ++      +  K A+R  +     L++++
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL----LKHMQ 81
Query: 604 HRNLIKIITICSSIDS--KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV-- 659
           H N+I ++ + +   S     DF  LV  +M+            D  ++  L   +    
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDF-YLVMPFMQT-----------DLQKIMGLKFSEEKIQ 129
Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSS 718
            +   +   ++Y+H      +VH DLKP N+ ++ D  +   +F L+   D      +  
Sbjct: 130 YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD------AEM 180
Query: 719 IGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
            G   T  Y APE  +     + T D++S G ++ EM TG+
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 67/149 (44%), Gaps = 7/149 (4%)
Query: 220 FGGELPHSIANLS--STMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDG 276
            GG   H I+ L   + +    + GNQ+  ++P+G+   L NL  L +  NQL  + PDG
Sbjct: 70  LGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSL-PDG 127
Query: 277 V-GELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFD 335
           V  +L +L  LY++ N LQ         LT L  L L  N LQ            LK   
Sbjct: 128 VFDKLTNLTYLYLYHNQLQSLPKGVFDKLTNLTRLDLDNNQLQSLPEGVFDKLTQLKQLS 187
Query: 336 ASHNKLTGAIPQQVLSITTLSVYLALAHN 364
            + N+L  ++P  V    T   ++ L +N
Sbjct: 188 LNDNQL-KSVPDGVFDRLTSLTHIWLLNN 215

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
            +IG+GSFG V K         VA+K++   +K   R    E   L ++R ++    + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
              +++    F+  +    E  S+  +     +  +   L L+++   A  +   ++ LH
Sbjct: 162 IHMLEN--FTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALH 217
Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLD---SASKTPSSSIGIKGTVGYVAP 730
            +    I+H DLKP N+LL       Q  S    +D   S  +       I+    Y AP
Sbjct: 218 KN---RIIHCDLKPENILL-----KQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF-YRAP 268
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTG 757
           E  +G+   M  D++S G +L E+ TG
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 63/139 (45%), Gaps = 18/139 (12%)
Query: 627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLK 686
           ++ E ME G L   + +  D       T  +   I  D+ +AI++LH H    I H D+K
Sbjct: 84  IIMECMEGGELFSRIQERGDQ----AFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVK 136
Query: 687 PSNVLL---DHDMVAH-QNFSLSHQL-DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMT 741
           P N+L    + D V    +F  + +   +A +TP        T  YVAPE     +   +
Sbjct: 137 PENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY------TPYYVAPEVLGPEKYDKS 190
Query: 742 GDVYSFGILLLEMFTGRRP 760
            D++S G+++  +  G  P
Sbjct: 191 CDMWSLGVIMYILLCGFPP 209

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 110/246 (44%), Gaps = 39/246 (15%)
Query: 534 QFPMISYAELSKATSEFASSNMIGQGSFGSVYKGI---LGGEEMIVAVKVINLKQKGAF- 589
           Q P     E  +   +F  +  +G G+FG V +     LG E+ ++ V V  LK      
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 590 --RSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN- 645
              + ++E + + ++ +H N++ ++  C+     G     ++ EY   G L ++L +   
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKRP 146
Query: 646 ---------DHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHD 695
                     H    +L+    ++ +  VA  + +L   +C    +H D+   NVLL + 
Sbjct: 147 PGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNG 202
Query: 696 MVAH-QNFSLSHQLDSASKTPSSSIGIKGT----VGYVAPEYGMGSEASMTGDVYSFGIL 750
            VA   +F L+  + +      S+  +KG     V ++APE       ++  DV+S+GIL
Sbjct: 203 HVAKIGDFGLARDIMN-----DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 257
Query: 751 LLEMFT 756
           L E+F+
Sbjct: 258 LWEIFS 263

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 548 SEFASSNMIGQGSFGSVY--KGILGGEEMIVAV----KVINLKQKGAFRSFVAECEALRN 601
            +F     +G GSFG V   K +  G    + +    KV+ LKQ       + E   L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           +    L+K+         K      +V EY+  G +   L +      + + +       
Sbjct: 98  VNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFY 146
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           A  +    EYLH      +++ DLKP N+L+D      Q +        A +    +  +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ-----QGYIQVTDFGFAKRVKGRTWXL 198
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 56/255 (21%), Positives = 102/255 (40%), Gaps = 38/255 (14%)
Query: 521 SAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKV 580
           SAH    ++P K + P +      +    +     +G+G F   Y+      + + A KV
Sbjct: 18  SAHVDPKSAPLK-EIPDVLVD--PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 581 INLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS----------KGADFKALVFE 630
                       V +   L+  +   +   I I  S+D+          +  DF  +V E
Sbjct: 75  ------------VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLE 122
Query: 631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV 690
                SL + LH+    +   +     R  I       ++YLH++    ++H DLK  N+
Sbjct: 123 ICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-----QGVQYLHNNR---VIHRDLKLGNL 173
Query: 691 LLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGI 749
            L+ DM V   +F L+ +++   +       + GT  Y+APE       S   D++S G 
Sbjct: 174 FLNDDMDVKIGDFGLATKIEFDGERKKD---LCGTPNYIAPEVLCKKGHSFEVDIWSLGC 230
Query: 750 LLLEMFTGRRPTDAA 764
           +L  +  G+ P + +
Sbjct: 231 ILYTLLVGKPPFETS 245

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
           A  +    EYLH      +++ DLKP N+L+D    +   +F  + ++  A+ T      
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT------ 218
Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           + GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 548 SEFASSNMIGQGSFGSVY--KGILGGEEMIVAV----KVINLKQKGAFRSFVAECEALRN 601
            +F     +G GSFG V   K +  G    + +    KV+ LKQ       + E   L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 98
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           +    L+K+         K      +V EY+  G +   L +      + + +       
Sbjct: 99  VNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFY 147
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           A  +    EYLH      +++ DLKP N+L+D      Q +        A +    +  +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ-----QGYIQVTDFGFAKRVKGRTWTL 199
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 548 SEFASSNMIGQGSFGSVY--KGILGGEEMIVAV----KVINLKQKGAFRSFVAECEALRN 601
            +F     +G GSFG V   K +  G    + +    KV+ LKQ       + E   L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           +    L+K+         K      +V EY+  G +   L +      + + +       
Sbjct: 98  VNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFY 146
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           A  +    EYLH      +++ DLKP N+L+D      Q +        A +    +  +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ-----QGYIQVTDFGFAKRVKGRTWXL 198
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
            +IG+GSFG V K         VA+K++   +K   R    E   L ++R ++    + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
              +++    F+  +    E  S+  +     +  +   L L+++   A  +   ++ LH
Sbjct: 162 IHMLEN--FTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALH 217
Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLD---SASKTPSSSIGIKGTVGYVAP 730
            +    I+H DLKP N+LL       Q  S    +D   S  +       I+    Y AP
Sbjct: 218 KN---RIIHCDLKPENILL-----KQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF-YRAP 268
Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTG 757
           E  +G+   M  D++S G +L E+ TG
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 548 SEFASSNMIGQGSFGSVY--KGILGGEEMIVAV----KVINLKQKGAFRSFVAECEALRN 601
            +F     +G GSFG V   K +  G    + +    KV+ LKQ       + E   L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 98
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           +    L+K+         K      +V EY+  G +   L +      + + +       
Sbjct: 99  VNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFY 147
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           A  +    EYLH      +++ DLKP N+L+D      Q +        A +    +  +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ-----QGYIQVTDFGFAKRVKGRTWXL 199
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 548 SEFASSNMIGQGSFGSVY--KGILGGEEMIVAV----KVINLKQKGAFRSFVAECEALRN 601
            +F     +G GSFG V   K +  G    + +    KV+ LKQ       + E   L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ---IEHTLNEKRILQA 97
Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           +    L+K+         K      +V EY+  G +   L +      + + +       
Sbjct: 98  VNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMFSHLRR------IGRFSEPHARFY 146
Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGI 721
           A  +    EYLH      +++ DLKP N+L+D      Q +        A +    +  +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ-----QGYIQVTDFGFAKRVKGRTWXL 198
Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y+APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	854
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-114
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-104
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-101
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-99
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-70
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-80
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-61
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-44
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-77
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-75
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-73
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-72
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-66
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-55
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-32
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-32
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-72
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-72
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-61
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-44
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-35
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-70
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-69
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-65
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-63
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-59
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-50
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-34
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-29
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-63
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-63
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-58
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-55
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-27
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-61
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-59
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-58
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-47
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-38
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-26
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-22
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-57
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-52
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-52
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-51
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-50
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-28
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-50
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-50
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-49
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-48
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-48
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-40
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-25
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-09
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-45
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-45
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-45
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-44
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-39
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-30
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-43
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-33
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-42
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-39
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-38
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-26
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-21
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-42
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-38
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-28
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-18
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-32
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-27
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-38
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-31
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-27
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-30
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-20
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-35
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-30
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-28
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-06
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-35
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-32
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-24
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-22
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-30
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-31
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-31
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-31
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-31
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-29
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-30
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-30
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-30
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-08
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-30
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-30
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-28
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-12
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-29
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-29
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-29
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-29
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-29
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-29
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-29
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-29
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-25
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-21
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-19
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-28
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-28
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-28
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-27
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-20
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-14
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-27
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-27
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-26
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-26
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-19
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-26
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-19
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-08
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-25
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-25
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-23
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-23
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-05
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-21
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-24
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-20
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-06
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-19
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-14
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-18
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-22
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-21
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-21
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-12
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-21
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-21
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-06
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-21
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-05
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-19
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-19
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-19
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-05
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-04
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-13
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-07
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-18
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-10
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-17
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-16
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-16
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-16
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-06
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-09
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	7e-13
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-06
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-11
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-11
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-11
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-07
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-10
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-07
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-10
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	9e-10
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	9e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-07
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	9e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	6e-06
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	2e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	9e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-04
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	5e-05
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	4e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	8e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	7e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  364 bits (937), Expect = e-114
 Identities = 127/507 (25%), Positives = 209/507 (41%), Gaps = 71/507 (14%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLP-DFVGNLSALGMLLIRWNSLGGQIPTTL 60
           N   G +P   GS   L++LA+  N  +G+LP D +  +  L +L + +N   G++P +L
Sbjct: 304 NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363

Query: 61  G-LLRNLVYLNVAENQFSGMFPRWICNI--SSLEFIYLTVNRFSGSLPFDILVNLPNLKE 117
             L  +L+ L+++ N FSG     +C    ++L+ +YL  N F+G +P  +  N   L  
Sbjct: 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL-SNCSELVS 422

Query: 118 LYL-----------TFCSLKNLWWLNLEQNNL-GMGTASSIPDSLSNASNLERLDLSGNQ 165
           L+L           +  SL  L  L L  N L G      IP  L     LE L L  N 
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG-----EIPQELMYVKTLETLILDFND 477

Query: 166 FKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELP 225
             G++    S+  NL W++L  N L  G          +    +L  L L +N F G +P
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRL-TGE-----IPKWIGRLENLAILKLSNNSFSGNIP 531

Query: 226 HSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQ 285
             + +  S +I   +  N  +GTIP+ +      IA     N + G     +      ++
Sbjct: 532 AELGDCRS-LIWLDLNTNLFNGTIPAAMFKQSGKIAA----NFIAGKRYVYIKNDGMKKE 586

Query: 286 LYMFRNFLQ--GSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTG 343
            +   N L+  G     L  L+      ++     G+   +  N  ++   D S+N L+G
Sbjct: 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG 646

Query: 344 AIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPF 403
            IP+++                         G++         L  L++  N   G IP 
Sbjct: 647 YIPKEI-------------------------GSMP-------YLFILNLGHNDISGSIPD 674

Query: 404 SLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISL 463
            +G ++ +  L++SSN L G+IP+ +  L+ L  ++LS N+L G +P  G F        
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKF 734

Query: 464 QVNVKLCGGIDELHLLSCPSKGSRKPK 490
             N  LCG      L  C    +    
Sbjct: 735 LNNPGLCG----YPLPRCDPSNADGYA 757

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  339 bits (871), Expect = e-104
 Identities = 125/485 (25%), Positives = 219/485 (45%), Gaps = 47/485 (9%)

Query: 2   NKLEGQIPEEI---GSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPT 58
           N + G              L+ LAI  N ++G +   V     L  L +  N+    IP 
Sbjct: 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF 218

Query: 59  TLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKEL 118
            LG    L +L+++ N+ SG F R I   + L+ + ++ N+F G +P      L +L+ L
Sbjct: 219 -LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYL 274

Query: 119 YLT------------FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF 166
            L               +   L  L+L  N+       ++P    + S LE L LS N F
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHF----YGAVPPFFGSCSLLESLALSSNNF 330

Query: 167 KGKVSID-FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELP 225
            G++ +D    ++ L  L+L  N       +     +L    +SL  L L  N F G + 
Sbjct: 331 SGELPMDTLLKMRGLKVLDLSFNEF-----SGELPESLTNLSASLLTLDLSSNNFSGPIL 385

Query: 226 HSIANLSSTMIQ-FRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQ 284
            ++       +Q   +  N  +G IP  + N   L++L +  N L G IP  +G L  L+
Sbjct: 386 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445

Query: 285 QLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGA 344
            L ++ N L+G IP  L  +  L  L L FN+L G IPS L NC NL     S+N+LTG 
Sbjct: 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505

Query: 345 IPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFS 404
           IP+ +  +  L++ L L++N  + ++P ++G+ ++L+        LD+++N F+G IP +
Sbjct: 506 IPKWIGRLENLAI-LKLSNNSFSGNIPAELGDCRSLIW-------LDLNTNLFNGTIPAA 557

Query: 405 LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYN--HLEGEVPTK-GVFSNKTKI 461
           +          +++N ++G+   +++N    +  + + N    +G    +    S +   
Sbjct: 558 MFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613

Query: 462 SLQVN 466
           ++   
Sbjct: 614 NITSR 618

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  330 bits (849), Expect = e-101
 Identities = 123/460 (26%), Positives = 203/460 (44%), Gaps = 48/460 (10%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFV--GNLSALGMLLIRWNSLGGQIPTT 59
           + + G +        +L +L +  N L+G +      G+ S L  L +  N+L      +
Sbjct: 87  SHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVS 145

Query: 60  LGL-LRNLVYLNVAENQFSGMFPRWIC---NISSLEFIYLTVNRFSGSLPFDILVNLPNL 115
            GL L +L  L+++ N  SG              L+ + ++ N+ SG +           
Sbjct: 146 GGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD---------- 195

Query: 116 KELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS 175
                      NL +L++  NN     ++ IP  L + S L+ LD+SGN+  G  S   S
Sbjct: 196 ------VSRCVNLEFLDVSSNNF----STGIP-FLGDCSALQHLDISGNKLSGDFSRAIS 244

Query: 176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTM 235
           +   L  LN+  N    G               SL+ LSL +N+F GE+P  ++    T+
Sbjct: 245 TCTELKLLNISSNQFV-GPIPP-------LPLKSLQYLSLAENKFTGEIPDFLSGACDTL 296

Query: 236 IQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQ 294
               + GN   G +P    +   L +L +  N   G +P     +++ L+ L +  N   
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356

Query: 295 GSIPPSLGNLT-KLADLALSFNNLQGNIPSSLGNCQ--NLKGFDASHNKLTGAIPQQVLS 351
           G +P SL NL+  L  L LS NN  G I  +L       L+     +N  TG IP  + +
Sbjct: 357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN 416

Query: 352 ITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSI 411
            + L   L L+ N L+ ++P  +G+L         L  L +  N   G IP  L ++K++
Sbjct: 417 CSELV-SLHLSFNYLSGTIPSSLGSLSK-------LRDLKLWLNMLEGEIPQELMYVKTL 468

Query: 412 KELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPT 451
           + L +  N+L+G+IP  L N + L +++LS N L GE+P 
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  326 bits (837), Expect = 2e-99
 Identities = 110/445 (24%), Positives = 193/445 (43%), Gaps = 42/445 (9%)

Query: 13  GSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVA 72
             + ++   +   N     +   + +L+ L  L +  + + G +        +L  L+++
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108

Query: 73  ENQFSGMFP--RWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWW 130
            N  SG       + + S L+F+ ++ N           + L +L+ L L+  S+     
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI----- 163

Query: 131 LNLEQNNLGMGTASSIPDSL---SNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQ 187
                       + +             L+ L +SGN+  G   +D S   NL +L++  
Sbjct: 164 ------------SGANVVGWVLSDGCGELKHLAISGNKISG--DVDVSRCVNLEFLDVSS 209

Query: 188 NNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISG 247
           NN           +  L +CS+L+ L +  N+  G+   +I+  +  +    I  NQ  G
Sbjct: 210 NNFS-TG------IPFLGDCSALQHLDISGNKLSGDFSRAISTCTE-LKLLNISSNQFVG 261

Query: 248 TIPSGIRNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPPSLGNLTK 306
            IP     L +L  L++  N+  G IPD + G    L  L +  N   G++PP  G+ + 
Sbjct: 262 PIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319

Query: 307 LADLALSFNNLQGNIP-SSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNL 365
           L  LALS NN  G +P  +L   + LK  D S N+ +G +P+ + +++   + L L+ N 
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379

Query: 366 LNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQI 425
            +  +   +           +L+ L + +N F G IP +L     +  L++S N LSG I
Sbjct: 380 FSGPILPNLCQNPK-----NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434

Query: 426 PEFLQNLSFLEFLNLSYNHLEGEVP 450
           P  L +LS L  L L  N LEGE+P
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIP 459

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  244 bits (626), Expect = 9e-70
 Identities = 96/333 (28%), Positives = 150/333 (45%), Gaps = 22/333 (6%)

Query: 123 CSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWW 182
           C    +  ++L    L     S++  SL + + LE L LS +   G VS  F    +L  
Sbjct: 47  CRDDKVTSIDLSSKPLN-VGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTS 104

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG 242
           L+L +N+L       +  +T L +CS LK L++  N        S     +++    +  
Sbjct: 105 LDLSRNSLS----GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160

Query: 243 NQISGTIPSGIR---NLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP 299
           N ISG    G         L  L I  N++ G +   V    +L+ L +  N     I P
Sbjct: 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-P 217

Query: 300 SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYL 359
            LG+ + L  L +S N L G+   ++  C  LK  + S N+  G IP   L   +L  YL
Sbjct: 218 FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK--SL-QYL 274

Query: 360 ALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSN 419
           +LA N     +P  +         C +L  LD+S N F+G +P   G    ++ L +SSN
Sbjct: 275 SLAENKFTGEIPDFLSGA------CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328

Query: 420 NLSGQIP-EFLQNLSFLEFLNLSYNHLEGEVPT 451
           N SG++P + L  +  L+ L+LS+N   GE+P 
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  259 bits (663), Expect = 8e-80
 Identities = 87/343 (25%), Positives = 138/343 (40%), Gaps = 49/343 (14%)

Query: 145 SIPDSLSNASNL----ERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDF 200
            I   L N + L       D     + G +    +    +  L+L   NL          
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP-KP------ 65

Query: 201 VTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLI 260
                                  +P S+ANL      +  G N + G IP  I  L  L 
Sbjct: 66  ---------------------YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104

Query: 261 ALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGN 320
            L I    + G IPD + +++ L  L    N L G++PPS+ +L  L  +    N + G 
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164

Query: 321 IPSSLGNCQNL-KGFDASHNKLTGAIPQQVLSITTLS-VYLALAHNLLNDSLPLQVGNLK 378
           IP S G+   L      S N+LTG IP    +   L+  ++ L+ N+L     +  G+ K
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPP---TFANLNLAFVDLSRNMLEGDASVLFGSDK 221

Query: 379 NLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFL 438
           N        + + ++ NS    +   +G  K++  L++ +N + G +P+ L  L FL  L
Sbjct: 222 N-------TQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273

Query: 439 NLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSC 481
           N+S+N+L GE+P  G        +   N  LCG      L +C
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS----PLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  207 bits (530), Expect = 7e-61
 Identities = 71/348 (20%), Positives = 119/348 (34%), Gaps = 78/348 (22%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQ--LPDFVGNLSALGML-LIRWNSLGGQIPT 58
               G + +       +  L +    L     +P  + NL  L  L +   N+L G IP 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 59  TLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKEL 118
            +  L  L YL +     SG  P ++  I +L  +  + N  SG                
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG---------------- 139

Query: 119 YLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLK 178
                                     ++P S+S+  NL  +   GN+  G +   + S  
Sbjct: 140 --------------------------TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173

Query: 179 NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQF 238
            L                               ++++  N+  G++P + ANL+  +   
Sbjct: 174 KL-----------------------------FTSMTISRNRLTGKIPPTFANLN--LAFV 202

Query: 239 RIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIP 298
            +  N + G       +  N   + +  N L   +   VG  ++L  L +  N + G++P
Sbjct: 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLP 261

Query: 299 PSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIP 346
             L  L  L  L +SFNNL G IP   GN Q       ++NK     P
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  162 bits (413), Expect = 1e-44
 Identities = 75/301 (24%), Positives = 112/301 (37%), Gaps = 78/301 (25%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N L G IP  I  L  L  L I    ++G +PDF+  +  L  L   +N+L G +P ++ 
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSL-EFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
            L NLV +    N+ SG  P    + S L   + ++ NR +G                  
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG------------------ 188

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
                                    IP + +N  NL  +DLS N  +G  S+ F S KN 
Sbjct: 189 ------------------------KIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNT 223

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
             ++L +N+L                                +L   +    + +    +
Sbjct: 224 QKIHLAKNSL------------------------------AFDLG-KVGLSKN-LNGLDL 251

Query: 241 GGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRN-FLQGSIPP 299
             N+I GT+P G+  L  L +L +  N L G IP G G LQ         N  L GS  P
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLP 310

Query: 300 S 300
           +
Sbjct: 311 A 311

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  253 bits (649), Expect = 2e-77
 Identities = 103/316 (32%), Positives = 159/316 (50%), Gaps = 42/316 (13%)

Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILG-GEEMIVAVKVINLK-QKGAFRSFVAEC 596
           S  EL  A+  F++ N++G+G FG VYKG L  G    VAVK +  +  +G    F  E 
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL--VAVKRLKEERTQGGELQFQTEV 78

Query: 597 EALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
           E +    HRNL+++   C +        + LV+ YM NGS+   L +  +      L   
Sbjct: 79  EMISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPES--QPPLDWP 131

Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTP 715
           +R  IA+  A  + YLH HC P I+H D+K +N+LLD +  A   +F L+ +L     T 
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDTH 190

Query: 716 SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFT---EGLTLH 772
            ++  ++GT+G++APEY    ++S   DV+ +G++LLE+ TG+R  D A     + + L 
Sbjct: 191 VTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249

Query: 773 EFVKMTLPE-KVIEIVDPSL-----LMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSM 826
           ++VK  L E K+  +VD  L       EV     +IQ                  +LC+ 
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVE---QLIQ----------------VALLCTQ 290

Query: 827 ESPFERMEMRDVVAKL 842
            SP ER +M +VV  L
Sbjct: 291 SSPMERPKMSEVVRML 306

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  256 bits (655), Expect = 6e-75
 Identities = 68/488 (13%), Positives = 142/488 (29%), Gaps = 64/488 (13%)

Query: 2   NKLEGQ----IPEEIGSLLNLQTLAIDFNYLTGQLPDFVG--NLSALGMLLIRWNSLGGQ 55
           +  +       P+ I + ++ +       +      D+    + S L    I  +     
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174

Query: 56  IPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDI-----LV 110
           I  +  +      +    N  +    + +  ++ L   Y+  + F      +        
Sbjct: 175 IKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE 233

Query: 111 NLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKV 170
                K   L + +LK+L  + +          + +P  L     ++ ++++ N+     
Sbjct: 234 YAQQYKTEDLKWDNLKDLTDVEVYNCPN----LTKLPTFLKALPEMQLINVACNRGISGE 289

Query: 171 SI--------DFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGG 222
            +        D    + +  + +  NNL           T L     L  L    NQ  G
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE-----TSLQKMKKLGMLECLYNQLEG 344

Query: 223 ELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPD-GVGELQ 281
           +LP +  +    +    +  NQI+    +       +  L+   N+L  I        + 
Sbjct: 345 KLP-AFGSEIK-LASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVS 402

Query: 282 HLQQLYMFRNFLQG-------SIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGF 334
            +  +    N +          + P+      ++ + LS N +             L   
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462

Query: 335 DASHNKLTG-------AIPQQVLSITTLSVYLALAHNLLNDSLP--LQVGNLKNLVITCV 385
           +   N LT           +   +   L   + L  N L   L    +   L        
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLL-TSIDLRFNKLT-KLSDDFRATTLPY------ 514

Query: 386 SLEYLDISSNSFHGVIPFSLGFMKSIKELN------VSSNNLSGQIPEFLQNLSFLEFLN 439
            L  +D+S NSF    P       ++K            N    + PE +     L  L 
Sbjct: 515 -LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572

Query: 440 LSYNHLEG 447
           +  N +  
Sbjct: 573 IGSNDIRK 580

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  250 bits (641), Expect = 6e-73
 Identities = 72/468 (15%), Positives = 136/468 (29%), Gaps = 57/468 (12%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
            N +   + + +  L  L+   +  +    +                             
Sbjct: 192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKW 245

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
             L++L  + V         P ++  +  ++ I +  NR        +  +   L +   
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ--LKDDWQALADA-- 301

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
                + +  + +  NNL       +  SL     L  L+   NQ +GK+   F S   L
Sbjct: 302 --PVGEKIQIIYIGYNNL---KTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKL 355

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPH--SIANLSSTMIQF 238
             LNL  N +      ++           ++ LS   N+    +P+     ++S  M   
Sbjct: 356 ASLNLAYNQI-----TEIP-ANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSV-MSAI 407

Query: 239 RIGGNQISG-------TIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRN 291
               N+I          +       +N+ ++ +  NQ+     +       L  + +  N
Sbjct: 408 DFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGN 467

Query: 292 FLQG-------SIPPSLGNLTKLADLALSFNNLQGNIPS-SLGNCQNLKGFDASHNKLTG 343
            L             +  N   L  + L FN L              L G D S+N  + 
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK 527

Query: 344 AIPQQVLSITTLSV-----YLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFH 398
             P Q L+ +TL             N      P  +    +L         L I SN   
Sbjct: 528 -FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL-------TQLQIGSNDIR 579

Query: 399 GVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLE 446
            V         +I  L++  N        ++          L Y+  +
Sbjct: 580 KVNE---KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  249 bits (638), Expect = 2e-72
 Identities = 68/469 (14%), Positives = 140/469 (29%), Gaps = 51/469 (10%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           +  +  I +     L    +    N +T  +   V  L+ L    +  +    +      
Sbjct: 169 DPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAW 227

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
              N  Y                 N+  L  + +        LP  +   LP ++ + + 
Sbjct: 228 ENENSEYAQ-----QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL-KALPEMQLINVA 281

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFK-GKVSIDFSSLKNL 180
                +   L  +   L                 ++ + +  N  K   V      +K L
Sbjct: 282 CNRGISGEQLKDDWQALA---------DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
             L    N L          +    +   L +L+L  NQ    +P +    +  +     
Sbjct: 333 GMLECLYNQL-------EGKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSF 384

Query: 241 GGNQISGTIPS--GIRNLVNLIALTIEVNQLHGI-------IPDGVGELQHLQQLYMFRN 291
             N++   IP+    +++  + A+    N++  +       +     +  ++  + +  N
Sbjct: 385 AHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN 443

Query: 292 FLQGSIPPSLGNLTKLADLALSFNNLQG-------NIPSSLGNCQNLKGFDASHNKLTGA 344
            +           + L+ + L  N L         +   +  N   L   D   NKLT  
Sbjct: 444 QISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK- 502

Query: 345 IPQQVLSITTLS--VYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIP 402
           +       TTL   V + L++N  +   P Q  N   L          D   N      P
Sbjct: 503 LSDD-FRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLK-GFGIRNQRDAQGNRTLREWP 559

Query: 403 FSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPT 451
             +    S+ +L + SN++     +   N   +  L++  N       +
Sbjct: 560 EGITLCPSLTQLQIGSNDIRKVNEKITPN---ISVLDIKDNPNISIDLS 605

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  233 bits (595), Expect = 2e-66
 Identities = 67/466 (14%), Positives = 153/466 (32%), Gaps = 58/466 (12%)

Query: 6   GQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQ----IPTTLG 61
            Q    + S   +  L+++    +G++PD +G L+ L +L +  +          P  + 
Sbjct: 71  AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130

Query: 62  LLRNLVYLNVAENQFSGMFPRWI--CNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY 119
              +          +   F  +    + S L    +  +    S+     + L       
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL------- 183

Query: 120 LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKN 179
                      +    NN+     + +  ++   + L +  +  + F  +   +    +N
Sbjct: 184 -------KDTQIGQLSNNI-----TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN 231

Query: 180 LWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFR 239
             +    +         DL +     N   L  + + +     +LP  +  L   M    
Sbjct: 232 SEYAQQYKT-------EDLKW----DNLKDLTDVEVYNCPNLTKLPTFLKALPE-MQLIN 279

Query: 240 IGGNQI--------SGTIPSGIRNLVNLIALTIEVNQL-HGIIPDGVGELQHLQQLYMFR 290
           +  N+              +       +  + I  N L    +   + +++ L  L    
Sbjct: 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLY 339

Query: 291 NFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVL 350
           N L+G   P+ G+  KLA L L++N +     +  G  + ++    +HNKL   IP  + 
Sbjct: 340 NQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IP-NIF 396

Query: 351 SITTLS--VYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFM 408
              ++S    +  ++N +          L       +++  +++S+N             
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTG 456

Query: 409 KSIKELNVSSNNLSG-------QIPEFLQNLSFLEFLNLSYNHLEG 447
             +  +N+  N L+           E  +N   L  ++L +N L  
Sbjct: 457 SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  202 bits (515), Expect = 2e-55
 Identities = 55/424 (12%), Positives = 124/424 (29%), Gaps = 61/424 (14%)

Query: 49  WNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDI 108
            +  G Q   +L     +  L++     SG  P  I  ++ LE + L  +    +     
Sbjct: 66  LDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG 125

Query: 109 LVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKG 168
              +              +       + +         P    + S+L +  ++ +  + 
Sbjct: 126 PKGISA----------NMSDEQKQKMRMHYQKTFVDYDP--REDFSDLIKDCINSDPQQK 173

Query: 169 KVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL---LTNCSSLKALSLCDNQFGGELP 225
            +            +    NN+            +   +   + L+   + ++ F  E  
Sbjct: 174 SIKKSSRITLKDTQIGQLSNNIT----------FVSKAVMRLTKLRQFYMGNSPFVAENI 223

Query: 226 HSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQ 285
                  +          Q   T      NL +L  + +        +P  +  L  +Q 
Sbjct: 224 CEAWENEN------SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277

Query: 286 LYMFRNFL--------QGSIPPSLGNLTKLADLALSFNNLQ-GNIPSSLGNCQNLKGFDA 336
           + +  N                      K+  + + +NNL+   + +SL   + L   + 
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337

Query: 337 SHNKLTGAIPQQVLSITTLS--VYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISS 394
            +N+L G +P    +  +      L LA+N +   +P       N       +E L  + 
Sbjct: 338 LYNQLEGKLP----AFGSEIKLASLNLAYNQIT-EIP------ANFCGFTEQVENLSFAH 386

Query: 395 NSFHGV-IPFSLGFMKSIKELNVSSNNLSG-------QIPEFLQNLSFLEFLNLSYNHLE 446
           N    +   F    +  +  ++ S N +          +         +  +NLS N + 
Sbjct: 387 NKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446

Query: 447 GEVP 450
               
Sbjct: 447 KFPK 450

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  133 bits (337), Expect = 2e-32
 Identities = 53/302 (17%), Positives = 94/302 (31%), Gaps = 46/302 (15%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N+LEG      GS + L +L + +N +T    +F G    +  L    N L   IP    
Sbjct: 340 NQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFD 397

Query: 62  L--LRNLVYLNVAENQFSGM-------FPRWICNISSLEFIYLTVNRFSGSLPFDILVNL 112
              +  +  ++ + N+   +                ++  I L+ N+ S   P ++    
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK-FPKELFSTG 456

Query: 113 PNLKELYL------------------TFCSLKNLWWLNLEQNNLGMGTASSIPDSL--SN 152
             L  + L                   F +   L  ++L  N L     + + D    + 
Sbjct: 457 SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL-----TKLSDDFRATT 511

Query: 153 ASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFV-TLLTNCSSLK 211
              L  +DLS N F         +   L    + +N         L      +T C SL 
Sbjct: 512 LPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI-RNQRDAQGNRTLREWPEGITLCPSLT 569

Query: 212 ALSLCDNQFGGELPHSI-ANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLH 270
            L +  N     +   I  N+S       I  N       S +   +      +  ++  
Sbjct: 570 QLQIGSNDIRK-VNEKITPNISV----LDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

Query: 271 GI 272
            I
Sbjct: 625 DI 626

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  132 bits (333), Expect = 5e-32
 Identities = 36/269 (13%), Positives = 75/269 (27%), Gaps = 45/269 (16%)

Query: 204 LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISG----TIPSGIRNLVNL 259
           L +   +  LSL      G +P +I  L+  +    +G +          P GI   ++ 
Sbjct: 77  LNSNGRVTGLSLEGFGASGRVPDAIGQLTE-LEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 260 IALTIEVNQLHGIIPDGVGELQ--HLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNL 317
                          D         L +  +  +  Q SI  S     K   +    NN+
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195

Query: 318 QGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNL 377
              +  ++     L+ F   ++        +              +     +  L+  NL
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE------YAQQYKTEDLKWDNL 248

Query: 378 KNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEF 437
           K+L                                ++ V +     ++P FL+ L  ++ 
Sbjct: 249 KDL-------------------------------TDVEVYNCPNLTKLPTFLKALPEMQL 277

Query: 438 LNLSYNHLEGEVPTKGVFSNKTKISLQVN 466
           +N++ N        K  +       +   
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEK 306

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  249 bits (637), Expect = 7e-72
 Identities = 97/488 (19%), Positives = 179/488 (36%), Gaps = 35/488 (7%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVG---NLSALGMLLIRWNSLGGQIPT 58
           N+++   P    ++  L  L ++   L   L + +      +++  L +  + L     T
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 59  TLGLLR--NLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK 116
           T   L+  NL  L+++ N  + +       +  LE+ +L  N     L    L  L N++
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH-LFSHSLHGLFNVR 299

Query: 117 ELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS 176
            L L     ++    ++   +L          S      LE L++  N   G  S  F+ 
Sbjct: 300 YLNL----KRSFTKQSISLASL----PKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG 351

Query: 177 LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMI 236
           L NL +L+L  +   + T  +  FV+L    S L  L+L  N+       + + L   + 
Sbjct: 352 LINLKYLSLSNSFTSLRTLTNETFVSL--AHSPLHILNLTKNKISKIESDAFSWLGH-LE 408

Query: 237 QFRIGGNQISGTIPSG-IRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQG 295
              +G N+I   +     R L N+  + +  N+   +  +    +  LQ+L + R  L+ 
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468

Query: 296 --SIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT-------GAIP 346
             S P     L  L  L LS NN+       L   + L+  D  HN L           P
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528

Query: 347 QQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLG 406
              L   +    L L  N  ++       +L  L       + +D+  N+ + +      
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL-------KIIDLGLNNLNTLPASVFN 581

Query: 407 FMKSIKELNVSSNNLSGQIPE-FLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQV 465
              S+K LN+  N ++    + F      L  L++ +N  +    +   F N    +   
Sbjct: 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTN 641

Query: 466 NVKLCGGI 473
             +L    
Sbjct: 642 IPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  248 bits (636), Expect = 7e-72
 Identities = 93/479 (19%), Positives = 172/479 (35%), Gaps = 46/479 (9%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL 66
           Q+P+++ +  N+  L +  N L           S L  L + +N++    P     L  L
Sbjct: 18  QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75

Query: 67  VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL------ 120
             LN+  N+ S +  +     ++L  ++L  N     +  +  V   NL  L L      
Sbjct: 76  KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ-KIKNNPFVKQKNLITLDLSHNGLS 134

Query: 121 -----TFCSLKNLWWLNLEQNNLGMGTASSIPD---SLSNASNLERLDLSGNQFKGKVSI 172
                T   L+NL  L L  N +      ++      +   S+L++L+LS NQ K     
Sbjct: 135 STKLGTQVQLENLQELLLSNNKI-----QALKSEELDIFANSSLKKLELSSNQIKEFSPG 189

Query: 173 DFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLS 232
            F ++  L+ L L    L     +  + + L    +S++ LSL ++Q       +   L 
Sbjct: 190 CFHAIGRLFGLFLNNVQL---GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246

Query: 233 STMIQF-RIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRN 291
            T +    +  N ++         L  L    +E N +  +    +  L +++ L + R+
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306

Query: 292 FLQGSI---------PPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT 342
           F + SI           S   L  L  L +  N++ G   +      NLK    S++  +
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366

Query: 343 -GAIPQQVLSITTLS--VYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHG 399
              +  +       S    L L  N ++         L +       LE LD+  N    
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH-------LEVLDLGLNEIGQ 419

Query: 400 VIPFS-LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSN 457
            +       +++I E+ +S N            +  L+ L L    L+    +   F  
Sbjct: 420 ELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  217 bits (556), Expect = 8e-61
 Identities = 91/478 (19%), Positives = 161/478 (33%), Gaps = 51/478 (10%)

Query: 2   NKLEGQIPEEIG---SLLNLQTLAIDFNYLTGQLPDFVGNL--SALGMLLIRWNSLGGQI 56
            +L   + E++    +  +++ L++  + L+         L  + L ML + +N+L    
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264

Query: 57  PTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSL--------PFDI 108
             +   L  L Y  +  N    +F   +  + ++ ++ L  +    S+            
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324

Query: 109 LVNLPNLKELYL-----------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLE 157
              L  L+ L +            F  L NL +L+L  +   + T ++        S L 
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384

Query: 158 RLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCD 217
            L+L+ N+     S  FS L +L  L+L  N +G                 ++  + L  
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE-----WRGLENIFEIYLSY 439

Query: 218 NQFGGELPHSIANLSSTMIQFRIGGNQISG--TIPSGIRNLVNLIALTIEVNQLHGIIPD 275
           N++     +S A + S + +  +    +    + PS  + L NL  L +  N +  I  D
Sbjct: 440 NKYLQLTRNSFALVPS-LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498

Query: 276 GVGELQHLQQLYMFRNFLQ--------GSIPPSLGNLTKLADLALSFNNLQGNIPSSLGN 327
            +  L+ L+ L +  N L         G     L  L+ L  L L  N           +
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558

Query: 328 CQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSL 387
              LK  D   N L         +  +L   L L  NL+        G          +L
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLK-SLNLQKNLITSVEKKVFGPAFR------NL 611

Query: 388 EYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQI----PEFLQNLSFLEFLNLS 441
             LD+  N F         F+  I E + +   LS       P          F   S
Sbjct: 612 TELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSS 669

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  168 bits (428), Expect = 7e-44
 Identities = 64/307 (20%), Positives = 109/307 (35%), Gaps = 21/307 (6%)

Query: 155 NLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALS 214
           + E  D S  +      +      N+  LNL  N L    A +       T  S L +L 
Sbjct: 5   SHEVADCSHLKLT---QVPDDLPTNITVLNLTHNQLRRLPAAN------FTRYSQLTSLD 55

Query: 215 LCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIP 274
           +  N      P     L   +    +  N++S           NL  L +  N +  I  
Sbjct: 56  VGFNTISKLEPELCQKLPM-LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114

Query: 275 DGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQN--LK 332
           +   + ++L  L +  N L  +   +   L  L +L LS N +Q      L    N  LK
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174

Query: 333 GFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDI 392
             + S N++    P    +I  L   L L +  L  SL  ++           S+  L +
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLF-GLFLNNVQLGPSLTEKLCLELAN----TSIRNLSL 229

Query: 393 SSNSFHGVIPFSLGFMK--SIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVP 450
           S++        +   +K  ++  L++S NNL+    +    L  LE+  L YN+++    
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS 289

Query: 451 TKGVFSN 457
                  
Sbjct: 290 --HSLHG 294

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  143 bits (362), Expect = 2e-35
 Identities = 49/260 (18%), Positives = 96/260 (36%), Gaps = 15/260 (5%)

Query: 209 SLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQ 268
           S +       +   ++P    +L + +    +  NQ+     +       L +L +  N 
Sbjct: 5   SHEVADCSHLKLT-QVPD---DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 269 LHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNC 328
           +  + P+   +L  L+ L +  N L      +    T L +L L  N++Q    +     
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 329 QNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLE 388
           +NL   D SHN L+       + +  L   L L++N +      ++    N      SL+
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQ-ELLLSNNKIQALKSEELDIFAN-----SSLK 174

Query: 389 YLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQ---NLSFLEFLNLSYNHL 445
            L++SSN      P     +  +  L +++  L   + E L      + +  L+LS + L
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234

Query: 446 EGEVPTKGVFSNKTKISLQV 465
                    F      +L +
Sbjct: 235 STTSN--TTFLGLKWTNLTM 252

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  233 bits (596), Expect = 6e-70
 Identities = 94/339 (27%), Positives = 153/339 (45%), Gaps = 45/339 (13%)

Query: 517 RRRRSAHKSVDTSPAKKQFPM----ISYAELSKATSEFASSNMIGQGSFGSVYKGILGGE 572
           +  ++ +   D   +    P     +   +L +AT+ F    +IG G FG VYKG+L  +
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RD 62

Query: 573 EMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYM 632
              VA+K    +       F  E E L   RH +L+ +I  C        +   L+++YM
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYM 117

Query: 633 ENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 692
           ENG+L+  L+ S+       ++  QR+ I I  A  + YLH      I+H D+K  N+LL
Sbjct: 118 ENGNLKRHLYGSDLP--TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILL 172

Query: 693 DHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG------DVY 745
           D + V    +F +S +     +T  S++ +KGT+GY+ PEY       + G      DVY
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHLSTV-VKGTLGYIDPEY------FIKGRLTEKSDVY 225

Query: 746 SFGILLLEMFTGRRPTDAAFTEG-LTLHEFVKMTLPE-KVIEIVDPSLLMEVMANNSMIQ 803
           SFG++L E+   R     +     + L E+   +    ++ +IVDP+L  ++        
Sbjct: 226 SFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI-------- 277

Query: 804 EDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL 842
                   + L     T V C   S  +R  M DV+ KL
Sbjct: 278 ------RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  239 bits (613), Expect = 3e-69
 Identities = 96/488 (19%), Positives = 171/488 (35%), Gaps = 51/488 (10%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            +++        SL +L TL +  N +          LS+L  L+    +L       +G
Sbjct: 62  CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121

Query: 62  LLRNLVYLNVAENQFSGM-FPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK---- 116
            L+ L  LNVA N       P +  N+++LE + L+ N+       D L  L  +     
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD-LRVLHQMPLLNL 180

Query: 117 ELYLTFCSLK----------NLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF 166
            L L+   +            L  L L  N     + + +   +   + LE   L   +F
Sbjct: 181 SLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFD---SLNVMKTCIQGLAGLEVHRLVLGEF 237

Query: 167 KGKVSI---DFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE 223
           + + ++   D S+L+ L  L +E+  L        D + L    +++ + SL        
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297

Query: 224 LPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHL 283
              S    +       +   +        +++L  L           G       +L  L
Sbjct: 298 KDFS---YNFGWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSL 349

Query: 284 QQLYMFRNFLQ--GSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKL 341
           + L + RN L   G    S    T L  L LSFN +   + S+    + L+  D  H+ L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408

Query: 342 TGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVI------------------T 383
                  V       +YL ++H     +       L +L +                   
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

Query: 384 CVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYN 443
             +L +LD+S      + P +   + S++ LN+S NN         + L+ L+ L+ S N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528

Query: 444 HLEGEVPT 451
           H+      
Sbjct: 529 HIMTSKKQ 536

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  228 bits (583), Expect = 4e-65
 Identities = 98/506 (19%), Positives = 162/506 (32%), Gaps = 63/506 (12%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N L         S   LQ L +    +         +LS L  L++  N +         
Sbjct: 38  NPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 97

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL- 120
            L +L  L   E   + +    I ++ +L+ + +  N        +   NL NL+ L L 
Sbjct: 98  GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157

Query: 121 ----------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKV 170
                         L  +  LNL   +L +   + I         L +L L  N     V
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLS-LDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNV 216

Query: 171 S----------------------------IDFSSLKNLWWLNLEQNNLGMGTANDLDFVT 202
                                         D S+L+ L  L +E+  L        D + 
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276

Query: 203 LLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIAL 262
           L    +++ + SL           S    +       +   +        +++L  L   
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFS---YNFGWQHLELVNCKFGQFPTLKLKSLKRLT-- 331

Query: 263 TIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQ--GSIPPSLGNLTKLADLALSFNNLQGN 320
                   G       +L  L+ L + RN L   G    S    T L  L LSFN +   
Sbjct: 332 ---FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT- 387

Query: 321 IPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNL 380
           + S+    + L+  D  H+ L       V       +YL ++H     +       L   
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS-- 445

Query: 381 VITCVSLEYLDISSNSFHGVI-PFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLN 439
                SLE L ++ NSF     P     ++++  L++S   L    P    +LS L+ LN
Sbjct: 446 -----SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500

Query: 440 LSYNHLEGEVPTKGVFSNKTKISLQV 465
           +S+N+          +      SLQV
Sbjct: 501 MSHNNFFSLDT--FPYKCLN--SLQV 522

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  223 bits (571), Expect = 2e-63
 Identities = 93/471 (19%), Positives = 164/471 (34%), Gaps = 48/471 (10%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTG-QLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
             L       IG L  L+ L +  N +   +LP++  NL+ L  L +  N +     T L
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169

Query: 61  GLLRNL----VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK 116
            +L  +    + L+++ N  + + P     I  L  + L  N  S ++    +  L  L+
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLE 228

Query: 117 ELYL--------------TFCSLKNLWWLNLEQNNLGM--GTASSIPDSLSNASNLERLD 160
              L                 +L+ L  L +E+  L         I D  +  +N+    
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288

Query: 161 LSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQF 220
           L     +     DFS       L L               + L     SLK L+   N+ 
Sbjct: 289 LVSVTIER--VKDFSYNFGWQHLELVNCKF-----GQFPTLKLK----SLKRLTFTSNKG 337

Query: 221 GGELPHSIANLSSTMIQFRIGGNQIS--GTIPSGIRNLVNLIALTIEVNQLHGIIPDGVG 278
           G     S  +L S      +  N +S  G          +L  L +  N +  +      
Sbjct: 338 GN--AFSEVDLPSLEF-LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFL 393

Query: 279 ELQHLQQLYMFRNFLQGSIPPS-LGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDAS 337
            L+ L+ L    + L+     S   +L  L  L +S  + +           +L+    +
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453

Query: 338 HNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSF 397
            N         + +      +L L+   L    P    +L +L       + L++S N+F
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL-------QVLNMSHNNF 506

Query: 398 HGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNL-SFLEFLNLSYNHLEG 447
             +  F    + S++ L+ S N++     + LQ+  S L FLNL+ N    
Sbjct: 507 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  211 bits (538), Expect = 6e-59
 Identities = 85/471 (18%), Positives = 156/471 (33%), Gaps = 56/471 (11%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL 66
           +IP+ +    + + L + FN L         +   L +L +    +          L +L
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 67  VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL------ 120
             L +  N    +       +SSL+ +       +  L    + +L  LKEL +      
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQ 137

Query: 121 ------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLE----RLDLSGNQFKGKV 170
                  F +L NL  L+L  N +     S     L     +      LDLS N      
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQ----SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193

Query: 171 SIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE--LPHSI 228
              F  +  L  L L  N   +           +   + L+   L   +F  E  L    
Sbjct: 194 PGAFKEI-RLHKLTLRNNFDSLNVMKT-----CIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 229 ANLSSTMIQFRIGGNQIS------GTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQH 282
            +    +    I   +++        I      L N+ + ++    +  +          
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFG 305

Query: 283 LQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT 342
            Q L +            L +L +     L+F + +G    S  +  +L+  D S N L+
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKR-----LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360

Query: 343 --GAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGV 400
             G   Q     T+L  YL L+ N +  ++      L+        LE+LD   ++   +
Sbjct: 361 FKGCCSQSDFGTTSLK-YLDLSFNGVI-TMSSNFLGLEQ-------LEHLDFQHSNLKQM 411

Query: 401 IPFS-LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVP 450
             FS    ++++  L++S  +           LS LE L ++ N  +    
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  186 bits (475), Expect = 2e-50
 Identities = 76/456 (16%), Positives = 140/456 (30%), Gaps = 65/456 (14%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLP-DFVGNLSALGMLLIRWNSLGGQI---P 57
           N +   I       + L  L +  N+ +  +    +  L+ L +  +       +     
Sbjct: 187 NPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 58  TTLGLLRNLVYLNVAENQFSGM------FPRWICNISSLEFIYLTVNRFSGSLPFDILVN 111
                L  L  L + E + + +             ++++    L          F     
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG 305

Query: 112 LPNLKELY-----LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ- 165
             +L+ +           LK+L  L    N            S  +  +LE LDLS N  
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG------GNAFSEVDLPSLEFLDLSRNGL 359

Query: 166 -FKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGEL 224
            FKG  S       +L +L+L  N +   ++N             L+ L    +      
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-------FLGLEQLEHLDFQHSNLKQMS 412

Query: 225 PHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHG-IIPDGVGELQHL 283
             S+      +I   I               L +L  L +  N      +PD   EL++L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472

Query: 284 QQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTG 343
             L + +  L+   P +  +L+ L  L +S NN             +L+  D S N +  
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 532

Query: 344 AIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPF 403
           +  Q++    +                               SL +L+++ N F      
Sbjct: 533 SKKQELQHFPS-------------------------------SLAFLNLTQNDFACTCEH 561

Query: 404 S--LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEF 437
              L ++K  ++L V    +    P   Q +  L  
Sbjct: 562 QSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  137 bits (348), Expect = 5e-34
 Identities = 44/242 (18%), Positives = 86/242 (35%), Gaps = 9/242 (3%)

Query: 230 NLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMF 289
           NL  +     +  N +         +   L  L +   ++  I       L HL  L + 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 290 RNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQV 349
            N +Q     +   L+ L  L     NL       +G+ + LK  + +HN +      + 
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 350 LSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMK 409
            S  T   +L L+ N +       +  L  + +  +S   LD+S N  + + P +   + 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS---LDLSLNPMNFIQPGAFKEI- 200

Query: 410 SIKELNVSSNNLSGQIPE-FLQNLSFLEFLNLSYNHLEG----EVPTKGVFSNKTKISLQ 464
            + +L + +N  S  + +  +Q L+ LE   L           E   K        ++++
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 465 VN 466
             
Sbjct: 261 EF 262

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  122 bits (308), Expect = 4e-29
 Identities = 54/245 (22%), Positives = 88/245 (35%), Gaps = 22/245 (8%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPT-T 59
               +G   +      +L+ L + FN +     +F   L  L  L  + ++L        
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNF-LGLEQLEHLDFQHSNLKQMSEFSV 416

Query: 60  LGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY 119
              LRNL+YL+++       F      +SSLE + +  N F  +   DI   L NL  L 
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476

Query: 120 L-----------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKG 168
           L            F SL +L  LN+  NN      S         ++L+ LD S N    
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNF----FSLDTFPYKCLNSLQVLDYSLNHIMT 532

Query: 169 KVSIDFSSL-KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHS 227
               +      +L +LNL QN+    T     F+  + +    + L +   +     P  
Sbjct: 533 SKKQELQHFPSSLAFLNLTQNDF-ACTCEHQSFLQWIKD---QRQLLVEVERMECATPSD 588

Query: 228 IANLS 232
              + 
Sbjct: 589 KQGMP 593

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  214 bits (548), Expect = 2e-63
 Identities = 84/335 (25%), Positives = 139/335 (41%), Gaps = 56/335 (16%)

Query: 527 DTSPAKKQFPMISYAELSKATSEF------ASSNMIGQGSFGSVYKGILGGEEMIVAVK- 579
               +  +F   S+ EL   T+ F         N +G+G FG VYKG +      VAVK 
Sbjct: 4   SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKK 61

Query: 580 ---VINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGS 636
              ++++  +   + F  E + +   +H NL++++   S       D   LV+ YM NGS
Sbjct: 62  LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNGS 116

Query: 637 LEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 696
           L D L   +       L+   R  IA   A+ I +LH +     +H D+K +N+LLD   
Sbjct: 117 LLDRLSCLDGTP---PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAF 170

Query: 697 VAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG------DVYSFGI 749
            A   +F L+   +  ++T  +S  I GT  Y+APE        + G      D+YSFG+
Sbjct: 171 TAKISDFGLARASEKFAQTVMTS-RIVGTTAYMAPEA-------LRGEITPKSDIYSFGV 222

Query: 750 LLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK--VIEIVDPSLLMEVMANNSMIQEDRR 807
           +LLE+ TG    D        L +  +    E+  + + +D  +      N++       
Sbjct: 223 VLLEIITGLPAVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKM------NDADSTSVEA 275

Query: 808 ARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL 842
                           C  E   +R +++ V   L
Sbjct: 276 M---------YSVASQCLHEKKNKRPDIKKVQQLL 301

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  227 bits (581), Expect = 4e-63
 Identities = 71/484 (14%), Positives = 146/484 (30%), Gaps = 50/484 (10%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
           +N     I ++    L    +    N +T  +   +  L+ L ++    +          
Sbjct: 410 RNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVD 468

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
               N  Y      +          N+  L  + L        LP D L +LP L+ L +
Sbjct: 469 WEDANSDY-----AKQYENEELSWSNLKDLTDVELYNCPNMTQLP-DFLYDLPELQSLNI 522

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKG-KVSIDFSSLKN 179
                 +   L  +           + D       ++   +  N  +    S     +  
Sbjct: 523 ACNRGISAAQLKADWTR--------LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVK 574

Query: 180 LWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFR 239
           L  L+   N +          +        L  L L  NQ   E+P      +  +    
Sbjct: 575 LGLLDCVHNKVR--------HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLG 625

Query: 240 IGGNQISGTIPS--GIRNLVNLIALTIEVNQLHGIIPD-----GVGELQHLQQLYMFRNF 292
              N++   IP+    +++  + ++    N++     +        +  +   + +  N 
Sbjct: 626 FSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684

Query: 293 LQGSIPPSLGNLTKLADLALSFNNLQ-------GNIPSSLGNCQNLKGFDASHNKLTGAI 345
           +Q          + ++ + LS N +             +  N   L   D   NKLT  +
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-L 743

Query: 346 PQQVLSITTLSV--YLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPF 403
                  TTL     + +++N  + S P Q  N   L    +     D   N      P 
Sbjct: 744 SDD-FRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIR-HQRDAEGNRILRQWPT 800

Query: 404 SLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHL-EGEVPTKGVFSNKTKIS 462
            +    S+ +L + SN++     +       L  L+++ N     +V +   +       
Sbjct: 801 GITTCPSLIQLQIGSNDIRKVDEKLTPQ---LYILDIADNPNISIDVTSVCPYIEAGMYV 857

Query: 463 LQVN 466
           L  +
Sbjct: 858 LLYD 861

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  213 bits (544), Expect = 3e-58
 Identities = 61/479 (12%), Positives = 129/479 (26%), Gaps = 83/479 (17%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N++   I + I  L  LQ +    +  T                   +         +  
Sbjct: 435 NRITF-ISKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEELSWS 488

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPF--------DILVNLP 113
            L++L  + +         P ++ ++  L+ + +  NR   +           D     P
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548

Query: 114 NLKELYL------------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDL 161
            ++  Y+            +   +  L  L+   N +         ++      L  L L
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV------RHLEAFGTNVKLTDLKL 602

Query: 162 SGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFG 221
             NQ +       +    +  L    N L       +  +    +   + ++    N+ G
Sbjct: 603 DYNQIEEIPEDFCAFTDQVEGLGFSHNKL-----KYIPNIFNAKSVYVMGSVDFSYNKIG 657

Query: 222 GELPHSIANLSS----TMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGI----- 272
            E  +   ++            +  N+I             +  + +  N +  I     
Sbjct: 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSL 717

Query: 273 --IPDGVGELQHLQQLYMFRNFLQGSIPPSL--GNLTKLADLALSFNNLQGNIPSSLGNC 328
                       L  + +  N L  S+        L  L+++ +S+N      P+   N 
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775

Query: 329 QNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLE 388
             LK F   H                         N +    P  +    +L        
Sbjct: 776 SQLKAFGIRHQ-------------------RDAEGNRILRQWPTGITTCPSL-------I 809

Query: 389 YLDISSNSFHGVIPFSLGFMKSIKELNVSSNNL-SGQIPEFLQNLSFLEFLNLSYNHLE 446
            L I SN     +   L     +  L+++ N   S  +      +       L Y+  +
Sbjct: 810 QLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIE-AGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  203 bits (518), Expect = 9e-55
 Identities = 64/455 (14%), Positives = 138/455 (30%), Gaps = 50/455 (10%)

Query: 24  DFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRW 83
           + +    Q    + N   +  L +      G++P  +G L  L  L+   +  +     +
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366

Query: 84  ICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT---------FCSLKNLWWLNLE 134
                + +      +R         L     L    L             +K    ++L+
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK 426

Query: 135 QNNLGMGTA--SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGM 192
              +G  T   + I  ++   + L+ +  + + F            N  +    +N    
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEEL- 485

Query: 193 GTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISG----- 247
                       +N   L  + L +     +LP  + +L   +    I  N+        
Sbjct: 486 ----------SWSNLKDLTDVELYNCPNMTQLPDFLYDLPE-LQSLNIACNRGISAAQLK 534

Query: 248 ----TIPSGIRNLVNLIALTIEVNQLHGI-IPDGVGELQHLQQLYMFRNFLQGSIPPSLG 302
                +         +    +  N L        + ++  L  L    N +      + G
Sbjct: 535 ADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFG 592

Query: 303 NLTKLADLALSFNNLQGNIPSSLG-NCQNLKGFDASHNKLTGAIPQQVLSITTLS--VYL 359
              KL DL L +N ++  IP         ++G   SHNKL   IP  + +  ++     +
Sbjct: 593 TNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IP-NIFNAKSVYVMGSV 649

Query: 360 ALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSN 419
             ++N +  S    +    +     ++   + +S N               I  + +S+N
Sbjct: 650 DFSYNKIG-SEGRNISCSMDD-YKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707

Query: 420 NLS-------GQIPEFLQNLSFLEFLNLSYNHLEG 447
            ++              +N   L  ++L +N L  
Sbjct: 708 LMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  116 bits (292), Expect = 7e-27
 Identities = 44/365 (12%), Positives = 105/365 (28%), Gaps = 63/365 (17%)

Query: 107 DILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF 166
           ++ + L    E    + +LK +W     +N        +      N +  + LD+ G+Q 
Sbjct: 256 NVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQP 315

Query: 167 KGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPH 226
                +D  +   +  L+L                                    G +P 
Sbjct: 316 ----GVDLDNNGRVTGLSLAGFGA------------------------------KGRVPD 341

Query: 227 SIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGE-LQHLQQ 285
           +I  L+  +     G +  + +        +         +++         +  Q L  
Sbjct: 342 AIGQLTE-LKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNL 400

Query: 286 LYMFRNFLQG---SIPPSLGNLTKLADLALS-FNNLQGNIPSSLGNCQNLKGFDASHNKL 341
             + ++ +       P    +   L D  +    N    I  ++     L+    +++  
Sbjct: 401 SDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPF 460

Query: 342 TGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVI 401
           T                    +    ++  L   NLK+       L  +++ +      +
Sbjct: 461 TYDNIAVDWEDANSD------YAKQYENEELSWSNLKD-------LTDVELYNCPNMTQL 507

Query: 402 PFSLGFMKSIKELNVSSNNLSG---------QIPEFLQNLSFLEFLNLSYNHLEGEVPTK 452
           P  L  +  ++ LN++ N             ++ +       ++   + YN+LE E P  
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPAS 566

Query: 453 GVFSN 457
                
Sbjct: 567 ASLQK 571

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 10/94 (10%), Positives = 31/94 (32%)

Query: 390 LDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEV 449
            +   + +       L     +  L+++     G++P+ +  L+ L+ L+   +      
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 450 PTKGVFSNKTKISLQVNVKLCGGIDELHLLSCPS 483
              G       +S +   ++     ++ L     
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  217 bits (556), Expect = 2e-61
 Identities = 95/508 (18%), Positives = 170/508 (33%), Gaps = 68/508 (13%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N L          L+NL  L +    +     D   +   L  L++  N L     T L 
Sbjct: 43  NVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALS 102

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL- 120
             + L +L   +   S +    + N  +LE +YL  N  S S+          LK L   
Sbjct: 103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGFPTEKLKVLDFQ 161

Query: 121 ----------TFCSLKNL--WWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKG 168
                        SL+      LNL  N++     + I     +++  + L+  G Q   
Sbjct: 162 NNAIHYLSKEDMSSLQQATNLSLNLNGNDI-----AGIEPGAFDSAVFQSLNFGGTQNLL 216

Query: 169 KV--SIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNC-SSLKALSLCDNQFGGELP 225
            +   +  S++++LW    E  +       D+        C  S+++++L  + F     
Sbjct: 217 VIFKGLKNSTIQSLWLGTFEDMDD-----EDISPAVFEGLCEMSVESINLQKHYFFNISS 271

Query: 226 HSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQ 285
           ++    S  + +  +    +S  +PSG+  L  L  L +  N+   +          L  
Sbjct: 272 NTFHCFSG-LQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329

Query: 286 LYMFRNFLQGSIPP---------------------------SLGNLTKLADLALSFNNLQ 318
           L +  N  +  +                              L NL+ L  L LS+N   
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389

Query: 319 GNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLK 378
                +   C  L+  D +  +L     Q       L   L L+H+LL+ S       L 
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449

Query: 379 NLVITCVSLEYLDISSNSFHGVIPFSLGF---MKSIKELNVSSNNLSGQIPEFLQNLSFL 435
                   L++L++  N F             +  ++ L +S  +LS        +L  +
Sbjct: 450 A-------LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502

Query: 436 EFLNLSYNHLEGEVPTKGVFSNKTKISL 463
             ++LS+N L          S+   I L
Sbjct: 503 NHVDLSHNRLTSSSI--EALSHLKGIYL 528

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  210 bits (537), Expect = 8e-59
 Identities = 89/470 (18%), Positives = 150/470 (31%), Gaps = 40/470 (8%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL 66
           +IP  + +  + + L   FN L          L  L  L +    +      T      L
Sbjct: 26  EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83

Query: 67  VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL------ 120
             L +  N    M    +    +L+ ++      S S+ F  L N   L+ LYL      
Sbjct: 84  DTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTLESLYLGSNHIS 142

Query: 121 -----TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLER--LDLSGNQFKGKVSID 173
                     + L  L+ + N +         + +S+        L+L+GN   G +   
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAI----HYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPG 197

Query: 174 FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSS 233
                    LN       +     L   T+     SL   +  D       P     L  
Sbjct: 198 AFDSAVFQSLNFGGTQNLLVIFKGLKNSTI----QSLWLGTFEDMDDEDISPAVFEGLCE 253

Query: 234 TMIQ-FRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNF 292
             ++   +  +       +       L  L +    L   +P G+  L  L++L +  N 
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANK 312

Query: 293 LQGSIPPSLGNLTKLADLALSFNNLQGNIPS-SLGNCQNLKGFDASHNKLTGAIPQQVLS 351
            +     S  N   L  L++  N  +  + +  L N +NL+  D SH+ +        L 
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET-SDCCNLQ 371

Query: 352 ITTLS--VYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFS-LGFM 408
           +  LS    L L++N       L+    K        LE LD++          S    +
Sbjct: 372 LRNLSHLQSLNLSYNEPLS---LKTEAFKEC----PQLELLDLAFTRLKVKDAQSPFQNL 424

Query: 409 KSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTK-GVFSN 457
             +K LN+S + L     +    L  L+ LNL  NH       K      
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  208 bits (531), Expect = 6e-58
 Identities = 95/503 (18%), Positives = 169/503 (33%), Gaps = 61/503 (12%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            ++     +   S   L TL +  N L       +    AL  L      +       L 
Sbjct: 67  CQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLH 126

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL- 120
             + L  L +  N  S +          L+ +    N     L  + + +L     L L 
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLN 185

Query: 121 -------------------------------------TFCSLKNLWWLNLEQNNLGMGTA 143
                                                   ++++LW    E  +     +
Sbjct: 186 LNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD-EDIS 244

Query: 144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL 203
            ++ + L    ++E ++L  + F    S  F     L  L+L   +L        +  + 
Sbjct: 245 PAVFEGLCE-MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-------ELPSG 296

Query: 204 LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSG-IRNLVNLIAL 262
           L   S+LK L L  N+F      S +N  S +    I GN     + +G + NL NL  L
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPS-LTHLSIKGNTKRLELGTGCLENLENLREL 355

Query: 263 TIEVNQLHGI--IPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGN 320
            +  + +         +  L HLQ L +  N        +     +L  L L+F  L+  
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415

Query: 321 IP-SSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKN 379
              S   N   LK  + SH+ L  +  Q    +  L  +L L  N        +  +L+ 
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL-QHLNLQGNHFPKGNIQKTNSLQT 474

Query: 380 LVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLN 439
           L      LE L +S      +   +   +K +  +++S N L+    E L +L  + +LN
Sbjct: 475 LG----RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLN 529

Query: 440 LSYNHLEGEVPTKGVFSNKTKIS 462
           L+ NH+   +P   +    ++  
Sbjct: 530 LASNHISIILP--SLLPILSQQR 550

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  178 bits (453), Expect = 2e-47
 Identities = 88/468 (18%), Positives = 157/468 (33%), Gaps = 67/468 (14%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLT-GQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
           N +     E++ SL     L+++ N      +     + +    L          I   L
Sbjct: 163 NAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222

Query: 61  GL--LRNLVYLNVAENQFSGMFPRWICNIS--SLEFIYLTVNRFSGSLPFDILVNLPNLK 116
               +++L      +     + P     +   S+E I L  + F  ++  +       L+
Sbjct: 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF-NISSNTFHCFSGLQ 281

Query: 117 ELYL----------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF 166
           EL L              L  L  L L  N       +    S SN  +L  L + GN  
Sbjct: 282 ELDLTATHLSELPSGLVGLSTLKKLVLSANKFE----NLCQISASNFPSLTHLSIKGNTK 337

Query: 167 KGKVSID-FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELP 225
           + ++      +L+NL  L+L  +++      +L       N S L++L+L  N+      
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKT 393

Query: 226 HSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGVGELQHLQ 284
            +       +    +   ++         +NL  L  L +  + L          L  LQ
Sbjct: 394 EAFKECPQ-LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ 452

Query: 285 QLYMFRNFLQGSI---PPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKL 341
            L +  N           SL  L +L  L LSF +L      +  + + +   D SHN+L
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512

Query: 342 TGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVI 401
           T     + LS                        +LK +        YL+++SN    ++
Sbjct: 513 TS-SSIEALS------------------------HLKGI--------YLNLASNHISIIL 539

Query: 402 PFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEV 449
           P  L  +   + +N+  N L         N+ FLE+   +   LE   
Sbjct: 540 PSLLPILSQQRTINLRQNPLDCTC----SNIYFLEWYKENMQKLEDTE 583

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  150 bits (381), Expect = 3e-38
 Identities = 66/346 (19%), Positives = 112/346 (32%), Gaps = 50/346 (14%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
           K+               LQ L +   +L+                         ++P+ L
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-------------------------ELPSGL 297

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
             L  L  L ++ N+F  +      N  SL  + +  N     L    L NL NL+EL L
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
           +   ++                       L N S+L+ L+LS N+     +  F     L
Sbjct: 358 SHDDIETS---------------DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL 402

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
             L+L    L        D  +   N   LK L+L  +            L + +    +
Sbjct: 403 ELLDLAFTRL-----KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA-LQHLNL 456

Query: 241 GGNQISGTI---PSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSI 297
            GN          + ++ L  L  L +    L  I       L+ +  + +  N L  S 
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516

Query: 298 PPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTG 343
             +L +L  +  L L+ N++   +PS L      +  +   N L  
Sbjct: 517 IEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  113 bits (285), Expect = 4e-26
 Identities = 38/239 (15%), Positives = 73/239 (30%), Gaps = 11/239 (4%)

Query: 229 ANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYM 288
             L ++        N +     +    L+NL  L +   Q++ I  D       L  L +
Sbjct: 29  GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVL 88

Query: 289 FRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQ 348
             N L      +L     L  L      +       L N + L+      N ++     +
Sbjct: 89  TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148

Query: 349 VLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFM 408
                 L   L   +N ++      + +L+       +   L+++ N   G I       
Sbjct: 149 GFPTEKL-KVLDFQNNAIHYLSKEDMSSLQQA-----TNLSLNLNGNDIAG-IEPGAFDS 201

Query: 409 KSIKELNVSSNNLSGQIPEFLQNLSF--LEFLNLSYNHLEGEVPTKGVFSNKTKISLQV 465
              + LN         I + L+N +   L          E    +  VF    ++S++ 
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED--ISPAVFEGLCEMSVES 258

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 99.7 bits (249), Expect = 8e-22
 Identities = 35/213 (16%), Positives = 63/213 (29%), Gaps = 12/213 (5%)

Query: 273 IPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLK 332
           IP  +      + L    N L      +   L  L  L L+   +      +  +   L 
Sbjct: 27  IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84

Query: 333 GFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDI 392
               + N L       +     L   L      ++    + + N K L       E L +
Sbjct: 85  TLVLTANPLIFMAETALSGPKALKH-LFFIQTGISSIDFIPLHNQKTL-------ESLYL 136

Query: 393 SSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLE--FLNLSYNHLEGEVP 450
            SN    +        + +K L+  +N +     E + +L       LNL+ N + G  P
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP 196

Query: 451 TKGVFSNKTKISLQVNVKLCGGIDELHLLSCPS 483
                +    ++      L      L   +  S
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  199 bits (508), Expect = 1e-57
 Identities = 70/320 (21%), Positives = 131/320 (40%), Gaps = 35/320 (10%)

Query: 538 ISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECE 597
           +    L   +       +  +G FG V+K  L  E   VAVK+  ++ K +++    E  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQSWQ-NEYEVY 70

Query: 598 ALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQ 657
           +L  ++H N+++ I       +       L+  + E GSL D+L  +        ++  +
Sbjct: 71  SLPGMKHENILQFIGAEKR-GTSVDVDLWLITAFHEKGSLSDFLKAN-------VVSWNE 122

Query: 658 RVNIAIDVASAIEYLHHH-------CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLD 709
             +IA  +A  + YLH          +P I H D+K  NVLL +++ A   +F L+ + +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 710 SASKTPSSSIGIKGTVGYVAPEYGMGS-----EASMTGDVYSFGILLLEMFTGRRPTDAA 764
           +  K+   + G  GT  Y+APE   G+     +A +  D+Y+ G++L E+ +     D  
Sbjct: 183 A-GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

Query: 765 FTEGLTLHEFVKMTLP--EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGV 822
             E +   E      P  E + E+V       V+ +          +    +  +  T  
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW--------QKHAGMAMLCETIE 293

Query: 823 LCSMESPFERMEMRDVVAKL 842
            C       R+    V  ++
Sbjct: 294 ECWDHDAEARLSAGCVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  184 bits (469), Expect = 4e-52
 Identities = 76/333 (22%), Positives = 128/333 (38%), Gaps = 50/333 (15%)

Query: 538 ISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECE 597
            + +E S          +IG+G +G+VYKG L      VAVKV +   +   ++F+ E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNFINEKN 57

Query: 598 --ALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTL 655
              +  + H N+ + I     + + G     LV EY  NGSL  +L              
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-------TSDW 110

Query: 656 IQRVNIAIDVASAIEYLH------HHCQPPIVHGDLKPSNVLLDHDMVAHQN-FSLSHQL 708
           +    +A  V   + YLH       H +P I H DL   NVL+ +D     + F LS +L
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170

Query: 709 DSASKTPS-----SSIGIKGTVGYVAPEYGMGS-------EASMTGDVYSFGILLLEMFT 756
                        ++I   GT+ Y+APE   G+        A    D+Y+ G++  E+F 
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

Query: 757 GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRR-------AR 809
             R TD    E +      +  +  +      P+   E M    + +E +R         
Sbjct: 231 --RCTDLFPGESVP-----EYQMAFQTEVGNHPTF--EDM-QVLVSREKQRPKFPEAWKE 280

Query: 810 TQDCLNAITRTGVLCSMESPFERMEMRDVVAKL 842
               + ++  T   C  +    R+  +    ++
Sbjct: 281 NSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  190 bits (485), Expect = 8e-52
 Identities = 94/473 (19%), Positives = 163/473 (34%), Gaps = 48/473 (10%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL 66
           ++P++I S  + + + + FN L         N S L  L +    +          L +L
Sbjct: 25  KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82

Query: 67  VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL------ 120
             L +  N      P     ++SLE +     + + SL    +  L  LK+L +      
Sbjct: 83  SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFIH 141

Query: 121 ------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDF 174
                  F +L NL  ++L  N +   T + +     N      LD+S N         F
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF 201

Query: 175 SSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGEL------PHSI 228
             +  L  L L  N       +     T L N + L    L   +F  E       P  +
Sbjct: 202 QGI-KLHELTLRGNFN-----SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255

Query: 229 ANLSS-TMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLY 287
             L   T+ +FR+               L N+ A+++    +   + D     +  Q L 
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFK-WQSLS 313

Query: 288 MFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQ 347
           + R  L+   P    +L  L  L L+ N    +I        +L   D S N L+     
Sbjct: 314 IIRCQLK-QFPTL--DLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSF-SGC 367

Query: 348 QVLSITTLS--VYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFS- 404
              S    +   +L L+ N     +      L+        L++LD   ++   V  FS 
Sbjct: 368 CSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEE-------LQHLDFQHSTLKRVTEFSA 419

Query: 405 LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSN 457
              ++ +  L++S  N           L+ L  L ++ N  +    +  VF+N
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS-NVFAN 471

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  187 bits (478), Expect = 8e-51
 Identities = 91/484 (18%), Positives = 154/484 (31%), Gaps = 56/484 (11%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTG-QLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
            KL       IG L+ L+ L +  N++   +LP +  NL+ L  + + +N +       L
Sbjct: 114 TKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL 173

Query: 61  GLLRNL----VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK 116
             LR      + L+++ N               L  + L  N  S ++    L NL  L 
Sbjct: 174 QFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLH 232

Query: 117 ELYL-----------------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERL 159
              L                     L ++               S         +N+  +
Sbjct: 233 VHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTND--FSDDIVKFHCLANVSAM 290

Query: 160 DLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLL-------------TN 206
            L+G   K    +          L++ +  L      DL F+  L               
Sbjct: 291 SLAGVSIKYLEDVPKHF--KWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348

Query: 207 CSSLKALSLCDNQFGGELPHSIANLSSTMIQ-FRIGGNQISGTIPSGIRNLVNLIALTIE 265
             SL  L L  N        S ++L +  ++   +  N     + +    L  L  L  +
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQ 407

Query: 266 VNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSS 324
            + L  +        L+ L  L +     +         LT L  L ++ N+ + N  S+
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467

Query: 325 -LGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVIT 383
              N  NL   D S  +L   I   V         L ++HN L          L      
Sbjct: 468 VFANTTNLTFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY----- 521

Query: 384 CVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYN 443
             SL  LD S N           F KS+   N+++N+++  I E   +  FL+++     
Sbjct: 522 --SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC-ICE---HQKFLQWVKEQKQ 575

Query: 444 HLEG 447
            L  
Sbjct: 576 FLVN 579

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  187 bits (477), Expect = 1e-50
 Identities = 89/478 (18%), Positives = 146/478 (30%), Gaps = 46/478 (9%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N L+        +   LQ L +    +          L  L  L++  N +    P +  
Sbjct: 42  NPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFS 101

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL- 120
            L +L  L   E + + +    I  + +L+ + +  N            NL NL  + L 
Sbjct: 102 GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLS 161

Query: 121 ----------TFCSLKNLWW----LNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF 166
                         L+        L++  N +       I D       L  L L GN  
Sbjct: 162 YNYIQTITVNDLQFLRENPQVNLSLDMSLNPI-----DFIQDQAFQGIKLHELTLRGNFN 216

Query: 167 KGKV-SIDFSSLKNLWWLNLEQNNL-GMGTANDLDFVTLLTNCS-SLKALSLCDNQFGGE 223
              +      +L  L    L              +   +   C  ++    L       +
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276

Query: 224 LPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHL 283
                  L++ +    + G  I   +           +L+I   QL          L  L
Sbjct: 277 DIVKFHCLAN-VSAMSLAGVSIK-YLEDVP-KHFKWQSLSIIRCQLKQFPTLD---LPFL 330

Query: 284 QQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ--GNIPSSLGNCQNLKGFDASHNKL 341
           + L +  N  +GSI      L  L+ L LS N L   G    S     +L+  D S N  
Sbjct: 331 KSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388

Query: 342 TGAIPQQVLSITTLSVYLALAHNLLNDSLPLQV-GNLKNLVITCVSLEYLDISSNSFHGV 400
              +    + +  L  +L   H+ L          +L+        L YLDIS  +    
Sbjct: 389 II-MSANFMGLEEL-QHLDFQHSTLKRVTEFSAFLSLEK-------LLYLDISYTNTKID 439

Query: 401 IPFSLGFMKSIKELNVSSNNLSGQIP-EFLQNLSFLEFLNLSYNHLEGEVPTKGVFSN 457
                  + S+  L ++ N+           N + L FL+LS   LE      GVF  
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW--GVFDT 495

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  119 bits (301), Expect = 3e-28
 Identities = 48/243 (19%), Positives = 85/243 (34%), Gaps = 9/243 (3%)

Query: 229 ANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYM 288
            ++ S+     +  N +         N   L  L +   ++  I       L HL  L +
Sbjct: 28  DDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLIL 87

Query: 289 FRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQ 348
             N +Q   P S   LT L +L      L       +G    LK  + +HN +       
Sbjct: 88  TGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPA 147

Query: 349 VLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFM 408
             S  T  V++ L++N +     + V +L+ L         LD+S N    +   +   +
Sbjct: 148 YFSNLTNLVHVDLSYNYIQT---ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI 204

Query: 409 KSIKELNVSSNNLSGQIPE-FLQNLSFLEFLNLSYNHLEG----EVPTKGVFSNKTKISL 463
             + EL +  N  S  I +  LQNL+ L    L     +     E+    +      +++
Sbjct: 205 -KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263

Query: 464 QVN 466
              
Sbjct: 264 DEF 266

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  177 bits (451), Expect = 5e-50
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 26/217 (11%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
            E     ++G+G+FG V K     ++  VA+K   ++ +   ++F+ E   L  + H N+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQ--IESESERKAFIVELRQLSRVNHPNI 63

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           +K+   C +          LV EY E GSL + LH +     +   T    ++  +  + 
Sbjct: 64  VKLYGACLNPVC-------LVMEYAEGGSLYNVLHGAE---PLPYYTAAHAMSWCLQCSQ 113

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTPSSSIGIKG 723
            + YLH      ++H DLKP N+LL        +    F  +  +       +     KG
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD--FGTACDIQ------THMTNNKG 165

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +  ++APE   GS  S   DV+S+GI+L E+ T R+P
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  177 bits (451), Expect = 6e-50
 Identities = 68/249 (27%), Positives = 115/249 (46%), Gaps = 21/249 (8%)

Query: 517 RRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIV 576
                +   + T+        +   ++     +      IG GSFG+V++    G +  V
Sbjct: 6   HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD--V 63

Query: 577 AVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMEN 634
           AVK++  +         F+ E   ++ +RH N++  +   +          ++V EY+  
Sbjct: 64  AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PPNLSIVTEYLSR 118

Query: 635 GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH 694
           GSL   LH+S       +L   +R+++A DVA  + YLH+   PPIVH +LK  N+L+D 
Sbjct: 119 GSLYRLLHKSGARE---QLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK 174

Query: 695 DM---VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILL 751
                V   +F LS      + T  SS    GT  ++APE      ++   DVYSFG++L
Sbjct: 175 KYTVKVC--DFGLSRLK---ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVIL 229

Query: 752 LEMFTGRRP 760
            E+ T ++P
Sbjct: 230 WELATLQQP 238

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  175 bits (445), Expect = 1e-49
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 30/222 (13%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHR 605
            +      + +   G ++KG   G +  + VKV+ ++       R F  EC  LR   H 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N++ ++  C S     A    L+  +M  GSL + LH+  +      +   Q V  A+D+
Sbjct: 68  NVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALDM 120

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN-FSLSHQLDSASKTPSSSIGIKGT 724
           A  + +LH   +P I    L   +V++D DM A  +   +     S  +           
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM--------YA 171

Query: 725 VGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +VAPE            ++   D++SF +LL E+ T   P
Sbjct: 172 PAWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP 210

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  171 bits (436), Expect = 3e-48
 Identities = 60/220 (27%), Positives = 90/220 (40%), Gaps = 32/220 (14%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLK----QKGAFRSFVAECEALRNIRHRNLIK 609
            +IG G FG VY+    G+E  VAVK               +   E +    ++H N+I 
Sbjct: 13  EIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +C     K  +   LV E+   G L   L          ++     VN A+ +A  +
Sbjct: 71  LRGVCL----KEPNL-CLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGM 118

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN---------FSLSHQLDSASKTPSSSIG 720
            YLH     PI+H DLK SN+L+   +              F L+ +    +K       
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-----S 173

Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             G   ++APE    S  S   DV+S+G+LL E+ TG  P
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  176 bits (448), Expect = 7e-48
 Identities = 96/462 (20%), Positives = 174/462 (37%), Gaps = 64/462 (13%)

Query: 10  EEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYL 69
               +L       +    +T  +     +L  +  L      +  +    +  L NL  +
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73

Query: 70  NVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL--------- 120
           N + NQ + + P  + N++ L  I +  N+ +   P     NL NL  L L         
Sbjct: 74  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA---NLTNLTGLTLFNNQITDID 128

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
              +L NL  L L  N +      S   +LS  ++L++L               ++L  L
Sbjct: 129 PLKNLTNLNRLELSSNTI------SDISALSGLTSLQQLSFGNQVTD---LKPLANLTTL 179

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
             L++  N +     +D+     L   ++L++L   +NQ     P  +  L++ + +  +
Sbjct: 180 ERLDISSNKV-----SDISV---LAKLTNLESLIATNNQISDITP--LGILTN-LDELSL 228

Query: 241 GGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS 300
            GNQ+       + +L NL  L +  NQ+  + P  +  L  L +L +  N +    P  
Sbjct: 229 NGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 282

Query: 301 LGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLA 360
           L  LT L +L L+ N L+   P  + N +NL       N ++   P   L  T L   L 
Sbjct: 283 LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSL--TKLQ-RLF 337

Query: 361 LAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNN 420
             +N ++D   L   NL N+        +L    N    + P  L  +  I +L ++   
Sbjct: 338 FYNNKVSDVSSL--ANLTNI-------NWLSAGHNQISDLTP--LANLTRITQLGLNDQA 386

Query: 421 LSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKIS 462
            +     +  N+S     N   N + G +      S+    +
Sbjct: 387 WTNAPVNYKANVS---IPNTVKN-VTGALIAPATISDGGSYT 424

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  155 bits (393), Expect = 1e-40
 Identities = 101/434 (23%), Positives = 166/434 (38%), Gaps = 59/434 (13%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N+L    P  + +L  L  + ++ N +       + NL+ L  L +  N +    P  L 
Sbjct: 78  NQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--LK 131

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL- 120
            L NL  L ++ N  S +    +  ++SL+ +    N+ +   P     NL  L+ L + 
Sbjct: 132 NLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG-NQVTDLKPLA---NLTTLERLDIS 185

Query: 121 --------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSI 172
                       L NL  L    N +     S I   L   +NL+ L L+GNQ K   + 
Sbjct: 186 SNKVSDISVLAKLTNLESLIATNNQI-----SDIT-PLGILTNLDELSLNGNQLKDIGT- 238

Query: 173 DFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLS 232
             +SL NL  L+L  N +     ++L     L+  + L  L L  NQ     P  +A L+
Sbjct: 239 -LASLTNLTDLDLANNQI-----SNLAP---LSGLTKLTELKLGANQISNISP--LAGLT 287

Query: 233 STMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNF 292
           + +    +  NQ+    P  I NL NL  LT+  N +  I P  V  L  LQ+L+ + N 
Sbjct: 288 A-LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342

Query: 293 LQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSI 352
           +  S   SL NLT +  L+   N +    P  L N   +     +    T A      ++
Sbjct: 343 V--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANV 398

Query: 353 TTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIK 412
           +  +    +   L+  +     G+     IT     Y +  S +F               
Sbjct: 399 SIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTF-----------SQPV 447

Query: 413 ELNVSSNNLSGQIP 426
            +   +   SG + 
Sbjct: 448 TIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  109 bits (274), Expect = 3e-25
 Identities = 60/268 (22%), Positives = 94/268 (35%), Gaps = 38/268 (14%)

Query: 196 NDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRN 255
             ++ +   T  +      L        +     +L   +   +     I      G+  
Sbjct: 12  TPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQ-VTTLQADRLGI--KSIDGVEY 66

Query: 256 LVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFN 315
           L NL  +    NQL  I P  +  L  L  + M  N +    P  L NLT L  L L  N
Sbjct: 67  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 122

Query: 316 NLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVL-SITTLSVYLALAHNLLNDSLPLQV 374
            +       L N  NL   + S N ++       L S+  LS       N + D  PL  
Sbjct: 123 QITD--IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSF-----GNQVTDLKPL-- 173

Query: 375 GNLKNLVI---------------TCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSN 419
            NL  L                    +LE L  ++N    + P  LG + ++ EL+++ N
Sbjct: 174 ANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGN 231

Query: 420 NLSGQIPEFLQNLSFLEFLNLSYNHLEG 447
            L       L +L+ L  L+L+ N +  
Sbjct: 232 QLKD--IGTLASLTNLTDLDLANNQISN 257

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 60.0 bits (146), Expect = 2e-09
 Identities = 34/192 (17%), Positives = 65/192 (33%), Gaps = 34/192 (17%)

Query: 307 LADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVL-SITTLSV-------- 357
           L    ++ +     I  +                +T  + Q  L  +TTL          
Sbjct: 3   LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI 61

Query: 358 ----------YLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGF 407
                      +  ++N L D  PL   NL         L  + +++N    + P  L  
Sbjct: 62  DGVEYLNNLTQINFSNNQLTDITPL--KNLTK-------LVDILMNNNQIADITP--LAN 110

Query: 408 MKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNV 467
           + ++  L + +N ++   P  L+NL+ L  L LS N +   +      ++  ++S    V
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFGNQV 167

Query: 468 KLCGGIDELHLL 479
                +  L  L
Sbjct: 168 TDLKPLANLTTL 179

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  169 bits (430), Expect = 2e-47
 Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 34/228 (14%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI-------NLKQKGAFRSFVAECEALR 600
           +E      IG+G FG V+KG L  ++ +VA+K +         +    F+ F  E   + 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 601 NIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
           N+ H N++K+  +  +          +V E++  G L   L           +    ++ 
Sbjct: 79  NLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLR 126

Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN------FSLSHQLDSASKT 714
           + +D+A  IEY+  +  PPIVH DL+  N+ L               F LS Q   +   
Sbjct: 127 LMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS- 184

Query: 715 PSSSIGIKGTVGYVAPE--YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                G+ G   ++APE         +   D YSF ++L  + TG  P
Sbjct: 185 -----GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  164 bits (418), Expect = 4e-45
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 28/224 (12%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECE--ALRNIRHRNLIKII 611
             IG+G FG V++G   GEE  VAVK+ + +++   RS+  E E      +RH N++  I
Sbjct: 48  ESIGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
              +  +        LV +Y E+GSL D+L++         +T+   + +A+  AS + +
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAH 154

Query: 672 LH-----HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPS-SSIGIKGT 724
           LH        +P I H DLK  N+L+  +      +  L+ + DSA+ T   +     GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214

Query: 725 VGYVAPEYGMGS------EASMTGDVYSFGILLLEMFTGRRPTD 762
             Y+APE    S      E+    D+Y+ G++  E+        
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  163 bits (414), Expect = 6e-45
 Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 32/226 (14%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECE--ALRNIRHRNLIKII 611
             +G+G +G V++G   GE   VAVK+ + + +   +S+  E E      +RH N++  I
Sbjct: 14  ECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
               +          L+  Y E GSL D+L  +        L  +  + I + +AS + +
Sbjct: 69  ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAH 120

Query: 672 LH-----HHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPS-SSIGIK 722
           LH        +P I H DLK  N+L+  +    +A     L+     ++      +    
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD--LGLAVMHSQSTNQLDVGNNPRV 178

Query: 723 GTVGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
           GT  Y+APE           ++    D+++FG++L E+        
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  162 bits (413), Expect = 1e-44
 Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 29/220 (13%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
            +IG+G FG VY G   GE   VA+++I++++  +   ++F  E  A R  RH N++  +
Sbjct: 39  ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
             C S         A++    +  +L   +  +        L + +   IA ++   + Y
Sbjct: 96  GACMS-----PPHLAIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGY 145

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLS--HQLDSASKTPSSSIGIKGTVGYVA 729
           LH      I+H DLK  NV  D+  V   +F L     +  A +         G + ++A
Sbjct: 146 LH---AKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 730 PEYGMGSEASMTG---------DVYSFGILLLEMFTGRRP 760
           PE                    DV++ G +  E+     P
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  161 bits (410), Expect = 1e-44
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 53/296 (17%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            ++         A+V ++ E  SL   LH S       K  + + ++IA   A  ++YLH
Sbjct: 89  STA------PQLAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLH 137

Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE- 731
                 I+H DLK +N+ L  D      +F L+    S          + G++ ++APE 
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA-TEKSRWSGSHQFEQLSGSILWMAPEV 193

Query: 732 -----YGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI 786
                    S  S   DVY+FGI+L E+ TG+ P             +  +   +++IE+
Sbjct: 194 IRMQDSNPYSFQS---DVYAFGIVLYELMTGQLP-------------YSNINNRDQIIEM 237

Query: 787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL 842
           V    L   ++              +C   + R    C  +   ER     ++A++
Sbjct: 238 VGRGSLSPDLSKVR----------SNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  162 bits (412), Expect = 2e-44
 Identities = 57/226 (25%), Positives = 91/226 (40%), Gaps = 32/226 (14%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECE--ALRNIRHRNLIKII 611
             IG+G +G V+ G   GE+  VAVKV    ++    S+  E E      +RH N++  I
Sbjct: 43  KQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
                          L+ +Y ENGSL D+L  +        L     + +A    S + +
Sbjct: 98  AADIKGTGSWTQL-YLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCH 149

Query: 672 LH-----HHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPS-SSIGIK 722
           LH        +P I H DLK  N+L+  +    +A     L+ +  S +           
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD--LGLAVKFISDTNEVDIPPNTRV 207

Query: 723 GTVGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
           GT  Y+ PE           ++ +  D+YSFG++L E+        
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  157 bits (400), Expect = 4e-43
 Identities = 55/270 (20%), Positives = 95/270 (35%), Gaps = 44/270 (16%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
           S+     ++G+G FG   K        ++ +K +    +   R+F+ E + +R + H N+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           +K I +      K       + EY++ G+L   +   +      +    QRV+ A D+AS
Sbjct: 70  LKFIGVL----YKDKRL-NFITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIAS 119

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA------------HQNFSLSHQLDSASKTP 715
            + YLH      I+H DL   N L+  +                +               
Sbjct: 120 GMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176

Query: 716 SSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFTGRRPTD------AAFT 766
                + G   ++APE        E     DV+SFGI+L E+                F 
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKV---DVFSFGIVLCEIIGRVNADPDYLPRTMDF- 232

Query: 767 EGLTLHEFVKMTLPEKVIEIVDPSLLMEVM 796
            GL +  F+    P        P     + 
Sbjct: 233 -GLNVRGFLDRYCPPNC-----PPSFFPIT 256

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  159 bits (404), Expect = 5e-43
 Identities = 82/429 (19%), Positives = 164/429 (38%), Gaps = 84/429 (19%)

Query: 18  LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFS 77
             TLA     +    PD   +L+     +++  S+      T   L ++  L VA  + +
Sbjct: 2   AATLATLPAPINQIFPD--ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 78  GMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNN 137
            +    I  +++LE++ L  N+ +   P                  +L  L  L +  N 
Sbjct: 58  SIQG--IEYLTNLEYLNLNGNQITDISPL----------------SNLVKLTNLYIGTNK 99

Query: 138 LGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTAND 197
           +      +   +L N +NL  L L+ +          ++L  ++ LNL  N+        
Sbjct: 100 I------TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHN------- 144

Query: 198 LDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLV 257
           L  ++ L+N + L  L++ +++     P  IANL+  +    +  NQI    P  + +L 
Sbjct: 145 LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTD-LYSLSLNYNQIEDISP--LASLT 199

Query: 258 NLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNL 317
           +L   T  VNQ+  I P  V  +  L  L +  N +    P  L NL++L  L +  N +
Sbjct: 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255

Query: 318 QGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNL 377
                +++ +   LK  +   N+++                               + NL
Sbjct: 256 SD--INAVKDLTKLKMLNVGSNQISDISV---------------------------LNNL 286

Query: 378 KNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEF 437
             L         L +++N         +G + ++  L +S N+++   P  L +LS ++ 
Sbjct: 287 SQL-------NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337

Query: 438 LNLSYNHLE 446
            + +   ++
Sbjct: 338 ADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  155 bits (393), Expect = 1e-41
 Identities = 76/350 (21%), Positives = 137/350 (39%), Gaps = 53/350 (15%)

Query: 109 LVNLPNLKELYL---------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERL 159
             +L       L         T   L+++  L +    +     +SI   +   +NLE L
Sbjct: 18  DADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKV-----ASIQG-IEYLTNLEYL 71

Query: 160 DLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQ 219
           +L+GNQ         S+L  L  L +  N +      D+     L N ++L+ L L ++ 
Sbjct: 72  NLNGNQITD--ISPLSNLVKLTNLYIGTNKI-----TDISA---LQNLTNLRELYLNEDN 121

Query: 220 FGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGE 279
                   +ANL+  M    +G N    +  S + N+  L  LT+  +++  + P  +  
Sbjct: 122 ISD--ISPLANLTK-MYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IAN 175

Query: 280 LQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHN 339
           L  L  L +  N ++   P  L +LT L       N +    P  + N   L      +N
Sbjct: 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN 231

Query: 340 KLTGAIPQQVLSITTLS--VYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSF 397
           K+T   P     +  LS   +L +  N ++D   +   +L  L       + L++ SN  
Sbjct: 232 KITDLSP-----LANLSQLTWLEIGTNQISDINAV--KDLTKL-------KMLNVGSNQI 277

Query: 398 HGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEG 447
             +   +   +  +  L +++N L  +  E +  L+ L  L LS NH+  
Sbjct: 278 SDISVLN--NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  146 bits (372), Expect = 8e-39
 Identities = 86/346 (24%), Positives = 143/346 (41%), Gaps = 42/346 (12%)

Query: 10  EEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYL 69
                L       +    +T  +      L ++  L++    +       +  L NL YL
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--ASIQGIEYLTNLEYL 71

Query: 70  NVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL--------- 120
           N+  NQ + + P  + N+  L  +Y+  N+ +       L NL NL+ELYL         
Sbjct: 72  NLNGNQITDISP--LSNLVKLTNLYIGTNKITD---ISALQNLTNLRELYLNEDNISDIS 126

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
              +L  ++ LNL  N+       S    LSN + L  L ++ ++ K       ++L +L
Sbjct: 127 PLANLTKMYSLNLGANHN-----LSDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDL 179

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
           + L+L  N +      D+     L + +SL   +   NQ     P  +AN++  +   +I
Sbjct: 180 YSLSLNYNQI-----EDISP---LASLTSLHYFTAYVNQITDITP--VANMTR-LNSLKI 228

Query: 241 GGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS 300
           G N+I+   P  + NL  L  L I  NQ+  I  + V +L  L+ L +  N +  S    
Sbjct: 229 GNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI--SDISV 282

Query: 301 LGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIP 346
           L NL++L  L L+ N L       +G   NL     S N +T   P
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  121 bits (307), Expect = 3e-30
 Identities = 54/293 (18%), Positives = 108/293 (36%), Gaps = 44/293 (15%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           NK+       + +L NL+ L ++ + ++      + NL+ +  L +  N       + L 
Sbjct: 98  NKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLS 152

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
            +  L YL V E++   + P  I N++ L  + L  N+     P     +L +L      
Sbjct: 153 NMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLA---SLTSLHYFTAY 207

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
              + ++                     ++N + L  L +  N+         ++L  L 
Sbjct: 208 VNQITDI-------------------TPVANMTRLNSLKIGNNKITD--LSPLANLSQLT 246

Query: 182 WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
           WL +  N +     +D++    + + + LK L++  NQ        + NLS  +    + 
Sbjct: 247 WLEIGTNQI-----SDINA---VKDLTKLKMLNVGSNQISD--ISVLNNLSQ-LNSLFLN 295

Query: 242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQ 294
            NQ+       I  L NL  L +  N +  I P  +  L  +         ++
Sbjct: 296 NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 70.6 bits (174), Expect = 4e-13
 Identities = 30/208 (14%), Positives = 68/208 (32%), Gaps = 44/208 (21%)

Query: 259 LIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ 318
              L      ++ I PD   +L    +  + +  +   +      L  +  L ++   + 
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 319 GNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLK 378
                 +    NL+  + + N++T   P                           + NL 
Sbjct: 58  S--IQGIEYLTNLEYLNLNGNQITDISP---------------------------LSNLV 88

Query: 379 NLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFL 438
            L         L I +N    +       + +++EL ++ +N+S      L NL+ +  L
Sbjct: 89  KL-------TNLYIGTNKITDISALQ--NLTNLRELYLNEDNISD--ISPLANLTKMYSL 137

Query: 439 NLSYNHLEGEVPTKGVFSNKTKISLQVN 466
           NL  NH   ++      +    +++  +
Sbjct: 138 NLGANHNLSDLSPLSNMTGLNYLTVTES 165

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  167 bits (425), Expect = 5e-43
 Identities = 93/486 (19%), Positives = 171/486 (35%), Gaps = 56/486 (11%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQI-PTTLGLLRN 65
           Q+P+    L   + L + FNY+          L  L +L +        I       L N
Sbjct: 18  QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74

Query: 66  LVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFS-GSLPFDILVNLPNLKELYL---- 120
           L  L++  ++   + P     +  L  + L     S   L      NL  L  L L    
Sbjct: 75  LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134

Query: 121 --------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSI 172
                   +F  L +L  ++   N + +     + + L     L    L+ N    +VS+
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL-EPLQG-KTLSFFSLAANSLYSRVSV 192

Query: 173 DFSSLKN------LWWLNLEQNNLGMGTANDLD------FVTLLTNCSSLKALSLCDNQF 220
           D+    N      L  L++  N   +    +            L     +       +  
Sbjct: 193 DWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252

Query: 221 GGELPHSIANLSSTMIQ-FRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGVG 278
                ++ A L+ + ++   +    +  ++ S +   L +L  L +  N+++ I  +   
Sbjct: 253 KDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311

Query: 279 ELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASH 338
            L +LQ L +  N L      +   L K+A + L  N++      +    + L+  D   
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371

Query: 339 NKLT-----GAIPQQVLSITTLSV--YLALAHNLLNDSLPLQVGNLKNLVITCV-----S 386
           N LT      +IP   LS   L     + L  NL++    L    L+NL I         
Sbjct: 372 NALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIH----LSENRLENLDILYFLLRVPH 427

Query: 387 LEYLDISSNSFHGVIP-FSLGFMKSIKELNVSSNNLSGQI-----PEFLQNLSFLEFLNL 440
           L+ L ++ N F       +     S+++L +  N L          +  + LS L+ L L
Sbjct: 428 LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487

Query: 441 SYNHLE 446
           ++N+L 
Sbjct: 488 NHNYLN 493

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  135 bits (342), Expect = 7e-33
 Identities = 98/551 (17%), Positives = 174/551 (31%), Gaps = 112/551 (20%)

Query: 2   NKLEGQIPEEIGSLLN------LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQ 55
           N L  ++  + G  +N      L+ L +  N  T  +                 N++   
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITG------------NFSNAISKS 231

Query: 56  IPTTLGLLRNLVYLNVAENQFSGMFPRWICNI--SSLEFIYLTVNRFSGSLPFDILVNLP 113
              +L L  +++      +            +  SS+  + L+      SL   +   L 
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLK 290

Query: 114 NLKELYL-----------TFCSLKNLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDL 161
           +LK L L            F  L NL  LNL  N L       +   +      +  +DL
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL-----GELYSSNFYGLPKVAYIDL 345

Query: 162 SGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFG 221
             N         F  L+ L  L+L  N L           T +    S+  + L  N+  
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----------TTIHFIPSIPDIFLSGNKL- 393

Query: 222 GELPHSIANLSSTMIQFRIGGNQISG-TIPSGIRNLVNLIALTIEVNQLHGIIPDGV-GE 279
                ++  ++ T     +  N++    I   +  + +L  L +  N+      D    E
Sbjct: 394 ----VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449

Query: 280 LQHLQQLYMFRNFLQGSIPPSL-----GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGF 334
              L+QL++  N LQ +    L       L+ L  L L+ N L    P    +   L+G 
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509

Query: 335 DASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISS 394
             + N+LT                      L ++ LP              +LE LDIS 
Sbjct: 510 SLNSNRLT---------------------VLSHNDLP-------------ANLEILDISR 535

Query: 395 NSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGV 454
           N      P       S+  L+++ N    +     +  +F+ +LN +   + G       
Sbjct: 536 NQLLAPNPDVF---VSLSVLDITHNKFICEC----ELSTFINWLNHTNVTIAG------- 581

Query: 455 FSNKTKISLQVNVKLCG-GIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTI 513
                 I         G  +  L    C  +   K     L ++  V ++  +++     
Sbjct: 582 --PPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVT 639

Query: 514 VFARRRRSAHK 524
            F       +K
Sbjct: 640 KFRGFCFICYK 650

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  162 bits (413), Expect = 2e-42
 Identities = 97/490 (19%), Positives = 156/490 (31%), Gaps = 67/490 (13%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N L         S   LQ L +    +         +LS L  L++  N +         
Sbjct: 38  NPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 97

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL- 120
            L +L  L   E   + +    I ++ +L+ + +  N        +   NL NL+ L L 
Sbjct: 98  GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157

Query: 121 ----------TFCSLKNL----WWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF 166
                         L  +      L+L  N +     + I         L +L L  N  
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-----NFIQPGAFKEIRLHKLTLRNNFD 212

Query: 167 KGKV----------------------------SIDFSSLKNLWWLNLEQNNLGMGTANDL 198
              V                              D S+L+ L  L +E+  L        
Sbjct: 213 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD 272

Query: 199 DFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVN 258
           D + L    +++ + SL           S       +        Q           L +
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL------KLKS 326

Query: 259 LIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQ--GSIPPSLGNLTKLADLALSFNN 316
           L  LT   N+      +   +L  L+ L + RN L   G    S    T L  L LSFN 
Sbjct: 327 LKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384

Query: 317 LQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGN 376
           +   + S+    + L+  D  H+ L       V       +YL ++H           G 
Sbjct: 385 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV---AFNGI 440

Query: 377 LKNLVITCVSLEYLDISSNSFHGVI-PFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFL 435
              L     SLE L ++ NSF     P     ++++  L++S   L    P    +LS L
Sbjct: 441 FNGL----SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496

Query: 436 EFLNLSYNHL 445
           + LN++ N L
Sbjct: 497 QVLNMASNQL 506

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  157 bits (398), Expect = 1e-40
 Identities = 98/482 (20%), Positives = 169/482 (35%), Gaps = 51/482 (10%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
            +++        SL +L TL +  N +          LS+L  L+    +L       +G
Sbjct: 62  CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121

Query: 62  LLRNLVYLNVAENQF-SGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK---- 116
            L+ L  LNVA N   S   P +  N+++LE + L+ N+   S+    L  L  +     
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL 180

Query: 117 ELYLTFCSLK----------NLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF 166
            L L+   +            L  L L  N     + + +   +   + LE   L   +F
Sbjct: 181 SLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFD---SLNVMKTCIQGLAGLEVHRLVLGEF 237

Query: 167 KGK---VSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE 223
           + +      D S+L+ L  L +E+  L        D + L    +++ + SL        
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297

Query: 224 LPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHL 283
              S       +        Q           L +L  LT   N+      +   +L  L
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPTL------KLKSLKRLTFTSNKGGNAFSEV--DLPSL 349

Query: 284 QQLYMFRNFLQ--GSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKL 341
           + L + RN L   G    S    T L  L LSFN +   + S+    + L+  D  H+ L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL 408

Query: 342 TGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVI------------------T 383
                  V       +YL ++H     +       L +L +                   
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

Query: 384 CVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYN 443
             +L +LD+S      + P +   + S++ LN++SN L          L+ L+ + L  N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528

Query: 444 HL 445
             
Sbjct: 529 PW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  154 bits (391), Expect = 1e-39
 Identities = 83/483 (17%), Positives = 154/483 (31%), Gaps = 67/483 (13%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL 66
           +IP+ +    + + L + FN L         +   L +L +    +          L +L
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 67  VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLK 126
             L +  N    +       +SSL+ +       + SL    + +L  LKEL +    ++
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137

Query: 127 NLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL----WW 182
           +                  +P+  SN +NLE LDLS N+ +     D   L  +      
Sbjct: 138 SFK----------------LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPH-SIANLSSTMIQ---- 237
           L+L  N +          +        L  L+L +N     +    I  L+   +     
Sbjct: 182 LDLSLNPMNFIQPGAFKEI-------RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234

Query: 238 -FRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYM--FRNFLQ 294
                   +     S +  L NL      +  L   + D +     L  +      +   
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 295 GSIPPS--LGNLTKLADLALSFNNLQGNIPSSL----------------GNCQNLKGFDA 336
             +           L  +   F         SL                 +  +L+  D 
Sbjct: 295 ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDL 354

Query: 337 SHNKLTG-AIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSN 395
           S N L+      Q    TT   YL L+ N +  ++      L+        LE+LD   +
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQ-------LEHLDFQHS 406

Query: 396 SFHGVIPFS-LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGV 454
           +   +  FS    ++++  L++S  +           LS LE L ++ N  +       +
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDI 465

Query: 455 FSN 457
           F+ 
Sbjct: 466 FTE 468

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  150 bits (380), Expect = 3e-38
 Identities = 77/456 (16%), Positives = 151/456 (33%), Gaps = 69/456 (15%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLT-GQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
             L       IG L  L+ L +  N +   +LP++  NL+ L  L +  N +     T L
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169

Query: 61  GLLRNL----VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK 116
            +L  +    + L+++ N  +            L  + L  N  S ++    +  L  L+
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLE 228

Query: 117 ELYLTFCS--------------LKNLWWLNLEQNNLGMGT--ASSIPDSLSNASNLERLD 160
              L                  L+ L  L +E+  L         I D  +  +N+    
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288

Query: 161 LSGNQFKGKVSIDF-SSLKNLWWLNLEQNNLGMGTANDLDFVTLLTN----------CSS 209
           L     +      +    ++L  +N +           L  +T  +N            S
Sbjct: 289 LVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348

Query: 210 LKALSLCDNQFGGELPHSIANLSSTMIQF-RIGGNQISGTIPSGIRNLVNLIALTIEVNQ 268
           L+ L L  N    +   S ++  +T +++  +  N +  T+ S    L  L  L  + + 
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN 407

Query: 269 LHGIIPDGV-GELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPS-SLG 326
           L  +    V   L++L  L +     + +       L+ L  L ++ N+ Q N       
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467

Query: 327 NCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVS 386
             +NL   D S  +L   +     +  +                               S
Sbjct: 468 ELRNLTFLDLSQCQLE-QLSPTAFNSLS-------------------------------S 495

Query: 387 LEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLS 422
           L+ L+++SN    V       + S++++ + +N   
Sbjct: 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  112 bits (281), Expect = 8e-26
 Identities = 68/363 (18%), Positives = 114/363 (31%), Gaps = 54/363 (14%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPT--- 58
           N +   I       + L  L +  N+ +  +      +  L  L +    LG        
Sbjct: 187 NPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMK--TCIQGLAGLEVHRLVLGEFRNEGNL 243

Query: 59  ---TLGLLRNLVYLNVAENQFSGM------FPRWICNISSLEFIYLTVNRFSGSLPFDIL 109
                  L  L  L + E + + +             ++++    L          F   
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303

Query: 110 VNL------------------PNLKELYL---------TFCSLKNLWWLNLEQNNLGMGT 142
                                 +LK L           +   L +L +L+L +N L    
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS--F 361

Query: 143 ASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVT 202
                 S    ++L+ LDLS N     +S +F  L+ L  L+ + +NL       +   +
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-----KQMSEFS 415

Query: 203 LLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIA 261
           +  +  +L  L +               LSS +   ++ GN         I   L NL  
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSS-LEVLKMAGNSFQENFLPDIFTELRNLTF 474

Query: 262 LTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS-LGNLTKLADLALSFNNLQGN 320
           L +   QL  + P     L  LQ L M  N L+ S+P      LT L  + L  N    +
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 533

Query: 321 IPS 323
            P 
Sbjct: 534 CPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 98.6 bits (246), Expect = 2e-21
 Identities = 44/243 (18%), Positives = 86/243 (35%), Gaps = 9/243 (3%)

Query: 229 ANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYM 288
            NL  +     +  N +         +   L  L +   ++  I       L HL  L +
Sbjct: 24  DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83

Query: 289 FRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQ 348
             N +Q     +   L+ L  L     NL       +G+ + LK  + +HN +      +
Sbjct: 84  TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143

Query: 349 VLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFM 408
             S  T   +L L+ N +       +  L  + +  +S   LD+S N  + + P +   +
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS---LDLSLNPMNFIQPGAFKEI 200

Query: 409 KSIKELNVSSNNLSGQIPE-FLQNLSFLEFLNLSYNHLEG----EVPTKGVFSNKTKISL 463
             + +L + +N  S  + +  +Q L+ LE   L           E   K        +++
Sbjct: 201 -RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259

Query: 464 QVN 466
           +  
Sbjct: 260 EEF 262

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  161 bits (409), Expect = 4e-42
 Identities = 88/489 (17%), Positives = 182/489 (37%), Gaps = 53/489 (10%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL 66
            IP  +     +++L + FN +T      +   + L +L+++ + +          L +L
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 67  VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL------ 120
            +L++++N  S +   W   +SSL+++ L  N +       +  NL NL+ L +      
Sbjct: 77  EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136

Query: 121 ------TFCSLKNLWWLNLEQNNLGMGTASSIPD-SLSNASNLERLDLSGNQFKGKVSID 173
                  F  L +L  L ++  +L      +    SL +  ++  L L  ++    + I 
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSL-----RNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191

Query: 174 FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCS--SLKALSLCDNQFGGELPHSIANL 231
              L ++ +L L   NL     + L    + +     + +   L D  F   L      L
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251

Query: 232 SSTMIQF---------RIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQH 282
             + ++F             ++       G    V +  L I    L   +      L+ 
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311

Query: 283 LQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNI---PSSLGNCQNLKGFDASHN 339
           ++++ +  + +         +L  L  L LS N +        +  G   +L+    S N
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371

Query: 340 KLTGAIPQQVLSITTLS--VYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSF 397
            L  ++ +    + TL     L ++ N  +  +P      + +        +L++SS   
Sbjct: 372 HLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM-------RFLNLSSTGI 422

Query: 398 HGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSN 457
             V        ++++ L+VS+NNL      FL  L   + L +S N L+  +P   +F  
Sbjct: 423 RVV---KTCIPQTLEVLDVSNNNLD-SFSLFLPRL---QELYISRNKLK-TLPDASLFPV 474

Query: 458 KTKISLQVN 466
              + +  N
Sbjct: 475 LLVMKISRN 483

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  114 bits (286), Expect = 2e-26
 Identities = 66/401 (16%), Positives = 133/401 (33%), Gaps = 42/401 (10%)

Query: 9   PEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVY 68
             +   L +L  L I    L       + ++  +  L +  +     +     +L ++ Y
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200

Query: 69  LNVAENQFSGMFPRWICNISSLEFIYLTVNRFS--GSLPFDILVNLPN----LKELYLTF 122
           L + +   +      +        +     R S      F+ L+ L      L E+    
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260

Query: 123 CSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWW 182
           C+L  L   N  ++++                 + RL +        +S  +S L+ +  
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKV------ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR 314

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHS---IANLSSTMIQFR 239
           + +E + + +   +         +  SL+ L L +N    E   +        S      
Sbjct: 315 ITVENSKVFLVPCS------FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT-LV 367

Query: 240 IGGNQIS--GTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSI 297
           +  N +         +  L NL +L I  N  H  +PD     + ++ L +    ++  +
Sbjct: 368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VV 425

Query: 298 PPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSV 357
                    L  L +S NNL  +    L     L+    S NKL   +P   L    L  
Sbjct: 426 KT--CIPQTLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLK-TLPDASLF-PVLL- 476

Query: 358 YLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFH 398
            + ++ N L  S+P        +     SL+ + + +N + 
Sbjct: 477 VMKISRNQLK-SVP------DGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 99.4 bits (248), Expect = 9e-22
 Identities = 65/369 (17%), Positives = 122/369 (33%), Gaps = 68/369 (18%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
             L     + + S+ ++  L +  +     L  F   LS++  L +R  +L     + L 
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLP 217

Query: 62  LLRNLVYLNVAENQFSGM----------FPRWICNISSLEFIYLTVNRFS--GSLPFDIL 109
           +      +     + S +            R+I  +S +EF   T+N          D++
Sbjct: 218 VDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVV 277

Query: 110 VNLPNLKELYL----------------TFCSLKNLWWLNLEQNNLGMGTASSIP-DSLSN 152
             L  ++ + +                 +  L+ +  + +E + +       +P     +
Sbjct: 278 SELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV-----FLVPCSFSQH 332

Query: 153 ASNLERLDLSGNQFKGKV---SIDFSSLKNLWWLNLEQNNLGMGTANDLDFVT-LLTNCS 208
             +LE LDLS N    +    S    +  +L  L L QN+L       +     +L    
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL-----RSMQKTGEILLTLK 387

Query: 209 SLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI--------------- 253
           +L +L +  N F   +P S       M    +    I   + + I               
Sbjct: 388 NLTSLDISRNTFH-PMPDSCQWPEK-MRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLD 444

Query: 254 ---RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS-LGNLTKLAD 309
                L  L  L I  N+L  +    +     L  + + RN L+ S+P      LT L  
Sbjct: 445 SFSLFLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLK-SVPDGIFDRLTSLQK 501

Query: 310 LALSFNNLQ 318
           + L  N   
Sbjct: 502 IWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 72.1 bits (177), Expect = 3e-13
 Identities = 43/294 (14%), Positives = 93/294 (31%), Gaps = 84/294 (28%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
           +  L   +      L  ++ + ++ + +   +P                        +  
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVF-LVP-----------------------CSFS 330

Query: 61  GLLRNLVYLNVAENQFSGMFPRW---ICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKE 117
             L++L +L+++EN     + +         SL+ + L+ N               ++++
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR------------SMQK 378

Query: 118 LYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL 177
                 +LKNL  L++ +N         +PDS      +  L+LS    +    +     
Sbjct: 379 TGEILLTLKNLTSLDISRNTF-----HPMPDSCQWPEKMRFLNLSSTGIR---VVKTCIP 430

Query: 178 KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQ 237
           + L  L++  NNL           +       L+ L +  N+                  
Sbjct: 431 QTLEVLDVSNNNLD----------SFSLFLPRLQELYISRNKL----------------- 463

Query: 238 FRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRN 291
                     T+P        L+ + I  NQL  +       L  LQ++++  N
Sbjct: 464 ---------KTLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  157 bits (398), Expect = 2e-41
 Identities = 78/487 (16%), Positives = 164/487 (33%), Gaps = 98/487 (20%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGG------- 54
           + L  ++P E  ++ +       ++      P   G    + +  +R             
Sbjct: 21  SNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELN 79

Query: 55  -----QIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDIL 109
                 +P       +L  L  + N  +   P    ++ SL      +   S  LP    
Sbjct: 80  NLGLSSLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-DLP---- 130

Query: 110 VNLPNLKELYLT---------FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLD 160
              P L+ L ++           +   L  ++++ N+L       +PD   +   LE + 
Sbjct: 131 ---PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL-----KKLPDLPPS---LEFIA 179

Query: 161 LSGNQFKGKVSI-DFSSLKNLWWLNLEQNNL-----GMGT-------ANDLDFVTLLTNC 207
              NQ +    + +  +L  L  +  + N+L        +        N L+ +  L N 
Sbjct: 180 AGNNQLE---ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 236

Query: 208 SSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVN 267
             L  +   +N     LP    +L +      +  N ++  +P   ++L  L       +
Sbjct: 237 PFLTTIYADNNLLK-TLPDLPPSLEA----LNVRDNYLT-DLPELPQSLTFLDVSENIFS 290

Query: 268 QLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGN 327
            L  + P       +L  L    N ++ S+     +L +L    +S N L   +P+    
Sbjct: 291 GLSELPP-------NLYYLNASSNEIR-SLCDLPPSLEELN---VSNNKLI-ELPALPPR 338

Query: 328 CQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVI----- 382
            + L    AS N L   +P+   ++  L     + +N L    P    ++++L +     
Sbjct: 339 LERL---IASFNHLA-EVPELPQNLKQLH----VEYNPLR-EFPDIPESVEDLRMNSHLA 389

Query: 383 ----TCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFL 438
                  +L+ L + +N      P       S+++L ++S  +        +    LE  
Sbjct: 390 EVPELPQNLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDD 445

Query: 439 NLSYNHL 445
              ++H 
Sbjct: 446 VFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  155 bits (394), Expect = 8e-41
 Identities = 94/466 (20%), Positives = 166/466 (35%), Gaps = 86/466 (18%)

Query: 8   IPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG------ 61
           I     S   LQ      + LT ++P    N+ +       W+      P   G      
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 62  -------LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPN 114
                  L R    L +     S   P    ++ SL     + N  +  LP ++  +L +
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELP-ELPQSLKS 115

Query: 115 LKELYLTFCSL----KNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKV 170
           L        +L      L +L +  N L       +P+ L N+S L+ +D+  N  K   
Sbjct: 116 LLVDNNNLKALSDLPPLLEYLGVSNNQL-----EKLPE-LQNSSFLKIIDVDNNSLK--- 166

Query: 171 SIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIAN 230
            +      +L ++    N         L+ +  L N   L A+   +N    +LP    +
Sbjct: 167 KL-PDLPPSLEFIAAGNNQ--------LEELPELQNLPFLTAIYADNNSL-KKLPDLPLS 216

Query: 231 LSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFR 290
           L S       G N +       ++NL  L  +  + N L   +PD       L+ L +  
Sbjct: 217 LES----IVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRD 266

Query: 291 NFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVL 350
           N+L   +P    +LT L      F+ L    P       NL   +AS N++  ++     
Sbjct: 267 NYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCDLPP 317

Query: 351 SITTLSVYLALAHNLLNDSLPLQVGNLKNLVITC----------VSLEYLDISSNSFHGV 400
           S+  L+    +++N L   LP     L+ L+ +            +L+ L +  N     
Sbjct: 318 SLEELN----VSNNKLI-ELPALPPRLERLIASFNHLAEVPELPQNLKQLHVEYNPLR-E 371

Query: 401 IPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLE 446
            P     ++ ++      N+   ++PE  QN   L+ L++  N L 
Sbjct: 372 FPDIPESVEDLR-----MNSHLAEVPELPQN---LKQLHVETNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  147 bits (374), Expect = 4e-38
 Identities = 89/442 (20%), Positives = 155/442 (35%), Gaps = 88/442 (19%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
              L   +PE      +L++L    N LT +LP+   +L +L +      +L        
Sbjct: 80  NLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD------ 128

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
            L   L YL V+ NQ   +    + N S L+ I +  N     LP       P+L+ +  
Sbjct: 129 -LPPLLEYLGVSNNQLEKLPE--LQNSSFLKIIDVDNNSLK-KLP----DLPPSLEFIAA 180

Query: 121 ---------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS 171
                       +L  L  +  + N+L       +PD   +   LE +    N  +    
Sbjct: 181 GNNQLEELPELQNLPFLTAIYADNNSL-----KKLPDLPLS---LESIVAGNNILE---E 229

Query: 172 I-DFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIAN 230
           + +  +L  L  +  + N L           TL     SL+AL++ DN    +LP    +
Sbjct: 230 LPELQNLPFLTTIYADNNLL----------KTLPDLPPSLEALNVRDNYLT-DLPELPQS 278

Query: 231 LSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFR 290
           L+       +  N  S  +     NL  L       N++  +          L++L +  
Sbjct: 279 LTF----LDVSENIFS-GLSELPPNLYYL---NASSNEIRSLC----DLPPSLEELNVSN 326

Query: 291 NFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVL 350
           N L   +P     L +L     SFN+L   +P    N + L      +N L    P    
Sbjct: 327 NKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDIPE 377

Query: 351 SITTLSVYLALAHNLLNDSLPLQVGNLKNLVITC----------VSLEYLDISSNSFHGV 400
           S+  L +     ++ L   +P    NLK L +             S+E L ++S      
Sbjct: 378 SVEDLRM-----NSHLA-EVPELPQNLKQLHVETNPLREFPDIPESVEDLRMNSERVVDP 431

Query: 401 IPFSLGFMKSIKELNVSSNNLS 422
             F+      +++     ++  
Sbjct: 432 YEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  119 bits (300), Expect = 1e-28
 Identities = 58/340 (17%), Positives = 118/340 (34%), Gaps = 62/340 (18%)

Query: 123 CSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWW 182
            S   L       +NL     + +P    N  +      + ++++          + +  
Sbjct: 8   VSNTFLQEPLRHSSNL-----TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG 242
             L                           L L +      LP    +L S         
Sbjct: 63  SRLRDCL-----------------DRQAHELELNNLGLS-SLPELPPHLES----LVASC 100

Query: 243 NQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLG 302
           N ++  +P   ++L +L+     +  L  + P        L+ L +  N L+  +P  L 
Sbjct: 101 NSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQ 150

Query: 303 NLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALA 362
           N + L  + +  N+L+  +P    + + +    A +N+L   +P+ + ++  L   +   
Sbjct: 151 NSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE-ELPE-LQNLPFL-TAIYAD 203

Query: 363 HNLLNDSLPLQVGNLKNLVI------------TCVSLEYLDISSNSFHGVIPFSLGFMKS 410
           +N L   LP    +L+++V                 L  +   +N     +P       S
Sbjct: 204 NNSLK-KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPP---S 258

Query: 411 IKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVP 450
           ++ LNV  N L+  +PE  Q+L+FL+     ++ L    P
Sbjct: 259 LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP 297

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 88.1 bits (219), Expect = 2e-18
 Identities = 42/211 (19%), Positives = 81/211 (38%), Gaps = 37/211 (17%)

Query: 279 ELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGN----------- 327
               LQ+     + L   +P    N+    +   +++  + N P   G            
Sbjct: 9   SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67

Query: 328 --CQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCV 385
              +     + ++  L+ ++P+    + +L      + N L   LP    +LK+L++   
Sbjct: 68  CLDRQAHELELNNLGLS-SLPELPPHLESLV----ASCNSLT-ELPELPQSLKSLLVDNN 121

Query: 386 S----------LEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFL 435
           +          LEYL +S+N     +P  L     +K ++V +N+L  ++P+   +   L
Sbjct: 122 NLKALSDLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPS---L 175

Query: 436 EFLNLSYNHLEGEVPTKGVFSNKTKISLQVN 466
           EF+    N LE E+P        T I    N
Sbjct: 176 EFIAAGNNQLE-ELPELQNLPFLTAIYADNN 205

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  147 bits (372), Expect = 2e-38
 Identities = 72/388 (18%), Positives = 138/388 (35%), Gaps = 45/388 (11%)

Query: 8   IPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLV 67
           I   +        + ID              L+   ++  + +++       L   R + 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 68  YLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL------- 120
            LN+ + Q   +         +++ +Y+  N     LP  +  N+P L  L L       
Sbjct: 73  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS 131

Query: 121 ----TFCSLKNLWWLNLEQNNLGMGTASSIPDS-LSNASNLERLDLSGNQFKGKVSIDFS 175
                F +   L  L++  NNL       I D      ++L+ L LS N+      +D S
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNL-----ERIEDDTFQATTSLQNLQLSSNRLT---HVDLS 183

Query: 176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTM 235
            + +L+  N+  N L           + L    +++ L    N            L+   
Sbjct: 184 LIPSLFHANVSYNLL-----------STLAIPIAVEELDASHNSINVVRGPVNVELTI-- 230

Query: 236 IQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQG 295
              ++  N +  T  + + N   L+ + +  N+L  I+     ++Q L++LY+  N L  
Sbjct: 231 --LKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV- 285

Query: 296 SIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTL 355
           ++      +  L  L LS N+L  ++  +      L+     HN +   +        TL
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH--TL 341

Query: 356 SVYLALAHN-LLNDSLPLQVGNLKNLVI 382
              L L+HN    +SL     N+    +
Sbjct: 342 K-NLTLSHNDWDCNSLRALFRNVARPAV 368

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  130 bits (328), Expect = 1e-32
 Identities = 75/369 (20%), Positives = 133/369 (36%), Gaps = 71/369 (19%)

Query: 81  PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGM 140
           P + C  S+L++  +  +        D+     ++        +L N   +  + + +  
Sbjct: 8   PEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDI--------TLNNQKIVTFKNSTM-- 57

Query: 141 GTASSIP-DSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD 199
                +P   L +   +E L+L+  Q +   +  F+    +  L +  N +     +   
Sbjct: 58  ---RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH--- 111

Query: 200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVN 258
              +  N   L  L L                           N +S ++P GI  N   
Sbjct: 112 ---VFQNVPLLTVLVL-------------------------ERNDLS-SLPRGIFHNTPK 142

Query: 259 LIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ 318
           L  L++  N L  I  D       LQ L +  N L   +      +  L    +S+N L 
Sbjct: 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL- 198

Query: 319 GNIPSSLGNCQNLKGFDASHNKLTGAIPQQVL-SITTLSVYLALAHNLLNDSLPLQVGNL 377
               S+L     ++  DASHN +   +   V   +T L     L HN L D        L
Sbjct: 199 ----STLAIPIAVEELDASHNSIN-VVRGPVNVELTILK----LQHNNLTD-----TAWL 244

Query: 378 KNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEF 437
            N       L  +D+S N    ++      M+ ++ L +S+N L   +  + Q +  L+ 
Sbjct: 245 LNYP----GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299

Query: 438 LNLSYNHLE 446
           L+LS+NHL 
Sbjct: 300 LDLSHNHLL 308

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  127 bits (320), Expect = 1e-31
 Identities = 70/430 (16%), Positives = 137/430 (31%), Gaps = 82/430 (19%)

Query: 56  IPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL 115
           I + L        +++        F      +++ + +    +     LP  +L +   +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 116 KELYL-----------TFCSLKNLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLSG 163
           + L L            F     +  L +  N +       +P     N   L  L L  
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-----RYLPPHVFQNVPLLTVLVLER 126

Query: 164 NQFKGKVSID---FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQF 220
           N      S+    F +   L  L++  NNL       ++        +SL+ L L  N+ 
Sbjct: 127 NDLS---SLPRGIFHNTPKLTTLSMSNNNL-----ERIE-DDTFQATTSLQNLQLSSNRL 177

Query: 221 GGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGEL 280
                  I +L        +  N +S      +   + +  L    N ++ ++   V   
Sbjct: 178 THVDLSLIPSLFH----ANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRGPV--N 225

Query: 281 QHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNK 340
             L  L +  N L       L N   L ++ LS+N L+  +       Q L+    S+N+
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283

Query: 341 LTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGV 400
           L                           +L L    +  L       + LD+S N     
Sbjct: 284 LV--------------------------ALNLYGQPIPTL-------KVLDLSHNHLL-H 309

Query: 401 IPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTK 460
           +  +      ++ L +  N++   +   L     L+ L LS+N  +     + +F N  +
Sbjct: 310 VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVAR 365

Query: 461 ISLQVNVKLC 470
            ++    + C
Sbjct: 366 PAVDDADQHC 375

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  112 bits (282), Expect = 9e-27
 Identities = 58/328 (17%), Positives = 103/328 (31%), Gaps = 61/328 (18%)

Query: 2   NKLEGQIPEEI-GSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
            ++E +I          +Q L + FN +   LP                       P   
Sbjct: 79  LQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLP-----------------------PHVF 113

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
             +  L  L +  N  S +      N   L  + ++ N     +  D      +L+ L L
Sbjct: 114 QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQL 172

Query: 121 --------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSI 172
                       + +L+  N+  N L          +L+    +E LD S N       +
Sbjct: 173 SSNRLTHVDLSLIPSLFHANVSYNLL---------STLAIPIAVEELDASHNSIN---VV 220

Query: 173 DFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLS 232
                  L  L L+ NN        L     L N   L  + L  N+    + H    + 
Sbjct: 221 RGPVNVELTILKLQHNN--------LTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272

Query: 233 STMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNF 292
             + +  I  N++   +    + +  L  L +  N L   +     +   L+ LY+  N 
Sbjct: 273 R-LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329

Query: 293 LQGSIPPSLGNLTKLADLALSFNNLQGN 320
           +  ++         L +L LS N+   N
Sbjct: 330 IV-TLKL--STHHTLKNLTLSHNDWDCN 354

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  147 bits (373), Expect = 7e-38
 Identities = 58/422 (13%), Positives = 122/422 (28%), Gaps = 57/422 (13%)

Query: 32  LPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLE 91
           + +   N +   +  +  +SL   + +      N+  L+++ N  S +    +   + LE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 92  FIYLTVNRFSGSLPFDILVNLPNLKELYL------TFCSLKNLWWLNLEQNNLGMGTASS 145
            + L+ N    +L  +   +L  L+ L L            ++  L+   NN+     S 
Sbjct: 62  LLNLSSNVLYETLDLE---SLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI-----SR 113

Query: 146 IPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLT 205
           +    S     + + L+ N+      +D      + +L+L+ N +     + ++F  L  
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-----DTVNFAELAA 166

Query: 206 NCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIE 265
           +  +L+ L+L                           N I   +   +     L  L + 
Sbjct: 167 SSDTLEHLNL-------------------------QYNFIY-DVKGQV-VFAKLKTLDLS 199

Query: 266 VNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ-GNIPSS 324
            N+L   +         +  + +  N L   I  +L     L    L  N    G +   
Sbjct: 200 SNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257

Query: 325 LGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITC 384
               Q ++       K    +  Q     T+            D        L  L    
Sbjct: 258 FSKNQRVQTVAKQTVKK---LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIAL--KR 312

Query: 385 VSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNH 444
                L    +     +          +E++         I +          L      
Sbjct: 313 KEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKA 371

Query: 445 LE 446
           L+
Sbjct: 372 LD 373

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  128 bits (324), Expect = 1e-31
 Identities = 59/451 (13%), Positives = 132/451 (29%), Gaps = 55/451 (12%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N L      ++     L+ L +  N L  +  D   +LS L  L +  N +       L 
Sbjct: 44  NPLSQISAADLAPFTKLELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYV-----QELL 96

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
           +  ++  L+ A N  S +           + IYL  N+         +  L +     L 
Sbjct: 97  VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNK---------ITMLRD-----LD 139

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSI-DFSSLKNL 180
                 + +L+L+ N +      +  +  +++  LE L+L  N       +        L
Sbjct: 140 EGCRSRVQYLDLKLNEI---DTVNFAELAASSDTLEHLNLQYNFIY---DVKGQVVFAKL 193

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
             L+L  N L               + + +  +SL +N+    +  ++    + +  F +
Sbjct: 194 KTLDLSSNKLAFMGPE-------FQSAAGVTWISLRNNKL-VLIEKALRFSQN-LEHFDL 244

Query: 241 GGNQIS-GTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP 299
            GN    GT+         +   T+    +  +      E       +      +    P
Sbjct: 245 RGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302

Query: 300 SLGNLTKLADLALSFNNLQGN----IPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTL 355
               L  L     +  + QG+    +     N    +  DA   +    +  QV      
Sbjct: 303 FADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQVTLRKQA 361

Query: 356 SVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELN 415
            + L      L++ +         L                           ++ ++ + 
Sbjct: 362 KITLEQKKKALDEQVSNGRRAHAEL-----DGTLQQAVGQIELQHATEEQSPLQLLRAIV 416

Query: 416 VSSNNLSGQIPEFLQNLSFLEFLNLSYNHLE 446
                +   + +     + +   ++  +   
Sbjct: 417 KRYEEMY--VEQQSVQNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  116 bits (291), Expect = 2e-27
 Identities = 44/302 (14%), Positives = 107/302 (35%), Gaps = 31/302 (10%)

Query: 145 SIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLL 204
           +I +   N +  +   ++ +  K  ++    S  N+  L+L  N L   +A        L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA------DL 54

Query: 205 TNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTI 264
              + L+ L+L  N    E    + +LS+ +    +  N +       +    ++  L  
Sbjct: 55  APFTKLELLNLSSNVL-YETL-DLESLST-LRTLDLNNNYV-----QELLVGPSIETLHA 106

Query: 265 EVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQG-NIPS 323
             N +  +        Q  + +Y+  N +        G  +++  L L  N +   N   
Sbjct: 107 ANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163

Query: 324 SLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVIT 383
              +   L+  +  +N +   +  Q +    L   L L+ N L   +  +  +       
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKT-LDLSSNKLA-FMGPEFQSAAG---- 215

Query: 384 CVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLS-GQIPEFLQNLSFLEFLNLSY 442
              + ++ + +N    +I  +L F ++++  ++  N    G + +F      ++ +    
Sbjct: 216 ---VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

Query: 443 NH 444
             
Sbjct: 272 VK 273

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 54.5 bits (131), Expect = 1e-07
 Identities = 17/62 (27%), Positives = 27/62 (43%)

Query: 386 SLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHL 445
             +   ++ +S    +        ++KEL++S N LS      L   + LE LNLS N L
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 446 EG 447
             
Sbjct: 71  YE 72

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  142 bits (361), Expect = 1e-37
 Identities = 63/407 (15%), Positives = 117/407 (28%), Gaps = 88/407 (21%)

Query: 30  GQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISS 89
           G       + S    L  + ++        L   +     +      +        N ++
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 90  LEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDS 149
            +    T            L    +L    L   +      L L    L        PD 
Sbjct: 58  PQIETRTGRA---------LKATADL----LEDATQPGRVALELRSVPL-----PQFPDQ 99

Query: 150 LSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL---LTN 206
               S+L+ + +       ++         L  L L +N L            L   + +
Sbjct: 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL----------RALPASIAS 148

Query: 207 CSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEV 266
            + L+ LS+       ELP  +A+  +                    + LVNL +L +E 
Sbjct: 149 LNRLRELSIRACPELTELPEPLASTDA----------------SGEHQGLVNLQSLRLEW 192

Query: 267 NQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLG 326
             +  + P  +  LQ+L+ L +  + L  ++ P++ +L KL +L L       N P   G
Sbjct: 193 TGIRSL-PASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFG 250

Query: 327 NCQNLKGFDASH-NKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCV 385
               LK       + L                           +LPL +  L  L     
Sbjct: 251 GRAPLKRLILKDCSNLL--------------------------TLPLDIHRLTQL----- 279

Query: 386 SLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNL 432
             E LD+        +P  +  + +   + V  +  +          
Sbjct: 280 --EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  141 bits (358), Expect = 4e-37
 Identities = 50/317 (15%), Positives = 110/317 (34%), Gaps = 34/317 (10%)

Query: 144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL 203
            S      ++S  E L   G+          S  +  +  +  + +              
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----------AWR 51

Query: 204 LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQF-RIGGNQISGTIPSGIRNLVNLIAL 262
             N ++ +  +             + + +        +    +    P     L +L  +
Sbjct: 52  QANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM 109

Query: 263 TIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIP 322
           TI+   L   +PD + +   L+ L + RN L+ ++P S+ +L +L +L++        +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167

Query: 323 SSLGNC---------QNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQ 373
             L +           NL+        +  ++P  + ++  L   L + ++ L+ +L   
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL-KSLKIRNSPLS-ALGPA 224

Query: 374 VGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLS 433
           + +L  L       E LD+   +     P   G    +K L +   +    +P  +  L+
Sbjct: 225 IHHLPKL-------EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277

Query: 434 FLEFLNLSYNHLEGEVP 450
            LE L+L        +P
Sbjct: 278 QLEKLDLRGCVNLSRLP 294

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  137 bits (347), Expect = 1e-35
 Identities = 55/347 (15%), Positives = 108/347 (31%), Gaps = 53/347 (15%)

Query: 111 NLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKV 170
           +    + LY    +        L              D LS        D +      + 
Sbjct: 10  HSSGRENLYFQGST-------ALR----------PYHDVLSQWQRHYNADRNRWHSAWR- 51

Query: 171 SIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSS--LKALSLCDNQFGGELPHSI 228
               ++  N          L            LL + +     AL L       + P   
Sbjct: 52  ---QANSNNPQIETRTGRALK-------ATADLLEDATQPGRVALELRSVPLP-QFPDQA 100

Query: 229 ANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYM 288
             LS  +    I    +   +P  ++    L  LT+  N L   +P  +  L  L++L +
Sbjct: 101 FRLSH-LQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157

Query: 289 FRNFLQGSIPPSLGN---------LTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHN 339
                   +P  L +         L  L  L L +  ++ ++P+S+ N QNLK     ++
Sbjct: 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216

Query: 340 KLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHG 399
            L+ A+   +  +  L   L L       + P   G    L       + L +   S   
Sbjct: 217 PLS-ALGPAIHHLPKL-EELDLRGCTALRNYPPIFGGRAPL-------KRLILKDCSNLL 267

Query: 400 VIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLE 446
            +P  +  +  +++L++       ++P  +  L     + +  +   
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  121 bits (306), Expect = 3e-30
 Identities = 52/267 (19%), Positives = 85/267 (31%), Gaps = 29/267 (10%)

Query: 8   IPEEIGSL--LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRN 65
             + +          L +    L  Q PD    LS L  + I    L  ++P T+     
Sbjct: 71  TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAG 128

Query: 66  LVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSL 125
           L  L +A N      P  I +++ L  + +        LP  +        +       L
Sbjct: 129 LETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPL-----ASTDASGEHQGL 182

Query: 126 KNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNL 185
            NL  L LE   +      S+P S++N  NL+ L +  +     +      L  L  L+L
Sbjct: 183 VNLQSLRLEWTGI-----RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDL 236

Query: 186 EQNNLGMGTANDLDFVTL---LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG 242
                                    + LK L L D      LP  I  L+  + +  + G
Sbjct: 237 RGCTA---------LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ-LEKLDLRG 286

Query: 243 NQISGTIPSGIRNLVNLIALTIEVNQL 269
                 +PS I  L     + +  +  
Sbjct: 287 CVNLSRLPSLIAQLPANCIILVPPHLQ 313

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 41/200 (20%), Positives = 72/200 (36%), Gaps = 30/200 (15%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGM---------LLIRWNSL 52
           N L   +P  I SL  L+ L+I       +LP+ + +  A G          L + W  +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195

Query: 53  GGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNL 112
              +P ++  L+NL  L +  +  S      I ++  LE + L       + P       
Sbjct: 196 -RSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFG-GR 252

Query: 113 PNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSI 172
             LK L L  C            +NL      ++P  +   + LE+LDL G     ++  
Sbjct: 253 APLKRLILKDC------------SNL-----LTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295

Query: 173 DFSSLKNLWWLNLEQNNLGM 192
             + L     + +  +    
Sbjct: 296 LIAQLPANCIILVPPHLQAQ 315

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 21/113 (18%), Positives = 37/113 (32%), Gaps = 4/113 (3%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAI-DFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
           + L   +   I  L  L+ L +     L    P   G  + L  L+++  S    +P  +
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNLLTLPLDI 273

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLP 113
             L  L  L++         P  I  + +   I +  +     L     V  P
Sbjct: 274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPVARP 325

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  142 bits (359), Expect = 2e-35
 Identities = 84/472 (17%), Positives = 162/472 (34%), Gaps = 56/472 (11%)

Query: 8   IPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLV 67
           I   +        + ID              L+   ++  + +++       L   R + 
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 68  YLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL------- 120
            LN+ + Q   +         +++ +Y+  N     LP  +  N+P L  L L       
Sbjct: 79  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS 137

Query: 121 ----TFCSLKNLWWLNLEQNNLGMGTASSIPDS-LSNASNLERLDLSGNQFKGKVSIDFS 175
                F +   L  L++  NNL       I D      ++L+ L LS N+      +D S
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNL-----ERIEDDTFQATTSLQNLQLSSNRLT---HVDLS 189

Query: 176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTM 235
            + +L+  N+  N L           + L    +++ L    N            L+   
Sbjct: 190 LIPSLFHANVSYNLL-----------STLAIPIAVEELDASHNSINVVRGPVNVELTI-- 236

Query: 236 IQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQG 295
              ++  N +  T  + + N   L+ + +  N+L  I+     ++Q L++LY+  N L  
Sbjct: 237 --LKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV- 291

Query: 296 SIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTL 355
           ++      +  L  L LS N+L  ++  +      L+     HN +   +        TL
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH--TL 347

Query: 356 SVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELN 415
              L L+HN           +L+ L     ++    +     H  I + L      KE  
Sbjct: 348 K-NLTLSHN------DWDCNSLRALF---RNVARPAVDDADQHCKIDYQLEHGLCCKE-- 395

Query: 416 VSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNV 467
            S      ++ +++   S +E +  +            V S    I+ Q  V
Sbjct: 396 -SDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGV 446

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  125 bits (316), Expect = 4e-30
 Identities = 74/368 (20%), Positives = 132/368 (35%), Gaps = 69/368 (18%)

Query: 81  PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGM 140
           P + C  S+L++  +  +        D+     ++        +L N   +  + + +  
Sbjct: 14  PEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDI--------TLNNQKIVTFKNSTM-- 63

Query: 141 GTASSIP-DSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD 199
                +P   L +   +E L+L+  Q +   +  F+    +  L +  N +     +   
Sbjct: 64  ---RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH--- 117

Query: 200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVN 258
              +  N   L  L L                           N +S ++P GI  N   
Sbjct: 118 ---VFQNVPLLTVLVL-------------------------ERNDLS-SLPRGIFHNTPK 148

Query: 259 LIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ 318
           L  L++  N L  I  D       LQ L +  N L   +      +  L    +S+N L 
Sbjct: 149 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL- 204

Query: 319 GNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLK 378
               S+L     ++  DASHN +        + +T L     L HN L D        L 
Sbjct: 205 ----STLAIPIAVEELDASHNSINVVRGPVNVELTILK----LQHNNLTD-----TAWLL 251

Query: 379 NLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFL 438
           N       L  +D+S N    ++      M+ ++ L +S+N L   +  + Q +  L+ L
Sbjct: 252 NYP----GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 306

Query: 439 NLSYNHLE 446
           +LS+NHL 
Sbjct: 307 DLSHNHLL 314

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  118 bits (298), Expect = 7e-28
 Identities = 74/457 (16%), Positives = 143/457 (31%), Gaps = 69/457 (15%)

Query: 2   NKLEGQIPEEI-GSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
            ++E +I          +Q L + FN +   LP                       P   
Sbjct: 85  LQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLP-----------------------PHVF 119

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
             +  L  L +  N  S +      N   L  + ++ N     +  D      +L+ L L
Sbjct: 120 QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQL 178

Query: 121 --------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSI 172
                       + +L+  N+  N L          +L+    +E LD S N       +
Sbjct: 179 SSNRLTHVDLSLIPSLFHANVSYNLL---------STLAIPIAVEELDASHNSIN---VV 226

Query: 173 DFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLS 232
                  L  L L+ NNL             L N   L  + L  N+    + H    + 
Sbjct: 227 RGPVNVELTILKLQHNNLTD--------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 278

Query: 233 STMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNF 292
             + +  I  N++   +    + +  L  L +  N L   +     +   L+ LY+  N 
Sbjct: 279 R-LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 335

Query: 293 LQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSI 352
           +  ++         L +L LS N+   N   +L   +N+             I  Q+   
Sbjct: 336 IV-TLKL--STHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHG 390

Query: 353 TTLSVYLALAHNLLNDSLPLQ--VGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKS 410
                      + L   + L   V  ++     C + + ++   +  H +       ++ 
Sbjct: 391 LCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQG 450

Query: 411 IKELNVSSNNLSGQI----PEFLQNLSFLEFLNLSYN 443
            ++L    N L  ++     E +Q    L+ L+   +
Sbjct: 451 NEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEID 487

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 13/121 (10%), Positives = 40/121 (33%), Gaps = 5/121 (4%)

Query: 337 SHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNS 396
            +N      P+     + L          ++          +++  T  + + +   +++
Sbjct: 6   RYNVKP-RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDI--TLNNQKIVTFKNST 62

Query: 397 FHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFS 456
              +    L   + ++ LN++   +             ++ L + +N +   +P   VF 
Sbjct: 63  MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP-PHVFQ 120

Query: 457 N 457
           N
Sbjct: 121 N 121

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  134 bits (340), Expect = 7e-35
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 33/225 (14%)

Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVINLKQKGA----FRSFVAECEALRNIRHRN 606
            ++G+G FGSV +G L    G  + VAVK   +K   +       F++E   +++  H N
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           +I+++ +C  + S+G     ++  +M+ G L  +L  S        + L   +   +D+A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 667 SAIEYL-HHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLS---HQLDSASKTPSSSI 719
             +EYL + +     +H DL   N +L  DM   VA  +F LS   +  D   +   + +
Sbjct: 158 LGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVA--DFGLSKKIYSGDYYRQGRIAKM 211

Query: 720 GIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            +K      A E     + +  S   DV++FG+ + E+ T G  P
Sbjct: 212 PVKWI----AIESLADRVYTSKS---DVWAFGVTMWEIATRGMTP 249

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  132 bits (334), Expect = 1e-33
 Identities = 61/243 (25%), Positives = 99/243 (40%), Gaps = 32/243 (13%)

Query: 527 DTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ- 585
                 +  P   +  L+    +      IG+G+FG V+ G L  +  +VAVK       
Sbjct: 96  SGVVLHRAVPKDKW-VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP 152

Query: 586 KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN 645
                 F+ E   L+   H N++++I +C+           +V E ++ G    +L ++ 
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP-----IYIVMELVQGGDFLTFL-RTE 206

Query: 646 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSL 704
                 +L +   + +  D A+ +EYL        +H DL   N L+    V    +F +
Sbjct: 207 GA----RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM 259

Query: 705 SHQLDSASKTPSSSIG---IKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-G 757
           S +        S  +    +K T    APE   YG  S  S   DV+SFGILL E F+ G
Sbjct: 260 SREEADGVYAASGGLRQVPVKWT----APEALNYGRYSSES---DVWSFGILLWETFSLG 312

Query: 758 RRP 760
             P
Sbjct: 313 ASP 315

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  128 bits (324), Expect = 5e-33
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG+GSF +VYKG+     + VA   +  ++  K   + F  E E L+ ++H N+++    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY-- 91

Query: 614 CSSIDSKGADFKALVF--EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
             S +S     K +V   E M +G+L+ +L           + +    +    +   +++
Sbjct: 92  -DSWESTVKGKKCIVLVTELMTSGTLKTYLK------RFKVMKIKVLRSWCRQILKGLQF 144

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD--MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           LH    PPI+H DLK  N+ +      V   +  L+     AS   +    + GT  ++A
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKA----VIGTPEFMA 198

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE     +   + DVY+FG+ +LEM T   P
Sbjct: 199 PEMYE-EKYDESVDVYAFGMCMLEMATSEYP 228

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  127 bits (321), Expect = 1e-32
 Identities = 63/224 (28%), Positives = 89/224 (39%), Gaps = 28/224 (12%)

Query: 548 SEFASSNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN---LKQKGAFRSFVAECEALRN 601
            +      +G GSFG V +G      G+ + VAVK +    L Q  A   F+ E  A+ +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + HRNLI++  +  +          +V E    GSL D L +   H       L      
Sbjct: 78  LDHRNLIRLYGVVLT------PPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRY 126

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIG 720
           A+ VA  + YL        +H DL   N+LL    +    +F L   L            
Sbjct: 127 AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183

Query: 721 IKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            K    + APE       S AS   D + FG+ L EMFT G+ P
Sbjct: 184 RKVPFAWCAPESLKTRTFSHAS---DTWMFGVTLWEMFTYGQEP 224

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  128 bits (323), Expect = 1e-32
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 30/224 (13%)

Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVI--NLKQKGAFRSFVAECEALRNIRHRNLI 608
            M+G+G FGSV +  L    G  + VAVK++  ++        F+ E   ++   H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 609 KIITICSSIDSKGADFKAL-VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           K++ +     +KG     + +  +M++G L  +L  S        L L   V   +D+A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 668 AIEYL-HHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLS---HQLDSASKTPSSSIG 720
            +EYL   +     +H DL   N +L  DM   VA  +F LS   +  D   +  +S + 
Sbjct: 149 GMEYLSSRNF----IHRDLAARNCMLAEDMTVCVA--DFGLSRKIYSGDYYRQGCASKLP 202

Query: 721 IKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           +K      A E     + +  S   DV++FG+ + E+ T G+ P
Sbjct: 203 VKWL----ALESLADNLYTVHS---DVWAFGVTMWEIMTRGQTP 239

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  127 bits (321), Expect = 2e-32
 Identities = 53/347 (15%), Positives = 113/347 (32%), Gaps = 55/347 (15%)

Query: 32  LPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLE 91
           + +   N +   +  +  +SL   + +      N+  L+++ N  S +    +   + LE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 92  FIYLTVNRFSGSLPFDILVNLPNLKELYL------TFCSLKNLWWLNLEQNNLGMGTASS 145
            + L+ N    +L  +   +L  L+ L L            ++  L+   NN+     S 
Sbjct: 62  LLNLSSNVLYETLDLE---SLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI-----SR 113

Query: 146 IPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLT 205
           +    S     + + L+ N+      +D      + +L+L+ N +     + ++F  L  
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI-----DTVNFAELAA 166

Query: 206 NCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIE 265
           +  +L+ L+L                           N I   +   +     L  L + 
Sbjct: 167 SSDTLEHLNL-------------------------QYNFIY-DVKGQV-VFAKLKTLDLS 199

Query: 266 VNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ-GNIPSS 324
            N+L   +         +  + +  N L   I  +L     L    L  N    G +   
Sbjct: 200 SNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257

Query: 325 LGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLP 371
               Q ++       K      ++  ++ TL  Y         + LP
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY----GAYCCEDLP 300

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  119 bits (300), Expect = 1e-29
 Identities = 44/302 (14%), Positives = 107/302 (35%), Gaps = 31/302 (10%)

Query: 145 SIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLL 204
           +I +   N +  +   ++ +  K  ++    S  N+  L+L  N L   +A        L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA------DL 54

Query: 205 TNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTI 264
              + L+ L+L  N    E    + +LS+ +    +  N +   +        ++  L  
Sbjct: 55  APFTKLELLNLSSNVL-YETL-DLESLST-LRTLDLNNNYVQ-ELL----VGPSIETLHA 106

Query: 265 EVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQG-NIPS 323
             N +  +        Q  + +Y+  N +        G  +++  L L  N +   N   
Sbjct: 107 ANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163

Query: 324 SLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVIT 383
              +   L+  +  +N +   +  Q +    L   L L+ N L   +  +  +       
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKT-LDLSSNKLA-FMGPEFQSAAG---- 215

Query: 384 CVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLS-GQIPEFLQNLSFLEFLNLSY 442
              + ++ + +N    +I  +L F ++++  ++  N    G + +F      ++ +    
Sbjct: 216 ---VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

Query: 443 NH 444
             
Sbjct: 272 VK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  103 bits (259), Expect = 3e-24
 Identities = 45/245 (18%), Positives = 94/245 (38%), Gaps = 23/245 (9%)

Query: 203 LLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIAL 262
           +  N +  K   + D+     L     +  + + +  + GN +S    + +     L  L
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWN-VKELDLSGNPLSQISAADLAPFTKLELL 63

Query: 263 TIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIP 322
            +  N L+  +   +  L  L+ L +  N++Q      L     +  L  + NN+   + 
Sbjct: 64  NLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS 115

Query: 323 SSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLND-SLPLQVGNLKNLV 381
            S G  Q  K    ++NK+T          + +  YL L  N ++  +      +   L 
Sbjct: 116 CSRG--QGKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTL- 171

Query: 382 ITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLS 441
                 E+L++  N  +  +         +K L++SSN L+  +    Q+ + + +++L 
Sbjct: 172 ------EHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222

Query: 442 YNHLE 446
            N L 
Sbjct: 223 NNKLV 227

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 96.2 bits (240), Expect = 8e-22
 Identities = 35/201 (17%), Positives = 67/201 (33%), Gaps = 23/201 (11%)

Query: 249 IPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLA 308
           I    +N        +  + L   +        ++++L +  N L       L   TKL 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 309 DLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLS--VYLALAHNLL 366
            L LS N L       L +   L+  D ++N +          +        L  A+N +
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ--------ELLVGPSIETLHAANNNI 111

Query: 367 NDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSG-QI 425
           +  +    G            + + +++N    +     G    ++ L++  N +     
Sbjct: 112 S-RVSCSRGQ---------GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161

Query: 426 PEFLQNLSFLEFLNLSYNHLE 446
            E   +   LE LNL YN + 
Sbjct: 162 AELAASSDTLEHLNLQYNFIY 182

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  127 bits (321), Expect = 3e-32
 Identities = 55/247 (22%), Positives = 104/247 (42%), Gaps = 47/247 (19%)

Query: 530 PAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGIL----GGEEMIVAVKVINLK- 584
           P +    ++   E  K         ++G G+FG+VYKG+        ++ VA+K   L+ 
Sbjct: 4   PNQALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LRE 54

Query: 585 --QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 642
                A +  + E   + ++ + ++ +++ IC +          L+ + M  G L D++ 
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVR 108

Query: 643 QSNDHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-Q 700
           +  D++    L     +N  + +A  + YL         VH DL   NVL+         
Sbjct: 109 EHKDNIGSQYL-----LNWCVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKIT 159

Query: 701 NFSLSHQLDSASKTPSSSIG---IKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEM 754
           +F L+  L +  K   +  G   IK      A E   + + +  S   DV+S+G+ + E+
Sbjct: 160 DFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQS---DVWSYGVTVWEL 212

Query: 755 FT-GRRP 760
            T G +P
Sbjct: 213 MTFGSKP 219

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  130 bits (328), Expect = 3e-32
 Identities = 77/271 (28%), Positives = 114/271 (42%), Gaps = 47/271 (17%)

Query: 517 RRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIV 576
            R         T  A+ +F    +  L+    E      IG+G FG V  G   G +  V
Sbjct: 165 TRLIKPKVMEGTVAAQDEFYRSGW-ALNM--KELKLLQTIGKGEFGDVMLGDYRGNK--V 219

Query: 577 AVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGS 636
           AVK   +K     ++F+AE   +  +RH NL++++ +      +      +V EYM  GS
Sbjct: 220 AVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGS 273

Query: 637 LEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 696
           L D+L           L     +  ++DV  A+EYL  +     VH DL   NVL+  D 
Sbjct: 274 LVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDN 326

Query: 697 ---VAHQNFSLSHQLDSAS---KTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSF 747
              V+  +F L+ +  S     K P     +K T    APE       S  S   DV+SF
Sbjct: 327 VAKVS--DFGLTKEASSTQDTGKLP-----VKWT----APEALREKKFSTKS---DVWSF 372

Query: 748 GILLLEMFT-GRRPTDAAFTEGLTLHEFVKM 777
           GILL E+++ GR P        + L + V  
Sbjct: 373 GILLWEIYSFGRVP-----YPRIPLKDVVPR 398

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  130 bits (329), Expect = 4e-32
 Identities = 60/239 (25%), Positives = 114/239 (47%), Gaps = 36/239 (15%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 605
           ++    + +G G +G VY+G+     + VAVK +    +       F+ E   ++ I+H 
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 276

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           NL++++ +C    ++   F  ++ E+M  G+L D+L + N      +++ +  + +A  +
Sbjct: 277 NLVQLLGVC----TREPPFY-IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQI 327

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQL--DSASKTPSSSIGIK 722
           +SA+EYL        +H +L   N L+  + +    +F LS  +  D+ +    +   IK
Sbjct: 328 SSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384

Query: 723 GTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKM 777
            T    APE   Y   S  S   DV++FG+LL E+ T G  P       G+ L +  ++
Sbjct: 385 WT----APESLAYNKFSIKS---DVWAFGVLLWEIATYGMSP-----YPGIDLSQVYEL 431

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  131 bits (331), Expect = 6e-32
 Identities = 72/338 (21%), Positives = 117/338 (34%), Gaps = 68/338 (20%)

Query: 114 NLKELYLTFCSL--------KNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ 165
               L +    L         ++  L +  NNL     +S+P        L  L++SGNQ
Sbjct: 41  GNAVLNVGESGLTTLPDCLPAHITTLVIPDNNL-----TSLPALPPE---LRTLEVSGNQ 92

Query: 166 FKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELP 225
               + +    L  L   +    +L            L +    L  L +  NQ    LP
Sbjct: 93  LT-SLPVLPPGLLELSIFSNPLTHL----------PALPSG---LCKLWIFGNQLT-SLP 137

Query: 226 HSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQ 285
                L        +  NQ++ ++P+    L  L A     NQL  + P        LQ+
Sbjct: 138 VLPPGLQE----LSVSDNQLA-SLPALPSELCKLWAYN---NQLTSL-PM---LPSGLQE 185

Query: 286 LYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAI 345
           L +  N L  S+P     L KL        +L    P+     + L     S N+LT ++
Sbjct: 186 LSVSDNQLA-SLPTLPSELYKLWAYNNRLTSL----PALPSGLKEL---IVSGNRLT-SL 236

Query: 346 PQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSL 405
           P      + L   L ++ N L  SLP+    L            L +  N     +P SL
Sbjct: 237 PV---LPSELK-ELMVSGNRL-TSLPMLPSGL----------LSLSVYRNQLT-RLPESL 280

Query: 406 GFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYN 443
             + S   +N+  N LS +  + L+ ++     +    
Sbjct: 281 IHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPII 318

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  127 bits (320), Expect = 1e-30
 Identities = 75/327 (22%), Positives = 123/327 (37%), Gaps = 63/327 (19%)

Query: 120 LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKN 179
           +  C       LN+ ++ L     +++PD L    ++  L +  N      S+  +    
Sbjct: 34  MRACLNNGNAVLNVGESGL-----TTLPDCLPA--HITTLVIPDNNLT---SLP-ALPPE 82

Query: 180 LWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFR 239
           L  L +  N L       L    L      L   S         LP   + L        
Sbjct: 83  LRTLEVSGNQL-----TSLP--VLPPGLLELSIFSNPLTH----LPALPSGLCK----LW 127

Query: 240 IGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP 299
           I GNQ++ ++P     L  L   ++  NQL   +P        L +L+ + N L  S+P 
Sbjct: 128 IFGNQLT-SLPVLPPGLQEL---SVSDNQL-ASLPALPS---ELCKLWAYNNQLT-SLPM 178

Query: 300 SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYL 359
               L +L+   +S N L  ++P+       L    A +N+LT ++P     +  L    
Sbjct: 179 LPSGLQELS---VSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPALPSGLKELI--- 227

Query: 360 ALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSN 419
            ++ N L  SLP+    LK L           +S N     +P        +  L+V  N
Sbjct: 228 -VSGNRLT-SLPVLPSELKEL----------MVSGNRLTS-LPMLPS---GLLSLSVYRN 271

Query: 420 NLSGQIPEFLQNLSFLEFLNLSYNHLE 446
            L+ ++PE L +LS    +NL  N L 
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  116 bits (292), Expect = 5e-27
 Identities = 73/372 (19%), Positives = 121/372 (32%), Gaps = 73/372 (19%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           + L   +P+ + +  ++ TL I  N LT  LP     L  L    +  N L   +P    
Sbjct: 50  SGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLE---VSGNQLT-SLPVLPP 101

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
            L  L   +        +        S L  +++  N+ + SLP                
Sbjct: 102 GLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLP---------------- 137

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
                 L  L++  N L     +S+P   S    L +L    NQ     S+       L 
Sbjct: 138 -VLPPGLQELSVSDNQL-----ASLPALPSE---LCKLWAYNNQLT---SLP-MLPSGLQ 184

Query: 182 WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
            L++  N L           +L T  S L  L   +N+    LP   + L        + 
Sbjct: 185 ELSVSDNQL----------ASLPTLPSELYKLWAYNNRLT-SLPALPSGLKE----LIVS 229

Query: 242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
           GN+++ ++P     L  L    +  N+L   +P        L  L ++RN L   +P SL
Sbjct: 230 GNRLT-SLPVLPSELKEL---MVSGNRL-TSLPM---LPSGLLSLSVYRNQLT-RLPESL 280

Query: 302 GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
            +L+    + L  N L      +L   + +         +         S    +  L L
Sbjct: 281 IHLSSETTVNLEGNPLS---ERTLQALREITSAPGYSGPII-RFDMAGASAPRETRALHL 336

Query: 362 AHNLLNDSLPLQ 373
           A           
Sbjct: 337 AAADWLVPAREG 348

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (332), Expect = 6e-32
 Identities = 47/221 (21%), Positives = 90/221 (40%), Gaps = 29/221 (13%)

Query: 555 MIGQGSFGSVYKG---ILGGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 610
            I  G  G +Y      + G    V +K +        ++  +AE + L  + H ++++I
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRP--VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
                  D  G     +V EY+   SL+    Q        KL + + +   +++  A+ 
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALS 196

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           YLH      +V+ DLKP N++L  + +   +     +++S          + GT G+ AP
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFG-------YLYGTPGFQAP 246

Query: 731 EYGMG--SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL 769
           E      + A+   D+Y+ G  L  +       +  + +GL
Sbjct: 247 EIVRTGPTVAT---DIYTVGRTLAALTLDLPTRNGRYVDGL 284

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  124 bits (313), Expect = 1e-31
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 33/215 (15%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITI 613
           +G G +G VY+G+     + VAVK +    +       F+ E   ++ I+H NL++++ +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL- 672
           C+           ++ E+M  G+L D+L + N      +++ +  + +A  ++SA+EYL 
Sbjct: 78  CTREPP-----FYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLE 128

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS--HQLDSASKTPSSSIGIKGTVGYVA 729
             +     +H DL   N L+  + +    +F LS     D+ +    +   IK T    A
Sbjct: 129 KKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----A 180

Query: 730 PE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           PE   Y   S  S   DV++FG+LL E+ T G  P
Sbjct: 181 PESLAYNKFSIKS---DVWAFGVLLWEIATYGMSP 212

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  124 bits (314), Expect = 2e-31
 Identities = 58/246 (23%), Positives = 103/246 (41%), Gaps = 31/246 (12%)

Query: 556 IGQGSFGSVYKGIL----GGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIK 609
           +G+G+FGSV              +VAVK   L+  G    R F  E + L+ +    ++K
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
              +      +      LV EY+ +G L D+L +    L+  +L     +  +  +   +
Sbjct: 89  YRGVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGM 140

Query: 670 EYLH-HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           EYL    C    VH DL   N+L++ +      +F L+  L             +  + +
Sbjct: 141 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196

Query: 728 VAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP-TDAAFTEGLTLHEFVKMTLPEK 782
            APE     + S  S   DV+SFG++L E+FT   +  + +A    +   E     L   
Sbjct: 197 YAPESLSDNIFSRQS---DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR- 252

Query: 783 VIEIVD 788
           ++E+++
Sbjct: 253 LLELLE 258

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  123 bits (311), Expect = 2e-31
 Identities = 75/260 (28%), Positives = 112/260 (43%), Gaps = 45/260 (17%)

Query: 527 DTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK 586
            +  A+ +F    +  L+    E      IG+G FG V  G   G +  VAVK   +K  
Sbjct: 3   GSVAAQDEFYRSGW-ALNM--KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKC--IKND 55

Query: 587 GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSND 646
              ++F+AE   +  +RH NL++++ +      +      +V EYM  GSL D+L     
Sbjct: 56  ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGR 111

Query: 647 HLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSL 704
                 L     +  ++DV  A+EYL  ++     VH DL   NVL+  D VA   +F L
Sbjct: 112 S----VLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGL 163

Query: 705 S---HQLDSASKTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-G 757
           +          K P     +K T    APE       S  S   DV+SFGILL E+++ G
Sbjct: 164 TKEASSTQDTGKLP-----VKWT----APEALREKKFSTKS---DVWSFGILLWEIYSFG 211

Query: 758 RRPTDAAFTEGLTLHEFVKM 777
           R P        + L + V  
Sbjct: 212 RVP-----YPRIPLKDVVPR 226

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  123 bits (311), Expect = 3e-31
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 43/226 (19%)

Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 607
            +IG+G FG VY G L    G+++  AVK   L +    G    F+ E   +++  H N+
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQFLTEGIIMKDFSHPNV 88

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           + ++ IC    S+G+    +V  YM++G L +++ ++  H      T+   +   + VA 
Sbjct: 89  LSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI-RNETH----NPTVKDLIGFGLQVAK 139

Query: 668 AIEYLH-HHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSAS--KTPSSSIG- 720
            ++YL         VH DL   N +LD      VA  +F L+  +         + +   
Sbjct: 140 GMKYLASKKF----VHRDLAARNCMLDEKFTVKVA--DFGLARDMYDKEYYSVHNKTGAK 193

Query: 721 --IKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
             +K      A E       +  S   DV+SFG+LL E+ T G  P
Sbjct: 194 LPVKWM----ALESLQTQKFTTKS---DVWSFGVLLWELMTRGAPP 232

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  125 bits (316), Expect = 3e-31
 Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 37/220 (16%)

Query: 556 IGQGSFGSVYKGIL---GGEEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLI 608
           +G G FG V  G L     +E+ VA+K +      KQ+   R F+ E   +    H N+I
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNII 109

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           ++  + +           +V EYMENGSL+ +L + +D     + T+IQ V +   +AS 
Sbjct: 110 RLEGVVTKSKPV-----MIVTEYMENGSLDSFL-RKHDA----QFTVIQLVGMLRGIASG 159

Query: 669 IEYL-HHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGIKGT 724
           ++YL         VH DL   N+L++ ++   V+  +F L   L+   +   ++ G K  
Sbjct: 160 MKYLSDMGY----VHRDLAARNILINSNLVCKVS--DFGLGRVLEDDPEAAYTTRGGKIP 213

Query: 725 VGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           + + +PE   Y   + AS   DV+S+GI+L E+ + G RP
Sbjct: 214 IRWTSPEAIAYRKFTSAS---DVWSYGIVLWEVMSYGERP 250

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  123 bits (311), Expect = 5e-31
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 31/217 (14%)

Query: 556 IGQGSFGSVYKGIL---GGEEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLI 608
           IG G  G V  G L   G  ++ VA+K +      +Q+   R F++E   +    H N+I
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDFLSEASIMGQFDHPNII 113

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           ++  + +           +V EYMENGSL+ +L +++D     + T++Q V +   V + 
Sbjct: 114 RLEGVVTRGRLA-----MIVTEYMENGSLDTFL-RTHDG----QFTIMQLVGMLRGVGAG 163

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           + YL        VH DL   NVL+D ++V    +F LS  L+       ++ G K  + +
Sbjct: 164 MRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220

Query: 728 VAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            APE   +   S AS   DV+SFG+++ E+   G RP
Sbjct: 221 TAPEAIAFRTFSSAS---DVWSFGVVMWEVLAYGERP 254

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  121 bits (307), Expect = 7e-31
 Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 31/216 (14%)

Query: 556 IGQGSFGSVYKGIL--GGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKI 610
           +G G+FGSV +G+     +++ VA+KV  LK   +K      + E + +  + +  ++++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           I +C +      +   LV E    G L  +L          ++ +     +   V+  ++
Sbjct: 76  IGVCQA------EALMLVMEMAGGGPLHKFL-VGKRE----EIPVSNVAELLHQVSMGMK 124

Query: 671 YL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           YL   +     VH DL   NVLL +   A   +F LS  L +     ++    K  + + 
Sbjct: 125 YLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180

Query: 729 APE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           APE   +   S  S   DV+S+G+ + E  + G++P
Sbjct: 181 APECINFRKFSSRS---DVWSYGVTMWEALSYGQKP 213

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  123 bits (311), Expect = 1e-30
 Identities = 69/309 (22%), Positives = 121/309 (39%), Gaps = 55/309 (17%)

Query: 483 SKGSRKPKLTLLKVLIPVVVS---CLILSSCLTIVFARRRRSAHKSVDTSPAKKQFPMIS 539
               R+       +L+P        +     L+    ++  S +     +          
Sbjct: 12  HHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71

Query: 540 YAELSKATSEFAS---------SNMIGQGSFGSVYKGIL---GGEEMIVAVKVINLKQ-- 585
             EL +A               + +IG+G FG VY G L    G+++  AVK   L +  
Sbjct: 72  NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRIT 129

Query: 586 -KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS 644
             G    F+ E   +++  H N++ ++ IC    S+G+    +V  YM++G L +++ ++
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI-RN 184

Query: 645 NDHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDM---VAHQ 700
             H      T+   +   + VA  +++L         VH DL   N +LD      VA  
Sbjct: 185 ETH----NPTVKDLIGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVA-- 234

Query: 701 NFSLSHQL-----DSASKTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLL 752
           +F L+  +     DS      + + +K      A E       +  S   DV+SFG+LL 
Sbjct: 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKS---DVWSFGVLLW 287

Query: 753 EMFT-GRRP 760
           E+ T G  P
Sbjct: 288 ELMTRGAPP 296

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  125 bits (317), Expect = 1e-30
 Identities = 66/311 (21%), Positives = 108/311 (34%), Gaps = 29/311 (9%)

Query: 45  LLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSL 104
           L +  N +            +L  L + EN  S + P    N+ +L  + L  NR    +
Sbjct: 37  LDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LI 95

Query: 105 PFDILVNLPNLKELYL-----------TFCSLKNLWWLNLEQNNLGMGTASSIPD-SLSN 152
           P  +   L NL +L +            F  L NL  L +  N+L       I   + S 
Sbjct: 96  PLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL-----VYISHRAFSG 150

Query: 153 ASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKA 212
            ++LE+L L         +   S L  L  L L   N+                   LK 
Sbjct: 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY------SFKRLYRLKV 204

Query: 213 LSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSG-IRNLVNLIALTIEVNQLHG 271
           L +    +   +  +     + +    I    ++  +P   +R+LV L  L +  N +  
Sbjct: 205 LEISHWPYLDTMTPNCLYGLN-LTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST 262

Query: 272 IIPDGVGELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNNLQGNIPSSLGNCQN 330
           I    + EL  LQ++ +    L   + P +   L  L  L +S N L     S   +  N
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGN 321

Query: 331 LKGFDASHNKL 341
           L+      N L
Sbjct: 322 LETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  125 bits (316), Expect = 1e-30
 Identities = 69/324 (21%), Positives = 128/324 (39%), Gaps = 29/324 (8%)

Query: 127 NLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLSGNQFKGKVSID---FSSLKNLWW 182
               L+L +N +      ++  D  ++  +LE L+L+ N      +++   F++L NL  
Sbjct: 33  ETRLLDLGKNRI-----KTLNQDEFASFPHLEELELNENIVS---AVEPGAFNNLFNLRT 84

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG 242
           L L  N L +          + T  S+L  L + +N+    L +   +L + +    +G 
Sbjct: 85  LGLRSNRLKLIPLG------VFTGLSNLTKLDISENKIVILLDYMFQDLYN-LKSLEVGD 137

Query: 243 NQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
           N +   I       L +L  LT+E   L  I  + +  L  L  L +    +      S 
Sbjct: 138 NDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSF 196

Query: 302 GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
             L +L  L +S       +  +     NL     +H  LT A+P   +       +L L
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNL 255

Query: 362 AHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNL 421
           ++N ++    ++   L  L    + L+ + +       V P++   +  ++ LNVS N L
Sbjct: 256 SYNPIST---IEGSMLHEL----LRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL 308

Query: 422 SGQIPEFLQNLSFLEFLNLSYNHL 445
           +        ++  LE L L  N L
Sbjct: 309 TTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  124 bits (313), Expect = 3e-30
 Identities = 71/306 (23%), Positives = 126/306 (41%), Gaps = 23/306 (7%)

Query: 144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL 203
            ++P+ +   +    LDL  N+ K     +F+S  +L  L L +N +             
Sbjct: 24  VAVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG------A 75

Query: 204 LTNCSSLKALSLCDNQFGGELPHSI-ANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIA 261
             N  +L+ L L  N+    +P  +   LS+ + +  I  N+I   +   + ++L NL +
Sbjct: 76  FNNLFNLRTLGLRSNRLK-LIPLGVFTGLSN-LTKLDISENKIV-ILLDYMFQDLYNLKS 132

Query: 262 LTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNNLQGN 320
           L +  N L  I       L  L+QL + +  L  SIP  +L +L  L  L L   N+   
Sbjct: 133 LEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAI 191

Query: 321 IPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNL 380
              S      LK  + SH      +    L    L+  L++ H  L     +    +++L
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT-SLSITHCNLTA---VPYLAVRHL 247

Query: 381 VITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNL 440
           V     L +L++S N    +    L  +  ++E+ +    L+   P   + L++L  LN+
Sbjct: 248 V----YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303

Query: 441 SYNHLE 446
           S N L 
Sbjct: 304 SGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  124 bits (313), Expect = 4e-30
 Identities = 70/326 (21%), Positives = 116/326 (35%), Gaps = 30/326 (9%)

Query: 55  QIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPN 114
            +P   G+      L++ +N+   +      +   LE + L  N  S ++      NL N
Sbjct: 25  AVPE--GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81

Query: 115 LKELYL-----------TFCSLKNLWWLNLEQNNLGMGTASSIPD-SLSNASNLERLDLS 162
           L+ L L            F  L NL  L++ +N +       + D    +  NL+ L++ 
Sbjct: 82  LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKI-----VILLDYMFQDLYNLKSLEVG 136

Query: 163 GNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGG 222
            N         FS L +L  L LE+ NL             L++   L  L L       
Sbjct: 137 DNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE------ALSHLHGLIVLRLRHLNINA 190

Query: 223 ELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQH 282
              +S   L    +   I       T+       +NL +L+I    L  +    V  L +
Sbjct: 191 IRDYSFKRLYRLKVL-EISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249

Query: 283 LQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKL 341
           L+ L +  N +  +I    L  L +L ++ L    L    P +      L+  + S N+L
Sbjct: 250 LRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL 308

Query: 342 TGAIPQQVLSITTLSVYLALAHNLLN 367
           T  + + V         L L  N L 
Sbjct: 309 T-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  120 bits (303), Expect = 6e-29
 Identities = 69/326 (21%), Positives = 116/326 (35%), Gaps = 31/326 (9%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL 66
            +PE I      + L +  N +     D   +   L  L +  N +    P     L NL
Sbjct: 25  AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82

Query: 67  VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL------ 120
             L +  N+   +       +S+L  + ++ N+    L   +  +L NLK L +      
Sbjct: 83  RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV 141

Query: 121 -----TFCSLKNLWWLNLEQNNLGMGTASSIPD-SLSNASNLERLDLSGNQFKGKVSIDF 174
                 F  L +L  L LE+ NL     +SIP  +LS+   L  L L            F
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNL-----TSIPTEALSHLHGLIVLRLRHLNINAIRDYSF 196

Query: 175 SSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSST 234
             L  L  L +           +           +L +LS+           ++ +L   
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNC------LYGLNLTSLSITHCNLTAVPYLAVRHLVY- 249

Query: 235 MIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFL 293
           +    +  N IS TI   +   L+ L  + +   QL  + P     L +L+ L +  N L
Sbjct: 250 LRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL 308

Query: 294 QGSIPPSL-GNLTKLADLALSFNNLQ 318
             ++  S+  ++  L  L L  N L 
Sbjct: 309 T-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  116 bits (293), Expect = 1e-27
 Identities = 72/349 (20%), Positives = 129/349 (36%), Gaps = 61/349 (17%)

Query: 88  SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL-----------TFCSLKNLWWLNLEQN 136
           +    + L  NR   +L  D   + P+L+EL L            F +L NL  L L  N
Sbjct: 32  TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90

Query: 137 NLGMGTASSIP-DSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTA 195
            L       IP    +  SNL +LD+S N+    +   F  L NL  L +  N+L     
Sbjct: 91  RL-----KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV--YI 143

Query: 196 NDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-R 254
           +   F  L    +SL+ L+L                             ++ +IP+    
Sbjct: 144 SHRAFSGL----NSLEQLTL-------------------------EKCNLT-SIPTEALS 173

Query: 255 NLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSF 314
           +L  LI L +    ++ I       L  L+ L +       ++ P+      L  L+++ 
Sbjct: 174 HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233

Query: 315 NNLQGNIPS-SLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQ 373
            NL   +P  ++ +   L+  + S+N ++  I   +L        + L    L     ++
Sbjct: 234 CNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAV---VE 288

Query: 374 VGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLS 422
               + L      L  L++S N    +       + +++ L + SN L+
Sbjct: 289 PYAFRGLN----YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 92.1 bits (229), Expect = 1e-19
 Identities = 47/252 (18%), Positives = 87/252 (34%), Gaps = 15/252 (5%)

Query: 207 CSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEV 266
           CS+     LC  +    +P     + +      +G N+I         +  +L  L +  
Sbjct: 9   CSAQDRAVLCHRKRFVAVP---EGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNE 65

Query: 267 NQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNNLQGNIPSSL 325
           N +  + P     L +L+ L +  N L+  IP      L+ L  L +S N +   +    
Sbjct: 66  NIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMF 124

Query: 326 GNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCV 385
            +  NLK  +   N L   I  +  S       L L    L     +    L +L     
Sbjct: 125 QDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS---IPTEALSHLH---- 176

Query: 386 SLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHL 445
            L  L +   + + +  +S   +  +K L +S       +         L  L++++ +L
Sbjct: 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236

Query: 446 EGEVPTKGVFSN 457
              VP      +
Sbjct: 237 T-AVPY-LAVRH 246

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  125 bits (315), Expect = 1e-30
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 25/218 (11%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
                   +G G FG V+          VAVK +      +  +F+AE   ++ ++H  L
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKL 245

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           +K+  + +       +   ++ E+M  GSL D+L          K  L + ++ +  +A 
Sbjct: 246 VKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAE 295

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
            + ++        +H DL+ +N+L+    +    +F L+  ++    T     G K  + 
Sbjct: 296 GMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIK 350

Query: 727 YVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           + APE   +G  +  S   DV+SFGILL+E+ T GR P
Sbjct: 351 WTAPEAINFGSFTIKS---DVWSFGILLMEIVTYGRIP 385

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  121 bits (305), Expect = 2e-30
 Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 43/226 (19%)

Query: 554 NMIGQGSFGSVYKGIL---GGEEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 607
            +IG+G FG VY G         +  A+K   L +    +    F+ E   +R + H N+
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKS--LSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           + +I I      +G     ++  YM +G L  ++     +      T+   ++  + VA 
Sbjct: 85  LALIGIML--PPEGLPH--VLLPYMCHGDLLQFIRSPQRN-----PTVKDLISFGLQVAR 135

Query: 668 AIEYL-HHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDS-----ASKTPSSS 718
            +EYL         VH DL   N +LD      VA  +F L+  +         +   + 
Sbjct: 136 GMEYLAEQKF----VHRDLAARNCMLDESFTVKVA--DFGLARDILDREYYSVQQHRHAR 189

Query: 719 IGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           + +K T    A E       +  S   DV+SFG+LL E+ T G  P
Sbjct: 190 LPVKWT----ALESLQTYRFTTKS---DVWSFGVLLWELLTRGAPP 228

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  120 bits (304), Expect = 2e-30
 Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 32/247 (12%)

Query: 556 IGQGSFGSVYKGIL----GGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLI 608
           +G+G FG V               VAVK   LK             E E LRN+ H N++
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           K   IC+     G +   L+ E++ +GSL+++L   N +    K+ L Q++  A+ +   
Sbjct: 87  KYKGICTE---DGGNGIKLIMEFLPSGSLKEYL-PKNKN----KINLKQQLKYAVQICKG 138

Query: 669 IEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVG 726
           ++YL         VH DL   NVL++ +      +F L+  +++  +  +        V 
Sbjct: 139 MDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194

Query: 727 YVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFV-KMTLPE 781
           + APE         AS   DV+SFG+ L E+ T     +         +     +MT+  
Sbjct: 195 WYAPECLMQSKFYIAS---DVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251

Query: 782 KVIEIVD 788
            ++  + 
Sbjct: 252 -LVNTLK 257

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  121 bits (305), Expect = 3e-30
 Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 34/226 (15%)

Query: 548 SEFASSNMIGQGSFGSVYKGIL----GGEEMIVAVKVINLK-QKGAFRSFVAECEALRNI 602
           +E     ++G G FG+V+KG+        ++ V +KVI  K  + +F++      A+ ++
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            H ++++++ +C            LV +Y+  GSL D + Q         L     +N  
Sbjct: 73  DHAHIVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRGA-----LGPQLLLNWG 121

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIG- 720
           + +A  + YL  H    +VH +L   NVLL         +F ++  L    K    S   
Sbjct: 122 VQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK 178

Query: 721 --IKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
             IK      A E   +G  +  S   DV+S+G+ + E+ T G  P
Sbjct: 179 TPIKWM----ALESIHFGKYTHQS---DVWSYGVTVWELMTFGAEP 217

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  120 bits (302), Expect = 3e-30
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 40/232 (17%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKIITI 613
           +G G FG V  G   G+   VA+K+I    +G+     F+ E + + N+ H  L+++  +
Sbjct: 32  LGTGQFGVVKYGKWRGQ-YDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL- 672
           C+           ++ EYM NG L ++L +   H    +    Q + +  DV  A+EYL 
Sbjct: 88  CTKQRPI-----FIITEYMANGCLLNYL-REMRH----RFQTQQLLEMCKDVCEAMEYLE 137

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSS--IGIKGTVGYVA 729
                   +H DL   N L++   V    +F LS  +     T S      ++ +     
Sbjct: 138 SKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----P 189

Query: 730 PE---YGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKM 777
           PE   Y   S  S   D+++FG+L+ E+++ G+ P      E  T  E  + 
Sbjct: 190 PEVLMYSKFSSKS---DIWAFGVLMWEIYSLGKMP-----YERFTNSETAEH 233

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  121 bits (304), Expect = 3e-30
 Identities = 46/220 (20%), Positives = 86/220 (39%), Gaps = 27/220 (12%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITI 613
           ++GQG+  +V++G       + A+KV N           + E E L+ + H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
               +      K L+ E+   GSL   L +         L   + + +  DV   + +L 
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVLEE---PSNAYGLPESEFLIVLRDVVGGMNHLR 129

Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAHQN-----FSLSHQLDSASKTPSSSIGIKGTVGYV 728
            +    IVH ++KP N++               F  + +L+   +  S    + GT  Y+
Sbjct: 130 ENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS----LYGTEEYL 182

Query: 729 APEYGMGSEASMTG--------DVYSFGILLLEMFTGRRP 760
            P+    +              D++S G+      TG  P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  121 bits (305), Expect = 3e-30
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 38/221 (17%)

Query: 556 IGQGSFGSVYKGIL----GGEEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNL 607
           IG G FG VYKG+L    G +E+ VA+K +      KQ+     F+ E   +    H N+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VDFLGEAGIMGQFSHHNI 108

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           I++  + S           ++ EYMENG+L+ +L +  D     + +++Q V +   +A+
Sbjct: 109 IRLEGVISKYKPM-----MIITEYMENGALDKFL-REKDG----EFSVLQLVGMLRGIAA 158

Query: 668 AIEYL-HHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGIKG 723
            ++YL + +     VH DL   N+L++ ++   V+   F LS  L+   +   ++ G K 
Sbjct: 159 GMKYLANMNY----VHRDLAARNILVNSNLVCKVSD--FGLSRVLEDDPEATYTTSGGKI 212

Query: 724 TVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            + + APE   Y   + AS   DV+SFGI++ E+ T G RP
Sbjct: 213 PIRWTAPEAISYRKFTSAS---DVWSFGIVMWEVMTYGERP 250

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  120 bits (302), Expect = 3e-30
 Identities = 46/229 (20%), Positives = 93/229 (40%), Gaps = 50/229 (21%)

Query: 556 IGQGSFGSVYKGIL-------GGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
           +GQG+F  ++KG+           E  V +KV++   +    SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
               +C   D        LV E+++ GSL+ +L + N +     + ++ ++ +A  +A+A
Sbjct: 76  LNYGVCVCGDE-----NILVQEFVKFGSLDTYL-KKNKN----CINILWKLEVAKQLAAA 125

Query: 669 IEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHQN---------FSLSHQLDSAS--KTPS 716
           + +L  +      +HG++   N+LL  +                 +S  +      +   
Sbjct: 126 MHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER- 180

Query: 717 SSIGIKGTVGYVAPE----YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
               I        PE        + A+   D +SFG  L E+ + G +P
Sbjct: 181 ----IPWV----PPECIENPKNLNLAT---DKWSFGTTLWEICSGGDKP 218

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  120 bits (304), Expect = 4e-30
 Identities = 53/228 (23%), Positives = 101/228 (44%), Gaps = 38/228 (16%)

Query: 548 SEFASSNMIGQGSFGSVYKGIL----GGEEMIVAVKVINLK---QKGAFRSFVAECEALR 600
           +EF    ++G G+FG+VYKG+        ++ VA+K   L+      A +  + E   + 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 72

Query: 601 NIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVN 660
           ++ + ++ +++ IC +          L+ + M  G L D++ +  D+     +     +N
Sbjct: 73  SVDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121

Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSI 719
             + +A  + YL       +VH DL   NVL+         +F L+  L +  K   +  
Sbjct: 122 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 720 G---IKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           G   IK      A E   + + +  S   DV+S+G+ + E+ T G +P
Sbjct: 179 GKVPIKWM----ALESILHRIYTHQS---DVWSYGVTVWELMTFGSKP 219

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  119 bits (301), Expect = 5e-30
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 29/215 (13%)

Query: 556 IGQGSFGSVYKGIL--GGEEMIVAVKVI--NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G G+FG+V KG          VAVK++             +AE   ++ + +  ++++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            IC +      +   LV E  E G L  +L Q N H     +     + +   V+  ++Y
Sbjct: 85  GICEA------ESWMLVMEMAELGPLNKYL-QQNRH-----VKDKNIIELVHQVSMGMKY 132

Query: 672 L-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           L   +     VH DL   NVLL     A   +F LS  L +      +    K  V + A
Sbjct: 133 LEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 188

Query: 730 PE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           PE   Y   S  S   DV+SFG+L+ E F+ G++P
Sbjct: 189 PECINYYKFSSKS---DVWSFGVLMWEAFSYGQKP 220

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  118 bits (299), Expect = 9e-30
 Identities = 61/247 (24%), Positives = 110/247 (44%), Gaps = 32/247 (12%)

Query: 556 IGQGSFGSVYKGIL----GGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV              +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L Q +      ++  I+ +     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYL-QKHKE----RIDHIKLLQYTSQICKGMEY 129

Query: 672 LH-HHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           L         +H DL   N+L++++    +   +F L+  L    +        +  + +
Sbjct: 130 LGTKRY----IHRDLATRNILVENENRVKIG--DFGLTKVLPQDKEFFKVKEPGESPIFW 183

Query: 728 VAPE---YGMGSEASMTGDVYSFGILLLEMFT---GRRPTDAAFTEGLTLHEFVKMTLPE 781
            APE       S AS   DV+SFG++L E+FT     +   A F   +   +  +M +  
Sbjct: 184 YAPESLTESKFSVAS---DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240

Query: 782 KVIEIVD 788
            +IE++ 
Sbjct: 241 -LIELLK 246

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  123 bits (310), Expect = 1e-29
 Identities = 94/464 (20%), Positives = 171/464 (36%), Gaps = 38/464 (8%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFV-GNLSALGMLLIRWNSLGGQIPTTL 60
           N +      +I SL  L+ L I  N +   L   V      L  L +  N L   I    
Sbjct: 31  NYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVK-IS--C 86

Query: 61  GLLRNLVYLNVAENQFSGM-FPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY 119
               NL +L+++ N F  +   +   N+S L+F+ L+            + +L   K L 
Sbjct: 87  HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE-KSSVLPIAHLNISKVLL 145

Query: 120 LT---------FCSLKNLWWLNLEQNNLGMGTASSIPD-SLSNASNLERLDLSGNQFKGK 169
           +             L++    +L            I D S+   +NLE  ++       K
Sbjct: 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205

Query: 170 VSIDFSSL----KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELP 225
            S   S L     N    NL  NN+   T N    +  L   +++   S+ + +  G+L 
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIET-TWNSFIRILQLVWHTTVWYFSISNVKLQGQLD 264

Query: 226 HSIANLSSTMIQF----RIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQ 281
               + S T ++     ++  +              N+      V+    +      ++ 
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324

Query: 282 HLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ--GNIPSSLGNCQNLKGFDASHN 339
               L    N L  ++  + G+LT+L  L L  N L+    I       ++L+  D S N
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQN 384

Query: 340 KLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHG 399
            ++    +   S T   + L ++ N+L D++   +            ++ LD+ SN    
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP---------PRIKVLDLHSNKIK- 434

Query: 400 VIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYN 443
            IP  +  +++++ELNV+SN L          L+ L+ + L  N
Sbjct: 435 SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  120 bits (302), Expect = 1e-28
 Identities = 83/475 (17%), Positives = 167/475 (35%), Gaps = 36/475 (7%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL 66
            +P+++        L I  NY++      + +LS L +L+I  N +     +     + L
Sbjct: 14  HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71

Query: 67  VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT----- 121
            YL+++ N+   +         +L+ + L+ N F          N+  LK L L+     
Sbjct: 72  EYLDLSHNKLVKISCHPT---VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128

Query: 122 ---FCSLKNLWWLNLEQNNLGMGTASSIPDSLSN--ASNLERLDLSGNQFKGKVSIDFSS 176
                 + +L    +             P+ L +    +L  +  +  +F   + +   +
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188

Query: 177 LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANL--SST 234
           + NL   N++        +  L  +  L     L  L+L + +        I  L   +T
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248

Query: 235 MIQFRIGGNQISGTIPSGI-----RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMF 289
           +  F I   ++ G +          +L  L    +  +              ++      
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308

Query: 290 RNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQV 349
            +  +         ++    L  S N L   +  + G+   L+      N+L   + +  
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIA 367

Query: 350 LSITTLS--VYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGF 407
              T +     L ++ N ++       G+         SL  L++SSN     I   L  
Sbjct: 368 EMTTQMKSLQQLDISQNSVSYDEK--KGDCSWT----KSLLSLNMSSNILTDTIFRCL-- 419

Query: 408 MKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKIS 462
              IK L++ SN +   IP+ +  L  L+ LN++ N L+  VP  G+F   T + 
Sbjct: 420 PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVP-DGIFDRLTSLQ 471

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  106 bits (266), Expect = 3e-24
 Identities = 70/401 (17%), Positives = 145/401 (36%), Gaps = 36/401 (8%)

Query: 8   IPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLV 67
           I +E G++  L+ L +   +L       + +L+   +LL+   + G +       L++  
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFN 164

Query: 68  YLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKN 127
             ++     +     +I ++S      L ++     L  +      ++           N
Sbjct: 165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL-----AKLQTN 219

Query: 128 LWWLNLEQNNLGM-GTASSIPDSLSNASNLERLDLSGNQFKG-----KVSIDFSSLKNLW 181
               NL  NN+     +      L   + +    +S  + +G           +SLK L 
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279

Query: 182 WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
              +  +  G   +   +  + +     +K  ++   +    +     +  S  +     
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMN----IKNFTVSGTRM---VHMLCPSKISPFLHLDFS 332

Query: 242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVG---ELQHLQQLYMFRNFLQGSIP 298
            N ++ T+     +L  L  L +++NQL   +        +++ LQQL + +N +     
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391

Query: 299 PSL-GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSV 357
                    L  L +S N L   I   L     +K  D   NK+  +IP+QV+ +  L  
Sbjct: 392 KGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQ- 447

Query: 358 YLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFH 398
            L +A N L  S+P   G    L     SL+ + + +N + 
Sbjct: 448 ELNVASNQLK-SVP--DGIFDRLT----SLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.9 bits (171), Expect = 2e-12
 Identities = 56/288 (19%), Positives = 90/288 (31%), Gaps = 9/288 (3%)

Query: 229 ANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYM 288
            +LS       I  N IS    S I +L  L  L I  N++  +        Q L+ L +
Sbjct: 17  KDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDL 76

Query: 289 FRNFLQGSIPPSLGNLTKLADLALSFNNLQG-NIPSSLGNCQNLKGFDASHNKLTGAIPQ 347
             N L   I         L  L LSFN      I    GN   LK    S   L  +   
Sbjct: 77  SHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133

Query: 348 QVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGF 407
            +  +    V L L         P     L++      SL  +  ++  FH ++  S+  
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDP---EGLQDFNTE--SLHIVFPTNKEFHFILDVSVKT 188

Query: 408 MKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNV 467
           + +++  N+       +   FL  L+ L+      N     + T      +    +    
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248

Query: 468 KLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIVF 515
                I  + L             T LK L    V   +     + ++
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  118 bits (298), Expect = 1e-29
 Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 46/223 (20%)

Query: 556 IGQGSFGSVYKGIL---GGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIK 609
           IG+G FG V++GI        + VA+K    K          F+ E   +R   H +++K
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 610 IITICSS----IDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           +I + +     I          + E    G L  +L Q   +     L L   +  A  +
Sbjct: 81  LIGVITENPVWI----------IMELCTLGELRSFL-QVRKY----SLDLASLILYAYQL 125

Query: 666 ASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQL--DSASKTPSSSIGI 721
           ++A+ YL         VH D+   NVL+  +      +F LS  +   +  K     + I
Sbjct: 126 STALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181

Query: 722 KGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           K      APE   +   + AS   DV+ FG+ + E+   G +P
Sbjct: 182 KWM----APESINFRRFTSAS---DVWMFGVCMWEILMHGVKP 217

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  118 bits (297), Expect = 1e-29
 Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 34/217 (15%)

Query: 556 IGQGSFGSVYKGIL---GGEEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G FG VY+G+     GE++ VAVK             F++E   ++N+ H +++K+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            I         +   ++ E    G L  +L + N +     L ++  V  ++ +  A+ Y
Sbjct: 80  GIIEE------EPTWIIMELYPYGELGHYL-ERNKN----SLKVLTLVLYSLQICKAMAY 128

Query: 672 L-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQL--DSASKTPSSSIGIKGTVGY 727
           L   +C    VH D+   N+L+         +F LS  +  +   K   + + IK     
Sbjct: 129 LESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM--- 181

Query: 728 VAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            +PE   +   + AS   DV+ F + + E+ + G++P
Sbjct: 182 -SPESINFRRFTTAS---DVWMFAVCMWEILSFGKQP 214

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  119 bits (300), Expect = 2e-29
 Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 40/229 (17%)

Query: 554 NMIGQGSFGSVYKGIL--GGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNL 607
           ++IG+G+FG V K  +   G  M  A+K   +K+   K   R F  E E L  +  H N+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS----------NDHLEVCKLTLIQ 657
           I ++  C            L  EY  +G+L D+L +S            +     L+  Q
Sbjct: 89  INLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 658 RVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTP 715
            ++ A DVA  ++YL         +H DL   N+L+  + VA   +F LS   +   K  
Sbjct: 144 LLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 199

Query: 716 SSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
              + ++      A E   Y + +  S   DV+S+G+LL E+ + G  P
Sbjct: 200 MGRLPVRWM----AIESLNYSVYTTNS---DVWSYGVLLWEIVSLGGTP 241

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  117 bits (296), Expect = 2e-29
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 35/215 (16%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKIITI 613
           +G G FG V  G   G+   VAVK+I    +G+     F  E + +  + H  L+K   +
Sbjct: 16  LGSGQFGVVKLGKWKGQ-YDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL- 672
           CS           +V EY+ NG L ++L +S+       L   Q + +  DV   + +L 
Sbjct: 72  CSKEYPI-----YIVTEYISNGCLLNYL-RSHGK----GLEPSQLLEMCYDVCEGMAFLE 121

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSS--IGIKGTVGYVA 729
            H      +H DL   N L+D D+     +F ++  +       S      +K +    A
Sbjct: 122 SHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----A 173

Query: 730 PE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           PE   Y   S  S   DV++FGIL+ E+F+ G+ P
Sbjct: 174 PEVFHYFKYSSKS---DVWAFGILMWEVFSLGKMP 205

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  123 bits (310), Expect = 2e-29
 Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 51/277 (18%)

Query: 523 HKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGIL--GGEEMIVAVKV 580
               D    K +   +    L  A  E      +G G+FGSV +G+     +++ VA+KV
Sbjct: 317 SPFSDPEELKDKKLFLKRDNLLIADIE------LGCGNFGSVRQGVYRMRKKQIDVAIKV 370

Query: 581 INLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSL 637
             LK   +K      + E + +  + +  ++++I +C +      +   LV E    G L
Sbjct: 371 --LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEMAGGGPL 422

Query: 638 EDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDM 696
             +L    +      + +     +   V+  ++YL   +     VH +L   NVLL +  
Sbjct: 423 HKFLVGKREE-----IPVSNVAELLHQVSMGMKYLEEKNF----VHRNLAARNVLLVNRH 473

Query: 697 VAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLL 752
            A   +F LS  L +     ++    K  + + APE   +   S  S   DV+S+G+ + 
Sbjct: 474 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS---DVWSYGVTMW 530

Query: 753 EMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD 788
           E  + G++P             + KM  PE V+  ++
Sbjct: 531 EALSYGQKP-------------YKKMKGPE-VMAFIE 553

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  118 bits (298), Expect = 2e-29
 Identities = 49/230 (21%), Positives = 93/230 (40%), Gaps = 24/230 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G+G F  V       +    A+K I   ++        E +  R   H N+++++    
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA--Y 94

Query: 616 SIDSKGADFKA-LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            +  +GA  +A L+  + + G+L + + +  D      LT  Q + + + +   +E +H 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN--FLTEDQILWLLLGICRGLEAIH- 151

Query: 675 HCQPPIVHGDLKPSNVLLDHDMVA-------HQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
                  H DLKP+N+LL  +               +  +    + T       + T+ Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 728 VAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
            APE      + +  E +   DV+S G +L  M  G  P D  F +G ++
Sbjct: 210 RAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  118 bits (298), Expect = 2e-29
 Identities = 61/247 (24%), Positives = 110/247 (44%), Gaps = 32/247 (12%)

Query: 556 IGQGSFGSVYKGIL----GGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +G+G+FGSV              +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +C S   +      L+ EY+  GSL D+L Q +      ++  I+ +     +   +EY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYL-QKHKE----RIDHIKLLQYTSQICKGMEY 160

Query: 672 LH-HHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           L         +H DL   N+L++++    +   +F L+  L    +        +  + +
Sbjct: 161 LGTKRY----IHRDLATRNILVENENRVKIG--DFGLTKVLPQDKEYYKVKEPGESPIFW 214

Query: 728 VAPE---YGMGSEASMTGDVYSFGILLLEMFT---GRRPTDAAFTEGLTLHEFVKMTLPE 781
            APE       S AS   DV+SFG++L E+FT     +   A F   +   +  +M +  
Sbjct: 215 YAPESLTESKFSVAS---DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271

Query: 782 KVIEIVD 788
            +IE++ 
Sbjct: 272 -LIELLK 277

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  116 bits (294), Expect = 3e-29
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 35/215 (16%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKIITI 613
           IG G FG V+ G    ++  VA+K I    +GA     F+ E E +  + H  L+++  +
Sbjct: 16  IGSGQFGLVHLGYWLNKDK-VAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL- 672
           C            LV E+ME+G L D+L ++              + + +DV   + YL 
Sbjct: 72  CLEQAPI-----CLVTEFMEHGCLSDYL-RTQRG----LFAAETLLGMCLDVCEGMAYLE 121

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSS--IGIKGTVGYVA 729
                   +H DL   N L+  + V    +F ++  +     T S+     +K      +
Sbjct: 122 EACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----S 173

Query: 730 PE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           PE   +   S  S   DV+SFG+L+ E+F+ G+ P
Sbjct: 174 PEVFSFSRYSSKS---DVWSFGVLMWEVFSEGKIP 205

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  117 bits (295), Expect = 3e-29
 Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 35/223 (15%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 605
                   +G G FG V+ G   G    VAVK +    +G+    +F+AE   ++ ++H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
            L+++  + +       +   ++ EYMENGSL D+L   +      KLT+ + +++A  +
Sbjct: 69  RLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQI 118

Query: 666 ASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSS--IGI 721
           A  + ++   +     +H DL+ +N+L+   +     +F L+  ++    T        I
Sbjct: 119 AEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174

Query: 722 KGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           K T    APE   YG  +  S   DV+SFGILL E+ T GR P
Sbjct: 175 KWT----APEAINYGTFTIKS---DVWSFGILLTEIVTHGRIP 210

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  118 bits (297), Expect = 3e-29
 Identities = 63/251 (25%), Positives = 96/251 (38%), Gaps = 42/251 (16%)

Query: 556 IGQGSFGSVYKGIL----GGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLI 608
           +G+G FG V          G   +VAVK   LK          +  E + LR + H ++I
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           K    C    +       LV EY+  GSL D+L +         + L Q +  A  +   
Sbjct: 97  KYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEG 146

Query: 669 IEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS----HQLDSASKTPSSSIGIK 722
           + YLH  H     +H DL   NVLLD+D +    +F L+       +           + 
Sbjct: 147 MAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202

Query: 723 GTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP-TDAAFTEGLTLHEFVKM 777
                 APE         AS   DV+SFG+ L E+ T      +       L      +M
Sbjct: 203 WY----APECLKEYKFYYAS---DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255

Query: 778 TLPEKVIEIVD 788
           T+   + E+++
Sbjct: 256 TVLR-LTELLE 265

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  120 bits (303), Expect = 4e-29
 Identities = 69/236 (29%), Positives = 107/236 (45%), Gaps = 32/236 (13%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRN 606
                   +GQG FG V+ G   G    VA+K   LK       +F+ E + ++ +RH  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEK 240

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           L+++  + S       +   +V EYM  GSL D+L           L L Q V++A  +A
Sbjct: 241 LVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIA 290

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTV 725
           S + Y+        VH DL+ +N+L+  ++V    +F L+  ++    T     G K  +
Sbjct: 291 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFPI 345

Query: 726 GYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKM 777
            + APE   YG  +  S   DV+SFGILL E+ T GR P       G+   E +  
Sbjct: 346 KWTAPEAALYGRFTIKS---DVWSFGILLTELTTKGRVP-----YPGMVNREVLDQ 393

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  117 bits (294), Expect = 5e-29
 Identities = 53/243 (21%), Positives = 91/243 (37%), Gaps = 46/243 (18%)

Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR 603
            +  S+F    ++GQG+FG V K     +    A+K I    +    + ++E   L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60

Query: 604 HRNLIKIITICSSIDSKGADFKA--------LVFEYMENGSLEDWLHQSNDHLEVCKLTL 655
           H+ +++         +      A        +  EY ENG+L D +H  N + +      
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR----- 115

Query: 656 IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSAS 712
            +   +   +  A+ Y+H      I+H DLKP N+ +D      +   +F L+  +  + 
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG--DFGLAKNVHRSL 170

Query: 713 KTPSSSIGIK-----------GTVGYVAPE-------YGMGSEASMTGDVYSFGILLLEM 754
                                GT  YVA E       Y    E     D+YS GI+  EM
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN---EKI---DMYSLGIIFFEM 224

Query: 755 FTG 757
              
Sbjct: 225 IYP 227

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  118 bits (298), Expect = 7e-29
 Identities = 46/220 (20%), Positives = 87/220 (39%), Gaps = 27/220 (12%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           ++GQG+  +V++G       + A+KV N +         + E E L+ + H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
               +      K L+ E+   GSL   L    +      L   + + +  DV   + +L 
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGGMNHLR 129

Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAHQN-----FSLSHQLDSASKTPSSSIGIKGTVGYV 728
            +    IVH ++KP N++               F  + +L+   +  S    + GT  Y+
Sbjct: 130 ENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS----LYGTEEYL 182

Query: 729 APEYGMGSEASMTG--------DVYSFGILLLEMFTGRRP 760
            P+    +              D++S G+      TG  P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (296), Expect = 7e-29
 Identities = 30/273 (10%), Positives = 68/273 (24%), Gaps = 38/273 (13%)

Query: 516 ARRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMI 575
            +   +  ++V  +   +       + LS+   +      +  G    V+          
Sbjct: 30  LKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLED 89

Query: 576 VAVKVINLKQK---GAFRSFVAECEALRNIRHRNLI---------------------KII 611
            A+KV  +  +              A   +   +                          
Sbjct: 90  FALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFA 149

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEV-CKLTLIQRVNIAIDVASAIE 670
            +    D        L+        LE      +          ++    +   +     
Sbjct: 150 QLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAA 208

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
            L       +VHG   P N+ +  D      + S   ++ +     S        V Y  
Sbjct: 209 NLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS------VPVTYAP 259

Query: 730 PEYGMGSEASMTG--DVYSFGILLLEMFTGRRP 760
            E+   S A+ T   + +  G+ +  ++    P
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  121 bits (304), Expect = 8e-29
 Identities = 72/261 (27%), Positives = 113/261 (43%), Gaps = 39/261 (14%)

Query: 528 TSPAKKQFPMISYA-----ELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN 582
           T+      P          E+ +          +GQG FG V+ G   G    VA+K   
Sbjct: 244 TTVCPTSKPQTQGLAKDAWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKT-- 298

Query: 583 LKQKGAFR-SFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL 641
           LK       +F+ E + ++ +RH  L+++  + S       +   +V EYM  GSL D+L
Sbjct: 299 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFL 352

Query: 642 HQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-Q 700
                      L L Q V++A  +AS + Y+        VH DL+ +N+L+  ++V    
Sbjct: 353 KGETGK----YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 405

Query: 701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT- 756
           +F L+  ++    T     G K  + + APE   YG  +  S   DV+SFGILL E+ T 
Sbjct: 406 DFGLARLIEDNEYTARQ--GAKFPIKWTAPEAALYGRFTIKS---DVWSFGILLTELTTK 460

Query: 757 GRRPTDAAFTEGLTLHEFVKM 777
           GR P       G+   E +  
Sbjct: 461 GRVP-----YPGMVNREVLDQ 476

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  119 bits (300), Expect = 1e-28
 Identities = 56/369 (15%), Positives = 121/369 (32%), Gaps = 64/369 (17%)

Query: 86  NISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT--------FCSLKNLWWLNLEQNN 137
            +++L  +    +  +  +    +  L  L +L  T             NL +L  + N 
Sbjct: 40  QLATLTSLDCHNSSIT-DMTG--IEKLTGLTKLICTSNNITTLDLSQNTNLTYLACDSNK 96

Query: 138 LGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTAND 197
           L     +++   ++  + L  L+   N+      +D S    L +LN  +N L      +
Sbjct: 97  L-----TNLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTL-----TE 141

Query: 198 LDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLV 257
           +D    +++ + L  L    N+   +L   +   +  +       N+I+  +   +    
Sbjct: 142 ID----VSHNTQLTELDCHLNKKITKLD--VTPQTQ-LTTLDCSFNKIT-ELD--VSQNK 191

Query: 258 NLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNL 317
            L  L  + N +  +    + +   L  L    N L   I   +  LT+L     S N L
Sbjct: 192 LLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPL 245

Query: 318 QGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNL 377
              +  S      L         L        + +T  +  +            L V + 
Sbjct: 246 T-ELDVS--TLSKLTTLHCIQTDLL------EIDLTHNTQLIYFQAEGCRKIKELDVTHN 296

Query: 378 KNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEF 437
             L         LD  +          L     +  L +++  L+ ++   + + + L+ 
Sbjct: 297 TQL-------YLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKS 343

Query: 438 LNLSYNHLE 446
           L+    H++
Sbjct: 344 LSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  115 bits (289), Expect = 3e-27
 Identities = 68/427 (15%), Positives = 122/427 (28%), Gaps = 63/427 (14%)

Query: 10  EEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYL 69
             I  L  L  L    N +T  L   +   + L  L    N L   +   +  L  L YL
Sbjct: 58  TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYL 111

Query: 70  NVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL--------- 120
           N   N+ + +    +     L ++    N  +  +      +   L EL           
Sbjct: 112 NCDTNKLTKLD---VSQNPLLTYLNCARNTLT-EIDVS---HNTQLTELDCHLNKKITKL 164

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
                  L  L+   N +     + +   +S    L RL+   N       +D +    L
Sbjct: 165 DVTPQTQLTTLDCSFNKI-----TELD--VSQNKLLNRLNCDTNNIT---KLDLNQNIQL 214

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
            +L+   N L      ++D     T  + L       N        +++ L++       
Sbjct: 215 TFLDCSSNKL-----TEIDV----TPLTQLTYFDCSVNPLTELDVSTLSKLTT----LHC 261

Query: 241 GGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS 300
               +     +    L+       +      I    V     L  L      +   +   
Sbjct: 262 IQTDLLEIDLTHNTQLIYF-----QAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD-- 313

Query: 301 LGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLA 360
           L    KL  L L+   L   +   + +   LK     +  +        +          
Sbjct: 314 LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS--SVGKIPALNNNF 367

Query: 361 LAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNN 420
            A      ++P +     +L I  VS + LD   N  +  I    G +       ++  N
Sbjct: 368 EAEGQTI-TMPKETLTNNSLTIA-VSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWEN 423

Query: 421 LSGQIPE 427
           LS   P 
Sbjct: 424 LSTDNPA 430

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  109 bits (275), Expect = 2e-25
 Identities = 55/341 (16%), Positives = 102/341 (29%), Gaps = 56/341 (16%)

Query: 108 ILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFK 167
           +           ++   L  L  L+   +++     + +   +   + L +L  + N   
Sbjct: 24  VAAAFEMQATDTISEEQLATLTSLDCHNSSI-----TDMTG-IEKLTGLTKLICTSNNIT 77

Query: 168 GKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHS 227
              ++D S   NL +L  + N L      +LD     T  + L  L+   N+        
Sbjct: 78  ---TLDLSQNTNLTYLACDSNKL-----TNLDV----TPLTKLTYLNCDTNKLTKLDVSQ 125

Query: 228 IANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLY 287
              L+          N ++  I   + +   L  L   +N+   I    V     L  L 
Sbjct: 126 NPLLTY----LNCARNTLT-EID--VSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLD 176

Query: 288 MFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQ 347
              N +   +   +     L  L    NN+   +   L     L   D S NKLT     
Sbjct: 177 CSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---- 226

Query: 348 QVLSITTLS--VYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSL 405
             + +T L+   Y   + N L +   L V  L  L         L         +    L
Sbjct: 227 --IDVTPLTQLTYFDCSVNPLTE---LDVSTLSKL-------TTLHCIQTDLLEI---DL 271

Query: 406 GFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLE 446
                +            ++   + + + L  L+     + 
Sbjct: 272 THNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 98.2 bits (245), Expect = 1e-21
 Identities = 58/356 (16%), Positives = 98/356 (27%), Gaps = 80/356 (22%)

Query: 125 LKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGK--------------- 169
             +      E              S    + L  LD   +                    
Sbjct: 20  FASEVAAAFEMQATD-------TISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICT 72

Query: 170 ----VSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELP 225
                ++D S   NL +L  + N L      +LD     T  + L  L+   N+      
Sbjct: 73  SNNITTLDLSQNTNLTYLACDSNKL-----TNLDV----TPLTKLTYLNCDTNKLTKLDV 123

Query: 226 HSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQ 285
                L+          N ++  I   + +   L  L   +N+   I    V     L  
Sbjct: 124 SQNPLLTY----LNCARNTLT-EID--VSHNTQLTELDCHLNKK--ITKLDVTPQTQLTT 174

Query: 286 LYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAI 345
           L    N +   +   +     L  L    NN+   +   L     L   D S NKLT   
Sbjct: 175 LDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE-- 226

Query: 346 PQQVLSITTLS--VYLALAHNLLNDSLPLQVGNLKNL--------------VITCVSLEY 389
               + +T L+   Y   + N L +   L V  L  L              +     L Y
Sbjct: 227 ----IDVTPLTQLTYFDCSVNPLTE---LDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIY 279

Query: 390 LDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHL 445
                      +  +      +  L+  +  ++ ++   L     L +L L+   L
Sbjct: 280 FQAEGCRKIKELDVTH--NTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL 330

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 90.5 bits (225), Expect = 4e-19
 Identities = 54/295 (18%), Positives = 99/295 (33%), Gaps = 47/295 (15%)

Query: 154 SNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKAL 213
            N      +  + +   +I    L  L  L+   +++      D+  +  LT    L  L
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI-----TDMTGIEKLTG---LTKL 69

Query: 214 SLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGII 273
               N     L   ++  ++ +       N+++  +   +  L  L  L  + N+L  + 
Sbjct: 70  ICTSNNI-TTLD--LSQNTN-LTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL- 121

Query: 274 PDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKG 333
              V +   L  L   RN L   I   + + T+L +L    N     +   +     L  
Sbjct: 122 --DVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTT 174

Query: 334 FDASHNKLTGAIPQQVLSITTLS--VYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLD 391
            D S NK+T       L ++       L    N +     L +            L +LD
Sbjct: 175 LDCSFNKITE------LDVSQNKLLNRLNCDTNNITK---LDLNQNIQ-------LTFLD 218

Query: 392 ISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLE 446
            SSN     I  +   +  +   + S N L+ ++   +  LS L  L+     L 
Sbjct: 219 CSSNKLTE-IDVTP--LTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 85.1 bits (211), Expect = 2e-17
 Identities = 51/336 (15%), Positives = 104/336 (30%), Gaps = 51/336 (15%)

Query: 11  EIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLN 70
           ++     L  L    N    +L   V   + L  L   +N +       +   + L  LN
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI---TELDVSQNKLLNRLN 197

Query: 71  VAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT--------F 122
              N  + +    +     L F+  + N+ +  +       L  L     +         
Sbjct: 198 CDTNNITKL---DLNQNIQLTFLDCSSNKLT-EIDVT---PLTQLTYFDCSVNPLTELDV 250

Query: 123 CSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWW 182
            +L  L  L+  Q +L       I   L++ + L      G +      +D +    L+ 
Sbjct: 251 STLSKLTTLHCIQTDL-----LEID--LTHNTQLIYFQAEGCRKIK--ELDVTHNTQLYL 301

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG 242
           L+ +   +      +LD     +    L  L L + +   EL   +++ +  +       
Sbjct: 302 LDCQAAGI-----TELDL----SQNPKLVYLYLNNTEL-TELD--VSHNTK-LKSLSCVN 348

Query: 243 NQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQ-----HLQQLYMFRNFLQGSI 297
             I     S +  +  L        Q   +  + +             L  F N +  +I
Sbjct: 349 AHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM--NI 404

Query: 298 PPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKG 333
            P  G +   A   +++ NL  + P+      +  G
Sbjct: 405 EPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENG 440

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  115 bits (291), Expect = 2e-28
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 43/230 (18%)

Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G+FG V+           ++M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWL---------HQSNDHLEVCKLTLIQRVNI 661
             +C+           +VFEYM +G L  +L             + +    L L Q + +
Sbjct: 109 FGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 662 AIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMV---AHQNFSLSHQLDSA---SKT 714
           A  VA+ + YL   H     VH DL   N L+   +V      +F +S  + S       
Sbjct: 164 ASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIG--DFGMSRDIYSTDYYRVG 217

Query: 715 PSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
             + + I+       PE   Y   +  S   DV+SFG++L E+FT G++P
Sbjct: 218 GRTMLPIRWM----PPESILYRKFTTES---DVWSFGVVLWEIFTYGKQP 260

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  114 bits (287), Expect = 3e-28
 Identities = 48/229 (20%), Positives = 89/229 (38%), Gaps = 27/229 (11%)

Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR 603
            +   +F    +IG G FG V+K     +     +K +    + A R    E +AL  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62

Query: 604 HRNLIK-----------IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK 652
           H N++              T   +          +  E+ + G+LE W+ +        K
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----K 118

Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSA 711
           L  +  + +   +   ++Y+H      +++ DLKPSN+ L         +F L   L + 
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175

Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            K        KGT+ Y++PE     +     D+Y+ G++L E+      
Sbjct: 176 GKRTR----SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  114 bits (287), Expect = 4e-28
 Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 49/234 (20%)

Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 607
           +G+  FG VYKG L     G +   VA+K   LK          F  E      ++H N+
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWL----------HQSNDHLEVCKLTLIQ 657
           + ++ + +          +++F Y  +G L ++L             +D      L    
Sbjct: 75  VCLLGVVTKDQPL-----SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 658 RVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMV---AHQNFSLSHQLDSAS- 712
            V++   +A+ +EYL  HH     VH DL   NVL+   +    +  +  L  ++ +A  
Sbjct: 130 FVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKIS--DLGLFREVYAADY 183

Query: 713 --KTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
                +S + I+      APE   YG  S  S   D++S+G++L E+F+ G +P
Sbjct: 184 YKLLGNSLLPIRWM----APEAIMYGKFSIDS---DIWSYGVVLWEVFSYGLQP 230

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  114 bits (288), Expect = 5e-28
 Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 39/226 (17%)

Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 607
           +G G+FG VY+G +         + VAVK   L +  + +    F+ E   +    H+N+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS-NDHLEVCKLTLIQRVNIAIDVA 666
           ++ I +           + ++ E M  G L+ +L ++     +   L ++  +++A D+A
Sbjct: 96  VRCIGVSLQSLP-----RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 667 SAIEYL-HHHCQPPIVHGDLKPSNVLLD---HDMVAH-QNFSLSHQLDSAS---KTPSSS 718
              +YL  +H     +H D+   N LL       VA   +F ++  +  AS   K   + 
Sbjct: 151 CGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206

Query: 719 IGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           + +K       PE    G+ +  +   D +SFG+LL E+F+ G  P
Sbjct: 207 LPVKWM----PPEAFMEGIFTSKT---DTWSFGVLLWEIFSLGYMP 245

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  113 bits (286), Expect = 5e-28
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 44/231 (19%)

Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G+FG V+           ++M+VAVK +      A + F  E E L N++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWL----------HQSNDHLEVCKLTLIQRVN 660
             +C   D        +VFEYM++G L  +L                    +L L Q ++
Sbjct: 83  YGVCGDGDP-----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 661 IAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMV---AHQNFSLSHQLDSA---SK 713
           IA  +AS + YL   H     VH DL   N L+  +++      +F +S  + S      
Sbjct: 138 IASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIG--DFGMSRDVYSTDYYRV 191

Query: 714 TPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
              + + I+       PE   Y   +  S   DV+SFG++L E+FT G++P
Sbjct: 192 GGHTMLPIRWM----PPESIMYRKFTTES---DVWSFGVILWEIFTYGKQP 235

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  117 bits (294), Expect = 7e-28
 Identities = 73/425 (17%), Positives = 137/425 (32%), Gaps = 67/425 (15%)

Query: 55  QIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPN 114
           Q+P    L  ++ Y++++ N  + +       +  L+F+ +        +  +    L +
Sbjct: 24  QVPE---LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80

Query: 115 LKELYL-----------TFCSLKNLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLS 162
           L  L L            F  L NL  L L Q NL     + +  +     ++LE L L 
Sbjct: 81  LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNL---DGAVLSGNFFKPLTSLEMLVLR 137

Query: 163 GNQFKGKVSID----FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDN 218
            N  K    I     F +++    L+L  N +      DL              L L   
Sbjct: 138 DNNIK---KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGK----HFTLLRLSSI 190

Query: 219 QFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVG 278
                                +    +            ++  L +  N     +     
Sbjct: 191 TL-----------------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFF 233

Query: 279 ELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASH 338
           +     ++         ++  S G+         +F  L+ +          +K  D S 
Sbjct: 234 DAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS---------GVKTCDLSK 284

Query: 339 NKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFH 398
           +K+  A+ + V S  T    L LA N +N    +       L      L  L++S N   
Sbjct: 285 SKIF-ALLKSVFSHFTDLEQLTLAQNEINK---IDDNAFWGL----THLLKLNLSQNFLG 336

Query: 399 GVIPFSLGFMKSIKELNVSSNNLSGQIPE-FLQNLSFLEFLNLSYNHLEGEVPTKGVFSN 457
            +       +  ++ L++S N++   + +     L  L+ L L  N L+  VP  G+F  
Sbjct: 337 SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVP-DGIFDR 393

Query: 458 KTKIS 462
            T + 
Sbjct: 394 LTSLQ 398

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  115 bits (289), Expect = 3e-27
 Identities = 75/419 (17%), Positives = 140/419 (33%), Gaps = 78/419 (18%)

Query: 17  NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPT-TLGLLRNLVYLNVAENQ 75
           ++  + +  N +          L  L  L +   + G  I   T   L +L+ L +  NQ
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 76  FSGMFPRWICNISSLEFIYLTVNRF-SGSLPFDILVNLPNLKELYL------------TF 122
           F  +       +++LE + LT        L  +    L +L+ L L             F
Sbjct: 91  FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 123 CSLKNLWWLNLEQNNLGMGTASSIP----DSLSNASNLERLDLSGNQ--------FKGKV 170
            +++    L+L  N +      SI      +     +   L LS              + 
Sbjct: 151 LNMRRFHVLDLTFNKV-----KSICEEDLLNFQG-KHFTLLRLSSITLQDMNEYWLGWEK 204

Query: 171 SIDFSSLKNLWWLNLEQNNLGM-------GTANDLDFVTLLTNCSSLKALSLCDNQFGGE 223
             +     ++  L+L  N                    +L+ + S     S     F   
Sbjct: 205 CGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP 264

Query: 224 LPHSIANLSSTMIQF-RIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGV-GEL 280
              +   L ++ ++   +  ++I   +   +  +  +L  LT+  N+++  I D     L
Sbjct: 265 DNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGL 322

Query: 281 QHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHN 339
            HL +L + +NFL  SI      NL KL  L LS+N+++     S     NLK      N
Sbjct: 323 THLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTN 381

Query: 340 KLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFH 398
           +L  ++P  +                  D L               SL+ + + +N + 
Sbjct: 382 QLK-SVPDGIF-----------------DRLT--------------SLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 93.7 bits (233), Expect = 4e-20
 Identities = 69/348 (19%), Positives = 118/348 (33%), Gaps = 59/348 (16%)

Query: 2   NKLEGQIPEEI-GSLLNLQTLAIDFNYLTG-QLPDFVGNLSALGMLLIRWNSLGGQIPTT 59
           N+   Q+       L NL+ L +    L G  L                           
Sbjct: 89  NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNF----------------------- 124

Query: 60  LGLLRNLVYLNVAENQFSGMFPRWI-CNISSLEFIYLTVNRFSGSLPFDILVNLPNLKEL 118
              L +L  L + +N    + P     N+     + LT N+   S+  + L+N       
Sbjct: 125 FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFT 183

Query: 119 YLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLK 178
            L       L  + L+  N           +    +++  LDLSGN FK  ++  F    
Sbjct: 184 LL------RLSSITLQDMNE-YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAI 236

Query: 179 NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQF 238
                                  +L+ + S     S     F      +   L ++ ++ 
Sbjct: 237 AG-----------------TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKT 279

Query: 239 -RIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQG 295
             +  ++I   +   +  +  +L  LT+  N+++  I D     L HL +L + +NFL  
Sbjct: 280 CDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG- 336

Query: 296 SIPP-SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT 342
           SI      NL KL  L LS+N+++     S     NLK      N+L 
Sbjct: 337 SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK 384

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 76.3 bits (188), Expect = 1e-14
 Identities = 40/243 (16%), Positives = 77/243 (31%), Gaps = 13/243 (5%)

Query: 226 HSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGV-GELQHLQ 284
           H +  L + +    +  N I+    +    L +L  L +E      +I +     L  L 
Sbjct: 23  HQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82

Query: 285 QLYMFRNFLQGSIPPS-LGNLTKLADLALSFNNLQGNI--PSSLGNCQNLKGFDASHNKL 341
            L +  N     +       L  L  L L+  NL G +   +      +L+      N +
Sbjct: 83  ILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141

Query: 342 TGAIPQQVL-SITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEY---LDISSNSF 397
               P     ++      L L  N +       + N +    T + L      D++    
Sbjct: 142 KKIQPASFFLNMRRFH-VLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200

Query: 398 HGVIPFSLGFMKSIKELNVSSNNLSGQIPEF---LQNLSFLEFLNLSYNHLEGEVPTKGV 454
                 +     SI  L++S N     + +        + ++ L LS ++  G       
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260

Query: 455 FSN 457
           F +
Sbjct: 261 FKD 263

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  118 bits (298), Expect = 8e-28
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 38/219 (17%)

Query: 556 IGQGSFGSVYKGIL---GGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIK 609
           IG+G FG V++GI        M VA+K    K          F+ E   +R   H +++K
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +I + +       +   ++ E    G L  +L Q         L L   +  A  +++A+
Sbjct: 456 LIGVIT------ENPVWIIMELCTLGELRSFL-QVRKF----SLDLASLILYAYQLSTAL 504

Query: 670 EYLH-HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQL--DSASKTPSSSIGIKGTV 725
            YL         VH D+   NVL+  +      +F LS  +   +  K     + IK   
Sbjct: 505 AYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM- 559

Query: 726 GYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
              APE   +   + AS   DV+ FG+ + E+   G +P
Sbjct: 560 ---APESINFRRFTSAS---DVWMFGVCMWEILMHGVKP 592

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  113 bits (285), Expect = 8e-28
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 34/216 (15%)

Query: 556 IGQGSFGSVYKG---ILGGEEMIVAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLIK 609
           +G G   +VY     IL    + VA+K I    ++K      F  E      + H+N++ 
Sbjct: 19  LGGGGMSTVYLAEDTILN---IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 610 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           +I      D    +     LV EY+E  +L +++           L++   +N    +  
Sbjct: 76  MI------DV-DEEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILD 122

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            I++ H      IVH D+KP N+L+D +    +   +F ++  L   S T ++ +   GT
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIF--DFGIAKALSETSLTQTNHV--LGT 175

Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           V Y +PE   G       D+YS GI+L EM  G  P
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  113 bits (285), Expect = 1e-27
 Identities = 47/228 (20%), Positives = 96/228 (42%), Gaps = 43/228 (18%)

Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 607
           +GQGSFG VY+G+         E  VA+K   + +         F+ E   ++     ++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKT--VNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWL----HQSNDHLEVCKLTLIQRVNIAI 663
           ++++ + S           ++ E M  G L+ +L        ++  +   +L + + +A 
Sbjct: 91  VRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 664 DVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMV---AHQNFSLSHQLDSAS---KTPS 716
           ++A  + YL+ +      VH DL   N ++  D        +F ++  +       K   
Sbjct: 146 EIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIG--DFGMTRDIYETDYYRKGGK 199

Query: 717 SSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
             + ++      +PE    G+ +  S   DV+SFG++L E+ T   +P
Sbjct: 200 GLLPVRWM----SPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQP 240

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  117 bits (294), Expect = 2e-27
 Identities = 59/218 (27%), Positives = 88/218 (40%), Gaps = 20/218 (9%)

Query: 555 MIGQGSFGSVYKGI--LGGEEMIVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLIKII 611
            +G G FG V + I    GE+  VA+K    +     R     E + ++ + H N++   
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQ--VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 612 -TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
                       D   L  EY E G L  +L   N     C L       +  D++SA+ 
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCGLKEGPIRTLLSDISSALR 135

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ----NFSLSHQLDSASKTPSSSIGIKGTVG 726
           YLH +    I+H DLKP N++L            +   + +LD             GT+ 
Sbjct: 136 YLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF----VGTLQ 188

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA 764
           Y+APE     + ++T D +SFG L  E  TG RP    
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  112 bits (283), Expect = 3e-27
 Identities = 55/211 (26%), Positives = 79/211 (37%), Gaps = 23/211 (10%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
             +G+GSFG V++          AVK + L+        V E  A   +        I  
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPR----IVP 114

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
                 +G     +  E +E GSL   + Q     E                   +EYLH
Sbjct: 115 LYGAVREGPWVN-IFMELLEGGSLGQLIKQMGCLPE----DRAL--YYLGQALEGLEYLH 167

Query: 674 HHCQPPIVHGDLKPSNVLLDHD--MVAHQNFSLSHQL--DSASKTPSSSIGIKGTVGYVA 729
                 I+HGD+K  NVLL  D    A  +F  +  L  D   K+  +   I GT  ++A
Sbjct: 168 TRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE  MG       D++S   ++L M  G  P
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  114 bits (288), Expect = 3e-27
 Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 32/224 (14%)

Query: 549 EFASSNMIGQGSFGS-VYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHR 605
            F   +++G G+ G+ VY+G+    +  VAVK I  +    A R    E + LR    H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRD--VAVKRILPECFSFADR----EVQLLRESDEHP 78

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N+I+    C+  D     F+ +  E     +L++++ Q +          ++ + +    
Sbjct: 79  NVIRYF--CTEKDR---QFQYIAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQT 127

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN------FSLSHQLDSASKTPSSSI 719
            S + +LH      IVH DLKP N+L+       +       F L  +L     + S   
Sbjct: 128 TSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184

Query: 720 GIKGTVGYVAPEYGMGSEASMTG---DVYSFGILLLEMFTGRRP 760
           G+ GT G++APE              D++S G +   + +    
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  113 bits (284), Expect = 4e-27
 Identities = 53/226 (23%), Positives = 100/226 (44%), Gaps = 39/226 (17%)

Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 607
           +G G+FG VY+G +         + VAVK   L +  + +    F+ E   +    H+N+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS-NDHLEVCKLTLIQRVNIAIDVA 666
           ++ I +           + ++ E M  G L+ +L ++     +   L ++  +++A D+A
Sbjct: 137 VRCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 667 SAIEYL-HHHCQPPIVHGDLKPSNVLLD---HDMVAH-QNFSLSHQLDSAS---KTPSSS 718
              +YL  +H     +H D+   N LL       VA   +F ++  +  A    K   + 
Sbjct: 192 CGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247

Query: 719 IGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
           + +K       PE    G+ +  +   D +SFG+LL E+F+ G  P
Sbjct: 248 LPVKWM----PPEAFMEGIFTSKT---DTWSFGVLLWEIFSLGYMP 286

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  111 bits (280), Expect = 4e-27
 Identities = 47/215 (21%), Positives = 93/215 (43%), Gaps = 24/215 (11%)

Query: 555 MIGQGSFGSVYKG---ILGGEEMIVAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLI 608
           ++G G    V+             VAVKV+  +L +  +F   F  E +    + H  ++
Sbjct: 19  ILGFGGMSEVHLARDLRDH---RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            +     + ++       +V EY++  +L D +H          +T  + + +  D   A
Sbjct: 76  AVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQA 128

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
           + + H +    I+H D+KP+N+++       V   +F ++  +  +  + + +  + GT 
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVM--DFGIARAIADSGNSVTQTAAVIGTA 183

Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            Y++PE   G       DVYS G +L E+ TG  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  111 bits (279), Expect = 5e-27
 Identities = 47/215 (21%), Positives = 84/215 (39%), Gaps = 30/215 (13%)

Query: 555 MIGQGSFGSVYKG---ILGGEEMIVAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLI 608
           ++G+G  G VY+    +      IVA+K++   L     FR+    E      ++  +  
Sbjct: 41  LVGRGGMGDVYEAEDTVRE---RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH-- 95

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ I    +  G  +  +    +    L   L +         L   + V I   + SA
Sbjct: 96  -VVPIHDFGEIDGQLY--VDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSA 146

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
           ++  H        H D+KP N+L+  D    +   +F ++        T   +    GT+
Sbjct: 147 LDAAHAA---GATHRDVKPENILVSADDFAYLV--DFGIASATTDEKLTQLGNT--VGTL 199

Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            Y+APE    S A+   D+Y+   +L E  TG  P
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  110 bits (278), Expect = 6e-27
 Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 18/210 (8%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           ++G+G++G VY G     ++ +A+K I  +     +    E    ++++H+N    I   
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN----IVQY 84

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
               S+    K +  E +  GSL   L      L+  +   I        +   ++YLH 
Sbjct: 85  LGSFSENGFIK-IFMEQVPGGSLSALLRSKWGPLKDNE-QTIG--FYTKQILEGLKYLHD 140

Query: 675 HCQPPIVHGDLKPSNVLLDHD--MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE- 731
           +    IVH D+K  NVL++    ++   +F  S +L   +    +     GT+ Y+APE 
Sbjct: 141 NQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---FTGTLQYMAPEI 194

Query: 732 -YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                       D++S G  ++EM TG+ P
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  110 bits (278), Expect = 8e-27
 Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 48/230 (20%)

Query: 554 NMIGQGSFGSVYKGI-LGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKI 610
             IG G    V++ +    +  I A+K +NL++       S+  E   L  ++  +  KI
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQ--IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKI 90

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           I +     +    +  +V E   N  L  WL +         +   +R +   ++  A+ 
Sbjct: 91  IRLYDYEITDQYIY--MVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVH 141

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMV---------AHQNFSLSHQLDSASKTPSSSIGI 721
            +H H    IVH DLKP+N L+   M+           Q  + S   DS           
Sbjct: 142 TIHQHG---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDS----------Q 188

Query: 722 KGTVGYVAPEYGMGSEASMTG-----------DVYSFGILLLEMFTGRRP 760
            GTV Y+ PE      +S              DV+S G +L  M  G+ P
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  112 bits (281), Expect = 1e-26
 Identities = 44/277 (15%), Positives = 85/277 (30%), Gaps = 40/277 (14%)

Query: 517 RRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKG--ILGGEEM 574
             + +A   V TS      P    +EL +         ++GQ    +  +      GE  
Sbjct: 47  YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGES- 105

Query: 575 IVAVKVINLKQK---GAFRSFVAECEALRNIRH----------------RNLIKIITICS 615
              V V    ++    A +    E   LR +R                  +L+K      
Sbjct: 106 -FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164

Query: 616 SIDSKGADFKALVFEY-----MENGSLEDWLHQSNDHLEVCK-LTLIQRVNIAIDVASAI 669
            I  +  +    V            +L+ +      H    K L    R+ + + V   +
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 224

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
             LHH+    +VH  L+P +++LD         F    +  +++ +P             
Sbjct: 225 ASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGR--GFAPPETT 279

Query: 729 APEYGMGSEASMTG-----DVYSFGILLLEMFTGRRP 760
           A       +   T      D ++ G+ +  ++    P
Sbjct: 280 AERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  108 bits (273), Expect = 2e-26
 Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 13/214 (6%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIIT 612
            IG GS+G   K     +  I+  K ++     +   +  V+E   LR ++H N   I+ 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVR 69

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
               I  +      +V EY E G L   + +     +      +  + +   +  A++  
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV--LRVMTQLTLALKEC 127

Query: 673 H--HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           H        ++H DLKP+NV LD        +F L+  L+  +    + +   GT  Y++
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV---GTPYYMS 184

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           PE       +   D++S G LL E+     P  A
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  110 bits (277), Expect = 2e-26
 Identities = 58/261 (22%), Positives = 96/261 (36%), Gaps = 48/261 (18%)

Query: 554 NMIGQGSFGSVYKGI-LGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKI 610
             IG G    V++ +    +  I A+K +NL++       S+  E   L  ++  +  KI
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQ--IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKI 71

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           I +     +    +  +V E   N  L  WL +         +   +R +   ++  A+ 
Sbjct: 72  IRLYDYEITDQYIY--MVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVH 122

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMV---------AHQNFSLSHQLDSASKTPSSSIGI 721
            +H H    IVH DLKP+N L+   M+           Q  + S   DS           
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDS----------Q 169

Query: 722 KGTVGYVAPEYGMGSEASMTG-----------DVYSFGILLLEMFTGRRPTDAAFTEGLT 770
            GTV Y+ PE      +S              DV+S G +L  M  G+ P      +   
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229

Query: 771 LHEFVKMTLPEKVIEIVDPSL 791
           LH  +      +  +I +  L
Sbjct: 230 LHAIIDPNHEIEFPDIPEKDL 250

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  111 bits (279), Expect = 2e-26
 Identities = 57/261 (21%), Positives = 95/261 (36%), Gaps = 48/261 (18%)

Query: 554 NMIGQGSFGSVYKGI-LGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKI 610
             IG G    V++ +    +  I A+K +NL++       S+  E   L  ++  +  KI
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQ--IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKI 118

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           I +     +    +  +V E   N  L  WL +         +   +R +   ++  A+ 
Sbjct: 119 IRLYDYEITDQYIY--MVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVH 169

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMV---------AHQNFSLSHQLDSASKTPSSSIGI 721
            +H H    IVH DLKP+N L+   M+           Q  + S   DS           
Sbjct: 170 TIHQHG---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDS----------Q 216

Query: 722 KGTVGYVAPEYGMGSEASMTG-----------DVYSFGILLLEMFTGRRPTDAAFTEGLT 770
            G V Y+ PE      +S              DV+S G +L  M  G+ P      +   
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276

Query: 771 LHEFVKMTLPEKVIEIVDPSL 791
           LH  +      +  +I +  L
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDL 297

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  109 bits (275), Expect = 3e-26
 Identities = 53/300 (17%), Positives = 100/300 (33%), Gaps = 45/300 (15%)

Query: 88  SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL-----------TFCSLKNLWWLNLEQN 136
                + L  N+ +  +      NL NL  L L            F  L  L  L L +N
Sbjct: 52  PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110

Query: 137 NLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID---FSSLKNLWWLNLEQNNLGMG 193
            L       +P+ +     L+ L +  N+      +    F+ L  +  + L  N L   
Sbjct: 111 QL-----KELPEKM--PKTLQELRVHENEIT---KVRKSVFNGLNQMIVVELGTNPLKSS 160

Query: 194 TANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI 253
              +  F         L  + + D      +P     L  ++ +  + GN+I+  + +  
Sbjct: 161 GIENGAF----QGMKKLSYIRIADTNI-TTIP---QGLPPSLTELHLDGNKIT-KVDAAS 211

Query: 254 -RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLAL 312
            + L NL  L +  N +  +    +    HL++L++  N L   +P  L +   +  + L
Sbjct: 212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270

Query: 313 SFNNLQGNIPSS-------LGNCQNLKGFDASHNKLT-GAIPQQVLSITTLSVYLALAHN 364
             NN+   I S+            +  G     N +    I         +   + L + 
Sbjct: 271 HNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  103 bits (260), Expect = 3e-24
 Identities = 67/327 (20%), Positives = 116/327 (35%), Gaps = 58/327 (17%)

Query: 126 KNLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLSGNQFKGKVSID---FSSLKNLW 181
            +   L+L+ N +     + I      N  NL  L L  N+      I    F+ L  L 
Sbjct: 52  PDTALLDLQNNKI-----TEIKDGDFKNLKNLHTLILINNKI---SKISPGAFAPLVKLE 103

Query: 182 WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
            L L +N L                  +L+ L + +N+           L+  MI   +G
Sbjct: 104 RLYLSKNQLKELPEKMP---------KTLQELRVHENEITKVRKSVFNGLNQ-MIVVELG 153

Query: 242 GNQI-SGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP 299
            N + S  I +G  + +  L  + I    +   IP G+     L +L++  N +   +  
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKIT-KVDA 209

Query: 300 -SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVY 358
            SL  L  LA L LSFN++      SL N  +L+    ++NKL   +P  +     + V 
Sbjct: 210 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV- 267

Query: 359 LALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSS 418
           + L +N ++                        I SN F      +     S   +++ S
Sbjct: 268 VYLHNNNIS-----------------------AIGSNDFCPPGYNTK--KASYSGVSLFS 302

Query: 419 NNLS-GQIPEFL-QNLSFLEFLNLSYN 443
           N +   +I     + +     + L   
Sbjct: 303 NPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  102 bits (256), Expect = 8e-24
 Identities = 53/279 (18%), Positives = 98/279 (35%), Gaps = 38/279 (13%)

Query: 57  PTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK 116
                 L+NL  L +  N+ S + P     +  LE +YL+ N+    LP  +      L+
Sbjct: 69  DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM---PKTLQ 124

Query: 117 ELYL-----------TFCSLKNLWWLNLEQNNLGMGTASSIPD-SLSNASNLERLDLSGN 164
           EL +            F  L  +  + L  N L    +S I + +      L  + ++  
Sbjct: 125 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPL---KSSGIENGAFQGMKKLSYIRIADT 181

Query: 165 QFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGEL 224
                 +I      +L  L+L+ N +    A  L         ++L  L L  N      
Sbjct: 182 NIT---TIPQGLPPSLTELHLDGNKITKVDAASLK------GLNNLAKLGLSFNSISAVD 232

Query: 225 PHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGI------IPDGVG 278
             S+AN    + +  +  N++   +P G+ +   +  + +  N +  I       P    
Sbjct: 233 NGSLANTPH-LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 290

Query: 279 ELQHLQQLYMFRNFLQ-GSIPPSL-GNLTKLADLALSFN 315
           +      + +F N +Q   I PS    +   A + L   
Sbjct: 291 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  101 bits (254), Expect = 1e-23
 Identities = 68/375 (18%), Positives = 124/375 (33%), Gaps = 79/375 (21%)

Query: 101 SGSLPFDILVNLPNLKELYLT-----FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASN 155
           SG  P +    +P ++ +         C L+ +         L       +P  L    +
Sbjct: 4   SGIGPEEHFPEVPEIEPMGPVCPFRCQCHLRVV---QCSDLGL-----EKVPKDLP--PD 53

Query: 156 LERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSL 215
              LDL  N+       DF +LKNL  L L  N +   +               L+ L L
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG------AFAPLVKLERLYL 107

Query: 216 CDNQ---FGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHG 271
             NQ      ++P ++  L       R+  N+I+  +   +   L  +I + +  N L  
Sbjct: 108 SKNQLKELPEKMPKTLQEL-------RVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKS 159

Query: 272 I-IPDGV-GELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPS-SLGNC 328
             I +G    ++ L  + +    +  +IP  L     L +L L  N +   + + SL   
Sbjct: 160 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGL 215

Query: 329 QNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLE 388
            NL     S N ++ A+    L+                                   L 
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLA-------------------------------NTPHLR 243

Query: 389 YLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSG------QIPEFLQNLSFLEFLNLSY 442
            L +++N     +P  L   K I+ + + +NN+S         P +    +    ++L  
Sbjct: 244 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 302

Query: 443 NHLEGEVPTKGVFSN 457
           N ++        F  
Sbjct: 303 NPVQYWEIQPSTFRC 317

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 88.1 bits (219), Expect = 6e-19
 Identities = 47/220 (21%), Positives = 86/220 (39%), Gaps = 27/220 (12%)

Query: 14  SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAE 73
            L+ L+ L +  N L  +LP+ +     L  L +  N +     +    L  ++ + +  
Sbjct: 98  PLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154

Query: 74  NQFSGMF--PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL----------- 120
           N              +  L +I +     + ++P  +    P+L EL+L           
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP---PSLTELHLDGNKITKVDAA 210

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPD-SLSNASNLERLDLSGNQFKGKVSIDFSSLKN 179
           +   L NL  L L  N++     S++ + SL+N  +L  L L+ N+   KV    +  K 
Sbjct: 211 SLKGLNNLAKLGLSFNSI-----SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 264

Query: 180 LWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQ 219
           +  + L  NN+    +ND       T  +S   +SL  N 
Sbjct: 265 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 304

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  112 bits (282), Expect = 4e-26
 Identities = 81/472 (17%), Positives = 157/472 (33%), Gaps = 42/472 (8%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFV-GNLSALGMLLIRWNSLGGQIPTTLGLLRN 65
            +P+++      + L++  N ++ +L       LS L +L +  N +           ++
Sbjct: 45  HVPKDL--PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQD 101

Query: 66  LVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLP----FDILVNLPNLKELYLT 121
           L YL+V+ N+   +    +   +SL  + L+ N F   LP    F    NL  L  L L+
Sbjct: 102 LEYLDVSHNRLQNISCCPM---ASLRHLDLSFNDFD-VLPVCKEFG---NLTKLTFLGLS 154

Query: 122 --------FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID 173
                      + +L    +  + +         +SL    N   L L  +         
Sbjct: 155 AAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQI-PNTTVLHLVFHPNSLFSVQV 213

Query: 174 FSSLKNLWWLNLEQNNLGMGTANDLD-FVTLLTNCSSLKALSLCDNQFGGELPHSIANL- 231
             S+  L  L L    L       L  F++ LT   +L  ++L   +   +    +    
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273

Query: 232 -SSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHG----IIPDGVG-ELQHLQQ 285
               +    I    I+  I             ++ +  +         + +      +  
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333

Query: 286 LYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAI 345
             +  +           + +    L  + N    ++       + L+      N L    
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NF 392

Query: 346 PQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSL 405
            +  L    +S  L      LN    L             S+  L++SSN   G +   L
Sbjct: 393 FKVALMTKNMS-SLETLDVSLNS---LNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448

Query: 406 GFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSN 457
                +K L++ +N +   IP+ + +L  L+ LN++ N L+  VP  GVF  
Sbjct: 449 P--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDR 495

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =   99 bits (249), Expect = 5e-22
 Identities = 68/452 (15%), Positives = 147/452 (32%), Gaps = 38/452 (8%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFV-GNLSALGMLLIRWNSLGGQIPTTL 60
           N +      +I  L  L+ L +  N +   L   V      L  L +  N L   I    
Sbjct: 62  NSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-ISC-- 117

Query: 61  GLLRNLVYLNVAENQFSGM-FPRWICNISSLEFIYLTVNRFSGSLPFDILVNLP------ 113
             + +L +L+++ N F  +   +   N++ L F+ L+  +F   L    + +L       
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILL 176

Query: 114 NLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNA-SNLERLDLSGNQFKGKVSI 172
           +L   ++     ++L   N    +L     S     ++ + + L  L LS  +   +   
Sbjct: 177 DLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ 236

Query: 173 DFSSLKNLWWLNLEQNNLGMGTANDLDFVTL----LTNCSSLKALSLCDNQFGGELPHSI 228
              +  +         N+ +         ++          ++ L++ +      +    
Sbjct: 237 RLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREE 296

Query: 229 ANLSSTMIQF----RIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQ 284
              S T ++      +       +  +       +    + ++    I            
Sbjct: 297 FTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356

Query: 285 QLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ--GNIPSSLGNCQNLKGFDASHNKLT 342
            L   +N    S+      L +L  L L  N L+    +     N  +L+  D S N L 
Sbjct: 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN 416

Query: 343 GAIPQQVLSITTLSVYLALAHNLLN----DSLP-------LQVGNLKNL---VITCVSLE 388
                +  +     + L L+ N+L       LP       L    + ++   V    +L+
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQ 476

Query: 389 YLDISSNSFHGVIPFSLGFMKSIKELNVSSNN 420
            L+++SN    V       + S++ + +  N 
Sbjct: 477 ELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 91.1 bits (226), Expect = 4e-19
 Identities = 62/387 (16%), Positives = 122/387 (31%), Gaps = 44/387 (11%)

Query: 103 SLPFDILVNLPNLKELYLT-----------FCSLKNLWWLNLEQNNLGMGTASSIPDSL- 150
            +P D+    P  K L L+              L  L  L L  N +      S+   + 
Sbjct: 45  HVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-----RSLDFHVF 96

Query: 151 SNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSL 210
               +LE LD+S N+ +   +I    + +L  L+L  N+      + L       N + L
Sbjct: 97  LFNQDLEYLDVSHNRLQ---NISCCPMASLRHLDLSFNDF-----DVLPVCKEFGNLTKL 148

Query: 211 KALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQ-- 268
             L L   +F       +A+L  + I   +    I G   +    + N   L +  +   
Sbjct: 149 TFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKG-GETESLQIPNTTVLHLVFHPNS 207

Query: 269 -LHGIIPDGVGELQHLQ--QLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSL 325
                +   V  L HLQ   + +     Q  +            L ++  +++     S+
Sbjct: 208 LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV 267

Query: 326 GNCQNLKG-----FDASHNKLTGAIPQQVLSITTLSV-YLALAHNLLNDSLPLQVGNLKN 379
              Q          +  +  +T  I ++  + +  ++  L + H      L  +      
Sbjct: 268 KLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSV 327

Query: 380 LVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLN 439
                  +    +S +    +         S   LN + N  +  + +    L  L+ L 
Sbjct: 328 FA----EMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383

Query: 440 LSYNHLEGEVPTKGVFSNKTKISLQVN 466
           L  N L+       +  N + +     
Sbjct: 384 LQRNGLKNFFKVALMTKNMSSLETLDV 410

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 71.8 bits (176), Expect = 4e-13
 Identities = 38/221 (17%), Positives = 77/221 (34%), Gaps = 28/221 (12%)

Query: 14  SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAE 73
           +L +L    +                + + + ++  +              +  +LN  +
Sbjct: 303 ALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQ 362

Query: 74  NQFSGMFPRWICNISSLEFIYLTVNRFSGSLP--FDILVNLPNLKELYLTFCSL------ 125
           N F+    +    +  L+ + L  N    +      +  N+ +L+ L ++  SL      
Sbjct: 363 NVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYD 421

Query: 126 ------KNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKN 179
                 +++  LNL  N L      S+   L     ++ LDL  N+    +  D + L+ 
Sbjct: 422 RTCAWAESILVLNLSSNML----TGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQA 474

Query: 180 LWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQF 220
           L  LN+  N L        D        +SL+ + L DN +
Sbjct: 475 LQELNVASNQLKSVPDGVFD------RLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 34/169 (20%), Positives = 57/169 (33%), Gaps = 24/169 (14%)

Query: 13  GSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVA 72
            S  +   L    N  T  +      L  L  L+++ N L         + +N+  L   
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408

Query: 73  ENQF----SGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT------- 121
           +       S  + R      S+  + L+ N  +    F  L   P +K L L        
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT-GSVFRCLP--PKVKVLDLHNNRIMSI 465

Query: 122 ---FCSLKNLWWLNLEQNNLGMGTASSIPD-SLSNASNLERLDLSGNQF 166
                 L+ L  LN+  N L      S+PD      ++L+ + L  N +
Sbjct: 466 PKDVTHLQALQELNVASNQL-----KSVPDGVFDRLTSLQYIWLHDNPW 509

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  108 bits (271), Expect = 7e-26
 Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 45/233 (19%)

Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI-RHRN 606
           +G+G+FG V +              VAVK+  LK+       R+ ++E + L +I  H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWL----------HQSNDHLEVCKLTLI 656
           ++ ++  C+           ++ E+ + G+L  +L            + + L    LTL 
Sbjct: 93  VVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 657 QRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLDSA 711
             +  +  VA  +E+L    C    +H DL   N+LL    V    +F L+   ++    
Sbjct: 149 HLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204

Query: 712 SKTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            +   + + +K      APE     + +  S   DV+SFG+LL E+F+ G  P
Sbjct: 205 VRKGDARLPLKWM----APETIFDRVYTIQS---DVWSFGVLLWEIFSLGASP 250

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  107 bits (270), Expect = 7e-26
 Identities = 54/275 (19%), Positives = 100/275 (36%), Gaps = 35/275 (12%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLIKIIT- 612
            +G+G FG V++     ++   A+K I L  +   R   + E +AL  + H  +++    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 613 ------ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
                       S    +  +  +     +L+DW++      E  +   +   +I + +A
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL---HIFLQIA 128

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV----------AHQNFSLSHQLDSASKTPS 716
            A+E+LH      ++H DLKPSN+    D V          A         + +     +
Sbjct: 129 EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK 776
              G  GT  Y++PE   G+  S   D++S G++L E+     P         TL +   
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN 242

Query: 777 MTLPEKVIEIVDPSLLMEVMAN--NSMIQEDRRAR 809
           +  P         +            M+      R
Sbjct: 243 LKFPP------LFTQKYPCEYVMVQDMLSPSPMER 271

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  107 bits (269), Expect = 9e-26
 Identities = 53/263 (20%), Positives = 100/263 (38%), Gaps = 47/263 (17%)

Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF--RSFVAECEALRN 601
           S+ T+EF     IG G FGSV+K +   +  I A+K       G+   ++ + E  A   
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 602 I-RHRNLIKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
           + +H ++++            A  +     +  EY   GSL D + ++   +   K   +
Sbjct: 67  LGQHSHVVRY---------FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117

Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS 716
           +  ++ + V   + Y+H      +VH D+KPSN+ +    + +       + D AS    
Sbjct: 118 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172

Query: 717 SSIG-------------IKGTVGYVAPE-----YGMGSEASMTGDVYSFGILLLEMFTGR 758
             IG              +G   ++A E     Y    +A    D+++  + ++      
Sbjct: 173 FKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKA----DIFALALTVVCAAGAE 228

Query: 759 RPTDAAFTEGLTLHEFVKMTLPE 781
                    G   HE  +  LP 
Sbjct: 229 PL----PRNGDQWHEIRQGRLPR 247

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  108 bits (271), Expect = 1e-25
 Identities = 64/252 (25%), Positives = 109/252 (43%), Gaps = 53/252 (21%)

Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVINLKQK---GAFRSFVAECEALRNI-RH 604
           +G+G+FG V      G       E + VAVK+  LK           V+E E ++ I +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL----------HQSNDHLEVCKLT 654
           +N+I ++  C+           ++ EY   G+L ++L              + +   ++T
Sbjct: 101 KNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 655 LIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQLD 709
               V+    +A  +EYL    C    +H DL   NVL+  + V    +F L+   + +D
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 710 SASKTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAF 765
              KT +  + +K      APE     + +  S   DV+SFG+L+ E+FT G  P     
Sbjct: 212 YYKKTTNGRLPVKWM----APEALFDRVYTHQS---DVWSFGVLMWEIFTLGGSP----- 259

Query: 766 TEGLTLHEFVKM 777
             G+ + E  K+
Sbjct: 260 YPGIPVEELFKL 271

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  108 bits (271), Expect = 1e-25
 Identities = 49/230 (21%), Positives = 86/230 (37%), Gaps = 42/230 (18%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA-----------------ECEA 598
           + QG F  +       +    A+K          R F                   E + 
Sbjct: 39  LNQGKFNKIILCEKDNK--FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL--HQSNDHLEVCKLTLI 656
           + +I++   +    I   I +    +  +++EYMEN S+  +       D    C + + 
Sbjct: 97  ITDIKNEYCLTCEGI---ITNYDEVY--IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLS-HQLDSAS 712
               I   V ++  Y+H+     I H D+KPSN+L+D +    ++  +F  S + +D   
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLS--DFGESEYMVDKKI 207

Query: 713 KTPSSSIGIKGTVGYVAPE--YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           K        +GT  ++ PE      S      D++S GI L  MF    P
Sbjct: 208 KG------SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  107 bits (269), Expect = 1e-25
 Identities = 52/236 (22%), Positives = 95/236 (40%), Gaps = 50/236 (21%)

Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGA----FRSFVAECEALRNI-RHR 605
           +G G+FG V +    G       M VAVK++      A      + ++E + L  +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL------------HQSNDHLEVCKL 653
           N++ ++  C+           ++ EY   G L ++L              +    +   L
Sbjct: 88  NIVNLLGACTIGGPT-----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 654 TLIQRVNIAIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQL 708
            L   ++ +  VA  + +L   +C    +H DL   N+LL H  +    +F L+      
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 709 DSASKTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
            +     ++ + +K      APE     + +  S   DV+S+GI L E+F+ G  P
Sbjct: 199 SNYVVKGNARLPVKWM----APESIFNCVYTFES---DVWSYGIFLWELFSLGSSP 247

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  107 bits (270), Expect = 2e-25
 Identities = 47/237 (19%), Positives = 91/237 (38%), Gaps = 34/237 (14%)

Query: 539 SYAELSKATSEFASSNM--------IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGA 588
             + +   T      +M        IG+GSFG         +     +K IN+ +     
Sbjct: 7   HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66

Query: 589 FRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL 648
                 E   L N++H N   I+    S +  G+ +  +V +Y E G L   ++     L
Sbjct: 67  REESRREVAVLANMKHPN---IVQYRESFEENGSLY--IVMDYCEGGDLFKRINAQKGVL 121

Query: 649 ----EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFS 703
               ++            + +  A++++H      I+H D+K  N+ L  D      +F 
Sbjct: 122 FQEDQILD--------WFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFG 170

Query: 704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++  L+S  +   +     GT  Y++PE       +   D+++ G +L E+ T +  
Sbjct: 171 IARVLNSTVELARA---CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  106 bits (268), Expect = 2e-25
 Identities = 65/258 (25%), Positives = 100/258 (38%), Gaps = 60/258 (23%)

Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGA----FRSFVAECEALRNIRHRN 606
           +G+G FG V K              VAVK+  LK + A     R  ++E   L+ + H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LK-ENASPSELRDLLSEFNVLKQVNHPH 87

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWL------------------HQSNDHL 648
           +IK+   CS           L+ EY + GSL  +L                    S DH 
Sbjct: 88  VIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 649 EVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS- 705
           +   LT+   ++ A  ++  ++YL         VH DL   N+L+         +F LS 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSR 198

Query: 706 --HQLDSASKTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRR 759
             ++ DS  K     I +K      A E     + +  S   DV+SFG+LL E+ T G  
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWM----AIESLFDHIYTTQS---DVWSFGVLLWEIVTLGGN 251

Query: 760 PTDAAFTEGLTLHEFVKM 777
           P       G+       +
Sbjct: 252 P-----YPGIPPERLFNL 264

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  107 bits (268), Expect = 2e-25
 Identities = 58/297 (19%), Positives = 101/297 (34%), Gaps = 40/297 (13%)

Query: 88  SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL-----------TFCSLKNLWWLNLEQN 136
                + L  N  S  L  D    L +L  L L            F  L+ L  L + +N
Sbjct: 54  PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112

Query: 137 NLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTAN 196
           +L       IP +L   S+L  L +  N+ +      FS L+N+  + +  N L      
Sbjct: 113 HL-----VEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFE 165

Query: 197 DLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RN 255
              F  L      L  L + + +    +P    +L  T+ +  +  N+I   I       
Sbjct: 166 PGAFDGL-----KLNYLRISEAKL-TGIP---KDLPETLNELHLDHNKIQ-AIELEDLLR 215

Query: 256 LVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFN 315
              L  L +  NQ+  I    +  L  L++L++  N L   +P  L +L  L  + L  N
Sbjct: 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274

Query: 316 NLQGNIPSS-------LGNCQNLKGFDASHNKLT-GAIPQQVLSITTLSVYLALAHN 364
           N+   +  +               G    +N +    +        T  + +   + 
Sbjct: 275 NIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  102 bits (255), Expect = 1e-23
 Identities = 71/370 (19%), Positives = 123/370 (33%), Gaps = 78/370 (21%)

Query: 107 DILVNLPNLKELYLT---------FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLE 157
           +    +P+L  L  T          C L+ +         L      ++P  +S   +  
Sbjct: 8   ETTSGIPDLDSLPPTYSAMCPFGCHCHLRVV---QCSDLGL-----KAVPKEIS--PDTT 57

Query: 158 RLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCD 217
            LDL  N        DF  L++L+ L L  N +              +    L+ L +  
Sbjct: 58  LLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK------AFSPLRKLQKLYISK 111

Query: 218 NQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQL-HGIIPD 275
           N    E+P    NL S++++ RI  N+I   +P G+   L N+  + +  N L +     
Sbjct: 112 NHLV-EIP---PNLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166

Query: 276 GVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPS-SLGNCQNLKGF 334
           G  +   L  L +    L   IP  L     L +L L  N +Q  I    L     L   
Sbjct: 167 GAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRL 222

Query: 335 DASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISS 394
              HN++   I    LS                         L  L         L + +
Sbjct: 223 GLGHNQIR-MIENGSLS------------------------FLPTL-------RELHLDN 250

Query: 395 NSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPE-------FLQNLSFLEFLNLSYNHLEG 447
           N     +P  L  +K ++ + + +NN++ ++         F    ++   ++L  N +  
Sbjct: 251 NKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308

Query: 448 EVPTKGVFSN 457
                  F  
Sbjct: 309 WEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  100 bits (251), Expect = 4e-23
 Identities = 49/290 (16%), Positives = 105/290 (36%), Gaps = 37/290 (12%)

Query: 45  LLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSL 104
           L ++ N +          L++L  L +  N+ S +  +    +  L+ +Y++ N     +
Sbjct: 59  LDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EI 117

Query: 105 PFDILVNLPNLKELYL-----------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNA 153
           P ++     +L EL +            F  L+N+  + +  N L     S       + 
Sbjct: 118 PPNL---PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPL---ENSGFEPGAFDG 171

Query: 154 SNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKAL 213
             L  L +S  +      I     + L  L+L+ N +      D      L   S L  L
Sbjct: 172 LKLNYLRISEAKLT---GIPKDLPETLNELHLDHNKIQAIELED------LLRYSKLYRL 222

Query: 214 SLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGII 273
            L  NQ       S++ L + + +  +  N++S  +P+G+ +L  L  + +  N +  + 
Sbjct: 223 GLGHNQIRMIENGSLSFLPT-LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVG 280

Query: 274 PD------GVGELQHLQQLYMFRNFLQ-GSIPPSL-GNLTKLADLALSFN 315
            +         +  +   + +F N +    + P+    +T    +     
Sbjct: 281 VNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 50/219 (22%), Positives = 80/219 (36%), Gaps = 26/219 (11%)

Query: 14  SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAE 73
            L  LQ L I  N+L  ++P  +   S+L  L I  N +          LRN+  + +  
Sbjct: 100 PLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156

Query: 74  NQF-SGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL-----------T 121
           N   +  F     +   L ++ ++  + +  +P D+      L EL+L            
Sbjct: 157 NPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLP---ETLNELHLDHNKIQAIELED 212

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPD-SLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
                 L+ L L  N +       I + SLS    L  L L  N+   +V      LK L
Sbjct: 213 LLRYSKLYRLGLGHNQI-----RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLL 266

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQ 219
             + L  NN+     ND   V      +    +SL +N 
Sbjct: 267 QVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNP 305

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 33/183 (18%), Positives = 57/183 (31%), Gaps = 27/183 (14%)

Query: 2   NKL-EGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPT-T 59
           N L            L L  L I    LT  +P        L  L +  N +   I    
Sbjct: 157 NPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELED 212

Query: 60  LGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY 119
           L     L  L +  NQ   +    +  + +L  ++L  N+ S  +P   L +L  L+ +Y
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP-AGLPDLKLLQVVY 270

Query: 120 L-----------TFCSLK------NLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLS 162
           L            FC +           ++L  N +        P +    ++   +   
Sbjct: 271 LHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQ--PATFRCVTDRLAIQFG 328

Query: 163 GNQ 165
             +
Sbjct: 329 NYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 17/81 (20%), Positives = 35/81 (43%), Gaps = 2/81 (2%)

Query: 386 SLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHL 445
               LD+ +N    +       ++ +  L + +N +S    +    L  L+ L +S NHL
Sbjct: 55  DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114

Query: 446 EGEVPTKGVFSNKTKISLQVN 466
             E+P   + S+  ++ +  N
Sbjct: 115 V-EIPP-NLPSSLVELRIHDN 133

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  106 bits (267), Expect = 4e-25
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 57/242 (23%)

Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 607
           IG+G+FG V++             +VAVK+  LK+         F  E   +    + N+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDNPNI 112

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK--------------- 652
           +K++ +C+           L+FEYM  G L ++L   + H                    
Sbjct: 113 VKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 653 ---LTLIQRVNIAIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMV---AHQNFSLS 705
              L+  +++ IA  VA+ + YL         VH DL   N L+  +MV   A  +F LS
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIA--DFGLS 221

Query: 706 HQLDSAS---KTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GR 758
             + SA       + +I I+       PE   Y   +  S   DV+++G++L E+F+ G 
Sbjct: 222 RNIYSADYYKADGNDAIPIRWM----PPESIFYNRYTTES---DVWAYGVVLWEIFSYGL 274

Query: 759 RP 760
           +P
Sbjct: 275 QP 276

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  106 bits (267), Expect = 4e-25
 Identities = 42/252 (16%), Positives = 81/252 (32%), Gaps = 28/252 (11%)

Query: 527 DTSPAKKQFPMIS-YAELSKATSEFASSNMIGQGSFGSVYKGILGGEE-----MIVAVKV 580
           +T   + + P I    E    +      +++G+G+F  VY+   G            +KV
Sbjct: 43  NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV 102

Query: 581 INLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDW 640
                   F       E L+          +   S+   +  +   LV E    G+L + 
Sbjct: 103 QKPANPWEFYIGTQLMERLKPSMQHM---FMKFYSAHLFQ--NGSVLVGELYSYGTLLNA 157

Query: 641 LHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ 700
           ++   +  E   +     ++ A+ +   IE +H      I+HGD+KP N +L +  +   
Sbjct: 158 INLYKNTPEKV-MPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213

Query: 701 N------------FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFG 748
           +               S  +    K  +       T G+   E       +   D +   
Sbjct: 214 DEDDLSAGLALIDLGQSIDMKLFPKG-TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVA 272

Query: 749 ILLLEMFTGRRP 760
             +  M  G   
Sbjct: 273 ATVYCMLFGTYM 284

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  107 bits (270), Expect = 5e-25
 Identities = 54/237 (22%), Positives = 93/237 (39%), Gaps = 40/237 (16%)

Query: 550 FASSNMIGQGSFGSV-YKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALR-NIRHRNL 607
             S  ++G GS G+V ++G   G    VAVK +           + E + L  +  H N+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRP--VAVKRML---IDFCDIALMEIKLLTESDDHPNV 71

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK-LTLIQRVNIAIDVA 666
           I+     ++       F  +  E     +L+D +   N   E  K       +++   +A
Sbjct: 72  IRYYCSETT-----DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN--------------FSLSHQLDSAS 712
           S + +LH      I+H DLKP N+L+        +              F L  +LDS  
Sbjct: 126 SGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 713 KTPSSSI-GIKGTVGYVAPEYGMGSEASMTG-------DVYSFGILLLEMFT-GRRP 760
            +  +++    GT G+ APE    S    T        D++S G +   + + G+ P
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  105 bits (265), Expect = 6e-25
 Identities = 54/232 (23%), Positives = 101/232 (43%), Gaps = 46/232 (19%)

Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGA----FRSFVAECEALRNI-RHR 605
           +G G+FG V +    G       + VAVK+  LK   A      + ++E + + ++ +H 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LK-STAHADEKEALMSELKIMSHLGQHE 110

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL--------HQSNDHLEVCKLTLIQ 657
           N++ ++  C+     G     ++ EY   G L ++L              +     +   
Sbjct: 111 NIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 658 RVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSAS--- 712
            ++ +  VA  + +L   +C    +H D+   NVLL +  VA   +F L+  + + S   
Sbjct: 166 LLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221

Query: 713 KTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRP 760
              ++ + +K      APE     + +  S   DV+S+GILL E+F+ G  P
Sbjct: 222 VKGNARLPVKWM----APESIFDCVYTVQS---DVWSYGILLWEIFSLGLNP 266

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  106 bits (266), Expect = 7e-25
 Identities = 65/255 (25%), Positives = 109/255 (42%), Gaps = 59/255 (23%)

Query: 556 IGQGSFGSVYKGIL-------GGEEMIVAVKVINLKQKGA----FRSFVAECEALRNI-R 603
           +G+G FG V              E + VAVK+  LK   A        V+E E ++ I +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LK-DDATEKDLSDLVSEMEMMKMIGK 145

Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL----------HQSNDHLEVCKL 653
           H+N+I ++  C+           ++ EY   G+L ++L              + +   ++
Sbjct: 146 HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 654 TLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMV---AHQNFSLS---H 706
           T    V+    +A  +EYL    C    +H DL   NVL+  + V   A  +F L+   +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIA--DFGLARDIN 254

Query: 707 QLDSASKTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRPTD 762
            +D   KT +  + +K      APE     + +  S   DV+SFG+L+ E+FT G  P  
Sbjct: 255 NIDYYKKTTNGRLPVKWM----APEALFDRVYTHQS---DVWSFGVLMWEIFTLGGSP-- 305

Query: 763 AAFTEGLTLHEFVKM 777
                G+ + E  K+
Sbjct: 306 ---YPGIPVEELFKL 317

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  104 bits (262), Expect = 1e-24
 Identities = 61/305 (20%), Positives = 110/305 (36%), Gaps = 47/305 (15%)

Query: 517 RRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIV 576
           + RR + +   +   +      S  E S     F   + +G GS+G V+K     +  + 
Sbjct: 27  QPRRVSFRGEASETLQSPGYDPSRPE-SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLY 85

Query: 577 AVKVINLKQKGAF--RSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVFEYME 633
           AVK      +G       +AE  +   + +H   +++     + +  G  +  L  E   
Sbjct: 86  AVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE---QAWEEGGILY--LQTELCG 140

Query: 634 NGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV 690
             SL+         L   +V             D   A+ +LH      +VH D+KP+N+
Sbjct: 141 -PSLQQHCEAWGASLPEAQVW--------GYLRDTLLALAHLHSQ---GLVHLDVKPANI 188

Query: 691 LLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE-----YGMGSEASMTGDV 744
            L         +F L  +L +A          +G   Y+APE     YG  +      DV
Sbjct: 189 FLGPRGRCKLGDFGLLVELGTAGAGEV----QEGDPRYMAPELLQGSYGTAA------DV 238

Query: 745 YSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQE 804
           +S G+ +LE+             G    +  +  LP +    +   L   ++    M++ 
Sbjct: 239 FSLGLTILEVACNMEL----PHGGEGWQQLRQGYLPPEFTAGLSSELRSVLV---MMLEP 291

Query: 805 DRRAR 809
           D + R
Sbjct: 292 DPKLR 296

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  104 bits (261), Expect = 1e-24
 Identities = 62/312 (19%), Positives = 105/312 (33%), Gaps = 26/312 (8%)

Query: 131 LNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNL 190
           +      L     +S+P  +   S+  RL+L  N+ +      F  L  L  L+L  N L
Sbjct: 12  IRCNSKGL-----TSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 191 GMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIP 250
                            +SLK L L  N     +  +   L   +       + +     
Sbjct: 65  SFKGCCSQSDFGT----TSLKYLDLSFNGVI-TMSSNFLGLEQ-LEHLDFQHSNLKQMSE 118

Query: 251 SGI-RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP-SLGNLTKLA 308
             +  +L NLI L I               L  L+ L M  N  Q +  P     L  L 
Sbjct: 119 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 178

Query: 309 DLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLND 368
            L LS   L+   P++  +  +L+  + SHN    ++             L  + N +  
Sbjct: 179 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMT 237

Query: 369 SLPLQVGNLKNLVITCVSLEYLDISSNSFH---GVIPFSLGFMKSIKELNVSSNNLSGQI 425
               +   L++      SL +L+++ N F        F L ++K  ++L V    +    
Sbjct: 238 ---SKKQELQHFPS---SLAFLNLTQNDFACTCEHQSF-LQWIKDQRQLLVEVERMECAT 290

Query: 426 PEFLQNLSFLEF 437
           P   Q +  L  
Sbjct: 291 PSDKQGMPVLSL 302

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 48/270 (17%), Positives = 87/270 (32%), Gaps = 35/270 (12%)

Query: 55  QIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFS-GSLPFDILVNLP 113
            +PT  G+  +   L +  N+   +       ++ L  + L+ N  S             
Sbjct: 21  SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 114 NLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID 173
           +LK L              L  N +      ++  +      LE LD   +  K      
Sbjct: 79  SLKYLD-------------LSFNGV-----ITMSSNFLGLEQLEHLDFQHSNLKQMSEFS 120

Query: 174 -FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSI-ANL 231
            F SL+NL +L++   +  +          +    SSL+ L +  N F       I   L
Sbjct: 121 VFLSLRNLIYLDISHTHTRVAFNG------IFNGLSSLEVLKMAGNSFQENFLPDIFTEL 174

Query: 232 SSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFR 290
            + +    +   Q+   +      +L +L  L +  N    +       L  LQ L    
Sbjct: 175 RN-LTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232

Query: 291 NFLQGSIPPSL--GNLTKLADLALSFNNLQ 318
           N +  +          + LA L L+ N+  
Sbjct: 233 NHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 95.8 bits (239), Expect = 9e-22
 Identities = 47/246 (19%), Positives = 95/246 (38%), Gaps = 18/246 (7%)

Query: 216 CDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGI-I 273
           C+++    +P     + S+  +  +  N++  ++P G+   L  L  L++  N L     
Sbjct: 14  CNSKGLTSVP---TGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGC 69

Query: 274 PDGVGE-LQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSL-GNCQNL 331
                     L+ L +  N +  ++  +   L +L  L    +NL+     S+  + +NL
Sbjct: 70  CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 128

Query: 332 KGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLD 391
              D SH          + +  +    L +A N   ++          L     +L +LD
Sbjct: 129 IYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFL--PDIFTELR----NLTFLD 181

Query: 392 ISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPT 451
           +S      + P +   + S++ LN+S NN         + L+ L+ L+ S NH+      
Sbjct: 182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSK- 239

Query: 452 KGVFSN 457
           K    +
Sbjct: 240 KQELQH 245

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 93.2 bits (232), Expect = 8e-21
 Identities = 50/256 (19%), Positives = 88/256 (34%), Gaps = 31/256 (12%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQ--IPTTLGLLR 64
            +P  I    +   L ++ N L          L+ L  L +  N L  +     +     
Sbjct: 21  SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 65  NLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL---- 120
           +L YL+++ N    M       +  LE +    +       F + ++L NL  L +    
Sbjct: 79  SLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137

Query: 121 -------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID 173
                   F  L +L  L +  N+      + +PD  +   NL  LDLS  Q +    + 
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSF---QENFLPDIFTELRNLTFLDLSQCQLE---QLS 191

Query: 174 ---FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIAN 230
              F+SL +L  LN+  NN                  +SL+ L    N         + +
Sbjct: 192 PTAFNSLSSLQVLNMSHNNFFSLDTF------PYKCLNSLQVLDYSLNHIMTSKKQELQH 245

Query: 231 LSSTMIQFRIGGNQIS 246
             S++    +  N  +
Sbjct: 246 FPSSLAFLNLTQNDFA 261

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  104 bits (261), Expect = 1e-24
 Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 27/240 (11%)

Query: 528 TSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL---- 583
             P K   P + Y  L+     F     IG+G F  VY+     + + VA+K + +    
Sbjct: 16  FQPQKALRPDMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71

Query: 584 --KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL 641
             K +      + E + L+ + H N   +I   +S          +V E  + G L   +
Sbjct: 72  DAKAR---ADCIKEIDLLKQLNHPN---VIKYYASFIEDNELN--IVLELADAGDLSRMI 123

Query: 642 HQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQ 700
                   +     +      + + SA+E++H      ++H D+KP+NV +    +V   
Sbjct: 124 KHFKKQKRLIPERTVW--KYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLG 178

Query: 701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +  L     S +    S   + GT  Y++PE    +  +   D++S G LL EM   + P
Sbjct: 179 DLGLGRFFSSKTTAAHS---LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  105 bits (264), Expect = 2e-24
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 55/253 (21%)

Query: 556 IGQGSFGSVYKGILGG-------EEMIVAVKVINLKQKGA----FRSFVAECEALRNI-R 603
           +G+G+FG V      G           VAVK++      A        ++E E ++ I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133

Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL----------HQSNDHLEVCKL 653
           H+N+I ++  C+           ++ EY   G+L ++L            +  H    +L
Sbjct: 134 HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 654 TLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS---HQL 708
           +    V+ A  VA  +EYL    C    +H DL   NVL+  D V    +F L+   H +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244

Query: 709 DSASKTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAA 764
           D   KT +  + +K      APE     + +  S   DV+SFG+LL E+FT G  P    
Sbjct: 245 DYYKKTTNGRLPVKWM----APEALFDRIYTHQS---DVWSFGVLLWEIFTLGGSP---- 293

Query: 765 FTEGLTLHEFVKM 777
              G+ + E  K+
Sbjct: 294 -YPGVPVEELFKL 305

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  104 bits (262), Expect = 2e-24
 Identities = 60/241 (24%), Positives = 100/241 (41%), Gaps = 55/241 (22%)

Query: 556 IGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQKGA----FRSFVAECEALRNI-RHR 605
           +G G+FG V           G  + VAVK+  LK + A      + ++E + +  +  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKM--LK-EKADSSEREALMSELKMMTQLGSHE 109

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL-----------------HQSNDHL 648
           N++ ++  C+           L+FEY   G L ++L                  +  +  
Sbjct: 110 NIVNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 649 EVCKLTLIQRVNIAIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLS- 705
           ++  LT    +  A  VA  +E+L    C    VH DL   NVL+ H  V    +F L+ 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR 220

Query: 706 --HQLDSASKTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMFT-GRR 759
                 +     ++ + +K      APE    G+ +  S   DV+S+GILL E+F+ G  
Sbjct: 221 DIMSDSNYVVRGNARLPVKWM----APESLFEGIYTIKS---DVWSYGILLWEIFSLGVN 273

Query: 760 P 760
           P
Sbjct: 274 P 274

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  104 bits (262), Expect = 2e-24
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 40/217 (18%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+ G V+K       +++A K+I+L+ K A R                +I+ + +  
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--------------NQIIRELQVLH 86

Query: 616 SIDSK------GADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
             +S       GA +      +  E+M+ GSL+  L ++    E      + +  ++I V
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGK--VSIAV 140

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQL-DSASKTPSSSIGIKG 723
              + YL    +  I+H D+KPSN+L++    +   +F +S QL DS + +        G
Sbjct: 141 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVG 192

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           T  Y++PE   G+  S+  D++S G+ L+EM  GR P
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  105 bits (262), Expect = 2e-24
 Identities = 39/281 (13%), Positives = 86/281 (30%), Gaps = 47/281 (16%)

Query: 517 RRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIV 576
             + +A   V TS      P    +EL +         ++GQ    +  +          
Sbjct: 42  YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101

Query: 577 AVKVINLKQKGA----------------FRSFVAECEALRNIRHRNLIKIITICSS---- 616
            V V    ++                   R    + +A  ++R      ++         
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161

Query: 617 ---IDSKGADFKALVFEYM-ENGSLEDWLHQSNDHLEVCK-LTLIQRVNIAIDVASAIEY 671
              +D +     +  F Y     +L+ +      H    K L    R+ + + V   +  
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           LHH+    +VH  L+P +++LD         F    +  +   +         + G+  P
Sbjct: 222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSS-------VSRGFEPP 271

Query: 731 EY-----------GMGSEASMTGDVYSFGILLLEMFTGRRP 760
           E               +  + + D ++ G+++  ++    P
Sbjct: 272 ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  105 bits (263), Expect = 1e-23
 Identities = 56/320 (17%), Positives = 97/320 (30%), Gaps = 71/320 (22%)

Query: 131 LNLEQNNLGMGTASSIPDSLSNA-SNLERLDLSGNQFKGKVS-IDFSSLKNLWWLNLEQN 188
            N   N +     S       +A    E+  L G      VS +    +     L L + 
Sbjct: 15  QNSFYNTI-----SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRL 69

Query: 189 NLGMGTANDLDFVTLL--TNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQIS 246
           NL           + L       +  L +  N     LP   A+L           N++S
Sbjct: 70  NL-----------SSLPDNLPPQITVLEITQNALI-SLPELPASLEY----LDACDNRLS 113

Query: 247 GTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTK 306
            T+P    +L +L    ++ NQL  ++P+       L+ +    N L   +P    +L  
Sbjct: 114 -TLPELPASLKHL---DVDNNQLT-MLPE---LPALLEYINADNNQLT-MLPELPTSLEV 164

Query: 307 LADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLL 366
           L+   +  N L   +P    + + L   D S N L                         
Sbjct: 165 LS---VRNNQLTF-LPELPESLEAL---DVSTNLLE------------------------ 193

Query: 367 NDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIP 426
             SLP       +      +  +     N     IP ++  +     + +  N LS +I 
Sbjct: 194 --SLPAVPVRNHHSE---ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247

Query: 427 EFLQNLSFLEFLNLSYNHLE 446
           E L   +     +    +  
Sbjct: 248 ESLSQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  103 bits (259), Expect = 3e-23
 Identities = 66/374 (17%), Positives = 118/374 (31%), Gaps = 63/374 (16%)

Query: 103 SLPFDILVNLPNLKELYLTF------------CSLKNLWWLNLEQNNLGMGTASSIPDSL 150
               D        ++  L              C +     L L + NL     SS+PD+L
Sbjct: 24  GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNL-----SSLPDNL 78

Query: 151 SNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSL 210
                +  L+++ N      S+      +L +L+   N L           TL    +SL
Sbjct: 79  --PPQITVLEITQNALI---SLP-ELPASLEYLDACDNRL----------STLPELPASL 122

Query: 211 KALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLH 270
           K L + +NQ    LP   A L           NQ++  +P    +L     L++  NQL 
Sbjct: 123 KHLDVDNNQL-TMLPELPALLEY----INADNNQLT-MLPELPTSLEV---LSVRNNQLT 173

Query: 271 GIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKL----ADLALSFNNLQGNIPSSLG 326
             +P+     + L+ L +  N L+ S+P                    N +  +IP ++ 
Sbjct: 174 F-LPE---LPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227

Query: 327 NCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDS---LPLQVGNLKNLVIT 383
           +           N L+ +  ++ LS  T            + S          L + V  
Sbjct: 228 SLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA 286

Query: 384 CVSLEYLDISSNSFHGV--IPFSLGFMKSIKELNVSSN-----NLSGQIPEFLQNLSFLE 436
                     S  +H       +  F   +  L+ + +         Q+  +L+ LS   
Sbjct: 287 WFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASA 346

Query: 437 FLNLSYNHLEGEVP 450
            L      +  +  
Sbjct: 347 ELRQQSFAVAADAT 360

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 95.8 bits (238), Expect = 1e-20
 Identities = 61/347 (17%), Positives = 111/347 (31%), Gaps = 59/347 (17%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAI---DFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPT 58
           N + G   +   +    +  A+   + N     L +    ++    L +   +L   +P 
Sbjct: 20  NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS-SLPD 76

Query: 59  TLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKEL 118
            L     +  L + +N      P    +   LE++    NR         L  LP L   
Sbjct: 77  NLP--PQITVLEITQNALI-SLPELPAS---LEYLDACDNR---------LSTLPEL--- 118

Query: 119 YLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLK 178
                   +L  L+++ N L     + +P+     + LE ++   NQ      +      
Sbjct: 119 ------PASLKHLDVDNNQL-----TMLPELP---ALLEYINADNNQLT---MLP-ELPT 160

Query: 179 NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIA---NLSSTM 235
           +L  L++  N L            L     SL+AL +  N     LP       +   T 
Sbjct: 161 SLEVLSVRNNQLT----------FLPELPESLEALDVSTNLL-ESLPAVPVRNHHSEETE 209

Query: 236 IQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQG 295
           I FR   N+I+  IP  I +L     + +E N L   I + + +       +  R +   
Sbjct: 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF-- 266

Query: 296 SIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT 342
           S+     N                N  S +    +    +   N  +
Sbjct: 267 SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS 313

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 80.0 bits (197), Expect = 1e-15
 Identities = 64/427 (14%), Positives = 120/427 (28%), Gaps = 70/427 (16%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
             L   +P+ +     +  L I  N L   LP+   +L     L    N L   +P    
Sbjct: 69  LNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLEY---LDACDNRLS-TLPELPA 120

Query: 62  LLRNLVYLNVAENQFSGMFPRWICN-----------------ISSLEFIYLTVNRFSGSL 104
              +L +L+V  NQ + M P                       +SLE + +  N+ +  L
Sbjct: 121 ---SLKHLDVDNNQLT-MLPELPALLEYINADNNQLTMLPELPTSLEVLSVRNNQLT-FL 175

Query: 105 PFDILVNLPNLKELYLTFCSLKNL--------------WWLNLEQNNLGMGTASSIPDSL 150
           P        +L+ L ++   L++L               +    +N +     + IP+++
Sbjct: 176 P----ELPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRI-----THIPENI 226

Query: 151 SNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSL 210
            +      + L  N      S    SL                            N    
Sbjct: 227 LSLDPTCTIILEDNPLS---SRIRESLSQQTAQPDYHGPR-----IYFSMSDGQQNTLHR 278

Query: 211 KALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLH 270
                    F       ++ +     +     N  S      + + V+    +    Q+ 
Sbjct: 279 PLADAVTAWFPENKQSDVSQIWH-AFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQVA 336

Query: 271 GIIPDGVGELQHL-QQLYMFRNFLQGSIPPSLG-NLTKLADLALSFNNLQGNIPSSLGNC 328
             +   +     L QQ +        S    +      L    L     +G   +  G  
Sbjct: 337 AWLEK-LSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGAL 395

Query: 329 QNLKGFDASHNKLTGAIPQQVLSITT---LSVYLALAHNLLND-SLPLQVGNLKNLVITC 384
            +L         L      +V ++     + VYLA    L     L   V  ++   ++ 
Sbjct: 396 LSLGREMFRLEILEDIARDKVRTLHFVDEIEVYLAFQTMLAEKLQLSTAVKEMRFYGVSG 455

Query: 385 VSLEYLD 391
           V+   L 
Sbjct: 456 VTANDLR 462

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  100 bits (252), Expect = 2e-23
 Identities = 56/301 (18%), Positives = 104/301 (34%), Gaps = 42/301 (13%)

Query: 109 LVNLPNLKELYL---------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERL 159
              L N  ++           T   L  +  L+     +     ++I   +   +NL  L
Sbjct: 15  DPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGV-----TTIE-GVQYLNNLIGL 68

Query: 160 DLSGNQFKGKVSID-FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDN 218
           +L  NQ      +    +L  +  L L  N L      ++  +  L +   +K L L   
Sbjct: 69  ELKDNQIT---DLAPLKNLTKITELELSGNPL-----KNVSAIAGLQS---IKTLDLTST 117

Query: 219 QFGGELPHSIANLS--STMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDG 276
           Q        +  L+  S +    +  NQI+    S +  L NL  L+I   Q+  +    
Sbjct: 118 QI-----TDVTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TP 168

Query: 277 VGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDA 336
           +  L  L  L    N +   I P L +L  L ++ L  N +     S L N  NL     
Sbjct: 169 LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTL 224

Query: 337 SHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNS 396
           ++  +T        ++   +V    +   +  +     G   +  +T     +++  S +
Sbjct: 225 TNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYT 284

Query: 397 F 397
           F
Sbjct: 285 F 285

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 41/204 (20%), Positives = 72/204 (35%), Gaps = 24/204 (11%)

Query: 243 NQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLG 302
             I+   P     L N I +    + +   +     +L  +  L  F   +  +I   + 
Sbjct: 7   TAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQ 60

Query: 303 NLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALA 362
            L  L  L L  N +  ++ + L N   +   + S N L        L   ++   L L 
Sbjct: 61  YLNNLIGLELKDNQIT-DL-APLKNLTKITELELSGNPLKNVSAIAGL--QSI-KTLDLT 115

Query: 363 HNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLS 422
              + D  PL    L N       L+ L +  N    + P  L  + +++ L++ +  +S
Sbjct: 116 STQITDVTPLA--GLSN-------LQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164

Query: 423 GQIPEFLQNLSFLEFLNLSYNHLE 446
                 L NLS L  L    N + 
Sbjct: 165 D--LTPLANLSKLTTLKADDNKIS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 54/263 (20%), Positives = 104/263 (39%), Gaps = 41/263 (15%)

Query: 10  EEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYL 69
           E +  L NL  L +  N +T  L     NL+ +  L +  N L  +  + +  L+++  L
Sbjct: 57  EGVQYLNNLIGLELKDNQIT-DLAPL-KNLTKITELELSGNPL--KNVSAIAGLQSIKTL 112

Query: 70  NVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLW 129
           ++   Q + + P  +  +S+L+ +YL +N+ +   P      L NL+ L +    + +L 
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLA---GLTNLQYLSIGNAQVSDL- 166

Query: 130 WLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNN 189
                               L+N S L  L    N+    +S   +SL NL  ++L+ N 
Sbjct: 167 ------------------TPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQ 206

Query: 190 LGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTI 249
           +     +D+     L N S+L  ++L +     +      NL    +   + G   +   
Sbjct: 207 I-----SDVSP---LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNV---VKGPSGAPIA 255

Query: 250 PSGIRNLVNLIALTIEVNQLHGI 272
           P+ I +     +  +  N    I
Sbjct: 256 PATISDNGTYASPNLTWNLTSFI 278

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 43/182 (23%), Positives = 70/182 (38%), Gaps = 22/182 (12%)

Query: 10  EEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYL 69
             +  L NLQ L +D N +T  +      L+ L  L I    +     T L  L  L  L
Sbjct: 123 TPLAGLSNLQVLYLDLNQIT-NISPL-AGLTNLQYLSIGNAQV--SDLTPLANLSKLTTL 178

Query: 70  NVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSL---- 125
              +N+ S + P  + ++ +L  ++L  N+ S       L N  NL  + LT  ++    
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISD---VSPLANTSNLFIVTLTNQTITNQP 233

Query: 126 ----KNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ--FKGKVSIDFSSLKN 179
                NL   N+ +   G   A   P ++S+       +L+ N   F   VS  F+    
Sbjct: 234 VFYNNNLVVPNVVKGPSG---APIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVT 290

Query: 180 LW 181
             
Sbjct: 291 FK 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  103 bits (258), Expect = 2e-23
 Identities = 55/250 (22%), Positives = 99/250 (39%), Gaps = 40/250 (16%)

Query: 88  SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL-----------TFCSLKNLWWLNLEQN 136
           ++   + L  N+    +  +   +L +L+ L L            F  L NL  L L  N
Sbjct: 64  TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122

Query: 137 NLGMGTASSIP-DSLSNASNLERLDLSGNQFKGKVSID---FSSLKNLWWLNLEQNNLGM 192
            L     ++IP  +    S L+ L L  N  +   SI    F+ + +L  L+L +     
Sbjct: 123 RL-----TTIPNGAFVYLSKLKELWLRNNPIE---SIPSYAFNRIPSLRRLDLGELKR-- 172

Query: 193 GTANDLDFVT--LLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIP 250
                L +++       S+L+ L+L       E+P+ +  L   + +  + GN +S  I 
Sbjct: 173 -----LSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIK-LDELDLSGNHLS-AIR 223

Query: 251 SGI-RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS-LGNLTKLA 308
            G  + L++L  L +  +Q+  I  +    LQ L ++ +  N L   +P      L  L 
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLE 282

Query: 309 DLALSFNNLQ 318
            + L  N   
Sbjct: 283 RIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 96.4 bits (240), Expect = 4e-21
 Identities = 60/257 (23%), Positives = 100/257 (38%), Gaps = 22/257 (8%)

Query: 144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL 203
             +PD +S  +N   L+L  NQ +      F  L++L  L L +N++             
Sbjct: 56  REVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG------A 107

Query: 204 LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIAL 262
               ++L  L L DN+       +   LS  + +  +  N I  +IPS     + +L  L
Sbjct: 108 FNGLANLNTLELFDNRLTTIPNGAFVYLSK-LKELWLRNNPIE-SIPSYAFNRIPSLRRL 165

Query: 263 TI-EVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNI 321
            + E+ +L  I       L +L+ L +    L     P+L  L KL +L LS N+L    
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNL--REIPNLTPLIKLDELDLSGNHLSAIR 223

Query: 322 PSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLV 381
           P S     +L+      +++   I +         V + LAHN L     L       L 
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTL---LPHDLFTPLH 279

Query: 382 ITCVSLEYLDISSNSFH 398
                LE + +  N ++
Sbjct: 280 ----HLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 95.6 bits (238), Expect = 6e-21
 Identities = 58/249 (23%), Positives = 98/249 (39%), Gaps = 28/249 (11%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL 66
           ++P+ I +  N + L +  N +     +   +L  L +L +  N +          L NL
Sbjct: 57  EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 67  VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL------ 120
             L + +N+ + +       +S L+ ++L  N    S+P      +P+L+ L L      
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRL 173

Query: 121 ------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDF 174
                  F  L NL +LNL   NL       IP+ L+    L+ LDLSGN         F
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNL-----REIPN-LTPLIKLDELDLSGNHLSAIRPGSF 227

Query: 175 SSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSST 234
             L +L  L + Q+ + +   N         N  SL  ++L  N     LPH +      
Sbjct: 228 QGLMHLQKLWMIQSQIQVIERN------AFDNLQSLVEINLAHNNL-TLLPHDLFTPLHH 280

Query: 235 MIQFRIGGN 243
           + +  +  N
Sbjct: 281 LERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 90.2 bits (224), Expect = 3e-19
 Identities = 59/244 (24%), Positives = 104/244 (42%), Gaps = 20/244 (8%)

Query: 207 CSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIE 265
           CS+  +  +C  +   E+P     +S+      +  NQI   I     ++L +L  L + 
Sbjct: 41  CSNQFSKVICVRKNLREVP---DGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLS 96

Query: 266 VNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNNLQGNIPSS 324
            N +  I       L +L  L +F N L  +IP  +   L+KL +L L  N ++ +IPS 
Sbjct: 97  RNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSY 154

Query: 325 L-GNCQNLKGFDASH-NKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVI 382
                 +L+  D     +L+  I +      +   YL LA   L +     + NL  L  
Sbjct: 155 AFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE-----IPNLTPL-- 206

Query: 383 TCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSY 442
             + L+ LD+S N    + P S   +  +++L +  + +         NL  L  +NL++
Sbjct: 207 --IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAH 264

Query: 443 NHLE 446
           N+L 
Sbjct: 265 NNLT 268

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  100 bits (252), Expect = 3e-23
 Identities = 41/227 (18%), Positives = 84/227 (37%), Gaps = 30/227 (13%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKII-- 611
           ++ +G F  VY+    G     A+K +   ++   R+ + E   ++ +  H N+++    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
                 +S     + L+   +  G L ++L +         L+    + I      A+++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG---PLSCDTVLKIFYQTCRAVQH 151

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM-----------VAHQNFSLSHQLDSASKTPSSSIG 720
           +H   +PPI+H DLK  N+LL +                     S      +      I 
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA-LVEEEIT 209

Query: 721 IKGTVGYVAPE-------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              T  Y  PE       + +G +     D+++ G +L  +   + P
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQ----DIWALGCILYLLCFRQHP 252

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =   99 bits (250), Expect = 3e-23
 Identities = 46/221 (20%), Positives = 87/221 (39%), Gaps = 37/221 (16%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 611
            +G+G F   ++      + + A K++    L +         E    R++ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASA 668
                 +     F  +V E     SL + LH+    L   E     L Q       +   
Sbjct: 82  GF---FEDNDFVF--VVLELCRRRSLLE-LHKRRKALTEPEARYY-LRQ-------IVLG 127

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSAS---KTPSSSIGIK 722
            +YLH +    ++H DLK  N+ L+ D+   +   +F L+ +++      K       + 
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIG--DFGLATKVEYDGERKKV------LC 176

Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           GT  Y+APE       S   DV+S G ++  +  G+ P + 
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  100 bits (252), Expect = 4e-23
 Identities = 61/306 (19%), Positives = 106/306 (34%), Gaps = 40/306 (13%)

Query: 144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL 203
           +SIP  L+    ++ LDLS N+     + D     NL  L L  N +     +       
Sbjct: 44  NSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEED------S 95

Query: 204 LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIAL 262
            ++  SL+ L L  N            LS+               + S   + L +L  L
Sbjct: 96  FSSLGSLEHLDLSYNY-----------LSN---------------LSSSWFKPLSSLTFL 129

Query: 263 TIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNNLQGN 320
            +  N    +    +   L  LQ L +        I       LT L +L +  ++LQ  
Sbjct: 130 NLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189

Query: 321 IPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLK-N 379
            P SL + QN+        +    + +  + +T+    L L    L+     ++   + N
Sbjct: 190 EPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248

Query: 380 LVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLN 439
            +I   +   + I+  S    +   L  +  + EL  S N L          L+ L+ + 
Sbjct: 249 SLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIW 307

Query: 440 LSYNHL 445
           L  N  
Sbjct: 308 LHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 96.0 bits (239), Expect = 2e-21
 Identities = 51/279 (18%), Positives = 104/279 (37%), Gaps = 26/279 (9%)

Query: 8   IPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLV 67
           IP  +     +++L +  N +T      +     L  L++  N +      +   L +L 
Sbjct: 46  IPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE 103

Query: 68  YLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL------- 120
           +L+++ N  S +   W   +SSL F+ L  N +       +  +L  L+ L +       
Sbjct: 104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT 163

Query: 121 -----TFCSLKNLWWLNLEQNNLGMGTASSIPD-SLSNASNLERLDLSGNQFKGKVSIDF 174
                 F  L  L  L ++ ++L      S    SL +  N+  L L   Q    + I  
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDL-----QSYEPKSLKSIQNVSHLILHMKQHILLLEIFV 218

Query: 175 SSLKNLWWLNLEQNNLGMGTANDLDFVT--LLTNCSSLKALSLCDNQFGGELPHSIANLS 232
               ++  L L   +L     ++L       L    + + + + D     ++   +  +S
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL-FQVMKLLNQIS 277

Query: 233 STMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLH 270
             +++     NQ+  ++P GI   L +L  + +  N   
Sbjct: 278 G-LLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 93.3 bits (232), Expect = 1e-20
 Identities = 52/286 (18%), Positives = 107/286 (37%), Gaps = 40/286 (13%)

Query: 56  IPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL 115
           IP+  GL   +  L+++ N+ + +    +    +L+ + LT N  + ++  D   +L +L
Sbjct: 46  IPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102

Query: 116 KELYL-----------TFCSLKNLWWLNLEQNNLGMGTASSIPDS--LSNASNLERLDLS 162
           + L L            F  L +L +LNL  N        ++ ++   S+ + L+ L + 
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY-----KTLGETSLFSHLTKLQILRVG 157

Query: 163 GNQFKGKVSID-FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFG 221
                 K+    F+ L  L  L ++ ++L       L       +  ++  L L   Q  
Sbjct: 158 NMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLK------SIQNVSHLILHMKQHI 211

Query: 222 GELPHSIANLSSTMIQFRIGGNQISGT----IPSGI----RNLVNLIALTIEVNQLHGII 273
             L     +++S++    +    +       + +G             + I    L  + 
Sbjct: 212 -LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQV- 269

Query: 274 PDGVGELQHLQQLYMFRNFLQGSIPPS-LGNLTKLADLALSFNNLQ 318
              + ++  L +L   RN L+ S+P      LT L  + L  N   
Sbjct: 270 MKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 56/287 (19%), Positives = 104/287 (36%), Gaps = 40/287 (13%)

Query: 127 NLWWLNLEQNNLGMGTASSIPDS-LSNASNLERLDLSGNQFKGKVSID---FSSLKNLWW 182
            +  L+L  N +     + I +S L    NL+ L L+ N      +I+   FSSL +L  
Sbjct: 53  AVKSLDLSNNRI-----TYISNSDLQRCVNLQALVLTSNGIN---TIEEDSFSSLGSLEH 104

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG 242
           L+L  N L   +++           SSL  L+L  N +      S+ +  + +   R+G 
Sbjct: 105 LDLSYNYLSNLSSS------WFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158

Query: 243 NQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP-S 300
                 I       L  L  L I+ + L    P  +  +Q++  L +        +    
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF 217

Query: 301 LGNLTKLADLALSFNNLQGN--------IPSSLGNCQNLKGFDASHNKLTGAIPQQVLSI 352
           +   + +  L L   +L             +SL      +    +   L   + + +  I
Sbjct: 218 VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQI 276

Query: 353 TTLSVYLALAHNLLNDSLPLQV-GNLKNLVITCVSLEYLDISSNSFH 398
           + L   L  + N L  S+P  +   L        SL+ + + +N + 
Sbjct: 277 SGLL-ELEFSRNQLK-SVPDGIFDRLT-------SLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 41/249 (16%), Positives = 89/249 (35%), Gaps = 20/249 (8%)

Query: 229 ANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLY 287
           + L+  +    +  N+I+  I +   +  VNL AL +  N ++ I  D    L  L+ L 
Sbjct: 48  SGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106

Query: 288 MFRNFLQGSIPPSL-GNLTKLADLALSFNNLQGNIPSSL-GNCQNLKGFDASHNKLTGAI 345
           +  N+L  ++  S    L+ L  L L  N  +    +SL  +   L+     +      I
Sbjct: 107 LSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI 165

Query: 346 PQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSL 405
            ++  +  T    L +  + L      +  +LK++     ++ +L +       ++   +
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQS---YEPKSLKSI----QNVSHLILHMKQHILLLEIFV 218

Query: 406 GFMKSIKELNVSSNNLSG-QIPEF-------LQNLSFLEFLNLSYNHLEGEVPTKGVFSN 457
               S++ L +   +L      E        L        + ++   L   +      S 
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISG 278

Query: 458 KTKISLQVN 466
             ++    N
Sbjct: 279 LLELEFSRN 287

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 99.7 bits (249), Expect = 8e-23
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 37/218 (16%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 611
            +G+G F   ++      + + A K++    L +         E    R++ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASA 668
                 +     F  +V E     SL + LH+    L   E     L Q       +   
Sbjct: 108 GF---FEDNDFVF--VVLELCRRRSLLE-LHKRRKALTEPEARYY-LRQ-------IVLG 153

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSAS---KTPSSSIGIK 722
            +YLH +    ++H DLK  N+ L+ D+   +   +F L+ +++      K       + 
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIG--DFGLATKVEYDGERKKV------LC 202

Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           GT  Y+APE       S   DV+S G ++  +  G+ P
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 98.4 bits (246), Expect = 9e-23
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 36/217 (16%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G+GSF  VY+       + VA+K+I+   + + G  +    E +    ++H +++++  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL---EVCKLTLIQRVNIAIDVASAI 669
                +     +  LV E   NG +  +L          E     + Q       + + +
Sbjct: 79  Y---FEDSNYVY--LVLEMCHNGEMNRYLKNRVKPFSENEARHF-MHQ-------IITGM 125

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSAS---KTPSSSIGIKG 723
            YLH H    I+H DL  SN+LL  +M   +A  +F L+ QL        T      + G
Sbjct: 126 LYLHSHG---ILHRDLTLSNLLLTRNMNIKIA--DFGLATQLKMPHEKHYT------LCG 174

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           T  Y++PE    S   +  DV+S G +   +  GR P
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  100 bits (251), Expect = 2e-22
 Identities = 56/250 (22%), Positives = 94/250 (37%), Gaps = 40/250 (16%)

Query: 88  SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL-----------TFCSLKNLWWLNLEQN 136
           S+  ++ L  N     +  D   +L +L+ L L            F  L +L  L L  N
Sbjct: 75  SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133

Query: 137 NLGMGTASSIP-DSLSNASNLERLDLSGNQFKGKVSID---FSSLKNLWWLNLEQNNLGM 192
            L     + IP  +    S L  L L  N  +   SI    F+ + +L  L+L +     
Sbjct: 134 WL-----TVIPSGAFEYLSKLRELWLRNNPIE---SIPSYAFNRVPSLMRLDLGELK--- 182

Query: 193 GTANDLDFVT--LLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIP 250
                L++++        +LK L+L       ++P+ +  L   + +  + GN     I 
Sbjct: 183 ----KLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVG-LEELEMSGNHFP-EIR 234

Query: 251 SG-IRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS-LGNLTKLA 308
            G    L +L  L +  +Q+  I  +    L  L +L +  N L  S+P      L  L 
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV 293

Query: 309 DLALSFNNLQ 318
           +L L  N   
Sbjct: 294 ELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 96.7 bits (241), Expect = 3e-21
 Identities = 59/274 (21%), Positives = 103/274 (37%), Gaps = 27/274 (9%)

Query: 127 NLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLE 186
               +   +  L     S +P  +   SN   L+L  N  +   +  F  L +L  L L 
Sbjct: 55  QFSKVVCTRRGL-----SEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107

Query: 187 QNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQIS 246
           +N++                 +SL  L L DN        +   LS  + +  +  N I 
Sbjct: 108 RNSIRQIEVG------AFNGLASLNTLELFDNWLTVIPSGAFEYLSK-LRELWLRNNPIE 160

Query: 247 GTIPSGI-RNLVNLIALTI-EVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNL 304
            +IPS     + +L+ L + E+ +L  I       L +L+ L +    ++  +P +L  L
Sbjct: 161 -SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPL 217

Query: 305 TKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHN 364
             L +L +S N+     P S     +LK     +++++  I +         V L LAHN
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHN 276

Query: 365 LLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFH 398
            L+    L       L      L  L +  N ++
Sbjct: 277 NLSS---LPHDLFTPLR----YLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 93.7 bits (233), Expect = 3e-20
 Identities = 56/249 (22%), Positives = 96/249 (38%), Gaps = 28/249 (11%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL 66
           ++P+ I    N + L +  N +     D   +L  L +L +  NS+          L +L
Sbjct: 68  EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125

Query: 67  VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL------ 120
             L + +N  + +       +S L  ++L  N    S+P      +P+L  L L      
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKL 184

Query: 121 ------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDF 174
                  F  L NL +LNL   N+       +P+ L+    LE L++SGN F       F
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNI-----KDMPN-LTPLVGLEELEMSGNHFPEIRPGSF 238

Query: 175 SSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSST 234
             L +L  L +  + + +   N           +SL  L+L  N     LPH +      
Sbjct: 239 HGLSSLKKLWVMNSQVSLIERN------AFDGLASLVELNLAHNNL-SSLPHDLFTPLRY 291

Query: 235 MIQFRIGGN 243
           +++  +  N
Sbjct: 292 LVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 91.3 bits (227), Expect = 1e-19
 Identities = 65/244 (26%), Positives = 103/244 (42%), Gaps = 20/244 (8%)

Query: 207 CSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIE 265
           CS+  +  +C  +   E+P     + S      +  N I   I +   R+L +L  L + 
Sbjct: 52  CSNQFSKVVCTRRGLSEVP---QGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLG 107

Query: 266 VNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNNLQGNIPS- 323
            N +  I       L  L  L +F N+L   IP  +   L+KL +L L  N ++ +IPS 
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165

Query: 324 SLGNCQNLKGFDASH-NKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVI 382
           +     +L   D     KL   I +          YL L    + D     + NL  LV 
Sbjct: 166 AFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIKD-----MPNLTPLV- 218

Query: 383 TCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSY 442
               LE L++S N F  + P S   + S+K+L V ++ +S         L+ L  LNL++
Sbjct: 219 ---GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAH 275

Query: 443 NHLE 446
           N+L 
Sbjct: 276 NNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 86.7 bits (215), Expect = 5e-18
 Identities = 49/221 (22%), Positives = 74/221 (33%), Gaps = 29/221 (13%)

Query: 14  SLLNLQTLAIDFNYLTGQLPDFV-GNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVA 72
            L +L+ L +  N +  Q+       L++L  L +  N L          L  L  L + 
Sbjct: 97  HLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155

Query: 73  ENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL---------TFC 123
            N    +       + SL  + L   +    +       L NLK L L            
Sbjct: 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLT 215

Query: 124 SLKNLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLSGNQFKGKVSID---FSSLKN 179
            L  L  L +  N+        I   S    S+L++L +  +Q      I+   F  L +
Sbjct: 216 PLVGLEELEMSGNHF-----PEIRPGSFHGLSSLKKLWVMNSQVS---LIERNAFDGLAS 267

Query: 180 LWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQF 220
           L  LNL  NNL     +      L T    L  L L  N +
Sbjct: 268 LVELNLAHNNLSSLPHD------LFTPLRYLVELHLHHNPW 302

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 97.1 bits (242), Expect = 5e-22
 Identities = 55/257 (21%), Positives = 103/257 (40%), Gaps = 37/257 (14%)

Query: 519 RRSAHKSVDTSPAKKQFPMISYAELSKATSEFASS----------NMIGQGSFGSVYKGI 568
             S+   + T     Q  ++++ +   A                   IG+GS G V    
Sbjct: 6   HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65

Query: 569 LGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA-- 626
                  VAVK+++L+++        E   +R+ +H N++++           +      
Sbjct: 66  EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMY---------KSYLVGEE 116

Query: 627 --LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGD 684
             ++ E+++ G+L D + Q        +L   Q   +   V  A+ YLH      ++H D
Sbjct: 117 LWVLMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRD 166

Query: 685 LKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGD 743
           +K  ++LL  D  V   +F    Q+        S +   GT  ++APE    S  +   D
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---GTPYWMAPEVISRSLYATEVD 223

Query: 744 VYSFGILLLEMFTGRRP 760
           ++S GI+++EM  G  P
Sbjct: 224 IWSLGIMVIEMVDGEPP 240

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 29/214 (13%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKI 610
             +G+G FG+VY       + I+A+KV+    L++ G       E E   ++RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
                        +  L+ EY   G++   L + +      K    +      ++A+A+ 
Sbjct: 75  YGY---FHDATRVY--LILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALS 123

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLS-HQLDSASKTPSSSIGIKGTVG 726
           Y H      ++H D+KP N+LL       +A  +F  S H   S          + GT+ 
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIA--DFGWSVHAPSSRRTD------LCGTLD 172

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           Y+ PE   G       D++S G+L  E   G+ P
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 56/239 (23%), Positives = 99/239 (41%), Gaps = 54/239 (22%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVIN----LKQKGAFRSFVA--------------- 594
           IG+GS+G V              A+KV++    ++Q G  R                   
Sbjct: 21  IGKGSYGVVKLAYNENDNTY--YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 595 -------ECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDH 647
                  E   L+ + H N++K++ +   +D    D   +VFE +  G + +        
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLK--- 132

Query: 648 LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSL 704
                L+  Q      D+   IEYLH+     I+H D+KPSN+L+  D    +A  +F +
Sbjct: 133 ----PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIA--DFGV 183

Query: 705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG---DVYSFGILLLEMFTGRRP 760
           S++   +    S+++   GT  ++APE    +    +G   DV++ G+ L     G+ P
Sbjct: 184 SNEFKGSDALLSNTV---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 27/210 (12%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IGQG+ G+VY  +       VA++ +NL+Q+      + E   +R  ++ N++  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL---- 83

Query: 616 SIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
                 +        +V EY+  GSL D + +         +   Q   +  +   A+E+
Sbjct: 84  -----DSYLVGDELWVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEF 131

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           LH +    ++H D+K  N+LL  D  V   +F    Q+       S+ +   GT  ++AP
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAP 185

Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           E           D++S GI+ +EM  G  P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 53/245 (21%), Positives = 91/245 (37%), Gaps = 20/245 (8%)

Query: 123 CSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWW 182
           C  +     +  Q  L      ++P  +   +  +R+ L GN+     +  F + +NL  
Sbjct: 8   CYNEPKVTTSCPQQGL-----QAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTI 60

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSI-ANLSSTMIQFRIG 241
           L L  N L    A         T  + L+ L L DN     +  +    L   +    + 
Sbjct: 61  LWLHSNVLARIDAA------AFTGLALLEQLDLSDNAQLRSVDPATFHGLGR-LHTLHLD 113

Query: 242 GNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP- 299
              +   +  G+ R L  L  L ++ N L  +  D   +L +L  L++  N +  S+P  
Sbjct: 114 RCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPER 171

Query: 300 SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYL 359
           +   L  L  L L  N +    P +  +   L       N L+ A+P + L+      YL
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYL 230

Query: 360 ALAHN 364
            L  N
Sbjct: 231 RLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 41/187 (21%), Positives = 65/187 (34%), Gaps = 23/187 (12%)

Query: 45  LLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSL 104
           + +  N +      +    RNL  L +  N  + +       ++ LE + L+ N    S+
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96

Query: 105 PFDILVNLPNLKELYL-----------TFCSLKNLWWLNLEQNNLGMGTASSIPD-SLSN 152
                  L  L  L+L            F  L  L +L L+ N L      ++PD +  +
Sbjct: 97  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL-----QALPDDTFRD 151

Query: 153 ASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKA 212
             NL  L L GN+        F  L +L  L L QN +     +         +   L  
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH------AFRDLGRLMT 205

Query: 213 LSLCDNQ 219
           L L  N 
Sbjct: 206 LYLFANN 212

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 57/242 (23%), Positives = 94/242 (38%), Gaps = 19/242 (7%)

Query: 207 CSSLKALSL-CDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTI 264
           C +   ++  C  Q    +P     + +   +  + GN+IS  +P+   R   NL  L +
Sbjct: 8   CYNEPKVTTSCPQQGLQAVP---VGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWL 63

Query: 265 EVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS-LGNLTKLADLALSFNNLQGNIPS 323
             N L  I       L  L+QL +  N    S+ P+    L +L  L L    LQ  +  
Sbjct: 64  HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP 122

Query: 324 -SLGNCQNLKGFDASHNKLTGAIPQQVLS-ITTLSVYLALAHNLLNDSLPLQVGNLKNLV 381
                   L+      N L  A+P      +  L+ +L L  N ++    +     + L 
Sbjct: 123 GLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLT-HLFLHGNRISS---VPERAFRGLH 177

Query: 382 ITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLS 441
               SL+ L +  N    V P +   +  +  L + +NNLS    E L  L  L++L L+
Sbjct: 178 ----SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233

Query: 442 YN 443
            N
Sbjct: 234 DN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 51/270 (18%), Positives = 88/270 (32%), Gaps = 62/270 (22%)

Query: 55  QIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPN 114
            +P   G+      + +  N+ S +         +L  ++L  N  +  +       L  
Sbjct: 25  AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81

Query: 115 LKELYLTFCSLKNLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLSGNQFKGKVSID 173
           L++L L               +N  +    S+   +      L  L L     +    + 
Sbjct: 82  LEQLDL--------------SDNAQL---RSVDPATFHGLGRLHTLHLDRCGLQ---ELG 121

Query: 174 ---FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIAN 230
              F  L  L +L L+ N L     +         +  +L  L L               
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDD------TFRDLGNLTHLFL--------------- 160

Query: 231 LSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMF 289
                      GN+IS ++P    R L +L  L +  N++  + P    +L  L  LY+F
Sbjct: 161 ----------HGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209

Query: 290 RNFLQGSIPPS-LGNLTKLADLALSFNNLQ 318
            N L  ++P   L  L  L  L L+ N   
Sbjct: 210 ANNLS-ALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 39/217 (17%), Positives = 72/217 (33%), Gaps = 15/217 (6%)

Query: 248 TIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP-SLGNLTK 306
            +P GI        + +  N++  +        ++L  L++  N L   I   +   L  
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81

Query: 307 LADLALSFNNLQGNIPSS-LGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNL 365
           L  L LS N    ++  +       L         L   +   +        YL L  N 
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140

Query: 366 LNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQI 425
           L     L     ++L     +L +L +  N    V   +   + S+  L +  N ++   
Sbjct: 141 LQA---LPDDTFRDLG----NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193

Query: 426 PEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKIS 462
           P   ++L  L  L L  N+L   +P     +    + 
Sbjct: 194 PHAFRDLGRLMTLYLFANNLS-ALP-TEALAPLRALQ 228

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 39/166 (23%), Positives = 63/166 (37%), Gaps = 21/166 (12%)

Query: 15  LLNLQTLAIDFNYLTGQLPDFV-GNLSALGMLLIRWNSLGGQIPT-TLGLLRNLVYLNVA 72
           L  L+ L +  N     +       L  L  L +    L  ++       L  L YL + 
Sbjct: 79  LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQ 137

Query: 73  ENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL-----------T 121
           +N    +      ++ +L  ++L  NR S S+P      L +L  L L            
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLSGNQF 166
           F  L  L  L L  NNL     S++P ++L+    L+ L L+ N +
Sbjct: 197 FRDLGRLMTLYLFANNL-----SALPTEALAPLRALQYLRLNDNPW 237

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 40/227 (17%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKII 611
           IG+G+F  V     IL G E  VA+K+I+  Q      +    E   ++ + H N++K+ 
Sbjct: 23  IGKGNFAKVKLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +   I+++   +  L+ EY   G + D+L          ++   +  +    + SA++Y
Sbjct: 81  EV---IETEKTLY--LIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQY 129

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            H      IVH DLK  N+LLD DM   +A   FS    +              G   Y 
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC------GAPPYA 180

Query: 729 APE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL 769
           APE      Y  G E     DV+S G++L  + +G  P D    + L
Sbjct: 181 APELFQGKKY-DGPEV----DVWSLGVILYTLVSGSLPFDGQNLKEL 222

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 32/267 (11%), Positives = 68/267 (25%), Gaps = 61/267 (22%)

Query: 556 IGQGSFGSVYKG---ILGGEEMIVAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLIK 609
            G       ++     L  +   VA+  +              ++    L  I       
Sbjct: 39  HGGVPPLQFWQALDTALDRQ---VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG--- 92

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +   + ++      +V E++  GSL++    S         + +  +     +A+A 
Sbjct: 93  VARVLDVVHTRAGGL--VVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAA 142

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           +  H      +      PS V +  D                           G V    
Sbjct: 143 DAAHRA---GVALSIDHPSRVRVSID---------------------------GDVVLAY 172

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP----TDAAFTEGLTLHEFVKMTLPEKVIE 785
           P      +A+   D+   G  L  +   R P       +           +   P  +  
Sbjct: 173 P--ATMPDANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDR 230

Query: 786 IVDPSLLMEVMANNSMIQEDRRARTQD 812
            +   +          +Q D   R+  
Sbjct: 231 DIPFQISAVAAR---SVQGDGGIRSAS 254

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 29/212 (13%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G+G FG+VY       + I+A+KV+    L+++G       E E   ++RH N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
                  +   +  L+ E+   G L   L +        +    +      ++A A+ Y 
Sbjct: 82  Y---FHDRKRIY--LMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYC 130

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLS-HQLDSASKTPSSSIGIKGTVGYV 728
           H      ++H D+KP N+L+ +     +A  +F  S H      +T      + GT+ Y+
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIA--DFGWSVHAPSLRRRT------MCGTLDYL 179

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            PE   G       D++  G+L  E   G  P
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 96.6 bits (241), Expect = 4e-21
 Identities = 76/423 (17%), Positives = 135/423 (31%), Gaps = 78/423 (18%)

Query: 88  SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSL---------------KNLWWLN 132
             ++ + +     S +   ++L  L   + + L  C L                 L  LN
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 133 LEQNNLGMGTASSIPDSLSNAS-NLERLDLSGNQFKGKVSIDFSSL----KNLWWLNLEQ 187
           L  N LG      +   L   S  +++L L      G      SS       L  L+L  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 188 NNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANL---SSTMIQFRIGGNQ 244
           N LG      L    LL     L+ L L            +A++        +  +  N 
Sbjct: 123 NLLGDAGLQLL-CEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181

Query: 245 ISGTIPSGIRNL--------VNLIALTIEVNQLHGIIPDGVGEL-------QHLQQLYMF 289
           I+    +G+R L          L AL +E   +     D   +L         L++L + 
Sbjct: 182 IN---EAGVRVLCQGLKDSPCQLEALKLESCGVT---SDNCRDLCGIVASKASLRELALG 235

Query: 290 RNFLQGS-----IPPSLGNLTKLADLALSFNNLQ----GNIPSSLGNCQNLKGFDASHNK 340
            N L         P  L   ++L  L +    +     G++   L   ++LK    + N+
Sbjct: 236 SNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295

Query: 341 LTG--------AIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDI 392
           L           + +    + +L     +       +      +  +++     L  L I
Sbjct: 296 LGDEGARLLCETLLEPGCQLESLW----VKSCSFTAA---CCSHFSSVLAQNRFLLELQI 348

Query: 393 SSNSFH--GVIPFSLGFMK---SIKELNVSSNNLSGQ----IPEFLQNLSFLEFLNLSYN 443
           S+N     GV     G  +    ++ L ++  ++S      +   L     L  L+LS N
Sbjct: 349 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 408

Query: 444 HLE 446
            L 
Sbjct: 409 CLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 87.3 bits (217), Expect = 3e-18
 Identities = 58/382 (15%), Positives = 120/382 (31%), Gaps = 69/382 (18%)

Query: 110 VNLPNLKELYLTFCS------------LKNLWWLNLEQNNLGMGTASSIPDSLSNASNLE 157
           ++L +++ L +                L+    + L+   L       I  +L     L 
Sbjct: 1   MSL-DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 59

Query: 158 RLDLSGNQFKGK-VSIDFSSLKN----LWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKA 212
            L+L  N+     V      L+     +  L+L+   L       L   + L    +L+ 
Sbjct: 60  ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL--SSTLRTLPTLQE 117

Query: 213 LSLCDNQFGGE----LPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQ 268
           L L DN  G      L   + +    + + ++    +S    +    L    A  +    
Sbjct: 118 LHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS---AASCEPL----ASVLRAK- 169

Query: 269 LHGIIPDGVGELQHLQQLYMFRNFLQGS----IPPSLGNLT-KLADLALSFNNLQ----G 319
                          ++L +  N +  +    +   L +   +L  L L    +      
Sbjct: 170 ------------PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR 217

Query: 320 NIPSSLGNCQNLKGFDASHNKLTG----AIPQQVLSITTLSVYLALAHNLLNDSLPLQVG 375
           ++   + +  +L+      NKL       +   +L  ++    L +    +        G
Sbjct: 218 DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK---GCG 274

Query: 376 NLKNLVITCVSLEYLDISSNSFH--GVIPFSLGFMK---SIKELNVSSNNLSGQ----IP 426
           +L  ++    SL+ L ++ N     G        ++    ++ L V S + +        
Sbjct: 275 DLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334

Query: 427 EFLQNLSFLEFLNLSYNHLEGE 448
             L    FL  L +S N LE  
Sbjct: 335 SVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 62.3 bits (152), Expect = 3e-10
 Identities = 39/240 (16%), Positives = 71/240 (29%), Gaps = 41/240 (17%)

Query: 45  LLIRWNSLGGQ----IPTTLGLLRNLVYLNVAENQFSGMFPRWICNI-----SSLEFIYL 95
           L +    +       +   +    +L  L +  N+   +    +C       S L  +++
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263

Query: 96  TVNRFS----GSLPFDILVNLPNLKELYLTFCSL----------------KNLWWLNLEQ 135
                +    G L   +L    +LKEL L    L                  L  L ++ 
Sbjct: 264 WECGITAKGCGDL-CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 322

Query: 136 NNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS-----SLKNLWWLNLEQNNL 190
            +      S     L+    L  L +S N+ +     +           L  L L   ++
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382

Query: 191 GMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE----LPHSIANLSSTMIQFRIGGNQIS 246
              + + L     L    SL+ L L +N  G      L  S+      + Q  +     S
Sbjct: 383 SDSSCSSL--AATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 49/255 (19%), Positives = 81/255 (31%), Gaps = 38/255 (14%)

Query: 14  SLLNLQTLAIDFNYLTGQ----LPDFVGNLSALGMLLIRWNSLGGQ-----IPTTLGLLR 64
           S   L+ L ++   +T      L   V + ++L  L +  N LG        P  L    
Sbjct: 197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS 256

Query: 65  NLVYLNVAENQFSGMFPRWICNI----SSLEFIYLTVNRFSGS----LPFDILVNLPNLK 116
            L  L + E   +      +C +     SL+ + L  N         L   +L     L+
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE 316

Query: 117 ELYLTFCSL---------------KNLWWLNLEQNNLGMGTASSIPDSL-SNASNLERLD 160
            L++  CS                + L  L +  N L       +   L    S L  L 
Sbjct: 317 SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376

Query: 161 LSGNQFKGKVSIDFSSL----KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLC 216
           L+            ++      +L  L+L  N LG      L   ++      L+ L L 
Sbjct: 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQPGCLLEQLVLY 435

Query: 217 DNQFGGELPHSIANL 231
           D  +  E+   +  L
Sbjct: 436 DIYWSEEMEDRLQAL 450

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 50.7 bits (122), Expect = 1e-06
 Identities = 41/209 (19%), Positives = 71/209 (33%), Gaps = 37/209 (17%)

Query: 40  SALGMLLIRWNSLGGQ----IPTTLGLLRNLVYLNVAENQFSGMFPRWICNI-----SSL 90
           S L  L I    +  +    +   L    +L  L++A N+      R +C         L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315

Query: 91  EFIYLTVNRFSGSLPFDI---LVNLPNLKELYLTFCSLK----------------NLWWL 131
           E +++    F+ +        L     L EL ++   L+                 L  L
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375

Query: 132 NLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF--KGKVSIDFSSLKN----LWWLNL 185
            L   ++   + SS+  +L    +L  LDLS N     G + +   S++     L  L L
Sbjct: 376 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQPGCLLEQLVL 434

Query: 186 EQNNLGMGTANDLDFVTLLTNCSSLKALS 214
                     + L    L  +  SL+ +S
Sbjct: 435 YDIYWSEEMEDRL--QALEKDKPSLRVIS 461

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 93.2 bits (232), Expect = 7e-21
 Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 42/221 (19%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+FG VYK        + A KVI  K +     ++ E E L    H  ++K++    
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL---- 82

Query: 616 SIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLE------VCKLTLIQRVNIAIDV 665
                GA +      ++ E+   G+++  + + +  L       VC+  L          
Sbjct: 83  -----GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---------- 127

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
             A+ +LH      I+H DLK  NVL+  +  +   +F +S +     +   S I   GT
Sbjct: 128 -EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI---GT 180

Query: 725 VGYVAPEYGMGSEASMTG-----DVYSFGILLLEMFTGRRP 760
             ++APE  M      T      D++S GI L+EM     P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 94.6 bits (235), Expect = 8e-21
 Identities = 45/221 (20%), Positives = 80/221 (36%), Gaps = 33/221 (14%)

Query: 556 IGQG--SFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
           IG+G     +V           V V+ INL+            E    +   H N++   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQS-NDHLEVCKLTLIQRVNIAIDVASAIE 670
              + I     +   +V  +M  GS +D +     D +    +  I +      V  A++
Sbjct: 93  --ATFI--ADNEL-WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ-----GVLKALD 142

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQL-DSASKTPSSSIGIKGTVG-- 726
           Y+HH      VH  +K S++L+  D  V       +  +     +        K +V   
Sbjct: 143 YIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 727 -YVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            +++PE       G  +++    D+YS GI   E+  G  P
Sbjct: 200 PWLSPEVLQQNLQGYDAKS----DIYSVGITACELANGHVP 236

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 31/220 (14%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA-FRSFVAECEALRNIRHRNLIKIITIC 614
           IG G+   V       ++  VA+K INL++        + E +A+    H N++      
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY--YT 80

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVASAIEY 671
           S +     +   LV + +  GS+ D +       E     L +   IA    +V   +EY
Sbjct: 81  SFV--VKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVLEGLEY 136

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIK-----GTV 725
           LH + Q   +H D+K  N+LL  D  V   +F +S  L   +     +         GT 
Sbjct: 137 LHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL---ATGGDITRNKVRKTFVGTP 190

Query: 726 GYVAPE-----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            ++APE      G   +A    D++SFGI  +E+ TG  P
Sbjct: 191 CWMAPEVMEQVRGYDFKA----DIWSFGITAIELATGAAP 226

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 39/221 (17%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G+G++G V K        I+AVK I                     + R L+ +     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRA-------------TVNSQEQKRLLMDLDISMR 61

Query: 616 SIDSK------GADFK----ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           ++D        GA F+     +  E M + SL+ +  Q  D  +     ++ +  IA+ +
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSI 118

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQL-DSASKTPSSSIGIKG 723
             A+E+LH      ++H D+KPSNVL++    V   +F +S  L D  +K         G
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD--IDA---G 171

Query: 724 TVGYVAPE----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              Y+APE           S+  D++S GI ++E+   R P
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 46/280 (16%), Positives = 84/280 (30%), Gaps = 30/280 (10%)

Query: 156 LERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSL 215
           L+R+D   +  +     D     +L  L +    +    +  L     +   S L+ L+L
Sbjct: 49  LKRVDTEADLGQ---FTDIIKSLSLKRLTVRAARI---PSRILFGALRVLGISGLQELTL 102

Query: 216 CDNQFGGELPHSIANLSSTMIQ-FRIGGNQISG--TIPSGIRNLV--NLIALTIEVNQLH 270
            + +  G  P  +   +   +    +     +      + ++  +   L  L+I      
Sbjct: 103 ENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL 162

Query: 271 GIIPDGVGELQHLQQLYMFRNFLQGSIPPS----LGNLTKLADLALSFNNLQ---GNIPS 323
               + V     L  L +  N   G               L  LAL    ++   G   +
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222

Query: 324 SLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVIT 383
                  L+G D SHN L  A         +    L L+   L   +P  +         
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGLPA------- 274

Query: 384 CVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSG 423
              L  LD+S N      P     +  +  L++  N    
Sbjct: 275 --KLSVLDLSYNRLDR-NPSPDE-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 58/326 (17%), Positives = 91/326 (27%), Gaps = 48/326 (14%)

Query: 25  FNYLTGQLPDFVGNLSALGMLLIRWNSLG--GQIPTTLGLLRNLVYLNVAENQFSGMFPR 82
           FN L     +  G   +L  LL R ++    GQ    +  L  L  L V   +       
Sbjct: 28  FNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLS-LKRLTVRAARIPSRILF 86

Query: 83  W---ICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLG 139
               +  IS L+ + L     +G+ P  +L              +  +L  LNL   +  
Sbjct: 87  GALRVLGISGLQELTLENLEVTGTAPPPLL------------EATGPDLNILNLRNVSWA 134

Query: 140 MGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD 199
              A            L+ L ++                 L  L+L  N         L 
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE--LGERGLI 192

Query: 200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNL 259
                    +L+ L+L +                            SG   +     V L
Sbjct: 193 SALCPLKFPTLQVLALRNAGM----------------------ETPSGVCSALAAARVQL 230

Query: 260 IALTIEVNQLHGIIPDGVGE-LQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ 318
             L +  N L         +    L  L +    L+  +P  L    KL+ L LS+N L 
Sbjct: 231 QGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD 287

Query: 319 GNIPSSLGNCQNLKGFDASHNKLTGA 344
              PS       +       N    +
Sbjct: 288 R-NPSPDE-LPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 44/244 (18%), Positives = 72/244 (29%), Gaps = 14/244 (5%)

Query: 213 LSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGI 272
              C      EL     +L   + +     +    T      +L  L      +      
Sbjct: 27  AFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILF 86

Query: 273 IPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ----GNIPSSLGNC 328
               V  +  LQ+L +    + G+ PP L   T      L+  N+         + L   
Sbjct: 87  GALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQW 146

Query: 329 --QNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVS 386
               LK    +         +QV     LS  L L+ N       L             +
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALS-TLDLSDNPELGERGLISALCPL---KFPT 202

Query: 387 LEYLDISSNSFH---GVIPFSLGFMKSIKELNVSSNNLSGQIPE-FLQNLSFLEFLNLSY 442
           L+ L + +       GV          ++ L++S N+L            S L  LNLS+
Sbjct: 203 LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF 262

Query: 443 NHLE 446
             L+
Sbjct: 263 TGLK 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 35/184 (19%), Positives = 54/184 (29%), Gaps = 29/184 (15%)

Query: 14  SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIP----TTLGLLRNLVYL 69
               L+ L+I   +      + V    AL  L +  N   G+              L  L
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206

Query: 70  NVAENQF---SGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLK 126
            +        SG+          L+ + L+ N    +           L  L L+F  L 
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL- 265

Query: 127 NLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLE 186
                              +P  L   + L  LDLS N+     S D   L  +  L+L+
Sbjct: 266 -----------------KQVPKGLP--AKLSVLDLSYNRLDRNPSPDE--LPQVGNLSLK 304

Query: 187 QNNL 190
            N  
Sbjct: 305 GNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 32/184 (17%), Positives = 56/184 (30%), Gaps = 24/184 (13%)

Query: 283 LQQLYMFRNFLQGSIPPS---LGNLTKLADLALSFNNLQGNIPSSLGNCQ--NLKGFDAS 337
           L++L +    +   I      +  ++ L +L L    + G  P  L      +L   +  
Sbjct: 70  LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129

Query: 338 HNKLTGAIPQ----QVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDIS 393
           +             Q      L V L++A     +    QV     L         LD+S
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKV-LSIAQAHSLNFSCEQVRVFPAL-------STLDLS 181

Query: 394 SNSFHGVIPFS----LGFMKSIKELNVSSNN---LSGQIPEFLQNLSFLEFLNLSYNHLE 446
            N   G              +++ L + +      SG           L+ L+LS+N L 
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241

Query: 447 GEVP 450
               
Sbjct: 242 DAAG 245

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 26/170 (15%), Positives = 52/170 (30%), Gaps = 11/170 (6%)

Query: 302 GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLS--VYL 359
           G  +    L            + +    +LK       ++   I    L +  +S    L
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 360 ALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGF----MKSIKELN 415
            L +  +  + P  +            L  L++ + S+     +           +K L+
Sbjct: 101 TLENLEVTGTAPPPLLEATGP-----DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155

Query: 416 VSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQV 465
           ++  +      E ++    L  L+LS N   GE             +LQV
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQV 205

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 94.4 bits (234), Expect = 3e-20
 Identities = 53/245 (21%), Positives = 88/245 (35%), Gaps = 40/245 (16%)

Query: 109 LVNLPNLKELYL---------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERL 159
                   +  L         T   L ++  +    +++      S+   +    N+ +L
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDI-----KSV-QGIQYLPNVTKL 70

Query: 160 DLSGNQFKGKVSID-FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDN 218
            L+GN+      I   ++LKNL WL L++N +      DL     L +   LK+LSL  N
Sbjct: 71  FLNGNKLT---DIKPLTNLKNLGWLFLDENKI-----KDLSS---LKDLKKLKSLSLEHN 119

Query: 219 QFGGELPHSIANLS--STMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDG 276
                    I  L     +    +G N+I  T  + +  L  L  L++E NQ+  I    
Sbjct: 120 GI-----SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDI--VP 170

Query: 277 VGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDA 336
           +  L  LQ LY+ +N +   +   L  L  L  L L          +   N         
Sbjct: 171 LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 228

Query: 337 SHNKL 341
           +   L
Sbjct: 229 TDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.0 bits (220), Expect = 2e-18
 Identities = 51/290 (17%), Positives = 97/290 (33%), Gaps = 63/290 (21%)

Query: 63  LRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT- 121
               +  N+ +   +         ++S++ I    +    S+    +  LPN+ +L+L  
Sbjct: 20  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNG 74

Query: 122 --------FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID 173
                     +LKNL WL L++N +       +  SL +   L+ L L  N       I+
Sbjct: 75  NKLTDIKPLTNLKNLGWLFLDENKI-----KDL-SSLKDLKKLKSLSLEHNGIS---DIN 125

Query: 174 -FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLS 232
               L  L  L L  N +      D+     L+  + L  LSL DNQ        I+++ 
Sbjct: 126 GLVHLPQLESLYLGNNKI-----TDITV---LSRLTKLDTLSLEDNQ--------ISDIV 169

Query: 233 STMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNF 292
                               +  L  L  L +  N +  +    +  L++L  L +F   
Sbjct: 170 -------------------PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQE 208

Query: 293 LQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT 342
                     NL     +  +  +L    P  + +  + +  +   +   
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 88.2 bits (218), Expect = 4e-18
 Identities = 45/205 (21%), Positives = 78/205 (38%), Gaps = 24/205 (11%)

Query: 242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
              I   I          I   ++   +   +     EL  + Q+    + ++ S+   +
Sbjct: 8   STPIK-QI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-I 61

Query: 302 GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
             L  +  L L+ N L  +I   L N +NL       NK+      + L    L   L+L
Sbjct: 62  QYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSSLKDL--KKLK-SLSL 116

Query: 362 AHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNL 421
            HN ++D     +  L +L      LE L + +N    +   S   +  +  L++  N +
Sbjct: 117 EHNGISD-----INGLVHLP----QLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQI 165

Query: 422 SGQIPEFLQNLSFLEFLNLSYNHLE 446
           S  I   L  L+ L+ L LS NH+ 
Sbjct: 166 S-DI-VPLAGLTKLQNLYLSKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 86.3 bits (213), Expect = 1e-17
 Identities = 45/243 (18%), Positives = 87/243 (35%), Gaps = 41/243 (16%)

Query: 210 LKALSLCDNQFGGELPHSIANLSS--TMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVN 267
           +                 I    +    I+  +    ++  +      L ++  +    +
Sbjct: 1   MGETITVSTPI-----KQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS 53

Query: 268 QLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGN 327
            +  +   G+  L ++ +L++  N L   I P L NL  L  L L  N ++ ++ SSL +
Sbjct: 54  DIKSV--QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKD 107

Query: 328 CQNLKGFDASHNKLTGAIPQQVLSITTLS-----VYLALAHNLLNDSLPLQVGNLKNLVI 382
            + LK     HN ++         I  L        L L +N + D     +  L  L  
Sbjct: 108 LKKLKSLSLEHNGIS--------DINGLVHLPQLESLYLGNNKITD-----ITVLSRLT- 153

Query: 383 TCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSY 442
               L+ L +  N    ++P +   +  ++ L +S N++S      L  L  L+ L L  
Sbjct: 154 ---KLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFS 206

Query: 443 NHL 445
              
Sbjct: 207 QEC 209

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 86.3 bits (213), Expect = 2e-17
 Identities = 53/311 (17%), Positives = 94/311 (30%), Gaps = 63/311 (20%)

Query: 38  NLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTV 97
             +      ++  S+      T   L ++  +    +    +    I  + ++  ++L  
Sbjct: 19  AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 74

Query: 98  NRFSGSLPFDILVNLPNLKELYL---------TFCSLKNLWWLNLEQNNLGMGTASSIPD 148
           N+ +       L NL NL  L+L         +   LK L  L+LE N +     S I +
Sbjct: 75  NKLTD---IKPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGI-----SDI-N 125

Query: 149 SLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCS 208
            L +   LE L L  N+    ++   S L  L  L+LE N +     +D+     L   +
Sbjct: 126 GLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQI-----SDIVP---LAGLT 175

Query: 209 SLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQ 268
            L+ L L  N         I++L                     +  L NL  L +   +
Sbjct: 176 KLQNLYLSKNH--------ISDL-------------------RALAGLKNLDVLELFSQE 208

Query: 269 LHGIIPDGVGELQHLQQLYMFRNFLQG----SIPPSLGNLTKLADLALSFNNLQGNIPSS 324
                 +    L     +      L      S             L    N +       
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQP 268

Query: 325 LGNCQNLKGFD 335
           +   +    F 
Sbjct: 269 VTIGKAKARFH 279

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 69.4 bits (169), Expect = 3e-12
 Identities = 46/192 (23%), Positives = 76/192 (39%), Gaps = 28/192 (14%)

Query: 10  EEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGL--LRNLV 67
           + I  L N+  L ++ N LT   P  + NL  LG L +  N    +I     L  L+ L 
Sbjct: 59  QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN----KIKDLSSLKDLKKLK 112

Query: 68  YLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT------ 121
            L++  N  S +    + ++  LE +YL  N+ +      +L  L  L  L L       
Sbjct: 113 SLSLEHNGISDING--LVHLPQLESLYLGNNKITD---ITVLSRLTKLDTLSLEDNQISD 167

Query: 122 ---FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLK 178
                 L  L  L L +N++     S +  +L+   NL+ L+L   +   K     S+L 
Sbjct: 168 IVPLAGLTKLQNLYLSKNHI-----SDL-RALAGLKNLDVLELFSQECLNKPINHQSNLV 221

Query: 179 NLWWLNLEQNNL 190
               +     +L
Sbjct: 222 VPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 10/86 (11%), Positives = 30/86 (34%), Gaps = 8/86 (9%)

Query: 361 LAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNN 420
           +   +   +   Q+                ++   S    +      + SI ++  ++++
Sbjct: 1   MGETITVSTPIKQIFPDDAFA----ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD 54

Query: 421 LSGQIPEFLQNLSFLEFLNLSYNHLE 446
           +   + + +Q L  +  L L+ N L 
Sbjct: 55  IK-SV-QGIQYLPNVTKLFLNGNKLT 78

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 90.5 bits (225), Expect = 8e-20
 Identities = 46/218 (21%), Positives = 85/218 (38%), Gaps = 35/218 (16%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA-FRSFVAECEAL-RNIRHRNLIKIITI 613
           +G G+ G V+K        ++AVK +         +  + + + + ++     +++    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---- 88

Query: 614 CSSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
                  G         +  E M     E    +    +    L       + + +  A+
Sbjct: 89  -----CFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG-----KMTVAIVKAL 137

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQL-DSASKTPSSSIGIKGTVGY 727
            YL       ++H D+KPSN+LLD    +   +F +S +L D  +K    S    G   Y
Sbjct: 138 YYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD--RSA---GCAAY 190

Query: 728 VAPE-----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +APE          +  +  DV+S GI L+E+ TG+ P
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 46/225 (20%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA-FRSFVAECE-ALRNIRHRNLIKIITI 613
           IG+G++GSV K +      I+AVK I         +  + + +  +R+     +++    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---- 85

Query: 614 CSSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV--NIAIDVAS 667
                  GA F+     +  E M + S + +         V    + + +   I +    
Sbjct: 86  -----FYGALFREGDCWICMELM-STSFDKFYKYV---YSVLDDVIPEEILGKITLATVK 136

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDH-------DMVAHQNFSLSHQL-DSASKTPSSSI 719
           A+ +L  + +  I+H D+KPSN+LLD        D      F +S QL DS +KT  +  
Sbjct: 137 ALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCD------FGISGQLVDSIAKTRDA-- 186

Query: 720 GIKGTVGYVAPE----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              G   Y+APE            +  DV+S GI L E+ TGR P
Sbjct: 187 ---GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 90.3 bits (224), Expect = 1e-19
 Identities = 51/301 (16%), Positives = 99/301 (32%), Gaps = 72/301 (23%)

Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNI 602
           S+  ++F     +G+G FG V++     ++   A+K I L  +  A    + E +AL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61

Query: 603 R-----------------------HRNLIKIITICSSIDSKGADFKA------------- 626
                                       +K  +    + S                    
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121

Query: 627 ----------------LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
                           +  +     +L+DW+++     +      +   +I I +A A+E
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL---HIFIQIAEAVE 178

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMV----------AHQNFSLSHQLDSASKTPSSSIG 720
           +LH      ++H DLKPSN+    D V          A         + +     ++  G
Sbjct: 179 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235

Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP 780
             GT  Y++PE   G+  S   D++S G++L E+                + +   +  P
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFP 292

Query: 781 E 781
            
Sbjct: 293 L 293

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 47/224 (20%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVA----ECEALRNIRHRNLIK 609
           +G G+FG V  G   L G +  VAVK++N +QK      V     E + L+  RH ++IK
Sbjct: 19  LGVGTFGKVKIGEHQLTGHK--VAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +   I +    F  +V EY+  G L D++ +        ++  ++   +   + SA+
Sbjct: 76  LYQV---ISTPTDFF--MVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAV 124

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLS--HQLDSASKTPSSSIGIKGT 724
           +Y H H    +VH DLKP NVLLD  M   +A  +F LS         +T        G+
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIA--DFGLSNMMSDGEFLRTSC------GS 173

Query: 725 VGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
             Y APE      Y  G E     D++S G++L  +  G  P D
Sbjct: 174 PNYAAPEVISGRLYA-GPEV----DIWSCGVILYALLCGTLPFD 212

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 47/228 (20%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVIN---LKQKGAFRSFVA-ECEALRNIRHRNLIK 609
           +G+GS+G V +            AVK++    L++     + V  E + LR +RH+N+I+
Sbjct: 13  LGEGSYGKVKEVLDSETLCR--RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           ++ +  + + K   +  +V EY   G  E  +    D +   +  + Q       +   +
Sbjct: 71  LVDVLYN-EEKQKMY--MVMEYCVCGMQE--ML---DSVPEKRFPVCQAHGYFCQLIDGL 122

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSAS-----KTPSSSIGI 721
           EYLH      IVH D+KP N+LL       ++     ++  L   +     +T       
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKIS--ALGVAEALHPFAADDTCRTSQ----- 172

Query: 722 KGTVGYVAPE-------YGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
            G+  +  PE       +  G +     D++S G+ L  + TG  P +
Sbjct: 173 -GSPAFQPPEIANGLDTFS-GFKV----DIWSAGVTLYNITTGLYPFE 214

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 39/244 (15%)

Query: 528 TSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG 587
             P ++   +   +   +    F     +G+GS+GSVYK I      IVA+K + ++   
Sbjct: 9   NPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD- 67

Query: 588 AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQ 643
             +  + E   ++     +++K           G+ FK     +V EY   GS+ D +  
Sbjct: 68  -LQEIIKEISIMQQCDSPHVVKYY---------GSYFKNTDLWIVMEYCGAGSVSDIIRL 117

Query: 644 SNDHLE------VCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-M 696
            N  L       + + TL             +EYLH       +H D+K  N+LL+ +  
Sbjct: 118 RNKTLTEDEIATILQSTL-----------KGLEYLHFM---RKIHRDIKAGNILLNTEGH 163

Query: 697 VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT 756
               +F ++ QL       ++ I   GT  ++APE       +   D++S GI  +EM  
Sbjct: 164 AKLADFGVAGQLTDTMAKRNTVI---GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220

Query: 757 GRRP 760
           G+ P
Sbjct: 221 GKPP 224

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 34/214 (15%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITIC 614
           IG+GSFG V+KGI    + +VA+K+I+L++ +        E   L       + K     
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK----- 84

Query: 615 SSIDSKGADFKA----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVAS 667
                 G+  K     ++ EY+  GS  D L          +   +    IA    ++  
Sbjct: 85  ----YYGSYLKDTKLWIIMEYLGGGSALDLL----------EPGPLDETQIATILREILK 130

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
            ++YLH       +H D+K +NVLL     V   +F ++ QL       ++ +   GT  
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV---GTPF 184

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           ++APE    S      D++S GI  +E+  G  P
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 90.9 bits (226), Expect = 3e-19
 Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 40/219 (18%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G+GSFG V            AVKVI+   +KQK    S + E + L+ + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
                      +  LV E    G L D +       EV    +I++      V S I Y+
Sbjct: 94  FFED-----KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYM 142

Query: 673 HHHCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKGTVG 726
           H +    IVH DLKP N+LL+         +   +F LS   +++ K         GT  
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRII--DFGLSTHFEASKKM----KDKIGTAY 193

Query: 727 YVAPE-----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           Y+APE     Y          DV+S G++L  + +G  P
Sbjct: 194 YIAPEVLHGTYDEKC------DVWSTGVILYILLSGCPP 226

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 56/268 (20%), Positives = 98/268 (36%), Gaps = 68/268 (25%)

Query: 521 SAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKG--ILGGEEMIVAV 578
           +   +   +P K++ P+ S  ++           ++G G FGSVY G  +       VA+
Sbjct: 25  NDLHATKLAPGKEKEPLESQYQVGP---------LLGSGGFGSVYSGIRVSDNLP--VAI 73

Query: 579 KVINLKQKGAFRSFVA-------ECEALRNIRHR--NLIKIITICSSIDSKGADFKALVF 629
           K +  K + +    +        E   L+ +      +I+++      +   +    L+ 
Sbjct: 74  KHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW---FERPDSFV--LIL 127

Query: 630 EYMEN-GSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLK 686
           E  E    L D++      L  E+ +    Q       V  A+ + H+     ++H D+K
Sbjct: 128 ERPEPVQDLFDFI-TERGALQEELARSFFWQ-------VLEAVRHCHNCG---VLHRDIK 176

Query: 687 PSNVLLDHDMVAHQN-----FSLSHQL-DSASKTPSSSIGIKGTVGYVAPE------YGM 734
             N+L+D +           F     L D+            GT  Y  PE      Y  
Sbjct: 177 DENILIDLN---RGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHRY-H 226

Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTD 762
           G  A     V+S GILL +M  G  P +
Sbjct: 227 GRSA----AVWSLGILLYDMVCGDIPFE 250

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 88.6 bits (220), Expect = 4e-19
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 25/216 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITIC 614
           +G G++G VYKG       + A+KV+++           E   L+    HRN+       
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF 90

Query: 615 SSIDSKGADFKA-LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI---DVASAIE 670
              +  G D +  LV E+   GS+ D +  +  +     L       IA    ++   + 
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEW---IAYICREILRGLS 143

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           +LH H    ++H D+K  NVLL  +  V   +F +S QLD      ++ I   GT  ++A
Sbjct: 144 HLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWMA 197

Query: 730 PEYGMGSEASMTG-----DVYSFGILLLEMFTGRRP 760
           PE     E          D++S GI  +EM  G  P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 90.1 bits (224), Expect = 6e-19
 Identities = 55/218 (25%), Positives = 84/218 (38%), Gaps = 39/218 (17%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           +G G++G V         +  A+K+I        +    + E   L+ + H N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
                        LV E  + G L D +       EV    +I+       V S + YLH
Sbjct: 105 FED-----KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK------QVLSGVTYLH 153

Query: 674 HHCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
            H    IVH DLKP N+LL+         +   +F LS   ++  K         GT  Y
Sbjct: 154 KHN---IVHRDLKPENLLLESKEKDALIKIV--DFGLSAVFENQKKM----KERLGTAYY 204

Query: 728 VAPE-----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +APE     Y          DV+S G++L  +  G  P
Sbjct: 205 IAPEVLRKKYDEKC------DVWSIGVILFILLAGYPP 236

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 52/231 (22%), Positives = 86/231 (37%), Gaps = 60/231 (25%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLIKIIT 612
           +G+G++G V      +  E   VAVK++++K+       +  E    + + H N++K   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA------ 666
                      +  L  EY   G L D +                 + +    A      
Sbjct: 73  H---RREGNIQY--LFLEYCSGGELFDRI--------------EPDIGMPEPDAQRFFHQ 113

Query: 667 --SAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGI 721
             + + YLH      I H D+KP N+LLD      ++  +F L     +     ++   +
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKIS--DFGL-----ATVFRYNNRERL 163

Query: 722 K----GTVGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
                GT+ YVAPE      +          DV+S GI+L  M  G  P D
Sbjct: 164 LNKMCGTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWD 209

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 88.3 bits (219), Expect = 6e-19
 Identities = 55/256 (21%), Positives = 86/256 (33%), Gaps = 65/256 (25%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLIKI 610
           IGQGS+G V   I      I A+K++N  +              E   ++ + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRV----------- 659
             +          +  LV E    G L D L+   D         + +            
Sbjct: 94  YEVYED-----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 660 -----------------------NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD- 695
                                  NI   + SA+ YLH+     I H D+KP N L   + 
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205

Query: 696 ----MVAHQNFSLSHQLDSASKTPSSSIGIK-GTVGYVAPE------YGMGSEASMTGDV 744
                +   +F LS +    +      +  K GT  +VAPE         G +     D 
Sbjct: 206 SFEIKLV--DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC----DA 259

Query: 745 YSFGILLLEMFTGRRP 760
           +S G+LL  +  G  P
Sbjct: 260 WSAGVLLHLLLMGAVP 275

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 50/220 (22%), Positives = 77/220 (35%), Gaps = 27/220 (12%)

Query: 123 CSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWW 182
            S   +   N ++ NL     +++P  L    +   L LS N               L  
Sbjct: 10  ASHLEV---NCDKRNL-----TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG 242
           LNL++  L     +             L  L L  NQ    LP     L +      +  
Sbjct: 60  LNLDRAELTKLQVDG--------TLPVLGTLDLSHNQL-QSLPLLGQTLPAL-TVLDVSF 109

Query: 243 NQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPPS 300
           N+++ ++P G  R L  L  L ++ N+L   +P G+      L++L +  N L   +P  
Sbjct: 110 NRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAG 166

Query: 301 L-GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHN 339
           L   L  L  L L  N+L   IP        L       N
Sbjct: 167 LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 38/178 (21%), Positives = 62/178 (34%), Gaps = 33/178 (18%)

Query: 56  IPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL 115
           +P    L ++   L+++EN         +   + L  + L     +       L     L
Sbjct: 25  LPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLP---VL 79

Query: 116 KELYL----------TFCSLKNLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLSGN 164
             L L             +L  L  L++  N L     +S+P  +L     L+ L L GN
Sbjct: 80  GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRL-----TSLPLGALRGLGELQELYLKGN 134

Query: 165 QFKGKVSID---FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQ 219
           + K   ++     +    L  L+L  NNL    A       LL    +L  L L +N 
Sbjct: 135 ELK---TLPPGLLTPTPKLEKLSLANNNLTELPAG------LLNGLENLDTLLLQENS 183

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 38/161 (23%), Positives = 61/161 (37%), Gaps = 27/161 (16%)

Query: 45  LLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSL 104
           L +  N L      TL     L  LN+   + + +       +  L  + L+ N+   SL
Sbjct: 36  LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVLGTLDLSHNQLQ-SL 92

Query: 105 PFDILVNLPNLKELYL-----------TFCSLKNLWWLNLEQNNLGMGTASSIPDSL-SN 152
           P  +   LP L  L +               L  L  L L+ N L      ++P  L + 
Sbjct: 93  PL-LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL-----KTLPPGLLTP 146

Query: 153 ASNLERLDLSGNQFKGKVSID---FSSLKNLWWLNLEQNNL 190
              LE+L L+ N       +     + L+NL  L L++N+L
Sbjct: 147 TPKLEKLSLANNNLT---ELPAGLLNGLENLDTLLLQENSL 184

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.7 bits (145), Expect = 8e-10
 Identities = 53/224 (23%), Positives = 81/224 (36%), Gaps = 47/224 (20%)

Query: 248 TIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKL 307
            +P  +    +   L +  N L+      +     L QL + R  L   +    G L  L
Sbjct: 24  ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVL 79

Query: 308 ADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVL-SITTLSVYLALAHNLL 366
             L LS N LQ ++P        L   D S N+LT ++P   L  +  L   L L  N L
Sbjct: 80  GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQ-ELYLKGNEL 136

Query: 367 NDSLPLQV-GNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQI 425
             +LP  +      L                               ++L++++NNL+ ++
Sbjct: 137 -KTLPPGLLTPTPKL-------------------------------EKLSLANNNLT-EL 163

Query: 426 PEFL-QNLSFLEFLNLSYNHLEGEVPTKGVFSNK--TKISLQVN 466
           P  L   L  L+ L L  N L   +P KG F +       L  N
Sbjct: 164 PAGLLNGLENLDTLLLQENSLYT-IP-KGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 37/174 (21%), Positives = 54/174 (31%), Gaps = 66/174 (37%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N+L+  +P    +L  L  L + FN LT  LP                          L 
Sbjct: 87  NQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLP-----------------------LGALR 121

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL- 120
            L  L  L +  N+                           +LP  +L   P L++L L 
Sbjct: 122 GLGELQELYLKGNELK-------------------------TLPPGLLTPTPKLEKLSLA 156

Query: 121 ----------TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGN 164
                         L+NL  L L++N+L      +IP     +  L    L GN
Sbjct: 157 NNNLTELPAGLLNGLENLDTLLLQENSL-----YTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 31/133 (23%), Positives = 50/133 (37%), Gaps = 19/133 (14%)

Query: 337 SHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNS 396
               LT A+P  +   TT    L L+ NLL       +  L         L  L++    
Sbjct: 18  DKRNLT-ALPPDLPKDTT---ILHLSENLLYT---FSLATLMPYT----RLTQLNLDRAE 66

Query: 397 FHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVF- 455
              +     G +  +  L++S N L   +P   Q L  L  L++S+N L   +P  G   
Sbjct: 67  LTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL-GALR 121

Query: 456 --SNKTKISLQVN 466
                 ++ L+ N
Sbjct: 122 GLGELQELYLKGN 134

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 39/224 (17%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ---------KGAFRSFVAECEALRNI-RHR 605
           +G+G    V + I        AVK+I++           +    + + E + LR +  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
           N+I++     +       F  LVF+ M+ G L D+L       E   L+  +   I   +
Sbjct: 85  NIIQLKDTYET-----NTFFFLVFDLMKKGELFDYL------TEKVTLSEKETRKIMRAL 133

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTPSSSIGIK 722
              I  LH      IVH DLKP N+LLD D    +   +F  S QLD   K       + 
Sbjct: 134 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLT--DFGFSCQLDPGEKL----REVC 184

Query: 723 GTVGYVAPEYGMGSEASMTG------DVYSFGILLLEMFTGRRP 760
           GT  Y+APE    S            D++S G+++  +  G  P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 87.6 bits (217), Expect = 1e-18
 Identities = 51/263 (19%), Positives = 92/263 (34%), Gaps = 31/263 (11%)

Query: 55  QIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPN 114
           +IP+   L RN + L     +   +          LE I ++ N     +  D+  NLP 
Sbjct: 23  EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 115 LKELYLTFCSLKNLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLSGNQFKGKVSID 173
           L E+ +             + NNL       I  ++  N  NL+ L +S    K    + 
Sbjct: 81  LHEIRI------------EKANNL-----LYINPEAFQNLPNLQYLLISNTGIKHLPDVH 123

Query: 174 FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSS 233
                    L+++ N   + T     FV L         L L  N    E+ +S  N + 
Sbjct: 124 KIHSLQKVLLDIQDNIN-IHTIERNSFVGL---SFESVILWLNKNGI-QEIHNSAFNGTQ 178

Query: 234 TMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNF 292
                    N +   +P+ +       + L I   ++H +   G+  L+ L+    +   
Sbjct: 179 LDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL- 236

Query: 293 LQGSIPPSLGNLTKLADLALSFN 315
                 P+L  L  L + +L++ 
Sbjct: 237 ---KKLPTLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 41/222 (18%), Positives = 73/222 (32%), Gaps = 21/222 (9%)

Query: 126 KNLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLSGNQFKGKVSID-FSSLKNLWWL 183
           +N   L      L       I   + S   +LE++++S N     +  D FS+L  L  +
Sbjct: 30  RNAIELRFVLTKL-----RVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 84

Query: 184 NLEQNNLGMGTANDLDFV--TLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG 241
            +E+ N       +L ++      N  +L+ L + +      LP      S   +   I 
Sbjct: 85  RIEKAN-------NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQ 136

Query: 242 GNQISGTIPSG-IRNL-VNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP 299
            N    TI       L    + L +  N +  I        Q  +      N L+  +P 
Sbjct: 137 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPN 195

Query: 300 -SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNK 340
                 +    L +S   +       L N + L+     + K
Sbjct: 196 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 48/261 (18%), Positives = 84/261 (32%), Gaps = 22/261 (8%)

Query: 216 CDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIP 274
           C      E+P   ++L    I+ R    ++   I  G      +L  + I  N +  +I 
Sbjct: 16  CQESKVTEIP---SDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIE 71

Query: 275 DGV-GELQHLQQLYMFR-NFLQGSIPPS-LGNLTKLADLALSFNNLQGNIPS-SLGNCQN 330
             V   L  L ++ + + N L   I P    NL  L  L +S   ++ ++P     +   
Sbjct: 72  ADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQ 129

Query: 331 LKGFDASHNKLTGAIPQQVLS-ITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEY 389
               D   N     I +     ++  SV L L  N +   +     N   L       E 
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQL------DEL 182

Query: 390 LDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEV 449
               +N+   +             L++S   +       L+NL  L   +        ++
Sbjct: 183 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KL 239

Query: 450 PTKGVFSNKTKISLQVNVKLC 470
           PT        + SL      C
Sbjct: 240 PTLEKLVALMEASLTYPSHCC 260

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 30/215 (13%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G G+FG V+        +   +K IN  + +       AE E L+++ H N+IKI  + 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                       +V E  E G L + +  +    +   L+      +   + +A+ Y H 
Sbjct: 90  ED-----YHNMYIVMETCEGGELLERIVSAQARGK--ALSEGYVAELMKQMMNALAYFHS 142

Query: 675 HCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
                +VH DLKP N+L           +   +F L+    S   + +      GT  Y+
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKII--DFGLAELFKSDEHSTN----AAGTALYM 193

Query: 729 APE---YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           APE     +  +     D++S G+++  + TG  P
Sbjct: 194 APEVFKRDVTFKC----DIWSAGVVMYFLLTGCLP 224

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 53/235 (22%), Positives = 88/235 (37%), Gaps = 59/235 (25%)

Query: 555 MIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVA-------ECEALRNIR-- 603
           ++G+G FG+V+ G  +    +  VA+KVI  + +    S ++       E   L  +   
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQ--VAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAG 94

Query: 604 --HRNLIKIITICSSIDSKGADFKALVFEYMENGS-LEDWLHQSNDHL--EVCKLTLIQR 658
             H  +I+++      +++      LV E       L D++      L     +    Q 
Sbjct: 95  GGHPGVIRLLDW---FETQEGFM--LVLERPLPAQDLFDYI-TEKGPLGEGPSRCFFGQ- 147

Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQL-DSASK 713
                 V +AI++ H      +VH D+K  N+L+D       +   +F     L D    
Sbjct: 148 ------VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI--DFGSGALLHDEPYT 196

Query: 714 TPSSSIGIKGTVGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
                    GT  Y  PE      Y     A     V+S GILL +M  G  P +
Sbjct: 197 DFD------GTRVYSPPEWISRHQY-HALPA----TVWSLGILLYDMVCGDIPFE 240

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 57/206 (27%), Positives = 80/206 (38%), Gaps = 31/206 (15%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+F  V+         + A+K I         S   E   L+ I+H N++ +  I  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
           S          LV + +  G L D +      LE    T      +   V SA++YLH +
Sbjct: 77  S-----TTHYYLVMQLVSGGELFDRI------LERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 676 CQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
               IVH DLKP N+L          M+   +F LS    +   +        GT GYVA
Sbjct: 126 G---IVHRDLKPENLLYLTPEENSKIMIT--DFGLSKMEQNGIMS-----TACGTPGYVA 175

Query: 730 PEYGMGSEASMTGDVYSFG----ILL 751
           PE       S   D +S G    ILL
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILL 201

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 52/231 (22%), Positives = 86/231 (37%), Gaps = 60/231 (25%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLIKIIT 612
           +G+G++G V      +  E   VAVK++++K+       +  E    + + H N++K   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA------ 666
                      +  L  EY   G L D +                 + +    A      
Sbjct: 73  H---RREGNIQY--LFLEYCSGGELFDRI--------------EPDIGMPEPDAQRFFHQ 113

Query: 667 --SAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGI 721
             + + YLH      I H D+KP N+LLD      ++  +F L     +     ++   +
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKIS--DFGL-----ATVFRYNNRERL 163

Query: 722 K----GTVGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
                GT+ YVAPE      +          DV+S GI+L  M  G  P D
Sbjct: 164 LNKMCGTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWD 209

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 52/232 (22%), Positives = 80/232 (34%), Gaps = 28/232 (12%)

Query: 144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGM---GTANDLDF 200
             IPD+L    + + LDLS N  +   S  F S   L  L+L +  +     G    L  
Sbjct: 20  YKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSL-- 75

Query: 201 VTLLTNCSSLKALSLCDNQFGGELPHSI-ANLSSTMIQFRIGGNQISGTIPSGI-RNLVN 258
                  S L  L L  N     L     + LSS   +       ++ ++ +    +L  
Sbjct: 76  -------SHLSTLILTGNPI-QSLALGAFSGLSSLQ-KLVAVETNLA-SLENFPIGHLKT 125

Query: 259 LIALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPP----SLGNLTKLA-DLAL 312
           L  L +  N +           L +L+ L +  N +Q SI       L  +  L   L L
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDL 184

Query: 313 SFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHN 364
           S N +   I         LK      N+L  ++P  +    T    + L  N
Sbjct: 185 SLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 42/220 (19%), Positives = 78/220 (35%), Gaps = 29/220 (13%)

Query: 88  SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL-----------TFCSLKNLWWLNLEQN 136
            S + + L+ N     L      + P L+ L L            + SL +L  L L  N
Sbjct: 28  FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 137 NLGMGTASSIP-DSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTA 195
            +      S+   + S  S+L++L           +     LK L  LN+  N +     
Sbjct: 87  PI-----QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI----- 136

Query: 196 NDLDFVTLLTNCSSLKALSLCDNQFGGELPHSI----ANLSSTMIQFRIGGNQISGTIPS 251
                    +N ++L+ L L  N+    +  +       +    +   +  N ++  I  
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194

Query: 252 GIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRN 291
           G    + L  L ++ NQL  +       L  LQ++++  N
Sbjct: 195 GAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 47/226 (20%), Positives = 83/226 (36%), Gaps = 26/226 (11%)

Query: 229 ANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQL 286
            NL  +     +  N +   + S    +   L  L +   ++   I DG    L HL  L
Sbjct: 24  DNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTL 81

Query: 287 YMFRNFLQGSIPPSL-GNLTKLADLALSFNNLQGNIPSSL-GNCQNLKGFDASHNKLTGA 344
            +  N +Q S+       L+ L  L     NL  ++ +   G+ + LK  + +HN +   
Sbjct: 82  ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 345 IPQQVLSITTLSVYLALAHNLLNDSLPLQV-GNLKNLVITCVSLEYLD------ISSNSF 397
              +  S  T   +L L+ N +  S+       L  + +  +SL  L       I   +F
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSL-DLSLNPMNFIQPGAF 197

Query: 398 HGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYN 443
             +          +KEL + +N L          L+ L+ + L  N
Sbjct: 198 KEI---------RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 46/181 (25%), Positives = 69/181 (38%), Gaps = 26/181 (14%)

Query: 14  SLLNLQTLAIDFNYLTGQLPDFV-GNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVA 72
           SL +L TL +  N +   L       LS+L  L+    +L       +G L+ L  LNVA
Sbjct: 74  SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 73  ENQFS-----GMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKN 127
            N          F     N+++LE + L+ N+   S+    L  L  +  L L+      
Sbjct: 133 HNLIQSFKLPEYFS----NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS------ 181

Query: 128 LWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQ 187
              L+L  N +     + I         L+ L L  NQ K      F  L +L  + L  
Sbjct: 182 ---LDLSLNPM-----NFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 233

Query: 188 N 188
           N
Sbjct: 234 N 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 13/166 (7%)

Query: 296 SIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTL 355
            IP +L   TK  +L LSFN L+     S  +   L+  D S  ++   I        + 
Sbjct: 21  KIPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 356 SVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELN 415
              L L  N +  SL   +G    L     SL+ L     +   +  F +G +K++KELN
Sbjct: 78  LSTLILTGNPIQ-SLA--LGAFSGLS----SLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 416 VSSNNL-SGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTK 460
           V+ N + S ++PE+  NL+ LE L+LS N ++  +          +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC-TDLRVLHQ 174

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 63/234 (26%), Positives = 94/234 (40%), Gaps = 48/234 (20%)

Query: 556 IGQGSFGSVYKGI--LGGEEMIVAVKVINLKQKGAFRSFVA---------ECEALRNIRH 604
           +G G+ G V         ++  VA+++I+ K+K A  S            E E L+ + H
Sbjct: 143 LGSGACGEVKLAFERKTCKK--VAIRIIS-KRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIA 662
             +IKI     + D        +V E ME G L D +   N  L    CKL   Q     
Sbjct: 200 PCIIKIKNFFDAED------YYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQ----- 247

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPS 716
             +  A++YLH +    I+H DLKP NVLL          +   +F  S  L   S    
Sbjct: 248 --MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT--DFGHSKILGETSLMR- 299

Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTG---DVYSFGILLLEMFTGRRPTDAAFTE 767
               + GT  Y+APE  +    +      D +S G++L    +G  P     T+
Sbjct: 300 ---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 87.4 bits (217), Expect = 4e-18
 Identities = 62/220 (28%), Positives = 90/220 (40%), Gaps = 39/220 (17%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
            M+G+GSFG V K      +   AVKVIN          + + E E L+ + H N++K+ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            I        +    +V E    G L D + +     E     +I+       V S I Y
Sbjct: 88  EILED-----SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGITY 136

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
           +H H    IVH DLKP N+LL+         +   +F LS      +K         GT 
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKII--DFGLSTCFQQNTK----MKDRIGTA 187

Query: 726 GYVAPE-----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            Y+APE     Y          DV+S G++L  + +G  P
Sbjct: 188 YYIAPEVLRGTYDEKC------DVWSAGVILYILLSGTPP 221

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 88.0 bits (218), Expect = 4e-18
 Identities = 43/217 (19%), Positives = 85/217 (39%), Gaps = 38/217 (17%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+FG V++          A K +    +    +   E + +  +RH  L+ +     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +++E+M  G L + +   ++      ++  + V     V   + ++H +
Sbjct: 225 D-----DNEMVMIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHEN 274

Query: 676 CQPPIVHGDLKPSNVLLDHD-----MVAHQNFSLSHQLDSASKTPSSSIGIK-GTVGYVA 729
                VH DLKP N++          +   +F L+  LD     P  S+ +  GT  + A
Sbjct: 275 ---NYVHLDLKPENIMFTTKRSNELKLI--DFGLTAHLD-----PKQSVKVTTGTAEFAA 324

Query: 730 PE------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE       G  +      D++S G+L   + +G  P
Sbjct: 325 PEVAEGKPVGYYT------DMWSVGVLSYILLSGLSP 355

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 85.7 bits (213), Expect = 4e-18
 Identities = 58/244 (23%), Positives = 105/244 (43%), Gaps = 38/244 (15%)

Query: 533 KQFPMISYAELSKATSEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL-KQKGAF 589
           KQ+  +      +  S++     IGQG+FG V+K      G+   VA+K + +  +K  F
Sbjct: 3   KQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQ--KVALKKVLMENEKEGF 59

Query: 590 RSF-VAECEALRNIRHRNLIKIITICSSIDSKGADFKA---LVFEYMENGSLEDWLHQSN 645
               + E + L+ ++H N++ +I IC +  S     K    LVF++ E+  L   L    
Sbjct: 60  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL 118

Query: 646 DHLEV--CKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV---AHQ 700
               +   K  +         + + + Y+H +    I+H D+K +NVL+  D V   A  
Sbjct: 119 VKFTLSEIKRVMQM-------LLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA-- 166

Query: 701 NFSLSHQLDSASKTPSSS-----IGIKGTVGYVAPEYGMGSEASMTG-DVYSFGILLLEM 754
           +F L+     A  +  +      +    T+ Y  PE  +G        D++  G ++ EM
Sbjct: 167 DFGLARAFSLAKNSQPNRYTNRVV----TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

Query: 755 FTGR 758
           +T  
Sbjct: 223 WTRS 226

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 84.5 bits (210), Expect = 4e-18
 Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 33/217 (15%)

Query: 554 NMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIK 609
             IG+G++G+V+K       E  IVA+K + L     G   S + E   L+ ++H+N+++
Sbjct: 8   EKIGEGTYGTVFKAKNRETHE--IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC--KLTLIQRVNIAIDVAS 667
           +  +  S          LVFE+ +   L+ +    N  L+    K  L Q       +  
Sbjct: 66  LHDVLHSDKKL-----TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ-------LLK 112

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            + + H      ++H DLKP N+L++ +    +A  NF L+       +  S+ +    T
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLA--NFGLARAFGIPVRCYSAEV---VT 164

Query: 725 VGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGRRP 760
           + Y  P+   G++   T  D++S G +  E+    RP
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 85.0 bits (211), Expect = 5e-18
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 46/217 (21%)

Query: 556 IGQGSFGSVYKGI--LGGEEMIVAVKVIN--------LKQKGAFRSFVAECEALRNIRHR 605
           +G G+ G V         ++  VA+K+I+         ++     +   E E L+ + H 
Sbjct: 18  LGSGACGEVKLAFERKTCKK--VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 606 NLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAI 663
            +IKI       D++      +V E ME G L D +   N  L    CKL   Q      
Sbjct: 76  CIIKIKNF---FDAE---DYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQ------ 122

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSS 717
            +  A++YLH +    I+H DLKP NVLL          +   +F  S  L   S   + 
Sbjct: 123 -MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT--DFGHSKILGETSLMRTL 176

Query: 718 SIGIKGTVGYVAPEYGMGSEASMTG---DVYSFGILL 751
                GT  Y+APE  +    +      D +S G++L
Sbjct: 177 C----GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 84.2 bits (209), Expect = 5e-18
 Identities = 51/216 (23%), Positives = 81/216 (37%), Gaps = 37/216 (17%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GS+G V   +  G  +  A K I          F  E E ++++ H N+I++     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                      LV E    G L + +       E     +++      DV SA+ Y H  
Sbjct: 77  D-----NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCHKL 125

Query: 676 CQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
               + H DLKP N L   D       +   +F L+ +        +      GT  YV+
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLI--DFGLAARFKPGKMMRT----KVGTPYYVS 176

Query: 730 PE-----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           P+     Y  G E     D +S G+++  +  G  P
Sbjct: 177 PQVLEGLY--GPEC----DEWSAGVMMYVLLCGYPP 206

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 86.8 bits (215), Expect = 5e-18
 Identities = 70/230 (30%), Positives = 104/230 (45%), Gaps = 59/230 (25%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVA----ECEALRNIRHRNLIK 609
           +G G+FG V  G   L G +  VAVK++N +QK      V     E + L+  RH ++IK
Sbjct: 24  LGVGTFGKVKVGKHELTGHK--VAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWL--HQSNDHLEVCKLTLIQRVNIAIDVAS 667
           +  +   I +    F  +V EY+  G L D++  +   D  E  +L   Q +       S
Sbjct: 81  LYQV---ISTPSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRL-FQQIL-------S 127

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLS------HQLDSASKTPSSS 718
            ++Y H H    +VH DLKP NVLLD  M   +A  +F LS        L ++  +P+  
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIA--DFGLSNMMSDGEFLRTSCGSPN-- 180

Query: 719 IGIKGTVGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
                   Y APE      Y  G E     D++S G++L  +  G  P D
Sbjct: 181 --------YAAPEVISGRLYA-GPEV----DIWSSGVILYALLCGTLPFD 217

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 84.6 bits (210), Expect = 7e-18
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 23/212 (10%)

Query: 554 NMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKI 610
             +G G++ +VYKG     G    VA+K + L  + G   + + E   ++ ++H N++++
Sbjct: 11  EKLGNGTYATVYKGLNKTTGV--YVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
             +  + +        LVFE+M+N  L+ ++           L L         +   + 
Sbjct: 69  YDVIHTENKL-----TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           + H +    I+H DLKP N+L++      +   +F L+        T SS +    T+ Y
Sbjct: 123 FCHENK---ILHRDLKPQNLLINKRGQLKLG--DFGLARAFGIPVNTFSSEV---VTLWY 174

Query: 728 VAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
            AP+  MGS    T  D++S G +L EM TG+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 84.6 bits (210), Expect = 8e-18
 Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 28/217 (12%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNL 607
            +   + +G+G++ +VYKG     + +VA+K I L+ + GA  + + E   L++++H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC--KLTLIQRVNIAIDV 665
           + +  I  +  S       LVFEY++   L+ +L    + + +   KL L Q +      
Sbjct: 63  VTLHDIIHTEKS-----LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL------ 110

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGIK 722
              + Y H      ++H DLKP N+L++      +A  +F L+      +KT  + +   
Sbjct: 111 -RGLAYCHRQK---VLHRDLKPQNLLINERGELKLA--DFGLARAKSIPTKTYDNEV--- 161

Query: 723 GTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
            T+ Y  P+  +GS    T  D++  G +  EM TGR
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 86.8 bits (215), Expect = 8e-18
 Identities = 57/263 (21%), Positives = 101/263 (38%), Gaps = 28/263 (10%)

Query: 529 SPAKKQFPMISYAELSKATSE-FASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN---LK 584
           S    +F    + E    T   F    ++G+G FG V    +     + A K +    +K
Sbjct: 164 SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223

Query: 585 QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQS 644
           ++      + E + L  +  R    ++++  + ++K A    LV   M  G L+  ++  
Sbjct: 224 KRKGEAMALNEKQILEKVNSRF---VVSLAYAYETKDALC--LVLTLMNGGDLKFHIYHM 278

Query: 645 NDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFS 703
                       + V  A ++   +E LH      IV+ DLKP N+LLD    +   +  
Sbjct: 279 GQA----GFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLG 331

Query: 704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA 763
           L+  +              GTVGY+APE       + + D ++ G LL EM  G+ P   
Sbjct: 332 LAVHVPEGQTIKGRV----GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP--- 384

Query: 764 AFT---EGLTLHEFVKMTLPEKV 783
            F    + +   E  ++      
Sbjct: 385 -FQQRKKKIKREEVERLVKEVPE 406

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 85.5 bits (212), Expect = 9e-18
 Identities = 39/202 (19%), Positives = 78/202 (38%), Gaps = 26/202 (12%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+FG V++ +      +   K IN        +   E   +  + H  LI +     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                      L+ E++  G L D +   +      K++  + +N        ++++H H
Sbjct: 119 D-----KYEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH 168

Query: 676 CQPPIVHGDLKPSNVLLDHD-----MVAHQNFSLSHQLDSASKTPSSSIGIK-GTVGYVA 729
               IVH D+KP N++ +        +   +F L+ +L+     P   + +   T  + A
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKII--DFGLATKLN-----PDEIVKVTTATAEFAA 218

Query: 730 PEYGMGSEASMTGDVYSFGILL 751
           PE           D+++ G+L 
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLG 240

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 86.3 bits (214), Expect = 9e-18
 Identities = 58/266 (21%), Positives = 93/266 (34%), Gaps = 54/266 (20%)

Query: 523 HKSVDTSPAKKQFPMISYAELSKATSEFAS----SNMIGQGSFGSVYKGILGGEEMIVAV 578
           H S   +   +   +     + K   +          +G G++G V            A+
Sbjct: 7   HSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAI 66

Query: 579 KVINLKQ-------------KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK 625
           KVI   Q             +        E   L+++ H N+IK+  +          + 
Sbjct: 67  KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED-----KKYF 121

Query: 626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDL 685
            LV E+ E G L + +   +   E          NI   + S I YLH H    IVH D+
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDEC------DAANIMKQILSGICYLHKHN---IVHRDI 172

Query: 686 KPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE-----YGM 734
           KP N+LL++        +   +F LS             +   GT  Y+APE     Y  
Sbjct: 173 KPENILLENKNSLLNIKIV--DFGLSSFFSK-DYKLRDRL---GTAYYIAPEVLKKKYNE 226

Query: 735 GSEASMTGDVYSFGILLLEMFTGRRP 760
                   DV+S G+++  +  G  P
Sbjct: 227 KC------DVWSCGVIMYILLCGYPP 246

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 34/223 (15%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA-ECEALRNIR-HRNLIKIIT 612
           ++G+G+   V   I        AVK+I  KQ G  RS V  E E L   + HRN++++I 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
                     D   LVFE M  GS+   +H+     E+    ++Q      DVASA+++L
Sbjct: 79  FFEE-----EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ------DVASALDFL 127

Query: 673 HHHCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIK---- 722
           H+     I H DLKP N+L +H        +   +F L   +         S        
Sbjct: 128 HNKG---IAHRDLKPENILCEHPNQVSPVKIC--DFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 723 GTVGYVAPEYGMGSEASMTG-----DVYSFGILLLEMFTGRRP 760
           G+  Y+APE         +      D++S G++L  + +G  P
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 39/218 (17%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           +G+GSFG V K      +   AVKVIN          + + E E L+ + H N++K+  I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
                   +    +V E    G L D + +     E     +I+       V S I Y+H
Sbjct: 90  LED-----SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGITYMH 138

Query: 674 HHCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
            H    IVH DLKP N+LL+         +   +F LS      +K         GT  Y
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKII--DFGLSTCFQQNTKMKD----RIGTAYY 189

Query: 728 VAPE-----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           +APE     Y    +     DV+S G++L  + +G  P
Sbjct: 190 IAPEVLRGTY--DEKC----DVWSAGVILYILLSGTPP 221

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 36/232 (15%)

Query: 516 ARRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFAS----SNMIGQGSFGSVYKGILGG 571
           A++   A      +   +            A  EF       ++IG+G    V + +   
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117

Query: 572 EEMIVAVKVINLKQKGAFRSFVA--------ECEALRNIR-HRNLIKIITICSSIDSKGA 622
                AVK++ +  +      +         E   LR +  H ++I +I    S     +
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-----S 172

Query: 623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVH 682
            F  LVF+ M  G L D+L       E   L+  +  +I   +  A+ +LH +    IVH
Sbjct: 173 SFMFLVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLLEAVSFLHANN---IVH 223

Query: 683 GDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
            DLKP N+LLD +    ++  +F  S  L+   K       + GT GY+APE
Sbjct: 224 RDLKPENILLDDNMQIRLS--DFGFSCHLEPGEKL----RELCGTPGYLAPE 269

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 86.4 bits (214), Expect = 1e-17
 Identities = 66/279 (23%), Positives = 115/279 (41%), Gaps = 19/279 (6%)

Query: 510 CLTIVFARRRRSAHKSVDTSPAKKQFPMISYAELSKATSE-FASSNMIGQGSFGSVYKGI 568
            L  V A   ++  +    S    +F    + E      + F    ++G+G FG V+   
Sbjct: 146 LLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQ 205

Query: 569 LGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK 625
           +     + A K +N   LK++  ++  + E + L  +  R    I+++  + ++K     
Sbjct: 206 MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF---IVSLAYAFETKTDLC- 261

Query: 626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDL 685
            LV   M  G +    H  N   +       + +     + S +E+LH      I++ DL
Sbjct: 262 -LVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDL 315

Query: 686 KPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDV 744
           KP NVLLD D  V   +  L+ +L +         G   T G++APE  +G E   + D 
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG---TPGFMAPELLLGEEYDFSVDY 372

Query: 745 YSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV 783
           ++ G+ L EM   R P   A  E +   E  +  L + V
Sbjct: 373 FALGVTLYEMIAARGPFR-ARGEKVENKELKQRVLEQAV 410

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 30/213 (14%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 608
             + + ++G G FG V+K       + +A K+I  +          E   +  + H NLI
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           ++     + +SK  +   LV EY++ G L D +   +       LT +  +     +   
Sbjct: 150 QLY---DAFESK--NDIVLVMEYVDGGELFDRIIDES-----YNLTELDTILFMKQICEG 199

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHD-----MVAHQNFSLSHQLDSASKTPSSSIGIK- 722
           I ++H      I+H DLKP N+L  +       +   +F L+ +       P   + +  
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKII--DFGLARRYK-----PREKLKVNF 249

Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFG----ILL 751
           GT  ++APE       S   D++S G    +LL
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 44/214 (20%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           +G+G+F  V + +     +  A K+IN K+     F+    E    R ++H N++++   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
                     F  LVF+ +  G L + +     + E      IQ       +  +I Y H
Sbjct: 74  IQE-----ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------QILESIAYCH 122

Query: 674 HHCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
            +    IVH +LKP N+LL          +A  +F L+ +++ +        G  GT GY
Sbjct: 123 SNG---IVHRNLKPENLLLASKAKGAAVKLA--DFGLAIEVNDSEAW----HGFAGTPGY 173

Query: 728 VAPE------YGMGSEASMTGDVYSFG----ILL 751
           ++PE      Y          D+++ G    ILL
Sbjct: 174 LSPEVLKKDPYSK--PV----DIWACGVILYILL 201

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 59/225 (26%), Positives = 82/225 (36%), Gaps = 51/225 (22%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG G+FG        L  E   VAVK I  +      +   E    R++RH N+++   +
Sbjct: 28  IGSGNFGVARLMRDKLTKEL--VAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL---EVCKL--TLIQRVNIAIDVASA 668
              I +      A++ EY   G L + +  +       E       L+          S 
Sbjct: 85  ---ILTP--THLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLL----------SG 128

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH---QNFSLS--HQLDSASKTPSSSIGIKG 723
           + Y H      I H DLK  N LLD          +F  S    L S  K+        G
Sbjct: 129 VSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------G 179

Query: 724 TVGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
           T  Y+APE      Y  G  A    DV+S G+ L  M  G  P +
Sbjct: 180 TPAYIAPEVLLRQEYD-GKIA----DVWSCGVTLYVMLVGAYPFE 219

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 53/230 (23%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVA---------ECEALRNIRH 604
           +G G+FG V+        +E  V VK I  K+K     ++          E   L  + H
Sbjct: 32  LGSGAFGFVWTAVDKEKNKE--VVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88

Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGS-LEDWL--HQSNDHLEVCKLTLIQRVNI 661
            N+IK++ I    +++G     LV E   +G  L  ++  H   D      +   Q    
Sbjct: 89  ANIIKVLDI---FENQGFFQ--LVMEKHGSGLDLFAFIDRHPRLDEPLASYI-FRQ---- 138

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSS 718
              + SA+ YL       I+H D+K  N+++  D    +   +F  +  L+      +  
Sbjct: 139 ---LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLI--DFGSAAYLERGKLFYTFC 190

Query: 719 IGIKGTVGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
               GT+ Y APE      Y  G E     +++S G+ L  +     P  
Sbjct: 191 ----GTIEYCAPEVLMGNPYR-GPEL----EMWSLGVTLYTLVFEENPFC 231

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 51/284 (17%), Positives = 110/284 (38%), Gaps = 33/284 (11%)

Query: 124 SLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID-FSSLKNLWW 182
           +       NL++ ++     +    + +  ++++++  + +  K   S+     L N+  
Sbjct: 22  AFAETIKDNLKKKSV-----TDAV-TQNELNSIDQIIANNSDIK---SVQGIQYLPNVTK 72

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSS--TMIQFRI 240
           L L  N L      D+  +  L N   L  L L +N+        +++L     +    +
Sbjct: 73  LFLNGNKL-----TDIKPLANLKN---LGWLFLDENKV-----KDLSSLKDLKKLKSLSL 119

Query: 241 GGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS 300
             N IS  I +G+ +L  L +L +  N++  I    +  L  L  L +  N +   I P 
Sbjct: 120 EHNGIS-DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DIVP- 173

Query: 301 LGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLA 360
           L  LTKL +L LS N++  ++  +L   +NL   +    +          ++   +    
Sbjct: 174 LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 231

Query: 361 LAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFS 404
              +L+   +    G+ +   +     E+ +  S  F+  +   
Sbjct: 232 TDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIG 275

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 51/295 (17%), Positives = 91/295 (30%), Gaps = 67/295 (22%)

Query: 38  NLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTV 97
             +      ++  S+      T   L ++  +    +            I S++      
Sbjct: 22  AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSD-----------IKSVQG----- 63

Query: 98  NRFSGSLPFDILVNLPNLKELYLT---------FCSLKNLWWLNLEQNNLGMGTASSIPD 148
                      +  LPN+ +L+L            +LKNL WL L++N +       +  
Sbjct: 64  -----------IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKV-----KDL-S 106

Query: 149 SLSNASNLERLDLSGNQFKGKVSID-FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNC 207
           SL +   L+ L L  N       I+    L  L  L L  N +      D+     L+  
Sbjct: 107 SLKDLKKLKSLSLEHNGIS---DINGLVHLPQLESLYLGNNKI-----TDITV---LSRL 155

Query: 208 SSLKALSLCDNQFGGELPHSIANLSS--TMIQFRIGGNQISGTIPSGIRNLVNLIALTIE 265
           + L  LSL DNQ        I  L+    +    +  N IS      +  L NL  L + 
Sbjct: 156 TKLDTLSLEDNQI-----SDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELF 208

Query: 266 VNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGN 320
             +      +    L     +      L    P  + +        + ++  +  
Sbjct: 209 SQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFT 261

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 43/296 (14%), Positives = 91/296 (30%), Gaps = 79/296 (26%)

Query: 150 LSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSS 209
               +   + +L        V+   + L ++  +    +++       +  +  L N   
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDI-----KSVQGIQYLPN--- 69

Query: 210 LKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQL 269
           +  L L  N+        + ++                     + NL NL  L ++ N++
Sbjct: 70  VTKLFLNGNK--------LTDIK-------------------PLANLKNLGWLFLDENKV 102

Query: 270 HGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQ 329
             +    + +L+ L+ L +  N +   I   L +L +L  L L  N +  +I + L    
Sbjct: 103 KDL--SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DI-TVLSRLT 156

Query: 330 NLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEY 389
            L       N+           I+ +                     L  L      L+ 
Sbjct: 157 KLDTLSLEDNQ-----------ISDIV-------------------PLAGLT----KLQN 182

Query: 390 LDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHL 445
           L +S N    +    L  +K++  L + S     +      NL     +  +   L
Sbjct: 183 LYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 44/192 (22%), Positives = 75/192 (39%), Gaps = 28/192 (14%)

Query: 10  EEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGL--LRNLV 67
           + I  L N+  L ++ N LT  +     NL  LG L +  N    ++     L  L+ L 
Sbjct: 62  QGIQYLPNVTKLFLNGNKLT-DIKPL-ANLKNLGWLFLDEN----KVKDLSSLKDLKKLK 115

Query: 68  YLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT------ 121
            L++  N  S +    + ++  LE +YL  N+ +      +L  L  L  L L       
Sbjct: 116 SLSLEHNGISDING--LVHLPQLESLYLGNNKITD---ITVLSRLTKLDTLSLEDNQISD 170

Query: 122 ---FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLK 178
                 L  L  L L +N++     S +  +L+   NL+ L+L   +   K     S+L 
Sbjct: 171 IVPLAGLTKLQNLYLSKNHI-----SDL-RALAGLKNLDVLELFSQECLNKPINHQSNLV 224

Query: 179 NLWWLNLEQNNL 190
               +     +L
Sbjct: 225 VPNTVKNTDGSL 236

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 43/226 (19%)

Query: 542 ELSKATSEFAS----SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECE 597
           +L + + +F         IG GS+    + I     M  AVK+I+  ++        E E
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIE 67

Query: 598 AL-RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
            L R  +H N+I +  +          +  +V E M+ G L D + +          +  
Sbjct: 68  ILLRYGQHPNIITLKDVYDD-----GKYVYVVTELMKGGELLDKILRQK------FFSER 116

Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHQNFSLSHQLDSA 711
           +   +   +   +EYLH      +VH DLKPSN+L      + + +   +F  + QL + 
Sbjct: 117 EASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

Query: 712 SKTPSSSIGIKGTVGYVAPE------YGMGSEASMTGDVYSFGILL 751
           +    +      T  +VAPE      Y          D++S G+LL
Sbjct: 174 NGLLMTPC---YTANFVAPEVLERQGYDA--AC----DIWSLGVLL 210

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 46/217 (21%), Positives = 84/217 (38%), Gaps = 28/217 (12%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           IG+G F  V + I        AVK+++   K      ++      E      ++H ++++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVD-VAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           ++   SS          +VFE+M+   L   + +  D       +     +    +  A+
Sbjct: 91  LLETYSS-----DGMLYMVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEAL 143

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKG 723
            Y H +    I+H D+KP  VLL          +    F ++ QL  +        G  G
Sbjct: 144 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLG--GFGVAIQLGESGLVAG---GRVG 195

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           T  ++APE           DV+  G++L  + +G  P
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 53/246 (21%), Positives = 95/246 (38%), Gaps = 44/246 (17%)

Query: 524 KSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINL 583
            S+       +         +K +  +     +G+G+F  V + +     +  A K+IN 
Sbjct: 5   ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64

Query: 584 KQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWL 641
           K+     F+    E    R ++H N++++             F  LVF+ +  G L + +
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESFHYLVFDLVTGGELFEDI 119

Query: 642 HQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD------ 695
                + E      IQ       +  +I Y H +    IVH +LKP N+LL         
Sbjct: 120 VAREFYSEADASHCIQ------QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAV 170

Query: 696 MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE------YGMGSEASMTGDVYSFG- 748
            +A  +F L+ +++ +        G  GT GY++PE      Y          D+++ G 
Sbjct: 171 KLA--DFGLAIEVNDSEAW----HGFAGTPGYLSPEVLKKDPY--SKPV----DIWACGV 218

Query: 749 ---ILL 751
              ILL
Sbjct: 219 ILYILL 224

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 51/258 (19%), Positives = 96/258 (37%), Gaps = 49/258 (18%)

Query: 517 RRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIV 576
               S  + +   P  K++ +    +LSK         ++G G  G V +          
Sbjct: 6   HHHSSGLEVLFQGPEPKKYAVTDDYQLSK--------QVLGLGVNGKVLECFHRRTGQKC 57

Query: 577 AVKVINLKQKGAFRSFVAECEAL-RNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG 635
           A+K++      A +    E +   +     +++ I+ +  ++         ++ E ME G
Sbjct: 58  ALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDVYENMHHGKRCL-LIIMECMEGG 111

Query: 636 SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 695
            L   + +  D       T  +   I  D+ +AI++LH H    I H D+KP N+L    
Sbjct: 112 ELFSRIQERGDQ----AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSK 164

Query: 696 ------MVAHQNFSLSHQLDSAS-KTPSSSIGIKGTVGYVAPE------YGMGSEASMTG 742
                  +   +F  + +    + +TP        T  YVAPE      Y          
Sbjct: 165 EKDAVLKLT--DFGFAKETTQNALQTPC------YTPYYVAPEVLGPEKYDKSC------ 210

Query: 743 DVYSFGILLLEMFTGRRP 760
           D++S G+++  +  G  P
Sbjct: 211 DMWSLGVIMYILLCGFPP 228

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 82.6 bits (205), Expect = 3e-17
 Identities = 68/249 (27%), Positives = 110/249 (44%), Gaps = 42/249 (16%)

Query: 519 RRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGI-LGGEEMIVA 577
               H S        Q  M  Y +L K          +G+G++G VYK     G   IVA
Sbjct: 2   HHHHHHSSGRENLYFQGLMEKYQKLEK----------VGEGTYGVVYKAKDSQGR--IVA 49

Query: 578 VKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENG 635
           +K I L  +  G   + + E   L+ + H N++ +I +  S          LVFE+ME  
Sbjct: 50  LKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL-----TLVFEFMEK- 103

Query: 636 SLEDWLHQSNDHLEVC--KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD 693
            L+  L ++   L+    K+ L Q       +   + + H H    I+H DLKP N+L++
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQ-------LLRGVAHCHQHR---ILHRDLKPQNLLIN 153

Query: 694 HDM---VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG-DVYSFGI 749
            D    +A  +F L+       ++ +  +    T+ Y AP+  MGS+   T  D++S G 
Sbjct: 154 SDGALKLA--DFGLARAFGIPVRSYTHEV---VTLWYRAPDVLMGSKKYSTSVDIWSIGC 208

Query: 750 LLLEMFTGR 758
           +  EM TG+
Sbjct: 209 IFAEMITGK 217

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 84.7 bits (210), Expect = 3e-17
 Identities = 44/214 (20%), Positives = 84/214 (39%), Gaps = 43/214 (20%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           +G+G+F  V + +        A  +IN K+      +    E    R ++H N++++   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            S           L+F+ +  G L + +      +     +     +    +  A+ + H
Sbjct: 79  ISE-----EGHHYLIFDLVTGGELFEDI------VAREYYSEADASHCIQQILEAVLHCH 127

Query: 674 HHCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
                 +VH +LKP N+LL          +A  +F L+ +++   +      G  GT GY
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLA--DFGLAIEVEGEQQAWF---GFAGTPGY 179

Query: 728 VAPE------YGMGSEASMTGDVYSFG----ILL 751
           ++PE      YG         D+++ G    ILL
Sbjct: 180 LSPEVLRKDPYGKPV------DLWACGVILYILL 207

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 56/256 (21%), Positives = 99/256 (38%), Gaps = 44/256 (17%)

Query: 519 RRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKG--ILGGEEMIV 576
                ++    P             + +   +     +G+G++G VYK    +  E   V
Sbjct: 8   HMGTLEAQTQGPGSMSVSAAPS---ATSIDRYRRITKLGEGTYGEVYKAIDTVTNE--TV 62

Query: 577 AVKVINLKQKG------AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE 630
           A+K I L+ +       A R    E   L+ ++HRN+I++ ++             L+FE
Sbjct: 63  AIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIELKSVIHHNHRL-----HLIFE 113

Query: 631 YMENGSLEDWLHQSND-HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSN 689
           Y EN  L+ ++ ++ D  + V K  L Q       + + + + H       +H DLKP N
Sbjct: 114 YAEN-DLKKYMDKNPDVSMRVIKSFLYQ-------LINGVNFCHSRR---CLHRDLKPQN 162

Query: 690 VLLDHDMVAHQN------FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG- 742
           +LL     +         F L+       +  +  I    T+ Y  PE  +GS    T  
Sbjct: 163 LLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI---ITLWYRPPEILLGSRHYSTSV 219

Query: 743 DVYSFGILLLEMFTGR 758
           D++S   +  EM    
Sbjct: 220 DIWSIACIWAEMLMKT 235

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 82.7 bits (205), Expect = 4e-17
 Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 56/228 (24%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVA----ECEALRNIRHRNLIK 609
           +G+GSFG V         ++  VA+K I+ +Q             E   L+ +RH ++IK
Sbjct: 17  LGEGSFGKVKLATHYKTQQK--VALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIK 73

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +   I +       +V EY   G L D++ +        ++T  +       +  AI
Sbjct: 74  LYDV---ITTPTDIV--MVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAI 121

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLS------HQLDSASKTPSSSIG 720
           EY H H    IVH DLKP N+LLD ++   +A  +F LS      + L ++  +P+    
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIA--DFGLSNIMTDGNFLKTSCGSPN---- 172

Query: 721 IKGTVGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
                 Y APE      Y  G E     DV+S GI+L  M  GR P D
Sbjct: 173 ------YAAPEVINGKLYA-GPEV----DVWSCGIVLYVMLVGRLPFD 209

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 83.6 bits (207), Expect = 4e-17
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 54/225 (24%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII-TIC 614
           IG GSFG VY+  L     +VA+K +   ++   R    E + +R + H N++++     
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 117

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDH---------LEVCKLTLIQRVNIAIDV 665
           SS + K   +  LV +Y+     E  +++   H         +   KL + Q       +
Sbjct: 118 SSGEKKDEVYLNLVLDYVP----ET-VYRVARHYSRAKQTLPVIYVKLYMYQ-------L 165

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQL---D--SASKTPSSSIG 720
             ++ Y+H      I H D+KP N+LLD D         +  L   D  SA +       
Sbjct: 166 FRSLAYIHSFG---ICHRDIKPQNLLLDPD---------TAVLKLCDFGSAKQLVRGEP- 212

Query: 721 IKGTVGYV------APEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
               V Y+      APE   G+ + + + DV+S G +L E+  G+
Sbjct: 213 ---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 81.9 bits (203), Expect = 5e-17
 Identities = 42/218 (19%), Positives = 82/218 (37%), Gaps = 41/218 (18%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G+G FG V++ +    +     K +   +         E   L   RHRN++ +     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASAIEYLHH 674
           S      +   ++FE++    + + ++ S   L E   ++ +        V  A+++LH 
Sbjct: 72  S-----MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH------QVCEALQFLHS 120

Query: 675 HCQPPIVHGDLKPSNVLLDHD-----MVAHQNFSLSHQLDSASKTPSSSIGIK-GTVGYV 728
           H    I H D++P N++          +    F  + QL      P  +  +      Y 
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKII--EFGQARQLK-----PGDNFRLLFTAPEYY 170

Query: 729 APE------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           APE          +      D++S G L+  + +G  P
Sbjct: 171 APEVHQHDVVSTAT------DMWSLGTLVYVLLSGINP 202

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 81.9 bits (203), Expect = 5e-17
 Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 53/226 (23%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKV------INLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G+GSF +V            A+K+      I   +         E + +  + H   +K
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENK---VPYVTRERDVMSRLDHPFFVK 94

Query: 610 IITICSSIDSKGADFKA-----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI--- 661
           +             F+          Y +NG L               L  I+++     
Sbjct: 95  L---------YFT-FQDDEKLYFGLSYAKNGEL---------------LKYIRKIGSFDE 129

Query: 662 ------AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKT 714
                   ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK 
Sbjct: 130 TCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186

Query: 715 PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             ++    GT  YV+PE      A  + D+++ G ++ ++  G  P
Sbjct: 187 ARAN-SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 41/218 (18%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITIC 614
           +G+GSF    K +        AVK+I+ + +   +    E  AL+    H N++K+  + 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                       LV E +  G L + + +     E     +++       + SA+ ++H 
Sbjct: 76  HD-----QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR------KLVSAVSHMHD 124

Query: 675 HCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
                +VH DLKP N+L   +       +   +F  +      ++   +      T+ Y 
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKII--DFGFARLKPPDNQPLKTPC---FTLHYA 176

Query: 729 APE------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           APE      Y          D++S G++L  M +G+ P
Sbjct: 177 APELLNQNGYDESC------DLWSLGVILYTMLSGQVP 208

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 82.2 bits (203), Expect = 1e-16
 Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 18/213 (8%)

Query: 556 IGQGSFGSVYKGI--LGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           +G+G++G VYK     G ++   A+K I  +  G   S   E   LR ++H N+I +  +
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 86

Query: 614 CSSIDSKGADFKALVFEYMEN--GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
                S       L+F+Y E+    +  +   S  + +  +L      ++   +   I Y
Sbjct: 87  ---FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAHQN-----FSLSHQLDSASKTPSSSIGIKGTVG 726
           LH +    ++H DLKP+N+L+  +              +   +S  K  +    +  T  
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200

Query: 727 YVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
           Y APE  +G+       D+++ G +  E+ T  
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.2 bits (199), Expect = 1e-16
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 32/214 (14%)

Query: 554 NMIGQGSFGSVYKGI-LGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKI 610
             IG+G++G VYK     GE    A+K I L+++  G   + + E   L+ ++H N++K+
Sbjct: 8   EKIGEGTYGVVYKAQNNYGE--TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE--VCKLTLIQRVNIAIDVASA 668
             +  +          LVFE+++   L+  L      LE    K  L+Q       + + 
Sbjct: 66  YDVIHTKKRL-----VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ-------LLNG 112

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQLDSASKTPSSSIGIKGTV 725
           I Y H      ++H DLKP N+L++ +    +A  +F L+       +  +  I    T+
Sbjct: 113 IAYCHDRR---VLHRDLKPQNLLINREGELKIA--DFGLARAFGIPVRKYTHEI---VTL 164

Query: 726 GYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
            Y AP+  MGS+   T  D++S G +  EM  G 
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 62/261 (23%), Positives = 103/261 (39%), Gaps = 70/261 (26%)

Query: 523 HKSVDTSPAKKQFP-MISYAELSKATSEFASSNMIGQGSFGSVYKGIL--GGEEMIVAVK 579
              V  S  K      I+Y               IG GSFG V++  L    E   VA+K
Sbjct: 24  VIKVLASDGKTGEQREIAYTNCKV----------IGNGSFGVVFQAKLVESDE---VAIK 70

Query: 580 VINLKQKGAFRSFVAECEALRNIRHRNLIKII-TICSSIDSKGADFKALVFEYMENGSLE 638
            +   ++   R    E + +R ++H N++ +     S+ D K   F  LV EY+     E
Sbjct: 71  KVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----E 122

Query: 639 DWLHQSNDH---------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSN 689
             +++++ H         + + KL + Q       +  ++ Y+H      I H D+KP N
Sbjct: 123 T-VYRASRHYAKLKQTMPMLLIKLYMYQ-------LLRSLAYIHSIG---ICHRDIKPQN 171

Query: 690 VLLDHDMVAHQNFSLSHQL---D--SASKTPSSSIGIKGTVGYV------APEYGMGS-E 737
           +LLD           S  L   D  SA    +     +  V Y+      APE   G+  
Sbjct: 172 LLLDPP---------SGVLKLIDFGSAKILIAG----EPNVSYICSRYYRAPELIFGATN 218

Query: 738 ASMTGDVYSFGILLLEMFTGR 758
            +   D++S G ++ E+  G+
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQ 239

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 54/260 (20%)

Query: 524 KSVDTSPAKKQFPMISYAELSKATSE------FASSNMIGQGSFGSVYKGILGGEEMIVA 577
            ++D  PA  +   +   ++++   +      F+    IG GSFG+VY         +VA
Sbjct: 24  GAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVA 83

Query: 578 VKVINLKQKGA---FRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA----LVFE 630
           +K ++   K +   ++  + E   L+ +RH N I+           G   +     LV E
Sbjct: 84  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR---------GCYLREHTAWLVME 134

Query: 631 YMENGSLEDWLHQSNDHLE------VCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGD 684
           Y   GS  D L      L+      V    L             + YLH H    ++H D
Sbjct: 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGAL-----------QGLAYLHSH---NMIHRD 179

Query: 685 LKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG- 742
           +K  N+LL    +V   +F  +  +  A    +S +   GT  ++APE  +  +      
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIMAPA----NSFV---GTPYWMAPEVILAMDEGQYDG 232

Query: 743 --DVYSFGILLLEMFTGRRP 760
             DV+S GI  +E+   + P
Sbjct: 233 KVDVWSLGITCIELAERKPP 252

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 41/213 (19%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K       +  A K I  +Q  A R  V       E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +  +          L+ E +  G L D+L Q     E    + I+       +   +
Sbjct: 80  LHDVYEN-----RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK------QILDGV 128

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN-----FSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N++L    +   +     F L+H+++   +       I GT
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGT 181

Query: 725 VGYVAPE------YGMGSEASMTGDVYSFGILL 751
             +VAPE       G+ +      D++S G++ 
Sbjct: 182 PEFVAPEIVNYEPLGLEA------DMWSIGVIT 208

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 41/213 (19%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K       +  A K I  +Q  A R  V+      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +  +          L+ E +  G L D+L Q         L+  +  +    +   +
Sbjct: 80  LHDVYEN-----RTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGV 128

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN-----FSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N++L    +   +     F L+H+++   +       I GT
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGT 181

Query: 725 VGYVAPE------YGMGSEASMTGDVYSFGILL 751
             +VAPE       G+ +      D++S G++ 
Sbjct: 182 PEFVAPEIVNYEPLGLEA------DMWSIGVIT 208

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 54/210 (25%), Positives = 83/210 (39%), Gaps = 40/210 (19%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G+G+   VY+    G +   A+KV+        +    E   L  + H N+IK+  I  
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEIF- 117

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
             ++       LV E +  G L D +      +E    +     +    +  A+ YLH +
Sbjct: 118 --ETPTEIS--LVLELVTGGELFDRI------VEKGYYSERDAADAVKQILEAVAYLHEN 167

Query: 676 CQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
               IVH DLKP N+L           +A  +F LS  ++           + GT GY A
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIA--DFGLSKIVEHQVLM----KTVCGTPGYCA 218

Query: 730 PE----YGMGSEASMTGDVYSFG----ILL 751
           PE       G E     D++S G    ILL
Sbjct: 219 PEILRGCAYGPEV----DMWSVGIITYILL 244

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 41/217 (18%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQ------KGAFRSFVAECEALRNIRHRNL 607
           +G+GS+G V K      G   IVA+K            K A R    E + L+ +RH NL
Sbjct: 33  VGEGSYGMVMKCRNKDTGR--IVAIKKFLESDDDKMVKKIAMR----EIKLLKQLRHENL 86

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDV 665
           + ++ +C     K   +  LVFE++++ ++ D L    + L  +V +  L Q       +
Sbjct: 87  VNLLEVCKK---KKRWY--LVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ-------I 133

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV---AHQNFSLSHQLDSASKTPSSSIGIK 722
            + I + H H    I+H D+KP N+L+    V      +F  +  L +  +     +   
Sbjct: 134 INGIGFCHSHN---IIHRDIKPENILVSQSGVVKLC--DFGFARTLAAPGEVYDDEV--- 185

Query: 723 GTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
            T  Y APE  +G        DV++ G L+ EMF G 
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.1 bits (198), Expect = 5e-16
 Identities = 54/229 (23%), Positives = 86/229 (37%), Gaps = 50/229 (21%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +IG+G+F  V    +     + A+K++N   + ++G    F  E + L N   R    I 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR---WIT 124

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID------- 664
            +  +   +   +  LV EY   G L               LTL+ +    I        
Sbjct: 125 QLHFAFQDENYLY--LVMEYYVGGDL---------------LTLLSKFGERIPAEMARFY 167

Query: 665 ---VASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSASKTPSSS 718
              +  AI+ +H       VH D+KP N+LLD   H  +A  +F    +L +     S  
Sbjct: 168 LAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA--DFGSCLKLRADGTVRSLV 222

Query: 719 IGIKGTVGYVAPEYGMGSEASMTGDVY-------SFGILLLEMFTGRRP 760
               GT  Y++PE             Y       + G+   EMF G+ P
Sbjct: 223 AV--GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 39/233 (16%)

Query: 544 SKATSEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINL-KQKGAFRSFVAECEALR 600
           S ATS +     IG G++G+VYK      G    VA+K + +    G           +R
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGH--FVALKSVRVPNGGGGGGGL--PISTVR 60

Query: 601 NI---------RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSND---HL 648
            +          H N+++++ +C++  +       LVFE+++   L  +L ++       
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119

Query: 649 EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFSLS 705
           E  K  + Q           +++LH +C   IVH DLKP N+L+       +A  +F L+
Sbjct: 120 ETIKDLMRQ-------FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA--DFGLA 167

Query: 706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGR 758
                        +    T+ Y APE  + S  +   D++S G +  EMF  +
Sbjct: 168 RIYSYQMALTPVVV----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 79.8 bits (197), Expect = 7e-16
 Identities = 59/382 (15%), Positives = 110/382 (28%), Gaps = 78/382 (20%)

Query: 131 LNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL----KNLWWLNLE 186
            +L+ + +      S+   L    +++ + LSGN    + +   S      K+L      
Sbjct: 9   KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 68

Query: 187 QNNLG----MGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANL---SSTMIQFR 239
               G             +  L  C  L  + L DN FG      + +     + +    
Sbjct: 69  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 128

Query: 240 IGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQG---- 295
           +  N +    P     +   +       +              L+ +   RN L+     
Sbjct: 129 LHNNGLG---PQAGAKIARALQELAVNKKAKN--------APPLRSIICGRNRLENGSMK 177

Query: 296 SIPPSLGNLTKLADLALSFNNL-----QGNIPSSLGNCQNLKGFDASHNKLT--GAIPQQ 348
               +  +   L  + +  N +     +  +   L  CQ LK  D   N  T  G+    
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS--- 234

Query: 349 VLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSF--HGVIPFSLG 406
                      ALA  L +                  +L  L ++       G       
Sbjct: 235 -----------ALAIALKS----------------WPNLRELGLNDCLLSARGAAAVVDA 267

Query: 407 FM----KSIKELNVSSNNLSGQ----IPEFLQ-NLSFLEFLNLSYNHL--EGEVPT--KG 453
           F       ++ L +  N +       +   +   +  L FL L+ N    E +V    + 
Sbjct: 268 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIRE 327

Query: 454 VFSNKTKISLQVNVKLCGGIDE 475
           VFS + +  L     +    DE
Sbjct: 328 VFSTRGRGELDELDDMEELTDE 349

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 47/328 (14%), Positives = 97/328 (29%), Gaps = 59/328 (17%)

Query: 36  VGNLSALGMLLIRWNSLGGQ----IPTTLGLLRNLVYLNVAENQFSGMFPRWIC------ 85
           +   S +    ++ +++  +    +   L    ++  + ++ N       RW+       
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 86  -NISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTAS 144
            ++   EF  +   R    +P         L+ L         L  + L  N  G     
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIP-------EALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 112

Query: 145 SIPDSLSNASNLERLDLSGNQF-------------KGKVSIDFSSLKNLWWLNLEQNNLG 191
            + D LS  + LE L L  N               +  V+    +   L  +   +N L 
Sbjct: 113 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172

Query: 192 MGTANDLDFVTLLTNCSSLKALSLCDNQFGGE-LPHSIANL---SSTMIQFRIGGNQISG 247
            G+  +        +   L  + +  N    E + H +         +    +  N  + 
Sbjct: 173 NGSMKEW--AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230

Query: 248 T----IPSGIRNLVNLIALTIEVNQLHGIIPDGVGEL---------QHLQQLYMFRNFLQ 294
                +   +++  NL  L +    L      G   +           LQ L +  N ++
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLS---ARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287

Query: 295 GSIPPSLG-----NLTKLADLALSFNNL 317
                +L       +  L  L L+ N  
Sbjct: 288 LDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 22/135 (16%), Positives = 42/135 (31%), Gaps = 23/135 (17%)

Query: 109 LVNLPNLKELYLTFCSL----------------KNLWWLNLEQNNLGMGTASSIPDSLSN 152
             +   L  + +    +                + L  L+L+ N      +S++  +L +
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242

Query: 153 ASNLERLDLSGNQFKGKVSIDFSSL------KNLWWLNLEQNNLGMGTANDLDFVTLLTN 206
             NL  L L+      + +              L  L L+ N + +     L  V +   
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV-IDEK 301

Query: 207 CSSLKALSLCDNQFG 221
              L  L L  N+F 
Sbjct: 302 MPDLLFLELNGNRFS 316

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 79.4 bits (196), Expect = 8e-16
 Identities = 42/215 (19%), Positives = 83/215 (38%), Gaps = 19/215 (8%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR--------HRN 606
            +G G F +V+          VA+K++   +     +   E + L+ +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 607 LIKIITICSSIDSKGADFK--ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
              I+ +    + KG +     +VFE +   +L   + +         L  +++  I+  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQ--ISKQ 139

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLS-HQLDSASKTPSSSIGIKG 723
           +   ++Y+H  C   I+H D+KP NVL++          +    L +A            
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGR 758
           T  Y +PE  +G+      D++S   L+ E+ TG 
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 39/242 (16%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 611
            IG+GSFG V        + + A+K +N     ++   R+   E + ++ + H  L+ + 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL- 80

Query: 612 TICSSIDSKGADFKA-----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDV 665
                     + F+      +V + +  G L         HL+       + V +   ++
Sbjct: 81  --------WYS-FQDEEDMFMVVDLLLGGDLRY-------HLQQNVHFKEETVKLFICEL 124

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGT 724
             A++YL +     I+H D+KP N+LLD     H  +F+++  L   ++  + +    GT
Sbjct: 125 VMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA----GT 177

Query: 725 VGYVAPE---YGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE 781
             Y+APE      G+  S   D +S G+   E+  GRRP     +   +  E V      
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHTFETT 235

Query: 782 KV 783
            V
Sbjct: 236 VV 237

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 52/217 (23%), Positives = 88/217 (40%), Gaps = 41/217 (18%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQ------KGAFRSFVAECEALRNIRHRNL 607
           IG+GS+G V+K      G+  IVA+K     +      K A R    E   L+ ++H NL
Sbjct: 11  IGEGSYGVVFKCRNRDTGQ--IVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNL 64

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL--EVCKLTLIQRVNIAIDV 665
           + ++ +      K      LVFEY ++ ++   L +    +   + K    Q        
Sbjct: 65  VNLLEV---FRRKRRLH--LVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ-------T 111

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV---AHQNFSLSHQLDSASKTPSSSIGIK 722
             A+ + H H     +H D+KP N+L+    V      +F  +  L   S      +   
Sbjct: 112 LQAVNFCHKHN---CIHRDVKPENILITKHSVIKLC--DFGFARLLTGPSDYYDDEV--- 163

Query: 723 GTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
            T  Y +PE  +G        DV++ G +  E+ +G 
Sbjct: 164 ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 49/237 (20%)

Query: 544 SKATSEFASSNMIGQGSFGSVYKGI---LGGEEMIVAVKVINLKQKGAFRSFVAECE--- 597
            +A  ++     IG+G++G V+K      GG    VA+K + ++            E   
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGR--FVALKRVRVQT---------GEEGMP 55

Query: 598 --ALRNI---------RHRNLIKIITICSSIDSKGADFKALVFEYMEN--GSLEDWLHQS 644
              +R +          H N++++  +C+   +       LVFE+++    +  D + + 
Sbjct: 56  LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP 115

Query: 645 NDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQN 701
               E  K  + Q       +   +++LH H    +VH DLKP N+L+       +A  +
Sbjct: 116 GVPTETIKDMMFQ-------LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA--D 163

Query: 702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGR 758
           F L+          S  +    T+ Y APE  + S  +   D++S G +  EMF  +
Sbjct: 164 FGLARIYSFQMALTSVVV----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.9 bits (197), Expect = 2e-15
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 23/212 (10%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 611
           +IG+G FG VY         + A+K ++   +K K      + E   L  +   +   I+
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAIE 670
            +  +  +        + + M  G L   L Q     E         +   A ++   +E
Sbjct: 256 CMSYAFHTPDKLS--FILDLMNGGDLHYHLSQHGVFSE-------ADMRFYAAEIILGLE 306

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           ++H+     +V+ DLKP+N+LLD    V   +  L+       K P +S+   GT GY+A
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASV---GTHGYMA 358

Query: 730 PE-YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE    G     + D +S G +L ++  G  P
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 45/217 (20%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K    G     A K I  ++  + R  V+      E   LR IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  I  +          L+ E +  G L D+L +     E      ++       +   +
Sbjct: 73  LHDIFEN-----KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK------QILDGV 121

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN-----FSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N++L    V +       F ++H++++ ++       I GT
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KNIFGT 174

Query: 725 VGYVAPE------YGMGSEASMTGDVYSFG----ILL 751
             +VAPE       G+ +      D++S G    ILL
Sbjct: 175 PEFVAPEIVNYEPLGLEA------DMWSIGVITYILL 205

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 41/213 (19%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +  +          L+ E +  G L D+L +     E      ++       + + +
Sbjct: 79  LHEVYEN-----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLK------QILNGV 127

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN-----FSLSHQLDSASKTPSSSIGIKGT 724
            YLH      I H DLKP N++L    V         F L+H++D  ++  +    I GT
Sbjct: 128 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGT 180

Query: 725 VGYVAPE------YGMGSEASMTGDVYSFGILL 751
             +VAPE       G+ +      D++S G++ 
Sbjct: 181 PEFVAPEIVNYEPLGLEA------DMWSIGVIT 207

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 26/194 (13%), Positives = 68/194 (35%), Gaps = 18/194 (9%)

Query: 255 NLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSF 314
                +   +  +    I      ++  L  + +    +   +   +     + DL ++ 
Sbjct: 21  TFKAYLNGLLGQSSTANITE---AQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75

Query: 315 NNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQV 374
            +   N  + +    NL+        +T      +  +T+L+  L ++H+  +DS+  ++
Sbjct: 76  IHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT-LLDISHSAHDDSILTKI 132

Query: 375 GNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSF 434
             L  +         +D+S N     I   L  +  +K LN+  + +       +++   
Sbjct: 133 NTLPKV-------NSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPK 182

Query: 435 LEFLNLSYNHLEGE 448
           L  L      + G+
Sbjct: 183 LNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.1 bits (180), Expect = 6e-15
 Identities = 37/226 (16%), Positives = 65/226 (28%), Gaps = 48/226 (21%)

Query: 145 SIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLL 204
           +IPDS           L  +      +I  + + +L ++ L   N+      DL  +   
Sbjct: 16  NIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-----TDLTGIEYA 65

Query: 205 TNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTI 264
            N   +K L++ +            N +                    I  L NL  L I
Sbjct: 66  HN---IKDLTINNIH--------ATNYN-------------------PISGLSNLERLRI 95

Query: 265 EVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSS 324
               +       +  L  L  L +  +    SI   +  L K+  + LS+N    +I   
Sbjct: 96  MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MP 154

Query: 325 LGNCQNLKGFDASHNKLTGAIPQQVLSITTLS--VYLALAHNLLND 368
           L     LK  +   + +          I        L      +  
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRG-----IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.3 bits (165), Expect = 7e-13
 Identities = 30/184 (16%), Positives = 69/184 (37%), Gaps = 22/184 (11%)

Query: 264 IEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPS 323
           ++ +Q +  IPD     +      + ++        +   +  L  + L+  N+  ++ +
Sbjct: 8   LKASQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-T 60

Query: 324 SLGNCQNLKGFDASHNKLTGAIPQQVLSITTLS--VYLALAHNLLNDSLPLQVGNLKNLV 381
            +    N+K    ++   T   P     I+ LS    L +    +       +  L +L 
Sbjct: 61  GIEYAHNIKDLTINNIHATNYNP-----ISGLSNLERLRIMGKDVTSDKIPNLSGLTSL- 114

Query: 382 ITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLS 441
                   LDIS ++    I   +  +  +  +++S N     I   L+ L  L+ LN+ 
Sbjct: 115 ------TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQ 167

Query: 442 YNHL 445
           ++ +
Sbjct: 168 FDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 30/173 (17%), Positives = 61/173 (35%), Gaps = 30/173 (17%)

Query: 86  NISSLEFIYLTVNRFSGSLPFDI--LVNLPNLKELYLTFC---------SLKNLWWLNLE 134
            ++SL +I L     +     D+  +    N+K+L +             L NL  L + 
Sbjct: 42  QMNSLTYITLANINVT-----DLTGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIM 96

Query: 135 QNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGT 194
             ++     S    +LS  ++L  LD+S +     +    ++L  +  ++L  N      
Sbjct: 97  GKDVT----SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA---- 148

Query: 195 ANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISG 247
              +  +  L     LK+L++  +         I +    + Q       I G
Sbjct: 149 ---ITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPK-LNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 26/156 (16%), Positives = 48/156 (30%), Gaps = 45/156 (28%)

Query: 10  EEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYL 69
             I  L NL+ L I    +T      +  L++L +L I  ++    I T +  L  +  +
Sbjct: 82  NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141

Query: 70  NVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLW 129
           +++ N         I +I  L+                    LP LK L + F  + +  
Sbjct: 142 DLSYNGA-------ITDIMPLK-------------------TLPELKSLNIQFDGVHDY- 174

Query: 130 WLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ 165
                               + +   L +L      
Sbjct: 175 ------------------RGIEDFPKLNQLYAFSQT 192

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 47.6 bits (114), Expect = 4e-06
 Identities = 26/151 (17%), Positives = 56/151 (37%), Gaps = 18/151 (11%)

Query: 320 NIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKN 379
           NIP S    +         +        Q+ S+T ++    LA+  + D   ++     N
Sbjct: 16  NIPDS--TFKAYLNGLLGQSSTANITEAQMNSLTYIT----LANINVTDLTGIE--YAHN 67

Query: 380 LVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLN 439
           +       + L I++       P S   + +++ L +   +++      L  L+ L  L+
Sbjct: 68  I-------KDLTINNIHATNYNPISG--LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118

Query: 440 LSYNHLEGEVPTK-GVFSNKTKISLQVNVKL 469
           +S++  +  + TK         I L  N  +
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 17/120 (14%), Positives = 34/120 (28%), Gaps = 28/120 (23%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
              +       +  L +L  L I  +     +   +  L  +  + + +N     I   L
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPL 155

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
             L  L  LN+  +         + +   +E                   + P L +LY 
Sbjct: 156 KTLPELKSLNIQFDG--------VHDYRGIE-------------------DFPKLNQLYA 188

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 55/238 (23%), Positives = 91/238 (38%), Gaps = 50/238 (21%)

Query: 544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR 603
            K    F    M GQG+FG+V  G      M VA+K +    +   R  +   + L  + 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77

Query: 604 HRNLIKIITICSSIDSKGAD--FKALVFEYMENGSLEDWLHQSNDH---------LEVCK 652
           H N++++ +   ++  +     +  +V EY+     +  LH+   +           + K
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DT-LHRCCRNYYRRQVAPPPILIK 132

Query: 653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQL---D 709
           + L Q       +  +I  LH      + H D+KP NVL++              L   D
Sbjct: 133 VFLFQ-------LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEA---------DGTLKLCD 175

Query: 710 --SASKTPSSSIGIKGTVGYV------APEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
             SA K   S       V Y+      APE   G++   T  D++S G +  EM  G 
Sbjct: 176 FGSAKKLSPSEP----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 40/204 (19%), Positives = 80/204 (39%), Gaps = 25/204 (12%)

Query: 242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL 301
              I+   P     L N +   +    +  ++     EL  +Q      + +Q S+   +
Sbjct: 6   PTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-M 59

Query: 302 GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL 361
              T L +L LS N +  ++ S L +   L+    + N+L          ++ L     L
Sbjct: 60  QFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLF----L 113

Query: 362 AHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNL 421
            +N L D       +L +L     +LE L I +N    ++   LGF+  ++ L++  N +
Sbjct: 114 DNNELRD-----TDSLIHL----KNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEI 162

Query: 422 SGQIPEFLQNLSFLEFLNLSYNHL 445
           +      L  L  + +++L+    
Sbjct: 163 TN--TGGLTRLKKVNWIDLTGQKC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 43/259 (16%), Positives = 86/259 (33%), Gaps = 44/259 (16%)

Query: 74  NQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFC---------S 124
              + +FP     +++     L     +  +       L  ++                 
Sbjct: 7   TPINQVFP--DPGLANAVKQNLGKQSVTDLVSQK---ELSGVQNFNGDNSNIQSLAGMQF 61

Query: 125 LKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLN 184
             NL  L+L  N +     S +   L + + LE L ++ N+ K   +++      L  L 
Sbjct: 62  FTNLKELHLSHNQI-----SDL-SPLKDLTKLEELSVNRNRLK---NLNGIPSACLSRLF 112

Query: 185 LEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLS--STMIQFRIGG 242
           L+ N L      D D    L +  +L+ LS+ +N+       SI  L   S +    + G
Sbjct: 113 LDNNEL-----RDTDS---LIHLKNLEILSIRNNKL-----KSIVMLGFLSKLEVLDLHG 159

Query: 243 NQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS-L 301
           N+I+     G+  L  +  + +   +    + + V     L      ++     I P  +
Sbjct: 160 NEITN--TGGLTRLKKVNWIDLTGQK---CVNEPVKYQPELYITNTVKDPDGRWISPYYI 214

Query: 302 GNLTKLADLALSFNNLQGN 320
            N     D  + +      
Sbjct: 215 SNGGSYVDGCVLWELPVYT 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 34/185 (18%), Positives = 74/185 (40%), Gaps = 33/185 (17%)

Query: 267 NQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLG 326
             ++ + PD    L +  +  + +  +  +   S   L+ + +     +N+Q ++ + + 
Sbjct: 7   TPINQVFPDP--GLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQ 60

Query: 327 NCQNLKGFDASHNKLTGAIPQQVLSITTLS-----VYLALAHNLLNDSLPLQVGNLKNLV 381
              NLK    SHN+++         ++ L        L++  N L +     +  + +  
Sbjct: 61  FFTNLKELHLSHNQIS--------DLSPLKDLTKLEELSVNRNRLKN-----LNGIPSA- 106

Query: 382 ITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLS 441
                L  L + +N         L  +K+++ L++ +N L   I   L  LS LE L+L 
Sbjct: 107 ----CLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLH 158

Query: 442 YNHLE 446
            N + 
Sbjct: 159 GNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 43/260 (16%), Positives = 93/260 (35%), Gaps = 44/260 (16%)

Query: 196 NDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLS--STMIQFRIGGNQISGTIPSGI 253
             ++ V      ++    +L            + +    S +  F    + I  ++ +G+
Sbjct: 7   TPINQVFPDPGLANAVKQNLGKQSV-----TDLVSQKELSGVQNFNGDNSNIQ-SL-AGM 59

Query: 254 RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALS 313
           +   NL  L +  NQ+  +    + +L  L++L + RN L+ ++         L+ L L 
Sbjct: 60  QFFTNLKELHLSHNQISDL--SPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLD 114

Query: 314 FNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLS-----VYLALAHNLLND 368
            N L+     SL + +NL+     +NKL         SI  L        L L  N + +
Sbjct: 115 NNELRD--TDSLIHLKNLEILSIRNNKLK--------SIVMLGFLSKLEVLDLHGNEITN 164

Query: 369 SLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQI--P 426
           +  L    LK        + ++D++       +   + +   +   N +  +  G+   P
Sbjct: 165 TGGLT--RLKK-------VNWIDLTGQK---CVNEPVKYQPELYITN-TVKDPDGRWISP 211

Query: 427 EFLQNLSFLEFLNLSYNHLE 446
            ++ N        + +    
Sbjct: 212 YYISNGGSYVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 35/195 (17%), Positives = 67/195 (34%), Gaps = 36/195 (18%)

Query: 10  EEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIP--TTLGLLRNLV 67
                L  +Q    D + +       +   + L  L +  N    QI   + L  L  L 
Sbjct: 35  VSQKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSHN----QISDLSPLKDLTKLE 88

Query: 68  YLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDI--LVNLPNLKELYLTFC-- 123
            L+V  N+        + N++ +    L+      +   D   L++L NL+ L +     
Sbjct: 89  ELSVNRNR--------LKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKL 140

Query: 124 -------SLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS 176
                   L  L  L+L  N +     ++    L+    +  +DL+G +    V+     
Sbjct: 141 KSIVMLGFLSKLEVLDLHGNEI-----TNT-GGLTRLKKVNWIDLTGQKC---VNEPVKY 191

Query: 177 LKNLWWLNLEQNNLG 191
              L+  N  ++  G
Sbjct: 192 QPELYITNTVKDPDG 206

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 76.8 bits (190), Expect = 4e-15
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 44/234 (18%)

Query: 542 ELSKATSEFASSNMIGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKG---------AFR 590
           ++      +   + +G+G F +VYK       +  IVA+K I L  +          A R
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQ--IVAIKKIKLGHRSEAKDGINRTALR 61

Query: 591 SFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE- 649
               E + L+ + H N+I ++       +      +LVF++ME   LE  +  ++  L  
Sbjct: 62  ----EIKLLQELSHPNIIGLLDAFGHKSNI-----SLVFDFMET-DLEVIIKDNSLVLTP 111

Query: 650 -VCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV---AHQNFSLS 705
              K  ++            +EYLH H    I+H DLKP+N+LLD + V   A  +F L+
Sbjct: 112 SHIKAYMLM-------TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA--DFGLA 159

Query: 706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
               S ++  +  +    T  Y APE   G+     G D+++ G +L E+    
Sbjct: 160 KSFGSPNRAYTHQV---VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 46/220 (20%), Positives = 82/220 (37%), Gaps = 42/220 (19%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITIC 614
           +G G  G V +      +   A+K++      A R    E E      +  ++++I+ + 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            ++ +       +V E ++ G L   +    D       T  +   I   +  AI+YLH 
Sbjct: 125 ENLYAGRKCL-LIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHS 179

Query: 675 HCQPPIVHGDLKPSNVLLDHD------MVAHQNFSLSHQLDSAS--KTPSSSIGIKGTVG 726
                I H D+KP N+L           +   +F  + +  S +   TP        T  
Sbjct: 180 IN---IAHRDVKPENLLYTSKRPNAILKLT--DFGFAKETTSHNSLTTPC------YTPY 228

Query: 727 YVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           YVAPE      Y          D++S G+++  +  G  P
Sbjct: 229 YVAPEVLGPEKYDKSC------DMWSLGVIMYILLCGYPP 262

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 49/230 (21%), Positives = 88/230 (38%), Gaps = 57/230 (24%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS----FVAECEALRNIRHRNLIKI 610
           +IG+G+FG V          + A+K+++ K +   RS    F  E + +       ++++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 611 ITICSSIDSKGADFKA-----LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
                      A F+      +V EYM  G L               + L+   ++    
Sbjct: 135 ---------FYA-FQDDRYLYMVMEYMPGGDL---------------VNLMSNYDVPEKW 169

Query: 666 A--------SAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSASKT 714
           A         A++ +H       +H D+KP N+LLD   H  +A  +F    +++     
Sbjct: 170 ARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA--DFGTCMKMNKEGMV 224

Query: 715 PSSSIGIKGTVGYVAPE--YGMGSEASMTGDV--YSFGILLLEMFTGRRP 760
              +    GT  Y++PE     G +     +   +S G+ L EM  G  P
Sbjct: 225 RCDTAV--GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 52/211 (24%), Positives = 84/211 (39%), Gaps = 22/211 (10%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           ++G+G+FG V            A+K++    +  K      + E   L+N RH  L  + 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAIE 670
               S  +        V EY   G L   L +     E        R      ++ SA++
Sbjct: 215 ---YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSE-------DRARFYGAEIVSALD 262

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           YLH      +V+ DLK  N++LD D  +   +F L  +      T  +     GT  Y+A
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLA 317

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE    ++     D +  G+++ EM  GR P
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 74.8 bits (184), Expect = 3e-14
 Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 48/234 (20%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRH 604
            +F    +IG+G+FG V    L   + + A+K++N   + ++     F  E + L N   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID 664
           +    I T+  +       +  LV +Y   G L               LTL+ +    + 
Sbjct: 134 K---WITTLHYAFQDDNNLY--LVMDYYVGGDL---------------LTLLSKFEDRLP 173

Query: 665 ----------VASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHQNFSLSHQLDSA 711
                     +  AI+ +H       VH D+KP N+L+D   H  +A  +F    +L   
Sbjct: 174 EEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA--DFGSCLKLMED 228

Query: 712 SKTPSSSIGIKGTVGYVAPEYGMGSEASMTG-----DVYSFGILLLEMFTGRRP 760
               SS     GT  Y++PE     E          D +S G+ + EM  G  P
Sbjct: 229 GTVQSSVAV--GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 72.7 bits (179), Expect = 7e-14
 Identities = 43/218 (19%), Positives = 78/218 (35%), Gaps = 35/218 (16%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHR-NLIKIIT 612
           +G+G F  V + I        A K +  +++G       + E   L   +    +I +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +  +          L+ EY   G +               ++    + +   +   + YL
Sbjct: 97  VYEN-----TSEIILILEYAAGGEIFSLCLPELAE----MVSENDVIRLIKQILEGVYYL 147

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAHQ----NFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           H +    IVH DLKP N+LL            +F +S ++  A +       I GT  Y+
Sbjct: 148 HQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR----EIMGTPEYL 200

Query: 729 APE------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           APE          +      D+++ GI+   + T   P
Sbjct: 201 APEILNYDPITTAT------DMWNIGIIAYMLLTHTSP 232

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 72.7 bits (179), Expect = 9e-14
 Identities = 49/227 (21%), Positives = 88/227 (38%), Gaps = 44/227 (19%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFV----AECEALRNIR 603
            +F     +G GSFG V            A+K+++ KQK      +     E   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVN 99

Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-- 661
              L+K+    S  D+       +V EY+  G +                + ++R+    
Sbjct: 100 FPFLVKLE--FSFKDN---SNLYMVMEYVAGGEM---------------FSHLRRIGRFS 139

Query: 662 -------AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASK 713
                  A  +    EYLH      +++ DLKP N+L+D    +   +F  + ++   + 
Sbjct: 140 EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196

Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           T      + GT   +APE  +    +   D ++ G+L+ EM  G  P
Sbjct: 197 T------LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 51/228 (22%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN-----LKQKGAFRSFVAECEALRNIRHRNLIKI 610
           +G+G++G V          IVA+K I      L      R    E + L++ +H N+I I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74

Query: 611 ITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------SNDHLEVCKLTLIQRVNI 661
             I      +  +F    ++ E M+     D LH+       S+DH    +  + Q    
Sbjct: 75  FNIQRPDSFE--NFNEVYIIQELMQ----TD-LHRVISTQMLSDDH---IQYFIYQ---- 120

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQLDSASKTPSSS 718
                 A++ LH      ++H DLKPSN+L++ +    V   +F L+  +D ++   S  
Sbjct: 121 ---TLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVC--DFGLARIIDESAADNSEP 172

Query: 719 IGIKGTV-GYV------APEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
            G +  +  +V      APE  + S   S   DV+S G +L E+F  R
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 45/221 (20%), Positives = 86/221 (38%), Gaps = 50/221 (22%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINL-KQKGAFRSFVAECEALRNIR-HRNLIKIITI 613
           +G+G +  V++ I       V VK++   K+K   R    E + L N+R   N+I +  I
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQ-SNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
                S+     ALVFE++ N   +      ++      +  + +       +  A++Y 
Sbjct: 100 VKDPVSRT---PALVFEHVNNTDFKQLYQTLTDYD---IRFYMYE-------ILKALDYC 146

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDM------------VAHQNFSLSHQLDSASKTPSSSIG 720
           H      I+H D+KP NV++DH+               H     + ++            
Sbjct: 147 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV------------ 191

Query: 721 IKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRP 760
              +  +  PE  +  +    + D++S G +L  M   + P
Sbjct: 192 --ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.9 bits (178), Expect = 2e-13
 Identities = 39/214 (18%), Positives = 68/214 (31%), Gaps = 33/214 (15%)

Query: 8   IPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLV 67
           +  E+ S   LQ L  +  +    +   +  L  L            +       L+ + 
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEK--------ETLQYFSTLKAVD 415

Query: 68  YLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKN 127
            +  A         R    + +        +     L    L  L +L+        L  
Sbjct: 416 PMRAAYLDD----LRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLE-------QLLL 464

Query: 128 LWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID-FSSLKNLWWLNLE 186
           +  L+L  N L      ++P +L+    LE L  S N  +   ++D  ++L  L  L L 
Sbjct: 465 VTHLDLSHNRL-----RALPPALAALRCLEVLQASDNALE---NVDGVANLPRLQELLLC 516

Query: 187 QNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQF 220
            N L          +  L +C  L  L+L  N  
Sbjct: 517 NNRL-----QQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 66.7 bits (162), Expect = 2e-11
 Identities = 53/407 (13%), Positives = 120/407 (29%), Gaps = 91/407 (22%)

Query: 60  LGLLRNLVYLNVAENQFSGMFPRWICNISSLE----FIYLTVNRFSGSLPFDILVNLPNL 115
           L L++N  + +   +Q +  + RW+   +        ++++      S+ F   + + + 
Sbjct: 212 LELVQNAFFTD-PNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSR 270

Query: 116 KELYLTFC----------------SLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERL 159
               L                      ++W  +L   +L           +   S+ ++ 
Sbjct: 271 MGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKE 330

Query: 160 DLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQ 219
            +           D ++ + L+   L      +         + L +C  L+ L   +  
Sbjct: 331 CVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQ-------SELESCKELQELEPENKW 383

Query: 220 FGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTI--------EVNQLHG 271
               +   +  L                     ++    L A+            ++   
Sbjct: 384 CLLTIILLMRAL------------DPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431

Query: 272 IIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNL 331
                  E   ++ L++    L  ++   L  L  +  L LS N L+  +P +L   + L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCL 488

Query: 332 KGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLD 391
           +   AS N L                           ++      + NL      L+ L 
Sbjct: 489 EVLQASDNALE--------------------------NVD----GVANLP----RLQELL 514

Query: 392 ISSN---SFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFL 435
           + +N       + P  L     +  LN+  N+L  Q     + L+ +
Sbjct: 515 LCNNRLQQSAAIQP--LVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 60.5 bits (146), Expect = 1e-09
 Identities = 34/197 (17%), Positives = 66/197 (33%), Gaps = 17/197 (8%)

Query: 250 PSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLAD 309
                    L    + V +   ++   +   + LQ+L     +   +I   +  L  L  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 310 LALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDS 369
              +      +   ++   +     D     L                 L LAH  L   
Sbjct: 401 EKETLQYF--STLKAVDPMRAAYLDDLRSKFLLENSVL--KMEYADVRVLHLAHKDLTV- 455

Query: 370 LPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFL 429
               + +L+ L+     + +LD+S N     +P +L  ++ ++ L  S N L   +   +
Sbjct: 456 ----LCHLEQLL----LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-V 504

Query: 430 QNLSFLEFLNLSYNHLE 446
            NL  L+ L L  N L+
Sbjct: 505 ANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 54.4 bits (130), Expect = 1e-07
 Identities = 28/181 (15%), Positives = 52/181 (28%), Gaps = 17/181 (9%)

Query: 279 ELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASH 338
                Q+  +                 +L    LS       + S L +C+ L+  +  +
Sbjct: 323 TGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPEN 381

Query: 339 NKLTGAIPQQVLSITTLSVYLALAHNLLN----DSLPL---------QVGNLKNLVITCV 385
                 I   + ++  L                D +            +     L +   
Sbjct: 382 KWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYA 441

Query: 386 SLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHL 445
            +  L ++      +    L  +  +  L++S N L   +P  L  L  LE L  S N L
Sbjct: 442 DVRVLHLAHKDLTVLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 498

Query: 446 E 446
           E
Sbjct: 499 E 499

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 73.3 bits (179), Expect = 2e-13
 Identities = 105/642 (16%), Positives = 200/642 (31%), Gaps = 175/642 (27%)

Query: 80  FPRWICNISSLEFIYLTVNRFSGS-LPFDILVNLPNLKELYLTFC--SL-KNLWWL---- 131
            P+ I +   ++ I ++ +  SG+   F  L++    +E+   F    L  N  +L    
Sbjct: 41  MPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ--EEMVQKFVEEVLRINYKFLMSPI 98

Query: 132 NLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF-KGKVSI--DFSSLKNLWWLNLEQN 188
             EQ    M T   I          +RL      F K  VS    +  L+    L L   
Sbjct: 99  KTEQRQPSMMTRMYI-------EQRDRLYNDNQVFAKYNVSRLQPYLKLRQ-ALLELRPA 150

Query: 189 NL----GMGTANDLDFVTLLTNC--SSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG 242
                 G+                 + +        +   ++   I  L+       +  
Sbjct: 151 KNVLIDGVL------------GSGKTWVALDVCLSYKVQCKMDFKIFWLN-------LKN 191

Query: 243 NQISGTIPSGIRNLVNLIALTIEVNQLHGI-IPDGVGELQ-HLQQLYMFRNFLQGSIPPS 300
                T+   ++ L+  I         H   I   +  +Q  L++L   + +        
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-----ENC 246

Query: 301 LGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITT--LSVY 358
           L        L L   N+Q        N +    F+         +  ++L +TT    V 
Sbjct: 247 L--------LVLL--NVQ--------NAKAWNAFN---------LSCKIL-LTTRFKQVT 278

Query: 359 LALA-----HNLLND-SLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLG-FMKSI 411
             L+     H  L+  S+ L    +K+L++  +     D+         P  L    +SI
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR-EVLTTNPRRLSIIAESI 337

Query: 412 KE--------LNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISL 463
           ++         +V+ + L+  I   L  L   E+  + ++ L        VF     I  
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM-FDRL-------SVFPPSAHIPT 389

Query: 464 QVNVKLCGG---------IDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSSCLTIV 514
            +   +            +++LH  S   K  ++  +++           + L   + + 
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS---------IYLELKVKL- 439

Query: 515 FARRRRSAHKS-VDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEE 573
                 + H+S VD            Y         F S ++I        Y  I  G  
Sbjct: 440 --ENEYALHRSIVD-----------HY----NIPKTFDSDDLIPPYLDQYFYSHI--GHH 480

Query: 574 MIVAVKVINLKQKGA-FR------SFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA 626
           +    K I   ++   FR       F+      + IRH +         SI +     K 
Sbjct: 481 L----KNIEHPERMTLFRMVFLDFRFLE-----QKIRHDSTA--WNASGSILNTLQQLKF 529

Query: 627 ---------LVFEYMENGSLEDWLHQSNDHLEVCKLT-LIQR 658
                      +E + N ++ D+L +  ++L   K T L++ 
Sbjct: 530 YKPYICDNDPKYERLVN-AILDFLPKIEENLICSKYTDLLRI 570

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.7 bits (128), Expect = 2e-07
 Identities = 67/468 (14%), Positives = 144/468 (30%), Gaps = 126/468 (26%)

Query: 425 IPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSCPSK 484
           +  F     F++  N     ++     K + S +              ID  H++     
Sbjct: 22  LSVFEDA--FVD--NFDCKDVQDM--PKSILSKEE-------------ID--HIIMSKDA 60

Query: 485 GSRKPKL--TLL----KVLIPVVVSCL------ILS---------SCLTIVFARRRRSAH 523
            S   +L  TLL    +++   V   L      ++S         S +T ++  +R   +
Sbjct: 61  VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120

Query: 524 KSVDTSPAKKQFPMIS-YAELSKATSEFASSNMI---GQGSFGSVYKGILGGEEMIVAVK 579
                   K     +  Y +L +A  E   +  +   G    G   K  +  +       
Sbjct: 121 NDNQVFA-KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWVALD----VCL 172

Query: 580 VINLKQKGAFRSF---VAECEALRNIRHRNLIKII-TICSSIDSKGADFKALVFEYMENG 635
              ++ K  F+ F   +  C          +++++  +   ID    ++ +   ++  N 
Sbjct: 173 SYKVQCKMDFKIFWLNLKNCN-----SPETVLEMLQKLLYQIDP---NWTSRS-DHSSNI 223

Query: 636 SLEDWLHQSNDHLEVCKLTLIQRVNIAI----DVASA--IEYLHHHCQPPIVHGDLKPSN 689
            L   +H     L   +L   +     +    +V +A      +  C+  +     + ++
Sbjct: 224 KLR--IHSIQAELR--RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279

Query: 690 VLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA------PEYGMGSEASMTGD 743
            L         + SL H   + +     S+ +K    Y+       P      E   T  
Sbjct: 280 FL---SAATTTHISLDHHSMTLTPDEVKSLLLK----YLDCRPQDLPR-----EVLTTNP 327

Query: 744 VYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQ 803
                   L +         +  +GL   +  K    +K+  I++ SL       N +  
Sbjct: 328 ------RRLSIIA------ESIRDGLATWDNWKHVNCDKLTTIIESSL-------NVLEP 368

Query: 804 EDRRARTQDCLNAITR------TGVLCSM--ESPFERMEMRDVVAKLC 843
            + R        ++        T +L  +  +      ++  VV KL 
Sbjct: 369 AEYRKMFDRL--SVFPPSAHIPTILLSLIWFDVIKS--DVMVVVNKLH 412

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 71.0 bits (175), Expect = 2e-13
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 29/215 (13%)

Query: 555 MIGQGSFGSVY---KGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLI 608
           ++GQGSFG V+   K        + A+KV+    LK +   R+   E + L  + H  ++
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIV 89

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVAS 667
           K+     +  ++G  +  L+ +++  G L          L    +   + V     ++A 
Sbjct: 90  KLH---YAFQTEGKLY--LILDFLRGGDL---FT----RLSKEVMFTEEDVKFYLAELAL 137

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLS-HQLDSASKTPSSSIGIKGTV 725
           A+++LH      I++ DLKP N+LLD +  +   +F LS   +D   K  S      GTV
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS----FCGTV 190

Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            Y+APE       + + D +SFG+L+ EM TG  P
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 46/220 (20%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLIK 609
           IG G+ G V        E  VA+K ++         K A+R    E   ++ + H+N+I 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88

Query: 610 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ--SNDHLEVCKLTLIQRVNIAIDV 665
           ++ + +   S   +F+   +V E M+  +L   +     ++        L Q       +
Sbjct: 89  LLNVFTPQKSLE-EFQDVYIVMELMDA-NLCQVIQMELDHER---MSYLLYQ-------M 136

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
              I++LH      I+H DLKPSN+++  D  +   +F L+    ++             
Sbjct: 137 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT--------- 184

Query: 725 VGYV------APEYGMGSEASMTGDVYSFGILLLEMFTGR 758
             YV      APE  +G       D++S G ++ EM  G 
Sbjct: 185 -PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.0 bits (174), Expect = 6e-13
 Identities = 53/295 (17%), Positives = 101/295 (34%), Gaps = 60/295 (20%)

Query: 516 ARRRRSAHKSVDTSPAKKQFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMI 575
           +  ++   +      +K    M       +    +   ++IG GS+G V +     E+ +
Sbjct: 21  SGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRV 80

Query: 576 VAVKVINLKQ------KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA--L 627
           VA+K I          K   R    E   L  + H +++K++ I    D +   F    +
Sbjct: 81  VAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVE--KFDELYV 134

Query: 628 VFEYMENGSLEDWLHQ---SNDHLEV--CKLTLIQRVNIAIDVASAIEYLHHHCQPPIVH 682
           V E  ++    D   +   +  +L     K  L         +   ++Y+H      I+H
Sbjct: 135 VLEIADS----D-FKKLFRTPVYLTELHIKTLLYN-------LLVGVKYVHSA---GILH 179

Query: 683 GDLKPSNVLLD-------------------HDMVAHQNFSLSHQLDSASKTPSSSIGIKG 723
            DLKP+N L++                    +  +    S      +    P +    + 
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQ 239

Query: 724 TVGYV------APEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL 771
             G+V      APE  +  E  +   DV+S G +  E+    +   A   +   L
Sbjct: 240 LTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPL 294

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 27/193 (13%)

Query: 131 LNLEQNNLGMGTASSIPDS-LSNASNLERLDLSGNQFKGKVSID---FSSLKNLWWLNLE 186
           L+L+ N L     SS+P       + L  L L+ N+ +   ++    F  LKNL  L + 
Sbjct: 42  LDLQSNKL-----SSLPSKAFHRLTKLRLLYLNDNKLQ---TLPAGIFKELKNLETLWVT 93

Query: 187 QNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSI-ANLSSTMIQFRIGGNQI 245
            N L    A  +     L N   L  L L  NQ    LP  +  +L+  +    +G N++
Sbjct: 94  DNKL---QALPIGVFDQLVN---LAELRLDRNQLK-SLPPRVFDSLTK-LTYLSLGYNEL 145

Query: 246 SGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPP-SLG 302
             ++P G+   L +L  L +  NQL  + P+G   +L  L+ L +  N L+  +P  +  
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQLKRV-PEGAFDKLTELKTLKLDNNQLK-RVPEGAFD 202

Query: 303 NLTKLADLALSFN 315
           +L KL  L L  N
Sbjct: 203 SLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 50/197 (25%), Positives = 76/197 (38%), Gaps = 28/197 (14%)

Query: 8   IPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLV 67
           IP  I +  + + L +  N L+         L+ L +L +  N L          L+NL 
Sbjct: 31  IPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88

Query: 68  YLNVAENQF----SGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL--- 120
            L V +N+      G+F      + +L  + L  N+   SLP  +  +L  L  L L   
Sbjct: 89  TLWVTDNKLQALPIGVFD----QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN 143

Query: 121 --------TFCSLKNLWWLNLEQNNLGMGTASSIPDSL-SNASNLERLDLSGNQFKGKVS 171
                    F  L +L  L L  N L       +P+      + L+ L L  NQ K    
Sbjct: 144 ELQSLPKGVFDKLTSLKELRLYNNQL-----KRVPEGAFDKLTELKTLKLDNNQLKRVPE 198

Query: 172 IDFSSLKNLWWLNLEQN 188
             F SL+ L  L L++N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 20/201 (9%)

Query: 248 TIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSL-GNLTK 306
            IPS I    +   L ++ N+L  +       L  L+ LY+  N LQ ++P  +   L  
Sbjct: 30  AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 307 LADLALSFNNLQ---GNIPSSLGNCQNLKGFDASHNKLTGAIPQQVL-SITTLSVYLALA 362
           L  L ++ N LQ     +   L N   L       N+L  ++P +V  S+T L+ YL+L 
Sbjct: 87  LETLWVTDNKLQALPIGVFDQLVNLAEL---RLDRNQLK-SLPPRVFDSLTKLT-YLSLG 141

Query: 363 HNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLS 422
           +N L  SLP   G    L     SL+ L + +N    V   +   +  +K L + +N L 
Sbjct: 142 YNEL-QSLP--KGVFDKL----TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194

Query: 423 GQIPEFLQNLSFLEFLNLSYN 443
                   +L  L+ L L  N
Sbjct: 195 RVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 57/189 (30%), Positives = 76/189 (40%), Gaps = 28/189 (14%)

Query: 283 LQQLYMFRNFLQGSIPPS-LGNLTKLADLALSFNNLQ---GNIPSSLGNCQNLKGFDASH 338
            ++L +  N L  S+P      LTKL  L L+ N LQ     I   L    NL+    + 
Sbjct: 39  TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK---NLETLWVTD 94

Query: 339 NKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSF- 397
           NKL  A+P  V         L L  N L  SLP       +L      L YL +  N   
Sbjct: 95  NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLP--PRVFDSL----TKLTYLSLGYNELQ 146

Query: 398 ---HGVIPF-SLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKG 453
               GV  F  L    S+KEL + +N L          L+ L+ L L  N L+  VP +G
Sbjct: 147 SLPKGV--FDKLT---SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVP-EG 199

Query: 454 VFSNKTKIS 462
            F +  K+ 
Sbjct: 200 AFDSLEKLK 208

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 70.1 bits (172), Expect = 7e-13
 Identities = 67/366 (18%), Positives = 115/366 (31%), Gaps = 77/366 (21%)

Query: 126 KNLWWLNLEQNNLGMGTASSIPDSL-SNASNLERLDLSGNQFKGKVSIDFSSL-----KN 179
             +  L+L  NNL   +   +  +  +  +++  L+LSGN    K S +   +      N
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81

Query: 180 LWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE----LPHSIANLSSTM 235
           +  LNL  N L   ++++L   TL     ++  L L  N F  +       + +NL +++
Sbjct: 82  VTSLNLSGNFLSYKSSDEL-VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASI 140

Query: 236 IQFRIGGNQISGTIPSGIRNL--------VNLIALTIEVNQLHGIIPDGVGEL------- 280
               + GN +          L         N+ +L +  N L         EL       
Sbjct: 141 TSLNLRGNDLG---IKSSDELIQILAAIPANVNSLNLRGNNLA---SKNCAELAKFLASI 194

Query: 281 -QHLQQLYMFRNFLQGSIPPSLG-----NLTKLADLALSFNNLQGNIPSSLGNCQNLKGF 334
              +  L +  N L       L          +  L L  N L G       + +NLK  
Sbjct: 195 PASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP------SLENLKLL 248

Query: 335 DASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISS 394
             S   L                 + L ++++ +    Q   L         +  +D + 
Sbjct: 249 KDSLKHLQ---------------TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNG 293

Query: 395 NSFH--GVIPFSLGFMKSIKELN--VSSNNLSGQIPEF----------LQNLSFLEFLNL 440
              H    IP S      I+EL+      +L  Q   F          L     L     
Sbjct: 294 KEIHPSHSIPIS----NLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQ 349

Query: 441 SYNHLE 446
           +   L 
Sbjct: 350 TCKPLL 355

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 45/356 (12%), Positives = 100/356 (28%), Gaps = 70/356 (19%)

Query: 203 LLTNCSSLKALSLCDNQFGGELPHSIA----NLSSTMIQFRIGGNQISGTIPSGIRNL-- 256
             +    + +L L  N         +     N  +++    + GN +          L  
Sbjct: 17  FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG---FKNSDELVQ 73

Query: 257 ------VNLIALTIEVNQLHGIIPDGVGEL--------QHLQQLYMFRNFLQGSIPPSLG 302
                  N+ +L +  N L         EL          +  L +  N           
Sbjct: 74  ILAAIPANVTSLNLSGNFLS---YKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFK 130

Query: 303 NL-----TKLADLALSFNNLQGN----IPSSLGNCQ-NLKGFDASHNKLT--------GA 344
                    +  L L  N+L       +   L     N+   +   N L           
Sbjct: 131 QAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKF 190

Query: 345 IPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGV---- 400
           +     S+T+L     L+ NLL      ++  +         +  L++  N  HG     
Sbjct: 191 LASIPASVTSLD----LSANLLGLKSYAELAYI--FSSIPNHVVSLNLCLNCLHGPSLEN 244

Query: 401 IPFSLGFMKSIKELNVSSNNLSGQ-------IPEFLQNLSFLEFLNLSYNHLEGEVPTKG 453
           +      +K ++ + +  + +          +     N+  +  ++ +   +        
Sbjct: 245 LKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSH---- 300

Query: 454 VFSNKTKISLQVNVKLCGGIDELHLLSCPSKGSRKPKLTLLKVLIPVVVSCLILSS 509
                +     +  +L G  D   LL+     ++K +  +  + IP  +   I + 
Sbjct: 301 -----SIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTC 351

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 23/167 (13%), Positives = 52/167 (31%), Gaps = 18/167 (10%)

Query: 65  NLVYLNVAENQFSGMFPRWIC-----NISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY 119
           ++  L+++ N         +        + +  + L +N   G        +L NLK L 
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP-------SLENLKLLK 249

Query: 120 LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL-- 177
            +   L+ ++       N+      ++  +  N   +  +D +G +     SI  S+L  
Sbjct: 250 DSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIR 309

Query: 178 ---KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFG 221
                    +L    L     +  + +  L     L+          
Sbjct: 310 ELSGKADVPSLLNQCLIFAQKHQTN-IEDLNIPDELRESIQTCKPLL 355

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 49/261 (18%), Positives = 89/261 (34%), Gaps = 67/261 (25%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-----HRNLIK 609
            +G G F +V+       +  VA+KV+   +     + + E   L+++R       N   
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102

Query: 610 IITICSS--IDSKGADFKALVFEYMENG-SLEDWLHQSND---HLEVCKLTLIQRVNIAI 663
           ++ +     I         +VFE +  G  L  W+ +SN     L   K  + Q      
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQ------ 154

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQNFSLSHQLDSASKTPSSSIGIK 722
            V   ++YLH  C+  I+H D+KP N+LL   +    +  + + +   +   P S   + 
Sbjct: 155 -VLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 723 G-------------------------------------------TVGYVAPEYGMGSEAS 739
                                                       T  Y + E  +GS  +
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYN 271

Query: 740 MTGDVYSFGILLLEMFTGRRP 760
              D++S   +  E+ TG   
Sbjct: 272 TPADIWSTACMAFELATGDYL 292

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.7 bits (169), Expect = 1e-12
 Identities = 58/235 (24%), Positives = 94/235 (40%), Gaps = 60/235 (25%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKV------INLKQKGAFRSFV----AECE 597
            +F     +G GSFG V+           A+KV      + LKQ       V     E  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-------VEHTNDERL 58

Query: 598 ALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQ 657
            L  + H  +I++    +  D+       ++ +Y+E G L                +L++
Sbjct: 59  MLSIVTHPFIIRMW--GTFQDA---QQIFMIMDYIEGGEL---------------FSLLR 98

Query: 658 RVNI---------AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLS 705
           +            A +V  A+EYLH      I++ DLKP N+LLD +    +   +F  +
Sbjct: 99  KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT--DFGFA 153

Query: 706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +   + T      + GT  Y+APE       + + D +SFGIL+ EM  G  P
Sbjct: 154 KYVPDVTYT------LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 46/257 (17%), Positives = 88/257 (34%), Gaps = 86/257 (33%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G GSFG V +          A+K +    +   R    E + ++ + H N+IK++    
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70

Query: 616 SIDSKGADFKA---------------------------------LVFEYMENGSLEDWLH 642
           +   +                                       ++ EY+     +  LH
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP----DT-LH 125

Query: 643 QSNDH---------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD 693
           +             + +  + + Q       +  A+ ++H      I H D+KP N+L++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQ-------LFRAVGFIHSL---GICHRDIKPQNLLVN 175

Query: 694 HDMVAHQNFSLSHQL---D--SASKTPSSSIGIKGTVGYV------APEYGMGSEASMTG 742
                    S  + L   D  SA K   S    + +V Y+      APE  +G+      
Sbjct: 176 ---------SKDNTLKLCDFGSAKKLIPS----EPSVAYICSRFYRAPELMLGATEYTPS 222

Query: 743 -DVYSFGILLLEMFTGR 758
            D++S G +  E+  G+
Sbjct: 223 IDLWSIGCVFGELILGK 239

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 45/231 (19%), Positives = 92/231 (39%), Gaps = 39/231 (16%)

Query: 556 IGQGSFGSVYKGILGGEEMI-----VAVKVIN-----LKQKGAFRSFVAECEALRNIRHR 605
           IGQG FG +Y   +   E +       VKV       L  +  F    A+ E ++     
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 606 NLIKIITICS-----SIDSKGADFKALVFEYMENG-SLEDWLHQSNDHLEVCKLTLIQRV 659
             +K + +         D  G  ++ ++ +    G  L+  ++++N      + +    +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANAK----RFSRKTVL 155

Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN------FSLSHQ-LDSAS 712
            +++ +   +EY+H H     VHGD+K SN+LL++    + +      + L+++      
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK---NPDQVYLVDYGLAYRYCPEGV 209

Query: 713 KTP---SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                        GT+ + + +   G   S  GD+   G  +++  TG  P
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 67.8 bits (166), Expect = 4e-12
 Identities = 45/229 (19%), Positives = 87/229 (37%), Gaps = 38/229 (16%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA--------FRSFVAECEALRNIRHRNL 607
           IG G FG +Y      +    A  V+ ++ +          F   VA+ + ++    R  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 608 IKIITI-----CSSIDSKGADFKALVFEYMENG-SLEDWLHQSNDHLEVCKLTLIQRVNI 661
           +  + I         + KG  ++ +V E +  G  L+    Q+              + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG------TFKKSTVLQL 156

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN------FSLSHQ-LDSASKT 714
            I +   +EY+H +     VHGD+K +N+LL      + +      + LS++   + +  
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLG---YKNPDQVYLADYGLSYRYCPNGNHK 210

Query: 715 P---SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
               +   G  GT+ + + +   G   S   DV   G  +L    G+ P
Sbjct: 211 QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 67.2 bits (165), Expect = 4e-12
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 23/211 (10%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIKII 611
           ++G+G+FG V            A+K++    +  K      V E   L+N RH  L  + 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVASAIE 670
               +  +        V EY   G L         HL   ++   +R      ++ SA+E
Sbjct: 72  ---YAFQTHDRLC--FVMEYANGGEL---FF----HLSRERVFTEERARFYGAEIVSALE 119

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           YLH      +V+ D+K  N++LD D  +   +F L  +  S   T  +     GT  Y+A
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLA 173

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE    ++     D +  G+++ EM  GR P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.5 bits (167), Expect = 5e-12
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 22/211 (10%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEAL-RNIRHRNLIKI 610
           ++G+GSFG V      G + + AVK++    + Q       + E   L    +   L ++
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
               S   +    +   V EY+  G L   + Q        +      V  A ++A  + 
Sbjct: 408 H---SCFQTMDRLY--FVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLF 456

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           +L       I++ DLK  NV+LD +  +   +F +  +      T  +     GT  Y+A
Sbjct: 457 FLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT---FCGTPDYIA 510

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE         + D ++FG+LL EM  G+ P
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 57/176 (32%), Positives = 81/176 (46%), Gaps = 20/176 (11%)

Query: 144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL 203
           S IP      ++ E+LDL            F  L  L WLNL+ N L   +A   D +T 
Sbjct: 31  SGIP------ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE 84

Query: 204 LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIAL 262
           L        L L +NQ    LP  + +  + + +  +GGNQ+  ++PSG+   L  L  L
Sbjct: 85  LGT------LGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKEL 136

Query: 263 TIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNN 316
            +  NQL   IP G   +L +LQ L +  N LQ S+P  +   L KL  + L F N
Sbjct: 137 RLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITL-FGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 46/163 (28%), Positives = 63/163 (38%), Gaps = 32/163 (19%)

Query: 45  LLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFS----GMFPRWICNISSLEFIYLTVNRF 100
           L ++   L      T   L  L +LN+  NQ      G+F      ++ L  + L  N+ 
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD----LTELGTLGLANNQL 95

Query: 101 SGSLPFDILVNLPNLKELYLT-----------FCSLKNLWWLNLEQNNLGMGTASSIP-- 147
           + SLP  +  +L  L +LYL            F  L  L  L L  N L      SIP  
Sbjct: 96  A-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL-----QSIPAG 149

Query: 148 --DSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQN 188
             D L   +NL+ L LS NQ +      F  L  L  + L  N
Sbjct: 150 AFDKL---TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.0 bits (112), Expect = 9e-06
 Identities = 45/171 (26%), Positives = 61/171 (35%), Gaps = 44/171 (25%)

Query: 56  IPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL 115
           IP     L     L       + +       ++ L ++ L  N+   +L   +       
Sbjct: 33  IPADTEKL----DLQS--TGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGV------- 78

Query: 116 KELYLTFCSLKNLWWLNLEQNNLGMGTASSIP----DSLSNASNLERLDLSGNQFKGKVS 171
                 F  L  L  L L  N L     +S+P    D L   + L++L L GNQ K   S
Sbjct: 79  ------FDDLTELGTLGLANNQL-----ASLPLGVFDHL---TQLDKLYLGGNQLK---S 121

Query: 172 ID---FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQ 219
           +    F  L  L  L L  N L    A   D    LTN   L+ LSL  NQ
Sbjct: 122 LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDK---LTN---LQTLSLSTNQ 166

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 66.9 bits (164), Expect = 7e-12
 Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 57/225 (25%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G++GSV   I       VA+K ++      +  K A+R    E   L++++H N+I 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87

Query: 610 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ------SNDHLEVCKLTLIQRVNI 661
           ++ + +   S   +F    LV  +M+     D L +      S +     +  + Q    
Sbjct: 88  LLDVFTP-ASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEK---IQYLVYQ---- 134

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
              +   ++Y+H      +VH DLKP N+ ++ D  +   +F L+   D+   T      
Sbjct: 135 ---MLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-EMT------ 181

Query: 721 IKGTVGYV------APEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                GYV      APE  +     + T D++S G ++ EM TG+
Sbjct: 182 -----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 67.6 bits (165), Expect = 8e-12
 Identities = 48/229 (20%), Positives = 91/229 (39%), Gaps = 46/229 (20%)

Query: 547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN------LKQKGAFRSFVAECEALR 600
              + +   IG G+ G V        +  VA+K ++         K A+R    E   ++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 116

Query: 601 NIRHRNLIKIITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ--SNDHLEVCKLTLI 656
            + H+N+I ++ + +   +   +F+   LV E M+  +L   +     ++        L 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLE-EFQDVYLVMELMDA-NLCQVIQMELDHER---MSYLLY 171

Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTP 715
           Q       +   I++LH      I+H DLKPSN+++  D  +   +F L+    ++    
Sbjct: 172 Q-------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221

Query: 716 SSSIGIKGTVGYV------APEYGMGSEASMTGDVYSFGILLLEMFTGR 758
                      YV      APE  +G       D++S G ++ EM   +
Sbjct: 222 ----------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.4 bits (161), Expect = 8e-12
 Identities = 41/248 (16%), Positives = 76/248 (30%), Gaps = 48/248 (19%)

Query: 546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVI--------NLKQKGAFRSFVAECE 597
            T +      IG+G FG V++ I       VA+K+I        N   +  F   + E  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 598 ALR---NIRHRNLIKIITICSSIDS---KGADFKALVFEYM----ENGSLEDWLHQSNDH 647
             +    +      +             +G+    L+  +       GS  D      D 
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 648 -----LEVC------------KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV 690
                LE                +L    +I   + +++       +    H DL   NV
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193

Query: 691 LLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGIL 750
           LL    +   +++L      +S  PS  + +         +Y +         V+    +
Sbjct: 194 LLKKTSLKKLHYTL---NGKSSTIPSCGLQVSII------DYTLSRLERDGIVVFCDVSM 244

Query: 751 LLEMFTGR 758
             ++FTG 
Sbjct: 245 DEDLFTGD 252

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 67.1 bits (164), Expect = 1e-11
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 23/210 (10%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR---NLIKII 611
           +IG+GSFG V K         VA+K++  +++   R    E   L ++R +   N + +I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR-FHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVASAIE 670
            +  +   +      + FE +   +L + + ++         L L+++   A  +   ++
Sbjct: 163 HMLENFTFRN--HICMTFELLSM-NLYELIKKNKFQGFS---LPLVRK--FAHSILQCLD 214

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLD--SASKTPSSSIGIKGTVGYV 728
            LH +    I+H DLKP N+LL       Q  S    +D  S+            +  Y 
Sbjct: 215 ALHKNR---IIHCDLKPENILL-----KQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR 266

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGR 758
           APE  +G+   M  D++S G +L E+ TG 
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY 296

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 45/261 (17%), Positives = 89/261 (34%), Gaps = 25/261 (9%)

Query: 205 TNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI--RNLVNLIAL 262
            NC     +  C  Q    +P    +L S      +  N +S  + +      L NL +L
Sbjct: 14  ANCLCASNILSCSKQQLPNVP---QSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSL 69

Query: 263 TIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNNLQGNI 321
            +  N L+ I  +    + +L+ L +  N L  ++      +L  L  L L  N++   +
Sbjct: 70  LLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VV 127

Query: 322 PS-SLGNCQNLKGFDASHNKLTGAIPQQVL----SITTLSVYLALAHNLLNDSLPLQVGN 376
              +  +   L+    S N+++   P +++     +  L   L L+ N L       +  
Sbjct: 128 DRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLM-LLDLSSNKLKKLPLTDLQK 185

Query: 377 LKNLVITCVSLEYLDISSNSFH---GVIPFSLGFM-KSIKELNVSSNNLSGQIPEFLQNL 432
           L            L + +N       +      +  + +  +     +L     + L N+
Sbjct: 186 LPAW-----VKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKKLHNI 240

Query: 433 SFLEFLNLSYNHLEGEVPTKG 453
             L+F N S           G
Sbjct: 241 FSLDFFNCSEYKESAWEAHLG 261

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 33/143 (23%), Positives = 50/143 (34%), Gaps = 22/143 (15%)

Query: 63  LRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL-- 120
           L NL  L ++ N  + +       + +L ++ L+ N    +L   +  +L  L+ L L  
Sbjct: 63  LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYN 121

Query: 121 ---------TFCSLKNLWWLNLEQNNLGMGTASSIP----DSLSNASNLERLDLSGNQFK 167
                     F  +  L  L L QN +     S  P       +    L  LDLS N+ K
Sbjct: 122 NHIVVVDRNAFEDMAQLQKLYLSQNQI-----SRFPVELIKDGNKLPKLMLLDLSSNKLK 176

Query: 168 GKVSIDFSSLKNLWWLNLE-QNN 189
                D   L       L   NN
Sbjct: 177 KLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 38/195 (19%), Positives = 61/195 (31%), Gaps = 49/195 (25%)

Query: 131 LNLEQNNLGMGTASSIP--DSLSNASNLERLDLSGNQFKGKVSID---FSSLKNLWWLNL 185
           L+L  NNL     S +    + +  +NL  L LS N       I    F  + NL +L+L
Sbjct: 44  LDLSHNNL-----SRLRAEWTPTRLTNLHSLLLSHNHLN---FISSEAFVPVPNLRYLDL 95

Query: 186 EQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQI 245
             N+L               +  +L+ L L +N                 I         
Sbjct: 96  SSNHLHTLDEFLFS------DLQALEVLLLYNNH----------------IV-------- 125

Query: 246 SGTIPSGI-RNLVNLIALTIEVNQLHGIIPD---GVGELQHLQQLYMFRNFLQGSIPPSL 301
              +      ++  L  L +  NQ+     +      +L  L  L +  N L+      L
Sbjct: 126 --VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL 183

Query: 302 GNLTKLADLALSFNN 316
             L       L  +N
Sbjct: 184 QKLPAWVKNGLYLHN 198

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 40/219 (18%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLIKI 610
           IG+G++G V        ++ VA+K I+  +     +   R    E + L   RH N+I I
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90

Query: 611 ITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------SNDHLEVCKLTLIQRVNI 661
             I  +   +    K   +V + ME     D L++       SNDH       L Q    
Sbjct: 91  NDIIRAPTIE--QMKDVYIVQDLME----TD-LYKLLKTQHLSNDH---ICYFLYQ---- 136

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIG 720
              +   ++Y+H      ++H DLKPSN+LL+    +   +F L+   D           
Sbjct: 137 ---ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190

Query: 721 IKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
              T  Y APE  + S+  + + D++S G +L EM + R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 65.6 bits (161), Expect = 2e-11
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 29/216 (13%)

Query: 555 MIGQGSFGSVY---KGILGGEEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNL 607
           ++G+G +G V+   K        I A+KV+     ++         AE   L  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVA 666
           + +I    +  + G  +  L+ EY+  G L   L +    +E               +++
Sbjct: 84  VDLI---YAFQTGGKLY--LILEYLSGGELFMQLEREGIFME-------DTACFYLAEIS 131

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSSIGIKGT 724
            A+ +LH      I++ DLKP N++L+H   V   +F L  + +   + T +      GT
Sbjct: 132 MALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT----FCGT 184

Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           + Y+APE  M S  +   D +S G L+ +M TG  P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.7 bits (161), Expect = 2e-11
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 22/211 (10%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEAL-RNIRHRNLIKI 610
           M+G+GSFG V+           A+K +    +         + E   L     H  L  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
                +  +K   F   V EY+  G L   +   +      K  L +    A ++   ++
Sbjct: 84  F---CTFQTKENLF--FVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQ 132

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
           +LH      IV+ DLK  N+LLD D  +   +F +  +        ++     GT  Y+A
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT---FCGTPDYIA 186

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE  +G + + + D +SFG+LL EM  G+ P
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 48/226 (21%), Positives = 90/226 (39%), Gaps = 45/226 (19%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLIKII 611
           +G G  G V+  +    +  VA+K I L      K A R    E + +R + H N++K+ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74

Query: 612 TI-------CSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------SNDHLEVCKLTL 655
            I        +       +  +  +V EYME     D L           +H    +L +
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMET----D-LANVLEQGPLLEEH---ARLFM 126

Query: 656 IQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD--MVAHQNFSLSHQLDSASK 713
            Q       +   ++Y+H      ++H DLKP+N+ ++ +  ++   +F L+  +D    
Sbjct: 127 YQ-------LLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
                     T  Y +P   +     +   D+++ G +  EM TG+
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 55/236 (23%), Positives = 91/236 (38%), Gaps = 55/236 (23%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHR-----NLI 608
            +G G+FG V        +   AVKV+  +    +  S   E + L+ I++      N++
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 609 KIIT-------ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           K          +C            L+FE +   SL + +   N++     +  I+    
Sbjct: 100 KYHGKFMYYDHMC------------LIFEPLGP-SLYEII-TRNNYNGF-HIEDIKL--Y 142

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS--SSI 719
            I++  A+ YL       + H DLKP N+LLD         ++    D          S 
Sbjct: 143 CIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 720 GIK----G--------------TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTG 757
           GIK    G              T  Y APE  +     ++ D++SFG +L E++TG
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 36/209 (17%), Positives = 65/209 (31%), Gaps = 24/209 (11%)

Query: 154 SNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNN----LGMGTANDLDFVTLLTNCSS 209
            + + L L     +   S  FS+L N+  + +  +     L   +  +L         S 
Sbjct: 31  PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNL---------SK 81

Query: 210 LKALSLCDNQFGGELPHSI-ANLSSTMIQFRIGGNQISGTIP--SGIRNLVNLIALTIEV 266
           +  + + + +    +       L   +    I    +    P  + + +      L I  
Sbjct: 82  VTHIEIRNTRNLTYIDPDALKELPL-LKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITD 139

Query: 267 NQLHGIIPDGV--GELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSS 324
           N     IP     G       L ++ N    S+     N TKL  + L+ N     I   
Sbjct: 140 NPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKD 198

Query: 325 L--GNCQNLKGFDASHNKLTGAIPQQVLS 351
              G        D S   +T A+P + L 
Sbjct: 199 AFGGVYSGPSLLDVSQTSVT-ALPSKGLE 226

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 39/229 (17%), Positives = 74/229 (32%), Gaps = 26/229 (11%)

Query: 238 FRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSI 297
           FR+    I   IPS      +   L +    L  I       L ++ ++Y+  +     +
Sbjct: 16  FRVTCKDIQ-RIPSL---PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQL 71

Query: 298 PP-SLGNLTKLADLALSFNNLQGNIPSS-LGNCQNLKGFDASHNKLTGAIPQQV-LSITT 354
              S  NL+K+  + +        I    L     LK     +  L    P    +  T 
Sbjct: 72  ESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTD 130

Query: 355 LSVYLALAHNLLNDSLPLQV-GNLKNLVITCVSLEYLDISSNSFHGVIP---FSLGFMKS 410
           +   L +  N    S+P+     L N          L + +N F   +    F+      
Sbjct: 131 IFFILEITDNPYMTSIPVNAFQGLCNE------TLTLKLYNNGFT-SVQGYAFNG---TK 180

Query: 411 IKELNVSSNNLSGQIPE--FLQNLSFLEFLNLSYNHLEGEVPTKGVFSN 457
           +  + ++ N     I +  F    S    L++S   +   +P+     +
Sbjct: 181 LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS-KGLEH 227

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 59.6 bits (145), Expect = 6e-10
 Identities = 36/233 (15%), Positives = 71/233 (30%), Gaps = 31/233 (13%)

Query: 207 CSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIE 265
           C   +   +            I +L  +    ++    +  TIPS    NL N+  + + 
Sbjct: 10  CHQEEDFRVTCKDI-----QRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVS 63

Query: 266 VNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPPS-LGNLTKLADLALSFNNLQGNIP- 322
           ++     +       L  +  + +        I P  L  L  L  L +    L+   P 
Sbjct: 64  IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122

Query: 323 -SSLGNCQNLKGFDASHNKLTGAIPQQVLS-ITTLSVYLALAHNLLN-------DSLPLQ 373
            + + +       + + N    +IP      +   ++ L L +N          +   L 
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLD 182

Query: 374 VGNLK-NLVITCVS----------LEYLDISSNSFHGVIPFSLGFMKSIKELN 415
              L  N  +T +              LD+S  S   +    L  +K +   N
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 37/207 (17%), Positives = 68/207 (32%), Gaps = 33/207 (15%)

Query: 63  LRNLVYLNVAEN-QFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
           L N+  + V+ +     +      N+S +  I +   R    +  D L  LP LK L + 
Sbjct: 54  LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPD--SLSNASNLERLDLSGNQFKGKVSID-FSSLK 178
              L                     PD   + +      L+++ N +   + ++ F  L 
Sbjct: 114 NTGL------------------KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155

Query: 179 N-LWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELP-HSIANLSSTMI 236
           N    L L  N                 N + L A+ L  N++   +   +   + S   
Sbjct: 156 NETLTLKLYNNGFTSVQGYAF-------NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208

Query: 237 QFRIGGNQISGTIPSGI-RNLVNLIAL 262
              +    ++  +PS    +L  LIA 
Sbjct: 209 LLDVSQTSVT-ALPSKGLEHLKELIAR 234

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 48/248 (19%), Positives = 83/248 (33%), Gaps = 61/248 (24%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLIK 609
           IG+GS+G VY       E  VA+K +N      +  K   R    E   L  ++   +I+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89

Query: 610 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ--------SNDHLEVCKLTLIQRV 659
           +  +    D     F    +V E  +     D L +        + +H    K  L    
Sbjct: 90  LYDLIIPDDLL--KFDELYIVLEIAD----SD-LKKLFKTPIFLTEEH---IKTILYN-- 137

Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD------------MVAHQNFSLSHQ 707
                +     ++H   +  I+H DLKP+N LL+ D             +  +  +    
Sbjct: 138 -----LLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 708 LDSASKTPSSSIGIKGTV--GYV------APEYGMGSEASMTG-DVYSFGILLLEMFTGR 758
               ++ P             +V      APE  +  E      D++S G +  E+    
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249

Query: 759 RPTDAAFT 766
           +      T
Sbjct: 250 QSHINDPT 257

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 43/216 (19%), Positives = 75/216 (34%), Gaps = 55/216 (25%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITIC 614
           +G G  G V +      +   A+K++      A R    E E      +  ++++I+ + 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            +    G     +V E ++ G L   +    D       T  +   I   +  AI+YLH 
Sbjct: 81  EN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHS 135

Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSI-----GIKGTVGYVA 729
                I H D+KP N+L                    SK P++ +     G        A
Sbjct: 136 IN---IAHRDVKPENLLY------------------TSKRPNAILKLTDFGF-------A 167

Query: 730 PE-----YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            E     Y          D++S G+++  +  G  P
Sbjct: 168 KETTGEKYDK--SC----DMWSLGVIMYILLCGYPP 197

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 29/205 (14%)

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLW 181
           F         NL++ ++     +    + +  ++++++  + +  K    I    L N+ 
Sbjct: 18  FAETIKA---NLKKKSV-----TDAV-TQNELNSIDQIIANNSDIKSVQGIQ--YLPNVR 66

Query: 182 WLNLEQNNL-GMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
           +L L  N L  +    +L         ++L  L L  NQ    LP+ + +  + + +  +
Sbjct: 67  YLALGGNKLHDISALKEL---------TNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVL 116

Query: 241 GGNQISGTIPSGIRN-LVNLIALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIP 298
             NQ+  ++P G+ + L NL  L +  NQL  + P GV  +L +L +L +  N LQ S+P
Sbjct: 117 VENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSL-PKGVFDKLTNLTELDLSYNQLQ-SLP 173

Query: 299 PSL-GNLTKLADLALSFNNLQGNIP 322
             +   LT+L DL L  N L+ ++P
Sbjct: 174 EGVFDKLTQLKDLRLYQNQLK-SVP 197

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 60/243 (24%), Positives = 90/243 (37%), Gaps = 55/243 (22%)

Query: 86  NIS-SLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT------FCSLKNLWWLNLEQNNL 138
           +         L     + ++  + L ++  +               L N+ +L L  N L
Sbjct: 16  DAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKL 75

Query: 139 GMGTASSIP--DSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTAN 196
                  I     L+N   L  L L+GNQ +   +  F  L NL  L L +N L      
Sbjct: 76  -----HDISALKELTN---LTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDG 127

Query: 197 DLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RN 255
             D    LTN   L  L+L  NQ           L S               +P G+   
Sbjct: 128 VFD---KLTN---LTYLNLAHNQ-----------LQS---------------LPKGVFDK 155

Query: 256 LVNLIALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALS 313
           L NL  L +  NQL   +P+GV  +L  L+ L +++N L+ S+P      LT L  + L 
Sbjct: 156 LTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWL- 212

Query: 314 FNN 316
            +N
Sbjct: 213 HDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 25/180 (13%)

Query: 144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL 203
              PD     +   + +L        V+   + L ++  +    +++             
Sbjct: 11  QIFPDDAF--AETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQY----- 61

Query: 204 LTNCSSLKALSLCDNQFGGELP--HSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLI 260
           L N   ++ L+L  N+   ++     + NL+       + GNQ+  ++P+G+   L NL 
Sbjct: 62  LPN---VRYLALGGNKLH-DISALKELTNLT----YLILTGNQLQ-SLPNGVFDKLTNLK 112

Query: 261 ALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPPSL-GNLTKLADLALSFNNLQ 318
            L +  NQL  + PDGV  +L +L  L +  N LQ S+P  +   LT L +L LS+N LQ
Sbjct: 113 ELVLVENQLQSL-PDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ 170

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 64.7 bits (158), Expect = 4e-11
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 58/226 (25%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G G++G+V   + G     VA+K +       L  K A+R    E   L+++RH N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88

Query: 610 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------SNDHLEVCKLTLIQRVN 660
           ++ + +  D    DF    LV  +M      D L +         D     +  + Q   
Sbjct: 89  LLDVFTP-DETLDDFTDFYLVMPFMG----TD-LGKLMKHEKLGEDR---IQFLVYQ--- 136

Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSI 719
               +   + Y+H      I+H DLKP N+ ++ D  +   +F L+ Q DS   T     
Sbjct: 137 ----MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-EMT----- 183

Query: 720 GIKGTVGYV------APEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                 GYV      APE  +     + T D++S G ++ EM TG+
Sbjct: 184 ------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 64.2 bits (157), Expect = 5e-11
 Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 40/220 (18%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIK-- 609
           +IG+GSFG V       EE+  AVKV+    + +K   +  ++E    RN+    L+K  
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE----RNV----LLKNV 96

Query: 610 ----IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AID 664
               ++ +  S  +    +   V +Y+  G L   L +    LE        R    A +
Sbjct: 97  KHPFLVGLHFSFQTADKLY--FVLDYINGGELFYHLQRERCFLE-------PRARFYAAE 147

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLSHQ-LDSASKTPSSSIG 720
           +ASA+ YLH      IV+ DLKP N+LLD     ++   +F L  + ++  S T +    
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQGHIVLT--DFGLCKENIEHNSTTST---- 198

Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             GT  Y+APE         T D +  G +L EM  G  P
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 44/224 (19%), Positives = 88/224 (39%), Gaps = 35/224 (15%)

Query: 555 MIGQGSFGSVYKGI-LGGEEMIVAVKVINLKQKGAFR--SFVAECEALRNIRHR---NLI 608
            +G+G+FG V + +     +  VA+K+I  +  G +R  + + E   L+ I+ +   N  
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARL-EINVLKKIKEKDKENKF 82

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVAS 667
             + +    +  G     + FE +   +  ++L ++N        L  ++   +A  +  
Sbjct: 83  LCVLMSDWFNFHG--HMCIAFELLGK-NTFEFLKENNFQPY---PLPHVRH--MAYQLCH 134

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS-------SSIG 720
           A+ +LH +    + H DLKP N+L  +              + + K  S       S+  
Sbjct: 135 ALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191

Query: 721 IKGTVGYV-------APEYGMGSEASMTGDVYSFGILLLEMFTG 757
                  +        PE  +    +   DV+S G +L E + G
Sbjct: 192 DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 64.3 bits (157), Expect = 6e-11
 Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 58/226 (25%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 609
           +G G++GSV         + VAVK    K    F+S +       E   L++++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92

Query: 610 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------SNDHLEVCKLTLIQRVN 660
           ++ + +   S   +F    LV   M      D L+        ++DH    +  + Q   
Sbjct: 93  LLDVFTPARSLE-EFNDVYLVTHLMG----AD-LNNIVKCQKLTDDH---VQFLIYQ--- 140

Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSI 719
               +   ++Y+H      I+H DLKPSN+ ++ D  +   +F L+        T     
Sbjct: 141 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-MT----- 187

Query: 720 GIKGTVGYV------APEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                 GYV      APE  +     + T D++S G ++ E+ TGR
Sbjct: 188 ------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 63.5 bits (155), Expect = 8e-11
 Identities = 50/228 (21%), Positives = 91/228 (39%), Gaps = 49/228 (21%)

Query: 555 MIGQGSFGSVY---KGILGGEEMIVAVKVINLKQKGAFRSFVAEC-EALRNIRHRNLIK- 609
           ++G G++G V+   K        + A+KV+  K     ++   E     R +    L   
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-KATIVQKAKTTEHTRTERQV----LEHI 115

Query: 610 -----IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AI 663
                ++T+  +  ++      L+ +Y+  G L         HL   +      V I   
Sbjct: 116 RQSPFLVTLHYAFQTETKLH--LILDYINGGEL---FT----HLSQRERFTEHEVQIYVG 166

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHQNFSLS--HQLDSASKTPSSS 718
           ++  A+E+LH      I++ D+K  N+LLD +   ++   +F LS     D   +     
Sbjct: 167 EIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT--DFGLSKEFVADETERAYD-- 219

Query: 719 IGIKGTVGYVAPE------YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
               GT+ Y+AP+       G         D +S G+L+ E+ TG  P
Sbjct: 220 --FCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 63.2 bits (154), Expect = 9e-11
 Identities = 39/227 (17%), Positives = 84/227 (37%), Gaps = 31/227 (13%)

Query: 556 IGQGSFGSVYKGI--------LGGEEMIVAVKV----INLKQKGAFRSFVAECEALRNIR 603
             + + G +Y+           G ++   ++K+      L  +  F    A+   +   +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 604 HRNLIKIITICSSIDS--KGADFKALVFEYMENG-SLEDWLHQSNDHLEVCKLTLIQRVN 660
                 ++ I + +        ++ LV   +  G SL+  L  S  H+   +  L     
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVL----Q 163

Query: 661 IAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHQNFSLSHQLDSASK---- 713
           +A  +  A+E+LH +     VHG++   N+ +   D   V    +  + +   + K    
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220

Query: 714 TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
              S    +G + +++ +   G   S   D+ S G  +L+   G  P
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.4 bits (155), Expect = 9e-11
 Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 32/216 (14%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIK-- 609
           ++G+GSFG V      G + + AVK++    + Q       + E    + +    L    
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE----KRV----LALPG 78

Query: 610 ----IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
               +  + S   +    +   V EY+  G L   + Q        +      V  A ++
Sbjct: 79  KPPFLTQLHSCFQTMDRLY--FVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEI 130

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
           A  + +L       I++ DLK  NV+LD +  +   +F +  +      T  +     GT
Sbjct: 131 AIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT---FCGT 184

Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             Y+APE         + D ++FG+LL EM  G+ P
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 48/218 (22%), Positives = 90/218 (41%), Gaps = 36/218 (16%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIK-- 609
           +IG+GS+  V    L   + I A++V+    +           E    +++      +  
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE----KHV----FEQAS 110

Query: 610 ----IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AID 664
               ++ + S   ++   F   V EY+  G L   + +     E       +     + +
Sbjct: 111 NHPFLVGLHSCFQTESRLF--FVIEYVNGGDLMFHMQRQRKLPE-------EHARFYSAE 161

Query: 665 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSSIGIK 722
           ++ A+ YLH      I++ DLK  NVLLD +  +   ++ +  + L     T +      
Sbjct: 162 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST----FC 214

Query: 723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           GT  Y+APE   G +   + D ++ G+L+ EM  GR P
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 29/216 (13%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG +Y G  I  GEE  VA+K+  +K K        E +  + ++    I  I  
Sbjct: 17  IGSGSFGDIYLGTDIAAGEE--VAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72

Query: 614 CSSIDSKGADFKALVFEYMENG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           C +      D+  +V E +  G SLED L          K +L   + +A  + S IEY+
Sbjct: 73  CGAEG----DYNVMVMELL--GPSLED-LFNFCSR----KFSLKTVLLLADQMISRIEYI 121

Query: 673 HHHCQPPIVHGDLKPSNVLL----DHDMVAHQNFSLSHQ-LDSASKT---PSSSIGIKGT 724
           H       +H D+KP N L+      ++V   +F L+ +  D+ +        +  + GT
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178

Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             Y +    +G E S   D+ S G +L+    G  P
Sbjct: 179 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 62.6 bits (153), Expect = 2e-10
 Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 30/215 (13%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK----- 609
           +IG+GS+  V    L   + I A+KV+  K+       +   +  +++      +     
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHV----FEQASNHP 70

Query: 610 -IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI-AIDVAS 667
            ++ + S   ++   F   V EY+  G L   + +     E       +     + +++ 
Sbjct: 71  FLVGLHSCFQTESRLF--FVIEYVNGGDLMFHMQRQRKLPE-------EHARFYSAEISL 121

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSSIGIKGTV 725
           A+ YLH      I++ DLK  NVLLD +  +   ++ +  + L     T +      GT 
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST----FCGTP 174

Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            Y+APE   G +   + D ++ G+L+ EM  GR P
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 46/223 (20%), Positives = 87/223 (39%), Gaps = 33/223 (14%)

Query: 555 MIGQGSFGSVYKGI-LGGEEMIVAVKVINLKQKGAFR--SFVAECEALRNIRHR---NLI 608
            +G+G+FG V + I        VAVK++  K    +   +   E + L ++      +  
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRYCEAARS-EIQVLEHLNTTDPNSTF 77

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           + + +    +  G     +VFE +   S  D++ + N  L   +L  I++  +A  +  +
Sbjct: 78  RCVQMLEWFEHHG--HICIVFELLGL-STYDFI-KENGFLPF-RLDHIRK--MAYQICKS 130

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS-------SSIGI 721
           + +LH +    + H DLKP N+L               + +     P        S+   
Sbjct: 131 VNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187

Query: 722 KGTVGYV-------APEYGMGSEASMTGDVYSFGILLLEMFTG 757
                 +       APE  +    S   DV+S G +L+E + G
Sbjct: 188 DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 54/239 (22%), Positives = 96/239 (40%), Gaps = 63/239 (26%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-------HRNLI 608
           +G+G++G V+K I      +VAVK    K   AF++        R I        H N++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK----KIFDAFQNSTDAQRTFREIMILTELSGHENIV 72

Query: 609 KIITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------SNDHLEVCKLTLIQRV 659
            ++ +  +      + +   LVF+YME     D LH           H    +  + Q +
Sbjct: 73  NLLNVLRA-----DNDRDVYLVFDYME----TD-LHAVIRANILEPVH---KQYVVYQLI 119

Query: 660 NIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD------------MVAHQNFSLSHQ 707
                    I+YLH      ++H D+KPSN+LL+ +               +     ++ 
Sbjct: 120 K-------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

Query: 708 LDSASKTPSSSIGIKGTV-GYV------APEYGMGSEA-SMTGDVYSFGILLLEMFTGR 758
             S ++   +    +  +  YV      APE  +GS   +   D++S G +L E+  G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 34/217 (15%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIK-- 609
           ++G+GSFG V    +     + AVKV+    + Q       + E    + I    L    
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE----KRI----LSLAR 81

Query: 610 ----IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDV 665
               +  +     +    F   V E++  G L   + +S       +    +    A ++
Sbjct: 82  NHPFLTQLFCCFQTPDRLF--FVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEI 133

Query: 666 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQ-LDSASKTPSSSIGIKG 723
            SA+ +LH      I++ DLK  NVLLDH+      +F +  + + +   T +      G
Sbjct: 134 ISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT----FCG 186

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           T  Y+APE           D ++ G+LL EM  G  P
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 23/212 (10%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHR---NLIK 609
           ++IG+GSFG V K     E+  VA+K+I  K K AF      E   L  +          
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEVRLLELMNKHDTEMKYY 117

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVASA 668
           I+ +      +      LVFE +   +L D L  +N   +    L L ++   A  + +A
Sbjct: 118 IVHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRNTNFRGVS---LNLTRK--FAQQMCTA 169

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLD--SASKTPSSSIGIKGTVG 726
           + +L    +  I+H DLKP N+LL      +   S    +D  S+ +          +  
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILL-----CNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF 223

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGR 758
           Y +PE  +G    +  D++S G +L+EM TG 
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 62.7 bits (152), Expect = 3e-10
 Identities = 61/425 (14%), Positives = 135/425 (31%), Gaps = 40/425 (9%)

Query: 82  RWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMG 141
           RW   I S    ++T+     + P  +    PNL+ L L       +   NL   N G  
Sbjct: 43  RW-FKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAM--FNLIPENWGGY 99

Query: 142 TASSIPDSLSNASNLERLDLSGNQF--KGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD 199
               + +  +N   L+ +              +  +   +L  L L+             
Sbjct: 100 VTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLD----KCSGFTTDG 155

Query: 200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI------GGNQIS----GTI 249
            ++++T+C  +K L + ++ F  +    +  L+       +         +IS     TI
Sbjct: 156 LLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETI 215

Query: 250 PSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLAD 309
               R+LV++     E+ +L G        L+      +  +        +L    KL  
Sbjct: 216 ARNCRSLVSVKVGDFEILELVGFFK-AAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR 274

Query: 310 LALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDS 369
           L LS+      +P        ++  D  +  L       ++        L   + + +  
Sbjct: 275 LGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRG 333

Query: 370 LPLQVGNLKNL----VITCVSLEYLDISSNSF--HGVIPFSLGFMKSIKELNVSSNNLSG 423
           L +     K L    +      + ++         G+I  + G  + ++ + V  ++++ 
Sbjct: 334 LEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGC-QELEYMAVYVSDITN 392

Query: 424 Q----IPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLL 479
           +    I  +L+NL     + L       ++P            ++  +  C  +      
Sbjct: 393 ESLESIGTYLKNLCDFRLVLLDREERITDLPLDN--------GVRSLLIGCKKLRRFAFY 444

Query: 480 SCPSK 484
                
Sbjct: 445 LRQGG 449

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 52.6 bits (126), Expect = 4e-07
 Identities = 65/430 (15%), Positives = 124/430 (28%), Gaps = 57/430 (13%)

Query: 64  RNLVYLNVAENQFSGMFPRWICNIS-------SLEFIYLTVNRFSGSLPFDILVNLPNLK 116
           R +  L + E+ FS    +W+  ++        L F      + S      I  N  +L 
Sbjct: 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV 223

Query: 117 ELYLTFCSLKNLWWLNLEQNNL------GMGTASSIPDSLSNASNLERLDLSGNQFKGKV 170
            + +    +  L        NL       +     +P+   N     +L   G  + G  
Sbjct: 224 SVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN 283

Query: 171 SID--FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSI 228
            +   F     +  L+L    L        D  TL+  C +L+ L    N  G      +
Sbjct: 284 EMPILFPFAAQIRKLDLLYALL-----ETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVL 337

Query: 229 ANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYM 288
           A     + + RI               LV+   L                    L+ + +
Sbjct: 338 AQYCKQLKRLRIERGA-DEQGMEDEEGLVSQRGLIALAQGCQ-----------ELEYMAV 385

Query: 289 FRNFLQ----GSIPPSLGNLTKLADLALSFNNLQGNIPSSLG------NCQNLKGFDASH 338
           + + +      SI   L NL     + L       ++P   G       C+ L+ F    
Sbjct: 386 YVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYL 445

Query: 339 N--KLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNS 396
               LT      +   +    ++ L +   +D        L      C +L+ L++    
Sbjct: 446 RQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDE------GLMEFSRGCPNLQKLEMRGCC 499

Query: 397 F--HGVIPFSLGFMKSIKELNVSSNNLSGQIPEFL---QNLSFLEFLNLSYNHLEGEVPT 451
           F    +       + S++ L V     S    + +   +    +E +         +   
Sbjct: 500 FSERAIAAAVTK-LPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPEVNQQGE 558

Query: 452 KGVFSNKTKI 461
                +   I
Sbjct: 559 IREMEHPAHI 568

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 29/207 (14%), Positives = 63/207 (30%), Gaps = 16/207 (7%)

Query: 88  SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIP 147
             LE++ + V+  +      I   L NL +          L  L+ E+    +   + + 
Sbjct: 378 QELEYMAVYVSDITNESLESIGTYLKNLCDF--------RLVLLDREERITDLPLDNGVR 429

Query: 148 DSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL--WWLNLEQNNLGMGTANDLDFVTLLT 205
             L     L R      Q      +    L  +  +  N+    LG    +D   +    
Sbjct: 430 SLLIGCKKLRRFAFYLRQGG----LTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSR 485

Query: 206 NCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALT-I 264
            C +L+ L +    F      +      ++    + G + S T    ++       +  I
Sbjct: 486 GCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELI 545

Query: 265 EVNQLHGIIPDGVGEL-QHLQQLYMFR 290
              ++  +   G     +H   +  + 
Sbjct: 546 PSRRVPEVNQQGEIREMEHPAHILAYY 572

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.4 bits (147), Expect = 5e-10
 Identities = 45/219 (20%), Positives = 81/219 (36%), Gaps = 33/219 (15%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG+GSFG +++G  +L  ++  VA+K    +          E         + L     I
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQ--VAIKFEPRRSDA--PQLRDEYRTY-----KLLAGCTGI 68

Query: 614 CSSIDS-KGADFKALVFEYMENG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +     +      LV + +  G SLED L          K ++      A  + + ++ 
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL--GPSLED-LLDLCGR----KFSVKTVAMAAKQMLARVQS 121

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAHQN------FSLSHQ-LDSASKT---PSSSIGI 721
           +H      +V+ D+KP N L+      + N      F +     D  +K          +
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y++    +G E S   D+ + G + +    G  P
Sbjct: 179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 35/145 (24%), Positives = 55/145 (37%), Gaps = 20/145 (13%)

Query: 56  IPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL 115
           IPT   L   +  + + +N    + P        L  I L+ N+ S  L  D    L +L
Sbjct: 26  IPT--NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82

Query: 116 KELYL-----------TFCSLKNLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLSG 163
             L L            F  L +L  L L  N +     + +  D+  +  NL  L L  
Sbjct: 83  NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKI-----NCLRVDAFQDLHNLNLLSLYD 137

Query: 164 NQFKGKVSIDFSSLKNLWWLNLEQN 188
           N+ +      FS L+ +  ++L QN
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 32/175 (18%), Positives = 62/175 (35%), Gaps = 39/175 (22%)

Query: 144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL 203
           + IP +L     +  + L  N  K      FS  K L  ++L  N +     +       
Sbjct: 24  TEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ---G 78

Query: 204 LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIAL 262
           L +   L +L L  N+           ++                +P  +   L +L  L
Sbjct: 79  LRS---LNSLVLYGNK-----------ITE---------------LPKSLFEGLFSLQLL 109

Query: 263 TIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFN 315
            +  N+++  +      +L +L  L ++ N LQ +I   +   L  +  + L+ N
Sbjct: 110 LLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 34/139 (24%), Positives = 52/139 (37%), Gaps = 7/139 (5%)

Query: 229 ANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQL 286
            NL  T+ + R+  N I   IP G       L  + +  NQ+  +        L+ L  L
Sbjct: 28  TNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISEL-APDAFQGLRSLNSL 85

Query: 287 YMFRNFLQGSIPPSL-GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAI 345
            ++ N +   +P SL   L  L  L L+ N +      +  +  NL       NKL   I
Sbjct: 86  VLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TI 143

Query: 346 PQQVLSITTLSVYLALAHN 364
            +   S       + LA N
Sbjct: 144 AKGTFSPLRAIQTMHLAQN 162

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 60.4 bits (147), Expect = 8e-10
 Identities = 48/233 (20%), Positives = 81/233 (34%), Gaps = 61/233 (26%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN--LKQKGAFRSFVAECEALRNIR---------H 604
           I  GS+G+V  G+   E + VA+K +   +                R +R         H
Sbjct: 30  ISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 605 RNLIKIITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ---------SNDHLEVCKL 653
            N++ +  I    +          LV E M      D L Q         S  H    + 
Sbjct: 89  PNILGLRDIFVHFEEP--AMHKLYLVTELMRT----D-LAQVIHDQRIVISPQH---IQY 138

Query: 654 TLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHQNFSLSHQLDSAS 712
            +         +   +  LH   +  +VH DL P N+LL  +  +   +F+L+ +  + +
Sbjct: 139 FMYH-------ILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 713 KTPSSSIGIKGTVGYV------APEYGMGS-EASMTGDVYSFGILLLEMFTGR 758
                         YV      APE  M     +   D++S G ++ EMF  +
Sbjct: 189 NKT----------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 48/165 (29%), Positives = 63/165 (38%), Gaps = 37/165 (22%)

Query: 154 SNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKAL 213
           +N + L L  NQ        F SL NL  L L  N LG       D    LT    L  L
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD---SLTQ---LTVL 93

Query: 214 SLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGI 272
            L  NQ           L+                +PS +   LV+L  L +  N+L   
Sbjct: 94  DLGTNQ-----------LTV---------------LPSAVFDRLVHLKELFMCCNKLTE- 126

Query: 273 IPDGVGELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNN 316
           +P G+  L HL  L + +N L+ SIP  +   L+ L    L F N
Sbjct: 127 LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYL-FGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 37/144 (25%), Positives = 58/144 (40%), Gaps = 23/144 (15%)

Query: 56  IPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL 115
           IPT   +L    YL+   NQ + + P    ++ +L+ +YL  N+   +LP  +  +L  L
Sbjct: 38  IPTNAQIL----YLHD--NQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 116 KELYLT-----------FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGN 164
             L L            F  L +L  L +  N L     + +P  +   ++L  L L  N
Sbjct: 91  TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKL-----TELPRGIERLTHLTHLALDQN 145

Query: 165 QFKGKVSIDFSSLKNLWWLNLEQN 188
           Q K      F  L +L    L  N
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 38/124 (30%), Positives = 46/124 (37%), Gaps = 26/124 (20%)

Query: 122 FCSLKNLWWLNLEQNNLGMGTA--SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKN 179
           F SL NL  L L  N L    A    + DSL   + L  LDL  NQ     S  F  L +
Sbjct: 60  FDSLINLKELYLGSNQL---GALPVGVFDSL---TQLTVLDLGTNQLTVLPSAVFDRLVH 113

Query: 180 LWWLNLEQNNL-----GMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSS- 233
           L  L +  N L     G         +  LT+   L  L+L  NQ       +   LSS 
Sbjct: 114 LKELFMCCNKLTELPRG---------IERLTH---LTHLALDQNQLKSIPHGAFDRLSSL 161

Query: 234 TMIQ 237
           T   
Sbjct: 162 THAY 165

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 52/219 (23%), Positives = 84/219 (38%), Gaps = 33/219 (15%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG G+FG +  G  +   E   VA+K+     K        E         + L     I
Sbjct: 17  IGCGNFGELRLGKNLYTNEY--VAIKL--EPMKSRAPQLHLEYRFY-----KQLGSGDGI 67

Query: 614 CSSIDS-KGADFKALVFEYMENG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
                      + A+V E +  G SLED L    D       +L   + IAI + S +EY
Sbjct: 68  PQVYYFGPCGKYNAMVLELL--GPSLED-LFDLCDR----TFSLKTVLMIAIQLISRMEY 120

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAHQN------FSLSHQ-LDSASKT---PSSSIGI 721
           +H      +++ D+KP N L+       Q       F+L+ + +D  +K          +
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
            GT  Y++    +G E S   D+ + G + +    G  P
Sbjct: 178 TGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 61.1 bits (148), Expect = 9e-10
 Identities = 64/440 (14%), Positives = 128/440 (29%), Gaps = 56/440 (12%)

Query: 38  NLSALGMLLIRWNSLGGQ-IPTTLGLLRNLVYLNVAENQFSGMFPRWIC-NISSLEFIYL 95
           + +   ++   W       I         L  + +     +      I  +  + + + L
Sbjct: 78  HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVL 137

Query: 96  T-VNRFSGSLPFDILVNLPNLKELYLTFCSLKNL--WWL--------NLEQNNLGMG--- 141
           +    FS      I     NLKEL L    + ++   WL        +L   N+      
Sbjct: 138 SSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASE 197

Query: 142 -TASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDF 200
            + S++   ++   NL+ L L+      K++        L  L        +        
Sbjct: 198 VSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGL 257

Query: 201 VTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLI 260
              L+ C  L+ LS   +     LP   +  S                    +  L NL 
Sbjct: 258 SVALSGCKELRCLSGFWDAVPAYLPAVYSVCSR-------------------LTTL-NLS 297

Query: 261 ALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGN 320
             T++   L  ++     +   LQ+L++        +         L +L +  +     
Sbjct: 298 YATVQSYDLVKLL----CQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVM 353

Query: 321 IPSS----------LGNCQNLKGFDASHNKLTG----AIPQQVLSITTLSVYLALAHNLL 366
            P+              C  L+       ++T      I +   ++T   + +       
Sbjct: 354 EPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPD 413

Query: 367 NDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQ-I 425
             +L         +V  C  L  L +S      V  +   + K ++ L+V+    S   +
Sbjct: 414 YLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGM 473

Query: 426 PEFLQNLSFLEFLNLSYNHL 445
              L     L  L +     
Sbjct: 474 HHVLSGCDSLRKLEIRDCPF 493

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 59.5 bits (144), Expect = 3e-09
 Identities = 59/422 (13%), Positives = 126/422 (29%), Gaps = 37/422 (8%)

Query: 82  RWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMG 141
            W   I       + +       P  ++   P ++ + L      +    NL  +  G  
Sbjct: 36  SW-YEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKP--HFADFNLVPDGWGGY 92

Query: 142 TASSIPDSLSNASNLERLDLSGNQF--KGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD 199
               I    S+ + LE + L            I   S KN   L L          +   
Sbjct: 93  VYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELI-AKSFKNFKVLVLS----SCEGFSTDG 147

Query: 200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQ-----FRIGGNQISGTIPSGIR 254
              +   C +LK L L ++       H +++   T             +++S    S + 
Sbjct: 148 LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSF---SALE 204

Query: 255 NLV----NLIALTIEVNQLHGIIPDGVGELQHLQQLYMF------RNFLQGSIPPSLGNL 304
            LV    NL +L +        +   +     L++L         R  +   +  +L   
Sbjct: 205 RLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGC 264

Query: 305 TKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHN 364
            +L  L+  ++ +   +P+    C  L   + S+  +      ++L        L +   
Sbjct: 265 KELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324

Query: 365 LLNDSLPLQVGNLKNL----VITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNN 420
           + +  L +     K+L    V            + +  G++  S+G    ++ +      
Sbjct: 325 IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMG-CPKLESVLYFCRQ 383

Query: 421 LSGQ-IPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLL 479
           ++   +    +N   +    L     +       +      I     V+ C  +  L L 
Sbjct: 384 MTNAALITIARNRPNMTRFRLCIIEPKAPD---YLTLEPLDIGFGAIVEHCKDLRRLSLS 440

Query: 480 SC 481
             
Sbjct: 441 GL 442

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 56.6 bits (137), Expect = 1e-09
 Identities = 29/120 (24%), Positives = 48/120 (40%), Gaps = 23/120 (19%)

Query: 111 NLPNLKELYLTFC------------SLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLER 158
              ++KEL L                 + L +L+     L     +SI + L   + L++
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIAN-LPKLNKLKK 68

Query: 159 LDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDN 218
           L+LS N+  G + +      NL  LNL  N +      DL  +  L    +LK+L L + 
Sbjct: 69  LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 19/79 (24%), Positives = 33/79 (41%), Gaps = 2/79 (2%)

Query: 368 DSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPE 427
           D+     G L+ L      LE+L   +     +       +  +K+L +S N +SG +  
Sbjct: 25  DNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK--LNKLKKLELSDNRVSGGLEV 82

Query: 428 FLQNLSFLEFLNLSYNHLE 446
             +    L  LNLS N ++
Sbjct: 83  LAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 20/69 (28%), Positives = 30/69 (43%)

Query: 60  LGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY 119
           L  L  L  L +++N+ SG          +L  + L+ N+       + L  L NLK L 
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119

Query: 120 LTFCSLKNL 128
           L  C + NL
Sbjct: 120 LFNCEVTNL 128

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 23/90 (25%), Positives = 38/90 (42%), Gaps = 3/90 (3%)

Query: 254 RNLVNLIALTIEVNQLHGI-IPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLAL 312
           R   ++  L ++ ++ +   +     E + L+ L      L  SI  +L  L KL  L L
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLEL 71

Query: 313 SFNNLQGNIPSSLGNCQNLKGFDASHNKLT 342
           S N + G +      C NL   + S NK+ 
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 29/216 (13%)

Query: 556 IGQGSFGSVYKG--ILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG GSFG +Y G  I   EE  VA+K+ N+K K      + E +  R ++    I  +  
Sbjct: 15  IGSGSFGEIYLGTNIQTNEE--VAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70

Query: 614 CSSIDSKGADFKALVFEYMENG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
                    D+  LV + +  G SLED L          KL+L   + +A  + + +E++
Sbjct: 71  FGVEG----DYNVLVMDLL--GPSLED-LFNFCSR----KLSLKTVLMLADQMINRVEFV 119

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAHQ----NFSLSHQ-LDSASKT---PSSSIGIKGT 724
           H       +H D+KP N L+     A+Q    +F L+ +  D+++        +  + GT
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176

Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             Y +    +G E S   D+ S G +L+    G  P
Sbjct: 177 ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.2 bits (138), Expect = 8e-09
 Identities = 41/186 (22%), Positives = 75/186 (40%), Gaps = 19/186 (10%)

Query: 584 KQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ 643
            ++  F  +  +    R  +       + +   +DS  +   +    ++E  SL D   +
Sbjct: 120 SKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

Query: 644 S-NDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QN 701
              + L    LTL   +  +  VA  +E+L        +H DL   N+LL    V    +
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 236

Query: 702 FSLS---HQLDSASKTPSSSIGIKGTVGYVAPE---YGMGSEASMTGDVYSFGILLLEMF 755
           F L+   ++     +   + + +K      APE     + +  S   DV+SFG+LL E+F
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWM----APETIFDRVYTIQS---DVWSFGVLLWEIF 289

Query: 756 T-GRRP 760
           + G  P
Sbjct: 290 SLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 22/104 (21%), Positives = 45/104 (43%), Gaps = 15/104 (14%)

Query: 554 NMIGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI-RH 604
             +G+G+FG V +              VAVK+  LK+       R+ ++E + L +I  H
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHH 85

Query: 605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL 648
            N++ ++  C+           ++ E+ + G+L  +L    +  
Sbjct: 86  LNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEF 125

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 27/177 (15%), Positives = 60/177 (33%), Gaps = 41/177 (23%)

Query: 144 SSIPDSLSNASNLERLDLSGNQFKG-KVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVT 202
           + IP+ +        L L+ N+F   + +  F  L  L  +N   N +        +   
Sbjct: 24  NKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFE--- 78

Query: 203 LLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIA 261
             +    +  + L  N+           L +               +   + + L +L  
Sbjct: 79  GASG---VNEILLTSNR-----------LEN---------------VQHKMFKGLESLKT 109

Query: 262 LTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNN 316
           L +  N++  +  +     L  ++ L ++ N +  ++ P +   L  L+ L L   N
Sbjct: 110 LMLRSNRITCV-GNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNL-LAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 30/148 (20%), Positives = 49/148 (33%), Gaps = 29/148 (19%)

Query: 88  SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL-----------TFCSLKNLWWLNLEQN 136
                + L  N F+      I   LP L+++              F     +  + L  N
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 137 NLGMGTASSIPDSL-SNASNLERLDLSGNQFKGKVSID---FSSLKNLWWLNLEQNNLGM 192
            L      ++   +     +L+ L L  N+      +    F  L ++  L+L  N +  
Sbjct: 92  RL-----ENVQHKMFKGLESLKTLMLRSNRIT---CVGNDSFIGLSSVRLLSLYDNQI-- 141

Query: 193 GTANDLDFVTLLTNCSSLKALSLCDNQF 220
            T     F TL     SL  L+L  N F
Sbjct: 142 TTVAPGAFDTL----HSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 22/137 (16%), Positives = 53/137 (38%), Gaps = 10/137 (7%)

Query: 229 ANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQL 286
            ++     + R+  N+ +    +GI + L  L  +    N++  I  +G       + ++
Sbjct: 28  EHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDI-EEGAFEGASGVNEI 86

Query: 287 YMFRNFLQGSIPPSL-GNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAI 345
            +  N L+ ++   +   L  L  L L  N +      S     +++      N++T  +
Sbjct: 87  LLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TV 144

Query: 346 PQQVL----SITTLSVY 358
                    S++TL++ 
Sbjct: 145 APGAFDTLHSLSTLNLL 161

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 22/120 (18%), Positives = 39/120 (32%), Gaps = 21/120 (17%)

Query: 109 LVNLPNLKELYLTFC----------SLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLER 158
             N    +EL L             +L     ++   N +       + D       L+ 
Sbjct: 15  YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEI-----RKL-DGFPLLRRLKT 68

Query: 159 LDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDN 218
           L ++ N+          +L +L  L L  N+L      +L  +  L +  SL  L +  N
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSL-----VELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 21/88 (23%), Positives = 34/88 (38%), Gaps = 10/88 (11%)

Query: 359 LALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSS 418
           L L    +          ++NL  T    + +D S N    +  F L  ++ +K L V++
Sbjct: 24  LDLRGYKIPV--------IENLGATLDQFDAIDFSDNEIRKLDGFPL--LRRLKTLLVNN 73

Query: 419 NNLSGQIPEFLQNLSFLEFLNLSYNHLE 446
           N +        Q L  L  L L+ N L 
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 19/111 (17%), Positives = 37/111 (33%), Gaps = 3/111 (2%)

Query: 10  EEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYL 69
            +  + +  + L +    +   + +    L     +    N +  +      LLR L  L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 69

Query: 70  NVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
            V  N+   +       +  L  + LT N        D L +L +L  L +
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 120

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 27/133 (20%), Positives = 48/133 (36%), Gaps = 24/133 (18%)

Query: 86  NISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASS 145
             +++  + L   + +      +     NL+ L L    L ++                 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV----------------- 64

Query: 146 IPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLT 205
              +L     L++L+LS N+  G + +    L NL  LNL  N L      D+  +  L 
Sbjct: 65  --SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLK 117

Query: 206 NCSSLKALSLCDN 218
               LK+L L + 
Sbjct: 118 KLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 21/79 (26%), Positives = 36/79 (45%), Gaps = 2/79 (2%)

Query: 368 DSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPE 427
           D+     G ++ L    V+LE+L + +     V       +  +K+L +S N + G +  
Sbjct: 32  DNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPK--LPKLKKLELSENRIFGGLDM 89

Query: 428 FLQNLSFLEFLNLSYNHLE 446
             + L  L  LNLS N L+
Sbjct: 90  LAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 19/69 (27%), Positives = 29/69 (42%)

Query: 60  LGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY 119
           L  L  L  L ++EN+  G        + +L  + L+ N+       + L  L  LK L 
Sbjct: 67  LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126

Query: 120 LTFCSLKNL 128
           L  C + NL
Sbjct: 127 LFNCEVTNL 135

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.1 bits (94), Expect = 9e-04
 Identities = 23/90 (25%), Positives = 35/90 (38%), Gaps = 3/90 (3%)

Query: 254 RNLVNLIALTIEVNQLHGI-IPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLAL 312
           R    +  L ++  + +   I     E  +L+ L +    L  S+   L  L KL  L L
Sbjct: 21  RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLEL 78

Query: 313 SFNNLQGNIPSSLGNCQNLKGFDASHNKLT 342
           S N + G +        NL   + S NKL 
Sbjct: 79  SENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 37/136 (27%), Positives = 53/136 (38%), Gaps = 24/136 (17%)

Query: 68  YLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT------ 121
           YL++  N    +       ++SL  +YL  N+   SLP  +   L +L  L L+      
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 122 -----FCSLKNLWWLNLEQNNLGMGTASSIP----DSLSNASNLERLDLSGNQFKGKVSI 172
                F  L  L  L L  N L      S+P    D L   + L+ L L  NQ K     
Sbjct: 91  LPNGVFDKLTQLKELALNTNQL-----QSLPDGVFDKL---TQLKDLRLYQNQLKSVPDG 142

Query: 173 DFSSLKNLWWLNLEQN 188
            F  L +L ++ L  N
Sbjct: 143 VFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 45/163 (27%), Positives = 64/163 (39%), Gaps = 38/163 (23%)

Query: 157 ERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLC 216
             LDL  N  K   +  F  L +L  L L  N L        +    LT+   L  L+L 
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN---KLTS---LTYLNLS 84

Query: 217 DNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPD 275
            NQ           L S               +P+G+   L  L  L +  NQL   +PD
Sbjct: 85  TNQ-----------LQS---------------LPNGVFDKLTQLKELALNTNQLQS-LPD 117

Query: 276 GV-GELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNN 316
           GV  +L  L+ L +++N L+ S+P      LT L  + L  +N
Sbjct: 118 GVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWL-HDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 37/114 (32%), Positives = 63/114 (55%), Gaps = 7/114 (6%)

Query: 208 SSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRN-LVNLIALTIEV 266
           +    L L  N     LP+ + +  +++ Q  +GGN++  ++P+G+ N L +L  L +  
Sbjct: 28  AQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLST 85

Query: 267 NQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPPSL-GNLTKLADLALSFNNLQ 318
           NQL  + P+GV  +L  L++L +  N LQ S+P  +   LT+L DL L  N L+
Sbjct: 86  NQLQSL-PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK 137

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 26/92 (28%), Positives = 42/92 (45%), Gaps = 4/92 (4%)

Query: 229 ANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQLY 287
             + +      +  N +          L +L  L +  N+L   +P+GV  +L  L  L 
Sbjct: 24  TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLN 82

Query: 288 MFRNFLQGSIPPSL-GNLTKLADLALSFNNLQ 318
           +  N LQ S+P  +   LT+L +LAL+ N LQ
Sbjct: 83  LSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 21/97 (21%), Positives = 31/97 (31%), Gaps = 16/97 (16%)

Query: 81  PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL-----------TFCSLKNLW 129
              +    +L  +Y+   +    L    L  L  L+ L +            F     L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 130 WLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF 166
            LNL  N L      S+        +L+ L LSGN  
Sbjct: 84  RLNLSFNAL-----ESLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.7 bits (105), Expect = 8e-05
 Identities = 25/113 (22%), Positives = 38/113 (33%), Gaps = 4/113 (3%)

Query: 207 CSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSG-IRNLVNLIALTIE 265
                 L  C      +  H +    +   +  I   Q    +    +R L  L  LTI 
Sbjct: 7   PHGSSGL-RCTRDGALDSLHHLPGAENLT-ELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 266 VNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ 318
            + L  + PD       L +L +  N L+ S+         L +L LS N L 
Sbjct: 65  KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.0 bits (103), Expect = 2e-04
 Identities = 26/118 (22%), Positives = 42/118 (35%), Gaps = 9/118 (7%)

Query: 328 CQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSL 387
                G   + +         +     L   L + +        L++ +L+ L      L
Sbjct: 7   PHGSSGLRCTRDGAL-DSLHHLPGAENL-TELYIENQ--QHLQHLELRDLRGLG----EL 58

Query: 388 EYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHL 445
             L I  +    V P +  F   +  LN+S N L     + +Q LS L+ L LS N L
Sbjct: 59  RNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 43.6 bits (102), Expect = 2e-04
 Identities = 19/104 (18%), Positives = 31/104 (29%), Gaps = 10/104 (9%)

Query: 296 SIPPSLGNLTKLADLALSFNNLQGNIPS-SLGNCQNLKGFDASHNKLTGAIPQQVLSITT 354
                L     L +L +       ++    L     L+      + L   +       T 
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 355 LSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFH 398
               L L+ N L     L    ++ L     SL+ L +S N  H
Sbjct: 81  RLSRLNLSFNALES---LSWKTVQGL-----SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 41.6 bits (97), Expect = 7e-04
 Identities = 17/95 (17%), Positives = 27/95 (28%), Gaps = 7/95 (7%)

Query: 145 SIPDSLSNASNLERLDLSGNQFKGKV-SIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL 203
                L  A NL  L +   Q    +   D   L  L  L + ++ L     +       
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFH---- 77

Query: 204 LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQF 238
                 L  L+L  N        ++  LS   +  
Sbjct: 78  --FTPRLSRLNLSFNALESLSWKTVQGLSLQELVL 110

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 47/325 (14%), Positives = 97/325 (29%), Gaps = 36/325 (11%)

Query: 107 DILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSL-SNASNLERLDLSGNQ 165
           D L      +    +   L +L  LNL    +     + +   L S    L+ ++L+  Q
Sbjct: 53  DHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQ 112

Query: 166 FKGKVSIDFSS-LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGEL 224
                             L L+ N+LG     DL  + LL +   +  L L +N      
Sbjct: 113 LDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDL-LLHDQCQITTLRLSNNPLTAAG 171

Query: 225 PHSIANL---SSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQ 281
              +      ++++    +    +      G    + L+A  ++ N             +
Sbjct: 172 VAVLMEGLAGNTSVTHLSLLHTGLG---DEG----LELLAAQLDRN-------------R 211

Query: 282 HLQQLYMFRNFLQGS----IPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDAS 337
            LQ+L +  N    +    +  +      L  L L FN L       L          A+
Sbjct: 212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL--RDLGG---AA 266

Query: 338 HNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSF 397
                  +     +  +    + L+    N +   +    ++L +    LE    ++ + 
Sbjct: 267 EGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNP 326

Query: 398 HGVIPFSLGFMKSIKELNVSSNNLS 422
                  L     ++ L     +  
Sbjct: 327 W-RKAQLLRVEGEVRALLEQLGSSG 350

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 50.9 bits (122), Expect = 9e-07
 Identities = 31/184 (16%), Positives = 60/184 (32%), Gaps = 27/184 (14%)

Query: 63  LRNLVYLNVAENQFSGMFPRWIC-----NISSLEFIYLTVNRFSGSLPFDILVNLPNLKE 117
           L +L  LN+A  + + +    +         +L+ + L   +   +    +L      ++
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130

Query: 118 LYLTFCSLKN----------------LWWLNLEQNNLGMGTASSIPDSLSNASNLERLDL 161
           L L   SL                  +  L L  N L     + + + L+  +++  L L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL 190

Query: 162 SGNQFKGKVSIDFSSL----KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCD 217
                  +     ++     + L  LN+  N  G   A  L          SL+ L L  
Sbjct: 191 LHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL--ARAAREHPSLELLHLYF 248

Query: 218 NQFG 221
           N+  
Sbjct: 249 NELS 252

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 25/114 (21%), Positives = 37/114 (32%), Gaps = 29/114 (25%)

Query: 93  IYLTVNRFSGSLPFDILVNLPNLKELYLT-----------FCSLKNLWWLNLEQNNLGMG 141
           + L  N         +   LP+L +L L            F    ++  L L +N +   
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI--- 90

Query: 142 TASSIP----DSLSNASNLERLDLSGNQFKGKVSI---DFSSLKNLWWLNLEQN 188
               I       L     L+ L+L  NQ      +    F  L +L  LNL  N
Sbjct: 91  --KEISNKMFLGL---HQLKTLNLYDNQIS---CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 20/93 (21%), Positives = 39/93 (41%), Gaps = 5/93 (5%)

Query: 229 ANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQL 286
            ++     +  +  N++      G+   L +L+ L ++ NQL GI          H+Q+L
Sbjct: 25  RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI-EPNAFEGASHIQEL 83

Query: 287 YMFRNFLQGSIPPSL-GNLTKLADLALSFNNLQ 318
            +  N ++  I   +   L +L  L L  N + 
Sbjct: 84  QLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS 115

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 21/76 (27%), Positives = 31/76 (40%), Gaps = 18/76 (23%)

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIP----DSLSNASNLERLDLSGNQFKGKVSID---F 174
           F  L +L  L L++N L     + I     +  S+   ++ L L  N+ K    I    F
Sbjct: 50  FGRLPHLVKLELKRNQL-----TGIEPNAFEGASH---IQELQLGENKIK---EISNKMF 98

Query: 175 SSLKNLWWLNLEQNNL 190
             L  L  LNL  N +
Sbjct: 99  LGLHQLKTLNLYDNQI 114

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 26/94 (27%), Positives = 38/94 (40%), Gaps = 19/94 (20%)

Query: 131 LNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNL 190
           L L  N LG  ++  +   L +   L +L+L  NQ  G     F    ++  L L +N +
Sbjct: 34  LLLNDNELGRISSDGLFGRLPH---LVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90

Query: 191 -----GMGTANDLDFVTLLTNCSSLKALSLCDNQ 219
                 M       F+ L      LK L+L DNQ
Sbjct: 91  KEISNKM-------FLGL----HQLKTLNLYDNQ 113

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 22/72 (30%), Positives = 35/72 (48%), Gaps = 5/72 (6%)

Query: 249 IPSGIRNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPPSL-GNLTK 306
           IP  I   ++   L +  N+L  I  DG+ G L HL +L + RN L   I P+     + 
Sbjct: 23  IPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79

Query: 307 LADLALSFNNLQ 318
           + +L L  N ++
Sbjct: 80  IQELQLGENKIK 91

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 34/165 (20%), Positives = 53/165 (32%), Gaps = 52/165 (31%)

Query: 56  IPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL 115
           +  TL  L+   +L ++ N         I  ISSL                     + NL
Sbjct: 40  MDATLSTLKACKHLALSTNN--------IEKISSLS-------------------GMENL 72

Query: 116 KELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS 175
           +              L+L +N +       I +  + A  LE L +S NQ    +S    
Sbjct: 73  R-------------ILSLGRNLI-----KKIENLDAVADTLEELWISYNQIA-SLS-GIE 112

Query: 176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQF 220
            L NL  L +  N +      +   +  L     L+ L L  N  
Sbjct: 113 KLVNLRVLYMSNNKI-----TNWGEIDKLAALDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 39/174 (22%), Positives = 61/174 (35%), Gaps = 41/174 (23%)

Query: 122 FCSLKNLWWLNLEQNNLGMGTA--SSIPDSLSNASNLERLDLSGNQFKGKVSID-FSSLK 178
           F   K++     E+  L         +  +LS     + L LS N  +    I   S ++
Sbjct: 14  FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE---KISSLSGME 70

Query: 179 NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQF 238
           NL  L+L +N +            L     +L+ L +  NQ        IA+L       
Sbjct: 71  NLRILSLGRNLIK-------KIENLDAVADTLEELWISYNQ--------IASL------- 108

Query: 239 RIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIP-DGVGELQHLQQLYMFRN 291
                       SGI  LVNL  L +  N++      D +  L  L+ L +  N
Sbjct: 109 ------------SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 32/171 (18%), Positives = 66/171 (38%), Gaps = 13/171 (7%)

Query: 226 HSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQ 285
            S+    +  ++       I   + + +  L     L +  N +  I    +  +++L+ 
Sbjct: 18  KSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRI 74

Query: 286 LYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAI 345
           L + RN ++  I         L +L +S+N +  ++ S +    NL+    S+NK+T   
Sbjct: 75  LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITN-- 129

Query: 346 PQQVLSITTLS--VYLALAHNLLNDSLPLQVGNL---KNLVITCVSLEYLD 391
             ++  +  L     L LA N L +              +V    +L+ LD
Sbjct: 130 WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 27/124 (21%), Positives = 52/124 (41%), Gaps = 14/124 (11%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGG----QIP 57
             +E  +   + +L   + LA+  N +       + +LS +  L  R  SLG     +I 
Sbjct: 35  PPIEK-MDATLSTLKACKHLALSTNNIEK-----ISSLSGMENL--RILSLGRNLIKKIE 86

Query: 58  TTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKE 117
               +   L  L ++ NQ + +    I  + +L  +Y++ N+ +     D L  L  L++
Sbjct: 87  NLDAVADTLEELWISYNQIASLSG--IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLED 144

Query: 118 LYLT 121
           L L 
Sbjct: 145 LLLA 148

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 18/141 (12%), Positives = 45/141 (31%), Gaps = 38/141 (26%)

Query: 306 KLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNL 365
           +  +L      ++  + ++L   +  K    S N +                        
Sbjct: 26  EKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE----------------------- 61

Query: 366 LNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQI 425
                  ++ +L  +     +L  L +  N    +         +++EL +S N ++  +
Sbjct: 62  -------KISSLSGME----NLRILSLGRNLIKKIENLD-AVADTLEELWISYNQIA-SL 108

Query: 426 PEFLQNLSFLEFLNLSYNHLE 446
              ++ L  L  L +S N + 
Sbjct: 109 -SGIEKLVNLRVLYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 17/88 (19%), Positives = 39/88 (44%), Gaps = 6/88 (6%)

Query: 362 AHNLLNDSLPLQVGNLKNL---VITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSS 418
           A       L   +  ++ +   + T  + ++L +S+N+   +    L  M++++ L++  
Sbjct: 22  ATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGR 79

Query: 419 NNLSGQIPEFLQNLSFLEFLNLSYNHLE 446
           N +  +I         LE L +SYN + 
Sbjct: 80  NLIK-KIENLDAVADTLEELWISYNQIA 106

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.1 bits (121), Expect = 9e-07
 Identities = 27/167 (16%), Positives = 64/167 (38%), Gaps = 17/167 (10%)

Query: 294 QGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLS-- 351
           Q  + P L  +  L +L +   N   N+        NLK  +     L  ++ + +L   
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217

Query: 352 ---ITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLG-- 406
              +  L +Y+ +     +  + +             +L++L I       V+       
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKD--RFPNLKWLGIVDAEEQNVVVEMFLES 275

Query: 407 -FMKSIKELNVSSNNLSG----QIPEFLQNLSFLEFLNLSYNHLEGE 448
             +  ++ +++S+  L+      + + +  +  L+F+N+ YN+L  E
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.2 bits (116), Expect = 3e-06
 Identities = 24/161 (14%), Positives = 46/161 (28%), Gaps = 26/161 (16%)

Query: 31  QLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWIC----- 85
           +  D    L A+ +L          +        NL  L +            I      
Sbjct: 160 EQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLP 219

Query: 86  NISSLEFIYLTVNRFSGSLPFDILV------NLPNLKELYLTFCS--------------L 125
           N+  L  +Y+ V  +      ++          PNLK L +                  L
Sbjct: 220 NLEKLV-LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 126 KNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF 166
             L  +++    L    A  + D +    +L+ +++  N  
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.8 bits (102), Expect = 2e-04
 Identities = 34/183 (18%), Positives = 61/183 (33%), Gaps = 21/183 (11%)

Query: 54  GQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILV-NL 112
             +   L  +  L  L +       +  +   N+ SLE I         S+  DIL  +L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIIS---GGLPDSVVEDILGSDL 218

Query: 113 PNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNAS--NLERLDLSGNQFKGKV 170
           PNL++L L              ++    G  +      S     NL+ L +   + +  V
Sbjct: 219 PNLEKLVLYVGV----------EDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVV 268

Query: 171 SIDFSS---LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHS 227
              F     L  L  +++    L    A  L  +  +     LK +++  N    E+   
Sbjct: 269 VEMFLESDILPQLETMDISAGVLTDEGARLL--LDHVDKIKHLKFINMKYNYLSDEMKKE 326

Query: 228 IAN 230
           +  
Sbjct: 327 LQK 329

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 26/132 (19%), Positives = 55/132 (41%), Gaps = 12/132 (9%)

Query: 126 KNLWWLNL-EQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL----KNL 180
            +L  +NL    N+ + T  +  ++L   + +++  + G +    V+   + +      L
Sbjct: 36  PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTL 95

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDN--QFGGELPHSIANL---SSTM 235
             LN+E N +       L    L +N +SL  L + +     G  +   IAN+   ++T+
Sbjct: 96  KSLNVESNFISGSGILAL-VEALQSN-TSLIELRIDNQSQPLGNNVEMEIANMLEKNTTL 153

Query: 236 IQFRIGGNQISG 247
           ++F     Q   
Sbjct: 154 LKFGYHFTQQGP 165

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 14/99 (14%), Positives = 39/99 (39%), Gaps = 6/99 (6%)

Query: 130 WLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF--KGKVSIDFSSLKN---LWWLN 184
             ++         A ++ + L   + L+ L++  N     G +++   +L++   L  L 
Sbjct: 69  KFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL-VEALQSNTSLIELR 127

Query: 185 LEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE 223
           ++  +  +G   +++   +L   ++L        Q G  
Sbjct: 128 IDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGPR 166

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.1 bits (110), Expect = 9e-06
 Identities = 33/116 (28%), Positives = 44/116 (37%), Gaps = 24/116 (20%)

Query: 88  SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT-----------FCSLKNLWWLNLEQN 136
           SS   + L  N+   SLP  +   L  L +L L+           F  L  L  L L +N
Sbjct: 28  SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86

Query: 137 NLGMGTASSIP----DSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQN 188
            L      S+P    D L   + L+ L L  NQ K      F  L +L  + L  N
Sbjct: 87  KL-----QSLPNGVFDKL---TQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 36/140 (25%), Positives = 55/140 (39%), Gaps = 35/140 (25%)

Query: 154 SNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKAL 213
           S+  RL+L  N+ +      F  L  L  L+L QN +        D    LT    L  L
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFD---KLTK---LTIL 81

Query: 214 SLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGI 272
            L +N+           L S               +P+G+   L  L  L ++ NQL   
Sbjct: 82  YLHENK-----------LQS---------------LPNGVFDKLTQLKELALDTNQLKS- 114

Query: 273 IPDGV-GELQHLQQLYMFRN 291
           +PDG+   L  LQ++++  N
Sbjct: 115 VPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 23/76 (30%), Positives = 31/76 (40%), Gaps = 18/76 (23%)

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIP----DSLSNASNLERLDLSGNQFKGKVSID---F 174
           F  L  L  L+L QN +      S+P    D L   + L  L L  N+ +   S+    F
Sbjct: 48  FDKLTQLTKLSLSQNQI-----QSLPDGVFDKL---TKLTILYLHENKLQ---SLPNGVF 96

Query: 175 SSLKNLWWLNLEQNNL 190
             L  L  L L+ N L
Sbjct: 97  DKLTQLKELALDTNQL 112

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 5/79 (6%)

Query: 242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPPS 300
           GNQ +  +P  + N  +L  + +  N++   + +     +  L  L +  N L+  IPP 
Sbjct: 40  GNQFT-LVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLR-CIPPR 96

Query: 301 L-GNLTKLADLALSFNNLQ 318
               L  L  L+L  N++ 
Sbjct: 97  TFDGLKSLRLLSLHGNDIS 115

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 37/140 (26%), Positives = 52/140 (37%), Gaps = 39/140 (27%)

Query: 56  IPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL 115
           IP  +  L    YL+   NQF+ + P+ + N   L  I L+ NR S +L           
Sbjct: 29  IPRDVTEL----YLDG--NQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQ-------- 72

Query: 116 KELYLTFCSLKNLWWLNLEQNNLGMGTASSIP----DSLSNASNLERLDLSGNQFKGKVS 171
                +F ++  L  L L  N L       IP    D L    +L  L L GN       
Sbjct: 73  -----SFSNMTQLLTLILSYNRL-----RCIPPRTFDGL---KSLRLLSLHGNDIS---V 116

Query: 172 I---DFSSLKNLWWLNLEQN 188
           +    F+ L  L  L +  N
Sbjct: 117 VPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 26/89 (29%), Positives = 37/89 (41%), Gaps = 11/89 (12%)

Query: 131 LNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNL 190
           L L+ N       + +P  LSN  +L  +DLS N+     +  FS++  L  L L  N L
Sbjct: 36  LYLDGNQF-----TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90

Query: 191 GMGTANDLDFVTLLTNCSSLKALSLCDNQ 219
                   D +       SL+ LSL  N 
Sbjct: 91  RCIPPRTFDGLK------SLRLLSLHGND 113

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 14/122 (11%), Positives = 41/122 (33%), Gaps = 9/122 (7%)

Query: 115 LKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF--KGKVSI 172
           ++ L    C+ K++   +L    +    A  + + +  + +L  L++  N    +    +
Sbjct: 59  IRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118

Query: 173 DFSSLKN---LWWLNLEQNNLG-MGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSI 228
              S      +     +      +G   ++D +  +    SL  + +          H +
Sbjct: 119 -LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASMEAR--HRV 175

Query: 229 AN 230
           + 
Sbjct: 176 SE 177

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 19/124 (15%), Positives = 40/124 (32%), Gaps = 11/124 (8%)

Query: 115 LKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDF 174
           +  L      LK +   N     +      S+ ++  N+ ++E+  L+        +   
Sbjct: 33  INRLREDDTDLKEVNINN--MKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGL 90

Query: 175 SSL----KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCD---NQFGGELPHS 227
             L     +L  LN+E N L       L   + L    S+      +   +  G ++   
Sbjct: 91  IELIETSPSLRVLNVESNFLTPELLARL-LRSTLVT-QSIVEFKADNQRQSVLGNQVEMD 148

Query: 228 IANL 231
           +   
Sbjct: 149 MMMA 152

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 44.9 bits (106), Expect = 8e-05
 Identities = 41/227 (18%), Positives = 76/227 (33%), Gaps = 24/227 (10%)

Query: 9   PEEIGSLLNLQTLAIDF--NYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL 66
           P+  G LL+   +A     +++   L +         M L         +   L     L
Sbjct: 61  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120

Query: 67  VYLNVAENQFSGMFPRWICNISSLEFIYLT-VNRFSGSLPFDILVNLPNLKELYLTFCS- 124
             L++   + S      +   S+L  + L+  + FS      +L +   L EL L++C  
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 180

Query: 125 -------------LKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS 171
                         + +  LNL      +   S +   +    NL  LDLS +     V 
Sbjct: 181 FTEKHVQVAVAHVSETITQLNLSGYRKNL-QKSDLSTLVRRCPNLVHLDLSDS-----VM 234

Query: 172 IDFSSLKNLWWL-NLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCD 217
           +     +  + L  L+  +L        + +  L    +LK L +  
Sbjct: 235 LKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 7/76 (9%)

Query: 249 IPSGIRNLVNLIALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIPPSL-GNLTK 306
           +P+GI    +   L +  NQ+  +   GV   L +LQQLY   N L  +IP  +   LT+
Sbjct: 27  VPAGI--PTDKQRLWLNNNQITKL-EPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82

Query: 307 LADLALSFNNLQGNIP 322
           L  L L+ N+L+ +IP
Sbjct: 83  LTQLDLNDNHLK-SIP 97

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	854
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.92
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.82
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.82
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.82
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.82
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.82
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.81
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.81
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.81
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.81
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.79
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.79
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.78
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.78
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.78
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.77
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.76
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.76
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.74
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.72
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.71
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.7
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.67
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.67
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.66
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.63
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.62
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.61
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.61
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.6
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.58
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.53
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.52
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.51
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.49
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.47
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.46
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.43
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.4
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.34
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.33
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.28
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.26
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.16
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.95
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.93
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.88
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.85
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.63
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.5
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.48
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.48
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.42
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.39
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.35
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.29
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.13
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.04
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.96
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.85
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.83
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.78
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.72
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.68
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.62
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.48
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.35
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.2
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.15
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.14
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.12
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.96
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.85
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.76
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.69
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.59
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.57
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.56
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.38
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.89
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.14
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.08
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.03

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.4e-59  Score=564.71  Aligned_cols=460  Identities=30%  Similarity=0.463  Sum_probs=289.7

Q ss_pred             CcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCC-CCCcEEecccccCcccC
Q 043388            2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLL-RNLVYLNVAENQFSGMF   80 (854)
Q Consensus         2 n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~   80 (854)
                      |+++|.+|..|+.+++|++|+|++|.+++.+|..  .+++|++|+|++|++++.+|..+..+ ++|++|+|++|++++..
T Consensus       233 n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~  310 (768)
T 3rgz_A          233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV  310 (768)
T ss_dssp             SCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECC
T ss_pred             CcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCcc
Confidence            3444444444444444444444444444433332  34444444444444444555555443 55555555555555555


Q ss_pred             hhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCC------------CCceeeccCccCCCCCCCCCCc
Q 043388           81 PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLK------------NLWWLNLEQNNLGMGTASSIPD  148 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~------------~L~~L~L~~N~l~~~~~~~~p~  148 (854)
                      |..|+++++|++|+|++|+++|.+|...|.++++|++|++++|++.            +|+.|+|++|.+.    +.+|.
T Consensus       311 p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~----~~~~~  386 (768)
T 3rgz_A          311 PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS----GPILP  386 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEE----EECCT
T ss_pred             chHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcC----CCcCh
Confidence            5555555555555555555555555555555555555555555442            5555555555552    23344


Q ss_pred             cccC--CCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCCh
Q 043388          149 SLSN--ASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPH  226 (854)
Q Consensus       149 ~~~~--l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  226 (854)
                      .+..  +++|++|+|++|++++..|..|..+++|++|+|++|+++....      ..+..+++|++|++++|.+++.+|.
T Consensus       387 ~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p------~~l~~l~~L~~L~L~~n~l~~~~p~  460 (768)
T 3rgz_A          387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP------SSLGSLSKLRDLKLWLNMLEGEIPQ  460 (768)
T ss_dssp             TTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCC------GGGGGCTTCCEEECCSSCCCSCCCG
T ss_pred             hhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCccc------HHHhcCCCCCEEECCCCcccCcCCH
Confidence            4433  4555555555555555555555555555555555555543221      2345555555555555555555555


Q ss_pred             hhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccc
Q 043388          227 SIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTK  306 (854)
Q Consensus       227 ~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  306 (854)
                      .+..+. .|+.|++++|++++.+|..|.++++|++|+|++|++++.+|.+|+.+++|++|+|++|++++.+|..++.+++
T Consensus       461 ~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  539 (768)
T 3rgz_A          461 ELMYVK-TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRS  539 (768)
T ss_dssp             GGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTT
T ss_pred             HHcCCC-CceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCC
Confidence            555554 4555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             cchhccccceecccCCCCCcCCCCCc----------------------------------------------ccccCCCc
Q 043388          307 LADLALSFNNLQGNIPSSLGNCQNLK----------------------------------------------GFDASHNK  340 (854)
Q Consensus       307 L~~L~L~~N~l~~~~~~~~~~l~~L~----------------------------------------------~L~ls~N~  340 (854)
                      |+.|++++|++++.+|..+.....+.                                              .++++.|.
T Consensus       540 L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  619 (768)
T 3rgz_A          540 LIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV  619 (768)
T ss_dssp             CCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCE
T ss_pred             CCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccce
Confidence            55555555555555555443322221                                              22333344


Q ss_pred             ccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcc
Q 043388          341 LTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNN  420 (854)
Q Consensus       341 l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  420 (854)
                      +.|.+|..+..+..+.. +++++|.+++.+|..+++       +..|+.|+|++|+++|.+|..|+.+++|+.|||++|+
T Consensus       620 ~~g~~~~~~~~l~~L~~-LdLs~N~l~g~ip~~l~~-------l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~  691 (768)
T 3rgz_A          620 YGGHTSPTFDNNGSMMF-LDMSYNMLSGYIPKEIGS-------MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK  691 (768)
T ss_dssp             EEEECCCSCSSSBCCCE-EECCSSCCBSCCCGGGGG-------CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred             ecccCchhhhccccccE-EECcCCcccccCCHHHhc-------cccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence            55555555544555544 899999999999999998       4579999999999999999999999999999999999


Q ss_pred             cccccchhhcCccCCCeeecccccCcccCCCCccccCcccccccccccccCCccccccccCCCCCC
Q 043388          421 LSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLSCPSKGS  486 (854)
Q Consensus       421 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~c~~~~~  486 (854)
                      ++|.+|..+..+++|++|||++|+++|.+|..++|..+...++.+|+++||.|..    .|.....
T Consensus       692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~----~C~~~~~  753 (768)
T 3rgz_A          692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP----RCDPSNA  753 (768)
T ss_dssp             CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC----CCCSCC-
T ss_pred             ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc----CCCCCcc
Confidence            9999999999999999999999999999999999999999999999999998632    6765443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.1e-54  Score=519.65  Aligned_cols=454  Identities=31%  Similarity=0.442  Sum_probs=334.0

Q ss_pred             CcccccCchh---hhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcc
Q 043388            2 NKLEGQIPEE---IGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSG   78 (854)
Q Consensus         2 n~~~~~~p~~---~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~   78 (854)
                      |++++..|..   +.++++|++|+|++|.+++..|  ++.+++|++|+|++|++++.+|. |+.+++|++|+|++|++++
T Consensus       161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~  237 (768)
T 3rgz_A          161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSG  237 (768)
T ss_dssp             SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCS
T ss_pred             CccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCC
Confidence            5566666655   5666666666666666665443  26677788888888888766666 7888888888888888887


Q ss_pred             cChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCC------------CCCceeeccCccCCCCCCCCC
Q 043388           79 MFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSL------------KNLWWLNLEQNNLGMGTASSI  146 (854)
Q Consensus        79 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l------------~~L~~L~L~~N~l~~~~~~~~  146 (854)
                      ..|.+|.++++|++|+|++|++++.+|..   .+++|++|++++|++            ++|+.|+|++|.+.    +.+
T Consensus       238 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~----~~~  310 (768)
T 3rgz_A          238 DFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY----GAV  310 (768)
T ss_dssp             CHHHHTTTCSSCCEEECCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEE----ECC
T ss_pred             cccHHHhcCCCCCEEECCCCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCC----Ccc
Confidence            78888888888888888888877666543   666777777766542            45677777777663    345


Q ss_pred             CccccCCCCCCEEecCCCcCcccCCcC-ccccCCCCeEecccccccCCCCCChh-------------------hhhhccC
Q 043388          147 PDSLSNASNLERLDLSGNQFKGKVSID-FSSLKNLWWLNLEQNNLGMGTANDLD-------------------FVTLLTN  206 (854)
Q Consensus       147 p~~~~~l~~L~~L~Ls~N~i~~~~~~~-f~~l~~L~~L~L~~N~l~~~~~~~~~-------------------~~~~~~~  206 (854)
                      |..|+++++|++|+|++|++++..|.. |..+++|++|+|++|+++......+.                   .+..+..
T Consensus       311 p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~  390 (768)
T 3rgz_A          311 PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ  390 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTC
T ss_pred             chHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhh
Confidence            666667777777777777766444433 66666666666666666421111110                   0111222


Q ss_pred             --CCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCc
Q 043388          207 --CSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQ  284 (854)
Q Consensus       207 --l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  284 (854)
                        +++|++|++++|++++.+|..+..+. .|+.|++++|.+++.+|..|.++++|+.|++++|++++..|..|..+++|+
T Consensus       391 ~~~~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  469 (768)
T 3rgz_A          391 NPKNTLQELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE  469 (768)
T ss_dssp             STTCCCCEEECCSSEEEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred             cccCCccEEECCCCccccccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCce
Confidence              56677777777777777777777775 677788888887777777777777888888888887777777777778888


Q ss_pred             eeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcC
Q 043388          285 QLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHN  364 (854)
Q Consensus       285 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n  364 (854)
                      +|++++|++++.+|..+.++++|+.|+|++|++++.+|.+++.+++|+.|++++|++++.+|..+..+..+.. +++++|
T Consensus       470 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~-L~Ls~N  548 (768)
T 3rgz_A          470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIW-LDLNTN  548 (768)
T ss_dssp             EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCE-EECCSS
T ss_pred             EEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCE-EECCCC
Confidence            8888888887777777888888888888888887777878888888888888888887777777777776655 778888


Q ss_pred             CCCCCcCccccccccc---------------------------------------------------------------c
Q 043388          365 LLNDSLPLQVGNLKNL---------------------------------------------------------------V  381 (854)
Q Consensus       365 ~l~~~~p~~~~~l~~l---------------------------------------------------------------~  381 (854)
                      .+++.+|..+.....+                                                               +
T Consensus       549 ~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~  628 (768)
T 3rgz_A          549 LFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF  628 (768)
T ss_dssp             EEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSC
T ss_pred             ccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhh
Confidence            8777777665432111                                                               1


Q ss_pred             ccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCCC-ccccCccc
Q 043388          382 ITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTK-GVFSNKTK  460 (854)
Q Consensus       382 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~  460 (854)
                      ..+.+|+.|||++|+++|.+|..|+.++.|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|.. ..+.....
T Consensus       629 ~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~  708 (768)
T 3rgz_A          629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE  708 (768)
T ss_dssp             SSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSE
T ss_pred             hccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE
Confidence            12467999999999999999999999999999999999999999999999999999999999999999975 44566777


Q ss_pred             ccccccc
Q 043388          461 ISLQVNV  467 (854)
Q Consensus       461 ~~~~~n~  467 (854)
                      +++..|.
T Consensus       709 L~ls~N~  715 (768)
T 3rgz_A          709 IDLSNNN  715 (768)
T ss_dssp             EECCSSE
T ss_pred             EECcCCc
Confidence            7777774

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=4.6e-52  Score=488.43  Aligned_cols=455  Identities=22%  Similarity=0.199  Sum_probs=384.1

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      +|+|++..|..|+.+++|++|+|++|++++..|.+|+.+++|++|+|++|++++..|..|+.+++|++|+|++|+++++.
T Consensus        42 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~  121 (606)
T 3t6q_A           42 FNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSID  121 (606)
T ss_dssp             TCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGG
T ss_pred             CCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCC
Confidence            47888888889999999999999999998888888999999999999999998888889999999999999999999877


Q ss_pred             hhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCC-----------CCCc--eeeccCccCCCCCCCCCC
Q 043388           81 PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSL-----------KNLW--WLNLEQNNLGMGTASSIP  147 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l-----------~~L~--~L~L~~N~l~~~~~~~~p  147 (854)
                      |..|+++++|++|+|++|+++ .++...+..+++|++|++++|.+           .+|+  .|++++|.+.......+.
T Consensus       122 ~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~  200 (606)
T 3t6q_A          122 FIPLHNQKTLESLYLGSNHIS-SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFD  200 (606)
T ss_dssp             GSCCTTCTTCCEEECCSSCCC-CCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTT
T ss_pred             cchhccCCcccEEECCCCccc-ccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhh
Confidence            888899999999999999988 65544455689999999988865           3556  788888888432211110


Q ss_pred             ---------------------------------------------ccccCCC--CCCEEecCCCcCcccCCcCccccCCC
Q 043388          148 ---------------------------------------------DSLSNAS--NLERLDLSGNQFKGKVSIDFSSLKNL  180 (854)
Q Consensus       148 ---------------------------------------------~~~~~l~--~L~~L~Ls~N~i~~~~~~~f~~l~~L  180 (854)
                                                                   ..|.++.  +|+.|++++|+++++.+..|..+++|
T Consensus       201 ~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L  280 (606)
T 3t6q_A          201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGL  280 (606)
T ss_dssp             TCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTC
T ss_pred             hccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCC
Confidence                                                         0111111  68889999999998888889999999


Q ss_pred             CeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCc-cccccccC
Q 043388          181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPS-GIRNLVNL  259 (854)
Q Consensus       181 ~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~-~~~~l~~L  259 (854)
                      ++|++++|+++.++.       .+.++++|++|++++|.+++..|..+..++ .|+.|++++|.+.+.+|. .|.++++|
T Consensus       281 ~~L~l~~n~l~~lp~-------~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L  352 (606)
T 3t6q_A          281 QELDLTATHLSELPS-------GLVGLSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENL  352 (606)
T ss_dssp             SEEECTTSCCSCCCS-------SCCSCTTCCEEECTTCCCSBGGGGCGGGCT-TCSEEECCSCSSCCBCCSSTTTTCTTC
T ss_pred             CEEeccCCccCCCCh-------hhcccccCCEEECccCCcCcCchhhhhccC-cCCEEECCCCCcccccchhhhhccCcC
Confidence            999999999986654       478899999999999999977788888886 799999999999866654 48999999


Q ss_pred             CeeeccccccccCC--CCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCC-CCcCCCCCccccc
Q 043388          260 IALTIEVNQLHGII--PDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPS-SLGNCQNLKGFDA  336 (854)
Q Consensus       260 ~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l  336 (854)
                      ++|++++|++++..  +..+..+++|++|++++|++.+..|..|..+++|+.|++++|.+++..|. .+..+++|+.|++
T Consensus       353 ~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l  432 (606)
T 3t6q_A          353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL  432 (606)
T ss_dssp             CEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEEC
T ss_pred             CEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEEC
Confidence            99999999998776  78899999999999999999988899999999999999999999977654 4889999999999


Q ss_pred             CCCcccCccchhhcchhhhHHHHHhhcCCCCCCcC---ccccccccccccccccceeeccCcccccCCCcccccCCCCCE
Q 043388          337 SHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLP---LQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKE  413 (854)
Q Consensus       337 s~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p---~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  413 (854)
                      ++|.+++..|..+..+..+.. +++++|.+.+...   ..++.       +.+|++|+|++|++++.+|..|+.+++|++
T Consensus       433 ~~n~l~~~~~~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~~~~-------l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  504 (606)
T 3t6q_A          433 SHSLLDISSEQLFDGLPALQH-LNLQGNHFPKGNIQKTNSLQT-------LGRLEILVLSFCDLSSIDQHAFTSLKMMNH  504 (606)
T ss_dssp             TTCCCBTTCTTTTTTCTTCCE-EECTTCBCGGGEECSSCGGGG-------CTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             CCCccCCcCHHHHhCCCCCCE-EECCCCCCCccccccchhhcc-------CCCccEEECCCCccCccChhhhccccCCCE
Confidence            999999878887877777765 9999999876322   33444       568999999999999999999999999999


Q ss_pred             EEccCcccccccchhhcCccCCCeeecccccCcccCCCC-ccccCcccccccccccccCCc
Q 043388          414 LNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTK-GVFSNKTKISLQVNVKLCGGI  473 (854)
Q Consensus       414 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  473 (854)
                      |+|++|++++..|..+.+++.| .|++++|++++.+|.. ..+.....+.+.+|++.|.++
T Consensus       505 L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             EECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             EECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            9999999999999999999999 9999999999887763 456778889999999998654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=439.64  Aligned_cols=261  Identities=29%  Similarity=0.438  Sum_probs=202.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +++.+.++||+|+||+||+|++.+   .||||+++...  ....+.|.+|++++++++|||||+++|+|...      ..
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~------~~  106 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD------NL  106 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC------eE
Confidence            567788999999999999999863   48999987443  33457899999999999999999999998542      36


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      +||||||++|+|.+++.....     .+++.+++.|+.|||.||+|||++   +||||||||+|||+++++.+|+ |||+
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             EEEEEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccC
Confidence            999999999999999976542     689999999999999999999999   9999999999999999988887 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMG---SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |+......... .....+||+.|||||++.+   +.|+.++|||||||++|||+||+.||....... .....+......
T Consensus       179 a~~~~~~~~~~-~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~~~  256 (307)
T 3omv_A          179 ATVKSRWSGSQ-QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGYAS  256 (307)
T ss_dssp             CBC-------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTCCC
T ss_pred             ceecccCCcce-eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCC
Confidence            98765433221 2233579999999999864   458999999999999999999999997543211 111111111100


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                             |..               .....+|+.++.+++.+||+.||++||||.||++.|+.+...+
T Consensus       257 -------p~~---------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          257 -------PDL---------------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             -------CCS---------------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             -------CCc---------------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence                   000               0011234667889999999999999999999999999887665

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-53  Score=446.61  Aligned_cols=264  Identities=24%  Similarity=0.399  Sum_probs=211.8

Q ss_pred             hhccccCccCCCcceEEEEeEEC-----CCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILG-----GEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ++|.+.+.||+|+||+||+|++.     .++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+    
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~----   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD----   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence            57889999999999999999975     357899999998766666788999999999999999999999998755    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCC-------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC
Q 043388          623 DFKALVFEYMENGSLEDWLHQSND-------HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD  695 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  695 (854)
                       ..+||||||++|+|.++++..+.       ......++|.+++.|+.|||.||+|||++   +||||||||+|||++.+
T Consensus        89 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           89 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             -EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence             68999999999999999986531       11223799999999999999999999999   99999999999999999


Q ss_pred             ccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhH
Q 043388          696 MVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHE  773 (854)
Q Consensus       696 ~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~  773 (854)
                      +.+|+ |||+|+......... ......||+.|||||++.+..++.++|||||||++|||+| |+.||......  .+..
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~-~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~  241 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIE  241 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEE-ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHH
T ss_pred             CcEEECCcccceecCCCCcee-ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH
Confidence            88887 999998765543221 1122458999999999999999999999999999999999 99999754221  1111


Q ss_pred             HhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       774 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      .+...   .                       +.+.+..|+.++.+++.+||+.||++||||+||.+.|+++.+.
T Consensus       242 ~i~~~---~-----------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          242 CITQG---R-----------------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHT---C-----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcC---C-----------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            11110   0                       0111223466788999999999999999999999999987653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.1e-53  Score=448.13  Aligned_cols=264  Identities=25%  Similarity=0.393  Sum_probs=206.7

Q ss_pred             hhccccCccCCCcceEEEEeEEC-----CCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILG-----GEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ++|.+.++||+|+||+||+|++.     .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+    
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~----  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR----  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence            57888899999999999999975     357899999998766666788999999999999999999999998755    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCc---------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDH---------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD  693 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  693 (854)
                       ..+||||||++|+|.++++.....         ....+++|.+++.|+.|||.||+|||+.   +||||||||+|||++
T Consensus       117 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          117 -PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG  192 (329)
T ss_dssp             -SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             -EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence             689999999999999999875421         1123699999999999999999999999   999999999999999


Q ss_pred             CCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchH
Q 043388          694 HDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTL  771 (854)
Q Consensus       694 ~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~  771 (854)
                      .++.+|+ |||+|+......... ......||+.|||||++.+..++.++|||||||++|||+| |+.||......  ..
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~-~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~  269 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EA  269 (329)
T ss_dssp             TTTEEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HH
T ss_pred             CCCcEEEcccccceeccCCCcce-ecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HH
Confidence            9998887 999998775443221 1223569999999999999999999999999999999999 99999754221  11


Q ss_pred             hHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          772 HEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       772 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ...+....                          +.+.+..|++++.+++.+||+.||++||||+||++.|+.+.+.
T Consensus       270 ~~~i~~g~--------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          270 IDCITQGR--------------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHHTC--------------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHcCC--------------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            11111100                          0111223466788999999999999999999999999988754

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=6.2e-51  Score=485.38  Aligned_cols=472  Identities=22%  Similarity=0.224  Sum_probs=336.8

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      +|+|++..|..|+++++|++|+|++|.+++..|.+|+++++|++|+|++|++++..+..|+.+++|++|+|++|+++++.
T Consensus        34 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~  113 (680)
T 1ziw_A           34 HNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK  113 (680)
T ss_dssp             SSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred             CCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccC
Confidence            47788777778888888888888888888878888888888888888888888665567888888888888888888777


Q ss_pred             hhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCC-------------CCCceeeccCccCCCCCCC---
Q 043388           81 PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSL-------------KNLWWLNLEQNNLGMGTAS---  144 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l-------------~~L~~L~L~~N~l~~~~~~---  144 (854)
                      |.+|+++++|++|+|++|+++ .++...|.++++|++|++++|.+             ++|+.|+|++|.+......   
T Consensus       114 ~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~  192 (680)
T 1ziw_A          114 NNPFVKQKNLITLDLSHNGLS-STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH  192 (680)
T ss_dssp             SCTTTTCTTCCEEECCSSCCS-CCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGG
T ss_pred             hhHccccCCCCEEECCCCccc-ccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhh
Confidence            788888888888888888887 55666678888888888887753             4577888888877432211   


Q ss_pred             --------------------------------------------CCCccccCCC--CCCEEecCCCcCcccCCcCccccC
Q 043388          145 --------------------------------------------SIPDSLSNAS--NLERLDLSGNQFKGKVSIDFSSLK  178 (854)
Q Consensus       145 --------------------------------------------~~p~~~~~l~--~L~~L~Ls~N~i~~~~~~~f~~l~  178 (854)
                                                                  ..|..|.+++  +|++|+|++|+++++.+..|..++
T Consensus       193 ~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~  272 (680)
T 1ziw_A          193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLP  272 (680)
T ss_dssp             GSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCT
T ss_pred             hhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcc
Confidence                                                        1123344443  378888888888777777788888


Q ss_pred             CCCeEecccccccCCCCCChh-----------------------hh----hhccCCCCCcEEEcccCcCcccCChhhhhh
Q 043388          179 NLWWLNLEQNNLGMGTANDLD-----------------------FV----TLLTNCSSLKALSLCDNQFGGELPHSIANL  231 (854)
Q Consensus       179 ~L~~L~L~~N~l~~~~~~~~~-----------------------~~----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  231 (854)
                      +|++|+|++|++.......+.                       ++    ..|..+++|++|++++|.+++..|..|..+
T Consensus       273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  352 (680)
T 1ziw_A          273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL  352 (680)
T ss_dssp             TCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTC
T ss_pred             cccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccc
Confidence            888888888877654332111                       00    145566777777777777776656555554


Q ss_pred             c---------------------------ccccEEEccCCcccccCCccccccccCCeeeccccccccCCC-CCccCcccC
Q 043388          232 S---------------------------STMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIP-DGVGELQHL  283 (854)
Q Consensus       232 ~---------------------------~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L  283 (854)
                      +                           +.|+.|++++|++++..|.+|.++++|+.|+|++|++++.+| ..|.++++|
T Consensus       353 ~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  432 (680)
T 1ziw_A          353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENI  432 (680)
T ss_dssp             TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTC
T ss_pred             cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccc
Confidence            3                           123344444455555555666666666666666666654333 456666666


Q ss_pred             ceeeCccccccccCCccccCccccchhccccceec--ccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHh
Q 043388          284 QQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ--GNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL  361 (854)
Q Consensus       284 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l  361 (854)
                      ++|++++|++.+..+..|..+++|+.|++++|.++  +..|..|..+++|+.|++++|++++..|..+..+..+.. +++
T Consensus       433 ~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~-L~L  511 (680)
T 1ziw_A          433 FEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI-LDL  511 (680)
T ss_dssp             CEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE-EEC
T ss_pred             cEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCE-EeC
Confidence            66666666666666666666666666666666665  456777777788888888888887555555556666554 778


Q ss_pred             hcCCCCCCcCccccccc-cccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeec
Q 043388          362 AHNLLNDSLPLQVGNLK-NLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNL  440 (854)
Q Consensus       362 ~~n~l~~~~p~~~~~l~-~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  440 (854)
                      ++|.+.+..+..+..-. ..+..+.+|++|+|++|+++...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus       512 s~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L  591 (680)
T 1ziw_A          512 QHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNL  591 (680)
T ss_dssp             CSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEEC
Confidence            88877654322211000 00112578999999999999666668999999999999999999888888999999999999


Q ss_pred             ccccCcccCCCCc--cccCcccccccccccccCCcc
Q 043388          441 SYNHLEGEVPTKG--VFSNKTKISLQVNVKLCGGID  474 (854)
Q Consensus       441 s~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~~~  474 (854)
                      ++|++++..|...  .+.+...+.+.+|++.|.+..
T Consensus       592 ~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          592 QKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             CCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            9999998776532  467888899999999998753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-51  Score=434.39  Aligned_cols=261  Identities=23%  Similarity=0.347  Sum_probs=208.9

Q ss_pred             hhccccCccCCCcceEEEEeEEC-----CCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILG-----GEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      ++++..++||+|+||+||+|++.     .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+   
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~---  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ---  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC---
Confidence            46777899999999999999974     356899999997543 334578999999999999999999999997755   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceE
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVL  691 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl  691 (854)
                        ..+||||||++|+|.+++......          .....++|.+++.|+.|||+||+|||++   +||||||||+|||
T Consensus       103 --~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL  177 (308)
T 4gt4_A          103 --PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL  177 (308)
T ss_dssp             --SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             --EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence              579999999999999999764321          1123689999999999999999999999   9999999999999


Q ss_pred             ecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCc
Q 043388          692 LDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGL  769 (854)
Q Consensus       692 l~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~  769 (854)
                      +++++.+|+ |||+|+......... ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+....  
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~~~~-~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--  254 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAADYYK-LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--  254 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGGCBC-SSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--
T ss_pred             ECCCCCEEECCcccceeccCCCcee-EecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999988887 999998775543222 1223579999999999999999999999999999999999 89999754221  


Q ss_pred             hHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          770 TLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      .+.+.+..   ..                       +.+.+++|+..+.+++.+||+.||++||||+||++.|+..
T Consensus       255 ~~~~~i~~---~~-----------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          255 DVVEMIRN---RQ-----------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHHHT---TC-----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHc---CC-----------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11111111   00                       0111233466788999999999999999999999999764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.3e-51  Score=433.74  Aligned_cols=258  Identities=22%  Similarity=0.250  Sum_probs=207.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .+.|...++||+|+||.||+|++..+|+.||||+++....     ..+|+.++++++|||||++++++.+.+     ..|
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~-----~~~  126 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP-----WVN  126 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC-----EEE
Confidence            4578889999999999999999999999999999975432     247999999999999999999998765     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc--cccccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM--VAHQNFSL  704 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~~~Dfg~  704 (854)
                      ||||||+||+|.++++..+      .+++.+++.|+.||+.||+|||++   +||||||||+|||++.++  ++++|||+
T Consensus       127 ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGl  197 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGH  197 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred             EEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCC
Confidence            9999999999999998765      789999999999999999999999   999999999999999875  34459999


Q ss_pred             ccccccCCCCC--CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          705 SHQLDSASKTP--SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       705 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+.........  .....++||+.|||||++.+..|+.++||||+||++|||+||+.||....... ..........+. 
T Consensus       198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~~-  275 (336)
T 4g3f_A          198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEPPPI-  275 (336)
T ss_dssp             CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSCCGG-
T ss_pred             CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCCCCc-
Confidence            99876543221  12233579999999999999999999999999999999999999998653332 222222211100 


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                       .                       .....++..+.+++.+||+.||++|||+.|+++.+.......
T Consensus       276 -~-----------------------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          276 -R-----------------------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             -G-----------------------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -h-----------------------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence             0                       011123556789999999999999999999999988876554

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.1e-51  Score=435.20  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=207.5

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ..|+..++||+|+||.||+|++..+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+     ..||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence            46999999999999999999999999999999998766666678899999999999999999999998766     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      |||||+||+|.+++...       .+++.+++.|+.||+.||+|||++   +||||||||+|||++.++..|+ |||+|+
T Consensus       149 vmEy~~gg~L~~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             EECCCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence            99999999999999753       689999999999999999999999   9999999999999999887776 999999


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .+......   ....+||+.|||||++.+..|+.++||||+||++|||++|++||......  .....+....+....  
T Consensus       219 ~~~~~~~~---~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~~~~~--  291 (346)
T 4fih_A          219 QVSKEVPR---RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPRLK--  291 (346)
T ss_dssp             ECCSSSCC---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSSCCCCS--
T ss_pred             ecCCCCCc---ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCCCCCC--
Confidence            87654322   22367999999999999999999999999999999999999999753211  111111111111100  


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                                            ....++.++.+++.+||+.||++|||+.|+++
T Consensus       292 ----------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 ----------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ----------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                                  01112456789999999999999999999976

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-50  Score=487.92  Aligned_cols=444  Identities=20%  Similarity=0.209  Sum_probs=309.2

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccC-CccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCccc
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQL-PDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGM   79 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~   79 (854)
                      .|+|++..|..|+++++|++|+|++|.+.+.+ |.+|+++++|++|+|++|.|++..|..|+.+++|++|+|++|.+++.
T Consensus        33 ~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~  112 (844)
T 3j0a_A           33 FNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA  112 (844)
T ss_dssp             SCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSC
T ss_pred             CCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcc
Confidence            47777777788888888888888888554444 67788888888888888888877788888888888888888888765


Q ss_pred             Chhh--hcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCC-------------CCCceeeccCccCCCCCCC
Q 043388           80 FPRW--ICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSL-------------KNLWWLNLEQNNLGMGTAS  144 (854)
Q Consensus        80 ~p~~--~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l-------------~~L~~L~L~~N~l~~~~~~  144 (854)
                      .|..  |+++++|++|+|++|.+++..+...|.++++|++|++++|.+             .+|+.|+|+.|.+.    +
T Consensus       113 ~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~----~  188 (844)
T 3j0a_A          113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY----S  188 (844)
T ss_dssp             CSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSC----C
T ss_pred             cccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccc----c
Confidence            5544  778888888888888887444445678888888888887765             46777777777774    2


Q ss_pred             CCCccccCCCC------CCEEecCCCcCcccCCcCcccc--------------------------------------CCC
Q 043388          145 SIPDSLSNASN------LERLDLSGNQFKGKVSIDFSSL--------------------------------------KNL  180 (854)
Q Consensus       145 ~~p~~~~~l~~------L~~L~Ls~N~i~~~~~~~f~~l--------------------------------------~~L  180 (854)
                      ..|..+..+++      |++|+|++|++++..+..|...                                      ++|
T Consensus       189 ~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L  268 (844)
T 3j0a_A          189 RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV  268 (844)
T ss_dssp             CCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCC
T ss_pred             ccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCc
Confidence            33444444443      7777777776665444433221                                      456


Q ss_pred             CeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCC
Q 043388          181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLI  260 (854)
Q Consensus       181 ~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~  260 (854)
                      +.|+|++|.+..+...      .|..+++|+.|+|++|++++..|..|..+. .|+.|++++|.+++..|..|.++++|+
T Consensus       269 ~~L~Ls~n~l~~~~~~------~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~  341 (844)
T 3j0a_A          269 RHLDLSHGFVFSLNSR------VFETLKDLKVLNLAYNKINKIADEAFYGLD-NLQVLNLSYNLLGELYSSNFYGLPKVA  341 (844)
T ss_dssp             CEEECTTCCCCEECSC------CSSSCCCCCEEEEESCCCCEECTTTTTTCS-SCCEEEEESCCCSCCCSCSCSSCTTCC
T ss_pred             cEEECCCCcccccChh------hhhcCCCCCEEECCCCcCCCCChHHhcCCC-CCCEEECCCCCCCccCHHHhcCCCCCC
Confidence            6666666666544332      455666666666666666655566666654 566666666666666666666666666


Q ss_pred             eeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCC-----------------
Q 043388          261 ALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPS-----------------  323 (854)
Q Consensus       261 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-----------------  323 (854)
                      .|++++|+++++.+..|..+++|++|+|++|.+++. +    .+++|+.|++++|+++ .+|.                 
T Consensus       342 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N~l~-~l~~~~~~l~~L~ls~N~l~~  415 (844)
T 3j0a_A          342 YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLEN  415 (844)
T ss_dssp             EEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESCCCC-CCCCCCTTCCEEECCSCCCCS
T ss_pred             EEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCCCCcc-cccccccccceeecccCcccc
Confidence            666666666666666666666666666666666532 1    1344444444444444 2222                 


Q ss_pred             -----CCcCCCCCcccccCCCcccCccchh-hcchhhhHHHHHhhcCCCCCCc-----Cccccccccccccccccceeec
Q 043388          324 -----SLGNCQNLKGFDASHNKLTGAIPQQ-VLSITTLSVYLALAHNLLNDSL-----PLQVGNLKNLVITCVSLEYLDI  392 (854)
Q Consensus       324 -----~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~l~~~l~l~~n~l~~~~-----p~~~~~l~~l~~~~~~L~~L~L  392 (854)
                           .+.++++|+.|++++|++++..+.. +.....+. .|++++|.+....     +..+.+       +++|+.|+|
T Consensus       416 l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~-~L~Ls~N~l~~~~~~~~~~~~~~~-------l~~L~~L~L  487 (844)
T 3j0a_A          416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLE-QLFLGENMLQLAWETELCWDVFEG-------LSHLQVLYL  487 (844)
T ss_dssp             STTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCC-BCEEESCCCSSSCCSCCCSSCSSC-------BCCEECCCC
T ss_pred             CchhhhhhcCCccceeeCCCCcccccccccccccCCccc-cccCCCCccccccccccchhhhcC-------cccccEEEC
Confidence                 1336777888888888877543332 22333443 3788888876333     233444       567999999


Q ss_pred             cCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCCCccccCcccccccccccccCC
Q 043388          393 SSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGG  472 (854)
Q Consensus       393 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  472 (854)
                      ++|+|++.+|..|..+++|+.|+|++|+|++..|..+.  ++|+.|||++|++++..|..  |.....+.+.+|++.|.+
T Consensus       488 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c  563 (844)
T 3j0a_A          488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICEC  563 (844)
T ss_dssp             CHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSS
T ss_pred             CCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCccccc
Confidence            99999999999999999999999999999987777776  89999999999999998864  678888999999999976


Q ss_pred             c
Q 043388          473 I  473 (854)
Q Consensus       473 ~  473 (854)
                      .
T Consensus       564 ~  564 (844)
T 3j0a_A          564 E  564 (844)
T ss_dssp             S
T ss_pred             c
Confidence            5

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.8e-50  Score=474.82  Aligned_cols=430  Identities=20%  Similarity=0.172  Sum_probs=382.9

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      +|+|++..|..|+.+++|++|+|++|++++..|..|+.+++|++|++++|++++..|..|+.+++|++|+|++|+++++.
T Consensus        66 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~  145 (606)
T 3t6q_A           66 RCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIK  145 (606)
T ss_dssp             TCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCC
T ss_pred             CCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccC
Confidence            48899999999999999999999999999888999999999999999999999877899999999999999999999866


Q ss_pred             hhhhcCCCCCceeeecccccccccCcccccCCCCCc--EEEcccCCCC--------------------------------
Q 043388           81 PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK--ELYLTFCSLK--------------------------------  126 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~--~L~l~~n~l~--------------------------------  126 (854)
                      +..+..+++|++|+|++|+++ .++...|..+++|+  +|++++|.+.                                
T Consensus       146 ~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~  224 (606)
T 3t6q_A          146 LPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN  224 (606)
T ss_dssp             CCTTCCCTTCCEEECCSSCCC-EECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTT
T ss_pred             cccccCCcccCEEEcccCccc-ccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccc
Confidence            556666999999999999998 77778889999999  8888887653                                


Q ss_pred             ------------------------------CCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccc
Q 043388          127 ------------------------------NLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS  176 (854)
Q Consensus       127 ------------------------------~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~  176 (854)
                                                    +|+.|++++|.+.    ...+..|.++++|++|+|++|+++. .|..|..
T Consensus       225 ~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~L~l~~n~l~~-lp~~l~~  299 (606)
T 3t6q_A          225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF----NISSNTFHCFSGLQELDLTATHLSE-LPSGLVG  299 (606)
T ss_dssp             CEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCS----SCCTTTTTTCTTCSEEECTTSCCSC-CCSSCCS
T ss_pred             cchhheechhhccccccccChhHhchhhcCceeEEEeecCccC----ccCHHHhccccCCCEEeccCCccCC-CChhhcc
Confidence                                          5677888888883    2334559999999999999999994 5667999


Q ss_pred             cCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChh-hhhhcccccEEEccCCcccccC--Cccc
Q 043388          177 LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHS-IANLSSTMIQFRIGGNQISGTI--PSGI  253 (854)
Q Consensus       177 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~~L~~L~l~~N~l~~~~--~~~~  253 (854)
                      +++|++|++++|.+..+..      ..+..+++|++|++++|.+.+.+|.. +..++ .|+.|++++|.+++..  +..+
T Consensus       300 l~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~  372 (606)
T 3t6q_A          300 LSTLKKLVLSANKFENLCQ------ISASNFPSLTHLSIKGNTKRLELGTGCLENLE-NLRELDLSHDDIETSDCCNLQL  372 (606)
T ss_dssp             CTTCCEEECTTCCCSBGGG------GCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT-TCCEEECCSSCCCEEEESTTTT
T ss_pred             cccCCEEECccCCcCcCch------hhhhccCcCCEEECCCCCcccccchhhhhccC-cCCEEECCCCccccccCcchhc
Confidence            9999999999999986543      35788999999999999999777765 66665 8999999999999876  8889


Q ss_pred             cccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCcc-ccCccccchhccccceecccCCCCCcCCCCCc
Q 043388          254 RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS-LGNLTKLADLALSFNNLQGNIPSSLGNCQNLK  332 (854)
Q Consensus       254 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  332 (854)
                      .++++|++|++++|++++..|..|..+++|++|++++|++.+..|.. +..+++|+.|++++|.+++..|..+..+++|+
T Consensus       373 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  452 (606)
T 3t6q_A          373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ  452 (606)
T ss_dssp             TTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCC
T ss_pred             ccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCC
Confidence            99999999999999999999999999999999999999999876654 99999999999999999998999999999999


Q ss_pred             ccccCCCcccCcc---chhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCC
Q 043388          333 GFDASHNKLTGAI---PQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMK  409 (854)
Q Consensus       333 ~L~ls~N~l~~~~---p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~  409 (854)
                      .|++++|++++..   +..+..+..+.. +++++|.+.+..|..++.       +++|++|+|++|++++.+|..|..++
T Consensus       453 ~L~L~~n~l~~~~~~~~~~~~~l~~L~~-L~Ls~n~l~~~~~~~~~~-------l~~L~~L~Ls~N~l~~~~~~~l~~l~  524 (606)
T 3t6q_A          453 HLNLQGNHFPKGNIQKTNSLQTLGRLEI-LVLSFCDLSSIDQHAFTS-------LKMMNHVDLSHNRLTSSSIEALSHLK  524 (606)
T ss_dssp             EEECTTCBCGGGEECSSCGGGGCTTCCE-EECTTSCCCEECTTTTTT-------CTTCCEEECCSSCCCGGGGGGGTTCC
T ss_pred             EEECCCCCCCccccccchhhccCCCccE-EECCCCccCccChhhhcc-------ccCCCEEECCCCccCcCChhHhCccc
Confidence            9999999998632   244666666655 999999999988888887       56799999999999999999999999


Q ss_pred             CCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCCC
Q 043388          410 SIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTK  452 (854)
Q Consensus       410 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  452 (854)
                      .| +|+|++|++++.+|..+..+++|+.|++++|+++|.++..
T Consensus       525 ~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~  566 (606)
T 3t6q_A          525 GI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI  566 (606)
T ss_dssp             SC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGH
T ss_pred             cc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcH
Confidence            99 9999999999999999999999999999999999988754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6e-51  Score=423.67  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=196.2

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      |+..++||+|+||+||+|.+..+++.||+|++....  ....+.+.+|++++++++|||||+++++|.+.. .+....||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            356678999999999999999999999999997543  234567999999999999999999999986532 12236899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC-Cccccc-ccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQ-NFSLS  705 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~~~-Dfg~~  705 (854)
                      |||||+||+|.+++....      .+++.+++.|+.||+.||+|||++ .++||||||||+|||++. ++.+++ |||+|
T Consensus       107 vmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            999999999999998764      789999999999999999999998 113999999999999974 555555 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      +.....     .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||..................+.... 
T Consensus       180 ~~~~~~-----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~-  252 (290)
T 3fpq_A          180 TLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-  252 (290)
T ss_dssp             GGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG-
T ss_pred             EeCCCC-----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC-
Confidence            754332     2234679999999998865 699999999999999999999999975322111111111111110000 


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                                               ..+++++.+++.+||+.||++|||++|+++
T Consensus       253 -------------------------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          253 -------------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------------------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                     011345778999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.5e-51  Score=435.39  Aligned_cols=251  Identities=19%  Similarity=0.278  Sum_probs=200.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...  ....+.+.+|++++++++|||||++++++.+.+     .
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-----~   97 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG-----S   97 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-----E
Confidence            368999999999999999999999999999999997543  234567899999999999999999999998765     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|||||||+||+|.+++...+..    .+++.+++.|+.||+.||+|||++   +||||||||+|||++.++..++ |||
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  170 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGV----LFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFG  170 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccc
Confidence            89999999999999999765422    678999999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +|+.......   .....+||+.|||||++.+..|+.++||||+||++|||+||+.||...... ..+........+.  
T Consensus       171 la~~~~~~~~---~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~~~~--  244 (350)
T 4b9d_A          171 IARVLNSTVE---LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-NLVLKIISGSFPP--  244 (350)
T ss_dssp             EESCCCHHHH---HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCCCC--
T ss_pred             cceeecCCcc---cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcCCCCC--
Confidence            9987654321   112357999999999999999999999999999999999999999754221 1111122211110  


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                         ..                      ..++.++.+++.+||+.||++|||++|+++
T Consensus       245 ---~~----------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 ---VS----------------------LHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ---CC----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CC----------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               00                      112455789999999999999999999986

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=9.3e-50  Score=468.82  Aligned_cols=444  Identities=20%  Similarity=0.175  Sum_probs=351.8

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      +|+|++..|..|+++++|++|+|++|.+++..|.+|+++++|++|+|++|++++..|..|+.+++|++|+|++|+++++.
T Consensus        41 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~  120 (606)
T 3vq2_A           41 FNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE  120 (606)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSS
T ss_pred             CCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccccc
Confidence            46777777778888888888888888888777777888888888888888888777888888888888888888888777


Q ss_pred             hhhhcCCCCCceeeeccccccc-ccCcccccCCCCCcEEEcccCCCCC---------------CceeeccCccCCCCCCC
Q 043388           81 PRWICNISSLEFIYLTVNRFSG-SLPFDILVNLPNLKELYLTFCSLKN---------------LWWLNLEQNNLGMGTAS  144 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~~l~~L~~L~l~~n~l~~---------------L~~L~L~~N~l~~~~~~  144 (854)
                      |..|+++++|++|+|++|++++ .+| ..|.++++|++|++++|+++.               +..|++++|.+.     
T Consensus       121 ~~~~~~l~~L~~L~L~~n~l~~~~lp-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~-----  194 (606)
T 3vq2_A          121 SFPIGQLITLKKLNVAHNFIHSCKLP-AYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-----  194 (606)
T ss_dssp             SSCCTTCTTCCEEECCSSCCCCCCCC-GGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCC-----
T ss_pred             ccccCCCCCCCEEeCCCCcccceech-HhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcc-----
Confidence            7778888888888888888763 234 457788888888888776642               236778888773     


Q ss_pred             CCCccccCCCCCCEEecCCCcCc---------------------------------------------------------
Q 043388          145 SIPDSLSNASNLERLDLSGNQFK---------------------------------------------------------  167 (854)
Q Consensus       145 ~~p~~~~~l~~L~~L~Ls~N~i~---------------------------------------------------------  167 (854)
                      .+|.......+|++|+|++|.++                                                         
T Consensus       195 ~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~  274 (606)
T 3vq2_A          195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF  274 (606)
T ss_dssp             EECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTC
T ss_pred             eeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccc
Confidence            34444333446777777776553                                                         


Q ss_pred             -ccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCccc
Q 043388          168 -GKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQIS  246 (854)
Q Consensus       168 -~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~  246 (854)
                       +..+. |..+++|+.|++++|.+..++        .+..+++|++|++++|.+ +.+| .+ .++ .|+.|++++|...
T Consensus       275 ~~~~~~-~~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~-~L~~L~l~~n~~~  341 (606)
T 3vq2_A          275 SDDIVK-FHCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSIIRCQL-KQFP-TL-DLP-FLKSLTLTMNKGS  341 (606)
T ss_dssp             CGGGGS-CGGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEEESCCC-SSCC-CC-CCS-SCCEEEEESCSSC
T ss_pred             cccccc-cccCCCCCEEEecCccchhhh--------hccccccCCEEEcccccC-cccc-cC-CCC-ccceeeccCCcCc
Confidence             22222 666777888888888776544        367788899999999998 4788 44 554 7899999999655


Q ss_pred             ccCCccccccccCCeeeccccccccC--CCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCC-C
Q 043388          247 GTIPSGIRNLVNLIALTIEVNQLHGI--IPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIP-S  323 (854)
Q Consensus       247 ~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~  323 (854)
                      +..  .+..+++|++|++++|++++.  .|..+..+++|++|++++|.+++ +|..+..+++|+.|++++|++.+..| .
T Consensus       342 ~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~  418 (606)
T 3vq2_A          342 ISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFS  418 (606)
T ss_dssp             EEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTT
T ss_pred             cch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChh
Confidence            443  677899999999999999876  37888999999999999999984 66889999999999999999998777 6


Q ss_pred             CCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCC-CcCccccccccccccccccceeeccCcccccCCC
Q 043388          324 SLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLND-SLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIP  402 (854)
Q Consensus       324 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~-~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p  402 (854)
                      .+..+++|+.|++++|.+++..|..+..+..+.. +++++|.+.+ .+|..++.       +.+|++|+|++|++++.+|
T Consensus       419 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~~-------l~~L~~L~Ls~n~l~~~~~  490 (606)
T 3vq2_A          419 AFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNT-LKMAGNSFKDNTLSNVFAN-------TTNLTFLDLSKCQLEQISW  490 (606)
T ss_dssp             TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE-EECTTCEEGGGEECSCCTT-------CTTCCEEECTTSCCCEECT
T ss_pred             hhhccccCCEEECcCCCCCccchhhhcCCCCCCE-EECCCCcCCCcchHHhhcc-------CCCCCEEECCCCcCCccCh
Confidence            8899999999999999999888888888877765 8999999987 46777777       5679999999999999999


Q ss_pred             cccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCCCcccc-CcccccccccccccCCcc
Q 043388          403 FSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFS-NKTKISLQVNVKLCGGID  474 (854)
Q Consensus       403 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~-~~~~~~~~~n~~~c~~~~  474 (854)
                      ..|+.+++|++|+|++|++++.+|..|.++++|+.|+|++|+++...+....+. +...+.+.+|++.|.++.
T Consensus       491 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             hhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            999999999999999999999889999999999999999999995443333343 467788999999987654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.8e-51  Score=424.76  Aligned_cols=248  Identities=21%  Similarity=0.339  Sum_probs=206.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.++||+|+||+||+|++..+++.||||+++..   .....+.+.+|++++++++|||||++++++.+.+     .
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----K  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----E
Confidence            5899999999999999999999999999999999743   3445678999999999999999999999998765     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+|||||+||+|.+++...+      .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..++ |||
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence            899999999999999998765      789999999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +|+.+....... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||...... ..+.......+  .+
T Consensus       178 la~~~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~~--~~  253 (311)
T 4aw0_A          178 TAKVLSPESKQA-RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-LIFAKIIKLEY--DF  253 (311)
T ss_dssp             TCEECCTTTTCC-CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC--CC
T ss_pred             CceecCCCCCcc-cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC--CC
Confidence            999876443221 223468999999999999999999999999999999999999999754211 11111111111  00


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVV  839 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  839 (854)
                      .                          +.++.++.+++.+||+.||++|||++|+.
T Consensus       254 p--------------------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 P--------------------------EKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             C--------------------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             C--------------------------cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            0                          01134577899999999999999999874

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.9e-50  Score=425.60  Aligned_cols=273  Identities=25%  Similarity=0.323  Sum_probs=203.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|.+.++||+|+||+||+|++.  |+.||||+++..... ...+.+|+..+.+++|||||+++++|.+.+. .....||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEE
Confidence            56888899999999999999984  788999999654321 1223345555678899999999999976542 2235799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeecCCCCceEecCCccccc-c
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC-----QPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      |||||++|+|.++++..       .++|.++.+|+.|+|.||+|||+++     .++||||||||+|||++.++.+++ |
T Consensus        79 V~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            99999999999999764       6899999999999999999999862     458999999999999999988887 9


Q ss_pred             cccccccccCCCCC-CcccccCCcccccCccccCCC------CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchH---
Q 043388          702 FSLSHQLDSASKTP-SSSIGIKGTVGYVAPEYGMGS------EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL---  771 (854)
Q Consensus       702 fg~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~---  771 (854)
                      ||+|+......... ......+||+.|||||++.+.      .++.++|||||||++|||+||++||.........+   
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~  231 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence            99998876544322 122345799999999998764      36789999999999999999998876433221111   


Q ss_pred             -------hHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          772 -------HEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       772 -------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                             .+.......+..    +|.+             .......+++..+.+++.+||+.||++||||.||++.|++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~----rp~~-------------p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          232 VPSDPSVEEMRKVVCEQKL----RPNI-------------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSCC----CCCC-------------CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHhcccC----CCCC-------------CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence                   111111111100    0100             0011122456778999999999999999999999999999


Q ss_pred             hhhh
Q 043388          845 TRET  848 (854)
Q Consensus       845 ~~~~  848 (854)
                      +.+.
T Consensus       295 l~~~  298 (303)
T 3hmm_A          295 LSQQ  298 (303)
T ss_dssp             HHHC
T ss_pred             HHHH
Confidence            8764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.7e-50  Score=436.34  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=207.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ..|++.++||+|+||.||+|++..+|+.||||+++.......+.+.+|+.+|++++|||||+++++|.+.+     ..||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC-----EEEE
Confidence            46999999999999999999999999999999998776666678999999999999999999999998765     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      |||||+||+|.+++...       .+++.++..|+.||+.||+|||++   +||||||||+|||++.++..++ |||+|+
T Consensus       226 VmEy~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~  295 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  295 (423)
T ss_dssp             EEECCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence            99999999999999753       689999999999999999999999   9999999999999999887776 999999


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .+......   ....+||+.|||||++.+..|+.++||||+||++|||++|+.||......  .....+....+....  
T Consensus       296 ~~~~~~~~---~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~~~~~--  368 (423)
T 4fie_A          296 QVSKEVPR---RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPRLK--  368 (423)
T ss_dssp             ECCSSCCC---BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCCCS--
T ss_pred             ECCCCCcc---ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCCCCCc--
Confidence            87654322   22357999999999999999999999999999999999999999753211  111111111111100  


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                                            ....++.++.+++.+||+.||++|||+.|+++
T Consensus       369 ----------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 ----------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ----------------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                                  00112455789999999999999999999976

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=9.2e-49  Score=466.68  Aligned_cols=431  Identities=23%  Similarity=0.245  Sum_probs=333.0

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      .|++++..|..|+++++|++|+|++|.+++..+.+|+.+++|++|+|++|++++..|..|+.+++|++|+|++|.+++..
T Consensus        58 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  137 (680)
T 1ziw_A           58 FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK  137 (680)
T ss_dssp             SSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccC
Confidence            36777777778888888888888888887544456778888888888888887666677777788888888888777777


Q ss_pred             hhhhcCCCCCceeeecccccccccCccccc--CCCCCcEEEccc------------------------------------
Q 043388           81 PRWICNISSLEFIYLTVNRFSGSLPFDILV--NLPNLKELYLTF------------------------------------  122 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--~l~~L~~L~l~~------------------------------------  122 (854)
                      |..|.++++|++|+|++|+++ .++...|.  .+++|++|++++                                    
T Consensus       138 ~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~  216 (680)
T 1ziw_A          138 LGTQVQLENLQELLLSNNKIQ-ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC  216 (680)
T ss_dssp             CCSSSCCTTCCEEECCSSCCC-CBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHH
T ss_pred             chhhcccccCCEEEccCCccc-ccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHH
Confidence            777777777777777777766 33333222  223444444433                                    


Q ss_pred             ---------------CCC-------------CCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCc
Q 043388          123 ---------------CSL-------------KNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDF  174 (854)
Q Consensus       123 ---------------n~l-------------~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f  174 (854)
                                     |++             ++|+.|+|++|++.    +..|..|.++++|++|+|++|+++++.+..|
T Consensus       217 ~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  292 (680)
T 1ziw_A          217 LELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN----VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL  292 (680)
T ss_dssp             HHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCC----EECTTTTTTCTTCCEEECCSCCBSEECTTTT
T ss_pred             HHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcC----ccCcccccCcccccEeeCCCCccCccChhhh
Confidence                           322             12677777777763    2234567778888888888888877666544


Q ss_pred             cc---------------------------------cCCCCeEecccccccCCCCCChhhhhhccCC--------------
Q 043388          175 SS---------------------------------LKNLWWLNLEQNNLGMGTANDLDFVTLLTNC--------------  207 (854)
Q Consensus       175 ~~---------------------------------l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l--------------  207 (854)
                      .+                                 +++|++|++++|.+..+...      .|.++              
T Consensus       293 ~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~Ls~n~~~  366 (680)
T 1ziw_A          293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN------MFTGLINLKYLSLSNSFTS  366 (680)
T ss_dssp             TTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTT------TTTTCTTCCEEECTTCBSC
T ss_pred             cCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChh------HhccccCCcEEECCCCchh
Confidence            44                                 44444555555555444332      23333              


Q ss_pred             --------------CCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCC-ccccccccCCeeeccccccccC
Q 043388          208 --------------SSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIP-SGIRNLVNLIALTIEVNQLHGI  272 (854)
Q Consensus       208 --------------~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~  272 (854)
                                    ++|+.|++++|++++..|..+..+. .|+.|++++|.+++.+| ..|.++++|++|++++|+++++
T Consensus       367 ~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~  445 (680)
T 1ziw_A          367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG-HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL  445 (680)
T ss_dssp             CCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEEC
T ss_pred             hhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCC-CCCEEeCCCCcCccccCcccccCcccccEEecCCCCccee
Confidence                          3566666677778877788888876 89999999999998666 7899999999999999999999


Q ss_pred             CCCCccCcccCceeeCcccccc--ccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccch---
Q 043388          273 IPDGVGELQHLQQLYMFRNFLQ--GSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQ---  347 (854)
Q Consensus       273 ~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~---  347 (854)
                      .+..|..+++|+.|++++|.+.  +.+|..|..+++|+.|+|++|++++..+..|.++++|+.|++++|++++..+.   
T Consensus       446 ~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  525 (680)
T 1ziw_A          446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANP  525 (680)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTST
T ss_pred             ChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhcc
Confidence            9999999999999999999987  57899999999999999999999988888999999999999999999853221   


Q ss_pred             -----hhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccc
Q 043388          348 -----QVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLS  422 (854)
Q Consensus       348 -----~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  422 (854)
                           .+..+..+.. +++++|.+....+..+++       +.+|+.|+|++|++++.++..|..+++|+.|+|++|+|+
T Consensus       526 ~~~~~~~~~l~~L~~-L~L~~N~l~~i~~~~~~~-------l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~  597 (680)
T 1ziw_A          526 GGPIYFLKGLSHLHI-LNLESNGFDEIPVEVFKD-------LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT  597 (680)
T ss_dssp             TSCCCTTTTCTTCCE-EECCSSCCCCCCTTTTTT-------CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred             CCcchhhcCCCCCCE-EECCCCCCCCCCHHHccc-------ccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCC
Confidence                 2455566654 999999998655556777       567999999999999888888999999999999999999


Q ss_pred             cccchhhc-CccCCCeeecccccCcccCCC
Q 043388          423 GQIPEFLQ-NLSFLEFLNLSYNHLEGEVPT  451 (854)
Q Consensus       423 ~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~  451 (854)
                      +..|..+. .+++|+.|++++|+|.|.++.
T Consensus       598 ~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          598 SVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             BCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             ccChhHhcccccccCEEEccCCCcccCCcc
Confidence            98888888 799999999999999999885

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8e-50  Score=411.28  Aligned_cols=246  Identities=26%  Similarity=0.367  Sum_probs=188.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..   .....+.+.+|++++++++|||||++++++.+.+     
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD-----   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----
Confidence            47899999999999999999999999999999999643   2334567999999999999999999999998765     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+||||| +|+|.+++...+      .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..++ ||
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF  156 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF  156 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred             EEEEEEeCC-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence            789999999 679999998765      789999999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |+|+........    ...+||+.|||||++.+..+ +.++||||+||++|||+||+.||...... ...........  
T Consensus       157 Gla~~~~~~~~~----~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-~~~~~i~~~~~--  229 (275)
T 3hyh_A          157 GLSNIMTDGNFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-VLFKNISNGVY--  229 (275)
T ss_dssp             SCC-------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC--
T ss_pred             CCCeecCCCCcc----CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCC--
Confidence            999876543322    23579999999999998775 68999999999999999999999753211 11111111100  


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...                          ..+++++.+++.+||+.||++|||++|+++
T Consensus       230 ~~p--------------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 TLP--------------------------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCC--------------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCC--------------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            000                          112445778999999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.6e-50  Score=428.12  Aligned_cols=268  Identities=22%  Similarity=0.332  Sum_probs=212.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCC-----ceEEEEEEeecccc-cchHHHHHHHHHHHhccC-CCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGE-----EMIVAVKVINLKQK-GAFRSFVAECEALRNIRH-RNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~  619 (854)
                      .++|++.+.||+|+||+||+|++.+.     ++.||||+++.... ...+.+.+|+++|.+++| ||||+++|+|...+.
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            47899999999999999999998643     46899999975432 345679999999999965 899999999865431


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCc
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSN  689 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  689 (854)
                          ..+||||||++|+|.++|+.....          .....+++.+++.|+.|||+||+|||++   +||||||||+|
T Consensus       143 ----~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N  215 (353)
T 4ase_A          143 ----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN  215 (353)
T ss_dssp             ----CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             ----EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence                479999999999999999865321          0123589999999999999999999999   99999999999


Q ss_pred             eEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccC
Q 043388          690 VLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTE  767 (854)
Q Consensus       690 Ill~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~  767 (854)
                      ||+++++.+|+ |||+|+......... .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||......
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~-~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCce-eeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999988887 999998775543221 2223568999999999999999999999999999999998 99999764322


Q ss_pred             CchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          768 GLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       768 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                      . .+...+.....                          ...++.++.++.+++.+||+.||++||||.||++.|+++.+
T Consensus       295 ~-~~~~~i~~g~~--------------------------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          295 E-EFCRRLKEGTR--------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             H-HHHHHHHHTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H-HHHHHHHcCCC--------------------------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            1 12221111110                          01112235668899999999999999999999999999876


Q ss_pred             hh
Q 043388          848 TF  849 (854)
Q Consensus       848 ~~  849 (854)
                      .-
T Consensus       348 ~~  349 (353)
T 4ase_A          348 AN  349 (353)
T ss_dssp             HT
T ss_pred             Hh
Confidence            53

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.2e-48  Score=459.26  Aligned_cols=427  Identities=19%  Similarity=0.181  Sum_probs=374.5

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcc-c
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSG-M   79 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~   79 (854)
                      +|+|++..|..|+++++|++|+|++|.+++..|.+|+.+++|++|+|++|++++..+..|+.+++|++|+|++|.+++ .
T Consensus        65 ~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  144 (606)
T 3vq2_A           65 RCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK  144 (606)
T ss_dssp             TCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCC
T ss_pred             CCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCccccee
Confidence            488999999999999999999999999998889999999999999999999998888999999999999999999986 4


Q ss_pred             ChhhhcCCCCCceeeecccccccccCcccccCCCCCc----EEEcccCCCC----------CCceeeccCccCCC-----
Q 043388           80 FPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK----ELYLTFCSLK----------NLWWLNLEQNNLGM-----  140 (854)
Q Consensus        80 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~----~L~l~~n~l~----------~L~~L~L~~N~l~~-----  140 (854)
                      +|..|+++++|++|+|++|+++ .++...|..+++|+    +|+++.|.++          +|+.|++++|.+..     
T Consensus       145 lp~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~  223 (606)
T 3vq2_A          145 LPAYFSNLTNLVHVDLSYNYIQ-TITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKT  223 (606)
T ss_dssp             CCGGGGTCTTCCEEECCSSCCC-EECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHH
T ss_pred             chHhHhhcCCCCEEEccCCcce-ecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHH
Confidence            6999999999999999999999 67666677776655    7999888765          67888888887630     


Q ss_pred             -------------------------------------------------CCCCCCCccccCCCCCCEEecCCCcCcccCC
Q 043388          141 -------------------------------------------------GTASSIPDSLSNASNLERLDLSGNQFKGKVS  171 (854)
Q Consensus       141 -------------------------------------------------~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~  171 (854)
                                                                       ...+.+|. +..+++|+.|++++|.+..++ 
T Consensus       224 ~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~-  301 (606)
T 3vq2_A          224 CLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE-  301 (606)
T ss_dssp             HHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC-
T ss_pred             HhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhhh-
Confidence                                                             00122333 788899999999999998665 


Q ss_pred             cCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCccccc--C
Q 043388          172 IDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGT--I  249 (854)
Q Consensus       172 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~--~  249 (854)
                       .+..+++|++|++++|.++.++        .+ .+++|++|++++|...+.+  .+..++ .|+.|++++|.+++.  .
T Consensus       302 -~l~~~~~L~~L~l~~n~l~~lp--------~~-~l~~L~~L~l~~n~~~~~~--~~~~l~-~L~~L~ls~n~l~~~~~~  368 (606)
T 3vq2_A          302 -DVPKHFKWQSLSIIRCQLKQFP--------TL-DLPFLKSLTLTMNKGSISF--KKVALP-SLSYLDLSRNALSFSGCC  368 (606)
T ss_dssp             -CCCTTCCCSEEEEESCCCSSCC--------CC-CCSSCCEEEEESCSSCEEC--CCCCCT-TCCEEECCSSCEEEEEEC
T ss_pred             -hccccccCCEEEcccccCcccc--------cC-CCCccceeeccCCcCccch--hhccCC-CCCEEECcCCccCCCcch
Confidence             8999999999999999996554        24 8899999999999766444  455665 799999999999977  4


Q ss_pred             CccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCC-ccccCccccchhccccceecccCCCCCcCC
Q 043388          250 PSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIP-PSLGNLTKLADLALSFNNLQGNIPSSLGNC  328 (854)
Q Consensus       250 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  328 (854)
                      |..+..+++|++|++++|++++ .|..|..+++|+.|++++|++.+..| ..+..+++|+.|++++|.+++..|..+..+
T Consensus       369 ~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  447 (606)
T 3vq2_A          369 SYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL  447 (606)
T ss_dssp             CHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTC
T ss_pred             hhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCC
Confidence            8889999999999999999996 45889999999999999999998877 689999999999999999999999999999


Q ss_pred             CCCcccccCCCcccCc-cchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCccccc
Q 043388          329 QNLKGFDASHNKLTGA-IPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGF  407 (854)
Q Consensus       329 ~~L~~L~ls~N~l~~~-~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~  407 (854)
                      ++|+.|++++|++++. +|..+..+..+.. +++++|.+.+..|..++.       +.+|++|+|++|++++.+|..|..
T Consensus       448 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~-L~Ls~n~l~~~~~~~~~~-------l~~L~~L~Ls~N~l~~~~~~~~~~  519 (606)
T 3vq2_A          448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTF-LDLSKCQLEQISWGVFDT-------LHRLQLLNMSHNNLLFLDSSHYNQ  519 (606)
T ss_dssp             TTCCEEECTTCEEGGGEECSCCTTCTTCCE-EECTTSCCCEECTTTTTT-------CTTCCEEECCSSCCSCEEGGGTTT
T ss_pred             CCCCEEECCCCcCCCcchHHhhccCCCCCE-EECCCCcCCccChhhhcc-------cccCCEEECCCCcCCCcCHHHccC
Confidence            9999999999999974 6777777877766 999999999988888887       567999999999999999999999


Q ss_pred             CCCCCEEEccCcccccccchhhcCcc-CCCeeecccccCcccCCCCc
Q 043388          408 MKSIKELNVSSNNLSGQIPEFLQNLS-FLEFLNLSYNHLEGEVPTKG  453 (854)
Q Consensus       408 l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p~~~  453 (854)
                      +++|++|+|++|+|+ .+|..+..++ +|+.|++++|++.|.++..+
T Consensus       520 l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~  565 (606)
T 3vq2_A          520 LYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQK  565 (606)
T ss_dssp             CTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTHH
T ss_pred             CCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccHH
Confidence            999999999999999 6777799997 59999999999999888654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.3e-49  Score=411.51  Aligned_cols=258  Identities=22%  Similarity=0.357  Sum_probs=191.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC-----
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSK-----  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-----  620 (854)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+..     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            5689999999999999999999999999999999975443 3346789999999999999999999998765421     


Q ss_pred             --CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccc
Q 043388          621 --GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA  698 (854)
Q Consensus       621 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  698 (854)
                        ...+.|+|||||++|+|.+++......   ...++..++.|+.||+.||+|||++   +||||||||+|||++.++..
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence              123479999999999999999876432   1456777889999999999999999   99999999999999998877


Q ss_pred             cc-ccccccccccCCCCC---------CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC
Q 043388          699 HQ-NFSLSHQLDSASKTP---------SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG  768 (854)
Q Consensus       699 ~~-Dfg~~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~  768 (854)
                      ++ |||+|+.........         ....+.+||+.|||||++.+..|+.++|||||||++|||++   ||.......
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~  234 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV  234 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence            76 999999876543221         12234579999999999999999999999999999999996   775321110


Q ss_pred             chHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       769 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..+........                           ++......+...+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~---------------------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 RTLTDVRNLKF---------------------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHTTCC---------------------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhcCCC---------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00111000000                           0111222344668999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-49  Score=414.53  Aligned_cols=242  Identities=25%  Similarity=0.308  Sum_probs=190.4

Q ss_pred             hhccccCccCCCcceEEEEeEEC---CCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILG---GEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ++|++.+.||+|+||+||+|+..   .+++.||||+++...  ......+.+|++++++++|||||++++++.+.+    
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----   99 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG----   99 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT----
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC----
Confidence            58999999999999999999884   467899999996432  223456889999999999999999999998765    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..|+|||||+||+|.+++...+      .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..++ |
T Consensus       100 -~~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D  169 (304)
T 3ubd_A          100 -KLYLILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD  169 (304)
T ss_dssp             -EEEEEECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred             -EEEEEEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence             7899999999999999998765      789999999999999999999999   9999999999999999887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||+|+........   ....+||+.|||||++.+..|+.++||||+||++|||+||+.||...... ..+......... 
T Consensus       170 FGla~~~~~~~~~---~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~~~-  244 (304)
T 3ubd_A          170 FGLSKESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ETMTMILKAKLG-  244 (304)
T ss_dssp             SEEEEC-----CC---CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCC-
T ss_pred             cccceeccCCCcc---ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-HHHHHHHcCCCC-
Confidence            9999876443322   22357999999999999999999999999999999999999999754221 111111111100 


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM  835 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  835 (854)
                       .                          +..++.++.+++.+||+.||++|||+
T Consensus       245 -~--------------------------p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          245 -M--------------------------PQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             -C--------------------------CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             -C--------------------------CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence             0                          01124557889999999999999985

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-48  Score=469.67  Aligned_cols=425  Identities=22%  Similarity=0.215  Sum_probs=354.3

Q ss_pred             CcccccC-chhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcC--ccCCCCCcEEecccccCcc
Q 043388            2 NKLEGQI-PEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTT--LGLLRNLVYLNVAENQFSG   78 (854)
Q Consensus         2 n~~~~~~-p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~   78 (854)
                      |++.+.+ |..|+++++|++|+|++|.|++..|.+|+.+++|++|+|++|.+++.+|..  |+.+++|++|+|++|.+++
T Consensus        58 n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~  137 (844)
T 3j0a_A           58 QYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS  137 (844)
T ss_dssp             TCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCC
T ss_pred             CCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccc
Confidence            4455566 789999999999999999999888999999999999999999999866665  9999999999999999998


Q ss_pred             cCh-hhhcCCCCCceeeecccccccccCcccccCC--CCCcEEEcccCCCCC-----------------CceeeccCccC
Q 043388           79 MFP-RWICNISSLEFIYLTVNRFSGSLPFDILVNL--PNLKELYLTFCSLKN-----------------LWWLNLEQNNL  138 (854)
Q Consensus        79 ~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l--~~L~~L~l~~n~l~~-----------------L~~L~L~~N~l  138 (854)
                      ..+ ..|+++++|++|+|++|.++ .+....|..+  ++|+.|+++.|.+..                 |+.|+|++|.+
T Consensus       138 ~~~~~~~~~L~~L~~L~Ls~N~i~-~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l  216 (844)
T 3j0a_A          138 LYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGW  216 (844)
T ss_dssp             CCCCGGGGTCSSCCEEEEESSCCC-CCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCS
T ss_pred             cccchhHhhCCCCCEEECCCCcCC-eeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcC
Confidence            765 68999999999999999998 5555567777  899999999887643                 89999999987


Q ss_pred             CCCCCCCCCc--------------------------------cccC--CCCCCEEecCCCcCcccCCcCccccCCCCeEe
Q 043388          139 GMGTASSIPD--------------------------------SLSN--ASNLERLDLSGNQFKGKVSIDFSSLKNLWWLN  184 (854)
Q Consensus       139 ~~~~~~~~p~--------------------------------~~~~--l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~  184 (854)
                      .......+..                                .|.+  .++|++|+|++|.+.++.+..|..+++|++|+
T Consensus       217 ~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  296 (844)
T 3j0a_A          217 TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN  296 (844)
T ss_dssp             STTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEE
T ss_pred             chhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEE
Confidence            5332222211                                1222  27899999999999999999999999999999


Q ss_pred             cccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeec
Q 043388          185 LEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTI  264 (854)
Q Consensus       185 L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  264 (854)
                      |++|+++.+...      .|.++++|++|+|++|.+++..|..+..++ .|+.|++++|.+++..+..|.++++|+.|+|
T Consensus       297 L~~n~i~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  369 (844)
T 3j0a_A          297 LAYNKINKIADE------AFYGLDNLQVLNLSYNLLGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL  369 (844)
T ss_dssp             EESCCCCEECTT------TTTTCSSCCEEEEESCCCSCCCSCSCSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEE
T ss_pred             CCCCcCCCCChH------HhcCCCCCCEEECCCCCCCccCHHHhcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEEC
Confidence            999999876544      578899999999999999977788888886 7999999999999888889999999999999


Q ss_pred             cccccccCCCCCccCcccCceeeCccccccccCCc----------------------cccCccccchhccccceecccCC
Q 043388          265 EVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP----------------------SLGNLTKLADLALSFNNLQGNIP  322 (854)
Q Consensus       265 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----------------------~~~~l~~L~~L~L~~N~l~~~~~  322 (854)
                      ++|.++++.     .+++|+.|++++|+++ .+|.                      .+.++++|+.|+|++|++++..+
T Consensus       370 s~N~l~~i~-----~~~~L~~L~l~~N~l~-~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~  443 (844)
T 3j0a_A          370 RDNALTTIH-----FIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG  443 (844)
T ss_dssp             ETCCSCCCS-----SCCSCSEEEEESCCCC-CCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCS
T ss_pred             CCCCCCccc-----CCCCcchhccCCCCcc-cccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccc
Confidence            999998542     2566666666666665 2222                      24578999999999999996544


Q ss_pred             C-CCcCCCCCcccccCCCcccC-----ccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcc
Q 043388          323 S-SLGNCQNLKGFDASHNKLTG-----AIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNS  396 (854)
Q Consensus       323 ~-~~~~l~~L~~L~ls~N~l~~-----~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~  396 (854)
                      . .+..+++|+.|++++|.+++     ..|..+..+..+.. |++++|.+++..|..+..       +.+|+.|+|++|+
T Consensus       444 ~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~-------l~~L~~L~Ls~N~  515 (844)
T 3j0a_A          444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV-LYLNHNYLNSLPPGVFSH-------LTALRGLSLNSNR  515 (844)
T ss_dssp             SSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEEC-CCCCHHHHTTCCTTSSSS-------CCSCSEEEEESCC
T ss_pred             ccccccCCccccccCCCCccccccccccchhhhcCcccccE-EECCCCcccccChhHccc-------hhhhheeECCCCC
Confidence            3 46678999999999999973     33444556666665 999999999988888887       5579999999999


Q ss_pred             cccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCCCc
Q 043388          397 FHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKG  453 (854)
Q Consensus       397 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  453 (854)
                      |++.+|..+.  ++|+.|+|++|+|++.+|..|   .+|+.|++++|++.|.++..+
T Consensus       516 l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~~~  567 (844)
T 3j0a_A          516 LTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELST  567 (844)
T ss_dssp             CSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSCCS
T ss_pred             CCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccccHH
Confidence            9988777776  899999999999999999876   478999999999999887643

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=447.83  Aligned_cols=419  Identities=21%  Similarity=0.174  Sum_probs=247.9

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      ++++|+|++|.+++..+.+|..+++|++|+|++|++++..|..|+.+++|++|+|++|+++++.|++|.++++|++|+|+
T Consensus        29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  108 (570)
T 2z63_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (570)
T ss_dssp             SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence            55556666666555555555555666666666665555555555555666666666666555555555556666666666


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCC------------CCCceeeccCccCCCCCCCCCCccccCCCCC----CEEe
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSL------------KNLWWLNLEQNNLGMGTASSIPDSLSNASNL----ERLD  160 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l------------~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L----~~L~  160 (854)
                      +|+++ .+|...|.++++|++|++++|.+            ++|+.|++++|.+.    ...|..|+.+++|    +.|+
T Consensus       109 ~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~~~~~L~  183 (570)
T 2z63_A          109 ETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ----SIYCTDLRVLHQMPLLNLSLD  183 (570)
T ss_dssp             TSCCC-CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC----EECGGGGHHHHTCTTCCCEEE
T ss_pred             ccccc-cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccc----eecHHHccchhccchhhhhcc
Confidence            66555 45544455555666665555432            34555555555552    1123344555555    5555


Q ss_pred             cCCCcCcccCCcCccccCCCCeEecccccccC-------------------------------CCCCC------------
Q 043388          161 LSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGM-------------------------------GTAND------------  197 (854)
Q Consensus       161 Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~-------------------------------~~~~~------------  197 (854)
                      +++|.++++.+..|... +|++|++++|....                               +....            
T Consensus       184 l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l  262 (570)
T 2z63_A          184 LSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF  262 (570)
T ss_dssp             CTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEE
T ss_pred             cCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhh
Confidence            55555555555544443 44444444441100                               00000            


Q ss_pred             ---------hhhhhhccCCCCCcEEEcccCcCcccCChhhhhh-------------------cccccEEEccCCcccccC
Q 043388          198 ---------LDFVTLLTNCSSLKALSLCDNQFGGELPHSIANL-------------------SSTMIQFRIGGNQISGTI  249 (854)
Q Consensus       198 ---------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-------------------~~~L~~L~l~~N~l~~~~  249 (854)
                               ...+..+..+++|++|++++|.++ .+|..+..+                   .+.|+.|++++|.+.+..
T Consensus       263 ~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~  341 (570)
T 2z63_A          263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF  341 (570)
T ss_dssp             EEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBC
T ss_pred             hhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccc
Confidence                     001122333444444444444444 344433333                   124555555555554433


Q ss_pred             CccccccccCCeeeccccccccCC--CCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCC-CCCc
Q 043388          250 PSGIRNLVNLIALTIEVNQLHGII--PDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIP-SSLG  326 (854)
Q Consensus       250 ~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~  326 (854)
                      +.  ..+++|++|++++|++++..  |..+..+++|++|++++|.+.+..+. +..+++|+.|++++|.+.+..| ..+.
T Consensus       342 ~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~  418 (570)
T 2z63_A          342 SE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFL  418 (570)
T ss_dssp             CC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTT
T ss_pred             cc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhh
Confidence            33  55667777777777776543  55666777777777777777754443 7777777777777777776554 4567


Q ss_pred             CCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCC-CCcCccccccccccccccccceeeccCcccccCCCccc
Q 043388          327 NCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLN-DSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSL  405 (854)
Q Consensus       327 ~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~-~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~  405 (854)
                      .+++|+.|++++|.+++..|..+..+..+.. +++++|.+. +.+|..++.       +++|++|+|++|++++..|..|
T Consensus       419 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~p~~~~~-------l~~L~~L~l~~n~l~~~~~~~~  490 (570)
T 2z63_A          419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEV-LKMAGNSFQENFLPDIFTE-------LRNLTFLDLSQCQLEQLSPTAF  490 (570)
T ss_dssp             TCTTCCEEECTTSCCEECCTTTTTTCTTCCE-EECTTCEEGGGEECSCCTT-------CTTCCEEECTTSCCCEECTTTT
T ss_pred             cCCCCCEEeCcCCcccccchhhhhcCCcCcE-EECcCCcCccccchhhhhc-------ccCCCEEECCCCccccCChhhh
Confidence            7777777777777777666666666666654 777777776 456666655       4567777777777777777777


Q ss_pred             ccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCCCc
Q 043388          406 GFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKG  453 (854)
Q Consensus       406 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  453 (854)
                      ..+++|++|+|++|++++.+|..|.++++|+.|++++|+++|.+|..+
T Consensus       491 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~  538 (570)
T 2z63_A          491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  538 (570)
T ss_dssp             TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             hcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence            777777788887777777777777777777777888887777777643

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.4e-47  Score=447.63  Aligned_cols=347  Identities=21%  Similarity=0.258  Sum_probs=244.9

Q ss_pred             cccccccCCcCccCCCCCcEEecccccCccc-----------------Chhhhc--CCCCCceeeecccccccccCcccc
Q 043388           49 WNSLGGQIPTTLGLLRNLVYLNVAENQFSGM-----------------FPRWIC--NISSLEFIYLTVNRFSGSLPFDIL  109 (854)
Q Consensus        49 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~~~~~~~~~  109 (854)
                      +|++++ +|..|+.+++|++|+|++|+|++.                 +|+.++  ++++|++|+|++|++.+.+| ..|
T Consensus       192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p-~~l  269 (636)
T 4eco_A          192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP-TFL  269 (636)
T ss_dssp             SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCC-TTT
T ss_pred             cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccCh-HHH
Confidence            345555 566666666666666666666654                 666666  66666666666666665555 335


Q ss_pred             cCCCCCcEEEcccCC-C------------------CCCceeeccCccCCCCCCCCCCc--cccCCCCCCEEecCCCcCcc
Q 043388          110 VNLPNLKELYLTFCS-L------------------KNLWWLNLEQNNLGMGTASSIPD--SLSNASNLERLDLSGNQFKG  168 (854)
Q Consensus       110 ~~l~~L~~L~l~~n~-l------------------~~L~~L~L~~N~l~~~~~~~~p~--~~~~l~~L~~L~Ls~N~i~~  168 (854)
                      .++++|++|++++|+ +                  ++|+.|+|++|++     +.+|.  .|+++++|++|+|++|++++
T Consensus       270 ~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l-----~~ip~~~~l~~l~~L~~L~L~~N~l~g  344 (636)
T 4eco_A          270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL-----KTFPVETSLQKMKKLGMLECLYNQLEG  344 (636)
T ss_dssp             TTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCC-----SSCCCHHHHTTCTTCCEEECCSCCCEE
T ss_pred             hcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcC-----CccCchhhhccCCCCCEEeCcCCcCcc
Confidence            566666666666665 3                  4555566666655     35677  77778888888888888876


Q ss_pred             cCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCC-CcEEEcccCcCcccCChhhhhhc-ccccEEEccCCccc
Q 043388          169 KVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSS-LKALSLCDNQFGGELPHSIANLS-STMIQFRIGGNQIS  246 (854)
Q Consensus       169 ~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~-~~L~~L~l~~N~l~  246 (854)
                      ..| .|..+++|++|+|++|+++.++.       .+..+++ |++|++++|.++ .+|..+.... +.|+.|++++|.++
T Consensus       345 ~ip-~~~~l~~L~~L~L~~N~l~~lp~-------~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~  415 (636)
T 4eco_A          345 KLP-AFGSEIKLASLNLAYNQITEIPA-------NFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIG  415 (636)
T ss_dssp             ECC-CCEEEEEESEEECCSSEEEECCT-------TSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTT
T ss_pred             chh-hhCCCCCCCEEECCCCccccccH-------hhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCC
Confidence            666 77777888888888887764433       3666777 888888888877 6776665542 25777788888887


Q ss_pred             ccCCcccc-------ccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCcc-ccCc-------cccchhc
Q 043388          247 GTIPSGIR-------NLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPS-LGNL-------TKLADLA  311 (854)
Q Consensus       247 ~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l-------~~L~~L~  311 (854)
                      +..|..|.       .+++|++|+|++|+++++.+..|..+++|++|+|++|+++ .+|.. +..+       ++|+.|+
T Consensus       416 ~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~  494 (636)
T 4eco_A          416 SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSID  494 (636)
T ss_dssp             TTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEE
T ss_pred             CcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEE
Confidence            77777777       6777778888888777655555666777888888888777 44433 3322       2777777


Q ss_pred             cccceecccCCCCCc--CCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccce
Q 043388          312 LSFNNLQGNIPSSLG--NCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEY  389 (854)
Q Consensus       312 L~~N~l~~~~~~~~~--~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~  389 (854)
                      |++|+++ .+|..+.  .+++|+.|++++|++++ +|..                         +++       +.+|++
T Consensus       495 Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~-------------------------~~~-------l~~L~~  540 (636)
T 4eco_A          495 LRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQ-------------------------PLN-------SSTLKG  540 (636)
T ss_dssp             CCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCG-------------------------GGG-------CSSCCE
T ss_pred             CcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChh-------------------------hhc-------CCCCCE
Confidence            7777777 5666665  77777777777777764 4443                         333       456889


Q ss_pred             eec------cCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccC
Q 043388          390 LDI------SSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEV  449 (854)
Q Consensus       390 L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  449 (854)
                      |+|      ++|++.+.+|..++.+++|++|+|++|+| +.+|..+.  ++|+.|||++|++...-
T Consensus       541 L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~~  603 (636)
T 4eco_A          541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISID  603 (636)
T ss_dssp             EECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEEE
T ss_pred             EECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcccc
Confidence            998      56888899999999999999999999999 47888766  79999999999987643

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=438.93  Aligned_cols=431  Identities=22%  Similarity=0.215  Sum_probs=360.1

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      ...+++.++.+++ .+|..+.  +++++|+|++|++++..+..|..+++|++|+|++|+++++.|++|+++++|++|+|+
T Consensus         8 ~~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~   84 (570)
T 2z63_A            8 PNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT   84 (570)
T ss_dssp             TTTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CCcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCc
Confidence            4567899999998 7887665  589999999999998889999999999999999999999999999999999999999


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCC-----------CCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCc
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSL-----------KNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ  165 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l-----------~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~  165 (854)
                      +|+++ .+|...|.++++|++|++++|++           ++|++|+|++|.+..   ..+|..|.++++|++|++++|+
T Consensus        85 ~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~---~~lp~~~~~l~~L~~L~l~~n~  160 (570)
T 2z63_A           85 GNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS---FKLPEYFSNLTNLEHLDLSSNK  160 (570)
T ss_dssp             TCCCC-EECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCC---CCCCGGGGGCTTCCEEECTTSC
T ss_pred             CCcCC-ccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccce---ecChhhhcccCCCCEEeCcCCc
Confidence            99998 78888999999999999997754           578999999999842   1468999999999999999999


Q ss_pred             CcccCCcCccccCCC----CeEecccccccCCCCCChhhhhhccCCCCCcEEEcccC-----------------------
Q 043388          166 FKGKVSIDFSSLKNL----WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDN-----------------------  218 (854)
Q Consensus       166 i~~~~~~~f~~l~~L----~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N-----------------------  218 (854)
                      ++++.+..|..+++|    +.|++++|.++.+...      .|..+ +|+.|++++|                       
T Consensus       161 l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~------~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~  233 (570)
T 2z63_A          161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG------AFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV  233 (570)
T ss_dssp             CCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTT------TTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEE
T ss_pred             cceecHHHccchhccchhhhhcccCCCCceecCHH------HhccC-cceeEecccccccccchhhhhcCccccceeeec
Confidence            999999999999999    8999999999877654      23333 6777777666                       


Q ss_pred             -----------------------------------cCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeee
Q 043388          219 -----------------------------------QFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALT  263 (854)
Q Consensus       219 -----------------------------------~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  263 (854)
                                                         .+.+..|..+..+. .|+.|++++|.++ .+|..+..+ +|++|+
T Consensus       234 ~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~-~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~  310 (570)
T 2z63_A          234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT-NVSSFSLVSVTIE-RVKDFSYNF-GWQHLE  310 (570)
T ss_dssp             EEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGT-TCSEEEEESCEEC-SCCBCCSCC-CCSEEE
T ss_pred             cccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcC-cccEEEecCccch-hhhhhhccC-CccEEe
Confidence                                               34445566677665 7999999999998 578888777 888888


Q ss_pred             ccccccccCCCCCc-------------------cCcccCceeeCccccccccC--CccccCccccchhccccceecccCC
Q 043388          264 IEVNQLHGIIPDGV-------------------GELQHLQQLYMFRNFLQGSI--PPSLGNLTKLADLALSFNNLQGNIP  322 (854)
Q Consensus       264 L~~N~l~~~~~~~~-------------------~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~  322 (854)
                      +++|.+..+....+                   ..+++|++|++++|++++..  |..+..+++|+.|++++|.+.+..+
T Consensus       311 l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  390 (570)
T 2z63_A          311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS  390 (570)
T ss_dssp             EESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE
T ss_pred             eccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc
Confidence            88887774332221                   46778888888888887554  6778888899999999999886544


Q ss_pred             CCCcCCCCCcccccCCCcccCccch-hhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccc-cC
Q 043388          323 SSLGNCQNLKGFDASHNKLTGAIPQ-QVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFH-GV  400 (854)
Q Consensus       323 ~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~-~~  400 (854)
                      . +..+++|+.|++++|.+++..|. .+..+..+.. +++++|.+.+..|..+..       +++|++|+|++|.++ +.
T Consensus       391 ~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~-------l~~L~~L~l~~n~l~~~~  461 (570)
T 2z63_A          391 N-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY-LDISHTHTRVAFNGIFNG-------LSSLEVLKMAGNSFQENF  461 (570)
T ss_dssp             E-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE-EECTTSCCEECCTTTTTT-------CTTCCEEECTTCEEGGGE
T ss_pred             c-ccccCCCCEEEccCCccccccchhhhhcCCCCCE-EeCcCCcccccchhhhhc-------CCcCcEEECcCCcCcccc
Confidence            4 88899999999999999876663 4556666654 899999998888877777       567999999999998 57


Q ss_pred             CCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCCC-ccccCcccccccccccccCCc
Q 043388          401 IPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTK-GVFSNKTKISLQVNVKLCGGI  473 (854)
Q Consensus       401 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  473 (854)
                      +|..+..+++|++|+|++|++++..|..|..+++|+.|++++|++++..|.. ..+.+...+.+.+|+..|.++
T Consensus       462 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  535 (570)
T 2z63_A          462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  535 (570)
T ss_dssp             ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             chhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence            8999999999999999999999988999999999999999999999887753 456777888999999888754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-47  Score=411.97  Aligned_cols=282  Identities=20%  Similarity=0.211  Sum_probs=204.5

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  624 (854)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++....  ...+.+.+|+++|++++|||||++++++..... .....
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            479999999999999999999999999999999964432  234678899999999999999999999865432 12346


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|||||||+ |+|.+++...+      .+++.++..|+.||+.||+|||++   +||||||||+|||++.++..++ |||
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence            899999996 58999998754      789999999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCC-CCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc--C
Q 043388          704 LSHQLDSASK-TPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--L  779 (854)
Q Consensus       704 ~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~  779 (854)
                      +|+.+..... ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+.... ..+..+....  .
T Consensus       204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p  282 (398)
T 4b99_A          204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTP  282 (398)
T ss_dssp             TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCC
T ss_pred             eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCC
Confidence            9987754322 22233456899999999998875 4699999999999999999999999864321 1122222211  1


Q ss_pred             CcccccccCchhhHHHhhcc-chhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANN-SMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +................... ...+.........+..++.+++.+||+.||++|||+.|+++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11111111111111110000 00000000011122456789999999999999999999876

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.1e-46  Score=437.35  Aligned_cols=420  Identities=20%  Similarity=0.245  Sum_probs=297.1

Q ss_pred             CcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccCh
Q 043388            2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFP   81 (854)
Q Consensus         2 n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p   81 (854)
                      |.++ .+|..+.  ++|++|+|++|++++..|.+|+.+++|++|+|++|++++..|+.|+.+++|++|+|++|++++..|
T Consensus        15 ~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~   91 (549)
T 2z81_A           15 RSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS   91 (549)
T ss_dssp             SCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH
T ss_pred             Cccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCH
Confidence            4555 6777665  689999999999998888889999999999999999998888899999999999999999998888


Q ss_pred             hhhcCCCCCceeeecccccccccC-cccccCCCCCcEEEcccCC------------CCCCceeeccCccCCCCCCCCCCc
Q 043388           82 RWICNISSLEFIYLTVNRFSGSLP-FDILVNLPNLKELYLTFCS------------LKNLWWLNLEQNNLGMGTASSIPD  148 (854)
Q Consensus        82 ~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~l~~L~~L~l~~n~------------l~~L~~L~L~~N~l~~~~~~~~p~  148 (854)
                      .+|+++++|++|+|++|+++ .++ ...|.++++|++|++++|.            +++|++|++++|.+.    +.+|.
T Consensus        92 ~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~----~~~~~  166 (549)
T 2z81_A           92 SWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR----NYQSQ  166 (549)
T ss_dssp             HHHTTCTTCCEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC----EECTT
T ss_pred             HHhccCCCCcEEECCCCccc-ccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc----ccChh
Confidence            88999999999999999987 432 3568889999999998775            356788888888884    34677


Q ss_pred             cccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhh
Q 043388          149 SLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSI  228 (854)
Q Consensus       149 ~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  228 (854)
                      .+.++++|++|++++|.+..++...+..+++|++|++++|+++.......   .....+++|+.|++++|.+++..+..+
T Consensus       167 ~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~~~~~~~L~~L~l~~n~l~~~~~~~l  243 (549)
T 2z81_A          167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL---PVDEVSSPMKKLAFRGSVLTDESFNEL  243 (549)
T ss_dssp             TTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCC---SSCCCCCCCCEEEEESCEEEHHHHHHH
T ss_pred             hhhccccCceEecccCcccccchhhHhhcccccEEEccCCcccccccccc---chhhhhhcccceeccccccchhHHHHH
Confidence            78888888888888888775555445667888888888888765432110   011223344444444443332211111


Q ss_pred             --------------------------------------------------------------hhhcccccEEEccCCccc
Q 043388          229 --------------------------------------------------------------ANLSSTMIQFRIGGNQIS  246 (854)
Q Consensus       229 --------------------------------------------------------------~~l~~~L~~L~l~~N~l~  246 (854)
                                                                                    ......++.|++++|.++
T Consensus       244 ~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~  323 (549)
T 2z81_A          244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF  323 (549)
T ss_dssp             HGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC
T ss_pred             HHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc
Confidence                                                                          112235677777777776


Q ss_pred             ccCCccc-cccccCCeeeccccccccCCC---CCccCcccCceeeCccccccccCC--ccccCccccchhccccceeccc
Q 043388          247 GTIPSGI-RNLVNLIALTIEVNQLHGIIP---DGVGELQHLQQLYMFRNFLQGSIP--PSLGNLTKLADLALSFNNLQGN  320 (854)
Q Consensus       247 ~~~~~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~  320 (854)
                       .+|..+ .++++|++|+|++|++++..|   ..++.+++|++|++++|++++..+  ..+..+++|+.|++++|+++ .
T Consensus       324 -~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~  401 (549)
T 2z81_A          324 -LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-P  401 (549)
T ss_dssp             -CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-C
T ss_pred             -cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-c
Confidence             455554 467778888888887776543   346677778888888887775432  45777777888888888777 5


Q ss_pred             CCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccC
Q 043388          321 IPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGV  400 (854)
Q Consensus       321 ~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~  400 (854)
                      +|..+..+++|+.|++++|+++ .+|..+.  ..+. .+++++|.+++.+    +.       +++|++|+|++|+|+ .
T Consensus       402 lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~-~L~Ls~N~l~~~~----~~-------l~~L~~L~Ls~N~l~-~  465 (549)
T 2z81_A          402 MPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLE-VLDVSNNNLDSFS----LF-------LPRLQELYISRNKLK-T  465 (549)
T ss_dssp             CCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCS-EEECCSSCCSCCC----CC-------CTTCCEEECCSSCCS-S
T ss_pred             CChhhcccccccEEECCCCCcc-cccchhc--CCce-EEECCCCChhhhc----cc-------CChhcEEECCCCccC-c
Confidence            6777777777888888888776 3444332  1222 3777777776542    12       456778888888887 4


Q ss_pred             CCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCC
Q 043388          401 IPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPT  451 (854)
Q Consensus       401 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  451 (854)
                      +|. ...+++|++|+|++|++++.+|..|..+++|+.|++++|++.|.+|.
T Consensus       466 ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          466 LPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             CCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             CCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence            554 45677788888888888877777777788888888888888777764

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=9.9e-47  Score=442.45  Aligned_cols=417  Identities=19%  Similarity=0.240  Sum_probs=345.9

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeeccccccc---------------------------------ccCCcCcc-
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLG---------------------------------GQIPTTLG-   61 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~---------------------------------~~~~~~~~-   61 (854)
                      ..++.|+|++|.++|.+|.+++.+++|++|+|++|.+.                                 +.+|..+. 
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~  160 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD  160 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence            46778888888888888888888888888888888662                                 12222221 


Q ss_pred             ------------------CCCCCcEEecc--cccCcccChhhhcCCCCCceeeecccccccc-----------------c
Q 043388           62 ------------------LLRNLVYLNVA--ENQFSGMFPRWICNISSLEFIYLTVNRFSGS-----------------L  104 (854)
Q Consensus        62 ------------------~l~~L~~L~Ls--~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~  104 (854)
                                        ....++.+++.  .|++++ +|.+|+++++|++|+|++|+|++.                 +
T Consensus       161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~i  239 (636)
T 4eco_A          161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK  239 (636)
T ss_dssp             HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccC
Confidence                              11122223332  689998 899999999999999999999964                 7


Q ss_pred             Ccccc-cCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCc-Ccc-cCCcCcccc----
Q 043388          105 PFDIL-VNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ-FKG-KVSIDFSSL----  177 (854)
Q Consensus       105 ~~~~~-~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~-i~~-~~~~~f~~l----  177 (854)
                      |..+. .++++|++|++++|++.                 +.+|..|+++++|++|+|++|+ +++ ..|..+..+    
T Consensus       240 p~~l~~~~l~~L~~L~L~~n~l~-----------------~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~  302 (636)
T 4eco_A          240 TEDLKWDNLKDLTDVEVYNCPNL-----------------TKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP  302 (636)
T ss_dssp             TSCCCGGGCTTCCEEEEECCTTC-----------------SSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSG
T ss_pred             chhhhhcccCCCCEEEecCCcCC-----------------ccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccc
Confidence            76531 27777777777777654                 5689999999999999999999 998 778888776    


Q ss_pred             --CCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccc
Q 043388          178 --KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRN  255 (854)
Q Consensus       178 --~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~  255 (854)
                        ++|++|+|++|+++.++.     ...+.++++|++|++++|+++|.+| .+..+. .|+.|++++|+++ .+|..|.+
T Consensus       303 ~l~~L~~L~L~~n~l~~ip~-----~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~-~L~~L~L~~N~l~-~lp~~l~~  374 (636)
T 4eco_A          303 VGEKIQIIYIGYNNLKTFPV-----ETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAYNQIT-EIPANFCG  374 (636)
T ss_dssp             GGGTCCEEECCSSCCSSCCC-----HHHHTTCTTCCEEECCSCCCEEECC-CCEEEE-EESEEECCSSEEE-ECCTTSEE
T ss_pred             cCCCCCEEECCCCcCCccCc-----hhhhccCCCCCEEeCcCCcCccchh-hhCCCC-CCCEEECCCCccc-cccHhhhh
Confidence              999999999999985443     0158899999999999999999999 888886 8999999999999 88999999


Q ss_pred             ccc-CCeeeccccccccCCCCCccCcc--cCceeeCccccccccCCcccc-------CccccchhccccceecccCCCCC
Q 043388          256 LVN-LIALTIEVNQLHGIIPDGVGELQ--HLQQLYMFRNFLQGSIPPSLG-------NLTKLADLALSFNNLQGNIPSSL  325 (854)
Q Consensus       256 l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~  325 (854)
                      +++ |++|++++|+++ .+|..+..++  +|++|++++|.+++.+|..|.       .+++|+.|+|++|+++...+..+
T Consensus       375 l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~  453 (636)
T 4eco_A          375 FTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF  453 (636)
T ss_dssp             ECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHH
T ss_pred             hcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHH
Confidence            999 999999999999 6788887765  999999999999999999998       88899999999999995444456


Q ss_pred             cCCCCCcccccCCCcccCccchhhcchh--------hhHHHHHhhcCCCCCCcCcccc--ccccccccccccceeeccCc
Q 043388          326 GNCQNLKGFDASHNKLTGAIPQQVLSIT--------TLSVYLALAHNLLNDSLPLQVG--NLKNLVITCVSLEYLDISSN  395 (854)
Q Consensus       326 ~~l~~L~~L~ls~N~l~~~~p~~~~~~~--------~l~~~l~l~~n~l~~~~p~~~~--~l~~l~~~~~~L~~L~Ls~N  395 (854)
                      ..+++|+.|++++|+++ .+|...+...        .+.. +++++|.++ .+|..+.  .       +++|++|+|++|
T Consensus       454 ~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~-L~Ls~N~l~-~lp~~~~~~~-------l~~L~~L~Ls~N  523 (636)
T 4eco_A          454 STGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTS-IDLRFNKLT-KLSDDFRATT-------LPYLVGIDLSYN  523 (636)
T ss_dssp             HTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCE-EECCSSCCC-BCCGGGSTTT-------CTTCCEEECCSS
T ss_pred             ccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccE-EECcCCcCC-ccChhhhhcc-------CCCcCEEECCCC
Confidence            67999999999999999 7887766543        4444 999999998 6777665  5       567999999999


Q ss_pred             ccccCCCcccccCCCCCEEEc------cCcccccccchhhcCccCCCeeecccccCcccCCCCccccCcccccccccccc
Q 043388          396 SFHGVIPFSLGFMKSIKELNV------SSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKL  469 (854)
Q Consensus       396 ~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~  469 (854)
                      ++++ +|..+..+++|+.|+|      ++|++.+.+|..+.++++|+.|+|++|++ +.+|.. .+.....+.+.+|+..
T Consensus       524 ~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          524 SFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNI  600 (636)
T ss_dssp             CCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTC
T ss_pred             CCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCc
Confidence            9997 8999999999999999      56889999999999999999999999999 778865 4478888889999877


Q ss_pred             cCC
Q 043388          470 CGG  472 (854)
Q Consensus       470 c~~  472 (854)
                      |-.
T Consensus       601 ~~~  603 (636)
T 4eco_A          601 SID  603 (636)
T ss_dssp             EEE
T ss_pred             ccc
Confidence            644

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=3.9e-46  Score=443.48  Aligned_cols=395  Identities=20%  Similarity=0.224  Sum_probs=233.8

Q ss_pred             CCcccccCchhhhcCCCCCEEec-ccccccccCCccc-------------------------------------------
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAI-DFNYLTGQLPDFV-------------------------------------------   36 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L-~~n~l~~~~~~~~-------------------------------------------   36 (854)
                      .|+++|.+|+.|++|++|++|+| ++|.+.|..|-..                                           
T Consensus       332 ~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~  411 (876)
T 4ecn_A          332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN  411 (876)
T ss_dssp             TTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTC
T ss_pred             cCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhC
Confidence            36788888888888888888888 8887766532110                                           


Q ss_pred             --------cCcCCCCeeeccc--ccccccCCcCccCCCCCcEEecccccCcc-----------------cChhhhc--CC
Q 043388           37 --------GNLSALGMLLIRW--NSLGGQIPTTLGLLRNLVYLNVAENQFSG-----------------MFPRWIC--NI   87 (854)
Q Consensus        37 --------~~l~~L~~L~l~~--n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l   87 (854)
                              .....++.+.+..  |++++ +|..|+.+++|++|+|++|+|++                 .+|+.++  ++
T Consensus       412 ~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L  490 (876)
T 4ecn_A          412 PEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNL  490 (876)
T ss_dssp             TTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGC
T ss_pred             ccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccC
Confidence                    1112233333333  67775 78888888888888888888887                 2777766  88


Q ss_pred             CCCceeeecccccccccCcccccCCCCCcEEEcccCC-CC-------------------CCceeeccCccCCCCCCCCCC
Q 043388           88 SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCS-LK-------------------NLWWLNLEQNNLGMGTASSIP  147 (854)
Q Consensus        88 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~-l~-------------------~L~~L~L~~N~l~~~~~~~~p  147 (854)
                      ++|++|+|++|++.+.+| ..|.++++|++|++++|+ ++                   +|+.|+|++|++     ..+|
T Consensus       491 ~~L~~L~Ls~N~l~~~iP-~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L-----~~ip  564 (876)
T 4ecn_A          491 KDLTDVELYNCPNMTQLP-DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL-----EEFP  564 (876)
T ss_dssp             TTCCEEEEESCTTCCSCC-GGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC-----CBCC
T ss_pred             CCCCEEECcCCCCCccCh-HHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC-----CccC
Confidence            888888888888877777 456778888888877776 43                   344444444444     2344


Q ss_pred             c--cccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCC-CcEEEcccCcCcccC
Q 043388          148 D--SLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSS-LKALSLCDNQFGGEL  224 (854)
Q Consensus       148 ~--~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~-L~~L~L~~N~l~~~~  224 (854)
                      .  .|.++++|++|+|++|+|+ .+| .|..+++|++|+|++|+++.++.       .+..+++ |+.|+|++|.++ .+
T Consensus       565 ~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp~-------~l~~l~~~L~~L~Ls~N~L~-~l  634 (876)
T 4ecn_A          565 ASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPE-------DFCAFTDQVEGLGFSHNKLK-YI  634 (876)
T ss_dssp             CHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCCT-------TSCEECTTCCEEECCSSCCC-SC
T ss_pred             ChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccchH-------HHhhccccCCEEECcCCCCC-cC
Confidence            4  4555555555555555554 222 44555555555555555442221       2344444 555555555554 44


Q ss_pred             Chhhhhhc-ccccEEEccCCcccccCCccc---c--ccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCC
Q 043388          225 PHSIANLS-STMIQFRIGGNQISGTIPSGI---R--NLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIP  298 (854)
Q Consensus       225 p~~~~~l~-~~L~~L~l~~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  298 (854)
                      |..+..+. ..|+.|++++|++++.+|...   .  .+++|+.|+|++|+++.+.+..+..+++|+.|+|++|+|+ .+|
T Consensus       635 p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip  713 (876)
T 4ecn_A          635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIP  713 (876)
T ss_dssp             CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCC
T ss_pred             chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccC
Confidence            44443332 124455555555544333211   1  2224455555555554332222334445555555555554 233


Q ss_pred             ccccC--------ccccchhccccceecccCCCCCc--CCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCC
Q 043388          299 PSLGN--------LTKLADLALSFNNLQGNIPSSLG--NCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLND  368 (854)
Q Consensus       299 ~~~~~--------l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~  368 (854)
                      ..+..        +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|++                         .+
T Consensus       714 ~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L-------------------------~~  767 (876)
T 4ecn_A          714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF-------------------------SS  767 (876)
T ss_dssp             TTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCC-------------------------SS
T ss_pred             hHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCC-------------------------Cc
Confidence            22211        124555555555554 3444443  445555555555544                         44


Q ss_pred             CcCccccccccccccccccceeeccC------cccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeeccc
Q 043388          369 SLPLQVGNLKNLVITCVSLEYLDISS------NSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSY  442 (854)
Q Consensus       369 ~~p~~~~~l~~l~~~~~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  442 (854)
                       +|..+++       +++|+.|+|++      |++.+.+|..|..+++|+.|+|++|+| +.+|..+.  ++|+.|||++
T Consensus       768 -lp~~l~~-------L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~  836 (876)
T 4ecn_A          768 -FPTQPLN-------SSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIAD  836 (876)
T ss_dssp             -CCCGGGG-------CTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCS
T ss_pred             -cchhhhc-------CCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCC
Confidence             4444444       45688888866      888889999999999999999999999 58888765  6999999999


Q ss_pred             ccCcccCC
Q 043388          443 NHLEGEVP  450 (854)
Q Consensus       443 N~l~~~~p  450 (854)
                      |++....+
T Consensus       837 N~l~~i~~  844 (876)
T 4ecn_A          837 NPNISIDV  844 (876)
T ss_dssp             CTTCEEEC
T ss_pred             CCCCccCh
Confidence            99876543

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.2e-45  Score=439.29  Aligned_cols=412  Identities=20%  Similarity=0.249  Sum_probs=344.3

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeec-ccccccccCCcCc----------------------------------
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLI-RWNSLGGQIPTTL----------------------------------   60 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l-~~n~l~~~~~~~~----------------------------------   60 (854)
                      ..++.|+|++|.+.|.+|.+|++|++|++|+| ++|.+++..|-.-                                  
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57999999999999999999999999999999 9998876633221                                  


Q ss_pred             -----------------cCCCCCcEEeccc--ccCcccChhhhcCCCCCceeeeccccccc-----------------cc
Q 043388           61 -----------------GLLRNLVYLNVAE--NQFSGMFPRWICNISSLEFIYLTVNRFSG-----------------SL  104 (854)
Q Consensus        61 -----------------~~l~~L~~L~Ls~--N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~  104 (854)
                                       .....++.+++..  |++++ +|..|+++++|++|+|++|+|++                 .+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence                             1122344455544  89998 89999999999999999999996                 38


Q ss_pred             Cccc-ccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCc-Ccc-cCCcCccccC---
Q 043388          105 PFDI-LVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ-FKG-KVSIDFSSLK---  178 (854)
Q Consensus       105 ~~~~-~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~-i~~-~~~~~f~~l~---  178 (854)
                      |..+ |.++++|++|+|++|++.                 +.+|..|.++++|++|+|++|+ +++ ..|..|..++   
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~-----------------~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~  544 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNM-----------------TQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE  544 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTC-----------------CSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCT
T ss_pred             ChhhhhccCCCCCEEECcCCCCC-----------------ccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcc
Confidence            8765 558888888888777653                 5679999999999999999998 887 6676666555   


Q ss_pred             ----CCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccc
Q 043388          179 ----NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIR  254 (854)
Q Consensus       179 ----~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~  254 (854)
                          +|++|+|++|+++.++.     ...+.++++|+.|+|++|+++ .+| .+..++ .|+.|+|++|+++ .+|..+.
T Consensus       545 ~~l~~L~~L~Ls~N~L~~ip~-----~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~-~L~~L~Ls~N~l~-~lp~~l~  615 (876)
T 4ecn_A          545 DTGPKIQIFYMGYNNLEEFPA-----SASLQKMVKLGLLDCVHNKVR-HLE-AFGTNV-KLTDLKLDYNQIE-EIPEDFC  615 (876)
T ss_dssp             TTTTTCCEEECCSSCCCBCCC-----HHHHTTCTTCCEEECTTSCCC-BCC-CCCTTS-EESEEECCSSCCS-CCCTTSC
T ss_pred             cccCCccEEEeeCCcCCccCC-----hhhhhcCCCCCEEECCCCCcc-cch-hhcCCC-cceEEECcCCccc-cchHHHh
Confidence                99999999999985443     015889999999999999999 888 788876 7999999999999 8898999


Q ss_pred             cccc-CCeeeccccccccCCCCCccCccc--CceeeCccccccccCCccc---c--CccccchhccccceecccCCCC-C
Q 043388          255 NLVN-LIALTIEVNQLHGIIPDGVGELQH--LQQLYMFRNFLQGSIPPSL---G--NLTKLADLALSFNNLQGNIPSS-L  325 (854)
Q Consensus       255 ~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~-~  325 (854)
                      ++++ |+.|+|++|+++ .+|..+..++.  |+.|+|++|++.+.+|...   .  .+++|+.|+|++|.++ .+|.. +
T Consensus       616 ~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~  693 (876)
T 4ecn_A          616 AFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELF  693 (876)
T ss_dssp             EECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHH
T ss_pred             hccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHH
Confidence            9999 999999999999 67788877754  9999999999998766432   2  3458999999999999 45554 4


Q ss_pred             cCCCCCcccccCCCcccCccchhhcchh--------hhHHHHHhhcCCCCCCcCcccc--ccccccccccccceeeccCc
Q 043388          326 GNCQNLKGFDASHNKLTGAIPQQVLSIT--------TLSVYLALAHNLLNDSLPLQVG--NLKNLVITCVSLEYLDISSN  395 (854)
Q Consensus       326 ~~l~~L~~L~ls~N~l~~~~p~~~~~~~--------~l~~~l~l~~n~l~~~~p~~~~--~l~~l~~~~~~L~~L~Ls~N  395 (854)
                      ..+++|+.|+|++|+++ .+|..++...        .+.. |++++|.+. .+|..+.  .       +++|+.|+|++|
T Consensus       694 ~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~-L~Ls~N~L~-~lp~~l~~~~-------l~~L~~L~Ls~N  763 (876)
T 4ecn_A          694 ATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTT-IDLRFNKLT-SLSDDFRATT-------LPYLSNMDVSYN  763 (876)
T ss_dssp             HTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCE-EECCSSCCC-CCCGGGSTTT-------CTTCCEEECCSS
T ss_pred             ccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccE-EECCCCCCc-cchHHhhhcc-------CCCcCEEEeCCC
Confidence            58999999999999998 7888776543        4444 999999998 6777765  5       567999999999


Q ss_pred             ccccCCCcccccCCCCCEEEccC------cccccccchhhcCccCCCeeecccccCcccCCCCccccCcccccccccccc
Q 043388          396 SFHGVIPFSLGFMKSIKELNVSS------NNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKL  469 (854)
Q Consensus       396 ~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~  469 (854)
                      +|++ +|..+..+++|+.|+|++      |++.+.+|..|.++++|+.|+|++|++ +.+|.. .+.+...+.+.+|+..
T Consensus       764 ~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~l~  840 (876)
T 4ecn_A          764 CFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNPNI  840 (876)
T ss_dssp             CCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCTTC
T ss_pred             CCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCCCC
Confidence            9997 788999999999999976      889999999999999999999999999 788875 4467788888888754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1e-45  Score=399.23  Aligned_cols=202  Identities=25%  Similarity=0.359  Sum_probs=168.5

Q ss_pred             HHhhccccCccCCCcceEEEEeEEC---CCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILG---GEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  621 (854)
                      ..+.|++.++||+|+||+||+|+++   .+++.||+|++....  ...++.+|+++++.+ +|||||++++++.+.+   
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~---   93 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND---   93 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT---
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC---
Confidence            4567999999999999999999874   467899999986543  346788999999998 6999999999998765   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-cccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAH-  699 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~~-  699 (854)
                        +.|+|||||++|+|.+++.         .+++.+++.++.|++.||+|||++   +|+||||||+|||++.+ +..+ 
T Consensus        94 --~~~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl  159 (361)
T 4f9c_A           94 --HVVIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYAL  159 (361)
T ss_dssp             --EEEEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred             --EEEEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEE
Confidence              7899999999999999984         578899999999999999999999   99999999999999876 4444 


Q ss_pred             cccccccccccCCCC-------------------------CCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHH
Q 043388          700 QNFSLSHQLDSASKT-------------------------PSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLE  753 (854)
Q Consensus       700 ~Dfg~~~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~e  753 (854)
                      +|||+|+........                         .......+||+.|+|||++.+. .++.++||||+||++||
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e  239 (361)
T 4f9c_A          160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS  239 (361)
T ss_dssp             CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred             CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence            599999866443211                         0112235799999999998875 48999999999999999


Q ss_pred             HHhCCCCCCCccc
Q 043388          754 MFTGRRPTDAAFT  766 (854)
Q Consensus       754 lltg~~pf~~~~~  766 (854)
                      |+||+.||....+
T Consensus       240 ll~G~~Pf~~~~~  252 (361)
T 4f9c_A          240 LLSGRYPFYKASD  252 (361)
T ss_dssp             HHHTCSSSSCCSS
T ss_pred             HHHCCCCCCCCCC
Confidence            9999999975543

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.1e-46  Score=428.43  Aligned_cols=425  Identities=21%  Similarity=0.281  Sum_probs=262.4

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      +|+|+ .+|..+.  ++|++|+|++|.+++..|..|..+++|++|+|++|+|++..|..|+.+++|++|+|++|+|++ +
T Consensus         9 ~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l   84 (520)
T 2z7x_B            9 KNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-I   84 (520)
T ss_dssp             TSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-E
T ss_pred             CCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-c
Confidence            46777 5777666  789999999999987777788888999999999999988888888889999999999999884 5


Q ss_pred             hhhhcCCCCCceeeecccccccccC-cccccCCCCCcEEEcccCCCC--------CC--ceeeccCccCCCCCCCCCCcc
Q 043388           81 PRWICNISSLEFIYLTVNRFSGSLP-FDILVNLPNLKELYLTFCSLK--------NL--WWLNLEQNNLGMGTASSIPDS  149 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~l~~L~~L~l~~n~l~--------~L--~~L~L~~N~l~~~~~~~~p~~  149 (854)
                      |..  .+++|++|+|++|+|+ .++ +..|.++++|++|++++|.++        +|  +.|+|++|.+..  .+..|..
T Consensus        85 p~~--~l~~L~~L~L~~N~l~-~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~--~~~~~~~  159 (520)
T 2z7x_B           85 SCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG--EKEDPEG  159 (520)
T ss_dssp             ECC--CCCCCSEEECCSSCCS-SCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTT--SSCCTTT
T ss_pred             Ccc--ccCCccEEeccCCccc-cccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccccc--ccccccc
Confidence            554  7888999999999887 433 256788899999998888764        56  888888888721  1234444


Q ss_pred             ccCCC-CCCEEecCCCcCcccC-CcCccccCCCCeEecccccccCCCCCChhhhhhccCCC-------------------
Q 043388          150 LSNAS-NLERLDLSGNQFKGKV-SIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCS-------------------  208 (854)
Q Consensus       150 ~~~l~-~L~~L~Ls~N~i~~~~-~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~-------------------  208 (854)
                      |..+. +...+++++|++.+.. +..|..+++|+.|++++|.-...-..-......+..++                   
T Consensus       160 l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~  239 (520)
T 2z7x_B          160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR  239 (520)
T ss_dssp             TTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHH
T ss_pred             ccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHH
Confidence            44433 2224455555544322 23444555555555555530000000000111334444                   


Q ss_pred             --------CCcEEEcccCcCcccCChhh-----hhhcccccEEEccCCcccccCC-cccccc---ccCCeeecccccccc
Q 043388          209 --------SLKALSLCDNQFGGELPHSI-----ANLSSTMIQFRIGGNQISGTIP-SGIRNL---VNLIALTIEVNQLHG  271 (854)
Q Consensus       209 --------~L~~L~L~~N~l~~~~p~~~-----~~l~~~L~~L~l~~N~l~~~~~-~~~~~l---~~L~~L~L~~N~l~~  271 (854)
                              +|++|++++|++++.+|..+     ..+. .|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+..
T Consensus       240 ~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~-~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~  316 (520)
T 2z7x_B          240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLK-ALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVH  316 (520)
T ss_dssp             HHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCC-EEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCC
T ss_pred             HHHHhhhCcccEEEeecccccCccccchhhcccccCc-eeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccc
Confidence                    45555555555554444444     3333 444555555554  222 333333   345555555555543


Q ss_pred             CCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecc--cCCCCCcCCCCCcccccCCCcccCccchh-
Q 043388          272 IIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQG--NIPSSLGNCQNLKGFDASHNKLTGAIPQQ-  348 (854)
Q Consensus       272 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~ls~N~l~~~~p~~-  348 (854)
                      ..  .+..+++|++|++++|++++.+|..++.+++|+.|++++|++++  .+|..+..+++|+.|++++|++++.+|.. 
T Consensus       317 ~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~  394 (520)
T 2z7x_B          317 ML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD  394 (520)
T ss_dssp             CC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCS
T ss_pred             cc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccch
Confidence            21  12566667777777777766666666667777777777777664  34455666677777777777776545554 


Q ss_pred             hcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccch-
Q 043388          349 VLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPE-  427 (854)
Q Consensus       349 ~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-  427 (854)
                      +..+..+.. +++++|.+++..|..+.         .+|++|+|++|+|+ .+|..+..+++|++|+|++|+|++ +|. 
T Consensus       395 ~~~l~~L~~-L~Ls~N~l~~~~~~~l~---------~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~  462 (520)
T 2z7x_B          395 CSWTKSLLS-LNMSSNILTDTIFRCLP---------PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDG  462 (520)
T ss_dssp             CCCCTTCCE-EECCSSCCCGGGGGSCC---------TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTT
T ss_pred             hccCccCCE-EECcCCCCCcchhhhhc---------ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHH
Confidence            333333333 66666666655554432         24667777777776 556655567777777777777773 443 


Q ss_pred             hhcCccCCCeeecccccCcccCCC
Q 043388          428 FLQNLSFLEFLNLSYNHLEGEVPT  451 (854)
Q Consensus       428 ~~~~l~~L~~L~ls~N~l~~~~p~  451 (854)
                      .|..+++|+.|++++|+++|.++.
T Consensus       463 ~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          463 IFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             TTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             HhccCCcccEEECcCCCCcccCCc
Confidence            366677777777777777766553

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-44  Score=409.10  Aligned_cols=249  Identities=22%  Similarity=0.284  Sum_probs=198.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHH---HHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVA---ECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|.+.++||+|+||.||+|+++.+|+.||||+++...   ........+   ++.+++.++|||||++++++.+.+  
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~--  265 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--  265 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC--
Confidence            568999999999999999999999999999999996431   222233334   456667779999999999998766  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                         ..|+|||||+||+|.+++...+      .+++.+++.++.||+.||+|||++   +||||||||+|||++.++..++
T Consensus       266 ---~lylVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL  333 (689)
T 3v5w_A          266 ---KLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI  333 (689)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             ---EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence               7999999999999999998765      789999999999999999999999   9999999999999999988777


Q ss_pred             -ccccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                       |||+|+.+.....     ...+||+.|||||++.+ ..|+.++||||+||++|||++|++||........  .+.....
T Consensus       334 ~DFGlA~~~~~~~~-----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i  406 (689)
T 3v5w_A          334 SDLGLACDFSKKKP-----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMT  406 (689)
T ss_dssp             CCCTTCEECSSCCC-----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHH
T ss_pred             cccceeeecCCCCC-----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhh
Confidence             9999988754332     23589999999999975 5799999999999999999999999976433221  1111111


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-----HHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-----MRDVVA  840 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  840 (854)
                      ..... .                       .+..++.++.+++.+||+.||.+|++     ++||.+
T Consensus       407 ~~~~~-~-----------------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          407 LTMAV-E-----------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHCCC-C-----------------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             cCCCC-C-----------------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            00000 0                       00112445779999999999999998     577654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=416.13  Aligned_cols=413  Identities=19%  Similarity=0.186  Sum_probs=317.4

Q ss_pred             CEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeeccc
Q 043388           19 QTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVN   98 (854)
Q Consensus        19 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N   98 (854)
                      ++||+++|+|+ .+|..+.  ++|++|+|++|++++..|..|..+++|++|+|++|+|+++.|++|+++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            58999999999 6888776  89999999999999888889999999999999999999999999999999999999999


Q ss_pred             ccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccC
Q 043388           99 RFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLK  178 (854)
Q Consensus        99 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~  178 (854)
                      +|+ .+|..   .+++|++|++++|+++.+                .+|..|+++++|++|+|++|+|++   ..|..++
T Consensus        80 ~l~-~lp~~---~l~~L~~L~L~~N~l~~~----------------~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~  136 (520)
T 2z7x_B           80 KLV-KISCH---PTVNLKHLDLSFNAFDAL----------------PICKEFGNMSQLKFLGLSTTHLEK---SSVLPIA  136 (520)
T ss_dssp             CCC-EEECC---CCCCCSEEECCSSCCSSC----------------CCCGGGGGCTTCCEEEEEESSCCG---GGGGGGT
T ss_pred             cee-ecCcc---ccCCccEEeccCCccccc----------------cchhhhccCCcceEEEecCcccch---hhccccc
Confidence            998 78865   677888888777766532                357788888888888888888875   4567777


Q ss_pred             CC--CeEecccccc--cCCCCCChhh--------------------hhhccCCCCCcEEEcccCc-------CcccCChh
Q 043388          179 NL--WWLNLEQNNL--GMGTANDLDF--------------------VTLLTNCSSLKALSLCDNQ-------FGGELPHS  227 (854)
Q Consensus       179 ~L--~~L~L~~N~l--~~~~~~~~~~--------------------~~~~~~l~~L~~L~L~~N~-------l~~~~p~~  227 (854)
                      +|  ++|++++|.+  .......+..                    ...+.++++|+.|++++|.       +.+.+| .
T Consensus       137 ~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~  215 (520)
T 2z7x_B          137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-K  215 (520)
T ss_dssp             TSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-G
T ss_pred             cceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-h
Confidence            77  8888888887  3222221111                    1134567888888888886       444333 3


Q ss_pred             hhhhc--------------------------ccccEEEccCCcccccCCccc-----cccccCCeeeccccccccCCCCC
Q 043388          228 IANLS--------------------------STMIQFRIGGNQISGTIPSGI-----RNLVNLIALTIEVNQLHGIIPDG  276 (854)
Q Consensus       228 ~~~l~--------------------------~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~  276 (854)
                      +..+.                          +.|+.|++++|++++.+|..+     .++++|+.+++++|.+ .+.+..
T Consensus       216 l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~  294 (520)
T 2z7x_B          216 LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSY  294 (520)
T ss_dssp             GGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHH
T ss_pred             hccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhh
Confidence            33333                          145556666666665556555     5566666666666666 222233


Q ss_pred             ccCc---ccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccC--ccchhhcc
Q 043388          277 VGEL---QHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTG--AIPQQVLS  351 (854)
Q Consensus       277 ~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~  351 (854)
                      +..+   .+|+.|++++|.+....  .+..+++|++|++++|++++..|..+..+++|+.|++++|++++  .+|..+..
T Consensus       295 ~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~  372 (520)
T 2z7x_B          295 IYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ  372 (520)
T ss_dssp             HHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTT
T ss_pred             hhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhh
Confidence            3333   45667777777665322  12688999999999999998899999999999999999999986  55667777


Q ss_pred             hhhhHHHHHhhcCCCCCCcCcc-ccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhc
Q 043388          352 ITTLSVYLALAHNLLNDSLPLQ-VGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQ  430 (854)
Q Consensus       352 ~~~l~~~l~l~~n~l~~~~p~~-~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  430 (854)
                      +..+.. +++++|.+.+.+|.. +..       +.+|++|+|++|++++..|..+.  ++|+.|+|++|+|+ .+|..+.
T Consensus       373 l~~L~~-L~Ls~N~l~~~l~~~~~~~-------l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~  441 (520)
T 2z7x_B          373 MKSLQQ-LDISQNSVSYDEKKGDCSW-------TKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV  441 (520)
T ss_dssp             CTTCCE-EECCSSCCBCCGGGCSCCC-------CTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG
T ss_pred             CCCCCE-EECCCCcCCcccccchhcc-------CccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh
Confidence            777765 999999999866654 444       56799999999999988877665  79999999999999 7888888


Q ss_pred             CccCCCeeecccccCcccCCC-CccccCcccccccccccccCC
Q 043388          431 NLSFLEFLNLSYNHLEGEVPT-KGVFSNKTKISLQVNVKLCGG  472 (854)
Q Consensus       431 ~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~  472 (854)
                      .+++|+.|+|++|+++...+. ...+.+...+.+.+|+..|.+
T Consensus       442 ~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c  484 (520)
T 2z7x_B          442 KLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  484 (520)
T ss_dssp             GCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             cCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccC
Confidence            999999999999999954333 344667778889999988864

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=6.2e-45  Score=422.57  Aligned_cols=425  Identities=21%  Similarity=0.229  Sum_probs=318.9

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeee
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYL   95 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L   95 (854)
                      +..-+.|+++|.++ .+|..+.  ++|++|+|++|++++..|..|+.+++|++|+|++|+|+++.|++|+++++|++|+|
T Consensus         5 ~~~~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L   81 (549)
T 2z81_A            5 DASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL   81 (549)
T ss_dssp             CTTSEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence            34455789999999 7887765  79999999999999888999999999999999999999999999999999999999


Q ss_pred             cccccccccCcccccCCCCCcEEEcccCCCC------------CCceeeccCccCCCCCCCCCC-ccccCCCCCCEEecC
Q 043388           96 TVNRFSGSLPFDILVNLPNLKELYLTFCSLK------------NLWWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLS  162 (854)
Q Consensus        96 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~------------~L~~L~L~~N~l~~~~~~~~p-~~~~~l~~L~~L~Ls  162 (854)
                      ++|+++ .++...|.++++|++|++++|.++            +|+.|+|++|.+.    +.+| ..|.++++|++|+|+
T Consensus        82 s~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~----~~~~~~~~~~l~~L~~L~L~  156 (549)
T 2z81_A           82 SDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF----SEIRRIDFAGLTSLNELEIK  156 (549)
T ss_dssp             TTSCCC-SCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC----CEECTTTTTTCCEEEEEEEE
T ss_pred             CCCccC-ccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccc----cccCHhhhhcccccCeeecc
Confidence            999999 788888999999999999988653            6788899988731    3444 578889999999999


Q ss_pred             CCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccC--ChhhhhhcccccEEEc
Q 043388          163 GNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGEL--PHSIANLSSTMIQFRI  240 (854)
Q Consensus       163 ~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~~L~~L~l  240 (854)
                      +|++++..|..|..+++|++|+++.|.+..++.      ..+..+++|++|++++|++++..  |..+....+.|+.|++
T Consensus       157 ~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l  230 (549)
T 2z81_A          157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE------IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF  230 (549)
T ss_dssp             ETTCCEECTTTTTTCSEEEEEEEECSBSTTHHH------HHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEE
T ss_pred             CCcccccChhhhhccccCceEecccCcccccch------hhHhhcccccEEEccCCccccccccccchhhhhhcccceec
Confidence            999998888899999999999999988753321      13456889999999999998532  3333333346777777


Q ss_pred             cCCcccccCCcc----cccc-----------------------------------------------------------c
Q 043388          241 GGNQISGTIPSG----IRNL-----------------------------------------------------------V  257 (854)
Q Consensus       241 ~~N~l~~~~~~~----~~~l-----------------------------------------------------------~  257 (854)
                      ++|.+++..+..    +..+                                                           .
T Consensus       231 ~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~  310 (549)
T 2z81_A          231 RGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLE  310 (549)
T ss_dssp             ESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHST
T ss_pred             cccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcc
Confidence            777665432211    1122                                                           3


Q ss_pred             cCCeeeccccccccCCCCCc-cCcccCceeeCccccccccCC---ccccCccccchhccccceecccCC--CCCcCCCCC
Q 043388          258 NLIALTIEVNQLHGIIPDGV-GELQHLQQLYMFRNFLQGSIP---PSLGNLTKLADLALSFNNLQGNIP--SSLGNCQNL  331 (854)
Q Consensus       258 ~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L  331 (854)
                      +|+.|++++|+++. +|..+ ..+++|++|++++|++++.+|   ..++.+++|+.|+|++|++++..+  ..+..+++|
T Consensus       311 ~L~~L~l~~n~l~~-ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L  389 (549)
T 2z81_A          311 KVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL  389 (549)
T ss_dssp             TCCEEEEESSCCCC-CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTC
T ss_pred             cceEEEeccCcccc-CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCC
Confidence            45556666666553 33333 467777777777777776553   236667777777777777764322  346677777


Q ss_pred             cccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCC
Q 043388          332 KGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSI  411 (854)
Q Consensus       332 ~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L  411 (854)
                      +.|++++|+++ .+|..+..+..+.. +++++|.+.+ +|..+         ..+|++|+|++|+|++.+    ..+++|
T Consensus       390 ~~L~Ls~N~l~-~lp~~~~~~~~L~~-L~Ls~N~l~~-l~~~~---------~~~L~~L~Ls~N~l~~~~----~~l~~L  453 (549)
T 2z81_A          390 TSLDISRNTFH-PMPDSCQWPEKMRF-LNLSSTGIRV-VKTCI---------PQTLEVLDVSNNNLDSFS----LFLPRL  453 (549)
T ss_dssp             CEEECTTCCCC-CCCSCCCCCTTCCE-EECTTSCCSC-CCTTS---------CTTCSEEECCSSCCSCCC----CCCTTC
T ss_pred             CEEECCCCCCc-cCChhhcccccccE-EECCCCCccc-ccchh---------cCCceEEECCCCChhhhc----ccCChh
Confidence            77777777776 56666655555544 7777777653 22221         136888999999888643    578999


Q ss_pred             CEEEccCcccccccchhhcCccCCCeeecccccCcccCCC-CccccCcccccccccccccCCc
Q 043388          412 KELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPT-KGVFSNKTKISLQVNVKLCGGI  473 (854)
Q Consensus       412 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~~  473 (854)
                      ++|+|++|+|+ .+|. ...+++|+.|||++|++++.+|. ...+.+...+.+.+|++.|.++
T Consensus       454 ~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          454 QELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             CEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             cEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            99999999999 6776 46789999999999999998776 3567778888999999888643

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.7e-43  Score=418.35  Aligned_cols=166  Identities=23%  Similarity=0.260  Sum_probs=131.6

Q ss_pred             cCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcC
Q 043388            7 QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICN   86 (854)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~   86 (854)
                      .||+.+..  ++++|||++|+|++..|.+|.++++|++|+|++|+|+++.|++|+.+++|++|+|++|+|+++.+++|.+
T Consensus        45 ~vP~~lp~--~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~  122 (635)
T 4g8a_A           45 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG  122 (635)
T ss_dssp             SCCSSSCT--TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTT
T ss_pred             ccCCCCCc--CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcC
Confidence            57776653  8999999999999777789999999999999999999888889999999999999999999888889999


Q ss_pred             CCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcC
Q 043388           87 ISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF  166 (854)
Q Consensus        87 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i  166 (854)
                      +++|++|+|++|+|+ .+|...|.++++|++|++++|.++.+                .+|..++++++|++|+|++|+|
T Consensus       123 L~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~----------------~~~~~~~~l~~L~~L~L~~N~l  185 (635)
T 4g8a_A          123 LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSF----------------KLPEYFSNLTNLEHLDLSSNKI  185 (635)
T ss_dssp             CTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCC----------------CCCGGGGGCTTCCEEECCSSCC
T ss_pred             CCCCCEEECCCCcCC-CCChhhhhcCcccCeeccccCccccC----------------CCchhhccchhhhhhcccCccc
Confidence            999999999999998 88888899999999999988876532                2355556666666666666666


Q ss_pred             cccCCcCccccCCCC----eEeccccccc
Q 043388          167 KGKVSIDFSSLKNLW----WLNLEQNNLG  191 (854)
Q Consensus       167 ~~~~~~~f~~l~~L~----~L~L~~N~l~  191 (854)
                      +++.+..|..+.+++    .++++.|.++
T Consensus       186 ~~~~~~~l~~L~~l~~~~~~~~ls~n~l~  214 (635)
T 4g8a_A          186 QSIYCTDLRVLHQMPLLNLSLDLSLNPMN  214 (635)
T ss_dssp             CEECGGGGHHHHTCTTCCCEEECTTCCCC
T ss_pred             cccccccccchhhhhhhhhhhhcccCccc
Confidence            666555555444332    3445554443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.6e-44  Score=408.38  Aligned_cols=252  Identities=19%  Similarity=0.282  Sum_probs=205.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++........+.+.+|+++|+.++|||||++++++.+..     ..|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS-----EEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEE
Confidence            468999999999999999999999999999999997665555678899999999999999999999998765     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC--cccc-cccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD--MVAH-QNFS  703 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~~-~Dfg  703 (854)
                      +|||||+||+|.+++.....     .+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +..+ +|||
T Consensus       231 iv~E~~~gg~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             EEEeecCCCcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence            99999999999999975432     689999999999999999999999   99999999999999854  4444 5999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +|+.+.....    ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... ..+..........  
T Consensus       303 ~a~~~~~~~~----~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-~~~~~i~~~~~~~--  375 (573)
T 3uto_A          303 LTAHLDPKQS----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWNM--  375 (573)
T ss_dssp             SCEECCTTSE----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCCC--
T ss_pred             ceeEccCCCc----eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHhCCCCC--
Confidence            9998764332    22357999999999999999999999999999999999999999754221 1111111111100  


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                          ++.                  ....++..+.+++.+||+.||.+|||+.|+++
T Consensus       376 ----~~~------------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          376 ----DDS------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ----CSG------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----Ccc------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000                  00112445778999999999999999999986

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.6e-42  Score=390.62  Aligned_cols=375  Identities=19%  Similarity=0.186  Sum_probs=284.0

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeecccccccc-cCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceee
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGG-QIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIY   94 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~   94 (854)
                      ++|++|+|++|.+++..|..|+.+++|++|+|++|.+.+ +.+..|..+++|++|+|++|++++..|.+|+++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            578888888888887777788888888888888887763 3356778888888888888888877788888888888888


Q ss_pred             ecccccccccC-cccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCcc-ccCCCCCCEEecCCCcCcccCCc
Q 043388           95 LTVNRFSGSLP-FDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDS-LSNASNLERLDLSGNQFKGKVSI  172 (854)
Q Consensus        95 L~~N~l~~~~~-~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~-~~~l~~L~~L~Ls~N~i~~~~~~  172 (854)
                      |++|++++.+| ...|.++++|++|++++|++..+                 .|.. |.++++|++|+|++|+++++.+.
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~-----------------~~~~~~~~l~~L~~L~L~~n~l~~~~~~  172 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI-----------------QPASFFLNMRRFHVLDLTFNKVKSICEE  172 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSC-----------------CCCGGGGGCTTCCEEECTTCCBSCCCTT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCcc-----------------CcccccCCCCcccEEeCCCCcccccChh
Confidence            88888774333 34466777777777666665432                 2444 77788888888888888888777


Q ss_pred             Ccccc--CCCCeEecccccccCCCCCChhh--hhhccCCCCCcEEEcccCcCcccCChhhhhhc--ccccEEEccCCccc
Q 043388          173 DFSSL--KNLWWLNLEQNNLGMGTANDLDF--VTLLTNCSSLKALSLCDNQFGGELPHSIANLS--STMIQFRIGGNQIS  246 (854)
Q Consensus       173 ~f~~l--~~L~~L~L~~N~l~~~~~~~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~~L~~L~l~~N~l~  246 (854)
                      .+..+  .+|+.|++++|.+..+....+..  ...+..+++|++|++++|++++..|..+....  ..++.|++++|.+.
T Consensus       173 ~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~  252 (455)
T 3v47_A          173 DLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM  252 (455)
T ss_dssp             TSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTT
T ss_pred             hhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccc
Confidence            77766  67888888888877665442211  11234557788888888888777777666541  35677777777655


Q ss_pred             ccCCccccccccCCeeeccccccccCCCCCccCc--ccCceeeCccccccccCCccccCccccchhccccceecccCCCC
Q 043388          247 GTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGEL--QHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSS  324 (854)
Q Consensus       247 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  324 (854)
                      +..              +..+.+....+..|..+  ++|+.|++++|.+++..|..|..+++|+.|+|++|.+++..|..
T Consensus       253 ~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~  318 (455)
T 3v47_A          253 GSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA  318 (455)
T ss_dssp             SCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT
T ss_pred             ccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhH
Confidence            321              12233333334444443  68999999999999889999999999999999999999888899


Q ss_pred             CcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcc
Q 043388          325 LGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFS  404 (854)
Q Consensus       325 ~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~  404 (854)
                      |.++++|+.|++++|++++..|..                         +++       +.+|++|+|++|++++..|..
T Consensus       319 ~~~l~~L~~L~Ls~N~l~~~~~~~-------------------------~~~-------l~~L~~L~Ls~N~l~~~~~~~  366 (455)
T 3v47_A          319 FWGLTHLLKLNLSQNFLGSIDSRM-------------------------FEN-------LDKLEVLDLSYNHIRALGDQS  366 (455)
T ss_dssp             TTTCTTCCEEECCSSCCCEECGGG-------------------------GTT-------CTTCCEEECCSSCCCEECTTT
T ss_pred             hcCcccCCEEECCCCccCCcChhH-------------------------hcC-------cccCCEEECCCCcccccChhh
Confidence            999999999999999987433332                         222       456999999999999998999


Q ss_pred             cccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCCCc
Q 043388          405 LGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKG  453 (854)
Q Consensus       405 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  453 (854)
                      |..+++|++|+|++|+|++..+..|..+++|+.|++++|+++|.+|...
T Consensus       367 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  415 (455)
T 3v47_A          367 FLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  415 (455)
T ss_dssp             TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             ccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence            9999999999999999998777888999999999999999999999643

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=372.23  Aligned_cols=266  Identities=23%  Similarity=0.341  Sum_probs=214.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|.+.++||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++.+.+     ..+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK-----RLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC-----eeE
Confidence            368999999999999999999999899999999987666666778999999999999999999999998655     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  155 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLA  155 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccc
Confidence            99999999999999987532     689999999999999999999999   9999999999999999887766 99999


Q ss_pred             cccccCCCCCC-----------cccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHH
Q 043388          706 HQLDSASKTPS-----------SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEF  774 (854)
Q Consensus       706 ~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~  774 (854)
                      +..........           ......||+.|+|||++.+..++.++|||||||++|||++|..||.............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~  235 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN  235 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred             eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence            87754432211           1113579999999999999999999999999999999999999987543221110000


Q ss_pred             hhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhc
Q 043388          775 VKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLG  851 (854)
Q Consensus       775 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  851 (854)
                      ...                          .........++..+.+++.+||+.||++|||+.|+++.|+.+.....+
T Consensus       236 ~~~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          236 VRG--------------------------FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             HHH--------------------------HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             hhc--------------------------cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence            000                          000000112345678999999999999999999999999999876543

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.2e-42  Score=403.56  Aligned_cols=395  Identities=20%  Similarity=0.235  Sum_probs=249.7

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      ..+++++++|+++ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.|++|.++++|++|+|+
T Consensus        32 ~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  108 (562)
T 3a79_B           32 LESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS  108 (562)
T ss_dssp             -CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence            3467777777777 4665554  677777777777776666677777777777777777777777777777777777777


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccc
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS  176 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~  176 (854)
                      +|+|+ .+|..   .+++|++|++++|+++.+                .+|..|+++++|++|+|++|+|+.   ..|..
T Consensus       109 ~N~l~-~lp~~---~l~~L~~L~Ls~N~l~~l----------------~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~  165 (562)
T 3a79_B          109 HNRLQ-NISCC---PMASLRHLDLSFNDFDVL----------------PVCKEFGNLTKLTFLGLSAAKFRQ---LDLLP  165 (562)
T ss_dssp             TSCCC-EECSC---CCTTCSEEECCSSCCSBC----------------CCCGGGGGCTTCCEEEEECSBCCT---TTTGG
T ss_pred             CCcCC-ccCcc---ccccCCEEECCCCCcccc----------------CchHhhcccCcccEEecCCCcccc---Cchhh
Confidence            77776 66654   566666666666554322                123445555555555555555443   22333


Q ss_pred             cCCC--CeEecccccc--cCCCCCChhh--------------------hhhccCCCCCcEEEcccC--------------
Q 043388          177 LKNL--WWLNLEQNNL--GMGTANDLDF--------------------VTLLTNCSSLKALSLCDN--------------  218 (854)
Q Consensus       177 l~~L--~~L~L~~N~l--~~~~~~~~~~--------------------~~~~~~l~~L~~L~L~~N--------------  218 (854)
                      +++|  ++|+|++|.+  +......+..                    ...+..+++|+.|++++|              
T Consensus       166 l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l  245 (562)
T 3a79_B          166 VAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSEL  245 (562)
T ss_dssp             GTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHH
T ss_pred             hhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHH
Confidence            3333  5555555544  2221111100                    001222333333333333              


Q ss_pred             --------------cCcccC----ChhhhhhcccccEEEccCCcccccCCccc-----ccc-------------------
Q 043388          219 --------------QFGGEL----PHSIANLSSTMIQFRIGGNQISGTIPSGI-----RNL-------------------  256 (854)
Q Consensus       219 --------------~l~~~~----p~~~~~l~~~L~~L~l~~N~l~~~~~~~~-----~~l-------------------  256 (854)
                                    .+.+..    +..+. . +.|++|++++|.+++.+|..+     .++                   
T Consensus       246 ~~l~~L~~L~L~~~~l~~~~~~~~~~~~~-~-~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~  323 (562)
T 3a79_B          246 TRGPTLLNVTLQHIETTWKCSVKLFQFFW-P-RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA  323 (562)
T ss_dssp             HSCSSCEEEEEEEEEECHHHHHHHHHHHT-T-SSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHH
T ss_pred             hccCcceEEEecCCcCcHHHHHHHHHhhh-c-ccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhh
Confidence                          322111    11111 1 157777777777776666655     333                   


Q ss_pred             -------ccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceeccc--CCCCCcC
Q 043388          257 -------VNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGN--IPSSLGN  327 (854)
Q Consensus       257 -------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~  327 (854)
                             .+|+.|++++|++....  .+..+++|++|++++|++++.+|..+.++++|+.|+|++|++++.  +|..|.+
T Consensus       324 ~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  401 (562)
T 3a79_B          324 LYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKN  401 (562)
T ss_dssp             HHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTT
T ss_pred             hhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcC
Confidence                   34666666666654321  126778888888888888877888888888888888888888853  3466788


Q ss_pred             CCCCcccccCCCcccCccchhh-cchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccc
Q 043388          328 CQNLKGFDASHNKLTGAIPQQV-LSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLG  406 (854)
Q Consensus       328 l~~L~~L~ls~N~l~~~~p~~~-~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~  406 (854)
                      +++|+.|++++|++++.+|... ..+..+.. +++++|.+++..|..+.         .+|++|+|++|+|+ .+|..+.
T Consensus       402 l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~~~l~---------~~L~~L~L~~N~l~-~ip~~~~  470 (562)
T 3a79_B          402 MSSLETLDVSLNSLNSHAYDRTCAWAESILV-LNLSSNMLTGSVFRCLP---------PKVKVLDLHNNRIM-SIPKDVT  470 (562)
T ss_dssp             CTTCCEEECTTSCCBSCCSSCCCCCCTTCCE-EECCSSCCCGGGGSSCC---------TTCSEEECCSSCCC-CCCTTTT
T ss_pred             CCCCCEEECCCCcCCCccChhhhcCcccCCE-EECCCCCCCcchhhhhc---------CcCCEEECCCCcCc-ccChhhc
Confidence            8888888888888886566653 34444443 78888888776665443         35888999999888 5666666


Q ss_pred             cCCCCCEEEccCcccccccchh-hcCccCCCeeecccccCcccCCCCc
Q 043388          407 FMKSIKELNVSSNNLSGQIPEF-LQNLSFLEFLNLSYNHLEGEVPTKG  453 (854)
Q Consensus       407 ~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p~~~  453 (854)
                      .+++|++|+|++|+|++ +|.. |..+++|+.|++++|+++|.+|..+
T Consensus       471 ~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~  517 (562)
T 3a79_B          471 HLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPGIR  517 (562)
T ss_dssp             SSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHHHHH
T ss_pred             CCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcchHH
Confidence            88899999999999984 5544 8888889999999999988877543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.9e-42  Score=365.97  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=206.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++...+     ..+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-----EEE
Confidence            357999999999999999999998899999999998776666788999999999999999999999998755     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++...       .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++
T Consensus        94 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEECCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            999999999999999764       578999999999999999999999   9999999999999998877776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ..........   ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........+.    
T Consensus       164 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~----  235 (297)
T 3fxz_A          164 AQITPEQSKR---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE----  235 (297)
T ss_dssp             EECCSTTCCB---CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC----
T ss_pred             eecCCccccc---CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC----
Confidence            8776543322   23569999999999999999999999999999999999999997532211 111111110000    


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..                     ....++..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~---------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          236 LQ---------------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CS---------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC---------------------CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            00                     01122455789999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.9e-43  Score=375.72  Aligned_cols=281  Identities=32%  Similarity=0.516  Sum_probs=222.9

Q ss_pred             HHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          542 ELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       542 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      ++..++++|++.+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||+++++++...+   
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---  108 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN---  108 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT---
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC---
Confidence            34456789999999999999999999976 68899999988766666788999999999999999999999987654   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                        ..++||||+++|+|.+++......  ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ 
T Consensus       109 --~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          109 --EMILIYKYMENGNLKRHLYGSDLP--TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             --CCEEEEECCTTCBTGGGSSSSCCC--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEEC
T ss_pred             --eEEEEEEcCCCCcHHHHHhccCCC--ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEe
Confidence              679999999999999999765422  22689999999999999999999999   9999999999999999887776 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC-chHhHHhhhc-
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG-LTLHEFVKMT-  778 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~-~~~~~~~~~~-  778 (854)
                      |||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+.... 
T Consensus       182 Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  260 (321)
T 2qkw_B          182 DFGISKKGTELDQTH-LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH  260 (321)
T ss_dssp             CCTTCEECSSSSCCC-CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred             ecccccccccccccc-cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence            999998765433221 1223458999999999988899999999999999999999999998654322 2222222211 


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ........+++...              .....+++..+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus       261 ~~~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          261 NNGQLEQIVDPNLA--------------DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             TTTCCCSSSSSSCT--------------TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ccccHHHhcChhhc--------------cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            11222233332221              111234577899999999999999999999999999988754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.8e-42  Score=367.80  Aligned_cols=281  Identities=24%  Similarity=0.384  Sum_probs=210.0

Q ss_pred             HhhccccCccCCCcceEEEEeE----ECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGI----LGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|++.+.||+|+||.||+|+    ...+++.||||++........+.+.+|++++++++||||+++++++...+.   
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH---
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC---
Confidence            3689999999999999999999    455789999999986666666789999999999999999999999865432   


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++||||+++|+|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D  157 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD  157 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence            157999999999999999987642     589999999999999999999999   9999999999999998876666 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||++.................+|..|+|||.+.+..++.++|||||||++|||+||..||......      +.......
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~  231 (295)
T 3ugc_A          158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMRMIGND  231 (295)
T ss_dssp             CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH------HHHHHCTT
T ss_pred             CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH------HHhhhcCc
Confidence            999988765443322233345788899999999889999999999999999999999998743211      11110000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL  850 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  850 (854)
                      ..............      ....+.+....++.++.+++.+||+.||++|||+.|+++.|+++.+++.
T Consensus       232 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          232 KQGQMIVFHLIELL------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             CCTHHHHHHHHHHH------HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             cccchhHHHHHHHH------hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            00000000000000      0011111223446778999999999999999999999999999987754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-42  Score=373.81  Aligned_cols=288  Identities=34%  Similarity=0.586  Sum_probs=229.0

Q ss_pred             cCCcccHHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEE
Q 043388          534 QFPMISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIIT  612 (854)
Q Consensus       534 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~  612 (854)
                      ....+++.++....++|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            4567888999999999999999999999999999865 688999999975432 23347899999999999999999999


Q ss_pred             EeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe
Q 043388          613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL  692 (854)
Q Consensus       613 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  692 (854)
                      ++....     ..++||||+++|+|.+++......  ...+++..+..|+.|++.||+|||+.+.++|+||||||+||++
T Consensus        95 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~  167 (326)
T 3uim_A           95 FCMTPT-----ERLLVYPYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL  167 (326)
T ss_dssp             EECCSS-----CCEEEEECCTTCBHHHHHHCCSTT--CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred             EEecCC-----ceEEEEEeccCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence            997655     579999999999999999876432  2258999999999999999999999877799999999999999


Q ss_pred             cCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcc---cCC
Q 043388          693 DHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF---TEG  768 (854)
Q Consensus       693 ~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~---~~~  768 (854)
                      +.++..++ |||.+..........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||+...   ...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  245 (326)
T 3uim_A          168 DEEFEAVVGDFGLAKLMDYKDTHV--TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD  245 (326)
T ss_dssp             CTTCCEEECCCSSCEECCSSSSCE--ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred             CCCCCEEeccCccccccCcccccc--cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence            99877666 999998775443221  223469999999999988889999999999999999999999997431   223


Q ss_pred             chHhHHhhhcCCcc-cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          769 LTLHEFVKMTLPEK-VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       769 ~~~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      .....+........ .....+....              ......++..+.+++.+||+.||++|||+.||++.|+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          246 VMLLDWVKGLLKEKKLEALVDVDLQ--------------GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             SBHHHHHTTTTSSCCSTTSSCTTCT--------------TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhHHHHHHHHhhchhhhhhcChhhc--------------cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            34444544433332 2233332221              111234467899999999999999999999999999753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.9e-42  Score=369.84  Aligned_cols=263  Identities=26%  Similarity=0.389  Sum_probs=208.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCC---ceEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGE---EMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .+|.+.+.||+|+||.||+|++..+   +..||||+++.. .....+.+.+|++++++++||||+++++++.+..     
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----  123 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR-----  123 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG-----
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence            5789999999999999999999744   456999999754 2334567899999999999999999999997655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++.....     .+++.+++.|+.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  195 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDF  195 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ccEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCC
Confidence            67999999999999999976532     689999999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |+++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .....+......
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~~  273 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVEEGYRL  273 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCCC
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCCC
Confidence            999987655443333334457889999999988889999999999999999999 99999754221  111111110000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhc
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLG  851 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  851 (854)
                                                +....++..+.+++..||+.||++|||+.||++.|+.+.+...+
T Consensus       274 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          274 --------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             --------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence                                      00112255688999999999999999999999999998876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.8e-41  Score=362.48  Aligned_cols=263  Identities=21%  Similarity=0.290  Sum_probs=213.2

Q ss_pred             CCcccHHHHHHHHhh----------ccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccC
Q 043388          535 FPMISYAELSKATSE----------FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH  604 (854)
Q Consensus       535 ~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  604 (854)
                      .+.++++++..+++.          |...+.||+|+||.||+|++..+++.||||+++.......+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            356788888888864          7778899999999999999998999999999987766667889999999999999


Q ss_pred             CCeeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 043388          605 RNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGD  684 (854)
Q Consensus       605 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  684 (854)
                      |||+++++++...+     ..++||||+++|+|.+++...       .+++.++..++.|++.||+|||+.   +|+|||
T Consensus       102 ~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D  166 (321)
T 2c30_A          102 FNVVEMYKSYLVGE-----ELWVLMEFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRD  166 (321)
T ss_dssp             TTBCCEEEEEEETT-----EEEEEECCCCSCBHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             CCcceEEEEEEECC-----EEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            99999999998755     689999999999999998753       689999999999999999999999   999999


Q ss_pred             CCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 043388          685 LKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA  763 (854)
Q Consensus       685 lkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~  763 (854)
                      |||+||+++.++..++ |||++..........   ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       167 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECCSSSCCB---CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCHHHEEECCCCcEEEeeeeeeeecccCcccc---ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999998877776 999998775533221   235699999999999999999999999999999999999999975


Q ss_pred             cccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          764 AFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       764 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ....  ...............                        ....++..+.+++.+||+.||++|||+.|+++.
T Consensus       244 ~~~~--~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          244 DSPV--QAMKRLRDSPPPKLK------------------------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             SCHH--HHHHHHHHSSCCCCT------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCHH--HHHHHHhcCCCCCcC------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            3211  111111111110000                        001124457889999999999999999999874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1e-41  Score=365.88  Aligned_cols=248  Identities=24%  Similarity=0.356  Sum_probs=202.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||.||+|++..+++.||||++....  ....+.+.+|+++++.++||||+++++++...+     .
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~   88 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK-----T   88 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----E
Confidence            468999999999999999999998899999999997543  234567889999999999999999999997655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  159 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFG  159 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             EEEEEECCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeecc
Confidence            899999999999999998764      689999999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCC-ccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEAS-MTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      ++........    ....+||+.|+|||++.+..++ .++||||+||++|||++|+.||.....     .+.........
T Consensus       160 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~  230 (328)
T 3fe3_A          160 FSNEFTVGGK----LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KELRERVLRGK  230 (328)
T ss_dssp             CCGGGSSSCG----GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC
T ss_pred             CceecCCCCc----cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC
Confidence            9987654322    2235799999999999887764 899999999999999999999975421     11111100000


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      . . . |                     ..++..+.+++.+||+.||.+|||+.|+++.
T Consensus       231 ~-~-~-p---------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 Y-R-I-P---------------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             C-C-C-C---------------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             C-C-C-C---------------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0 0 0 0                     0113457789999999999999999999763

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.1e-42  Score=366.77  Aligned_cols=282  Identities=23%  Similarity=0.317  Sum_probs=209.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+|++.++||+|+||.||+|++.  ++.||||+++.... ......+|+.++++++||||+++++++..... .....+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~   98 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLW   98 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEE
Confidence            368999999999999999999986  68899999965432 23456678999999999999999999976542 123579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEeecCCCCceEecCCcccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC-------QPPIVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~~  699 (854)
                      +||||+++|+|.+++...       .+++.+++.++.|++.||+|||+.+       .++|+||||||+||+++.++..+
T Consensus        99 lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             EEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            999999999999999764       5899999999999999999999862       34899999999999999987777


Q ss_pred             c-ccccccccccCCCCCCcccccCCcccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch-Hh
Q 043388          700 Q-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-----SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT-LH  772 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~-~~  772 (854)
                      + |||+++......... ......||+.|+|||++.+     ..++.++|||||||++|||+||+.||......... ..
T Consensus       172 L~DFg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          172 IADFGLALKFEAGKSAG-DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             ECCCTTCEEECTTSCCC-CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EccCCcccccccccCcc-ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            6 999998776544322 2233569999999999887     34677899999999999999999999865432211 11


Q ss_pred             HHhhhcCCcccccccCchhhHHH-hhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEV-MANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ..... .+       ........ .................++.++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus       251 ~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          251 EEIGQ-HP-------SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHHCS-SC-------CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhcc-CC-------chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            10000 00       00000000 00000000000001123466789999999999999999999999999998764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.8e-41  Score=359.92  Aligned_cols=266  Identities=21%  Similarity=0.333  Sum_probs=204.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHh--ccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||.||+|++  +++.||||++...   ....+.+|.+++..  ++||||+++++++..... ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~-~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRH-SSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET-TEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC-CCce
Confidence            46899999999999999999998  4788999998643   23556677777777  799999999999765432 2336


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeecCCCCceEecCCc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH--------HHCQPPIVHGDLKPSNVLLDHDM  696 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~  696 (854)
                      .++||||+++|+|.++++..       .+++..++.++.|++.||+|||        +.   +|+||||||+||+++.++
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred             eEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence            79999999999999999643       6899999999999999999999        77   999999999999999888


Q ss_pred             cccc-ccccccccccCCCCC-CcccccCCcccccCccccCCC------CCCccchhHHHHHHHHHHHhC----------C
Q 043388          697 VAHQ-NFSLSHQLDSASKTP-SSSIGIKGTVGYVAPEYGMGS------EASMTGDVYSFGILLLEMFTG----------R  758 (854)
Q Consensus       697 ~~~~-Dfg~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvvl~elltg----------~  758 (854)
                      ..++ |||+++......... .......||+.|+|||++.+.      .++.++|||||||++|||+||          +
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            7776 999998765543321 112234699999999998876      456799999999999999999          8


Q ss_pred             CCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHH
Q 043388          759 RPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDV  838 (854)
Q Consensus       759 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev  838 (854)
                      .||...........................+.                 .....++..+.+++.+||+.||++|||+.||
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i  293 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR-----------------WFSDPTLTSLAKLMKECWYQNPSARLTALRI  293 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-----------------GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChh-----------------hccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence            88866544333333332222111111111100                 0112346779999999999999999999999


Q ss_pred             HHHHHhh
Q 043388          839 VAKLCHT  845 (854)
Q Consensus       839 l~~L~~~  845 (854)
                      ++.|+++
T Consensus       294 ~~~L~~i  300 (301)
T 3q4u_A          294 KKTLTKI  300 (301)
T ss_dssp             HHHHHHH
T ss_pred             HHHHhcc
Confidence            9999875

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=6.6e-41  Score=396.24  Aligned_cols=433  Identities=21%  Similarity=0.191  Sum_probs=302.4

Q ss_pred             cCchhhhcCC---CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhh
Q 043388            7 QIPEEIGSLL---NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRW   83 (854)
Q Consensus         7 ~~p~~~~~l~---~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~   83 (854)
                      .+|+....+.   .-.+.+.++-+++ .+|..+.  +++++|||++|+|+++.+.+|..+++|++|+|++|+|+++.|++
T Consensus        19 ~~p~~~~~c~~~~~~~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~   95 (635)
T 4g8a_A           19 SIPESWEPCVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA   95 (635)
T ss_dssp             ------CCSEEEETTTEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTT
T ss_pred             CCCCCCCCccccCCCCEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhH
Confidence            4676665442   2356789998999 7887775  58999999999999888899999999999999999999999999


Q ss_pred             hcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCC
Q 043388           84 ICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSG  163 (854)
Q Consensus        84 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~  163 (854)
                      |.++++|++|+|++|+|+ .+|.++|.++++|++|++++|+++.+                 .+..|+++++|++|+|++
T Consensus        96 f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~Ls~N~l~~l-----------------~~~~~~~L~~L~~L~Ls~  157 (635)
T 4g8a_A           96 YQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASL-----------------ENFPIGHLKTLKELNVAH  157 (635)
T ss_dssp             TTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEECTTSCCCCS-----------------TTCCCTTCTTCCEEECCS
T ss_pred             hcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEECCCCcCCCC-----------------ChhhhhcCcccCeecccc
Confidence            999999999999999999 89999999999999999998887654                 245699999999999999


Q ss_pred             CcCccc-CCcCccccCCCCeEecccccccCCCCCChhhhhhccCCC-CCcEEEcccCcCcccCChhhhhh----------
Q 043388          164 NQFKGK-VSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCS-SLKALSLCDNQFGGELPHSIANL----------  231 (854)
Q Consensus       164 N~i~~~-~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l----------  231 (854)
                      |+|+.+ .|..+..+++|++|+|++|+|+.+....+...   ..+. .+..++++.|.++...+..+...          
T Consensus       158 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L---~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n  234 (635)
T 4g8a_A          158 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL---HQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN  234 (635)
T ss_dssp             SCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHH---HTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred             CccccCCCchhhccchhhhhhcccCccccccccccccch---hhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcc
Confidence            999875 46788999999999999999987765433221   1111 12234444444432111111110          


Q ss_pred             ----------------------------------------------------------------------cccccEEEcc
Q 043388          232 ----------------------------------------------------------------------SSTMIQFRIG  241 (854)
Q Consensus       232 ----------------------------------------------------------------------~~~L~~L~l~  241 (854)
                                                                                            ...+..+.+.
T Consensus       235 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~  314 (635)
T 4g8a_A          235 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLV  314 (635)
T ss_dssp             CSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEE
T ss_pred             cccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccc
Confidence                                                                                  0011112222


Q ss_pred             CCcccccCCccccccccCCeeeccccccccCCCC-------------------CccCcccCceeeCccccccc-------
Q 043388          242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPD-------------------GVGELQHLQQLYMFRNFLQG-------  295 (854)
Q Consensus       242 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------------------~~~~l~~L~~L~L~~N~l~~-------  295 (854)
                      +|.+...  ..+....+|+.|++.+|.+....+.                   .+..+++|+.|++++|.+..       
T Consensus       315 ~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~  392 (635)
T 4g8a_A          315 SVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS  392 (635)
T ss_dssp             SCEEEEC--GGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHH
T ss_pred             ccccccc--cccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccc
Confidence            2221110  0112222333344443333322111                   12234455555555555431       


Q ss_pred             ------------------cCCccccCccccchhccccceecccCC-CCCcCCCCCcccccCCCcccCccchhhcchhhhH
Q 043388          296 ------------------SIPPSLGNLTKLADLALSFNNLQGNIP-SSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLS  356 (854)
Q Consensus       296 ------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~  356 (854)
                                        ..+..+..+++|+.+++++|+.....+ ..|..+++++.++++.|.+.+..|..+.....+.
T Consensus       393 ~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~  472 (635)
T 4g8a_A          393 DFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE  472 (635)
T ss_dssp             HHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred             hhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhh
Confidence                              233445666777777777776664433 4577788888888888888866666665555554


Q ss_pred             HHHHhhcCCCC-CCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCC
Q 043388          357 VYLALAHNLLN-DSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFL  435 (854)
Q Consensus       357 ~~l~l~~n~l~-~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  435 (854)
                      . +++++|.+. +..|..+..       +.+|++|+|++|+|++.+|.+|+.+++|++|+|++|+|++..|..|..+++|
T Consensus       473 ~-L~Ls~N~~~~~~~~~~~~~-------l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L  544 (635)
T 4g8a_A          473 V-LKMAGNSFQENFLPDIFTE-------LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL  544 (635)
T ss_dssp             E-EECTTCEEGGGEECSCCTT-------CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTC
T ss_pred             h-hhhhhcccccccCchhhhh-------ccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCC
Confidence            4 788888644 345666666       5579999999999999999999999999999999999998889999999999


Q ss_pred             CeeecccccCcccCCCCc-cc-cCcccccccccccccCCc
Q 043388          436 EFLNLSYNHLEGEVPTKG-VF-SNKTKISLQVNVKLCGGI  473 (854)
Q Consensus       436 ~~L~ls~N~l~~~~p~~~-~~-~~~~~~~~~~n~~~c~~~  473 (854)
                      ++|||++|+|++..|..- .+ .+...+.+.+|++.|.+.
T Consensus       545 ~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          545 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             CEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            999999999999887642 22 567778899999999754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.7e-41  Score=360.35  Aligned_cols=260  Identities=26%  Similarity=0.362  Sum_probs=198.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ..+|++.+.||+|+||.||+|++.  +..||||++....  ....+.+.+|++++++++||||+++++++...+     .
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~  108 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-----N  108 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-----C
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----c
Confidence            568999999999999999999884  7789999986543  233467889999999999999999999997655     5


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCceEecCCccccc-c
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--IVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      .++||||+++|+|.+++.....   ...+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++..++ |
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~D  182 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCD  182 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred             eEEEEecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECC
Confidence            7999999999999999986541   12589999999999999999999999   8  999999999999999877766 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||+++........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......  ............
T Consensus       183 fg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~~~~~  257 (309)
T 3p86_A          183 FGLSRLKASTFLS---SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKCKR  257 (309)
T ss_dssp             CC--------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHHSCCC
T ss_pred             CCCCccccccccc---cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCC
Confidence            9999865443221   12346999999999999999999999999999999999999999754221  111111100000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      .                         .....++..+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       258 ~-------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          258 L-------------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             C-------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             C-------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            0                         000112455789999999999999999999999999887653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.5e-41  Score=367.15  Aligned_cols=266  Identities=24%  Similarity=0.390  Sum_probs=211.0

Q ss_pred             HhhccccCccCCCcceEEEEeEEC-------CCceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeecc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILG-------GEEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSI  617 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  617 (854)
                      .++|.+.+.||+|+||.||+|++.       .++..||||+++... ....+.+.+|+++++++ +||||++++++|...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            368999999999999999999873       356789999997543 23456789999999999 899999999998765


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKP  687 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  687 (854)
                      +     ..|+||||+++|+|.+++......          .....+++.+++.++.||+.||+|||++   +|+||||||
T Consensus       160 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  231 (370)
T 2psq_A          160 G-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  231 (370)
T ss_dssp             S-----SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred             C-----CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence            5     679999999999999999875421          1112588999999999999999999999   999999999


Q ss_pred             CceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcc
Q 043388          688 SNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAF  765 (854)
Q Consensus       688 ~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~  765 (854)
                      +||+++.++..++ |||+++......... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTC-TTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hhEEECCCCCEEEccccCCcccCccccee-cccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999998887776 999998775543222 1223457899999999999999999999999999999999 999997542


Q ss_pred             cCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          766 TEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       766 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ..  ............                          .....++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       311 ~~--~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          311 VE--ELFKLLKEGHRM--------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             GG--GHHHHHHTTCCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH--HHHHHHhcCCCC--------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            21  111111111000                          00112345688999999999999999999999999998


Q ss_pred             hhhh
Q 043388          846 RETF  849 (854)
Q Consensus       846 ~~~~  849 (854)
                      ....
T Consensus       363 l~~~  366 (370)
T 2psq_A          363 LTLT  366 (370)
T ss_dssp             HHHH
T ss_pred             HHHh
Confidence            7643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-41  Score=372.68  Aligned_cols=261  Identities=26%  Similarity=0.422  Sum_probs=196.2

Q ss_pred             hhccccCccCCCcceEEEEeEEC---CCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILG---GEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .+|.+.+.||+|+||.||+|++.   .++..||||+++... ....+.+.+|+.++++++||||+++++++....     
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  119 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK-----  119 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-----
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----
Confidence            57999999999999999999886   467789999997543 334567999999999999999999999997654     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++.....     .+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  191 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDF  191 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcC
Confidence            67999999999999999986532     689999999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |+++................+|+.|+|||++.+..++.++|||||||++||+++ |+.||......  .....+..... 
T Consensus       192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~i~~~~~-  268 (373)
T 2qol_A          192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYR-  268 (373)
T ss_dssp             ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHHHHTTEE-
T ss_pred             ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-
Confidence            999877654332222223346788999999998899999999999999999998 99999753211  11111110000 


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                                               .+....++..+.+++.+||+.||++||++.||++.|+++....
T Consensus       269 -------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          269 -------------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             -------------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             -------------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                                     0001123556889999999999999999999999999987643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-40  Score=355.39  Aligned_cols=283  Identities=30%  Similarity=0.459  Sum_probs=220.1

Q ss_pred             cCCcccHHHHHHHHhhcccc------CccCCCcceEEEEeEECCCceEEEEEEeecc----cccchHHHHHHHHHHHhcc
Q 043388          534 QFPMISYAELSKATSEFASS------NMIGQGSFGSVYKGILGGEEMIVAVKVINLK----QKGAFRSFVAECEALRNIR  603 (854)
Q Consensus       534 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~  603 (854)
                      ....|++.++..++.+|...      +.||+|+||.||+|.+  ++..||||++...    .....+.+.+|+.++++++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            35678999999999999887      8999999999999987  4778999998643    2334567899999999999


Q ss_pred             CCCeeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 043388          604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHG  683 (854)
Q Consensus       604 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  683 (854)
                      ||||+++++++...+     ..++||||+++|+|.+++.....   ...+++..++.++.|++.||+|||+.   +|+||
T Consensus        89 h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~  157 (307)
T 2nru_A           89 HENLVELLGFSSDGD-----DLCLVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHEN---HHIHR  157 (307)
T ss_dssp             CTTBCCEEEEECSSS-----SCEEEEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             CCCeEEEEEEEecCC-----ceEEEEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecC
Confidence            999999999987654     67999999999999999975432   12689999999999999999999999   99999


Q ss_pred             cCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 043388          684 DLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTD  762 (854)
Q Consensus       684 Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~  762 (854)
                      ||||+||+++.++..++ |||.+.......... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||.
T Consensus       158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~  235 (307)
T 2nru_A          158 DIKSANILLDEAFTAKISDFGLARASEKFAQTV-MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD  235 (307)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSCSSCE-ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CCCHHHEEEcCCCcEEEeecccccccccccccc-cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcc
Confidence            99999999999876666 999998765433221 1223469999999998865 58899999999999999999999998


Q ss_pred             CcccCCchHhHHhhhcC--CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          763 AAFTEGLTLHEFVKMTL--PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       763 ~~~~~~~~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ....... ...+.....  ...+.+.+++..               ......++..+.+++.+||+.||.+|||+.||++
T Consensus       236 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          236 EHREPQL-LLDIKEEIEDEEKTIEDYIDKKM---------------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             TTBSSSB-TTHHHHHHHTTSCCHHHHSCSSC---------------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cCcchHH-HHHHHHHhhhhhhhhhhhccccc---------------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            6543221 111111100  001111111111               1112344677899999999999999999999999


Q ss_pred             HHHhhhh
Q 043388          841 KLCHTRE  847 (854)
Q Consensus       841 ~L~~~~~  847 (854)
                      .|+++..
T Consensus       300 ~L~~l~~  306 (307)
T 2nru_A          300 LLQEMTA  306 (307)
T ss_dssp             HHHHHC-
T ss_pred             HHHHHhc
Confidence            9998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3e-41  Score=362.32  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=203.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+     ..
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS-----EE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----eE
Confidence            4689999999999999999999999999999999975432 23456889999999999999999999987655     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++|+|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence            99999999999999997654      689999999999999999999999   9999999999999999877766 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +..+....... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||............+.........
T Consensus       152 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (323)
T 3tki_A          152 ATVFRYNNRER-LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP  230 (323)
T ss_dssp             CEECEETTEEC-CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTT
T ss_pred             cceeccCCccc-ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCc
Confidence            98765432211 1223579999999999988765 789999999999999999999998654433333333221111000


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                                                ...+...+.+++.+||+.||++|||+.|+++.
T Consensus       231 --------------------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          231 --------------------------WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             --------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                                      01124457789999999999999999999764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.6e-41  Score=363.39  Aligned_cols=251  Identities=21%  Similarity=0.309  Sum_probs=203.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc------chHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG------AFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .+.|.+.+.||+|+||.||+|++..+++.||+|+++.....      ..+.+.+|+.++++++||||+++++++.+..  
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--   88 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT--   88 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC--
Confidence            46799999999999999999999999999999999754321      3467899999999999999999999997655  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc----
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----  696 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----  696 (854)
                         ..++||||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++    
T Consensus        89 ---~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~  156 (361)
T 2yab_A           89 ---DVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP  156 (361)
T ss_dssp             ---EEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred             ---EEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence               7899999999999999997654      689999999999999999999999   999999999999998765    


Q ss_pred             -ccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          697 -VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       697 -~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                       ++++|||++.........    ....||+.|+|||++.+..++.++||||+||++|+|++|..||...... ..+..+.
T Consensus       157 ~vkl~DFG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~~~~i~  231 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANIT  231 (361)
T ss_dssp             CEEECCCSSCEECCTTCCC----CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHH
T ss_pred             CEEEEecCCceEcCCCCcc----ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence             344599999877653322    2356999999999999989999999999999999999999999754211 1111111


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .....      .++.                  ....++..+.+++..||..||++|||+.|+++
T Consensus       232 ~~~~~------~~~~------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          232 AVSYD------FDEE------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TTCCC------CCHH------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCCC------CCch------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11000      0000                  11122456789999999999999999999975

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.7e-41  Score=355.59  Aligned_cols=261  Identities=22%  Similarity=0.412  Sum_probs=204.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.....   ...+.+.+|+.++++++||||+++++++...+     .
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~   85 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD-----C   85 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS-----E
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC-----e
Confidence            579999999999999999999998999999999864332   23467889999999999999999999987655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  156 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFG  156 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred             EEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCC
Confidence            899999999999999998764      689999999999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      ++..........  .....||+.|+|||.+.+..++.++||||+||++|||+||+.||.......... .......+.  
T Consensus       157 ~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~--  231 (294)
T 4eqm_A          157 IAKALSETSLTQ--TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-KHIQDSVPN--  231 (294)
T ss_dssp             SSTTC---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH-HHHSSCCCC--
T ss_pred             Cccccccccccc--cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhhccCCC--
Confidence            998775443222  223469999999999999999999999999999999999999997542211111 111100000  


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-CHHHHHHHHHhhhhh
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-EMRDVVAKLCHTRET  848 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~  848 (854)
                             .              ......+++..+.+++.+|++.||++|| +++++.+.|+++...
T Consensus       232 -------~--------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          232 -------V--------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             -------H--------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             -------c--------------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                   0              0001112356688999999999999999 899999999887543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.7e-41  Score=359.23  Aligned_cols=249  Identities=25%  Similarity=0.329  Sum_probs=203.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|++.+.||+|+||.||+|+...+++.||+|+++..   .......+.+|+.+++.++||||+++++++.+.+     
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-----   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-----
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC-----
Confidence            46899999999999999999999999999999999753   3345577899999999999999999999997765     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++....      .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++..++ ||
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF  149 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence            7899999999999999998654      689999999999999999999999   9999999999999998887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+++........   ....+||+.|+|||++.+..++.++||||+||++|||++|+.||......  ...+.+..   ..
T Consensus       150 G~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~---~~  221 (337)
T 1o6l_A          150 GLCKEGISDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILM---EE  221 (337)
T ss_dssp             TTCBCSCCTTCC---BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH---CC
T ss_pred             cchhhcccCCCc---ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHHHHHHc---CC
Confidence            999864432221   22356999999999999999999999999999999999999999753211  11111100   00


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  841 (854)
                      . . .                      +..++.++.+++.+||+.||++||     +++|+++.
T Consensus       222 ~-~-~----------------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 I-R-F----------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             C-C-C----------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C-C-C----------------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            0 0 0                      001245578899999999999999     89988763

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-41  Score=373.52  Aligned_cols=261  Identities=25%  Similarity=0.377  Sum_probs=209.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++...+     ..
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~  187 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----PI  187 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS-----SC
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC-----Cc
Confidence            4689999999999999999999998899999999875422 23356889999999999999999999997654     57


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++|+|.+++.....     .+++.++..++.|++.||+|||++   +|+||||||+||+++.++..++ |||+
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCC
Confidence            999999999999999986532     689999999999999999999999   9999999999999998887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      ++.......... .....+++.|+|||.+.+..++.++|||||||++|||+| |+.||......  ...+.+.....   
T Consensus       260 s~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~---  333 (377)
T 3cbl_A          260 SREEADGVYAAS-GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKGGR---  333 (377)
T ss_dssp             CEECTTSEEECC-SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTTCC---
T ss_pred             ceecCCCceeec-CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC---
Confidence            986543321111 111235778999999988889999999999999999998 99999754221  11111111100   


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                                             .+....++.++.+++.+||+.||++|||+.++++.|+++.+..
T Consensus       334 -----------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          334 -----------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence                                   0011123556889999999999999999999999999987653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=356.41  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=202.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc------cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .+.|.+.+.||+|+||.||+|.+..+++.||+|+++....      ...+.+.+|+.++++++||||+++++++....  
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--   87 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT--   87 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--
Confidence            4679999999999999999999998999999999975432      13577899999999999999999999997655  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc----
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----  696 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----  696 (854)
                         ..++||||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++    
T Consensus        88 ---~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~  155 (326)
T 2y0a_A           88 ---DVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP  155 (326)
T ss_dssp             ---EEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred             ---EEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence               7899999999999999997654      689999999999999999999999   999999999999998876    


Q ss_pred             -ccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          697 -VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       697 -~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                       ++++|||++.........    ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus       156 ~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~  230 (326)
T 2y0a_A          156 RIKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVS  230 (326)
T ss_dssp             CEEECCCTTCEECCTTSCC----CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHH
T ss_pred             CEEEEECCCCeECCCCCcc----ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHH
Confidence             344599999877543322    2346999999999999889999999999999999999999999753211 0111111


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .....      ..                  ......++..+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~------~~------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          231 AVNYE------FE------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HTCCC------CC------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hcCCC------cC------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            10000      00                  0011122456789999999999999999999986

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2e-40  Score=371.71  Aligned_cols=375  Identities=26%  Similarity=0.303  Sum_probs=266.7

Q ss_pred             chhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCC-------------cEEeccccc
Q 043388            9 PEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL-------------VYLNVAENQ   75 (854)
Q Consensus         9 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-------------~~L~Ls~N~   75 (854)
                      |+.+. .++|++|++++|.+ +.+|.+++++++|++|++++|++++.+|..++.+++|             ++|++++|.
T Consensus         5 p~~~~-~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~   82 (454)
T 1jl5_A            5 PRNVS-NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLG   82 (454)
T ss_dssp             -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSC
T ss_pred             ccccc-cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCc
Confidence            44454 58899999999999 5899999999999999999999998999999988865             999999999


Q ss_pred             CcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCC-------CCceeeccCccCCCCCCCCCCc
Q 043388           76 FSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLK-------NLWWLNLEQNNLGMGTASSIPD  148 (854)
Q Consensus        76 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~-------~L~~L~L~~N~l~~~~~~~~p~  148 (854)
                      +++ +|..   .++|++|+|++|+++ .+|..    +++|++|++++|+++       +|++|++++|++     +.+| 
T Consensus        83 l~~-lp~~---~~~L~~L~l~~n~l~-~lp~~----~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l-----~~lp-  147 (454)
T 1jl5_A           83 LSS-LPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQL-----EKLP-  147 (454)
T ss_dssp             CSC-CCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCC-----SSCC-
T ss_pred             ccc-CCCC---cCCCCEEEccCCcCC-ccccc----cCCCcEEECCCCccCcccCCCCCCCEEECcCCCC-----CCCc-
Confidence            986 4442   478999999999998 57742    488999999988764       688999999998     4577 


Q ss_pred             cccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhh
Q 043388          149 SLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSI  228 (854)
Q Consensus       149 ~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  228 (854)
                      .|+++++|++|++++|++++++ ..   ..+|++|++++|+++.++        .+.++++|++|++++|++++ +|...
T Consensus       148 ~~~~l~~L~~L~l~~N~l~~lp-~~---~~~L~~L~L~~n~l~~l~--------~~~~l~~L~~L~l~~N~l~~-l~~~~  214 (454)
T 1jl5_A          148 ELQNSSFLKIIDVDNNSLKKLP-DL---PPSLEFIAAGNNQLEELP--------ELQNLPFLTAIYADNNSLKK-LPDLP  214 (454)
T ss_dssp             CCTTCTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCSS-CCCCC
T ss_pred             ccCCCCCCCEEECCCCcCcccC-CC---cccccEEECcCCcCCcCc--------cccCCCCCCEEECCCCcCCc-CCCCc
Confidence            5999999999999999999754 33   359999999999998653        37899999999999999984 55432


Q ss_pred             hhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccc
Q 043388          229 ANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLA  308 (854)
Q Consensus       229 ~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  308 (854)
                          ..|+.|++++|.++ .+| .|..+++|++|++++|+++++ |..   +++|+.|++++|++++ +|..   .++|+
T Consensus       215 ----~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~  280 (454)
T 1jl5_A          215 ----LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTL-PDL---PPSLEALNVRDNYLTD-LPEL---PQSLT  280 (454)
T ss_dssp             ----TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSC-CSC---CTTCCEEECCSSCCSC-CCCC---CTTCC
T ss_pred             ----CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCcc-ccc---ccccCEEECCCCcccc-cCcc---cCcCC
Confidence                37999999999999 667 499999999999999999964 432   4799999999999996 5554   37899


Q ss_pred             hhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccc
Q 043388          309 DLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLE  388 (854)
Q Consensus       309 ~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~  388 (854)
                      .|++++|++++. |..   .++|+.|++++|++++ ++...   ..+ +.+++++|.+.+ +|..          +.+|+
T Consensus       281 ~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~~~---~~L-~~L~Ls~N~l~~-lp~~----------~~~L~  340 (454)
T 1jl5_A          281 FLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCDLP---PSL-EELNVSNNKLIE-LPAL----------PPRLE  340 (454)
T ss_dssp             EEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECCCC---TTC-CEEECCSSCCSC-CCCC----------CTTCC
T ss_pred             EEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccCCc---CcC-CEEECCCCcccc-cccc----------CCcCC
Confidence            999999999963 321   2689999999999984 44221   123 238899999986 5543          34699


Q ss_pred             eeeccCcccccCCCcccccCCCCCEEEccCccccc--ccchhhcCc-------------cCCCeeecccccCcc--cCCC
Q 043388          389 YLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSG--QIPEFLQNL-------------SFLEFLNLSYNHLEG--EVPT  451 (854)
Q Consensus       389 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l-------------~~L~~L~ls~N~l~~--~~p~  451 (854)
                      +|++++|++++ +|.   .+++|++|++++|++++  .+|.++.++             ++|+.||+++|++++  .+|.
T Consensus       341 ~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~  416 (454)
T 1jl5_A          341 RLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPE  416 (454)
T ss_dssp             EEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------------
T ss_pred             EEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchh
Confidence            99999999995 555   47899999999999998  788999888             889999999999998  6664

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.8e-41  Score=349.37  Aligned_cols=256  Identities=26%  Similarity=0.405  Sum_probs=206.7

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+++.+|++++++++||||+++++++.+..     ..++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   82 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICL   82 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----ceEE
Confidence            58999999999999999999998 577899999975433 3467899999999999999999999987654     5899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+.
T Consensus        83 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             EEEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccc
Confidence            9999999999999976542     689999999999999999999999   9999999999999988876666 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........  .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......  ............    
T Consensus       155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~----  226 (269)
T 4hcu_A          155 FVLDDQYTS--STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRL----  226 (269)
T ss_dssp             GBCCHHHHS--TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCC----
T ss_pred             ccccccccc--ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCccC----
Confidence            765432211  122357889999999998899999999999999999999 99999753221  111111111000    


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                       ..+                     ..++..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       227 -~~~---------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          227 -YKP---------------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -CCC---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -CCC---------------------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence             000                     01134578999999999999999999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-40  Score=358.73  Aligned_cols=264  Identities=19%  Similarity=0.248  Sum_probs=208.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .+|.+.+.||+|+||.||+|++..+++.||||++.....  .+.+.+|+++++++ +||||+++++++...+     ..+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----~~~   81 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-----YNA   81 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT-----EEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC-----ccE
Confidence            579999999999999999999988999999999875433  34688999999999 9999999999987755     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc-----c-cc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV-----A-HQ  700 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~-~~  700 (854)
                      +||||+ +++|.+++.....     .+++.+++.|+.|++.||+|||+.   +|+||||||+||+++.++.     . ++
T Consensus        82 lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~  152 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHII  152 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred             EEEEeC-CCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEE
Confidence            999999 8999999987532     789999999999999999999999   9999999999999998764     4 45


Q ss_pred             ccccccccccCCCCC----CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh
Q 043388          701 NFSLSHQLDSASKTP----SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK  776 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~  776 (854)
                      |||+++.........    .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+...
T Consensus       153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~  230 (330)
T 2izr_A          153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQ  230 (330)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHH
T ss_pred             EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHH
Confidence            999998775543221    11234679999999999999999999999999999999999999998643221  111110


Q ss_pred             hcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       777 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      .......                   ..........++ ++.+++..||+.||.+||++++|.+.|+++.++.
T Consensus       231 ~i~~~~~-------------------~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          231 KIGDTKR-------------------ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHHHH-------------------HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHhhhc-------------------cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            0000000                   000000011124 7889999999999999999999999999887654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=358.26  Aligned_cols=283  Identities=18%  Similarity=0.240  Sum_probs=211.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|.+.++||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.....   ...+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~   85 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---RHKV   85 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---CCEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC---ceEE
Confidence            57999999999999999999999899999999997543 3345778899999999999999999999875442   2579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe----cCCccccc-c
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQ-N  701 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~~~-D  701 (854)
                      +||||+++|+|.+++......   ..+++.+++.++.|++.||+|||+.   +|+||||||+||++    +.+...++ |
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             EEEeCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEcc
Confidence            999999999999999875421   1489999999999999999999999   99999999999999    66665555 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccC--------CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCc---h
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM--------GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL---T  770 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~---~  770 (854)
                      ||+++........    ....||+.|+|||++.        +..++.++|||||||++|||++|+.||........   .
T Consensus       160 fg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  235 (319)
T 4euu_A          160 FGAARELEDDEQF----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV  235 (319)
T ss_dssp             CTTCEECCTTCCB----CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred             CCCceecCCCCce----eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence            9999877654332    2246999999999875        56789999999999999999999999975432211   1


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                      +........+..+........ ... ...... +............+.+++.+||+.||++|||++|+++...+..
T Consensus       236 ~~~~~~~~p~~~~~~~~~~~~-~~~-~~~~~~-~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          236 MYKIITGKPSGAISGVQKAEN-GPI-DWSGDM-PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHHCCTTCCEEEECSTT-CCE-EEESSC-CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHhcCCCcccchhhhcccC-Ccc-ccCccC-CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            222222222111111100000 000 000000 0001122445677899999999999999999999999877643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-41  Score=358.80  Aligned_cols=252  Identities=19%  Similarity=0.262  Sum_probs=203.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||+|+++... .....+.+|+.+++.++||||+++++++.+.+     ..+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME-----ELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-----EEE
Confidence            368999999999999999999999999999999997543 33467889999999999999999999997755     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC--Ccccc-cccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH--DMVAH-QNFS  703 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~~-~Dfg  703 (854)
                      +||||+++|+|.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.  ++..+ +|||
T Consensus        78 lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             EEEEeCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            99999999999999976532     689999999999999999999999   9999999999999986  45555 4999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      ++........    .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......  
T Consensus       150 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~--  222 (321)
T 1tki_A          150 QARQLKPGDN----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTF--  222 (321)
T ss_dssp             TCEECCTTCE----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCC--
T ss_pred             CCeECCCCCc----cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHcCCCCC--
Confidence            9987754322    12346899999999999988999999999999999999999999754221 1111111111000  


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                          +                  ......++.++.+++.+||+.||.+|||+.|+++.
T Consensus       223 ----~------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          223 ----D------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ----C------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----C------------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                0                  00111225568899999999999999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.5e-41  Score=367.89  Aligned_cols=276  Identities=21%  Similarity=0.319  Sum_probs=214.2

Q ss_pred             cHHHHHHHHhhccccCccCCCcceEEEEeE-----ECCCceEEEEEEeecccc-cchHHHHHHHHHHHhc-cCCCeeeEE
Q 043388          539 SYAELSKATSEFASSNMIGQGSFGSVYKGI-----LGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNI-RHRNLIKII  611 (854)
Q Consensus       539 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~  611 (854)
                      .........++|.+.+.||+|+||.||+|+     ...+++.||||+++.... ...+.+.+|++++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            334444556899999999999999999998     455678999999975432 3346789999999999 899999999


Q ss_pred             EEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcc-------------------------------------------
Q 043388          612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-------------------------------------------  648 (854)
Q Consensus       612 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------  648 (854)
                      ++|.+.+.    ..++||||+++|+|.+++.......                                           
T Consensus        93 ~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           93 GACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             EEECSTTS----CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeecCCC----ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            99876442    4799999999999999998754210                                           


Q ss_pred             -----------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccccc
Q 043388          649 -----------------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDS  710 (854)
Q Consensus       649 -----------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~  710 (854)
                                       ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++..++ |||++.....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                             011289999999999999999999999   9999999999999998877776 9999987654


Q ss_pred             CCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccccccCc
Q 043388          711 ASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDP  789 (854)
Q Consensus       711 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~  789 (854)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||........ .............      
T Consensus       246 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~------  317 (359)
T 3vhe_A          246 DPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRMRA------  317 (359)
T ss_dssp             CTTCE-EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCCCCC------
T ss_pred             cccch-hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCCCCC------
Confidence            33221 1223458899999999998899999999999999999998 9999976432221 1111111110000      


Q ss_pred             hhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          790 SLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                                          ...++.++.+++..||+.||++|||+.|+++.|+++.+..
T Consensus       318 --------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          318 --------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             --------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence                                0112455788999999999999999999999999988653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2e-40  Score=350.65  Aligned_cols=251  Identities=26%  Similarity=0.433  Sum_probs=200.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc-------chHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-------AFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      ++|++.+.||+|+||.||+|++..+++.||+|++......       ..+.+.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            6899999999999999999999989999999998644322       1267899999999999999999999986533  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCceEecCCc--
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--IVHGDLKPSNVLLDHDM--  696 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~--  696 (854)
                           ++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +  |+||||||+||+++.++  
T Consensus        97 -----~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~  163 (287)
T 4f0f_A           97 -----RMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDEN  163 (287)
T ss_dssp             -----EEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTT
T ss_pred             -----eEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCC
Confidence                 799999999999998876542     689999999999999999999999   8  99999999999998765  


Q ss_pred             ----ccccccccccccccCCCCCCcccccCCcccccCccccC--CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch
Q 043388          697 ----VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM--GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT  770 (854)
Q Consensus       697 ----~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~  770 (854)
                          ++++|||.++.....      .....||+.|+|||++.  ...++.++||||+||++|||++|+.||.........
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  237 (287)
T 4f0f_A          164 APVCAKVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK  237 (287)
T ss_dssp             CSCCEEECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH
T ss_pred             CceeEEeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH
Confidence                344599999754432      22346999999999984  455789999999999999999999999764333222


Q ss_pred             HhHHhhh-cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          771 LHEFVKM-TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       771 ~~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ....... ......                          ...++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       238 ~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          238 FINMIREEGLRPTI--------------------------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHHHSCCCCCC--------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHHhccCCCCCC--------------------------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1221111 111100                          112245688999999999999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-40  Score=348.75  Aligned_cols=258  Identities=26%  Similarity=0.386  Sum_probs=206.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||.||+|.+. ++..||+|+++.... ..+.+.+|++++.+++||||+++++++....     ..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   79 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY-----PIY   79 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----ceE
Confidence            468999999999999999999988 677899999975443 3467899999999999999999999986654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence            99999999999999987532     689999999999999999999999   9999999999999998887766 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      ..........  .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||....... ........ ..    
T Consensus       152 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~~-~~----  223 (268)
T 3sxs_A          152 RYVLDDQYVS--SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-VVLKVSQG-HR----  223 (268)
T ss_dssp             EECCTTCEEE--CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTT-CC----
T ss_pred             eecchhhhhc--ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-HHHHHHcC-CC----
Confidence            8765543221  223457788999999988889999999999999999999 999997542211 01111100 00    


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                       ...+                     ..++..+.+++..||+.||++|||+.|+++.|+.+.++.
T Consensus       224 -~~~~---------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          224 -LYRP---------------------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             -CCCC---------------------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             -CCCC---------------------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence             0000                     011345788999999999999999999999999987653

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=4.2e-40  Score=372.50  Aligned_cols=381  Identities=18%  Similarity=0.179  Sum_probs=288.6

Q ss_pred             CCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcc-cChhhhcCCCCCceeeec
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSG-MFPRWICNISSLEFIYLT   96 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~   96 (854)
                      -+.++.+++.++ .+|. +.  ++|++|+|++|.|++..|..|+.+++|++|+|++|.+.+ +.|.+|.++++|++|+|+
T Consensus        12 ~~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls   87 (455)
T 3v47_A           12 GYNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD   87 (455)
T ss_dssp             TTEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred             ccccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence            457888888888 6776 33  789999999999998888899999999999999998873 456788999999999999


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCc--cccCCCCCCEEecCCCcCcccCCcC-
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPD--SLSNASNLERLDLSGNQFKGKVSID-  173 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~--~~~~l~~L~~L~Ls~N~i~~~~~~~-  173 (854)
                      +|+++ .++...|.++++|++|++++|+++.                 .+|.  .|.++++|++|+|++|+|+++.|.. 
T Consensus        88 ~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~-----------------~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  149 (455)
T 3v47_A           88 YNQFL-QLETGAFNGLANLEVLTLTQCNLDG-----------------AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF  149 (455)
T ss_dssp             TCTTC-EECTTTTTTCTTCCEEECTTSCCBT-----------------HHHHSSTTTTCTTCCEEECCSSBCCSCCCCGG
T ss_pred             CCccC-ccChhhccCcccCCEEeCCCCCCCc-----------------cccCcccccCcccCCEEECCCCccCccCcccc
Confidence            99988 5655667888888888877776643                 1223  3778888888888888888887765 


Q ss_pred             ccccCCCCeEecccccccCCCCCChhhhhhccCC--CCCcEEEcccCcCcccCChhh--------hhhcccccEEEccCC
Q 043388          174 FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNC--SSLKALSLCDNQFGGELPHSI--------ANLSSTMIQFRIGGN  243 (854)
Q Consensus       174 f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~--------~~l~~~L~~L~l~~N  243 (854)
                      |..+++|++|+|++|.++......      +..+  .+|+.|++++|.+.+..+..+        ..++ .|+.|++++|
T Consensus       150 ~~~l~~L~~L~L~~n~l~~~~~~~------l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~-~L~~L~Ls~n  222 (455)
T 3v47_A          150 FLNMRRFHVLDLTFNKVKSICEED------LLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT-SITTLDLSGN  222 (455)
T ss_dssp             GGGCTTCCEEECTTCCBSCCCTTT------SGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTC-EEEEEECTTS
T ss_pred             cCCCCcccEEeCCCCcccccChhh------hhccccccccccccccCcccccchhhccccccccccccc-eeeeEecCCC
Confidence            788888888888888887665442      2222  577888888888774433222        1222 5666666666


Q ss_pred             cccccCCcccccc---ccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCc--cccchhccccceec
Q 043388          244 QISGTIPSGIRNL---VNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNL--TKLADLALSFNNLQ  318 (854)
Q Consensus       244 ~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~  318 (854)
                      .+++..|..+..+   ++|+.|++++|.+.+..              +..+.+....+..+..+  ++|+.|++++|.++
T Consensus       223 ~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~  288 (455)
T 3v47_A          223 GFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF  288 (455)
T ss_dssp             CCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCC
T ss_pred             cccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCcccc
Confidence            6666666555444   56666666666654321              11122222233334433  68999999999999


Q ss_pred             ccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccc
Q 043388          319 GNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFH  398 (854)
Q Consensus       319 ~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~  398 (854)
                      +..|..|..+++|+.|++++|++++..|..                         ++.       +.+|++|+|++|.++
T Consensus       289 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~-------------------------~~~-------l~~L~~L~Ls~N~l~  336 (455)
T 3v47_A          289 ALLKSVFSHFTDLEQLTLAQNEINKIDDNA-------------------------FWG-------LTHLLKLNLSQNFLG  336 (455)
T ss_dssp             EECTTTTTTCTTCCEEECTTSCCCEECTTT-------------------------TTT-------CTTCCEEECCSSCCC
T ss_pred             ccchhhcccCCCCCEEECCCCcccccChhH-------------------------hcC-------cccCCEEECCCCccC
Confidence            999999999999999999999998543332                         333       456999999999999


Q ss_pred             cCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCCC-ccccCcccccccccccccCCc
Q 043388          399 GVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTK-GVFSNKTKISLQVNVKLCGGI  473 (854)
Q Consensus       399 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  473 (854)
                      +..|..|+.+++|++|+|++|++++..|..|..+++|++|+|++|++++..+.. ..+.+...+.+.+|+..|.++
T Consensus       337 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          337 SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             EECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            988999999999999999999999988999999999999999999999866543 456778888999999988765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-40  Score=362.20  Aligned_cols=255  Identities=20%  Similarity=0.287  Sum_probs=202.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-----ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      .++|++.+.||+|+||.||+|++..+++.||||+++...     ....+.+.+|+.+++.++||||+++++++.+.+   
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---   99 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG---   99 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC---
Confidence            468999999999999999999999899999999996421     224578899999999999999999999997755   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc----c
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----V  697 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~  697 (854)
                        ..++||||+++|+|.+++......  ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++    +
T Consensus       100 --~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v  172 (351)
T 3c0i_A          100 --MLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV  172 (351)
T ss_dssp             --EEEEEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred             --EEEEEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence              789999999999999888754311  12589999999999999999999999   999999999999998654    4


Q ss_pred             cccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          698 AHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       698 ~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                      +++|||++.........   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....  .........
T Consensus       173 kl~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~  247 (351)
T 3c0i_A          173 KLGGFGVAIQLGESGLV---AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKG  247 (351)
T ss_dssp             EECCCTTCEECCTTSCB---CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHT
T ss_pred             EEecCcceeEecCCCee---ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcC
Confidence            45599999887654322   1234699999999999998999999999999999999999999975321  111111111


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...      .++                  .....++..+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~~------~~~------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          248 KYK------MNP------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCC------CCH------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCC------CCc------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000      000                  001122456889999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.8e-40  Score=366.50  Aligned_cols=254  Identities=18%  Similarity=0.260  Sum_probs=202.5

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+    
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----   83 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG----   83 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS----
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC----
Confidence            34678999999999999999999999999999999997543  223467889999999999999999999997655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC---Ccccc
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAH  699 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~~  699 (854)
                       ..++||||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++.   ++..+
T Consensus        84 -~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vk  153 (444)
T 3soa_A           84 -HHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVK  153 (444)
T ss_dssp             -EEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEE
T ss_pred             -EEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEE
Confidence             7899999999999999998764      689999999999999999999999   9999999999999984   34444


Q ss_pred             -cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          700 -QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       700 -~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                       +|||++.........   .....||+.|+|||++.+..++.++||||+||++|+|++|++||...... ..........
T Consensus       154 L~DFG~a~~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~  229 (444)
T 3soa_A          154 LADFGLAIEVEGEQQA---WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQQIKAGA  229 (444)
T ss_dssp             ECCCSSCBCCCTTCCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTC
T ss_pred             EccCceeEEecCCCce---eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCC
Confidence             599999877654322   22357999999999999989999999999999999999999999753211 1111111111


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..     ...+.                   ...++..+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~-----~~~~~-------------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          230 YD-----FPSPE-------------------WDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CC-----CCTTT-------------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CC-----CCccc-------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            10     00000                   0112455789999999999999999999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.1e-40  Score=354.04  Aligned_cols=274  Identities=23%  Similarity=0.328  Sum_probs=201.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.++||+|+||+||+|++. +++.||+|+++...  ....+.+.+|++++++++||||+++++++.+..     .
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER-----C   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-----C
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-----E
Confidence            468999999999999999999997 58899999996442  233467889999999999999999999987654     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++ +|.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEcCCCC-CHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence            8999999985 88888876542     689999999999999999999999   9999999999999998877776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh---cC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM---TL  779 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~---~~  779 (854)
                      +++.........   ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....+...   ..
T Consensus       165 ~a~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~  240 (311)
T 3niz_A          165 LARAFGIPVRSY---THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPN  240 (311)
T ss_dssp             TCEETTSCCC------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCC
T ss_pred             CceecCCCcccc---cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCC
Confidence            998775433222   22468999999999876 568999999999999999999999998654332 22222221   11


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +..+....+......... ..............+..++.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          241 PREWPQVQELPLWKQRTF-QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTTSGGGTTSHHHHSCCC-CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hHHhhhhhccchhhhccc-ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111111111000000000 000000001111223456789999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=359.39  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=201.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+++++.++||||+++++++.+.+     
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-----   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence            46899999999999999999999999999999999643   2345578899999999999999999999998765     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++....      .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF  159 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF  159 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence            7899999999999999998754      689999999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG---SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      |+++.......    ....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.......  ..+......
T Consensus       160 G~a~~~~~~~~----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~  233 (384)
T 4fr4_A          160 NIAAMLPRETQ----ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFE  233 (384)
T ss_dssp             TTCEECCTTCC----BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHH
T ss_pred             ceeeeccCCCc----eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHh
Confidence            99987654322    223579999999999874   458999999999999999999999997543221  111111100


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-HHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-MRDVVA  840 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~  840 (854)
                      ...                        ......++..+.+++.+||+.||.+||+ ++++.+
T Consensus       234 ~~~------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          234 TTV------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HCC------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             hcc------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            000                        0000112456789999999999999998 666653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.8e-41  Score=365.34  Aligned_cols=266  Identities=21%  Similarity=0.346  Sum_probs=206.9

Q ss_pred             HhhccccCccCCCcceEEEEeEEC-----CCceEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILG-----GEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|.+.+.||+|+||.||+|++.     .+++.||||+++.. .......+.+|+.++++++||||+++++++....  
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL--  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence            367999999999999999999953     46788999999643 2334457889999999999999999999987654  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCc-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc---
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---  696 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---  696 (854)
                         ..++||||+++|+|.+++...... .....+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++   
T Consensus       148 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          148 ---PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             ---SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             ---CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence               579999999999999999875421 1223689999999999999999999999   999999999999998544   


Q ss_pred             -ccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHH
Q 043388          697 -VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEF  774 (854)
Q Consensus       697 -~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~  774 (854)
                       ++++|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||......  ...+.
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~~~  298 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEF  298 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCT-TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHH
T ss_pred             eEEECCCccccccccccccc-cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH
Confidence             3445999998664432221 1122458999999999988899999999999999999998 99999754221  11111


Q ss_pred             hhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          775 VKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       775 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      +.......                          ....++..+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus       299 i~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          299 VTSGGRMD--------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHTTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHcCCCCC--------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            11100000                          01122456789999999999999999999999999887643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.1e-40  Score=359.77  Aligned_cols=253  Identities=20%  Similarity=0.302  Sum_probs=203.3

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+     
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----  101 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----  101 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----
Confidence            45789999999999999999999998999999999975432  33467889999999999999999999997655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc----ccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAH  699 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~~  699 (854)
                      ..++||||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++.+.    +++
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl  172 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL  172 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence            7899999999999999998654      689999999999999999999999   999999999999998643    444


Q ss_pred             cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          700 QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       700 ~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      +|||++.........    ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus       173 ~DfG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~i~~~~~  247 (362)
T 2bdw_A          173 ADFGLAIEVNDSEAW----HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAY  247 (362)
T ss_dssp             CCCTTCBCCTTCCSC----CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC
T ss_pred             eecCcceEecCCccc----ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCC
Confidence            599999877643221    2356999999999999989999999999999999999999999753211 11111111110


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .     ...+                   ....++..+.+++.+||+.||++|||+.|+++.
T Consensus       248 ~-----~~~~-------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          248 D-----YPSP-------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             C-----CCTT-------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             C-----CCcc-------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0     0000                   001124567899999999999999999998764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-40  Score=357.82  Aligned_cols=247  Identities=27%  Similarity=0.382  Sum_probs=200.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++...   .......+.+|+.+++.++||||+++++++....     
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT-----   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----
Confidence            46899999999999999999999889999999999643   2333467899999999999999999999998765     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+ +|+|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF  152 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF  152 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred             EEEEEEECC-CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence            689999999 679999987754      689999999999999999999999   9999999999999999877666 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |++.........    ...+||+.|+|||++.+..+ ++++||||+||++|||++|+.||........     ... ...
T Consensus       153 G~s~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----~~~-i~~  222 (336)
T 3h4j_B          153 GLSNIMTDGNFL----KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----FKK-VNS  222 (336)
T ss_dssp             SCTBTTTTSBTT----CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----BCC-CCS
T ss_pred             ccceeccCCccc----ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----HHH-HHc
Confidence            999876544322    23469999999999988775 7899999999999999999999975422210     000 000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ....  .|                     ..++..+.+++.+||+.||.+|||++|+++.
T Consensus       223 ~~~~--~p---------------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          223 CVYV--MP---------------------DFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             SCCC--CC---------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CCCC--Cc---------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            0000  00                     0114457789999999999999999999763

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.4e-40  Score=350.96  Aligned_cols=264  Identities=15%  Similarity=0.186  Sum_probs=210.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|.+.+.||+|+||.||+|++..+++.||||++.....  .+.+.+|+.+++++ +|+|++++++++....     ..+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~~   82 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-----HNV   82 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-----EEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc-----eeE
Confidence            579999999999999999999988999999999864432  35678999999999 8999999999987655     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc-----cc-c
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV-----AH-Q  700 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~~-~  700 (854)
                      +||||+ +++|.+++.....     .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.     .+ +
T Consensus        83 lv~e~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~  153 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV  153 (298)
T ss_dssp             EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             EEEEec-CCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence            999999 9999999987542     689999999999999999999999   9999999999999987653     44 5


Q ss_pred             ccccccccccCCCCC----CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch--HhHH
Q 043388          701 NFSLSHQLDSASKTP----SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT--LHEF  774 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~--~~~~  774 (854)
                      |||+++.........    .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ....
T Consensus       154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (298)
T 1csn_A          154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  233 (298)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence            999998876543321    1223457999999999999999999999999999999999999999864322110  0000


Q ss_pred             hhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043388          775 VKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL  850 (854)
Q Consensus       775 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  850 (854)
                      .....                       ..........++..+.+++.+||+.||++|||+++|++.|+++.++..
T Consensus       234 ~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          234 GEKKQ-----------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHHH-----------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             Hhhcc-----------------------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            00000                       000001111335678999999999999999999999999999987653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.9e-40  Score=361.58  Aligned_cols=275  Identities=16%  Similarity=0.258  Sum_probs=205.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCC-----ceEEEEEEeecccccc-----------hHHHHHHHHHHHhccCCCeeeE
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGE-----EMIVAVKVINLKQKGA-----------FRSFVAECEALRNIRHRNLIKI  610 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~  610 (854)
                      .++|.+.+.||+|+||.||+|.+..+     ++.||||++.......           ...+.+|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            45899999999999999999999754     5789999986543211           1223445556677789999999


Q ss_pred             EEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCce
Q 043388          611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV  690 (854)
Q Consensus       611 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  690 (854)
                      ++++.... .+..+.++||||+ +++|.+++.....     .+++.+++.|+.||+.||+|||+.   +|+||||||+||
T Consensus       114 ~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Ni  183 (364)
T 3op5_A          114 WGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNL  183 (364)
T ss_dssp             EEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             Eeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHE
Confidence            99987653 2233689999999 9999999987532     689999999999999999999999   999999999999


Q ss_pred             Eec--CCccccc-ccccccccccCCCCC----CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 043388          691 LLD--HDMVAHQ-NFSLSHQLDSASKTP----SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDA  763 (854)
Q Consensus       691 ll~--~~~~~~~-Dfg~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~  763 (854)
                      |++  .++..++ |||+++.+.......    .......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            998  6666655 999998775543221    112335699999999999999999999999999999999999999985


Q ss_pred             cccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          764 AFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       764 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      ..... ...............+..++.+                 ....++.++.+++..||+.||++||++.++++.|+
T Consensus       264 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~  325 (364)
T 3op5_A          264 NLKDP-KYVRDSKIRYRENIASLMDKCF-----------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL  325 (364)
T ss_dssp             GTTCH-HHHHHHHHHHHHCHHHHHHHHS-----------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             cccCH-HHHHHHHHHhhhhHHHHHHHhc-----------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence            32221 1111111111000000000000                 00122667899999999999999999999999999


Q ss_pred             hhhhhh
Q 043388          844 HTRETF  849 (854)
Q Consensus       844 ~~~~~~  849 (854)
                      ++.+..
T Consensus       326 ~~~~~~  331 (364)
T 3op5_A          326 QGLKAI  331 (364)
T ss_dssp             HHHHHT
T ss_pred             HHHHHc
Confidence            988764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.6e-41  Score=362.97  Aligned_cols=249  Identities=23%  Similarity=0.296  Sum_probs=198.3

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  621 (854)
                      ..++|++.++||+|+||.||+|++..+++.||||+++..   .....+.+.+|..+++.+ +||||+++++++.+.+   
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~---   97 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD---   97 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS---
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC---
Confidence            357899999999999999999999999999999999743   234456788999999988 7999999999997765   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                        ..|+||||+++|+|.+++....      .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..++ 
T Consensus        98 --~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~  166 (353)
T 3txo_A           98 --RLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLA  166 (353)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             --EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEc
Confidence              7899999999999999998765      689999999999999999999999   9999999999999999887776 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |||+++.......   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ............
T Consensus       167 DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~~~~  242 (353)
T 3txo_A          167 DFGMCKEGICNGV---TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-DLFEAILNDEVV  242 (353)
T ss_dssp             CCTTCBCSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCC
T ss_pred             cccceeecccCCc---cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCC
Confidence            9999986433222   122357999999999999888999999999999999999999999754221 111111111000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH------HHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM------RDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~  840 (854)
                        .     |                     ..+...+.+++.+||+.||++||++      .|+++
T Consensus       243 --~-----p---------------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          243 --Y-----P---------------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --C-----C---------------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --C-----C---------------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence              0     0                     0113457789999999999999998      66654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.2e-40  Score=359.76  Aligned_cols=248  Identities=22%  Similarity=0.296  Sum_probs=197.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|.+.++||+|+||.||+|++..+++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+.+    
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~----  126 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----  126 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS----
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC----
Confidence            568999999999999999999999999999999997542   23345688999999887 8999999999997755    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++|+|.+++....      .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++..++ |
T Consensus       127 -~~~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D  196 (396)
T 4dc2_A          127 -RLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD  196 (396)
T ss_dssp             -EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             -EEEEEEEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence             7899999999999999998764      789999999999999999999999   9999999999999999887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCc----hHhHHhhh
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL----TLHEFVKM  777 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~----~~~~~~~~  777 (854)
                      ||+++.......   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||........    ........
T Consensus       197 FGla~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~  273 (396)
T 4dc2_A          197 YGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  273 (396)
T ss_dssp             CTTCBCCCCTTC---CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred             cceeeecccCCC---ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence            999986433222   12335799999999999999999999999999999999999999974321110    00000000


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM  835 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  835 (854)
                      .....                        ...+..+...+.+++.+||+.||.+||++
T Consensus       274 i~~~~------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          274 ILEKQ------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHCC------------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             Hhccc------------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            00000                        00001124557899999999999999996

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.6e-40  Score=357.95  Aligned_cols=259  Identities=22%  Similarity=0.373  Sum_probs=200.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceE----EEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMI----VAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      .++|++.++||+|+||.||+|++..+++.    ||+|.++.. .....+.+.+|+.++++++||||++++++|....   
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS---
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC---
Confidence            36799999999999999999998766654    577777533 2344578999999999999999999999997643   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                         .++||||+++|+|.+++.....     .+++..++.|+.|++.||+|||++   +|+||||||+||+++.++..++ 
T Consensus        91 ---~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~  159 (327)
T 3poz_A           91 ---VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             ---EEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred             ---eEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEc
Confidence               6899999999999999987543     689999999999999999999999   9999999999999999887776 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      |||+++......... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......  ..........
T Consensus       160 Dfg~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~  236 (327)
T 3poz_A          160 DFGLAKLLGAEEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE  236 (327)
T ss_dssp             CTTHHHHHTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTC
T ss_pred             cCcceeEccCCcccc-cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHcCC
Confidence            999998876543322 1223457889999999999999999999999999999999 99999754322  1222221111


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ...                          ....++..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       237 ~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          237 RLP--------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCC--------------------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCC--------------------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            000                          0011244578899999999999999999999999887653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=351.33  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=194.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--------------------------cchHHHHHHHHHHH
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--------------------------GAFRSFVAECEALR  600 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  600 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3689999999999999999999998999999999964421                          12356889999999


Q ss_pred             hccCCCeeeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 043388          601 NIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPI  680 (854)
Q Consensus       601 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~i  680 (854)
                      +++||||+++++++.+..   ....++||||+++++|.+++...       .+++.++..++.|++.||+|||+.   +|
T Consensus        92 ~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i  158 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVPTLK-------PLSEDQARFYFQDLIKGIEYLHYQ---KI  158 (298)
T ss_dssp             TCCCTTBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSSCSS-------CCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hCCCCCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence            999999999999987633   23689999999999998865432       689999999999999999999999   99


Q ss_pred             EeecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCC---CCccchhHHHHHHHHHHHh
Q 043388          681 VHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE---ASMTGDVYSFGILLLEMFT  756 (854)
Q Consensus       681 vH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvvl~ellt  756 (854)
                      +||||||+||+++.++..++ |||++.........   .....||+.|+|||++.+..   ++.++|||||||++|||++
T Consensus       159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~  235 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL---LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF  235 (298)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE---ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred             eccCCCHHHEEECCCCCEEEecCCCcccccccccc---ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence            99999999999998877776 99999877544322   12346999999999988765   4788999999999999999


Q ss_pred             CCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHH
Q 043388          757 GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR  836 (854)
Q Consensus       757 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  836 (854)
                      |+.||......  ...........    ...+                     ...++..+.+++.+||+.||++|||+.
T Consensus       236 g~~pf~~~~~~--~~~~~~~~~~~----~~~~---------------------~~~~~~~l~~li~~~l~~dp~~R~s~~  288 (298)
T 2zv2_A          236 GQCPFMDERIM--CLHSKIKSQAL----EFPD---------------------QPDIAEDLKDLITRMLDKNPESRIVVP  288 (298)
T ss_dssp             SSCSSCCSSHH--HHHHHHHHCCC----CCCS---------------------SSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             CCCCCCCccHH--HHHHHHhcccC----CCCC---------------------ccccCHHHHHHHHHHhhcChhhCCCHH
Confidence            99999753211  11111110000    0000                     011245578999999999999999999


Q ss_pred             HHHH
Q 043388          837 DVVA  840 (854)
Q Consensus       837 evl~  840 (854)
                      |+++
T Consensus       289 e~l~  292 (298)
T 2zv2_A          289 EIKL  292 (298)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.9e-40  Score=356.39  Aligned_cols=259  Identities=22%  Similarity=0.313  Sum_probs=201.4

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-----
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-----  619 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  619 (854)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||++++++|.+...     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4678999999999999999999999899999999997543 3345789999999999999999999999865432     


Q ss_pred             -----------------------------------------------CCCceeeEEEeeccCCCHHHHhhhcCCcccccc
Q 043388          620 -----------------------------------------------KGADFKALVFEYMENGSLEDWLHQSNDHLEVCK  652 (854)
Q Consensus       620 -----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~  652 (854)
                                                                     ....+.++||||+++|+|.+++......   ..
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~  160 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---ED  160 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GG
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cc
Confidence                                                           1122479999999999999999876532   25


Q ss_pred             cCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccccccCCCCC---------CcccccC
Q 043388          653 LTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTP---------SSSIGIK  722 (854)
Q Consensus       653 ~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~---------~~~~~~~  722 (854)
                      .++..++.++.||+.||+|||++   +|+||||||+||+++.++..++ |||+++.........         .......
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            67778999999999999999999   9999999999999998877776 999998876543211         1223356


Q ss_pred             CcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchh
Q 043388          723 GTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMI  802 (854)
Q Consensus       723 gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  802 (854)
                      ||+.|+|||++.+..++.++|||||||++|||++|..|+...       ..........                     
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~~~~~---------------------  289 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITDVRNL---------------------  289 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHHHHTT---------------------
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHHhhcc---------------------
Confidence            999999999999999999999999999999999987774311       0000000000                     


Q ss_pred             hHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          803 QEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       803 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                        ............+.+++.+||+.||++|||+.|+++
T Consensus       290 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          290 --KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             --CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             --CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence              001112233455788999999999999999999986

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=6e-40  Score=380.88  Aligned_cols=401  Identities=18%  Similarity=0.214  Sum_probs=302.1

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      +|++++ +|..+.  ++|++|+|++|.|++..|.+|+.+++|++|+|++|+|++..|+.|+.+++|++|+|++|+|++ +
T Consensus        40 ~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l  115 (562)
T 3a79_B           40 NRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-I  115 (562)
T ss_dssp             TSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-E
T ss_pred             CCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-c
Confidence            467774 887765  799999999999998777899999999999999999999889999999999999999999995 5


Q ss_pred             hhhhcCCCCCceeeecccccccccCc-ccccCCCCCcEEEcccCCCC--------CC--ceeeccCccCCCCCCCCCCcc
Q 043388           81 PRWICNISSLEFIYLTVNRFSGSLPF-DILVNLPNLKELYLTFCSLK--------NL--WWLNLEQNNLGMGTASSIPDS  149 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~l~~n~l~--------~L--~~L~L~~N~l~~~~~~~~p~~  149 (854)
                      |..  .+++|++|+|++|+|+ .+|. ..|.++++|++|++++|+++        +|  +.|+|++|.+..  .+..|..
T Consensus       116 p~~--~l~~L~~L~Ls~N~l~-~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~--~~~~~~~  190 (562)
T 3a79_B          116 SCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHI--KGGETES  190 (562)
T ss_dssp             CSC--CCTTCSEEECCSSCCS-BCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCC--CSSSCCE
T ss_pred             Ccc--ccccCCEEECCCCCcc-ccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccc--cccCccc
Confidence            555  8999999999999998 6663 68999999999999998764        45  888999988711  1233444


Q ss_pred             ccCCC--CCCEEecCCCcCcccCC-cCccccCCCCeEecccc----------------------------cccCCCCCCh
Q 043388          150 LSNAS--NLERLDLSGNQFKGKVS-IDFSSLKNLWWLNLEQN----------------------------NLGMGTANDL  198 (854)
Q Consensus       150 ~~~l~--~L~~L~Ls~N~i~~~~~-~~f~~l~~L~~L~L~~N----------------------------~l~~~~~~~~  198 (854)
                      |..+.  .| .+++++|.+.+..+ ..+..+++|+.|++++|                            .+....   +
T Consensus       191 l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~---~  266 (562)
T 3a79_B          191 LQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC---S  266 (562)
T ss_dssp             EEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHH---H
T ss_pred             ccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHH---H
Confidence            54433  11 23444444433222 12333344444444443                            221100   0


Q ss_pred             hhhhhccCCCCCcEEEcccCcCcccCChhhh----------------------------hh--cccccEEEccCCccccc
Q 043388          199 DFVTLLTNCSSLKALSLCDNQFGGELPHSIA----------------------------NL--SSTMIQFRIGGNQISGT  248 (854)
Q Consensus       199 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~----------------------------~l--~~~L~~L~l~~N~l~~~  248 (854)
                      .........++|++|++++|.++|.+|..++                            .+  ...++.|++++|.+...
T Consensus       267 ~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~  346 (562)
T 3a79_B          267 VKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM  346 (562)
T ss_dssp             HHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCC
T ss_pred             HHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccc
Confidence            0000111234677777777777766665541                            11  02488888888887632


Q ss_pred             CCccccccccCCeeeccccccccCCCCCccCcccCceeeCcccccccc--CCccccCccccchhccccceecccCC-CCC
Q 043388          249 IPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGS--IPPSLGNLTKLADLALSFNNLQGNIP-SSL  325 (854)
Q Consensus       249 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~  325 (854)
                      .  ....+++|++|++++|++++..|..|.++++|++|+|++|++++.  +|..|.++++|+.|++++|++++.+| ..+
T Consensus       347 ~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  424 (562)
T 3a79_B          347 V--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTC  424 (562)
T ss_dssp             C--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCC
T ss_pred             c--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhh
Confidence            2  127889999999999999999999999999999999999999963  35679999999999999999998455 468


Q ss_pred             cCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCccc
Q 043388          326 GNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSL  405 (854)
Q Consensus       326 ~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~  405 (854)
                      ..+++|+.|++++|++++.+|..+.  ..+. .+++++|.++ .+|..+..       +++|++|+|++|+|+...+..|
T Consensus       425 ~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~-~L~L~~N~l~-~ip~~~~~-------l~~L~~L~L~~N~l~~l~~~~~  493 (562)
T 3a79_B          425 AWAESILVLNLSSNMLTGSVFRCLP--PKVK-VLDLHNNRIM-SIPKDVTH-------LQALQELNVASNQLKSVPDGVF  493 (562)
T ss_dssp             CCCTTCCEEECCSSCCCGGGGSSCC--TTCS-EEECCSSCCC-CCCTTTTS-------SCCCSEEECCSSCCCCCCTTST
T ss_pred             cCcccCCEEECCCCCCCcchhhhhc--CcCC-EEECCCCcCc-ccChhhcC-------CCCCCEEECCCCCCCCCCHHHH
Confidence            8999999999999999987777654  2333 3899999998 56666655       5679999999999995544459


Q ss_pred             ccCCCCCEEEccCcccccccch
Q 043388          406 GFMKSIKELNVSSNNLSGQIPE  427 (854)
Q Consensus       406 ~~l~~L~~L~Ls~N~l~~~~p~  427 (854)
                      ..+++|+.|+|++|.+++..|-
T Consensus       494 ~~l~~L~~L~l~~N~~~c~c~~  515 (562)
T 3a79_B          494 DRLTSLQYIWLHDNPWDCTCPG  515 (562)
T ss_dssp             TTCTTCCCEECCSCCBCCCHHH
T ss_pred             hcCCCCCEEEecCCCcCCCcch
Confidence            9999999999999999986663

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.5e-41  Score=360.55  Aligned_cols=263  Identities=20%  Similarity=0.363  Sum_probs=196.7

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||.||+|++..+++.||||+++....   .....+.+|++++++++||||+++++++...... ...
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-~~~   90 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA-GPL   90 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT-EEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC-Ccc
Confidence            679999999999999999999988999999999975432   2345788999999999999999999998765422 224


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++....      .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++..++ |||
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  161 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  161 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred             cEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeecc
Confidence            599999999999999998654      689999999999999999999999   9999999999999998877766 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      ++.................||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........   
T Consensus       162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~~---  237 (311)
T 3ork_A          162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-QHVREDPI---  237 (311)
T ss_dssp             CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHCCCC---
T ss_pred             CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhcCCCC---
Confidence            99877654433333334569999999999999999999999999999999999999997542211111 11110000   


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHH-HHHHhh
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVV-AKLCHT  845 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl-~~L~~~  845 (854)
                          .+                 ......++..+.+++.+||+.||++||++.+++ ..+.+.
T Consensus       238 ----~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          238 ----PP-----------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             ----CH-----------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ----Cc-----------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                00                 000112355688999999999999999766655 444443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-40  Score=351.55  Aligned_cols=245  Identities=24%  Similarity=0.306  Sum_probs=202.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|++.+.||+|+||.||+|+...+++.||+|+++..   .....+.+.+|+.+++.++||||+++++++.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-----   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-----   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-----
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC-----
Confidence            46899999999999999999999989999999999743   2334567889999999999999999999997655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++..++ ||
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df  150 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF  150 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence            7899999999999999998754      688999999999999999999999   9999999999999998887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+++......      ...+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ............  
T Consensus       151 g~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~--  221 (318)
T 1fot_A          151 GFAKYVPDVT------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNAELR--  221 (318)
T ss_dssp             SSCEECSSCB------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHCCCC--
T ss_pred             CcceecCCcc------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC--
Confidence            9998765432      2356999999999999999999999999999999999999999753211 111111111000  


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                      .     |                     ..+...+.+++.+|++.||++||     +++|+++
T Consensus       222 ~-----p---------------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 F-----P---------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             C-----C---------------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             C-----C---------------------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            0     0                     01134577899999999999999     8888874

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-40  Score=350.17  Aligned_cols=258  Identities=27%  Similarity=0.399  Sum_probs=198.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||.||+|++.  ++.||||++...  ...+.+.+|++++++++||||+++++++.+       ..+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~   75 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVC   75 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcE
Confidence            357999999999999999999986  678999998643  345788999999999999999999998753       358


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc--ccccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV--AHQNFSL  704 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~~~Dfg~  704 (854)
                      +||||+++|+|.+++.....   ...+++.+++.++.|+++||+|||+....+|+||||||+||+++.++.  +++|||.
T Consensus        76 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             EEEEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence            99999999999999986542   125788999999999999999999932229999999999999987764  4459999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +........      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....................  
T Consensus       153 ~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  224 (307)
T 2eva_A          153 ACDIQTHMT------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP--  224 (307)
T ss_dssp             ------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC--
T ss_pred             ccccccccc------cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC--
Confidence            976643322      235899999999999999999999999999999999999999754222111111111100000  


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL  850 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  850 (854)
                                              ....++..+.+++.+||+.||++|||++|+++.|+.+.+.+.
T Consensus       225 ------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          225 ------------------------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             ------------------------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             ------------------------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence                                    011124557899999999999999999999999999887654

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.7e-39  Score=366.14  Aligned_cols=356  Identities=26%  Similarity=0.357  Sum_probs=296.5

Q ss_pred             cccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChh
Q 043388            3 KLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPR   82 (854)
Q Consensus         3 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~   82 (854)
                      ++.+.++.  ..+++|++|++++|.++ .+|. +..+++|++|+|++|.+++..+  |..+++|++|+|++|++++..| 
T Consensus        35 ~~~~~i~~--~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-  107 (466)
T 1o6v_A           35 NVTDTVSQ--TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-  107 (466)
T ss_dssp             STTSEECH--HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-
T ss_pred             ccccccCh--hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh-
Confidence            33444443  45678999999999998 4664 8889999999999999996544  9999999999999999997655 


Q ss_pred             hhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecC
Q 043388           83 WICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLS  162 (854)
Q Consensus        83 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls  162 (854)
                       |.++++|++|+|++|+++ .++.  |.++++|++|++++|.+..+                  | .+.++++|++|+++
T Consensus       108 -~~~l~~L~~L~L~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~------------------~-~~~~l~~L~~L~l~  164 (466)
T 1o6v_A          108 -LANLTNLTGLTLFNNQIT-DIDP--LKNLTNLNRLELSSNTISDI------------------S-ALSGLTSLQQLSFG  164 (466)
T ss_dssp             -GTTCTTCCEEECCSSCCC-CCGG--GTTCTTCSEEEEEEEEECCC------------------G-GGTTCTTCSEEEEE
T ss_pred             -hcCCCCCCEEECCCCCCC-CChH--HcCCCCCCEEECCCCccCCC------------------h-hhccCCcccEeecC
Confidence             999999999999999998 6654  78888888888887776533                  3 47889999999997


Q ss_pred             CCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccC
Q 043388          163 GNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG  242 (854)
Q Consensus       163 ~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~  242 (854)
                       |.+.+..+  |..+++|++|++++|.++.++        .+..+++|++|++++|.+++..|  +..++ .|+.|++++
T Consensus       165 -~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~--------~l~~l~~L~~L~l~~n~l~~~~~--~~~l~-~L~~L~l~~  230 (466)
T 1o6v_A          165 -NQVTDLKP--LANLTTLERLDISSNKVSDIS--------VLAKLTNLESLIATNNQISDITP--LGILT-NLDELSLNG  230 (466)
T ss_dssp             -ESCCCCGG--GTTCTTCCEEECCSSCCCCCG--------GGGGCTTCSEEECCSSCCCCCGG--GGGCT-TCCEEECCS
T ss_pred             -CcccCchh--hccCCCCCEEECcCCcCCCCh--------hhccCCCCCEEEecCCccccccc--ccccC-CCCEEECCC
Confidence             56665543  889999999999999987542        36788999999999999986555  55554 799999999


Q ss_pred             CcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCC
Q 043388          243 NQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIP  322 (854)
Q Consensus       243 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  322 (854)
                      |.+++.  +.+..+++|+.|++++|++++..+  +..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..+
T Consensus       231 n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~  304 (466)
T 1o6v_A          231 NQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP  304 (466)
T ss_dssp             SCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG
T ss_pred             CCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh
Confidence            999854  468899999999999999987655  8899999999999999996544  8889999999999999986544


Q ss_pred             CCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCC
Q 043388          323 SSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIP  402 (854)
Q Consensus       323 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p  402 (854)
                        +..+++|+.|++++|++++..|                           ++.       +++|++|++++|++++.  
T Consensus       305 --~~~l~~L~~L~L~~n~l~~~~~---------------------------~~~-------l~~L~~L~l~~n~l~~~--  346 (466)
T 1o6v_A          305 --ISNLKNLTYLTLYFNNISDISP---------------------------VSS-------LTKLQRLFFYNNKVSDV--  346 (466)
T ss_dssp             --GGGCTTCSEEECCSSCCSCCGG---------------------------GGG-------CTTCCEEECCSSCCCCC--
T ss_pred             --hcCCCCCCEEECcCCcCCCchh---------------------------hcc-------CccCCEeECCCCccCCc--
Confidence              7889999999999999885433                           111       45799999999999975  


Q ss_pred             cccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCccc
Q 043388          403 FSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGE  448 (854)
Q Consensus       403 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  448 (854)
                      ..+..+++|+.|++++|++++..|  +..+++|+.|++++|++++.
T Consensus       347 ~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred             hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence            478999999999999999998877  89999999999999999984

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.1e-40  Score=355.33  Aligned_cols=281  Identities=21%  Similarity=0.311  Sum_probs=191.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++...+     ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN-----KL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT-----EE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC-----eE
Confidence            468999999999999999999999899999999997543 334567889999999999999999999987654     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||++ |+|.+++...........+++..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            99999998 59999997654322223689999999999999999999999   9999999999999998877776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc--CCc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LPE  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~~~  781 (854)
                      ++.........   ....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+....  ...
T Consensus       155 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~  230 (317)
T 2pmi_A          155 ARAFGIPVNTF---SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNE  230 (317)
T ss_dssp             CEETTSCCCCC---CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCT
T ss_pred             ceecCCCcccC---CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCh
Confidence            98775433221   224689999999998764 58999999999999999999999998643221 111111110  011


Q ss_pred             ccccccC--chhhHHHhhc--cchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVD--PSLLMEVMAN--NSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d--~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..+....  +.........  ....+.........+...+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0000000  0000000000  000000000001122456889999999999999999999976

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.6e-41  Score=371.34  Aligned_cols=263  Identities=20%  Similarity=0.230  Sum_probs=205.5

Q ss_pred             HHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeec
Q 043388          540 YAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSS  616 (854)
Q Consensus       540 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  616 (854)
                      +.++....++|.+.++||+|+||+||+|++..+++.||+|+++..   .......+.+|..++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            344445568999999999999999999999989999999999642   22233458899999999999999999999987


Q ss_pred             cCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc
Q 043388          617 IDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM  696 (854)
Q Consensus       617 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  696 (854)
                      .+     ..|+||||+++|+|.+++.....     .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++
T Consensus       146 ~~-----~~~lV~Ey~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g  212 (437)
T 4aw2_A          146 DN-----NLYLVMDYYVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNG  212 (437)
T ss_dssp             SS-----EEEEEECCCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             CC-----EEEEEEecCCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCC
Confidence            65     78999999999999999987432     689999999999999999999999   999999999999999988


Q ss_pred             cccc-ccccccccccCCCCCCcccccCCcccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch
Q 043388          697 VAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM-----GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT  770 (854)
Q Consensus       697 ~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~  770 (854)
                      ..++ |||+++........  .....+||+.|+|||++.     ...++.++|||||||++|||++|+.||...... ..
T Consensus       213 ~vkL~DFGla~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~  289 (437)
T 4aw2_A          213 HIRLADFGSCLKLMEDGTV--QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ET  289 (437)
T ss_dssp             CEEECCCTTCEECCTTSCE--ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HH
T ss_pred             CEEEcchhhhhhcccCCCc--ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HH
Confidence            7777 99999876543322  122357999999999986     566899999999999999999999999754221 11


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCC--CCCHHHHHHH
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFE--RMEMRDVVAK  841 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  841 (854)
                      ...+...........                       ....++..+.+++.+|+..+|++  ||+++|+++.
T Consensus       290 ~~~i~~~~~~~~~p~-----------------------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          290 YGKIMNHKERFQFPT-----------------------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHHHTHHHHCCCCS-----------------------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             HHhhhhccccccCCc-----------------------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            111111000000000                       00012445778999999888888  9999998763

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2e-40  Score=353.45  Aligned_cols=275  Identities=23%  Similarity=0.362  Sum_probs=207.3

Q ss_pred             hhccccCccCCCcceEEEEeE----ECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGI----LGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      +.|++.+.||+|+||.||+|+    ...+++.||+|+++... ....+.+.+|++++++++||||+++++++...+.   
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG---   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC---
Confidence            568999999999999999999    45678999999997443 3445788999999999999999999999876532   


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++||||+++|+|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECc
Confidence            257999999999999999966542     689999999999999999999999   9999999999999988876666 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.+.................||..|+|||++.+..++.++||||+||++|||++|+.|+....      ..+.....+.
T Consensus       170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~  243 (302)
T 4e5w_A          170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKMIGPT  243 (302)
T ss_dssp             CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHHHCSC
T ss_pred             ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhccCCc
Confidence            9999887665433223334568899999999998889999999999999999999999865321      1111110000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                      .. .............      ..+......++..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus       244 ~~-~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          244 HG-QMTVTRLVNTLKE------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CG-GGHHHHHHHHHHT------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cc-ccCHHHHHHHHhc------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            00 0000000000000      0001111233567889999999999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=360.08  Aligned_cols=250  Identities=22%  Similarity=0.301  Sum_probs=186.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||+++...  ..+.+.+|++++++++||||+++++++...+     ..+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  124 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-----EIS  124 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS-----EEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC-----eEE
Confidence            467999999999999999999999899999999997543  2356889999999999999999999997655     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC---Cccccc-cc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHQ-NF  702 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~~~-Df  702 (854)
                      +||||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.   ++..++ ||
T Consensus       125 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Df  195 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADF  195 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccC
Confidence            9999999999999998654      689999999999999999999999   9999999999999974   555554 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+++........    ....||+.|+|||++.+..++.++|||||||++|||++|+.||............+......  
T Consensus       196 g~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~--  269 (349)
T 2w4o_A          196 GLSKIVEHQVLM----KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY--  269 (349)
T ss_dssp             C--------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC--
T ss_pred             ccccccCccccc----ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc--
Confidence            999876543221    22469999999999999899999999999999999999999997543221122222111110  


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                         ...+                   ....++..+.+++.+||+.||++|||+.|+++
T Consensus       270 ---~~~~-------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          270 ---FISP-------------------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ---CCTT-------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---cCCc-------------------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0000                   00112456789999999999999999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.3e-40  Score=358.83  Aligned_cols=253  Identities=22%  Similarity=0.247  Sum_probs=192.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+.++++++||||+++++++.+..     ..+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~   92 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA   92 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-----EEE
Confidence            4689999999999999999999999999999999975433 3367889999999999999999999998655     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc---ccccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFS  703 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~~~Dfg  703 (854)
                      +||||+++|+|.+++....      .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++   ++++|||
T Consensus        93 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg  163 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG  163 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred             EEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence            9999999999999997654      689999999999999999999999   999999999999998765   4445999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCcc-chhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMT-GDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      +++........    ....||+.|+|||++.+..++.+ +||||+||++|||++|+.||........ ............
T Consensus       164 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~  238 (361)
T 3uc3_A          164 YSKSSVLHSQP----KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVK  238 (361)
T ss_dssp             CC-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTC
T ss_pred             ccccccccCCC----CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCC
Confidence            98754332221    22469999999999988777655 8999999999999999999986433221 111111111110


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .....+                      ..++..+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~~~~----------------------~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 YSIPDD----------------------IRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCCTT----------------------SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCCc----------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            000000                      0113457899999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-40  Score=359.41  Aligned_cols=278  Identities=23%  Similarity=0.306  Sum_probs=211.6

Q ss_pred             hhccccCccCCCcceEEEEeEE----CCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGIL----GGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ++|++.+.||+|+||.||+|++    ..+++.||||++........+.+.+|++++++++||||+++++++...+   ..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG---RQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS---SC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC---Cc
Confidence            6899999999999999999994    5678999999998766556677999999999999999999999986533   23


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++++|.+++.....     .+++.+++.|+.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  171 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADF  171 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCG
T ss_pred             eEEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccc
Confidence            68999999999999999986432     689999999999999999999999   9999999999999988877666 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |.+.................||+.|+|||++.+..++.++|||||||++|||++|+.||......      .........
T Consensus       172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~------~~~~~~~~~  245 (327)
T 3lxl_A          172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE------FLRMMGCER  245 (327)
T ss_dssp             GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH------HHHHCC---
T ss_pred             ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch------hhhhccccc
Confidence            99988765443322233346889999999998888999999999999999999999998643211      110000000


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ..... ....... .     ...+......++..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       246 ~~~~~-~~~~~~~-~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          246 DVPAL-SRLLELL-E-----EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             -CCHH-HHHHHHH-H-----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             ccccH-HHHHHHh-h-----cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            00000 0000000 0     00011112234567889999999999999999999999999886543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.8e-40  Score=358.04  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=201.2

Q ss_pred             HHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCC
Q 043388          544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDS  619 (854)
Q Consensus       544 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  619 (854)
                      ....++|.+.+.||+|+||.||+|+++.+++.||+|+++...   ....+.+.+|..++..+ +||||+++++++.+.+ 
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~-   91 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-   91 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC-
Confidence            345679999999999999999999999999999999997532   34456788999999887 9999999999997755 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~  699 (854)
                          ..|+||||+++|+|.+++....      .+++.++..++.||+.||+|||++   +|+||||||+||+++.++..+
T Consensus        92 ----~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk  158 (345)
T 1xjd_A           92 ----NLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK  158 (345)
T ss_dssp             ----EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             ----EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEE
Confidence                7899999999999999998754      689999999999999999999999   999999999999999888777


Q ss_pred             c-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          700 Q-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                      + |||+++........   ....+||+.|+|||++.+..++.++||||+||++|||++|+.||......  ...+.+...
T Consensus       159 L~DFG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~  233 (345)
T 1xjd_A          159 IADFGMCKENMLGDAK---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMD  233 (345)
T ss_dssp             ECCCTTCBCCCCTTCC---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC
T ss_pred             EeEChhhhhcccCCCc---ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHhC
Confidence            6 99999865432221   23357999999999999999999999999999999999999999754221  111111100


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHH-HHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR-DVV  839 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl  839 (854)
                      . ...     +                     ..++..+.+++.+||+.||++||++. |+.
T Consensus       234 ~-~~~-----p---------------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          234 N-PFY-----P---------------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             C-CCC-----C---------------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             C-CCC-----C---------------------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            0 000     0                     01134577899999999999999997 554

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.8e-40  Score=346.29  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=204.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||.||+|.+. ++..||+|+++.... ..+++.+|++++++++||||+++++++....     ..+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   95 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIF   95 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC-----CeE
Confidence            468999999999999999999998 677899999975543 3467899999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++.....     .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++..++ |||.+
T Consensus        96 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             EEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccc
Confidence            99999999999999986432     689999999999999999999999   9999999999999999877766 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      .........  ......+|+.|+|||++.+..++.++||||+|+++|||+| |+.||......  ...+.+........ 
T Consensus       168 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~~-  242 (283)
T 3gen_A          168 RYVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLYR-  242 (283)
T ss_dssp             GGBCCHHHH--STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCCCC-
T ss_pred             ccccccccc--cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhcccCCCC-
Confidence            876543211  1122347889999999998889999999999999999998 99999754221  11111111100000 


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                          +                     ..++..+.+++.+||+.||++|||+.|+++.|.++.+.
T Consensus       243 ----~---------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          243 ----P---------------------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             ----C---------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----C---------------------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                0                     01134578899999999999999999999999998764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.6e-40  Score=352.10  Aligned_cols=273  Identities=19%  Similarity=0.279  Sum_probs=201.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++...  ....+.+.+|+.++++++||||+++++++.+.+     ..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-----EE
Confidence            57999999999999999999999899999999997543  233467889999999999999999999997655     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++ ++.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.
T Consensus        77 ~lv~e~~~~-~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEECCSE-EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999976 66666655332     689999999999999999999999   9999999999999998877776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC---
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP---  780 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~---  780 (854)
                      ++.........   ....||+.|+|||++.+.. ++.++||||+||++|||++|..||...................   
T Consensus       148 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~  224 (292)
T 3o0g_A          148 ARAFGIPVRCY---SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_dssp             CEECCSCCSCC---CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ceecCCccccc---cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            98775433222   2246899999999988766 8999999999999999999888865433322222222221111   


Q ss_pred             cccccccC-chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVD-PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..+..... +... ..  ...............+...+.+++.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          225 EQWPSMTKLPDYK-PY--PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCTTGGGSTTCC-CC--CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhccccccc-cc--ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            10100000 0000 00  0000000000011123456789999999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-40  Score=357.11  Aligned_cols=271  Identities=23%  Similarity=0.375  Sum_probs=195.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCce---EEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      .++|.+.+.||+|+||.||+|++..++.   .||||+++..  .....+.+.+|++++++++||||+++++++......+
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4689999999999999999999876654   8999999754  3344678999999999999999999999987654221


Q ss_pred             C-ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          622 A-DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       622 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                      . ...++||||+++|+|.+++...........+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence            1 12489999999999999997654332333689999999999999999999999   9999999999999999877766


Q ss_pred             -ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhc
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~  778 (854)
                       |||.++......... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... .........
T Consensus       179 ~Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~~~~~~~  256 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYR-QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IYNYLIGGN  256 (323)
T ss_dssp             CCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHHTTC
T ss_pred             eecccccccccccccc-ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-HHHHHhcCC
Confidence             999998775543222 1122357889999999998899999999999999999999 999997543221 111111110


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ...                           ....++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       257 ~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          257 RLK---------------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             CCC---------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CCC---------------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            000                           00112456889999999999999999999999999987654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-40  Score=358.95  Aligned_cols=253  Identities=19%  Similarity=0.264  Sum_probs=203.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+|++++++++||||+++++++.+..     ..+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----EMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-----EEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-----EEE
Confidence            468999999999999999999999999999999997655445567899999999999999999999997655     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC--c-ccccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD--M-VAHQNFS  703 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~-~~~~Dfg  703 (854)
                      +||||+++|+|.+++.....     .+++.++..++.||+.||+|||+.   +|+||||||+||+++.+  + ++++|||
T Consensus       125 lv~E~~~gg~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence            99999999999999976532     689999999999999999999999   99999999999999743  3 4445999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +++........    ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............   
T Consensus       197 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~---  268 (387)
T 1kob_A          197 LATKLNPDEIV----KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWE---  268 (387)
T ss_dssp             TCEECCTTSCE----EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCC---
T ss_pred             cceecCCCcce----eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC---
Confidence            99877543221    2246999999999999999999999999999999999999999754211 111111111100   


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                         .++.                  ....++.++.+++.+||+.||++|||+.|+++.
T Consensus       269 ---~~~~------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          269 ---FDED------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ---CCSS------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CCcc------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence               0000                  001124567899999999999999999999863

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-39  Score=366.20  Aligned_cols=254  Identities=30%  Similarity=0.391  Sum_probs=205.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|.+.+.||+|+||.||+|.+.  ++.||||+++...  ..+.+.+|++++++++||||+++++++...+.    ..+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG----GLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS----CEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC----ceE
Confidence            468999999999999999999986  6789999997543  45789999999999999999999999865431    579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++......    .+++..++.++.||+.||+|||++   +|+||||||+||+++.++..++ |||++
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            999999999999999876421    478999999999999999999999   9999999999999998887776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +........      ..++..|+|||++.+..++.++|||||||++|||+| |+.||.......  ....+.....    
T Consensus       337 ~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~----  404 (450)
T 1k9a_A          337 KEASSTQDT------GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYK----  404 (450)
T ss_dssp             EECC------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTCC----
T ss_pred             ccccccccC------CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC----
Confidence            865432211      247889999999999999999999999999999998 999997543221  1111111100    


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                                            ...+..++..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       405 ----------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          405 ----------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence                                  0011223567889999999999999999999999999987653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5e-40  Score=363.30  Aligned_cols=282  Identities=17%  Similarity=0.169  Sum_probs=204.4

Q ss_pred             HhhccccCccCCC--cceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQG--SFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|++.++||+|  +||.||+|++..+++.||||+++...  ....+.+.+|++++++++||||+++++++.+.+    
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----   99 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN----   99 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC----
Confidence            4689999999999  99999999999999999999997543  233467888999999999999999999998765    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++|+|.+++......    .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus       100 -~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~d  171 (389)
T 3gni_B          100 -ELWVVTSFMAYGSAKDLICTHFMD----GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG  171 (389)
T ss_dssp             -EEEEEEECCTTCBHHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             -EEEEEEEccCCCCHHHHHhhhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence             789999999999999999875322    689999999999999999999999   9999999999999998877776 9


Q ss_pred             cccccccccCCC----CCCcccccCCcccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          702 FSLSHQLDSASK----TPSSSIGIKGTVGYVAPEYGMG--SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       702 fg~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                      ||.+........    .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||......... ....
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~  250 (389)
T 3gni_B          172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKL  250 (389)
T ss_dssp             GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH-HHC-
T ss_pred             cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHh
Confidence            999876533211    1111222468999999999987  57999999999999999999999999764332211 1111


Q ss_pred             hhcCCcccc------ccc---------CchhhHHHhh---ccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHH
Q 043388          776 KMTLPEKVI------EIV---------DPSLLMEVMA---NNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRD  837 (854)
Q Consensus       776 ~~~~~~~~~------~~~---------d~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e  837 (854)
                      ....+....      +..         ..........   ..........+....+...+.+++.+||+.||++|||+.|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  330 (389)
T 3gni_B          251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST  330 (389)
T ss_dssp             -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence            111100000      000         0000000000   0000000011122334567899999999999999999999


Q ss_pred             HHHH
Q 043388          838 VVAK  841 (854)
Q Consensus       838 vl~~  841 (854)
                      +++.
T Consensus       331 ll~h  334 (389)
T 3gni_B          331 LLNH  334 (389)
T ss_dssp             HTTS
T ss_pred             HhcC
Confidence            9854

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.5e-40  Score=374.63  Aligned_cols=258  Identities=23%  Similarity=0.430  Sum_probs=210.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+|.+.+.||+|+||.||+|++..++..||||+++... ...+.+.+|+.++++++||||++++++|...+     ..+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~  292 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFY  292 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC-----cEE
Confidence            357999999999999999999999889999999997543 34578999999999999999999999997654     579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++......    .+++..++.|+.||+.||+|||++   +|+||||||+|||++.++..++ |||++
T Consensus       293 lv~E~~~~g~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCTT----TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             EEEEccCCCCHHHHHHhcCcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence            999999999999999875422    689999999999999999999999   9999999999999998887776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +........  ......+|..|+|||++.+..++.++|||||||++|||+| |+.||......  ...+.+.....    
T Consensus       366 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~----  437 (495)
T 1opk_A          366 RLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYR----  437 (495)
T ss_dssp             ECCTTCCEE--CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCC----
T ss_pred             eeccCCcee--ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC----
Confidence            876543221  1223457889999999988889999999999999999999 99999754221  11111111110    


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                                            ......++..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus       438 ----------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          438 ----------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                                  00112235668899999999999999999999999988753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-40  Score=358.89  Aligned_cols=269  Identities=24%  Similarity=0.384  Sum_probs=209.4

Q ss_pred             HHhhccccCccCCCcceEEEEeEEC-----CCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILG-----GEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDS  619 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  619 (854)
                      ..++|.+.+.||+|+||.||+|++.     .+++.||||+++.... ...+.+.+|+.++++++||||+++++++...+ 
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-  123 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK-  123 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC-
Confidence            3578999999999999999999996     3568999999975432 33567899999999999999999999997654 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcc------------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHL------------------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIV  681 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~iv  681 (854)
                          ..++||||+++|+|.+++.......                  ....+++.+++.++.||+.||+|||++   +|+
T Consensus       124 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv  196 (343)
T 1luf_A          124 ----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  196 (343)
T ss_dssp             ----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ----ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence                6799999999999999998743210                  013689999999999999999999999   999


Q ss_pred             eecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCC
Q 043388          682 HGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRR  759 (854)
Q Consensus       682 H~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~  759 (854)
                      ||||||+||+++.++..++ |||+++......... ......||+.|+|||++.+..++.++|||||||++|||+| |+.
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCcccc-ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999998877776 999998765433211 1122458999999999988889999999999999999999 999


Q ss_pred             CCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 043388          760 PTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVV  839 (854)
Q Consensus       760 pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  839 (854)
                      ||......  .....+..   .....                       ....++..+.+++.+||+.||++|||+.|++
T Consensus       276 p~~~~~~~--~~~~~~~~---~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~  327 (343)
T 1luf_A          276 PYYGMAHE--EVIYYVRD---GNILA-----------------------CPENCPLELYNLMRLCWSKLPADRPSFCSIH  327 (343)
T ss_dssp             TTTTSCHH--HHHHHHHT---TCCCC-----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cCCCCChH--HHHHHHhC---CCcCC-----------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            99753211  11111111   00000                       0112245688999999999999999999999


Q ss_pred             HHHHhhhhhhhc
Q 043388          840 AKLCHTRETFLG  851 (854)
Q Consensus       840 ~~L~~~~~~~~~  851 (854)
                      +.|+++.+.+.+
T Consensus       328 ~~L~~~~~~~~~  339 (343)
T 1luf_A          328 RILQRMCERAEG  339 (343)
T ss_dssp             HHHHHTTC----
T ss_pred             HHHHHHHhhhhh
Confidence            999999887654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=355.32  Aligned_cols=282  Identities=24%  Similarity=0.393  Sum_probs=213.8

Q ss_pred             HhhccccCccCCCcceEEEEeEE----CCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGIL----GGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|++.+.||+|+||.||+|++    ..+++.||||++........+.+.+|++++++++||||+++++++...+.   
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC---
Confidence            35799999999999999999994    55789999999987666666789999999999999999999999865432   


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++||||+++++|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~D  188 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD  188 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred             CceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEec
Confidence            257899999999999999987542     689999999999999999999999   9999999999999998876666 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.+.................++..|+|||.+.+..++.++|||||||++|||+||..||....      ..+.......
T Consensus       189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~------~~~~~~~~~~  262 (326)
T 2w1i_A          189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMRMIGND  262 (326)
T ss_dssp             CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH------HHHHHHHCTT
T ss_pred             CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH------HHHHHhhccc
Confidence            9999887654332222223457888999999988889999999999999999999999976321      1111100000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhc
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLG  851 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  851 (854)
                      .........+.... .     ...+.+....++.++.+++.+||+.||++|||+.|+++.|+++.+.+.|
T Consensus       263 ~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~g  326 (326)
T 2w1i_A          263 KQGQMIVFHLIELL-K-----NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG  326 (326)
T ss_dssp             CCTHHHHHHHHHHH-H-----TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             cchhhhHHHHHHHh-h-----cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcC
Confidence            00000000000000 0     0000111223456788999999999999999999999999999887653

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.9e-40  Score=346.34  Aligned_cols=254  Identities=23%  Similarity=0.349  Sum_probs=200.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|.+.+.||+|+||.||+|++.  +..||||+++...  ....+.+.+|+.++++++||||+++++++.+.+.   ..
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA---PH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS---SS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC---CC
Confidence            468999999999999999999996  7789999997543  2334678999999999999999999999876531   26


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCceEecCCccccc-c
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--IVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      .++||||+++|+|.+++......    .+++.+++.++.|++.||+|||+.   +  |+||||||+||+++.++..++ |
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSC----CCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             eEeeecccCCCcHHHHHhhcccC----CCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence            79999999999999999875422    589999999999999999999998   7  999999999999999877666 7


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCc---cchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASM---TGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                      ||++......        ...||+.|+|||.+.+..++.   ++|||||||++|||++|+.||........ ........
T Consensus       157 ~~~~~~~~~~--------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~  227 (271)
T 3kmu_A          157 ADVKFSFQSP--------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALEG  227 (271)
T ss_dssp             GGSCCTTSCT--------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHHSC
T ss_pred             ccceeeeccc--------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHhcC
Confidence            7765442221        235899999999988765444   89999999999999999999975422111 11111111


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                      .....                          ...++..+.+++..||+.||++|||++|+++.|+++.+
T Consensus       228 ~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          228 LRPTI--------------------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCC--------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            11000                          01124568899999999999999999999999998864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.5e-41  Score=353.53  Aligned_cols=253  Identities=19%  Similarity=0.332  Sum_probs=200.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCc-------eEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEE-------MIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  619 (854)
                      .++|.+.+.||+|+||.||+|++..++       ..||+|+++.......+.+.+|++++++++||||+++++++...+ 
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD-   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT-
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC-
Confidence            368999999999999999999987655       579999997766666788999999999999999999999997654 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc--
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV--  697 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--  697 (854)
                          ..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.  
T Consensus        86 ----~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~  153 (289)
T 4fvq_A           86 ----ENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRK  153 (289)
T ss_dssp             ----CCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGG
T ss_pred             ----CCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccc
Confidence                57999999999999999987542     589999999999999999999999   9999999999999988763  


Q ss_pred             -------cccccccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCc
Q 043388          698 -------AHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL  769 (854)
Q Consensus       698 -------~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~  769 (854)
                             +++|||.+.......       ...||+.|+|||++.+ ..++.++|||||||++|||++|..|+........
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~  226 (289)
T 4fvq_A          154 TGNPPFIKLSDPGISITVLPKD-------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR  226 (289)
T ss_dssp             GTBCCEEEECCCCSCTTTSCHH-------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             ccccceeeeccCcccccccCcc-------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH
Confidence                   445999986553321       2347899999999987 6799999999999999999996555433211111


Q ss_pred             hHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          770 TLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                       .......  .......                          ++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       227 -~~~~~~~--~~~~~~~--------------------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          227 -KLQFYED--RHQLPAP--------------------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             -HHHHHHT--TCCCCCC--------------------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             -HHHHhhc--cCCCCCC--------------------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence             1111110  0000000                          023367899999999999999999999999988653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=352.67  Aligned_cols=278  Identities=21%  Similarity=0.269  Sum_probs=204.7

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-----ccchHHHHHHHHHHHhcc---CCCeeeEEEEeecc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIR---HRNLIKIITICSSI  617 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~  617 (854)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++...     ......+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3578999999999999999999998899999999997432     222356778888887775   99999999999876


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV  697 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  697 (854)
                      ........++||||++ |+|.+++......    .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            5444446899999997 5999999876532    489999999999999999999999   9999999999999998877


Q ss_pred             ccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh
Q 043388          698 AHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK  776 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~  776 (854)
                      .++ |||.++........    ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..
T Consensus       159 ~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~  233 (308)
T 3g33_A          159 VKLADFGLARIYSYQMAL----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFD  233 (308)
T ss_dssp             EEECSCSCTTTSTTCCCS----GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHH
T ss_pred             EEEeeCccccccCCCccc----CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence            776 99999876543322    23568999999999999999999999999999999999999997643221 1122211


Q ss_pred             hc---CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          777 MT---LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       777 ~~---~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..   ....+.....-. ...+...   ..........++...+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          234 LIGLPPEDDWPRDVSLP-RGAFPPR---GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHCCCCTTTSCSSCSSC-GGGSCCC---CCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhCCCChhhccchhhcc-ccccCCC---CCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            11   111111100000 0000000   000000111123566889999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.1e-40  Score=354.51  Aligned_cols=258  Identities=23%  Similarity=0.343  Sum_probs=202.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceE----EEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMI----VAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .+|++.+.||+|+||.||+|++..++..    ||+|++.... ......+.+|+.++++++||||+++++++...     
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   87 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS-----   87 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS-----
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence            5799999999999999999999777664    7777775332 33345678899999999999999999998532     


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        88 -~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D  158 (325)
T 3kex_A           88 -SLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVAD  158 (325)
T ss_dssp             -SEEEEEECCTTCBSHHHHHSSGG-----GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECS
T ss_pred             -ccEEEEEeCCCCCHHHHHHHccc-----cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECC
Confidence             47899999999999999986532     688899999999999999999999   9999999999999998877766 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||+++.......... .....||..|+|||++.+..++.++|||||||++|||+| |+.||......  ...........
T Consensus       159 fg~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~  235 (325)
T 3kex_A          159 FGVADLLPPDDKQLL-YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKGER  235 (325)
T ss_dssp             CSGGGGSCCCTTCCC------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTTCB
T ss_pred             CCcccccCccccccc-ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCC
Confidence            999998765433221 223468889999999998899999999999999999999 99999754322  22222211110


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ....                          ..++..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       236 ~~~~--------------------------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          236 LAQP--------------------------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             CCCC--------------------------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCCC--------------------------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            0000                          01133467899999999999999999999999987643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.3e-40  Score=350.81  Aligned_cols=265  Identities=25%  Similarity=0.370  Sum_probs=210.0

Q ss_pred             HhhccccCccCCCcceEEEEeEE-----CCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|.+.+.||+|+||.||+|.+     ..++..||||+++... ....+.+.+|++++++++||||+++++++...+  
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--   99 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG--   99 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC--
Confidence            46899999999999999999998     3456899999997543 334567899999999999999999999987654  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcc------------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHL------------------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVH  682 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  682 (854)
                         ..++||||+++|+|.+++.......                  ....+++.+++.++.|++.||+|||++   +|+|
T Consensus       100 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH  173 (314)
T 2ivs_A          100 ---PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH  173 (314)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             ---ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence               6799999999999999998754210                  112589999999999999999999999   9999


Q ss_pred             ecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCC
Q 043388          683 GDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP  760 (854)
Q Consensus       683 ~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p  760 (854)
                      |||||+||+++.++..++ |||++.......... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.|
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE-CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccce-eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999998876666 999998775443221 1122457889999999988889999999999999999999 9999


Q ss_pred             CCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          761 TDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       761 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      |......  .............                          ....++..+.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~--~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          253 YPGIPPE--RLFNLLKTGHRME--------------------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             STTCCGG--GHHHHHHTTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHH--HHHHHhhcCCcCC--------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9754322  1111111111000                          00112456889999999999999999999999


Q ss_pred             HHHhhhhh
Q 043388          841 KLCHTRET  848 (854)
Q Consensus       841 ~L~~~~~~  848 (854)
                      .|+++.++
T Consensus       305 ~l~~~~~~  312 (314)
T 2ivs_A          305 DLEKMMVK  312 (314)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHhh
Confidence            99998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.7e-40  Score=345.83  Aligned_cols=259  Identities=21%  Similarity=0.312  Sum_probs=196.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECC---CceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG---EEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|++.+.||+|+||.||+|.+..   .+..||+|+++... ....+.+.+|+.++++++||||+++++++.+.     
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   88 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-----   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccC-----
Confidence            4689999999999999999999864   35679999986543 23456789999999999999999999997432     


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++|+|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        89 -~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  159 (281)
T 1mp8_A           89 -PVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD  159 (281)
T ss_dssp             -SCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             -ccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECc
Confidence             46899999999999999986532     689999999999999999999999   9999999999999998776666 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||+++.........  .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .....+.....
T Consensus       160 fg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~~~  235 (281)
T 1mp8_A          160 FGLSRYMEDSTYYK--ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER  235 (281)
T ss_dssp             ---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC
T ss_pred             cccccccCcccccc--cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcCCC
Confidence            99998775543221  112347889999999988889999999999999999997 99999754322  11111111000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ..                          ....++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       236 ~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          236 LP--------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             CC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CC--------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            00                          00122456789999999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-40  Score=356.86  Aligned_cols=268  Identities=23%  Similarity=0.352  Sum_probs=207.2

Q ss_pred             HhhccccCccCCCcceEEEEeEE-----CCCceEEEEEEeecc-cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGIL-----GGEEMIVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  619 (854)
                      .++|.+.+.||+|+||.||+|++     .+++..||||+++.. .....+.+.+|+.+++++ +||||+++++++...+ 
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-  122 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG-  122 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC-
Confidence            47899999999999999999997     346778999999744 233457899999999999 8999999999987654 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcc-----------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHL-----------------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVH  682 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  682 (854)
                          ..++||||+++|+|.+++.......                 ....+++.+++.++.||+.||+|||+.   +|+|
T Consensus       123 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  195 (344)
T 1rjb_A          123 ----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  195 (344)
T ss_dssp             ----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             ----ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence                5799999999999999998754210                 012479999999999999999999999   9999


Q ss_pred             ecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCC
Q 043388          683 GDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRP  760 (854)
Q Consensus       683 ~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p  760 (854)
                      |||||+||+++.++..++ |||++.......... ......||+.|+|||++.+..++.++|||||||++|||+| |+.|
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccce-eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999998887766 999998775543221 1223457889999999988889999999999999999998 9999


Q ss_pred             CCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          761 TDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       761 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      |...... ...............                          ...++..+.+++.+||+.||.+|||+.|+++
T Consensus       275 ~~~~~~~-~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  327 (344)
T 1rjb_A          275 YPGIPVD-ANFYKLIQNGFKMDQ--------------------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTS  327 (344)
T ss_dssp             STTCCCS-HHHHHHHHTTCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCcH-HHHHHHHhcCCCCCC--------------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9764322 112222221111000                          0112456889999999999999999999999


Q ss_pred             HHHhhhhhhh
Q 043388          841 KLCHTRETFL  850 (854)
Q Consensus       841 ~L~~~~~~~~  850 (854)
                      .|+.+.+...
T Consensus       328 ~l~~~~~~~~  337 (344)
T 1rjb_A          328 FLGCQLADAE  337 (344)
T ss_dssp             HHHHHC----
T ss_pred             HHHHHHHHHH
Confidence            9999876554

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-39  Score=352.76  Aligned_cols=248  Identities=23%  Similarity=0.298  Sum_probs=197.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+..    
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~----   83 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----   83 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC----
Confidence            468999999999999999999999999999999997543   22345678999999988 8999999999997655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..|+||||+++|+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++..++ |
T Consensus        84 -~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D  153 (345)
T 3a8x_A           84 -RLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD  153 (345)
T ss_dssp             -EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             -EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEe
Confidence             7899999999999999998654      689999999999999999999999   9999999999999998887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC----chHhHHhhh
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG----LTLHEFVKM  777 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~----~~~~~~~~~  777 (854)
                      ||+++........   ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.......    .........
T Consensus       154 FG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (345)
T 3a8x_A          154 YGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  230 (345)
T ss_dssp             GGGCBCSCCTTCC---BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred             ccccccccCCCCc---ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence            9999864332221   223579999999999999999999999999999999999999997532110    000000000


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM  835 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  835 (854)
                      ..                 ....       ..+..++..+.+++.+||+.||.+||++
T Consensus       231 i~-----------------~~~~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          231 IL-----------------EKQI-------RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HH-----------------HCCC-------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             HH-----------------cCCC-------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            00                 0000       0001124557889999999999999996

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=358.47  Aligned_cols=267  Identities=25%  Similarity=0.380  Sum_probs=211.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECC-------CceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeecc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG-------EEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSI  617 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  617 (854)
                      .++|.+.+.||+|+||.||+|++.+       .+..||||+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            3689999999999999999999742       44689999997543 23346789999999999 999999999999765


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKP  687 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  687 (854)
                      +     ..++||||+++|+|.+++......          .....+++.+++.|+.||+.||+|||+.   +|+||||||
T Consensus       148 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  219 (382)
T 3tt0_A          148 G-----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  219 (382)
T ss_dssp             S-----SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             C-----ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence            5     579999999999999999876421          1112589999999999999999999999   999999999


Q ss_pred             CceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcc
Q 043388          688 SNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAF  765 (854)
Q Consensus       688 ~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~  765 (854)
                      +||+++.++..++ |||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTC-CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccc-cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999998887776 999998775543222 1223457899999999999999999999999999999999 999997532


Q ss_pred             cCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          766 TEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       766 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ..  ...+.+.......                          ....++.++.+++.+||+.||++|||++||++.|+++
T Consensus       299 ~~--~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          299 VE--ELFKLLKEGHRMD--------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             HH--HHHHHHHTTCCCC--------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH--HHHHHHHcCCCCC--------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11  1111111110000                          0011245688999999999999999999999999998


Q ss_pred             hhhhh
Q 043388          846 RETFL  850 (854)
Q Consensus       846 ~~~~~  850 (854)
                      .....
T Consensus       351 ~~~~~  355 (382)
T 3tt0_A          351 VALTS  355 (382)
T ss_dssp             HHHSC
T ss_pred             HHHHh
Confidence            86543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.9e-40  Score=354.81  Aligned_cols=245  Identities=19%  Similarity=0.253  Sum_probs=202.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||+|+++..   .....+.+.+|++++++++||||+++++++.+..     
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-----
Confidence            46899999999999999999999989999999999643   2344577889999999999999999999987655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+||||+++|+|.+++....      .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++..++ ||
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF  185 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccc
Confidence            7899999999999999998754      689999999999999999999999   9999999999999998887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+++......      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.....  .
T Consensus       186 g~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~--~  256 (350)
T 1rdq_E          186 GFAKRVKGRT------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKV--R  256 (350)
T ss_dssp             TTCEECSSCB------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC--C
T ss_pred             ccceeccCCc------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHHHHcCCC--C
Confidence            9998765432      2346999999999999999999999999999999999999999753211 11111111100  0


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-----HHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-----MRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  840 (854)
                      .                          +..++..+.+++.+||+.||.+||+     ++|+++
T Consensus       257 ~--------------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 F--------------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C--------------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C--------------------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            0                          0112455789999999999999998     788765

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-40  Score=371.84  Aligned_cols=200  Identities=24%  Similarity=0.356  Sum_probs=157.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|.+.++||+|+||.||+|++..+++.||||++...  .....+++.+|++++++++||||+++++++...........
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            6899999999999999999999999999999998643  22345678899999999999999999999976554444578


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      |+||||++ |+|.+++....      .+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++..++ |||+
T Consensus       133 ~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccc-cchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence            99999985 69999997654      689999999999999999999999   9999999999999999887776 9999


Q ss_pred             ccccccCCCCC------------------------CcccccCCcccccCcccc-CCCCCCccchhHHHHHHHHHHHhC
Q 043388          705 SHQLDSASKTP------------------------SSSIGIKGTVGYVAPEYG-MGSEASMTGDVYSFGILLLEMFTG  757 (854)
Q Consensus       705 ~~~~~~~~~~~------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvvl~elltg  757 (854)
                      ++.........                        ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            98775432110                        122346789999999976 456799999999999999999993

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.4e-39  Score=342.32  Aligned_cols=251  Identities=22%  Similarity=0.275  Sum_probs=203.7

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++.+..     ..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~   81 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT-----DI   81 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----eE
Confidence            3578999999999999999999999999999999998766666788999999999999999999999997655     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe---cCCccccc-c
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHQ-N  701 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~~~-D  701 (854)
                      ++||||+++++|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||++   +.++..++ |
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEe
Confidence            99999999999999998754      689999999999999999999999   99999999999999   55555555 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.+.........    ....||+.|+|||++.+. ++.++||||||+++|||++|+.||....... ............
T Consensus       153 fg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~  226 (277)
T 3f3z_A          153 FGLAARFKPGKMM----RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGTFTF  226 (277)
T ss_dssp             CTTCEECCTTSCB----CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCC
T ss_pred             cccceeccCccch----hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCC
Confidence            9999877644322    224699999999998664 8999999999999999999999997542211 111111110000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                             +                 ......++..+.+++.+||+.||++|||+.|+++
T Consensus       227 -------~-----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          227 -------P-----------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -------C-----------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -------C-----------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0                 0001122456889999999999999999999986

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=368.97  Aligned_cols=350  Identities=19%  Similarity=0.204  Sum_probs=214.9

Q ss_pred             CCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecc
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTV   97 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~   97 (854)
                      -+.++++++.++ .+|..+.  +++++|+|++|+|++..+..|..+++|++|+|++|.|+++.|.+|.++++|++|+|++
T Consensus        13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~   89 (477)
T 2id5_A           13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS   89 (477)
T ss_dssp             TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence            467888888888 6777664  5788888888888887788888888888888888888888888888888888888888


Q ss_pred             cccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcccc
Q 043388           98 NRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL  177 (854)
Q Consensus        98 N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l  177 (854)
                      |+|+ .+|...|.++++|++|++++|++..+                 .|..|.++++|++|+|++|+++++.+..|.++
T Consensus        90 n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~-----------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  151 (477)
T 2id5_A           90 NRLK-LIPLGVFTGLSNLTKLDISENKIVIL-----------------LDYMFQDLYNLKSLEVGDNDLVYISHRAFSGL  151 (477)
T ss_dssp             SCCC-SCCTTSSTTCTTCCEEECTTSCCCEE-----------------CTTTTTTCTTCCEEEECCTTCCEECTTSSTTC
T ss_pred             CcCC-ccCcccccCCCCCCEEECCCCccccC-----------------ChhHccccccCCEEECCCCccceeChhhccCC
Confidence            8887 77776666666666666666655432                 34556666666666666666666666555555


Q ss_pred             CCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccc
Q 043388          178 KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLV  257 (854)
Q Consensus       178 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~  257 (854)
                      ++|++|+|++|+++.++.      ..|.++++                         |+.|++++|.+++..+..|..++
T Consensus       152 ~~L~~L~l~~n~l~~~~~------~~l~~l~~-------------------------L~~L~l~~n~i~~~~~~~~~~l~  200 (477)
T 2id5_A          152 NSLEQLTLEKCNLTSIPT------EALSHLHG-------------------------LIVLRLRHLNINAIRDYSFKRLY  200 (477)
T ss_dssp             TTCCEEEEESCCCSSCCH------HHHTTCTT-------------------------CCEEEEESCCCCEECTTCSCSCT
T ss_pred             CCCCEEECCCCcCcccCh------hHhcccCC-------------------------CcEEeCCCCcCcEeChhhcccCc
Confidence            555555555554432221      12223333                         33333333333333334444455


Q ss_pred             cCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccC
Q 043388          258 NLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDAS  337 (854)
Q Consensus       258 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls  337 (854)
                      +|+.|++++|.+.+..|..                        .....+|+.|+|++|++++..+..|..+++|+.|+++
T Consensus       201 ~L~~L~l~~~~~~~~~~~~------------------------~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls  256 (477)
T 2id5_A          201 RLKVLEISHWPYLDTMTPN------------------------CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLS  256 (477)
T ss_dssp             TCCEEEEECCTTCCEECTT------------------------TTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECC
T ss_pred             ccceeeCCCCccccccCcc------------------------cccCccccEEECcCCcccccCHHHhcCccccCeeECC
Confidence            5555555554443333333                        3333344444444444443222344455555555555


Q ss_pred             CCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEcc
Q 043388          338 HNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVS  417 (854)
Q Consensus       338 ~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  417 (854)
                      +|++++..+.                         .+..       +.+|+.|+|++|++++..|.+|..+++|+.|+|+
T Consensus       257 ~n~l~~~~~~-------------------------~~~~-------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  304 (477)
T 2id5_A          257 YNPISTIEGS-------------------------MLHE-------LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS  304 (477)
T ss_dssp             SSCCCEECTT-------------------------SCTT-------CTTCCEEECCSSCCSEECTTTBTTCTTCCEEECC
T ss_pred             CCcCCccChh-------------------------hccc-------cccCCEEECCCCccceECHHHhcCcccCCEEECC
Confidence            5554421111                         1111       2346666666666666666777777777777777


Q ss_pred             CcccccccchhhcCccCCCeeecccccCcccCCCCccccCcccccccccccccCCccc
Q 043388          418 SNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDE  475 (854)
Q Consensus       418 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~  475 (854)
                      +|+|++..+..|..+++|+.|+|++|+|.+.++..+.+.......+.++...|.+|..
T Consensus       305 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~  362 (477)
T 2id5_A          305 GNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEF  362 (477)
T ss_dssp             SSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred             CCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCchH
Confidence            7777766666777777777777777777777665555444444455666667766554

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=8.6e-40  Score=357.60  Aligned_cols=248  Identities=22%  Similarity=0.278  Sum_probs=194.8

Q ss_pred             cccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          551 ASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       551 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      ...+.||+|+||.||+|++..+++.||+|+++.......+.+.+|++++++++||||+++++++.+.+     ..++|||
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~E  166 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN-----DIVLVME  166 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EEEEEEE
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEEEEEe
Confidence            33678999999999999999899999999998765555678999999999999999999999997755     6899999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe--cCCcccc-cccccccc
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL--DHDMVAH-QNFSLSHQ  707 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~~-~Dfg~~~~  707 (854)
                      |+++|+|.+++.....     .+++.+++.++.||+.||+|||+.   +|+||||||+||++  +.++..+ +|||+++.
T Consensus       167 ~~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~  238 (373)
T 2x4f_A          167 YVDGGELFDRIIDESY-----NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR  238 (373)
T ss_dssp             CCTTCEEHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred             CCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence            9999999999876432     689999999999999999999999   99999999999999  4444444 59999987


Q ss_pred             cccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccccc
Q 043388          708 LDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV  787 (854)
Q Consensus       708 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  787 (854)
                      .......    ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+....+..     .
T Consensus       239 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~-----~  308 (373)
T 2x4f_A          239 YKPREKL----KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWDL-----E  308 (373)
T ss_dssp             CCTTCBC----CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCS-----C
T ss_pred             cCCcccc----ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCC-----C
Confidence            7544322    1246999999999999889999999999999999999999999754221 1112222111100     0


Q ss_pred             CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       788 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +                   .....++.++.+++.+||+.||.+|||+.|+++
T Consensus       309 ~-------------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          309 D-------------------EEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             S-------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             h-------------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0                   001122456889999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.1e-40  Score=344.39  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=189.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc----ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|++.+.||+|+||.||+|.+.  +..||||+++...    ....+.+.+|+++++.++||||+++++++...+    
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   79 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP----   79 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC----
Confidence            357999999999999999999986  7789999986442    233567899999999999999999999997655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC--------
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH--------  694 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------  694 (854)
                       ..++||||+++++|.+++...       .+++..++.++.|++.||+|||++...+|+||||||+||+++.        
T Consensus        80 -~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~  151 (271)
T 3dtc_A           80 -NLCLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS  151 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred             -ceEEEEEcCCCCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence             679999999999999998643       6889999999999999999999992112999999999999985        


Q ss_pred             Ccccc-cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhH
Q 043388          695 DMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHE  773 (854)
Q Consensus       695 ~~~~~-~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~  773 (854)
                      ++..+ +|||.+.........     ...||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~  225 (271)
T 3dtc_A          152 NKILKITDFGLAREWHRTTKM-----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-AYG  225 (271)
T ss_dssp             SCCEEECCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-HHH
T ss_pred             CcceEEccCCccccccccccc-----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHh
Confidence            34444 599999876543322     24689999999999888899999999999999999999999975422111 001


Q ss_pred             HhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       774 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      .........    .                      ...++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       226 ~~~~~~~~~----~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          226 VAMNKLALP----I----------------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHTSCCCCC----C----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hhcCCCCCC----C----------------------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            000000000    0                      011245688999999999999999999999999764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.7e-40  Score=347.97  Aligned_cols=259  Identities=29%  Similarity=0.458  Sum_probs=193.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.++||+|+||.||+|++..   .||+|+++...  ....+.+.+|++++++++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~   93 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------Q   93 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------S
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC------c
Confidence            3579999999999999999998763   39999997543  23356789999999999999999999976432      4


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++++|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             cEEEEEecCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence            6899999999999999976542     689999999999999999999999   9999999999999998887666 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh-cC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGM---GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM-TL  779 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~-~~  779 (854)
                      ++.......... ......||+.|+|||++.   +..++.++|||||||++|||++|+.||....... ...+.... ..
T Consensus       166 ~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~  243 (289)
T 3og7_A          166 LATEKSRWSGSH-QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGRGSL  243 (289)
T ss_dssp             -------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHHTSC
T ss_pred             eccccccccccc-cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHhccccc
Confidence            998665422211 112346999999999986   5668899999999999999999999997543221 11121111 11


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                      ......                       ....++..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       244 ~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          244 SPDLSK-----------------------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCCTTS-----------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             Ccchhh-----------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            111100                       011225668899999999999999999999999998754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=365.96  Aligned_cols=285  Identities=18%  Similarity=0.235  Sum_probs=212.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|.+.++||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.....   ...+
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~~~~   85 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---RHKV   85 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---CCEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC---CeeE
Confidence            57999999999999999999999899999999997543 3345778899999999999999999999876442   2579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe----cCCccccc-c
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHQ-N  701 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~~~-D  701 (854)
                      +||||+++|+|.+++......   ..+++.+++.++.||+.||+|||+.   +|+||||||+||++    +.+...++ |
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             EEEecCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEec
Confidence            999999999999999875421   1489999999999999999999999   99999999999999    66665555 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCC--------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch---
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG--------SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT---  770 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~---  770 (854)
                      ||.++........    ....||+.|+|||++.+        ..++.++|||||||++|||++|+.||.........   
T Consensus       160 FG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  235 (396)
T 4eut_A          160 FGAARELEDDEQF----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV  235 (396)
T ss_dssp             GGGCEECCCGGGS----SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred             CCCceEccCCCcc----ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence            9999877554322    23469999999998764        46788999999999999999999999754322211   


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      +........+..+....... .... ..... .+........+...+.+++.+||+.||++|||++|+++.++++.+.
T Consensus       236 ~~~~~~~~p~~~~~~~~~~~-~~~~-~~~~~-~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          236 MYKIITGKPSGAISGVQKAE-NGPI-DWSGD-MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHSCCTTCCEEEECST-TCCE-EEESS-CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHHhcCCCcccchhheecc-CCCc-ccCcc-CCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            22222221111111100000 0000 00000 0000112244567788999999999999999999999999887654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-39  Score=349.76  Aligned_cols=276  Identities=24%  Similarity=0.337  Sum_probs=204.8

Q ss_pred             HHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc--cCCCeeeEEEEeeccCCCC
Q 043388          544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       544 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~  621 (854)
                      ....++|++.+.||+|+||.||+|++.  ++.||||++....   ...+.+|.+++...  +||||+++++++..... .
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~  106 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG-S  106 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-G
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-C
Confidence            345579999999999999999999986  7889999986432   24455666666655  89999999999876532 1


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeecCCCCceEecCCc
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC-----QPPIVHGDLKPSNVLLDHDM  696 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~  696 (854)
                      ....++||||+++|+|.+++...       .+++.+++.++.|++.||+|||+.+     +++|+||||||+||+++.++
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence            23689999999999999999754       6889999999999999999999762     34899999999999999887


Q ss_pred             cccc-ccccccccccCCCCCC-cccccCCcccccCccccCCCCCCcc------chhHHHHHHHHHHHhC----------C
Q 043388          697 VAHQ-NFSLSHQLDSASKTPS-SSIGIKGTVGYVAPEYGMGSEASMT------GDVYSFGILLLEMFTG----------R  758 (854)
Q Consensus       697 ~~~~-Dfg~~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~------sDv~slGvvl~elltg----------~  758 (854)
                      .+++ |||++........... ......||+.|+|||++.+...+.+      +|||||||++|||+||          +
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            7776 9999987654433211 1123469999999999988766554      9999999999999999          5


Q ss_pred             CCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHH
Q 043388          759 RPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDV  838 (854)
Q Consensus       759 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev  838 (854)
                      .||...........................                 .......++.++.+++.+||+.||++|||+.||
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  322 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFP-----------------NRWSSDECLRQMGKLMTECWAHNPASRLTALRV  322 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCC-----------------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ccHhhhcCCCCchhhhHHHHhhhccCcccc-----------------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence            555443322222222221111111111110                 011123567889999999999999999999999


Q ss_pred             HHHHHhhhhhh
Q 043388          839 VAKLCHTRETF  849 (854)
Q Consensus       839 l~~L~~~~~~~  849 (854)
                      ++.|+.+.+..
T Consensus       323 l~~L~~l~~~~  333 (337)
T 3mdy_A          323 KKTLAKMSESQ  333 (337)
T ss_dssp             HHHHHHHHHTT
T ss_pred             HHHHHHHHhhc
Confidence            99999998764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.6e-40  Score=353.11  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=198.4

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCce
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||+++.....    ..+|++++.++ +||||+++++++.+..     .
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~   90 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGK-----Y   90 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSS-----E
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCC-----E
Confidence            457899999999999999999999999999999999755332    35788888888 7999999999997655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-c----ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-M----VAH  699 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~----~~~  699 (854)
                      .|+||||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||++..+ +    +++
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence            899999999999999998654      689999999999999999999999   99999999999998543 2    445


Q ss_pred             cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          700 QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       700 ~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      +|||+++........   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...+......
T Consensus       162 ~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~  236 (342)
T 2qr7_A          162 CDFGFAKQLRAENGL---LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIG  236 (342)
T ss_dssp             CCCTTCEECBCTTCC---BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHH
T ss_pred             EECCCcccCcCCCCc---eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHc
Confidence            599999877554322   12346899999999998878999999999999999999999999753221  1111111100


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .... .... .                  ....++..+.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~~-~~~~-~------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          237 SGKF-SLSG-G------------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             HCCC-CCCS-T------------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cCCc-ccCc-c------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0000 0000 0                  001124557899999999999999999998763

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.3e-39  Score=346.12  Aligned_cols=266  Identities=20%  Similarity=0.282  Sum_probs=205.0

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ..++|++.+.||+|+||.||+|++..+++.||||++......  ..+.+|+++++.++|++++..++++....    ...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEET----TEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCC----Cce
Confidence            357899999999999999999999889999999987654332  45788999999999988887777765433    267


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe---cCCccccc-c
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHQ-N  701 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~~~-D  701 (854)
                      ++||||+ +++|.+++.....     .+++.++..++.|++.||+|||++   +|+||||||+||++   +.++..++ |
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D  151 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred             EEEEEcc-CCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence            9999999 8899999986432     689999999999999999999999   99999999999999   56665555 9


Q ss_pred             cccccccccCCCCC----CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC--chHhHHh
Q 043388          702 FSLSHQLDSASKTP----SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG--LTLHEFV  775 (854)
Q Consensus       702 fg~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~--~~~~~~~  775 (854)
                      ||.++.........    .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  .......
T Consensus       152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 4hgt_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence            99998876543321    12234579999999999999999999999999999999999999998643221  1111111


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ......                       ........++..+.+++..||+.||++|||++|+++.|+++.++.
T Consensus       232 ~~~~~~-----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          232 EKKMST-----------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHS-----------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccc-----------------------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            100000                       000011123567889999999999999999999999999988765

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.7e-40  Score=352.75  Aligned_cols=253  Identities=20%  Similarity=0.260  Sum_probs=181.2

Q ss_pred             hhcccc---CccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASS---NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~---~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  623 (854)
                      ++|.+.   +.||+|+||.||+|++..+++.||||++...   ....+.+|+.+++.+. ||||+++++++.+..     
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~-----   79 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQL-----   79 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----
Confidence            456654   7899999999999999989999999999643   3467789999999996 999999999997655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc----ccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAH  699 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~~  699 (854)
                      ..++||||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++    +++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl  150 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKI  150 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEE
T ss_pred             EEEEEEEccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEE
Confidence            7899999999999999998764      789999999999999999999999   999999999999997654    444


Q ss_pred             cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC--CchHhHHhhh
Q 043388          700 QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE--GLTLHEFVKM  777 (854)
Q Consensus       700 ~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~--~~~~~~~~~~  777 (854)
                      +|||+++.........   ....||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+....
T Consensus       151 ~Dfg~a~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~  227 (325)
T 3kn6_A          151 IDFGFARLKPPDNQPL---KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK  227 (325)
T ss_dssp             CCCTTCEECCC-------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH
T ss_pred             eccccceecCCCCCcc---cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH
Confidence            5999998765433222   2246899999999999999999999999999999999999999764321  1111111111


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...... .. .                  ......++.++.+++.+||+.||++|||++|+++
T Consensus       228 i~~~~~-~~-~------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          228 IKKGDF-SF-E------------------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HTTTCC-CC-C------------------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HHcCCC-CC-C------------------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            111100 00 0                  0111223566889999999999999999999874

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.8e-40  Score=353.87  Aligned_cols=249  Identities=22%  Similarity=0.301  Sum_probs=201.1

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  621 (854)
                      ..++|.+.+.||+|+||.||+|++..+++.||||+++..   .....+.+.+|..++..+ +||+|+++++++.+.+   
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~---   94 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD---   94 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS---
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC---
Confidence            357899999999999999999999989999999999753   234457788999999988 8999999999987655   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                        ..|+||||++||+|.+++....      .+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++..++ 
T Consensus        95 --~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           95 --RLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             --EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEE
Confidence              7899999999999999998754      689999999999999999999999   9999999999999999887776 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |||+++.......   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+......
T Consensus       164 DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~~~~  239 (353)
T 2i0e_A          164 DFGMCKENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNVA  239 (353)
T ss_dssp             CCTTCBCCCCTTC---CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCC
T ss_pred             eCCcccccccCCc---ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-HHHHHHHhCCCC
Confidence            9999986433222   122357999999999999999999999999999999999999999753211 111111111000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH-----HHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM-----RDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~  840 (854)
                        .                          +..++.++.+++.+||+.||++||++     +|+++
T Consensus       240 --~--------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          240 --Y--------------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             --C--------------------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             --C--------------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              0                          00124557899999999999999964     66554

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.8e-40  Score=350.43  Aligned_cols=267  Identities=21%  Similarity=0.358  Sum_probs=211.2

Q ss_pred             HhhccccCccCCCcceEEEEeEE-----CCCceEEEEEEeecccc-cchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQK-GAFRSFVAECEALRNI-RHRNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  619 (854)
                      .++|.+.+.||+|+||.||+|++     ..+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+ 
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-  100 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG-  100 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC-
Confidence            36899999999999999999985     44678999999975433 3356789999999999 9999999999997655 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCc------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDH------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKP  687 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  687 (854)
                          ..++||||+++|+|.+++......            .....+++.+++.++.|++.||+|||++   +|+||||||
T Consensus       101 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp  173 (313)
T 1t46_A          101 ----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (313)
T ss_dssp             ----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ----CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence                579999999999999999875421            1122589999999999999999999999   999999999


Q ss_pred             CceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcc
Q 043388          688 SNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAF  765 (854)
Q Consensus       688 ~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~  765 (854)
                      +||+++.++..++ |||.+.......... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSE-ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ceEEEcCCCCEEEccccccccccccccce-eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            9999998887666 999998776543321 1122347889999999988899999999999999999999 999997543


Q ss_pred             cCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          766 TEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       766 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ... ..............                          ...++..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus       253 ~~~-~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          253 VDS-KFYKMIKEGFRMLS--------------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             SSH-HHHHHHHHTCCCCC--------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             chh-HHHHHhccCCCCCC--------------------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            221 11121111111000                          011245678999999999999999999999999998


Q ss_pred             hhhh
Q 043388          846 RETF  849 (854)
Q Consensus       846 ~~~~  849 (854)
                      .+..
T Consensus       306 ~~~~  309 (313)
T 1t46_A          306 ISES  309 (313)
T ss_dssp             HHHT
T ss_pred             HHHh
Confidence            7754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.1e-39  Score=349.70  Aligned_cols=272  Identities=24%  Similarity=0.408  Sum_probs=201.3

Q ss_pred             HHhhccccCccCCCcceEEEEeEECC---CceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGG---EEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      ..++|.+.+.||+|+||.||+|.+..   ++..||+|+++...  ....+.+.+|+.++++++||||+++++++......
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            35789999999999999999998754   56689999997543  23346789999999999999999999999876644


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                      +....++||||+++|+|.+++...........+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence            4446799999999999999996543222233789999999999999999999999   9999999999999999877666


Q ss_pred             -ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhc
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~  778 (854)
                       |||.+.......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......  .........
T Consensus       189 ~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~  265 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYLLHG  265 (313)
T ss_dssp             CSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTT
T ss_pred             eecCcceecccccccC-cccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHHcC
Confidence             999998775443221 1122357889999999999999999999999999999999 88998754222  111111111


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ....                          ....++..+.+++.+||+.||++|||+.++++.|+++.+.+
T Consensus       266 ~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          266 HRLK--------------------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             CCCC--------------------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCC--------------------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            0000                          01122456889999999999999999999999999998765

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.6e-40  Score=345.61  Aligned_cols=259  Identities=24%  Similarity=0.432  Sum_probs=211.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ..+|.+.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|++++++++||||+++++++....     ..+
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   85 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFY   85 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----CEE
Confidence            568999999999999999999999889999999997543 34578899999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++......    .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTT----TSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             EEEEcCCCCcHHHHHHhcccC----CccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccc
Confidence            999999999999999875432    689999999999999999999999   9999999999999998876665 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      .........  ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......  ...+.........  
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~~--  232 (288)
T 3kfa_A          159 RLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRME--  232 (288)
T ss_dssp             GTSCSSSSE--EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCCC--
T ss_pred             eeccCCccc--cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccCCCC--
Confidence            877644322  1223457889999999998899999999999999999999 99999754221  1111111111000  


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                                              ....++..+.+++..|++.||.+|||+.|+++.|+.+...
T Consensus       233 ------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          233 ------------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             ------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------------------CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence                                    0112245688999999999999999999999999987754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.3e-40  Score=372.63  Aligned_cols=258  Identities=23%  Similarity=0.414  Sum_probs=207.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|.+.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.++++++||||+++++++.. +     ..+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~-----~~~  258 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E-----PIY  258 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS-S-----SCE
T ss_pred             hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC-C-----ccE
Confidence            468999999999999999999997 57789999997544 346789999999999999999999999852 2     479


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++.....    ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..++ |||++
T Consensus       259 lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             EEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            99999999999999986431    2678899999999999999999999   9999999999999999887776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +.........  .....+|..|+|||++.+..++.++|||||||++|||+| |+.||......  .....+....     
T Consensus       332 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~-----  402 (454)
T 1qcf_A          332 RVIEDNEYTA--REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGY-----  402 (454)
T ss_dssp             GGBCCHHHHT--TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTC-----
T ss_pred             eEcCCCceec--cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-----
Confidence            8765432111  122347889999999988889999999999999999999 99999753211  1111111100     


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                                           +.+....++..+.+++.+||+.||++|||+.+|++.|+++....
T Consensus       403 ---------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          403 ---------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             ---------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence                                 00111223567889999999999999999999999999886543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4e-39  Score=346.21  Aligned_cols=251  Identities=21%  Similarity=0.306  Sum_probs=203.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc------chHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG------AFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||+|+++.....      ..+.+.+|+.++++++||||+++++++.+..  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   88 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT--   88 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--
Confidence            46899999999999999999999989999999999754321      3567899999999999999999999987655  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc----
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----  696 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----  696 (854)
                         ..++||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++    
T Consensus        89 ---~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~  156 (321)
T 2a2a_A           89 ---DVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP  156 (321)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred             ---EEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence               7899999999999999998654      688999999999999999999999   999999999999998876    


Q ss_pred             -ccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          697 -VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       697 -~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                       ++++|||.+.........    ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus       157 ~~kl~Dfg~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~  231 (321)
T 2a2a_A          157 HIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANIT  231 (321)
T ss_dssp             CEEECCCTTCEECCTTCCC----CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHH
T ss_pred             CEEEccCccceecCccccc----cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHH
Confidence             344599999877653322    2346999999999999989999999999999999999999999753211 0111111


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ....      ..++.                  ....++..+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~------~~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          232 SVSY------DFDEE------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TTCC------CCCHH------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hccc------ccChh------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1000      00000                  01122456889999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.6e-39  Score=343.74  Aligned_cols=266  Identities=20%  Similarity=0.278  Sum_probs=208.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....  .+.+.+|+.+++.++|++++..+.++....    ...+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEET----TEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCC----CceE
Confidence            3689999999999999999999988999999999875443  356889999999999988777777665433    2679


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec---CCccccc-cc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHQ-NF  702 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~~~-Df  702 (854)
                      +||||+ +++|.+++.....     .+++.+++.++.|++.||+|||++   +|+||||||+||+++   .++..++ ||
T Consensus        82 lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  152 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEec-CCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence            999999 8899999985432     689999999999999999999999   999999999999994   5555554 99


Q ss_pred             ccccccccCCCCC----CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC--chHhHHhh
Q 043388          703 SLSHQLDSASKTP----SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG--LTLHEFVK  776 (854)
Q Consensus       703 g~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~--~~~~~~~~  776 (854)
                      |.+..........    .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ........
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  232 (296)
T 3uzp_A          153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  232 (296)
T ss_dssp             TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred             CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence            9998876543321    11234579999999999999999999999999999999999999998643211  11111111


Q ss_pred             hcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043388          777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL  850 (854)
Q Consensus       777 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  850 (854)
                      .....                       ........++..+.+++.+||+.||++|||+.||++.|+++..+..
T Consensus       233 ~~~~~-----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          233 KKMST-----------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHS-----------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cccCC-----------------------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            00000                       0000112235678899999999999999999999999999887653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.1e-40  Score=349.17  Aligned_cols=267  Identities=21%  Similarity=0.306  Sum_probs=197.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|++.+.||+|+||.||+|++. +++.||+|+++...  ....+.+.+|++++++++||||+++++++...+     ..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred             ccchhhhhcccCCCEEEEEEEcC-CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-----eE
Confidence            47999999999999999999994 78899999996443  233467889999999999999999999997654     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++ +|.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             EEEEECCSE-EHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             EEEEEecCC-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence            999999986 99999876532     688999999999999999999999   9999999999999998877776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc---CC
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT---LP  780 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~---~~  780 (854)
                      +..........   ....||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .........   ..
T Consensus       147 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  222 (288)
T 1ob3_A          147 ARAFGIPVRKY---THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNS  222 (288)
T ss_dssp             HHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred             ccccCcccccc---ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCCh
Confidence            98765432221   124589999999998764 58999999999999999999999997643221 111111110   00


Q ss_pred             ccccc-----ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIE-----IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~-----~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..+..     ..++...    ..   .+.........+...+.+++.+||+.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~----~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          223 KNWPNVTELPKYDPNFT----VY---EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTSTTGGGSTTCCTTCC----CC---CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhchhhhcccccccccc----cc---cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00100     0000000    00   000000011123456789999999999999999999976

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.3e-40  Score=363.47  Aligned_cols=259  Identities=18%  Similarity=0.244  Sum_probs=204.3

Q ss_pred             HHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeecc
Q 043388          541 AELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSI  617 (854)
Q Consensus       541 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  617 (854)
                      .++....++|.+.++||+|+||.||+|++..+++.||+|+++..   .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            34444567999999999999999999999999999999999642   223345678999999999999999999999865


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV  697 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  697 (854)
                      .     ..|+||||++||+|.+++...       .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.
T Consensus       142 ~-----~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~  206 (410)
T 3v8s_A          142 R-----YLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH  206 (410)
T ss_dssp             S-----EEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred             C-----EEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCC
Confidence            5     789999999999999998753       578899999999999999999999   9999999999999999887


Q ss_pred             ccc-ccccccccccCCCCCCcccccCCcccccCccccCCCC----CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh
Q 043388          698 AHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE----ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH  772 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~  772 (854)
                      .++ |||+++........  .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...... ....
T Consensus       207 ikL~DFG~a~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~  283 (410)
T 3v8s_A          207 LKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYS  283 (410)
T ss_dssp             EEECCCTTCEECCTTSEE--ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHH
T ss_pred             EEEeccceeEeeccCCcc--cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHH
Confidence            776 99999876543321  122357999999999987655    789999999999999999999999754211 1111


Q ss_pred             HHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCC--CCCHHHHHHH
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFE--RMEMRDVVAK  841 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  841 (854)
                      .+.........                        +....++.++.+++.+||..+|.+  ||++.||++.
T Consensus       284 ~i~~~~~~~~~------------------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          284 KIMNHKNSLTF------------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHTHHHHCCC------------------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             HHHhccccccC------------------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            11110000000                        000012455788999999999988  9999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.8e-39  Score=339.78  Aligned_cols=254  Identities=22%  Similarity=0.281  Sum_probs=205.4

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+     .
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   79 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----I   79 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----E
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-----E
Confidence            4578999999999999999999999899999999997543 334577899999999999999999999987655     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEEEecCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence            899999999999999987643      689999999999999999999999   9999999999999998877666 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      .+.......... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||............+........
T Consensus       151 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  229 (276)
T 2yex_A          151 LATVFRYNNRER-LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN  229 (276)
T ss_dssp             TCEECEETTEEC-CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTST
T ss_pred             CccccCCCcchh-cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccC
Confidence            998765432211 1123468999999999988665 78999999999999999999999865433333333222110000


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                                                ....++..+.+++.+||+.||++|||+.|+++
T Consensus       230 --------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 --------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             --------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------------------------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                                      00112445778999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.4e-40  Score=361.62  Aligned_cols=282  Identities=21%  Similarity=0.325  Sum_probs=196.1

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCC
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKG  621 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  621 (854)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++.++. ||||+++++++...+.  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--   83 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND--   83 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS--
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC--
Confidence            3467899999999999999999999999999999998533  2334567889999999997 9999999999875432  


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                       ...|+||||++ |+|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ 
T Consensus        84 -~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           84 -RDVYLVFDYME-TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             -SCEEEEEECCS-EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             -CEEEEEecccC-cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence             26799999997 5999998763       678999999999999999999999   9999999999999999887776 


Q ss_pred             ccccccccccCCCC------------------CCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCC
Q 043388          701 NFSLSHQLDSASKT------------------PSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPT  761 (854)
Q Consensus       701 Dfg~~~~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf  761 (854)
                      |||+++.+......                  .......+||+.|+|||++.+ ..++.++||||+||++|||++|++||
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            99999876432111                  111233579999999999887 57899999999999999999999999


Q ss_pred             CCcccCCchHhHHhhhc-CCc-ccccccCchhhHHHhhc----c--------chhhHhh-----hhhHHHHHHHHHHHhh
Q 043388          762 DAAFTEGLTLHEFVKMT-LPE-KVIEIVDPSLLMEVMAN----N--------SMIQEDR-----RARTQDCLNAITRTGV  822 (854)
Q Consensus       762 ~~~~~~~~~~~~~~~~~-~~~-~~~~~~d~~~~~~~~~~----~--------~~~~~~~-----~~~~~~~~~~l~~l~~  822 (854)
                      .+.... ..+..+.... .+. .....+...........    .        ...+...     ......+...+.+++.
T Consensus       232 ~~~~~~-~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  310 (388)
T 3oz6_A          232 PGSSTM-NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD  310 (388)
T ss_dssp             CCSSHH-HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred             CCCCHH-HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence            864321 1112221111 111 00011111110000000    0        0000000     0000123556889999


Q ss_pred             cccCCCCCCCCCHHHHHHH
Q 043388          823 LCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       823 ~cl~~dP~~RPs~~evl~~  841 (854)
                      +||+.||++|||++|+++.
T Consensus       311 ~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          311 KLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHCCSSGGGSCCHHHHTTS
T ss_pred             HhhccCcccCCCHHHHhCC
Confidence            9999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.3e-40  Score=346.14  Aligned_cols=262  Identities=24%  Similarity=0.331  Sum_probs=206.3

Q ss_pred             HhhccccC-ccCCCcceEEEEeEE--CCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          547 TSEFASSN-MIGQGSFGSVYKGIL--GGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       547 ~~~~~~~~-~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      ..+|.+.+ .||+|+||.||+|.+  ..+++.||||+++...  ....+.+.+|++++++++||||+++++++.. +   
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~---   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E---   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S---
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-C---
Confidence            46788888 999999999999954  5578899999997543  2235678999999999999999999999832 2   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                        ..++||||+++++|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ 
T Consensus        91 --~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           91 --SWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             --SEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred             --CcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEc
Confidence              4789999999999999998754      688999999999999999999999   9999999999999998886666 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      |||++.................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+....
T Consensus       160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~  237 (291)
T 1xbb_A          160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE  237 (291)
T ss_dssp             CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC
T ss_pred             cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCC
Confidence            99999877654432222223347889999999988889999999999999999999 99999754221  1111111110


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhc
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLG  851 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  851 (854)
                      ...                          ....++..+.+++.+||+.||++|||+.|+++.|+++.....+
T Consensus       238 ~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          238 RMG--------------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             CCC--------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             CCC--------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence            000                          0012245688999999999999999999999999998876543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.9e-40  Score=354.22  Aligned_cols=251  Identities=23%  Similarity=0.370  Sum_probs=192.8

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccC--CCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRH--RNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~  623 (854)
                      ++|++.+.||+|+||.||+|.+. +++.||||++.....  ...+.+.+|+.++.+++|  |||+++++++....     
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~-----   82 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-----   82 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred             CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC-----
Confidence            57999999999999999999986 688999999975432  334678999999999976  99999999987655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccccccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFS  703 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg  703 (854)
                      ..++|||| .+|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++++.++++|||
T Consensus        83 ~~~lv~e~-~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~~~~~kl~DFG  152 (343)
T 3dbq_A           83 YIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLIDFG  152 (343)
T ss_dssp             EEEEEECC-CSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTEEEECCCS
T ss_pred             EEEEEEeC-CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEECCcEEEeecc
Confidence            78999995 5789999998764      688999999999999999999999   9999999999999997776667999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-----------SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH  772 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~  772 (854)
                      +++......... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||...........
T Consensus       153 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  231 (343)
T 3dbq_A          153 IANQMQPDTTSV-VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH  231 (343)
T ss_dssp             SSCCC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred             cccccCcccccc-cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH
Confidence            998775443221 1223569999999999864           6789999999999999999999999975422211111


Q ss_pred             HHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .............                          .+...+.+++..||+.||.+|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~--------------------------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          232 AIIDPNHEIEFPD--------------------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHCTTSCCCCCC--------------------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhcCCcccCCcc--------------------------cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            1111111110100                          012457789999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.9e-40  Score=365.05  Aligned_cols=206  Identities=23%  Similarity=0.311  Sum_probs=170.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||+++..  .....+++.+|++++++++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            36899999999999999999999999999999999643  2234567899999999999999999999997665433456


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+||||+++ +|.+++....      .+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus       105 ~~lv~e~~~~-~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG  174 (432)
T 3n9x_A          105 LYIVLEIADS-DLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG  174 (432)
T ss_dssp             EEEEEECCSE-EHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecCCc-CHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence            8999999964 9999998654      689999999999999999999999   9999999999999999877776 999


Q ss_pred             cccccccCCCCC-------------------CcccccCCcccccCcccc-CCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 043388          704 LSHQLDSASKTP-------------------SSSIGIKGTVGYVAPEYG-MGSEASMTGDVYSFGILLLEMFTGRRPTD  762 (854)
Q Consensus       704 ~~~~~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvvl~elltg~~pf~  762 (854)
                      +++.........                   ......+||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            998875432210                   112346799999999986 55669999999999999999998666554

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=358.79  Aligned_cols=289  Identities=23%  Similarity=0.323  Sum_probs=203.8

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHH--HHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA--LRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|.+.+.||+|+||.||+|++  +++.||||+++...   ...+..|.++  +..++||||+++++++......+...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            46899999999999999999987  47899999997543   2344455555  44579999999998776544444556


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC------CCCeEeecCCCCceEecCCccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC------QPPIVHGDLKPSNVLLDHDMVA  698 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~  698 (854)
                      .++||||+++|+|.+++...       ..++..+..++.||+.||+|||+.+      .++|+||||||+||+++.++..
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             EEEEEecCCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            79999999999999999765       4588899999999999999999873      3389999999999999998777


Q ss_pred             cc-ccccccccccCCCC-----CCcccccCCcccccCccccCC-------CCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          699 HQ-NFSLSHQLDSASKT-----PSSSIGIKGTVGYVAPEYGMG-------SEASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       699 ~~-Dfg~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      ++ |||+++........     ........||+.|+|||++.+       ..++.++|||||||++|||++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            76 99999877543221     112223569999999999887       456789999999999999999977765432


Q ss_pred             cCCchHhHHhhhcCCcccccccCchhhHHHhhccchhh--HhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 043388          766 TEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQ--EDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLC  843 (854)
Q Consensus       766 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  843 (854)
                      ........+.........     ..............+  +........++..+.+++.+||+.||++|||++|+++.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPT-----FEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCC-----HHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             chhHHHHhhhcccCCCch-----HHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            211100000000000000     000000000000000  0000011234667999999999999999999999999999


Q ss_pred             hhhhhhhcC
Q 043388          844 HTRETFLGR  852 (854)
Q Consensus       844 ~~~~~~~~~  852 (854)
                      ++.+.+.+.
T Consensus       315 ~ll~~~~~~  323 (336)
T 3g2f_A          315 ELMMIWERN  323 (336)
T ss_dssp             HHHHCCCC-
T ss_pred             HHHHHHHhc
Confidence            999887654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=346.38  Aligned_cols=244  Identities=22%  Similarity=0.245  Sum_probs=192.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.++||+|+||+||+|++..+++.||||++.....  .......+|+..+.++ +||||++++++|.+.+     .
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~-----~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG-----I  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC-----E
Confidence            689999999999999999999998999999999864332  2234556666666666 8999999999997655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+ +++|.+++.....     .+++.+++.|+.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             EEEEEecc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence            89999999 6699999877542     689999999999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      ++.........    ....||+.|+|||++.+ .++.++|||||||++|||++|..|+....    ..........+   
T Consensus       203 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~~~~~---  270 (311)
T 3p1a_A          203 LLVELGTAGAG----EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQLRQGYLP---  270 (311)
T ss_dssp             TCEECC----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHHHTTTCCC---
T ss_pred             eeeecccCCCC----cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHhccCCC---
Confidence            99877544322    22459999999999876 78999999999999999999977765321    11111111000   


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                           +.                  ....++..+.+++.+||+.||++|||+.|+++
T Consensus       271 -----~~------------------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          271 -----PE------------------FTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -----HH------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----cc------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                 00                  11122566889999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-39  Score=352.33  Aligned_cols=262  Identities=27%  Similarity=0.429  Sum_probs=199.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCC----ceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGE----EMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .+|...+.||+|+||.||+|.+..+    +..||||+++.... .....+.+|++++++++||||+++++++...+    
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----  119 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK----  119 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC----
Confidence            4677889999999999999988643    35699999975432 33457889999999999999999999987654    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++|+|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus       120 -~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  190 (333)
T 1mqb_A          120 -PMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD  190 (333)
T ss_dssp             -SEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             -CcEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECC
Confidence             68999999999999999986532     689999999999999999999999   9999999999999998877766 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||.+.................+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .....+.....
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~~  268 (333)
T 1mqb_A          191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGFR  268 (333)
T ss_dssp             CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC
T ss_pred             CCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHCCCc
Confidence            9999887654332222223457889999999998899999999999999999999 99999753211  11111111000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL  850 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  850 (854)
                      .                          +....++..+.+++.+||+.||++||++.|+++.|+++.....
T Consensus       269 ~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          269 L--------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             C--------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             C--------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            0                          0011224568899999999999999999999999999876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.9e-39  Score=347.18  Aligned_cols=266  Identities=20%  Similarity=0.267  Sum_probs=199.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|+++...   ....+.+.+|+.++++++||||+++++++...+     
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-----  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----
Confidence            468999999999999999999998899999999997532   234567889999999999999999999998755     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++......  ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Df  180 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL  180 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             cEEEEEecCCCCCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEec
Confidence            689999999999999999753211  12689999999999999999999999   9999999999999998877766 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |++..........   ....|++.|+|||++.+..++.++|||||||++|||++|+.||................   ..
T Consensus       181 g~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~  254 (310)
T 2wqm_A          181 GLGRFFSSKTTAA---HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ---CD  254 (310)
T ss_dssp             ---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT---TC
T ss_pred             cceeeecCCCccc---cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc---cc
Confidence            9998765433221   22468999999999999899999999999999999999999997542221111111111   00


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL  850 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  850 (854)
                      .....                      ...++..+.+++.+||+.||++|||+.||++.|+++.+...
T Consensus       255 ~~~~~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          255 YPPLP----------------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             SCCCC----------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCCc----------------------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            00000                      01124568899999999999999999999999999987653

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=356.92  Aligned_cols=271  Identities=18%  Similarity=0.234  Sum_probs=200.4

Q ss_pred             hhccccCccCCCcceEEEEeEECC---CceEEEEEEeeccccc-----------chHHHHHHHHHHHhccCCCeeeEEEE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG---EEMIVAVKVINLKQKG-----------AFRSFVAECEALRNIRHRNLIKIITI  613 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~  613 (854)
                      ++|.+.+.||+|+||.||+|.+..   ++..||+|+.......           ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            579999999999999999999986   7889999998754321           12346678889999999999999999


Q ss_pred             eeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec
Q 043388          614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD  693 (854)
Q Consensus       614 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  693 (854)
                      +.... .+....++||||+ +++|.+++....      .+++.+++.|+.||+.||+|||+.   +|+||||||+||+++
T Consensus       117 ~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  185 (345)
T 2v62_A          117 GLTEF-KGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG  185 (345)
T ss_dssp             EEEES-SSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             ccccc-CCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence            87732 2233789999999 999999998654      789999999999999999999999   999999999999998


Q ss_pred             CCc--cccc-ccccccccccCCCC----CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCccc
Q 043388          694 HDM--VAHQ-NFSLSHQLDSASKT----PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFT  766 (854)
Q Consensus       694 ~~~--~~~~-Dfg~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~  766 (854)
                      .++  ..++ |||+++.+......    ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            765  5554 99999877543221    1112345799999999999998999999999999999999999999964322


Q ss_pred             CCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          767 EGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       767 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                      ............     ...+.+... .            ......++..+.+++..||+.||++|||+.+|++.|++..
T Consensus       266 ~~~~~~~~~~~~-----~~~~~~~~~-~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          266 DPVAVQTAKTNL-----LDELPQSVL-K------------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             CHHHHHHHHHHH-----HHTTTHHHH-H------------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             ccHHHHHHHHhh-----cccccHHHH-h------------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            211111111100     000000000 0            0000023567899999999999999999999999998765


Q ss_pred             h
Q 043388          847 E  847 (854)
Q Consensus       847 ~  847 (854)
                      .
T Consensus       328 ~  328 (345)
T 2v62_A          328 I  328 (345)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-39  Score=345.99  Aligned_cols=265  Identities=24%  Similarity=0.407  Sum_probs=205.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCC---ceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGE---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .+|.+.++||+|+||.||+|++..+   ...||+|.+.... ....+.+.+|+.++++++||||+++++++...+    .
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----G  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----S
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC----C
Confidence            4688899999999999999997533   3468999986533 334567899999999999999999999975543    2


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++.....     .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++..++ ||
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  172 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADF  172 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcc
Confidence            57899999999999999976432     678999999999999999999999   9999999999999999877666 99


Q ss_pred             ccccccccCCCC-CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          703 SLSHQLDSASKT-PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       703 g~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |.++........ ........||+.|+|||.+.+..++.++||||+||++|||++ |.+||....... .......... 
T Consensus       173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~~~~~~~~~~-  250 (298)
T 3f66_A          173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRR-  250 (298)
T ss_dssp             GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-HHHHHHTTCC-
T ss_pred             cccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHHhcCCC-
Confidence            999876543321 122233568889999999998899999999999999999999 555655432221 1111111110 


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhcC
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGR  852 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  852 (854)
                      .     ..                     ...++..+.+++.+||+.||++|||+.|+++.|+++...+.++
T Consensus       251 ~-----~~---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~  296 (298)
T 3f66_A          251 L-----LQ---------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  296 (298)
T ss_dssp             C-----CC---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred             C-----CC---------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            0     00                     0112445789999999999999999999999999999887765

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-39  Score=341.98  Aligned_cols=262  Identities=21%  Similarity=0.339  Sum_probs=208.0

Q ss_pred             hhccccC-ccCCCcceEEEEeEEC--CCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSN-MIGQGSFGSVYKGILG--GEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ++|.+.+ .||+|+||.||+|.+.  .++..||+|+++... ....+.+.+|++++++++||||+++++++.. +     
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-----   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-----   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-----
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-C-----
Confidence            4566666 9999999999999864  467889999997643 3345678999999999999999999999843 2     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++++|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df  154 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  154 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence            47999999999999999975432     689999999999999999999999   9999999999999998876665 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |.+.................||+.|+|||++.+..++.++|||||||++|||++ |+.||......  .....+......
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~~~~~  232 (287)
T 1u59_A          155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKRM  232 (287)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCCC
T ss_pred             cceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhcCCcC
Confidence            999887654432222233457899999999988889999999999999999999 99999754221  111111111000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhc
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLG  851 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  851 (854)
                      .                          ....++..+.+++..||+.||++|||+.|+++.|+++..+..+
T Consensus       233 ~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          233 E--------------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             C--------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             C--------------------------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence            0                          0112255688999999999999999999999999999876543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.3e-39  Score=342.71  Aligned_cols=248  Identities=23%  Similarity=0.370  Sum_probs=199.8

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      +.++|++.+.||+|+||.||+|.+..++..||+|++....   ......+.+|+.++++++||||+++++++.+..    
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   82 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT----   82 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC----
Confidence            3578999999999999999999999999999999996432   233567889999999999999999999997655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        83 -~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~D  152 (279)
T 3fdn_A           83 -RVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD  152 (279)
T ss_dssp             -EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECS
T ss_pred             -EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEe
Confidence             6899999999999999998764      689999999999999999999999   9999999999999998877776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||++........     ....||+.|+|||.+.+..++.++||||+|+++|||++|+.||....... ..........  
T Consensus       153 fg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--  224 (279)
T 3fdn_A          153 FGWSVHAPSSRR-----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVEF--  224 (279)
T ss_dssp             CCEESCC-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCC--
T ss_pred             ccccccCCcccc-----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-HHHHHHhCCC--
Confidence            999865544322     22468999999999999899999999999999999999999997532110 0011100000  


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..                          ...++..+.+++.+||+.||++|||+.|+++.
T Consensus       225 ~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          225 TF--------------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CC--------------------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CC--------------------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00                          01124457789999999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.6e-39  Score=347.23  Aligned_cols=270  Identities=22%  Similarity=0.277  Sum_probs=197.8

Q ss_pred             hhcccc-CccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASS-NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +.|.+. +.||+|+||.||+|++..+++.||||+++.......+.+.+|++++.++ +||||+++++++.+.+     ..
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~-----~~   86 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED-----RF   86 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-----EE
Confidence            467774 7899999999999999889999999999876666678899999999995 7999999999997755     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc----ccccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHQN  701 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~~~D  701 (854)
                      ++||||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++    ++++|
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             EEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEE
Confidence            99999999999999998754      689999999999999999999999   999999999999998765    34459


Q ss_pred             cccccccccCCCC----CCcccccCCcccccCccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh
Q 043388          702 FSLSHQLDSASKT----PSSSIGIKGTVGYVAPEYGMG-----SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH  772 (854)
Q Consensus       702 fg~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~  772 (854)
                      ||++.........    ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||......+....
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  237 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD  237 (316)
T ss_dssp             TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred             ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence            9998876432211    111223469999999999865     4588999999999999999999999986533221100


Q ss_pred             HHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..   ...    ..........+.......+.   .....++..+.+++.+||+.||++|||+.|+++.
T Consensus       238 ~~---~~~----~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          238 RG---EAC----PACQNMLFESIQEGKYEFPD---KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             ------CC----HHHHHHHHHHHHHCCCCCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cc---ccc----hhHHHHHHHHHhccCcccCc---hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00   000    00000000000000000000   0111235668899999999999999999999873

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-39  Score=351.91  Aligned_cols=266  Identities=22%  Similarity=0.260  Sum_probs=202.0

Q ss_pred             HHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc-----cccchHHHHHHHHHHHhccCCCeeeEEEEeecc
Q 043388          543 LSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLIKIITICSSI  617 (854)
Q Consensus       543 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  617 (854)
                      +....++|.+.+.||+|+||.||+|.+..+++.||+|++...     .....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            455678999999999999999999999999999999999643     234567899999999999999999999999765


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCc----------------------------------ccccccCHHHHHHHHH
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDH----------------------------------LEVCKLTLIQRVNIAI  663 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------~~~~~~~~~~~~~i~~  663 (854)
                      +     ..++||||+++|+|.+++......                                  .....+++..++.|+.
T Consensus       101 ~-----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A          101 Q-----YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             S-----EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             C-----eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence            5     789999999999999999632100                                  0012356778889999


Q ss_pred             HHHHHHHHHHhcCCCCeEeecCCCCceEecCCc--ccc-cccccccccccCCCCC-CcccccCCcccccCccccCC--CC
Q 043388          664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM--VAH-QNFSLSHQLDSASKTP-SSSIGIKGTVGYVAPEYGMG--SE  737 (854)
Q Consensus       664 ~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~~-~Dfg~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~  737 (854)
                      |++.||+|||+.   +|+||||||+||+++.++  ..+ +|||.+..+....... .......||+.|+|||++.+  ..
T Consensus       176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence            999999999999   999999999999998765  444 5999998765432211 11223569999999999875  67


Q ss_pred             CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHH
Q 043388          738 ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAI  817 (854)
Q Consensus       738 ~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  817 (854)
                      ++.++|||||||++|||++|+.||....... ............     ..+                   ....++..+
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~-----~~~-------------------~~~~~~~~~  307 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKLCF-----ENP-------------------NYNVLSPLA  307 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCT-----TSG-------------------GGGGSCHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhccccc-----CCc-------------------ccccCCHHH
Confidence            8999999999999999999999997543221 111111111000     000                   011124567


Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHH
Q 043388          818 TRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       818 ~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .+++.+||+.||.+|||+.|+++.
T Consensus       308 ~~li~~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          308 RDLLSNLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcC
Confidence            899999999999999999999873

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.2e-40  Score=352.53  Aligned_cols=277  Identities=25%  Similarity=0.360  Sum_probs=209.5

Q ss_pred             hccccCccCCCcceEEEEeEE----CCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          549 EFASSNMIGQGSFGSVYKGIL----GGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .|++.+.||+|+||.||++.+    ..+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+   ..
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~  108 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---AA  108 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---TT
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---Cc
Confidence            349999999999999988765    34788999999975432 33567899999999999999999999997643   23


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++...       .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Df  178 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDF  178 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred             eEEEEEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCc
Confidence            689999999999999999764       578999999999999999999999   9999999999999999886666 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |.+.................||..|+|||++.+..++.++|||||||++|||++|+.||.......   ....  .....
T Consensus       179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~--~~~~~  253 (318)
T 3lxp_A          179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF---LELI--GIAQG  253 (318)
T ss_dssp             GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHH--CSCCH
T ss_pred             cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh---hhhh--ccccc
Confidence            999887654432222233468899999999998889999999999999999999999987432110   0000  00000


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhc
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLG  851 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  851 (854)
                      ....  ... .....     ...+......++..+.+++.+||+.||++|||+.|+++.|+.+.+++.+
T Consensus       254 ~~~~--~~~-~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          254 QMTV--LRL-TELLE-----RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             HHHH--HHH-HHHHH-----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             chhH--HHH-HHHHh-----cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence            0000  000 00000     0001111223456789999999999999999999999999999988764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-39  Score=344.47  Aligned_cols=266  Identities=23%  Similarity=0.370  Sum_probs=206.8

Q ss_pred             hccccCccCCCcceEEEEeEECCC---ceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGE---EMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .|...++||+|+||.||+|++..+   +..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.    .
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG----L   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS----C
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC----C
Confidence            466679999999999999997543   34799999865332 345678999999999999999999999876442    3


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+.+|+|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  169 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFG  169 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred             cEEEEecccCCCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCC
Confidence            5899999999999999986432     678999999999999999999999   9999999999999999876666 999


Q ss_pred             cccccccCCC-CCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          704 LSHQLDSASK-TPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       704 ~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      .++....... .........+|+.|+|||.+.+..++.++|||||||++|||++|..|+...... ..............
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~  248 (298)
T 3pls_A          170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQGRRLP  248 (298)
T ss_dssp             SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTTCCCC
T ss_pred             CcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcCCCCC
Confidence            9986644321 111222346899999999999999999999999999999999966655432221 11222211111000


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhcCC
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGRR  853 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~  853 (854)
                      .                          ...++..+.+++.+||+.||.+|||+.|+++.|+++.+.+.+..
T Consensus       249 ~--------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~  293 (298)
T 3pls_A          249 Q--------------------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH  293 (298)
T ss_dssp             C--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred             C--------------------------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence            0                          01124557899999999999999999999999999998876643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-39  Score=366.70  Aligned_cols=277  Identities=17%  Similarity=0.202  Sum_probs=198.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  623 (854)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...  .....+++.+|+.+++.++||||+++++++..... ....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46899999999999999999999999999999999753  23345678899999999999999999999876542 2234


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+||||+++ ++.+.+..        .+++.++..++.||+.||+|||+.   +|+||||||+|||++.++..++ ||
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence            67999999976 56666643        478899999999999999999999   9999999999999999877776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC--
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP--  780 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~--  780 (854)
                      |+++.......    ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+..+......  
T Consensus       209 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~  283 (464)
T 3ttj_A          209 GLARTAGTSFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPC  283 (464)
T ss_dssp             CCC-----CCC----C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCC
T ss_pred             EeeeecCCCcc----cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence            99987654322    22357999999999999999999999999999999999999999764321 111111111110  


Q ss_pred             cccccccCchhhHHHhhcc-----chhh--------HhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANN-----SMIQ--------EDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~-----~~~~--------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ......+.+.... +....     ...+        .............+.+++.+||+.||++|||++|+++.
T Consensus       284 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          284 PEFMKKLQPTVRN-YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHTTSCHHHHH-HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHcchhhhh-HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0011111111100 00000     0000        00011112235678899999999999999999999863

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-40  Score=357.68  Aligned_cols=265  Identities=23%  Similarity=0.425  Sum_probs=197.8

Q ss_pred             hhccccCccCCCcceEEEEeEECC---CceEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG---EEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ..|.+.+.||+|+||.||+|++..   .+..||+|.++.. .....+.+.+|+.++++++||||++++++|...+    .
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----G  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----S
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----C
Confidence            357778899999999999998742   2357899998643 3344578999999999999999999999875433    2


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++.....     .+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DF  236 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF  236 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             CeEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeec
Confidence            57899999999999999976542     578999999999999999999999   9999999999999999877776 99


Q ss_pred             ccccccccCCCCC-CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          703 SLSHQLDSASKTP-SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       703 g~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |+++......... .......+|+.|+|||++.+..++.++|||||||++|||+| |.+||.......  ..........
T Consensus       237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~~~~  314 (373)
T 3c1x_A          237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGRR  314 (373)
T ss_dssp             ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHTTCC
T ss_pred             cccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHcCCC
Confidence            9998765432211 12223457889999999998899999999999999999999 677776543221  1111111000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhcC
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGR  852 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  852 (854)
                           ...                     ...++..+.+++.+||+.||++|||+.|+++.|+++...+.+.
T Consensus       315 -----~~~---------------------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          315 -----LLQ---------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             -----CCC---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             -----CCC---------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence                 000                     1112456889999999999999999999999999998877654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-39  Score=364.14  Aligned_cols=247  Identities=26%  Similarity=0.378  Sum_probs=202.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||+++...   ....+.+.+|+.+++.++||||+++++++...+     
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS-----   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----
Confidence            368999999999999999999999899999999996432   234567899999999999999999999997755     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++....      .+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence            6899999999999999998654      689999999999999999999999   9999999999999998877666 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |++.........    ...+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... ............ 
T Consensus       161 G~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~-  234 (476)
T 2y94_A          161 GLSNMMSDGEFL----RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-TLFKKICDGIFY-  234 (476)
T ss_dssp             SSCEECCTTCCB----CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-HHHHHHHTTCCC-
T ss_pred             cchhhccccccc----cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-HHHHHHhcCCcC-
Confidence            999877543321    23469999999999988765 78999999999999999999999753211 111111111000 


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                            .|                     ..+...+.+++.+||+.||++|||+.|+++
T Consensus       235 ------~p---------------------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          235 ------TP---------------------QYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ------CC---------------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------CC---------------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                  00                     011345778999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-39  Score=355.19  Aligned_cols=282  Identities=20%  Similarity=0.224  Sum_probs=207.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++...........
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            358999999999999999999999899999999997433 2334678899999999999999999999976654444568


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++ +|.+++...       .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.
T Consensus       106 ~iv~e~~~~-~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEcccCc-CHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence            999999975 999998753       588999999999999999999999   9999999999999999876666 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC--c
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP--E  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~  781 (854)
                      +.................||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .+.........  .
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQ  253 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence            98876554433333345799999999986654 48999999999999999999999997653221 12222211111  0


Q ss_pred             -ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 -KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 -~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       .+....+........................+...+.+++.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             01111110000000000000000000011123456889999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-39  Score=362.03  Aligned_cols=253  Identities=23%  Similarity=0.277  Sum_probs=192.9

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--------ccchHHHHHHHHHHHhccCCCeeeEEEEeecc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--------KGAFRSFVAECEALRNIRHRNLIKIITICSSI  617 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  617 (854)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++....        ......+.+|++++++++||||+++++++...
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  212 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE  212 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4578999999999999999999999999999999997432        11223578999999999999999999997542


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc-
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-  696 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-  696 (854)
                            ..++||||+++|+|.+++....      .+++.++..++.|++.||+|||++   +|+||||||+||+++.++ 
T Consensus       213 ------~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~  277 (419)
T 3i6u_A          213 ------DYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE  277 (419)
T ss_dssp             ------EEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSS
T ss_pred             ------ceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCC
Confidence                  4689999999999999987654      689999999999999999999999   999999999999997543 


Q ss_pred             ---ccccccccccccccCCCCCCcccccCCcccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch
Q 043388          697 ---VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG---SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT  770 (854)
Q Consensus       697 ---~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~  770 (854)
                         ++++|||+++........    ....||+.|+|||++.+   ..++.++|||||||++|||++|+.||.........
T Consensus       278 ~~~~kl~DFG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~  353 (419)
T 3i6u_A          278 DCLIKITDFGHSKILGETSLM----RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL  353 (419)
T ss_dssp             SCCEEECCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH
T ss_pred             cceEEEeecccceecCCCccc----cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH
Confidence               344599999877543222    23569999999999864   56888999999999999999999999754332222


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...........      .+                  .....++..+.+++.+||+.||++|||+.|+++.
T Consensus       354 ~~~i~~~~~~~------~~------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          354 KDQITSGKYNF------IP------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHHHHTTCCCC------CH------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhcCCCCC------Cc------------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            22211111100      00                  0111225568899999999999999999999863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.7e-39  Score=342.29  Aligned_cols=258  Identities=19%  Similarity=0.331  Sum_probs=202.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECC---CceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG---EEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|.+.+.||+|+||.||+|++..   ++..||+|+++... ....+.+.+|+.++++++||||+++++++...     
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----   85 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-----   85 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-----
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----
Confidence            4689999999999999999998643   45679999997542 23456789999999999999999999998643     


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++++|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        86 -~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  156 (281)
T 3cc6_A           86 -PTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGD  156 (281)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECC
T ss_pred             -CCEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCc
Confidence             35899999999999999986542     589999999999999999999999   9999999999999998876666 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||.+..........  .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  ...........
T Consensus       157 fg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~~~  232 (281)
T 3cc6_A          157 FGLSRYIEDEDYYK--ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKGDR  232 (281)
T ss_dssp             CCGGGCC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHTCC
T ss_pred             cCCCcccccccccc--cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcCCC
Confidence            99998775533221  122357889999999988889999999999999999998 99999754222  11111111100


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ..                          ....++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       233 ~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          233 LP--------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             CC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC--------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            00                          0011245578999999999999999999999999988754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=351.86  Aligned_cols=277  Identities=20%  Similarity=0.257  Sum_probs=197.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc--chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||.||+|++..+++.||+|++......  ..+.+.+|++++++++||||+++++++...+     .
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~   76 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR-----R   76 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-----e
Confidence            35799999999999999999999989999999998654322  2456789999999999999999999997655     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  147 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFG  147 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEeCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCC
Confidence            899999999999999887654      689999999999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc--CC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~~  780 (854)
                      .+..........   ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ........  ..
T Consensus       148 ~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~  223 (311)
T 4agu_A          148 FARLLTGPSDYY---DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTLGDLI  223 (311)
T ss_dssp             TCEECC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCC
T ss_pred             CchhccCccccc---CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhcccc
Confidence            998776433222   12468999999999876 5689999999999999999999999976432211 11111100  00


Q ss_pred             ccccccc-CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIV-DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~-d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ....... .........................++..+.+++.+||+.||++|||++|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000000 000000000000000000000112235568899999999999999999999863

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.7e-39  Score=352.01  Aligned_cols=247  Identities=23%  Similarity=0.320  Sum_probs=197.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ...|...+.||+|+||.||+|++..+++.||||++.....   ...+.+.+|++++++++||||+++++++...+     
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----  127 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----  127 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----
Confidence            3569999999999999999999988999999999975432   23457889999999999999999999997755     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||++ |++.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  198 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF  198 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             eEEEEEecCC-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeec
Confidence            7899999997 588888865432     689999999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM---GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      |++.......       ...||+.|+|||++.   +..++.++|||||||++|||++|+.||....... ..........
T Consensus       199 G~a~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~  270 (348)
T 1u5q_A          199 GSASIMAPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES  270 (348)
T ss_dssp             TTCBSSSSBC-------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCC
T ss_pred             cCceecCCCC-------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCC
Confidence            9998764322       246999999999874   5678999999999999999999999997532111 1111111110


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +.    ...                      ..++..+.+++.+||+.||++|||+.|+++.
T Consensus       271 ~~----~~~----------------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          271 PA----LQS----------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CC----CCC----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CC----CCC----------------------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00    000                      1114457789999999999999999999753

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-40  Score=361.67  Aligned_cols=261  Identities=22%  Similarity=0.271  Sum_probs=203.8

Q ss_pred             HHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeec
Q 043388          540 YAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSS  616 (854)
Q Consensus       540 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  616 (854)
                      +.+.....++|++.++||+|+||.||+|+.+.+++.||||+++..   .....+.+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            344445568999999999999999999999989999999999643   22234567899999999999999999999977


Q ss_pred             cCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc
Q 043388          617 IDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM  696 (854)
Q Consensus       617 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  696 (854)
                      .+     ..|+||||+++|+|.+++...+.     .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++
T Consensus       133 ~~-----~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g  199 (412)
T 2vd5_A          133 EN-----YLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCG  199 (412)
T ss_dssp             SS-----EEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             CC-----EEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCC
Confidence            65     78999999999999999986532     689999999999999999999999   999999999999999988


Q ss_pred             cccc-ccccccccccCCCCCCcccccCCcccccCccccC-------CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC
Q 043388          697 VAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM-------GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG  768 (854)
Q Consensus       697 ~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~  768 (854)
                      ..++ |||+++........  .....+||+.|+|||++.       +..++.++|||||||++|||++|+.||...... 
T Consensus       200 ~vkL~DFGla~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-  276 (412)
T 2vd5_A          200 HIRLADFGSCLKLRADGTV--RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-  276 (412)
T ss_dssp             CEEECCCTTCEECCTTSCE--ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-
T ss_pred             CEEEeechhheeccCCCcc--ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-
Confidence            7776 99999877543321  122357999999999987       456899999999999999999999999754221 


Q ss_pred             chHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCC---CCHHHHHH
Q 043388          769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFER---MEMRDVVA  840 (854)
Q Consensus       769 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~  840 (854)
                      .....+.....  ..   .-|.                  ....++.++.+++.+||. +|++|   |+++|+++
T Consensus       277 ~~~~~i~~~~~--~~---~~p~------------------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          277 ETYGKIVHYKE--HL---SLPL------------------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHHHHHTHHH--HC---CCC----------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHHHHHhccc--Cc---CCCc------------------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            11111111000  00   0000                  001224567899999999 99998   58888865

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.4e-39  Score=347.84  Aligned_cols=275  Identities=24%  Similarity=0.332  Sum_probs=211.7

Q ss_pred             HHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHh--ccCCCeeeEEEEeeccCC
Q 043388          542 ELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLIKIITICSSIDS  619 (854)
Q Consensus       542 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~  619 (854)
                      .-....++|.+.+.||+|+||.||+|++.  ++.||||++...   ..+.+.+|++++..  ++||||+++++++.....
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            33445679999999999999999999984  789999999643   24667889999988  699999999999876542


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeecCCCCceE
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH--------HHCQPPIVHGDLKPSNVL  691 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlkp~NIl  691 (854)
                       .....++||||+++|+|.+++...       .+++.+++.++.|++.||+|||        +.   +|+||||||+||+
T Consensus       111 -~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl  179 (342)
T 1b6c_B          111 -TWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL  179 (342)
T ss_dssp             -SCCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred             -ccceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence             223579999999999999999753       5889999999999999999999        67   9999999999999


Q ss_pred             ecCCccccc-ccccccccccCCCCCC-cccccCCcccccCccccCCC------CCCccchhHHHHHHHHHHHhC------
Q 043388          692 LDHDMVAHQ-NFSLSHQLDSASKTPS-SSIGIKGTVGYVAPEYGMGS------EASMTGDVYSFGILLLEMFTG------  757 (854)
Q Consensus       692 l~~~~~~~~-Dfg~~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvvl~elltg------  757 (854)
                      ++.++..++ |||++........... ......||+.|+|||++.+.      .++.++|||||||++|||+||      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            998877776 9999987765432210 12234699999999998775      234789999999999999999      


Q ss_pred             ----CCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC
Q 043388          758 ----RRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM  833 (854)
Q Consensus       758 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  833 (854)
                          +.||............+............+...                 ....+++..+.+++.+||+.||++||
T Consensus       260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rp  322 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR-----------------WQSCEALRVMAKIMRECWYANGAARL  322 (342)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-----------------GGTSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred             ccccccCccccCcCcccHHHHHHHHHHHHhCCCCccc-----------------ccchhHHHHHHHHHHHHhccChhhCC
Confidence                677765443333333333222111111111100                 01124467799999999999999999


Q ss_pred             CHHHHHHHHHhhhhhh
Q 043388          834 EMRDVVAKLCHTRETF  849 (854)
Q Consensus       834 s~~evl~~L~~~~~~~  849 (854)
                      |+.||++.|+++.+..
T Consensus       323 s~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          323 TALRIKKTLSQLSQQE  338 (342)
T ss_dssp             CHHHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHHHHHh
Confidence            9999999999998764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-39  Score=338.78  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=206.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|.+.+.||+|+||.||+|.+. ++..||+|+++.... ..+.+.+|++++++++||||+++++++...+     ..++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   80 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICL   80 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SCEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----CeEE
Confidence            57999999999999999999997 677899999975543 3467899999999999999999999987654     5799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+.
T Consensus        81 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             EEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccc
Confidence            9999999999999986532     688999999999999999999999   9999999999999998877666 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ........  ......+|..|+|||++.+..++.++||||+|+++|||++ |+.||......  .....+......    
T Consensus       153 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~~~----  224 (267)
T 3t9t_A          153 FVLDDQYT--SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRL----  224 (267)
T ss_dssp             GBCCHHHH--STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCC----
T ss_pred             cccccccc--ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCCcC----
Confidence            76432211  1122357889999999988889999999999999999999 89998753211  111111110000    


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                       ..+                     ..++..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       225 -~~~---------------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          225 -YKP---------------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             -CCC---------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -CCC---------------------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence             000                     01144578999999999999999999999999998764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-39  Score=352.17  Aligned_cols=270  Identities=21%  Similarity=0.321  Sum_probs=211.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCc-----eEEEEEEeecccc-cchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEE-----MIVAVKVINLKQK-GAFRSFVAECEALRNI-RHRNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  619 (854)
                      .++|.+.+.||+|+||.||+|.+..++     ..||+|+++.... ...+.+.+|+.+++++ +||||+++++++...+ 
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-  123 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG-  123 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC-
Confidence            468999999999999999999997655     3799999975432 3456789999999999 8999999999997655 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcc--------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceE
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHL--------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVL  691 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl  691 (854)
                          ..++||||+++|+|.+++.......        ....+++.+++.++.|++.||+|||+.   +|+||||||+||+
T Consensus       124 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          124 ----PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL  196 (333)
T ss_dssp             ----SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred             ----ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence                6799999999999999998643110        012578999999999999999999999   9999999999999


Q ss_pred             ecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCc
Q 043388          692 LDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGL  769 (854)
Q Consensus       692 l~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~  769 (854)
                      ++.++..++ |||++.......... ......||+.|+|||++.+..++.++|||||||++|||+| |..||....... 
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-  274 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-  274 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSE-ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-
T ss_pred             ECCCCeEEECcccccccccccccee-ecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-
Confidence            998887766 999998765443221 1122347889999999988889999999999999999999 999997543221 


Q ss_pred             hHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          770 TLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      .............     .                     ...++..+.+++..||+.||.+|||+.|+++.|+++.+..
T Consensus       275 ~~~~~~~~~~~~~-----~---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          275 KFYKLVKDGYQMA-----Q---------------------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHHHHHHHTCCCC-----C---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCC-----C---------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            1122221111100     0                     0111455788999999999999999999999999988766


Q ss_pred             hcC
Q 043388          850 LGR  852 (854)
Q Consensus       850 ~~~  852 (854)
                      ..+
T Consensus       329 ~~~  331 (333)
T 2i1m_A          329 RRE  331 (333)
T ss_dssp             HHH
T ss_pred             hcc
Confidence            543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.1e-39  Score=341.07  Aligned_cols=250  Identities=22%  Similarity=0.336  Sum_probs=197.5

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .|.+.+.||+|+||.||+|.+..++..||+|++....  ....+.+.+|+.++++++||||+++++++..... +....+
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  105 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIV  105 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-SCEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC-CCceEE
Confidence            4788889999999999999999999999999997543  3345678999999999999999999999875432 234689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCceEec-CCccccc-cc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--IVHGDLKPSNVLLD-HDMVAHQ-NF  702 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~~~-Df  702 (854)
                      +||||+++|+|.+++....      .+++..++.++.|++.||+|||+.   +  |+||||||+||+++ .++..++ ||
T Consensus       106 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEEecCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence            9999999999999998754      688999999999999999999999   7  99999999999997 5555555 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |++........     ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..................+..
T Consensus       177 g~~~~~~~~~~-----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (290)
T 1t4h_A          177 GLATLKRASFA-----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS  250 (290)
T ss_dssp             TGGGGCCTTSB-----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred             CCccccccccc-----ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc
Confidence            99975543322     22469999999998764 5899999999999999999999999754322111111111100000


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .                          ...++..+.+++..||+.||.+|||+.|+++
T Consensus       251 ~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          251 F--------------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             G--------------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c--------------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0                          0011345789999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.4e-39  Score=356.39  Aligned_cols=254  Identities=18%  Similarity=0.261  Sum_probs=191.6

Q ss_pred             Hhhcccc-CccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASS-NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|.+. ++||+|+||.||+|.+..+++.||||+++..     ..+.+|++++.++ +||||+++++++.... .+..+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcE
Confidence            4567776 7899999999999999999999999998632     4677899887554 8999999999986522 12236


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC---Cccccc-
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHQ-  700 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~~~-  700 (854)
                      .|+||||+++|+|.+++.....    ..+++.++..|+.||+.||+|||+.   +|+||||||+||+++.   ++..++ 
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence            8999999999999999987532    2689999999999999999999999   9999999999999987   455555 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCc---hHhHHhhh
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL---TLHEFVKM  777 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~---~~~~~~~~  777 (854)
                      |||+++.......    ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........   ........
T Consensus       207 DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~  282 (400)
T 1nxk_A          207 DFGFAKETTSHNS----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG  282 (400)
T ss_dssp             CCTTCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT
T ss_pred             ecccccccCCCCc----cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC
Confidence            9999987654322    1234689999999999999999999999999999999999999976432211   11111111


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...     ...+                   ....++.++.+++.+||+.||++|||+.|+++.
T Consensus       283 ~~~-----~~~~-------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          283 QYE-----FPNP-------------------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CCC-----CCTT-------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccc-----CCCc-------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000     0000                   001224567899999999999999999999874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=350.69  Aligned_cols=258  Identities=22%  Similarity=0.364  Sum_probs=199.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceE----EEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMI----VAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .+|++.++||+|+||.||+|++..+++.    ||+|.+... .....+.+.+|+.++++++||||+++++++....    
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----   90 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST----   90 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS----
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC----
Confidence            5799999999999999999999777664    466666433 3345678999999999999999999999987543    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                        .++||||+++|+|.+++.....     .+++..++.|+.|++.||+|||++   +|+||||||+||+++.++..++ |
T Consensus        91 --~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~D  160 (327)
T 3lzb_A           91 --VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD  160 (327)
T ss_dssp             --EEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred             --ceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEcc
Confidence              6899999999999999987543     689999999999999999999999   9999999999999998877666 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||+++.......... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......  ...........
T Consensus       161 fG~a~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~  237 (327)
T 3lzb_A          161 FGLAKLLGAEEKEYH-AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGER  237 (327)
T ss_dssp             TTC-----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC
T ss_pred             CcceeEccCcccccc-ccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC
Confidence            999987755433221 223457889999999999999999999999999999999 99999754322  12222211110


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ...                          ...++..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus       238 ~~~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 LPQ--------------------------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCC--------------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCC--------------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            000                          011244578899999999999999999999999988754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=351.79  Aligned_cols=244  Identities=22%  Similarity=0.324  Sum_probs=201.4

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--------cchHHHHHHHHHHHhccCCCeeeEEEEeec
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--------GAFRSFVAECEALRNIRHRNLIKIITICSS  616 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  616 (854)
                      ...++|.+.+.||+|+||.||+|++..+++.||||+++....        ...+.+.+|++++++++||||+++++++..
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            356789999999999999999999999999999999975431        123467789999999999999999999976


Q ss_pred             cCCCCCceeeEEEeeccCC-CHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC
Q 043388          617 IDSKGADFKALVFEYMENG-SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD  695 (854)
Q Consensus       617 ~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  695 (854)
                      .+     ..++||||+.+| +|.+++....      .+++..+..|+.|++.||+|||+.   +|+||||||+||+++.+
T Consensus       101 ~~-----~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  166 (335)
T 3dls_A          101 QG-----FFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED  166 (335)
T ss_dssp             SS-----EEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             CC-----EEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC
Confidence            55     789999999777 9999998765      689999999999999999999999   99999999999999988


Q ss_pred             ccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhH
Q 043388          696 MVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHE  773 (854)
Q Consensus       696 ~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~  773 (854)
                      +..++ |||.+.........    ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......      
T Consensus       167 ~~~kL~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------  236 (335)
T 3dls_A          167 FTIKLIDFGSAAYLERGKLF----YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------  236 (335)
T ss_dssp             SCEEECCCTTCEECCTTCCB----CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------
T ss_pred             CcEEEeecccceECCCCCce----eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------
Confidence            77766 99999877554322    23469999999999988776 88999999999999999999999742110      


Q ss_pred             HhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       774 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                       ......       .+.                     .++..+.+++.+||+.||++|||+.|+++.
T Consensus       237 -~~~~~~-------~~~---------------------~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -VEAAIH-------PPY---------------------LVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -TTTCCC-------CSS---------------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -HhhccC-------CCc---------------------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000000       000                     013457899999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-39  Score=346.15  Aligned_cols=262  Identities=20%  Similarity=0.241  Sum_probs=199.1

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ..++|.+.+.||+|+||.||+|++..+++.||+|++.....   ...+.+.+|+.++++++||||+++++++...+    
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----  107 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG----  107 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC----
Confidence            45789999999999999999999998999999999975432   22467889999999999999999999987755    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++++|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus       108 -~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~D  177 (309)
T 2h34_A          108 -QLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVD  177 (309)
T ss_dssp             -EEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred             -eEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEec
Confidence             7899999999999999998754      689999999999999999999999   9999999999999998877766 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.+..........  .....||+.|+|||++.+..++.++||||||+++|||++|+.||......  ..........+.
T Consensus       178 fg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~  253 (309)
T 2h34_A          178 FGIASATTDEKLTQ--LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR  253 (309)
T ss_dssp             CCC------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC
T ss_pred             CccCcccccccccc--ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC
Confidence            99998765433221  12346899999999999989999999999999999999999999754221  111111111100


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-CHHHHHHHHHhhhhhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-EMRDVVAKLCHTRETF  849 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~  849 (854)
                      .  ..                      ....++..+.+++.+||+.||++|| |++++++.|++..+..
T Consensus       254 ~--~~----------------------~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          254 P--ST----------------------VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             G--GG----------------------TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             c--cc----------------------cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            0  00                      0112245578899999999999999 9999999999876544

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.1e-39  Score=339.28  Aligned_cols=252  Identities=20%  Similarity=0.306  Sum_probs=202.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|++++++++||||+++++++....     .
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----F   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-----E
Confidence            468999999999999999999999899999999997543  233467889999999999999999999997655     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc----cccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHQ  700 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~~~  700 (854)
                      .++||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++    ++++
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence            899999999999999988754      689999999999999999999999   999999999999998654    3445


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |||.+.........    ....||+.|+|||++.+..++.++||||+|+++|+|++|+.||...... ............
T Consensus       151 Dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~  225 (284)
T 3kk8_A          151 DFGLAIEVNDSEAW----HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYD  225 (284)
T ss_dssp             CCTTCEECCSSCBC----CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC
T ss_pred             eceeeEEcccCccc----cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHHHHHHhcccc
Confidence            99999876543322    2346999999999999999999999999999999999999999753211 111111111100


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .     ..+                   ....++..+.+++.+||+.||++|||+.|+++.
T Consensus       226 ~-----~~~-------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          226 Y-----PSP-------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             C-----CTT-------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             C-----Cch-------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0     000                   001124557899999999999999999999873

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.1e-39  Score=357.01  Aligned_cols=251  Identities=22%  Similarity=0.367  Sum_probs=193.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhcc--CCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIR--HRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~  623 (854)
                      .+|.+.+.||+|+||.||+|.+. +++.||||++....  ....+.+.+|+.++++++  ||||+++++++...+     
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~-----  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-----  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred             CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-----
Confidence            45999999999999999999987 48899999997543  234567899999999996  599999999987755     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccccccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFS  703 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg  703 (854)
                      ..++||| +.+++|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+|||++++.++++|||
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~kl~DFG  199 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLIDFG  199 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEESSSCEEECCCS
T ss_pred             EEEEEEe-cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEECCeEEEEecC
Confidence            6899999 56789999998764      678889999999999999999999   9999999999999987666666999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-----------SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH  772 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~  772 (854)
                      +++.+....... .....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........+.
T Consensus       200 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~  278 (390)
T 2zmd_A          200 IANQMQPDTTSV-VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH  278 (390)
T ss_dssp             SSCCC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred             ccccccCCCccc-cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH
Confidence            998775433211 1223569999999999865           3689999999999999999999999975422211111


Q ss_pred             HHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .............                          .+...+.+++.+||+.||.+|||+.|+++.
T Consensus       279 ~~~~~~~~~~~~~--------------------------~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          279 AIIDPNHEIEFPD--------------------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHCTTSCCCCCC--------------------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCccccCCCCc--------------------------cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1111111000000                          013457789999999999999999999863

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.8e-40  Score=354.50  Aligned_cols=277  Identities=20%  Similarity=0.290  Sum_probs=195.1

Q ss_pred             HHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          543 LSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       543 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .....++|++.++||+|+||.||+|++..+++.||||+++....  ...+.+.+|++++++++||||+++++++.+.+  
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  106 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH--  106 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT--
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC--
Confidence            34456799999999999999999999999999999999964432  23456789999999999999999999998765  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC-----C
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-----D  695 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~  695 (854)
                         ..++||||+++ +|.+++....      .+++.+++.|+.||+.||+|||+.   +|+||||||+||+++.     +
T Consensus       107 ---~~~lv~e~~~~-~L~~~~~~~~------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  173 (329)
T 3gbz_A          107 ---RLHLIFEYAEN-DLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASET  173 (329)
T ss_dssp             ---EEEEEEECCSE-EHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----C
T ss_pred             ---EEEEEEecCCC-CHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCcc
Confidence               78999999985 9999998765      689999999999999999999999   9999999999999953     3


Q ss_pred             cccc-cccccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhH
Q 043388          696 MVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHE  773 (854)
Q Consensus       696 ~~~~-~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~  773 (854)
                      ...+ +|||.++.........   ....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~  249 (329)
T 3gbz_A          174 PVLKIGDFGLARAFGIPIRQF---THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFK  249 (329)
T ss_dssp             CEEEECCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH
T ss_pred             ceEEECcCCCccccCCccccc---CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHH
Confidence            3344 4999998775433222   224589999999998875 48999999999999999999999997643221 1111


Q ss_pred             Hhhh-cCCcc--ccccc-CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          774 FVKM-TLPEK--VIEIV-DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       774 ~~~~-~~~~~--~~~~~-d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .... ..+..  +.... .+.+.......  ............+..++.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          250 IFEVLGLPDDTTWPGVTALPDWKQSFPKF--RGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHCCCCTTTSTTGGGSTTCCTTCCCC--CCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCchhhhhhhhhhhhhhhhhhhh--ccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            1111 11100  00000 00000000000  0000000011113456789999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.1e-40  Score=351.34  Aligned_cols=271  Identities=19%  Similarity=0.218  Sum_probs=208.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||.||+|+...+++.||||++........+.+.+|++++++++||||+++++++.... ......+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence            357999999999999999999998899999999997666566678999999999999999999999986432 1223679


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++......  ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             EEEEeCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            999999999999999864221  12689999999999999999999999   9999999999999988877666 99998


Q ss_pred             cccccCCCCCC------cccccCCcccccCccccCCCC---CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh
Q 043388          706 HQLDSASKTPS------SSIGIKGTVGYVAPEYGMGSE---ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK  776 (854)
Q Consensus       706 ~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~  776 (854)
                      ...........      ......||+.|+|||++.+..   ++.++|||||||++|||++|+.||...............
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  261 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ  261 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence            76543211100      011234799999999987654   689999999999999999999999643222222222111


Q ss_pred             hcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       777 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ......                          ....++..+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus       262 ~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          262 NQLSIP--------------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             CC--CC--------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             ccCCCC--------------------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            100000                          00112456889999999999999999999999999876543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-39  Score=341.01  Aligned_cols=253  Identities=22%  Similarity=0.310  Sum_probs=194.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|.+.+.||+|+||.||+|++..++..||+|++.... ....+.+.+|++++++++||||+++++++.+..     ..
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~   95 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-----NM   95 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC-----eE
Confidence            468999999999999999999999899999999997543 334578899999999999999999999997655     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC---Ccccc-cc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAH-QN  701 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~~-~D  701 (854)
                      ++||||+++|+|.+++......  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++..+ +|
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~D  170 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIID  170 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEe
Confidence            9999999999999998754211  12689999999999999999999999   9999999999999954   34444 59


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.+.........    ....||+.|+|||++. ..++.++|||||||++|||++|+.||.......  .........+.
T Consensus       171 fg~a~~~~~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~  243 (285)
T 3is5_A          171 FGLAELFKSDEHS----TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKATYKEPN  243 (285)
T ss_dssp             CCCCCC--------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCC
T ss_pred             eecceecCCcccC----cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhccCCcc
Confidence            9999876543322    2346899999999875 468999999999999999999999997542211  11111100000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...   .                     .......+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~---~---------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          244 YAV---E---------------------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCC--------------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccc---c---------------------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000   0                     0001345778999999999999999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=340.64  Aligned_cols=250  Identities=23%  Similarity=0.387  Sum_probs=182.4

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ..++|.+.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+    
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   84 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN----   84 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS----
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC----
Confidence            3568999999999999999999998899999999996432   234577899999999999999999999987654    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++++|.+++.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ |
T Consensus        85 -~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d  155 (278)
T 3cok_A           85 -YVYLVLEMCHNGEMNRYLKNRVK-----PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIAD  155 (278)
T ss_dssp             -EEEEEEECCTTEEHHHHHHTCSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECC
T ss_pred             -eEEEEEecCCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEe
Confidence             78999999999999999986532     689999999999999999999999   9999999999999998877666 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.+..........   ....||+.|+|||.+.+..++.++||||||+++|||++|+.||........     .......
T Consensus       156 fg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~  227 (278)
T 3cok_A          156 FGLATQLKMPHEKH---YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNKVVLA  227 (278)
T ss_dssp             CTTCEECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCSS
T ss_pred             ecceeeccCCCCcc---eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHHHhhc
Confidence            99998765433221   224689999999999988899999999999999999999999975432110     0000000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..   ..+                     ..++.++.+++.+||+.||++|||++|+++
T Consensus       228 ~~---~~~---------------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 DY---EMP---------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CC---CCC---------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cc---CCc---------------------cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            00   000                     011345778999999999999999999986

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=5.6e-39  Score=359.96  Aligned_cols=376  Identities=23%  Similarity=0.257  Sum_probs=262.6

Q ss_pred             CCcccccCchhhhcCCCCCEEecccccccccCCccccCcCCC-------------CeeecccccccccCCcCccCCCCCc
Q 043388            1 KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSAL-------------GMLLIRWNSLGGQIPTTLGLLRNLV   67 (854)
Q Consensus         1 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-------------~~L~l~~n~l~~~~~~~~~~l~~L~   67 (854)
                      .|++ |.+|++|+++++|++|++++|.+++.+|.+++.+.+|             ++|++++|++++ +|..   .++|+
T Consensus        20 ~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~   94 (454)
T 1jl5_A           20 SSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLE   94 (454)
T ss_dssp             ---------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCS
T ss_pred             cCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCC
Confidence            3778 8999999999999999999999999999999998875             999999999994 5553   47899


Q ss_pred             EEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCC---------CCCceeeccCccC
Q 043388           68 YLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSL---------KNLWWLNLEQNNL  138 (854)
Q Consensus        68 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l---------~~L~~L~L~~N~l  138 (854)
                      +|+|++|++++ +|..   +++|++|++++|+++ .+|..    .++|++|++++|++         ++|++|++++|++
T Consensus        95 ~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~~lp~~~~l~~L~~L~l~~N~l  165 (454)
T 1jl5_A           95 SLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL  165 (454)
T ss_dssp             EEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCC
T ss_pred             EEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCCCCcccCCCCCCCEEECCCCcC
Confidence            99999999997 6653   488999999999998 56532    26899999988865         5688999999998


Q ss_pred             CCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccC
Q 043388          139 GMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDN  218 (854)
Q Consensus       139 ~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N  218 (854)
                           +.+|..+   ++|++|++++|+++++ | .|..+++|++|++++|+++.++..          .++|++|++++|
T Consensus       166 -----~~lp~~~---~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l~~l~~~----------~~~L~~L~l~~n  225 (454)
T 1jl5_A          166 -----KKLPDLP---PSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSLKKLPDL----------PLSLESIVAGNN  225 (454)
T ss_dssp             -----SCCCCCC---TTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSSCCCC----------CTTCCEEECCSS
T ss_pred             -----cccCCCc---ccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcCCcCCCC----------cCcccEEECcCC
Confidence                 3466543   5899999999999985 4 699999999999999999865432          258999999999


Q ss_pred             cCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCC
Q 043388          219 QFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIP  298 (854)
Q Consensus       219 ~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  298 (854)
                      .++ .+|. +..++ .|+.|++++|++++ +|..   +++|+.|++++|++++ +|..   +++|++|++++|++++. |
T Consensus       226 ~l~-~lp~-~~~l~-~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~  293 (454)
T 1jl5_A          226 ILE-ELPE-LQNLP-FLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-S  293 (454)
T ss_dssp             CCS-SCCC-CTTCT-TCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-S
T ss_pred             cCC-cccc-cCCCC-CCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-c
Confidence            998 7784 77775 79999999999995 4543   4789999999999997 4443   47899999999999963 2


Q ss_pred             ccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccc
Q 043388          299 PSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLK  378 (854)
Q Consensus       299 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~  378 (854)
                      ..   .++|+.|++++|++++ ++..   .++|+.|++++|++++ +|..+   ..+. .+++++|.+++ +|.   .  
T Consensus       294 ~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~~---~~L~-~L~L~~N~l~~-lp~---~--  355 (454)
T 1jl5_A          294 EL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPALP---PRLE-RLIASFNHLAE-VPE---L--  355 (454)
T ss_dssp             CC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCCC---TTCC-EEECCSSCCSC-CCC---C--
T ss_pred             Cc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-ccccC---CcCC-EEECCCCcccc-ccc---h--
Confidence            21   1689999999999985 3321   2589999999999985 67653   3333 38899999884 554   1  


Q ss_pred             cccccccccceeeccCccccc--CCCcccccC-------------CCCCEEEccCccccc--ccchhhcCccCCCeeecc
Q 043388          379 NLVITCVSLEYLDISSNSFHG--VIPFSLGFM-------------KSIKELNVSSNNLSG--QIPEFLQNLSFLEFLNLS  441 (854)
Q Consensus       379 ~l~~~~~~L~~L~Ls~N~l~~--~~p~~~~~l-------------~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls  441 (854)
                           +.+|++|++++|++++  .+|.+++.+             ++|+.|++++|++++  .+|.+      ++.|.++
T Consensus       356 -----l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~  424 (454)
T 1jl5_A          356 -----PQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPES------VEDLRMN  424 (454)
T ss_dssp             -----CTTCCEEECCSSCCSSCCCCCTTCCEEECCC--------------------------------------------
T ss_pred             -----hhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchhh------HhheeCc
Confidence                 4579999999999998  788888888             899999999999997  66654      5667789


Q ss_pred             cccCcccCCC
Q 043388          442 YNHLEGEVPT  451 (854)
Q Consensus       442 ~N~l~~~~p~  451 (854)
                      +|.+.+.+|.
T Consensus       425 ~~~~~~~~~~  434 (454)
T 1jl5_A          425 SERVVDPYEF  434 (454)
T ss_dssp             ----------
T ss_pred             CcccCCcccc
Confidence            9998877653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.3e-39  Score=354.96  Aligned_cols=250  Identities=27%  Similarity=0.339  Sum_probs=192.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHH-HHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEA-LRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||+++...   ......+.+|..+ ++.++||||+++++++.+.+    
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~----  112 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----  112 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS----
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC----
Confidence            468999999999999999999999999999999997543   2233456677776 46789999999999997755    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..|+||||++||+|.+++....      .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++..++ |
T Consensus       113 -~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D  182 (373)
T 2r5t_A          113 -KLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD  182 (373)
T ss_dssp             -EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             -EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence             7899999999999999998754      688999999999999999999999   9999999999999998887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||+++........   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.....  
T Consensus       183 FG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~~~--  256 (373)
T 2r5t_A          183 FGLCKENIEHNST---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILNKPL--  256 (373)
T ss_dssp             CCBCGGGBCCCCC---CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-HHHHHHHHSCC--
T ss_pred             CccccccccCCCc---cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccc--
Confidence            9999864432221   22357999999999999999999999999999999999999999753211 11111111100  


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                      ..    .+                      .+...+.+++.+||+.||.+||++.+.++.+
T Consensus       257 ~~----~~----------------------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          257 QL----KP----------------------NITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             CC----CS----------------------SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             CC----CC----------------------CCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence            00    00                      1134577899999999999999986544433

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.5e-39  Score=339.54  Aligned_cols=259  Identities=25%  Similarity=0.418  Sum_probs=206.5

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|++.+.||+|+||.||+|.+. ++..||+|+++.... ..+.+.+|++++++++||||+++++++...      ..++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~   84 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIYI   84 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEE
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcCC------CcEE
Confidence            68999999999999999999987 677899999975433 357889999999999999999999998532      3689


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++++|.+++....    ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+.
T Consensus        85 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  157 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR  157 (279)
T ss_dssp             EEECCTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence            999999999999997642    12689999999999999999999999   9999999999999998876666 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........  .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......  ............    
T Consensus       158 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~----  229 (279)
T 1qpc_A          158 LIEDNEYTA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRM----  229 (279)
T ss_dssp             ECSSSCEEC--CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCC----
T ss_pred             cccCccccc--ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccCC----
Confidence            776543221  122357889999999988889999999999999999999 99998753221  111111110000    


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhc
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLG  851 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  851 (854)
                       .                     ....++..+.+++..||+.||++|||+.++++.|+++.....+
T Consensus       230 -~---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          230 -V---------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             -C---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             -C---------------------CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence             0                     0011245688999999999999999999999999998876543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6e-40  Score=358.97  Aligned_cols=207  Identities=26%  Similarity=0.341  Sum_probs=175.9

Q ss_pred             ccHHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-----CCCeeeEEE
Q 043388          538 ISYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-----HRNLIKIIT  612 (854)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~  612 (854)
                      +++.+.....++|.+.++||+|+||.||+|++..+++.||||+++... ...+.+.+|+++++.+.     ||||+++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            344444445678999999999999999999998899999999996432 23456788999999996     999999999


Q ss_pred             EeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe
Q 043388          613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL  692 (854)
Q Consensus       613 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  692 (854)
                      ++...+     ..++||||+ +++|.+++......    .+++.+++.++.||+.||+|||+.   +|+||||||+|||+
T Consensus       104 ~~~~~~-----~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  170 (360)
T 3llt_A          104 KFMYYD-----HMCLIFEPL-GPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILL  170 (360)
T ss_dssp             EEEETT-----EEEEEECCC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             eeeECC-----eeEEEEcCC-CCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEE
Confidence            998765     789999999 88999999876432    589999999999999999999999   99999999999999


Q ss_pred             cC-------------------------Ccccc-cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHH
Q 043388          693 DH-------------------------DMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYS  746 (854)
Q Consensus       693 ~~-------------------------~~~~~-~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~s  746 (854)
                      +.                         ++..+ +|||++........      ...||+.|+|||++.+..++.++||||
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~Diws  244 (360)
T 3llt_A          171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG------SIINTRQYRAPEVILNLGWDVSSDMWS  244 (360)
T ss_dssp             SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC------SCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred             ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCc------CccCcccccCcHHHcCCCCCCccchHH
Confidence            74                         44444 49999986544322      246899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCc
Q 043388          747 FGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       747 lGvvl~elltg~~pf~~~  764 (854)
                      |||++|||++|+.||...
T Consensus       245 lG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          245 FGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHHHHHHHSSCSCCCS
T ss_pred             HHHHHHHHHHCCCCCCCC
Confidence            999999999999999754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.2e-39  Score=347.41  Aligned_cols=248  Identities=22%  Similarity=0.293  Sum_probs=190.1

Q ss_pred             HhhccccCccCCCcceEEEEeEEC---CCceEEEEEEeeccc----ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILG---GEEMIVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLIKIITICSSIDS  619 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  619 (854)
                      .++|.+.+.||+|+||.||+|+..   .+++.||+|+++...    ......+.+|+.++++++||||+++++++...+ 
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG-   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC-
Confidence            468999999999999999999984   578999999997432    233456789999999999999999999997655 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~  699 (854)
                          ..++||||+++|+|.+++....      .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++..+
T Consensus        95 ----~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k  161 (327)
T 3a62_A           95 ----KLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK  161 (327)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred             ----EEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence                6899999999999999998654      688999999999999999999999   999999999999999887777


Q ss_pred             c-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          700 Q-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                      + |||+++........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus       162 l~Dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~  237 (327)
T 3a62_A          162 LTDFGLCKESIHDGTV---THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-KTIDKILKCK  237 (327)
T ss_dssp             ECCCSCC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTC
T ss_pred             EEeCCcccccccCCcc---ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCC
Confidence            6 99998765433221   12356999999999999989999999999999999999999999754221 1111111110


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                      .  .    ..                      ..+...+.+++.+||+.||++||     ++.|+++
T Consensus       238 ~--~----~p----------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 L--N----LP----------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             C--C----CC----------------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             C--C----CC----------------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            0  0    00                      01145578999999999999999     6777765

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=374.87  Aligned_cols=260  Identities=20%  Similarity=0.329  Sum_probs=202.0

Q ss_pred             hccccC-ccCCCcceEEEEeEEC--CCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          549 EFASSN-MIGQGSFGSVYKGILG--GEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       549 ~~~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++.+.+ .||+|+||.||+|.+.  +++..||||+++... ....+.+.+|++++++++|||||+++++|...      .
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~  409 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------A  409 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS------S
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC------C
Confidence            334444 7999999999999874  456789999997543 34567899999999999999999999998652      4


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++|+|.+++.....     .+++.+++.|+.||+.||+|||++   +|+||||||+|||++.++..++ |||
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFG  481 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFG  481 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred             eEEEEEeCCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeecc
Confidence            7999999999999999976532     689999999999999999999999   9999999999999998887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      +++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  ...+.+.....  
T Consensus       482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~--  557 (613)
T 2ozo_A          482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKR--  557 (613)
T ss_dssp             TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTTCC--
T ss_pred             CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC--
Confidence            99877544332222222346789999999998899999999999999999998 99999754221  12222111100  


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL  850 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  850 (854)
                                              ......++..+.+++..||+.||++|||+.+|++.|+.+..+..
T Consensus       558 ------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          558 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             ------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence                                    00112235678899999999999999999999999999876653

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.1e-38  Score=357.94  Aligned_cols=351  Identities=19%  Similarity=0.239  Sum_probs=237.2

Q ss_pred             ccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhh
Q 043388            4 LEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRW   83 (854)
Q Consensus         4 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~   83 (854)
                      +.+..+..++.+++|++|+|++|.+++ +| .++.+++|++|+|++|++++. |  ++.+++|++|+|++|+|+++ |  
T Consensus        30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--  101 (457)
T 3bz5_A           30 MQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--  101 (457)
T ss_dssp             CCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--
T ss_pred             cCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--
Confidence            445566678888999999999999985 45 688889999999999999854 4  88889999999999999875 3  


Q ss_pred             hcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCC
Q 043388           84 ICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSG  163 (854)
Q Consensus        84 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~  163 (854)
                      |+++++|++|+|++|+++ .+|   |..+++|++|++++|+++.+                  |  ++++++|++|++++
T Consensus       102 ~~~l~~L~~L~L~~N~l~-~l~---~~~l~~L~~L~l~~N~l~~l------------------~--l~~l~~L~~L~l~~  157 (457)
T 3bz5_A          102 VTPLTKLTYLNCDTNKLT-KLD---VSQNPLLTYLNCARNTLTEI------------------D--VSHNTQLTELDCHL  157 (457)
T ss_dssp             CTTCTTCCEEECCSSCCS-CCC---CTTCTTCCEEECTTSCCSCC------------------C--CTTCTTCCEEECTT
T ss_pred             cCCCCcCCEEECCCCcCC-eec---CCCCCcCCEEECCCCcccee------------------c--cccCCcCCEEECCC
Confidence            888999999999999988 565   67777777777777665432                  2  56678888888888


Q ss_pred             CcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCC
Q 043388          164 NQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGN  243 (854)
Q Consensus       164 N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N  243 (854)
                      |+..+..  .|..+++|++|++++|+++.++         +..+++|+.|++++|++++. +  +..++ .|+.|++++|
T Consensus       158 n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~---------l~~l~~L~~L~l~~N~l~~~-~--l~~l~-~L~~L~Ls~N  222 (457)
T 3bz5_A          158 NKKITKL--DVTPQTQLTTLDCSFNKITELD---------VSQNKLLNRLNCDTNNITKL-D--LNQNI-QLTFLDCSSN  222 (457)
T ss_dssp             CSCCCCC--CCTTCTTCCEEECCSSCCCCCC---------CTTCTTCCEEECCSSCCSCC-C--CTTCT-TCSEEECCSS
T ss_pred             CCccccc--ccccCCcCCEEECCCCccceec---------cccCCCCCEEECcCCcCCee-c--cccCC-CCCEEECcCC
Confidence            8543333  4777888888888888887542         45677888888888888753 2  55554 6888888888


Q ss_pred             cccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCC
Q 043388          244 QISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPS  323 (854)
Q Consensus       244 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  323 (854)
                      ++++ +|  +..+++|+.|++++|+++++.+.   .+++|+.|++++|              +|+.|++++|.+.+.+| 
T Consensus       223 ~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~---~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~-  281 (457)
T 3bz5_A          223 KLTE-ID--VTPLTQLTYFDCSVNPLTELDVS---TLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ-  281 (457)
T ss_dssp             CCSC-CC--CTTCTTCSEEECCSSCCSCCCCT---TCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE-
T ss_pred             cccc-cC--ccccCCCCEEEeeCCcCCCcCHH---HCCCCCEEeccCC--------------CCCEEECCCCccCCccc-
Confidence            8876 44  77778888888888888776543   4455555555444              34455566665554444 


Q ss_pred             CCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCc
Q 043388          324 SLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPF  403 (854)
Q Consensus       324 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~  403 (854)
                       ++.+++|+.|++++|...+.+|.....+..    +++++                    +++|++|+|++|++++. + 
T Consensus       282 -~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~----L~l~~--------------------~~~L~~L~L~~N~l~~l-~-  334 (457)
T 3bz5_A          282 -AEGCRKIKELDVTHNTQLYLLDCQAAGITE----LDLSQ--------------------NPKLVYLYLNNTELTEL-D-  334 (457)
T ss_dssp             -CTTCTTCCCCCCTTCTTCCEEECTTCCCSC----CCCTT--------------------CTTCCEEECTTCCCSCC-C-
T ss_pred             -ccccccCCEEECCCCcccceeccCCCcceE----echhh--------------------cccCCEEECCCCccccc-c-
Confidence             345566666666666655555532211111    11111                    23455666666666553 2 


Q ss_pred             ccccCCCCCEEEccCcccccccchhh-------------cCccCCCeeecccccCcccCCCC
Q 043388          404 SLGFMKSIKELNVSSNNLSGQIPEFL-------------QNLSFLEFLNLSYNHLEGEVPTK  452 (854)
Q Consensus       404 ~~~~l~~L~~L~Ls~N~l~~~~p~~~-------------~~l~~L~~L~ls~N~l~~~~p~~  452 (854)
                       ++.+++|+.|++++|+|++ +|. +             ..+..|..+++++|+++|.+|..
T Consensus       335 -l~~l~~L~~L~l~~N~l~~-l~~-L~~L~l~~n~l~g~~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          335 -VSHNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             -CTTCTTCSEEECCSSCCCB-CTT-GGGSSGGGTSEEEEEEEEECCCBCCBTTBEEEECCTT
T ss_pred             -cccCCcCcEEECCCCCCCC-ccc-cccccccCCcEEecceeeecCccccccCcEEEEcChh
Confidence             5556666666666666654 110 1             23456777888888888888764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4e-39  Score=348.36  Aligned_cols=266  Identities=24%  Similarity=0.384  Sum_probs=207.8

Q ss_pred             HhhccccCccCCCcceEEEEeEEC-------CCceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeecc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILG-------GEEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSI  617 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  617 (854)
                      .++|.+.+.||+|+||.||+|++.       .++..||||+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            468999999999999999999985       356789999997543 23456789999999999 899999999998765


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCcc----------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDHL----------EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKP  687 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  687 (854)
                      +     ..++||||+++|+|.+++.......          ....+++.+++.++.||+.||+|||+.   +|+||||||
T Consensus       114 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  185 (334)
T 2pvf_A          114 G-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  185 (334)
T ss_dssp             S-----CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             C-----ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence            4     6799999999999999998754210          112589999999999999999999999   999999999


Q ss_pred             CceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcc
Q 043388          688 SNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAF  765 (854)
Q Consensus       688 ~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~  765 (854)
                      +||+++.++..++ |||++.......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEE-CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEEcCCCCEEEcccccccccccccccc-ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            9999998877766 999998775543211 1122357889999999988889999999999999999999 999997532


Q ss_pred             cCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          766 TEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       766 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ..  .....+.......                          ....++..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus       265 ~~--~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          265 VE--ELFKLLKEGHRMD--------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             HH--HHHHHHHHTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH--HHHHHHhcCCCCC--------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11  1111111100000                          0112245688999999999999999999999999998


Q ss_pred             hhhh
Q 043388          846 RETF  849 (854)
Q Consensus       846 ~~~~  849 (854)
                      ....
T Consensus       317 ~~~~  320 (334)
T 2pvf_A          317 LTLT  320 (334)
T ss_dssp             HHHH
T ss_pred             Hhcc
Confidence            7654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-39  Score=347.66  Aligned_cols=274  Identities=21%  Similarity=0.322  Sum_probs=212.4

Q ss_pred             HHHHHHhhccccCccCCCcceEEEEeEE-----CCCceEEEEEEeecccc-cchHHHHHHHHHHHhc-cCCCeeeEEEEe
Q 043388          542 ELSKATSEFASSNMIGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQK-GAFRSFVAECEALRNI-RHRNLIKIITIC  614 (854)
Q Consensus       542 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~  614 (854)
                      ......++|.+.+.||+|+||.||+|++     ..+++.||||+++.... ...+.+.+|++++.++ +||||+++++++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            3334467899999999999999999985     34678999999975432 2346789999999999 799999999998


Q ss_pred             eccCCCCCceeeEEEeeccCCCHHHHhhhcCCccc----------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 043388          615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----------VCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGD  684 (854)
Q Consensus       615 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  684 (854)
                      ...+    ...++||||+++|+|.+++........          ...+++.+++.++.|++.||+|||+.   +|+|||
T Consensus       101 ~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d  173 (316)
T 2xir_A          101 TKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  173 (316)
T ss_dssp             CCTT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             ecCC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            7543    247999999999999999987643110          11388999999999999999999999   999999


Q ss_pred             CCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 043388          685 LKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTD  762 (854)
Q Consensus       685 lkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~  762 (854)
                      |||+||+++.++..++ |||.++......... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CccceEEECCCCCEEECCCccccccccCccce-eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999998876666 999998765433221 1223457889999999988899999999999999999998 999997


Q ss_pred             CcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 043388          763 AAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL  842 (854)
Q Consensus       763 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  842 (854)
                      ....... .............                          ...++..+.+++.+||+.||.+|||+.|+++.|
T Consensus       253 ~~~~~~~-~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  305 (316)
T 2xir_A          253 GVKIDEE-FCRRLKEGTRMRA--------------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  305 (316)
T ss_dssp             TCCCSHH-HHHHHHHTCCCCC--------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccchhHH-HHHHhccCccCCC--------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            5432211 1111111100000                          011144578899999999999999999999999


Q ss_pred             Hhhhhhhh
Q 043388          843 CHTRETFL  850 (854)
Q Consensus       843 ~~~~~~~~  850 (854)
                      +++.+...
T Consensus       306 ~~~~~~~~  313 (316)
T 2xir_A          306 GNLLQANA  313 (316)
T ss_dssp             HHHHHHHC
T ss_pred             HHHHhhhc
Confidence            99887643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.3e-40  Score=353.33  Aligned_cols=274  Identities=21%  Similarity=0.295  Sum_probs=196.0

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|.+.+.||+|+||.||+|++..+++.||+|+++..... ....+.+|++++++++||||+++++++...+     ..+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-----CEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-----EEE
Confidence            5799999999999999999999989999999999644321 1224557999999999999999999997655     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++ +|.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        77 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  147 (324)
T 3mtl_A           77 LVFEYLDK-DLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA  147 (324)
T ss_dssp             EEEECCSE-EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred             EEeccccc-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence            99999975 99999887542     688999999999999999999999   9999999999999998877766 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh---hcCCc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK---MTLPE  781 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~---~~~~~  781 (854)
                      ..........   ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .......   .....
T Consensus       148 ~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  223 (324)
T 3mtl_A          148 RAKSIPTKTY---DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEE  223 (324)
T ss_dssp             ECC---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTT
T ss_pred             ccccCCcccc---ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChH
Confidence            8665433222   22468999999999877 568999999999999999999999998643221 1111111   11111


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .+................ ............+...+.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          224 TWPGILSNEEFKTYNYPK-YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TSTTGGGCHHHHHTCCCC-CCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hchhhhcchhhccccccc-ccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            121111111100000000 0000001111223456789999999999999999999987

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.2e-39  Score=337.98  Aligned_cols=257  Identities=23%  Similarity=0.327  Sum_probs=202.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc------cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++....      ...+.+.+|+.++++++||||+++++++....  
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   81 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT--   81 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC--
Confidence            3679999999999999999999998999999999975421      23578999999999999999999999997654  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc----
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----  696 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----  696 (854)
                         ..++||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++    
T Consensus        82 ---~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~  149 (283)
T 3bhy_A           82 ---DVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNP  149 (283)
T ss_dssp             ---EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSC
T ss_pred             ---eEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCC
Confidence               6899999999999999997654      689999999999999999999999   999999999999998775    


Q ss_pred             -ccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          697 -VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       697 -~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                       ++++|||.+.........    ....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+.
T Consensus       150 ~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~  224 (283)
T 3bhy_A          150 RIKLIDFGIAHKIEAGNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTNIS  224 (283)
T ss_dssp             CEEECCCTTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHH
T ss_pred             ceEEEecccceeccCCCcc----cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHHhH
Confidence             344599999876543322    22458999999999998899999999999999999999999997542110 111111


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH--HHHhhh
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA--KLCHTR  846 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~~~  846 (854)
                      .....      .+                  ......++..+.+++.+||+.||++|||+.|+++  .++.+.
T Consensus       225 ~~~~~------~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          225 AVNYD------FD------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             TTCCC------CC------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             hcccC------Cc------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            00000      00                  0011122456889999999999999999999997  344443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.3e-39  Score=365.15  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=204.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|.+.++||+|+||.||+|++..+++.||+|++...   .......+.+|++++++++||||+++++++.+.+     
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-----  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC-----
Confidence            46799999999999999999999999999999999643   2334567889999999999999999999987655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+||||++||+|.+++......    .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++..++ ||
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~----~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF  330 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQA----GFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL  330 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence            789999999999999999865421    589999999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCc--hHhHHhhhcCC
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL--TLHEFVKMTLP  780 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~--~~~~~~~~~~~  780 (854)
                      |+++.......    ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........  .+...+.. .+
T Consensus       331 Gla~~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~  405 (576)
T 2acx_A          331 GLAVHVPEGQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VP  405 (576)
T ss_dssp             TTCEECCTTCC----EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CC
T ss_pred             ccceecccCcc----ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-cc
Confidence            99987754322    1234799999999999998899999999999999999999999986432211  11111110 01


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                      ....                          ..++..+.+++.+||+.||++||     +++||++
T Consensus       406 ~~~p--------------------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 EEYS--------------------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCC--------------------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ccCC--------------------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            1000                          11245578999999999999999     6788865

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-39  Score=366.32  Aligned_cols=248  Identities=23%  Similarity=0.299  Sum_probs=192.8

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|++.++||+|+||.||+|++..+++.||||+++..   .......+.+|+.+++.++||||+++++++...+     
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-----  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-----
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-----
Confidence            46899999999999999999999999999999999743   3334466788999999999999999999998765     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCceEecCCccccc-c
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ..++||||+++|+|.+++....      .+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++..++ |
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D  292 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD  292 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred             EEEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence            6899999999999999998754      78999999999999999999998 7   9999999999999998887776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||+++........   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+.... .
T Consensus       293 FG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~-~  366 (446)
T 4ejn_A          293 FGLCKEGIKDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMEE-I  366 (446)
T ss_dssp             CCCCCTTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC-C
T ss_pred             CCCceeccCCCcc---cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHHhCC-C
Confidence            9999864433222   22357999999999999999999999999999999999999999753211  1111111000 0


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                      ..                          +..++..+.+++.+||+.||.+||     |++|+++
T Consensus       367 ~~--------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 RF--------------------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CC--------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC--------------------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            00                          001144578999999999999999     9999976

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.3e-39  Score=364.12  Aligned_cols=258  Identities=27%  Similarity=0.436  Sum_probs=201.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||.||+|.+.+ +..||||+++.... ..+.+.+|++++++++||||+++++++.. +     ..+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~-----~~~  254 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-----PIY  254 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-----SCE
T ss_pred             hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C-----ceE
Confidence            4678999999999999999999984 56799999975443 35789999999999999999999999864 2     479


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++.....    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++..++ |||++
T Consensus       255 iv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEehhhcCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccc
Confidence            99999999999999975421    2589999999999999999999999   9999999999999998877776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +.........  .....+|..|+|||++.+..++.++|||||||++|||++ |+.||......  .....+.....    
T Consensus       328 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~----  399 (452)
T 1fmk_A          328 RLIEDNEYTA--RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYR----  399 (452)
T ss_dssp             C----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC----
T ss_pred             eecCCCceec--ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC----
Confidence            8765432221  122357889999999988899999999999999999999 99999754211  11111111000    


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                                            .+....++..+.+++.+||+.||++|||++++++.|+++....
T Consensus       400 ----------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          400 ----------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                                  0011123566889999999999999999999999999886543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.3e-39  Score=375.89  Aligned_cols=253  Identities=25%  Similarity=0.336  Sum_probs=199.2

Q ss_pred             CccCCCcceEEEEeEE--CCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGIL--GGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      +.||+|+||.||+|.+  ..+++.||||+++...  ....+.+.+|++++++++|||||+++++|...      ..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------CEEEEE
Confidence            4799999999999965  4567899999997543  23457899999999999999999999998542      368999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++.+++.|+.||+.||+|||++   +|+||||||+|||++.++..++ |||+++.+
T Consensus       449 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             EccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            9999999999997654      689999999999999999999999   9999999999999999887766 99999887


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccccc
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV  787 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  787 (854)
                      ..............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  ...+.+......      
T Consensus       520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~~------  591 (635)
T 4fl3_A          520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERM------  591 (635)
T ss_dssp             TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCC------
T ss_pred             ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC------
Confidence            654433222333457889999999998899999999999999999998 99999754221  111111111000      


Q ss_pred             CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       788 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                                          .....++.++.+++..||+.||++|||+.+|+++|+++..++
T Consensus       592 --------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          592 --------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                                011123566889999999999999999999999999987664

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.9e-39  Score=338.84  Aligned_cols=257  Identities=19%  Similarity=0.317  Sum_probs=205.2

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC------
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS------  619 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------  619 (854)
                      ...+|++.+.||+|+||.||+|++..+++.||+|+++...    +.+.+|++++++++||||+++++++.....      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4578999999999999999999999899999999997543    356789999999999999999998854211      


Q ss_pred             -----CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC
Q 043388          620 -----KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH  694 (854)
Q Consensus       620 -----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~  694 (854)
                           ......++||||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                 112357999999999999999986532    2689999999999999999999999   9999999999999998


Q ss_pred             Cccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhH
Q 043388          695 DMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHE  773 (854)
Q Consensus       695 ~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~  773 (854)
                      ++..++ |||.+.........    ....||+.|+|||++.+..++.++|||||||++|||++|..|+...       ..
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~  226 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGKR----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SK  226 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSCC----CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HH
T ss_pred             CCCEEECcchhheeccccccc----cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HH
Confidence            877666 99999877654322    2245899999999999989999999999999999999999886421       01


Q ss_pred             HhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043388          774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL  850 (854)
Q Consensus       774 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  850 (854)
                      ...........                          ..++..+.+++.+||+.||++|||+.|+++.++.+.....
T Consensus       227 ~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          227 FFTDLRDGIIS--------------------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHHHTTCCC--------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHHHhhccccc--------------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            11100000000                          0113457789999999999999999999999998876543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.7e-39  Score=340.95  Aligned_cols=251  Identities=23%  Similarity=0.263  Sum_probs=198.8

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ..++|.+.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|+.++++++||||+++++++.+.+     ..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   81 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT-----HY   81 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS-----EE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC-----EE
Confidence            3568999999999999999999999899999999998655445567889999999999999999999987655     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe---cCCccccc-c
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHQ-N  701 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~~~-D  701 (854)
                      ++||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||++   +.++..++ |
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             EEEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEcc
Confidence            99999999999999997654      688999999999999999999999   99999999999999   55555555 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||.+.......     .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......
T Consensus       153 fg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~  226 (304)
T 2jam_A          153 FGLSKMEQNGI-----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-KLFEKIKEGYYEF  226 (304)
T ss_dssp             CSTTCCCCCBT-----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHCCCCC
T ss_pred             CCcceecCCCc-----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCC
Confidence            99987554321     11235899999999999999999999999999999999999999754221 1111111111000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                           ..                   .....++..+.+++.+||+.||++|||+.|+++
T Consensus       227 -----~~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          227 -----ES-------------------PFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             -----CT-------------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             -----Cc-------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 00                   000112456789999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-39  Score=352.14  Aligned_cols=275  Identities=21%  Similarity=0.276  Sum_probs=197.8

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC-CCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK-GADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  624 (854)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|++++++++||||+++++++...... ....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            57999999999999999999999899999999985432  22346788999999999999999999998765321 2234


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+||||+ +++|.+++...       .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus       105 ~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence            69999999 78999998763       678999999999999999999999   9999999999999999877766 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh--cCC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM--TLP  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~--~~~  780 (854)
                      +++......      ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+......  ..+
T Consensus       174 ~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          174 LARQADSEM------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPP  246 (367)
T ss_dssp             TCEECCSSC------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCC
T ss_pred             ccccccccc------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence            998765432      23468999999999877 67999999999999999999999999854321 111122111  111


Q ss_pred             cccccccCchhhHHHhhccchh-hHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMI-QEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ......+.......+....... ...-......+...+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            1111111111111111100000 00000111223556889999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3e-39  Score=342.40  Aligned_cols=263  Identities=27%  Similarity=0.360  Sum_probs=196.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECC---CceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG---EEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|++.+.||+|+||.||+|++..   .+..||||+++..   .....+.+.+|++++++++||||+++++++....  
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP--   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence            3689999999999999999998632   2347999998654   2334578899999999999999999999986533  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                          .++||||+++|+|.+++.....     .+++.++..++.|++.||+|||++   +|+||||||+||+++.++..++
T Consensus        95 ----~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl  162 (291)
T 1u46_A           95 ----MKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI  162 (291)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred             ----ceeeEecccCCCHHHHHHhccC-----CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEE
Confidence                6899999999999999986532     689999999999999999999999   9999999999999988876666


Q ss_pred             -ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhc
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~  778 (854)
                       |||.+.................+|..|+|||++.+..++.++||||||+++|||++ |+.||....... .........
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~~~  241 (291)
T 1u46_A          163 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKIDKEG  241 (291)
T ss_dssp             CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTSC
T ss_pred             ccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-HHHHHHccC
Confidence             99999887654432222223457889999999988889999999999999999999 999997542210 111111100


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL  850 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  850 (854)
                      ...                          .....++..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       242 ~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  287 (291)
T 1u46_A          242 ERL--------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM  287 (291)
T ss_dssp             CCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             CCC--------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence            000                          0001224568899999999999999999999999998876543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.6e-38  Score=345.44  Aligned_cols=258  Identities=24%  Similarity=0.351  Sum_probs=204.5

Q ss_pred             HHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc--------chHHHHHHHHHHHhc-cCCCeeeE
Q 043388          540 YAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--------AFRSFVAECEALRNI-RHRNLIKI  610 (854)
Q Consensus       540 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~~  610 (854)
                      +.......++|.+.+.||+|+||.||+|++..+|+.||||+++.....        ..+.+.+|+.+++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            444555678899999999999999999999888999999999754321        145678999999999 89999999


Q ss_pred             EEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCce
Q 043388          611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV  690 (854)
Q Consensus       611 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  690 (854)
                      ++++....     ..++||||+++++|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||
T Consensus       166 ~~~~~~~~-----~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NI  231 (365)
T 2y7j_A          166 IDSYESSS-----FMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENI  231 (365)
T ss_dssp             EEEEEBSS-----EEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEEEeeCC-----EEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            99987655     7899999999999999998654      689999999999999999999999   999999999999


Q ss_pred             EecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCC------CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 043388          691 LLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG------SEASMTGDVYSFGILLLEMFTGRRPTDA  763 (854)
Q Consensus       691 ll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~slGvvl~elltg~~pf~~  763 (854)
                      +++.++..++ |||++.........    ....||+.|+|||++.+      ..++.++|||||||++|||++|+.||..
T Consensus       232 l~~~~~~ikl~DfG~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          232 LLDDNMQIRLSDFGFSCHLEPGEKL----RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             EECTTCCEEECCCTTCEECCTTCCB----CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EECCCCCEEEEecCcccccCCCccc----ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence            9999877666 99999877654322    23569999999998753      3588999999999999999999999975


Q ss_pred             cccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          764 AFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       764 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .... ..............                        .+....++..+.+++.+||+.||++|||+.|+++
T Consensus       308 ~~~~-~~~~~i~~~~~~~~------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          308 RRQI-LMLRMIMEGQYQFS------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             SSHH-HHHHHHHHTCCCCC------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHH-HHHHHHHhCCCCCC------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            3211 00111111000000                        0001122456889999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.4e-39  Score=337.16  Aligned_cols=246  Identities=22%  Similarity=0.349  Sum_probs=201.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|.+.+.||+|+||.||+|++..++..||+|++...   .....+.+.+|++++++++||||+++++++.+.+     
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK-----   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-----
Confidence            46899999999999999999999989999999999643   2334567899999999999999999999987654     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df  158 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF  158 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence            7899999999999999998754      688999999999999999999999   9999999999999998877666 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |.+........     ....|++.|+|||++.+..++.++||||||+++|||++|+.||....... ..........  .
T Consensus       159 g~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~--~  230 (284)
T 2vgo_A          159 GWSVHAPSLRR-----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVNVDL--K  230 (284)
T ss_dssp             TTCEECSSSCB-----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCC--C
T ss_pred             cccccCccccc-----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-HHHHHhcccc--C
Confidence            99876644221     22468999999999999899999999999999999999999997542111 0111111000  0


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                          ..                      ..++..+.+++.+|++.||.+|||+.|+++
T Consensus       231 ----~~----------------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          231 ----FP----------------------PFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ----CC----------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CC----------------------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                00                      011345778999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.7e-39  Score=348.00  Aligned_cols=264  Identities=18%  Similarity=0.225  Sum_probs=191.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCC---CCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDS---KGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~---~~~~  623 (854)
                      .+|++.++||+|+||.||+|++..+++.||||++........+.+.+|+.++.++. ||||+++++++.....   ....
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            47999999999999999999999899999999997666556678899999999995 9999999999853321   2334


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCceEecCCccccc-
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--IVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                      ..++||||++ |+|.+++......   ..+++.+++.++.||+.||+|||+.   +  |+||||||+||+++.++..++ 
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTT---CSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             eEEEEEEecC-CCHHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence            5799999996 6999998763211   2689999999999999999999999   7  999999999999999877776 


Q ss_pred             ccccccccccCCCCC---------CcccccCCcccccCcccc---CCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC
Q 043388          701 NFSLSHQLDSASKTP---------SSSIGIKGTVGYVAPEYG---MGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG  768 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~  768 (854)
                      |||++..........         .......||+.|+|||++   .+..++.++|||||||++|||++|+.||...... 
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-  259 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-  259 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-
Confidence            999998776533211         111134589999999998   5667899999999999999999999999743211 


Q ss_pred             chHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       769 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                          ............                          ..+...+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       260 ----~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          260 ----RIVNGKYSIPPH--------------------------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ----------CCCCTT--------------------------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HhhcCcccCCcc--------------------------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                111110000000                          00122366899999999999999999999999988764


Q ss_pred             h
Q 043388          849 F  849 (854)
Q Consensus       849 ~  849 (854)
                      .
T Consensus       310 ~  310 (337)
T 3ll6_A          310 R  310 (337)
T ss_dssp             T
T ss_pred             c
Confidence            3

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=353.06  Aligned_cols=268  Identities=14%  Similarity=0.172  Sum_probs=204.6

Q ss_pred             hhccccCccCCCcceEEEEeEECC--------CceEEEEEEeecccccchHHHHHHHHHHHhccCCCeee----------
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG--------EEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK----------  609 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------  609 (854)
                      ++|.+.+.||+|+||.||+|++..        +++.||+|++...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            589999999999999999999986        4789999998744     45789999999999999987          


Q ss_pred             -----EEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 043388          610 -----IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGD  684 (854)
Q Consensus       610 -----~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  684 (854)
                           +++++...+    ...++||||+ +++|.+++.....    ..+++.+++.|+.||+.||+|||++   +|+|||
T Consensus       117 ~~i~~~~~~~~~~~----~~~~lv~e~~-~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D  184 (352)
T 2jii_A          117 LAIPTCMGFGVHQD----KYRFLVLPSL-GRSLQSALDVSPK----HVLSERSVLQVACRLLDALEFLHEN---EYVHGN  184 (352)
T ss_dssp             CSCCCCCEEEEETT----TEEEEEEECC-CEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSC
T ss_pred             cCccchhhccccCC----cEEEEEecCC-CcCHHHHHHhCCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCC
Confidence                 566655422    2689999999 9999999987521    2789999999999999999999999   999999


Q ss_pred             CCCCceEecCCc--cccc-ccccccccccCCCCC----CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhC
Q 043388          685 LKPSNVLLDHDM--VAHQ-NFSLSHQLDSASKTP----SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTG  757 (854)
Q Consensus       685 lkp~NIll~~~~--~~~~-Dfg~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg  757 (854)
                      |||+||+++.++  ..++ |||+++.........    .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  264 (352)
T 2jii_A          185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG  264 (352)
T ss_dssp             CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence            999999999986  4554 999998776543211    112234799999999999998999999999999999999999


Q ss_pred             CCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHH
Q 043388          758 RRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRD  837 (854)
Q Consensus       758 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e  837 (854)
                      +.||................. ........+...                 ....++..+.+++.+||+.||++|||++|
T Consensus       265 ~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~  326 (352)
T 2jii_A          265 FLPWTNCLPNTEDIMKQKQKF-VDKPGPFVGPCG-----------------HWIRPSETLQKYLKVVMALTYEEKPPYAM  326 (352)
T ss_dssp             CCTTGGGTTCHHHHHHHHHHH-HHSCCCEECTTS-----------------CEECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             CCCcccCCcCHHHHHHHHHhc-cCChhhhhhhcc-----------------ccCCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence            999986532222222211110 000000000000                 00011456889999999999999999999


Q ss_pred             HHHHHHhhhhhhh
Q 043388          838 VVAKLCHTRETFL  850 (854)
Q Consensus       838 vl~~L~~~~~~~~  850 (854)
                      +++.|+++.+...
T Consensus       327 l~~~L~~~~~~~~  339 (352)
T 2jii_A          327 LRNNLEALLQDLR  339 (352)
T ss_dssp             HHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcC
Confidence            9999999987653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.8e-39  Score=337.65  Aligned_cols=254  Identities=30%  Similarity=0.387  Sum_probs=197.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||.||+|.+.  ++.||||+++...  ..+.+.+|++++++++||||+++++++....    ...+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----CceE
Confidence            468999999999999999999885  7789999986443  4578899999999999999999999875533    2579


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++.....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        92 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEEecCCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence            99999999999999986531    2478999999999999999999999   9999999999999998877766 99998


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      .........      ..+++.|+|||.+.+..++.++||||||+++|||+| |+.||......  .....+.......  
T Consensus       165 ~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~--  234 (278)
T 1byg_A          165 KEASSTQDT------GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMD--  234 (278)
T ss_dssp             -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCCCC--
T ss_pred             ccccccccC------CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCCCC--
Confidence            866543221      247889999999988889999999999999999998 99999754221  1111111100000  


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                                              ....++..+.+++..||+.||++|||+.|+++.|+++....
T Consensus       235 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          235 ------------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             ------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ------------------------CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence                                    00112456889999999999999999999999999987653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=352.68  Aligned_cols=257  Identities=14%  Similarity=0.118  Sum_probs=200.2

Q ss_pred             HhhccccCccCCCcceEEEEeE-----ECCCceEEEEEEeecccccchHHHHHHHHHHHhcc---CCCeeeEEEEeeccC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGI-----LGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR---HRNLIKIITICSSID  618 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~  618 (854)
                      .++|.+.++||+|+||.||+|.     ...+++.||||+++..   ....+.+|++++++++   |+||+++++++...+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            4679999999999999999994     5567889999999644   3456788888888886   999999999997765


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC----
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH----  694 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----  694 (854)
                           ..++||||+++|+|.+++...... ....+++.+++.|+.||+.||+|||++   +|+||||||+|||++.    
T Consensus       141 -----~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          141 -----GSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             -----CEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTC
T ss_pred             -----CcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccC
Confidence                 679999999999999999864221 112689999999999999999999999   9999999999999987    


Q ss_pred             -------Cccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCccc
Q 043388          695 -------DMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFT  766 (854)
Q Consensus       695 -------~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~  766 (854)
                             ++..++ |||+|+.+...... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKG-TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTT-EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCC-ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                   565655 99999876533221 122345799999999999999999999999999999999999999864322


Q ss_pred             CCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCC-CCHHHHHHHHHhh
Q 043388          767 EGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFER-MEMRDVVAKLCHT  845 (854)
Q Consensus       767 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~evl~~L~~~  845 (854)
                      ......        .......                     .    .+.+.+++..|++.+|.+| |+++++.+.|++.
T Consensus       291 ~~~~~~--------~~~~~~~---------------------~----~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          291 GECKPE--------GLFRRLP---------------------H----LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             TEEEEC--------SCCTTCS---------------------S----HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             Cceeec--------hhccccC---------------------c----HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            111000        0000000                     0    3346678889999999998 6788888888887


Q ss_pred             hhhh
Q 043388          846 RETF  849 (854)
Q Consensus       846 ~~~~  849 (854)
                      .+..
T Consensus       338 l~~~  341 (365)
T 3e7e_A          338 FQQH  341 (365)
T ss_dssp             HHHH
T ss_pred             HHHh
Confidence            6654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.5e-38  Score=346.45  Aligned_cols=285  Identities=22%  Similarity=0.300  Sum_probs=203.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC---CC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDS---KG  621 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  621 (854)
                      .++|++.+.||+|+||.||+|++..+++.||||++....  ......+.+|++++++++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999999899999999986443  2334678899999999999999999999876431   11


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                      ....++||||+++ ++.+.+.....     .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ 
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence            2368999999976 88887765432     689999999999999999999999   9999999999999998877776 


Q ss_pred             ccccccccccCCCC-CCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh--
Q 043388          701 NFSLSHQLDSASKT-PSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK--  776 (854)
Q Consensus       701 Dfg~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~--  776 (854)
                      |||+++.+...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .......  
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~  245 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLC  245 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence            99999877543322 122234568999999999876 458999999999999999999999998643221 1111111  


Q ss_pred             hcCCcccccccC-chhhHHHhhccc-hhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          777 MTLPEKVIEIVD-PSLLMEVMANNS-MIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       777 ~~~~~~~~~~~d-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...+.......+ ............ ................+.+++.+||+.||++|||++|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            111111111111 000000000000 00000000000113557899999999999999999999863

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.6e-39  Score=339.72  Aligned_cols=249  Identities=18%  Similarity=0.290  Sum_probs=202.8

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+     
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-----   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC-----
Confidence            367999999999999999999999899999999987542   234567889999999999999999999997655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence            7899999999999999987654      689999999999999999999999   9999999999999998877766 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |.+..........   ....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..........  .
T Consensus       160 g~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~  233 (294)
T 2rku_A          160 GLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNEY--S  233 (294)
T ss_dssp             TTCEECCSTTCCB---CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCC--C
T ss_pred             cCceecccCcccc---ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhccC--C
Confidence            9998765433221   22468999999999999889999999999999999999999997542111 0111110000  0


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .                          ...+...+.+++.+||+.||++|||+.|+++.
T Consensus       234 ~--------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          234 I--------------------------PKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             C--------------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             C--------------------------ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0                          00113457789999999999999999999874

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-39  Score=351.59  Aligned_cols=277  Identities=22%  Similarity=0.292  Sum_probs=197.3

Q ss_pred             HHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-----cchHHHHHHHHHHHhccCCCeeeEEEEeeccC
Q 043388          544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-----GAFRSFVAECEALRNIRHRNLIKIITICSSID  618 (854)
Q Consensus       544 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  618 (854)
                      ....++|.+.+.||+|+||.||+|++..+++.||||+++....     ...+.+.+|++++++++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            3446789999999999999999999998899999999964321     12356889999999999999999999987654


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccc
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA  698 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  698 (854)
                           ..++||||+++ +|.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..
T Consensus        86 -----~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  151 (346)
T 1ua2_A           86 -----NISLVFDFMET-DLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVL  151 (346)
T ss_dssp             -----CCEEEEECCSE-EHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             -----ceEEEEEcCCC-CHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCE
Confidence                 67999999986 89998876542     678889999999999999999999   99999999999999998877


Q ss_pred             cc-ccccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh
Q 043388          699 HQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK  776 (854)
Q Consensus       699 ~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~  776 (854)
                      ++ |||+++.........   ....||+.|+|||++.+. .++.++|||||||++|||++|.+||....... .+.....
T Consensus       152 kl~Dfg~a~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~  227 (346)
T 1ua2_A          152 KLADFGLAKSFGSPNRAY---THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFE  227 (346)
T ss_dssp             EECCCGGGSTTTSCCCCC---CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred             EEEecccceeccCCcccC---CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHH
Confidence            76 999998775433222   234689999999998764 48999999999999999999999987643221 1222221


Q ss_pred             hc---CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          777 MT---LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       777 ~~---~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..   ....+.+....   .+..................+...+.+++.+||+.||++|||+.|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          228 TLGTPTEEQWPDMCSL---PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHCCCCTTTSSSTTSS---TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HcCCCChhhhhhhccC---cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            11   11111110000   0000000000000000112234668899999999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=338.39  Aligned_cols=252  Identities=21%  Similarity=0.310  Sum_probs=195.2

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      +|....+||+|+||.||+|++..+++.||||++........+.+.+|+.+++.++||||+++++++...+     ..++|
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv   97 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-----FIKIF   97 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-----cEEEE
Confidence            3444568999999999999999899999999998766666678999999999999999999999997655     68999


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC-Cccccc-cccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHQ-NFSLSH  706 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~~~-Dfg~~~  706 (854)
                      |||+++++|.+++......   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++. ++..++ |||.+.
T Consensus        98 ~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGP---LKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCC---CTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             EEeCCCCCHHHHHHhhccC---CCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence            9999999999999875321   2567888999999999999999999   9999999999999986 555555 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSE--ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      ........   .....||+.|+|||++.+..  ++.++|||||||++|||++|+.||...................... 
T Consensus       172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  247 (295)
T 2clq_A          172 RLAGINPC---TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI-  247 (295)
T ss_dssp             ESCC--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCC-
T ss_pred             ccCCCCCc---ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccc-
Confidence            76543221   12246899999999987643  8899999999999999999999996432211111110000000000 


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                                               ...++.++.+++.+||+.||++|||+.|+++
T Consensus       248 -------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          248 -------------------------PESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -------------------------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                                     0112456788999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-39  Score=350.79  Aligned_cols=277  Identities=22%  Similarity=0.302  Sum_probs=199.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc--chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||.||+|++..+++.||||++......  ..+.+.+|++++++++||||+++++++...+     .
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK-----R   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-----E
Confidence            46899999999999999999999989999999998654332  2456789999999999999999999997655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++++|.++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  169 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG  169 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence            899999999999988876544      689999999999999999999999   9999999999999998877766 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC--C
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL--P  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~--~  780 (854)
                      .+..........   ....||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ..........  .
T Consensus       170 ~~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~  245 (331)
T 4aaa_A          170 FARTLAAPGEVY---DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLI  245 (331)
T ss_dssp             TC---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCC
T ss_pred             CceeecCCcccc---CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCC
Confidence            998765433221   124689999999998875 68999999999999999999999997643221 1111111000  0


Q ss_pred             cccccccCchh-hHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSL-LMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ........... .....................++..+.+++.+||+.||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00000000000 00000000000000011112335678999999999999999999999764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4e-39  Score=352.28  Aligned_cols=199  Identities=26%  Similarity=0.399  Sum_probs=174.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|.+.+.||+|+||.||+|.+..++..||+|+++... ....+.+.+|+.++++++||||+++++++...+     ..+
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~  107 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EIS  107 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT-----EEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC-----EEE
Confidence            57999999999999999999999999999999997653 333567899999999999999999999998755     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++....      .+++..+..++.|++.||+|||+.+  +|+||||||+||+++.++..++ |||++
T Consensus       108 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  179 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS  179 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             EEEECCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCC
Confidence            9999999999999998764      6889999999999999999999842  7999999999999998877766 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      .........     ...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       180 ~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          180 GQLIDSMAN-----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             HHHHHHC---------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             ccccccccc-----CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            766433221     246999999999999999999999999999999999999999754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.9e-38  Score=359.44  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=201.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|.+.++||+|+||.||+|++..+++.||+|++...   .....+.+.+|++++++++||||+++++++.+..     
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT-----  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC-----
Confidence            36899999999999999999999989999999999643   2344567899999999999999999999987655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+||||++||+|.+++......  ...+++..++.++.||+.||+|||++   +|+||||||+||+++.++..++ ||
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DF  333 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL  333 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeec
Confidence            789999999999999999765321  12689999999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+++........   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...++........
T Consensus       334 Gla~~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~~~  409 (543)
T 3c4z_A          334 GLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLEQA  409 (543)
T ss_dssp             TTCEECCTTCCC---BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHHCC
T ss_pred             ceeeeccCCCcc---cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhhcc
Confidence            999877544322   223579999999999999999999999999999999999999998643211 1111111110000


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM  835 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~  835 (854)
                      . .                       .+..++..+.+++.+||+.||++||++
T Consensus       410 ~-~-----------------------~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 V-T-----------------------YPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             C-C-----------------------CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             c-C-----------------------CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence            0 0                       001124557889999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.8e-39  Score=345.53  Aligned_cols=263  Identities=26%  Similarity=0.395  Sum_probs=204.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEE--EEEEeecc-cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIV--AVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|.+.+.||+|+||.||+|++..++..+  |+|+++.. .....+.+.+|+++++++ +||||+++++++...+    
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----   99 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----   99 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT----
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC----
Confidence            368999999999999999999998777755  99988643 233456789999999999 9999999999997655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL  692 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  692 (854)
                       ..++||||+++|+|.+++......          .....+++.+++.++.|++.||+|||+.   +|+||||||+||++
T Consensus       100 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~  175 (327)
T 1fvr_A          100 -YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV  175 (327)
T ss_dssp             -EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             -ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEE
Confidence             789999999999999999865310          0112689999999999999999999999   99999999999999


Q ss_pred             cCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCch
Q 043388          693 DHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLT  770 (854)
Q Consensus       693 ~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~  770 (854)
                      +.++..++ |||+++........    ....+++.|+|||++.+..++.++|||||||++|||++ |+.||......  .
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~  249 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--E  249 (327)
T ss_dssp             CGGGCEEECCTTCEESSCEECCC--------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H
T ss_pred             cCCCeEEEcccCcCccccccccc----cCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--H
Confidence            98876666 99998754332221    12347889999999988889999999999999999998 99999754211  1


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ............                          ....++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       250 ~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          250 LYEKLPQGYRLE--------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HHHHGGGTCCCC--------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHhhcCCCCC--------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            111111000000                          00112456889999999999999999999999999987654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.8e-38  Score=354.95  Aligned_cols=263  Identities=20%  Similarity=0.276  Sum_probs=203.8

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCC-CeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR-NLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|.+.++||+|+||.||+|++..+++.||||++......  ..+.+|+++++.++|+ ++..+..++...+     ..+
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~-----~~~   79 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGD-----YNV   79 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETT-----EEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC-----EEE
Confidence            6899999999999999999999889999999998754432  4578999999999875 4545544444333     679


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe---cCCcccc-ccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAH-QNF  702 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~~-~Df  702 (854)
                      +||||+ +++|.+++.....     .+++.+++.|+.||+.||+|||++   +|+||||||+|||+   +.++..+ +||
T Consensus        80 lvme~~-g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DF  150 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEECC-CCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeC
Confidence            999999 8899999986432     689999999999999999999999   99999999999999   4555555 499


Q ss_pred             ccccccccCCCCC----CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch--HhHHhh
Q 043388          703 SLSHQLDSASKTP----SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT--LHEFVK  776 (854)
Q Consensus       703 g~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~--~~~~~~  776 (854)
                      |+++.+.......    .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  +..+..
T Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (483)
T 3sv0_A          151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE  230 (483)
T ss_dssp             TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred             CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence            9998876543321    1122467999999999999999999999999999999999999999864322110  011000


Q ss_pred             hcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       777 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ...                       ..........++.++.+++..||+.||++||++.+|++.|+++....
T Consensus       231 ~~~-----------------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          231 KKV-----------------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHH-----------------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccc-----------------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            000                       00001111233567899999999999999999999999999987643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.5e-39  Score=346.09  Aligned_cols=249  Identities=18%  Similarity=0.290  Sum_probs=202.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+     
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-----  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----
Confidence            368999999999999999999999899999999997542   234567889999999999999999999997655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++++|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  185 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF  185 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence            7899999999999999987654      689999999999999999999999   9999999999999999877666 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |.+..........   ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........  .
T Consensus       186 g~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~--~  259 (335)
T 2owb_A          186 GLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNEY--S  259 (335)
T ss_dssp             TTCEECCSTTCCB---CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCC--C
T ss_pred             cCceecccCcccc---cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcCCC--C
Confidence            9998775433221   23469999999999999889999999999999999999999997532111 0111111000  0


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .                          ...+...+.+++.+||+.||++|||+.|+++.
T Consensus       260 ~--------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          260 I--------------------------PKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             C--------------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             C--------------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0                          00113457789999999999999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.5e-39  Score=346.07  Aligned_cols=278  Identities=20%  Similarity=0.276  Sum_probs=195.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC--------
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS--------  619 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--------  619 (854)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++.....        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            579999999999999999999998999999999987666666789999999999999999999999854321        


Q ss_pred             -CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec-CCcc
Q 043388          620 -KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMV  697 (854)
Q Consensus       620 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~  697 (854)
                       ......++||||++ |+|.+++...       .+++..++.++.|++.||+|||+.   +|+||||||+||+++ .++.
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred             ccccCceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence             12346899999998 5999998653       678999999999999999999999   999999999999997 4445


Q ss_pred             ccc-ccccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          698 AHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                      .++ |||.++................+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~  238 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQMQLIL  238 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence            554 99999877543322222233457999999998765 67899999999999999999999999854321 1111111


Q ss_pred             hhcCCc--c-cccccC--chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          776 KMTLPE--K-VIEIVD--PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       776 ~~~~~~--~-~~~~~d--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ......  . ..+...  +..........   ..........++.++.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEP---HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSC---CCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCC---CCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            111000  0 000000  00000000000   00000111223567899999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.4e-39  Score=347.68  Aligned_cols=271  Identities=18%  Similarity=0.209  Sum_probs=200.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|++.+.||+|+||.||+|++..+++.||||+++..   ..+.+.+|++++++++ ||||+++++++....   ....+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCceE
Confidence            6899999999999999999999989999999998643   3467899999999997 999999999987643   22679


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc-cc-cccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VA-HQNFSL  704 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~-~~Dfg~  704 (854)
                      +||||+++++|.+++.         .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++ .. ++|||+
T Consensus       110 lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~  177 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  177 (330)
T ss_dssp             EEEECCCCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEeccCchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence            9999999999999874         478889999999999999999999   999999999999998665 44 459999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      ++........    ....||..|+|||++.+ ..++.++||||+||++|||++|+.||.........+............
T Consensus       178 a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~  253 (330)
T 3nsz_A          178 AEFYHPGQEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL  253 (330)
T ss_dssp             CEECCTTCCC----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             ceEcCCCCcc----ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence            9876544332    22468999999999877 668999999999999999999999996543322222222111111000


Q ss_pred             c-------cccCchhhHHHhhcc--chhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 I-------EIVDPSLLMEVMANN--SMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~-------~~~d~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .       ...++..........  .............+..++.+++.+||+.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0       001111100000000  00000000011123567889999999999999999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.6e-38  Score=334.80  Aligned_cols=248  Identities=19%  Similarity=0.264  Sum_probs=197.1

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  622 (854)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++...  ......+.+|+..+.++ +||||+++++++.+.+    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~----   84 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD----   84 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT----
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC----
Confidence            4578999999999999999999999899999999997542  33456788999999999 9999999999997655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc------
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM------  696 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~------  696 (854)
                       ..++||||+++|+|.+++......  ...+++.+++.|+.||+.||+|||++   +|+||||||+||+++.++      
T Consensus        85 -~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~  158 (289)
T 1x8b_A           85 -HMLIQNEYCNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS  158 (289)
T ss_dssp             -EEEEEEECCTTCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred             -eEEEEEEecCCCcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence             789999999999999999865311  12689999999999999999999999   999999999999998543      


Q ss_pred             -------------ccc-cccccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCC
Q 043388          697 -------------VAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPT  761 (854)
Q Consensus       697 -------------~~~-~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf  761 (854)
                                   ..+ +|||.+........       ..||+.|+|||++.+. .+++++|||||||++|||++|.+|+
T Consensus       159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQV-------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             -----------CCCEEECCCTTCEETTCSCC-------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cccccccccCCceEEEEcccccccccCCccc-------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence                         334 49999987754332       2489999999998876 5678999999999999999999876


Q ss_pred             CCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          762 DAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       762 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...    ...........+. .    .                      ..++..+.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~~----~~~~~~~~~~~~~-~----~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          232 RNG----DQWHEIRQGRLPR-I----P----------------------QVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             SSS----HHHHHHHTTCCCC-C----S----------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             cch----hHHHHHHcCCCCC-C----C----------------------cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            432    1122221111110 0    0                      0114557899999999999999999999763

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.7e-38  Score=337.11  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=203.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +.|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++....     ..+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eEE
Confidence            56999999999999999999999899999999997553 344678999999999999999999999997655     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++...       .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.+
T Consensus        97 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  166 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA  166 (303)
T ss_dssp             EEEECCTTEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccc
Confidence            999999999999998753       688999999999999999999999   9999999999999998877766 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ..........   ....||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..........+...  
T Consensus       167 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~--  239 (303)
T 3a7i_A          167 GQLTDTQIKR---NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPPTL--  239 (303)
T ss_dssp             EECBTTBCCB---CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCCC--
T ss_pred             eecCcccccc---CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCCCC--
Confidence            8775543221   2346899999999999999999999999999999999999999753211  11111111110000  


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                        .                      ..++..+.+++..||+.||++|||+.|+++.
T Consensus       240 --~----------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          240 --E----------------------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             --C----------------------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             --c----------------------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              0                      0114457899999999999999999999874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.1e-38  Score=359.04  Aligned_cols=252  Identities=26%  Similarity=0.314  Sum_probs=200.6

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ..++|.+.++||+|+||+||+|++..+++.||||++...  .......+.+|++++++++||||+++++++....     
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-----   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-----
Confidence            357899999999999999999999989999999999643  2334578899999999999999999999997655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC---Cc-ccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DM-VAH  699 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~-~~~  699 (854)
                      ..++||||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++.   +. +++
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  165 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI  165 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence            7899999999999999987754      689999999999999999999999   9999999999999954   33 444


Q ss_pred             cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          700 QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       700 ~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      +|||+++........    ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... ...........
T Consensus       166 ~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~  239 (486)
T 3mwu_A          166 IDFGLSTCFQQNTKM----KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKY  239 (486)
T ss_dssp             CSCSCTTTBCCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC
T ss_pred             EECCcCeECCCCCcc----CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC
Confidence            599999876543322    23469999999999876 5899999999999999999999999754221 11111111111


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...     .+                   ....++..+.+++.+||+.||.+|||+.|+++.
T Consensus       240 ~~~-----~~-------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          240 AFD-----LP-------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CSC-----SG-------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCC-----Cc-------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            100     00                   011124567899999999999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.5e-38  Score=360.30  Aligned_cols=251  Identities=23%  Similarity=0.309  Sum_probs=196.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||.||+|++..++..||+|+++...  ......+.+|+.+++.++||||++++++|.+..     .
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-----N  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----E
Confidence            468999999999999999999999999999999997542  334577899999999999999999999997655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC---c-cccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---M-VAHQ  700 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~-~~~~  700 (854)
                      .++||||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++..   . ++++
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence            899999999999999987654      689999999999999999999999   99999999999999763   3 3445


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |||++.........    ....||+.|+|||++. ..++.++||||+||++|+|++|+.||...... ............
T Consensus       182 DfG~a~~~~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~  255 (494)
T 3lij_A          182 DFGLSAVFENQKKM----KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILRKVEKGKYT  255 (494)
T ss_dssp             CCTTCEECBTTBCB----CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC
T ss_pred             ECCCCeECCCCccc----cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC
Confidence            99999877654322    2346999999999876 46999999999999999999999999754221 111111111110


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .     ..+.                   ...++..+.+++.+||+.||.+|||+.|+++.
T Consensus       256 ~-----~~~~-------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          256 F-----DSPE-------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             C-----CSGG-------------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             C-----Cchh-------------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            0     0000                   01124557899999999999999999999853

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.9e-39  Score=344.25  Aligned_cols=265  Identities=22%  Similarity=0.345  Sum_probs=200.9

Q ss_pred             HhhccccCccCCCcceEEEEeE-----ECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGI-----LGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|.+.+.||+|+||.||+|+     ...++..||||++.... .....++.+|+.++++++||||+++++++....  
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL--  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC--
Confidence            4689999999999999999999     44567889999996432 334567889999999999999999999987654  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCc-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc---
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDH-LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---  696 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---  696 (854)
                         ..++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++   
T Consensus       107 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          107 ---PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             ---SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             ---CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence               579999999999999999876421 1123589999999999999999999999   999999999999998443   


Q ss_pred             -ccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHH
Q 043388          697 -VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEF  774 (854)
Q Consensus       697 -~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~  774 (854)
                       ++++|||.+........... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||......  ...+.
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~  257 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEF  257 (327)
T ss_dssp             CEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHH
T ss_pred             eEEECcccccccccccccccc-CCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHH
Confidence             34459999986654332211 122457899999999988889999999999999999998 99998753211  11111


Q ss_pred             hhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          775 VKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       775 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      +.......                          ....++..+.+++.+||+.||.+|||+.|+++.++.+...
T Consensus       258 ~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          258 VTSGGRMD--------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHTTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhcCCCCC--------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            11110000                          0011245678999999999999999999999999987653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.9e-39  Score=341.55  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=197.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++...+     ..+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   92 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-----KLW   92 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-----eEE
Confidence            468999999999999999999999899999999998766667788999999999999999999999987654     689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++++|.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||++
T Consensus        93 lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS  164 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred             EEEEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence            99999999999999876432     689999999999999999999999   9999999999999998877666 99997


Q ss_pred             cccccCCCCCCcccccCCcccccCcccc-----CCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYG-----MGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      .........   .....||+.|+|||++     .+..++.++|||||||++|||++|+.||....... ..........+
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~  240 (302)
T 2j7t_A          165 AKNLKTLQK---RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPP  240 (302)
T ss_dssp             HHHHHHHHC--------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC
T ss_pred             ccccccccc---cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCc
Confidence            654322111   1124589999999987     46678999999999999999999999997542211 11111111100


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .    ...                     ...++..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~----~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          241 T----LLT---------------------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             C----CSS---------------------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             c----cCC---------------------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0    000                     0112455789999999999999999999976

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.1e-39  Score=344.79  Aligned_cols=268  Identities=21%  Similarity=0.363  Sum_probs=208.5

Q ss_pred             HHHHhhccccCccCCCcceEEEEeEEC-----CCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeecc
Q 043388          544 SKATSEFASSNMIGQGSFGSVYKGILG-----GEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSI  617 (854)
Q Consensus       544 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  617 (854)
                      ....++|.+.+.||+|+||.||+|++.     .+++.||+|++..... .....+.+|++++++++||||+++++++...
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            334678999999999999999999876     3578899999975432 2345688999999999999999999998765


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCc----ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDH----LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD  693 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  693 (854)
                      +     ..++||||+++|+|.+++......    .....+++.+++.++.|++.||+|||++   +|+||||||+||+++
T Consensus       101 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~  172 (322)
T 1p4o_A          101 Q-----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA  172 (322)
T ss_dssp             S-----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred             C-----ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence            4     679999999999999999864311    0012568999999999999999999999   999999999999999


Q ss_pred             CCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchH
Q 043388          694 HDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTL  771 (854)
Q Consensus       694 ~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~  771 (854)
                      .++..++ |||++.......... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||......  ..
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~  249 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QV  249 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEE-GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HH
T ss_pred             CCCeEEECcCccccccccccccc-cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HH
Confidence            9876666 999998765433221 1122347889999999988889999999999999999999 89998753211  11


Q ss_pred             hHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          772 HEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       772 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ...+..   .....                       ....++..+.+++.+||+.||++|||+.|+++.|++..+.
T Consensus       250 ~~~~~~---~~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          250 LRFVME---GGLLD-----------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             HHHHHT---TCCCC-----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHHc---CCcCC-----------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            111110   00000                       0012245688999999999999999999999999987653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=337.74  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=197.4

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++....  ..+.+.+|+.++++++||||+++++++...+     ..
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   99 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-----DL   99 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EE
Confidence            3568999999999999999999999899999999997543  3477899999999999999999999987655     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++++|.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  171 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV  171 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEeecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence            999999999999999974332     689999999999999999999999   9999999999999988877766 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +.........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ............. 
T Consensus       172 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~-  245 (314)
T 3com_A          172 AGQLTDTMAK---RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPPPTF-  245 (314)
T ss_dssp             CEECBTTBSC---BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCCC-
T ss_pred             chhhhhhccc---cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCCccc-
Confidence            9876543322   123468999999999999899999999999999999999999997532110  0000100000000 


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                        .                     ....++..+.+++.+||+.||.+|||+.|+++
T Consensus       246 --~---------------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 --R---------------------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             --S---------------------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --C---------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              0                     00112455789999999999999999999976

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=359.23  Aligned_cols=314  Identities=20%  Similarity=0.171  Sum_probs=286.6

Q ss_pred             cccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChh
Q 043388            3 KLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPR   82 (854)
Q Consensus         3 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~   82 (854)
                      +++ .+|..+.  +++++|+|++|+|++..|..|..+++|++|+|++|.|++..|..|..+++|++|+|++|+++++.+.
T Consensus        22 ~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~   98 (477)
T 2id5_A           22 RFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLG   98 (477)
T ss_dssp             CCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTT
T ss_pred             CcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcc
Confidence            444 5777665  4899999999999988889999999999999999999999999999999999999999999988888


Q ss_pred             hhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecC
Q 043388           83 WICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLS  162 (854)
Q Consensus        83 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls  162 (854)
                      .|.++++|++|+|++|+++ .++...|.++++|++|++++|.+..+                 .|..|.++++|++|+|+
T Consensus        99 ~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~-----------------~~~~~~~l~~L~~L~l~  160 (477)
T 2id5_A           99 VFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYI-----------------SHRAFSGLNSLEQLTLE  160 (477)
T ss_dssp             SSTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEEECCTTCCEE-----------------CTTSSTTCTTCCEEEEE
T ss_pred             cccCCCCCCEEECCCCccc-cCChhHccccccCCEEECCCCcccee-----------------ChhhccCCCCCCEEECC
Confidence            8999999999999999998 67777889999999999988877644                 36678999999999999


Q ss_pred             CCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccC
Q 043388          163 GNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG  242 (854)
Q Consensus       163 ~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~  242 (854)
                      +|+++++++..|..+++|+.|+|++|.+..+...      .|..+++|+.|++++|.+.+.+|....... .|+.|++++
T Consensus       161 ~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~------~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~-~L~~L~l~~  233 (477)
T 2id5_A          161 KCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY------SFKRLYRLKVLEISHWPYLDTMTPNCLYGL-NLTSLSITH  233 (477)
T ss_dssp             SCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTT------CSCSCTTCCEEEEECCTTCCEECTTTTTTC-CCSEEEEES
T ss_pred             CCcCcccChhHhcccCCCcEEeCCCCcCcEeChh------hcccCcccceeeCCCCccccccCcccccCc-cccEEECcC
Confidence            9999999888999999999999999999876554      578999999999999998888888777765 799999999


Q ss_pred             CcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCC
Q 043388          243 NQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIP  322 (854)
Q Consensus       243 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  322 (854)
                      |+++...+..|.++++|+.|+|++|+++++.+..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+
T Consensus       234 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  313 (477)
T 2id5_A          234 CNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEE  313 (477)
T ss_dssp             SCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCG
T ss_pred             CcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCH
Confidence            99996666789999999999999999999999999999999999999999999999999999999999999999998778


Q ss_pred             CCCcCCCCCcccccCCCcccCc
Q 043388          323 SSLGNCQNLKGFDASHNKLTGA  344 (854)
Q Consensus       323 ~~~~~l~~L~~L~ls~N~l~~~  344 (854)
                      ..|..+++|+.|++++|++...
T Consensus       314 ~~~~~l~~L~~L~l~~N~l~c~  335 (477)
T 2id5_A          314 SVFHSVGNLETLILDSNPLACD  335 (477)
T ss_dssp             GGBSCGGGCCEEECCSSCEECS
T ss_pred             hHcCCCcccCEEEccCCCccCc
Confidence            8899999999999999999853

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.6e-38  Score=341.74  Aligned_cols=252  Identities=23%  Similarity=0.280  Sum_probs=196.0

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--------ccchHHHHHHHHHHHhccCCCeeeEEEEeecc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--------KGAFRSFVAECEALRNIRHRNLIKIITICSSI  617 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  617 (854)
                      ..++|.+.+.||+|+||.||+|++..+++.||||++....        ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3478999999999999999999999899999999986432        12234578999999999999999999998643


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc-
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-  696 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-  696 (854)
                            ..++||||+++|+|.+++....      .+++.++..++.||+.||+|||++   +|+||||||+||+++.++ 
T Consensus        88 ------~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~  152 (322)
T 2ycf_A           88 ------DYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE  152 (322)
T ss_dssp             ------SEEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSS
T ss_pred             ------ceEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCC
Confidence                  2699999999999999987654      689999999999999999999999   999999999999998754 


Q ss_pred             ---ccccccccccccccCCCCCCcccccCCcccccCccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch
Q 043388          697 ---VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM---GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT  770 (854)
Q Consensus       697 ---~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~  770 (854)
                         ++++|||.+........    .....||+.|+|||++.   ...++.++|||||||++|||++|+.||.........
T Consensus       153 ~~~~kl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  228 (322)
T 2ycf_A          153 DCLIKITDFGHSKILGETSL----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL  228 (322)
T ss_dssp             SCCEEECCCTTCEECCCCHH----HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH
T ss_pred             CCeEEEccCccceecccccc----cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH
Confidence               44459999987654221    11245899999999863   466899999999999999999999999754332221


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..........      ..+.                  ....++..+.+++.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~------~~~~------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          229 KDQITSGKYN------FIPE------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHHTCCC------CCHH------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHhCccc------cCch------------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1111111100      0000                  01122456889999999999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.9e-38  Score=341.68  Aligned_cols=259  Identities=18%  Similarity=0.222  Sum_probs=200.2

Q ss_pred             HHHHHHhhcccc-CccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhc-cCCCeeeEEEEeecc
Q 043388          542 ELSKATSEFASS-NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNI-RHRNLIKIITICSSI  617 (854)
Q Consensus       542 ~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  617 (854)
                      ......+.|.+. +.||+|+||.||+|++..+++.||+|+++...  ......+.+|+.++.++ .||||+++++++...
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            344456678887 89999999999999999899999999997543  33457889999999999 569999999999765


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC---
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---  694 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---  694 (854)
                      .     ..++||||+++|+|.+++.....    ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.   
T Consensus       102 ~-----~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~  169 (327)
T 3lm5_A          102 S-----EIILILEYAAGGEIFSLCLPELA----EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYP  169 (327)
T ss_dssp             S-----EEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTT
T ss_pred             C-----eEEEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCC
Confidence            5     68999999999999999865432    2789999999999999999999999   9999999999999987   


Q ss_pred             Ccccc-cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhH
Q 043388          695 DMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHE  773 (854)
Q Consensus       695 ~~~~~-~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~  773 (854)
                      ++..+ +|||++.........    ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus       170 ~~~~kL~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~  244 (327)
T 3lm5_A          170 LGDIKIVDFGMSRKIGHACEL----REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-TYLN  244 (327)
T ss_dssp             BCCEEECCGGGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH
T ss_pred             CCcEEEeeCccccccCCcccc----ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHH
Confidence            44444 599999877544322    22469999999999999999999999999999999999999997542211 1111


Q ss_pred             HhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       774 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ........  .                      ......++..+.+++.+||+.||++|||++|+++.
T Consensus       245 i~~~~~~~--~----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          245 ISQVNVDY--S----------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHTCCCC--C----------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHhccccc--C----------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            11110000  0                      00011224557899999999999999999999763

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.5e-38  Score=361.30  Aligned_cols=251  Identities=24%  Similarity=0.298  Sum_probs=198.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-------------cchHHHHHHHHHHHhccCCCeeeEEEE
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-------------GAFRSFVAECEALRNIRHRNLIKIITI  613 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~  613 (854)
                      .++|.+.++||+|+||+||+|++..++..||+|++.....             ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            5789999999999999999999998999999999964321             335678999999999999999999999


Q ss_pred             eeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec
Q 043388          614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD  693 (854)
Q Consensus       614 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  693 (854)
                      +.+..     ..++|||||++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++
T Consensus       115 ~~~~~-----~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~  180 (504)
T 3q5i_A          115 FEDKK-----YFYLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLE  180 (504)
T ss_dssp             EECSS-----EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred             EEcCC-----EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEe
Confidence            97655     7899999999999999997754      689999999999999999999999   999999999999998


Q ss_pred             CCc----ccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCc
Q 043388          694 HDM----VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL  769 (854)
Q Consensus       694 ~~~----~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~  769 (854)
                      .++    ++++|||++.........    ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .
T Consensus       181 ~~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~  254 (504)
T 3q5i_A          181 NKNSLLNIKIVDFGLSSFFSKDYKL----RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-D  254 (504)
T ss_dssp             STTCCSSEEECCCTTCEECCTTSCB----CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H
T ss_pred             cCCCCccEEEEECCCCEEcCCCCcc----ccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence            764    445599999877554322    23469999999999874 6899999999999999999999999754221 0


Q ss_pred             hHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          770 TLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ............      +                  ......++..+.+++.+||+.||.+|||+.|+++.
T Consensus       255 ~~~~i~~~~~~~------~------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          255 IIKKVEKGKYYF------D------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHHHHHCCCCC------C------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHcCCCCC------C------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            111111110000      0                  00111224568899999999999999999999763

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.3e-39  Score=353.95  Aligned_cols=280  Identities=17%  Similarity=0.213  Sum_probs=196.4

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-----
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-----  619 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  619 (854)
                      ....+|.+.+.||+|+||.||+|++..+++.||||++......    ..+|+++++.++||||+++++++.....     
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4457899999999999999999999989999999998644322    2479999999999999999999865432     


Q ss_pred             ----------------------------CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHH
Q 043388          620 ----------------------------KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY  671 (854)
Q Consensus       620 ----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~  671 (854)
                                                  ....+.++||||+++ +|.+.+......  ...+++..+..++.||+.||+|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRS--GRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHH
Confidence                                        233458899999985 888877652111  1278999999999999999999


Q ss_pred             HHhcCCCCeEeecCCCCceEec-CCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHH
Q 043388          672 LHHHCQPPIVHGDLKPSNVLLD-HDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFG  748 (854)
Q Consensus       672 LH~~~~~~ivH~Dlkp~NIll~-~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slG  748 (854)
                      ||+.   +|+||||||+||+++ .++..++ |||.++........    ....||+.|+|||++.+. .++.++||||+|
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS----VAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC----CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC----cCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            9999   999999999999997 4555554 99999877544322    234689999999998875 489999999999


Q ss_pred             HHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc--cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccC
Q 043388          749 ILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK--VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSM  826 (854)
Q Consensus       749 vvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  826 (854)
                      |++|||++|+.||...... ..+..++.......  .....++.... ...........+......++..+.+++.+||+
T Consensus       230 ~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  307 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTE-VRFPTLKAKDWRKILPEGTPSLAIDLLEQILR  307 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC---CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred             HHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCccccc-ccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence            9999999999999864322 11222221111000  00000000000 00000000000011111235568899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 043388          827 ESPFERMEMRDVVA  840 (854)
Q Consensus       827 ~dP~~RPs~~evl~  840 (854)
                      .||++|||+.|+++
T Consensus       308 ~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          308 YEPDLRINPYEAMA  321 (383)
T ss_dssp             SSGGGSCCHHHHHT
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.3e-38  Score=332.71  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=194.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||++...   .....+.+.+|+.+++.++||||+++++++...+     
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT-----   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----
Confidence            35899999999999999999999989999999999643   2334568899999999999999999999987655     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df  155 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  155 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence            7899999999999999998754      688999999999999999999999   9999999999999998877666 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |.+.........    ....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......  ...+....... 
T Consensus       156 g~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~-  228 (276)
T 2h6d_A          156 GLSNMMSDGEFL----RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGGVF-  228 (276)
T ss_dssp             CGGGCCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC-
T ss_pred             ccccccCCCcce----ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcCcc-
Confidence            999876543221    12458999999999988765 68999999999999999999999753211  11111110000 


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                         . .                      ...+...+.+++.+||+.||++|||+.|+++.
T Consensus       229 ---~-~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 ---Y-I----------------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ---C-C----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---c-C----------------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               0 0                      01113457889999999999999999999874

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.3e-39  Score=338.25  Aligned_cols=259  Identities=19%  Similarity=0.266  Sum_probs=202.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++.....   ..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG---TE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC---ce
Confidence            468999999999999999999999899999999997543  2345678999999999999999999998854321   26


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeecCCCCceEecCCcccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP-----IVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~~  699 (854)
                      .++||||+++|+|.+++......  ...+++.+++.++.|++.||+|||+.   +     |+||||||+||+++.++..+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEE
T ss_pred             EEEEEeCCCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEE
Confidence            89999999999999999865321  12589999999999999999999999   7     99999999999999888766


Q ss_pred             c-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          700 Q-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                      + |||.+.........   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......  .....+...
T Consensus       157 l~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~  231 (279)
T 2w5a_A          157 LGDFGLARILNHDTSF---AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREG  231 (279)
T ss_dssp             ECCCCHHHHC---CHH---HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHT
T ss_pred             EecCchheeecccccc---ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHHhhc
Confidence            6 99999876543211   11235899999999999988999999999999999999999999754211  111111110


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH  844 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  844 (854)
                      ....    +                      ...++..+.+++.+||+.||++|||+.|+++.+..
T Consensus       232 ~~~~----~----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          232 KFRR----I----------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             CCCC----C----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccc----C----------------------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            0000    0                      01124568899999999999999999999986543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-39  Score=345.86  Aligned_cols=262  Identities=23%  Similarity=0.339  Sum_probs=198.2

Q ss_pred             HHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCC
Q 043388          541 AELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDS  619 (854)
Q Consensus       541 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  619 (854)
                      .++....++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+.+++++ +||||+++++++.....
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            3344456789999999999999999999988999999999975433 347889999999999 89999999999876432


Q ss_pred             CC-CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccc
Q 043388          620 KG-ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA  698 (854)
Q Consensus       620 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  698 (854)
                      .+ ....++||||+++|+|.+++.....    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++..
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence            11 3468999999999999999987532    2688999999999999999999999   99999999999999988777


Q ss_pred             cc-ccccccccccCCCCCCcccccCCcccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh
Q 043388          699 HQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM-----GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH  772 (854)
Q Consensus       699 ~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~  772 (854)
                      ++ |||++.........   .....||+.|+|||++.     +..++.++|||||||++|||++|+.||....... ...
T Consensus       169 kl~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~  244 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVGR---RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALF  244 (326)
T ss_dssp             EECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHH
T ss_pred             EEeeCcCceecCcCccc---cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHH
Confidence            66 99999876543221   12246899999999987     5568999999999999999999999996432110 111


Q ss_pred             HHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .......+.    ...                      ..++..+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~----~~~----------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          245 LIPRNPAPR----LKS----------------------KKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHSCCCC----CSC----------------------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhhcCcccc----CCc----------------------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            111110000    000                      011455789999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-38  Score=346.36  Aligned_cols=282  Identities=20%  Similarity=0.234  Sum_probs=203.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||+++.... .....+.+|++++++++||||+++++++...........
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            3689999999999999999999998999999999964332 234578899999999999999999999876543334578


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||++ |+|.+++...       .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||.
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccC-ccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            99999997 5999998763       688999999999999999999999   9999999999999998877666 9999


Q ss_pred             ccccccCCCCCC-------cccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh
Q 043388          705 SHQLDSASKTPS-------SSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK  776 (854)
Q Consensus       705 ~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~  776 (854)
                      +...........       ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .......
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~  237 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFG  237 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHH
Confidence            987754322111       1223568999999998754 678999999999999999999999998643211 1111111


Q ss_pred             h---cCCcccccccCchhhHHHhhccch-hhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          777 M---TLPEKVIEIVDPSLLMEVMANNSM-IQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       777 ~---~~~~~~~~~~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .   ................+....... ...........++..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1   010111111111111111100000 000001111234567889999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6e-39  Score=350.12  Aligned_cols=276  Identities=19%  Similarity=0.235  Sum_probs=186.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  624 (854)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+++++.++||||+++++++..... .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            68999999999999999999999899999999986432  2335678899999999999999999999865421 11235


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+ +++|.+++...       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus       109 ~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CEEEEECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             EEEEeccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence            79999999 67999988752       689999999999999999999999   9999999999999999877766 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC--C
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL--P  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~--~  780 (854)
                      +++......      ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+..+.....  .
T Consensus       178 ~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~  250 (367)
T 2fst_X          178 LARHTADEM------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG  250 (367)
T ss_dssp             -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCC
T ss_pred             ccccccccC------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence            998764321      23469999999999887 67899999999999999999999999764321 11122211111  1


Q ss_pred             cccccccCchhhHHHhhccchhhH-hhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQE-DRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ......+.......+.......+. ........+...+.+++.+||+.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            111111111111111110000000 0001111234568899999999999999999999863

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.8e-39  Score=366.88  Aligned_cols=258  Identities=27%  Similarity=0.437  Sum_probs=206.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.++||+|+||.||+|.+.+ +..||||+++.... ..+.+.+|+++|++++||||+++++++.. +     ..+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~-----~~~  337 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-----PIY  337 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-----SCE
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c-----cce
Confidence            4678999999999999999999984 56799999975443 35789999999999999999999999864 2     479


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++.....    ..+++.+++.|+.||+.||+|||++   +|+||||||+|||++.++..++ |||++
T Consensus       338 lv~e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  410 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred             EeeehhcCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence            99999999999999976421    1588999999999999999999999   9999999999999998877666 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +........  ......++..|+|||++.+..++.++|||||||++|||++ |+.||......  ...+.+.....    
T Consensus       411 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~----  482 (535)
T 2h8h_A          411 RLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYR----  482 (535)
T ss_dssp             TTCCCHHHH--TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHHHTTCC----
T ss_pred             eecCCCcee--cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC----
Confidence            876532111  1122347889999999988899999999999999999999 99999754221  11111111000    


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                                            ......++..+.+++.+||+.||++|||+++|++.|+++....
T Consensus       483 ----------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          483 ----------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                                  0011123566889999999999999999999999999886543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.5e-38  Score=351.65  Aligned_cols=197  Identities=24%  Similarity=0.323  Sum_probs=170.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc------cCCCeeeEEEEeeccCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI------RHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~  621 (854)
                      .+|++.++||+|+||.||+|.+..+++.||||+++... ...+.+.+|+++++.+      +|+||+++++++....   
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~---  172 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN---  172 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT---
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC---
Confidence            57999999999999999999999899999999997532 2345678899988887      5679999999997765   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc---c
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV---A  698 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~  698 (854)
                        ..++||||++ ++|.+++......    .+++..++.|+.||+.||+|||+.   +|+||||||+|||++.++.   +
T Consensus       173 --~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vk  242 (429)
T 3kvw_A          173 --HICMTFELLS-MNLYELIKKNKFQ----GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIK  242 (429)
T ss_dssp             --EEEEEECCCC-CBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEE
T ss_pred             --eEEEEEeccC-CCHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceE
Confidence              7899999996 5999999876432    589999999999999999999999   9999999999999998864   4


Q ss_pred             ccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          699 HQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       699 ~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ++|||+++.......      ...||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus       243 L~DFG~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          243 VIDFGSSCYEHQRVY------TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             ECCCTTCEETTCCCC------SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EeecccceecCCccc------ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            459999976544322      246899999999999999999999999999999999999999765

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.5e-38  Score=346.88  Aligned_cols=278  Identities=17%  Similarity=0.192  Sum_probs=195.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  623 (854)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+.+++.++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999999899999999997532  2334678899999999999999999999876442 2233


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++ +|.+++..        .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  171 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  171 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence            67999999975 78888752        578899999999999999999999   9999999999999998877776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC--
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP--  780 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~--  780 (854)
                      |+++.......    .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+.........  
T Consensus       172 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~  246 (371)
T 2xrw_A          172 GLARTAGTSFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPC  246 (371)
T ss_dssp             CC--------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC-CCCCC
T ss_pred             ecccccccccc----cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence            99987654321    12246999999999999989999999999999999999999999764321 111111111000  


Q ss_pred             cccccccCchhhHHHhhcc------------chhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANN------------SMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ......+.+..........            ....+............+.+++.+||+.||++|||++|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            0011111111100000000            000000011122346678999999999999999999999874

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=3.5e-37  Score=348.83  Aligned_cols=335  Identities=27%  Similarity=0.399  Sum_probs=282.6

Q ss_pred             CcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccCh
Q 043388            2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFP   81 (854)
Q Consensus         2 n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p   81 (854)
                      |.++ .+|. +..+++|++|+|++|.+++..|  ++.+++|++|++++|.+++..+  |+.+++|++|+|++|.+++..+
T Consensus        56 ~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~  129 (466)
T 1o6v_A           56 LGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP  129 (466)
T ss_dssp             SCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG
T ss_pred             CCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH
Confidence            4555 4664 8999999999999999996544  9999999999999999996554  9999999999999999997544


Q ss_pred             hhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEec
Q 043388           82 RWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDL  161 (854)
Q Consensus        82 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~L  161 (854)
                        +.++++|++|+|++|+++ .++  .+..+++|++|+++ |.+.                  .++ .+.++++|++|++
T Consensus       130 --~~~l~~L~~L~l~~n~l~-~~~--~~~~l~~L~~L~l~-~~~~------------------~~~-~~~~l~~L~~L~l  184 (466)
T 1o6v_A          130 --LKNLTNLNRLELSSNTIS-DIS--ALSGLTSLQQLSFG-NQVT------------------DLK-PLANLTTLERLDI  184 (466)
T ss_dssp             --GTTCTTCSEEEEEEEEEC-CCG--GGTTCTTCSEEEEE-ESCC------------------CCG-GGTTCTTCCEEEC
T ss_pred             --HcCCCCCCEEECCCCccC-CCh--hhccCCcccEeecC-Cccc------------------Cch-hhccCCCCCEEEC
Confidence              999999999999999998 665  37888999988885 3332                  122 3888999999999


Q ss_pred             CCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEcc
Q 043388          162 SGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG  241 (854)
Q Consensus       162 s~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~  241 (854)
                      ++|+++.+.  .+..+++|++|++++|.+.....        +..+++|+.|++++|++++ + ..+..++ .|+.|+++
T Consensus       185 ~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--------~~~l~~L~~L~l~~n~l~~-~-~~l~~l~-~L~~L~l~  251 (466)
T 1o6v_A          185 SSNKVSDIS--VLAKLTNLESLIATNNQISDITP--------LGILTNLDELSLNGNQLKD-I-GTLASLT-NLTDLDLA  251 (466)
T ss_dssp             CSSCCCCCG--GGGGCTTCSEEECCSSCCCCCGG--------GGGCTTCCEEECCSSCCCC-C-GGGGGCT-TCSEEECC
T ss_pred             cCCcCCCCh--hhccCCCCCEEEecCCccccccc--------ccccCCCCEEECCCCCccc-c-hhhhcCC-CCCEEECC
Confidence            999998763  48899999999999999875432        5678999999999999984 3 3566665 79999999


Q ss_pred             CCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccC
Q 043388          242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNI  321 (854)
Q Consensus       242 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  321 (854)
                      +|.+++..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..
T Consensus       252 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~  325 (466)
T 1o6v_A          252 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS  325 (466)
T ss_dssp             SSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCG
T ss_pred             CCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCch
Confidence            999997655  8999999999999999997655  8899999999999999996554  889999999999999999766


Q ss_pred             CCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCC
Q 043388          322 PSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVI  401 (854)
Q Consensus       322 ~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~  401 (854)
                      |  +..+++|+.|++++|++++. +                          .+.+       +.+|+.|++++|++++..
T Consensus       326 ~--~~~l~~L~~L~l~~n~l~~~-~--------------------------~l~~-------l~~L~~L~l~~n~l~~~~  369 (466)
T 1o6v_A          326 P--VSSLTKLQRLFFYNNKVSDV-S--------------------------SLAN-------LTNINWLSAGHNQISDLT  369 (466)
T ss_dssp             G--GGGCTTCCEEECCSSCCCCC-G--------------------------GGTT-------CTTCCEEECCSSCCCBCG
T ss_pred             h--hccCccCCEeECCCCccCCc-h--------------------------hhcc-------CCCCCEEeCCCCccCccc
Confidence            5  78999999999999999842 1                          1122       457999999999999887


Q ss_pred             CcccccCCCCCEEEccCcccccc
Q 043388          402 PFSLGFMKSIKELNVSSNNLSGQ  424 (854)
Q Consensus       402 p~~~~~l~~L~~L~Ls~N~l~~~  424 (854)
                      |  +..+++|+.|++++|.+++.
T Consensus       370 ~--~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          370 P--LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             G--GTTCTTCCEEECCCEEEECC
T ss_pred             h--hhcCCCCCEEeccCCcccCC
Confidence            7  89999999999999999963

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.8e-38  Score=361.16  Aligned_cols=251  Identities=27%  Similarity=0.355  Sum_probs=201.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|++.++||+|+||.||+|++..+++.||||++....   ....+.+.+|+.++++++||||+++++++....     
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG-----   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence            468999999999999999999999999999999996442   345678999999999999999999999997755     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec---CCcccc-
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAH-  699 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~~-  699 (854)
                      ..++||||+++|+|.+++....      .+++.++..++.||+.||+|||++   +|+||||||+||+++   .++..+ 
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  170 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI  170 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence            7899999999999999998754      689999999999999999999999   999999999999994   444444 


Q ss_pred             cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          700 QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       700 ~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      +|||++........    .....||+.|+|||++.+ .++.++||||+||++|+|++|++||...... .....+.....
T Consensus       171 ~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~  244 (484)
T 3nyv_A          171 IDFGLSTHFEASKK----MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKY  244 (484)
T ss_dssp             CCTTHHHHBCCCCS----HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC
T ss_pred             EeeeeeEEcccccc----cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCC
Confidence            59999987754432    123469999999999876 6899999999999999999999999754221 11111111111


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...     .+                   ....++..+.+++.+||+.||.+|||+.|+++.
T Consensus       245 ~~~-----~~-------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          245 TFE-----LP-------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             CCC-----SG-------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCC-----Cc-------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            000     00                   011124567899999999999999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.9e-38  Score=336.12  Aligned_cols=254  Identities=22%  Similarity=0.231  Sum_probs=184.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc--chHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++.....  ..+.+.++...++.++||||+++++++...+     .
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-----~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----D   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----S
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----C
Confidence            46899999999999999999999989999999999754221  2233444555578889999999999998655     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+++ +|.+++......  ...+++..++.++.|++.||+|||+++  +|+||||||+||+++.++..++ |||
T Consensus        81 ~~lv~e~~~~-~l~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           81 VWICMELMDT-SLDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             EEEEEehhcc-chHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecC
Confidence            8999999975 998887653111  127899999999999999999999853  8999999999999999877776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCcccc----CCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYG----MGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      .+..........    ...||+.|+|||++    .+..++.++||||+||++|||++|+.||..................
T Consensus       156 ~~~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  231 (290)
T 3fme_A          156 ISGYLVDDVAKD----IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS  231 (290)
T ss_dssp             ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC
T ss_pred             Cccccccccccc----ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC
Confidence            998775543322    23589999999996    5567899999999999999999999999753222222222222111


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +...                          ...++..+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 PQLP--------------------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CCCC--------------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCcc--------------------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1100                          0112455789999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2e-39  Score=356.60  Aligned_cols=257  Identities=14%  Similarity=0.166  Sum_probs=191.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHH---HHHhccCCCeeeEE-------EE
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECE---ALRNIRHRNLIKII-------TI  613 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~~  613 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||++...   .....+.+.+|++   ++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35789999999999999999999888999999999743   3345578899994   55555899999998       55


Q ss_pred             eeccCC---------CCCc---eeeEEEeeccCCCHHHHhhhcCCcc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 043388          614 CSSIDS---------KGAD---FKALVFEYMENGSLEDWLHQSNDHL-EVCKLTLIQRVNIAIDVASAIEYLHHHCQPPI  680 (854)
Q Consensus       614 ~~~~~~---------~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~i  680 (854)
                      +...+.         .+..   ..++||||+ +|+|.+++....... ....+++..++.|+.||+.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            544321         0000   268999999 679999998653111 112455688889999999999999999   99


Q ss_pred             EeecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCC-----------CCCccchhHHHH
Q 043388          681 VHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-----------EASMTGDVYSFG  748 (854)
Q Consensus       681 vH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~slG  748 (854)
                      +||||||+|||++.++..++ |||+++.....      .....| +.|+|||++.+.           .++.++||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTCE------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCCc------ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            99999999999998887776 99999864332      123457 999999999887           799999999999


Q ss_pred             HHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCC
Q 043388          749 ILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMES  828 (854)
Q Consensus       749 vvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d  828 (854)
                      |++|||++|+.||......... .. .        ....                       ..++..+.+++.+||+.|
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~-~~-~--------~~~~-----------------------~~~~~~~~~li~~~L~~d  347 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGS-EW-I--------FRSC-----------------------KNIPQPVRALLEGFLRYP  347 (377)
T ss_dssp             HHHHHHHHSSCCC------CCS-GG-G--------GSSC-----------------------CCCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHCCCCCcccccccch-hh-h--------hhhc-----------------------cCCCHHHHHHHHHHcCCC
Confidence            9999999999999754221110 00 0        0000                       011455788999999999


Q ss_pred             CCCCCCHHHHHH--HHHhhhh
Q 043388          829 PFERMEMRDVVA--KLCHTRE  847 (854)
Q Consensus       829 P~~RPs~~evl~--~L~~~~~  847 (854)
                      |++|||+.|+++  .+.++.+
T Consensus       348 p~~Rpt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          348 KEDRLLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             GGGCCCHHHHHTSHHHHHHHH
T ss_pred             chhCCCHHHHhhChHHHHHHH
Confidence            999999999986  3444443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-38  Score=345.17  Aligned_cols=254  Identities=21%  Similarity=0.288  Sum_probs=198.9

Q ss_pred             HhhccccCccCCCcceEEEEeEEC---CCceEEEEEEeeccc----ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILG---GEEMIVAVKVINLKQ----KGAFRSFVAECEALRNI-RHRNLIKIITICSSID  618 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  618 (854)
                      .++|.+.+.||+|+||.||+|+..   .+++.||||+++...    ....+.+.+|+++++++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            468999999999999999999984   478999999986432    23345677899999999 6999999999987655


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccc
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA  698 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  698 (854)
                           ..++||||+++|+|.+++....      .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++..
T Consensus       133 -----~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~  198 (355)
T 1vzo_A          133 -----KLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV  198 (355)
T ss_dssp             -----EEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             -----eEEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcE
Confidence                 6899999999999999998754      689999999999999999999999   99999999999999988777


Q ss_pred             cc-ccccccccccCCCCCCcccccCCcccccCccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          699 HQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS--EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       699 ~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                      ++ |||+++........  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||........ ...+.
T Consensus       199 kl~DfG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~  275 (355)
T 1vzo_A          199 VLTDFGLSKEFVADETE--RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEIS  275 (355)
T ss_dssp             EESCSSEEEECCGGGGG--GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHH
T ss_pred             EEeeCCCCeecccCCCC--cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHH
Confidence            76 99999876443221  12235699999999998863  478999999999999999999999975432211 11111


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHHH
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVAK  841 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  841 (854)
                      .......                        ......++..+.+++.+||+.||.+||     |++|+++.
T Consensus       276 ~~~~~~~------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          276 RRILKSE------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHHHCC------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHhccC------------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            1100000                        000011244577899999999999999     89999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.3e-39  Score=350.55  Aligned_cols=257  Identities=9%  Similarity=0.010  Sum_probs=181.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhc--cCCCeeeEE-------EEee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNI--RHRNLIKII-------TICS  615 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~  615 (854)
                      .+|.+.+.||+|+||.||+|++..+++.||||++.....   ...+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            468999999999999999999998999999999986542   3345677886655555  599988865       3333


Q ss_pred             ccCCC------------CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHH------HHHHHHHHHHHHHHHhcCC
Q 043388          616 SIDSK------------GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR------VNIAIDVASAIEYLHHHCQ  677 (854)
Q Consensus       616 ~~~~~------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~------~~i~~~ia~~L~~LH~~~~  677 (854)
                      .....            .....++||||++ |+|.+++.....     .+.+..+      ..++.||+.||+|||++  
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--  213 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQSK--  213 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC--
Confidence            22210            0134799999998 799999987532     3344445      67889999999999999  


Q ss_pred             CCeEeecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCC--CCCCccchhHHHHHHHHHH
Q 043388          678 PPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG--SEASMTGDVYSFGILLLEM  754 (854)
Q Consensus       678 ~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~el  754 (854)
                       +|+||||||+|||++.++..++ |||+++.......      ...+|+.|+|||++.+  ..++.++|||||||++|||
T Consensus       214 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el  286 (371)
T 3q60_A          214 -GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV  286 (371)
T ss_dssp             -TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE------GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred             -CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc------CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence             9999999999999999887776 9999987653221      2347799999999987  6799999999999999999


Q ss_pred             HhCCCCCCCcccCCchHhHHhhhcCCcc-cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC
Q 043388          755 FTGRRPTDAAFTEGLTLHEFVKMTLPEK-VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM  833 (854)
Q Consensus       755 ltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  833 (854)
                      ++|+.||..........  +........ ......+                   ....++..+.+++.+||+.||++||
T Consensus       287 ltg~~Pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~li~~~L~~dP~~Rp  345 (371)
T 3q60_A          287 WCLFLPFGLVTPGIKGS--WKRPSLRVPGTDSLAFG-------------------SCTPLPDFVKTLIGRFLNFDRRRRL  345 (371)
T ss_dssp             HHSSCSTTBCCTTCTTC--CCBCCTTSCCCCSCCCT-------------------TSSCCCHHHHHHHHHHTCSSTTTCC
T ss_pred             HhCCCCCCCcCcccccc--hhhhhhhhccccccchh-------------------hccCCCHHHHHHHHHHcCCChhhCC
Confidence            99999998653321110  000000000 0000000                   0011245688999999999999999


Q ss_pred             CHHHHHH
Q 043388          834 EMRDVVA  840 (854)
Q Consensus       834 s~~evl~  840 (854)
                      |+.|+++
T Consensus       346 t~~e~l~  352 (371)
T 3q60_A          346 LPLEAME  352 (371)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.5e-38  Score=368.91  Aligned_cols=249  Identities=23%  Similarity=0.323  Sum_probs=202.3

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  621 (854)
                      ..++|.+.++||+|+||.||+|++..+++.||||+++..   .....+.+.+|..++..+ +||+|+++++++.+.+   
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~---  415 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD---  415 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS---
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC---
Confidence            457899999999999999999999999999999999743   334457788999999988 7999999999987655   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                        ..|+||||+++|+|.+++....      .+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++..++ 
T Consensus       416 --~~~lV~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~  484 (674)
T 3pfq_A          416 --RLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA  484 (674)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred             --EEEEEEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence              7899999999999999998764      689999999999999999999999   9999999999999999887776 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |||+++........   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......     +.......
T Consensus       485 DFGla~~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~  556 (674)
T 3pfq_A          485 DFGMCKENIWDGVT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQSIME  556 (674)
T ss_dssp             CCTTCEECCCTTCC---BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHS
T ss_pred             ecceeeccccCCcc---cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-----HHHHHHHh
Confidence            99999865433222   23357999999999999999999999999999999999999999754221     11111111


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCH-----HHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEM-----RDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~  840 (854)
                      ... . . |                     .....++.+++..||+.||++||++     +||.+
T Consensus       557 ~~~-~-~-p---------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          557 HNV-A-Y-P---------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             SCC-C-C-C---------------------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CCC-C-C-C---------------------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            110 0 0 0                     0124557899999999999999997     56543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.5e-38  Score=348.63  Aligned_cols=209  Identities=22%  Similarity=0.306  Sum_probs=155.1

Q ss_pred             Hhhccc-cCccCCCcceEEEEeEEC--CCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFAS-SNMIGQGSFGSVYKGILG--GEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .+.|.+ .++||+|+||.||+|++.  .+++.||||++....  ....+.+|+.++++++||||+++++++....   ..
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA---DR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CC
Confidence            345766 568999999999999976  467899999996443  2357889999999999999999999986533   22


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCC---cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe----cCCc
Q 043388          624 FKALVFEYMENGSLEDWLHQSND---HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDM  696 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~  696 (854)
                      ..++||||+++ +|.+++.....   ......+++..++.|+.||+.||+|||+.   +|+||||||+|||+    +.++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred             eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence            78999999975 88888864321   11122589999999999999999999999   99999999999999    5555


Q ss_pred             cccc-ccccccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          697 VAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       697 ~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      ..++ |||+++...............+||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            5555 999998876543333333346799999999998874 5899999999999999999999999754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.1e-38  Score=344.71  Aligned_cols=288  Identities=20%  Similarity=0.222  Sum_probs=202.8

Q ss_pred             cHHHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc-----------chHHHHHHHHHHHhccCCCe
Q 043388          539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-----------AFRSFVAECEALRNIRHRNL  607 (854)
Q Consensus       539 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni  607 (854)
                      ..+++....++|.+.+.||+|+||.||+|.+. ++..||||++......           ..+.+.+|++++++++||||
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            45677788899999999999999999999987 5899999998543221           13678999999999999999


Q ss_pred             eeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 043388          608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKP  687 (854)
Q Consensus       608 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  687 (854)
                      +++++++...+.......++||||++ |+|.+++.....     .+++..+..++.||+.||+|||+.   +|+||||||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  162 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI-----VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHP  162 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCCh
Confidence            99999987665555557899999997 588888875432     689999999999999999999999   999999999


Q ss_pred             CceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          688 SNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       688 ~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      +||+++.++..++ |||.+.........    ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          163 GNILLADNNDITICDFNLAREDTADANK----THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             GGEEECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             HHEEEcCCCCEEEEecCccccccccccc----ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999998877666 99999755443322    22468999999999877 678999999999999999999999998643


Q ss_pred             cCCchHhHHhhhcCCcc---cccccCchhhHHHhhccch-hhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          766 TEGLTLHEFVKMTLPEK---VIEIVDPSLLMEVMANNSM-IQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       766 ~~~~~~~~~~~~~~~~~---~~~~~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ... .............   ......+............ ...........+...+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          239 FYN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            211 1111111111100   0000000000000000000 0000011112224568899999999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-37  Score=331.22  Aligned_cols=252  Identities=26%  Similarity=0.348  Sum_probs=201.1

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---------cchHHHHHHHHHHHhcc-CCCeeeEEEEee
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---------GAFRSFVAECEALRNIR-HRNLIKIITICS  615 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~  615 (854)
                      ..++|.+.+.||+|+||.||+|++..+++.||||+++....         ...+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            35789999999999999999999998999999999975431         22456789999999995 999999999987


Q ss_pred             ccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC
Q 043388          616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD  695 (854)
Q Consensus       616 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  695 (854)
                      ...     ..++||||+++++|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        95 ~~~-----~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~  160 (298)
T 1phk_A           95 TNT-----FFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD  160 (298)
T ss_dssp             CSS-----EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             cCC-----eEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC
Confidence            654     7899999999999999998654      689999999999999999999999   99999999999999988


Q ss_pred             ccccc-ccccccccccCCCCCCcccccCCcccccCccccC------CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC
Q 043388          696 MVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM------GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG  768 (854)
Q Consensus       696 ~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~  768 (854)
                      +..++ |||.+.........    ....||+.|+|||++.      ...++.++||||||+++|||++|+.||...... 
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-  235 (298)
T 1phk_A          161 MNIKLTDFGFSCQLDPGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-  235 (298)
T ss_dssp             CCEEECCCTTCEECCTTCCB----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred             CcEEEecccchhhcCCCccc----ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-
Confidence            77766 99999877543322    2246899999999875      456889999999999999999999999753211 


Q ss_pred             chHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       769 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ............     ...+                   ....++..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~-----~~~~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          236 LMLRMIMSGNYQ-----FGSP-------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHHTCCC-----CCTT-------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhcCCcc-----cCcc-------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            011111111000     0000                   01122456889999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.6e-38  Score=350.76  Aligned_cols=276  Identities=21%  Similarity=0.275  Sum_probs=194.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~  626 (854)
                      .+|.+.+.||+|+||.||+|++..+++.||||++.....    ...+|++++++++||||++++++|..... ....+.+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            468999999999999999999998999999999864322    23479999999999999999999865432 2233567


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-cc-ccccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MV-AHQNFSL  704 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~-~~~Dfg~  704 (854)
                      +||||+++ ++.+.+.....  ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.+ .. +++|||+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eehhcccc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence            99999986 77766654211  112789999999999999999999999   99999999999999965 44 4459999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc--
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE--  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--  781 (854)
                      ++........    ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+++......  
T Consensus       204 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          204 AKQLVRGEPN----VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTR  278 (420)
T ss_dssp             CEECCTTCCC----CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCH
T ss_pred             hhhcccCCCc----eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCH
Confidence            9876543322    234689999999998765 6899999999999999999999999864321 1222222211100  


Q ss_pred             -ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 -KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 -~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       .+.. .++.... +.................++.++.+++.+||+.||++|||+.|+++
T Consensus       279 ~~~~~-~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          279 EQIRE-MNPNYTE-FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHH-HCSCCCC-CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHh-hChhhhh-hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence             0000 0000000 0000000000000000112456889999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.7e-38  Score=345.43  Aligned_cols=275  Identities=19%  Similarity=0.236  Sum_probs=198.8

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC-CCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSK-GADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  624 (854)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++.....  ...+.+.+|+.++++++||||+++++++...+.. ....
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            579999999999999999999999999999999975432  2346788999999999999999999999765532 1123


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||++ ++|.+++..        .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..++ |||
T Consensus       122 ~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             EEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence            499999997 588888742        578999999999999999999999   9999999999999999887766 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc--CC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~~  780 (854)
                      .++.......      ...||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.......  .+
T Consensus       190 ~a~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~  262 (371)
T 4exu_A          190 LARHADAEMT------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPG  262 (371)
T ss_dssp             CC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred             cccccccCcC------CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCc
Confidence            9986654322      2468999999999887 678999999999999999999999997543211 111111111  11


Q ss_pred             cccccccCchhhHHHhhccc-hhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNS-MIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ......+............. ............+...+.+++.+||+.||++|||+.|+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            11111111111111111000 00000011112235678899999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=7.8e-38  Score=342.34  Aligned_cols=289  Identities=20%  Similarity=0.247  Sum_probs=193.9

Q ss_pred             HHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-
Q 043388          541 AELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-  619 (854)
Q Consensus       541 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-  619 (854)
                      .......++|.+.+.||+|+||.||+|++..+++.||||++.... .....+.+|++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            456677899999999999999999999999899999999986443 233567788888999999999999999876443 


Q ss_pred             -CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHH--hcCCCCeEeecCCCCceEecC-C
Q 043388          620 -KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH--HHCQPPIVHGDLKPSNVLLDH-D  695 (854)
Q Consensus       620 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~  695 (854)
                       ....+.++||||+++ ++.+.+.....  ....+++..+..++.|++.||+|||  +.   +|+||||||+||+++. +
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence             223347899999986 66555443211  1126889999999999999999999  77   9999999999999986 6


Q ss_pred             ccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhH
Q 043388          696 MVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHE  773 (854)
Q Consensus       696 ~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~  773 (854)
                      +..++ |||+++........    ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ..+..
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~  243 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSEPN----VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHE  243 (360)
T ss_dssp             TEEEECCCTTCBCCCTTSCC----CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred             CcEEEeeCCCceecCCCCCc----ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHH
Confidence            66655 99999877654332    2346899999999987654 899999999999999999999999864322 11222


Q ss_pred             HhhhcCC--cccccccCchhhH-HHhh-ccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          774 FVKMTLP--EKVIEIVDPSLLM-EVMA-NNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       774 ~~~~~~~--~~~~~~~d~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      +......  .......++.... .... ...............+...+.+++.+||+.||.+|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            2211110  0011111100000 0000 00000000000011135678899999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.3e-38  Score=347.56  Aligned_cols=271  Identities=21%  Similarity=0.285  Sum_probs=200.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc--------CCCeeeEEEEeeccCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR--------HRNLIKIITICSSIDS  619 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~~  619 (854)
                      ++|++.++||+|+||.||+|++..+++.||||+++... ...+.+.+|++++++++        |+||+++++++.....
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            67999999999999999999999899999999997432 33467889999999995        7889999999874321


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc---
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---  696 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---  696 (854)
                       .....++||||+ ++++.+++.....    ..+++.+++.|+.||+.||+|||+++  +|+||||||+|||++.++   
T Consensus       116 -~~~~~~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          116 -NGTHICMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             -TEEEEEEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred             -CCceEEEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence             223689999999 5577777665432    16899999999999999999999964  899999999999998764   


Q ss_pred             -----------------------------------------------ccccccccccccccCCCCCCcccccCCcccccC
Q 043388          697 -----------------------------------------------VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA  729 (854)
Q Consensus       697 -----------------------------------------------~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~a  729 (854)
                                                                     ++++|||.++.......      ...||+.|+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~------~~~gt~~y~a  261 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT------EDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC------SCCSCGGGCC
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc------cCCCCCcccC
Confidence                                                           34459999987754322      2368999999


Q ss_pred             ccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch-----HhHHhhh--cCCccc-----------------cc
Q 043388          730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT-----LHEFVKM--TLPEKV-----------------IE  785 (854)
Q Consensus       730 PE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~-----~~~~~~~--~~~~~~-----------------~~  785 (854)
                      ||++.+..++.++|||||||++|||++|+.||.........     .......  ..+...                 ..
T Consensus       262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            99999999999999999999999999999999865432211     1111110  000000                 00


Q ss_pred             ccC--chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          786 IVD--PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       786 ~~d--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ..+  +.-....       -.........+...+.+++.+||+.||++|||++|+++
T Consensus       342 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          342 ITKLKPWGLFEV-------LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCCCHHHH-------HHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccCCcchhHh-------hhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000  0000000       00011122445678999999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.7e-39  Score=340.64  Aligned_cols=267  Identities=22%  Similarity=0.299  Sum_probs=182.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+     ..
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   88 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----EL   88 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----CE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----Cc
Confidence            468999999999999999999998889999999986443 334567889999999999999999999997755     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCC--cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          626 ALVFEYMENGSLEDWLHQSND--HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ++||||+++++|.+++.....  ......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++..++ ||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEec
Confidence            999999999999999975211  00122689999999999999999999999   9999999999999998877776 99


Q ss_pred             ccccccccCCCC--CCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          703 SLSHQLDSASKT--PSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       703 g~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      |.+.........  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~  244 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLTLQNDP  244 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHTSSC
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHHHhccCC
Confidence            999876543211  111223469999999999876 4689999999999999999999999976432211 111111110


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +.......++.                  ....++..+.+++.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          245 PSLETGVQDKE------------------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCTTC-----C------------------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             Cccccccccch------------------hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00000000000                  00112456789999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=331.43  Aligned_cols=254  Identities=22%  Similarity=0.347  Sum_probs=198.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc----ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|+++...    ....+.+.+|++++++++||||+++++++...+   .
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE---K   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---C
Confidence            468999999999999999999999899999999996432    234577899999999999999999999985432   2


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                      ...++||||++++ +.+++......    .+++.++..++.|++.||+|||++   +|+||||||+||+++.++..++ |
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~d  152 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPEK----RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISA  152 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTTC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             CeEEEEehhccCC-HHHHHHhCccc----ccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeec
Confidence            2679999999886 87877764322    689999999999999999999999   9999999999999998877776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE--ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      ||.+.......... ......||+.|+|||++.+..  ++.++|||||||++|||++|+.||......  ...+.+....
T Consensus       153 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~~  229 (305)
T 2wtk_C          153 LGVAEALHPFAADD-TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFENIGKGS  229 (305)
T ss_dssp             CTTCEECCTTCSSC-EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCC
T ss_pred             cccccccCcccccc-ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHHhcCC
Confidence            99998765432221 122346999999999987644  478999999999999999999999753211  1111110000


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .                           .....++..+.+++.+||+.||.+|||+.|+++.
T Consensus       230 ~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 Y---------------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             C---------------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             C---------------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0                           0001124557889999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=340.71  Aligned_cols=260  Identities=22%  Similarity=0.305  Sum_probs=195.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|.+.+.||+|+||.||+|++.+   .||+|+++...  ....+.+.+|+.++++++||||+++++++...+     .
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~  103 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-----H  103 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-----C
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----c
Confidence            4689999999999999999999874   38999986432  233456788999999999999999999998655     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccccccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSL  704 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg~  704 (854)
                      .++||||+++++|.+++.....     .+++.+++.++.|++.||+|||++   +|+||||||+||+++.+.++++|||+
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~~~~~~l~Dfg~  175 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDNGKVVITDFGL  175 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCC-----CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC--CCEECCCSC
T ss_pred             eEEEeecccCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEeCCCEEEeecCC
Confidence            8999999999999999986532     688999999999999999999999   99999999999999976666669999


Q ss_pred             ccccccCCC--CCCcccccCCcccccCccccCC---------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhH
Q 043388          705 SHQLDSASK--TPSSSIGIKGTVGYVAPEYGMG---------SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHE  773 (854)
Q Consensus       705 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~  773 (854)
                      +........  .........||+.|+|||++.+         ..++.++|||||||++|||++|+.||......  ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~  253 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--AIIW  253 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--HHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence            876543221  1112223458999999999874         34789999999999999999999999754221  1111


Q ss_pred             HhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          774 FVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       774 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ..........   ...                      .++.++.+++..||+.||++|||+.|++++|+++.+..
T Consensus       254 ~~~~~~~~~~---~~~----------------------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          254 QMGTGMKPNL---SQI----------------------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             HHHTTCCCCC---CCS----------------------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             HhccCCCCCC---CcC----------------------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            1111100000   000                      11344778999999999999999999999999987654

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2.6e-37  Score=341.80  Aligned_cols=264  Identities=21%  Similarity=0.214  Sum_probs=139.5

Q ss_pred             cCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEE
Q 043388           39 LSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKEL  118 (854)
Q Consensus        39 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  118 (854)
                      +.++++|++++|.++...+..|..+++|++|+|++|.++++.+.+|.++++|++|+|++|+++ .++...|.++++|++|
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC-cCCHHHhcCCCCCCEE
Confidence            355555556555555433334555555666666666655555555555666666666666555 4554555555555555


Q ss_pred             EcccCCCCCCceeeccCccCCCCCCCCCCc-cccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCC
Q 043388          119 YLTFCSLKNLWWLNLEQNNLGMGTASSIPD-SLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTAND  197 (854)
Q Consensus       119 ~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~-~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~  197 (854)
                      ++++|+++.+                  |. .|.++++|++|+|++|+++++.+..|..+++|++|++++|+++.++   
T Consensus       123 ~L~~n~l~~l------------------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---  181 (390)
T 3o6n_A          123 VLERNDLSSL------------------PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---  181 (390)
T ss_dssp             ECCSSCCCCC------------------CTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---
T ss_pred             ECCCCccCcC------------------CHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---
Confidence            5555544322                  22 2455666666666666666666666666666666666666665432   


Q ss_pred             hhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCc
Q 043388          198 LDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGV  277 (854)
Q Consensus       198 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  277 (854)
                            +..+++|+.|++++|.+++. +     .+..++.|++++|.++.. |..  ..++|+.|++++|++++.  ..+
T Consensus       182 ------~~~l~~L~~L~l~~n~l~~~-~-----~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l  244 (390)
T 3o6n_A          182 ------LSLIPSLFHANVSYNLLSTL-A-----IPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWL  244 (390)
T ss_dssp             ------GGGCTTCSEEECCSSCCSEE-E-----CCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGG
T ss_pred             ------cccccccceeeccccccccc-C-----CCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHH
Confidence                  23445666666666666521 1     112455555555555433 211  124555566666655542  345


Q ss_pred             cCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCccc
Q 043388          278 GELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT  342 (854)
Q Consensus       278 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  342 (854)
                      ..+++|++|++++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|++++|+++
T Consensus       245 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~  308 (390)
T 3o6n_A          245 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL  308 (390)
T ss_dssp             GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC
T ss_pred             cCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce
Confidence            555555555555555555545555555555555555555542 2333344444444444444443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.8e-37  Score=326.34  Aligned_cols=252  Identities=25%  Similarity=0.310  Sum_probs=200.5

Q ss_pred             HHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       545 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++....    
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   94 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS----   94 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC----
Confidence            34578999999999999999999999899999999996542  344678899999999999999999999987654    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc----cc
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VA  698 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~  698 (854)
                       ..++||||+++++|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.+.    ++
T Consensus        95 -~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~k  164 (287)
T 2wei_A           95 -SFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (287)
T ss_dssp             -EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             -eEEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEE
Confidence             6899999999999999987654      689999999999999999999999   999999999999997643    44


Q ss_pred             ccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          699 HQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       699 ~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                      ++|||.+..........    ...||+.|+|||.+.+ .++.++||||||+++|+|++|+.||....... .........
T Consensus       165 L~Dfg~~~~~~~~~~~~----~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~  238 (287)
T 2wei_A          165 IIDFGLSTCFQQNTKMK----DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGK  238 (287)
T ss_dssp             ECSTTGGGTBCCCSSCS----CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC
T ss_pred             EeccCcceeecCCCccc----cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCC
Confidence            45999998765433221    2348999999999876 48999999999999999999999997542110 111111111


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .....                        +....++..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          239 YAFDL------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCCCS------------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCc------------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            00000                        001112456789999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-37  Score=332.44  Aligned_cols=253  Identities=23%  Similarity=0.362  Sum_probs=192.8

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhcc--CCCeeeEEEEeeccCCCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIR--HRNLIKIITICSSIDSKG  621 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~  621 (854)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||++....  ....+.+.+|++++.+++  ||||+++++++...+   
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~---  101 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---  101 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS---
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC---
Confidence            3467999999999999999999987 58899999997543  234567899999999997  599999999987655   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccccc
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN  701 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~D  701 (854)
                        ..++||| +.+++|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++++.++++|
T Consensus       102 --~~~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~kL~D  169 (313)
T 3cek_A          102 --YIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLID  169 (313)
T ss_dssp             --EEEEEEC-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTEEEECC
T ss_pred             --EEEEEEe-cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEECCeEEEee
Confidence              7899999 55789999998754      688999999999999999999999   99999999999999876666669


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-----------SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT  770 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~  770 (854)
                      ||.+.......... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........
T Consensus       170 fg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (313)
T 3cek_A          170 FGIANQMQPDTTSV-VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK  248 (313)
T ss_dssp             CSSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred             ccccccccCccccc-cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence            99998775433221 1123468999999999875           46889999999999999999999999754322111


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..............                          ..++..+.+++.+||+.||++|||+.|+++.
T Consensus       249 ~~~~~~~~~~~~~~--------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          249 LHAIIDPNHEIEFP--------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHHHCTTSCCCCC--------------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhcccccCCc--------------------------ccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            11111111000000                          0013457789999999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.9e-37  Score=336.30  Aligned_cols=272  Identities=19%  Similarity=0.254  Sum_probs=199.9

Q ss_pred             hhccccCccCCCcceEEEEeEE-CCCceEEEEEEeecccccchHHHHHHHHHHHhccCCC------eeeEEEEeeccCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGIL-GGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN------LIKIITICSSIDSK  620 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~  620 (854)
                      ++|++.+.||+|+||.||+|.+ ..+++.||||+++... ...+.+.+|+++++.++|++      ++++++++...+  
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~--   90 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG--   90 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT--
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC--
Confidence            5899999999999999999998 5578999999996432 33467889999999997654      999999987665  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-----
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-----  695 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----  695 (854)
                         ..++||||+ +++|.+++......    .+++.++..++.|++.||+|||++   +|+||||||+||+++.+     
T Consensus        91 ---~~~lv~e~~-~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  159 (339)
T 1z57_A           91 ---HICIVFELL-GLSTYDFIKENGFL----PFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEA  159 (339)
T ss_dssp             ---EEEEEEECC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEE
T ss_pred             ---cEEEEEcCC-CCCHHHHHHhcCCC----CCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccc
Confidence               789999999 88999999876422    688999999999999999999999   99999999999999863     


Q ss_pred             --------------cccc-cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 043388          696 --------------MVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP  760 (854)
Q Consensus       696 --------------~~~~-~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p  760 (854)
                                    +..+ +|||.+........      ...||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHS------TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             EC----CEEEEESCCCEEECCCSSCEETTSCCC------SSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCccccccccccCCCceEeeCcccccCccccc------cccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence                          3344 59999987543322      24689999999999998999999999999999999999999


Q ss_pred             CCCcccCCchHhHHhh--hcCCccccccc--------------C-chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhc
Q 043388          761 TDAAFTEGLTLHEFVK--MTLPEKVIEIV--------------D-PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVL  823 (854)
Q Consensus       761 f~~~~~~~~~~~~~~~--~~~~~~~~~~~--------------d-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  823 (854)
                      |....... ....+..  ...+..+....              . ............... ........+...+.+++.+
T Consensus       234 f~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~  311 (339)
T 1z57_A          234 FPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK-EFMLSQDVEHERLFDLIQK  311 (339)
T ss_dssp             CCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG-GGCSCCSHHHHHHHHHHHH
T ss_pred             CCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchh-hhcccchhhHHHHHHHHHH
Confidence            97543211 1111111  11111100000              0 000000000000000 0001112346778999999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 043388          824 CSMESPFERMEMRDVVAK  841 (854)
Q Consensus       824 cl~~dP~~RPs~~evl~~  841 (854)
                      ||+.||.+|||+.|+++.
T Consensus       312 ~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          312 MLEYDPAKRITLREALKH  329 (339)
T ss_dssp             HTCSSTTTSCCHHHHTTS
T ss_pred             HhCcCcccccCHHHHhcC
Confidence            999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.9e-37  Score=330.56  Aligned_cols=260  Identities=22%  Similarity=0.326  Sum_probs=193.3

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC------
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS------  619 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------  619 (854)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+.+|+.++++++||||+++++++.+...      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4578999999999999999999998899999999996432 345678999999999999999999999865321      


Q ss_pred             --CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc
Q 043388          620 --KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV  697 (854)
Q Consensus       620 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  697 (854)
                        ......++||||+++|+|.+++.....     .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENL-----NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCG-----GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcccc-----ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence              123468999999999999999986432     678889999999999999999999   9999999999999998887


Q ss_pred             ccc-ccccccccccCCC-----------CCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          698 AHQ-NFSLSHQLDSASK-----------TPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      .++ |||.+........           .........||+.|+|||++.+. .++.++|||||||++|||++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            776 9999987653211           01112234689999999998764 68999999999999999998   55422


Q ss_pred             ccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          765 FTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       765 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ......... .... ........                      ...++..+.+++.+||+.||.+|||+.|+++.
T Consensus       232 ~~~~~~~~~-~~~~-~~~~~~~~----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          232 MERVNILKK-LRSV-SIEFPPDF----------------------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHHHH-HHST-TCCCCTTC----------------------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hhHHHHHHh-cccc-ccccCccc----------------------cccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            111111111 1100 00000000                      01124457889999999999999999999873

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.5e-38  Score=347.14  Aligned_cols=277  Identities=19%  Similarity=0.245  Sum_probs=191.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~  626 (854)
                      .+|.+.++||+|+||.||+|++..++. ||+|++......    ..+|+++++.++||||+++++++..... ....+.+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            479999999999999999999986665 888877543221    2379999999999999999999876543 3344578


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec-CCccccc-cccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQ-NFSL  704 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~~~-Dfg~  704 (854)
                      +||||++++ +.+.+.....  ....+++..++.++.||+.||+|||+.   +|+||||||+||+++ .++..++ |||+
T Consensus       115 lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeeccCcc-HHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            999999874 4443332110  012789999999999999999999999   999999999999998 5666555 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc-
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK-  782 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-  782 (854)
                      ++........    ....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+.++........ 
T Consensus       189 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~  263 (394)
T 4e7w_A          189 AKILIAGEPN----VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSR  263 (394)
T ss_dssp             CEECCTTCCC----CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCH
T ss_pred             cccccCCCCC----cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCH
Confidence            9877543322    234689999999998765 5899999999999999999999999864321 11222221111000 


Q ss_pred             -cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 -VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 -~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                       .....++........ ..............++.++.+++.+||+.||.+|||+.|+++.
T Consensus       264 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          264 EQIKTMNPNYMEHKFP-QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHHCGGGSSSCCC-CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhChhhhhhccc-cccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence             000000000000000 0000000000011134568899999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.3e-37  Score=335.66  Aligned_cols=277  Identities=21%  Similarity=0.324  Sum_probs=202.3

Q ss_pred             HHhhccccCccCCCcceEEEEeEEC-CCceEEEEEEeeccc--ccchHHHHHHHHHHHhc---cCCCeeeEEEEeeccCC
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILG-GEEMIVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLIKIITICSSIDS  619 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~  619 (854)
                      +.++|++.+.||+|+||.||+|++. .+++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999994 678999999997432  22234567888887777   89999999999874332


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccc
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH  699 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~  699 (854)
                      ......++||||++ |+|.+++......    .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++..+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence            23347899999997 5999999876432    589999999999999999999999   999999999999999887776


Q ss_pred             c-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          700 Q-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       700 ~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                      + |||.+........    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........
T Consensus       161 l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~  235 (326)
T 1blx_A          161 LADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVI  235 (326)
T ss_dssp             ECSCCSCCCCCGGGG----GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred             EecCcccccccCCCC----ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHc
Confidence            6 9999987654321    123468999999999999899999999999999999999999998643211 111111110


Q ss_pred             -C--CcccccccC-chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          779 -L--PEKVIEIVD-PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       779 -~--~~~~~~~~d-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       .  ...+..... +..   .....  ...........++..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQ---AFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCCGGGSCTTCSSCGG---GSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCcccCccccccchh---hhccc--CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             0  001100000 000   00000  000000011123556789999999999999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1e-37  Score=339.73  Aligned_cols=264  Identities=20%  Similarity=0.300  Sum_probs=200.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccc-----------------hHHHHHHHHHHHhccCCCeee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGA-----------------FRSFVAECEALRNIRHRNLIK  609 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~  609 (854)
                      .++|.+.+.||+|+||.||+|++  +++.||||++.......                 .+.+.+|+.++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999999  78999999997432111                 178999999999999999999


Q ss_pred             EEEEeeccCCCCCceeeEEEeeccCCCHHHH------hhhcCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEe
Q 043388          610 IITICSSIDSKGADFKALVFEYMENGSLEDW------LHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPIVH  682 (854)
Q Consensus       610 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH  682 (854)
                      +++++.+.+     ..++||||+++|+|.++      +....    ...+++..++.++.|++.||+|||+ .   +|+|
T Consensus       108 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H  175 (348)
T 2pml_X          108 CEGIITNYD-----EVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH  175 (348)
T ss_dssp             CSEEEESSS-----EEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             EEEEEeeCC-----eEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence            999997755     78999999999999999      54421    2278999999999999999999999 8   9999


Q ss_pred             ecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCC-CCCc-cchhHHHHHHHHHHHhCCC
Q 043388          683 GDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASM-TGDVYSFGILLLEMFTGRR  759 (854)
Q Consensus       683 ~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~slGvvl~elltg~~  759 (854)
                      |||||+||+++.++..++ |||.+.......     .....||+.|+|||++.+. .++. ++|||||||++|||++|+.
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~  250 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV  250 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTTE-----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCChHhEEEcCCCcEEEecccccccccccc-----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence            999999999998887776 999998765431     1234699999999999887 5666 9999999999999999999


Q ss_pred             CCCCcccCCchHhHHhhhcC--CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHH
Q 043388          760 PTDAAFTEGLTLHEFVKMTL--PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRD  837 (854)
Q Consensus       760 pf~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e  837 (854)
                      ||..................  +........+..           ..........++..+.+++.+||+.||.+|||+.|
T Consensus       251 pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e  319 (348)
T 2pml_X          251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLT-----------NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED  319 (348)
T ss_dssp             SSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTC-----------C--------CCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCCCCCcHHHHHHHHhccCcCCccchhhhhcccc-----------ccccccchhhcCHHHHHHHHHHccCChhhCCCHHH
Confidence            99865332111111111111  100000000000           00000011223566889999999999999999999


Q ss_pred             HHH
Q 043388          838 VVA  840 (854)
Q Consensus       838 vl~  840 (854)
                      +++
T Consensus       320 ~l~  322 (348)
T 2pml_X          320 ALK  322 (348)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.1e-37  Score=339.67  Aligned_cols=200  Identities=28%  Similarity=0.364  Sum_probs=168.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-CC-----CeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HR-----NLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~  620 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||+++... .....+.+|+.+++.++ |+     +|+++++++...+  
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~--  129 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN--  129 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT--
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC--
Confidence            578999999999999999999999899999999997432 23466778999998885 54     4999999987755  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC--Cccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH--DMVA  698 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~  698 (854)
                         ..++||||+++ +|.+++......    .+++..++.++.|++.||+|||++ ..+|+||||||+|||++.  ++..
T Consensus       130 ---~~~lv~e~~~~-~L~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          130 ---HLCLVFEMLSY-NLYDLLRNTNFR----GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             ---EEEEEEECCCC-BHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred             ---ceEEEEecCCC-CHHHHHhhcCcC----CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence               78999999965 999999876422    689999999999999999999952 128999999999999954  4444


Q ss_pred             c-cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCc
Q 043388          699 H-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA  764 (854)
Q Consensus       699 ~-~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~  764 (854)
                      + +|||+++.......      ...||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       201 kL~DFG~a~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          201 KIVDFGSSCQLGQRIY------QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EECCCTTCEETTCCCC------SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEeccCceecccccc------cccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            4 49999987754322      246899999999999999999999999999999999999999864

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.1e-36  Score=341.70  Aligned_cols=333  Identities=19%  Similarity=0.167  Sum_probs=260.0

Q ss_pred             CCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecc
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTV   97 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~   97 (854)
                      ++......+...+..+..++.+++|++|++++|.+++. | .|+.+++|++|+|++|+|+++ |  ++.+++|++|+|++
T Consensus        20 l~~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~   94 (457)
T 3bz5_A           20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDS   94 (457)
T ss_dssp             HHHHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCS
T ss_pred             HHHHHHHhcCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcC
Confidence            33344445555556667889999999999999999954 5 689999999999999999975 4  88999999999999


Q ss_pred             cccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcccc
Q 043388           98 NRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL  177 (854)
Q Consensus        98 N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l  177 (854)
                      |+|+ .+|   |.++++|++|++++|+++.                  +|  ++++++|++|++++|+|+++   .+..+
T Consensus        95 N~l~-~~~---~~~l~~L~~L~L~~N~l~~------------------l~--~~~l~~L~~L~l~~N~l~~l---~l~~l  147 (457)
T 3bz5_A           95 NKLT-NLD---VTPLTKLTYLNCDTNKLTK------------------LD--VSQNPLLTYLNCARNTLTEI---DVSHN  147 (457)
T ss_dssp             SCCS-CCC---CTTCTTCCEEECCSSCCSC------------------CC--CTTCTTCCEEECTTSCCSCC---CCTTC
T ss_pred             CCCc-eee---cCCCCcCCEEECCCCcCCe------------------ec--CCCCCcCCEEECCCCcccee---ccccC
Confidence            9998 554   6777777777777776643                  33  77889999999999999986   38889


Q ss_pred             CCCCeEeccccc-ccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccccc
Q 043388          178 KNLWWLNLEQNN-LGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNL  256 (854)
Q Consensus       178 ~~L~~L~L~~N~-l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l  256 (854)
                      ++|++|++++|. ++.+         .+..+++|++|++++|++++ +|  +..++ .|+.|++++|++++.   .++.+
T Consensus       148 ~~L~~L~l~~n~~~~~~---------~~~~l~~L~~L~ls~n~l~~-l~--l~~l~-~L~~L~l~~N~l~~~---~l~~l  211 (457)
T 3bz5_A          148 TQLTELDCHLNKKITKL---------DVTPQTQLTTLDCSFNKITE-LD--VSQNK-LLNRLNCDTNNITKL---DLNQN  211 (457)
T ss_dssp             TTCCEEECTTCSCCCCC---------CCTTCTTCCEEECCSSCCCC-CC--CTTCT-TCCEEECCSSCCSCC---CCTTC
T ss_pred             CcCCEEECCCCCccccc---------ccccCCcCCEEECCCCccce-ec--cccCC-CCCEEECcCCcCCee---ccccC
Confidence            999999999994 4433         25678899999999999985 55  56664 789999999999865   38888


Q ss_pred             ccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCccccc
Q 043388          257 VNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDA  336 (854)
Q Consensus       257 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  336 (854)
                      ++|+.|++++|+++++ |  ++.+++|+.|++++|++++..   ++.+++|+.|++++|              +|+.|++
T Consensus       212 ~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l  271 (457)
T 3bz5_A          212 IQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDL  271 (457)
T ss_dssp             TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCC
T ss_pred             CCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEEC
Confidence            9999999999999874 4  788899999999999998654   455677888887776              4667899


Q ss_pred             CCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEc
Q 043388          337 SHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNV  416 (854)
Q Consensus       337 s~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  416 (854)
                      ++|.+.+.+|.  ..+..+.. +++++|...+.+|...          .+|+.|++++|             ++|++|+|
T Consensus       272 ~~n~~~~~~~~--~~l~~L~~-L~Ls~n~~l~~l~~~~----------~~L~~L~l~~~-------------~~L~~L~L  325 (457)
T 3bz5_A          272 THNTQLIYFQA--EGCRKIKE-LDVTHNTQLYLLDCQA----------AGITELDLSQN-------------PKLVYLYL  325 (457)
T ss_dssp             TTCTTCCEEEC--TTCTTCCC-CCCTTCTTCCEEECTT----------CCCSCCCCTTC-------------TTCCEEEC
T ss_pred             CCCccCCcccc--cccccCCE-EECCCCcccceeccCC----------CcceEechhhc-------------ccCCEEEC
Confidence            99998877773  33333333 6666666555555321          23445554444             78999999


Q ss_pred             cCcccccccchhhcCccCCCeeecccccCcc
Q 043388          417 SSNNLSGQIPEFLQNLSFLEFLNLSYNHLEG  447 (854)
Q Consensus       417 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  447 (854)
                      ++|+|++. +  +.++++|+.|++++|++++
T Consensus       326 ~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~  353 (457)
T 3bz5_A          326 NNTELTEL-D--VSHNTKLKSLSCVNAHIQD  353 (457)
T ss_dssp             TTCCCSCC-C--CTTCTTCSEEECCSSCCCB
T ss_pred             CCCccccc-c--cccCCcCcEEECCCCCCCC
Confidence            99999984 3  8999999999999999998

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=4.9e-37  Score=358.26  Aligned_cols=339  Identities=20%  Similarity=0.215  Sum_probs=212.8

Q ss_pred             cCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEE
Q 043388           39 LSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKEL  118 (854)
Q Consensus        39 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  118 (854)
                      +.+++.|++++|.++.+.+..|..+++|++|+|++|.|+++.|.+|+++++|++|+|++|.|+ .+|...|.++++|++|
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCC-CCCHHHHcCCCCCCEE
Confidence            466777777777777665666777777888888888777777777777778888888888777 5666777777777777


Q ss_pred             EcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCCh
Q 043388          119 YLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDL  198 (854)
Q Consensus       119 ~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~  198 (854)
                      ++++|.+..+                 .+..|+++++|++|+|++|+|++++|..|..+++|++|+|++|.++.++    
T Consensus       129 ~L~~n~l~~l-----------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----  187 (597)
T 3oja_B          129 VLERNDLSSL-----------------PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD----  187 (597)
T ss_dssp             ECCSSCCCCC-----------------CTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC----
T ss_pred             EeeCCCCCCC-----------------CHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC----
Confidence            7777666433                 1234677888888888888888888878888888888888888776542    


Q ss_pred             hhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCcc
Q 043388          199 DFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVG  278 (854)
Q Consensus       199 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  278 (854)
                           +..+++|+.|++++|.+++. +     .+..|+.|++++|.++...+..   .++|+.|+|++|.+++       
T Consensus       188 -----~~~l~~L~~L~l~~n~l~~l-~-----~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~-------  246 (597)
T 3oja_B          188 -----LSLIPSLFHANVSYNLLSTL-A-----IPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD-------  246 (597)
T ss_dssp             -----GGGCTTCSEEECCSSCCSEE-E-----CCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC-------
T ss_pred             -----hhhhhhhhhhhcccCccccc-c-----CCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC-------
Confidence                 33456777777777776631 1     1123555555555554322211   1344444444444443       


Q ss_pred             CcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHH
Q 043388          279 ELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVY  358 (854)
Q Consensus       279 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~  358 (854)
                                         +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++ +|..          
T Consensus       247 -------------------~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~----------  296 (597)
T 3oja_B          247 -------------------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLY----------  296 (597)
T ss_dssp             -------------------CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECS----------
T ss_pred             -------------------ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcc----------
Confidence                               2334445555555555555555555555555555555555555542 2211          


Q ss_pred             HHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCee
Q 043388          359 LALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFL  438 (854)
Q Consensus       359 l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  438 (854)
                                     ++.       +++|+.|+|++|.++ .+|..++.+++|+.|+|++|+|++. |  +..+++|+.|
T Consensus       297 ---------------~~~-------l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L  350 (597)
T 3oja_B          297 ---------------GQP-------IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNL  350 (597)
T ss_dssp             ---------------SSC-------CTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEE
T ss_pred             ---------------ccc-------CCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEE
Confidence                           111       234666666666666 4555566677777777777777643 2  5566777777


Q ss_pred             ecccccCcccCCCCccccCcccccccccccccCCccccc
Q 043388          439 NLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDELH  477 (854)
Q Consensus       439 ~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~  477 (854)
                      ++++|+|+|..+. ..+.......+.++...|+.+....
T Consensus       351 ~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~~~~  388 (597)
T 3oja_B          351 TLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQLE  388 (597)
T ss_dssp             ECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTCEEE
T ss_pred             EeeCCCCCChhHH-HHHHHHhhhccccccccCCcchhcc
Confidence            8888877776432 2355555556777888888765543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.9e-37  Score=360.92  Aligned_cols=258  Identities=21%  Similarity=0.319  Sum_probs=202.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECC---CceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG---EEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .++|.+.+.||+|+||.||+|.+..   .+..||+|+++... ....+.+.+|+.++++++||||+++++++.+.     
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----  463 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-----  463 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----
Confidence            4678899999999999999999854   35689999986543 23346789999999999999999999998432     


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++..++ |
T Consensus       464 -~~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~D  534 (656)
T 2j0j_A          464 -PVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD  534 (656)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             -ceEEEEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEe
Confidence             46899999999999999986532     688999999999999999999999   9999999999999998877776 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||+++.........  .....+|+.|+|||++.+..++.++|||||||++|||++ |..||......  .....+.....
T Consensus       535 FG~a~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~~  610 (656)
T 2j0j_A          535 FGLSRYMEDSTYYK--ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER  610 (656)
T ss_dssp             CCCCCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTCC
T ss_pred             cCCCeecCCCccee--ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCC
Confidence            99998775443221  122357889999999988899999999999999999997 99999754221  11111111000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      .                          .....++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       611 ~--------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          611 L--------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             C--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C--------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            0                          00112245688999999999999999999999999998764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.2e-37  Score=334.48  Aligned_cols=255  Identities=19%  Similarity=0.279  Sum_probs=172.5

Q ss_pred             HhhccccC-ccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHH-HHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSN-MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAEC-EALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|.+.+ +||+|+||.||+|++..+++.||||++...     ....+|+ ..++.++||||+++++++.... .+...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~  100 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRC  100 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCce
Confidence            46899854 699999999999999999999999998643     2223333 3456679999999999987633 12235


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC---c-cccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---M-VAHQ  700 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~-~~~~  700 (854)
                      .++||||+++|+|.+++......    .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.+   + ++++
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~----~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQ----AFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeccCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence            79999999999999999876422    689999999999999999999999   99999999999999753   3 3445


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |||++.........     ...||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. ...
T Consensus       174 Dfg~~~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~-~~~  246 (336)
T 3fhr_A          174 DFGFAKETTQNALQ-----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-KR-RIR  246 (336)
T ss_dssp             CCTTCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             ccccceeccccccc-----cCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH-HH-hhh
Confidence            99999876543222     245899999999998888999999999999999999999999754322110000 00 000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ........                   .....++..+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~-------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          247 LGQYGFPN-------------------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ----CCCT-------------------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccccCc-------------------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00000000                   000122456789999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=338.29  Aligned_cols=275  Identities=19%  Similarity=0.237  Sum_probs=197.5

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCC-CCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSK-GADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  624 (854)
                      .+|.+.+.||+|+||.||+|++..+++.||||++.....  ...+.+.+|+.++++++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            579999999999999999999998999999999965322  2346788999999999999999999998765421 1123


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||++ ++|.+++..        .+++.++..++.||+.||+|||++   +|+||||||+||+++.++..++ |||
T Consensus       104 ~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             EEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence            599999997 588887642        578999999999999999999999   9999999999999998876666 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc--CC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT--LP  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~--~~  780 (854)
                      .+.......      ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.......  .+
T Consensus       172 ~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~  244 (353)
T 3coi_A          172 LARHADAEM------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPG  244 (353)
T ss_dssp             CTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCC
T ss_pred             cccCCCCCc------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence            998654332      22468999999999877 678999999999999999999999997543211 111111111  11


Q ss_pred             cccccccCchhhHHHhhccch-hhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSM-IQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..+...+.............. ....-......++..+.+++.+||+.||++|||+.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            111111111111111000000 0000000112235678899999999999999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2e-37  Score=332.55  Aligned_cols=240  Identities=23%  Similarity=0.322  Sum_probs=195.1

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc------chHHHHHHHHHHHhcc--CCCeeeEEEEeeccC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG------AFRSFVAECEALRNIR--HRNLIKIITICSSID  618 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~  618 (854)
                      .++|++.+.||+|+||.||+|++..+++.||||+++.....      ..+.+.+|+.++++++  |+||+++++++...+
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            46899999999999999999999989999999999754321      2245678999999996  599999999997655


Q ss_pred             CCCCceeeEEEeeccC-CCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec-CCc
Q 043388          619 SKGADFKALVFEYMEN-GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDM  696 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~  696 (854)
                           ..++||||+.+ ++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++ .++
T Consensus       122 -----~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~  187 (320)
T 3a99_A          122 -----SFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG  187 (320)
T ss_dssp             -----EEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTT
T ss_pred             -----cEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCC
Confidence                 68999999976 89999998754      689999999999999999999999   999999999999998 555


Q ss_pred             cccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHH
Q 043388          697 VAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEF  774 (854)
Q Consensus       697 ~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~  774 (854)
                      ..++ |||++.........     ...||+.|+|||++.+..+ +.++|||||||++|||++|+.||....       ..
T Consensus       188 ~~kL~Dfg~~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~  255 (320)
T 3a99_A          188 ELKLIDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EI  255 (320)
T ss_dssp             EEEECCCTTCEECCSSCBC-----CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH
T ss_pred             CEEEeeCcccccccccccc-----CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hh
Confidence            5555 99999877543221     2469999999999877665 788999999999999999999997421       11


Q ss_pred             hhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          775 VKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       775 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ......      ..                      ..++.++.+++.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~------~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 IRGQVF------FR----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHCCCC------CS----------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hccccc------cc----------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111000      00                      011345788999999999999999999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.5e-37  Score=331.37  Aligned_cols=257  Identities=21%  Similarity=0.249  Sum_probs=175.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc-cchHHHHHHHH-HHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-GAFRSFVAECE-ALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|.+.+.||+|+||.||+|.+..+++.||||+++.... .....+.+|+. +++.++||||+++++++...+     ..
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-----~~   96 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-----DC   96 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-----EE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-----ce
Confidence            689999999999999999999998999999999975432 23345566666 667779999999999997655     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+++ +|.+++...... ....+++..+..++.|++.||+|||+..  +|+||||||+||+++.++..++ |||+
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             EEEEeecCC-ChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCC
Confidence            999999986 888887642110 0126899999999999999999999953  8999999999999998887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCcccc----CCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYG----MGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ++........    ....||+.|+|||++    .+..++.++|||||||++|||++|+.||...........    ....
T Consensus       173 ~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~  244 (327)
T 3aln_A          173 SGQLVDSIAK----TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT----QVVK  244 (327)
T ss_dssp             SCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C----CCCC
T ss_pred             ceeccccccc----ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH----HHhc
Confidence            9876543222    123589999999998    456689999999999999999999999975322111111    1111


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ........ .                  ....++..+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~-~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          245 GDPPQLSN-S------------------EEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             SCCCCCCC-C------------------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCC-c------------------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00000000 0                  00012456889999999999999999999976

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.1e-37  Score=338.37  Aligned_cols=276  Identities=17%  Similarity=0.255  Sum_probs=199.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-----------CCCeeeEEEEeec
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-----------HRNLIKIITICSS  616 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~  616 (854)
                      .+|.+.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|++++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            58999999999999999999998899999999996432 23467889999999886           8999999999876


Q ss_pred             cCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-
Q 043388          617 IDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-  695 (854)
Q Consensus       617 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-  695 (854)
                      .+. .....++||||+ +++|.+++......    .+++..+..++.||+.||+|||+++  +|+||||||+||+++.+ 
T Consensus        98 ~~~-~~~~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           98 KGP-NGVHVVMVFEVL-GENLLALIKKYEHR----GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EET-TEEEEEEEECCC-CEEHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred             cCC-CCceEEEEEecC-CCCHHHHHHHhhcc----CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence            432 223689999999 88999999875422    5899999999999999999999954  89999999999999532 


Q ss_pred             -----cccc-cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC-
Q 043388          696 -----MVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG-  768 (854)
Q Consensus       696 -----~~~~-~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~-  768 (854)
                           ...+ +|||++........      ...||+.|+|||++.+..++.++|||||||++|||++|+.||....... 
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEHYT------NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBCCC------SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCcCcceEEEcccccccccCCCCC------CCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence                 2344 49999987754322      2368999999999999999999999999999999999999998543211 


Q ss_pred             ----chHhHHhhhc--CCcccccccCchhhHHHhh----------c----cchhhHhhhhhHHHHHHHHHHHhhcccCCC
Q 043388          769 ----LTLHEFVKMT--LPEKVIEIVDPSLLMEVMA----------N----NSMIQEDRRARTQDCLNAITRTGVLCSMES  828 (854)
Q Consensus       769 ----~~~~~~~~~~--~~~~~~~~~d~~~~~~~~~----------~----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d  828 (854)
                          ..+.......  .+..+..  +.........          .    ..............+..++.+++.+||+.|
T Consensus       244 ~~~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  321 (373)
T 1q8y_A          244 TKDDDHIAQIIELLGELPSYLLR--NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  321 (373)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHH--HCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             CChHHHHHHHHHhcCCCCHHHHh--ccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence                1111111110  0000000  0000000000          0    000000111122456778999999999999


Q ss_pred             CCCCCCHHHHHH
Q 043388          829 PFERMEMRDVVA  840 (854)
Q Consensus       829 P~~RPs~~evl~  840 (854)
                      |++|||+.|+++
T Consensus       322 P~~Rpt~~ell~  333 (373)
T 1q8y_A          322 PRKRADAGGLVN  333 (373)
T ss_dssp             TTTCBCHHHHHT
T ss_pred             ccccCCHHHHhh
Confidence            999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-36  Score=332.39  Aligned_cols=271  Identities=18%  Similarity=0.220  Sum_probs=196.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCc-eEEEEEEeecccccchHHHHHHHHHHHhccCCC------eeeEEEEeeccCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEE-MIVAVKVINLKQKGAFRSFVAECEALRNIRHRN------LIKIITICSSIDSK  620 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~  620 (854)
                      ++|.+.+.||+|+||.||+|.+..++ ..||+|+++... ...+.+.+|+.++++++|++      ++.+++++...+  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~--   95 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG--   95 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT--
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC--
Confidence            68999999999999999999997666 799999996432 33467889999999997766      899999887655  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe--------
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL--------  692 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--------  692 (854)
                         ..++||||+ ++++.+++......    .+++.+++.++.||+.||+|||+.   +|+||||||+||++        
T Consensus        96 ---~~~lv~e~~-~~~l~~~l~~~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           96 ---HMCIAFELL-GKNTFEFLKENNFQ----PYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             ---EEEEEEECC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEE
T ss_pred             ---eEEEEEecc-CCChHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccc
Confidence               789999999 66787877765321    689999999999999999999999   99999999999999        


Q ss_pred             -----------cCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 043388          693 -----------DHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP  760 (854)
Q Consensus       693 -----------~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p  760 (854)
                                 +.++..++ |||.+........      ...||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  238 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT------TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL  238 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTSCCC------SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccccccCCCcEEEeecCcccccccccc------CCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence                       34455555 9999986543322      24699999999999999999999999999999999999999


Q ss_pred             CCCcccCCchHhHHhh--hcCCcccccc-------------cCch--hhHHHhhccchhhHhhhhhHHHHHHHHHHHhhc
Q 043388          761 TDAAFTEGLTLHEFVK--MTLPEKVIEI-------------VDPS--LLMEVMANNSMIQEDRRARTQDCLNAITRTGVL  823 (854)
Q Consensus       761 f~~~~~~~~~~~~~~~--~~~~~~~~~~-------------~d~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  823 (854)
                      |....... .......  ...+..+...             .+..  ........+.... ........+..++.+++.+
T Consensus       239 f~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~  316 (355)
T 2eu9_A          239 FQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK-SYMLQDSLEHVQLFDLMRR  316 (355)
T ss_dssp             CCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG-GGCSCCSHHHHHHHHHHHH
T ss_pred             CCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccc-ccccccchhHHHHHHHHHH
Confidence            98543211 1111111  1111110000             0000  0000000000000 0000112235678899999


Q ss_pred             ccCCCCCCCCCHHHHHH
Q 043388          824 CSMESPFERMEMRDVVA  840 (854)
Q Consensus       824 cl~~dP~~RPs~~evl~  840 (854)
                      ||+.||++|||+.|+++
T Consensus       317 ~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          317 MLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HTCSSTTTSCCHHHHTT
T ss_pred             HhcCChhhCcCHHHHhc
Confidence            99999999999999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.9e-37  Score=320.77  Aligned_cols=234  Identities=12%  Similarity=0.116  Sum_probs=183.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||.||+|++..+++.||||+++....   ...+.+.+|+.++.+++||||+++++++...+     .
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA-----G  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----E
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC-----c
Confidence            579999999999999999999998899999999975432   23467899999999999999999999997755     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccccccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSL  704 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg~  704 (854)
                      .|+||||++|++|.+++...        ....++.+|+.|++.||+|||++   +|+||||||+||+++.++..+++|+ 
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~-  173 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP-  173 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC-
T ss_pred             EEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec-
Confidence            89999999999999998542        24456888999999999999999   9999999999999999887777532 


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                                           +|++|       ++.++|||||||++|||+||+.||............ . ......  
T Consensus       174 ---------------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-~-~~~~~~--  221 (286)
T 3uqc_A          174 ---------------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-E-RDTAGQ--  221 (286)
T ss_dssp             ---------------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-C-BCTTSC--
T ss_pred             ---------------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-H-HHhccC--
Confidence                                 34443       789999999999999999999999865332110000 0 000000  


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                       ...+                 ......++..+.+++.+||+.||++| |+.|+++.|+++....
T Consensus       222 -~~~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          222 -PIEP-----------------ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             -BCCH-----------------HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             -CCCh-----------------hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence             0000                 00111235668899999999999999 9999999999987544

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-37  Score=329.28  Aligned_cols=243  Identities=23%  Similarity=0.328  Sum_probs=189.1

Q ss_pred             HHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc------cchHHHHHHHHHHHhc----cCCCeeeEEEE
Q 043388          544 SKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK------GAFRSFVAECEALRNI----RHRNLIKIITI  613 (854)
Q Consensus       544 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~~~~~  613 (854)
                      ....++|++.+.||+|+||.||+|++..+++.||||+++....      .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            3446789999999999999999999988999999999965432      1223456799999999    89999999999


Q ss_pred             eeccCCCCCceeeEEEee-ccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEe
Q 043388          614 CSSIDSKGADFKALVFEY-MENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLL  692 (854)
Q Consensus       614 ~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll  692 (854)
                      +...+     ..++|||| +++++|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||++
T Consensus       107 ~~~~~-----~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  172 (312)
T 2iwi_A          107 FETQE-----GFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILI  172 (312)
T ss_dssp             C----------CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEE
T ss_pred             EecCC-----eEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEE
Confidence            87654     57999999 78999999998754      689999999999999999999999   99999999999999


Q ss_pred             c-CCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCc
Q 043388          693 D-HDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGL  769 (854)
Q Consensus       693 ~-~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~  769 (854)
                      + .++..++ |||.+........     ....||..|+|||++.+..+ +.++|||||||++|||++|+.||....    
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----  243 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDEPY-----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----  243 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSSCB-----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred             eCCCCeEEEEEcchhhhcccCcc-----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----
Confidence            8 6665555 9999987754322     22468999999999877665 458999999999999999999997421    


Q ss_pred             hHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          770 TLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                         +.......  .    .                      ..+...+.+++.+||+.||++|||+.|+++
T Consensus       244 ---~~~~~~~~--~----~----------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 ---EILEAELH--F----P----------------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ---HHHHTCCC--C----C----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---HHhhhccC--C----c----------------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               11111000  0    0                      011345778999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.6e-37  Score=341.24  Aligned_cols=255  Identities=21%  Similarity=0.258  Sum_probs=181.6

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceeeE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      .|.+.++||+|+||+||.+... +++.||||++....   .+.+.+|++++.++ +||||+++++++.+..     ..++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~-~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-----~~~l   86 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDR-----FLYI   86 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEES-SSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS-----EEEE
T ss_pred             eeeccCeEeeCCCeEEEEEEEE-CCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCC-----eEEE
Confidence            3555788999999999876554 78899999986432   35678999999987 8999999999987654     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccc-cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc----------
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEV-CKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----------  696 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~-~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----------  696 (854)
                      ||||++ |+|.+++......... ...++..++.++.||+.||+|||+.   +|+||||||+||+++.++          
T Consensus        87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence            999996 5999999876432111 1123345678999999999999999   999999999999997642          


Q ss_pred             ---ccc-cccccccccccCCCCCC-cccccCCcccccCccccCC-------CCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 043388          697 ---VAH-QNFSLSHQLDSASKTPS-SSIGIKGTVGYVAPEYGMG-------SEASMTGDVYSFGILLLEMFT-GRRPTDA  763 (854)
Q Consensus       697 ---~~~-~Dfg~~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvvl~ellt-g~~pf~~  763 (854)
                         ..+ +|||+++.......... ......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||..
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence               344 49999998765432211 1223569999999999876       568999999999999999999 9999975


Q ss_pred             cccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          764 AFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       764 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ....   ...+.............                     ....++.++.+++.+||+.||.+|||+.||++
T Consensus       243 ~~~~---~~~i~~~~~~~~~~~~~---------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          243 KYSR---ESNIIRGIFSLDEMKCL---------------------HDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TTTH---HHHHHHTCCCCCCCTTC---------------------CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             chhh---HHHHhcCCCCccccccc---------------------ccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            4221   11122211111000000                     01223567889999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=326.04  Aligned_cols=252  Identities=19%  Similarity=0.255  Sum_probs=177.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc-c-hHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG-A-FRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||++...... . .+.+.++..+++.++||||+++++++...+     .
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-----~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT-----D   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----E
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----c
Confidence            57899999999999999999999989999999999754322 2 233444555678889999999999997655     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      .++||||+ ++.+..+......     .+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++..++ ||
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df  169 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF  169 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecc-CCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence            89999999 5566665544322     68999999999999999999998 6   8999999999999998877776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM-----GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM  777 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~  777 (854)
                      |.+.........    ....||+.|+|||++.     +..++.++|||||||++|||++|+.||................
T Consensus       170 g~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  245 (318)
T 2dyl_A          170 GISGRLVDDKAK----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE  245 (318)
T ss_dssp             TTC------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS
T ss_pred             CCchhccCCccc----cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc
Confidence            999776543322    1245899999999984     4568899999999999999999999997532221112221111


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..+ ....                        ...++..+.+++.+||+.||.+|||+.|+++.
T Consensus       246 ~~~-~~~~------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          246 EPP-LLPG------------------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             CCC-CCCS------------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCC-CCCc------------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            110 0000                        00114457889999999999999999999863

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-36  Score=348.00  Aligned_cols=277  Identities=22%  Similarity=0.296  Sum_probs=196.1

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCc
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGAD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  623 (854)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++.. .....+.+.+|++++++++||||+++++++..... ....
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            347899999999999999999999889999999998654 23345678999999999999999999999765221 1234


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc----ccc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAH  699 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~~  699 (854)
                      ..++||||+++|+|.+++.....   ...+++..++.|+.|++.||+|||+.   +|+||||||+||+++.++    +++
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             eEEEEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEE
Confidence            67999999999999999987542   12578889999999999999999999   999999999999998765    344


Q ss_pred             cccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          700 QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       700 ~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      +|||.+.........    ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....    ...|.....
T Consensus       166 ~DFG~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~  237 (676)
T 3qa8_A          166 IDLGYAKELDQGELC----TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVR  237 (676)
T ss_dssp             CSCCCCCBTTSCCCC----CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC
T ss_pred             ccccccccccccccc----ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhh
Confidence            599999877554322    234699999999999999999999999999999999999999975311    111111100


Q ss_pred             Cccccc-ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHH
Q 043388          780 PEKVIE-IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDV  838 (854)
Q Consensus       780 ~~~~~~-~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev  838 (854)
                      ...... ..............  ..+........++..+.+++..||++||++|||+.|+
T Consensus       238 ~~~~~~~~~~~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          238 EKSNEHIVVYDDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             ------CCSCCCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             cccchhhhhhhhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            000000 00000000000000  0000000112235678899999999999999999884

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-36  Score=336.03  Aligned_cols=249  Identities=21%  Similarity=0.296  Sum_probs=179.7

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .+|.+.++||+|+||+||..... +++.||||++.....   ..+.+|+++++++ +|||||++++++.+..     ..+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~-~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-----~~~   94 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQ-----FQY   94 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEES-SSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETT-----EEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEe-CCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCC-----EEE
Confidence            46888999999999996644333 688999999864332   2356899999999 8999999999987655     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC---c--cc-cc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---M--VA-HQ  700 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~--~~-~~  700 (854)
                      +||||++ |+|.+++.....     ...+.+++.++.||+.||+|||+.   +|+||||||+||+++.+   +  .+ ++
T Consensus        95 lv~E~~~-g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~  165 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMIS  165 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSSC-----CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred             EEEECCC-CCHHHHHHhcCC-----CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence            9999996 599999987643     334445678999999999999999   99999999999999532   2  23 45


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccC---CCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhh
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM---GSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVK  776 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~  776 (854)
                      |||+++................||+.|+|||++.   +..++.++|||||||++|||++ |..||......   ......
T Consensus       166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~~~~~~  242 (432)
T 3p23_A          166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---QANILL  242 (432)
T ss_dssp             CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---HHHHHT
T ss_pred             cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---HHHHHh
Confidence            9999988765543333334467999999999987   4567889999999999999999 99998543211   111111


Q ss_pred             hcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       777 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ....   .....+.                    ......+.+++.+||+.||++|||+.||++
T Consensus       243 ~~~~---~~~~~~~--------------------~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          243 GACS---LDCLHPE--------------------KHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TCCC---CTTSCTT--------------------CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCC---ccccCcc--------------------ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1000   0000100                    111344678999999999999999999984

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.1e-36  Score=356.22  Aligned_cols=246  Identities=22%  Similarity=0.338  Sum_probs=196.0

Q ss_pred             hhccccCccCCCcceEEEEeEECC-CceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG-EEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|++.++||+|+||.||+|.+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..+....
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999975 68999999986433 2344578899999999999999999999987664444447


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccccccccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLS  705 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg~~  705 (854)
                      |+||||+++++|.+++..        .+++.+++.|+.||+.||+|||++   +|+||||||+||+++.+.++++|||++
T Consensus       160 ~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~~~kl~DFG~a  228 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEEQLKLIDLGAV  228 (681)
T ss_dssp             EEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCCcEEEEecccc
Confidence            999999999999887653        578999999999999999999999   999999999999999987777799999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      +.....       ....||+.|+|||++.+. ++.++|||||||++|||++|.+||........          +.    
T Consensus       229 ~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~----  286 (681)
T 2pzi_A          229 SRINSF-------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PE----  286 (681)
T ss_dssp             EETTCC-------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CT----
T ss_pred             hhcccC-------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------cc----
Confidence            876543       124699999999998765 48999999999999999999998764321110          00    


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-HHHHHHHHHhhhh
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-MRDVVAKLCHTRE  847 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L~~~~~  847 (854)
                       ..                    ........+.+++.+||+.||++||+ ++++...+..+..
T Consensus       287 -~~--------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          287 -DD--------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             -TC--------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             -cc--------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence             00                    00112356789999999999999995 6667776766543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.4e-34  Score=319.96  Aligned_cols=289  Identities=19%  Similarity=0.258  Sum_probs=186.3

Q ss_pred             cCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCcee
Q 043388           14 SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFI   93 (854)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L   93 (854)
                      .++++++|++++|.++...+..|..+++|++|+|++|++++..+..|+.+++|++|+|++|.++++.|..|+++++|++|
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            45788999999999985555557888999999999999988777889999999999999999998888888999999999


Q ss_pred             eecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcC
Q 043388           94 YLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID  173 (854)
Q Consensus        94 ~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~  173 (854)
                      +|++|+|+ .+|..+|.++++|++|++++|+++.+                 .|..|.++++|++|+|++|+++++   .
T Consensus       123 ~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~-----------------~~~~~~~l~~L~~L~l~~n~l~~~---~  181 (390)
T 3o6n_A          123 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERI-----------------EDDTFQATTSLQNLQLSSNRLTHV---D  181 (390)
T ss_dssp             ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBC-----------------CTTTTSSCTTCCEEECCSSCCSBC---C
T ss_pred             ECCCCccC-cCCHHHhcCCCCCcEEECCCCccCcc-----------------ChhhccCCCCCCEEECCCCcCCcc---c
Confidence            99999998 88888888888888888887765422                 234455566666666666665544   2


Q ss_pred             ccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccc
Q 043388          174 FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI  253 (854)
Q Consensus       174 f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~  253 (854)
                      +..+++|+.|++++|.++.+           ...++|+.|++++|.++. +|...   .+.|+.|++++|.+++.  ..+
T Consensus       182 ~~~l~~L~~L~l~~n~l~~~-----------~~~~~L~~L~l~~n~l~~-~~~~~---~~~L~~L~l~~n~l~~~--~~l  244 (390)
T 3o6n_A          182 LSLIPSLFHANVSYNLLSTL-----------AIPIAVEELDASHNSINV-VRGPV---NVELTILKLQHNNLTDT--AWL  244 (390)
T ss_dssp             GGGCTTCSEEECCSSCCSEE-----------ECCSSCSEEECCSSCCCE-EECCC---CSSCCEEECCSSCCCCC--GGG
T ss_pred             cccccccceeeccccccccc-----------CCCCcceEEECCCCeeee-ccccc---cccccEEECCCCCCccc--HHH
Confidence            34455555555555555422           222345555555555552 22221   12455555555555532  345


Q ss_pred             cccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcc
Q 043388          254 RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKG  333 (854)
Q Consensus       254 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  333 (854)
                      ..+++|++|+|++|+++++.|..|..+++|++|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.
T Consensus       245 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~  322 (390)
T 3o6n_A          245 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN  322 (390)
T ss_dssp             GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred             cCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCE
Confidence            555555555555555555555555555555555555555553 3444445555555555555555 34444455555555


Q ss_pred             cccCCCccc
Q 043388          334 FDASHNKLT  342 (854)
Q Consensus       334 L~ls~N~l~  342 (854)
                      |++++|+++
T Consensus       323 L~L~~N~i~  331 (390)
T 3o6n_A          323 LYLDHNSIV  331 (390)
T ss_dssp             EECCSSCCC
T ss_pred             EECCCCccc
Confidence            555555554

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.8e-34  Score=313.75  Aligned_cols=298  Identities=24%  Similarity=0.350  Sum_probs=196.0

Q ss_pred             hhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCC
Q 043388           11 EIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSL   90 (854)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L   90 (854)
                      .+..+++|++|++++|.++ .+|. ++.+++|++|++++|++++. +. |..+++|++|+|++|.++++ | +|.++++|
T Consensus        39 ~~~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~-~-~~~~l~~L  112 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI-S-ALQNLTNL  112 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC-G-GGTTCTTC
T ss_pred             cchhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc-h-HHcCCCcC
Confidence            4568899999999999998 4554 89999999999999999954 44 99999999999999999963 4 69999999


Q ss_pred             ceeeecccccccccCcccccCCCCCcEEEcccCC----------CCCCceeeccCccCCCCCCCCCCccccCCCCCCEEe
Q 043388           91 EFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCS----------LKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLD  160 (854)
Q Consensus        91 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~----------l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~  160 (854)
                      ++|+|++|+++ .++.  +..+++|++|++++|.          +++|+.|++++|.+.     .++. +..+++|++|+
T Consensus       113 ~~L~l~~n~i~-~~~~--~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~-----~~~~-~~~l~~L~~L~  183 (347)
T 4fmz_A          113 RELYLNEDNIS-DISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVK-----DVTP-IANLTDLYSLS  183 (347)
T ss_dssp             SEEECTTSCCC-CCGG--GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCC-----CCGG-GGGCTTCSEEE
T ss_pred             CEEECcCCccc-Cchh--hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcC-----Cchh-hccCCCCCEEE
Confidence            99999999998 6665  8899999999998883          345556666665552     2222 55556666666


Q ss_pred             cCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEc
Q 043388          161 LSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI  240 (854)
Q Consensus       161 Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l  240 (854)
                      +++|++.++.+  +..+++|++|++++|.+....        .+..+++|++|++++|.+++ +|. +..++ .|+.|++
T Consensus       184 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--------~~~~~~~L~~L~l~~n~l~~-~~~-~~~l~-~L~~L~l  250 (347)
T 4fmz_A          184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDIT--------PVANMTRLNSLKIGNNKITD-LSP-LANLS-QLTWLEI  250 (347)
T ss_dssp             CTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCG--------GGGGCTTCCEEECCSSCCCC-CGG-GTTCT-TCCEEEC
T ss_pred             ccCCccccccc--ccCCCccceeecccCCCCCCc--------hhhcCCcCCEEEccCCccCC-Ccc-hhcCC-CCCEEEC
Confidence            66666654443  555566666666666554322        14455566666666666653 222 44443 5666666


Q ss_pred             cCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceeccc
Q 043388          241 GGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGN  320 (854)
Q Consensus       241 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  320 (854)
                      ++|.+++.  +.+..+++|++|++++|+++++  +.+..+++|+.|++++|++++..|..+..+++|+.|++++|++++.
T Consensus       251 ~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~  326 (347)
T 4fmz_A          251 GTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI  326 (347)
T ss_dssp             CSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred             CCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence            66665532  3455556666666666665543  3455556666666666666555555555666666666666666544


Q ss_pred             CCCCCcCCCCCcccccCCCccc
Q 043388          321 IPSSLGNCQNLKGFDASHNKLT  342 (854)
Q Consensus       321 ~~~~~~~l~~L~~L~ls~N~l~  342 (854)
                      .|  +..+++|+.|++++|.++
T Consensus       327 ~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          327 RP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             GG--GGGCTTCSEESSSCC---
T ss_pred             cC--hhhhhccceeehhhhccc
Confidence            33  555566666666666553

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.2e-34  Score=313.18  Aligned_cols=307  Identities=24%  Similarity=0.386  Sum_probs=194.6

Q ss_pred             ccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCC
Q 043388           36 VGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL  115 (854)
Q Consensus        36 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  115 (854)
                      +..+++|++|++++|.++ .++. |..+++|++|+|++|+++++.+  |.++++|++|+|++|+++ .+|  .|.++++|
T Consensus        40 ~~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~-~~~--~~~~l~~L  112 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DIS--ALQNLTNL  112 (347)
T ss_dssp             HHHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG--GGTTCTTC
T ss_pred             chhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCccc-Cch--HHcCCCcC
Confidence            345566666666666666 3333 6666666666666666664333  666666666666666665 343  24555555


Q ss_pred             cEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCC
Q 043388          116 KELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTA  195 (854)
Q Consensus       116 ~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~  195 (854)
                      ++|++++|.+..+                  |. +.++++|++|++++|......+ .+..+++|++|++++|.+.....
T Consensus       113 ~~L~l~~n~i~~~------------------~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~  172 (347)
T 4fmz_A          113 RELYLNEDNISDI------------------SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP  172 (347)
T ss_dssp             SEEECTTSCCCCC------------------GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG
T ss_pred             CEEECcCCcccCc------------------hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh
Confidence            5555544444322                  22 4555555555555554332222 24455555555555554432211


Q ss_pred             CChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCC
Q 043388          196 NDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPD  275 (854)
Q Consensus       196 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  275 (854)
                              +..++                         .|+.|++++|.+++..+  +..+++|+.|++++|++++..+ 
T Consensus       173 --------~~~l~-------------------------~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-  216 (347)
T 4fmz_A          173 --------IANLT-------------------------DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-  216 (347)
T ss_dssp             --------GGGCT-------------------------TCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-
T ss_pred             --------hccCC-------------------------CCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch-
Confidence                    33344                         45555555555543322  6666777777777777775544 


Q ss_pred             CccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhh
Q 043388          276 GVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTL  355 (854)
Q Consensus       276 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l  355 (854)
                       +..+++|++|++++|++++..+  +..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++ +|.        
T Consensus       217 -~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~--------  282 (347)
T 4fmz_A          217 -VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-ISV--------  282 (347)
T ss_dssp             -GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CGG--------
T ss_pred             -hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-Chh--------
Confidence             6777777777777777774433  77778888888888887743  467788888888888888873 211        


Q ss_pred             HHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCC
Q 043388          356 SVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFL  435 (854)
Q Consensus       356 ~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  435 (854)
                                        +..       +++|++|++++|++++..|..++.+++|++|+|++|++++..|  +..+++|
T Consensus       283 ------------------~~~-------l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L  335 (347)
T 4fmz_A          283 ------------------LNN-------LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM  335 (347)
T ss_dssp             ------------------GGG-------CTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTC
T ss_pred             ------------------hcC-------CCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhcc
Confidence                              111       4568899999999988888888999999999999999997666  8889999


Q ss_pred             CeeecccccCc
Q 043388          436 EFLNLSYNHLE  446 (854)
Q Consensus       436 ~~L~ls~N~l~  446 (854)
                      +.|++++|+++
T Consensus       336 ~~L~l~~N~i~  346 (347)
T 4fmz_A          336 DSADFANQVIK  346 (347)
T ss_dssp             SEESSSCC---
T ss_pred             ceeehhhhccc
Confidence            99999999875

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.1e-34  Score=310.93  Aligned_cols=298  Identities=18%  Similarity=0.254  Sum_probs=239.7

Q ss_pred             cCchhhhcC------CCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            7 QIPEEIGSL------LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         7 ~~p~~~~~l------~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      .+|..+...      .+++++++++|.++ .+|..+.  ++|++|+|++|++++..|..|..+++|++|+|++|+|+++.
T Consensus        18 ~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~   94 (332)
T 2ft3_A           18 SLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH   94 (332)
T ss_dssp             -------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             cCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccC
Confidence            456555443      47999999999998 6787764  68999999999999888889999999999999999999888


Q ss_pred             hhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEe
Q 043388           81 PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLD  160 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~  160 (854)
                      |.+|+++++|++|+|++|+++ .+|..++   ++|++|++++|+++.+                 .+..|.++++|++|+
T Consensus        95 ~~~~~~l~~L~~L~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~-----------------~~~~~~~l~~L~~L~  153 (332)
T 2ft3_A           95 EKAFSPLRKLQKLYISKNHLV-EIPPNLP---SSLVELRIHDNRIRKV-----------------PKGVFSGLRNMNCIE  153 (332)
T ss_dssp             GGGSTTCTTCCEEECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCC-----------------CSGGGSSCSSCCEEE
T ss_pred             HhHhhCcCCCCEEECCCCcCC-ccCcccc---ccCCEEECCCCccCcc-----------------CHhHhCCCccCCEEE
Confidence            999999999999999999998 8887765   6677777766665433                 245688899999999


Q ss_pred             cCCCcCcc--cCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEE
Q 043388          161 LSGNQFKG--KVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQF  238 (854)
Q Consensus       161 Ls~N~i~~--~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L  238 (854)
                      +++|+++.  ..+..|..+ +|++|++++|+++.++..       +  .++|++|++++|.+++..|..+..+. .|+.|
T Consensus       154 l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~-------~--~~~L~~L~l~~n~i~~~~~~~l~~l~-~L~~L  222 (332)
T 2ft3_A          154 MGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKD-------L--PETLNELHLDHNKIQAIELEDLLRYS-KLYRL  222 (332)
T ss_dssp             CCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSS-------S--CSSCSCCBCCSSCCCCCCTTSSTTCT-TCSCC
T ss_pred             CCCCccccCCCCcccccCC-ccCEEECcCCCCCccCcc-------c--cCCCCEEECCCCcCCccCHHHhcCCC-CCCEE
Confidence            99999963  778888888 999999999999876553       1  26888999999999877777788776 78899


Q ss_pred             EccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCc------cccchhcc
Q 043388          239 RIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNL------TKLADLAL  312 (854)
Q Consensus       239 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~L  312 (854)
                      ++++|++++..+..|..+++|++|+|++|+++ .+|..+..+++|+.|++++|++++..+..|...      ..|+.|++
T Consensus       223 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l  301 (332)
T 2ft3_A          223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISL  301 (332)
T ss_dssp             BCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEEC
T ss_pred             ECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEe
Confidence            99999998888888888999999999999988 567778888999999999999987777777653      56888899


Q ss_pred             ccceec--ccCCCCCcCCCCCcccccCCCc
Q 043388          313 SFNNLQ--GNIPSSLGNCQNLKGFDASHNK  340 (854)
Q Consensus       313 ~~N~l~--~~~~~~~~~l~~L~~L~ls~N~  340 (854)
                      ++|.+.  +..|.+|..+++|+.+++++|+
T Consensus       302 ~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          302 FNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ecCcccccccCcccccccchhhhhhccccc
Confidence            999887  5677888888999999888875

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=5.7e-34  Score=307.32  Aligned_cols=291  Identities=19%  Similarity=0.229  Sum_probs=245.9

Q ss_pred             CCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceee
Q 043388           15 LLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIY   94 (854)
Q Consensus        15 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~   94 (854)
                      ..++++++++++.++ .+|..+.  ++|++|+|++|+|++..+..|+.+++|++|+|++|+++++.|.+|.++++|++|+
T Consensus        30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            458999999999998 6787665  6899999999999988788999999999999999999988899999999999999


Q ss_pred             ecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcc--cCCc
Q 043388           95 LTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKG--KVSI  172 (854)
Q Consensus        95 L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~--~~~~  172 (854)
                      |++|+|+ .+|..++   ++|++|++++|++..+                 .+..|.++++|++|+|++|+++.  +.+.
T Consensus       107 Ls~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~-----------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  165 (330)
T 1xku_A          107 LSKNQLK-ELPEKMP---KTLQELRVHENEITKV-----------------RKSVFNGLNQMIVVELGTNPLKSSGIENG  165 (330)
T ss_dssp             CCSSCCS-BCCSSCC---TTCCEEECCSSCCCBB-----------------CHHHHTTCTTCCEEECCSSCCCGGGBCTT
T ss_pred             CCCCcCC-ccChhhc---ccccEEECCCCccccc-----------------CHhHhcCCccccEEECCCCcCCccCcChh
Confidence            9999998 8887665   5677777766665433                 34568999999999999999964  7788


Q ss_pred             CccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcc
Q 043388          173 DFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSG  252 (854)
Q Consensus       173 ~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~  252 (854)
                      .|..+++|++|++++|.++.++..       +  .++|++|++++|++++..|..+..+. .|+.|++++|.+++..+..
T Consensus       166 ~~~~l~~L~~L~l~~n~l~~l~~~-------~--~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~  235 (330)
T 1xku_A          166 AFQGMKKLSYIRIADTNITTIPQG-------L--PPSLTELHLDGNKITKVDAASLKGLN-NLAKLGLSFNSISAVDNGS  235 (330)
T ss_dssp             GGGGCTTCCEEECCSSCCCSCCSS-------C--CTTCSEEECTTSCCCEECTGGGTTCT-TCCEEECCSSCCCEECTTT
T ss_pred             hccCCCCcCEEECCCCccccCCcc-------c--cccCCEEECCCCcCCccCHHHhcCCC-CCCEEECCCCcCceeChhh
Confidence            899999999999999999876653       1  27899999999999987788888886 7999999999999888888


Q ss_pred             ccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCc------cccchhccccceecc--cCCCC
Q 043388          253 IRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNL------TKLADLALSFNNLQG--NIPSS  324 (854)
Q Consensus       253 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~~--~~~~~  324 (854)
                      |..+++|++|+|++|+++ .+|..+..+++|++|++++|+|++..+..|...      +.|+.|++++|.+..  ..|..
T Consensus       236 ~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~  314 (330)
T 1xku_A          236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST  314 (330)
T ss_dssp             GGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGG
T ss_pred             ccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccc
Confidence            999999999999999998 567788999999999999999997777777543      678889999999863  56778


Q ss_pred             CcCCCCCcccccCCCc
Q 043388          325 LGNCQNLKGFDASHNK  340 (854)
Q Consensus       325 ~~~l~~L~~L~ls~N~  340 (854)
                      |..+.+++.+++++|+
T Consensus       315 f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          315 FRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             GTTCCCGGGEEC----
T ss_pred             cccccceeEEEecccC
Confidence            8889999999999885

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=2e-34  Score=336.10  Aligned_cols=311  Identities=20%  Similarity=0.252  Sum_probs=217.7

Q ss_pred             cCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCcee
Q 043388           14 SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFI   93 (854)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L   93 (854)
                      .+.+++.|++++|.++...+..|+.+++|++|+|++|.|++..|..|+.+++|++|+|++|.|+++.|..|+++++|++|
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            35788889999998886666667888889999999999988888888889999999999999988888888889999999


Q ss_pred             eecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcC
Q 043388           94 YLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID  173 (854)
Q Consensus        94 ~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~  173 (854)
                      +|++|+|+ .+|..+|.++++|++|++++|.+..+                 .|..|.++++|++|+|++|+|+++.   
T Consensus       129 ~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~-----------------~~~~~~~l~~L~~L~L~~N~l~~~~---  187 (597)
T 3oja_B          129 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERI-----------------EDDTFQATTSLQNLQLSSNRLTHVD---  187 (597)
T ss_dssp             ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBC-----------------CTTTTTTCTTCCEEECTTSCCSBCC---
T ss_pred             EeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCC-----------------ChhhhhcCCcCcEEECcCCCCCCcC---
Confidence            99999988 88888888888888888887766432                 3456677777777777777776553   


Q ss_pred             ccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccc
Q 043388          174 FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI  253 (854)
Q Consensus       174 f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~  253 (854)
                      +..+++|+.|++++|.++.           +...++|+.|++++|.++. +|..+.   +.|+.|+|++|.+++  +..+
T Consensus       188 ~~~l~~L~~L~l~~n~l~~-----------l~~~~~L~~L~ls~n~l~~-~~~~~~---~~L~~L~L~~n~l~~--~~~l  250 (597)
T 3oja_B          188 LSLIPSLFHANVSYNLLST-----------LAIPIAVEELDASHNSINV-VRGPVN---VELTILKLQHNNLTD--TAWL  250 (597)
T ss_dssp             GGGCTTCSEEECCSSCCSE-----------EECCTTCSEEECCSSCCCE-EECSCC---SCCCEEECCSSCCCC--CGGG
T ss_pred             hhhhhhhhhhhcccCcccc-----------ccCCchhheeeccCCcccc-cccccC---CCCCEEECCCCCCCC--Chhh
Confidence            4556667777777776653           2234566777777776663 332221   356667777777664  3556


Q ss_pred             cccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcc
Q 043388          254 RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKG  333 (854)
Q Consensus       254 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  333 (854)
                      ..+++|+.|+|++|.++++.|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.
T Consensus       251 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~  328 (597)
T 3oja_B          251 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN  328 (597)
T ss_dssp             GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred             ccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCE
Confidence            667777777777777766666667777777777777777764 4555566667777777777766 45556666677777


Q ss_pred             cccCCCcccCccchhhcchhhhHHHHHhhcCCCCC
Q 043388          334 FDASHNKLTGAIPQQVLSITTLSVYLALAHNLLND  368 (854)
Q Consensus       334 L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~  368 (854)
                      |++++|.+++. |  +..+..+.. +++++|.+..
T Consensus       329 L~L~~N~l~~~-~--~~~~~~L~~-L~l~~N~~~~  359 (597)
T 3oja_B          329 LYLDHNSIVTL-K--LSTHHTLKN-LTLSHNDWDC  359 (597)
T ss_dssp             EECCSSCCCCC-C--CCTTCCCSE-EECCSSCEEH
T ss_pred             EECCCCCCCCc-C--hhhcCCCCE-EEeeCCCCCC
Confidence            77777776643 2  222223322 6666666553

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-35  Score=328.25  Aligned_cols=250  Identities=15%  Similarity=0.171  Sum_probs=180.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccC-CCe---------e-----
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRH-RNL---------I-----  608 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni---------v-----  608 (854)
                      ...|...++||+|+||.||+|++..+++.||||+++....   ...+.+.+|+.+++.++| +|.         +     
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3468888999999999999999998999999999874322   236789999999999977 221         1     


Q ss_pred             -------eEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCC-cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 043388          609 -------KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSND-HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPI  680 (854)
Q Consensus       609 -------~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~i  680 (854)
                             .+..++...........+++|+++ +++|.+++..... ......+++..++.|+.||+.||+|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                   111111111111122356777766 5799999853210 00122688899999999999999999999   99


Q ss_pred             EeecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCcccc----------CCCCCCccchhHHHHH
Q 043388          681 VHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG----------MGSEASMTGDVYSFGI  749 (854)
Q Consensus       681 vH~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~slGv  749 (854)
                      +||||||+|||++.++..++ |||+++......      ...+| +.|+|||++          .+..++.++|||||||
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA------VSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEEE------CCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCcc------ccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            99999999999999877776 999988765442      22457 999999998          5566899999999999


Q ss_pred             HHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCC
Q 043388          750 LLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESP  829 (854)
Q Consensus       750 vl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  829 (854)
                      ++|||+||+.||.........     .......                            ..++..+.+++.+||+.||
T Consensus       306 il~elltg~~Pf~~~~~~~~~-----~~~~~~~----------------------------~~~~~~~~~li~~~l~~dP  352 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGGS-----EWIFRSC----------------------------KNIPQPVRALLEGFLRYPK  352 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSCS-----GGGGSSC----------------------------CCCCHHHHHHHHHHTCSSG
T ss_pred             HHHHHHHCCCCCCCcchhhhH-----HHHHhhc----------------------------ccCCHHHHHHHHHHccCCh
Confidence            999999999999754321110     0000000                            0113558899999999999


Q ss_pred             CCCCCHHHHHH
Q 043388          830 FERMEMRDVVA  840 (854)
Q Consensus       830 ~~RPs~~evl~  840 (854)
                      ++|||+.|+++
T Consensus       353 ~~Rpt~~~~l~  363 (413)
T 3dzo_A          353 EDRLLPLQAME  363 (413)
T ss_dssp             GGSCCHHHHTT
T ss_pred             hhCcCHHHHHh
Confidence            99999888754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.6e-35  Score=308.69  Aligned_cols=236  Identities=17%  Similarity=0.298  Sum_probs=177.9

Q ss_pred             Hhhcccc-CccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHH-HhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASS-NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEAL-RNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|.+. +.||+|+||.||+|.+..+++.||+|+++..     ..+.+|+.++ +..+||||+++++++.... .+...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCce
Confidence            4678777 7899999999999999989999999998632     5677899888 5559999999999987522 11236


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC---Cccccc-
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHQ-  700 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~~~-  700 (854)
                      .++||||+++|+|.+++......    .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.   ++..++ 
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEeecCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence            89999999999999999875422    689999999999999999999999   9999999999999997   555555 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |||++....                         +..++.++||||+||++|||++|+.||........     .. ...
T Consensus       163 Dfg~a~~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----~~-~~~  211 (299)
T 3m2w_A          163 DFGFAKETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SP-GMK  211 (299)
T ss_dssp             CCTTCEECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------C-CSC
T ss_pred             ccccccccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----hH-HHH
Confidence            999886432                         23467899999999999999999999975422110     00 000


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ..... .....              .......++..+.+++.+||+.||++|||+.|+++.
T Consensus       212 ~~~~~-~~~~~--------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          212 TRIRM-GQYEF--------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CSSCT-TCCSS--------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhh-ccccC--------------CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00000 00000              000111235668899999999999999999999873

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=1.1e-33  Score=305.35  Aligned_cols=245  Identities=20%  Similarity=0.264  Sum_probs=164.9

Q ss_pred             CCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEE
Q 043388           40 SALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY  119 (854)
Q Consensus        40 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~  119 (854)
                      .+++.+++++|.++ .+|..+.  ++|++|+|++|.|+++.|.+|.++++|++|+|++|+|+ .++...|.++++|++|+
T Consensus        33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~  108 (332)
T 2ft3_A           33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLY  108 (332)
T ss_dssp             EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECGGGSTTCTTCCEEE
T ss_pred             ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccC-ccCHhHhhCcCCCCEEE
Confidence            47999999999998 6777664  78999999999999888889999999999999999998 66667788888888888


Q ss_pred             cccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChh
Q 043388          120 LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD  199 (854)
Q Consensus       120 l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~  199 (854)
                      +++|+++.+                  |..+.  ++|++|+|++|+|+.+++..|..+++|++|++++|.++.....   
T Consensus       109 L~~n~l~~l------------------~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~---  165 (332)
T 2ft3_A          109 ISKNHLVEI------------------PPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFE---  165 (332)
T ss_dssp             CCSSCCCSC------------------CSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSC---
T ss_pred             CCCCcCCcc------------------Ccccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCC---
Confidence            777766533                  44433  7888888888888887777788888888888888877532111   


Q ss_pred             hhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccC
Q 043388          200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGE  279 (854)
Q Consensus       200 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  279 (854)
                       +..+..+ +|++|++++|+++ .+|..                         +.  ++|++|++++|+++++.+..|..
T Consensus       166 -~~~~~~l-~L~~L~l~~n~l~-~l~~~-------------------------~~--~~L~~L~l~~n~i~~~~~~~l~~  215 (332)
T 2ft3_A          166 -PGAFDGL-KLNYLRISEAKLT-GIPKD-------------------------LP--ETLNELHLDHNKIQAIELEDLLR  215 (332)
T ss_dssp             -TTSSCSC-CCSCCBCCSSBCS-SCCSS-------------------------SC--SSCSCCBCCSSCCCCCCTTSSTT
T ss_pred             -cccccCC-ccCEEECcCCCCC-ccCcc-------------------------cc--CCCCEEECCCCcCCccCHHHhcC
Confidence             1233444 5555555555555 23322                         11  34555555555555555555555


Q ss_pred             cccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCccc
Q 043388          280 LQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT  342 (854)
Q Consensus       280 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  342 (854)
                      +++|+.|++++|++++..+..|..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++
T Consensus       216 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~  277 (332)
T 2ft3_A          216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT  277 (332)
T ss_dssp             CTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCC
T ss_pred             CCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCC
Confidence            555555555555555544445555555555555555555 44555555555555555555555

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6e-35  Score=315.81  Aligned_cols=246  Identities=15%  Similarity=0.151  Sum_probs=182.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--------ccchHHHHHHHHHHHhcc---------CCCeee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--------KGAFRSFVAECEALRNIR---------HRNLIK  609 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~  609 (854)
                      .++|++.+.||+|+||+||+|++  +++.||||+++...        ....+.+.+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            47899999999999999999998  57899999997542        223478899999999986         888888


Q ss_pred             EEEEeeccC-------------------------CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHH
Q 043388          610 IITICSSID-------------------------SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAID  664 (854)
Q Consensus       610 ~~~~~~~~~-------------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~  664 (854)
                      +.+++....                         .......|+||||+++|++.+.+...       .+++.+++.|+.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-------~~~~~~~~~i~~q  169 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-------LSSLATAKSILHQ  169 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-------CCCHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-------CCCHHHHHHHHHH
Confidence            877653211                         00134789999999999776666432       6789999999999


Q ss_pred             HHHHHHHHH-hcCCCCeEeecCCCCceEecCCc--------------------ccc-cccccccccccCCCCCCcccccC
Q 043388          665 VASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDM--------------------VAH-QNFSLSHQLDSASKTPSSSIGIK  722 (854)
Q Consensus       665 ia~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~~-~Dfg~~~~~~~~~~~~~~~~~~~  722 (854)
                      |+.||+||| +.   +|+||||||+|||++.++                    ..+ +|||+|+.....        ..+
T Consensus       170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~  238 (336)
T 2vuw_A          170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVV  238 (336)
T ss_dssp             HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEE
T ss_pred             HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEE
Confidence            999999999 88   999999999999999874                    444 499999877542        136


Q ss_pred             CcccccCccccCCCCCCccchhHHHHHH-HHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccch
Q 043388          723 GTVGYVAPEYGMGSEASMTGDVYSFGIL-LLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSM  801 (854)
Q Consensus       723 gt~~y~aPE~~~~~~~~~~sDv~slGvv-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  801 (854)
                      ||+.|+|||++.+.. +.++||||+|++ .+++++|..||....................                    
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------  297 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK--------------------  297 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS--------------------
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC--------------------
Confidence            999999999998766 899999998777 7788889999853100000000000000000                    


Q ss_pred             hhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 043388          802 IQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVV  839 (854)
Q Consensus       802 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  839 (854)
                       ..........++.++.+++.+||+.|     |++|++
T Consensus       298 -~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          298 -TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             -SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             -cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence             00011123345778999999999976     898887

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2e-33  Score=299.86  Aligned_cols=251  Identities=27%  Similarity=0.428  Sum_probs=181.4

Q ss_pred             CCCCeeecccccccc--cCCcCccCCCCCcEEeccc-ccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCc
Q 043388           40 SALGMLLIRWNSLGG--QIPTTLGLLRNLVYLNVAE-NQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK  116 (854)
Q Consensus        40 ~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  116 (854)
                      .+++.|+|++|.+++  .+|..|+.+++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|. .|.++++|+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~  128 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD-FLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG-GGGGCTTCC
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCH-HHhCCCCCC
Confidence            467888888888887  7788888888888888884 888878888888888888888888887744442 233444444


Q ss_pred             EEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCC
Q 043388          117 ELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTAN  196 (854)
Q Consensus       117 ~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~  196 (854)
                      +|++++|.+.                 +.+|..|.++++|++|+|++|+|++..|..|                      
T Consensus       129 ~L~Ls~N~l~-----------------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l----------------------  169 (313)
T 1ogq_A          129 TLDFSYNALS-----------------GTLPPSISSLPNLVGITFDGNRISGAIPDSY----------------------  169 (313)
T ss_dssp             EEECCSSEEE-----------------SCCCGGGGGCTTCCEEECCSSCCEEECCGGG----------------------
T ss_pred             EEeCCCCccC-----------------CcCChHHhcCCCCCeEECcCCcccCcCCHHH----------------------
Confidence            4433333332                 2234555555555555555555554444444                      


Q ss_pred             ChhhhhhccCCC-CCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCC
Q 043388          197 DLDFVTLLTNCS-SLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPD  275 (854)
Q Consensus       197 ~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  275 (854)
                              ..++ +|++|++++|++++.+|..+..+.  |+.|++++|.+++..|..|..+++|+.|+|++|++++..|.
T Consensus       170 --------~~l~~~L~~L~L~~N~l~~~~~~~~~~l~--L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  239 (313)
T 1ogq_A          170 --------GSFSKLFTSMTISRNRLTGKIPPTFANLN--LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK  239 (313)
T ss_dssp             --------GCCCTTCCEEECCSSEEEEECCGGGGGCC--CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred             --------hhhhhcCcEEECcCCeeeccCChHHhCCc--ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc
Confidence                    3444 566666666666667777777763  78888888888877888888888888888888888866655


Q ss_pred             CccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCc-cc
Q 043388          276 GVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNK-LT  342 (854)
Q Consensus       276 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~-l~  342 (854)
                       +..+++|++|+|++|++++.+|..|..+++|+.|+|++|++++.+|.. ..+++|+.+++++|+ +.
T Consensus       240 -~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc  305 (313)
T 1ogq_A          240 -VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLC  305 (313)
T ss_dssp             -CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEE
T ss_pred             -ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCcc
Confidence             778888888888888888888888888888888888888888888776 778888888888887 44

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=2.4e-32  Score=294.60  Aligned_cols=282  Identities=17%  Similarity=0.191  Sum_probs=241.9

Q ss_pred             CcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccCh
Q 043388            2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFP   81 (854)
Q Consensus         2 n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p   81 (854)
                      |.++ .+|..+.  ++|++|+|++|.+++..+..|+.+++|++|+|++|++++..|..|+.+++|++|+|++|+++. +|
T Consensus        41 ~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~  116 (330)
T 1xku_A           41 LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LP  116 (330)
T ss_dssp             SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CC
T ss_pred             CCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc-cC
Confidence            3444 4666554  589999999999998777799999999999999999998889999999999999999999994 55


Q ss_pred             hhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEec
Q 043388           82 RWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDL  161 (854)
Q Consensus        82 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~L  161 (854)
                      ..+.  ++|++|++++|+++ .++...|.++++|++|+++.|.+...               +..+..|.++++|++|++
T Consensus       117 ~~~~--~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~---------------~~~~~~~~~l~~L~~L~l  178 (330)
T 1xku_A          117 EKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSS---------------GIENGAFQGMKKLSYIRI  178 (330)
T ss_dssp             SSCC--TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGG---------------GBCTTGGGGCTTCCEEEC
T ss_pred             hhhc--ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcCCcc---------------CcChhhccCCCCcCEEEC
Confidence            5443  79999999999998 88888899999999999988877542               245678999999999999


Q ss_pred             CCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEcc
Q 043388          162 SGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG  241 (854)
Q Consensus       162 s~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~  241 (854)
                      ++|+++.++...+   ++|++|++++|+++.+..      ..|..+++|++|+|++|.+++..+..+..++ .|+.|+++
T Consensus       179 ~~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~  248 (330)
T 1xku_A          179 ADTNITTIPQGLP---PSLTELHLDGNKITKVDA------ASLKGLNNLAKLGLSFNSISAVDNGSLANTP-HLRELHLN  248 (330)
T ss_dssp             CSSCCCSCCSSCC---TTCSEEECTTSCCCEECT------GGGTTCTTCCEEECCSSCCCEECTTTGGGST-TCCEEECC
T ss_pred             CCCccccCCcccc---ccCCEEECCCCcCCccCH------HHhcCCCCCCEEECCCCcCceeChhhccCCC-CCCEEECC
Confidence            9999997655443   899999999999986543      3688999999999999999977777888876 79999999


Q ss_pred             CCcccccCCccccccccCCeeeccccccccCCCCCccCc------ccCceeeCccccccc--cCCccccCccccchhccc
Q 043388          242 GNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGEL------QHLQQLYMFRNFLQG--SIPPSLGNLTKLADLALS  313 (854)
Q Consensus       242 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~  313 (854)
                      +|+++ .+|..+..+++|++|++++|+|+++.+..|...      +.|+.|++++|.+..  ..|..|..+..|+.++|+
T Consensus       249 ~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~  327 (330)
T 1xku_A          249 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLG  327 (330)
T ss_dssp             SSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC-
T ss_pred             CCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEec
Confidence            99999 788899999999999999999999888888644      789999999999863  567889999999999999


Q ss_pred             cce
Q 043388          314 FNN  316 (854)
Q Consensus       314 ~N~  316 (854)
                      +|+
T Consensus       328 ~N~  330 (330)
T 1xku_A          328 NYK  330 (330)
T ss_dssp             ---
T ss_pred             ccC
Confidence            985

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=7e-34  Score=303.39  Aligned_cols=259  Identities=28%  Similarity=0.419  Sum_probs=222.8

Q ss_pred             CCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEccc-CcCcccCChhhhhhcccccEEEccCCcccccCCcccccc
Q 043388          178 KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCD-NQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNL  256 (854)
Q Consensus       178 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l  256 (854)
                      .+++.|+|++|.++..    ...+..+.++++|++|+|++ |.+.+.+|..+..+. .|++|++++|.+++.+|..|.++
T Consensus        50 ~~l~~L~L~~~~l~~~----~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~l  124 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKP----YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT-QLHYLYITHTNVSGAIPDFLSQI  124 (313)
T ss_dssp             CCEEEEEEECCCCSSC----EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCT-TCSEEEEEEECCEEECCGGGGGC
T ss_pred             ceEEEEECCCCCccCC----cccChhHhCCCCCCeeeCCCCCcccccCChhHhcCC-CCCEEECcCCeeCCcCCHHHhCC
Confidence            5788999999988631    01234678888999999985 888888888888886 79999999999988888889999


Q ss_pred             ccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCcc-ccchhccccceecccCCCCCcCCCCCcccc
Q 043388          257 VNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLT-KLADLALSFNNLQGNIPSSLGNCQNLKGFD  335 (854)
Q Consensus       257 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  335 (854)
                      ++|++|+|++|++++..|..|..+++|++|+|++|++++.+|..+..++ +|+.|++++|++++.+|..+..++ |+.|+
T Consensus       125 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~  203 (313)
T 1ogq_A          125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVD  203 (313)
T ss_dssp             TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEE
T ss_pred             CCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEE
Confidence            9999999999999888888888999999999999999888888888887 889999999999888888888887 89999


Q ss_pred             cCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEE
Q 043388          336 ASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELN  415 (854)
Q Consensus       336 ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  415 (854)
                      +++|++++.+|.                         .++.       +.+|+.|+|++|++++.+|. +..+++|++|+
T Consensus       204 Ls~N~l~~~~~~-------------------------~~~~-------l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~  250 (313)
T 1ogq_A          204 LSRNMLEGDASV-------------------------LFGS-------DKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLD  250 (313)
T ss_dssp             CCSSEEEECCGG-------------------------GCCT-------TSCCSEEECCSSEECCBGGG-CCCCTTCCEEE
T ss_pred             CcCCcccCcCCH-------------------------HHhc-------CCCCCEEECCCCceeeecCc-ccccCCCCEEE
Confidence            998888754443                         2333       45699999999999977665 88899999999


Q ss_pred             ccCcccccccchhhcCccCCCeeecccccCcccCCCCccccCcccccccccccccCCccc
Q 043388          416 VSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGIDE  475 (854)
Q Consensus       416 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~  475 (854)
                      |++|++++.+|..|..+++|+.|+|++|+++|.+|..+.+.+...+.+.+|+++||.|..
T Consensus       251 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~  310 (313)
T 1ogq_A          251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             CCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred             CcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence            999999999999999999999999999999999999888999999999999999997543

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=9.6e-36  Score=337.43  Aligned_cols=364  Identities=17%  Similarity=0.153  Sum_probs=180.9

Q ss_pred             CCCCEEecccccccccCCcc-ccCcCCCCeeecccccccc----cCCcCccCCCCCcEEecccccCcccChhhhc-CCC-
Q 043388           16 LNLQTLAIDFNYLTGQLPDF-VGNLSALGMLLIRWNSLGG----QIPTTLGLLRNLVYLNVAENQFSGMFPRWIC-NIS-   88 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~-   88 (854)
                      ++|++|||++|+++...... +..+++|++|+|++|+++.    .++..+..+++|++|+|++|.+++..+..+. .++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            35566666666665333222 5555566666666666553    2344455555566666666655543333222 233 


Q ss_pred             ---CCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCc
Q 043388           89 ---SLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ  165 (854)
Q Consensus        89 ---~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~  165 (854)
                         +|++|+|++|+|+ ..                                     +...+|..|.++++|++|+|++|+
T Consensus        83 ~~~~L~~L~L~~n~i~-~~-------------------------------------~~~~l~~~l~~~~~L~~L~Ls~n~  124 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLT-GA-------------------------------------GCGVLSSTLRTLPTLQELHLSDNL  124 (461)
T ss_dssp             TTCCCCEEECTTSCCB-GG-------------------------------------GHHHHHHHTTSCTTCCEEECCSSB
T ss_pred             CCCceeEEEccCCCCC-HH-------------------------------------HHHHHHHHHccCCceeEEECCCCc
Confidence               3555555555554 11                                     111234445555555555555555


Q ss_pred             CcccCCcCcc-----ccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhh----ccccc
Q 043388          166 FKGKVSIDFS-----SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANL----SSTMI  236 (854)
Q Consensus       166 i~~~~~~~f~-----~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l----~~~L~  236 (854)
                      |+...+..+.     ..++|++|+|++|+++.....  .++..+..+++|++|++++|.++...+..+...    .+.|+
T Consensus       125 i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~  202 (461)
T 1z7x_W          125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE--PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE  202 (461)
T ss_dssp             CHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCC
T ss_pred             CchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH--HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCce
Confidence            5433222221     133455555555554432111  123344445555555555555553333333221    12455


Q ss_pred             EEEccCCccccc----CCccccccccCCeeeccccccccCC-----CCCccCcccCceeeCcccccccc----CCccccC
Q 043388          237 QFRIGGNQISGT----IPSGIRNLVNLIALTIEVNQLHGII-----PDGVGELQHLQQLYMFRNFLQGS----IPPSLGN  303 (854)
Q Consensus       237 ~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~  303 (854)
                      .|++++|.++..    ++..+..+++|++|++++|++++..     +..+..+++|++|++++|.++..    ++..+..
T Consensus       203 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~  282 (461)
T 1z7x_W          203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA  282 (461)
T ss_dssp             EEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHH
T ss_pred             EEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhh
Confidence            566666655542    3445555566666666666655321     22223455666666666666543    4445555


Q ss_pred             ccccchhccccceecccCCCCCcC-----CCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccc
Q 043388          304 LTKLADLALSFNNLQGNIPSSLGN-----CQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLK  378 (854)
Q Consensus       304 l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~  378 (854)
                      +++|+.|++++|.+.+..+..+..     .++|+.|++++|.+++.....+                     +..+..  
T Consensus       283 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l---------------------~~~l~~--  339 (461)
T 1z7x_W          283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF---------------------SSVLAQ--  339 (461)
T ss_dssp             CTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH---------------------HHHHHH--
T ss_pred             CCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHH---------------------HHHHhh--
Confidence            666666666666665433322222     2466666666666653211111                     000111  


Q ss_pred             cccccccccceeeccCcccccCCCccccc-----CCCCCEEEccCccccc----ccchhhcCccCCCeeecccccCcc
Q 043388          379 NLVITCVSLEYLDISSNSFHGVIPFSLGF-----MKSIKELNVSSNNLSG----QIPEFLQNLSFLEFLNLSYNHLEG  447 (854)
Q Consensus       379 ~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~  447 (854)
                           +++|++|+|++|.+++..+..+..     .++|++|+|++|++++    .+|..+..+++|++|++++|++++
T Consensus       340 -----~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          340 -----NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             -----CSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             -----CCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence                 344666666666665544433332     4566666666666664    556666666666666666666654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=1.3e-35  Score=336.29  Aligned_cols=384  Identities=20%  Similarity=0.164  Sum_probs=248.9

Q ss_pred             CcccccCchh-hhcCCCCCEEecccccccc----cCCccccCcCCCCeeecccccccccCCcCc-cCCC----CCcEEec
Q 043388            2 NKLEGQIPEE-IGSLLNLQTLAIDFNYLTG----QLPDFVGNLSALGMLLIRWNSLGGQIPTTL-GLLR----NLVYLNV   71 (854)
Q Consensus         2 n~~~~~~p~~-~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~----~L~~L~L   71 (854)
                      |+++...... +..+++|++|+|++|.+++    .++..+..+++|++|+|++|.+++..+..+ ..++    +|++|+|
T Consensus        13 ~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L   92 (461)
T 1z7x_W           13 EELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL   92 (461)
T ss_dssp             CCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEEC
T ss_pred             cccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEc
Confidence            5565544443 8899999999999999984    457778888999999999999986544433 3355    7999999


Q ss_pred             ccccCcc----cChhhhcCCCCCceeeecccccccccCc----ccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCC
Q 043388           72 AENQFSG----MFPRWICNISSLEFIYLTVNRFSGSLPF----DILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTA  143 (854)
Q Consensus        72 s~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~  143 (854)
                      ++|+|++    .+|.+|..+++|++|+|++|++++..+.    ..+...++|++|++++|+++.             ...
T Consensus        93 ~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~-------------~~~  159 (461)
T 1z7x_W           93 QNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA-------------ASC  159 (461)
T ss_dssp             TTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG-------------GGH
T ss_pred             cCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCH-------------HHH
Confidence            9999994    5689999999999999999998732222    222334556666665554432             222


Q ss_pred             CCCCccccCCCCCCEEecCCCcCcccCCcCccc-----cCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccC
Q 043388          144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS-----LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDN  218 (854)
Q Consensus       144 ~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~-----l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N  218 (854)
                      ..++..+..+++|++|+|++|+++...+..+..     .++|++|+|++|.++.....  .++..+..+++|++|++++|
T Consensus       160 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~L~Ls~n  237 (461)
T 1z7x_W          160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR--DLCGIVASKASLRELALGSN  237 (461)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH--HHHHHHHHCTTCCEEECCSS
T ss_pred             HHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH--HHHHHHHhCCCccEEeccCC
Confidence            345667777888999999998887655444432     55788888888877542211  23445666777777777777


Q ss_pred             cCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccC----CCCCccCcccCceeeCcccccc
Q 043388          219 QFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGI----IPDGVGELQHLQQLYMFRNFLQ  294 (854)
Q Consensus       219 ~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~  294 (854)
                      .+++.....+.                    +..+..+++|++|++++|+++..    ++..+..+++|++|++++|.+.
T Consensus       238 ~l~~~~~~~l~--------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~  297 (461)
T 1z7x_W          238 KLGDVGMAELC--------------------PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG  297 (461)
T ss_dssp             BCHHHHHHHHH--------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred             cCChHHHHHHH--------------------HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence            76632221111                    11122345556666666655542    3344555666666666666665


Q ss_pred             ccCCccccCc-----cccchhccccceeccc----CCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCC
Q 043388          295 GSIPPSLGNL-----TKLADLALSFNNLQGN----IPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNL  365 (854)
Q Consensus       295 ~~~~~~~~~l-----~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~  365 (854)
                      +..+..+...     ++|+.|++++|.+++.    ++..+..+++|+.|++++|.+++..+..+...        +..  
T Consensus       298 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~--------l~~--  367 (461)
T 1z7x_W          298 DEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG--------LGQ--  367 (461)
T ss_dssp             HHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHH--------HTS--
T ss_pred             hHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHH--------HcC--
Confidence            4433333322     4677777777776644    34556667888888888887764322222110        000  


Q ss_pred             CCCCcCccccccccccccccccceeeccCccccc----CCCcccccCCCCCEEEccCcccccccchhhc-----CccCCC
Q 043388          366 LNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHG----VIPFSLGFMKSIKELNVSSNNLSGQIPEFLQ-----NLSFLE  436 (854)
Q Consensus       366 l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~  436 (854)
                                       ..++|++|+|++|.+++    .+|..+..+++|++|+|++|++++.-...+.     ....|+
T Consensus       368 -----------------~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~  430 (461)
T 1z7x_W          368 -----------------PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE  430 (461)
T ss_dssp             -----------------TTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCC
T ss_pred             -----------------CCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchh
Confidence                             02468888888888885    6777788888899999999988754322222     133577


Q ss_pred             eeecccccCcc
Q 043388          437 FLNLSYNHLEG  447 (854)
Q Consensus       437 ~L~ls~N~l~~  447 (854)
                      .|++.+|.+..
T Consensus       431 ~L~~~~~~~~~  441 (461)
T 1z7x_W          431 QLVLYDIYWSE  441 (461)
T ss_dssp             EEECTTCCCCH
T ss_pred             heeecccccCH
Confidence            77777776654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=4.7e-31  Score=287.26  Aligned_cols=278  Identities=19%  Similarity=0.128  Sum_probs=218.7

Q ss_pred             cCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCcee
Q 043388           14 SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFI   93 (854)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L   93 (854)
                      .++.....++++|.++ .+|..+.  ++|++|++++|++++..+..|..+++|++|+|++|+++++.|.+|.++++|++|
T Consensus        29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            4455667888888888 6777665  488999999999987777788889999999999999988888888889999999


Q ss_pred             eecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCc--cccCCCCCCEEecCCC-cCcccC
Q 043388           94 YLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPD--SLSNASNLERLDLSGN-QFKGKV  170 (854)
Q Consensus        94 ~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~--~~~~l~~L~~L~Ls~N-~i~~~~  170 (854)
                      +|++|+|+ .+|...|.++++|++|++++|+++.+                  |.  .|.++++|++|++++| .++.+.
T Consensus       106 ~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l------------------~~~~~~~~l~~L~~L~l~~n~~~~~~~  166 (353)
T 2z80_A          106 DLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTL------------------GETSLFSHLTKLQILRVGNMDTFTKIQ  166 (353)
T ss_dssp             ECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSS------------------CSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred             ECCCCcCC-cCCHhHhCCCccCCEEECCCCCCccc------------------CchhhhccCCCCcEEECCCCccccccC
Confidence            99999988 78888788888888888887776543                  33  6788889999999988 577777


Q ss_pred             CcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCC
Q 043388          171 SIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIP  250 (854)
Q Consensus       171 ~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~  250 (854)
                      +..|.++++|++|++++|.++....      ..+..+++|++|++++|.++ .+|..+....+.|+.|++++|.+++..+
T Consensus       167 ~~~~~~l~~L~~L~l~~n~l~~~~~------~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~  239 (353)
T 2z80_A          167 RKDFAGLTFLEELEIDASDLQSYEP------KSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHF  239 (353)
T ss_dssp             TTTTTTCCEEEEEEEEETTCCEECT------TTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCC
T ss_pred             HHHccCCCCCCEEECCCCCcCccCH------HHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccc
Confidence            8888888999999999998876533      35778888999999999886 5666655544578899999999887665


Q ss_pred             cccc---ccccCCeeecccccccc----CCCCCccCcccCceeeCccccccccCCccccCccccchhccccceeccc
Q 043388          251 SGIR---NLVNLIALTIEVNQLHG----IIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGN  320 (854)
Q Consensus       251 ~~~~---~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  320 (854)
                      ..+.   ....++.++|++|.+++    .+|..+..+++|++|++++|+++...+..|..+++|+.|+|++|++.+.
T Consensus       240 ~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~  316 (353)
T 2z80_A          240 SELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  316 (353)
T ss_dssp             C------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             cccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence            5443   35667778888877765    3566788899999999999999844444468899999999999988753

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=6.3e-31  Score=286.23  Aligned_cols=282  Identities=17%  Similarity=0.156  Sum_probs=233.5

Q ss_pred             cCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCc
Q 043388           37 GNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK  116 (854)
Q Consensus        37 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  116 (854)
                      ...+.....++++|+++ .+|..+.  ++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+ .++...|.++++|+
T Consensus        28 ~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~  103 (353)
T 2z80_A           28 LSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLE  103 (353)
T ss_dssp             CEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC-EECTTTTTTCTTCC
T ss_pred             CCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccC-ccCHhhcCCCCCCC
Confidence            34455667899999999 6777665  58999999999999888889999999999999999998 77777888888888


Q ss_pred             EEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCC-cCccccCCCCeEecccc-cccCCC
Q 043388          117 ELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS-IDFSSLKNLWWLNLEQN-NLGMGT  194 (854)
Q Consensus       117 ~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~-~~f~~l~~L~~L~L~~N-~l~~~~  194 (854)
                      +|++++|+++.+                 .+..|.++++|++|+|++|+++.+++ ..|..+++|++|++++| .++.+.
T Consensus       104 ~L~Ls~n~l~~~-----------------~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~  166 (353)
T 2z80_A          104 HLDLSYNYLSNL-----------------SSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ  166 (353)
T ss_dssp             EEECCSSCCSSC-----------------CHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred             EEECCCCcCCcC-----------------CHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccC
Confidence            888888877543                 13348899999999999999998777 68999999999999999 466554


Q ss_pred             CCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCC
Q 043388          195 ANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIP  274 (854)
Q Consensus       195 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  274 (854)
                      ..      .|.++++|++|++++|++++..|..+..+. +|+.|++++|.++...+..+..+++|+.|++++|++++..+
T Consensus       167 ~~------~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~  239 (353)
T 2z80_A          167 RK------DFAGLTFLEELEIDASDLQSYEPKSLKSIQ-NVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF  239 (353)
T ss_dssp             TT------TTTTCCEEEEEEEEETTCCEECTTTTTTCS-EEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCC
T ss_pred             HH------HccCCCCCCEEECCCCCcCccCHHHHhccc-cCCeecCCCCccccchhhhhhhcccccEEECCCCccccccc
Confidence            33      578899999999999999988899999886 79999999999985555556678999999999999998766


Q ss_pred             CCcc---CcccCceeeCccccccc----cCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccc
Q 043388          275 DGVG---ELQHLQQLYMFRNFLQG----SIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIP  346 (854)
Q Consensus       275 ~~~~---~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p  346 (854)
                      ..+.   ....++.++|++|.+.+    .+|..+..+++|+.|++++|+++...+..|..+++|+.|++++|++.+..|
T Consensus       240 ~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          240 SELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             C------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            5543   45677888888888775    467788999999999999999995444446899999999999999987554

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=1.1e-29  Score=285.13  Aligned_cols=247  Identities=21%  Similarity=0.277  Sum_probs=146.9

Q ss_pred             CCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecc
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTV   97 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~   97 (854)
                      .+.++++++.++ .+|..+.  ++++.|+|++|+|++..+..|..+++|++|+|++|+|+++.+.+|.++++|++|+|++
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~  121 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD  121 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence            445555555555 4454443  4555555555555555555555555555555555555555555555555555555555


Q ss_pred             cccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcccc
Q 043388           98 NRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL  177 (854)
Q Consensus        98 N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l  177 (854)
                      |+|+ .+|...|.++++|+                                         +|+|++|+|+.+.+..|..+
T Consensus       122 n~l~-~~~~~~~~~l~~L~-----------------------------------------~L~L~~N~i~~~~~~~~~~l  159 (440)
T 3zyj_A          122 NRLT-TIPNGAFVYLSKLK-----------------------------------------ELWLRNNPIESIPSYAFNRI  159 (440)
T ss_dssp             SCCS-SCCTTTSCSCSSCC-----------------------------------------EEECCSCCCCEECTTTTTTC
T ss_pred             CcCC-eeCHhHhhccccCc-----------------------------------------eeeCCCCcccccCHHHhhhC
Confidence            5555 45544444444444                                         44444444444444444444


Q ss_pred             CCCCeEeccc-ccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccccc
Q 043388          178 KNLWWLNLEQ-NNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNL  256 (854)
Q Consensus       178 ~~L~~L~L~~-N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l  256 (854)
                      ++|++|+|++ |.++.++..      .|.++++|++|+|++|+++ .+|. +..+. +|+.|+|++|.|++..|..|.++
T Consensus       160 ~~L~~L~l~~~~~l~~i~~~------~~~~l~~L~~L~L~~n~l~-~~~~-~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l  230 (440)
T 3zyj_A          160 PSLRRLDLGELKRLSYISEG------AFEGLSNLRYLNLAMCNLR-EIPN-LTPLI-KLDELDLSGNHLSAIRPGSFQGL  230 (440)
T ss_dssp             TTCCEEECCCCTTCCEECTT------TTTTCSSCCEEECTTSCCS-SCCC-CTTCS-SCCEEECTTSCCCEECTTTTTTC
T ss_pred             cccCEeCCCCCCCcceeCcc------hhhcccccCeecCCCCcCc-cccc-cCCCc-ccCEEECCCCccCccChhhhccC
Confidence            4444444444 223222221      3444455555555555554 3332 33333 56666666666666667777778


Q ss_pred             ccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceec
Q 043388          257 VNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ  318 (854)
Q Consensus       257 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  318 (854)
                      ++|+.|+|++|+|+++.+.+|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus       231 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             TTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             ccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            88888888888888777788888888888888888888777777788888888888888876

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=1e-29  Score=286.26  Aligned_cols=248  Identities=21%  Similarity=0.224  Sum_probs=152.4

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      ....++++++.++ .+|..+.  +++++|+|++|+|++..|..|..+++|++|+|++|+|+++.|.+|.++++|++|+|+
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~  131 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF  131 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence            3456666666666 4555444  466666666666666666666666666666666666666666666666666666666


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCC-CcCcccCCcCcc
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSG-NQFKGKVSIDFS  175 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~-N~i~~~~~~~f~  175 (854)
                      +|+|+ .+|...|.++++|++|++++|+++.+                 .+..|.++++|++|+|++ |.+..+.+..|.
T Consensus       132 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~-----------------~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~  193 (452)
T 3zyi_A          132 DNWLT-VIPSGAFEYLSKLRELWLRNNPIESI-----------------PSYAFNRVPSLMRLDLGELKKLEYISEGAFE  193 (452)
T ss_dssp             SSCCS-BCCTTTSSSCTTCCEEECCSCCCCEE-----------------CTTTTTTCTTCCEEECCCCTTCCEECTTTTT
T ss_pred             CCcCC-ccChhhhcccCCCCEEECCCCCccee-----------------CHhHHhcCCcccEEeCCCCCCccccChhhcc
Confidence            66666 55555555555555555555544322                 123455555556666555 444444444555


Q ss_pred             ccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccc
Q 043388          176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRN  255 (854)
Q Consensus       176 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~  255 (854)
                      ++++|++|+|++|+++.++        .+..++                         .|+.|+|++|.|++..|..|.+
T Consensus       194 ~l~~L~~L~L~~n~l~~~~--------~~~~l~-------------------------~L~~L~Ls~N~l~~~~~~~~~~  240 (452)
T 3zyi_A          194 GLFNLKYLNLGMCNIKDMP--------NLTPLV-------------------------GLEELEMSGNHFPEIRPGSFHG  240 (452)
T ss_dssp             TCTTCCEEECTTSCCSSCC--------CCTTCT-------------------------TCCEEECTTSCCSEECGGGGTT
T ss_pred             CCCCCCEEECCCCcccccc--------cccccc-------------------------cccEEECcCCcCcccCcccccC
Confidence            5555555555555554332        123333                         4555555555555566666777


Q ss_pred             cccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceec
Q 043388          256 LVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ  318 (854)
Q Consensus       256 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  318 (854)
                      +++|+.|+|++|+++++.+.+|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus       241 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             ccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            777777777777777777777777777777777777777666666777777777777777765

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=7.2e-30  Score=272.13  Aligned_cols=283  Identities=18%  Similarity=0.169  Sum_probs=193.8

Q ss_pred             CCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCccc--ChhhhcCCCCCceeee
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGM--FPRWICNISSLEFIYL   95 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L   95 (854)
                      -+.++++++.++ .+|..+.  ++|++|+|++|+++...+..|..+++|++|+|++|+++..  .|..+..+++|++|+|
T Consensus         9 ~~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L   85 (306)
T 2z66_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL   85 (306)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred             CCEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence            467899999998 6777654  6899999999999966566789999999999999999843  3677888999999999


Q ss_pred             cccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcc
Q 043388           96 TVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS  175 (854)
Q Consensus        96 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~  175 (854)
                      ++|+++ .+|.. |..+++|++|++++|+++.+.                .+..|.++++|++|+|++|++++..+..|.
T Consensus        86 s~n~i~-~l~~~-~~~l~~L~~L~l~~n~l~~~~----------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  147 (306)
T 2z66_A           86 SFNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMS----------------EFSVFLSLRNLIYLDISHTHTRVAFNGIFN  147 (306)
T ss_dssp             CSCSEE-EEEEE-EETCTTCCEEECTTSEEESST----------------TTTTTTTCTTCCEEECTTSCCEECSTTTTT
T ss_pred             CCCccc-cChhh-cCCCCCCCEEECCCCcccccc----------------cchhhhhccCCCEEECCCCcCCccchhhcc
Confidence            999988 67654 667777777777776664331                114677888888888888888888888888


Q ss_pred             ccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccc
Q 043388          176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRN  255 (854)
Q Consensus       176 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~  255 (854)
                      .+++|++|+|++|.++..     ..+..+..+++|++|+|++|++++..|..+..++ .|+.|++++|.+++..+..|..
T Consensus       148 ~l~~L~~L~l~~n~l~~~-----~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~  221 (306)
T 2z66_A          148 GLSSLEVLKMAGNSFQEN-----FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS-SLQVLNMSHNNFFSLDTFPYKC  221 (306)
T ss_dssp             TCTTCCEEECTTCEEGGG-----EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT-TCCEEECTTSCCSBCCSGGGTT
T ss_pred             cCcCCCEEECCCCccccc-----cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCC-CCCEEECCCCccCccChhhccC
Confidence            888888888888877531     1123466677777777777777755566665554 5666666666666555556666


Q ss_pred             cccCCeeeccccccccCCCCCccCcc-cCceeeCccccccccCCc--cccCccccchhccccceecccCCCCCcC
Q 043388          256 LVNLIALTIEVNQLHGIIPDGVGELQ-HLQQLYMFRNFLQGSIPP--SLGNLTKLADLALSFNNLQGNIPSSLGN  327 (854)
Q Consensus       256 l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~  327 (854)
                      +++|+.|+|++|++++..|..+..++ +|++|+|++|.+++..+.  ....+...+.+....+.+....|..+.+
T Consensus       222 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g  296 (306)
T 2z66_A          222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG  296 (306)
T ss_dssp             CTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred             cccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCC
Confidence            66666666666666666666666653 666666666666543221  1122333444444444444444444433

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=3.5e-30  Score=274.58  Aligned_cols=249  Identities=20%  Similarity=0.228  Sum_probs=153.7

Q ss_pred             CeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccC--cccccCCCCCcEEEc
Q 043388           43 GMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLP--FDILVNLPNLKELYL  120 (854)
Q Consensus        43 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~~l~~L~~L~l  120 (854)
                      +.++++++.++ .+|..+.  ++|++|+|++|+++++.+..|.++++|++|+|++|+++ .+.  ...+..+++|++|++
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~~~~~~L~~L~L   85 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFGTTSLKYLDL   85 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-EEEEEEHHHHSCSCCCEEEC
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccC-cccCcccccccccccCEEEC
Confidence            46777777777 5565543  57777777777777655566777777777777777775 321  112233444444444


Q ss_pred             ccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCC-cCccccCCCCeEecccccccCCCCCChh
Q 043388          121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS-IDFSSLKNLWWLNLEQNNLGMGTANDLD  199 (854)
Q Consensus       121 ~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~-~~f~~l~~L~~L~L~~N~l~~~~~~~~~  199 (854)
                      ++|.+.                  .+|..+.++++|++|+|++|+++++.+ ..|..+++                    
T Consensus        86 s~n~i~------------------~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~--------------------  127 (306)
T 2z66_A           86 SFNGVI------------------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN--------------------  127 (306)
T ss_dssp             CSCSEE------------------EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTT--------------------
T ss_pred             CCCccc------------------cChhhcCCCCCCCEEECCCCcccccccchhhhhccC--------------------
Confidence            444332                  234445555666666666665555443 34444444                    


Q ss_pred             hhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccc-cCCccccccccCCeeeccccccccCCCCCcc
Q 043388          200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISG-TIPSGIRNLVNLIALTIEVNQLHGIIPDGVG  278 (854)
Q Consensus       200 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  278 (854)
                                |++|++++|.+++..|..+..+. .|+.|++++|.+++ ..|..|..+++|++|+|++|+++++.|..|.
T Consensus       128 ----------L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~  196 (306)
T 2z66_A          128 ----------LIYLDISHTHTRVAFNGIFNGLS-SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN  196 (306)
T ss_dssp             ----------CCEEECTTSCCEECSTTTTTTCT-TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred             ----------CCEEECCCCcCCccchhhcccCc-CCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhc
Confidence                      45555555554444444444443 45555555555554 4566666777777777777777766667777


Q ss_pred             CcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCC-CCcccccCCCcccCc
Q 043388          279 ELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQ-NLKGFDASHNKLTGA  344 (854)
Q Consensus       279 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~ls~N~l~~~  344 (854)
                      .+++|++|+|++|++++..+..+..+++|+.|+|++|++++..|..+..++ +|+.|++++|++++.
T Consensus       197 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             TCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred             CCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence            777777777777777766665677777777777777777766777777763 677777777777643

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=2.6e-29  Score=264.75  Aligned_cols=268  Identities=20%  Similarity=0.209  Sum_probs=176.0

Q ss_pred             CEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeeccc
Q 043388           19 QTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVN   98 (854)
Q Consensus        19 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N   98 (854)
                      ++++++++.++ .+|..+  .++|++|+|++|++++..+..|..+++|++|+|++|.++++.|.+|.++++|++|+|++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            67888888887 566554  357888888888888777778888888888888888888777888888888888888888


Q ss_pred             c-cccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcccc
Q 043388           99 R-FSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL  177 (854)
Q Consensus        99 ~-l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l  177 (854)
                      + ++ .++...|..+++|++|++++|++..+                 .|..|.++++|++|+|++|+++++.+..|..+
T Consensus        91 ~~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~-----------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  152 (285)
T 1ozn_A           91 AQLR-SVDPATFHGLGRLHTLHLDRCGLQEL-----------------GPGLFRGLAALQYLYLQDNALQALPDDTFRDL  152 (285)
T ss_dssp             TTCC-CCCTTTTTTCTTCCEEECTTSCCCCC-----------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             CCcc-ccCHHHhcCCcCCCEEECCCCcCCEE-----------------CHhHhhCCcCCCEEECCCCcccccCHhHhccC
Confidence            6 65 66555566666666666555554422                 24455666666666666666665555555555


Q ss_pred             CCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccc
Q 043388          178 KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLV  257 (854)
Q Consensus       178 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~  257 (854)
                      ++|++|+|++|+++.++                              +..+..+. .|+.|++++|.+++..|..|.+++
T Consensus       153 ~~L~~L~l~~n~l~~~~------------------------------~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~  201 (285)
T 1ozn_A          153 GNLTHLFLHGNRISSVP------------------------------ERAFRGLH-SLDRLLLHQNRVAHVHPHAFRDLG  201 (285)
T ss_dssp             TTCCEEECCSSCCCEEC------------------------------TTTTTTCT-TCCEEECCSSCCCEECTTTTTTCT
T ss_pred             CCccEEECCCCcccccC------------------------------HHHhcCcc-ccCEEECCCCcccccCHhHccCcc
Confidence            55555555555554333                              22333332 455555555555555666677777


Q ss_pred             cCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcC--CCCCcccc
Q 043388          258 NLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGN--CQNLKGFD  335 (854)
Q Consensus       258 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--l~~L~~L~  335 (854)
                      +|+.|++++|+++++.+..|..+++|+.|++++|.+....+.. .-...++.+..+.+.+....|..+.+  +..++..+
T Consensus       202 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~g~~l~~l~~~~  280 (285)
T 1ozn_A          202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAAND  280 (285)
T ss_dssp             TCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCGGG
T ss_pred             cccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhCCcChhhcCHHH
Confidence            7777777777777766666777777777777777776433321 22244666667777777677766654  44555555


Q ss_pred             cCCC
Q 043388          336 ASHN  339 (854)
Q Consensus       336 ls~N  339 (854)
                      +.+|
T Consensus       281 l~~C  284 (285)
T 1ozn_A          281 LQGC  284 (285)
T ss_dssp             SCCC
T ss_pred             hccC
Confidence            5544

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=5.8e-29  Score=279.16  Aligned_cols=248  Identities=22%  Similarity=0.281  Sum_probs=204.6

Q ss_pred             CCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcc
Q 043388           42 LGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT  121 (854)
Q Consensus        42 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~  121 (854)
                      ...++.+++.++ .+|..+.  +++++|+|++|+|+++.+.+|.++++|++|+|++|+|+ .++                
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~----------------  104 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIE----------------  104 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCC-EEC----------------
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCC-ccC----------------
Confidence            456666666666 4555443  55666666666666666666666666666666666654 222                


Q ss_pred             cCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhh
Q 043388          122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFV  201 (854)
Q Consensus       122 ~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~  201 (854)
                                               +..|.++++|++|+|++|+|+.+++..|..+++|++|+|++|.|+.++..     
T Consensus       105 -------------------------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~-----  154 (440)
T 3zyj_A          105 -------------------------IGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSY-----  154 (440)
T ss_dssp             -------------------------GGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTT-----
T ss_pred             -------------------------hhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHH-----
Confidence                                     45677888999999999999999888999999999999999999877654     


Q ss_pred             hhccCCCCCcEEEcccCcCcccCCh-hhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCc
Q 043388          202 TLLTNCSSLKALSLCDNQFGGELPH-SIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGEL  280 (854)
Q Consensus       202 ~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  280 (854)
                       .|..+++|++|+|++|+..+.++. .|..+. +|+.|++++|+++ .+| .+..+++|++|+|++|+|+++.|..|.++
T Consensus       155 -~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~-~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  230 (440)
T 3zyj_A          155 -AFNRIPSLRRLDLGELKRLSYISEGAFEGLS-NLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGL  230 (440)
T ss_dssp             -TTTTCTTCCEEECCCCTTCCEECTTTTTTCS-SCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTC
T ss_pred             -HhhhCcccCEeCCCCCCCcceeCcchhhccc-ccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccC
Confidence             578999999999999544445554 566665 8999999999999 445 58999999999999999999999999999


Q ss_pred             ccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccC
Q 043388          281 QHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTG  343 (854)
Q Consensus       281 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  343 (854)
                      ++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.-
T Consensus       231 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC  293 (440)
T ss_dssp             TTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred             ccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence            999999999999999999999999999999999999998888889999999999999999873

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=5.4e-29  Score=262.31  Aligned_cols=256  Identities=20%  Similarity=0.240  Sum_probs=184.3

Q ss_pred             CeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEccc
Q 043388           43 GMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTF  122 (854)
Q Consensus        43 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~  122 (854)
                      ++++++++.++ .+|..+  .++|++|+|++|.|+++.+.+|.++++|++|+|++|+++ .++...|.++++|++|++++
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccc-eeCHhhcCCccCCCEEeCCC
Confidence            67888888887 556554  468888888888888777778888888888888888887 55545556666666555555


Q ss_pred             CC-CCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhh
Q 043388          123 CS-LKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFV  201 (854)
Q Consensus       123 n~-l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~  201 (854)
                      |. +..+                 .|..|.++++|++|+|++|+++++.+..|..+++|++|+|++|+            
T Consensus        90 n~~l~~~-----------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~------------  140 (285)
T 1ozn_A           90 NAQLRSV-----------------DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA------------  140 (285)
T ss_dssp             CTTCCCC-----------------CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC------------
T ss_pred             CCCcccc-----------------CHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCc------------
Confidence            54 3322                 24455566666666666666665555555555555555555554            


Q ss_pred             hhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcc
Q 043388          202 TLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQ  281 (854)
Q Consensus       202 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  281 (854)
                                        +++..+..+..++ +|+.|++++|++++..+..|.++++|+.|+|++|++++..|..|..++
T Consensus       141 ------------------l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  201 (285)
T 1ozn_A          141 ------------------LQALPDDTFRDLG-NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG  201 (285)
T ss_dssp             ------------------CCCCCTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred             ------------------ccccCHhHhccCC-CccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcc
Confidence                              4433333344443 567777777777767777899999999999999999999999999999


Q ss_pred             cCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcc
Q 043388          282 HLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLS  351 (854)
Q Consensus       282 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~  351 (854)
                      +|+.|++++|++++..+..+..+++|+.|++++|.+....+. ..-+..++.+..+.+.+....|..+..
T Consensus       202 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l~g  270 (285)
T 1ozn_A          202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG  270 (285)
T ss_dssp             TCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred             cccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHhCC
Confidence            999999999999987777899999999999999999843221 122244666778888888788876543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=7.7e-29  Score=279.19  Aligned_cols=249  Identities=21%  Similarity=0.256  Sum_probs=204.4

Q ss_pred             CCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEc
Q 043388           41 ALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL  120 (854)
Q Consensus        41 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l  120 (854)
                      ....++.+++.++ .+|..+.  ++|++|+|++|+|+++.|+.|.++++|++|+|++|+|+ .++...|.++++|++|+|
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L  130 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLEL  130 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEEC
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC-CcChhhccCcccCCEEEC
Confidence            4678899999998 6777664  78999999999999888999999999999999999998 677777788887777777


Q ss_pred             ccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEeccc-ccccCCCCCChh
Q 043388          121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQ-NNLGMGTANDLD  199 (854)
Q Consensus       121 ~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~-N~l~~~~~~~~~  199 (854)
                      ++|+++.+                 .+..|.++++|++|+|++|+|+.+++..|..+++|++|+|++ |.++.++..   
T Consensus       131 ~~n~l~~~-----------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~---  190 (452)
T 3zyi_A          131 FDNWLTVI-----------------PSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG---  190 (452)
T ss_dssp             CSSCCSBC-----------------CTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT---
T ss_pred             CCCcCCcc-----------------ChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChh---
Confidence            77766533                 244577788888888888888877777788888888888877 444443332   


Q ss_pred             hhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccC
Q 043388          200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGE  279 (854)
Q Consensus       200 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  279 (854)
                         .|.++++|++|+|++|+++                         +. | .+..+++|+.|+|++|+|+++.|..|.+
T Consensus       191 ---~~~~l~~L~~L~L~~n~l~-------------------------~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  240 (452)
T 3zyi_A          191 ---AFEGLFNLKYLNLGMCNIK-------------------------DM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHG  240 (452)
T ss_dssp             ---TTTTCTTCCEEECTTSCCS-------------------------SC-C-CCTTCTTCCEEECTTSCCSEECGGGGTT
T ss_pred             ---hccCCCCCCEEECCCCccc-------------------------cc-c-cccccccccEEECcCCcCcccCcccccC
Confidence               3555566666666666554                         22 2 3678899999999999999999999999


Q ss_pred             cccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccC
Q 043388          280 LQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTG  343 (854)
Q Consensus       280 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  343 (854)
                      +++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|.+..
T Consensus       241 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred             ccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence            9999999999999999999999999999999999999998888889999999999999999873

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=2.4e-28  Score=281.65  Aligned_cols=268  Identities=26%  Similarity=0.276  Sum_probs=222.1

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeee
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYL   95 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L   95 (854)
                      .++++|++++|.|+ .+|..+.  ++|++|+|++|.|+ .+|.   .+++|++|+|++|+|++ +|.   .+++|++|+|
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L  108 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI  108 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence            46999999999999 7888776  89999999999999 5666   57999999999999995 554   7899999999


Q ss_pred             cccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcc
Q 043388           96 TVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS  175 (854)
Q Consensus        96 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~  175 (854)
                      ++|+|+ .+|.    .+++|+.|++++|+++.                  +|..   +++|++|+|++|+|++++.    
T Consensus       109 s~N~l~-~l~~----~l~~L~~L~L~~N~l~~------------------lp~~---l~~L~~L~Ls~N~l~~l~~----  158 (622)
T 3g06_A          109 FSNPLT-HLPA----LPSGLCKLWIFGNQLTS------------------LPVL---PPGLQELSVSDNQLASLPA----  158 (622)
T ss_dssp             CSCCCC-CCCC----CCTTCCEEECCSSCCSC------------------CCCC---CTTCCEEECCSSCCSCCCC----
T ss_pred             cCCcCC-CCCC----CCCCcCEEECCCCCCCc------------------CCCC---CCCCCEEECcCCcCCCcCC----
Confidence            999998 6775    45667777766666543                  4543   4899999999999997643    


Q ss_pred             ccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccc
Q 043388          176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRN  255 (854)
Q Consensus       176 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~  255 (854)
                      .+++|+.|++++|.|+.++          ..+++|+.|+|++|.++ .+|..+    +.|+.|++++|.++ .+|..   
T Consensus       159 ~~~~L~~L~L~~N~l~~l~----------~~~~~L~~L~Ls~N~l~-~l~~~~----~~L~~L~L~~N~l~-~l~~~---  219 (622)
T 3g06_A          159 LPSELCKLWAYNNQLTSLP----------MLPSGLQELSVSDNQLA-SLPTLP----SELYKLWAYNNRLT-SLPAL---  219 (622)
T ss_dssp             CCTTCCEEECCSSCCSCCC----------CCCTTCCEEECCSSCCS-CCCCCC----TTCCEEECCSSCCS-SCCCC---
T ss_pred             ccCCCCEEECCCCCCCCCc----------ccCCCCcEEECCCCCCC-CCCCcc----chhhEEECcCCccc-ccCCC---
Confidence            3578999999999998765          24688999999999998 455432    47899999999999 45543   


Q ss_pred             cccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccc
Q 043388          256 LVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFD  335 (854)
Q Consensus       256 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  335 (854)
                      +++|+.|+|++|+|+++ |   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..+.++++|+.|+
T Consensus       220 ~~~L~~L~Ls~N~L~~l-p---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~  290 (622)
T 3g06_A          220 PSGLKELIVSGNRLTSL-P---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVN  290 (622)
T ss_dssp             CTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEE
T ss_pred             CCCCCEEEccCCccCcC-C---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEE
Confidence            47899999999999974 4   46689999999999999 5665   5689999999999999 7799999999999999


Q ss_pred             cCCCcccCccchhhcch
Q 043388          336 ASHNKLTGAIPQQVLSI  352 (854)
Q Consensus       336 ls~N~l~~~~p~~~~~~  352 (854)
                      +++|++++..|..+..+
T Consensus       291 L~~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          291 LEGNPLSERTLQALREI  307 (622)
T ss_dssp             CCSCCCCHHHHHHHHHH
T ss_pred             ecCCCCCCcCHHHHHhc
Confidence            99999998777655443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=2.6e-28  Score=261.76  Aligned_cols=236  Identities=18%  Similarity=0.173  Sum_probs=166.9

Q ss_pred             cCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCcee
Q 043388           14 SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFI   93 (854)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L   93 (854)
                      ...++++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..|+.+++|++|+|++|+++ .+|..|.++++|++|
T Consensus        79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L  155 (328)
T 4fcg_A           79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL  155 (328)
T ss_dssp             TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred             cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence            3478999999999999 78888999999999999999999 88999999999999999999999 678899999999999


Q ss_pred             eecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcC
Q 043388           94 YLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID  173 (854)
Q Consensus        94 ~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~  173 (854)
                      +|++|++.+.+|..+..       .                          .++..|.++++|++|+|++|+|+ ..|..
T Consensus       156 ~L~~n~~~~~~p~~~~~-------~--------------------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~  201 (328)
T 4fcg_A          156 SIRACPELTELPEPLAS-------T--------------------------DASGEHQGLVNLQSLRLEWTGIR-SLPAS  201 (328)
T ss_dssp             EEEEETTCCCCCSCSEE-------E--------------------------C-CCCEEESTTCCEEEEEEECCC-CCCGG
T ss_pred             ECCCCCCccccChhHhh-------c--------------------------cchhhhccCCCCCEEECcCCCcC-cchHh
Confidence            99998887788765421       0                          01223344455555555555554 23334


Q ss_pred             ccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccc
Q 043388          174 FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI  253 (854)
Q Consensus       174 f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~  253 (854)
                      |..+++|++|+|++|+++.++.       .+..+++|++|+|++|.+.+.+|..+..++ .|+.|++++|.+.+.+|..+
T Consensus       202 l~~l~~L~~L~L~~N~l~~l~~-------~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~-~L~~L~L~~n~~~~~~p~~~  273 (328)
T 4fcg_A          202 IANLQNLKSLKIRNSPLSALGP-------AIHHLPKLEELDLRGCTALRNYPPIFGGRA-PLKRLILKDCSNLLTLPLDI  273 (328)
T ss_dssp             GGGCTTCCEEEEESSCCCCCCG-------GGGGCTTCCEEECTTCTTCCBCCCCTTCCC-CCCEEECTTCTTCCBCCTTG
T ss_pred             hcCCCCCCEEEccCCCCCcCch-------hhccCCCCCEEECcCCcchhhhHHHhcCCC-CCCEEECCCCCchhhcchhh
Confidence            5555555555555555543221       244555666666666666666666666654 56666666666666777777


Q ss_pred             cccccCCeeeccccccccCCCCCccCcccCceeeCcccccc
Q 043388          254 RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQ  294 (854)
Q Consensus       254 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  294 (854)
                      .++++|++|+|++|++.+.+|..++.+++|+.+++..|.+.
T Consensus       274 ~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             GGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             hcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            77777777777777777777777777777777777766554

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=1e-29  Score=271.84  Aligned_cols=270  Identities=15%  Similarity=0.157  Sum_probs=200.6

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeee
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYL   95 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L   95 (854)
                      ..++.++++.+.+...++..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|  |..+++|++|+|
T Consensus        10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L   87 (317)
T 3o53_A           10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL   87 (317)
T ss_dssp             TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred             CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence            346667777777775555666677788888888888887767788888888888888888876554  788888888888


Q ss_pred             cccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcc
Q 043388           96 TVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS  175 (854)
Q Consensus        96 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~  175 (854)
                      ++|+|+ .++     ..++|++|++++|+++.+                  +.  ..+++|++|+|++|+|+++.+..|.
T Consensus        88 s~n~l~-~l~-----~~~~L~~L~l~~n~l~~~------------------~~--~~~~~L~~L~l~~N~l~~~~~~~~~  141 (317)
T 3o53_A           88 NNNYVQ-ELL-----VGPSIETLHAANNNISRV------------------SC--SRGQGKKNIYLANNKITMLRDLDEG  141 (317)
T ss_dssp             CSSEEE-EEE-----ECTTCCEEECCSSCCSEE------------------EE--CCCSSCEEEECCSSCCCSGGGBCTG
T ss_pred             cCCccc-ccc-----CCCCcCEEECCCCccCCc------------------Cc--cccCCCCEEECCCCCCCCccchhhh
Confidence            888887 444     225666666665555432                  21  2367788899999998888888888


Q ss_pred             ccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccc
Q 043388          176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRN  255 (854)
Q Consensus       176 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~  255 (854)
                      .+++|++|+|++|.++.....     ..+..+++|++|+|++|.+++. |... .+ +.|+.|++++|+|++. |..|..
T Consensus       142 ~l~~L~~L~Ls~N~l~~~~~~-----~~~~~l~~L~~L~L~~N~l~~~-~~~~-~l-~~L~~L~Ls~N~l~~l-~~~~~~  212 (317)
T 3o53_A          142 CRSRVQYLDLKLNEIDTVNFA-----ELAASSDTLEHLNLQYNFIYDV-KGQV-VF-AKLKTLDLSSNKLAFM-GPEFQS  212 (317)
T ss_dssp             GGSSEEEEECTTSCCCEEEGG-----GGGGGTTTCCEEECTTSCCCEE-ECCC-CC-TTCCEEECCSSCCCEE-CGGGGG
T ss_pred             ccCCCCEEECCCCCCCcccHH-----HHhhccCcCCEEECCCCcCccc-cccc-cc-ccCCEEECCCCcCCcc-hhhhcc
Confidence            888888888888888754332     1234678888888888888844 3322 23 3788888888888854 445888


Q ss_pred             cccCCeeeccccccccCCCCCccCcccCceeeCcccccc-ccCCccccCccccchhccc-cceecccCCC
Q 043388          256 LVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQ-GSIPPSLGNLTKLADLALS-FNNLQGNIPS  323 (854)
Q Consensus       256 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~  323 (854)
                      +++|+.|+|++|+|++ +|..+..+++|+.|++++|++. +.+|..+..+++|+.|+++ .+.+++..|.
T Consensus       213 l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          213 AAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             GTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             cCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            8899999999999885 5667888889999999999988 7778888888889999888 4455555444

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=6e-30  Score=273.71  Aligned_cols=258  Identities=18%  Similarity=0.126  Sum_probs=159.3

Q ss_pred             CCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEc
Q 043388           41 ALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL  120 (854)
Q Consensus        41 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l  120 (854)
                      .++.++++++.+.......+..+++|++|+|++|+|+++.|.+|.++++|++|+|++|++++ ++.  |..+++|++|++
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~--~~~l~~L~~L~L   87 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLD--LESLSTLRTLDL   87 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEE-EEE--ETTCTTCCEEEC
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCc-chh--hhhcCCCCEEEC
Confidence            34556788888876666677778889999999999998888889999999999999998873 332  666666666666


Q ss_pred             ccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhh
Q 043388          121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDF  200 (854)
Q Consensus       121 ~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~  200 (854)
                      ++|+++.+                  |    ..++|++|++++|+|+++.+..   +++|++|++++|+++.+...    
T Consensus        88 s~n~l~~l------------------~----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~----  138 (317)
T 3o53_A           88 NNNYVQEL------------------L----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDL----  138 (317)
T ss_dssp             CSSEEEEE------------------E----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGB----
T ss_pred             cCCccccc------------------c----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccch----
Confidence            66655322                  2    2367777777777777665443   34566666666665543221    


Q ss_pred             hhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccc-cccccCCeeeccccccccCCCCCccC
Q 043388          201 VTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI-RNLVNLIALTIEVNQLHGIIPDGVGE  279 (854)
Q Consensus       201 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~  279 (854)
                        .+..+++|++|+|++|.++                         +..+..+ ..+++|++|+|++|+|+++.+  ...
T Consensus       139 --~~~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~  189 (317)
T 3o53_A          139 --DEGCRSRVQYLDLKLNEID-------------------------TVNFAELAASSDTLEHLNLQYNFIYDVKG--QVV  189 (317)
T ss_dssp             --CTGGGSSEEEEECTTSCCC-------------------------EEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCC
T ss_pred             --hhhccCCCCEEECCCCCCC-------------------------cccHHHHhhccCcCCEEECCCCcCccccc--ccc
Confidence              2334445555555555554                         4444443 245556666666666554422  223


Q ss_pred             cccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCccc-CccchhhcchhhhHHH
Q 043388          280 LQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT-GAIPQQVLSITTLSVY  358 (854)
Q Consensus       280 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~~~~l~~~  358 (854)
                      +++|++|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++ +.+|..+..+..+.. 
T Consensus       190 l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~-  266 (317)
T 3o53_A          190 FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT-  266 (317)
T ss_dssp             CTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHH-
T ss_pred             cccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceE-
Confidence            5666666666666663 3333666666666666666666 34555666666666666666665 445555555555443 


Q ss_pred             HHhh
Q 043388          359 LALA  362 (854)
Q Consensus       359 l~l~  362 (854)
                      ++++
T Consensus       267 l~l~  270 (317)
T 3o53_A          267 VAKQ  270 (317)
T ss_dssp             HHHH
T ss_pred             EECC
Confidence            5555

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=1.5e-27  Score=275.07  Aligned_cols=268  Identities=26%  Similarity=0.310  Sum_probs=163.0

Q ss_pred             CCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEc
Q 043388           41 ALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL  120 (854)
Q Consensus        41 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l  120 (854)
                      +++.|++++|.|+ .+|..+.  ++|++|+|++|.|++ +|.   .+++|++|+|++|+|+ .+|.    .+++|++|++
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~L  108 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV----LPPGLLELSI  108 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCS-CCCC----CCTTCCEEEE
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCC-cCCC----CCCCCCEEEC
Confidence            4777777777777 5666554  677777777777773 443   4667777777777776 5554    3455555555


Q ss_pred             ccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhh
Q 043388          121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDF  200 (854)
Q Consensus       121 ~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~  200 (854)
                      ++|+++.+                  |.   .+++|++|+|++|+|+.+++.    +++|++|+|++|+|+.++.     
T Consensus       109 s~N~l~~l------------------~~---~l~~L~~L~L~~N~l~~lp~~----l~~L~~L~Ls~N~l~~l~~-----  158 (622)
T 3g06_A          109 FSNPLTHL------------------PA---LPSGLCKLWIFGNQLTSLPVL----PPGLQELSVSDNQLASLPA-----  158 (622)
T ss_dssp             CSCCCCCC------------------CC---CCTTCCEEECCSSCCSCCCCC----CTTCCEEECCSSCCSCCCC-----
T ss_pred             cCCcCCCC------------------CC---CCCCcCEEECCCCCCCcCCCC----CCCCCEEECcCCcCCCcCC-----
Confidence            54444322                  22   345566666666666544321    2455555555555443221     


Q ss_pred             hhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCc
Q 043388          201 VTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGEL  280 (854)
Q Consensus       201 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  280 (854)
                           .++                         .|+.|++++|.|++ +|   ..+++|+.|++++|+|+++. .   .+
T Consensus       159 -----~~~-------------------------~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~-~---~~  200 (622)
T 3g06_A          159 -----LPS-------------------------ELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLP-T---LP  200 (622)
T ss_dssp             -----CCT-------------------------TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCC-C---CC
T ss_pred             -----ccC-------------------------CCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCC-C---cc
Confidence                 112                         34455555555553 33   23456666777777766532 2   23


Q ss_pred             ccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHH
Q 043388          281 QHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLA  360 (854)
Q Consensus       281 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~  360 (854)
                      ++|+.|++++|.++ .+|..   +++|+.|+|++|.|++ +|   ..+++|+.|++++|+|+ .+|.             
T Consensus       201 ~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~-------------  258 (622)
T 3g06_A          201 SELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM-------------  258 (622)
T ss_dssp             TTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC-------------
T ss_pred             chhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc-------------
Confidence            56777777777776 34432   3567777777777774 44   34567777777777776 2332             


Q ss_pred             hhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCcc
Q 043388          361 LAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLS  433 (854)
Q Consensus       361 l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  433 (854)
                                     .       +.+|+.|+|++|+|+ .+|..|..+++|+.|+|++|.+++.+|..+..++
T Consensus       259 ---------------~-------~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          259 ---------------L-------PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             ---------------C-------CTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             ---------------c-------cccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence                           0       235778888888887 5677788888888888888888887777776655

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=3.5e-28  Score=260.79  Aligned_cols=234  Identities=19%  Similarity=0.204  Sum_probs=131.0

Q ss_pred             CCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCC
Q 043388           64 RNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTA  143 (854)
Q Consensus        64 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~  143 (854)
                      +++++|+|++|.++ .+|..+.++++|++|+|++|+|+ .+|. .|.++++|++|++++|.++                 
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~-~~~~l~~L~~L~Ls~n~l~-----------------  140 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPD-TMQQFAGLETLTLARNPLR-----------------  140 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCS-CGGGGTTCSEEEEESCCCC-----------------
T ss_pred             cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhH-HHhccCCCCEEECCCCccc-----------------
Confidence            34445555555554 33444444555555555555554 4442 2233444444443333332                 


Q ss_pred             CCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCccc
Q 043388          144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE  223 (854)
Q Consensus       144 ~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~  223 (854)
                       .+|..|.++++|++|+|++|++.+..|..+...      .               ....|.++++|++|+|++|+++ .
T Consensus       141 -~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~------~---------------~~~~~~~l~~L~~L~L~~n~l~-~  197 (328)
T 4fcg_A          141 -ALPASIASLNRLRELSIRACPELTELPEPLAST------D---------------ASGEHQGLVNLQSLRLEWTGIR-S  197 (328)
T ss_dssp             -CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE------C----------------CCCEEESTTCCEEEEEEECCC-C
T ss_pred             -cCcHHHhcCcCCCEEECCCCCCccccChhHhhc------c---------------chhhhccCCCCCEEECcCCCcC-c
Confidence             235566666777777777766666666554330      0               0012334455555555555555 5


Q ss_pred             CChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccC
Q 043388          224 LPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGN  303 (854)
Q Consensus       224 ~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  303 (854)
                      +|..+..+. .|+.|++++|.+++ +|..+..+++|++|+|++|++.+..|..|+.+++|++|+|++|.+.+.+|..+.+
T Consensus       198 lp~~l~~l~-~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~  275 (328)
T 4fcg_A          198 LPASIANLQ-NLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHR  275 (328)
T ss_dssp             CCGGGGGCT-TCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGG
T ss_pred             chHhhcCCC-CCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhc
Confidence            555555554 45566666666653 4445666666666666666666666666666666666666666666666666666


Q ss_pred             ccccchhccccceecccCCCCCcCCCCCcccccCCCccc
Q 043388          304 LTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT  342 (854)
Q Consensus       304 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  342 (854)
                      +++|+.|+|++|++.+.+|..++.+++|+.+++..|.+.
T Consensus       276 l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          276 LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             CCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            666666666666666666666666666666666665554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=4e-29  Score=266.66  Aligned_cols=255  Identities=20%  Similarity=0.190  Sum_probs=162.5

Q ss_pred             cccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCc-ccChhhhc-------CCCCCceeeecccccccccCc
Q 043388           35 FVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFS-GMFPRWIC-------NISSLEFIYLTVNRFSGSLPF  106 (854)
Q Consensus        35 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~  106 (854)
                      .++...+|+.|++++|.+  .+|..+...  |++|+|++|+++ ..+|..+.       ++++|++|+|++|++++.+|.
T Consensus        38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  113 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP  113 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred             EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence            345666788888888888  566666544  788888888884 34555554       678888888888888777776


Q ss_pred             ccc-cCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCC-----CCCCEEecCCCcCcccCCcCccccCCC
Q 043388          107 DIL-VNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNA-----SNLERLDLSGNQFKGKVSIDFSSLKNL  180 (854)
Q Consensus       107 ~~~-~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l-----~~L~~L~Ls~N~i~~~~~~~f~~l~~L  180 (854)
                      .+| ..+++|++|++++|+++.                  +|..+..+     ++|++|+|++|+|+++.+..|..+++|
T Consensus       114 ~~~~~~l~~L~~L~Ls~N~l~~------------------~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L  175 (312)
T 1wwl_A          114 PLLEATGPDLNILNLRNVSWAT------------------RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL  175 (312)
T ss_dssp             CSSSCCSCCCSEEEEESCBCSS------------------SSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC
T ss_pred             HHHHhcCCCccEEEccCCCCcc------------------hhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC
Confidence            654 666776666666665542                  25566655     888888888888888888888888888


Q ss_pred             CeEecccccccCCCCCChhhhhhc--cCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccccccc
Q 043388          181 WWLNLEQNNLGMGTANDLDFVTLL--TNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVN  258 (854)
Q Consensus       181 ~~L~L~~N~l~~~~~~~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~  258 (854)
                      ++|+|++|++...    ...+..+  ..+++|++|+|++|++++ +|..                     ....+.++++
T Consensus       176 ~~L~Ls~N~l~~~----~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~---------------------~~~~~~~l~~  229 (312)
T 1wwl_A          176 STLDLSDNPELGE----RGLISALCPLKFPTLQVLALRNAGMET-PSGV---------------------CSALAAARVQ  229 (312)
T ss_dssp             CEEECCSCTTCHH----HHHHHHSCTTSCTTCCEEECTTSCCCC-HHHH---------------------HHHHHHTTCC
T ss_pred             CEEECCCCCcCcc----hHHHHHHHhccCCCCCEEECCCCcCcc-hHHH---------------------HHHHHhcCCC
Confidence            8888888886421    1122223  677788888888887762 2111                     1112234455


Q ss_pred             CCeeeccccccccCCC-CCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccC
Q 043388          259 LIALTIEVNQLHGIIP-DGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDAS  337 (854)
Q Consensus       259 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls  337 (854)
                      |++|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+.|+++
T Consensus       230 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~  304 (312)
T 1wwl_A          230 LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLK  304 (312)
T ss_dssp             CSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECT
T ss_pred             CCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEecc
Confidence            5555555555555443 33444556666666666665 4454444  5666666666666643 43 5666666666666


Q ss_pred             CCccc
Q 043388          338 HNKLT  342 (854)
Q Consensus       338 ~N~l~  342 (854)
                      +|+++
T Consensus       305 ~N~l~  309 (312)
T 1wwl_A          305 GNPFL  309 (312)
T ss_dssp             TCTTT
T ss_pred             CCCCC
Confidence            66665

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=3.9e-30  Score=301.12  Aligned_cols=418  Identities=13%  Similarity=0.071  Sum_probs=267.3

Q ss_pred             cccCchhhhcCCCCCEEecccccc---cccCCcccc------------CcCCCCeeecccccccccCCcCccCC--CCCc
Q 043388            5 EGQIPEEIGSLLNLQTLAIDFNYL---TGQLPDFVG------------NLSALGMLLIRWNSLGGQIPTTLGLL--RNLV   67 (854)
Q Consensus         5 ~~~~p~~~~~l~~L~~L~L~~n~l---~~~~~~~~~------------~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~   67 (854)
                      ...++..+..+++|++|+|+++..   .+.+|..++            .+++|++|+|++|.+++..+..+...  .+|+
T Consensus        62 ~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~  141 (592)
T 3ogk_B           62 TATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLE  141 (592)
T ss_dssp             GSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCC
T ss_pred             ccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCc
Confidence            334455678889999999987543   124444433            67888999999888877666666653  4489


Q ss_pred             EEeccccc-Ccc-cChhhhcCCCCCceeeecccccccccC---cccccCCCCCcEEEcccCCCCCCceeeccCccCCCCC
Q 043388           68 YLNVAENQ-FSG-MFPRWICNISSLEFIYLTVNRFSGSLP---FDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGT  142 (854)
Q Consensus        68 ~L~Ls~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~  142 (854)
                      +|+|++|. ++. .++....++++|++|+|++|.+++.-.   ...+.++++|++|+++.|.+..+             .
T Consensus       142 ~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~-------------~  208 (592)
T 3ogk_B          142 TLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKI-------------S  208 (592)
T ss_dssp             EEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSC-------------C
T ss_pred             EEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCcc-------------C
Confidence            99998886 221 123334578889999999888763311   12345667777777776665421             1


Q ss_pred             CCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcc
Q 043388          143 ASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGG  222 (854)
Q Consensus       143 ~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~  222 (854)
                      ...++..+.++++|++|+|++|.+.++ +..+..+++|++|+++.+......   ......+..+++|+.|+++++... 
T Consensus       209 ~~~l~~~~~~~~~L~~L~L~~~~~~~l-~~~~~~~~~L~~L~l~~~~~~~~~---~~~~~~l~~~~~L~~L~l~~~~~~-  283 (592)
T 3ogk_B          209 PKDLETIARNCRSLVSVKVGDFEILEL-VGFFKAAANLEEFCGGSLNEDIGM---PEKYMNLVFPRKLCRLGLSYMGPN-  283 (592)
T ss_dssp             HHHHHHHHHHCTTCCEEECSSCBGGGG-HHHHHHCTTCCEEEECBCCCCTTC---TTSSSCCCCCTTCCEEEETTCCTT-
T ss_pred             HHHHHHHHhhCCCCcEEeccCccHHHH-HHHHhhhhHHHhhcccccccccch---HHHHHHhhccccccccCccccchh-
Confidence            123455566778888888888888764 466777888888888753322110   112234666777888888776443 


Q ss_pred             cCChhhhhhcccccEEEccCCcccccCC-ccccccccCCeeeccccccccCCCCCccCcccCceeeCc-----------c
Q 043388          223 ELPHSIANLSSTMIQFRIGGNQISGTIP-SGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMF-----------R  290 (854)
Q Consensus       223 ~~p~~~~~l~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-----------~  290 (854)
                      .+|..+..++ +|+.|++++|.+++... ..+.++++|+.|+++++......+..+..+++|++|+++           .
T Consensus       284 ~l~~~~~~~~-~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~  362 (592)
T 3ogk_B          284 EMPILFPFAA-QIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEE  362 (592)
T ss_dssp             TGGGGGGGGG-GCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTT
T ss_pred             HHHHHHhhcC-CCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCcccccccccc
Confidence            5666666654 68888888887665433 335677788888887332222233334567778888887           3


Q ss_pred             ccccccC-CccccCccccchhccccceecccCCCCCcC-CCCCcccccC----CCcccCc-----cchhhcchhhhHHHH
Q 043388          291 NFLQGSI-PPSLGNLTKLADLALSFNNLQGNIPSSLGN-CQNLKGFDAS----HNKLTGA-----IPQQVLSITTLSVYL  359 (854)
Q Consensus       291 N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~ls----~N~l~~~-----~p~~~~~~~~l~~~l  359 (854)
                      |.+++.. +..+..+++|+.|+++.|.+++..+..+.. +++|+.|+++    .|.+++.     ++..+..+..+.. +
T Consensus       363 ~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~-L  441 (592)
T 3ogk_B          363 GLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRR-F  441 (592)
T ss_dssp             CCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCE-E
T ss_pred             CccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCE-E
Confidence            5555432 222345677888888777777655555554 7778888875    5666642     2222333333332 5


Q ss_pred             HhhcC--CCCCCcCccccccccccccccccceeeccCcccccC-CCcccccCCCCCEEEccCcccccc-cchhhcCccCC
Q 043388          360 ALAHN--LLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGV-IPFSLGFMKSIKELNVSSNNLSGQ-IPEFLQNLSFL  435 (854)
Q Consensus       360 ~l~~n--~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L  435 (854)
                      +++++  .+++..+..++.      .+++|++|+|++|++++. ++..+..+++|++|+|++|.+++. ++..+..+++|
T Consensus       442 ~L~~~~~~l~~~~~~~~~~------~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L  515 (592)
T 3ogk_B          442 AFYLRQGGLTDLGLSYIGQ------YSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSL  515 (592)
T ss_dssp             EEECCGGGCCHHHHHHHHH------SCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSC
T ss_pred             EEecCCCCccHHHHHHHHH------hCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCcc
Confidence            55432  233332222221      256799999999999763 344567889999999999998754 45556788999


Q ss_pred             CeeecccccCccc
Q 043388          436 EFLNLSYNHLEGE  448 (854)
Q Consensus       436 ~~L~ls~N~l~~~  448 (854)
                      +.|+|++|+++..
T Consensus       516 ~~L~ls~n~it~~  528 (592)
T 3ogk_B          516 RYLWVQGYRASMT  528 (592)
T ss_dssp             CEEEEESCBCCTT
T ss_pred             CeeECcCCcCCHH
Confidence            9999999998764

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=1.5e-28  Score=262.20  Aligned_cols=254  Identities=18%  Similarity=0.194  Sum_probs=204.9

Q ss_pred             hhhcCCCCCEEecccccccccCCccccCcCCCCeeeccccccc-ccCCcCcc-------CCCCCcEEecccccCcccChh
Q 043388           11 EIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLG-GQIPTTLG-------LLRNLVYLNVAENQFSGMFPR   82 (854)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~p~   82 (854)
                      .++..++|++|++++|.+  .+|..+...  |+.|+|++|.++ ..+|..+.       .+++|++|+|++|++++..|.
T Consensus        38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  113 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP  113 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred             EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence            346678899999999999  688877654  999999999994 45666665       789999999999999988888


Q ss_pred             hh--cCCCCCceeeecccccccccCcccccCC-----CCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCC
Q 043388           83 WI--CNISSLEFIYLTVNRFSGSLPFDILVNL-----PNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASN  155 (854)
Q Consensus        83 ~~--~~l~~L~~L~L~~N~l~~~~~~~~~~~l-----~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~  155 (854)
                      .+  ..+++|++|+|++|+|+ .+| ..|..+     ++|++|++++|++..+                 .|..|+++++
T Consensus       114 ~~~~~~l~~L~~L~Ls~N~l~-~~~-~~~~~l~~~~~~~L~~L~L~~N~l~~~-----------------~~~~~~~l~~  174 (312)
T 1wwl_A          114 PLLEATGPDLNILNLRNVSWA-TRD-AWLAELQQWLKPGLKVLSIAQAHSLNF-----------------SCEQVRVFPA  174 (312)
T ss_dssp             CSSSCCSCCCSEEEEESCBCS-SSS-SHHHHHHTTCCTTCCEEEEESCSCCCC-----------------CTTTCCCCSS
T ss_pred             HHHHhcCCCccEEEccCCCCc-chh-HHHHHHHHhhcCCCcEEEeeCCCCccc-----------------hHHHhccCCC
Confidence            76  89999999999999998 455 556665     6777777777666433                 3578999999


Q ss_pred             CCEEecCCCcCcccC--Cc--CccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhh
Q 043388          156 LERLDLSGNQFKGKV--SI--DFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANL  231 (854)
Q Consensus       156 L~~L~Ls~N~i~~~~--~~--~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  231 (854)
                      |++|+|++|++.+..  +.  .|..+++|++|+|++|+|+.++.   .....+.++++|++|+|++|++++..|......
T Consensus       175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  251 (312)
T 1wwl_A          175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG---VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW  251 (312)
T ss_dssp             CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHH---HHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred             CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHH---HHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence            999999999987642  22  34889999999999999974321   112345688999999999999997775433332


Q ss_pred             cccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccc
Q 043388          232 SSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQG  295 (854)
Q Consensus       232 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  295 (854)
                      .+.|+.|++++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|++|++++|++++
T Consensus       252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            348999999999999 7777776  8999999999999987 55 9999999999999999985

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=9.6e-28  Score=271.52  Aligned_cols=234  Identities=16%  Similarity=0.173  Sum_probs=148.0

Q ss_pred             CCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEc
Q 043388           41 ALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL  120 (854)
Q Consensus        41 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l  120 (854)
                      +|++|+|++|.|++..|..|+.+++|++|+|++|.|++..|  |..+++|++|+|++|+|+ .+|.     .++|++|++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-~l~~-----~~~L~~L~L  106 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHA  106 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE-EEEE-----CTTCCEEEC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC-CCCC-----CCCcCEEEC
Confidence            56666666666665555566666666666666666665444  666666666666666665 3332     144444444


Q ss_pred             ccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhh
Q 043388          121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDF  200 (854)
Q Consensus       121 ~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~  200 (854)
                      ++|.+..+                  |.  ..+++|++|+|++|+|+++.|..|..+++|++|+|++|.|+.....    
T Consensus       107 ~~N~l~~~------------------~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~----  162 (487)
T 3oja_A          107 ANNNISRV------------------SC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA----  162 (487)
T ss_dssp             CSSCCCCE------------------EE--CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGG----
T ss_pred             cCCcCCCC------------------Cc--cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChH----
Confidence            44444322                  11  1245677777777777766666677777777777777776543221    


Q ss_pred             hhhc-cCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccC
Q 043388          201 VTLL-TNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGE  279 (854)
Q Consensus       201 ~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  279 (854)
                        .+ ..+++|++|+|++|.+++..+ . ..+ +.|+.|+|++|.|++..| .|..+++|+.|+|++|+|++ +|..+..
T Consensus       163 --~l~~~l~~L~~L~Ls~N~l~~~~~-~-~~l-~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~  235 (487)
T 3oja_A          163 --ELAASSDTLEHLNLQYNFIYDVKG-Q-VVF-AKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRF  235 (487)
T ss_dssp             --GGGGGTTTCCEEECTTSCCCEEEC-C-CCC-TTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred             --HHhhhCCcccEEecCCCccccccc-c-ccC-CCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhcc
Confidence              23 256677777777777764422 1 123 357777777777775433 47778888888888888885 4566778


Q ss_pred             cccCceeeCcccccc-ccCCccccCccccchhccc
Q 043388          280 LQHLQQLYMFRNFLQ-GSIPPSLGNLTKLADLALS  313 (854)
Q Consensus       280 l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~  313 (854)
                      +++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus       236 l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             CTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             CCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            888888888888887 5667777777888877776

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=9.4e-29  Score=283.40  Aligned_cols=185  Identities=13%  Similarity=0.001  Sum_probs=128.7

Q ss_pred             ccCCCcceEEEEeEECCCceEEEEEEeeccc----------ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCc
Q 043388          555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQ----------KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       555 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ..+.|+.|.+..++..-.|..||+|++....          ....+++.+|+++|+++ .|+||+++++++++..     
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~-----  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ-----  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS-----
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC-----
Confidence            4567777777777776677889999996432          12245699999999999 7999999999998766     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..||||||++|++|.++|...+      +++..   +|+.||+.||+|+|++   |||||||||+|||++.++.+|+ ||
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF  383 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGE------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF  383 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTC------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEecCCCCcHHHHHHhCC------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence            7899999999999999998765      45543   5899999999999999   9999999999999999987776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP  760 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p  760 (854)
                      |+|+........   ....+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       384 GlAr~~~~~~~~---~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          384 GSIVTTPQDCSW---PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             TTEESCC---CC---SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ccCeeCCCCCcc---ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            999877554332   223579999999999876 467789999999998877665444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=4.6e-27  Score=265.94  Aligned_cols=234  Identities=19%  Similarity=0.152  Sum_probs=162.9

Q ss_pred             ccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCC
Q 043388           60 LGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLG  139 (854)
Q Consensus        60 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~  139 (854)
                      ...+++|++|+|++|.|+++.|.+|.++++|++|+|++|.|++..|   |..+++|++|++++|.++.+           
T Consensus        30 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l-----------   95 (487)
T 3oja_A           30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQEL-----------   95 (487)
T ss_dssp             STTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEE-----------
T ss_pred             cccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCC-----------
Confidence            3445588888888888888888888888888888888888874332   45555555555554443321           


Q ss_pred             CCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCc
Q 043388          140 MGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQ  219 (854)
Q Consensus       140 ~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~  219 (854)
                             |    ..++|++|+|++|+|+++++.                                 .+++|+.|+|++|.
T Consensus        96 -------~----~~~~L~~L~L~~N~l~~~~~~---------------------------------~l~~L~~L~L~~N~  131 (487)
T 3oja_A           96 -------L----VGPSIETLHAANNNISRVSCS---------------------------------RGQGKKNIYLANNK  131 (487)
T ss_dssp             -------E----ECTTCCEEECCSSCCCCEEEC---------------------------------CCSSCEEEECCSSC
T ss_pred             -------C----CCCCcCEEECcCCcCCCCCcc---------------------------------ccCCCCEEECCCCC
Confidence                   1    125555555555555544332                                 23456666666666


Q ss_pred             CcccCChhhhhhcccccEEEccCCcccccCCcccc-ccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCC
Q 043388          220 FGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIR-NLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIP  298 (854)
Q Consensus       220 l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  298 (854)
                      +++..|..+..++ .|+.|+|++|.+++..|..|. .+++|+.|+|++|.|+++.+  +..+++|+.|+|++|.+++.+|
T Consensus       132 l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~  208 (487)
T 3oja_A          132 ITMLRDLDEGCRS-RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP  208 (487)
T ss_dssp             CCSGGGBCGGGGS-SEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG
T ss_pred             CCCCCchhhcCCC-CCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH
Confidence            6655566666654 677777777777777777765 67888888888888887633  3458888889999998886444


Q ss_pred             ccccCccccchhccccceecccCCCCCcCCCCCcccccCCCccc-CccchhhcchhhhH
Q 043388          299 PSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT-GAIPQQVLSITTLS  356 (854)
Q Consensus       299 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~~~~l~  356 (854)
                       .+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|.+. +.+|..+..+..+.
T Consensus       209 -~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~  265 (487)
T 3oja_A          209 -EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ  265 (487)
T ss_dssp             -GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHH
T ss_pred             -hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCc
Confidence             48888899999999999985 6777888899999999999887 55555555554443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=1.5e-25  Score=234.79  Aligned_cols=224  Identities=19%  Similarity=0.199  Sum_probs=127.9

Q ss_pred             EEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccc
Q 043388           20 TLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNR   99 (854)
Q Consensus        20 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~   99 (854)
                      ..+.++..++ .+|..+.  ++|++|++++|++++..+..|..+++|++|+|++|+++++.+.+|.++++|++|+|++|+
T Consensus        11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~   87 (276)
T 2z62_A           11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (276)
T ss_dssp             EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence            4566666666 5666554  467777777777776666677777777777777777776666677777777777777777


Q ss_pred             cccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCC
Q 043388          100 FSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKN  179 (854)
Q Consensus       100 l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~  179 (854)
                      ++ .++...|.++++|++|+++.                                         |+++++.+..|..+++
T Consensus        88 l~-~~~~~~~~~l~~L~~L~l~~-----------------------------------------n~l~~~~~~~~~~l~~  125 (276)
T 2z62_A           88 IQ-SLALGAFSGLSSLQKLVAVE-----------------------------------------TNLASLENFPIGHLKT  125 (276)
T ss_dssp             CC-EECTTTTTTCTTCCEEECTT-----------------------------------------SCCCCSTTCCCTTCTT
T ss_pred             cC-ccChhhhcCCccccEEECCC-----------------------------------------CCccccCchhcccCCC
Confidence            76 44444444444444444444                                         4444444334444444


Q ss_pred             CCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhccccc----EEEccCCcccccCCccccc
Q 043388          180 LWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMI----QFRIGGNQISGTIPSGIRN  255 (854)
Q Consensus       180 L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~----~L~l~~N~l~~~~~~~~~~  255 (854)
                      |++|+|++|.++.+.     ++..+.++++|++|+|++|++++..+..+..+. .++    .|++++|.+++..+..+..
T Consensus       126 L~~L~l~~n~l~~~~-----l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~l~l~L~ls~n~l~~~~~~~~~~  199 (276)
T 2z62_A          126 LKELNVAHNLIQSFK-----LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH-QMPLLNLSLDLSLNPMNFIQPGAFKE  199 (276)
T ss_dssp             CCEEECCSSCCCCCC-----CCGGGGGCTTCCEEECCSSCCCEECGGGGHHHH-TCTTCCEEEECCSSCCCEECTTSSCS
T ss_pred             CCEEECcCCccceec-----CchhhccCCCCCEEECCCCCCCcCCHHHhhhhh-hccccceeeecCCCcccccCccccCC
Confidence            444444444443221     112344445555555555555544444444443 333    5556666665444443333


Q ss_pred             cccCCeeeccccccccCCCCCccCcccCceeeCccccccc
Q 043388          256 LVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQG  295 (854)
Q Consensus       256 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  295 (854)
                       .+|++|+|++|+++++.+..|..+++|+.|++++|++.+
T Consensus       200 -~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          200 -IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             -CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             -CcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence             356666666666666655556666666666666666654

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.93  E-value=2.1e-28  Score=286.46  Aligned_cols=391  Identities=17%  Similarity=0.126  Sum_probs=285.2

Q ss_pred             hcCCCCCEEecccccccccCCccccCc--CCCCeeeccccc-ccc-cCCcCccCCCCCcEEecccccCccc----Chhhh
Q 043388           13 GSLLNLQTLAIDFNYLTGQLPDFVGNL--SALGMLLIRWNS-LGG-QIPTTLGLLRNLVYLNVAENQFSGM----FPRWI   84 (854)
Q Consensus        13 ~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~l~~n~-l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~   84 (854)
                      ..+++|++|+|++|.+++..+..+...  .+|++|+|++|. ++. .++..+..+++|++|+|++|.+++.    ++..+
T Consensus       109 ~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~  188 (592)
T 3ogk_B          109 NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELA  188 (592)
T ss_dssp             HHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHH
T ss_pred             hhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHH
Confidence            389999999999999987777777664  459999999987 221 1233345789999999999998866    45567


Q ss_pred             cCCCCCceeeecccccccccC----cccccCCCCCcEEEcccCCC----------CCCceeeccCccCCCCCCCCCCccc
Q 043388           85 CNISSLEFIYLTVNRFSGSLP----FDILVNLPNLKELYLTFCSL----------KNLWWLNLEQNNLGMGTASSIPDSL  150 (854)
Q Consensus        85 ~~l~~L~~L~L~~N~l~~~~~----~~~~~~l~~L~~L~l~~n~l----------~~L~~L~L~~N~l~~~~~~~~p~~~  150 (854)
                      .++++|++|+|++|+++ .+.    ..++.++++|++|+++.|.+          ++|+.|+++..... ......+..+
T Consensus       189 ~~~~~L~~L~L~~n~~~-~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~-~~~~~~~~~l  266 (592)
T 3ogk_B          189 QHNTSLEVLNFYMTEFA-KISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNED-IGMPEKYMNL  266 (592)
T ss_dssp             HHCCCCCEEECTTCCCS-SCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCC-TTCTTSSSCC
T ss_pred             hcCCCccEEEeeccCCC-ccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccc-cchHHHHHHh
Confidence            78999999999999986 232    23456889999999998864          57889999864321 1123455678


Q ss_pred             cCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhh
Q 043388          151 SNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIAN  230 (854)
Q Consensus       151 ~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  230 (854)
                      ..+++|+.|+++++... ..+..+..+++|++|+|++|.++.     ..+...+..+++|++|+++ |.+.......+..
T Consensus       267 ~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~-----~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~  339 (592)
T 3ogk_B          267 VFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLET-----EDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQ  339 (592)
T ss_dssp             CCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCH-----HHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHH
T ss_pred             hccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCH-----HHHHHHHHhCcCCCEEecc-CccCHHHHHHHHH
Confidence            88999999999997554 556778899999999999999642     2233457899999999999 5555333333433


Q ss_pred             hcccccEEEcc-----------CCcccccCC-ccccccccCCeeeccccccccCCCCCccC-cccCceeeCc----cccc
Q 043388          231 LSSTMIQFRIG-----------GNQISGTIP-SGIRNLVNLIALTIEVNQLHGIIPDGVGE-LQHLQQLYMF----RNFL  293 (854)
Q Consensus       231 l~~~L~~L~l~-----------~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l  293 (854)
                      ..++|+.|+++           .|.+++... ..+.++++|++|+++.|++++..+..+.. +++|+.|+++    .|.+
T Consensus       340 ~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l  419 (592)
T 3ogk_B          340 YCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERI  419 (592)
T ss_dssp             HCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCC
T ss_pred             hCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccc
Confidence            33479999999           467765433 33456899999999999998766666655 8999999996    7788


Q ss_pred             ccc-----CCccccCccccchhccccce--ecccCCCCCc-CCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCC
Q 043388          294 QGS-----IPPSLGNLTKLADLALSFNN--LQGNIPSSLG-NCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNL  365 (854)
Q Consensus       294 ~~~-----~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~  365 (854)
                      ++.     ++..+.++++|+.|++++|.  +++..+..+. .+++|+.|++++|++++....                  
T Consensus       420 ~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~------------------  481 (592)
T 3ogk_B          420 TDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM------------------  481 (592)
T ss_dssp             SSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHH------------------
T ss_pred             cCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHH------------------
Confidence            753     33446778999999998543  6554444443 488999999999998731110                  


Q ss_pred             CCCCcCccccccccccccccccceeeccCcccccC-CCcccccCCCCCEEEccCcccccccchhh-cCccCCCeeecccc
Q 043388          366 LNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGV-IPFSLGFMKSIKELNVSSNNLSGQIPEFL-QNLSFLEFLNLSYN  443 (854)
Q Consensus       366 l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N  443 (854)
                            ..+..       +++|++|+|++|.+++. ++..+..+++|++|+|++|+++..--..+ ..++.+....+..+
T Consensus       482 ------~~~~~-------~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          482 ------EFSRG-------CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             ------HHHTC-------CTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             ------HHHhc-------CcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence                  00111       45799999999998754 34445679999999999999986533333 35676666655554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=1.7e-25  Score=234.42  Aligned_cols=214  Identities=21%  Similarity=0.240  Sum_probs=170.1

Q ss_pred             cCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcC
Q 043388            7 QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICN   86 (854)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~   86 (854)
                      .+|..+.  ++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+++++.+.+|.+
T Consensus        21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (276)
T 2z62_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG   98 (276)
T ss_dssp             SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred             ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence            4676665  48999999999999877779999999999999999999888889999999999999999999999999999


Q ss_pred             CCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcC
Q 043388           87 ISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF  166 (854)
Q Consensus        87 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i  166 (854)
                      +++|++|++++|+++ .++...|.++++|++|++++|+++.+                .+|..|.++++|++|+|++|+|
T Consensus        99 l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~----------------~l~~~~~~l~~L~~L~Ls~N~l  161 (276)
T 2z62_A           99 LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSF----------------KLPEYFSNLTNLEHLDLSSNKI  161 (276)
T ss_dssp             CTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCC----------------CCCGGGGGCTTCCEEECCSSCC
T ss_pred             CccccEEECCCCCcc-ccCchhcccCCCCCEEECcCCcccee----------------cCchhhccCCCCCEEECCCCCC
Confidence            999999999999998 67766688888888888877776543                2578888899999999999999


Q ss_pred             cccCCcCccccCCCC----eEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccC
Q 043388          167 KGKVSIDFSSLKNLW----WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG  242 (854)
Q Consensus       167 ~~~~~~~f~~l~~L~----~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~  242 (854)
                      +++.+..|..+++|+    +|++++|.++.++                              +..+. .. +|+.|++++
T Consensus       162 ~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~------------------------------~~~~~-~~-~L~~L~L~~  209 (276)
T 2z62_A          162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ------------------------------PGAFK-EI-RLKELALDT  209 (276)
T ss_dssp             CEECGGGGHHHHTCTTCCEEEECCSSCCCEEC------------------------------TTSSC-SC-CEEEEECCS
T ss_pred             CcCCHHHhhhhhhccccceeeecCCCcccccC------------------------------ccccC-CC-cccEEECCC
Confidence            888777777666665    4555555554332                              22222 22 466666666


Q ss_pred             CcccccCCccccccccCCeeecccccccc
Q 043388          243 NQISGTIPSGIRNLVNLIALTIEVNQLHG  271 (854)
Q Consensus       243 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  271 (854)
                      |++++..+..|.++++|+.|+|++|+++.
T Consensus       210 n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          210 NQLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             SCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             CceeecCHhHhcccccccEEEccCCcccc
Confidence            66665556667778888888888888774

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=5.2e-28  Score=283.18  Aligned_cols=410  Identities=14%  Similarity=0.113  Sum_probs=206.9

Q ss_pred             hhhhcCCCCCEEecccccccc---cCCc------------cccCcCCCCeeecccccccccCCcCcc-CCCCCcEEeccc
Q 043388           10 EEIGSLLNLQTLAIDFNYLTG---QLPD------------FVGNLSALGMLLIRWNSLGGQIPTTLG-LLRNLVYLNVAE   73 (854)
Q Consensus        10 ~~~~~l~~L~~L~L~~n~l~~---~~~~------------~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~   73 (854)
                      ..+..+++|++|+|++|....   ..|.            .+..+++|++|+|++|.+++..+..+. .+++|++|+|++
T Consensus        60 ~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~  139 (594)
T 2p1m_B           60 TVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSS  139 (594)
T ss_dssp             HHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEES
T ss_pred             HHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCC
Confidence            356788999999999876321   1221            134677899999999999877777775 689999999999


Q ss_pred             c-cCccc-ChhhhcCCCCCceeeecccccccccCc---ccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCc
Q 043388           74 N-QFSGM-FPRWICNISSLEFIYLTVNRFSGSLPF---DILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPD  148 (854)
Q Consensus        74 N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~  148 (854)
                      | .++.. ++..+.++++|++|+|++|.+++..+.   .....+++|++|++++|. ..+             ....++.
T Consensus       140 ~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~-------------~~~~l~~  205 (594)
T 2p1m_B          140 CEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEV-------------SFSALER  205 (594)
T ss_dssp             CEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCC-------------CHHHHHH
T ss_pred             cCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcC-------------CHHHHHH
Confidence            9 56543 455556899999999999998732221   223366688888887765 111             0011112


Q ss_pred             cccCCCCCCEEecCCC-cCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEE-EcccCcCcccCCh
Q 043388          149 SLSNASNLERLDLSGN-QFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKAL-SLCDNQFGGELPH  226 (854)
Q Consensus       149 ~~~~l~~L~~L~Ls~N-~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L-~L~~N~l~~~~p~  226 (854)
                      .+.++++|++|+|++| .+.+ .+..+..+++|++|+++.+........-...+..+.++++|+.| .+.+... +.+|.
T Consensus       206 l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~-~~l~~  283 (594)
T 2p1m_B          206 LVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVP-AYLPA  283 (594)
T ss_dssp             HHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCG-GGGGG
T ss_pred             HHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccch-hhHHH
Confidence            2233455666666555 3332 34445555555555544332100000000112234455555555 2222221 12333


Q ss_pred             hhhhhcccccEEEccCCcccccCCc-cccccccCCeeeccccccccC-CCCCccCcccCceeeC---------ccccccc
Q 043388          227 SIANLSSTMIQFRIGGNQISGTIPS-GIRNLVNLIALTIEVNQLHGI-IPDGVGELQHLQQLYM---------FRNFLQG  295 (854)
Q Consensus       227 ~~~~l~~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L---------~~N~l~~  295 (854)
                      .+..++ +|+.|++++|.+++.... .+..+++|+.|++++| ++.. .+.....+++|++|++         ..|.+++
T Consensus       284 ~~~~~~-~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~  361 (594)
T 2p1m_B          284 VYSVCS-RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTE  361 (594)
T ss_dssp             GHHHHT-TCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCH
T ss_pred             HHHhhC-CCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCH
Confidence            322332 455555555554432211 1334455555555554 2211 1111123445555544         2233332


Q ss_pred             cCCcccc-CccccchhccccceecccCCCCCc-CCCCCcccccC--C----CcccCccch------hhcchhhhHHHHHh
Q 043388          296 SIPPSLG-NLTKLADLALSFNNLQGNIPSSLG-NCQNLKGFDAS--H----NKLTGAIPQ------QVLSITTLSVYLAL  361 (854)
Q Consensus       296 ~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~ls--~----N~l~~~~p~------~~~~~~~l~~~l~l  361 (854)
                      .....+. .+++|+.|+++.|.+++..+..+. .+++|+.|+++  +    |.++. .|.      .+..+..+.. |++
T Consensus       362 ~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~~~l~~~~~~L~~-L~L  439 (594)
T 2p1m_B          362 QGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEHCKDLRR-LSL  439 (594)
T ss_dssp             HHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC-CCTHHHHHHHHHHCTTCCE-EEC
T ss_pred             HHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC-CchhhHHHHHHhhCCCccE-Eee
Confidence            2111221 244555555555555433333332 24555555555  2    23321 110      0111111111 222


Q ss_pred             hcCCCCCCcCccccccccccccccccceeeccCcccccCCCccc-ccCCCCCEEEccCcccccccch-hhcCccCCCeee
Q 043388          362 AHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSL-GFMKSIKELNVSSNNLSGQIPE-FLQNLSFLEFLN  439 (854)
Q Consensus       362 ~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~  439 (854)
                      ++ .+++..+..++.      .+.+|++|+|++|.+++..+..+ ..+++|++|+|++|.+++..+. .+..+++|+.|+
T Consensus       440 ~~-~l~~~~~~~l~~------~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~  512 (594)
T 2p1m_B          440 SG-LLTDKVFEYIGT------YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLW  512 (594)
T ss_dssp             CS-SCCHHHHHHHHH------HCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEE
T ss_pred             cC-cccHHHHHHHHH------hchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEe
Confidence            22 111111111111      14568888888888765544444 5678888888888888644443 344577888888


Q ss_pred             cccccCc
Q 043388          440 LSYNHLE  446 (854)
Q Consensus       440 ls~N~l~  446 (854)
                      +++|+++
T Consensus       513 l~~~~~~  519 (594)
T 2p1m_B          513 MSSCSVS  519 (594)
T ss_dssp             EESSCCB
T ss_pred             eeCCCCC
Confidence            8888774

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.92  E-value=2.3e-24  Score=224.78  Aligned_cols=203  Identities=22%  Similarity=0.279  Sum_probs=122.3

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      +.+++++++++++ .+|..+.  +++++|+|++|+|++..+..|..+++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            4667777777777 4665554  466777777777765555567777777777777777766555666667777777777


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccc
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS  176 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~  176 (854)
                      +|+++ .+|...|.++++|++|++++|+++.+                 .|..|.++++|++|+|++|+|+++++..|..
T Consensus        94 ~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~-----------------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  155 (270)
T 2o6q_A           94 DNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSL-----------------PPRVFDSLTKLTYLSLGYNELQSLPKGVFDK  155 (270)
T ss_dssp             SSCCC-CCCTTTTTTCSSCCEEECCSSCCCCC-----------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             CCcCC-cCCHhHcccccCCCEEECCCCccCee-----------------CHHHhCcCcCCCEEECCCCcCCccCHhHccC
Confidence            77666 56655555555555555555544332                 2334555566666666666665555555555


Q ss_pred             cCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccccc
Q 043388          177 LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNL  256 (854)
Q Consensus       177 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l  256 (854)
                      +++|++|+|++|+++.++                              +..|..++ .|+.|++++|+|++..+..|..+
T Consensus       156 l~~L~~L~L~~n~l~~~~------------------------------~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l  204 (270)
T 2o6q_A          156 LTSLKELRLYNNQLKRVP------------------------------EGAFDKLT-ELKTLKLDNNQLKRVPEGAFDSL  204 (270)
T ss_dssp             CTTCCEEECCSSCCSCCC------------------------------TTTTTTCT-TCCEEECCSSCCSCCCTTTTTTC
T ss_pred             CcccceeEecCCcCcEeC------------------------------hhHhccCC-CcCEEECCCCcCCcCCHHHhccc
Confidence            555555555555554433                              33333333 45555555555554555556677


Q ss_pred             ccCCeeecccccccc
Q 043388          257 VNLIALTIEVNQLHG  271 (854)
Q Consensus       257 ~~L~~L~L~~N~l~~  271 (854)
                      ++|+.|+|++|.+..
T Consensus       205 ~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          205 EKLKMLQLQENPWDC  219 (270)
T ss_dssp             TTCCEEECCSSCBCC
T ss_pred             cCCCEEEecCCCeeC
Confidence            777777777777753

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=4.2e-28  Score=283.96  Aligned_cols=396  Identities=16%  Similarity=0.184  Sum_probs=262.4

Q ss_pred             hhhhcCCCCCEEecccccccccCCcccc-CcCCCCeeecccc-ccccc-CCcCccCCCCCcEEecccccCcccChhhhc-
Q 043388           10 EEIGSLLNLQTLAIDFNYLTGQLPDFVG-NLSALGMLLIRWN-SLGGQ-IPTTLGLLRNLVYLNVAENQFSGMFPRWIC-   85 (854)
Q Consensus        10 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~n-~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-   85 (854)
                      .-+..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+..+++|++|+|++|.+++..+.++. 
T Consensus        99 ~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~  178 (594)
T 2p1m_B           99 AMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSH  178 (594)
T ss_dssp             HHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGG
T ss_pred             HHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHH
Confidence            3456789999999999999877777775 6899999999999 66532 455556899999999999999877666555 


Q ss_pred             ---CCCCCceeeecccccccccCcc----cccCCCCCcEEEcccC-----------CCCCCceeeccCccC--CCCCCCC
Q 043388           86 ---NISSLEFIYLTVNRFSGSLPFD----ILVNLPNLKELYLTFC-----------SLKNLWWLNLEQNNL--GMGTASS  145 (854)
Q Consensus        86 ---~l~~L~~L~L~~N~l~~~~~~~----~~~~l~~L~~L~l~~n-----------~l~~L~~L~L~~N~l--~~~~~~~  145 (854)
                         .+++|++|+|++|. . .++..    ++.++++|++|++++|           .+.+|+.|+++.+..  .......
T Consensus       179 ~~~~~~~L~~L~l~~~~-~-~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~  256 (594)
T 2p1m_B          179 FPDTYTSLVSLNISCLA-S-EVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG  256 (594)
T ss_dssp             SCTTCCCCCEEECTTCC-S-CCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH
T ss_pred             HhhcCCcCcEEEecccC-C-cCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHH
Confidence               66799999999997 2 33333    3345699999999987           356777777554321  1111133


Q ss_pred             CCccccCCCCCCEE-ecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccC
Q 043388          146 IPDSLSNASNLERL-DLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGEL  224 (854)
Q Consensus       146 ~p~~~~~l~~L~~L-~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  224 (854)
                      ++..+.++++|+.| .+.+.... ..+..+..+++|++|+|++|.++.     ..+...+..+++|++|++++| ++...
T Consensus       257 l~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~~~~~~L~~L~L~~~~l~~-----~~l~~~~~~~~~L~~L~l~~~-~~~~~  329 (594)
T 2p1m_B          257 LSVALSGCKELRCLSGFWDAVPA-YLPAVYSVCSRLTTLNLSYATVQS-----YDLVKLLCQCPKLQRLWVLDY-IEDAG  329 (594)
T ss_dssp             HHHHHHTCTTCCEEECCBTCCGG-GGGGGHHHHTTCCEEECTTCCCCH-----HHHHHHHTTCTTCCEEEEEGG-GHHHH
T ss_pred             HHHHHhcCCCcccccCCcccchh-hHHHHHHhhCCCCEEEccCCCCCH-----HHHHHHHhcCCCcCEEeCcCc-cCHHH
Confidence            45567778888888 44443332 234444567888888888888542     123344667888888888887 44332


Q ss_pred             ChhhhhhcccccEEEcc---------CCcccccCCcccc-ccccCCeeeccccccccCCCCCcc-CcccCceeeCc--c-
Q 043388          225 PHSIANLSSTMIQFRIG---------GNQISGTIPSGIR-NLVNLIALTIEVNQLHGIIPDGVG-ELQHLQQLYMF--R-  290 (854)
Q Consensus       225 p~~~~~l~~~L~~L~l~---------~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~--~-  290 (854)
                      ...+....++|+.|++.         .+.+++.....+. ++++|+.|.++.|++++.....+. .+++|+.|+++  + 
T Consensus       330 l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~  409 (594)
T 2p1m_B          330 LEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEP  409 (594)
T ss_dssp             HHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESST
T ss_pred             HHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccC
Confidence            23333322368888873         3455543333333 477888888888887765444443 47788888887  3 


Q ss_pred             ---cccccc-----CCccccCccccchhccccceecccCCCCCcC-CCCCcccccCCCcccCccchhhcchhhhHHHHHh
Q 043388          291 ---NFLQGS-----IPPSLGNLTKLADLALSFNNLQGNIPSSLGN-CQNLKGFDASHNKLTGAIPQQVLSITTLSVYLAL  361 (854)
Q Consensus       291 ---N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l  361 (854)
                         |.++..     ++..+..+++|+.|+|++ .+++..+..+.. +++|+.|++++|.+++..+..             
T Consensus       410 ~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~-------------  475 (594)
T 2p1m_B          410 KAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHH-------------  475 (594)
T ss_dssp             TCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHH-------------
T ss_pred             CCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHH-------------
Confidence               455521     112255667788888876 555444444444 677888888888775321111             


Q ss_pred             hcCCCCCCcCccccccccccccccccceeeccCcccccCCCc-ccccCCCCCEEEccCcccccccchhh-cCccCCCeee
Q 043388          362 AHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPF-SLGFMKSIKELNVSSNNLSGQIPEFL-QNLSFLEFLN  439 (854)
Q Consensus       362 ~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~  439 (854)
                                  +      ...+++|++|+|++|.+++.... ....+++|++|++++|+++......+ ..+++|+...
T Consensus       476 ------------l------~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~  537 (594)
T 2p1m_B          476 ------------V------LSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEV  537 (594)
T ss_dssp             ------------H------HHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEE
T ss_pred             ------------H------HhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEE
Confidence                        0      00156799999999999654443 34568999999999999965444445 5567777766


Q ss_pred             cccccCc
Q 043388          440 LSYNHLE  446 (854)
Q Consensus       440 ls~N~l~  446 (854)
                      +..+.-.
T Consensus       538 ~~~~~~~  544 (594)
T 2p1m_B          538 IDERGAP  544 (594)
T ss_dssp             ECSSSCG
T ss_pred             ecCCCcc
Confidence            6665443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=2.7e-25  Score=231.89  Aligned_cols=228  Identities=20%  Similarity=0.214  Sum_probs=124.6

Q ss_pred             CCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEc
Q 043388           41 ALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL  120 (854)
Q Consensus        41 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l  120 (854)
                      .+..+++..+.+...  ..+..+++|+.|++++|.++. + ..+..+++|++|+|++|+++ .++  .+..         
T Consensus        20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~-~~~--~l~~---------   83 (272)
T 3rfs_A           20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLH-DIS--ALKE---------   83 (272)
T ss_dssp             HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCC-CCG--GGTT---------
T ss_pred             HHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCC-Cch--hhcC---------
Confidence            445556666665532  334556666666666666663 2 23566666666666666665 222  2333         


Q ss_pred             ccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhh
Q 043388          121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDF  200 (854)
Q Consensus       121 ~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~  200 (854)
                                                      +++|++|+|++|+|+++.+..|..+++|++|+|++|+++.++..    
T Consensus        84 --------------------------------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----  127 (272)
T 3rfs_A           84 --------------------------------LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDG----  127 (272)
T ss_dssp             --------------------------------CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT----
T ss_pred             --------------------------------CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHH----
Confidence                                            44444444444444444444444444444444444444433221    


Q ss_pred             hhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCc
Q 043388          201 VTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGEL  280 (854)
Q Consensus       201 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  280 (854)
                        .|..+++|++|+|++|++++..|..+..++ .|+.|++++|++++..+..|.++++|++|++++|+++++.+..|..+
T Consensus       128 --~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  204 (272)
T 3rfs_A          128 --VFDKLTNLTYLNLAHNQLQSLPKGVFDKLT-NLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL  204 (272)
T ss_dssp             --TTTTCTTCCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred             --HhccCCCCCEEECCCCccCccCHHHhccCc-cCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCC
Confidence              233444444555555544433333333333 45555555555555555556666677777777777776666666777


Q ss_pred             ccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCC
Q 043388          281 QHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQN  330 (854)
Q Consensus       281 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  330 (854)
                      ++|+.|++++|.+.+.       +++|+.|+++.|.++|.+|..++.++.
T Consensus       205 ~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          205 TSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             TTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             cCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence            7777777777766533       335666777777777666666665543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.92  E-value=2.2e-24  Score=224.85  Aligned_cols=203  Identities=22%  Similarity=0.315  Sum_probs=178.3

Q ss_pred             CceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCC
Q 043388          128 LWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNC  207 (854)
Q Consensus       128 L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l  207 (854)
                      .+.+++++|++     +.+|..+.  ++|++|+|++|+|+++.+..|..+++|++|+|++|+|+.++..      .|.++
T Consensus        18 ~~~l~~~~~~l-----~~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~------~~~~l   84 (270)
T 2o6q_A           18 KNSVDCSSKKL-----TAIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG------IFKEL   84 (270)
T ss_dssp             TTEEECTTSCC-----SSCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTT------TTSSC
T ss_pred             CCEEEccCCCC-----CccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChh------hhcCC
Confidence            34455555555     44566553  6899999999999999999999999999999999999877654      57889


Q ss_pred             CCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceee
Q 043388          208 SSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLY  287 (854)
Q Consensus       208 ~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  287 (854)
                      ++|++|+|++|++++..+..+..+. .|+.|++++|.+++..+..|.++++|++|+|++|+|+++.+..|..+++|++|+
T Consensus        85 ~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  163 (270)
T 2o6q_A           85 KNLETLWVTDNKLQALPIGVFDQLV-NLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELR  163 (270)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCS-SCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCcCCcCCHhHccccc-CCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeE
Confidence            9999999999999965566667775 899999999999988888999999999999999999998888899999999999


Q ss_pred             CccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCc
Q 043388          288 MFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGA  344 (854)
Q Consensus       288 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  344 (854)
                      |++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++...
T Consensus       164 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          164 LYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred             ecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence            999999988888899999999999999999987777899999999999999998743

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=2e-24  Score=226.99  Aligned_cols=203  Identities=23%  Similarity=0.173  Sum_probs=104.8

Q ss_pred             hhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCc
Q 043388           12 IGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLE   91 (854)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~   91 (854)
                      ++++++++++++++|.++ .+|..+.  ++++.|+|++|+|++..+..|..+++|++|+|++|.|+++.+.  ..+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            455566666666666666 4444443  4555666666666555555555556666666666655543221  4555555


Q ss_pred             eeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCC
Q 043388           92 FIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS  171 (854)
Q Consensus        92 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~  171 (854)
                      +|+|++|+|+ .+|                                          ..+.++++|++|+|++|+|+++++
T Consensus        81 ~L~Ls~N~l~-~l~------------------------------------------~~~~~l~~L~~L~l~~N~l~~l~~  117 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLP------------------------------------------LLGQTLPALTVLDVSFNRLTSLPL  117 (290)
T ss_dssp             EEECCSSCCS-SCC------------------------------------------CCTTTCTTCCEEECCSSCCCCCCS
T ss_pred             EEECCCCcCC-cCc------------------------------------------hhhccCCCCCEEECCCCcCcccCH
Confidence            5555555554 444                                          334444444444444444444444


Q ss_pred             cCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCc
Q 043388          172 IDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPS  251 (854)
Q Consensus       172 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~  251 (854)
                      ..|..+++|++|+|++|+|+.++..      .|..+++|+.|+|++|++++..+..+..+. .|+.|+|++|+|+ .+|.
T Consensus       118 ~~~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~-~L~~L~L~~N~l~-~ip~  189 (290)
T 1p9a_G          118 GALRGLGELQELYLKGNELKTLPPG------LLTPTPKLEKLSLANNNLTELPAGLLNGLE-NLDTLLLQENSLY-TIPK  189 (290)
T ss_dssp             STTTTCTTCCEEECTTSCCCCCCTT------TTTTCTTCCEEECTTSCCSCCCTTTTTTCT-TCCEEECCSSCCC-CCCT
T ss_pred             HHHcCCCCCCEEECCCCCCCccChh------hcccccCCCEEECCCCcCCccCHHHhcCcC-CCCEEECCCCcCC-ccCh
Confidence            4444444444444444444433332      234444555555555555422222223332 4555555555555 4455


Q ss_pred             cccccccCCeeeccccccc
Q 043388          252 GIRNLVNLIALTIEVNQLH  270 (854)
Q Consensus       252 ~~~~l~~L~~L~L~~N~l~  270 (854)
                      .+..+.+|+.|+|++|.+.
T Consensus       190 ~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          190 GFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             TTTTTCCCSEEECCSCCBC
T ss_pred             hhcccccCCeEEeCCCCcc
Confidence            5555566677777777664

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.92  E-value=2.7e-26  Score=250.24  Aligned_cols=260  Identities=18%  Similarity=0.200  Sum_probs=141.1

Q ss_pred             CcccccCchhhhcCCCCCEEecccccccccCC----ccccCcC-CCCeeecccccccccCCcCccCC-----CCCcEEec
Q 043388            2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLP----DFVGNLS-ALGMLLIRWNSLGGQIPTTLGLL-----RNLVYLNV   71 (854)
Q Consensus         2 n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~L   71 (854)
                      |+++|.+|+.+...++|++|+|++|.|++..+    ..|..++ +|++|+|++|+|++..+..|..+     ++|++|+|
T Consensus         8 n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~L   87 (362)
T 3goz_A            8 HPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNL   87 (362)
T ss_dssp             CTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEEC
T ss_pred             ccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEEC
Confidence            55666666666655566666666666664444    4555555 56666666666665555555554     66666666


Q ss_pred             ccccCcccChhhhcC----C-CCCceeeecccccccccCcccc----cCC-CCCcEEEcccCCCCCCceeeccCccCCCC
Q 043388           72 AENQFSGMFPRWICN----I-SSLEFIYLTVNRFSGSLPFDIL----VNL-PNLKELYLTFCSLKNLWWLNLEQNNLGMG  141 (854)
Q Consensus        72 s~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~~~~~~----~~l-~~L~~L~l~~n~l~~L~~L~L~~N~l~~~  141 (854)
                      ++|++++..+..+..    + ++|++|+|++|+|+ ..+...|    ..+ ++|++|++++|++.             ..
T Consensus        88 s~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~-------------~~  153 (362)
T 3goz_A           88 SGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS-SKSSSEFKQAFSNLPASITSLNLRGNDLG-------------IK  153 (362)
T ss_dssp             CSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGG-GSCHHHHHHHHTTSCTTCCEEECTTSCGG-------------GS
T ss_pred             cCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCC-cHHHHHHHHHHHhCCCceeEEEccCCcCC-------------HH
Confidence            666666555553332    2 56666666666665 3333221    111 23333333333222             11


Q ss_pred             CCCCCCccccCCC-CCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCC-CCCcEEEcccCc
Q 043388          142 TASSIPDSLSNAS-NLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNC-SSLKALSLCDNQ  219 (854)
Q Consensus       142 ~~~~~p~~~~~l~-~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l-~~L~~L~L~~N~  219 (854)
                      ....++..+..++ +|++|+|++|+|++..+..+.                          ..+..+ ++|++|+|++|.
T Consensus       154 ~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~--------------------------~~l~~~~~~L~~L~Ls~N~  207 (362)
T 3goz_A          154 SSDELIQILAAIPANVNSLNLRGNNLASKNCAELA--------------------------KFLASIPASVTSLDLSANL  207 (362)
T ss_dssp             CHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHH--------------------------HHHHTSCTTCCEEECTTSC
T ss_pred             HHHHHHHHHhcCCccccEeeecCCCCchhhHHHHH--------------------------HHHHhCCCCCCEEECCCCC
Confidence            1122333333333 555555555555444333222                          233333 255555555555


Q ss_pred             Cccc----CChhhhhhcccccEEEccCCcccccCC----ccccccccCCeeeccccccccCCC-------CCccCcccCc
Q 043388          220 FGGE----LPHSIANLSSTMIQFRIGGNQISGTIP----SGIRNLVNLIALTIEVNQLHGIIP-------DGVGELQHLQ  284 (854)
Q Consensus       220 l~~~----~p~~~~~l~~~L~~L~l~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~-------~~~~~l~~L~  284 (854)
                      +++.    ++..+....+.|+.|+|++|.|++..+    ..+..+++|+.|+|++|++.++.+       ..+..+++|+
T Consensus       208 i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~  287 (362)
T 3goz_A          208 LGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKII  287 (362)
T ss_dssp             GGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEE
T ss_pred             CChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceE
Confidence            5532    333444433356666666666654333    335667889999999998655433       3677888899


Q ss_pred             eeeCccccccccCCccc
Q 043388          285 QLYMFRNFLQGSIPPSL  301 (854)
Q Consensus       285 ~L~L~~N~l~~~~~~~~  301 (854)
                      .|++++|++....+..+
T Consensus       288 ~LdL~~N~l~~~~~~~~  304 (362)
T 3goz_A          288 LVDKNGKEIHPSHSIPI  304 (362)
T ss_dssp             EECTTSCBCCGGGCHHH
T ss_pred             EEecCCCcCCCcchHHH
Confidence            99999999886655444

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=1.1e-24  Score=227.38  Aligned_cols=229  Identities=22%  Similarity=0.285  Sum_probs=165.8

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      .+..+++..+.+...  ..+..+++|+.|++++|.++ .+ ..+..+++|++|+|++|.+++.  ..+.++++|++|+|+
T Consensus        20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~   93 (272)
T 3rfs_A           20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT   93 (272)
T ss_dssp             HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred             HHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-cc-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence            445566666666533  23566777788888888776 22 3477778888888888887753  367777888888888


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccc
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS  176 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~  176 (854)
                      +|+|+ .++...|.++++|++|++++|+++.+                 .|..|.++++|++|+|++|+|+++++..|..
T Consensus        94 ~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~-----------------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  155 (272)
T 3rfs_A           94 GNQLQ-SLPNGVFDKLTNLKELVLVENQLQSL-----------------PDGVFDKLTNLTYLNLAHNQLQSLPKGVFDK  155 (272)
T ss_dssp             TSCCC-CCCTTTTTTCTTCCEEECTTSCCCCC-----------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             CCccC-ccChhHhcCCcCCCEEECCCCcCCcc-----------------CHHHhccCCCCCEEECCCCccCccCHHHhcc
Confidence            88877 67767777777777777777766533                 2445677888888888888888777777788


Q ss_pred             cCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccccc
Q 043388          177 LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNL  256 (854)
Q Consensus       177 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l  256 (854)
                      +++|++|+|++|+++.++..      .|..+++|++|++++|++++..|..+..++ .|+.|++++|.+.+.       +
T Consensus       156 l~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~~~~~-------~  221 (272)
T 3rfs_A          156 LTNLTELDLSYNQLQSLPEG------VFDKLTQLKDLRLYQNQLKSVPDGVFDRLT-SLQYIWLHDNPWDCT-------C  221 (272)
T ss_dssp             CTTCCEEECCSSCCCCCCTT------TTTTCTTCCEEECCSSCCSCCCTTTTTTCT-TCCEEECCSSCBCCC-------T
T ss_pred             CccCCEEECCCCCcCccCHH------HhcCCccCCEEECCCCcCCccCHHHHhCCc-CCCEEEccCCCcccc-------C
Confidence            88888888888887765543      466778888888888888866666666665 688888888877643       4


Q ss_pred             ccCCeeeccccccccCCCCCccCcccC
Q 043388          257 VNLIALTIEVNQLHGIIPDGVGELQHL  283 (854)
Q Consensus       257 ~~L~~L~L~~N~l~~~~~~~~~~l~~L  283 (854)
                      ++|+.|++..|+++|.+|.+++.+...
T Consensus       222 ~~l~~l~~~~n~~~g~ip~~~~~~~~~  248 (272)
T 3rfs_A          222 PGIRYLSEWINKHSGVVRNSAGSVAPD  248 (272)
T ss_dssp             TTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred             cHHHHHHHHHHhCCCcccCcccccCCC
Confidence            468888888888888888888776543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=3.9e-24  Score=224.81  Aligned_cols=204  Identities=20%  Similarity=0.187  Sum_probs=163.6

Q ss_pred             ccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCC
Q 043388           36 VGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL  115 (854)
Q Consensus        36 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  115 (854)
                      ++++++++.+++++|+++ .+|..+.  ++|++|+|++|.|+++.|..|.++++|++|+|++|+|+ .++          
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~----------   71 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ----------   71 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE----------
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC-ccc----------
Confidence            566677777777777777 4555443  56777777777777666677777777777777777665 222          


Q ss_pred             cEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCC
Q 043388          116 KELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTA  195 (854)
Q Consensus       116 ~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~  195 (854)
                                                      . ...+++|++|+|++|+|+. .|..+..+++|++|+|++|+|+.++.
T Consensus        72 --------------------------------~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~  117 (290)
T 1p9a_G           72 --------------------------------V-DGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPL  117 (290)
T ss_dssp             --------------------------------C-CSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCS
T ss_pred             --------------------------------C-CCCCCcCCEEECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCH
Confidence                                            1 1457889999999999985 46688999999999999999998775


Q ss_pred             CChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCC
Q 043388          196 NDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPD  275 (854)
Q Consensus       196 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  275 (854)
                      .      .|.++++|++|+|++|++++..+..|..++ +|+.|+|++|+|++..+..|.++++|+.|+|++|+|+ .+|.
T Consensus       118 ~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~  189 (290)
T 1p9a_G          118 G------ALRGLGELQELYLKGNELKTLPPGLLTPTP-KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK  189 (290)
T ss_dssp             S------TTTTCTTCCEEECTTSCCCCCCTTTTTTCT-TCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCT
T ss_pred             H------HHcCCCCCCEEECCCCCCCccChhhccccc-CCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccCh
Confidence            4      578999999999999999966566666665 8999999999999877788899999999999999999 4666


Q ss_pred             CccCcccCceeeCccccccc
Q 043388          276 GVGELQHLQQLYMFRNFLQG  295 (854)
Q Consensus       276 ~~~~l~~L~~L~L~~N~l~~  295 (854)
                      .+..+++|+.|+|++|.+..
T Consensus       190 ~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          190 GFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             TTTTTCCCSEEECCSCCBCC
T ss_pred             hhcccccCCeEEeCCCCccC
Confidence            77788899999999999873

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=1.1e-25  Score=245.58  Aligned_cols=262  Identities=17%  Similarity=0.236  Sum_probs=172.7

Q ss_pred             EecccccccccCCccccCcCCCCeeecccccccccCC----cCccCCC-CCcEEecccccCcccChhhhcCC-----CCC
Q 043388           21 LAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIP----TTLGLLR-NLVYLNVAENQFSGMFPRWICNI-----SSL   90 (854)
Q Consensus        21 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L   90 (854)
                      ++|++|.+++.+|..+...++|++|+|++|.|++..+    ..|..++ +|++|+|++|+|++..+..|..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            5666666666666666666666666666666665444    5556666 66666666666666656555554     666


Q ss_pred             ceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCC-CCCCEEecCCCcCccc
Q 043388           91 EFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNA-SNLERLDLSGNQFKGK  169 (854)
Q Consensus        91 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l-~~L~~L~Ls~N~i~~~  169 (854)
                      ++|+|++|+|+ ..+...                                     +...+..+ ++|++|+|++|+|+..
T Consensus        83 ~~L~Ls~n~l~-~~~~~~-------------------------------------l~~~l~~~~~~L~~L~Ls~N~l~~~  124 (362)
T 3goz_A           83 TSLNLSGNFLS-YKSSDE-------------------------------------LVKTLAAIPFTITVLDLGWNDFSSK  124 (362)
T ss_dssp             CEEECCSSCGG-GSCHHH-------------------------------------HHHHHHTSCTTCCEEECCSSCGGGS
T ss_pred             cEEECcCCcCC-hHHHHH-------------------------------------HHHHHHhCCCCccEEECcCCcCCcH
Confidence            66666666665 222111                                     11234444 6777777777777766


Q ss_pred             CCcCccc-----cCCCCeEecccccccCCCCCChhhhhhccCCC-CCcEEEcccCcCcccCChhhhhh----cccccEEE
Q 043388          170 VSIDFSS-----LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCS-SLKALSLCDNQFGGELPHSIANL----SSTMIQFR  239 (854)
Q Consensus       170 ~~~~f~~-----l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l----~~~L~~L~  239 (854)
                      .+..|..     .++|++|+|++|.|+.....  .+...+..++ +|++|+|++|++++..+..+...    ++.|+.|+
T Consensus       125 ~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~--~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~  202 (362)
T 3goz_A          125 SSSEFKQAFSNLPASITSLNLRGNDLGIKSSD--ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLD  202 (362)
T ss_dssp             CHHHHHHHHTTSCTTCCEEECTTSCGGGSCHH--HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEE
T ss_pred             HHHHHHHHHHhCCCceeEEEccCCcCCHHHHH--HHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEE
Confidence            5544433     25777777777777643322  3344555665 89999999999987776655543    23799999


Q ss_pred             ccCCccccc----CCccccc-cccCCeeeccccccccCCC----CCccCcccCceeeCcccccccc-------CCccccC
Q 043388          240 IGGNQISGT----IPSGIRN-LVNLIALTIEVNQLHGIIP----DGVGELQHLQQLYMFRNFLQGS-------IPPSLGN  303 (854)
Q Consensus       240 l~~N~l~~~----~~~~~~~-l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~  303 (854)
                      |++|.|++.    ++..+.. .++|++|+|++|+|++..+    ..+..+++|+.|+|++|.+.+.       ++..+..
T Consensus       203 Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~  282 (362)
T 3goz_A          203 LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPN  282 (362)
T ss_dssp             CTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTT
T ss_pred             CCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhcc
Confidence            999999863    4445555 3589999999999987654    3456778899999999985433       3346777


Q ss_pred             ccccchhccccceecccCC
Q 043388          304 LTKLADLALSFNNLQGNIP  322 (854)
Q Consensus       304 l~~L~~L~L~~N~l~~~~~  322 (854)
                      +++|+.||+++|.+....+
T Consensus       283 l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          283 IQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             CCEEEEECTTSCBCCGGGC
T ss_pred             CCceEEEecCCCcCCCcch
Confidence            8888888888888875543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=2.9e-24  Score=219.72  Aligned_cols=206  Identities=17%  Similarity=0.172  Sum_probs=136.7

Q ss_pred             cccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEeccccc-CcccChhhhcCCCCCceeeecc-ccccccc
Q 043388           27 YLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQ-FSGMFPRWICNISSLEFIYLTV-NRFSGSL  104 (854)
Q Consensus        27 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~  104 (854)
                      .++ .+|. +.  .+|++|++++|+|+++.+..|+.+++|++|+|++|+ ++++.+.+|.++++|++|+|++ |+|+ .+
T Consensus        22 ~l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i   96 (239)
T 2xwt_C           22 DIQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YI   96 (239)
T ss_dssp             SCS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EE
T ss_pred             Ccc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-Ec
Confidence            355 5666 44  378888888888887666678888888888888886 7777777788888888888887 7887 67


Q ss_pred             CcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCC---EEecCCC-cCcccCCcCccccCCC
Q 043388          105 PFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLE---RLDLSGN-QFKGKVSIDFSSLKNL  180 (854)
Q Consensus       105 ~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~---~L~Ls~N-~i~~~~~~~f~~l~~L  180 (854)
                      |...|.++++|++|++++|+++.                  +|+ |..+++|+   +|++++| +++++++..|.++++|
T Consensus        97 ~~~~f~~l~~L~~L~l~~n~l~~------------------lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L  157 (239)
T 2xwt_C           97 DPDALKELPLLKFLGIFNTGLKM------------------FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE  157 (239)
T ss_dssp             CTTSEECCTTCCEEEEEEECCCS------------------CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSS
T ss_pred             CHHHhCCCCCCCEEeCCCCCCcc------------------ccc-cccccccccccEEECCCCcchhhcCcccccchhcc
Confidence            77777777777777777666543                  344 55666666   7777777 7776666666666666


Q ss_pred             C-eEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCc-ccccCCcccccc-c
Q 043388          181 W-WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQ-ISGTIPSGIRNL-V  257 (854)
Q Consensus       181 ~-~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~-l~~~~~~~~~~l-~  257 (854)
                      + +|++++|+++.+                               |...+.. +.|+.|++++|+ ++++.+..|.++ +
T Consensus       158 ~~~L~l~~n~l~~i-------------------------------~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~  205 (239)
T 2xwt_C          158 TLTLKLYNNGFTSV-------------------------------QGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYS  205 (239)
T ss_dssp             EEEEECCSCCCCEE-------------------------------CTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSB
T ss_pred             eeEEEcCCCCCccc-------------------------------CHhhcCC-CCCCEEEcCCCCCcccCCHHHhhcccc
Confidence            6 666665555433                               3222222 245555666663 555555666666 7


Q ss_pred             cCCeeeccccccccCCCCCccCcccCceeeCccc
Q 043388          258 NLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRN  291 (854)
Q Consensus       258 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  291 (854)
                      +|+.|++++|+|+++.+.   .+++|+.|+++++
T Consensus       206 ~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          206 GPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            777777777777754443   4556666666654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.91  E-value=1.4e-24  Score=235.32  Aligned_cols=240  Identities=20%  Similarity=0.237  Sum_probs=118.1

Q ss_pred             eeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcE-EEccc
Q 043388           44 MLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKE-LYLTF  122 (854)
Q Consensus        44 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~-L~l~~  122 (854)
                      +++.++++++ .+|..+  .+++++|+|++|+|+++.+++|.++++|++|+|++|++.+.+|.++|.++++|++ +.+..
T Consensus        13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~   89 (350)
T 4ay9_X           13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   89 (350)
T ss_dssp             EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred             EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence            3444555554 344433  2455555555555554444555555555555555555543455555555555443 22233


Q ss_pred             CCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEeccc-ccccCCCCCChhhh
Q 043388          123 CSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQ-NNLGMGTANDLDFV  201 (854)
Q Consensus       123 n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~-N~l~~~~~~~~~~~  201 (854)
                      |+++.+                 .|+.|.++++|++|++++|+|+.+++..+....++..|++.+ |++..++..     
T Consensus        90 N~l~~l-----------------~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~-----  147 (350)
T 4ay9_X           90 NNLLYI-----------------NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN-----  147 (350)
T ss_dssp             TTCCEE-----------------CTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTT-----
T ss_pred             Cccccc-----------------CchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccccc-----
Confidence            333322                 134455566666666666666655555555555555555533 344433332     


Q ss_pred             hhccCC-CCCcEEEcccCcCcccCChhhhhhcccccEEEccC-CcccccCCccccccccCCeeeccccccccCCCCCccC
Q 043388          202 TLLTNC-SSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG-NQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGE  279 (854)
Q Consensus       202 ~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  279 (854)
                       .|..+ ..++.|+|++|+|+ .+|...+... .++.|++.+ |.++.+.++.|.++++|++|+|++|+|+.+.+..|.+
T Consensus       148 -~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~-~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~  224 (350)
T 4ay9_X          148 -SFVGLSFESVILWLNKNGIQ-EIHNSAFNGT-QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN  224 (350)
T ss_dssp             -SSTTSBSSCEEEECCSSCCC-EECTTSSTTE-EEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT
T ss_pred             -chhhcchhhhhhcccccccc-CCChhhcccc-chhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc
Confidence             12222 23555555555555 3333333333 455555543 4444344445566666666666666666554444444


Q ss_pred             cccCceeeCccccccccCCccccCccccchhccccc
Q 043388          280 LQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFN  315 (854)
Q Consensus       280 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  315 (854)
                      +++|+.+++  +.++ .+| .+.++++|+.++++++
T Consensus       225 L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          225 LKKLRARST--YNLK-KLP-TLEKLVALMEASLTYP  256 (350)
T ss_dssp             CCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCH
T ss_pred             chHhhhccC--CCcC-cCC-CchhCcChhhCcCCCC
Confidence            444433332  1222 333 2455555555555544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=1.6e-25  Score=255.18  Aligned_cols=189  Identities=15%  Similarity=0.149  Sum_probs=140.3

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc--------chHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG--------AFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .+...++||+|+||.||+|...  +..+|+|+.......        ..+++.+|++++++++||||+++..++...+  
T Consensus       337 ~~~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--  412 (540)
T 3en9_A          337 RKIPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--  412 (540)
T ss_dssp             -----------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--
T ss_pred             cCCCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--
Confidence            3345679999999999999554  667888886432211        1345799999999999999994444444333  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                         ..++||||+++++|.+++..              +..++.|++.||+|||++   +|+||||||+|||++. .++++
T Consensus       413 ---~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~-~~kL~  471 (540)
T 3en9_A          413 ---NKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK-DLYII  471 (540)
T ss_dssp             ---TTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS-SEEEC
T ss_pred             ---ccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC-eEEEE
Confidence               45999999999999999875              357899999999999999   9999999999999999 66666


Q ss_pred             ccccccccccCCCCCC----cccccCCcccccCccccCC--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 043388          701 NFSLSHQLDSASKTPS----SSIGIKGTVGYVAPEYGMG--SEASMTGDVYSFGILLLEMFTGRRPTD  762 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~pf~  762 (854)
                      |||+++..........    ......||+.|||||++..  ..|+.++|+||..+-..+-+.++.+|.
T Consensus       472 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          472 DFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9999998755322110    0123569999999999877  557888999999999999888877764

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=1e-23  Score=215.55  Aligned_cols=185  Identities=16%  Similarity=0.178  Sum_probs=156.1

Q ss_pred             cCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeeccccc-ccccCCcCccCCCCCcEEeccc-ccCcccChhhh
Q 043388            7 QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNS-LGGQIPTTLGLLRNLVYLNVAE-NQFSGMFPRWI   84 (854)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~   84 (854)
                      .+|. +..  +|++|+|++|++++..+..|+.+++|++|++++|+ ++.+.+..|..+++|++|+|++ |+|+++.+.+|
T Consensus        25 ~ip~-~~~--~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f  101 (239)
T 2xwt_C           25 RIPS-LPP--STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL  101 (239)
T ss_dssp             SCCC-CCT--TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred             ccCC-CCC--cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence            5676 544  89999999999997777799999999999999997 9977778999999999999999 99998888999


Q ss_pred             cCCCCCceeeecccccccccCcccccCCCCCc---EEEcccC-CCCCCceeeccCccCCCCCCCCCCccccCCCCCC-EE
Q 043388           85 CNISSLEFIYLTVNRFSGSLPFDILVNLPNLK---ELYLTFC-SLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLE-RL  159 (854)
Q Consensus        85 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~---~L~l~~n-~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~-~L  159 (854)
                      .++++|++|+|++|+++ .+|.  |..+++|+   +|++++| +++.+                 .+..|.++++|+ +|
T Consensus       102 ~~l~~L~~L~l~~n~l~-~lp~--~~~l~~L~~L~~L~l~~N~~l~~i-----------------~~~~~~~l~~L~~~L  161 (239)
T 2xwt_C          102 KELPLLKFLGIFNTGLK-MFPD--LTKVYSTDIFFILEITDNPYMTSI-----------------PVNAFQGLCNETLTL  161 (239)
T ss_dssp             ECCTTCCEEEEEEECCC-SCCC--CTTCCBCCSEEEEEEESCTTCCEE-----------------CTTTTTTTBSSEEEE
T ss_pred             CCCCCCCEEeCCCCCCc-cccc--cccccccccccEEECCCCcchhhc-----------------CcccccchhcceeEE
Confidence            99999999999999999 6885  77777777   6666666 55433                 235689999999 99


Q ss_pred             ecCCCcCcccCCcCccccCCCCeEeccccc-ccCCCCCChhhhhhccCC-CCCcEEEcccCcCc
Q 043388          160 DLSGNQFKGKVSIDFSSLKNLWWLNLEQNN-LGMGTANDLDFVTLLTNC-SSLKALSLCDNQFG  221 (854)
Q Consensus       160 ~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~~~~l-~~L~~L~L~~N~l~  221 (854)
                      +|++|+|+.+++..|.. ++|++|+|++|+ ++.++..      .|.++ ++|+.|++++|+++
T Consensus       162 ~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~------~~~~l~~~L~~L~l~~N~l~  218 (239)
T 2xwt_C          162 KLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKD------AFGGVYSGPSLLDVSQTSVT  218 (239)
T ss_dssp             ECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTT------TTTTCSBCCSEEECTTCCCC
T ss_pred             EcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHH------HhhccccCCcEEECCCCccc
Confidence            99999999888888877 889999999994 8766543      46667 77888888887777

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=5.1e-23  Score=211.96  Aligned_cols=181  Identities=24%  Similarity=0.289  Sum_probs=161.2

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeee
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYL   95 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L   95 (854)
                      .+.++++++++.++ .+|..+.  ++++.|+|++|++++..+..|..+++|++|+|++|+|+++.|..|.++++|++|+|
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            46789999999999 6887776  68999999999999888889999999999999999999999999999999999999


Q ss_pred             cccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcc
Q 043388           96 TVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS  175 (854)
Q Consensus        96 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~  175 (854)
                      ++|+|+ .+|...|..+++|++|++++|+++.+                 .+..|.++++|++|+|++|+|+++++..|.
T Consensus        91 ~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~-----------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  152 (251)
T 3m19_A           91 ANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSL-----------------PSGVFDRLTKLKELRLNTNQLQSIPAGAFD  152 (251)
T ss_dssp             TTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCC-----------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             CCCccc-ccChhHhcccCCCCEEEcCCCcCCCc-----------------ChhHhccCCcccEEECcCCcCCccCHHHcC
Confidence            999998 88888899999998888888877644                 245578899999999999999999888999


Q ss_pred             ccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCccc
Q 043388          176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE  223 (854)
Q Consensus       176 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~  223 (854)
                      .+++|++|+|++|+|+.++..      .|..+++|++|+|++|.+...
T Consensus       153 ~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          153 KLTNLQTLSLSTNQLQSVPHG------AFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TCTTCCEEECCSSCCSCCCTT------TTTTCTTCCEEECCSCCBCTT
T ss_pred             cCcCCCEEECCCCcCCccCHH------HHhCCCCCCEEEeeCCceeCC
Confidence            999999999999999877654      577889999999999999854

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=2.2e-25  Score=245.69  Aligned_cols=179  Identities=17%  Similarity=0.232  Sum_probs=103.5

Q ss_pred             CCccccCCCCCCEEecCCCcCcccCCcCccc----c---------CCCCeEecccccccCCCCCChhhhhhccCCCCCcE
Q 043388          146 IPDSLSNASNLERLDLSGNQFKGKVSIDFSS----L---------KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKA  212 (854)
Q Consensus       146 ~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~----l---------~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~  212 (854)
                      +|..+.++++|++|+|++|+|+...+..+..    +         ++|++|+|++|+++.....  .+...+..+++|++
T Consensus       114 l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~  191 (386)
T 2ca6_A          114 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK--EWAKTFQSHRLLHT  191 (386)
T ss_dssp             HHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHH--HHHHHHHHCTTCCE
T ss_pred             HHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHH--HHHHHHHhCCCcCE
Confidence            4556666677777777777765443333332    2         5555555555555321110  11123444455555


Q ss_pred             EEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccc----cCCCCCccCcccCceeeC
Q 043388          213 LSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLH----GIIPDGVGELQHLQQLYM  288 (854)
Q Consensus       213 L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L  288 (854)
                      |+|++|+++..   .+.                 ...|..+..+++|+.|+|++|+|+    ..+|..+..+++|++|+|
T Consensus       192 L~L~~n~l~~~---g~~-----------------~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L  251 (386)
T 2ca6_A          192 VKMVQNGIRPE---GIE-----------------HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL  251 (386)
T ss_dssp             EECCSSCCCHH---HHH-----------------HHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred             EECcCCCCCHh---HHH-----------------HHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEEC
Confidence            55555554410   000                 022335666667777777777764    345556667777777777


Q ss_pred             cccccccc----CCccc--cCccccchhccccceecc----cCCCCC-cCCCCCcccccCCCcccCccc
Q 043388          289 FRNFLQGS----IPPSL--GNLTKLADLALSFNNLQG----NIPSSL-GNCQNLKGFDASHNKLTGAIP  346 (854)
Q Consensus       289 ~~N~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~ls~N~l~~~~p  346 (854)
                      ++|.+++.    ++..+  +.+++|+.|+|++|.+++    .+|..+ .++++|+.|++++|++++..+
T Consensus       252 ~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          252 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             CCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            77777654    44555  337777888888887775    366655 557888888888888875443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=9.9e-24  Score=224.72  Aligned_cols=233  Identities=15%  Similarity=0.111  Sum_probs=175.7

Q ss_pred             CCCCEEecccccccccC-Cc--cccCcCCCCeeecccccccccCCcCc--cCCCCCcEEecccccCcccCh----hhhcC
Q 043388           16 LNLQTLAIDFNYLTGQL-PD--FVGNLSALGMLLIRWNSLGGQIPTTL--GLLRNLVYLNVAENQFSGMFP----RWICN   86 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~-~~--~~~~l~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~   86 (854)
                      ..++.|.+.++.++... ..  .+..+++|++|++++|++++..|..+  ..+++|++|+|++|.+++..+    ..+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            35678888887775321 11  12334679999999999998888888  889999999999999987554    45568


Q ss_pred             CCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcC
Q 043388           87 ISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQF  166 (854)
Q Consensus        87 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i  166 (854)
                      +++|++|+|++|+|+ .++...|.++++|++|++++|++.....             -..+..+.++++|++|+|++|+|
T Consensus       144 ~~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-------------~~~~~~~~~l~~L~~L~Ls~N~l  209 (310)
T 4glp_A          144 KPGLKVLSIAQAHSP-AFSCEQVRAFPALTSLDLSDNPGLGERG-------------LMAALCPHKFPAIQNLALRNTGM  209 (310)
T ss_dssp             CSCCCEEEEECCSSC-CCCTTSCCCCTTCCEEECCSCTTCHHHH-------------HHTTSCTTSSCCCCSCBCCSSCC
T ss_pred             ccCCCEEEeeCCCcc-hhhHHHhccCCCCCEEECCCCCCccchh-------------hhHHHhhhcCCCCCEEECCCCCC
Confidence            999999999999997 7777788888888888888887642100             00122346788999999999999


Q ss_pred             cccCCc---CccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCC
Q 043388          167 KGKVSI---DFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGN  243 (854)
Q Consensus       167 ~~~~~~---~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N  243 (854)
                      +.+.+.   .+..+++|++|+|++|+|+...+..+   ..+..+++|++|+|++|+++ .+|..+.   +.|+.|+|++|
T Consensus       210 ~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~---~~~~~~~~L~~L~Ls~N~l~-~lp~~~~---~~L~~L~Ls~N  282 (310)
T 4glp_A          210 ETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSA---PRCMWSSALNSLNLSFAGLE-QVPKGLP---AKLRVLDLSSN  282 (310)
T ss_dssp             CCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCC---SSCCCCTTCCCEECCSSCCC-SCCSCCC---SCCSCEECCSC
T ss_pred             CchHHHHHHHHhcCCCCCEEECCCCCCCccchhhH---HhccCcCcCCEEECCCCCCC-chhhhhc---CCCCEEECCCC
Confidence            754332   35778999999999999987632211   12333479999999999999 7787765   48999999999


Q ss_pred             cccccCCccccccccCCeeecccccccc
Q 043388          244 QISGTIPSGIRNLVNLIALTIEVNQLHG  271 (854)
Q Consensus       244 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~  271 (854)
                      +|++. |. +..+++|+.|+|++|+|+.
T Consensus       283 ~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          283 RLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             cCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            99965 43 7888999999999999974

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=4.7e-23  Score=223.33  Aligned_cols=242  Identities=17%  Similarity=0.118  Sum_probs=198.5

Q ss_pred             cEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCC
Q 043388           67 VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSI  146 (854)
Q Consensus        67 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~  146 (854)
                      ++++.++|+++ .+|..+  .+++++|+|++|+|+ .+|.++|.++++|++|+|++|++..                 .+
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~-----------------~i   70 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLE-----------------VI   70 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCC-----------------EE
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCC-----------------cc
Confidence            57899999999 567655  468999999999999 9999999999999999999888642                 23


Q ss_pred             C-ccccCCCCCCE-EecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEccc-CcCccc
Q 043388          147 P-DSLSNASNLER-LDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCD-NQFGGE  223 (854)
Q Consensus       147 p-~~~~~l~~L~~-L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~-N~l~~~  223 (854)
                      | ..|.++++|.+ +.+++|+|+.+.+..|..+++|++|++++|+|..++..      .+....++..|++.+ |++...
T Consensus        71 ~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~------~~~~~~~l~~l~l~~~~~i~~l  144 (350)
T 4ay9_X           71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV------HKIHSLQKVLLDIQDNINIHTI  144 (350)
T ss_dssp             CTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCC------TTCCBSSCEEEEEESCTTCCEE
T ss_pred             ChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCch------hhcccchhhhhhhccccccccc
Confidence            3 56889998875 67788999999999999999999999999999877654      355667788999866 677755


Q ss_pred             CChhhhhhcccccEEEccCCcccccCCccccccccCCeeecc-ccccccCCCCCccCcccCceeeCccccccccCCcccc
Q 043388          224 LPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIE-VNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLG  302 (854)
Q Consensus       224 ~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  302 (854)
                      .+..|..+...++.|+|++|+|+.+.+..| ...+|++|+++ +|.++.+.+++|.++++|++|+|++|+|+...+..|.
T Consensus       145 ~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~  223 (350)
T 4ay9_X          145 ERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE  223 (350)
T ss_dssp             CTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT
T ss_pred             cccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc
Confidence            556677777679999999999996555544 56789999997 5788888788999999999999999999977677788


Q ss_pred             CccccchhccccceecccCCCCCcCCCCCcccccCCCc
Q 043388          303 NLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNK  340 (854)
Q Consensus       303 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~  340 (854)
                      ++++|+.+++.  .++ .+| .+.++++|+.++++++.
T Consensus       224 ~L~~L~~l~~~--~l~-~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          224 NLKKLRARSTY--NLK-KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             TCCEEECTTCT--TCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred             cchHhhhccCC--CcC-cCC-CchhCcChhhCcCCCCc
Confidence            88888887764  344 566 48889999999987653

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=2.2e-25  Score=245.64  Aligned_cols=204  Identities=18%  Similarity=0.209  Sum_probs=138.3

Q ss_pred             cccCCCCCCEEecCCCcCcc----cCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccC
Q 043388          149 SLSNASNLERLDLSGNQFKG----KVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGEL  224 (854)
Q Consensus       149 ~~~~l~~L~~L~Ls~N~i~~----~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  224 (854)
                      .|.++++|++|+|++|+|+.    ..+..|..+++|++|+|++|.++.....  .+...+..+        ..|.+.+. 
T Consensus        89 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~l--------~~~~~~~~-  157 (386)
T 2ca6_A           89 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA--KIARALQEL--------AVNKKAKN-  157 (386)
T ss_dssp             HHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHH--HHHHHHHHH--------HHHHHHHT-
T ss_pred             HHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHH--HHHHHHHHH--------hhhhhccc-
Confidence            34677888888888888875    2444555666666666666655321111  111112222        00000000 


Q ss_pred             ChhhhhhcccccEEEccCCccc-ccCC---ccccccccCCeeecccccccc-----CCCCCccCcccCceeeCcccccc-
Q 043388          225 PHSIANLSSTMIQFRIGGNQIS-GTIP---SGIRNLVNLIALTIEVNQLHG-----IIPDGVGELQHLQQLYMFRNFLQ-  294 (854)
Q Consensus       225 p~~~~~l~~~L~~L~l~~N~l~-~~~~---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~-  294 (854)
                             .+.|+.|++++|+++ ...+   ..+..+++|++|+|++|+|+.     ..|..+..+++|+.|+|++|.++ 
T Consensus       158 -------~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~  230 (386)
T 2ca6_A          158 -------APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH  230 (386)
T ss_dssp             -------CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHH
T ss_pred             -------CCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCc
Confidence                   024555555555554 2222   356678889999999998872     45558899999999999999996 


Q ss_pred             ---ccCCccccCccccchhccccceeccc----CCCCC--cCCCCCcccccCCCcccC----ccchhhcc-hhhhHHHHH
Q 043388          295 ---GSIPPSLGNLTKLADLALSFNNLQGN----IPSSL--GNCQNLKGFDASHNKLTG----AIPQQVLS-ITTLSVYLA  360 (854)
Q Consensus       295 ---~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~--~~l~~L~~L~ls~N~l~~----~~p~~~~~-~~~l~~~l~  360 (854)
                         +.+|..+..+++|+.|+|++|.+++.    ++..+  +.+++|+.|+|++|.+++    .+|..+.. +..+.. ++
T Consensus       231 ~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~-L~  309 (386)
T 2ca6_A          231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF-LE  309 (386)
T ss_dssp             HHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCE-EE
T ss_pred             HHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceE-EE
Confidence               57888999999999999999999865    46666  448999999999999996    48877743 566654 99


Q ss_pred             hhcCCCCCCcC
Q 043388          361 LAHNLLNDSLP  371 (854)
Q Consensus       361 l~~n~l~~~~p  371 (854)
                      +++|.+++..+
T Consensus       310 l~~N~l~~~~~  320 (386)
T 2ca6_A          310 LNGNRFSEEDD  320 (386)
T ss_dssp             CTTSBSCTTSH
T ss_pred             ccCCcCCcchh
Confidence            99999987654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=1.7e-23  Score=222.98  Aligned_cols=228  Identities=17%  Similarity=0.155  Sum_probs=130.4

Q ss_pred             CCCeeecccccccccCCc---CccCCCCCcEEecccccCcccChhhh--cCCCCCceeeecccccccccC---cccccCC
Q 043388           41 ALGMLLIRWNSLGGQIPT---TLGLLRNLVYLNVAENQFSGMFPRWI--CNISSLEFIYLTVNRFSGSLP---FDILVNL  112 (854)
Q Consensus        41 ~L~~L~l~~n~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~~---~~~~~~l  112 (854)
                      .++.|.+.++.++...-.   .+..+++|++|+|++|.+++..|..+  ..+++|++|+|++|++++..+   ...+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            467888888877531111   12345779999999999999999988  999999999999999985433   1222344


Q ss_pred             CCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcc---cCC-cCccccCCCCeEecccc
Q 043388          113 PNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKG---KVS-IDFSSLKNLWWLNLEQN  188 (854)
Q Consensus       113 ~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~---~~~-~~f~~l~~L~~L~L~~N  188 (854)
                      ++|++|++++|++..                 ..|..|+++++|++|+|++|++.+   +.+ ..+..+++|++|+|++|
T Consensus       145 ~~L~~L~Ls~n~l~~-----------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N  207 (310)
T 4glp_A          145 PGLKVLSIAQAHSPA-----------------FSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNT  207 (310)
T ss_dssp             SCCCEEEEECCSSCC-----------------CCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSS
T ss_pred             cCCCEEEeeCCCcch-----------------hhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCC
Confidence            455555444444432                 224455566666666666666543   211 22345555555555555


Q ss_pred             cccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccccc---ccCCeeecc
Q 043388          189 NLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNL---VNLIALTIE  265 (854)
Q Consensus       189 ~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~L~L~  265 (854)
                      +++.++..   ....+.++++|                         +.|+|++|+|++..|..+..+   ++|++|+|+
T Consensus       208 ~l~~l~~~---~~~l~~~l~~L-------------------------~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls  259 (310)
T 4glp_A          208 GMETPTGV---CAALAAAGVQP-------------------------HSLDLSHNSLRATVNPSAPRCMWSSALNSLNLS  259 (310)
T ss_dssp             CCCCHHHH---HHHHHHHTCCC-------------------------SSEECTTSCCCCCCCSCCSSCCCCTTCCCEECC
T ss_pred             CCCchHHH---HHHHHhcCCCC-------------------------CEEECCCCCCCccchhhHHhccCcCcCCEEECC
Confidence            55322110   00012344444                         445555555544444444444   466666666


Q ss_pred             ccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceec
Q 043388          266 VNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ  318 (854)
Q Consensus       266 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  318 (854)
                      +|+|+. +|..+.  ++|++|+|++|+|++. |. +..+++|+.|+|++|+|+
T Consensus       260 ~N~l~~-lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          260 FAGLEQ-VPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             SSCCCS-CCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred             CCCCCc-hhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence            666663 344332  5666666666666643 22 455566666666666655

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=4.5e-23  Score=219.02  Aligned_cols=210  Identities=24%  Similarity=0.319  Sum_probs=139.3

Q ss_pred             CCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecc
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTV   97 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~   97 (854)
                      +..+.+..+.+++.+  .+..+++|++|++++|.++. +| .+..+++|++|+|++|+++++.+  +.++++|++|+|++
T Consensus        21 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~   94 (308)
T 1h6u_A           21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG   94 (308)
T ss_dssp             HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred             HHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccC
Confidence            444556666666433  34567788888888888873 44 57888888888888888886544  88888888888888


Q ss_pred             cccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcccc
Q 043388           98 NRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL  177 (854)
Q Consensus        98 N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l  177 (854)
                      |+++ .++  .|..+++|++|++++|+++.+                  | .+..+++|++|+|++|+++++.+  |..+
T Consensus        95 n~l~-~~~--~~~~l~~L~~L~l~~n~l~~~------------------~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l  150 (308)
T 1h6u_A           95 NPLK-NVS--AIAGLQSIKTLDLTSTQITDV------------------T-PLAGLSNLQVLYLDLNQITNISP--LAGL  150 (308)
T ss_dssp             CCCS-CCG--GGTTCTTCCEEECTTSCCCCC------------------G-GGTTCTTCCEEECCSSCCCCCGG--GGGC
T ss_pred             CcCC-Cch--hhcCCCCCCEEECCCCCCCCc------------------h-hhcCCCCCCEEECCCCccCcCcc--ccCC
Confidence            8887 554  366666666666666655432                  2 26777888888888888876654  7777


Q ss_pred             CCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccc
Q 043388          178 KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLV  257 (854)
Q Consensus       178 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~  257 (854)
                      ++|++|+|++|+++.++        .+..+++|+.|++++|++++. +. +..++ .|+.|++++|++++..  .+..++
T Consensus       151 ~~L~~L~l~~n~l~~~~--------~l~~l~~L~~L~l~~n~l~~~-~~-l~~l~-~L~~L~L~~N~l~~~~--~l~~l~  217 (308)
T 1h6u_A          151 TNLQYLSIGNAQVSDLT--------PLANLSKLTTLKADDNKISDI-SP-LASLP-NLIEVHLKNNQISDVS--PLANTS  217 (308)
T ss_dssp             TTCCEEECCSSCCCCCG--------GGTTCTTCCEEECCSSCCCCC-GG-GGGCT-TCCEEECTTSCCCBCG--GGTTCT
T ss_pred             CCccEEEccCCcCCCCh--------hhcCCCCCCEEECCCCccCcC-hh-hcCCC-CCCEEEccCCccCccc--cccCCC
Confidence            77778888777776432        156677777777777777632 22 44443 4555555555555433  255555


Q ss_pred             cCCeeeccccccc
Q 043388          258 NLIALTIEVNQLH  270 (854)
Q Consensus       258 ~L~~L~L~~N~l~  270 (854)
                      +|+.|+|++|+++
T Consensus       218 ~L~~L~l~~N~i~  230 (308)
T 1h6u_A          218 NLFIVTLTNQTIT  230 (308)
T ss_dssp             TCCEEEEEEEEEE
T ss_pred             CCCEEEccCCeee
Confidence            5555555555555

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=7e-24  Score=229.08  Aligned_cols=252  Identities=20%  Similarity=0.251  Sum_probs=132.6

Q ss_pred             CCEEecccccccccCCccccCc--CCCCeeecccccccccCCcCccCCCCCcEEecccccCccc-ChhhhcCCCCCceee
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNL--SALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGM-FPRWICNISSLEFIY   94 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~   94 (854)
                      ++.|++++|.+.   +..+..+  .+++.|++++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            445555555444   2334444  4555555555555533333 33445555555555555433 444455555555555


Q ss_pred             ecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCC-cCccc-CCc
Q 043388           95 LTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGN-QFKGK-VSI  172 (854)
Q Consensus        95 L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N-~i~~~-~~~  172 (854)
                      |++|++++.                                          .|..+.++++|++|+|++| .+++. .+.
T Consensus       125 L~~~~l~~~------------------------------------------~~~~l~~~~~L~~L~L~~~~~l~~~~l~~  162 (336)
T 2ast_B          125 LEGLRLSDP------------------------------------------IVNTLAKNSNLVRLNLSGCSGFSEFALQT  162 (336)
T ss_dssp             CTTCBCCHH------------------------------------------HHHHHTTCTTCSEEECTTCBSCCHHHHHH
T ss_pred             CcCcccCHH------------------------------------------HHHHHhcCCCCCEEECCCCCCCCHHHHHH
Confidence            555544422                                          2334444555555555555 34431 233


Q ss_pred             CccccCCCCeEecccc-cccCCCCCChhhhhhccCCC-CCcEEEcccC--cCc-ccCChhhhhhcccccEEEccCCc-cc
Q 043388          173 DFSSLKNLWWLNLEQN-NLGMGTANDLDFVTLLTNCS-SLKALSLCDN--QFG-GELPHSIANLSSTMIQFRIGGNQ-IS  246 (854)
Q Consensus       173 ~f~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~~l~-~L~~L~L~~N--~l~-~~~p~~~~~l~~~L~~L~l~~N~-l~  246 (854)
                      .+..+++|++|++++| .++.     ...+..+..++ +|++|++++|  .++ +.+|..+..++ +|+.|++++|. ++
T Consensus       163 ~~~~~~~L~~L~l~~~~~l~~-----~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~-~L~~L~l~~~~~l~  236 (336)
T 2ast_B          163 LLSSCSRLDELNLSWCFDFTE-----KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP-NLVHLDLSDSVMLK  236 (336)
T ss_dssp             HHHHCTTCCEEECCCCTTCCH-----HHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCT-TCSEEECTTCTTCC
T ss_pred             HHhcCCCCCEEcCCCCCCcCh-----HHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCC-CCCEEeCCCCCcCC
Confidence            3445555555555555 4431     11223344555 6666666666  333 23444444443 56666666666 55


Q ss_pred             ccCCccccccccCCeeeccccccccCCCC---CccCcccCceeeCccccccccCCccccCcc-ccchhccccceecccCC
Q 043388          247 GTIPSGIRNLVNLIALTIEVNQLHGIIPD---GVGELQHLQQLYMFRNFLQGSIPPSLGNLT-KLADLALSFNNLQGNIP  322 (854)
Q Consensus       247 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~  322 (854)
                      +..+..+..+++|++|++++|.  ++.+.   .+..+++|+.|++++| ++   ...+..+. .|..|++++|++++..|
T Consensus       237 ~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~  310 (336)
T 2ast_B          237 NDCFQEFFQLNYLQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIAR  310 (336)
T ss_dssp             GGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTC
T ss_pred             HHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccC
Confidence            5555666777777777777774  22233   4667777777777777 22   22344443 47777777777777777


Q ss_pred             CCCcC
Q 043388          323 SSLGN  327 (854)
Q Consensus       323 ~~~~~  327 (854)
                      ..++.
T Consensus       311 ~~~~~  315 (336)
T 2ast_B          311 PTIGN  315 (336)
T ss_dssp             SSCSS
T ss_pred             Ccccc
Confidence            66654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=2.1e-22  Score=213.77  Aligned_cols=216  Identities=23%  Similarity=0.301  Sum_probs=165.9

Q ss_pred             CCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEE
Q 043388           40 SALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY  119 (854)
Q Consensus        40 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~  119 (854)
                      ..+..+.+..+.+++..  .+..+++|++|++++|.++. +| .+..+++|++|+|++|+++ .++.  |..+++|++|+
T Consensus        19 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~-~~~~--~~~l~~L~~L~   91 (308)
T 1h6u_A           19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQIT-DLAP--LKNLTKITELE   91 (308)
T ss_dssp             HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCCSCCEEE
T ss_pred             HHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCC-CChh--HccCCCCCEEE
Confidence            34455567777776432  35568889999999998885 44 5888889999999999888 6665  77788888877


Q ss_pred             cccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChh
Q 043388          120 LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD  199 (854)
Q Consensus       120 l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~  199 (854)
                      +++|+++.+                   +.+.++++|++|+|++|+|+++.+  |..+++|++|+|++|.++.++.    
T Consensus        92 L~~n~l~~~-------------------~~~~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~----  146 (308)
T 1h6u_A           92 LSGNPLKNV-------------------SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP----  146 (308)
T ss_dssp             CCSCCCSCC-------------------GGGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG----
T ss_pred             ccCCcCCCc-------------------hhhcCCCCCCEEECCCCCCCCchh--hcCCCCCCEEECCCCccCcCcc----
Confidence            777766533                   257788889999999999887643  8888899999999998875432    


Q ss_pred             hhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccC
Q 043388          200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGE  279 (854)
Q Consensus       200 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  279 (854)
                          +..+++|++|+|++|++++ ++. +..++ .|+.|++++|.+++..+  +..+++|++|+|++|++++..+  +..
T Consensus       147 ----l~~l~~L~~L~l~~n~l~~-~~~-l~~l~-~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~  215 (308)
T 1h6u_A          147 ----LAGLTNLQYLSIGNAQVSD-LTP-LANLS-KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LAN  215 (308)
T ss_dssp             ----GGGCTTCCEEECCSSCCCC-CGG-GTTCT-TCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTT
T ss_pred             ----ccCCCCccEEEccCCcCCC-Chh-hcCCC-CCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccC
Confidence                6778889999999998884 443 66665 78899999999886544  8888889999999999887653  788


Q ss_pred             cccCceeeCccccccccCCc
Q 043388          280 LQHLQQLYMFRNFLQGSIPP  299 (854)
Q Consensus       280 l~~L~~L~L~~N~l~~~~~~  299 (854)
                      +++|+.|++++|++++ .|.
T Consensus       216 l~~L~~L~l~~N~i~~-~~~  234 (308)
T 1h6u_A          216 TSNLFIVTLTNQTITN-QPV  234 (308)
T ss_dssp             CTTCCEEEEEEEEEEC-CCE
T ss_pred             CCCCCEEEccCCeeec-CCe
Confidence            8899999999998874 443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=2.9e-22  Score=206.30  Aligned_cols=171  Identities=25%  Similarity=0.306  Sum_probs=154.9

Q ss_pred             CcccccCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccCh
Q 043388            2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFP   81 (854)
Q Consensus         2 n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p   81 (854)
                      |+++ .+|..+.  ++|++|+|++|.+++..+..|+.+++|++|+|++|+|++..+..|..+++|++|+|++|+|+++.+
T Consensus        24 ~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  100 (251)
T 3m19_A           24 KSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPL  100 (251)
T ss_dssp             CCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred             CCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccCh
Confidence            4455 5777666  599999999999998888899999999999999999999888999999999999999999999888


Q ss_pred             hhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEec
Q 043388           82 RWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDL  161 (854)
Q Consensus        82 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~L  161 (854)
                      ..|.++++|++|+|++|+|+ .+|...|.++++|++|++++|+++.+                 .+..|.++++|++|+|
T Consensus       101 ~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~-----------------~~~~~~~l~~L~~L~L  162 (251)
T 3m19_A          101 GVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSI-----------------PAGAFDKLTNLQTLSL  162 (251)
T ss_dssp             TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCC-----------------CTTTTTTCTTCCEEEC
T ss_pred             hHhcccCCCCEEEcCCCcCC-CcChhHhccCCcccEEECcCCcCCcc-----------------CHHHcCcCcCCCEEEC
Confidence            99999999999999999999 89988899999999998888877644                 2457899999999999


Q ss_pred             CCCcCcccCCcCccccCCCCeEecccccccCC
Q 043388          162 SGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMG  193 (854)
Q Consensus       162 s~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~  193 (854)
                      ++|+|+++++..|..+++|++|+|++|.+...
T Consensus       163 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          163 STNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            99999999999999999999999999998643

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=4e-23  Score=223.09  Aligned_cols=244  Identities=16%  Similarity=0.196  Sum_probs=160.5

Q ss_pred             chhhhcC--CCCCEEecccccccccCCccccCcCCCCeeeccccccccc-CCcCccCCCCCcEEecccccCcccChhhhc
Q 043388            9 PEEIGSL--LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQ-IPTTLGLLRNLVYLNVAENQFSGMFPRWIC   85 (854)
Q Consensus         9 p~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~   85 (854)
                      |..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++|+|++|.+++..|..|+
T Consensus        61 ~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~  139 (336)
T 2ast_B           61 PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLA  139 (336)
T ss_dssp             HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHT
T ss_pred             HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHh
Confidence            5677777  8999999999999976655 56799999999999999866 888899999999999999999988999999


Q ss_pred             CCCCCceeeeccc-ccccccCcccccCCCCCcEEEcccC-CCCCCceeeccCccCCCCCCCCCCccccCCC-CCCEEecC
Q 043388           86 NISSLEFIYLTVN-RFSGSLPFDILVNLPNLKELYLTFC-SLKNLWWLNLEQNNLGMGTASSIPDSLSNAS-NLERLDLS  162 (854)
Q Consensus        86 ~l~~L~~L~L~~N-~l~~~~~~~~~~~l~~L~~L~l~~n-~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~-~L~~L~Ls  162 (854)
                      .+++|++|+|++| .+++.--...+.++++|++|++++| .++.                ..++..+..++ +|++|+|+
T Consensus       140 ~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~----------------~~~~~~~~~l~~~L~~L~l~  203 (336)
T 2ast_B          140 KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE----------------KHVQVAVAHVSETITQLNLS  203 (336)
T ss_dssp             TCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH----------------HHHHHHHHHSCTTCCEEECC
T ss_pred             cCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh----------------HHHHHHHHhcccCCCEEEeC
Confidence            9999999999999 6763212233555666666666555 4431                01344556666 66666666


Q ss_pred             CCc--Cc-ccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEE
Q 043388          163 GNQ--FK-GKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFR  239 (854)
Q Consensus       163 ~N~--i~-~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~  239 (854)
                      +|.  ++ ...+..+..+++|++|++++|.+                             +++..+..+..++ +|+.|+
T Consensus       204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~-----------------------------l~~~~~~~l~~l~-~L~~L~  253 (336)
T 2ast_B          204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM-----------------------------LKNDCFQEFFQLN-YLQHLS  253 (336)
T ss_dssp             SCGGGSCHHHHHHHHHHCTTCSEEECTTCTT-----------------------------CCGGGGGGGGGCT-TCCEEE
T ss_pred             CCcccCCHHHHHHHHhhCCCCCEEeCCCCCc-----------------------------CCHHHHHHHhCCC-CCCEee
Confidence            663  33 22233444455555555555541                             3333344444442 455555


Q ss_pred             ccCCc-ccccCCccccccccCCeeeccccccccCCCCCccCcc-cCceeeCccccccccCCccccC
Q 043388          240 IGGNQ-ISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQ-HLQQLYMFRNFLQGSIPPSLGN  303 (854)
Q Consensus       240 l~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~  303 (854)
                      +++|. ++......+.++++|+.|++++|    +....+..+. +|..|++++|++++..|..+++
T Consensus       254 l~~~~~~~~~~~~~l~~~~~L~~L~l~~~----i~~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          254 LSRCYDIIPETLLELGEIPTLKTLQVFGI----VPDGTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             CTTCTTCCGGGGGGGGGCTTCCEEECTTS----SCTTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CCCCCCCCHHHHHHHhcCCCCCEEeccCc----cCHHHHHHHHhhCcceEEecccCccccCCcccc
Confidence            55542 21111124556677777777777    2233444443 3666777777777777766654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=7e-22  Score=197.21  Aligned_cols=181  Identities=24%  Similarity=0.279  Sum_probs=136.0

Q ss_pred             CCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecc
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTV   97 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~   97 (854)
                      -+.++++++.++ .+|..+.  ++|++|++++|++++..+..|+.+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus         9 ~~~v~c~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~   85 (208)
T 2o6s_A            9 GTTVECYSQGRT-SVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST   85 (208)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCcc-CCCCCCC--CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence            367888888888 5665553  5788888888888877777788888888888888888877777788888888888888


Q ss_pred             cccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcccc
Q 043388           98 NRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL  177 (854)
Q Consensus        98 N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l  177 (854)
                      |+|+ .+|...|.++++|++|++++|+++.+                 .+..|.++++|++|+|++|+|+++++..|..+
T Consensus        86 n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~-----------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  147 (208)
T 2o6s_A           86 NQLQ-SLPNGVFDKLTQLKELALNTNQLQSL-----------------PDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL  147 (208)
T ss_dssp             SCCC-CCCTTTTTTCTTCCEEECCSSCCCCC-----------------CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred             CcCC-ccCHhHhcCccCCCEEEcCCCcCccc-----------------CHhHhccCCcCCEEECCCCccceeCHHHhccC
Confidence            8887 77777777777777777777666533                 23446778888888888888887777777777


Q ss_pred             CCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhc
Q 043388          178 KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLS  232 (854)
Q Consensus       178 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  232 (854)
                      ++|++|+|++|.+.             ..+++|++|+++.|+++|.+|..++.+.
T Consensus       148 ~~L~~L~l~~N~~~-------------~~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          148 TSLQYIWLHDNPWD-------------CTCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             TTCCEEECCSCCBC-------------CCTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             CCccEEEecCCCee-------------cCCCCHHHHHHHHHhCCceeeccCcccc
Confidence            78888888777653             3455677777777777777776666554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=2.1e-22  Score=210.04  Aligned_cols=147  Identities=19%  Similarity=0.175  Sum_probs=113.8

Q ss_pred             HHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc------------------cchHHHHHHHHHHHhccCCCe
Q 043388          546 ATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK------------------GAFRSFVAECEALRNIRHRNL  607 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~ni  607 (854)
                      ....|.+.+.||+|+||.||+|.+ .+++.||+|+++....                  .....+.+|+.++++++|   
T Consensus        88 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---  163 (282)
T 1zar_A           88 SGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---  163 (282)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---
T ss_pred             CCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---
Confidence            334566779999999999999999 6899999999964321                  124568899999999985   


Q ss_pred             eeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 043388          608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKP  687 (854)
Q Consensus       608 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp  687 (854)
                      +++.+++.. +     ..++||||++||+|.+ +...            +...++.|++.||+|||+.   +|+||||||
T Consensus       164 ~~v~~~~~~-~-----~~~lvmE~~~g~~L~~-l~~~------------~~~~i~~qi~~~l~~lH~~---giiHrDlkp  221 (282)
T 1zar_A          164 LAVPKVYAW-E-----GNAVLMELIDAKELYR-VRVE------------NPDEVLDMILEEVAKFYHR---GIVHGDLSQ  221 (282)
T ss_dssp             SSSCCEEEE-E-----TTEEEEECCCCEEGGG-CCCS------------CHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred             CCcCeEEec-c-----ceEEEEEecCCCcHHH-cchh------------hHHHHHHHHHHHHHHHHHC---CCEeCCCCH
Confidence            444444432 1     4699999999999998 4221            2346999999999999999   999999999


Q ss_pred             CceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCC
Q 043388          688 SNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG  735 (854)
Q Consensus       688 ~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  735 (854)
                      +|||++ ++..++ |||+|+.                +..|+|||++.+
T Consensus       222 ~NILl~-~~~vkl~DFG~a~~----------------~~~~~a~e~l~r  253 (282)
T 1zar_A          222 YNVLVS-EEGIWIIDFPQSVE----------------VGEEGWREILER  253 (282)
T ss_dssp             TSEEEE-TTEEEECCCTTCEE----------------TTSTTHHHHHHH
T ss_pred             HHEEEE-CCcEEEEECCCCeE----------------CCCCCHHHHHHH
Confidence            999999 665555 9999852                445788998643

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=1.8e-21  Score=221.48  Aligned_cols=108  Identities=27%  Similarity=0.322  Sum_probs=51.6

Q ss_pred             CCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhc
Q 043388          153 ASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLS  232 (854)
Q Consensus       153 l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  232 (854)
                      +++|++|+|++|+|+++++    .+++|++|+|++|+|+.++.        |.  ++|+.|+|++|+|+ .+|. +..  
T Consensus       139 l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~~lp~--------l~--~~L~~L~Ls~N~L~-~lp~-~~~--  200 (571)
T 3cvr_A          139 PALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTFLPE--------LP--ESLEALDVSTNLLE-SLPA-VPV--  200 (571)
T ss_dssp             CTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCC--------CC--TTCCEEECCSSCCS-SCCC-CC---
T ss_pred             CccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCCCcch--------hh--CCCCEEECcCCCCC-chhh-HHH--
Confidence            3444444444444444322    23444444444444443221        11  44555555555554 3443 222  


Q ss_pred             ccc-------cEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCc
Q 043388          233 STM-------IQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGEL  280 (854)
Q Consensus       233 ~~L-------~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  280 (854)
                       .|       +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..|..|..+
T Consensus       201 -~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l  253 (571)
T 3cvr_A          201 -RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ  253 (571)
T ss_dssp             --------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred             -hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence             33       55666666665 345555556666666666666665555555444

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=1.3e-20  Score=187.92  Aligned_cols=180  Identities=21%  Similarity=0.228  Sum_probs=140.0

Q ss_pred             eeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCC
Q 043388          130 WLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSS  209 (854)
Q Consensus       130 ~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~  209 (854)
                      .++++.+.+     ..+|..+  .++|++|+|++|+|+++.+..|..+++|++|+|++|+++.++..      .|..+++
T Consensus        11 ~v~c~~~~l-----~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~------~~~~l~~   77 (208)
T 2o6s_A           11 TVECYSQGR-----TSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG------VFNKLTS   77 (208)
T ss_dssp             EEECCSSCC-----SSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT------TTTTCTT
T ss_pred             EEEecCCCc-----cCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh------hcCCCCC
Confidence            344444544     4456544  46899999999999988888899999999999999999876553      4678889


Q ss_pred             CcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCc
Q 043388          210 LKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMF  289 (854)
Q Consensus       210 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  289 (854)
                      |++|+|++|++++..+..+..+. .|+.|++++|+|++..+..|.++++|++|+|++|+++++.+..|..+++|++|+++
T Consensus        78 L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  156 (208)
T 2o6s_A           78 LTYLNLSTNQLQSLPNGVFDKLT-QLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLH  156 (208)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             cCEEECCCCcCCccCHhHhcCcc-CCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEec
Confidence            99999999998855555566665 78888888888887777778888888888888888887777778888888888888


Q ss_pred             cccccccCCccccCccccchhccccceecccCCCCCcCCCC
Q 043388          290 RNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQN  330 (854)
Q Consensus       290 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  330 (854)
                      +|.+.+       .+++|+.|+++.|+++|.+|..++.++.
T Consensus       157 ~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          157 DNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             SCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             CCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            887664       3457888888888888888887776654

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=1.1e-21  Score=223.27  Aligned_cols=189  Identities=23%  Similarity=0.304  Sum_probs=142.2

Q ss_pred             CCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCC
Q 043388           65 NLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTAS  144 (854)
Q Consensus        65 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~  144 (854)
                      +|+.|+|++|.|++ +|..+  +++|++|+|++|+|+ .+| .   .+++|++|++++|+++.                 
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip-~---~l~~L~~L~Ls~N~l~~-----------------  114 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP-E---LPASLEYLDACDNRLST-----------------  114 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC-C---CCTTCCEEECCSSCCSC-----------------
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc-c---ccCCCCEEEccCCCCCC-----------------
Confidence            77788888888775 55544  367888888888877 676 2   34555555555554432                 


Q ss_pred             CCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccC
Q 043388          145 SIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGEL  224 (854)
Q Consensus       145 ~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  224 (854)
                       +|. |.+  +|++|+|++|+|+++++    .+++|++|+|++|+|+.++.          .+++|++|+|++|++++ +
T Consensus       115 -ip~-l~~--~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~lp~----------~l~~L~~L~Ls~N~L~~-l  175 (571)
T 3cvr_A          115 -LPE-LPA--SLKHLDVDNNQLTMLPE----LPALLEYINADNNQLTMLPE----------LPTSLEVLSVRNNQLTF-L  175 (571)
T ss_dssp             -CCC-CCT--TCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCC----------CCTTCCEEECCSSCCSC-C
T ss_pred             -cch-hhc--CCCEEECCCCcCCCCCC----cCccccEEeCCCCccCcCCC----------cCCCcCEEECCCCCCCC-c
Confidence             455 444  89999999999998554    67899999999999986543          46789999999999985 7


Q ss_pred             ChhhhhhcccccEEEccCCcccccCCccccccccC-------CeeeccccccccCCCCCccCcccCceeeCccccccccC
Q 043388          225 PHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNL-------IALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSI  297 (854)
Q Consensus       225 p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  297 (854)
                      |. +.   ++|+.|+|++|+|+ .+|. |..  +|       +.|+|++|+|+. +|..+..+++|+.|+|++|++++.+
T Consensus       176 p~-l~---~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~  246 (571)
T 3cvr_A          176 PE-LP---ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRI  246 (571)
T ss_dssp             CC-CC---TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHH
T ss_pred             ch-hh---CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcC
Confidence            76 54   58999999999998 5666 655  77       999999999995 5677777999999999999999888


Q ss_pred             CccccCccc
Q 043388          298 PPSLGNLTK  306 (854)
Q Consensus       298 ~~~~~~l~~  306 (854)
                      |..+..++.
T Consensus       247 p~~l~~l~~  255 (571)
T 3cvr_A          247 RESLSQQTA  255 (571)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHhhc
Confidence            888877654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.84  E-value=1.7e-20  Score=188.48  Aligned_cols=153  Identities=22%  Similarity=0.269  Sum_probs=130.2

Q ss_pred             CCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecc
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTV   97 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~   97 (854)
                      -+.++++++.++ .+|..+.  ++|+.|+|++|+|+++.+..|..+++|++|+|++|+|+++.|++|.++++|++|+|++
T Consensus        13 ~~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~   89 (220)
T 2v9t_B           13 NNIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG   89 (220)
T ss_dssp             TTEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred             CCEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence            368999999998 6787665  6899999999999988888999999999999999999998899999999999999999


Q ss_pred             cccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcccc
Q 043388           98 NRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL  177 (854)
Q Consensus        98 N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l  177 (854)
                      |+|+ .+|..+|.++++|++|+|++|+++.+                 .|..|.++++|++|+|++|+|+++.+..|..+
T Consensus        90 N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~-----------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  151 (220)
T 2v9t_B           90 NKIT-ELPKSLFEGLFSLQLLLLNANKINCL-----------------RVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL  151 (220)
T ss_dssp             SCCC-CCCTTTTTTCTTCCEEECCSSCCCCC-----------------CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred             CcCC-ccCHhHccCCCCCCEEECCCCCCCEe-----------------CHHHcCCCCCCCEEECCCCcCCEECHHHHhCC
Confidence            9998 88888888888888888877777543                 35678888888888888888888887778778


Q ss_pred             CCCCeEeccccccc
Q 043388          178 KNLWWLNLEQNNLG  191 (854)
Q Consensus       178 ~~L~~L~L~~N~l~  191 (854)
                      ++|++|+|++|.+.
T Consensus       152 ~~L~~L~L~~N~~~  165 (220)
T 2v9t_B          152 RAIQTMHLAQNPFI  165 (220)
T ss_dssp             TTCCEEECCSSCEE
T ss_pred             CCCCEEEeCCCCcC
Confidence            78888887777764

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=8.2e-20  Score=184.78  Aligned_cols=153  Identities=22%  Similarity=0.264  Sum_probs=114.4

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      .-+.+++++++++ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        20 s~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls   96 (229)
T 3e6j_A           20 SGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG   96 (229)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             eCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence            4567888888887 6666554  778888888888887778888888888888888888877767777888888888888


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccc
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS  176 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~  176 (854)
                      +|+|+ .+|...|..+++|++|++++|+++                  .+|..+.++++|++|+|++|+|+++++..|..
T Consensus        97 ~N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~------------------~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  157 (229)
T 3e6j_A           97 TNQLT-VLPSAVFDRLVHLKELFMCCNKLT------------------ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR  157 (229)
T ss_dssp             SSCCC-CCCTTTTTTCTTCCEEECCSSCCC------------------SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred             CCcCC-ccChhHhCcchhhCeEeccCCccc------------------ccCcccccCCCCCEEECCCCcCCccCHHHHhC
Confidence            88887 777777777777777776666553                  34666777777777777777777777666766


Q ss_pred             cCCCCeEeccccccc
Q 043388          177 LKNLWWLNLEQNNLG  191 (854)
Q Consensus       177 l~~L~~L~L~~N~l~  191 (854)
                      +++|+.|+|++|.+.
T Consensus       158 l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A          158 LSSLTHAYLFGNPWD  172 (229)
T ss_dssp             CTTCCEEECTTSCBC
T ss_pred             CCCCCEEEeeCCCcc
Confidence            666666666666654

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.82  E-value=7e-20  Score=183.95  Aligned_cols=153  Identities=22%  Similarity=0.219  Sum_probs=115.8

Q ss_pred             CCEEecccccccccCCccccCcCCCCeeecccccccccCC-cCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIP-TTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      -+++++++|.++ .+|..+.  ..+++|+|++|+|++..+ ..|..+++|++|+|++|+|+++.+.+|.++++|++|+|+
T Consensus        13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   89 (220)
T 2v70_A           13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT   89 (220)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence            468899999988 5777664  356888999998887644 457888888999999888888888888888888888888


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccc
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS  176 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~  176 (854)
                      +|+|+ .++...|.++++|++|++++|+++.+                 .|..|.++++|++|+|++|+|+++.|..|..
T Consensus        90 ~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~-----------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  151 (220)
T 2v70_A           90 SNRLE-NVQHKMFKGLESLKTLMLRSNRITCV-----------------GNDSFIGLSSVRLLSLYDNQITTVAPGAFDT  151 (220)
T ss_dssp             SSCCC-CCCGGGGTTCSSCCEEECTTSCCCCB-----------------CTTSSTTCTTCSEEECTTSCCCCBCTTTTTT
T ss_pred             CCccC-ccCHhHhcCCcCCCEEECCCCcCCeE-----------------CHhHcCCCccCCEEECCCCcCCEECHHHhcC
Confidence            88887 67777777777777777666666533                 3566777777777777777777777777777


Q ss_pred             cCCCCeEeccccccc
Q 043388          177 LKNLWWLNLEQNNLG  191 (854)
Q Consensus       177 l~~L~~L~L~~N~l~  191 (854)
                      +++|++|+|++|.+.
T Consensus       152 l~~L~~L~L~~N~l~  166 (220)
T 2v70_A          152 LHSLSTLNLLANPFN  166 (220)
T ss_dssp             CTTCCEEECCSCCEE
T ss_pred             CCCCCEEEecCcCCc
Confidence            766666666666654

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.82  E-value=4.1e-20  Score=194.33  Aligned_cols=171  Identities=22%  Similarity=0.349  Sum_probs=81.5

Q ss_pred             cCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCc
Q 043388           37 GNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK  116 (854)
Q Consensus        37 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  116 (854)
                      ..+++|+.|++++|.++. ++ .+..+++|++|+|++|+++++.+  +.++++|++|+|++|+++ .+|.  +..+++|+
T Consensus        43 ~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~  115 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSS--LKDLKKLK  115 (291)
T ss_dssp             HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CGGG--GTTCTTCC
T ss_pred             hhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCC-CChh--hccCCCCC
Confidence            344555555555555542 22 24555555555555555554332  555555555555555554 3332  44444444


Q ss_pred             EEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCC
Q 043388          117 ELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTAN  196 (854)
Q Consensus       117 ~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~  196 (854)
                      +|++++|+++.+                   +.+..+++|++|+|++|+|+++  ..|..+++|++|+|++|+|+.+.  
T Consensus       116 ~L~L~~n~i~~~-------------------~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~--  172 (291)
T 1h6t_A          116 SLSLEHNGISDI-------------------NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--  172 (291)
T ss_dssp             EEECTTSCCCCC-------------------GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--
T ss_pred             EEECCCCcCCCC-------------------hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccch--
Confidence            444444433321                   2344455555555555555543  34555555555555555554321  


Q ss_pred             ChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCccc
Q 043388          197 DLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQIS  246 (854)
Q Consensus       197 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~  246 (854)
                            .+..+++|+.|+|++|.+++ +| .+..++ .|+.|++++|.++
T Consensus       173 ------~l~~l~~L~~L~L~~N~i~~-l~-~l~~l~-~L~~L~l~~n~i~  213 (291)
T 1h6t_A          173 ------PLAGLTKLQNLYLSKNHISD-LR-ALAGLK-NLDVLELFSQECL  213 (291)
T ss_dssp             ------GGTTCTTCCEEECCSSCCCB-CG-GGTTCT-TCSEEEEEEEEEE
T ss_pred             ------hhcCCCccCEEECCCCcCCC-Ch-hhccCC-CCCEEECcCCccc
Confidence                  14445555555555555552 22 244443 4555555555554

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.82  E-value=3.3e-20  Score=213.70  Aligned_cols=197  Identities=20%  Similarity=0.292  Sum_probs=131.8

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      .+..+.|+.+.+....+  +..+.+|+.|++++|.|+. ++ .|..+++|++|+|++|+|+++.|  |..+++|+.|+|+
T Consensus        22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls   95 (605)
T 1m9s_A           22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD   95 (605)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred             HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence            45556667776664333  4667777888888887773 33 47777888888888888776544  7778888888888


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccc
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS  176 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~  176 (854)
                      +|+|+ .+|  .|..+++|++|+|++|++..+                   +.+..+++|+.|+|++|+|+++  ..|..
T Consensus        96 ~N~l~-~l~--~l~~l~~L~~L~Ls~N~l~~l-------------------~~l~~l~~L~~L~Ls~N~l~~l--~~l~~  151 (605)
T 1m9s_A           96 ENKIK-DLS--SLKDLKKLKSLSLEHNGISDI-------------------NGLVHLPQLESLYLGNNKITDI--TVLSR  151 (605)
T ss_dssp             SSCCC-CCT--TSTTCTTCCEEECTTSCCCCC-------------------GGGGGCTTCSEEECCSSCCCCC--GGGGS
T ss_pred             CCCCC-CCh--hhccCCCCCEEEecCCCCCCC-------------------ccccCCCccCEEECCCCccCCc--hhhcc
Confidence            88776 454  356666666666666655432                   3466777788888888877765  46777


Q ss_pred             cCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccc
Q 043388          177 LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIR  254 (854)
Q Consensus       177 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~  254 (854)
                      +++|+.|+|++|.|..+..        +..+++|+.|+|++|.|++ +| .+..++ .|+.|+|++|.+++.....+.
T Consensus       152 l~~L~~L~Ls~N~l~~~~~--------l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~-~L~~L~L~~N~l~~~p~~~~~  218 (605)
T 1m9s_A          152 LTKLDTLSLEDNQISDIVP--------LAGLTKLQNLYLSKNHISD-LR-ALAGLK-NLDVLELFSQECLNKPINHQS  218 (605)
T ss_dssp             CTTCSEEECCSSCCCCCGG--------GTTCTTCCEEECCSSCCCB-CG-GGTTCT-TCSEEECCSEEEECCCCCCCS
T ss_pred             cCCCCEEECcCCcCCCchh--------hccCCCCCEEECcCCCCCC-Ch-HHccCC-CCCEEEccCCcCcCCcccccc
Confidence            7778888888877764321        5677778888888887774 33 455554 577777777777654333333

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.82  E-value=2.3e-20  Score=203.02  Aligned_cols=180  Identities=19%  Similarity=0.157  Sum_probs=99.8

Q ss_pred             CEEecccccccccCCccccCcCCCCeeecccccccccCCcCcc-CCCCCcEEecccccCcccChhhhcCCCCCceeeecc
Q 043388           19 QTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG-LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTV   97 (854)
Q Consensus        19 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~   97 (854)
                      +++++++|.|+ .+|..+.  ..++.|+|++|+|++..+..|. .+++|++|+|++|+|+++.+.+|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            56677777766 4555543  3466666666666666566665 666666666666666666666666666666666666


Q ss_pred             cccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcccc
Q 043388           98 NRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL  177 (854)
Q Consensus        98 N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l  177 (854)
                      |+|+ .++...|.+++                                         +|++|+|++|+|+.+.+..|..+
T Consensus        98 N~l~-~~~~~~~~~l~-----------------------------------------~L~~L~L~~N~i~~~~~~~~~~l  135 (361)
T 2xot_A           98 NHLH-TLDEFLFSDLQ-----------------------------------------ALEVLLLYNNHIVVVDRNAFEDM  135 (361)
T ss_dssp             SCCC-EECTTTTTTCT-----------------------------------------TCCEEECCSSCCCEECTTTTTTC
T ss_pred             CcCC-cCCHHHhCCCc-----------------------------------------CCCEEECCCCcccEECHHHhCCc
Confidence            6665 55544444444                                         44444444444444444445555


Q ss_pred             CCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhccc-ccEEEccCCccc
Q 043388          178 KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSST-MIQFRIGGNQIS  246 (854)
Q Consensus       178 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~-L~~L~l~~N~l~  246 (854)
                      ++|++|+|++|+|+.++...+   ..+..+++|+.|+|++|+|++..+..+..++.. ++.|+|++|.+.
T Consensus       136 ~~L~~L~L~~N~l~~l~~~~~---~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          136 AQLQKLYLSQNQISRFPVELI---KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             TTCCEEECCSSCCCSCCGGGT---C----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             ccCCEEECCCCcCCeeCHHHh---cCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            555555555555444332200   001345566666666666663333444444321 356777777765

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.82  E-value=4.7e-20  Score=212.38  Aligned_cols=200  Identities=22%  Similarity=0.252  Sum_probs=149.3

Q ss_pred             cCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEE
Q 043388           39 LSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKEL  118 (854)
Q Consensus        39 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  118 (854)
                      +..+..+.++.+.+....+  +..+++|+.|+|++|.|..+ | .|..+++|+.|+|++|+|+ .++.  |..+++|+.|
T Consensus        20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~-~~~~--l~~l~~L~~L   92 (605)
T 1m9s_A           20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLT-DIKP--LTNLKNLGWL   92 (605)
T ss_dssp             HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCC-CCGG--GGGCTTCCEE
T ss_pred             HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCC-CChh--hccCCCCCEE
Confidence            3456777888888875443  57889999999999999854 4 5889999999999999998 5554  7778888887


Q ss_pred             EcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCCh
Q 043388          119 YLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDL  198 (854)
Q Consensus       119 ~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~  198 (854)
                      +|++|.+..+                  | .|..+++|++|+|++|+|+++  ..|..+++|+.|+|++|.|+.+     
T Consensus        93 ~Ls~N~l~~l------------------~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l-----  146 (605)
T 1m9s_A           93 FLDENKIKDL------------------S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-----  146 (605)
T ss_dssp             ECCSSCCCCC------------------T-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC-----
T ss_pred             ECcCCCCCCC------------------h-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc-----
Confidence            7777766533                  2 577889999999999999875  3588888899999999888754     


Q ss_pred             hhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCcc
Q 043388          199 DFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVG  278 (854)
Q Consensus       199 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  278 (854)
                         ..+..+++|+.|+|++|.+++..|  +..++ .|+.|+|++|.|++.  ..+..+++|+.|+|++|++.+.....+.
T Consensus       147 ---~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~-~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~  218 (605)
T 1m9s_A          147 ---TVLSRLTKLDTLSLEDNQISDIVP--LAGLT-KLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS  218 (605)
T ss_dssp             ---GGGGSCTTCSEEECCSSCCCCCGG--GTTCT-TCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCS
T ss_pred             ---hhhcccCCCCEEECcCCcCCCchh--hccCC-CCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccc
Confidence               246788888888888888885544  55554 677777777777753  3567777777777777777654433333


Q ss_pred             C
Q 043388          279 E  279 (854)
Q Consensus       279 ~  279 (854)
                      .
T Consensus       219 ~  219 (605)
T 1m9s_A          219 N  219 (605)
T ss_dssp             S
T ss_pred             c
Confidence            3

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.82  E-value=2.5e-20  Score=195.99  Aligned_cols=191  Identities=24%  Similarity=0.262  Sum_probs=135.1

Q ss_pred             CCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEc
Q 043388           41 ALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL  120 (854)
Q Consensus        41 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l  120 (854)
                      .+..+.+..+.+++.  ..+..+++|++|++++|.++++ + .+..+++|++|+|++|+++ .++.  +.++++|++|++
T Consensus        25 ~~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~-~~~~--l~~l~~L~~L~l   97 (291)
T 1h6t_A           25 ETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLT-DIKP--LANLKNLGWLFL   97 (291)
T ss_dssp             HHHHHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEEC
T ss_pred             HHHHHHhcCCCcccc--cchhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccC-CCcc--cccCCCCCEEEC
Confidence            345556666666633  2345677888888888888754 3 3777888888888888887 5554  667777777777


Q ss_pred             ccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhh
Q 043388          121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDF  200 (854)
Q Consensus       121 ~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~  200 (854)
                      ++|.++.+                  | .+.++++|++|+|++|+|+++  ..+..+++|++|++++|+++.+       
T Consensus        98 ~~n~l~~~------------------~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-------  149 (291)
T 1h6t_A           98 DENKVKDL------------------S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-------  149 (291)
T ss_dssp             CSSCCCCG------------------G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-------
T ss_pred             CCCcCCCC------------------h-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-------
Confidence            66665432                  2 367778888888888888765  3577788888888888887654       


Q ss_pred             hhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccC
Q 043388          201 VTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGI  272 (854)
Q Consensus       201 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  272 (854)
                       ..+..+++|++|++++|++++..|  +..++ .|+.|++++|.|++. + .+..+++|+.|++++|+++..
T Consensus       150 -~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~-~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          150 -TVLSRLTKLDTLSLEDNQISDIVP--LAGLT-KLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             -GGGGGCTTCSEEECCSSCCCCCGG--GTTCT-TCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred             -hhhccCCCCCEEEccCCccccchh--hcCCC-ccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCC
Confidence             246677888888888888875433  66664 688888888888753 3 477788888888888887753

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.82  E-value=1.9e-20  Score=200.98  Aligned_cols=288  Identities=12%  Similarity=0.026  Sum_probs=191.1

Q ss_pred             CCCCCEEecccccccccCCccccC-cCCCCeeeccccccc--ccCCcCccCCCCCcEEecccccCcccChhhhcC-----
Q 043388           15 LLNLQTLAIDFNYLTGQLPDFVGN-LSALGMLLIRWNSLG--GQIPTTLGLLRNLVYLNVAENQFSGMFPRWICN-----   86 (854)
Q Consensus        15 l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----   86 (854)
                      +.+|++|.++++- ....-..+.. +++|++|||++|+|.  ...+..+   +.++.+.+..|.   +.+.+|.+     
T Consensus        24 ~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I~~~aF~~~~~~~   96 (329)
T 3sb4_A           24 ANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---VPAYAFSNVVNGV   96 (329)
T ss_dssp             HHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---ECTTTTEEEETTE
T ss_pred             hCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccc---cCHHHhccccccc
Confidence            5677888887642 2111122333 667888888888777  3333333   224555555552   44456666     


Q ss_pred             ---CCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCC
Q 043388           87 ---ISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSG  163 (854)
Q Consensus        87 ---l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~  163 (854)
                         +++|+.|+|.+ .++ .|+..+|.++++|++|++..|.+..+                 -+.+|.++.++..+.+..
T Consensus        97 ~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i-----------------~~~aF~~~~~l~~l~~~~  157 (329)
T 3sb4_A           97 TKGKQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNL-----------------LPEALADSVTAIFIPLGS  157 (329)
T ss_dssp             EEECTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEE-----------------CTTSSCTTTCEEEECTTC
T ss_pred             ccccCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCcccc-----------------chhhhcCCCceEEecCcc
Confidence               77777777777 676 77777777777777777776666544                 134566666666666655


Q ss_pred             C----cCcccCCcCccccCCCC-eEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEE
Q 043388          164 N----QFKGKVSIDFSSLKNLW-WLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQF  238 (854)
Q Consensus       164 N----~i~~~~~~~f~~l~~L~-~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L  238 (854)
                      +    ....+...+|.++.+|+ .+.+....-  ++.   ..........++..+.+.++-.. .....+....+.|+.+
T Consensus       158 ~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~--l~~---~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l  231 (329)
T 3sb4_A          158 SDAYRFKNRWEHFAFIEGEPLETTIQVGAMGK--LED---EIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSL  231 (329)
T ss_dssp             THHHHTSTTTTTSCEEESCCCEEEEEECTTCC--HHH---HHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEE
T ss_pred             hhhhhccccccccccccccccceeEEecCCCc--HHH---HHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEE
Confidence            3    22334555666666666 444433211  000   00111123456667777665322 2222333333479999


Q ss_pred             EccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCc-eeeCccccccccCCccccCccccchhcccccee
Q 043388          239 RIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQ-QLYMFRNFLQGSIPPSLGNLTKLADLALSFNNL  317 (854)
Q Consensus       239 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  317 (854)
                      ++++|+++.+.+.+|.++++|+.|+|.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.+++++|++
T Consensus       232 ~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i  309 (329)
T 3sb4_A          232 DISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKI  309 (329)
T ss_dssp             ECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCC
T ss_pred             ECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCcc
Confidence            99999999888888999999999999998 8888889999999999 999988 77777888999999999999999999


Q ss_pred             cccCCCCCcCCCCCccccc
Q 043388          318 QGNIPSSLGNCQNLKGFDA  336 (854)
Q Consensus       318 ~~~~~~~~~~l~~L~~L~l  336 (854)
                      +.+.+.+|.++++|+.++.
T Consensus       310 ~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          310 TTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             CEECTTTTCTTCCCCEEEC
T ss_pred             CccchhhhcCCcchhhhcc
Confidence            9888889999999998764

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.81  E-value=3.8e-20  Score=185.93  Aligned_cols=66  Identities=15%  Similarity=0.164  Sum_probs=41.1

Q ss_pred             ccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCC
Q 043388          386 SLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPT  451 (854)
Q Consensus       386 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  451 (854)
                      +|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.+.+..
T Consensus       105 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l  170 (220)
T 2v9t_B          105 SLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL  170 (220)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred             CCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence            355555555555555556666666666666666666665555666666666666666666665543

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.81  E-value=1.4e-20  Score=194.61  Aligned_cols=171  Identities=24%  Similarity=0.259  Sum_probs=136.4

Q ss_pred             cCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCcee
Q 043388           14 SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFI   93 (854)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L   93 (854)
                      .+.+++.+++++|.+++ ++ .+..+++|++|++++|+|+ .++ .+..+++|++|+|++|+|+++.+  |.++++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            56678888999999984 44 6888999999999999998 455 68899999999999999996555  8999999999


Q ss_pred             eecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcC
Q 043388           94 YLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID  173 (854)
Q Consensus        94 ~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~  173 (854)
                      +|++|+|+ .+|...  . ++|++|++++|+++.                  + +.+.++++|++|+|++|+|+++.  .
T Consensus        91 ~L~~N~l~-~l~~~~--~-~~L~~L~L~~N~l~~------------------~-~~l~~l~~L~~L~Ls~N~i~~~~--~  145 (263)
T 1xeu_A           91 SVNRNRLK-NLNGIP--S-ACLSRLFLDNNELRD------------------T-DSLIHLKNLEILSIRNNKLKSIV--M  145 (263)
T ss_dssp             ECCSSCCS-CCTTCC--C-SSCCEEECCSSCCSB------------------S-GGGTTCTTCCEEECTTSCCCBCG--G
T ss_pred             ECCCCccC-CcCccc--c-CcccEEEccCCccCC------------------C-hhhcCcccccEEECCCCcCCCCh--H
Confidence            99999998 566432  2 566666666555543                  2 35788999999999999998773  6


Q ss_pred             ccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCccc
Q 043388          174 FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE  223 (854)
Q Consensus       174 f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~  223 (854)
                      +..+++|++|+|++|+|+.+        ..+..+++|+.|++++|.+++.
T Consensus       146 l~~l~~L~~L~L~~N~i~~~--------~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          146 LGFLSKLEVLDLHGNEITNT--------GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             GGGCTTCCEEECTTSCCCBC--------TTSTTCCCCCEEEEEEEEEECC
T ss_pred             HccCCCCCEEECCCCcCcch--------HHhccCCCCCEEeCCCCcccCC
Confidence            88899999999999998765        2477888899999999888743

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.81  E-value=4.9e-20  Score=200.39  Aligned_cols=168  Identities=23%  Similarity=0.327  Sum_probs=138.9

Q ss_pred             CcccccCchhhhcCCCCCEEecccccccccCCcccc-CcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            2 NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVG-NLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         2 n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      |+|+ .+|..+..  .+++|+|++|+|++..+..|. .+++|+.|+|++|+|+++.+..|..+++|++|+|++|+|+++.
T Consensus        28 ~~l~-~iP~~~~~--~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~  104 (361)
T 2xot_A           28 QQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLD  104 (361)
T ss_dssp             SCCS-SCCSSCCT--TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCcC-ccCccCCC--CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCC
Confidence            5566 57876654  799999999999987888887 9999999999999999888899999999999999999999988


Q ss_pred             hhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCcc-c---cCCCCC
Q 043388           81 PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDS-L---SNASNL  156 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~-~---~~l~~L  156 (854)
                      +..|.++++|++|+|++|+|+ .++...|.++++|++|+|++|+++.+                  |.. |   ..+++|
T Consensus       105 ~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~l------------------~~~~~~~~~~l~~L  165 (361)
T 2xot_A          105 EFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRF------------------PVELIKDGNKLPKL  165 (361)
T ss_dssp             TTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCSC------------------CGGGTC----CTTC
T ss_pred             HHHhCCCcCCCEEECCCCccc-EECHHHhCCcccCCEEECCCCcCCee------------------CHHHhcCcccCCcC
Confidence            899999999999999999998 77777788888888888877776543                  333 3   568888


Q ss_pred             CEEecCCCcCcccCCcCccccCCC--CeEeccccccc
Q 043388          157 ERLDLSGNQFKGKVSIDFSSLKNL--WWLNLEQNNLG  191 (854)
Q Consensus       157 ~~L~Ls~N~i~~~~~~~f~~l~~L--~~L~L~~N~l~  191 (854)
                      ++|+|++|+|+.+++..|..++.+  +.|+|++|.+.
T Consensus       166 ~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          166 MLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             CEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            888888888887777777777663  66777776653

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.81  E-value=4.3e-20  Score=185.50  Aligned_cols=158  Identities=18%  Similarity=0.154  Sum_probs=105.1

Q ss_pred             eeeccccccccCCCCCccCcccCceeeCccccccccCC-ccccCccccchhccccceecccCCCCCcCCCCCcccccCCC
Q 043388          261 ALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIP-PSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHN  339 (854)
Q Consensus       261 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N  339 (854)
                      .+++++|.++. +|..+.  +.+++|+|++|+|++..| ..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus        15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   91 (220)
T 2v70_A           15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN   91 (220)
T ss_dssp             EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence            45555555553 233222  234566666666665433 34566666666666666666655666677777777777777


Q ss_pred             cccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCc
Q 043388          340 KLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSN  419 (854)
Q Consensus       340 ~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  419 (854)
                      ++++..|..                         +..       +.+|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus        92 ~l~~~~~~~-------------------------~~~-------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  139 (220)
T 2v70_A           92 RLENVQHKM-------------------------FKG-------LESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN  139 (220)
T ss_dssp             CCCCCCGGG-------------------------GTT-------CSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTS
T ss_pred             ccCccCHhH-------------------------hcC-------CcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCC
Confidence            766332221                         222       345777888888888777888888888888888888


Q ss_pred             ccccccchhhcCccCCCeeecccccCcccCCCCc
Q 043388          420 NLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKG  453 (854)
Q Consensus       420 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  453 (854)
                      +|++..|..|..+++|+.|+|++|+|+|.++..+
T Consensus       140 ~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~  173 (220)
T 2v70_A          140 QITTVAPGAFDTLHSLSTLNLLANPFNCNCYLAW  173 (220)
T ss_dssp             CCCCBCTTTTTTCTTCCEEECCSCCEECSGGGHH
T ss_pred             cCCEECHHHhcCCCCCCEEEecCcCCcCCCchHH
Confidence            8888778888888888888888888888776543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.79  E-value=1.4e-21  Score=223.81  Aligned_cols=189  Identities=15%  Similarity=0.135  Sum_probs=128.1

Q ss_pred             cCCCCCcEEecccccCcccChhhhcCCCCCceeeecccc-------------cccccCcccccCCCCCcEEE-cccCCCC
Q 043388           61 GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNR-------------FSGSLPFDILVNLPNLKELY-LTFCSLK  126 (854)
Q Consensus        61 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~~l~~L~~L~-l~~n~l~  126 (854)
                      ..+++|+.|+|++|+|+ .+|+.++++++|+.|++++|.             +. ..++..+.++++|+.|+ ++.|.+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~-~~~~~~l~~l~~L~~L~~l~~n~~~  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL-LYEKETLQYFSTLKAVDPMRAAYLD  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTG-GGHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccc-cCCHHHHHHHHhcccCcchhhcccc
Confidence            55778888888888887 678888888888888887764             34 23445677888888888 7888888


Q ss_pred             CCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccC
Q 043388          127 NLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTN  206 (854)
Q Consensus       127 ~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~  206 (854)
                      +|+.+.+++|.|     +.+|.     ..|+.|+|++|+|++++ . |..+++|++|+|++|+|+.++       ..+.+
T Consensus       424 ~L~~l~l~~n~i-----~~l~~-----~~L~~L~Ls~n~l~~lp-~-~~~l~~L~~L~Ls~N~l~~lp-------~~~~~  484 (567)
T 1dce_A          424 DLRSKFLLENSV-----LKMEY-----ADVRVLHLAHKDLTVLC-H-LEQLLLVTHLDLSHNRLRALP-------PALAA  484 (567)
T ss_dssp             HHHHHHHHHHHH-----HHHHH-----TTCSEEECTTSCCSSCC-C-GGGGTTCCEEECCSSCCCCCC-------GGGGG
T ss_pred             hhhhhhhhcccc-----cccCc-----cCceEEEecCCCCCCCc-C-ccccccCcEeecCcccccccc-------hhhhc
Confidence            888888888877     33332     25888999999888754 3 888888888888888776443       24566


Q ss_pred             CCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccC-CccccccccCCeeeccccccccCC
Q 043388          207 CSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTI-PSGIRNLVNLIALTIEVNQLHGII  273 (854)
Q Consensus       207 l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~  273 (854)
                      +++|+.|+|++|+|++ +| .+..++ .|+.|+|++|+|++.. |..|+++++|+.|+|++|+|++.+
T Consensus       485 l~~L~~L~Ls~N~l~~-lp-~l~~l~-~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~  549 (567)
T 1dce_A          485 LRCLEVLQASDNALEN-VD-GVANLP-RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE  549 (567)
T ss_dssp             CTTCCEEECCSSCCCC-CG-GGTTCS-SCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             CCCCCEEECCCCCCCC-Cc-ccCCCC-CCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence            6677777777776663 44 444443 4555555555555444 555555555555555555555443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.79  E-value=1.2e-19  Score=187.72  Aligned_cols=125  Identities=24%  Similarity=0.252  Sum_probs=73.4

Q ss_pred             CcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcE
Q 043388           38 NLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKE  117 (854)
Q Consensus        38 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~  117 (854)
                      .+.++..+++++|.+++. + .+..+++|++|++++|.|+. +| .+..+++|++|+|++|+|+ .+|.  |.++++|++
T Consensus        17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~-~~~~--l~~l~~L~~   89 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQIS-DLSP--LKDLTKLEE   89 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCE
T ss_pred             HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccC-CChh--hccCCCCCE
Confidence            456677777777777743 3 56777777777777777774 34 5777777777777777776 4443  555555555


Q ss_pred             EEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEeccccccc
Q 043388          118 LYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLG  191 (854)
Q Consensus       118 L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  191 (854)
                      |++++|+++.+                  |. +.. ++|++|+|++|+|+++.  .|..+++|++|+|++|+|+
T Consensus        90 L~L~~N~l~~l------------------~~-~~~-~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~Ls~N~i~  141 (263)
T 1xeu_A           90 LSVNRNRLKNL------------------NG-IPS-ACLSRLFLDNNELRDTD--SLIHLKNLEILSIRNNKLK  141 (263)
T ss_dssp             EECCSSCCSCC------------------TT-CCC-SSCCEEECCSSCCSBSG--GGTTCTTCCEEECTTSCCC
T ss_pred             EECCCCccCCc------------------Cc-ccc-CcccEEEccCCccCCCh--hhcCcccccEEECCCCcCC
Confidence            55555554432                  11 111 55556666666555432  3444444444444444443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.78  E-value=1.1e-19  Score=214.71  Aligned_cols=199  Identities=22%  Similarity=0.198  Sum_probs=109.6

Q ss_pred             ecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCcc
Q 043388           70 NVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDS  149 (854)
Q Consensus        70 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~  149 (854)
                      +++.|.+. ..|+.|..+++|+.|+|++|+|+ .+|..+| ++++|++|+|++|.+                  +.+|..
T Consensus       207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-~l~~L~~L~Ls~N~l------------------~~lp~~  265 (727)
T 4b8c_D          207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIF-KYDFLTRLYLNGNSL------------------TELPAE  265 (727)
T ss_dssp             ----------------CCCCCCEEECTTSCCS-CCCGGGG-GCCSCSCCBCTTSCC------------------SCCCGG
T ss_pred             ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhc-CCCCCCEEEeeCCcC------------------cccChh
Confidence            44455555 56778888888888888888887 7887765 555555555555544                  346788


Q ss_pred             ccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhh
Q 043388          150 LSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIA  229 (854)
Q Consensus       150 ~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~  229 (854)
                      |.++++|++|+|++|+|+ .+|..|..+++|++|+|++|.|+.++.       .|..+++|++|+|++|.|++.+|..+.
T Consensus       266 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~-------~~~~l~~L~~L~L~~N~l~~~~p~~~~  337 (727)
T 4b8c_D          266 IKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPW-------EFGNLCNLQFLGVEGNPLEKQFLKILT  337 (727)
T ss_dssp             GGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCS-------STTSCTTCCCEECTTSCCCSHHHHHHH
T ss_pred             hhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccCh-------hhhcCCCccEEeCCCCccCCCChHHHh
Confidence            888999999999999998 447788999999999999998876654       378889999999999999988888887


Q ss_pred             hhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccch
Q 043388          230 NLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLAD  309 (854)
Q Consensus       230 ~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  309 (854)
                      .+......++|++|.+++.+|..      |..|+++.|...   -..+             +.+.+..+..+..+..+..
T Consensus       338 ~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~---~~~~-------------~~l~~~~~~~~~~l~~~~~  395 (727)
T 4b8c_D          338 EKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEP---QREY-------------DSLQQSTEHLATDLAKRTF  395 (727)
T ss_dssp             HHHHHHHHHHHHHCCCCCCCCCC---------------------------------------------------------
T ss_pred             hcchhhhHHhhccCcccCcCccc------cceeEeeccccc---cccc-------------CCccccccchhhcccccce
Confidence            76544445677777777766653      344555555111   0111             1233334444556666777


Q ss_pred             hccccceecc
Q 043388          310 LALSFNNLQG  319 (854)
Q Consensus       310 L~L~~N~l~~  319 (854)
                      ..+++|-+.+
T Consensus       396 ~~ls~Nil~~  405 (727)
T 4b8c_D          396 TVLSYNTLCQ  405 (727)
T ss_dssp             ------CCCG
T ss_pred             eeeecccccc
Confidence            7778887653

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.78  E-value=5.5e-19  Score=174.34  Aligned_cols=153  Identities=16%  Similarity=0.190  Sum_probs=76.3

Q ss_pred             cCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCc
Q 043388           37 GNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK  116 (854)
Q Consensus        37 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  116 (854)
                      +.+++|++|++++|.++ .+| .+..+++|++|++++|.++.  +..+..+++|++|+|++|++++..| ..|..+++|+
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~  115 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKI-PNLSGLTSLT  115 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGS-CCCTTCTTCC
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccC-hhhcCCCCCC
Confidence            44445555555555555 333 35555555555555554441  1245555555555555555542222 2244444444


Q ss_pred             EEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCc-CcccCCcCccccCCCCeEecccccccCCCC
Q 043388          117 ELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ-FKGKVSIDFSSLKNLWWLNLEQNNLGMGTA  195 (854)
Q Consensus       117 ~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~-i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~  195 (854)
                      +|++++|+++.                 ..|..|.++++|++|+|++|+ ++.+.  .|..+++|++|++++|.++.++ 
T Consensus       116 ~L~Ls~n~i~~-----------------~~~~~l~~l~~L~~L~L~~n~~i~~~~--~l~~l~~L~~L~l~~n~i~~~~-  175 (197)
T 4ezg_A          116 LLDISHSAHDD-----------------SILTKINTLPKVNSIDLSYNGAITDIM--PLKTLPELKSLNIQFDGVHDYR-  175 (197)
T ss_dssp             EEECCSSBCBG-----------------GGHHHHTTCSSCCEEECCSCTBCCCCG--GGGGCSSCCEEECTTBCCCCCT-
T ss_pred             EEEecCCccCc-----------------HhHHHHhhCCCCCEEEccCCCCccccH--hhcCCCCCCEEECCCCCCcChH-
Confidence            44444444321                 124455556666666666665 44432  4556666666666666655432 


Q ss_pred             CChhhhhhccCCCCCcEEEcccCcCc
Q 043388          196 NDLDFVTLLTNCSSLKALSLCDNQFG  221 (854)
Q Consensus       196 ~~~~~~~~~~~l~~L~~L~L~~N~l~  221 (854)
                             .+..+++|++|++++|++.
T Consensus       176 -------~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          176 -------GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             -------TGGGCSSCCEEEECBC---
T ss_pred             -------HhccCCCCCEEEeeCcccC
Confidence                   2455566666666666654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.78  E-value=2.2e-19  Score=212.25  Aligned_cols=236  Identities=20%  Similarity=0.189  Sum_probs=123.9

Q ss_pred             CCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcc
Q 043388          154 SNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSS  233 (854)
Q Consensus       154 ~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  233 (854)
                      +.++.|+|++|.+..+.      ...|+.++|+.|.|.                    .++++.|.+. ..|..+..+. 
T Consensus       173 ~~~~~l~L~~n~~~~~~------~~~l~~l~Ls~~~i~--------------------~~~~~~n~~~-~~~~~~~~l~-  224 (727)
T 4b8c_D          173 PLTPKIELFANGKDEAN------QALLQHKKLSQYSID--------------------EDDDIENRMV-MPKDSKYDDQ-  224 (727)
T ss_dssp             ----------------------------------------------------------------------------CCC-
T ss_pred             CccceEEeeCCCCCcch------hhHhhcCccCccccc--------------------Ccccccccee-cChhhhccCC-
Confidence            56788888888887532      233566667766653                    3345566665 5566666665 


Q ss_pred             cccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccc
Q 043388          234 TMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALS  313 (854)
Q Consensus       234 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  313 (854)
                      .|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|+.+++|++|+|++|+|+ .+|..|+++++|++|+|+
T Consensus       225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~  301 (727)
T 4b8c_D          225 LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF  301 (727)
T ss_dssp             CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred             CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence            6888888888887 66777778999999999999999 67888999999999999999999 779999999999999999


Q ss_pred             cceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeecc
Q 043388          314 FNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDIS  393 (854)
Q Consensus       314 ~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls  393 (854)
                      +|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+.........+++++|.+++.+|..             |..|+++
T Consensus       302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~-------------l~~l~l~  367 (727)
T 4b8c_D          302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE-------------RRFIEIN  367 (727)
T ss_dssp             SSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--------------------
T ss_pred             CCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc-------------cceeEee
Confidence            99998 678889999999999999999999888887766555445788888888776643             4456666


Q ss_pred             CcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCC
Q 043388          394 SNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVP  450 (854)
Q Consensus       394 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  450 (854)
                      .|...   -.             ..+.|++..+..+.++..+....+++|-+.+...
T Consensus       368 ~n~~~---~~-------------~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~~  408 (727)
T 4b8c_D          368 TDGEP---QR-------------EYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHYA  408 (727)
T ss_dssp             --------------------------------------------------CCCGGGC
T ss_pred             ccccc---cc-------------ccCCccccccchhhcccccceeeeeccccccccC
Confidence            66111   01             1123444445555666677777888888765444

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=3.6e-21  Score=220.47  Aligned_cols=211  Identities=16%  Similarity=0.123  Sum_probs=137.5

Q ss_pred             cCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCcee
Q 043388           14 SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFI   93 (854)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L   93 (854)
                      .+++|+.|+|++|+|+ .+|..++++++|+.|++++|......|.           .+..+.+.+..|..++++++|+.|
T Consensus       347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~L  414 (567)
T 1dce_A          347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKAV  414 (567)
T ss_dssp             TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHHH
T ss_pred             cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhcccC
Confidence            3455555555555554 4555555555555555544431000000           000011445566666666666666


Q ss_pred             e-ecccccccccCcccccCCCCCcEEEcccCCC-----CCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCc
Q 043388           94 Y-LTVNRFSGSLPFDILVNLPNLKELYLTFCSL-----KNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFK  167 (854)
Q Consensus        94 ~-L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l-----~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~  167 (854)
                      + ++.|.+. .++           .+.++.|.+     ..|+.|+|++|.|     +.+|. |.++++|++|+|++|+|+
T Consensus       415 ~~l~~n~~~-~L~-----------~l~l~~n~i~~l~~~~L~~L~Ls~n~l-----~~lp~-~~~l~~L~~L~Ls~N~l~  476 (567)
T 1dce_A          415 DPMRAAYLD-DLR-----------SKFLLENSVLKMEYADVRVLHLAHKDL-----TVLCH-LEQLLLVTHLDLSHNRLR  476 (567)
T ss_dssp             CGGGHHHHH-HHH-----------HHHHHHHHHHHHHHTTCSEEECTTSCC-----SSCCC-GGGGTTCCEEECCSSCCC
T ss_pred             cchhhcccc-hhh-----------hhhhhcccccccCccCceEEEecCCCC-----CCCcC-ccccccCcEeecCccccc
Confidence            6 5555443 222           122222221     1245566666666     34676 899999999999999999


Q ss_pred             ccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccC-ChhhhhhcccccEEEccCCccc
Q 043388          168 GKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGEL-PHSIANLSSTMIQFRIGGNQIS  246 (854)
Q Consensus       168 ~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~~L~~L~l~~N~l~  246 (854)
                       ..|..|..+++|++|+|++|+|+.++        .+.++++|++|+|++|+|++.. |..+..++ .|+.|+|++|.|+
T Consensus       477 -~lp~~~~~l~~L~~L~Ls~N~l~~lp--------~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~-~L~~L~L~~N~l~  546 (567)
T 1dce_A          477 -ALPPALAALRCLEVLQASDNALENVD--------GVANLPRLQELLLCNNRLQQSAAIQPLVSCP-RLVLLNLQGNSLC  546 (567)
T ss_dssp             -CCCGGGGGCTTCCEEECCSSCCCCCG--------GGTTCSSCCEEECCSSCCCSSSTTGGGGGCT-TCCEEECTTSGGG
T ss_pred             -ccchhhhcCCCCCEEECCCCCCCCCc--------ccCCCCCCcEEECCCCCCCCCCCcHHHhcCC-CCCEEEecCCcCC
Confidence             45678999999999999999998643        4788999999999999999776 99999987 7999999999999


Q ss_pred             ccCCcc---ccccccCCeeec
Q 043388          247 GTIPSG---IRNLVNLIALTI  264 (854)
Q Consensus       247 ~~~~~~---~~~l~~L~~L~L  264 (854)
                      +.+|..   +..+++|+.|++
T Consensus       547 ~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          547 QEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             GSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCccHHHHHHHHCcccCccCC
Confidence            765532   334777887764

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.77  E-value=3.2e-18  Score=173.07  Aligned_cols=156  Identities=22%  Similarity=0.255  Sum_probs=134.5

Q ss_pred             CCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEc
Q 043388           41 ALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL  120 (854)
Q Consensus        41 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l  120 (854)
                      .-+.+++++++++ .+|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ .+|...|.++++|++|+|
T Consensus        20 s~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~L   95 (229)
T 3e6j_A           20 SGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDL   95 (229)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred             eCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEEC
Confidence            4678999999998 6777664  89999999999999999999999999999999999998 899888999999998888


Q ss_pred             ccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhh
Q 043388          121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDF  200 (854)
Q Consensus       121 ~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~  200 (854)
                      ++|+++.+                 .+..|..+++|++|+|++|+|+. .|..+..+++|++|+|++|+|+.++..    
T Consensus        96 s~N~l~~l-----------------~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~L~L~~N~l~~~~~~----  153 (229)
T 3e6j_A           96 GTNQLTVL-----------------PSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHG----  153 (229)
T ss_dssp             CSSCCCCC-----------------CTTTTTTCTTCCEEECCSSCCCS-CCTTGGGCTTCSEEECCSSCCCCCCTT----
T ss_pred             CCCcCCcc-----------------ChhHhCcchhhCeEeccCCcccc-cCcccccCCCCCEEECCCCcCCccCHH----
Confidence            88877644                 24567889999999999999994 467789999999999999999877654    


Q ss_pred             hhhccCCCCCcEEEcccCcCcccC
Q 043388          201 VTLLTNCSSLKALSLCDNQFGGEL  224 (854)
Q Consensus       201 ~~~~~~l~~L~~L~L~~N~l~~~~  224 (854)
                        .|..+++|+.|+|++|.+....
T Consensus       154 --~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A          154 --AFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             --TTTTCTTCCEEECTTSCBCTTB
T ss_pred             --HHhCCCCCCEEEeeCCCccCCc
Confidence              5778899999999999987543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=6e-19  Score=181.78  Aligned_cols=137  Identities=19%  Similarity=0.189  Sum_probs=105.4

Q ss_pred             ccccCccCCCcceEEEEeEECCCceE--EEEEEeeccccc------------------------chHHHHHHHHHHHhcc
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMI--VAVKVINLKQKG------------------------AFRSFVAECEALRNIR  603 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  603 (854)
                      |.+.+.||+|+||.||+|.+..+|+.  ||||+++.....                        ....+.+|+.++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            66788999999999999999557888  999997543111                        0135789999999998


Q ss_pred             CCCe--eeEEEEeeccCCCCCceeeEEEeeccC-C----CHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHH-hc
Q 043388          604 HRNL--IKIITICSSIDSKGADFKALVFEYMEN-G----SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH-HH  675 (854)
Q Consensus       604 h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH-~~  675 (854)
                      |+++  ..++++    .     ..++||||+.+ |    +|.++...         .++.++..++.|++.||+||| +.
T Consensus       129 ~~~i~~p~~~~~----~-----~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~  190 (258)
T 1zth_A          129 EAGVSVPQPYTY----M-----KNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEA  190 (258)
T ss_dssp             HTTCCCCCEEEE----E-----TTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred             hCCCCCCeEEEc----C-----CCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHC
Confidence            8753  444443    1     35899999942 4    67665432         123456789999999999999 88


Q ss_pred             CCCCeEeecCCCCceEecCCccccccccccccc
Q 043388          676 CQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQL  708 (854)
Q Consensus       676 ~~~~ivH~Dlkp~NIll~~~~~~~~Dfg~~~~~  708 (854)
                         +|+||||||+|||++. .++++|||+|...
T Consensus       191 ---givHrDlkp~NILl~~-~~~liDFG~a~~~  219 (258)
T 1zth_A          191 ---ELVHADLSEYNIMYID-KVYFIDMGQAVTL  219 (258)
T ss_dssp             ---CEECSSCSTTSEEESS-SEEECCCTTCEET
T ss_pred             ---CEEeCCCCHHHEEEcC-cEEEEECcccccC
Confidence               9999999999999999 6666799999754

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.76  E-value=1.7e-18  Score=185.78  Aligned_cols=265  Identities=10%  Similarity=0.025  Sum_probs=180.4

Q ss_pred             hhhc-CCCCCEEeccccccc--ccCCccccCcCCCCeeecccccccccCCcCccC--------CCCCcEEecccccCccc
Q 043388           11 EIGS-LLNLQTLAIDFNYLT--GQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGL--------LRNLVYLNVAENQFSGM   79 (854)
Q Consensus        11 ~~~~-l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--------l~~L~~L~Ls~N~l~~~   79 (854)
                      .+.. +++|++|||++|+|.  ...+..+   +.+..+.+..|.|   .+.+|.+        +++|+.|+|.+ .++.+
T Consensus        43 ~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I  115 (329)
T 3sb4_A           43 HLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNI  115 (329)
T ss_dssp             HHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEE
T ss_pred             HHHHhhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccch
Confidence            3444 788999999999998  3333333   3356667777744   4678888        99999999999 89989


Q ss_pred             ChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCC----CCCCceeeccCccCCCCCCCCCCccccCCCC
Q 043388           80 FPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCS----LKNLWWLNLEQNNLGMGTASSIPDSLSNASN  155 (854)
Q Consensus        80 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~----l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~  155 (854)
                      .+.+|.++++|++|+|++|.++ .++..+|.++.++..+.+..+.    +..+                 -+.+|.++.+
T Consensus       116 ~~~aF~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i-----------------~~~~f~~~~~  177 (329)
T 3sb4_A          116 EDAAFKGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLGSSDAYRFKNRW-----------------EHFAFIEGEP  177 (329)
T ss_dssp             CTTTTTTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTTCTHHHHTSTTT-----------------TTSCEEESCC
T ss_pred             hHHHhhcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCcchhhhhccccc-----------------cccccccccc
Confidence            9999999999999999999998 8999999998888877765421    1111                 1234555666


Q ss_pred             CC-EEecCCCcCcccCCcCc---cccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhh
Q 043388          156 LE-RLDLSGNQFKGKVSIDF---SSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANL  231 (854)
Q Consensus       156 L~-~L~Ls~N~i~~~~~~~f---~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  231 (854)
                      |+ .+++....-  +....|   ....+++.+.+.++-..      .++......+++|+.|+|++|+++...+.+|.++
T Consensus       178 L~~~i~~~~~~~--l~~~~~~~~~~~~~~~~l~~~~~l~~------~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~  249 (329)
T 3sb4_A          178 LETTIQVGAMGK--LEDEIMKAGLQPRDINFLTIEGKLDN------ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQK  249 (329)
T ss_dssp             CEEEEEECTTCC--HHHHHHHTTCCGGGCSEEEEEECCCH------HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTC
T ss_pred             cceeEEecCCCc--HHHHHhhcccCccccceEEEeeeecH------HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCC
Confidence            66 444443211  111111   12455566666554211      1111222236777777777777774444455555


Q ss_pred             cccccEEEccCCcccccCCccccccccCC-eeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchh
Q 043388          232 SSTMIQFRIGGNQISGTIPSGIRNLVNLI-ALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADL  310 (854)
Q Consensus       232 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  310 (854)
                      . .|+.+++.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.+++++|.++.+.+.+|.++++|+.+
T Consensus       250 ~-~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l  326 (329)
T 3sb4_A          250 K-YLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI  326 (329)
T ss_dssp             T-TCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred             C-CCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence            4 6777777776 6667777788888888 888877 6777777888888888888888888887777788888888776


Q ss_pred             c
Q 043388          311 A  311 (854)
Q Consensus       311 ~  311 (854)
                      +
T Consensus       327 y  327 (329)
T 3sb4_A          327 Y  327 (329)
T ss_dssp             E
T ss_pred             c
Confidence            5

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.76  E-value=2e-17  Score=181.02  Aligned_cols=265  Identities=12%  Similarity=0.090  Sum_probs=167.4

Q ss_pred             CCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEE
Q 043388           40 SALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY  119 (854)
Q Consensus        40 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~  119 (854)
                      ..++.+.+.+ .++.+...+|.+. +|+.++|..| ++.+...+|.+. +|+.+.|.+ .++ .|+..+|.++++|+.++
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~  186 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLE-QLKEDIFYYCYNLKKAD  186 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCC-EECSSTTTTCTTCCEEE
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-Ccc-EehHHHhhCcccCCeee
Confidence            4455555543 3444555555553 5666666555 555555566553 466666654 444 55556666666666655


Q ss_pred             cccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChh
Q 043388          120 LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD  199 (854)
Q Consensus       120 l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~  199 (854)
                      +..|+++.+.                 ..+|. .++|+.+.|..| ++.+...+|.++++|+.+++..| ++.+...   
T Consensus       187 l~~n~l~~I~-----------------~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~---  243 (401)
T 4fdw_A          187 LSKTKITKLP-----------------ASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQE---  243 (401)
T ss_dssp             CTTSCCSEEC-----------------TTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTT---
T ss_pred             cCCCcceEec-----------------hhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccc---
Confidence            5555444331                 12233 355666666533 55556666666666666666543 4444433   


Q ss_pred             hhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCccc-----ccCCccccccccCCeeeccccccccCCC
Q 043388          200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQIS-----GTIPSGIRNLVNLIALTIEVNQLHGIIP  274 (854)
Q Consensus       200 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~  274 (854)
                         +|.+ ++|+.+.+ .|.++...+.+|.++. .|+.+.+.+|.+.     .+.+.+|.++++|+.++|. +.++.+..
T Consensus       244 ---aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~-~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~  316 (401)
T 4fdw_A          244 ---AFRE-SGITTVKL-PNGVTNIASRAFYYCP-ELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQ  316 (401)
T ss_dssp             ---TTTT-CCCSEEEE-ETTCCEECTTTTTTCT-TCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECT
T ss_pred             ---cccc-CCccEEEe-CCCccEEChhHhhCCC-CCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhh
Confidence               3444 45666666 3334433344444443 5666666655553     4677889999999999998 55888888


Q ss_pred             CCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCC-CCcccccCCCccc
Q 043388          275 DGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQ-NLKGFDASHNKLT  342 (854)
Q Consensus       275 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~ls~N~l~  342 (854)
                      .+|.++++|+.+.|..| ++.+.+.+|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.+.
T Consensus       317 ~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          317 GLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             TTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             hhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            89999999999999665 776778889999 999999999998877778888885 6788888777654

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.74  E-value=5.1e-17  Score=177.80  Aligned_cols=267  Identities=12%  Similarity=0.126  Sum_probs=199.0

Q ss_pred             cCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCcee
Q 043388           14 SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFI   93 (854)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L   93 (854)
                      .+..++.+.+.. .++.+...+|.+ .+|+.+.+..| ++.+...+|.+. +|+.++|.+ .++.+.+.+|.++++|+.+
T Consensus       111 ~~~~l~~i~ip~-~i~~I~~~aF~~-~~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l  185 (401)
T 4fdw_A          111 ILKGYNEIILPN-SVKSIPKDAFRN-SQIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKA  185 (401)
T ss_dssp             ECSSCSEEECCT-TCCEECTTTTTT-CCCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred             ecCCccEEEECC-ccCEehHhhccc-CCccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCee
Confidence            446777777765 355455667776 47888888766 776777788774 688888886 6777777888888888888


Q ss_pred             eecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcC
Q 043388           94 YLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID  173 (854)
Q Consensus        94 ~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~  173 (854)
                      +|++|+++ .++..+|. ..+|+.+.+.. .++.+                 -..+|.++++|+.++|..| ++.+...+
T Consensus       186 ~l~~n~l~-~I~~~aF~-~~~L~~l~lp~-~l~~I-----------------~~~aF~~~~~L~~l~l~~~-l~~I~~~a  244 (401)
T 4fdw_A          186 DLSKTKIT-KLPASTFV-YAGIEEVLLPV-TLKEI-----------------GSQAFLKTSQLKTIEIPEN-VSTIGQEA  244 (401)
T ss_dssp             ECTTSCCS-EECTTTTT-TCCCSEEECCT-TCCEE-----------------CTTTTTTCTTCCCEECCTT-CCEECTTT
T ss_pred             ecCCCcce-EechhhEe-ecccCEEEeCC-chhee-----------------hhhHhhCCCCCCEEecCCC-ccCccccc
Confidence            88888888 88888887 47777777763 24333                 1356778888888888764 67777788


Q ss_pred             ccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCc-----ccCChhhhhhcccccEEEccCCccccc
Q 043388          174 FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFG-----GELPHSIANLSSTMIQFRIGGNQISGT  248 (854)
Q Consensus       174 f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~~L~~L~l~~N~l~~~  248 (854)
                      |.+ .+|+.+.+ .|.++.+...      +|.+|++|+.+++.+|.+.     ...+.+|..+. .|+.+.+. +.++.+
T Consensus       245 F~~-~~L~~i~l-p~~i~~I~~~------aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~-~L~~l~l~-~~i~~I  314 (401)
T 4fdw_A          245 FRE-SGITTVKL-PNGVTNIASR------AFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCP-KLARFEIP-ESIRIL  314 (401)
T ss_dssp             TTT-CCCSEEEE-ETTCCEECTT------TTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCT-TCCEECCC-TTCCEE
T ss_pred             ccc-CCccEEEe-CCCccEEChh------HhhCCCCCCEEEeCCccccCCcccEECHHHhhCCc-cCCeEEeC-CceEEE
Confidence            887 77888888 4556665554      6778888888888877664     23455666665 68888888 457777


Q ss_pred             CCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCcc-ccchhccccceec
Q 043388          249 IPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLT-KLADLALSFNNLQ  318 (854)
Q Consensus       249 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~  318 (854)
                      ...+|.++++|+.++|..| ++.+.+.+|.++ +|+.+++.+|.+....+..|.+++ .++.|++..+.+.
T Consensus       315 ~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          315 GQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             hhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            7888999999999999655 777888889998 899999999988877777788774 6788888777655

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=8.3e-18  Score=165.85  Aligned_cols=153  Identities=16%  Similarity=0.171  Sum_probs=67.5

Q ss_pred             cCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCC
Q 043388           61 GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGM  140 (854)
Q Consensus        61 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~  140 (854)
                      +.+++|++|++++|.|+ .+| .+..+++|++|++++|.++ .++  .|..+++|++|++++|+++.             
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~~--~l~~l~~L~~L~l~~n~l~~-------------  102 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NYN--PISGLSNLERLRIMGKDVTS-------------  102 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CCG--GGTTCTTCCEEEEECTTCBG-------------
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cch--hhhcCCCCCEEEeECCccCc-------------
Confidence            44444555555555554 223 3444555555555555443 222  23444444444444443321             


Q ss_pred             CCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEeccccc-ccCCCCCChhhhhhccCCCCCcEEEcccCc
Q 043388          141 GTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNN-LGMGTANDLDFVTLLTNCSSLKALSLCDNQ  219 (854)
Q Consensus       141 ~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~  219 (854)
                          ..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|. ++.++        .+..+++|++|++++|+
T Consensus       103 ----~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~--------~l~~l~~L~~L~l~~n~  170 (197)
T 4ezg_A          103 ----DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM--------PLKTLPELKSLNIQFDG  170 (197)
T ss_dssp             ----GGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG--------GGGGCSSCCEEECTTBC
T ss_pred             ----ccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH--------hhcCCCCCCEEECCCCC
Confidence                123344445555555555555544444444555555555555554 43221        23444455555555555


Q ss_pred             CcccCChhhhhhcccccEEEccCCccc
Q 043388          220 FGGELPHSIANLSSTMIQFRIGGNQIS  246 (854)
Q Consensus       220 l~~~~p~~~~~l~~~L~~L~l~~N~l~  246 (854)
                      +++ ++ .+..++ +|+.|++++|+|.
T Consensus       171 i~~-~~-~l~~l~-~L~~L~l~~N~i~  194 (197)
T 4ezg_A          171 VHD-YR-GIEDFP-KLNQLYAFSQTIG  194 (197)
T ss_dssp             CCC-CT-TGGGCS-SCCEEEECBC---
T ss_pred             CcC-hH-HhccCC-CCCEEEeeCcccC
Confidence            542 22 333433 4555555555443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.72  E-value=2.6e-17  Score=161.34  Aligned_cols=133  Identities=20%  Similarity=0.279  Sum_probs=115.9

Q ss_pred             cEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCc-cccccccCCeeeccccccccCCCCCccCcccCceeeCc
Q 043388          211 KALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPS-GIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMF  289 (854)
Q Consensus       211 ~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  289 (854)
                      +++++++|+++ .+|..+..   .++.|++++|+|++..+. .|..+++|++|+|++|+|+++.|.+|.++++|++|+|+
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~---~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls   86 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL---HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT---TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CEEEcCCCCcC-cCccCCCC---CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence            67777777776 67765543   688888888888877665 48899999999999999999999999999999999999


Q ss_pred             cccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccch
Q 043388          290 RNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQ  347 (854)
Q Consensus       290 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~  347 (854)
                      +|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|++++|.+++..+.
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  144 (192)
T 1w8a_A           87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence            9999988888899999999999999999998899999999999999999999876553

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.71  E-value=8.6e-18  Score=164.79  Aligned_cols=80  Identities=23%  Similarity=0.326  Sum_probs=44.4

Q ss_pred             CeeeccccccccCCCCCccCcccCceeeCccccccccCCc-cccCccccchhccccceecccCCCCCcCCCCCcccccCC
Q 043388          260 IALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP-SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASH  338 (854)
Q Consensus       260 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  338 (854)
                      +.+++++|+++. +|..+..  +|++|++++|+|++..+. .|..+++|+.|+|++|.|++..|..|.++++|+.|+|++
T Consensus        11 ~~l~~s~~~l~~-ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSS-CCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcCc-CccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            566666666653 3333322  566666666666644443 355566666666666666555555555555555555555


Q ss_pred             Cccc
Q 043388          339 NKLT  342 (854)
Q Consensus       339 N~l~  342 (854)
                      |+++
T Consensus        88 N~l~   91 (192)
T 1w8a_A           88 NKIK   91 (192)
T ss_dssp             CCCC
T ss_pred             CcCC
Confidence            5554

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.70  E-value=4.5e-17  Score=156.11  Aligned_cols=136  Identities=18%  Similarity=0.198  Sum_probs=85.9

Q ss_pred             CCCCEEeccccccc-ccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceee
Q 043388           16 LNLQTLAIDFNYLT-GQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIY   94 (854)
Q Consensus        16 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~   94 (854)
                      ++|++|+|++|.++ +.+|..+..+++|++|+|++|.|++.  ..|..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            56777777777776 55666666677777777777776643  6666667777777777777665666666666666666


Q ss_pred             ecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCC---
Q 043388           95 LTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS---  171 (854)
Q Consensus        95 L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~---  171 (854)
                      |++|+|+ .+|.                                        +..+..+++|++|+|++|+++++++   
T Consensus       102 Ls~N~l~-~~~~----------------------------------------~~~l~~l~~L~~L~l~~N~l~~~~~~~~  140 (168)
T 2ell_A          102 LSGNKLK-DIST----------------------------------------LEPLKKLECLKSLDLFNCEVTNLNDYRE  140 (168)
T ss_dssp             CBSSSCC-SSGG----------------------------------------GGGGSSCSCCCEEECCSSGGGTSTTHHH
T ss_pred             ccCCccC-cchh----------------------------------------HHHHhcCCCCCEEEeeCCcCcchHHHHH
Confidence            6666665 3331                                        1345555666666666666665544   


Q ss_pred             cCccccCCCCeEecccccccCCC
Q 043388          172 IDFSSLKNLWWLNLEQNNLGMGT  194 (854)
Q Consensus       172 ~~f~~l~~L~~L~L~~N~l~~~~  194 (854)
                      ..|..+++|++|++++|.+..++
T Consensus       141 ~~~~~l~~L~~L~l~~n~~~~~~  163 (168)
T 2ell_A          141 SVFKLLPQLTYLDGYDREDQEAP  163 (168)
T ss_dssp             HHHTTCSSCCEETTEETTSCBCC
T ss_pred             HHHHhCccCcEecCCCCChhhcc
Confidence            35666666666666666665444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.68  E-value=1.1e-16  Score=153.35  Aligned_cols=140  Identities=23%  Similarity=0.208  Sum_probs=95.7

Q ss_pred             CCCcEEecccccCc-ccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCC
Q 043388           64 RNLVYLNVAENQFS-GMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGT  142 (854)
Q Consensus        64 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~  142 (854)
                      ++|++|+|++|.++ +.+|..+..+++|++|+|++|+|+ .+  ..|..+++|++|++++|++..               
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~-~~--~~~~~l~~L~~L~Ls~N~l~~---------------   85 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV--SNLPKLPKLKKLELSENRIFG---------------   85 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCC-CC--SSCCCCSSCCEEEEESCCCCS---------------
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCC-Ch--hhhccCCCCCEEECcCCcCch---------------
Confidence            45555555555554 344555555555555555555555 33  334445555555544444432               


Q ss_pred             CCCCCccccCCCCCCEEecCCCcCcccCC-cCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCc
Q 043388          143 ASSIPDSLSNASNLERLDLSGNQFKGKVS-IDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFG  221 (854)
Q Consensus       143 ~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~-~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  221 (854)
                        .+|..+.++++|++|+|++|+|+++.. ..|..+++|++|++++|.++..+.-   ....+..+++|++|++++|.+.
T Consensus        86 --~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~---~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A           86 --GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDY---RESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             --CCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTH---HHHHHTTCSSCCEETTEETTSC
T ss_pred             --HHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHH---HHHHHHhCccCcEecCCCCChh
Confidence              246777789999999999999998754 7899999999999999999865430   1136889999999999999998


Q ss_pred             ccCChh
Q 043388          222 GELPHS  227 (854)
Q Consensus       222 ~~~p~~  227 (854)
                       .+|.+
T Consensus       161 -~~~~~  165 (168)
T 2ell_A          161 -EAPDS  165 (168)
T ss_dssp             -BCCSS
T ss_pred             -hcccc
Confidence             66654

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.67  E-value=2.4e-15  Score=165.55  Aligned_cols=329  Identities=12%  Similarity=0.094  Sum_probs=192.8

Q ss_pred             ccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCC
Q 043388           34 DFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLP  113 (854)
Q Consensus        34 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~  113 (854)
                      .+|.++++|+.+.|.. .++.+-..+|.++++|+.++|..+ ++.+...+|.++++|+.+.+..+ ++ .+...+|.+..
T Consensus        65 ~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~~aF~~~~  140 (394)
T 4fs7_A           65 AAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGVEAFKGCD  140 (394)
T ss_dssp             TTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTTTTTTCC
T ss_pred             HHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecceeeeccc
Confidence            3444444555555442 244344444555555555555433 33344444555555544444433 22 34444444433


Q ss_pred             CCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCC
Q 043388          114 NLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMG  193 (854)
Q Consensus       114 ~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~  193 (854)
                      .++.....  ...                 ..-..+|.++++|+.+.+.++ +..+....|.++.+|+.+++..| +..+
T Consensus       141 ~~~~~~~~--~~~-----------------~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I  199 (394)
T 4fs7_A          141 FKEITIPE--GVT-----------------VIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKII  199 (394)
T ss_dssp             CSEEECCT--TCC-----------------EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEE
T ss_pred             ccccccCc--ccc-----------------ccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEe
Confidence            22211111  000                 011346888888888888765 44577888888888888888776 5544


Q ss_pred             CCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCC
Q 043388          194 TANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGII  273 (854)
Q Consensus       194 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  273 (854)
                      ...      +|.++..|+.+.+..+...  +...+.... .++.+.+..+ ++.+....|.++.+|+.+.+..+... +.
T Consensus       200 ~~~------~F~~~~~L~~i~~~~~~~~--i~~~~~~~~-~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~  268 (394)
T 4fs7_A          200 RDY------CFAECILLENMEFPNSLYY--LGDFALSKT-GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IG  268 (394)
T ss_dssp             CTT------TTTTCTTCCBCCCCTTCCE--ECTTTTTTC-CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-EC
T ss_pred             Cch------hhccccccceeecCCCceE--eehhhcccC-CCceEEECCC-ceecccccccccccceeEEcCCCcce-ee
Confidence            443      5778888888877766543  223333332 5777766543 34456667778888888888776544 66


Q ss_pred             CCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchh
Q 043388          274 PDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSIT  353 (854)
Q Consensus       274 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~  353 (854)
                      ..+|..+..++.+....+.+   ....|..+.+|+.+.+..+ ++.+...+|.++.+|+.+++..+ ++ .++.      
T Consensus       269 ~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~------  336 (394)
T 4fs7_A          269 GSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGK------  336 (394)
T ss_dssp             SCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECT------
T ss_pred             ccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhH------
Confidence            67778888888777766543   3446777777777777655 55566677778888887777543 33 2221      


Q ss_pred             hhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCcc
Q 043388          354 TLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLS  433 (854)
Q Consensus       354 ~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  433 (854)
                                        ..|.+       |.+|+.+++..| ++.+...+|.++.+|+.+++..+ ++ .+...|.+++
T Consensus       337 ------------------~aF~~-------c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~  388 (394)
T 4fs7_A          337 ------------------RSFRG-------CTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTT  388 (394)
T ss_dssp             ------------------TTTTT-------CTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTC
T ss_pred             ------------------HhccC-------CCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCC
Confidence                              12222       556777777766 66566677777888888877654 33 3455677777


Q ss_pred             CCCee
Q 043388          434 FLEFL  438 (854)
Q Consensus       434 ~L~~L  438 (854)
                      +|+.+
T Consensus       389 ~L~~I  393 (394)
T 4fs7_A          389 KFKWI  393 (394)
T ss_dssp             EEEEE
T ss_pred             CCcEE
Confidence            66643

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.67  E-value=2.7e-16  Score=154.00  Aligned_cols=128  Identities=19%  Similarity=0.258  Sum_probs=112.7

Q ss_pred             CCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecc
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTV   97 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~   97 (854)
                      -+++++++|.|+ .+|..+.  ++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+++.+.+|.++++|++|+|++
T Consensus        12 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~   87 (193)
T 2wfh_A           12 DTVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY   87 (193)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence            468999999999 6787664  68999999999998 7789999999999999999999999999999999999999999


Q ss_pred             cccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCc
Q 043388           98 NRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFK  167 (854)
Q Consensus        98 N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~  167 (854)
                      |+|+ .++...|.++++|++|+|++|.++.+                 .+..|..+++|++|+|++|.+.
T Consensus        88 N~l~-~i~~~~f~~l~~L~~L~L~~N~l~~~-----------------~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           88 NRLR-CIPPRTFDGLKSLRLLSLHGNDISVV-----------------PEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             SCCC-BCCTTTTTTCTTCCEEECCSSCCCBC-----------------CTTTTTTCTTCCEEECCSSCEE
T ss_pred             CccC-EeCHHHhCCCCCCCEEECCCCCCCee-----------------ChhhhhcCccccEEEeCCCCee
Confidence            9999 88888899999999988888877644                 2346888899999999999886

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.67  E-value=9.7e-17  Score=150.40  Aligned_cols=129  Identities=22%  Similarity=0.245  Sum_probs=86.2

Q ss_pred             CCCCCEEeccccccc-ccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCcee
Q 043388           15 LLNLQTLAIDFNYLT-GQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFI   93 (854)
Q Consensus        15 l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L   93 (854)
                      .++|++|++++|.++ +.+|..++.+++|++|++++|.+++.  ..|+.+++|++|+|++|++++.+|..+.++++|++|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            356777777777776 56777777777777777777777744  667777777777777777776667766667777777


Q ss_pred             eecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCC--
Q 043388           94 YLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS--  171 (854)
Q Consensus        94 ~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~--  171 (854)
                      +|++|+|+ .+|                                        .|..+..+++|++|++++|+++++++  
T Consensus        94 ~ls~N~i~-~~~----------------------------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~  132 (149)
T 2je0_A           94 NLSGNKIK-DLS----------------------------------------TIEPLKKLENLKSLDLFNCEVTNLNDYR  132 (149)
T ss_dssp             ECTTSCCC-SHH----------------------------------------HHGGGGGCTTCCEEECTTCGGGGSTTHH
T ss_pred             ECCCCcCC-ChH----------------------------------------HHHHHhhCCCCCEEeCcCCcccchHHHH
Confidence            77777765 322                                        12445556666666666666665554  


Q ss_pred             -cCccccCCCCeEecc
Q 043388          172 -IDFSSLKNLWWLNLE  186 (854)
Q Consensus       172 -~~f~~l~~L~~L~L~  186 (854)
                       ..|..+++|+.|+++
T Consensus       133 ~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A          133 ENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             HHHHHHCTTCCEETTB
T ss_pred             HHHHHHCCCcccccCC
Confidence             455666666666654

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.66  E-value=5.1e-16  Score=152.02  Aligned_cols=128  Identities=26%  Similarity=0.361  Sum_probs=95.9

Q ss_pred             CCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcc
Q 043388           42 LGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT  121 (854)
Q Consensus        42 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~  121 (854)
                      -+++++++|+|+ .+|..+.  ++|++|+|++|+|+ .+|.+|.++++|++|+|++|+|+ .++...|.++++|++|+|+
T Consensus        12 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls   86 (193)
T 2wfh_A           12 DTVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILS   86 (193)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCC-EeCHhHccCCCCCCEEECC
Confidence            367889999998 6676553  68999999999998 56788889999999999999988 7777777777777777776


Q ss_pred             cCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEeccccccc
Q 043388          122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLG  191 (854)
Q Consensus       122 ~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  191 (854)
                      +|+++.+                 .|..|.++++|++|+|++|+|+.+++..|..+++|+.|+|++|.+.
T Consensus        87 ~N~l~~i-----------------~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           87 YNRLRCI-----------------PPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             SSCCCBC-----------------CTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCccCEe-----------------CHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            6666543                 2456777777777777777777766666777777777777666653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=1.7e-16  Score=168.95  Aligned_cols=135  Identities=15%  Similarity=0.194  Sum_probs=99.0

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--------------cchHH--------HHHHHHHHHhccCCCe
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--------------GAFRS--------FVAECEALRNIRHRNL  607 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~ni  607 (854)
                      |++.+.||+|++|.||+|... +|+.||||+++....              .....        ..+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            888999999999999999987 789999999753210              00111        2356777777755443


Q ss_pred             --eeEEEEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 043388          608 --IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDL  685 (854)
Q Consensus       608 --v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  685 (854)
                        ...+++.         ..+|||||++|++|.++...            .....++.|++.+|.|||+.   |||||||
T Consensus       176 ~vp~p~~~~---------~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~~---gIVHrDL  231 (397)
T 4gyi_A          176 PVPEPIAQS---------RHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAKH---GLIHGDF  231 (397)
T ss_dssp             SCCCEEEEE---------TTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             CCCeeeecc---------CceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHHC---CCcCCCC
Confidence              2333321         23799999999888765321            12356889999999999999   9999999


Q ss_pred             CCCceEecCCc-----------ccccccccccccc
Q 043388          686 KPSNVLLDHDM-----------VAHQNFSLSHQLD  709 (854)
Q Consensus       686 kp~NIll~~~~-----------~~~~Dfg~~~~~~  709 (854)
                      ||.|||+++++           ..+|||+-+....
T Consensus       232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            99999998775           4567999776543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.63  E-value=1.2e-15  Score=147.50  Aligned_cols=103  Identities=24%  Similarity=0.279  Sum_probs=59.3

Q ss_pred             CCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecc
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTV   97 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~   97 (854)
                      .+.+++++|+++ .+|..+.  ++|++|++++|++++..+..|+.+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            456666666666 4454333  4666666666666655555566666666666666666655555566666666666666


Q ss_pred             cccccccCcccccCCCCCcEEEcccCC
Q 043388           98 NRFSGSLPFDILVNLPNLKELYLTFCS  124 (854)
Q Consensus        98 N~l~~~~~~~~~~~l~~L~~L~l~~n~  124 (854)
                      |+|+ .+|...|.++++|++|++++|+
T Consensus        86 N~l~-~~~~~~~~~l~~L~~L~l~~N~  111 (177)
T 2o6r_A           86 NKLQ-SLPNGVFDKLTQLKELALDTNQ  111 (177)
T ss_dssp             SCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCcc-ccCHHHhhCCcccCEEECcCCc
Confidence            6665 4444444444444444443333

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.62  E-value=4.9e-16  Score=150.06  Aligned_cols=134  Identities=20%  Similarity=0.184  Sum_probs=77.7

Q ss_pred             ccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCC
Q 043388           36 VGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL  115 (854)
Q Consensus        36 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  115 (854)
                      +.+..+|+.|++++|+++ .+|......++|++|+|++|+|+++  +.|..+++|++|+|++|+|+ .+|..+|..+++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L   90 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDL   90 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTC
T ss_pred             cCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcCCCC
Confidence            445556666666666665 2333222223666666666666644  45666666666666666665 5555555555555


Q ss_pred             cEEEcccCCCCCCceeeccCccCCCCCCCCCCc--cccCCCCCCEEecCCCcCcccCCc---CccccCCCCeEecccccc
Q 043388          116 KELYLTFCSLKNLWWLNLEQNNLGMGTASSIPD--SLSNASNLERLDLSGNQFKGKVSI---DFSSLKNLWWLNLEQNNL  190 (854)
Q Consensus       116 ~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~--~~~~l~~L~~L~Ls~N~i~~~~~~---~f~~l~~L~~L~L~~N~l  190 (854)
                      ++|++++|.+..+                  |.  .+..+++|++|+|++|+++.+++.   .+..+++|++|++++|.+
T Consensus        91 ~~L~L~~N~i~~~------------------~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~  152 (176)
T 1a9n_A           91 TELILTNNSLVEL------------------GDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKL  152 (176)
T ss_dssp             CEEECCSCCCCCG------------------GGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred             CEEECCCCcCCcc------------------hhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence            5555555554322                  33  566677777777777777654332   366666666666666655


Q ss_pred             c
Q 043388          191 G  191 (854)
Q Consensus       191 ~  191 (854)
                      .
T Consensus       153 ~  153 (176)
T 1a9n_A          153 K  153 (176)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=1.3e-15  Score=147.34  Aligned_cols=133  Identities=20%  Similarity=0.261  Sum_probs=114.1

Q ss_pred             CcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCc
Q 043388          210 LKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMF  289 (854)
Q Consensus       210 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  289 (854)
                      .+.+++++|+++ .+|..+.   +.++.|++++|++++..+..|.++++|++|++++|+|+++.+..|..+++|++|+|+
T Consensus         9 ~~~l~~~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~   84 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH   84 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCCc-cCCCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence            467777777777 5665443   378888999998887777788999999999999999998888889999999999999


Q ss_pred             cccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccc
Q 043388          290 RNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIP  346 (854)
Q Consensus       290 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p  346 (854)
                      +|++++..+..|..+++|+.|++++|.+++..+..|..+++|+.|++++|++.+..|
T Consensus        85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            999998777788999999999999999997777778899999999999999986554

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.61  E-value=1.9e-14  Score=158.32  Aligned_cols=329  Identities=12%  Similarity=0.055  Sum_probs=242.0

Q ss_pred             hhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCC
Q 043388           10 EEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISS   89 (854)
Q Consensus        10 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~   89 (854)
                      ..|.++++|+.+.|..+ ++.+-..+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+ +..+...+|.+...
T Consensus        65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~  141 (394)
T 4fs7_A           65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF  141 (394)
T ss_dssp             TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred             HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence            46889999999999754 77566778999999999999865 77677889999999999998876 55588889988876


Q ss_pred             CceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCccc
Q 043388           90 LEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGK  169 (854)
Q Consensus        90 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~  169 (854)
                      ++.......  . .+...+|.++++|+.+.+..+ +..+                 -...|.++++|+.+++..| ++.+
T Consensus       142 ~~~~~~~~~--~-~i~~~aF~~c~~L~~i~l~~~-~~~I-----------------~~~~F~~c~~L~~i~l~~~-~~~I  199 (394)
T 4fs7_A          142 KEITIPEGV--T-VIGDEAFATCESLEYVSLPDS-METL-----------------HNGLFSGCGKLKSIKLPRN-LKII  199 (394)
T ss_dssp             SEEECCTTC--C-EECTTTTTTCTTCCEEECCTT-CCEE-----------------CTTTTTTCTTCCBCCCCTT-CCEE
T ss_pred             cccccCccc--c-ccchhhhcccCCCcEEecCCc-ccee-----------------ccccccCCCCceEEEcCCC-ceEe
Confidence            555444333  3 677788999999998888543 2222                 1356888999999999877 7778


Q ss_pred             CCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccC
Q 043388          170 VSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTI  249 (854)
Q Consensus       170 ~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~  249 (854)
                      ...+|.+...|+.+.+..+..... .       .+....+|+.+.+..+- +......+.... .++.+.+..+..+ +.
T Consensus       200 ~~~~F~~~~~L~~i~~~~~~~~i~-~-------~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~-~l~~~~~~~~~~~-i~  268 (394)
T 4fs7_A          200 RDYCFAECILLENMEFPNSLYYLG-D-------FALSKTGVKNIIIPDSF-TELGKSVFYGCT-DLESISIQNNKLR-IG  268 (394)
T ss_dssp             CTTTTTTCTTCCBCCCCTTCCEEC-T-------TTTTTCCCCEEEECTTC-CEECSSTTTTCS-SCCEEEECCTTCE-EC
T ss_pred             CchhhccccccceeecCCCceEee-h-------hhcccCCCceEEECCCc-eecccccccccc-cceeEEcCCCcce-ee
Confidence            888999999999998887654321 1       23455788888886543 323344455544 7888888877655 77


Q ss_pred             CccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCC
Q 043388          250 PSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQ  329 (854)
Q Consensus       250 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  329 (854)
                      ...|..+..++.+.+..+.+   ...+|..+.+|+.+.+.++ ++.+...+|.++++|+.++|..+ ++.+...+|.++.
T Consensus       269 ~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~  343 (394)
T 4fs7_A          269 GSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCT  343 (394)
T ss_dssp             SCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCT
T ss_pred             ccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCC
Confidence            78888889999888877654   3457888899999988765 66567778999999999999755 6667778899999


Q ss_pred             CCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCC
Q 043388          330 NLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMK  409 (854)
Q Consensus       330 ~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~  409 (854)
                      +|+.+++..| ++ .++..                        .|.+       |.+|+.+++..+ ++ .+..+|.+++
T Consensus       344 ~L~~i~lp~~-l~-~I~~~------------------------aF~~-------C~~L~~i~lp~~-~~-~~~~~F~~c~  388 (394)
T 4fs7_A          344 SLSNINFPLS-LR-KIGAN------------------------AFQG-------CINLKKVELPKR-LE-QYRYDFEDTT  388 (394)
T ss_dssp             TCCEECCCTT-CC-EECTT------------------------TBTT-------CTTCCEEEEEGG-GG-GGGGGBCTTC
T ss_pred             CCCEEEECcc-cc-EehHH------------------------HhhC-------CCCCCEEEECCC-CE-EhhheecCCC
Confidence            9999888766 44 22221                        2222       667888888755 33 3346777777


Q ss_pred             CCCEE
Q 043388          410 SIKEL  414 (854)
Q Consensus       410 ~L~~L  414 (854)
                      +|+.+
T Consensus       389 ~L~~I  393 (394)
T 4fs7_A          389 KFKWI  393 (394)
T ss_dssp             EEEEE
T ss_pred             CCcEE
Confidence            77654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.61  E-value=6.6e-16  Score=149.11  Aligned_cols=135  Identities=18%  Similarity=0.154  Sum_probs=115.2

Q ss_pred             hhhcCCCCCEEecccccccccCCccccCcC-CCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCC
Q 043388           11 EIGSLLNLQTLAIDFNYLTGQLPDFVGNLS-ALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISS   89 (854)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~   89 (854)
                      .+.++.+|++|+|++|.++ .+|. +..+. +|+.|+|++|.|++.  ..|..+++|++|+|++|+|+++.+..|..+++
T Consensus        14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            4677899999999999999 4565 55554 999999999999965  78999999999999999999877777899999


Q ss_pred             CceeeecccccccccCc-ccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCcc----ccCCCCCCEEecCCC
Q 043388           90 LEFIYLTVNRFSGSLPF-DILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDS----LSNASNLERLDLSGN  164 (854)
Q Consensus        90 L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~----~~~l~~L~~L~Ls~N  164 (854)
                      |++|+|++|+|+ .+|. ..|..+++|+.|++++|.+..                  +|..    +..+++|++||+++|
T Consensus        90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~------------------~~~~~~~~~~~l~~L~~Ld~~~n  150 (176)
T 1a9n_A           90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN------------------KKHYRLYVIYKVPQVRVLDFQKV  150 (176)
T ss_dssp             CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG------------------STTHHHHHHHHCTTCSEETTEEC
T ss_pred             CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC------------------cHhHHHHHHHHCCccceeCCCcC
Confidence            999999999997 7775 467788888888887777643                  3554    889999999999999


Q ss_pred             cCcc
Q 043388          165 QFKG  168 (854)
Q Consensus       165 ~i~~  168 (854)
                      .+..
T Consensus       151 ~~~~  154 (176)
T 1a9n_A          151 KLKE  154 (176)
T ss_dssp             CHHH
T ss_pred             CHHH
Confidence            8864

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.60  E-value=2.6e-17  Score=162.46  Aligned_cols=157  Identities=23%  Similarity=0.257  Sum_probs=123.3

Q ss_pred             hhhcCCCCCEEecccccccccCCc------cccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhh
Q 043388           11 EIGSLLNLQTLAIDFNYLTGQLPD------FVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWI   84 (854)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~   84 (854)
                      .+.....++.++++.+.+++.+|.      .|+.+++|++|+|++|++++ +| .|..+++|++|+|++|+|+ .+|..+
T Consensus        13 ~~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~   89 (198)
T 1ds9_A           13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLD   89 (198)
T ss_dssp             HHHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHH
T ss_pred             HHHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchh
Confidence            367788999999999999988887      88999999999999999985 66 8899999999999999998 577788


Q ss_pred             cCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCC
Q 043388           85 CNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGN  164 (854)
Q Consensus        85 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N  164 (854)
                      ..+++|++|+|++|+|+ .+|  .|..+++|++|++++|+++.+.                ....+..+++|++|++++|
T Consensus        90 ~~~~~L~~L~L~~N~l~-~l~--~~~~l~~L~~L~l~~N~i~~~~----------------~~~~l~~l~~L~~L~l~~N  150 (198)
T 1ds9_A           90 AVADTLEELWISYNQIA-SLS--GIEKLVNLRVLYMSNNKITNWG----------------EIDKLAALDKLEDLLLAGN  150 (198)
T ss_dssp             HHHHHCSEEEEEEEECC-CHH--HHHHHHHSSEEEESEEECCCHH----------------HHHHHTTTTTCSEEEECSC
T ss_pred             hcCCcCCEEECcCCcCC-cCC--ccccCCCCCEEECCCCcCCchh----------------HHHHHhcCCCCCEEEecCC
Confidence            88899999999999998 566  3667777777777777665431                0136778888888888888


Q ss_pred             cCcccCCcC----------ccccCCCCeEeccccccc
Q 043388          165 QFKGKVSID----------FSSLKNLWWLNLEQNNLG  191 (854)
Q Consensus       165 ~i~~~~~~~----------f~~l~~L~~L~L~~N~l~  191 (854)
                      ++++..|..          +..+++|+.||  +|.++
T Consensus       151 ~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          151 PLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             ccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            887765543          66666666665  55554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.58  E-value=2.3e-15  Score=140.98  Aligned_cols=128  Identities=21%  Similarity=0.246  Sum_probs=92.2

Q ss_pred             CCCCCEEecCCCcCc-ccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhh
Q 043388          153 ASNLERLDLSGNQFK-GKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANL  231 (854)
Q Consensus       153 l~~L~~L~Ls~N~i~-~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  231 (854)
                      .++|++|++++|+++ +..|..|..+++|++|++++|.++.+        ..+..+++|++|+|++|.+++.+|..+..+
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--------~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l   87 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--------ANLPKLNKLKKLELSDNRVSGGLEVLAEKC   87 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--------TTCCCCTTCCEEECCSSCCCSCTHHHHHHC
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--------hhhhcCCCCCEEECCCCcccchHHHHhhhC
Confidence            367888888888887 56666778888888888888888755        246778888888888888886566666555


Q ss_pred             cccccEEEccCCccccc-CCccccccccCCeeeccccccccCCC---CCccCcccCceeeCc
Q 043388          232 SSTMIQFRIGGNQISGT-IPSGIRNLVNLIALTIEVNQLHGIIP---DGVGELQHLQQLYMF  289 (854)
Q Consensus       232 ~~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~  289 (854)
                      + .|+.|++++|.+++. .+..+..+++|++|++++|++++..+   ..+..+++|+.|+++
T Consensus        88 ~-~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           88 P-NLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             T-TCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             C-CCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            4 677777777777753 23667777777777777777776555   456667777777665

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.53  E-value=2.7e-14  Score=136.64  Aligned_cols=106  Identities=19%  Similarity=0.220  Sum_probs=97.5

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      ..++|++++|.|+ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            5689999999999 6887764  899999999999998889999999999999999999999888899999999999999


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCC
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLK  126 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~  126 (854)
                      +|+|+ .+|.+.|.++++|++|+|++|.+.
T Consensus        87 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           87 DNQLK-SIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             SSCCC-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCccC-EeCHHHhcCCCCCCEEEeCCCCCC
Confidence            99999 899889999999999998888765

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.52  E-value=1.7e-16  Score=156.60  Aligned_cols=156  Identities=22%  Similarity=0.272  Sum_probs=113.8

Q ss_pred             ccccccCCeeeccccccccCCCC------CccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCc
Q 043388          253 IRNLVNLIALTIEVNQLHGIIPD------GVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLG  326 (854)
Q Consensus       253 ~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  326 (854)
                      +.....++.++++.|.+++..|.      .|..+++|++|++++|.+++ +| .+..+++|+.|++++|.++ .+|..+.
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence            44455667777777777776665      67777788888888888775 55 7777788888888888887 5666667


Q ss_pred             CCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCC-ccc
Q 043388          327 NCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIP-FSL  405 (854)
Q Consensus       327 ~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p-~~~  405 (854)
                      .+++|+.|++++|++++ +| .+                         +.       +.+|++|+|++|++++..+ ..+
T Consensus        91 ~~~~L~~L~L~~N~l~~-l~-~~-------------------------~~-------l~~L~~L~l~~N~i~~~~~~~~l  136 (198)
T 1ds9_A           91 VADTLEELWISYNQIAS-LS-GI-------------------------EK-------LVNLRVLYMSNNKITNWGEIDKL  136 (198)
T ss_dssp             HHHHCSEEEEEEEECCC-HH-HH-------------------------HH-------HHHSSEEEESEEECCCHHHHHHH
T ss_pred             cCCcCCEEECcCCcCCc-CC-cc-------------------------cc-------CCCCCEEECCCCcCCchhHHHHH
Confidence            77788888888888773 33 11                         11       3458888888888885433 467


Q ss_pred             ccCCCCCEEEccCcccccccch----------hhcCccCCCeeecccccCcc
Q 043388          406 GFMKSIKELNVSSNNLSGQIPE----------FLQNLSFLEFLNLSYNHLEG  447 (854)
Q Consensus       406 ~~l~~L~~L~Ls~N~l~~~~p~----------~~~~l~~L~~L~ls~N~l~~  447 (854)
                      ..+++|++|++++|.+++.+|.          .+..+++|+.||  +|+++.
T Consensus       137 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          137 AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             TTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred             hcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence            8888999999999999877665          378889999887  777654

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.51  E-value=5.2e-14  Score=135.09  Aligned_cols=106  Identities=19%  Similarity=0.203  Sum_probs=97.0

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      .-+.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|+.+++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        13 ~~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~   89 (174)
T 2r9u_A           13 DQTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLN   89 (174)
T ss_dssp             CSSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECC
Confidence            3478999999998 7888775  899999999999998889999999999999999999998888889999999999999


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCC
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLK  126 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~  126 (854)
                      +|+|+ .+|...|..+++|++|++++|.+.
T Consensus        90 ~N~l~-~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           90 DNHLK-SIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             SSCCC-CCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             CCccc-eeCHHHhccccCCCEEEeCCCCcc
Confidence            99999 899888999999999998888765

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.49  E-value=1.5e-12  Score=142.98  Aligned_cols=329  Identities=13%  Similarity=0.109  Sum_probs=159.0

Q ss_pred             cccCc-CCCCeeecccccccccCCcCccCCCCCcEEeccccc---CcccChhhhcCCCCCceeeecccccccccCccccc
Q 043388           35 FVGNL-SALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQ---FSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILV  110 (854)
Q Consensus        35 ~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  110 (854)
                      +|.+. ..|+.+.+-.+ ++.+-..+|.++++|+.+.++.|.   ++.+...+|.++.+|+.+.+..+ ++ .++..+|.
T Consensus        58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-~I~~~aF~  134 (394)
T 4gt6_A           58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-EIDSEAFH  134 (394)
T ss_dssp             TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-EECTTTTT
T ss_pred             hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-eehhhhhh
Confidence            44443 23555555432 444445555555555555555442   44444455555555555554433 33 44555555


Q ss_pred             CCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccc
Q 043388          111 NLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNL  190 (854)
Q Consensus       111 ~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l  190 (854)
                      ++.+|+.+.+..+ +..+                 -...|..+.+|+.+.+..+ ++.+...+|.. .+|+.+.+..+-.
T Consensus       135 ~c~~L~~i~lp~~-~~~I-----------------~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~  194 (394)
T 4gt6_A          135 HCEELDTVTIPEG-VTSV-----------------ADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT  194 (394)
T ss_dssp             TCTTCCEEECCTT-CCEE-----------------CTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC
T ss_pred             hhcccccccccce-eeee-----------------cccceecccccccccccce-eeEeccccccc-cceeEEEECCccc
Confidence            5555555544311 1111                 1234555555666655543 44455555543 3455555544322


Q ss_pred             cCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccc
Q 043388          191 GMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLH  270 (854)
Q Consensus       191 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  270 (854)
                      . +..      .+|.++.+++......+... .+...+....           .........+.....+..+.+. +.++
T Consensus       195 ~-i~~------~af~~c~~l~~~~~~~~~~~-~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ip-~~v~  254 (394)
T 4gt6_A          195 R-IGT------NAFSECFALSTITSDSESYP-AIDNVLYEKS-----------ANGDYALIRYPSQREDPAFKIP-NGVA  254 (394)
T ss_dssp             E-ECT------TTTTTCTTCCEEEECCSSSC-BSSSCEEEEC-----------TTSCEEEEECCTTCCCSEEECC-TTEE
T ss_pred             c-ccc------chhhhccccceecccccccc-cccceeeccc-----------ccccccccccccccccceEEcC-Ccce
Confidence            1 111      14555555555555444433 1111111100           0000000011122233334333 2344


Q ss_pred             cCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhc
Q 043388          271 GIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVL  350 (854)
Q Consensus       271 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~  350 (854)
                      .+...+|.++.+|+.+.+.++... +...+|.+++.|+.+.+. +.++.+...+|.++.+|+.+++..+ ++ .+..   
T Consensus       255 ~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~---  327 (394)
T 4gt6_A          255 RIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILD---  327 (394)
T ss_dssp             EECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECT---
T ss_pred             EcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehH---
Confidence            455667777777777777655444 556667777777777775 3455455667777777777776543 32 1111   


Q ss_pred             chhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhc
Q 043388          351 SITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQ  430 (854)
Q Consensus       351 ~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  430 (854)
                                           ..|.+       |.+|+.+.|..+ ++.+...+|.++.+|+.+++.+|....   ..+.
T Consensus       328 ---------------------~aF~~-------C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~  375 (394)
T 4gt6_A          328 ---------------------DAFAG-------CEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAIS  375 (394)
T ss_dssp             ---------------------TTTTT-------CTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCB
T ss_pred             ---------------------hHhhC-------CCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhh
Confidence                                 12222       556777777544 554556677788888888887776541   4566


Q ss_pred             CccCCCeeecccccC
Q 043388          431 NLSFLEFLNLSYNHL  445 (854)
Q Consensus       431 ~l~~L~~L~ls~N~l  445 (854)
                      .+.+|+.+.+..|.+
T Consensus       376 ~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          376 TDSGLQNLPVAPGSI  390 (394)
T ss_dssp             CCCCC----------
T ss_pred             ccCCCCEEEeCCCCE
Confidence            667777777766654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.47  E-value=1.5e-13  Score=131.45  Aligned_cols=109  Identities=21%  Similarity=0.251  Sum_probs=95.8

Q ss_pred             CCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEc
Q 043388           41 ALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL  120 (854)
Q Consensus        41 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l  120 (854)
                      ..+++++++|+++ .+|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ .+|.++|.++++|++|+|
T Consensus        10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L   85 (170)
T 3g39_A           10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSL   85 (170)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcC-ccChhhccCCCCCCEEEC
Confidence            4679999999999 5777664  89999999999999999999999999999999999999 899999999999999999


Q ss_pred             ccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccC
Q 043388          121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKV  170 (854)
Q Consensus       121 ~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~  170 (854)
                      ++|+++.+                 .+..|.++++|++|+|++|.++...
T Consensus        86 ~~N~l~~~-----------------~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           86 NDNQLKSI-----------------PRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             CSSCCCCC-----------------CTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             CCCccCEe-----------------CHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            88887644                 2456889999999999999987543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.46  E-value=2.1e-13  Score=130.88  Aligned_cols=107  Identities=19%  Similarity=0.303  Sum_probs=94.3

Q ss_pred             CCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcc
Q 043388           42 LGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT  121 (854)
Q Consensus        42 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~  121 (854)
                      -+.+++++|+++ .+|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ .+|..+|.++++|++|+|+
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~   89 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLN   89 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCC-ccChhHhCCcchhhEEECC
Confidence            478999999998 7787775  89999999999999999999999999999999999999 8999999999999999988


Q ss_pred             cCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCccc
Q 043388          122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGK  169 (854)
Q Consensus       122 ~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~  169 (854)
                      +|+++.+                 .+..|.++++|++|+|++|.+...
T Consensus        90 ~N~l~~l-----------------~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           90 DNHLKSI-----------------PRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             SSCCCCC-----------------CTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             CCcccee-----------------CHHHhccccCCCEEEeCCCCcccc
Confidence            8877644                 234588999999999999998744

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.43  E-value=2.7e-12  Score=141.05  Aligned_cols=302  Identities=10%  Similarity=0.080  Sum_probs=188.0

Q ss_pred             hhhhcCC-CCCEEecccccccccCCccccCcCCCCeeeccccc---ccccCCcCccCCCCCcEEecccccCcccChhhhc
Q 043388           10 EEIGSLL-NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNS---LGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWIC   85 (854)
Q Consensus        10 ~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~   85 (854)
                      ..|.+++ .|+.+.+-.+ ++.+-..+|.++++|+.+.+..|.   ++.+-..+|..+.+|+.+.+..+ ++.+...+|.
T Consensus        57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~  134 (394)
T 4gt6_A           57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH  134 (394)
T ss_dssp             TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred             hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence            4677774 5999999765 775677899999999999999874   77777889999999999999876 6668888999


Q ss_pred             CCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCc
Q 043388           86 NISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ  165 (854)
Q Consensus        86 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~  165 (854)
                      ++.+|+.+.+..+ ++ .++...|.+..+|+.+.+..+ ++.+.                 ..+|. ..+|+.+.+..+-
T Consensus       135 ~c~~L~~i~lp~~-~~-~I~~~~F~~c~~L~~i~~~~~-~~~I~-----------------~~aF~-~~~l~~i~ip~~~  193 (394)
T 4gt6_A          135 HCEELDTVTIPEG-VT-SVADGMFSYCYSLHTVTLPDS-VTAIE-----------------ERAFT-GTALTQIHIPAKV  193 (394)
T ss_dssp             TCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEECCTT-CCEEC-----------------TTTTT-TCCCSEEEECTTC
T ss_pred             hhcccccccccce-ee-eecccceecccccccccccce-eeEec-----------------ccccc-ccceeEEEECCcc
Confidence            9999999999865 44 788999999999999988643 32221                 12333 2567777776543


Q ss_pred             CcccCCcCccccCCCCeEecccccccCCCCCChh-------hhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEE
Q 043388          166 FKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD-------FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQF  238 (854)
Q Consensus       166 i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~-------~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L  238 (854)
                       +.+...+|....+|.......+....+....+.       ....+.....+..+.+.. .++.....+|.... .|+.+
T Consensus       194 -~~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~-~L~~i  270 (394)
T 4gt6_A          194 -TRIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCA-YLASV  270 (394)
T ss_dssp             -CEECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCS-SCCEE
T ss_pred             -cccccchhhhccccceecccccccccccceeecccccccccccccccccccceEEcCC-cceEcccceeeecc-cccEE
Confidence             335666677777777666655544322211000       000011122233333321 12212233344433 45555


Q ss_pred             EccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceec
Q 043388          239 RIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ  318 (854)
Q Consensus       239 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  318 (854)
                      .+..+..+ +...+|.++++|+.+.+. +.++.+...+|.++.+|+.+.+..+ ++.+...+|.++++|+.+.+..+ ++
T Consensus       271 ~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~  346 (394)
T 4gt6_A          271 KMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT  346 (394)
T ss_dssp             ECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC
T ss_pred             ecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC
Confidence            55544333 555566666666666664 3455555566666666666666544 44455556666666666666543 44


Q ss_pred             ccCCCCCcCCCCCcccccCCCcc
Q 043388          319 GNIPSSLGNCQNLKGFDASHNKL  341 (854)
Q Consensus       319 ~~~~~~~~~l~~L~~L~ls~N~l  341 (854)
                      .+...+|.+|++|+.+++.+|..
T Consensus       347 ~I~~~aF~~C~~L~~i~~~~~~~  369 (394)
T 4gt6_A          347 KIPESAFSNCTALNNIEYSGSRS  369 (394)
T ss_dssp             BCCGGGGTTCTTCCEEEESSCHH
T ss_pred             EEhHhHhhCCCCCCEEEECCcee
Confidence            44455666666666666666543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.40  E-value=6.5e-15  Score=159.52  Aligned_cols=175  Identities=17%  Similarity=0.154  Sum_probs=90.1

Q ss_pred             CCCcEEecccccCcccChhhhcCC-----CCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccC
Q 043388           64 RNLVYLNVAENQFSGMFPRWICNI-----SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNL  138 (854)
Q Consensus        64 ~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l  138 (854)
                      +.|++|+|++|.|+......|...     ++|++|+|++|.|++.-...++..+++|++|+|++|.+.            
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~------------  139 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG------------  139 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC------------
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC------------
Confidence            556677777776664443333322     566777777776652222222233344444444444332            


Q ss_pred             CCCCCCCCCccc-cCCCCCCEEecCCCcCcccC----CcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEE
Q 043388          139 GMGTASSIPDSL-SNASNLERLDLSGNQFKGKV----SIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKAL  213 (854)
Q Consensus       139 ~~~~~~~~p~~~-~~l~~L~~L~Ls~N~i~~~~----~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L  213 (854)
                       ......+...+ ...++|++|+|++|+|+...    +..+...++|++|+|++|.|+.....  .+...+..+++|++|
T Consensus       140 -~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~--~L~~~L~~~~~L~~L  216 (372)
T 3un9_A          140 -PEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--LLAAQLDRNRQLQEL  216 (372)
T ss_dssp             -HHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH--HHHHHGGGCSCCCEE
T ss_pred             -HHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH--HHHHHHhcCCCcCeE
Confidence             11111122222 23566777777777665432    22335566677777777766532211  233455666677777


Q ss_pred             EcccCcCcccCChh----hhhhcccccEEEccCCcccccCCcccc
Q 043388          214 SLCDNQFGGELPHS----IANLSSTMIQFRIGGNQISGTIPSGIR  254 (854)
Q Consensus       214 ~L~~N~l~~~~p~~----~~~l~~~L~~L~l~~N~l~~~~~~~~~  254 (854)
                      +|++|.|+......    +...+ .|+.|+|++|.|+......+.
T Consensus       217 ~Ls~N~i~~~g~~~l~~~L~~~~-~L~~L~Ls~N~i~~~g~~~L~  260 (372)
T 3un9_A          217 NVAYNGAGDTAALALARAAREHP-SLELLHLYFNELSSEGRQVLR  260 (372)
T ss_dssp             ECCSSCCCHHHHHHHHHHHHHCS-SCCEEECTTSSCCHHHHHHHH
T ss_pred             ECCCCCCCHHHHHHHHHHHHhCC-CCCEEeccCCCCCHHHHHHHH
Confidence            77777776432222    22233 577777777777654444443

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.34  E-value=2.1e-14  Score=155.58  Aligned_cols=189  Identities=14%  Similarity=0.056  Sum_probs=124.2

Q ss_pred             CCCCEEecccccccccCCccccCc-----CCCCeeecccccccccCCcC-ccCCCCCcEEecccccCcccChhhhc----
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNL-----SALGMLLIRWNSLGGQIPTT-LGLLRNLVYLNVAENQFSGMFPRWIC----   85 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~----   85 (854)
                      ++|++|+|++|.|+......+...     ++|++|+|++|.|+...... ...+++|++|+|++|.|++.....++    
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            578999999999875544444333     68999999999987543333 34567899999999999865555553    


Q ss_pred             -CCCCCceeeecccccccccCcc----cccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEe
Q 043388           86 -NISSLEFIYLTVNRFSGSLPFD----ILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLD  160 (854)
Q Consensus        86 -~l~~L~~L~L~~N~l~~~~~~~----~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~  160 (854)
                       ..++|++|+|++|.|+ .....    .+..+++|++|+|++|.+.             ..++..++..+...++|++|+
T Consensus       152 ~~~~~L~~L~Ls~n~l~-~~~~~~l~~~L~~~~~L~~L~Ls~N~l~-------------~~g~~~L~~~L~~~~~L~~L~  217 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLT-AAGVAVLMEGLAGNTSVTHLSLLHTGLG-------------DEGLELLAAQLDRNRQLQELN  217 (372)
T ss_dssp             STTCCCCEEECCSSCCH-HHHHHHHHHHHHTCSSCCEEECTTSSCH-------------HHHHHHHHHHGGGCSCCCEEE
T ss_pred             hcCCccceeeCCCCCCC-hHHHHHHHHHHhcCCCcCEEeCCCCCCC-------------cHHHHHHHHHHhcCCCcCeEE
Confidence             4678999999999886 32211    2345566666666555543             323344567788889999999


Q ss_pred             cCCCcCcccCC----cCccccCCCCeEecccccccCCCCCChhhhhhccCCCC--CcEEE--cccCcCc
Q 043388          161 LSGNQFKGKVS----IDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSS--LKALS--LCDNQFG  221 (854)
Q Consensus       161 Ls~N~i~~~~~----~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~--L~~L~--L~~N~l~  221 (854)
                      |++|+|+....    ..+...++|++|+|++|.|+......   ...+.....  |+.+.  +..|.+.
T Consensus       218 Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~---L~~~~~~~~~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          218 VAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQV---LRDLGGAAEGGARVVVSLTEGTAVS  283 (372)
T ss_dssp             CCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHH---HHHCC------CEEECCCC----CH
T ss_pred             CCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHH---HHHHhcCCCccchhhHhhhcCCccC
Confidence            99999986543    34456789999999999987543321   112222232  77887  7777776

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.33  E-value=2.2e-12  Score=139.29  Aligned_cols=104  Identities=22%  Similarity=0.187  Sum_probs=93.9

Q ss_pred             CEEecccc-cccccCCccccCcCCCCeeeccc-ccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           19 QTLAIDFN-YLTGQLPDFVGNLSALGMLLIRW-NSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        19 ~~L~L~~n-~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      ..++++++ +|+ .+|. ++.+++|+.|+|++ |+|+++.+..|+.+++|++|+|++|+|+++.|.+|.++++|++|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            46799998 899 5888 99999999999996 99998888999999999999999999999999999999999999999


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCC
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLK  126 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~  126 (854)
                      +|+|+ .+|...|..++ |+.|+|.+|.+.
T Consensus        89 ~N~l~-~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           89 FNALE-SLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SSCCS-CCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CCccc-eeCHHHcccCC-ceEEEeeCCCcc
Confidence            99999 89988888776 888777777665

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.28  E-value=2.3e-10  Score=124.94  Aligned_cols=101  Identities=7%  Similarity=-0.056  Sum_probs=70.2

Q ss_pred             hhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCc
Q 043388           12 IGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLE   91 (854)
Q Consensus        12 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~   91 (854)
                      +....+|+.+.+.. .++.+...+|.++.+|+.+.|..+ ++.+-..+|.+. +|+.+.+..+ ++.+...+|.+. +|+
T Consensus        42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~  116 (379)
T 4h09_A           42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLD  116 (379)
T ss_dssp             GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCS
T ss_pred             cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Ccc
Confidence            55667888888864 466455668888889999988754 766777788876 6888877655 665677777764 788


Q ss_pred             eeeecccccccccCcccccCCCCCcEEEc
Q 043388           92 FIYLTVNRFSGSLPFDILVNLPNLKELYL  120 (854)
Q Consensus        92 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~l  120 (854)
                      .+.+..+ ++ .+...+|.+. +|+.+.+
T Consensus       117 ~i~lp~~-~~-~i~~~~F~~~-~l~~~~~  142 (379)
T 4h09_A          117 DFEFPGA-TT-EIGNYIFYNS-SVKRIVI  142 (379)
T ss_dssp             EEECCTT-CC-EECTTTTTTC-CCCEEEE
T ss_pred             cccCCCc-cc-cccccccccc-eeeeeec
Confidence            8888765 33 5666666654 3444443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.26  E-value=5.8e-12  Score=135.97  Aligned_cols=97  Identities=21%  Similarity=0.165  Sum_probs=90.0

Q ss_pred             CcccccCchhhhcCCCCCEEeccc-ccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC
Q 043388            2 NKLEGQIPEEIGSLLNLQTLAIDF-NYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF   80 (854)
Q Consensus         2 n~~~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   80 (854)
                      |+|+ .+|. |..+++|++|+|++ |.|++..+..|+.+++|+.|+|++|+|+++.|..|..+++|++|+|++|+|+++.
T Consensus        19 n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~   96 (347)
T 2ifg_A           19 GALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLS   96 (347)
T ss_dssp             CCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCC
T ss_pred             CCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeC
Confidence            3677 4888 99999999999996 9999877789999999999999999999999999999999999999999999888


Q ss_pred             hhhhcCCCCCceeeecccccc
Q 043388           81 PRWICNISSLEFIYLTVNRFS  101 (854)
Q Consensus        81 p~~~~~l~~L~~L~L~~N~l~  101 (854)
                      +..|..++ |++|+|++|.+.
T Consensus        97 ~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           97 WKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             STTTCSCC-CCEEECCSSCCC
T ss_pred             HHHcccCC-ceEEEeeCCCcc
Confidence            88888877 999999999997

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.26  E-value=1.9e-11  Score=126.18  Aligned_cols=147  Identities=17%  Similarity=0.146  Sum_probs=112.4

Q ss_pred             HHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCC
Q 043388          542 ELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSK  620 (854)
Q Consensus       542 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  620 (854)
                      .+......|++...++.|+.+.||++...  +..+++|+...........+.+|+++++.+. +..+.++++++...+  
T Consensus         8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~--   83 (263)
T 3tm0_A            8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG--   83 (263)
T ss_dssp             HHHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT--
T ss_pred             HHHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC--
Confidence            34566778988899999999999999754  5679999987532233356889999999994 677889998876543  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC------------------------
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC------------------------  676 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~------------------------  676 (854)
                         ..|+||||++|.++.+.+...           .+...++.+++++|+.||+..                        
T Consensus        84 ---~~~lv~e~i~G~~l~~~~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (263)
T 3tm0_A           84 ---WSNLLMSEADGVLCSEEYEDE-----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND  149 (263)
T ss_dssp             ---EEEEEEECCSSEEHHHHCCTT-----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred             ---ceEEEEEecCCeehhhccCCc-----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence               679999999999998763211           123468889999999999810                        


Q ss_pred             --------------------------------CCCeEeecCCCCceEecCCccc-cccccccc
Q 043388          677 --------------------------------QPPIVHGDLKPSNVLLDHDMVA-HQNFSLSH  706 (854)
Q Consensus       677 --------------------------------~~~ivH~Dlkp~NIll~~~~~~-~~Dfg~~~  706 (854)
                                                      .+.++|+|++|.||+++.+.+. +|||+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                            1359999999999999877654 66998653

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.16  E-value=1.4e-09  Score=118.77  Aligned_cols=310  Identities=11%  Similarity=0.092  Sum_probs=170.9

Q ss_pred             cccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCC
Q 043388           35 FVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPN  114 (854)
Q Consensus        35 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~  114 (854)
                      ++....+|+.+.+.. .++.+-..+|.++.+|+.++|..+ ++.+...+|.++ +|+.+.+..+ ++ .++..+|.+. +
T Consensus        41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~~~-~  114 (379)
T 4h09_A           41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQGT-D  114 (379)
T ss_dssp             TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTTTC-C
T ss_pred             ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-EeccceeccC-C
Confidence            355566788777764 466666778888888888888654 666777788776 6777777644 55 6777777654 6


Q ss_pred             CcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCC
Q 043388          115 LKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGT  194 (854)
Q Consensus       115 L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~  194 (854)
                      |+.+.+..+ +..+                 -...|.+ .+|+.+.+-.+ ++.+....|....+++.+.+..+......
T Consensus       115 L~~i~lp~~-~~~i-----------------~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~  174 (379)
T 4h09_A          115 LDDFEFPGA-TTEI-----------------GNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVA  174 (379)
T ss_dssp             CSEEECCTT-CCEE-----------------CTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEE
T ss_pred             cccccCCCc-cccc-----------------ccccccc-ceeeeeeccce-eeccccchhcccccccccccccccceeec
Confidence            776666432 1111                 0122333 35555555443 45566667777777777766655432211


Q ss_pred             CCCh------hhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccc
Q 043388          195 ANDL------DFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQ  268 (854)
Q Consensus       195 ~~~~------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~  268 (854)
                      ....      .....+..+.++.                         .+.+..+. .......+....+|+.+.+..+ 
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-  227 (379)
T 4h09_A          175 ENYVLYNKNKTILESYPAAKTGT-------------------------EFTIPSTV-KTVTAYGFSYGKNLKKITITSG-  227 (379)
T ss_dssp             ETTEEEETTSSEEEECCTTCCCS-------------------------EEECCTTC-CEECTTTTTTCSSCSEEECCTT-
T ss_pred             ccceecccccceecccccccccc-------------------------ccccccce-eEEeecccccccccceeeeccc-
Confidence            1100      0001112222222                         22222221 2234445555666666666443 


Q ss_pred             cccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchh
Q 043388          269 LHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQ  348 (854)
Q Consensus       269 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~  348 (854)
                      +..+...+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ +......+|.++.+|+.+.+.++.++ .++..
T Consensus       228 ~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~  304 (379)
T 4h09_A          228 VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPR  304 (379)
T ss_dssp             CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTT
T ss_pred             eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccc-eehhh
Confidence            33355556666666666666554 44455556666666666666543 44345556666666766666665554 22221


Q ss_pred             hcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchh
Q 043388          349 VLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEF  428 (854)
Q Consensus       349 ~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  428 (854)
                                              .|.+       |.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++..-..+
T Consensus       305 ------------------------aF~~-------c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~a  351 (379)
T 4h09_A          305 ------------------------VFMD-------CVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGA  351 (379)
T ss_dssp             ------------------------TTTT-------CTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred             ------------------------hhcC-------CCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhH
Confidence                                    1112       445666666543 55455567777777777777554 55444556


Q ss_pred             hcCcc
Q 043388          429 LQNLS  433 (854)
Q Consensus       429 ~~~l~  433 (854)
                      |.+++
T Consensus       352 F~~c~  356 (379)
T 4h09_A          352 FEGSS  356 (379)
T ss_dssp             TTTSS
T ss_pred             hhCCC
Confidence            66654

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.05  E-value=2.6e-10  Score=117.56  Aligned_cols=137  Identities=13%  Similarity=0.088  Sum_probs=97.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCC--eeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN--LIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~  624 (854)
                      ..+|.+....+.|..+.||++... +|..+++|+....   ....+.+|+.+++.+.+.+  +.+++++....+     .
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~-----~   89 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG-----R   89 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS-----C
T ss_pred             cCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC-----C
Confidence            345555444456667999999764 5677999987543   2345788999999996544  556888765433     5


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC----------------------------  676 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~----------------------------  676 (854)
                      .++||||++|.++.  ...         .+   ...++.++++.|+.||+..                            
T Consensus        90 ~~~v~e~i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (264)
T 1nd4_A           90 DWLLLGEVPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ  155 (264)
T ss_dssp             EEEEEECCSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred             CEEEEEecCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence            79999999998884  211         11   1256778888888888752                            


Q ss_pred             ---------------------------CCCeEeecCCCCceEecCCccc-cccccccc
Q 043388          677 ---------------------------QPPIVHGDLKPSNVLLDHDMVA-HQNFSLSH  706 (854)
Q Consensus       677 ---------------------------~~~ivH~Dlkp~NIll~~~~~~-~~Dfg~~~  706 (854)
                                                 ++.++|+|++|+||+++.+.+. ++||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                       1139999999999999887765 66998764

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.95  E-value=1.7e-10  Score=123.66  Aligned_cols=67  Identities=18%  Similarity=0.130  Sum_probs=29.8

Q ss_pred             CCCCCEEecCCCcCcccCCcCcc---ccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCc
Q 043388          153 ASNLERLDLSGNQFKGKVSIDFS---SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFG  221 (854)
Q Consensus       153 l~~L~~L~Ls~N~i~~~~~~~f~---~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  221 (854)
                      +++|++|+|++|++....+..+.   .+++|++|+|+.|.|+.....  .+...+..+++|+.|+|++|.++
T Consensus       251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~--~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGAR--LLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHH--HHHTTHHHHTTCSEEECCSBBCC
T ss_pred             CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHH--HHHhhcccCCcceEEECCCCcCC
Confidence            45666666666665532222221   345555555555555422111  11111233445555555555544

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.93  E-value=2.7e-10  Score=122.09  Aligned_cols=182  Identities=19%  Similarity=0.191  Sum_probs=117.2

Q ss_pred             chhhhcCCCCCEEeccccccc---------ccCCccccCcCCCCeeeccccc-ccccCCcCccCCCCCcEEecccccCcc
Q 043388            9 PEEIGSLLNLQTLAIDFNYLT---------GQLPDFVGNLSALGMLLIRWNS-LGGQIPTTLGLLRNLVYLNVAENQFSG   78 (854)
Q Consensus         9 p~~~~~l~~L~~L~L~~n~l~---------~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~   78 (854)
                      .+++..+++|+.|.+..+...         +.++..+..+++|+.|+|++|. +.  ++. +. +++|++|+|..|.++.
T Consensus       132 ~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~  207 (362)
T 2ra8_A          132 VENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPD  207 (362)
T ss_dssp             HTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCH
T ss_pred             HHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCCh
Confidence            445677889999999765431         1244456777899999999884 33  333 43 8999999999999875


Q ss_pred             cChhhhc--CCCCCceeeecc--cccccccCc----ccc--cCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCc
Q 043388           79 MFPRWIC--NISSLEFIYLTV--NRFSGSLPF----DIL--VNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPD  148 (854)
Q Consensus        79 ~~p~~~~--~l~~L~~L~L~~--N~l~~~~~~----~~~--~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~  148 (854)
                      .....+.  .+++|++|+|+.  |...+....    ..+  ..+|+|++|++..|.+..-                 .+.
T Consensus       208 ~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~-----------------~~~  270 (362)
T 2ra8_A          208 SVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNV-----------------VVE  270 (362)
T ss_dssp             HHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHH-----------------HHH
T ss_pred             HHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchH-----------------HHH
Confidence            5445555  789999999864  222111100    112  2356666666665554310                 111


Q ss_pred             cc---cCCCCCCEEecCCCcCcccC----CcCccccCCCCeEecccccccCCCCCChhhhhhccC-CCCCcEEEcccCc
Q 043388          149 SL---SNASNLERLDLSGNQFKGKV----SIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTN-CSSLKALSLCDNQ  219 (854)
Q Consensus       149 ~~---~~l~~L~~L~Ls~N~i~~~~----~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~-l~~L~~L~L~~N~  219 (854)
                      .+   ..+++|++|+|+.|+|....    +..+..+++|+.|+|++|.|+....      .++.. +  ...+++++|+
T Consensus       271 ~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~------~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMK------KELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHH------HHHHHHC--CSEEECCSBC
T ss_pred             HHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHH------HHHHHHc--CCEEEecCCc
Confidence            11   24789999999999998643    3344567999999999998864222      12222 2  4568999887

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.88  E-value=5e-10  Score=118.14  Aligned_cols=191  Identities=16%  Similarity=0.124  Sum_probs=121.3

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCC--eeeEEEEeeccCCCCCceeeEEE
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRN--LIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      .+.++.|....||++.     ..+++|+....  .....+.+|+++++.+ .+..  +.+++.+....+  .....|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~--~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE--TYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS--SCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC--CCCcceEEE
Confidence            4568899999999874     24888986432  2346788999999988 3332  455555443221  112458999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC---------------------------------  676 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~---------------------------------  676 (854)
                      |+++|.++.+....        .++..++..++.++++.++.||+..                                 
T Consensus        96 ~~i~G~~l~~~~~~--------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN--------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             ECCCCEECCHHHHH--------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cccCCeECCccccc--------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            99999888653321        4677778888999999999998611                                 


Q ss_pred             ----------------------CCCeEeecCCCCceEecC--Ccc-cccccccccccccCCCCCCccc-----------c
Q 043388          677 ----------------------QPPIVHGDLKPSNVLLDH--DMV-AHQNFSLSHQLDSASKTPSSSI-----------G  720 (854)
Q Consensus       677 ----------------------~~~ivH~Dlkp~NIll~~--~~~-~~~Dfg~~~~~~~~~~~~~~~~-----------~  720 (854)
                                            .+.++|+|++|.||+++.  +.. .++||+.+........-.....           .
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence                                  135899999999999988  443 4569998875433211000000           0


Q ss_pred             cCCcccccC-ccccCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 043388          721 IKGTVGYVA-PEYGMGSEASMTGDVYSFGILLLEMFTGRRPTD  762 (854)
Q Consensus       721 ~~gt~~y~a-PE~~~~~~~~~~sDv~slGvvl~elltg~~pf~  762 (854)
                      +....++.. |+....  .....+.|++|.++|.+.+|..+|.
T Consensus       248 ~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            000001111 221111  1223689999999999999988753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.85  E-value=4.6e-09  Score=113.61  Aligned_cols=144  Identities=15%  Similarity=0.180  Sum_probs=104.0

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEee--ccc-ccchHHHHHHHHHHHhcc--CCCeeeEEEEeeccCCCCCceeeE
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVIN--LKQ-KGAFRSFVAECEALRNIR--HRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      .+.++.|.++.||++...  +..+++|+..  ... ......+.+|+.+++.+.  +..+.++++++.+...  ....++
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSCEE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCeEE
Confidence            467899999999999875  3468888775  322 122356788999999996  4568899988865431  124689


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC-------------------------------  676 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~-------------------------------  676 (854)
                      ||||++|..+.+...        ..++..++..++.+++++|+.||+..                               
T Consensus       119 vme~v~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          119 IMEFVSGRVLWDQSL--------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             EEECCCCBCCCCTTC--------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             EEEecCCeecCCCcc--------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            999999977754211        14677888899999999999999731                               


Q ss_pred             ------------------------CCCeEeecCCCCceEecCCc---cccccccccccc
Q 043388          677 ------------------------QPPIVHGDLKPSNVLLDHDM---VAHQNFSLSHQL  708 (854)
Q Consensus       677 ------------------------~~~ivH~Dlkp~NIll~~~~---~~~~Dfg~~~~~  708 (854)
                                              .+.++|+|++|.||+++.++   +.++||+.+...
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                    24799999999999998764   245699988654

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.63  E-value=3.4e-09  Score=107.34  Aligned_cols=107  Identities=22%  Similarity=0.211  Sum_probs=77.4

Q ss_pred             hhcCCCCCE--Eeccccccc---ccCCccccCcCCCCeeecccccccc--cCCcCccCCCCCcEEecccccCcccChhhh
Q 043388           12 IGSLLNLQT--LAIDFNYLT---GQLPDFVGNLSALGMLLIRWNSLGG--QIPTTLGLLRNLVYLNVAENQFSGMFPRWI   84 (854)
Q Consensus        12 ~~~l~~L~~--L~L~~n~l~---~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~   84 (854)
                      |...+.|+.  ++++.|+..   +.++....++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            444455555  667777443   2222233567889999999999987  4557778899999999999999865  334


Q ss_pred             cCCC--CCceeeecccccccccCc------ccccCCCCCcEEEc
Q 043388           85 CNIS--SLEFIYLTVNRFSGSLPF------DILVNLPNLKELYL  120 (854)
Q Consensus        85 ~~l~--~L~~L~L~~N~l~~~~~~------~~~~~l~~L~~L~l  120 (854)
                      ..++  +|++|+|++|.+.+.+|.      .++..+|+|+.||-
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LDg  258 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDG  258 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEESS
T ss_pred             hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeECC
Confidence            4444  899999999999876663      35778888888773

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.48  E-value=1.3e-08  Score=98.27  Aligned_cols=72  Identities=21%  Similarity=0.290  Sum_probs=36.9

Q ss_pred             ccccCCCCCCEEecCCCcCcccC----CcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEc--ccCcCc
Q 043388          148 DSLSNASNLERLDLSGNQFKGKV----SIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSL--CDNQFG  221 (854)
Q Consensus       148 ~~~~~l~~L~~L~Ls~N~i~~~~----~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L--~~N~l~  221 (854)
                      ..+...++|++|+|++|+|....    ...+...++|++|+|++|.|+....  ..+..++...++|++|+|  ++|.|+
T Consensus        59 ~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~--~~l~~~L~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A           59 EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI--LALVEALQSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH--HHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH--HHHHHHHHhCCCceEEEecCCCCCCC
Confidence            44455566666666666665322    2223334556666666665543211  123344555556666666  556655

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.48  E-value=1.5e-08  Score=97.79  Aligned_cols=128  Identities=17%  Similarity=0.172  Sum_probs=89.5

Q ss_pred             cChhhhcCCCCCceeeeccc-ccccccC---cccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCC
Q 043388           79 MFPRWICNISSLEFIYLTVN-RFSGSLP---FDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNAS  154 (854)
Q Consensus        79 ~~p~~~~~l~~L~~L~L~~N-~l~~~~~---~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~  154 (854)
                      .+...+...++|++|+|++| .|...--   ...+...++|++             |+|++|.|+..++..+...+...+
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~-------------L~Ls~n~i~~~g~~~l~~~L~~n~   93 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKK-------------FSIVGTRSNDPVAFALAEMLKVNN   93 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCE-------------EECTTSCCCHHHHHHHHHHHHHCS
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCE-------------EECcCCCCChHHHHHHHHHHHhCC
Confidence            45567788999999999999 8862110   122333444554             455555554444445566777788


Q ss_pred             CCCEEecCCCcCccc----CCcCccccCCCCeEec--ccccccCCCCCChhhhhhccCCCCCcEEEcccCcCc
Q 043388          155 NLERLDLSGNQFKGK----VSIDFSSLKNLWWLNL--EQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFG  221 (854)
Q Consensus       155 ~L~~L~Ls~N~i~~~----~~~~f~~l~~L~~L~L--~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  221 (854)
                      +|++|+|++|+|...    ....+...++|++|+|  ++|.|+.....  .+...+...++|++|+|++|.+.
T Consensus        94 ~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~--~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           94 TLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM--EIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             SCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH--HHHHHHHHCSSCCEEECCCSSHH
T ss_pred             CcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHH--HHHHHHHhCCCcCEEeccCCCCC
Confidence            999999999999864    2456777889999999  88998743322  34556777889999999999886

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.42  E-value=8.6e-08  Score=97.08  Aligned_cols=86  Identities=17%  Similarity=0.140  Sum_probs=70.4

Q ss_pred             CchhhhcCCCCCEEecccccccc--cCCccccCcCCCCeeecccccccccCCcCccCCC--CCcEEecccccCcccCh--
Q 043388            8 IPEEIGSLLNLQTLAIDFNYLTG--QLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLR--NLVYLNVAENQFSGMFP--   81 (854)
Q Consensus         8 ~p~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p--   81 (854)
                      ++....++++|++|+|++|+|++  .+|..++.+++|+.|+|++|+|++.  ..+..++  +|++|+|++|.+++..|  
T Consensus       162 l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~  239 (267)
T 3rw6_A          162 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQ  239 (267)
T ss_dssp             HHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSH
T ss_pred             HHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcc
Confidence            33344678999999999999997  4567888999999999999999965  4455555  99999999999997655  


Q ss_pred             -----hhhcCCCCCceeee
Q 043388           82 -----RWICNISSLEFIYL   95 (854)
Q Consensus        82 -----~~~~~l~~L~~L~L   95 (854)
                           ..+..+++|+.||=
T Consensus       240 ~~y~~~il~~~P~L~~LDg  258 (267)
T 3rw6_A          240 STYISAIRERFPKLLRLDG  258 (267)
T ss_dssp             HHHHHHHHHHCTTCCEESS
T ss_pred             hhHHHHHHHHCcccCeECC
Confidence                 35788999998873

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.35  E-value=1.6e-06  Score=89.41  Aligned_cols=142  Identities=15%  Similarity=0.063  Sum_probs=98.5

Q ss_pred             HHhhccccCccCCCcce-EEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCc
Q 043388          546 ATSEFASSNMIGQGSFG-SVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       546 ~~~~~~~~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  623 (854)
                      ....|+. +.+..|..| .||+.....++..+++|+-...   ....+.+|+..++.+. +--|.++++++.+.+     
T Consensus        23 ~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~-----   93 (272)
T 4gkh_A           23 DLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD-----   93 (272)
T ss_dssp             HHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT-----
T ss_pred             cccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC-----
Confidence            3344443 234445554 6999888767778999987543   2356788999999884 334778888876654     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC---------------------------  676 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~---------------------------  676 (854)
                      ..++|||+++|.++.+......          .....++.+++..|+.||+..                           
T Consensus        94 ~~~lvme~l~G~~~~~~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (272)
T 4gkh_A           94 DAWLLTTAIPGKTAFQVLEEYP----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVD  163 (272)
T ss_dssp             EEEEEEECCCSEEHHHHHHHCG----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCC
T ss_pred             eEEEEEEeeCCccccccccCCH----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhh
Confidence            6799999999988877654321          123356667777777777531                           


Q ss_pred             ----------------------------CCCeEeecCCCCceEecCCccc-cccccccc
Q 043388          677 ----------------------------QPPIVHGDLKPSNVLLDHDMVA-HQNFSLSH  706 (854)
Q Consensus       677 ----------------------------~~~ivH~Dlkp~NIll~~~~~~-~~Dfg~~~  706 (854)
                                                  .+.++|+|+.+.||+++.+.+. +|||+.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          164 ASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             GGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                        1138999999999999988765 56998654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.29  E-value=2.3e-06  Score=89.76  Aligned_cols=135  Identities=15%  Similarity=0.130  Sum_probs=89.9

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCC---CeeeEEEEeeccCCCCCceeeEEEe
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR---NLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      +.++.|....||+.     +..+++|+..  .......+.+|+++++.+.+.   .|.+++.++....    ...++|||
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~----g~~~~v~e   93 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD----GNPFVGYR   93 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT----SCEEEEEE
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC----CceEEEEe
Confidence            45788888899998     3447888753  222346788999999999642   3667777664221    24689999


Q ss_pred             eccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 043388          631 YMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH-----------------------------------  675 (854)
Q Consensus       631 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~-----------------------------------  675 (854)
                      |++|.++.+....        .++..+...++.++++.|+.||+.                                   
T Consensus        94 ~i~G~~l~~~~~~--------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~  165 (306)
T 3tdw_A           94 KVQGQILGEDGMA--------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD  165 (306)
T ss_dssp             CCCSEECHHHHHT--------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred             ccCCeECchhhhh--------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence            9999888763211        233444455555555555555542                                   


Q ss_pred             ----------------------CCCCeEeecCCCCceEecC----Ccc-cccccccccc
Q 043388          676 ----------------------CQPPIVHGDLKPSNVLLDH----DMV-AHQNFSLSHQ  707 (854)
Q Consensus       676 ----------------------~~~~ivH~Dlkp~NIll~~----~~~-~~~Dfg~~~~  707 (854)
                                            .++.++|+|++|.||+++.    +.+ .++||+.+..
T Consensus       166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                  2335799999999999987    343 4569987643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.13  E-value=1.3e-05  Score=87.54  Aligned_cols=76  Identities=14%  Similarity=0.093  Sum_probs=50.0

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecccc-------cchHHHHHHHHHHHhccC--C-CeeeEEEEeeccCCCCC
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-------GAFRSFVAECEALRNIRH--R-NLIKIITICSSIDSKGA  622 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~  622 (854)
                      .+.+|.|..+.||++....+++.|+||.......       ...+++.+|.++++.+..  + .+.+++.+..  +    
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~--~----  108 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--E----  108 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--T----
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcC--C----
Confidence            4578999999999998765667899998653211       223567889999988842  3 4456665421  1    


Q ss_pred             ceeeEEEeeccCC
Q 043388          623 DFKALVFEYMENG  635 (854)
Q Consensus       623 ~~~~lv~e~~~~g  635 (854)
                       ..++||||+++.
T Consensus       109 -~~~lvmE~l~g~  120 (397)
T 2olc_A          109 -MAVTVMEDLSHL  120 (397)
T ss_dssp             -TTEEEECCCTTS
T ss_pred             -ccEEEEEeCCCc
Confidence             247999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.96  E-value=2.4e-05  Score=84.12  Aligned_cols=85  Identities=11%  Similarity=0.021  Sum_probs=57.1

Q ss_pred             cCcc-CCCcceEEEEeEEC--C----CceEEEEEEeeccc---ccchHHHHHHHHHHHhcc-C--CCeeeEEEEeeccCC
Q 043388          553 SNMI-GQGSFGSVYKGILG--G----EEMIVAVKVINLKQ---KGAFRSFVAECEALRNIR-H--RNLIKIITICSSIDS  619 (854)
Q Consensus       553 ~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~  619 (854)
                      .+.| +.|....+|+....  .    ++..+++|+.....   ......+.+|+.+++.+. +  -.+.++++++.+...
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998753  1    15678899875432   111245788999999884 3  357788887754321


Q ss_pred             CCCceeeEEEeeccCCCHHH
Q 043388          620 KGADFKALVFEYMENGSLED  639 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~  639 (854)
                        ....++||||++|.++.+
T Consensus       105 --~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 --LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             --TSSCEEEEECCCCBCCCB
T ss_pred             --cCCceEEEEecCCCChhh
Confidence              124589999999877653

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.85  E-value=3.2e-06  Score=79.16  Aligned_cols=84  Identities=10%  Similarity=0.003  Sum_probs=56.4

Q ss_pred             CCCCeeecccccccccCCcCccCCCCCcEEeccccc-CcccChhhhcCC----CCCceeeecccc-cccccCcccccCCC
Q 043388           40 SALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQ-FSGMFPRWICNI----SSLEFIYLTVNR-FSGSLPFDILVNLP  113 (854)
Q Consensus        40 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~~l~  113 (854)
                      -.|+.|||++|.|+..--..+..+++|++|+|++|. |++.--..++.+    ++|++|+|+++. |+ .---..+..++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT-D~Gl~~L~~~~  139 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT-DKGIIALHHFR  139 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC-HHHHHHGGGCT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC-HHHHHHHhcCC
Confidence            467788888887776555566777888888888874 665444555554    368888888864 65 22223356677


Q ss_pred             CCcEEEcccCC
Q 043388          114 NLKELYLTFCS  124 (854)
Q Consensus       114 ~L~~L~l~~n~  124 (854)
                      +|++|++++|.
T Consensus       140 ~L~~L~L~~c~  150 (176)
T 3e4g_A          140 NLKYLFLSDLP  150 (176)
T ss_dssp             TCCEEEEESCT
T ss_pred             CCCEEECCCCC
Confidence            88888887764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.83  E-value=3.2e-05  Score=80.34  Aligned_cols=79  Identities=16%  Similarity=0.122  Sum_probs=58.4

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-C--CCeeeEEEEeeccCCCCCcee
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-H--RNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +....+.+|.|..+.||+.+.. +|+.|++|+...........+.+|+..|+.+. .  --+.+++++.         ..
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~   85 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DR   85 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TT
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cc
Confidence            3445677899999999999987 78889999876554444456889999999884 2  2456666642         23


Q ss_pred             eEEEeeccCCCH
Q 043388          626 ALVFEYMENGSL  637 (854)
Q Consensus       626 ~lv~e~~~~gsL  637 (854)
                      ++||||++++..
T Consensus        86 ~lv~e~l~~~~~   97 (288)
T 3f7w_A           86 TLAMEWVDERPP   97 (288)
T ss_dssp             EEEEECCCCCCC
T ss_pred             eEEEEeecccCC
Confidence            789999987643

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.78  E-value=9.7e-06  Score=75.86  Aligned_cols=92  Identities=9%  Similarity=0.082  Sum_probs=71.9

Q ss_pred             CchhhhcCCCCCEEecccccccccCCccccCcCCCCeeeccccc-ccccCCcCccCC----CCCcEEeccccc-CcccCh
Q 043388            8 IPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNS-LGGQIPTTLGLL----RNLVYLNVAENQ-FSGMFP   81 (854)
Q Consensus         8 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~p   81 (854)
                      +|.....-.+|++|||+++.|+..--..+..+++|++|+|++|. |++.--..++.+    ++|++|+|++|. |++.--
T Consensus        53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl  132 (176)
T 3e4g_A           53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI  132 (176)
T ss_dssp             SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred             CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence            45433333579999999999987666778899999999999995 775444555554    479999999985 887666


Q ss_pred             hhhcCCCCCceeeecccc
Q 043388           82 RWICNISSLEFIYLTVNR   99 (854)
Q Consensus        82 ~~~~~l~~L~~L~L~~N~   99 (854)
                      ..+..+++|++|+|+++.
T Consensus       133 ~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          133 IALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             HHGGGCTTCCEEEEESCT
T ss_pred             HHHhcCCCCCEEECCCCC
Confidence            678889999999999885

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.72  E-value=6.7e-06  Score=78.51  Aligned_cols=40  Identities=13%  Similarity=0.226  Sum_probs=19.6

Q ss_pred             CceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCc
Q 043388          128 LWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFK  167 (854)
Q Consensus       128 L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~  167 (854)
                      |+.|+|++|.|+..++..+...+..-+.|++|+|++|+|.
T Consensus        72 L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           72 IEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             CCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             cCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence            3334444444444444444445555555555555555554

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.68  E-value=7.4e-06  Score=78.19  Aligned_cols=73  Identities=15%  Similarity=0.173  Sum_probs=44.0

Q ss_pred             CCCCccccCCCCCCEEecCCCcCcccCCcC----ccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccC
Q 043388          144 SSIPDSLSNASNLERLDLSGNQFKGKVSID----FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDN  218 (854)
Q Consensus       144 ~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~----f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N  218 (854)
                      ..+-..+..-+.|+.|+|++|+|.......    +..-+.|++|+|+.|.|+....  ..+..++..-+.|++|+|++|
T Consensus        60 ~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga--~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A           60 RSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL--ARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH--HHHHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH--HHHHHHHhhCCceeEEECCCC
Confidence            344456666677888888888877444333    3345667777777777753222  233445556666777777654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.62  E-value=0.00024  Score=73.99  Aligned_cols=75  Identities=17%  Similarity=0.115  Sum_probs=57.6

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc---CCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR---HRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      .+.|+.|....+|+....  +..+++|+....   ....+.+|++.|+.+.   ...+.++++++...+     ..++||
T Consensus        41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g-----~~~lvm  110 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG-----HSFLLL  110 (312)
T ss_dssp             EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS-----EEEEEE
T ss_pred             eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC-----ceEEEE
Confidence            356899999999999763  557888987643   2467889999999884   356888888875533     579999


Q ss_pred             eeccCCCH
Q 043388          630 EYMENGSL  637 (854)
Q Consensus       630 e~~~~gsL  637 (854)
                      ||+++..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99998764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.48  E-value=0.00044  Score=73.63  Aligned_cols=78  Identities=18%  Similarity=0.174  Sum_probs=42.1

Q ss_pred             CccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccC--CCeeeEEEEeeccC-CCCCceeeEEEe
Q 043388          554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH--RNLIKIITICSSID-SKGADFKALVFE  630 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~-~~~~~~~~lv~e  630 (854)
                      +.|+.|..+.||++... ++ .+++|+....    ......|..+++.+..  -.+.+++....... .......++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD-SG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEET-TE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeC-CC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34666778999999875 34 4889988642    2344566777766631  23344443110000 000125689999


Q ss_pred             eccCCCH
Q 043388          631 YMENGSL  637 (854)
Q Consensus       631 ~~~~gsL  637 (854)
                      |++|.++
T Consensus       112 ~i~G~~~  118 (346)
T 2q83_A          112 WIEGRPF  118 (346)
T ss_dssp             CCCCBCC
T ss_pred             eecCccC
Confidence            9998654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.35  E-value=0.00053  Score=75.24  Aligned_cols=80  Identities=13%  Similarity=0.087  Sum_probs=49.4

Q ss_pred             CCCeEeecCCCCceEecCCcccccccccccccccCCCCCCcccccCCcccccCccccCCC---CCCccchhHHHHHHHHH
Q 043388          677 QPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS---EASMTGDVYSFGILLLE  753 (854)
Q Consensus       677 ~~~ivH~Dlkp~NIll~~~~~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slGvvl~e  753 (854)
                      .+.++|+|++|.|||++.+...+|||+.+........-.....  .-...|.+|+.....   ......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~~~lID~e~a~~G~p~~Dla~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDSTQVIDPEFSFYGPMGFDIGAYLG--NLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSCEEECCCTTCEEECHHHHHHHHHH--HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCCCEEEeCcccccCchHHHHHHHHH--HHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            3489999999999999988877789998875543211000000  011346666655321   12234566788888888


Q ss_pred             HHhCC
Q 043388          754 MFTGR  758 (854)
Q Consensus       754 lltg~  758 (854)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87653

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.20  E-value=0.00045  Score=61.57  Aligned_cols=62  Identities=21%  Similarity=0.296  Sum_probs=50.1

Q ss_pred             ceeeccCcccc-cCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeeecccccCcccCCC
Q 043388          388 EYLDISSNSFH-GVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPT  451 (854)
Q Consensus       388 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  451 (854)
                      ..++.+++.++ ..+|..+.  ++|+.|+|++|+|+...++.|..+++|+.|+|++|+|.+..-.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l   73 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRL   73 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGG
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCcc
Confidence            47889999987 34554432  4699999999999988888899999999999999999886543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.15  E-value=0.0012  Score=68.76  Aligned_cols=71  Identities=10%  Similarity=0.094  Sum_probs=44.7

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCe-eeEEEEeeccCCCCCceeeEEEee
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL-IKIITICSSIDSKGADFKALVFEY  631 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  631 (854)
                      .+.|+.|....+|++      ..+++|+........ .+..+|+.+++.+....+ .++++++.+       ..++|+||
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~-------~~~~v~e~   88 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPA-------TGVMVTRY   88 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTT-------TCCEEEEC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECC-------CCEEEEee
Confidence            567888999999999      248889876432221 223578888887743222 466655322       23789999


Q ss_pred             c-cCCCH
Q 043388          632 M-ENGSL  637 (854)
Q Consensus       632 ~-~~gsL  637 (854)
                      + +|.++
T Consensus        89 i~~g~~l   95 (301)
T 3dxq_A           89 IAGAQTM   95 (301)
T ss_dssp             CTTCEEC
T ss_pred             cCCCccC
Confidence            9 65444

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.14  E-value=0.00058  Score=60.82  Aligned_cols=57  Identities=19%  Similarity=0.239  Sum_probs=40.2

Q ss_pred             eeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEeccccccc
Q 043388          130 WLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLG  191 (854)
Q Consensus       130 ~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  191 (854)
                      .++.+++.|+.   ..+|..+  -++|++|+|++|+|+.+.+..|..+++|++|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~---~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTW---ASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCT---TTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCcc---ccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            44555555510   1456543  346889999999999888888888888888888888763

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.12  E-value=0.00086  Score=70.62  Aligned_cols=166  Identities=13%  Similarity=0.103  Sum_probs=89.4

Q ss_pred             CcccHHHHHHHHhhccc-----cCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCC--ee
Q 043388          536 PMISYAELSKATSEFAS-----SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN--LI  608 (854)
Q Consensus       536 ~~~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv  608 (854)
                      ..++.+++......|..     .+.|+.|....+|+.... ++ .+++|+.....  ..+.+..|+.++..+....  +.
T Consensus         5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCC
Confidence            34566777777777765     235667888899999875 34 58899886521  2245667888888874322  33


Q ss_pred             eEEEEeeccCC--CCCceeeEEEeeccCCCHHH--------------HhhhcC-Ccccc-----cccCHHHHHH------
Q 043388          609 KIITICSSIDS--KGADFKALVFEYMENGSLED--------------WLHQSN-DHLEV-----CKLTLIQRVN------  660 (854)
Q Consensus       609 ~~~~~~~~~~~--~~~~~~~lv~e~~~~gsL~~--------------~l~~~~-~~~~~-----~~~~~~~~~~------  660 (854)
                      +++... +...  ......+++|+|++|..+..              .++... .....     ....|.....      
T Consensus        81 ~~~~~~-~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~  159 (322)
T 2ppq_A           81 LPLPRK-DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA  159 (322)
T ss_dssp             CBCCBT-TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred             cccCCC-CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHH
Confidence            333211 0000  00124689999999865321              011110 00000     0011222100      


Q ss_pred             ------HHHHHHHHHHHHHhc----CCCCeEeecCCCCceEecCCcc-ccccccccc
Q 043388          661 ------IAIDVASAIEYLHHH----CQPPIVHGDLKPSNVLLDHDMV-AHQNFSLSH  706 (854)
Q Consensus       661 ------i~~~ia~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~-~~~Dfg~~~  706 (854)
                            +...+...++++++.    .+.+++|+|+++.||+++.+.+ .+|||+.+.
T Consensus       160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                  111244556666532    2347999999999999998776 467998653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.96  E-value=0.0059  Score=64.30  Aligned_cols=97  Identities=11%  Similarity=0.065  Sum_probs=60.2

Q ss_pred             CCcccHHHHHHHHhhcccc-----CccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCC--Ce
Q 043388          535 FPMISYAELSKATSEFASS-----NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR--NL  607 (854)
Q Consensus       535 ~~~~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni  607 (854)
                      +...+.+.+....+.|...     ..++ |....||++... +|+.+++|+...... ....+..|..++..+...  .+
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~v   84 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPV   84 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSB
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCee
Confidence            4556777777777777542     2355 777899988765 455789999864321 235677899888888432  24


Q ss_pred             eeEEEEeeccCC--CCCceeeEEEeeccCCC
Q 043388          608 IKIITICSSIDS--KGADFKALVFEYMENGS  636 (854)
Q Consensus       608 v~~~~~~~~~~~--~~~~~~~lv~e~~~~gs  636 (854)
                      ++++..  +...  ......++||||++|.+
T Consensus        85 p~~~~~--~g~~~~~~~g~~~~l~~~i~G~~  113 (328)
T 1zyl_A           85 AAPVAF--NGQTLLNHQGFYFAVFPSVGGRQ  113 (328)
T ss_dssp             CCCCCB--TTBSCEEETTEEEEEEECCCCEE
T ss_pred             cceeec--CCcEEEEECCEEEEEEEecCCCC
Confidence            444433  1110  00124578999998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.85  E-value=0.007  Score=63.90  Aligned_cols=78  Identities=5%  Similarity=-0.045  Sum_probs=41.0

Q ss_pred             CccCCCcceE-EEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccC--CCeeeEEEEeeccCCCCCceeeEEEe
Q 043388          554 NMIGQGSFGS-VYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH--RNLIKIITICSSIDSKGADFKALVFE  630 (854)
Q Consensus       554 ~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e  630 (854)
                      +.|+.|.... +|+.... ++..+++|.......   ..+..|+.+++.+..  -.+.+++.+....       .++|||
T Consensus        24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~-------g~ll~e   92 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR-------GLLLIE   92 (333)
T ss_dssp             CC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT-------TEEEEC
T ss_pred             eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC-------CEEEEe
Confidence            4565565544 6677643 355677776543321   234567777777742  2356677653221       268999


Q ss_pred             eccCCCHHHHhh
Q 043388          631 YMENGSLEDWLH  642 (854)
Q Consensus       631 ~~~~gsL~~~l~  642 (854)
                      ++.+.++.+++.
T Consensus        93 ~l~~~~l~~~l~  104 (333)
T 3csv_A           93 DLGDALFTEVIN  104 (333)
T ss_dssp             CCCSCBHHHHHH
T ss_pred             eCCCcchHHHhc
Confidence            998777765543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.76  E-value=0.0031  Score=69.02  Aligned_cols=74  Identities=22%  Similarity=0.159  Sum_probs=50.5

Q ss_pred             cCccCCCcceEEEEeEECC-------CceEEEEEEeecccccchHHHHHHHHHHHhccCCC-eeeEEEEeeccCCCCCce
Q 043388          553 SNMIGQGSFGSVYKGILGG-------EEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN-LIKIITICSSIDSKGADF  624 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~  624 (854)
                      .+.|+.|....||++...+       ++..+++|+....  ...+.+.+|..+++.+...+ ..++++.+.  +      
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~------  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G------  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T------
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C------
Confidence            3567888899999998753       2467899988432  11255668999999884333 356776542  1      


Q ss_pred             eeEEEeeccCCCH
Q 043388          625 KALVFEYMENGSL  637 (854)
Q Consensus       625 ~~lv~e~~~~gsL  637 (854)
                       .+||||++|.++
T Consensus       148 -g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 -GRLEEYIPSRPL  159 (429)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -CEEEEEeCCccc
Confidence             389999987443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.69  E-value=0.0021  Score=69.03  Aligned_cols=75  Identities=12%  Similarity=0.148  Sum_probs=45.6

Q ss_pred             cCccCCCcceEEEEeEECCC--------ceEEEEEEeecccccchHHHHHHHHHHHhccCCC-eeeEEEEeeccCCCCCc
Q 043388          553 SNMIGQGSFGSVYKGILGGE--------EMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN-LIKIITICSSIDSKGAD  623 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~  623 (854)
                      .+.++.|....+|++...+.        +..+++|+....... ..+..+|.++++.+...+ +.++++..  .      
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~------  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N------  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T------
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C------
Confidence            35678888889999987631        267889987543221 123467888888885333 44666543  1      


Q ss_pred             eeeEEEeeccCCCH
Q 043388          624 FKALVFEYMENGSL  637 (854)
Q Consensus       624 ~~~lv~e~~~~gsL  637 (854)
                       -++||||++|.++
T Consensus       109 -~~~v~e~i~G~~l  121 (369)
T 3c5i_A          109 -GGRIEEWLYGDPL  121 (369)
T ss_dssp             -TEEEEECCCSEEC
T ss_pred             -CcEEEEEecCCcC
Confidence             2689999987543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.59  E-value=0.014  Score=55.76  Aligned_cols=102  Identities=19%  Similarity=0.159  Sum_probs=65.0

Q ss_pred             CHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcccccccccccccccCCCCC
Q 043388          636 SLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTP  715 (854)
Q Consensus       636 sL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~Dfg~~~~~~~~~~~~  715 (854)
                      ||.++|...+.     ++++++++.++.|.+.+|.-.-.... + ..+=+.|..|++..+|.+-..+..+.         
T Consensus        34 SL~eIL~~~~~-----PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~~~s~---------   97 (229)
T 2yle_A           34 SLEEILRLYNQ-----PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAPAADD---------   97 (229)
T ss_dssp             EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECCC------------
T ss_pred             cHHHHHHHcCC-----CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccccccc---------
Confidence            89999987754     89999999999999999877622111 1 12223468888888776654322111         


Q ss_pred             CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 043388          716 SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRP  760 (854)
Q Consensus       716 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p  760 (854)
                            .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                  1233466888764 3567888999999999999874444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.57  E-value=0.005  Score=65.84  Aligned_cols=142  Identities=13%  Similarity=0.131  Sum_probs=79.3

Q ss_pred             CccCCCcceEEEEeEECC-------CceEEEEEEeecccccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCcee
Q 043388          554 NMIGQGSFGSVYKGILGG-------EEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +.+..|-...+|++....       ++..|++|+.... ........+|.++++.+. +.-..++++++..         
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---------  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE---------  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---------
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---------
Confidence            457778888999998752       3467899986332 223456679999998884 3334567766531         


Q ss_pred             eEEEeeccCCCHHHH-----------------hhhcCCccccccc--CHHHHHHHHHHHHH-------------------
Q 043388          626 ALVFEYMENGSLEDW-----------------LHQSNDHLEVCKL--TLIQRVNIAIDVAS-------------------  667 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~-----------------l~~~~~~~~~~~~--~~~~~~~i~~~ia~-------------------  667 (854)
                      .+||||++|.++..-                 ++....... ...  -+.++.++..++..                   
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~-~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFT-KEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSC-CSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCC-CCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence            389999998655311                 011110000 011  23444444443321                   


Q ss_pred             HHHHHHh----c-CCCCeEeecCCCCceEecCC-----ccccccccccc
Q 043388          668 AIEYLHH----H-CQPPIVHGDLKPSNVLLDHD-----MVAHQNFSLSH  706 (854)
Q Consensus       668 ~L~~LH~----~-~~~~ivH~Dlkp~NIll~~~-----~~~~~Dfg~~~  706 (854)
                      .++.|.+    . .+..++|+|+.+.||+++.+     .+.+|||..+.
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2333322    1 23468999999999999876     45566987654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.56  E-value=0.0059  Score=67.12  Aligned_cols=75  Identities=15%  Similarity=0.105  Sum_probs=49.2

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCe-eeEEEEeeccCCCCCceeeEEEee
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL-IKIITICSSIDSKGADFKALVFEY  631 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  631 (854)
                      .+.|+.|-...+|++...+.+..+++|+........ -+..+|..+++.+...++ .++++++.  +       .+||||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~-------G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N-------GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T-------EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C-------eEEEEe
Confidence            356788888999999987445788899875432221 122589999999864444 56777652  1       359999


Q ss_pred             ccCCCH
Q 043388          632 MENGSL  637 (854)
Q Consensus       632 ~~~gsL  637 (854)
                      ++|.++
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.38  E-value=0.026  Score=59.57  Aligned_cols=73  Identities=11%  Similarity=0.113  Sum_probs=43.1

Q ss_pred             CCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccC---CCeeeEEEEeeccC-CCCCceeeEEEeec
Q 043388          557 GQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH---RNLIKIITICSSID-SKGADFKALVFEYM  632 (854)
Q Consensus       557 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~-~~~~~~~~lv~e~~  632 (854)
                      |.|....||+.... ++ .+++|+......      .+|+.++..+..   |.|++.+....... .......++||+|+
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i  103 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFI  103 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECC
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEecc
Confidence            34446799999865 45 799998765432      357777777632   22445443211100 00123578999999


Q ss_pred             cCCCH
Q 043388          633 ENGSL  637 (854)
Q Consensus       633 ~~gsL  637 (854)
                      +|..+
T Consensus       104 ~G~~~  108 (339)
T 3i1a_A          104 HAPNG  108 (339)
T ss_dssp             CCCBT
T ss_pred             CCCcC
Confidence            98765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.14  E-value=0.082  Score=57.23  Aligned_cols=75  Identities=13%  Similarity=0.134  Sum_probs=49.0

Q ss_pred             cCccCCCcceEEEEeEECCC-------ceEEEEEEeecccccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCce
Q 043388          553 SNMIGQGSFGSVYKGILGGE-------EMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .+.+..|-...+|+......       +..|++|+....... .-+..+|..+++.+. +.-..++++.+.         
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~---------  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP---------  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET---------
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC---------
Confidence            35567788889999988621       467899987543222 223467888888884 333456665431         


Q ss_pred             eeEEEeeccCCCH
Q 043388          625 KALVFEYMENGSL  637 (854)
Q Consensus       625 ~~lv~e~~~~gsL  637 (854)
                      -+.||||++|.++
T Consensus       145 ~~~I~efI~G~~l  157 (424)
T 3mes_A          145 EGRIEEFIDGEPL  157 (424)
T ss_dssp             TEEEEECCCSEEC
T ss_pred             CCEEEEEeCCccC
Confidence            2689999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.08  E-value=0.64  Score=50.05  Aligned_cols=28  Identities=25%  Similarity=0.350  Sum_probs=20.2

Q ss_pred             CeEeecCCCCceEecC------C-ccccccccccc
Q 043388          679 PIVHGDLKPSNVLLDH------D-MVAHQNFSLSH  706 (854)
Q Consensus       679 ~ivH~Dlkp~NIll~~------~-~~~~~Dfg~~~  706 (854)
                      .++|+|+.+.||++..      + .+.+|||..|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            3679999999999943      2 34456887654

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.03  E-value=0.15  Score=55.97  Aligned_cols=61  Identities=13%  Similarity=0.074  Sum_probs=17.8

Q ss_pred             ccCccCCCcceEEEEeEECCCceEEEE------EEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEee
Q 043388          552 SSNMIGQGSFGSVYKGILGGEEMIVAV------KVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICS  615 (854)
Q Consensus       552 ~~~~lg~G~~g~V~~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  615 (854)
                      ..+.+|   ||.||+|.+.....+||+      |..+..  .......+.+|..+++.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            356676   999999999765567888      665432  2233456888999999999999999888754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	854
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-57
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-49
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-48
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-47
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-45
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-45
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-45
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-43
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-43
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-43
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-42
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-40
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-38
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-35
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-34
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-34
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-31
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-30
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-25
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-20
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-07
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-06
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-06
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-05
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.004
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-14
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-11
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-16
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.004
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	5e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	5e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 7e-57
 Identities = 75/295 (25%), Positives = 126/295 (42%), Gaps = 47/295 (15%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
             IG GSFG+VYKG   G+   VAVK++N+        ++F  E   LR  RH N++  +
Sbjct: 14  QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
              ++         A+V ++ E  SL   LH         K  +I+ ++IA   A  ++Y
Sbjct: 71  GYSTA------PQLAIVTQWCEGSSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDY 119

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           LH      I+H DLK +N+ L  D+     +F L+      S +      + G++ ++AP
Sbjct: 120 LHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAP 175

Query: 731 EYGMGSEA---SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV 787
           E     +    S   DVY+FGI+L E+ TG+ P             +  +   +++I +V
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-------------YSNINNRDQIIFMV 222

Query: 788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL 842
                         +  D      +C  A+ R    C  +   ER     ++A +
Sbjct: 223 ----------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (448), Expect = 3e-50
 Identities = 80/321 (24%), Positives = 145/321 (45%), Gaps = 58/321 (18%)

Query: 539 SYAELSKATSEFASS---------NMIGQGSFGSVYKGIL---GGEEMIVAVKVINLKQ- 585
           ++ + ++A  EFA            +IG G FG V  G L   G  E+ VA+K +     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 586 KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN 645
           +   R F++E   +    H N+I +  + +      +    ++ E+MENGSL+ +L Q++
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122

Query: 646 DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSL 704
                 + T+IQ V +   +A+ ++YL        VH DL   N+L++ ++V    +F L
Sbjct: 123 -----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174

Query: 705 SHQL--DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPT 761
           S  L  D++  T +S++G K  + + APE     + +   DV+S+GI++ E+ + G RP 
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP- 233

Query: 762 DAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTG 821
                       +  MT  + VI  ++              Q+ R     DC +A+ +  
Sbjct: 234 ------------YWDMT-NQDVINAIE--------------QDYRLPPPMDCPSALHQLM 266

Query: 822 VLCSMESPFERMEMRDVVAKL 842
           + C  +    R +   +V  L
Sbjct: 267 LDCWQKDRNHRPKFGQIVNTL 287

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 2e-49
 Identities = 66/300 (22%), Positives = 124/300 (41%), Gaps = 31/300 (10%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+G FG V++G   GEE  VAVK+ + +++ ++    AE      +RH N++  I   +
Sbjct: 11  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
             +        LV +Y E+GSL D+L++         +T+   + +A+  AS + +LH  
Sbjct: 68  KDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHME 119

Query: 676 C-----QPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPS-SSIGIKGTVGYV 728
                 +P I H DLK  N+L+  +      +  L+ + DSA+ T   +     GT  Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 729 APEYGMGSEASMTG------DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK 782
           APE    S            D+Y+ G++  E+                   +  +   + 
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ---LPYYDLVPSDP 236

Query: 783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL 842
            +E +   +  + +  N       R ++ + L  + +    C   +   R+    +   L
Sbjct: 237 SVEEMRKVVCEQKLRPNI----PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 5e-49
 Identities = 66/304 (21%), Positives = 119/304 (39%), Gaps = 23/304 (7%)

Query: 543 LSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS-FVAECEALRN 601
           +     +F   + +G G+ G V+K       +++A K+I+L+ K A R+  + E + L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
                ++       S         ++  E+M+ GSL+  L ++       ++       +
Sbjct: 61  CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKAG------RIPEQILGKV 109

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIG 720
           +I V   + YL       I+H D+KPSN+L++        +F +S QL  +         
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-----S 162

Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP 780
             GT  Y++PE   G+  S+  D++S G+ L+EM  GR P      + L L    ++   
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV--- 219

Query: 781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA 840
           E       P         +S   + R       L           + S    +E +D V 
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279

Query: 841 KLCH 844
           K   
Sbjct: 280 KCLI 283

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 5e-48
 Identities = 78/257 (30%), Positives = 117/257 (45%), Gaps = 30/257 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+G FG V  G   G +  VAVK I  K     ++F+AE   +  +RH NL++++ +  
Sbjct: 15  IGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 69

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
            ++ KG  +  +V EYM  GSL D+L      +    L     +  ++DV  A+EYL  +
Sbjct: 70  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 122

Query: 676 CQPPIVHGDLKPSNVLLDHDMVA-HQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                VH DL   NVL+  D VA   +F L+ +  S   T       K  V + APE   
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------GKLPVKWTAPEALR 173

Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD--PSLL 792
             + S   DV+SFGILL E+++  R         + L + V        ++  D  P  +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 229

Query: 793 MEVMANNSMIQEDRRAR 809
            EVM   +    D   R
Sbjct: 230 YEVM--KNCWHLDAAMR 244

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-47
 Identities = 56/261 (21%), Positives = 105/261 (40%), Gaps = 28/261 (10%)

Query: 556 IGQGSFGSVYKGIL--GGEEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G G+FGSV +G+     +++ VA+KV+    +K      + E + +  + +  ++++I 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           +C +          LV E    G L  +L    + +      +     +   V+  ++YL
Sbjct: 77  VCQAEA------LMLVMEMAGGGPLHKFLVGKREEI-----PVSNVAELLHQVSMGMKYL 125

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
                   VH DL   NVLL +   A   +F LS  L +     ++    K  + + APE
Sbjct: 126 EEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182

Query: 732 YGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD-- 788
                + S   DV+S+G+ + E  + G++P        +   E +      K +E     
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-----KMKGPEVMAFIEQGKRMECPPEC 237

Query: 789 PSLLMEVMANNSMIQEDRRAR 809
           P  L  +M+           R
Sbjct: 238 PPELYALMS--DCWIYKWEDR 256

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-47
 Identities = 60/258 (23%), Positives = 110/258 (42%), Gaps = 21/258 (8%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG+GSF +VYKG+     + VA   +  ++  K   + F  E E L+ ++H N+++    
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
             S   KG     LV E M +G+L+ +L +         + +    +    +   +++LH
Sbjct: 77  WES-TVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLH 129

Query: 674 HHCQPPIVHGDLKPSNVLLDHDM--VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
               PPI+H DLK  N+ +      V   +  L+    ++         + GT  ++APE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-----AVIGTPEFMAPE 183

Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL 791
                +   + DVY+FG+ +LEM T   P                   P    ++  P  
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE- 241

Query: 792 LMEVMANNSMIQEDRRAR 809
           + E++     I++++  R
Sbjct: 242 VKEII--EGCIRQNKDER 257

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 2e-47
 Identities = 65/305 (21%), Positives = 122/305 (40%), Gaps = 45/305 (14%)

Query: 553 SNMIGQGSFGSVYKGIL---GGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 608
           + +IG+G FG VY G L    G+++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++ IC  + S+G+    +V  YM++G L +++     +  V        +   + VA  
Sbjct: 92  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKG 142

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQL-DSASKTPSSSIGIKGTVG 726
              +        VH DL   N +LD        +F L+  + D    +  +  G K  V 
Sbjct: 143 ---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI 786
           ++A E     + +   DV+SFG+LL E+ T   P        +   +             
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVY--------- 246

Query: 787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR 846
                         ++Q  R  + + C + +    + C       R    ++V+++    
Sbjct: 247 --------------LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

Query: 847 ETFLG 851
            TF+G
Sbjct: 293 STFIG 297

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 2e-47
 Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 45/288 (15%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G FG V+ G   G    VAVK +  +   +  +F+AE   ++ ++H+ L+++  + +
Sbjct: 21  LGAGQFGEVWMGYYNGHT-KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   ++ EYMENGSL D+L   +      KLT+ + +++A  +A  + ++   
Sbjct: 79  Q------EPIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEER 128

Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                +H DL+ +N+L+   +     +F L+  ++    T     G K  + + APE   
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAIN 183

Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLME 794
               ++  DV+SFGILL E+ T  R      T                           E
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------------------------PE 218

Query: 795 VMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL 842
           V+ N  + +  R  R  +C   + +   LC  E P +R     + + L
Sbjct: 219 VIQN--LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-45
 Identities = 61/296 (20%), Positives = 109/296 (36%), Gaps = 47/296 (15%)

Query: 554 NMIGQGSFGSVYKGILGGEEM--IVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIK 609
             +G G+FG+V KG    +++   VAVK++  +          +AE   ++ + +  +++
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +I IC +      +   LV E  E G L  +L Q+        +     + +   V+  +
Sbjct: 73  MIGICEA------ESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGM 120

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           +YL        VH DL   NVLL     A   +F LS  L +      +    K  V + 
Sbjct: 121 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD 788
           APE     + S   DV+SFG+L+ E F+  +                      +V  +++
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------------GSEVTAMLE 224

Query: 789 PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH 844
               M   A             ++  + +      C       R     V  +L +
Sbjct: 225 KGERMGCPAGCP----------REMYDLMNL----CWTYDVENRPGFAAVELRLRN 266

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  163 bits (413), Expect = 1e-45
 Identities = 63/305 (20%), Positives = 127/305 (41%), Gaps = 43/305 (14%)

Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEA 598
           +Y +     ++    + +G G +G VY+G+     + VAVK +  +       F+ E   
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 66

Query: 599 LRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQR 658
           ++ I+H NL++++ +C+           ++ E+M  G+L D+L + N      +++ +  
Sbjct: 67  MKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNRQ----EVSAVVL 117

Query: 659 VNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSS 717
           + +A  ++SA+EYL        +H DL   N L+  + +    +F LS  +   + T  +
Sbjct: 118 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--A 172

Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM 777
             G K  + + APE    ++ S+  DV++FG+LL E+ T                     
Sbjct: 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------PYPG 219

Query: 778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRD 837
               +V E+++    ME              R + C   +      C   +P +R    +
Sbjct: 220 IDLSQVYELLEKDYRME--------------RPEGCPEKVYELMRACWQWNPSDRPSFAE 265

Query: 838 VVAKL 842
           +    
Sbjct: 266 IHQAF 270

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 2e-45
 Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 45/290 (15%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
             +GQG FG V+ G   G    VA+K +      +  +F+ E + ++ +RH  L+++  +
Sbjct: 23  VKLGQGCFGEVWMGTWNGTT-RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            S       +   +V EYM  GSL D+L               Q V++A  +AS + Y+ 
Sbjct: 81  VSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVE 130

Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
                  VH DL+ +N+L+  ++V    +F L+  ++    T     G K  + + APE 
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFPIKWTAPEA 185

Query: 733 GMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLL 792
            +    ++  DV+SFGILL E+ T  R                      +V++ V+    
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------------NREVLDQVERGYR 232

Query: 793 MEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL 842
           M                 +   + + +    C  + P ER     + A L
Sbjct: 233 MPCPPECP----------ESLHDLMCQ----CWRKEPEERPTFEYLQAFL 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-45
 Identities = 68/301 (22%), Positives = 127/301 (42%), Gaps = 46/301 (15%)

Query: 548 SEFASSNMIGQGSFGSVYKGIL----GGEEMIVAVKVINLKQKGAFR-SFVAECEALRNI 602
           S      +IG G FG VYKG+L    G +E+ VA+K +        R  F+ E   +   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            H N+I++  + S           ++ EYMENG+L+ +L + +        +++Q V + 
Sbjct: 67  SHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREKDGEF-----SVLQLVGML 116

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGI 721
             +A+ +    +      VH DL   N+L++ ++V    +F LS  L+   +   ++ G 
Sbjct: 117 RGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE 781
           K  + + APE     + +   DV+SFGI++ E+ T         +               
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------NH 220

Query: 782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK 841
           +V++ ++    +                  DC +AI +  + C  +    R +  D+V+ 
Sbjct: 221 EVMKAINDGFRLP--------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 266

Query: 842 L 842
           L
Sbjct: 267 L 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 3e-45
 Identities = 55/261 (21%), Positives = 95/261 (36%), Gaps = 22/261 (8%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG GS+G   K     +  I+  K ++     +   +  V+E   LR ++H N+++    
Sbjct: 12  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
                 +      +V EY E G L   + +     E   L     + +   +  A++  H
Sbjct: 72  IID---RTNTTLYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECH 126

Query: 674 HH--CQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
                   ++H DLKP+NV LD        +F L+  L+  +    +     GT  Y++P
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA---FVGTPYYMSP 183

Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD-- 788
           E       +   D++S G LL E+     P         +  E        K   I    
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKIREGKFRRIPYRY 238

Query: 789 PSLLMEVMANNSMIQEDRRAR 809
              L E++    M+      R
Sbjct: 239 SDELNEII--TRMLNLKDYHR 257

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 4e-44
 Identities = 57/257 (22%), Positives = 101/257 (39%), Gaps = 21/257 (8%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITIC 614
           +G+G++G V   +    E  VAVK++++K+      +   E    + + H N++K     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
                   + + L  EY   G L D +           +           + + + YLH 
Sbjct: 73  RE-----GNIQYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG 121

Query: 675 HCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                I H D+KP N+LLD        +F L+      ++    +  + GT+ YVAPE  
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN-KMCGTLPYVAPELL 177

Query: 734 MGSE-ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLL 792
              E  +   DV+S GI+L  M  G  P D          ++ +        + +D + L
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237

Query: 793 MEVMANNSMIQEDRRAR 809
             +     ++ E+  AR
Sbjct: 238 ALLH---KILVENPSAR 251

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 6e-44
 Identities = 59/265 (22%), Positives = 107/265 (40%), Gaps = 24/265 (9%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
             IGQG+ G+VY  +       VA++ +NL+Q+      + E   +R  ++ N++  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
                    D   +V EY+  GSL D + ++            Q   +  +   A+E+LH
Sbjct: 86  YLV-----GDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLH 133

Query: 674 HHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
            +    ++H D+K  N+LL  D  V   +F    Q+       S+   + GT  ++APE 
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPEV 187

Query: 733 GMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLL 792
                     D++S GI+ +EM  G  P          L+       PE        ++ 
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTPELQNPEKLSAIF 246

Query: 793 MEVMANNSMIQED--RRARTQDCLN 815
            + +  N  +  D  +R   ++ L 
Sbjct: 247 RDFL--NRCLDMDVEKRGSAKELLQ 269

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 1e-43
 Identities = 59/270 (21%), Positives = 104/270 (38%), Gaps = 31/270 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+FG VYK       ++ A KVI+ K +     ++ E + L +  H N++K++    
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   ++ E+   G+++  + +         LT  Q   +      A+ YLH +
Sbjct: 80  Y-----ENNLWILIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN 129

Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
               I+H DLK  N+L   D      +F +S +     +   S     GT  ++APE  M
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS---FIGTPYWMAPEVVM 183

Query: 735 GSEASMTG-----DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDP 789
              +         DV+S GI L+EM     P        L     +      +   +  P
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-----ELNPMRVLLKIAKSEPPTLAQP 238

Query: 790 SLLMEVMAN--NSMIQEDRRAR--TQDCLN 815
           S       +     ++++  AR  T   L 
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 1e-43
 Identities = 63/265 (23%), Positives = 107/265 (40%), Gaps = 26/265 (9%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 607
           SE      IG G FG V+ G    ++  VA+K I  +   +   F+ E E +  + H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVAS 667
           +++  +C            LVFE+ME+G L D+L       +         + + +DV  
Sbjct: 63  VQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRT-----QRGLFAAETLLGMCLDVCE 112

Query: 668 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVG 726
               + +  +  ++H DL   N L+  + V    +F ++  +     T S   G K  V 
Sbjct: 113 G---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS--TGTKFPVK 167

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI 786
           + +PE    S  S   DV+SFG+L+ E+F+  +       E  +  E V+         +
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI----PYENRSNSEVVEDIS--TGFRL 221

Query: 787 VDPSLLMEVMAN--NSMIQEDRRAR 809
             P L    +    N   +E    R
Sbjct: 222 YKPRLASTHVYQIMNHCWKERPEDR 246

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 1e-43
 Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 45/288 (15%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G FG V  G   G+   VA+K+I  +   +   F+ E + + N+ H  L+++  +C+
Sbjct: 12  LGTGQFGVVKYGKWRGQY-DVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                      ++ EYM NG L ++L +        +    Q + +  DV  A+EYL   
Sbjct: 70  K-----QRPIFIITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGM 734
                +H DL   N L++   V    +F LS  +     T  SS+G K  V +  PE  M
Sbjct: 120 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLM 174

Query: 735 GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLME 794
            S+ S   D+++FG+L+ E+++  +     FT               +  E +   L + 
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------------NSETAEHIAQGLRLY 221

Query: 795 VMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKL 842
                         R       +      C  E   ER   + +++ +
Sbjct: 222 --------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 2e-43
 Identities = 71/323 (21%), Positives = 125/323 (38%), Gaps = 61/323 (18%)

Query: 535 FPMISYAELSKATSEFASSNMIGQGSFGSVYKGIL--GGEEMIVAVKVIN-LKQKGAFRS 591
           +P++ +       ++    ++IG+G+FG V K  +   G  M  A+K +     K   R 
Sbjct: 4   YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 592 FVAECEALRNI-RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSN----- 645
           F  E E L  +  H N+I ++  C     +   +  L  EY  +G+L D+L +S      
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111

Query: 646 -----DHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH- 699
                 +     L+  Q ++ A DVA     + +  Q   +H DL   N+L+  + VA  
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKI 168

Query: 700 QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRR 759
            +F LS   +   K        +  V ++A E    S  +   DV+S+G+LL E+ +   
Sbjct: 169 ADFGLSRGQEVYVKKTMG----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224

Query: 760 PTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITR 819
                   G+T  E  +                        + Q  R  +  +C + +  
Sbjct: 225 T----PYCGMTCAELYEK-----------------------LPQGYRLEKPLNCDDEVYD 257

Query: 820 TGVLCSMESPFERMEMRDVVAKL 842
               C  E P+ER     ++  L
Sbjct: 258 LMRQCWREKPYERPSFAQILVSL 280

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 3e-43
 Identities = 61/280 (21%), Positives = 108/280 (38%), Gaps = 37/280 (13%)

Query: 555 MIGQGSFGSVYKGIL-----GGEEMIVAVKVINLKQKGAFR-SFVAECEALRNI-RHRNL 607
           ++G G+FG V           G  + VAVK++  K   + R + ++E + +  +  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL-----------------EV 650
           + ++  C+      +    L+FEY   G L ++L    +                   ++
Sbjct: 104 VNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158

Query: 651 CKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLD 709
             LT    +  A  VA  +E+L        VH DL   NVL+ H  V    +F L+  + 
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 710 SASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGL 769
           S S         +  V ++APE       ++  DV+S+GILL E+F+             
Sbjct: 216 SDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 770 TLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRAR 809
             ++ ++               +  +M   S    D R R
Sbjct: 275 NFYKLIQNGFKMDQPFYATEE-IYIIM--QSCWAFDSRKR 311

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 5e-43
 Identities = 66/261 (25%), Positives = 93/261 (35%), Gaps = 24/261 (9%)

Query: 556 IGQGSFGSVYKGIL---GGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 609
           +G GSFG V +G      G+ + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +  +          +V E    GSL D L +   H       L      A+ VA  +
Sbjct: 76  LYGVVLT------PPMKMVTELAPLGSLLDRLRKHQGHF-----LLGTLSRYAVQVAEGM 124

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYV 728
            YL        +H DL   N+LL    +    +F L   L             K    + 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVD 788
           APE       S   D + FG+ L EMFT  +           LH+  K        E   
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241

Query: 789 PSLLMEVMANNSMIQEDRRAR 809
             +   VM            R
Sbjct: 242 QDIY-NVMV--QCWAHKPEDR 259

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (393), Expect = 9e-43
 Identities = 64/329 (19%), Positives = 120/329 (36%), Gaps = 61/329 (18%)

Query: 539 SYAELSKATSEFASSNMIGQGSFGSVYKGILGGEE-----MIVAVKVINLKQKGAFRS-F 592
               L    +       IG+G+FG V++    G        +VAVK++  +     ++ F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 593 VAECEALRNIRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVC- 651
             E   +    + N++K++ +C+           L+FEYM  G L ++L   + H     
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 652 -----------------KLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH 694
                             L+  +++ IA  VA+ + YL        VH DL   N L+  
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175

Query: 695 DMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLE 753
           +MV    +F LS  + SA    +        + ++ PE    +  +   DV+++G++L E
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADG-NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234

Query: 754 MFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDC 813
           +F+                 +  M   E +  + D                +  A  ++C
Sbjct: 235 IFSYGLQP------------YYGMAHEEVIYYVRDG---------------NILACPENC 267

Query: 814 LNAITRTGVLCSMESPFERMEMRDVVAKL 842
              +     LC  + P +R     +   L
Sbjct: 268 PLELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-42
 Identities = 59/259 (22%), Positives = 108/259 (41%), Gaps = 31/259 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G+G FG+VY       + I+A+KV+    L++ G       E E   ++RH N++++  
Sbjct: 14  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
                    A    L+ EY   G++   L + +      K    +      ++A+A+ Y 
Sbjct: 74  YFHD-----ATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYC 122

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H      ++H D+KP N+LL         +F  S    S     S    + GT+ Y+ PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTTLCGTLDYLPPE 174

Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA-FTEGLTLHEFVKMTLPEKVIEIVDPS 790
              G       D++S G+L  E   G+ P +A  + E       V+ T P+ V       
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV-----TE 229

Query: 791 LLMEVMANNSMIQEDRRAR 809
              +++  + +++ +   R
Sbjct: 230 GARDLI--SRLLKHNPSQR 246

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 3e-42
 Identities = 52/273 (19%), Positives = 97/273 (35%), Gaps = 30/273 (10%)

Query: 556 IGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAECEALRNI-RHRNLI 608
           +G G+FG V +    G       M VAVK++        R + ++E + L  +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHL------------EVCKLTLI 656
            ++  C+           ++ EY   G L ++L +  D              +   L L 
Sbjct: 91  NLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS 716
             ++ +  VA  + +L        +H DL   N+LL H  +         +         
Sbjct: 146 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK 776
                +  V ++APE       +   DV+S+GI L E+F+               ++ +K
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

Query: 777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRAR 809
                   E     +  ++M   +    D   R
Sbjct: 263 EGFRMLSPEHAPAEMY-DIM--KTCWDADPLKR 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  154 bits (390), Expect = 9e-42
 Identities = 46/258 (17%), Positives = 91/258 (35%), Gaps = 24/258 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+FG V++          A K +    +    +   E + +  +RH  L+ +     
Sbjct: 34  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                  +   +++E+M  G L + +   ++     K++  + V     V   + ++H +
Sbjct: 94  D-----DNEMVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH---QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
                VH DLKP N++            +F L+  LD             GT  + APE 
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV----TTGTAEFAAPEV 196

Query: 733 GMGSEASMTGDVYSFGILLLEMFTGRRP-TDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL 791
             G       D++S G+L   + +G  P       E L   +     + +     +    
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256

Query: 792 LMEVMANNSMIQEDRRAR 809
              +     ++  D   R
Sbjct: 257 KDFIR---KLLLADPNTR 271

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  151 bits (383), Expect = 9e-42
 Identities = 50/263 (19%), Positives = 101/263 (38%), Gaps = 16/263 (6%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 611
           ++G G    V+          VAVKV+     +    +  F  E +    + H  ++ + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
               +    G     +V EY++  +L D +H          +T  + + +  D   A+ +
Sbjct: 74  DTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNF 126

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H +    I+H D+KP+N+++         +F ++  +  +  + + +  + GT  Y++P
Sbjct: 127 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 731 EYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPS 790
           E   G       DVYS G +L E+ TG  P        +      +  +P         +
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243

Query: 791 LLMEVMANNSMIQEDRRARTQDC 813
            L  V+     + ++   R Q  
Sbjct: 244 DLDAVV--LKALAKNPENRYQTA 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (386), Expect = 1e-41
 Identities = 54/267 (20%), Positives = 94/267 (35%), Gaps = 32/267 (11%)

Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRN 606
           F+    IG GSFG+VY         +VA+K ++   K     ++  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
            I+                 LV EY    + +              L  ++   +     
Sbjct: 77  TIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGAL 125

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTV 725
             + YLH H    ++H D+K  N+LL    +    +F  +  +  A+          GT 
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-------FVGTP 175

Query: 726 GYVAPEYGMGS---EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK 782
            ++APE  +     +     DV+S GI  +E+   + P          L+   +   P  
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPAL 234

Query: 783 VIEIVDPSLLMEVMANNSMIQEDRRAR 809
                       V    S +Q+  + R
Sbjct: 235 QSGHWSEYFRNFVD---SCLQKIPQDR 258

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-41
 Identities = 54/305 (17%), Positives = 116/305 (38%), Gaps = 45/305 (14%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKGAFR-SFVAECEALRN 601
            +   S  +GQGSFG VY+G+  G      E  VA+K +N       R  F+ E   ++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLE----VCKLTLIQ 657
               ++++++ + S           ++ E M  G L+ +L      +     +   +L +
Sbjct: 80  FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSS 717
            + +A ++A  + YL+ +     VH DL   N ++  D           +    +     
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191

Query: 718 SIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM 777
                  V +++PE       +   DV+SFG++L E+ T          +GL+  + ++ 
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSNEQVLRF 247

Query: 778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRD 837
            +   +++  D                       +C + +     +C   +P  R    +
Sbjct: 248 VMEGGLLDKPD-----------------------NCPDMLFELMRMCWQYNPKMRPSFLE 284

Query: 838 VVAKL 842
           +++ +
Sbjct: 285 IISSI 289

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  151 bits (382), Expect = 1e-40
 Identities = 48/258 (18%), Positives = 94/258 (36%), Gaps = 24/258 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G+FG V++ +      +   K IN        +   E   +  + H  LI +     
Sbjct: 37  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                      L+ E++  G L D +   +      K++  + +N        ++++H H
Sbjct: 97  D-----KYEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH 146

Query: 676 CQPPIVHGDLKPSNVLLDHDMVAH---QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
               IVH D+KP N++ +    +     +F L+ +L+              T  + APE 
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV----TTATAEFAAPEI 199

Query: 733 GMGSEASMTGDVYSFGILLLEMFTGRRP-TDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL 791
                     D+++ G+L   + +G  P       E L   +       E     V P  
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259

Query: 792 LMEVMANNSMIQEDRRAR 809
              +    +++Q++ R R
Sbjct: 260 KDFIK---NLLQKEPRKR 274

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 1e-40
 Identities = 58/301 (19%), Positives = 120/301 (39%), Gaps = 48/301 (15%)

Query: 548 SEFASSNMIGQGSFGSVYKGILGGE----EMIVAVKVINL-KQKGAFRSFVAECEALRNI 602
           +EF    ++G G+FG+VYKG+   E    ++ VA+K +       A +  + E   + ++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
            + ++ +++ IC +          L+ + M  G L D++ +  D++          +N  
Sbjct: 69  DNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNI-----GSQYLLNWC 117

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGI 721
           + +A  + YL       +VH DL   NVL+         +F L+  L +  K   +  G 
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GG 173

Query: 722 KGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE 781
           K  + ++A E  +    +   DV+S+G+ + E+ T          +G+   E   +    
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIPASEISSI---- 225

Query: 782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK 841
                              + + +R  +   C   +    V C M     R + R+++ +
Sbjct: 226 -------------------LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

Query: 842 L 842
            
Sbjct: 267 F 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-40
 Identities = 55/245 (22%), Positives = 99/245 (40%), Gaps = 22/245 (8%)

Query: 545 KATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRN 601
           K   +F    ++G+GSF +V            A+K++    + ++        E + +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 602 IRHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNI 661
           + H   +K+            +       Y +NG L  ++ +                  
Sbjct: 65  LDHPFFVKLYFTFQD-----DEKLYFGLSYAKNGELLKYIRKIG------SFDETCTRFY 113

Query: 662 AIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQNFSLSHQLDSASKTPSSSIG 720
             ++ SA+EYLH      I+H DLKP N+LL+ DM +   +F  +  L   SK   ++  
Sbjct: 114 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN-S 169

Query: 721 IKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM--T 778
             GT  YV+PE      A  + D+++ G ++ ++  G  P  A   E L   + +K+   
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYD 228

Query: 779 LPEKV 783
            PEK 
Sbjct: 229 FPEKF 233

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-39
 Identities = 52/260 (20%), Positives = 94/260 (36%), Gaps = 25/260 (9%)

Query: 555 MIGQGSFGSVYKGIL---GGEEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 610
            IG+G FG V++GI        + VA+K        + R  F+ E   +R   H +++K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           I + +       +   ++ E    G L  +L           L L   +  A  +++A  
Sbjct: 74  IGVITE------NPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTA-- 120

Query: 671 YLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
            L +      VH D+   NVL+  +D V   +F LS  ++ ++   +S       + ++A
Sbjct: 121 -LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK--LPIKWMA 177

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDP 789
           PE       +   DV+ FG+ + E+                +                 P
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--P 235

Query: 790 SLLMEVMANNSMIQEDRRAR 809
             L  +M        D   R
Sbjct: 236 PTLYSLMT--KCWAYDPSRR 253

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-38
 Identities = 60/306 (19%), Positives = 109/306 (35%), Gaps = 54/306 (17%)

Query: 556 IGQGSFGSVYKGIL-------GGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRN 606
           +G+G+FG V                  VAVK++     +      ++E E ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ----------SNDHLEVCKLTLI 656
           +I ++  C+           ++ EY   G+L ++L            +  H    +L+  
Sbjct: 81  IINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135

Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS 716
             V+ A  VA     + +      +H DL   NVL+  D V         +         
Sbjct: 136 DLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK 776
            +   +  V ++APE       +   DV+SFG+LL E+FT           G+ + E  K
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPGVPVEELFK 248

Query: 777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR 836
           +                       + +  R  +  +C N +      C    P +R   +
Sbjct: 249 L-----------------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 285

Query: 837 DVVAKL 842
            +V  L
Sbjct: 286 QLVEDL 291

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (352), Expect = 2e-37
 Identities = 51/273 (18%), Positives = 99/273 (36%), Gaps = 27/273 (9%)

Query: 554 NMIGQGSFGSVYKGILGGEEM-----IVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNL 607
             +G+G+FG V +    G +       VAVK++         R+ ++E + L +I H   
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 608 IKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCK----------LTLIQ 657
           +  +    +          ++ E+ + G+L  +L    +     K          LTL  
Sbjct: 79  VVNLLGACTKPG---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 658 RVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPS 716
            +  +  VA  +E+L        +H DL   N+LL    V    +F L+  +        
Sbjct: 136 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYV 191

Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK 776
                +  + ++APE       ++  DV+SFG+LL E+F+                  +K
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRAR 809
                +  +   P +   ++        +   R
Sbjct: 252 EGTRMRAPDYTTPEMYQTML---DCWHGEPSQR 281

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 3e-36
 Identities = 48/258 (18%), Positives = 99/258 (38%), Gaps = 25/258 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G+G FG V++ +    +     K + +K          E   L   RHRN++ +     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESFE 71

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
           S      +   ++FE++    + + ++ S       +L   + V+    V  A+++LH H
Sbjct: 72  S-----MEELVMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH 121

Query: 676 CQPPIVHGDLKPSNVLLDHDMVAHQ---NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
               I H D++P N++      +      F  + QL            +     Y APE 
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL----LFTAPEYYAPEV 174

Query: 733 GMGSEASMTGDVYSFGILLLEMFTGRRP-TDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL 791
                 S   D++S G L+  + +G  P       + +      + T  E+  + +    
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234

Query: 792 LMEVMANNSMIQEDRRAR 809
           +  V     ++ ++R++R
Sbjct: 235 MDFVD---RLLVKERKSR 249

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  137 bits (345), Expect = 3e-36
 Identities = 61/270 (22%), Positives = 100/270 (37%), Gaps = 29/270 (10%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIIT 612
           +++G G+F  V        + +VA+K I  K  +G   S   E   L  I+H N++ +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           I  S          L+ + +  G L D + +          T      +   V  A++YL
Sbjct: 75  IYES-----GGHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYL 123

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDM----VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           H      IVH DLKP N+L         +   +F LS   D  S   +      GT GYV
Sbjct: 124 HDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST----ACGTPGYV 176

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGRRP-TDAAFTEGLTLHEFVKMTLPEKVIEIV 787
           APE       S   D +S G++   +  G  P  D    +        +        + +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236

Query: 788 DPSLLMEVMANNSMIQED--RRARTQDCLN 815
             S    +     ++++D  +R   +  L 
Sbjct: 237 SDSAKDFIR---HLMEKDPEKRFTCEQALQ 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  138 bits (348), Expect = 4e-36
 Identities = 56/271 (20%), Positives = 103/271 (38%), Gaps = 34/271 (12%)

Query: 549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK------QKGAFRSFVAECEALRNI 602
           +F+   +IG+G FG VY         + A+K ++ K       +    +       +   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 603 RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIA 662
               ++ +     +      D  + + + M  G L   L Q     E            A
Sbjct: 65  DCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQHGVFSE------ADMRFYA 113

Query: 663 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGI 721
            ++   +E++H+     +V+ DLKP+N+LLD H  V   +  L+                
Sbjct: 114 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-----KKKPHAS 165

Query: 722 KGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP 780
            GT GY+APE      A   + D +S G +L ++  G  P     T+     + + +T+ 
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225

Query: 781 EKVIEIVDPSL--LMEVMANNSMIQEDRRAR 809
            ++ +   P L  L+E      ++Q D   R
Sbjct: 226 VELPDSFSPELRSLLE-----GLLQRDVNRR 251

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 4e-36
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 18/215 (8%)

Query: 550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 609
           +  + +IG GSFG VY+  L     +VA+K +   ++   R    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77

Query: 610 IITIC-SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
           +     SS + K   +  LV +Y+         H S        L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ--NFSLSHQLDSASKTPSSSIGIKGTVG 726
           + Y+H      I H D+KP N+LLD D    +  +F  + QL       S       +  
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC----SRY 187

Query: 727 YVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRP 760
           Y APE   G+   + + DV+S G +L E+  G+  
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (339), Expect = 1e-35
 Identities = 58/267 (21%), Positives = 97/267 (36%), Gaps = 29/267 (10%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 614
            IG GSFG +Y G        VA+K+  +K K        E +  + ++    I  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
            +      D+  +V E +     + +   S       K +L   + +A  + S IEY+H 
Sbjct: 72  GAEG----DYNVMVMELLGPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHS 121

Query: 675 HCQPPIVHGDLKPSNVLLDHD----MVAHQNFSLSHQLDSASKT----PSSSIGIKGTVG 726
                 +H D+KP N L+       +V   +F L+ +   A          +  + GT  
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 727 YVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFT----EGLTLHEFVKMTLPEK 782
           Y +    +G E S   D+ S G +L+    G  P          +        KM+ P +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238

Query: 783 VIEIVDPSLLMEVMANNSMIQEDRRAR 809
           V+    PS     +  N         +
Sbjct: 239 VLCKGYPSEFATYL--NFCRSLRFDDK 263

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  133 bits (336), Expect = 2e-35
 Identities = 66/274 (24%), Positives = 108/274 (39%), Gaps = 39/274 (14%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAF---------RSFVAECEALRNIR- 603
            ++G+G    V + I        AVK+I++   G+F          + + E + LR +  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
           H N+I++     +       F  LVF+ M+ G L D+L +         L+  +   I  
Sbjct: 69  HPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMR 117

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIK 722
            +   I  LH      IVH DLKP N+LLD DM     +F  S QLD   K       + 
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE----VC 170

Query: 723 GTVGYVAPEYGMGSEASMTG------DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK 776
           GT  Y+APE    S            D++S G+++  +  G  P      + L L   + 
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMS 229

Query: 777 MTLPEKVIEIVD-PSLLMEVMANNSMIQEDRRAR 809
                   E  D    + +++  +  +    + R
Sbjct: 230 GNYQFGSPEWDDYSDTVKDLV--SRFLVVQPQKR 261

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 3e-35
 Identities = 46/266 (17%), Positives = 101/266 (37%), Gaps = 18/266 (6%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEAL-RNIRHRNLIKIITI 613
           ++G G  G V +      +   A+K++    K        E E   R  +  ++++I+ +
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
             ++ +       +V E ++ G L   +    D       T  +   I   +  AI+YLH
Sbjct: 74  YENLYAGRKCL-LIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLH 128

Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYG 733
                 I H D+KP N+L                    + + +S      T  YVAPE  
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185

Query: 734 MGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLM 793
              +   + D++S G+++  +  G  P  +     ++     ++ + +      + S + 
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245

Query: 794 EVMAN--NSMIQED--RRARTQDCLN 815
           E +     ++++ +  +R    + +N
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  133 bits (335), Expect = 8e-35
 Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 24/209 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           +G GSFG V+           A+KV+    + +         E   L  + H  +I++  
Sbjct: 12  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
                    A    ++ +Y+E G L   L +S              V            L
Sbjct: 72  TFQD-----AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV---------CLAL 117

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
            +     I++ DLKP N+LLD +      +F  +  +   + T      + GT  Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT------LCGTPDYIAPE 171

Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
                  + + D +SFGIL+ EM  G  P
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 9e-35
 Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 22/212 (10%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEAL-RNIRHRNLIK 609
            M+G+GSFG V+           A+K +    +         + E   L     H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +     +      +    V EY+  G L   +   +      K  L +    A ++   +
Sbjct: 68  MFCTFQT-----KENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGL 116

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYV 728
           ++LH      IV+ DLK  N+LLD D      +F +  +        ++     GT  Y+
Sbjct: 117 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT---FCGTPDYI 170

Query: 729 APEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           APE  +G + + + D +SFG+LL EM  G+ P
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-34
 Identities = 58/311 (18%), Positives = 122/311 (39%), Gaps = 28/311 (9%)

Query: 543 LSKATSEFASSNMIGQGSFGSVYKGI-LGGEEMIVAVKVINLK--QKGAFRSFVAECEAL 599
           L +A  ++     IG+G++G V+K   L      VA+K + ++  ++G   S + E   L
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 600 RNI---RHRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLI 656
           R++    H N++++  +C+   +       LVFE+++                   +   
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTE 116

Query: 657 QRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPS 716
              ++   +   +++LH H    +VH DLKP N+L+              ++ S     +
Sbjct: 117 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 173

Query: 717 SSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK 776
           S +    T+ Y APE  + S  +   D++S G +  EMF  +     + ++   L + + 
Sbjct: 174 SVVV---TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILD 229

Query: 777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRART---QDCLNAITRTGVLCSMESPFERM 833
           +       +      L     ++   Q   +  T   +   + + +    C   +P +R+
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK----CLTFNPAKRI 285

Query: 834 EMRDVVAKLCH 844
                   L H
Sbjct: 286 SAYSA---LSH 293

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-34
 Identities = 49/210 (23%), Positives = 83/210 (39%), Gaps = 14/210 (6%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLIKIIT 612
           + IG+G++G V        ++ VA+K I+  + +   +  + E + L   RH N+I I  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 613 ICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
           I  +   +      LV   M               L+   L+          +   ++Y+
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLY--------KLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H      ++H DLKPSN+LL+        +F L+   D              T  Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 732 YGMGSEASMT-GDVYSFGILLLEMFTGRRP 760
             + S+      D++S G +L EM + R  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 4e-34
 Identities = 55/274 (20%), Positives = 101/274 (36%), Gaps = 35/274 (12%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS------FVAECEALRNIRHRNLIK 609
           +G G F  V K       +  A K I  ++  + R          E   L+ I+H N+I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 610 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAI 669
           +  +  +          L+ E +  G L D+L +     E      ++++         +
Sbjct: 78  LHEVYEN-----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI---------L 123

Query: 670 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQN-----FSLSHQLDSASKTPSSSIGIKGT 724
             +++     I H DLKP N++L    V         F L+H++D  ++  +    I GT
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGT 179

Query: 725 VGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAA-FTEGLTLHEFVKMTLPEKV 783
             +VAPE        +  D++S G++   + +G  P       E L     V     ++ 
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239

Query: 784 IEIVDPSLLMEVMANNSMIQED--RRARTQDCLN 815
                      +     ++ +D  +R   QD L 
Sbjct: 240 FSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 1e-33
 Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 24/214 (11%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLI 608
           + +G+G F +VYK        IVA+K I L      + G  R+ + E + L+ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
            ++              +LVF++ME          S                  +     
Sbjct: 64  GLLDAFGH-----KSNISLVFDFMETDLEVIIKDNSLVLTPS------HIKAYMLMTLQG 112

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVA-HQNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +EYLH H    I+H DLKP+N+LLD + V    +F L+    S ++  +  +    T  Y
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV---VTRWY 166

Query: 728 VAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRP 760
            APE   G+    +  D+++ G +L E+      
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-31
 Identities = 62/294 (21%), Positives = 121/294 (41%), Gaps = 20/294 (6%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITI 613
           IGQG+FG V+K         VA+K + ++  ++G   + + E + L+ ++H N++ +I I
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 614 CSSIDSKGADFKA---LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           C +  S     K    LVF++ E+       +         K TL +   +   + +   
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNG-- 129

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSI-GIKGTVGYV 728
            L++  +  I+H D+K +NVL+  D V    +F L+     A  +  +       T+ Y 
Sbjct: 130 -LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 729 APEYGMGSEA-SMTGDVYSFGILLLEMFTGRRP-TDAAFTEGLTLHEFVKMTLPEKVIEI 786
            PE  +G        D++  G ++ EM+T             L L   +  ++  +V   
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSM--ESPFERMEMRDV 838
           VD   L E +      +   + R +  +       ++  +    P +R++  D 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  121 bits (303), Expect = 7e-31
 Identities = 35/217 (16%), Positives = 68/217 (31%), Gaps = 25/217 (11%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           IG+GSFG +++G        VA+K    +          E    + +     I  +    
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 616 SIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHH 675
                      LV + +     +             K ++      A  + + ++ +H  
Sbjct: 71  QEG----LHNVLVIDLLGPSLEDLLDLCGR------KFSVKTVAMAAKQMLARVQSIHEK 120

Query: 676 CQPPIVHGDLKPSNVLLDHDMVAHQN------FSLSHQLD----SASKTPSSSIGIKGTV 725
               +V+ D+KP N L+      + N      F +                    + GT 
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 726 GYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTD 762
            Y++    +G E S   D+ + G + +    G  P  
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 2e-30
 Identities = 50/211 (23%), Positives = 80/211 (37%), Gaps = 21/211 (9%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKI 610
            ++G+G+FG V            A+K++    +  K      V E   L+N RH  L  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 611 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
                +      D    V EY   G L   L +          T  +      ++ SA  
Sbjct: 71  KYAFQT-----HDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSA-- 117

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVA 729
            L +     +V+ D+K  N++LD D      +F L  +  S   T        GT  Y+A
Sbjct: 118 -LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 173

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE    ++     D +  G+++ EM  GR P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 2e-30
 Identities = 49/266 (18%), Positives = 88/266 (33%), Gaps = 41/266 (15%)

Query: 555 MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRS------FVAECEALRNIR--HRN 606
           ++G G FGSVY GI   + + VA+K +   +   +           E   L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 607 LIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVA 666
           +I+++           D   L+ E  E                   L      +    V 
Sbjct: 71  VIRLLDWFER-----PDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVL 120

Query: 667 SAIEYLHHHCQPPIVHGDLKPSNVLLDHD--MVAHQNFSLSHQLDSASKTPSSSIGIKGT 724
            A+ + H+     ++H D+K  N+L+D +   +   +F     L     T        GT
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-----FDGT 172

Query: 725 VGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV 783
             Y  PE+         +  V+S GILL +M  G  P +    E +    F +  +  + 
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-EEIIRGQVFFRQRVSSEC 231

Query: 784 IEIVDPSLLMEVMANNSMIQEDRRAR 809
             ++              +      R
Sbjct: 232 QHLI-----------RWCLALRPSDR 246

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 2e-30
 Identities = 51/228 (22%), Positives = 94/228 (41%), Gaps = 26/228 (11%)

Query: 542 ELSKATSEFASS----NMIGQGSFGSVYKGILGGEEMIVAVKVIN--LKQKGAFRSFVAE 595
           E++K   E  +       +G G++G+V   + G     VA+K +    + +   +    E
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67

Query: 596 CEALRNIRHRNLIKIITICSSIDSKGADFK-ALVFEYMENGSLEDWLHQSNDHLEVCKLT 654
              L+++RH N+I ++ + +  ++        LV  +M  G+    L +        KL 
Sbjct: 68  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE------KLG 119

Query: 655 LIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA-HQNFSLSHQLDSASK 713
             +   +   +   + Y+H        H DLKP N+ ++ D      +F L+ Q DS   
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176

Query: 714 TPSSSIGIKGTVGYVAPEYGMGSE-ASMTGDVYSFGILLLEMFTGRRP 760
                     T  Y APE  +     + T D++S G ++ EM TG+  
Sbjct: 177 GY------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (303), Expect = 2e-30
 Identities = 51/253 (20%), Positives = 95/253 (37%), Gaps = 28/253 (11%)

Query: 516 ARRRRSAHKSVDTSPAKKQFPMISYAELSKATS----EFASSNMIGQGSFGSVYKGILGG 571
           A ++ S  +SV    AK +   +   E     +    +F     +G GSFG V       
Sbjct: 5   AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64

Query: 572 EEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALV 628
                A+K+++   + +       + E   L+ +    L+K+                +V
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SNLYMV 119

Query: 629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPS 688
            EY+  G +   L +        + +       A  +    EYLH      +++ DLKP 
Sbjct: 120 MEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170

Query: 689 NVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSF 747
           N+L+D        +F  + ++   + T      + GT   +APE  +    +   D ++ 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWT------LCGTPEALAPEIILSKGYNKAVDWWAL 224

Query: 748 GILLLEMFTGRRP 760
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  120 bits (301), Expect = 3e-30
 Identities = 53/271 (19%), Positives = 105/271 (38%), Gaps = 26/271 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITIC 614
           +G+G +  V++ I       V VK++   +K   +    E + L N+R   N+I +  I 
Sbjct: 43  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 99

Query: 615 SSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH 674
               S+     ALVFE++ N   +              LT         ++  A++Y H 
Sbjct: 100 KDPVSR---TPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHS 147

Query: 675 HCQPPIVHGDLKPSNVLLDHD--MVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
                I+H D+KP NV++DH+   +   ++ L+       +          +  +  PE 
Sbjct: 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPEL 200

Query: 733 GMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSL 791
            +  +    + D++S G +L  M   + P          L    K+   E + + +D   
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 792 LMEVMANNSMIQEDRRARTQDCLNAITRTGV 822
           +      N ++    R R +  +++  +  V
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLV 291

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 6e-30
 Identities = 52/293 (17%), Positives = 105/293 (35%), Gaps = 23/293 (7%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG+G++G+V+K        IVA+K + L    +G   S + E   L+ ++H+N++++  +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
             S          LVFE+ +    + +   + D       + + ++         ++ L 
Sbjct: 70  LHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL---------LKGLG 115

Query: 674 HHCQPPIVHGDLKPSNVLLDHDMVA-HQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
                 ++H DLKP N+L++ +      NF L+       +    S  +           
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVL 173

Query: 733 GMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLL 792
                 S + D++S G +  E+    RP          L    ++       +    + L
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 793 MEVMANNSMIQEDRRARTQDCLNAITRTGVL-CSMESPFERMEMRDVVAKLCH 844
            +                   LNA  R  +      +P +R+   +    L H
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA---LQH 283

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-29
 Identities = 47/211 (22%), Positives = 88/211 (41%), Gaps = 20/211 (9%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
             IG+G++G VYK        +VA+K I L    +G   + + E   L+ + H N++K++
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +  +      +   LVFE++     +     +        + L    +    +   + +
Sbjct: 68  DVIHT-----ENKLYLVFEFLHQDLKKFMDASAL-----TGIPLPLIKSYLFQLLQGLAF 117

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
            H H    ++H DLKP N+L++ +      +F L+       +T +  +     + Y AP
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT---LWYRAP 171

Query: 731 E-YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           E        S   D++S G +  EM T R  
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (291), Expect = 9e-29
 Identities = 44/211 (20%), Positives = 80/211 (37%), Gaps = 9/211 (4%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 615
           +G G F +V+          VA+K++    K    +   E + L+ +   +  K  ++ +
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 616 S-----IDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIE 670
           +     +D         V   M    L + L       E   + LI    I+  +   ++
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 671 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLS-HQLDSASKTPSSSIGIKGTVGYVA 729
           Y+H  C   I+H D+KP NVL++          +    L +A            T  Y +
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 730 PEYGMGSEASMTGDVYSFGILLLEMFTGRRP 760
           PE  +G+      D++S   L+ E+ TG   
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 4e-28
 Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 20/209 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN--LKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           +G G++GSV         + VAVK ++   +     +    E   L++++H N+I ++ +
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85

Query: 614 CSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLH 673
            +   S        +  ++    L + +          KLT      +   +   ++Y+H
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIH 138

Query: 674 HHCQPPIVHGDLKPSNVLLD-HDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEY 732
                   H DLKPSN+ ++    +   +F L+   D              T  Y APE 
Sbjct: 139 SADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEI 189

Query: 733 GMGSE-ASMTGDVYSFGILLLEMFTGRRP 760
            +     + T D++S G ++ E+ TGR  
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  110 bits (276), Expect = 2e-27
 Identities = 55/300 (18%), Positives = 114/300 (38%), Gaps = 35/300 (11%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 611
             IG+G++G VYK      E   A+K I L++  +G   + + E   L+ ++H N++K+ 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEY 671
            +  +          LVFE+++    +           V              +   +  
Sbjct: 67  DVIHT-----KKRLVLVFEHLDQDLKKLLDVCEGGLESVT---------AKSFLLQLLNG 112

Query: 672 LHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGYVAP 730
           + +     ++H DLKP N+L++ +      +F L+       +  +  I     + Y AP
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT---LWYRAP 169

Query: 731 EYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEIVDP 789
           +  MGS+  S T D++S G +  EM  G        +E   L    ++          + 
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV-SEADQLMRIFRILGTPNSKNWPNV 228

Query: 790 SLLMEVMANNSMIQEDRRAR-----TQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCH 844
           + L +   N ++ +            +  ++ +++         P +R+  +     L H
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK----MLKLDPNQRITAKQA---LEH 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 8e-27
 Identities = 50/264 (18%), Positives = 100/264 (37%), Gaps = 27/264 (10%)

Query: 556 IGQGSFGSVYKGILGGEE---MIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLI 608
           +G G++G V+            + A+KV+     +++         E + L +IR    +
Sbjct: 32  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91

Query: 609 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASA 668
             +      +        L+ +Y+  G L   L Q     E           + I V   
Sbjct: 92  VTLHYAFQTE----TKLHLILDYINGGELFTHLSQRERFTEHE---------VQIYVGEI 138

Query: 669 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-QNFSLSHQLDSASKTPSSSIGIKGTVGY 727
           +  L H  +  I++ D+K  N+LLD +      +F LS +  +       +    GT+ Y
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER--AYDFCGTIEY 196

Query: 728 VAPEYGMGSEASMTG--DVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE 785
           +AP+   G ++      D +S G+L+ E+ TG  P      +        ++   E    
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256

Query: 786 IVDPSLLMEVMANNSMIQEDRRAR 809
               +L  +++    ++ +D + R
Sbjct: 257 QEMSALAKDLI--QRLLMKDPKKR 278

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 1e-25
 Identities = 40/209 (19%), Positives = 81/209 (38%), Gaps = 20/209 (9%)

Query: 556 IGQGSFGSVYKGILGGEEMIVAVKVIN--LKQKGAFRSFVAECEALRNIRHRNLIKIITI 613
           IG G+ G V        +  VA+K ++   + +   +    E   ++ + H+N+I ++ +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 614 CSSIDSKGADFK-ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYL 672
            +   +        LV E M+    +    + +           +   +   +   I++L
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE---------RMSYLLYQMLCGIKHL 135

Query: 673 HHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPE 731
           H       +H DLKPSN+++  D      +F L+    ++            T  Y APE
Sbjct: 136 HSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP----YVVTRYYRAPE 188

Query: 732 YGMGSEASMTGDVYSFGILLLEMFTGRRP 760
             +G       D++S G ++ EM   +  
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 94.7 bits (234), Expect = 3e-21
 Identities = 65/355 (18%), Positives = 121/355 (34%), Gaps = 43/355 (12%)

Query: 111 NLPNLKELYLTFCS---------LKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDL 161
           +L  +  L               L NL  +N   N L     + I   L N + L  + +
Sbjct: 42  DLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQL-----TDIT-PLKNLTKLVDILM 95

Query: 162 SGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFG 221
           + NQ      +   +      L   Q        N  +   L  + +++  +S       
Sbjct: 96  NNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTS 155

Query: 222 GELPHSIAN------LSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPD 275
            +             L++     R+  +    +  S +  L NL +L    NQ+  I P 
Sbjct: 156 LQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL 215

Query: 276 GVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFD 335
           G+    +L +L +  N L+     +L +LT L DL L+ N +    P  L     L    
Sbjct: 216 GIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 269

Query: 336 ASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSN 395
              N+++   P   L+  T           ++    L+             L YL +  N
Sbjct: 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN------------LTYLTLYFN 317

Query: 396 SFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVP 450
           +   + P     +  ++ L  ++N +S      L NL+ + +L+  +N +    P
Sbjct: 318 NISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 80.0 bits (196), Expect = 2e-16
 Identities = 81/384 (21%), Positives = 140/384 (36%), Gaps = 51/384 (13%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
           K  +   + +    L  + TL  D   +     D V  L+ L  +    N L    P  L
Sbjct: 31  KTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--L 84

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
             L  LV +       +      I  +++L  +       +     D L NL NL  L L
Sbjct: 85  KNLTKLVDI-----LMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
           +  ++ ++  L+   +   +   + + D    A+      L  +  K       + L NL
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL 199

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
             L    N +          +T L   ++L  LSL  NQ       ++A+L++      +
Sbjct: 200 ESLIATNNQISD--------ITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTD-LDL 248

Query: 241 GGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIP--------------------DGVGEL 280
             NQIS   P  +  L  L  L +  NQ+  I P                      +  L
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306

Query: 281 QHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNK 340
           ++L  L ++ N +    P  + +LTKL  L  + N +     SSL N  N+    A HN+
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362

Query: 341 LTGAIPQQVLSITTLSVYLALAHN 364
           ++   P  + ++T ++  L L   
Sbjct: 363 ISDLTP--LANLTRIT-QLGLNDQ 383

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.7 bits (218), Expect = 6e-20
 Identities = 55/325 (16%), Positives = 100/325 (30%), Gaps = 49/325 (15%)

Query: 123 CSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWW 182
           C  +     +  Q  L      ++P  +   +  +R+ L GN+     +  F + +NL  
Sbjct: 8   CYNEPKVTTSCPQQGL-----QAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTI 60

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG 242
           L L  N L                                    +   L+          
Sbjct: 61  LWLHSNVLAR------------------------------IDAAAFTGLALLEQLDLSDN 90

Query: 243 NQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLG 302
            Q+    P+    L  L  L ++   L  + P     L  LQ LY+  N LQ     +  
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 303 NLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALA 362
           +L  L  L L  N +      +     +L       N++    P     +  L       
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL---- 206

Query: 363 HNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLS 422
           +   N+   L    L        +L+YL ++ N +      +      +++   SS+ + 
Sbjct: 207 YLFANNLSALPTEALAP----LRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVP 261

Query: 423 GQIPEFLQNLSFLEFLNLSYNHLEG 447
             +P+ L          L+ N L+G
Sbjct: 262 CSLPQRLAGRD---LKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.4 bits (173), Expect = 5e-14
 Identities = 45/289 (15%), Positives = 88/289 (30%), Gaps = 30/289 (10%)

Query: 55  QIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPN 114
            +P   G+      + +  N+ S +         +L  ++L  N  +             
Sbjct: 25  AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 115 LKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDF 174
            +        L+++                  P +      L  L L     +      F
Sbjct: 83  EQLDLSDNAQLRSVD-----------------PATFHGLGRLHTLHLDRCGLQELGPGLF 125

Query: 175 SSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSST 234
             L  L +L L+ N L     +         +  +L  L L  N+       +   L S 
Sbjct: 126 RGLAALQYLYLQDNALQALPDD------TFRDLGNLTHLFLHGNRISSVPERAFRGLHS- 178

Query: 235 MIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQ 294
           + +  +  N+++   P   R+L  L+ L +  N L  +  + +  L+ LQ L +  N   
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

Query: 295 GSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTG 343
                +      L     S + +  ++P  L           + N L G
Sbjct: 239 CDC-RARPLWAWLQKFRGSSSEVPCSLPQRL---AGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.1 bits (167), Expect = 3e-13
 Identities = 54/275 (19%), Positives = 86/275 (31%), Gaps = 28/275 (10%)

Query: 45  LLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSL 104
           + +  N +      +    RNL  L +  N  + +       ++ LE + L+ N    S+
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96

Query: 105 PFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGN 164
                  L  L  L+L  C L+ L                           L+ L L  N
Sbjct: 97  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA-----------------ALQYLYLQDN 139

Query: 165 QFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGEL 224
             +      F  L NL  L L  N +                  SL  L L  N+     
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPER------AFRGLHSLDRLLLHQNRVAHVH 193

Query: 225 PHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQ 284
           PH+  +L   ++   +  N +S      +  L  L  L +  N               LQ
Sbjct: 194 PHAFRDL-GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQ 251

Query: 285 QLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQG 319
           +     + +  S+P  L     L    L+ N+LQG
Sbjct: 252 KFRGSSSEVPCSLPQRLAGR-DLKR--LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.4 bits (160), Expect = 2e-12
 Identities = 51/276 (18%), Positives = 86/276 (31%), Gaps = 13/276 (4%)

Query: 207 CSSLKALSL-CDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNL-IALTI 264
           C +   ++  C  Q    +P     + +   +  + GN+IS    +  R   NL I    
Sbjct: 8   CYNEPKVTTSCPQQGLQAVP---VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLH 64

Query: 265 EVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSS 324
                        G     Q        L+   P +   L +L  L L    LQ   P  
Sbjct: 65  SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124

Query: 325 LGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITC 384
                 L+      N L          +  L  +L L  N ++         L +L    
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNL-THLFLHGNRISSVPERAFRGLHSL---- 179

Query: 385 VSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNH 444
              + L +  N    V P +   +  +  L + +NNLS    E L  L  L++L L+ N 
Sbjct: 180 ---DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236

Query: 445 LEGEVPTKGVFSNKTKISLQVNVKLCGGIDELHLLS 480
              +   + +++   K     +   C     L    
Sbjct: 237 WVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRD 272

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.8 bits (148), Expect = 7e-11
 Identities = 56/271 (20%), Positives = 91/271 (33%), Gaps = 30/271 (11%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQI-PTTL 60
           N++         +  NL  L +  N L          L+ L  L +  N+    + P T 
Sbjct: 42  NRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATF 101

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
             L  L  L++       + P     +++L+++YL  N                      
Sbjct: 102 HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD-------------- 147

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
           TF  L NL  L L  N +     S    +     +L+RL L  N+        F  L  L
Sbjct: 148 TFRDLGNLTHLFLHGNRIS----SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
             L L  NNL       L          +L+ L L DN +  +       L + + +FR 
Sbjct: 204 MTLYLFANNLSALPTEALA------PLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRG 255

Query: 241 GGNQISGTIPSGIRNLVNLIALTIEVNQLHG 271
             +++  ++P     L       +  N L G
Sbjct: 256 SSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 86.0 bits (211), Expect = 8e-19
 Identities = 70/271 (25%), Positives = 111/271 (40%), Gaps = 13/271 (4%)

Query: 205 TNCSSLKALSLCDNQFGG--ELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIAL 262
           T    +  L L          +P S+ANL      +  G N + G IP  I  L  L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 263 TIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIP 322
            I    + G IPD + +++ L  L    N L G++PPS+ +L  L  +    N + G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 323 SSLGNCQNLKG-FDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLV 381
            S G+   L      S N+LTG IP    ++          +    D     +    +++
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANL----------NLAFVDLSRNMLEGDASVL 216

Query: 382 ITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLS 441
                       + +        +G  K++  L++ +N + G +P+ L  L FL  LN+S
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276

Query: 442 YNHLEGEVPTKGVFSNKTKISLQVNVKLCGG 472
           +N+L GE+P  G        +   N  LCG 
Sbjct: 277 FNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 60.1 bits (144), Expect = 3e-10
 Identities = 50/262 (19%), Positives = 86/262 (32%), Gaps = 27/262 (10%)

Query: 65  NLVYLNVAENQFSGMF--PRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTF 122
            +  L+++       +  P  + N+  L F+Y+             +  L  L  LY+T 
Sbjct: 51  RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110

Query: 123 CSLKNLWWLNLE-------QNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS 175
            ++       L         +      + ++P S+S+  NL  +   GN+  G +   + 
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170

Query: 176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKAL----------------SLCDNQ 219
           S   L+       N   G          L      + +                 +   +
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230

Query: 220 FGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGE 279
                      LS  +    +  N+I GT+P G+  L  L +L +  N L G IP G G 
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GN 289

Query: 280 LQHLQQLYMFRN-FLQGSIPPS 300
           LQ         N  L GS  P+
Sbjct: 290 LQRFDVSAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 49.7 bits (117), Expect = 7e-07
 Identities = 17/58 (29%), Positives = 28/58 (48%), Gaps = 3/58 (5%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSL--GGQIP 57
           N++ G +P+ +  L  L +L + FN L G++P   GNL    +     N    G  +P
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 49.0 bits (115), Expect = 1e-06
 Identities = 16/60 (26%), Positives = 25/60 (41%), Gaps = 1/60 (1%)

Query: 46  LIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLP 105
            +R N + G +P  L  L+ L  LNV+ N   G  P+   N+   +      N+     P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 47.1 bits (110), Expect = 5e-06
 Identities = 12/57 (21%), Positives = 23/57 (40%), Gaps = 2/57 (3%)

Query: 64  RNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
           +NL  L++  N+  G  P+ +  +  L  + ++ N   G +P     NL        
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAY 298

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 45.9 bits (107), Expect = 1e-05
 Identities = 54/232 (23%), Positives = 88/232 (37%), Gaps = 14/232 (6%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           N L G IP  I  L  L  L I    ++G +PDF+  +  L  L   +N+L G +P ++ 
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVN-----RFSGSLPFDILVNLPNLK 116
            L NLV +    N+ SG  P    + S L             +   +     L  +   +
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSR 206

Query: 117 ELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS 176
            +     S+      N ++ +L   + +     +  + NL  LDL  N+  G +    + 
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266

Query: 177 LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQF--GGELPH 226
           LK L  LN+  NNL          +    N       +  +N+   G  LP 
Sbjct: 267 LKFLHSLNVSFNNL-------CGEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 37.8 bits (86), Expect = 0.004
 Identities = 42/154 (27%), Positives = 60/154 (38%), Gaps = 11/154 (7%)

Query: 270 HGIIPDGVGELQHLQQLYMFRNFLQG--SIPPSLGNLTKLADLALSFN-NLQGNIPSSLG 326
            G++ D   +   +  L +    L     IP SL NL  L  L +    NL G IP ++ 
Sbjct: 39  LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 327 NCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVS 386
               L     +H  ++GAIP  +  I TL       +N L+ +LP  + +L NLV     
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS-YNALSGTLPPSISSLPNLVGIT-- 155

Query: 387 LEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNN 420
                   N   G IP S G    +      S N
Sbjct: 156 -----FDGNRISGAIPDSYGSFSKLFTSMTISRN 184

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 79.3 bits (194), Expect = 1e-16
 Identities = 53/311 (17%), Positives = 99/311 (31%), Gaps = 56/311 (18%)

Query: 144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL 203
             +P  L    +   LDL  N+       DF +LKNL  L L  N +   +         
Sbjct: 23  EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA---- 76

Query: 204 LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALT 263
                 L+ L L  NQ                             +P  +   +    L 
Sbjct: 77  --PLVKLERLYLSKNQLK--------------------------ELPEKMPKTLQE--LR 106

Query: 264 IEVNQLHGIIPDGVGELQHLQQLYMFRNFLQ--GSIPPSLGNLTKLADLALSFNNLQGNI 321
           +  N++  +       L  +  + +  N L+  G    +   + KL+ + ++  N+   I
Sbjct: 107 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 165

Query: 322 PSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLV 381
           P  L    +L       NK+T      +  +  L+         L  S           +
Sbjct: 166 PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAK--------LGLSFNSISAVDNGSL 215

Query: 382 ITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSG------QIPEFLQNLSFL 435
                L  L +++N     +P  L   K I+ + + +NN+S         P +    +  
Sbjct: 216 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 274

Query: 436 EFLNLSYNHLE 446
             ++L  N ++
Sbjct: 275 SGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 78.5 bits (192), Expect = 2e-16
 Identities = 53/313 (16%), Positives = 105/313 (33%), Gaps = 46/313 (14%)

Query: 88  SSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIP 147
                + L  N+ +  +      NL NL  L L    +  +                  P
Sbjct: 31  PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKI-----------------SP 72

Query: 148 DSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNC 207
            + +    LERL LS NQ K        +L+ L     E   +     N L+ + ++   
Sbjct: 73  GAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 132

Query: 208 SSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVN 267
           +          +  G    +   +   +   RI    I+ TIP G+    +L  L ++ N
Sbjct: 133 T-------NPLKSSGIENGAFQGMKK-LSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 181

Query: 268 QLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGN 327
           ++  +    +  L +L +L +  N +      SL N   L +L L+ N L   +P  L +
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240

Query: 328 CQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSL 387
            + ++     +N ++             +                   +   + +    +
Sbjct: 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA----------------SYSGVSLFSNPV 284

Query: 388 EYLDISSNSFHGV 400
           +Y +I  ++F  V
Sbjct: 285 QYWEIQPSTFRCV 297

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 75.8 bits (185), Expect = 2e-15
 Identities = 49/278 (17%), Positives = 93/278 (33%), Gaps = 32/278 (11%)

Query: 7   QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNL 66
           ++P+++    +   L +  N +T        NL  L  L++  N +    P     L  L
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 67  VYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGS----LPFDILVNLPNLKELYL-- 120
             L +++NQ   +  +    +  L      + +   S    L   I+V L          
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 121 ---TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSL 177
               F  +K L ++ +   N+     ++IP  L    +L  L L GN+     +     L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNI-----TTIPQGLP--PSLTELHLDGNKITKVDAASLKGL 194

Query: 178 KNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQ 237
            NL  L L  N++       L     L            +N    ++P  +A+    +  
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELH-------LNNNKLVKVPGGLADHKY-IQV 246

Query: 238 FRIGGNQISG------TIPSGIRNLVNLIALTIEVNQL 269
             +  N IS         P       +   +++  N +
Sbjct: 247 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 74.3 bits (181), Expect = 7e-15
 Identities = 43/233 (18%), Positives = 77/233 (33%), Gaps = 18/233 (7%)

Query: 248 TIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKL 307
            +P  +    +   L ++ N++  I       L++L  L +  N +    P +   L KL
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 308 ADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLN 367
             L LS N L+          Q L+  +    K+  ++   +  +  +   L       +
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV--ELGTNPLKSS 139

Query: 368 DSLPLQVGNLKNLVI--------------TCVSLEYLDISSNSFHGVIPFSLGFMKSIKE 413
                    +K L                   SL  L +  N    V   SL  + ++ +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAK 199

Query: 414 LNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVN 466
           L +S N++S      L N   L  L+L+ N L               + L  N
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN 252

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 72.4 bits (176), Expect = 3e-14
 Identities = 50/240 (20%), Positives = 89/240 (37%), Gaps = 14/240 (5%)

Query: 208 SSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVN 267
                L L +N+          NL + +    +  N+IS   P     LV L  L +  N
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKN 89

Query: 268 QLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGN 327
           QL  +       LQ L+        ++ S+   L  +  + +L  +     G    +   
Sbjct: 90  QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQG 148

Query: 328 CQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSL 387
            + L     +   +T  IPQ +    T    L L  N +       +  L NL       
Sbjct: 149 MKKLSYIRIADTNIT-TIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNL------- 197

Query: 388 EYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEG 447
             L +S NS   V   SL     ++EL++++N L  ++P  L +  +++ + L  N++  
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 64.3 bits (155), Expect = 1e-11
 Identities = 44/226 (19%), Positives = 79/226 (34%), Gaps = 15/226 (6%)

Query: 2   NKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLG 61
           NK+    P     L+ L+ L +  N L          L  L +       +   +   L 
Sbjct: 65  NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124

Query: 62  LLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT 121
            +  +  L     + SG+       +  L +I +     + ++P  +    P+L EL+L 
Sbjct: 125 QMIVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLD 179

Query: 122 FCSLK--------NLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID 173
              +          L  L  +        ++    SL+N  +L  L L+ N+   KV   
Sbjct: 180 GNKITKVDAASLKGLNNLA-KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 237

Query: 174 FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQ 219
            +  K +  + L  NN+    +ND       T  +S   +SL  N 
Sbjct: 238 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.4 bits (182), Expect = 8e-16
 Identities = 31/210 (14%), Positives = 64/210 (30%), Gaps = 34/210 (16%)

Query: 554 NMIGQGSFGSVYKGILGGEEMIVAVKVINL----------KQKGAFRSFVAECEALRNIR 603
            ++G+G   +V+            VK   +          K+      F           
Sbjct: 6   KLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 604 HRNLIKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAI 663
            R L K+  +         +  A++ E ++   L     ++ D              +  
Sbjct: 65  FRALQKLQGLAV-PKVYAWEGNAVLMELIDAKELYRVRVENPDE-------------VLD 110

Query: 664 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQNFSLSHQLDSASKTPSSSIGIKG 723
            +   +   +H     IVHGDL   NVL+  + +   +F  S ++            ++ 
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRN 167

Query: 724 TVGYVAPEYGMGSEASMTGDVYSFGILLLE 753
            + Y +  Y          D+ S    +L+
Sbjct: 168 IITYFSRTYRTEK------DINSAIDRILQ 191

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.3 bits (147), Expect = 8e-11
 Identities = 40/222 (18%), Positives = 68/222 (30%), Gaps = 20/222 (9%)

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
               + +   +N ++ NL     +++P  L    +   L LS N               L
Sbjct: 5   EVSKVASHLEVNCDKRNL-----TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRL 57

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE-LPHSIANLSSTMIQFR 239
             LNL++  L                  +L  L   D           +      +    
Sbjct: 58  TQLNLDRAELTKL-----------QVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLD 106

Query: 240 IGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP 299
           +  N+++      +R L  L  L ++ N+L  + P  +     L++L +  N L      
Sbjct: 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166

Query: 300 SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKL 341
            L  L  L  L L  N+L   IP        L       N  
Sbjct: 167 LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.6 bits (109), Expect = 6e-06
 Identities = 35/188 (18%), Positives = 54/188 (28%), Gaps = 15/188 (7%)

Query: 296 SIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTL 355
           ++PP L   T +  L LS N L     ++L     L   +    +LT       L +   
Sbjct: 24  ALPPDLPKDTTI--LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81

Query: 356 SVYLALAHNLLNDSLPLQVGNLKNLVITCVSLE-------------YLDISSNSFHGVIP 402
                     L              V                     L +  N    + P
Sbjct: 82  LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141

Query: 403 FSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKIS 462
             L     +++L++++NNL+      L  L  L+ L L  N L                 
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAF 201

Query: 463 LQVNVKLC 470
           L  N  LC
Sbjct: 202 LHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.5 bits (93), Expect = 5e-04
 Identities = 35/207 (16%), Positives = 54/207 (26%), Gaps = 31/207 (14%)

Query: 11  EIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLN 70
           E+  + +   +  D   LT  LP  +       +L +  N L      TL     L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 71  VAENQFSGMFPRWI--------------------CNISSLEFIYLTVNRFSGSLPFDILV 110
           +   + + +                                 +         SLP   L 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 111 NLPNLKELYLTFC-------SLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSG 163
            L  L+ELYL           L        + +             L+   NL+ L L  
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 164 NQFKGKVSIDFSSLKNLWWLNLEQNNL 190
           N     +   F     L +  L  N  
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 0.001
 Identities = 13/59 (22%), Positives = 20/59 (33%), Gaps = 3/59 (5%)

Query: 386 SLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLSYNH 444
           S   ++    +    +P  L   K    L++S N L       L   + L  LNL    
Sbjct: 11  SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.9 bits (89), Expect = 0.001
 Identities = 24/175 (13%), Positives = 43/175 (24%), Gaps = 8/175 (4%)

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
            L ++   L+++EN         +   + L  + L     +       L  L  L   + 
Sbjct: 28  DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHN 87

Query: 121 TFCSLKNLWWLNLEQNNLGMGTA--SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLK 178
              SL  L         L +     +S+P          +           +     +  
Sbjct: 88  QLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147

Query: 179 NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSS 233
                    NN             LL    +L  L L +N     +P        
Sbjct: 148 PKLEKLSLANNNLTELPAG-----LLNGLENLDTLLLQENSL-YTIPKGFFGSHL 196

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.4 bits (129), Expect = 2e-08
 Identities = 54/328 (16%), Positives = 95/328 (28%), Gaps = 21/328 (6%)

Query: 120 LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKN 179
           L  C  +    L L    L     SS+P+   +   LE L  S N       +     ++
Sbjct: 32  LRDCLDRQAHELELNNLGL-----SSLPELPPH---LESLVASCNSLT---ELP-ELPQS 79

Query: 180 LWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFR 239
           L  L +  NN     ++    +  L   ++                  + N S   +   
Sbjct: 80  LKSLLV-DNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDL 138

Query: 240 IGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPP 299
               +      + +  L  L  L                    L    +          P
Sbjct: 139 PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELP 198

Query: 300 SLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYL 359
            L NL  L  +    N L+                +   +          L ++      
Sbjct: 199 ELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSG 258

Query: 360 ALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSN 419
                     L      +++L     SLE L++S+N     +P        ++ L  S N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFN 314

Query: 420 NLSGQIPEFLQNLSFLEFLNLSYNHLEG 447
           +L+ ++PE  QNL   + L++ YN L  
Sbjct: 315 HLA-EVPELPQNL---KQLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 21/91 (23%), Positives = 32/91 (35%), Gaps = 9/91 (9%)

Query: 267 NQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLG 326
           N     I         L++L +  N L   +P     L +   L  SFN+L   +P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELPQ 324

Query: 327 NCQNLKGFDASHNKLTGAIPQQVLSITTLSV 357
           N + L      +N L    P    S+  L +
Sbjct: 325 NLKQL---HVEYNPLRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.7 bits (109), Expect = 8e-06
 Identities = 20/109 (18%), Positives = 38/109 (34%), Gaps = 16/109 (14%)

Query: 79  MFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFC-------SLKNLWWL 131
                I +  S     L     S +    +    P+L+EL ++             L  L
Sbjct: 250 DVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERL 309

Query: 132 NLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
               N+L     + +P+   N   L++L +  N  +    I   S+++L
Sbjct: 310 IASFNHL-----AEVPELPQN---LKQLHVEYNPLREFPDI-PESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 2e-04
 Identities = 17/99 (17%), Positives = 29/99 (29%), Gaps = 16/99 (16%)

Query: 161 LSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQF 220
              N    ++        +L  LN+  N L          + L      L+ L    N  
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL----------IELPALPPRLERLIASFNHL 316

Query: 221 GGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNL 259
             E+P    NL        +  N +    P    ++ +L
Sbjct: 317 -AEVPELPQNLKQ----LHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 23/113 (20%), Positives = 41/113 (36%), Gaps = 28/113 (24%)

Query: 48  RWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFD 107
             N+   +I +   L  +L  LNV+ N+   +          LE +  + N  +      
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLA------ 317

Query: 108 ILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLD 160
               +P L          +NL  L++E N L        PD   +  +L R++
Sbjct: 318 ---EVPEL---------PQNLKQLHVEYNPL-----REFPDIPESVEDL-RMN 352

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.1 bits (125), Expect = 9e-08
 Identities = 20/98 (20%), Positives = 31/98 (31%), Gaps = 7/98 (7%)

Query: 122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS----- 176
                 L  L L   ++   + SS+  +L    +L  LDLS N       +         
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 177 LKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALS 214
              L  L L          + L    L  +  SL+ +S
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQ--ALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 2e-07
 Identities = 19/106 (17%), Positives = 31/106 (29%), Gaps = 5/106 (4%)

Query: 139 GMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS----LKNLWWLNLEQNNLGMGT 194
             G            S L  L L+            ++      +L  L+L  N LG   
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413

Query: 195 ANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRI 240
              L   ++      L+ L L D  +  E+   +  L       R+
Sbjct: 414 ILQL-VESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 2e-06
 Identities = 12/104 (11%), Positives = 29/104 (27%), Gaps = 13/104 (12%)

Query: 89  SLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPD 148
            ++ + +     S +   ++L  L   + +              L+   L       I  
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVV-------------RLDDCGLTEARCKDISS 49

Query: 149 SLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGM 192
           +L     L  L+L  N+                   +++ +L  
Sbjct: 50  ALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 7e-06
 Identities = 13/69 (18%), Positives = 23/69 (33%), Gaps = 5/69 (7%)

Query: 385 VSLEYLDISSNSF-HGVIPFSLGFMKSIKELNVSSNNLSGQ----IPEFLQNLSFLEFLN 439
           + ++ LDI             L  ++  + + +    L+      I   L+    L  LN
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 440 LSYNHLEGE 448
           L  N L   
Sbjct: 62  LRSNELGDV 70

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 9e-06
 Identities = 16/76 (21%), Positives = 27/76 (35%), Gaps = 9/76 (11%)

Query: 384 CVSLEYLDISSNSFHGV----IPFSLGFMKSIKELNVSSNNLSGQIPEFL-----QNLSF 434
              L  L ++           +  +L    S++EL++S+N L       L     Q    
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 435 LEFLNLSYNHLEGEVP 450
           LE L L   +   E+ 
Sbjct: 428 LEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 19/101 (18%), Positives = 35/101 (34%), Gaps = 11/101 (10%)

Query: 79  MFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNL 138
           +        S L  ++L     S S          +   L  T  +  +L  L+L  N L
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDS----------SCSSLAATLLANHSLRELDLSNNCL 409

Query: 139 GMGTASSIPDSL-SNASNLERLDLSGNQFKGKVSIDFSSLK 178
           G      + +S+      LE+L L    +  ++     +L+
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 16/87 (18%), Positives = 28/87 (32%), Gaps = 6/87 (6%)

Query: 174 FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE----LPHSIA 229
                 L  L L   ++   + + L     L    SL+ L L +N  G      L  S+ 
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSL--AATLLANHSLRELDLSNNCLGDAGILQLVESVR 422

Query: 230 NLSSTMIQFRIGGNQISGTIPSGIRNL 256
                + Q  +     S  +   ++ L
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 19/98 (19%), Positives = 34/98 (34%), Gaps = 8/98 (8%)

Query: 127 NLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSS----LKNLWW 182
           ++  L+++   L   + +   + L      + + L           D SS       L  
Sbjct: 3   DIQSLDIQCEEL---SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQF 220
           LNL  N LG    + +    L T    ++ LSL +   
Sbjct: 60  LNLRSNELGDVGVHCV-LQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 4e-04
 Identities = 12/95 (12%), Positives = 34/95 (35%), Gaps = 3/95 (3%)

Query: 330 NLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEY 389
           +++  D    +L+ A   ++L +      + L    L ++   +  ++ + +    +L  
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA---RCKDISSALRVNPALAE 59

Query: 390 LDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQ 424
           L++ SN    V    +          +   +L   
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 13/92 (14%), Positives = 30/92 (32%), Gaps = 5/92 (5%)

Query: 16  LNLQTLAIDFNYLT-GQLPDFVGNLSALGMLLIRWNSLGGQ----IPTTLGLLRNLVYLN 70
           L++Q+L I    L+  +  + +  L    ++ +    L       I + L +   L  LN
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 71  VAENQFSGMFPRWICNISSLEFIYLTVNRFSG 102
           +  N+   +    +          +       
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.002
 Identities = 11/96 (11%), Positives = 31/96 (32%), Gaps = 8/96 (8%)

Query: 179 NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANL---SSTM 235
           ++  L+++   L      D  +  LL      + + L D          I++    +  +
Sbjct: 3   DIQSLDIQCEELS-----DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 57

Query: 236 IQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHG 271
            +  +  N++       +   +   +  I+   L  
Sbjct: 58  AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.6 bits (117), Expect = 4e-07
 Identities = 32/223 (14%), Positives = 64/223 (28%), Gaps = 21/223 (9%)

Query: 124 SLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID-FSSLKNLWW 182
           +L N   +   ++N+      +   + ++   +  L   G       +I+    L NL  
Sbjct: 17  ALANAIKIAAGKSNV------TDTVTQADLDGITTLSAFGTGVT---TIEGVQYLNNLIG 67

Query: 183 LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG 242
           L L+ N +                 S     ++        +       +       + G
Sbjct: 68  LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127

Query: 243 NQISGTIPSGIRNLVNLIALTIEVNQLHG-------IIPDGVGELQHLQQLYMFRNFLQG 295
                 +   +  + N+  L    N  +             +  L  L  L    N +  
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 296 SIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASH 338
             P  L +L  L ++ L  N +    P  L N  NL     ++
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 2e-06
 Identities = 31/212 (14%), Positives = 65/212 (30%), Gaps = 14/212 (6%)

Query: 236 IQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQG 295
           I+   G + ++ T+     +L  +  L+     +  I  +GV  L +L  L +  N +  
Sbjct: 22  IKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITD 77

Query: 296 SIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTL 355
             P          +L+ +       I                 +    A    +  +   
Sbjct: 78  LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137

Query: 356 SVYLALAHNLL------NDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMK 409
              +     L         S+     +    +     L  L    N    + P     + 
Sbjct: 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL--ASLP 195

Query: 410 SIKELNVSSNNLSGQIPEFLQNLSFLEFLNLS 441
           ++ E+++ +N +S   P  L N S L  + L+
Sbjct: 196 NLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.6 bits (109), Expect = 4e-06
 Identities = 42/219 (19%), Positives = 74/219 (33%), Gaps = 19/219 (8%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
           K+ +   + +    L  + TL+     +T  +      L+ L  L ++ N +    P   
Sbjct: 28  KSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGV-QYLNNLIGLELKDNQITDLAPLKN 83

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
                 + L+    +                 + LT  + +   P   L NL  L     
Sbjct: 84  LTKITELELSGNPLKNVSAIAGLQSIK----TLDLTSTQITDVTPLAGLSNLQVLYLDLN 139

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
              ++  L  L   Q         S    L+N S L  L    N+         +SL NL
Sbjct: 140 QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNL 197

Query: 181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQ 219
             ++L+ N +     +D+     L N S+L  ++L  NQ
Sbjct: 198 IEVHLKNNQI-----SDVSP---LANTSNLFIVTL-TNQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 6e-06
 Identities = 34/202 (16%), Positives = 61/202 (30%), Gaps = 12/202 (5%)

Query: 255 NLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSF 314
            L N I +    + +   +     +L  +  L  F   +  +I   +  L  L  L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 315 NNLQGNIPSS------LGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLND 368
           N +    P                  + S      +I    L+ T ++    LA      
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 369 SLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEF 428
            L L +  + N+           +S  +        L  +  +  L    N +S   P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 429 LQNLSFLEFLNLSYNHLEGEVP 450
           L +L  L  ++L  N +    P
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP 212

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 36/272 (13%), Positives = 74/272 (27%), Gaps = 59/272 (21%)

Query: 146 IPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLT 205
            PD     +N  ++    +     V+   + L  +  L+     +       ++    + 
Sbjct: 13  FPDP--ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-----TTIEG---VQ 60

Query: 206 NCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIE 265
             ++L  L L DNQ     P       + +         +S          ++L +  I 
Sbjct: 61  YLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT 120

Query: 266 VNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSL 325
                  + +       L Q+         +    L           S  N Q +  + L
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYL-----------SIGNAQVSDLTPL 169

Query: 326 GNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCV 385
            N   L    A  NK++   P                           + +L NL     
Sbjct: 170 ANLSKLTTLKADDNKISDISP---------------------------LASLPNL----- 197

Query: 386 SLEYLDISSNSFHGVIPFSLGFMKSIKELNVS 417
               + + +N    V P  L    ++  + ++
Sbjct: 198 --IEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 49.9 bits (117), Expect = 7e-07
 Identities = 45/331 (13%), Positives = 85/331 (25%), Gaps = 34/331 (10%)

Query: 131 LNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGK----VSIDFSSLKNLWWLNLE 186
            +L+ + +      S+   L    +++ + LSGN    +    +S + +S K+L      
Sbjct: 8   KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 187 QNNL----GMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG 242
                             +  L  C  L  + L DN FG      + +  S         
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127

Query: 243 NQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLG 302
              +G  P             I        +         L+ +   RN L+        
Sbjct: 128 LHNNGLGPQAGAK--------IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179

Query: 303 NLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALA 362
              +   L  +   +Q  I         L+G           +     +    S      
Sbjct: 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239

Query: 363 HNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLS 422
            +  N         L +       ++      N               ++ L +  N + 
Sbjct: 240 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI-------------GLQTLRLQYNEIE 286

Query: 423 GQIPEFL-----QNLSFLEFLNLSYNHLEGE 448
                 L     + +  L FL L+ N    E
Sbjct: 287 LDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 14/82 (17%), Positives = 33/82 (40%), Gaps = 8/82 (9%)

Query: 119 YLTFCSLKNLWWLNLEQNNLGMGTASSIPDSL-SNASNLERLDLSGNQFKGKVSIDFSSL 177
             +      L  L L+ N + +    ++   +     +L  L+L+GN+F  +       +
Sbjct: 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEI 324

Query: 178 KNLWWLNLEQNNLGMGTANDLD 199
           + ++      +  G G  ++LD
Sbjct: 325 REVF------STRGRGELDELD 340

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.1 bits (102), Expect = 4e-05
 Identities = 33/329 (10%), Positives = 82/329 (24%), Gaps = 30/329 (9%)

Query: 114 NLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ---FKGKV 170
           + K ++       ++  + L  N +G   A  + +++++  +LE  + S       K ++
Sbjct: 19  DEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEI 78

Query: 171 SIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIAN 230
                 L        + + + +                  K   L             A 
Sbjct: 79  PEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 138

Query: 231 LSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFR 290
                    +  N+ +   P     +     L     +           L  ++ +    
Sbjct: 139 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI 198

Query: 291 NFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVL 350
                      G              L+                 A   K    + +  L
Sbjct: 199 RPEGIEHLLLEGL--------AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 250

Query: 351 SITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSL----- 405
           +             LL+      V +  +  +  + L+ L +  N        +L     
Sbjct: 251 N-----------DCLLSARGAAAVVDAFSK-LENIGLQTLRLQYNEIELDAVRTLKTVID 298

Query: 406 GFMKSIKELNVSSNNLS--GQIPEFLQNL 432
             M  +  L ++ N  S    + + ++ +
Sbjct: 299 EKMPDLLFLELNGNRFSEEDDVVDEIREV 327

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 9e-07
 Identities = 38/283 (13%), Positives = 76/283 (26%), Gaps = 22/283 (7%)

Query: 79  MFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNL 138
           + P     + S   I     R     P     +   ++ + L+   +             
Sbjct: 12  LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVI------------- 58

Query: 139 GMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLE--QNNLGMGTAN 196
                S++   LS  S L+ L L G +    +    +   NL  LNL             
Sbjct: 59  ---EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT 115

Query: 197 DLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNL 256
            L   + L   +        +      + H    ++   +       Q S       R  
Sbjct: 116 LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP 175

Query: 257 VNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFR-NFLQGSIPPSLGNLTKLADLALSFN 315
             +     +   L         +L +LQ L + R   +       LG +  L  L +   
Sbjct: 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235

Query: 316 NLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVY 358
              G +        +L+    + +  T      + +     ++
Sbjct: 236 VPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQEIW 275

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 2e-06
 Identities = 38/292 (13%), Positives = 96/292 (32%), Gaps = 27/292 (9%)

Query: 158 RLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCD 217
            LDL+G      V+    S   +      ++ +          +    +   ++ + L +
Sbjct: 4   TLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMD-------QPLAEHFSPFRVQHMDLSN 55

Query: 218 NQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIE--VNQLHGIIPD 275
           +       H I +  S +    + G ++S  I + +    NL+ L +          +  
Sbjct: 56  SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT 115

Query: 276 GVGELQHLQQLYM------FRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQ 329
            +     L +L +          +Q ++      +T+L       N  + ++ + +  C 
Sbjct: 116 LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP 175

Query: 330 NLKGFDASHNKLTGAIPQQVLSITTLSVYLALAH-NLLNDSLPLQVGNLKNLVITCVSLE 388
           NL   D S + +      Q         +L+L+    +     L++G +         L+
Sbjct: 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT-------LK 228

Query: 389 YLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNL 440
            L +      G +       +++  L ++ ++ +      + N    E   +
Sbjct: 229 TLQVFGIVPDGTLQL---LKEALPHLQINCSHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 8e-04
 Identities = 28/207 (13%), Positives = 73/207 (35%), Gaps = 4/207 (1%)

Query: 240 IGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQG-SIP 298
           + G  +   +   + +   +IA     + +   + +     + +Q + +  + ++  ++ 
Sbjct: 7   LTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLH 64

Query: 299 PSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVY 358
             L   +KL +L+L    L   I ++L    NL   + S          Q L  +   + 
Sbjct: 65  GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124

Query: 359 LALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSS 418
                   + +       + ++  T   L       N     +   +    ++  L++S 
Sbjct: 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 184

Query: 419 N-NLSGQIPEFLQNLSFLEFLNLSYNH 444
           +  L     +    L++L+ L+LS  +
Sbjct: 185 SVMLKNDCFQEFFQLNYLQHLSLSRCY 211

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (105), Expect = 1e-05
 Identities = 26/218 (11%), Positives = 54/218 (24%), Gaps = 23/218 (10%)

Query: 144 SSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL 203
           + IP  L    N   L     + +      FS   +L  + + QN++      D+     
Sbjct: 21  TEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 78

Query: 204 LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGG--------------------- 242
             +   ++  +           +        +    I                       
Sbjct: 79  KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 138

Query: 243 NQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLG 302
           N  +    S +      + L +  N +  I        Q  +      N L+        
Sbjct: 139 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFH 198

Query: 303 NLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNK 340
             +    L +S   +       L N + L+     + K
Sbjct: 199 GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 15/63 (23%), Positives = 20/63 (31%), Gaps = 3/63 (4%)

Query: 129 WWLNLEQNNLGMGTASSIP-DSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQ 187
                E N         +P D    AS    LD+S  +     S    +LK L   +   
Sbjct: 175 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST-- 232

Query: 188 NNL 190
            NL
Sbjct: 233 YNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.003
 Identities = 8/58 (13%), Positives = 16/58 (27%)

Query: 384 CVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLS 441
               E     +N+   +             L++S   +       L+NL  L   +  
Sbjct: 176 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 5e-05
 Identities = 29/186 (15%), Positives = 52/186 (27%), Gaps = 12/186 (6%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
           K  +   + +    L ++  +  + + +       +  L  +  L +  N L    P   
Sbjct: 33  KKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--- 85

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSL-PFDILVNLPNLKELY 119
             L NL  L       + +                  +     +     L  L +L    
Sbjct: 86  --LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGN 143

Query: 120 LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKN 179
                +  L  L             S    L+  + L+ L LS N      +   + LKN
Sbjct: 144 NKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRA--LAGLKN 201

Query: 180 LWWLNL 185
           L  L L
Sbjct: 202 LDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 1e-04
 Identities = 38/214 (17%), Positives = 70/214 (32%), Gaps = 27/214 (12%)

Query: 124 SLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWL 183
           +       NL++ ++      +   + +  ++++++  + +  K    I +  L N+  L
Sbjct: 22  AFAETIKDNLKKKSV------TDAVTQNELNSIDQIIANNSDIKSVQGIQY--LPNVTKL 73

Query: 184 NLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGN 243
            L  N L              T+   L  L      F  E      +  S     ++   
Sbjct: 74  FLNGNKL--------------TDIKPLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSL 117

Query: 244 QISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGN 303
            +     S I  LV+L  L       + I    V             +     I P L  
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAG 176

Query: 304 LTKLADLALSFNNLQGNIPSSLGNCQNLKGFDAS 337
           LTKL +L LS N++      +L   +NL   +  
Sbjct: 177 LTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.004
 Identities = 26/214 (12%), Positives = 59/214 (27%), Gaps = 41/214 (19%)

Query: 258 NLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNL 317
             I +   + Q   I  D         +  + +  +  ++  +   L  +  +  + +++
Sbjct: 6   ETITVPTPIKQ---IFSDDA--FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI 58

Query: 318 QGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTL---------------------- 355
           +      +    N+     + NKLT   P   L                           
Sbjct: 59  KSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116

Query: 356 ----SVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPF----SLGF 407
                  ++  + L++      +    N +     L  L                  L  
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAG 176

Query: 408 MKSIKELNVSSNNLSGQIPEFLQNLSFLEFLNLS 441
           +  ++ L +S N++S      L  L  L+ L L 
Sbjct: 177 LTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 7e-05
 Identities = 25/133 (18%), Positives = 42/133 (31%), Gaps = 20/133 (15%)

Query: 310 LALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDS 369
           L L+  +L   +   L     +   D SHN+L    P            LA    L    
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-----------LAALRCLEVLQ 49

Query: 370 LPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPF-SLGFMKSIKELNVSSNNLSG----- 423
                    + V     L+ L + +N          L     +  LN+  N+L       
Sbjct: 50  ASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 109

Query: 424 -QIPEFLQNLSFL 435
            ++ E L ++S +
Sbjct: 110 ERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.1 bits (93), Expect = 1e-04
 Identities = 23/127 (18%), Positives = 38/127 (29%), Gaps = 35/127 (27%)

Query: 131 LNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWW-------- 182
           L+L   +L      ++   L     +  LDLS N+ +       ++L+ L          
Sbjct: 3   LHLAHKDL------TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL 55

Query: 183 --------------LNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSI 228
                         L L  N L          +  L +C  L  L+L  N    E     
Sbjct: 56  ENVDGVANLPRLQELLLCNNRL-----QQSAAIQPLVSCPRLVLLNLQGNSLCQE-EGIQ 109

Query: 229 ANLSSTM 235
             L+  +
Sbjct: 110 ERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.7 bits (92), Expect = 2e-04
 Identities = 28/132 (21%), Positives = 49/132 (37%), Gaps = 12/132 (9%)

Query: 284 QQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTG 343
           + L++    L  ++   L  L  +  L LS N L+   P +L   + L+   AS N L  
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57

Query: 344 AIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPF 403
                 L        L L +N L  S  +Q       +++C  L  L++  NS       
Sbjct: 58  VDGVANLPRLQ---ELLLCNNRLQQSAAIQP------LVSCPRLVLLNLQGNSLCQEEGI 108

Query: 404 SLGFMKSIKELN 415
                + +  ++
Sbjct: 109 QERLAEMLPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.3 bits (91), Expect = 3e-04
 Identities = 22/124 (17%), Positives = 41/124 (33%), Gaps = 12/124 (9%)

Query: 68  YLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLP-FDILVNLPNLKELYLTFCSLK 126
            L++A    +      +  +  +  + L+ NR     P    L  L  L+       ++ 
Sbjct: 2   VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 127 NLWW------LNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
            +        L L  N L     S+    L +   L  L+L GN    +  I     + L
Sbjct: 60  GVANLPRLQELLLCNNRL---QQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 181 WWLN 184
             ++
Sbjct: 117 PSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.9 bits (90), Expect = 4e-04
 Identities = 17/114 (14%), Positives = 38/114 (33%), Gaps = 6/114 (5%)

Query: 8   IPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLV 67
           +   +  LL +  L +  N L    P     L  L +  ++ +    +    +  L  L 
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEV--LQASDNALENVDGVANLPRLQ 68

Query: 68  YLNVAENQFSGM-FPRWICNISSLEFIYLTVNRFSG--SLPFDILVNLPNLKEL 118
            L +  N+       + + +   L  + L  N       +   +   LP++  +
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.2 bits (95), Expect = 2e-04
 Identities = 41/183 (22%), Positives = 68/183 (37%), Gaps = 10/183 (5%)

Query: 1   KNKLEGQIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTL 60
           K  +   + +    L  + TL  D   +     D V  L+ L  +    N L    P   
Sbjct: 27  KTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--- 79

Query: 61  GLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYL 120
            L      +++  N         + N+++L  + L  N+ +   P   L NL  L+    
Sbjct: 80  -LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 138

Query: 121 TFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL 180
           T   +  L  L   Q         +    L+N + LERLD+S N+    +S+  + L NL
Sbjct: 139 TISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-ISV-LAKLTNL 196

Query: 181 WWL 183
             L
Sbjct: 197 ESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 26/197 (13%), Positives = 52/197 (26%), Gaps = 21/197 (10%)

Query: 146 IPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLT 205
             D+    +   +  L        VS   + L  +  L  ++  +       +D V  L 
Sbjct: 12  FTDT--ALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGI-----KSIDGVEYLN 62

Query: 206 NCSSLKA----------LSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRN 255
           N + +            L          + ++     + +                   +
Sbjct: 63  NLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122

Query: 256 LVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFN 315
            +  +     +      I D            +  +  Q +    L NLT L  L +S N
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSN 182

Query: 316 NLQGNIPSSLGNCQNLK 332
            +     S L    NL+
Sbjct: 183 KVSD--ISVLAKLTNLE 197

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 5e-04
 Identities = 26/190 (13%), Positives = 55/190 (28%), Gaps = 12/190 (6%)

Query: 255 NLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSF 314
            L   +   +    +   +     +L  +  L   R  ++ SI   +  L  L  +  S 
Sbjct: 16  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71

Query: 315 NNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLN------D 368
           N L    P            + +       +               +            +
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 369 SLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEF 428
            L L    + ++           ++ +S        L  + +++ L++SSN +S      
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189

Query: 429 LQNLSFLEFL 438
           L  L+ LE L
Sbjct: 190 LAKLTNLESL 199

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (93), Expect = 3e-04
 Identities = 25/114 (21%), Positives = 48/114 (42%), Gaps = 5/114 (4%)

Query: 103 SLPFDILVNLPN--LKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLD 160
           +   D+++N  +     L +   ++  L  LNL  +N  +     +   +  A NL+ L+
Sbjct: 40  AQNIDVVLNRRSSMAATLRIIEENIPELLSLNL--SNNRLYRLDDMSSIVQKAPNLKILN 97

Query: 161 LSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFV-TLLTNCSSLKAL 213
           LSGN+ K +  +D      L  L L+ N+L     +   ++  +      L  L
Sbjct: 98  LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (91), Expect = 5e-04
 Identities = 25/145 (17%), Positives = 48/145 (33%), Gaps = 6/145 (4%)

Query: 249 IPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLA 308
           +   +    +     +++  L       +        L    +    ++     N+ +L 
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68

Query: 309 DLALSFNNLQG--NIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLL 366
            L LS N L    ++ S +    NLK  + S N+L  +  +           L L  N L
Sbjct: 69  SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSL 127

Query: 367 NDSLPLQVGNLKNLVITCVSLEYLD 391
           +D+   Q   +  +      L  LD
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLD 152

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (88), Expect = 0.001
 Identities = 13/77 (16%), Positives = 25/77 (32%), Gaps = 7/77 (9%)

Query: 113 PNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSI 172
             L E    + +      L+L    +       I +  +     + +D S N+   +   
Sbjct: 5   AELIEQAAQYTNAVRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNEI--RKLD 57

Query: 173 DFSSLKNLWWLNLEQNN 189
            F  L+ L  L +  N 
Sbjct: 58  GFPLLRRLKTLLVNNNR 74

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 21/152 (13%), Positives = 41/152 (26%), Gaps = 9/152 (5%)

Query: 45  LLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSL 104
           LL+  N LG      L      +     +              +S              +
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI 93

Query: 105 PFDILVNLPNLKELYLTFCSLKNLW------WLNLEQNNLGMGTASSIPDSLSNASNLER 158
              + + L  LK L L    +  +         +L   NL     +        A  L +
Sbjct: 94  SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRK 153

Query: 159 LDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNL 190
             L+G   +       S ++++   +L  +  
Sbjct: 154 KSLNGGAARCGA---PSKVRDVQIKDLPHSEF 182

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	854
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.83
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.82
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.8
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.8
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.79
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.78
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.77
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.62
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.61
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.6
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.6
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.58
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.54
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.53
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.52
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.45
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.41
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.41
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.34
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.7
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.63
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.87
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.84
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.81
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.72
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.34
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.05
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.04
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.18
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.97

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=418.89  Aligned_cols=260  Identities=28%  Similarity=0.444  Sum_probs=202.7

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|.+.+.||+|+||+||+|++++   .||||+++..  .....+.|.+|++++++++|||||++++++.+.      ..
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~------~~   78 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------QL   78 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc------EE
Confidence            578899999999999999998763   4999999644  344567899999999999999999999997542      46


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++|||||++|+|.+++.....     .+++.++..|+.|||+||+|||++   +||||||||+|||++.++..++ |||+
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGl  150 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGL  150 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred             EEEEecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccc
Confidence            999999999999999976542     689999999999999999999999   9999999999999999988777 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc-CC
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMG---SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT-LP  780 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~  780 (854)
                      |+......... ......||+.|||||++.+   ..++.++|||||||++|||+||+.||....... .....+... .+
T Consensus       151 a~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~  228 (276)
T d1uwha_         151 ATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYLS  228 (276)
T ss_dssp             SCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHTSCC
T ss_pred             eeeccccCCcc-cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCC
Confidence            98775433221 2223579999999999865   347999999999999999999999997543221 111111111 11


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      ...                       ......+++++.+++.+||+.||++||||+||++.|+.+.++.
T Consensus       229 p~~-----------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         229 PDL-----------------------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CCG-----------------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             Ccc-----------------------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            110                       0011223567889999999999999999999999999987653

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=417.13  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=203.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++|||||++++++.+.+     ..
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-----~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-----ee
Confidence            468999999999999999999999899999999997543 233456899999999999999999999998765     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      |+|||||++|+|.+++....      .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..++ |||+
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~  149 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  149 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence            99999999999999997654      789999999999999999999999   9999999999999998876666 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      |+......... .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||............+.........
T Consensus       150 a~~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~  228 (271)
T d1nvra_         150 ATVFRYNNRER-LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP  228 (271)
T ss_dssp             CEECEETTEEC-CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT
T ss_pred             heeeccCCccc-cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence            99875443221 2234679999999999988775 678999999999999999999998654333222222221111000


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                                                ...++.++.+++.+||+.||++|||++|+++
T Consensus       229 --------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         229 --------------------------WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             --------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                                      0112345678999999999999999999865

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=414.96  Aligned_cols=249  Identities=22%  Similarity=0.308  Sum_probs=206.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+     ..|+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-----EEEE
Confidence            46999999999999999999999899999999998766666788999999999999999999999998765     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      |||||+||+|.+++...       .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..++ |||+|+
T Consensus        95 vmEy~~gg~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             EEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence            99999999999987653       689999999999999999999999   9999999999999998877666 999999


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .+.......   ...+||+.|+|||++.+..++.++||||+||++|||+||+.||....... .+........+.    .
T Consensus       165 ~~~~~~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~----~  236 (293)
T d1yhwa1         165 QITPEQSKR---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE----L  236 (293)
T ss_dssp             ECCSTTCCB---CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC----C
T ss_pred             eeccccccc---cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCC----C
Confidence            875543222   23579999999999999999999999999999999999999997542211 111111111000    0


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .                     ....++..+.+++.+||+.||++|||++|+++
T Consensus       237 ~---------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 Q---------------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             S---------------------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             C---------------------CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0                     01112456789999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-50  Score=410.43  Aligned_cols=246  Identities=23%  Similarity=0.363  Sum_probs=204.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++...   .....+.+.+|++++++++|||||++++++.+.+     
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-----   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-----
Confidence            46899999999999999999999999999999998642   3345677899999999999999999999998765     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+|||||++|+|.+++....      .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..++ ||
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DF  150 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF  150 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeeccc
Confidence            7899999999999999998765      789999999999999999999999   9999999999999998877776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+|+.......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........  .
T Consensus       151 G~a~~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~--~  222 (263)
T d2j4za1         151 GWSVHAPSSRR-----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRISRVEF--T  222 (263)
T ss_dssp             CSCSCCCCCCC-----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCC--C
T ss_pred             ceeeecCCCcc-----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCC--C
Confidence            99987654322     2357999999999999999999999999999999999999999753211 11111111100  0


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .                          ++.+++++.+++.+||+.||++|||++|+++
T Consensus       223 ~--------------------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 F--------------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             C--------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C--------------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            0                          0112455788999999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-50  Score=411.15  Aligned_cols=256  Identities=25%  Similarity=0.393  Sum_probs=197.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|++.+.||+|+||+||+|++. ++..||||+++... ...+++.+|++++++++|||||+++|+|...+     ..++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~l   77 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICL   77 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEE
Confidence            47888999999999999999997 57789999997543 34578999999999999999999999997655     5799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++|+|.+++.....     .+++..+..|+.|||.||+|||+.   +|+||||||+||+++.++..++ |||+++
T Consensus        78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             EEEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence            9999999999999876542     688999999999999999999999   9999999999999999987777 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhC-CCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTG-RRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      .........  .....||+.|+|||++.+..++.++|||||||++|||+|+ ++||... .. ....+.+.....     
T Consensus       150 ~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~-~~~~~~i~~~~~-----  220 (263)
T d1sm2a_         150 FVLDDQYTS--STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SN-SEVVEDISTGFR-----  220 (263)
T ss_dssp             -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CH-HHHHHHHHHTCC-----
T ss_pred             eccCCCcee--ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CH-HHHHHHHHhcCC-----
Confidence            775543322  2234689999999999999999999999999999999995 5555432 11 111111111110     


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ...                     +..++.++.+++.+||+.||++||||+||++.|+++.++
T Consensus       221 ~~~---------------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         221 LYK---------------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             CCC---------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCC---------------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            001                     112245688999999999999999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=411.50  Aligned_cols=262  Identities=21%  Similarity=0.331  Sum_probs=210.9

Q ss_pred             hhccccCc-cCCCcceEEEEeEECC--CceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNM-IGQGSFGSVYKGILGG--EEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~-lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ++|.+.+. ||+|+||+||+|.++.  ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+.      
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------
Confidence            46777774 9999999999998753  45689999997543 33457899999999999999999999998643      


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+|||||++|+|.+++...+.     .+++.++..|+.|||.||+|||++   +|+||||||+||+++.++.+++ ||
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             eEEEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence            36899999999999999866542     689999999999999999999999   9999999999999999988777 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |+|+................||+.|+|||++.+..++.++|||||||++|||+| |+.||.....  ......+..... 
T Consensus       154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~~~~-  230 (285)
T d1u59a_         154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKR-  230 (285)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTCC-
T ss_pred             hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC-
Confidence            999988765544333444569999999999998899999999999999999998 9999975422  122222211100 


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhc
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLG  851 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  851 (854)
                                               .+.+..++.++.+++.+||+.||++||||.+|.+.|+....++..
T Consensus       231 -------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~  275 (285)
T d1u59a_         231 -------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  275 (285)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             -------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence                                     011122356688999999999999999999999999988765543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-49  Score=415.78  Aligned_cols=260  Identities=26%  Similarity=0.419  Sum_probs=196.1

Q ss_pred             hccccCccCCCcceEEEEeEECCCce---EEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEM---IVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      +|++.++||+|+||+||+|++..+++   .||||++... .....+.|.+|+++|++++|||||+++|+|...+     .
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-----~  101 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-----P  101 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-----S
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-----E
Confidence            45567899999999999999975553   6899988654 3334567999999999999999999999997655     6


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++|||||++|+|.+++.....     .+++.++..|+.|||+||+|||++   +|+||||||+|||++.++.+++ |||
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  173 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFG  173 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcc
Confidence            7999999999999999886542     689999999999999999999999   9999999999999999988877 999


Q ss_pred             cccccccCCCCC--CcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          704 LSHQLDSASKTP--SSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       704 ~~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      +|+.........  ....+..||+.|+|||++.+..++.++|||||||++|||+| |+.||......  .....+.....
T Consensus       174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~~  251 (299)
T d1jpaa_         174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDYR  251 (299)
T ss_dssp             ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC
T ss_pred             cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC
Confidence            998876543322  22233568999999999999999999999999999999998 89999754221  11111111100


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                                                .+...+++.++.+++.+||+.||++||||+||++.|+++.++-
T Consensus       252 --------------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         252 --------------------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence                                      0011223566889999999999999999999999999987653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-49  Score=414.57  Aligned_cols=259  Identities=23%  Similarity=0.411  Sum_probs=210.9

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||+||+|++..+++.||||+++... ...+++.+|++++++++|||||+++++|.+.+     ..+
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~   89 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFY   89 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC-----eeE
Confidence            468999999999999999999999899999999987543 34578999999999999999999999997655     679


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +|||||++|+|.+++......    .+++..++.|+.|||.||+|||++   +|+||||||+|||++.++.+++ |||+|
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~----~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTT----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             EEeecccCcchHHHhhhcccc----chHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence            999999999999999865432    789999999999999999999999   9999999999999999988777 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      +.........  ..+..||+.|+|||++.+..++.++|||||||++|||++|..||...... ....+.+.......   
T Consensus       163 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~~~~i~~~~~~~---  236 (287)
T d1opja_         163 RLMTGDTYTA--HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME---  236 (287)
T ss_dssp             TTCCSSSSEE--ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTCCCC---
T ss_pred             eecCCCCcee--eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HHHHHHHhcCCCCC---
Confidence            8775543322  22345889999999999999999999999999999999977776533221 11112221111100   


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                                             ....++.++.+++.+||+.||++||||+||++.|+.+.+
T Consensus       237 -----------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         237 -----------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             -----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             -----------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                                   111235568899999999999999999999999988754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=409.08  Aligned_cols=256  Identities=25%  Similarity=0.404  Sum_probs=205.0

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|++.+.||+|+||+||+|+++ ++..||||+++... ...+.+.+|++++++++|||||+++|++.+.      ..++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------~~~i   84 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIYI   84 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC------CeEE
Confidence            58999999999999999999997 67889999997543 3457899999999999999999999988543      3689


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++|+|.+++.....    ..+++.+++.|+.|||+||+|||++   +|+||||||+|||++.++.+++ |||+|+
T Consensus        85 v~Ey~~~g~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~  157 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR  157 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceE
Confidence            9999999999998876532    2689999999999999999999999   9999999999999999988877 999999


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .........  .....||+.|+|||++.+..++.++|||||||++|||+||..|+....... .....+.....      
T Consensus       158 ~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i~~~~~------  228 (272)
T d1qpca_         158 LIEDNEYTA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGYR------  228 (272)
T ss_dssp             ECSSSCEEC--CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCC------
T ss_pred             EccCCcccc--ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCC------
Confidence            876543221  223468999999999998899999999999999999999665544322111 11111111000      


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                                          ...+..+++++.+++.+||+.||++||||+||++.|++...
T Consensus       229 --------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         229 --------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                                00111235568899999999999999999999999988754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=411.86  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=204.8

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      +.|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++.+.+     ..++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----eEEE
Confidence            46899999999999999999999999999999998776667788999999999999999999999998765     7899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      |||||++|+|.+++.....     .+++.++..++.||+.||+|||++   +|+||||||+|||++.++..++ |||+|+
T Consensus        87 vmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~  158 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA  158 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence            9999999999999876432     689999999999999999999999   9999999999999998887776 999997


Q ss_pred             ccccCCCCCCcccccCCcccccCccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGM-----GSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ........   .....||+.|+|||++.     +..++.++|||||||++|||+||+.||....... .+........+.
T Consensus       159 ~~~~~~~~---~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~~  234 (288)
T d2jfla1         159 KNTRTIQR---RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPPT  234 (288)
T ss_dssp             ECHHHHHH---HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCCC
T ss_pred             ccCCCccc---ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCCC
Confidence            66442211   12346999999999874     4558999999999999999999999997543221 112222111100


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                          ..                     ....++.++.+++.+||+.||++|||++|+++
T Consensus       235 ----~~---------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 ----LA---------------------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ----CS---------------------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CC---------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00                     01122456789999999999999999999976

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-49  Score=404.54  Aligned_cols=249  Identities=23%  Similarity=0.343  Sum_probs=196.3

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      |+..++||+|+||+||+|++..+++.||+|++....  ....+.+.+|++++++++|||||++++++.+.. .+....++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            356678999999999999999999999999997543  334567899999999999999999999987643 22336899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeecCCCCceEecC-Cccccc-ccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPP--IVHGDLKPSNVLLDH-DMVAHQ-NFS  703 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~-~~~~~~-Dfg  703 (854)
                      ||||+++|+|.+++....      .+++.+++.++.||+.||+|||++   +  |+||||||+|||++. ++..++ |||
T Consensus        90 vmE~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFG  160 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  160 (270)
T ss_dssp             EEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEeCCCCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence            999999999999998764      789999999999999999999998   6  999999999999964 555555 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +|+......     ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||..................+...
T Consensus       161 la~~~~~~~-----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~  234 (270)
T d1t4ha_         161 LATLKRASF-----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF  234 (270)
T ss_dssp             GGGGCCTTS-----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred             cceeccCCc-----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCccc
Confidence            997644322     223579999999999875 59999999999999999999999997542221111111111111100


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .                          ..+++++.+++.+||+.||++|||++|+++
T Consensus       235 ~--------------------------~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         235 D--------------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             G--------------------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C--------------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            0                          111345788999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=409.39  Aligned_cols=257  Identities=19%  Similarity=0.269  Sum_probs=193.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...  ....+.+.+|++++++++|||||++++++.+...   ...
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~---~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC---CEE
Confidence            68999999999999999999999999999999997543  2334678999999999999999999999865332   257


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeecCCCCceEecCCccccc-cc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC--QPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      |+|||||++|+|.+++......  ...+++.+++.++.||+.||+|||++.  ..+|+||||||+|||++.++..++ ||
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             EEEEecCCCCcHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            9999999999999999754211  127899999999999999999999972  114999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+|+........   .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ...........+ .
T Consensus       159 G~a~~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-~~~~~i~~~~~~-~  233 (269)
T d2java1         159 GLARILNHDTSF---AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIREGKFR-R  233 (269)
T ss_dssp             HHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCCC-C
T ss_pred             cceeecccCCCc---cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCCC-C
Confidence            999987654322   12357999999999999999999999999999999999999999753221 111111111110 0


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                          +                      ...+++++.+++.+||+.||.+|||++|+++
T Consensus       234 ----~----------------------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 ----I----------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----C----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----C----------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                0                      0112456889999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-49  Score=408.44  Aligned_cols=261  Identities=25%  Similarity=0.415  Sum_probs=199.8

Q ss_pred             hhccccCccCCCcceEEEEeEECCCc----eEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEE----MIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      ++|+..++||+|+||+||+|.++.++    ..||||+++... .....+|.+|++++++++|||||+++|++.+.+    
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~----   82 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK----   82 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC----
Confidence            56888999999999999999986543    579999996543 233457899999999999999999999997655    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                       ..++||||+++|++.+++.....     .+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++.+++ |
T Consensus        83 -~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~D  153 (283)
T d1mqba_          83 -PMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD  153 (283)
T ss_dssp             -SEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             -ceEEEEEecccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcc
Confidence             67999999999999998876543     789999999999999999999999   9999999999999999988887 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      ||+++................||+.|+|||++.+..++.++|||||||++|||++|..|+....... ...+.+..... 
T Consensus       154 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~~~-  231 (283)
T d1mqba_         154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFR-  231 (283)
T ss_dssp             CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCC-
T ss_pred             cchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHHHHhccCC-
Confidence            9999887655443333344568999999999999999999999999999999999766654322211 11111111100 


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                                               .+....++.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus       232 -------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         232 -------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                                     011122356688999999999999999999999999988764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-49  Score=406.60  Aligned_cols=252  Identities=25%  Similarity=0.339  Sum_probs=201.1

Q ss_pred             CccCCCcceEEEEeEEC--CCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEEE
Q 043388          554 NMIGQGSFGSVYKGILG--GEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALVF  629 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  629 (854)
                      ++||+|+||+||+|.+.  ++++.||||+++..  +....+++.+|++++++++|||||+++++|...      ..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence            47999999999999864  35678999999643  233456799999999999999999999998643      368999


Q ss_pred             eeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccccc
Q 043388          630 EYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQL  708 (854)
Q Consensus       630 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~~  708 (854)
                      ||+++|+|.+++....      .+++.+++.|+.|||.||+|||++   +|+||||||+|||++.++..++ |||+++..
T Consensus        87 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~  157 (277)
T d1xbba_          87 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  157 (277)
T ss_dssp             ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EcCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence            9999999999998765      789999999999999999999999   9999999999999999887776 99999987


Q ss_pred             ccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccccc
Q 043388          709 DSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIEIV  787 (854)
Q Consensus       709 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  787 (854)
                      ..............||+.|+|||.+.+..++.++|||||||++|||+| |+.||......  .....+.....       
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~~-------  228 (277)
T d1xbba_         158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER-------  228 (277)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC-------
T ss_pred             cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCCC-------
Confidence            655443333344579999999999999999999999999999999998 89999754221  11221111100       


Q ss_pred             CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          788 DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       788 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                                         .+.+..++.++.+++.+||+.||++||||+||.++|+....+
T Consensus       229 -------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         229 -------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -------------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                               011122356688999999999999999999999998876543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=417.75  Aligned_cols=201  Identities=25%  Similarity=0.382  Sum_probs=177.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      .++|++.++||+|+||+||+|++..+++.||+|+++... ....+.+.+|+.++++++|||||+++++|.+.+     ..
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-----EE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EE
Confidence            468999999999999999999999999999999997543 334567899999999999999999999998765     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      |+|||||+||+|.+++.+.+      .+++.+++.++.|++.||.|||+++  +|+||||||+|||++.++..++ |||+
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGl  151 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV  151 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCC
Confidence            99999999999999998765      6899999999999999999999732  8999999999999998877776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcc
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAF  765 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~  765 (854)
                      |+.......     ...+||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       152 a~~~~~~~~-----~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         152 SGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             CHHHHHHTC--------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             ccccCCCcc-----ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            997754322     23579999999999999999999999999999999999999997643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-48  Score=395.52  Aligned_cols=253  Identities=25%  Similarity=0.412  Sum_probs=207.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|+..++||+|+||+||+|+++ +++.||||+++.... ..+++.+|+.++++++||||++++|+|.+.+     ..++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-----~~~i   76 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIFI   76 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-----SEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceEE
Confidence            57899999999999999999997 788999999986543 3478999999999999999999999997654     6899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++|+|.+++.....     .+++..+++|+.|+|+||+|||+.   +|+||||||+||+++.++..++ |||+++
T Consensus        77 v~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             EEEccCCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence            9999999999999776542     688999999999999999999999   9999999999999999888777 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVIE  785 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  785 (854)
                      ........  ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......  .....+.....     
T Consensus       149 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~~~-----  219 (258)
T d1k2pa_         149 YVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLR-----  219 (258)
T ss_dssp             BCSSSSCC--CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCC-----
T ss_pred             eccCCCce--eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhCCC-----
Confidence            77654332  2233569999999999999999999999999999999998 89999754322  11111111100     


Q ss_pred             ccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          786 IVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       786 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ...|                     ..++.++.+++.+||+.||++|||++|+++.|.++
T Consensus       220 ~~~p---------------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         220 LYRP---------------------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCC---------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCc---------------------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            0011                     12245688999999999999999999999998653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=405.55  Aligned_cols=249  Identities=20%  Similarity=0.341  Sum_probs=202.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..   .....+.+.+|++++++++|||||++++++.+.+     .
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----K   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-----E
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-----E
Confidence            6899999999999999999999989999999999643   3345578999999999999999999999998765     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+|||||++|+|.+++...+      .+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++..++ |||
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEccCCCCHHHhhhccC------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence            899999999999999988765      789999999999999999999999   9999999999999999877766 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +|+.+....... .....+||+.|+|||++.+..++.++||||+||++|||+||+.||...... ...........  ..
T Consensus       154 ~a~~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~~--~~  229 (288)
T d1uu3a_         154 TAKVLSPESKQA-RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LIFQKIIKLEY--DF  229 (288)
T ss_dssp             TCEECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHTTCC--CC
T ss_pred             cceecccCCccc-ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-HHHHHHHcCCC--CC
Confidence            998876443222 122357999999999999999999999999999999999999999753211 11111111100  00


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                          .                      ..+++.+.+++.+||+.||++|||++|+++
T Consensus       230 ----p----------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         230 ----P----------------------EKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ----C----------------------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ----C----------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                0                      112445789999999999999999999754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-48  Score=407.05  Aligned_cols=245  Identities=22%  Similarity=0.292  Sum_probs=199.5

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc---cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ..|+..+.||+|+||+||+|++..+++.||||+++....   ...+.+.+|++++++++|||||++++++.+.+     .
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----E
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-----E
Confidence            459999999999999999999999999999999975432   23457889999999999999999999998765     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+|||||++|++..++....      .+++.+++.++.||+.||+|||++   +||||||||+|||++.++..++ |||
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG  160 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             EEEEEEecCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence            899999999999987776554      789999999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG---SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      +|+......       ...||+.|||||++.+   ..++.++|||||||++|||++|+.||...... ..+........+
T Consensus       161 ~a~~~~~~~-------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~~~~~~  232 (309)
T d1u5ra_         161 SASIMAPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP  232 (309)
T ss_dssp             TCBSSSSBC-------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCC
T ss_pred             cccccCCCC-------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCC
Confidence            998664422       2469999999999864   45899999999999999999999999754221 111111111111


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .    ..+                      ..+++++.+++.+||+.||++|||++|+++
T Consensus       233 ~----~~~----------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 A----LQS----------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             C----CSC----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C----CCC----------------------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            0    000                      012456789999999999999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.4e-48  Score=404.63  Aligned_cols=250  Identities=24%  Similarity=0.299  Sum_probs=186.7

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      +.|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+     ..|
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~   83 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-----HLY   83 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS-----EEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEE
Confidence            56999999999999999999999899999999997543 223456789999999999999999999997765     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec---CCcccc-ccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAH-QNF  702 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~~-~Df  702 (854)
                      +|||||+||+|.+++...+      .+++.++..++.||+.||+|||++   +|+||||||+||++.   .++..+ +||
T Consensus        84 lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DF  154 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDF  154 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecc
Confidence            9999999999999998754      789999999999999999999999   999999999999995   345455 499


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+|+........    ...+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..............
T Consensus       155 G~a~~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~~~~~  229 (307)
T d1a06a_         155 GLSKMEDPGSVL----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAEYEFD  229 (307)
T ss_dssp             ----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHTTCCCCC
T ss_pred             ceeEEccCCCee----eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCCCC
Confidence            999876544322    2356999999999999999999999999999999999999999754221 11111111111000


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                        .                      +....+++.+.+++.+||+.||++|||++|+++
T Consensus       230 --~----------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         230 --S----------------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             --T----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --C----------------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              0                      001112456789999999999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.2e-48  Score=400.61  Aligned_cols=264  Identities=19%  Similarity=0.335  Sum_probs=203.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...   ....+.+.+|++++++++|||||++++++...+. ....
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~-~~~~   85 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGPL   85 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS-SSEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC-CCce
Confidence            57999999999999999999999899999999997543   2334578999999999999999999999876542 2235


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+||||++||+|.+++...+      .+++.+++.|+.||+.||+|||++   +|+||||||+||+++.++..++ |||
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~  156 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  156 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred             EEEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence            799999999999999988765      789999999999999999999999   9999999999999998877776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      .+................+||+.|+|||++.+..+++++||||+||++|||+||+.||....... ............  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~~~~~~~~--  233 (277)
T d1o6ya_         157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVREDPIP--  233 (277)
T ss_dssp             TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCCCCC--
T ss_pred             hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHHHhcCCCC--
Confidence            98877655444444445679999999999999999999999999999999999999997542211 111111110000  


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-CHHHHHHHHHhhh
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-EMRDVVAKLCHTR  846 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~  846 (854)
                      ...                      ....+++++.+++.+||+.||++|| |++++.+.|.++.
T Consensus       234 ~~~----------------------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         234 PSA----------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             GGG----------------------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             Cch----------------------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            000                      0111245688999999999999999 8999999988765

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-48  Score=408.65  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=205.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCc-----eEEEEEEeecc-cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEE-----MIVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSK  620 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  620 (854)
                      ++|++.++||+|+||+||+|++.+.+     ..||+|++... .......+.+|+.++.++ +|||||+++++|.+.+  
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG--  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC--
Confidence            58999999999999999999986433     47999998643 334456789999999998 8999999999998765  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCc-----------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDH-----------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHG  683 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  683 (854)
                         ..++|||||++|+|.++++.....                 .....+++.+++.|+.||+.||+|||++   +||||
T Consensus       115 ---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR  188 (325)
T d1rjba_         115 ---PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  188 (325)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             ---eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence               689999999999999999865421                 1123589999999999999999999999   99999


Q ss_pred             cCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 043388          684 DLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPT  761 (854)
Q Consensus       684 Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf  761 (854)
                      ||||+||+++.++.+++ |||+|+......... ......||+.|||||++.+..++.++|||||||++|||+| |+.||
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCcee-eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            99999999999987777 999998776544322 1223458999999999999999999999999999999998 89999


Q ss_pred             CCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          762 DAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       762 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .+.... ..+...+.......                          .+..+++++.+++.+||+.||++||||+||++.
T Consensus       268 ~~~~~~-~~~~~~~~~~~~~~--------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         268 PGIPVD-ANFYKLIQNGFKMD--------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TTCCCS-HHHHHHHHTTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHH-HHHHHHHhcCCCCC--------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            754322 22222222211110                          111235568899999999999999999999999


Q ss_pred             HHh
Q 043388          842 LCH  844 (854)
Q Consensus       842 L~~  844 (854)
                      |..
T Consensus       321 L~~  323 (325)
T d1rjba_         321 LGC  323 (325)
T ss_dssp             HHH
T ss_pred             HhC
Confidence            853

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-47  Score=397.85  Aligned_cols=250  Identities=22%  Similarity=0.307  Sum_probs=203.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc------ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ------KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...      ....+.+.+|++++++++|||||++++++.+.+   
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---   86 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT---   86 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence            56999999999999999999999899999999996432      123577999999999999999999999998765   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc-----
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-----  696 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----  696 (854)
                        ..|+|||||++|+|.+++....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++     
T Consensus        87 --~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~  155 (293)
T d1jksa_          87 --DVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR  155 (293)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCC
T ss_pred             --EEEEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccc
Confidence              7899999999999999998764      789999999999999999999999   999999999999998765     


Q ss_pred             ccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh
Q 043388          697 VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK  776 (854)
Q Consensus       697 ~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~  776 (854)
                      ++++|||+|.........    ....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+.....
T Consensus       156 vkl~DfG~a~~~~~~~~~----~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~  230 (293)
T d1jksa_         156 IKIIDFGLAHKIDFGNEF----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSA  230 (293)
T ss_dssp             EEECCCTTCEECTTSCBC----SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHT
T ss_pred             eEecchhhhhhcCCCccc----cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-HHHHHHHh
Confidence            344599999887654322    2346999999999999999999999999999999999999999754211 11111111


Q ss_pred             hcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          777 MTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       777 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .....                        .......++..+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         231 VNYEF------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TCCCC------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCCC------------------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10000                        00011122456789999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.1e-47  Score=408.19  Aligned_cols=253  Identities=19%  Similarity=0.283  Sum_probs=205.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.++++++|||||++++++.+.+     ..|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-----EEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEE
Confidence            468999999999999999999999999999999997665555678899999999999999999999998765     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC--Ccccc-cccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH--DMVAH-QNFS  703 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~~-~Dfg  703 (854)
                      +|||||+||+|.+++.....     .+++.+++.|+.||+.||+|||++   +||||||||+|||++.  ++..+ +|||
T Consensus       100 ivmE~~~gg~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence            99999999999999965432     689999999999999999999999   9999999999999964  34444 5999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +|+........    ....||+.|||||++.+..++.++||||+||++|||++|+.||.+.... ..+..........  
T Consensus       172 ~a~~~~~~~~~----~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~--  244 (350)
T d1koaa2         172 LTAHLDPKQSV----KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWNM--  244 (350)
T ss_dssp             TCEECCTTSCE----EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCS--
T ss_pred             hheeccccccc----ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCC--
Confidence            99887654332    2356999999999999999999999999999999999999999754221 1111211111100  


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                          ++.                  ....+++.+.+++.+||+.||++|||++|+++.
T Consensus       245 ----~~~------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 ----DDS------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ----CCG------------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ----Ccc------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                000                  001124557899999999999999999999873

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6e-47  Score=404.88  Aligned_cols=252  Identities=18%  Similarity=0.243  Sum_probs=204.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.+.||+|+||.||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++.+.+     ..|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----EMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-----EEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEE
Confidence            357999999999999999999999899999999997665555567889999999999999999999998755     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec--CCccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDMVA-HQNFS  703 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~-~~Dfg  703 (854)
                      +|||||+||+|.+++.....     .+++.+++.|+.||+.||+|||++   +|+||||||+|||++  .++.. ++|||
T Consensus       103 ivmE~~~gg~L~~~~~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG  174 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  174 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             EEEEcCCCChHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence            99999999999998776532     689999999999999999999999   999999999999997  34444 45999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +|+........    ....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... ..+..........  
T Consensus       175 la~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~--  247 (352)
T d1koba_         175 LATKLNPDEIV----KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWEF--  247 (352)
T ss_dssp             TCEECCTTSCE----EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCCC--
T ss_pred             cceecCCCCce----eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCC--
Confidence            99987654322    2346999999999999999999999999999999999999999754221 1111111111110  


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...                      ....++.++.+++.+||+.||.+|||++|+++
T Consensus       248 ~~~----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         248 DED----------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             CSS----------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             Ccc----------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000                      00112455789999999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=395.88  Aligned_cols=256  Identities=27%  Similarity=0.413  Sum_probs=199.4

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|++.+.||+|+||.||+|++++ +..||||+++.... ..+.|.+|+.++++++|||||+++|+|.+.      ..++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~------~~~l   88 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIYI   88 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEecC------CeEE
Confidence            689999999999999999999984 45799999975433 357899999999999999999999998542      3689


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||+++|+|.+++.....    ..++|.+++.|+.|||.||+|||+.   +|+||||||+|||++.++.+++ |||+++
T Consensus        89 v~Ey~~~g~l~~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~  161 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR  161 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             EEEecCCCchhhhhhhccc----ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhh
Confidence            9999999999999876532    1689999999999999999999999   9999999999999999887776 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      .........  .....||+.|+|||++.++.++.++|||||||++|||+||..|+....... .....+.......    
T Consensus       162 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~i~~~~~~~----  234 (285)
T d1fmka3         162 LIEDNEYTA--RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYRMP----  234 (285)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCCCC----
T ss_pred             hccCCCcee--eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCCCC----
Confidence            775443222  223468999999999999999999999999999999999766654332221 1111111111100    


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                                            ....+++++.+++.+||+.||++||||++|+++|+....
T Consensus       235 ----------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         235 ----------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ----------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence                                  111235568899999999999999999999999887654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=389.50  Aligned_cols=253  Identities=30%  Similarity=0.395  Sum_probs=198.2

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|++.++||+|+||.||+|+++  +..||||+++..  ...+.+.+|++++++++||||++++|+|.+...    ..+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~----~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG----GLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC----cEE
Confidence            357889999999999999999995  678999999643  345789999999999999999999999865331    469


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      +||||+++|+|.+++.....    ..+++..+++|+.||+.||+|||+.   +|+||||||+||+++.++..++ |||++
T Consensus        78 lv~ey~~~g~L~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s  150 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  150 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccc
Confidence            99999999999999976531    2689999999999999999999999   9999999999999999988877 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCcccc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPEKVI  784 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  784 (854)
                      +........      ..+|+.|+|||++.+..+++++|||||||++|||+| |++||......  .....+.......  
T Consensus       151 ~~~~~~~~~------~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~~~~--  220 (262)
T d1byga_         151 KEASSTQDT------GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMD--  220 (262)
T ss_dssp             -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCCCC--
T ss_pred             eecCCCCcc------ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCCCC--
Confidence            876543322      358899999999999999999999999999999998 78887653222  2222221111110  


Q ss_pred             cccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          785 EIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       785 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                                              .+..++.++.+++.+||+.||++||||.|++++|++++..
T Consensus       221 ------------------------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         221 ------------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             ------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------------------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence                                    1112245678999999999999999999999999988653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=394.38  Aligned_cols=257  Identities=27%  Similarity=0.362  Sum_probs=197.3

Q ss_pred             hhccccCccCCCcceEEEEeEECC---CceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG---EEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      ++|++.+.||+|+||.||+|++..   ....||||+++..   .....++|.+|++++++++|||||+++|+|.+.    
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~----   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP----   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence            579999999999999999998743   2457999998643   333456899999999999999999999999653    


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                        ..++||||+++|++.+++.....     .+++..++.++.|||.||+|||++   +|+||||||+||+++.++.+++ 
T Consensus        84 --~~~lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~  153 (273)
T d1u46a_          84 --PMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG  153 (273)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred             --chheeeeeecCcchhhhhhcccC-----CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence              36899999999999998876542     689999999999999999999999   9999999999999999887777 


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                      |||+++................||..|+|||++.+..++.++|||||||++|||+| |+.||....... ..........
T Consensus       154 DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-~~~~i~~~~~  232 (273)
T d1u46a_         154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKIDKEGE  232 (273)
T ss_dssp             CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTSCC
T ss_pred             cchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-HHHHHHhCCC
Confidence            99999988665544333344568999999999999999999999999999999998 899997532211 1111111110


Q ss_pred             CcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 043388          780 PEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHT  845 (854)
Q Consensus       780 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  845 (854)
                      ..                          +....++..+.+++.+||+.||++||||.||.+.|++.
T Consensus       233 ~~--------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 RL--------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC--------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            00                          01112245688999999999999999999999998875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=397.92  Aligned_cols=257  Identities=23%  Similarity=0.378  Sum_probs=202.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCce----EEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEM----IVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGA  622 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  622 (854)
                      .+|++.++||+|+||+||+|++..+++    .||+|+++.. .....+.+.+|++++++++|||||+++|+|.+..    
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~----   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST----   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----
Confidence            479999999999999999999987765    5888888643 3445678999999999999999999999997643    


Q ss_pred             ceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-c
Q 043388          623 DFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-N  701 (854)
Q Consensus       623 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-D  701 (854)
                        .+++|||+.+|+|.+++.....     .+++.+++.|+.|||.||+|||++   +|+||||||+||+++.++.+++ |
T Consensus        85 --~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D  154 (317)
T d1xkka_          85 --VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD  154 (317)
T ss_dssp             --EEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred             --eeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeec
Confidence              6889999999999998887543     789999999999999999999999   9999999999999999987777 9


Q ss_pred             cccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCC
Q 043388          702 FSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       702 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      ||+|+......... ......||+.|+|||++.++.++.++|||||||++|||+| |++||+.....  .+...+.....
T Consensus       155 FGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~~~~~  231 (317)
T d1xkka_         155 FGLAKLLGAEEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGER  231 (317)
T ss_dssp             CSHHHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHHHTCC
T ss_pred             cccceecccccccc-cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC
Confidence            99999876544322 2223468999999999999999999999999999999999 78888754222  12222211110


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                                                .+.+..++..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus       232 --------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         232 --------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             --------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------------------------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                                      01112235568899999999999999999999999988754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=396.94  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=205.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|.+.+.||+|+||.||+|++..+++.||||+++..   .....+.+.+|+.+|++++||||+++++++.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-----
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc-----
Confidence            46899999999999999999999999999999999743   3445678899999999999999999999998766     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+|||||+||+|.+++...+      .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..++ ||
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF  149 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ccccceeccCCCchhhhhhccc------CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence            7899999999999999998765      789999999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+|+........   ....+||+.|+|||++.+..++.++||||+||++|||++|++||....... ..........  .
T Consensus       150 G~a~~~~~~~~~---~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~i~~~~~--~  223 (337)
T d1o6la_         150 GLCKEGISDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILMEEI--R  223 (337)
T ss_dssp             TTCBCSCCTTCC---BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC--C
T ss_pred             ccccccccCCcc---cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-HHHHHhcCCC--C
Confidence            999876543322   223579999999999999999999999999999999999999998643211 1111111100  0


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-----HHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-----MRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  840 (854)
                      .                          +..++.++.+++.+||+.||++||+     +.|+++
T Consensus       224 ~--------------------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 F--------------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             C--------------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C--------------------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            0                          0112445778999999999999995     777765

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=390.72  Aligned_cols=259  Identities=21%  Similarity=0.311  Sum_probs=197.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCC---ceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGE---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ++|.+.+.||+|+||.||+|++..+   +..||||+++... ....+.+.+|++++++++|||||++++++.+.      
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------   80 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN------   80 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS------
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------
Confidence            5799999999999999999998643   4578999886443 33356799999999999999999999998532      


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..++||||+++|++.+++.....     .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++..++ ||
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~Df  152 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF  152 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             eEEEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccc
Confidence            47999999999999998876542     689999999999999999999999   9999999999999999887776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCcccCCchHhHHhhhcCCc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFTEGLTLHEFVKMTLPE  781 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  781 (854)
                      |+|+.........  .....||+.|+|||++.+..++.++|||||||++|||+| |++||......  .....+......
T Consensus       153 G~a~~~~~~~~~~--~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~~~~~  228 (273)
T d1mp8a_         153 GLSRYMEDSTYYK--ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERL  228 (273)
T ss_dssp             --------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCC
T ss_pred             hhheeccCCccee--ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCC
Confidence            9998765443322  223468999999999999999999999999999999998 89998754322  111111111000


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFL  850 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  850 (854)
                                                +....+++++.+++.+||+.||++|||+.||++.|+++.+...
T Consensus       229 --------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k  271 (273)
T d1mp8a_         229 --------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  271 (273)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence                                      0111235668899999999999999999999999999887643

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-46  Score=396.89  Aligned_cols=264  Identities=24%  Similarity=0.382  Sum_probs=208.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECC-----CceEEEEEEeeccccc-chHHHHHHHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|++.+.||+|+||+||+|++++     +++.||||+++..... ..+++.+|++++++++||||++++++|...+  
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--   89 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK--   89 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC--
Confidence            4689999999999999999999853     5689999999754332 3567999999999999999999999997755  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCc------------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDH------------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVH  682 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  682 (854)
                         ..++||||+++|+|.+++......                  .....+++.+++.|+.|+|.||+|||++   +|||
T Consensus        90 ---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH  163 (301)
T d1lufa_          90 ---PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  163 (301)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             ---ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence               679999999999999999764321                  1123589999999999999999999999   9999


Q ss_pred             ecCCCCceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCC-CC
Q 043388          683 GDLKPSNVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGR-RP  760 (854)
Q Consensus       683 ~Dlkp~NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~-~p  760 (854)
                      |||||+|||++.++.+++ |||+|+......... ......||+.|+|||++.+..++.++|||||||++|||++|. +|
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCcccc-ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            999999999999988887 999998775543322 122356899999999999999999999999999999999986 56


Q ss_pred             CCCcccCCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          761 TDAAFTEGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       761 f~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      |......  .....+...   ..                       .+.++.++.++.+++.+||+.||++||||.||++
T Consensus       243 ~~~~~~~--e~~~~v~~~---~~-----------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         243 YYGMAHE--EVIYYVRDG---NI-----------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTTSCHH--HHHHHHHTT---CC-----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHH--HHHHHHHcC---CC-----------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6543211  111111111   00                       0011223556889999999999999999999999


Q ss_pred             HHHhhhh
Q 043388          841 KLCHTRE  847 (854)
Q Consensus       841 ~L~~~~~  847 (854)
                      +|+++.+
T Consensus       295 ~L~~i~~  301 (301)
T d1lufa_         295 ILQRMCE  301 (301)
T ss_dssp             HHHHTTC
T ss_pred             HHHHhcC
Confidence            9998753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-46  Score=393.39  Aligned_cols=261  Identities=23%  Similarity=0.414  Sum_probs=206.7

Q ss_pred             cCccCCCcceEEEEeEECCC---ceEEEEEEeecc-cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeEE
Q 043388          553 SNMIGQGSFGSVYKGILGGE---EMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKALV  628 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  628 (854)
                      .++||+|+||+||+|++..+   ...||||+++.. .....++|.+|++++++++|||||+++|+|...+.    ..++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~----~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG----SPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT----EEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC----ceEEE
Confidence            46899999999999998643   346999999643 44456789999999999999999999999865432    57999


Q ss_pred             EeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccccc
Q 043388          629 FEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSHQ  707 (854)
Q Consensus       629 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~~  707 (854)
                      ||||++|+|.+++.....     ..++.++++++.|+|.||.|+|+.   +|+||||||+|||+++++.+++ |||+++.
T Consensus       108 ~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~  179 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  179 (311)
T ss_dssp             EECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred             EEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhh
Confidence            999999999999886543     678889999999999999999999   9999999999999999988887 9999998


Q ss_pred             cccCCCC-CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcccccc
Q 043388          708 LDSASKT-PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKVIEI  786 (854)
Q Consensus       708 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  786 (854)
                      ....... ........||+.|+|||.+.+..++.++||||||+++|||+||+.||..................      .
T Consensus       180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~------~  253 (311)
T d1r0pa_         180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------L  253 (311)
T ss_dssp             TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC------C
T ss_pred             ccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC------C
Confidence            7654332 22233457999999999999999999999999999999999988887654322111111111110      0


Q ss_pred             cCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhhhcC
Q 043388          787 VDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETFLGR  852 (854)
Q Consensus       787 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~  852 (854)
                      ..                     +..++..+.+++.+||+.||++||||.||++.|+++.+.+.++
T Consensus       254 ~~---------------------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         254 LQ---------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             CC---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             CC---------------------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence            01                     1122456889999999999999999999999999999887665

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.3e-46  Score=393.69  Aligned_cols=245  Identities=24%  Similarity=0.297  Sum_probs=203.3

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCc
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+.++++++|||||++++++.+.+     
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----   77 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-----   77 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-----
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-----
Confidence            46899999999999999999999989999999999643   3345678899999999999999999999998765     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+|||||+||++.+++....      .+++..++.++.||+.||+|||++   +|+||||||+|||++.++..++ ||
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DF  148 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF  148 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eeeeEeeecCCccccccccccc------cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecC
Confidence            7899999999999999998765      678889999999999999999999   9999999999999999877776 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+|+.......      ..+||+.|+|||++.+..++.++||||+||++|||+||+.||...... ...........  .
T Consensus       149 G~a~~~~~~~~------~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~~--~  219 (316)
T d1fota_         149 GFAKYVPDVTY------TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNAEL--R  219 (316)
T ss_dssp             SSCEECSSCBC------CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHCCC--C
T ss_pred             ccceEeccccc------cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-HHHHHHHcCCC--C
Confidence            99988754332      357999999999999999999999999999999999999999753211 11111111110  0


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                      .    .                      ..+++.+.+++.+||+.||.+||     |++|+++
T Consensus       220 ~----p----------------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         220 F----P----------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             C----C----------------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             C----C----------------------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            0    0                      01134577899999999999996     8999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-46  Score=391.94  Aligned_cols=266  Identities=22%  Similarity=0.331  Sum_probs=199.6

Q ss_pred             hhccccCccCCCcceEEEEeEECC-----CceEEEEEEeeccc-ccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSK  620 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  620 (854)
                      ++|++.++||+|+||.||+|++..     +++.||||+++... ....+.+.+|..++.++ +|+||+++++++...+. 
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~-   91 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG-   91 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS-
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC-
Confidence            689999999999999999999743     45789999997433 33456788888888887 68999999999865442 


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCce
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNV  690 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  690 (854)
                         ..++|||||++|+|.+++......          .....+++.+++.++.||+.||+|||++   +||||||||+||
T Consensus        92 ---~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI  165 (299)
T d1ywna1          92 ---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  165 (299)
T ss_dssp             ---CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             ---eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence               579999999999999999865321          0123589999999999999999999999   999999999999


Q ss_pred             EecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCC-CCCCCcccCC
Q 043388          691 LLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGR-RPTDAAFTEG  768 (854)
Q Consensus       691 ll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~-~pf~~~~~~~  768 (854)
                      |++.++.+++ |||+|+......... ......||+.|+|||++.+..++.++|||||||++|||+||. +||...... 
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-  243 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-  243 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSC-CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-
T ss_pred             eECCCCcEEEccCcchhhcccccccc-ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999888877 999998765543322 223357999999999999999999999999999999999964 567643222 


Q ss_pred             chHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          769 LTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       769 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ..+...+.......                          .++.+++++.+++.+||+.||++||||+||++.|+++.++
T Consensus       244 ~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         244 EEFCRRLKEGTRMR--------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHHHHHHTCCCC--------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCC--------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            12222222111111                          0112245678999999999999999999999999998754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=393.74  Aligned_cols=280  Identities=24%  Similarity=0.303  Sum_probs=203.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHH--HHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECE--ALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~--~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|...+.||+|+||+||+|++.  |+.||||+++...   .+.+.+|.+  .+.+++|||||+++++|.+.+ ......
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEE
Confidence            57888999999999999999974  7899999996443   234444444  456789999999999998654 233367


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeecCCCCceEecCCccccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC-----QPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                      ++|||||++|+|.+++++.       .++|.++++++.|+|.||+|+|+.+     .++||||||||+|||++.++.+++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             EEEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence            9999999999999999864       6899999999999999999999731     249999999999999999988887


Q ss_pred             -ccccccccccCCCCC-CcccccCCcccccCccccCCCC------CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh
Q 043388          701 -NFSLSHQLDSASKTP-SSSIGIKGTVGYVAPEYGMGSE------ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH  772 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~  772 (854)
                       |||+++......... .......||+.|+|||++.+..      ++.++|||||||++|||+||..||...........
T Consensus       150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~  229 (303)
T d1vjya_         150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence             999999876544322 1223467999999999987642      67799999999999999999988865332211111


Q ss_pred             HHhhhcCCcccccccCchhhHHHh-hccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          773 EFVKMTLPEKVIEIVDPSLLMEVM-ANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       773 ~~~~~~~~~~~~~~~d~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      .......        ......... ......+........++...+.+++.+||+.||++||||.||++.|+++.+.
T Consensus       230 ~~~~~~~--------~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         230 DLVPSDP--------SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTSCSSC--------CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcccccc--------hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            1000000        000000000 0000000001112233467789999999999999999999999999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-45  Score=381.72  Aligned_cols=250  Identities=26%  Similarity=0.337  Sum_probs=202.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccccc---------chHHHHHHHHHHHhcc-CCCeeeEEEEeecc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKG---------AFRSFVAECEALRNIR-HRNLIKIITICSSI  617 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  617 (854)
                      ++|++.+.||+|+||+||+|++..+++.||||+++.....         ..+.+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5899999999999999999999989999999999754321         2346889999999996 99999999999876


Q ss_pred             CCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc
Q 043388          618 DSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV  697 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  697 (854)
                      +     ..|+|||||++|+|.+++....      .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.
T Consensus        83 ~-----~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~  148 (277)
T d1phka_          83 T-----FFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN  148 (277)
T ss_dssp             S-----EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             c-----ceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence            5     7899999999999999998755      789999999999999999999999   9999999999999998887


Q ss_pred             ccc-ccccccccccCCCCCCcccccCCcccccCccccCC------CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCch
Q 043388          698 AHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG------SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLT  770 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~  770 (854)
                      .++ |||+++........    ....||+.|+|||++.+      ..++.++||||+||++|||++|+.||....... .
T Consensus       149 ~kl~DFG~a~~~~~~~~~----~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~  223 (277)
T d1phka_         149 IKLTDFGFSCQLDPGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-M  223 (277)
T ss_dssp             EEECCCTTCEECCTTCCB----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred             eEEccchheeEccCCCce----eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-H
Confidence            776 99999987654332    23569999999998753      347889999999999999999999998543211 1


Q ss_pred             HhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          771 LHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       771 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ...........     .                   .+....+++++.+++.+||+.||++|||++||++
T Consensus       224 ~~~i~~~~~~~-----~-------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         224 LRMIMSGNYQF-----G-------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHTCCCC-----C-------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHhCCCCC-----C-------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11111111100     0                   0011122456889999999999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-45  Score=397.16  Aligned_cols=249  Identities=22%  Similarity=0.288  Sum_probs=197.4

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc---ccchHHHHH---HHHHHHhccCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ---KGAFRSFVA---ECEALRNIRHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~  620 (854)
                      .++|++.++||+|+||.||+|++..+|+.||||++....   ......+.+   |+.+++.++|||||++++++.+.+  
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~--   80 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--   80 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC--
Confidence            368999999999999999999999999999999986321   222233444   466677778999999999998765  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                         ..|+|||||+||+|.+++....      .+++.+++.++.||+.||+|||++   +||||||||+|||++.++..++
T Consensus        81 ---~~~ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl  148 (364)
T d1omwa3          81 ---KLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI  148 (364)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEE
T ss_pred             ---EEEEEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEE
Confidence               7899999999999999998765      678999999999999999999999   9999999999999999887766


Q ss_pred             -ccccccccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT  778 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~  778 (854)
                       |||+|+.......     ....||+.|+|||++.+ ..++.++||||+||++|||+||+.||.......  ........
T Consensus       149 ~DFGla~~~~~~~~-----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~  221 (364)
T d1omwa3         149 SDLGLACDFSKKKP-----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMT  221 (364)
T ss_dssp             CCCTTCEECSSSCC-----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHHS
T ss_pred             eeeceeeecCCCcc-----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhc
Confidence             9999987765432     23469999999999875 468999999999999999999999998643322  22222221


Q ss_pred             CCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-----HHHHHH
Q 043388          779 LPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-----MRDVVA  840 (854)
Q Consensus       779 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  840 (854)
                      ..... . ..                      ..+++++.+++.+||+.||++|||     ++|+++
T Consensus       222 ~~~~~-~-~~----------------------~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         222 LTMAV-E-LP----------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSCCC-C-CC----------------------SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ccCCC-C-CC----------------------CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            11110 0 00                      011445789999999999999999     577764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-46  Score=393.46  Aligned_cols=256  Identities=18%  Similarity=0.259  Sum_probs=198.3

Q ss_pred             HhhccccC-ccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSN-MIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|.+.+ +||+|+||.||+|++..+++.||||+++..     ..+.+|++++.++ +|||||+++++|.+... ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~-~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYA-GRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc-CCCE
Confidence            46898865 699999999999999989999999998632     5678899997765 89999999999865321 1236


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC---cc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MV-AHQ  700 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~-~~~  700 (854)
                      .|+|||||+||+|.+++......    .+++.+++.|+.||+.||+|||+.   +|+||||||+|||++.+   +. +++
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCC----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEECCCCCcHHHHHHhcCCC----CcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence            89999999999999999865322    689999999999999999999999   99999999999999863   33 445


Q ss_pred             ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC
Q 043388          701 NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP  780 (854)
Q Consensus       701 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~  780 (854)
                      |||+|+........    ....||+.|+|||++.+..++.++||||+||++|||+||+.||.+...... ....... ..
T Consensus       157 DFG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~~~-i~  230 (335)
T d2ozaa1         157 DFGFAKETTSHNSL----TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKTR-IR  230 (335)
T ss_dssp             CCTTCEECCCCCCC----CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------C-CC
T ss_pred             ccceeeeccCCCcc----ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHHHHH-Hh
Confidence            99999877654332    235699999999999999999999999999999999999999975432111 1111110 00


Q ss_pred             cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ........                   +....+++++.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~-------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         231 MGQYEFPN-------------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCSSSCCT-------------------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCCCCC-------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            00000000                   111233566889999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-46  Score=391.76  Aligned_cols=261  Identities=26%  Similarity=0.391  Sum_probs=203.7

Q ss_pred             hhccccCccCCCcceEEEEeEECCCce--EEEEEEeecc-cccchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEM--IVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ++|++.++||+|+||+||+|++++++.  .||||+++.. .....+.+.+|+++++++ +|||||+++++|.+.+     
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-----   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-----
Confidence            689999999999999999999987765  4677877533 334456899999999999 7999999999998765     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCC----------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEec
Q 043388          624 FKALVFEYMENGSLEDWLHQSND----------HLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD  693 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~  693 (854)
                      ..++||||+++|+|.++++....          ......+++.++.+++.|||.||.|+|+.   +|+||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence            78999999999999999976421          01123789999999999999999999999   999999999999999


Q ss_pred             CCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCC-CCCCcccCCchH
Q 043388          694 HDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRR-PTDAAFTEGLTL  771 (854)
Q Consensus       694 ~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~-pf~~~~~~~~~~  771 (854)
                      .++..++ |||+++.........    ...||..|+|||.+.+..++.++|||||||++|||++|.. ||.....  ..+
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~~~~----~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--~~~  235 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYVKKT----MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AEL  235 (309)
T ss_dssp             GGGCEEECCTTCEESSCEECCC--------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH
T ss_pred             CCCceEEcccccccccccccccc----ceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--HHH
Confidence            9988877 999998665443322    2458999999999999999999999999999999999765 5653211  111


Q ss_pred             hHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          772 HEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       772 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      ...+.....                          ......+++++.+++.+||+.||++||||+||++.|+++.+.
T Consensus       236 ~~~i~~~~~--------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         236 YEKLPQGYR--------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HHHGGGTCC--------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHhcCC--------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            111111000                          001112255688999999999999999999999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=391.13  Aligned_cols=251  Identities=19%  Similarity=0.269  Sum_probs=202.6

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .++|.+.+.||+|+||+||+|++..+++.||||+++.... ....+.+|+++|++++|||||++++++.+.+     ..|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESME-----ELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEE
Confidence            3679999999999999999999999999999999976543 2356889999999999999999999998765     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc---ccccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHQNFS  703 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~~~Dfg  703 (854)
                      +|||||+||+|.+++...+.     .+++.+++.|+.||+.||+|||++   +|+||||||+|||++.+.   ++++|||
T Consensus        78 lvmE~~~gg~L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             EEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence            99999999999999986542     689999999999999999999999   999999999999998643   3445999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +++........    ....||+.|+|||...+..++.++||||+||++|||++|+.||...... ..+.........   
T Consensus       150 ~~~~~~~~~~~----~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~~~i~~~~~~---  221 (321)
T d1tkia_         150 QARQLKPGDNF----RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYT---  221 (321)
T ss_dssp             TCEECCTTCEE----EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC---
T ss_pred             hhhccccCCcc----cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC---
Confidence            99876543322    2246899999999999999999999999999999999999999754221 111111111100   


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                         .+                  ......++.++.+++.+||+.||++|||++|+++
T Consensus       222 ---~~------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         222 ---FD------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---CC------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---CC------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               00                  0011122456789999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=388.84  Aligned_cols=266  Identities=20%  Similarity=0.333  Sum_probs=210.5

Q ss_pred             hhccccCccCCCcceEEEEeEEC-----CCceEEEEEEeecccc-cchHHHHHHHHHHHhc-cCCCeeeEEEEeeccCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILG-----GEEMIVAVKVINLKQK-GAFRSFVAECEALRNI-RHRNLIKIITICSSIDSK  620 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  620 (854)
                      ++|++.++||+|+||.||+|++.     .+++.||||+++.... .....+.+|+.+++++ +|||||+++++|.+.+  
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~--  100 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG--  100 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC--
Confidence            68999999999999999999863     4678999999975433 3345789999999999 6999999999997755  


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCc------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDH------------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPS  688 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~  688 (854)
                         ..++|||||++|+|.+++......            .....+++.++..++.|||+||+|||++   +||||||||+
T Consensus       101 ---~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~  174 (311)
T d1t46a_         101 ---PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR  174 (311)
T ss_dssp             ---SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             ---EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence               579999999999999999875421            1123689999999999999999999999   9999999999


Q ss_pred             ceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccC
Q 043388          689 NVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTE  767 (854)
Q Consensus       689 NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~  767 (854)
                      ||+++.++..++ |||.++......... ......||+.|+|||++.+..++.++|||||||++|||+|+..|+......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSE-ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             cccccccCcccccccchheeccCCCcce-EeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            999998887777 999999876544322 233457999999999999999999999999999999999954444333233


Q ss_pred             CchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          768 GLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       768 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                      ...+.+.+....+...                          ...++..+.+++.+||+.||++||||.||+++|+++..
T Consensus       254 ~~~~~~~i~~~~~~~~--------------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         254 DSKFYKMIKEGFRMLS--------------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             SHHHHHHHHHTCCCCC--------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCC--------------------------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            2333333332211111                          11124568899999999999999999999999988765


Q ss_pred             h
Q 043388          848 T  848 (854)
Q Consensus       848 ~  848 (854)
                      .
T Consensus       308 ~  308 (311)
T d1t46a_         308 E  308 (311)
T ss_dssp             H
T ss_pred             c
Confidence            3

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-46  Score=391.34  Aligned_cols=247  Identities=25%  Similarity=0.366  Sum_probs=201.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHH-hccCCCeeeEEEEeeccCCCCCc
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALR-NIRHRNLIKIITICSSIDSKGAD  623 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~  623 (854)
                      ++|.+.+.||+|+||+||+|++..+++.||||+++..   .....+.+.+|..++. .++|||||++++++.+.+     
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~-----   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-----   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-----
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-----
Confidence            5899999999999999999999999999999999743   2344566778887765 679999999999998766     


Q ss_pred             eeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cc
Q 043388          624 FKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NF  702 (854)
Q Consensus       624 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Df  702 (854)
                      ..|+|||||++|+|.+++....      .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..++ ||
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ceeEEEeecCCCcHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence            7899999999999999998765      688999999999999999999999   9999999999999999877766 99


Q ss_pred             ccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCcc
Q 043388          703 SLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEK  782 (854)
Q Consensus       703 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  782 (854)
                      |+++.........   ....||+.|+|||++.+..++.++||||+||++|||+||+.||.+....  .+...+....+ .
T Consensus       148 G~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~~~-~  221 (320)
T d1xjda_         148 GMCKENMLGDAKT---NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDNP-F  221 (320)
T ss_dssp             TTCBCCCCTTCCB---CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC-C
T ss_pred             chhhhcccccccc---cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCC-C
Confidence            9998765443322   2357999999999999999999999999999999999999999754221  11111111000 0


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHH-HHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMR-DVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~  840 (854)
                      .                          +..++.++.+++.+||+.||++|||+. |+++
T Consensus       222 ~--------------------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 Y--------------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             C--------------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             C--------------------------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            0                          011245578999999999999999995 6753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-45  Score=393.69  Aligned_cols=244  Identities=19%  Similarity=0.248  Sum_probs=202.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc---cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      ++|++.+.||+|+||.||+|+++.+|+.||||+++..   .....+.+.+|++++++++|||||++++++....     .
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----N  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-----c
Confidence            6899999999999999999999989999999999642   3345678899999999999999999999997765     7


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .++||||+.+|+|.+++...+      .+++.+++.++.||+.||.|||++   +||||||||+|||++.++..++ |||
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cccccccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence            899999999999999998765      789999999999999999999999   9999999999999998877666 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCccc
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPEKV  783 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  783 (854)
                      +|+.......      ...||+.|||||++.+..++.++||||+||++|||+||+.||...... ............  .
T Consensus       187 ~a~~~~~~~~------~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~~~--~  257 (350)
T d1rdqe_         187 FAKRVKGRTW------TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKVR--F  257 (350)
T ss_dssp             TCEECSSCBC------CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCC--C
T ss_pred             eeeecccccc------cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-HHHHHHhcCCCC--C
Confidence            9998764332      246999999999999999999999999999999999999999753211 111111111000  0


Q ss_pred             ccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCC-----CHHHHHH
Q 043388          784 IEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERM-----EMRDVVA  840 (854)
Q Consensus       784 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  840 (854)
                                                +..++..+.+++.+||+.||.+|+     |++|+++
T Consensus       258 --------------------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 --------------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --------------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --------------------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                                      011245578999999999999994     8999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=385.44  Aligned_cols=263  Identities=25%  Similarity=0.387  Sum_probs=205.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCC-------ceEEEEEEeecccc-cchHHHHHHHHHHHhc-cCCCeeeEEEEeeccC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGE-------EMIVAVKVINLKQK-GAFRSFVAECEALRNI-RHRNLIKIITICSSID  618 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  618 (854)
                      ++|.+.+.||+|+||.||+|+..+.       +..||||+++.... .....+.+|...+.++ +|||||+++++|.+.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            6899999999999999999987543       35799999975443 3356788999999998 8999999999998654


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCc----------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDH----------LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPS  688 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~  688 (854)
                           ..++||||+++|+|.+++......          .....+++.+++.++.|||.||+|||+.   +||||||||+
T Consensus        93 -----~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~  164 (299)
T d1fgka_          93 -----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  164 (299)
T ss_dssp             -----SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             -----eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence                 689999999999999999865421          1123689999999999999999999999   9999999999


Q ss_pred             ceEecCCccccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCCccc
Q 043388          689 NVLLDHDMVAHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFT-GRRPTDAAFT  766 (854)
Q Consensus       689 NIll~~~~~~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~pf~~~~~  766 (854)
                      |||++.++..++ |||+++......... ......||+.|+|||.+.++.++.++|||||||++|||+| |++||.....
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTC-CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceeecCCCCeEeccchhhcccccccccc-ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            999999988777 999999886654332 2234569999999999999999999999999999999998 7888864322


Q ss_pred             CCchHhHHhhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhh
Q 043388          767 EGLTLHEFVKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTR  846 (854)
Q Consensus       767 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  846 (854)
                      .  ...+.+.......                          .+..+++.+.+++.+||+.||++||||.||++.|+++.
T Consensus       244 ~--~~~~~i~~~~~~~--------------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 E--ELFKLLKEGHRMD--------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             H--HHHHHHHTTCCCC--------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H--HHHHHHHcCCCCC--------------------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            1  1112211111000                          00112456889999999999999999999999999886


Q ss_pred             h
Q 043388          847 E  847 (854)
Q Consensus       847 ~  847 (854)
                      +
T Consensus       296 a  296 (299)
T d1fgka_         296 A  296 (299)
T ss_dssp             H
T ss_pred             h
Confidence            4

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=388.14  Aligned_cols=274  Identities=22%  Similarity=0.313  Sum_probs=200.0

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...  ....+.+.+|++++++++|||||++++++.+..     ..
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-----~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-----ce
Confidence            58999999999999999999999899999999996443  234578899999999999999999999998765     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      |+||||+.+ ++.+++.....    ..+++.+++.++.||+.||+|||++   +||||||||+|||++.++..++ |||.
T Consensus        77 ~iv~e~~~~-~~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          77 YLVFEFLHQ-DLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             EEEEECCSE-EHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             eEEEeecCC-chhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence            999999976 55555544322    1689999999999999999999999   9999999999999998887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc-CCc-
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT-LPE-  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~-  781 (854)
                      |+.........   ....||+.|+|||...... ++.++||||+||++|||++|+.||......+ .+....... .+. 
T Consensus       149 a~~~~~~~~~~---~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~  224 (298)
T d1gz8a_         149 ARAFGVPVRTY---THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDE  224 (298)
T ss_dssp             HHHHCCCSBCT---TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred             ceeccCCcccc---eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCch
Confidence            98776543322   2346999999999877655 5889999999999999999999997643221 111111111 111 


Q ss_pred             cccccc--CchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIV--DPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~--d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ......  .+........   ............+...+.+++.+||+.||++|||++|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         225 VVWPGVTSMPDYKPSFPK---WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTSTTGGGSTTCCTTSCC---CCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhcccccccccccccccc---ccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            100000  0000000000   00000011111224567899999999999999999999873

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=389.56  Aligned_cols=267  Identities=23%  Similarity=0.264  Sum_probs=193.9

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecccc-----cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK-----GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      .++||+|+||+||+|++..+++.||||+++....     ...+.+.+|+.++++++|||||++++++...+     ..|+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-----~~~i   77 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-----NISL   77 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-----CCEE
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-----ceee
Confidence            4789999999999999998999999999864322     12356889999999999999999999997765     6899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLSH  706 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~~  706 (854)
                      ||||++++++..+.....      .+++.++..++.||+.||+|||++   +|+||||||+|||++.++..++ |||.|+
T Consensus        78 vmE~~~~~~~~~~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~  148 (299)
T d1ua2a_          78 VFDFMETDLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  148 (299)
T ss_dssp             EEECCSEEHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             hhhhhcchHHhhhhhccc------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcccc
Confidence            999999987776665443      678889999999999999999999   9999999999999999877776 999998


Q ss_pred             ccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC---Ccc
Q 043388          707 QLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL---PEK  782 (854)
Q Consensus       707 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~---~~~  782 (854)
                      .........   ...+||+.|+|||++.+. .++.++||||+||++|||+||++||......+ .+..+.....   .+.
T Consensus       149 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~  224 (299)
T d1ua2a_         149 SFGSPNRAY---THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQ  224 (299)
T ss_dssp             TTTSCCCCC---CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTT
T ss_pred             ccCCCcccc---cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhh
Confidence            776543322   234699999999988754 57999999999999999999999997543221 1122211111   110


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      +........   ....................+.+.+++.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         225 WPDMCSLPD---YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             SSSTTSSTT---CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccchhccch---hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            100000000   0000000000000011122456889999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-45  Score=384.03  Aligned_cols=277  Identities=19%  Similarity=0.271  Sum_probs=200.0

Q ss_pred             HhhccccCccCCCcceEEEEeEECCC-ceEEEEEEeeccc--ccchHHHHHHHHHHHhc---cCCCeeeEEEEeeccCCC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGE-EMIVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLIKIITICSSIDSK  620 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~  620 (854)
                      .++|++.+.||+|+||+||+|++..+ ++.||||+++...  ......+.+|+.+++.+   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999999654 6789999996432  22334567888887776   799999999998765444


Q ss_pred             CCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc
Q 043388          621 GADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ  700 (854)
Q Consensus       621 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~  700 (854)
                      .....+++|||++++++.........     .+++..++.++.|++.||+|||++   +||||||||+|||++.++..++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCceEEEEEEeccCCchhhhhhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence            44578999999988776554443322     688999999999999999999999   9999999999999999877776


Q ss_pred             -ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC
Q 043388          701 -NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL  779 (854)
Q Consensus       701 -Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~  779 (854)
                       |||.++.......    .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+........
T Consensus       158 ~dfg~~~~~~~~~~----~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~  232 (305)
T d1blxa_         158 ADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIG  232 (305)
T ss_dssp             CSCCSCCCCCGGGG----GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHC
T ss_pred             cchhhhhhhccccc----CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhC
Confidence             9999876544332    22357999999999999999999999999999999999999999864321 11222221111


Q ss_pred             C---cccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          780 P---EKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       780 ~---~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .   ..+.....  .........  .............+.+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~--~~~~~~~~~--~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         233 LPGEEDWPRDVA--LPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCCGGGSCTTCS--SCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCchhccccccc--chhhhhccc--cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0   00100000  000000000  000000111122455778999999999999999999976

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-45  Score=377.06  Aligned_cols=239  Identities=22%  Similarity=0.308  Sum_probs=193.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc------cchHHHHHHHHHHHhcc--CCCeeeEEEEeeccCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK------GAFRSFVAECEALRNIR--HRNLIKIITICSSIDS  619 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~  619 (854)
                      ++|++.++||+|+||+||+|++..+++.||||+++....      ....++.+|+.++++++  |||||++++++.+.+ 
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~-   82 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD-   82 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS-
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC-
Confidence            579999999999999999999998999999999964321      11234678999999996  899999999998765 


Q ss_pred             CCCceeeEEEeeccC-CCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC-cc
Q 043388          620 KGADFKALVFEYMEN-GSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MV  697 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~  697 (854)
                          ..++||||+.+ +++.+++....      .+++.+++.++.||+.||+|||+.   +|+||||||+|||++.+ +.
T Consensus        83 ----~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~  149 (273)
T d1xwsa_          83 ----SFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE  149 (273)
T ss_dssp             ----EEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred             ----eEEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCe
Confidence                78999999976 68888887654      789999999999999999999999   99999999999999854 44


Q ss_pred             c-ccccccccccccCCCCCCcccccCCcccccCccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          698 A-HQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEA-SMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       698 ~-~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                      . ++|||+|+.......     ....||+.|+|||++.+..+ +.++||||+||++|||+||+.||....       +..
T Consensus       150 vkl~DFG~a~~~~~~~~-----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~  217 (273)
T d1xwsa_         150 LKLIDFGSGALLKDTVY-----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EII  217 (273)
T ss_dssp             EEECCCTTCEECCSSCB-----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHH
T ss_pred             EEECccccceecccccc-----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHh
Confidence            4 459999987654322     23579999999999887665 677999999999999999999997421       111


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      .....      ..+                      .++.++.+++.+||+.||++|||++|+++
T Consensus       218 ~~~~~------~~~----------------------~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 RGQVF------FRQ----------------------RVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HCCCC------CSS----------------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcccC------CCC----------------------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            11100      000                      11345788999999999999999999976

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-45  Score=383.35  Aligned_cols=264  Identities=20%  Similarity=0.359  Sum_probs=207.8

Q ss_pred             hhccccCccCCCcceEEEEeEECC-----CceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCC
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGG-----EEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKG  621 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  621 (854)
                      ++|.+.+.||+|+||+||+|.+.+     ++..||||+++... ......+.+|++++++++|||||+++++|...+   
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---   96 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ---   96 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS---
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC---
Confidence            689999999999999999998852     35789999997432 233456899999999999999999999997655   


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCc----ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCcc
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDH----LEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV  697 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  697 (854)
                        ..++||||+++|+|.+++......    .....+++.++.+++.|+|+||.|||++   +|+||||||+|||++.++.
T Consensus        97 --~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          97 --PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred             --ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence              579999999999999998764311    0112578999999999999999999999   9999999999999999988


Q ss_pred             ccc-ccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCC-CCCCCcccCCchHhHHh
Q 043388          698 AHQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGR-RPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       698 ~~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~-~pf~~~~~~~~~~~~~~  775 (854)
                      +++ |||+|+.......... .....||+.|+|||.+.+..++.++|||||||++|||+||. +||....     ..+..
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~-~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-----~~~~~  245 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRK-GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----NEQVL  245 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEG-GGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----HHHHH
T ss_pred             EEEeecccceeccCCcceee-ccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-----HHHHH
Confidence            877 9999987765443221 22345899999999999999999999999999999999985 6665331     11111


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhh
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRET  848 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  848 (854)
                      .........                       ..+..++..+.+++.+||+.||++||||.||+++|++..+.
T Consensus       246 ~~i~~~~~~-----------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         246 RFVMEGGLL-----------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             HHHHTTCCC-----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHhCCCC-----------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            111111100                       01112355688999999999999999999999999887653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-44  Score=377.57  Aligned_cols=271  Identities=20%  Similarity=0.264  Sum_probs=198.0

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|++.++||+|+||+||+|+++ +++.||||+++..  .....+.+.+|+.+|++++|||||++++++...+     ..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence            57999999999999999999997 7889999999654  2334578999999999999999999999998766     68


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++||||+.++.+..+.....      .+++.+++.|+.||+.||+|||++   +||||||||+|||++.++..++ |||.
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             eEEEEeehhhhHHHHHhhcC------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence            99999998876666655443      789999999999999999999999   9999999999999999887776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc--
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE--  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--  781 (854)
                      |..........   ....|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+ .+..........  
T Consensus       147 a~~~~~~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~  222 (286)
T d1ob3a_         147 ARAFGIPVRKY---THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNS  222 (286)
T ss_dssp             HHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred             ceecccCcccc---ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCCh
Confidence            98876543322   224589999999998764 57999999999999999999999997543211 112211111110  


Q ss_pred             -ccccccC-chhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 -KVIEIVD-PSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 -~~~~~~d-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       .+..... +......   ................+.+.+++.+||+.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         223 KNWPNVTELPKYDPNF---TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTSTTGGGSTTCCTTC---CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccchhhhhhccccc---ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0100000 0000000   000000001111222456789999999999999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=380.83  Aligned_cols=282  Identities=19%  Similarity=0.214  Sum_probs=201.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc-ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      .+|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+++|++++||||+++++++...........+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            57999999999999999999999899999999997543 33456789999999999999999999998765433333344


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSLS  705 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~~  705 (854)
                      + ++|+.+|+|.+++...       .+++..++.++.|++.||+|||++   +||||||||+|||++.++..++ |||+|
T Consensus        88 l-~~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          88 L-VTHLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             E-EEECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             E-EEeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence            4 5566789999999753       689999999999999999999999   9999999999999999887776 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhc-CCcc-
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMT-LPEK-  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~-  782 (854)
                      +...............+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.. ....... .+.. 
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-~~~~~~~~~~~~~  235 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILGILGSPSQE  235 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-HHHhhhccCCChh
Confidence            887665544444445679999999999855 45789999999999999999999999764322111 1111111 1100 


Q ss_pred             -cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          783 -VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       783 -~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                       .................................++.+++.+||+.||.+|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00000001000000000000000000111223467899999999999999999999863

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-43  Score=372.47  Aligned_cols=285  Identities=22%  Similarity=0.282  Sum_probs=199.7

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecc--cccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC---CC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS---KG  621 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  621 (854)
                      .++|++.++||+|+||+||+|++..+++.||||++...  .....+++.+|+++|++++||||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999999989999999998543  33455788999999999999999999999865431   11


Q ss_pred             CceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-
Q 043388          622 ADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-  700 (854)
Q Consensus       622 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-  700 (854)
                      ....++||||++++.+..+.....      .++..+++.++.|++.||.|||+.   +|+||||||+|||++.++..++ 
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             CceEEEEEeccCCCccchhhhccc------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence            235799999998876665544433      678899999999999999999999   9999999999999999988887 


Q ss_pred             ccccccccccCCCC-CCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhh--
Q 043388          701 NFSLSHQLDSASKT-PSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVK--  776 (854)
Q Consensus       701 Dfg~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~--  776 (854)
                      |||+++........ .......+||+.|+|||++.+. .+++++||||+||++|||++|+.||....... .......  
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~  238 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLC  238 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhc
Confidence            99999877643322 1222335799999999998765 58999999999999999999999997543211 1111111  


Q ss_pred             hcCCcccccccC-chhhHHHhhccchhhHh-hhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          777 MTLPEKVIEIVD-PSLLMEVMANNSMIQED-RRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       777 ~~~~~~~~~~~d-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ...........+ ................. ...........+.+++.+||+.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            111111111111 11111100000000000 000011123456789999999999999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-43  Score=368.50  Aligned_cols=262  Identities=21%  Similarity=0.281  Sum_probs=198.9

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCceeeE
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFKAL  627 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  627 (854)
                      ++|++.+.||+|+||+||+|++..+++.||||++.....  .+++.+|+++++.++|+|++..++++...+    ...++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~----~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET----TEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC----CEEEE
Confidence            469999999999999999999998999999999875433  245789999999998877666555554333    26899


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCC---c-ccccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---M-VAHQNFS  703 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~-~~~~Dfg  703 (854)
                      ||||+ +|++.+.+.....     .+++..+..++.|++.||+|||++   +|+||||||+|||++..   . ++++|||
T Consensus        81 vme~~-~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          81 VMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             EEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             EEEEc-CCchhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence            99999 5577777665432     789999999999999999999999   99999999999998643   3 4445999


Q ss_pred             cccccccCCCC----CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHh--HHhhh
Q 043388          704 LSHQLDSASKT----PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLH--EFVKM  777 (854)
Q Consensus       704 ~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~--~~~~~  777 (854)
                      +|+.+......    ........||+.|+|||.+.+..+++++|||||||++|||+||+.||...........  .....
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~  231 (299)
T d1ckia_         152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  231 (299)
T ss_dssp             SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred             cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence            99987654322    1222346799999999999999999999999999999999999999976432211110  00000


Q ss_pred             cCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhh
Q 043388          778 TLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRE  847 (854)
Q Consensus       778 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  847 (854)
                      .                       ...........++.++.+++..||+.+|++||+++++.+.|+++..
T Consensus       232 ~-----------------------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         232 K-----------------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             H-----------------------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             c-----------------------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            0                       0000011112346778999999999999999999999999887754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=379.03  Aligned_cols=276  Identities=22%  Similarity=0.266  Sum_probs=193.4

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCceeeE
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGADFKAL  627 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l  627 (854)
                      +|...++||+|+||+||+|++..+++.||||+++.....    ..+|++++++++||||++++++|..... ....+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            688999999999999999999999999999999754322    2479999999999999999999865432 33446799


Q ss_pred             EEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc-cccc-ccccc
Q 043388          628 VFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHQ-NFSLS  705 (854)
Q Consensus       628 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~~~-Dfg~~  705 (854)
                      |||||+++.+..+......   ...+++.+++.|+.||+.||+|||++   +|+||||||+|||++.++ ..++ |||++
T Consensus        97 v~Ey~~~~~~~~l~~~~~~---~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEeccCCccHHHHHhhhhc---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence            9999987544333322111   12789999999999999999999999   999999999999998764 5544 99999


Q ss_pred             cccccCCCCCCcccccCCcccccCccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC--cc
Q 043388          706 HQLDSASKTPSSSIGIKGTVGYVAPEYGMG-SEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP--EK  782 (854)
Q Consensus       706 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~~  782 (854)
                      +.........    ...||+.|+|||.+.+ ..++.++||||+||++|||++|++||...... ..+..+......  ..
T Consensus       171 ~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         171 KQLVRGEPNV----SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             EECCTTSCCC----SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHH
T ss_pred             hhccCCcccc----cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHH
Confidence            8775543322    2469999999998775 46899999999999999999999999754321 111111111000  00


Q ss_pred             cccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          783 VIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       783 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ......+........ ..................+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         246 QIREMNPNYTEFKFP-QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHCC---CCCCC-CCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhccchhhcccc-ccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000000000000 000000000001122455789999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-43  Score=375.87  Aligned_cols=276  Identities=21%  Similarity=0.281  Sum_probs=197.6

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  624 (854)
                      ++|++.++||+|+||+||+|++..+++.||||+++...  ....+.+.+|+++|++++|||||+++++|...+. ....+
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            57999999999999999999999899999999997432  2335678899999999999999999999976542 22335


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+||||+ +.+|..+.+..       .+++..++.++.||+.||+|||++   +|+||||||+|||++.++..++ |||
T Consensus        98 ~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecc-cccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence            79999999 55888877543       689999999999999999999999   9999999999999999888777 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhh--cCC
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKM--TLP  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~--~~~  780 (854)
                      .|+.......      ...||+.|+|||++.+. .++.++||||+||++|||++|++||....... .+......  ..+
T Consensus       167 ~a~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~  239 (346)
T d1cm8a_         167 LARQADSEMT------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPP  239 (346)
T ss_dssp             TCEECCSSCC------SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCC
T ss_pred             ceeccCCccc------cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccCCCc
Confidence            9987755432      24699999999998764 57899999999999999999999997653211 11111111  111


Q ss_pred             cccccccCchhhHHHhhcc-chhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANN-SMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      ................... .............+...+.+++.+||..||.+|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            1111111111111111000 000000001111224557789999999999999999999874

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-42  Score=361.44  Aligned_cols=263  Identities=16%  Similarity=0.197  Sum_probs=206.3

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccC-CCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH-RNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|++.++||+|+||+||+|++..+++.||||+++....  ...+.+|++.++.+.| +|++.+++++....     ..+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~~   77 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-----HNV   77 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-----EEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC-----ccE
Confidence            579999999999999999999999999999999865432  2456789999999965 89999999987655     789


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecC-----C-ccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-----D-MVAHQ  700 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~-~~~~~  700 (854)
                      +||||+ +|+|.+++.....     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.     + .++++
T Consensus        78 ~vme~~-~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~  148 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV  148 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             EEEEec-CCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEc
Confidence            999999 6799999876543     689999999999999999999999   9999999999999974     2 34555


Q ss_pred             ccccccccccCCCC----CCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchH--hHH
Q 043388          701 NFSLSHQLDSASKT----PSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTL--HEF  774 (854)
Q Consensus       701 Dfg~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~--~~~  774 (854)
                      |||+|+........    .......+||+.|||||++.+..+++++|||||||++|||+||+.||..........  ...
T Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i  228 (293)
T d1csna_         149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  228 (293)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence            99999987543221    122334679999999999999999999999999999999999999997543321111  000


Q ss_pred             hhhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhhhhh
Q 043388          775 VKMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAKLCHTRETF  849 (854)
Q Consensus       775 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  849 (854)
                      .....                       ....+.....+++++.+++..|++.+|++||+++.+.+.|+++.++.
T Consensus       229 ~~~~~-----------------------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         229 GEKKQ-----------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHH-----------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HhccC-----------------------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            00000                       00001111234567889999999999999999999999998887654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-43  Score=366.60  Aligned_cols=275  Identities=18%  Similarity=0.226  Sum_probs=204.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCcee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      ++|++.++||+|+||+||+|++..+++.||||+++...  .....++.+|+.++++++||||++++++|....     ..
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-----ce
Confidence            47999999999999999999999999999999997543  334578899999999999999999999998766     78


Q ss_pred             eEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-cccc
Q 043388          626 ALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFSL  704 (854)
Q Consensus       626 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg~  704 (854)
                      ++|||++.++++..++...+      .+++..++.++.|++.||+|||++   +|+||||||+|||++.++..++ |||.
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             eEEeeecccccccccccccc------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence            99999999999988877654      678999999999999999999999   9999999999999998877776 9999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc--
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE--  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--  781 (854)
                      |+..........   ...+++.|+|||.+.+.. ++.++||||+||++|||++|+.||....+.......+.......  
T Consensus       148 a~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (292)
T d1unla_         148 ARAFGIPVRCYS---AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_dssp             CEECCSCCSCCC---SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             hhcccCCCccce---eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCCh
Confidence            988765443322   235788999999987665 69999999999999999999999764333222222222111111  


Q ss_pred             ccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ........ ........................+.+.+++.+|++.||.+||||+|+++
T Consensus       225 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         225 EQWPSMTK-LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCTTGGG-STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhh-cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000 00000000000000001111122455778999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.7e-42  Score=370.19  Aligned_cols=271  Identities=19%  Similarity=0.225  Sum_probs=197.1

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCceee
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADFKA  626 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  626 (854)
                      ++|++.++||+|+||+||+|++..+++.||||+++..   ..+++.+|+++|++++ ||||+++++++.....   ...+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~---~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVS---RTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---CSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCC---Ccee
Confidence            5899999999999999999999989999999998643   3467889999999995 9999999999875432   2689


Q ss_pred             EEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCc--cccccccc
Q 043388          627 LVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM--VAHQNFSL  704 (854)
Q Consensus       627 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~~~Dfg~  704 (854)
                      +|||||++++|.++.+         .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++  ++++|||+
T Consensus       109 ~v~e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             EEEECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             EEEeecCCCcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence            9999999999977632         688999999999999999999999   999999999999998654  34459999


Q ss_pred             ccccccCCCCCCcccccCCcccccCccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCCc--
Q 043388          705 SHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSE-ASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLPE--  781 (854)
Q Consensus       705 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~--  781 (854)
                      |+........    ....||+.|+|||.+.+.. ++.++||||+||++|||++|+.||....+...............  
T Consensus       177 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~  252 (328)
T d3bqca1         177 AEFYHPGQEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL  252 (328)
T ss_dssp             CEECCTTCCC----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred             ceeccCCCcc----cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence            9877654332    2346899999999987754 79999999999999999999999975433211111111100000  


Q ss_pred             -cccc----ccCchhhHHHhh--ccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          782 -KVIE----IVDPSLLMEVMA--NNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       782 -~~~~----~~d~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                       ....    ..++........  ...............+..++.+++.+||+.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000    000000000000  0000000000111223456789999999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=366.87  Aligned_cols=277  Identities=17%  Similarity=0.188  Sum_probs=193.2

Q ss_pred             hhccccCccCCCcceEEEEeEECCCceEEEEEEeeccc--ccchHHHHHHHHHHHhccCCCeeeEEEEeeccCC-CCCce
Q 043388          548 SEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSIDS-KGADF  624 (854)
Q Consensus       548 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  624 (854)
                      ++|++.++||+|+||+||+|++..+|+.||||+++...  .....++.+|+.++++++|||||++++++...+. ....+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999999999999999997543  2334578899999999999999999999875543 23457


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .|+|||||.++.+ +.+..        .+++.+++.++.||+.||+|||+.   ||+||||||+|||++.++..++ |||
T Consensus        97 ~~iv~Ey~~~~l~-~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EEEEEECCSEEHH-HHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEeccchHHH-Hhhhc--------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence            8999999977544 44432        578999999999999999999999   9999999999999998876666 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcCC--c
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTLP--E  781 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~--~  781 (854)
                      .++........    ....||+.|+|||++.+..+++++||||+||++|||++|+.||.+.... ............  .
T Consensus       165 ~~~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~  239 (355)
T d2b1pa1         165 LARTAGTSFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCP  239 (355)
T ss_dssp             C-------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCH
T ss_pred             hhhcccccccc----ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCH
Confidence            98876554332    2346999999999999999999999999999999999999999754321 111111111110  0


Q ss_pred             ccccccCchhhHHHhhc------------cchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 043388          782 KVIEIVDPSLLMEVMAN------------NSMIQEDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVAK  841 (854)
Q Consensus       782 ~~~~~~d~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  841 (854)
                      .................            ..................+.+++.+|++.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            01111111110000000            0000011111223346678899999999999999999999853

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-42  Score=360.94  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=199.3

Q ss_pred             HhhccccCccCCCcceEEEEeEE---CCCceEEEEEEeecc----cccchHHHHHHHHHHHhccC-CCeeeEEEEeeccC
Q 043388          547 TSEFASSNMIGQGSFGSVYKGIL---GGEEMIVAVKVINLK----QKGAFRSFVAECEALRNIRH-RNLIKIITICSSID  618 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~  618 (854)
                      .++|++.+.||+|+||+||+|+.   +.+|+.||||+++..    .....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            47899999999999999999987   346899999998532    22345678899999999977 79999999998766


Q ss_pred             CCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccc
Q 043388          619 SKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA  698 (854)
Q Consensus       619 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  698 (854)
                           ..++||||+.+|+|.+++....      .++...+..++.||+.||+|+|+.   +|+||||||+||+++.++.+
T Consensus       103 -----~~~~v~e~~~~~~L~~~i~~~~------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~v  168 (322)
T d1vzoa_         103 -----KLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV  168 (322)
T ss_dssp             -----EEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             -----ceeeeeecccccHHHHHHHhcc------cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCE
Confidence                 7899999999999999998776      667888999999999999999999   99999999999999998777


Q ss_pred             cc-ccccccccccCCCCCCcccccCCcccccCccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHh
Q 043388          699 HQ-NFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS--EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFV  775 (854)
Q Consensus       699 ~~-Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~  775 (854)
                      ++ |||+++.+.......  .....|++.|+|||.+.+.  .++.++||||+||++|||++|+.||......... ....
T Consensus       169 kL~DFG~a~~~~~~~~~~--~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-~~i~  245 (322)
T d1vzoa_         169 VLTDFGLSKEFVADETER--AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEIS  245 (322)
T ss_dssp             EESCSSEEEECCGGGGGG--GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHH
T ss_pred             EEeeccchhhhccccccc--ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH
Confidence            76 999998775543322  2234699999999998764  4788999999999999999999999765433221 1111


Q ss_pred             hhcCCcccccccCchhhHHHhhccchhhHhhhhhHHHHHHHHHHHhhcccCCCCCCCCC-----HHHHHH
Q 043388          776 KMTLPEKVIEIVDPSLLMEVMANNSMIQEDRRARTQDCLNAITRTGVLCSMESPFERME-----MRDVVA  840 (854)
Q Consensus       776 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  840 (854)
                      .......                        ...+..++.++.+++.+||++||++|||     ++|+++
T Consensus       246 ~~~~~~~------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         246 RRILKSE------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHCC------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HhcccCC------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1110000                        0001122566889999999999999994     788875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-42  Score=370.23  Aligned_cols=277  Identities=18%  Similarity=0.230  Sum_probs=199.5

Q ss_pred             HhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccc--cchHHHHHHHHHHHhccCCCeeeEEEEeeccCCCCCce
Q 043388          547 TSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSIDSKGADF  624 (854)
Q Consensus       547 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  624 (854)
                      .++|++.++||+|+||+||+|++..+++.||||+++....  ...+.+.+|++++++++|||||++++++..........
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            3579999999999999999999998999999999975432  33457889999999999999999999987654333334


Q ss_pred             eeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceEecCCccccc-ccc
Q 043388          625 KALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHQ-NFS  703 (854)
Q Consensus       625 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~~~-Dfg  703 (854)
                      .+++|+|+.+|+|.+++...       .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..++ |||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             eEEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence            56778888899999998643       689999999999999999999999   9999999999999999887776 999


Q ss_pred             cccccccCCCCCCcccccCCcccccCccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCCcccCCchHhHHhhhcC--C
Q 043388          704 LSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGS-EASMTGDVYSFGILLLEMFTGRRPTDAAFTEGLTLHEFVKMTL--P  780 (854)
Q Consensus       704 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~--~  780 (854)
                      .+........      ...||+.|+|||...+. .++.++||||+||++|+|++|+.||.+..... ..........  .
T Consensus       167 ~a~~~~~~~~------~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~~~~  239 (348)
T d2gfsa1         167 LARHTDDEMT------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPG  239 (348)
T ss_dssp             ---CCTGGGS------SSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred             hhcccCcccc------cccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCC
Confidence            9976654332      24689999999987765 46899999999999999999999997643211 1111111111  1


Q ss_pred             cccccccCchhhHHHhhccchhh-HhhhhhHHHHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 043388          781 EKVIEIVDPSLLMEVMANNSMIQ-EDRRARTQDCLNAITRTGVLCSMESPFERMEMRDVVA  840 (854)
Q Consensus       781 ~~~~~~~d~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  840 (854)
                      ....................... .........+...+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            11111111111111100000000 0000011122456789999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-36  Score=328.13  Aligned_cols=275  Identities=17%  Similarity=0.231  Sum_probs=188.4

Q ss_pred             hccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-----------CCCeeeEEEEeecc
Q 043388          549 EFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-----------HRNLIKIITICSSI  617 (854)
Q Consensus       549 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~  617 (854)
                      +|++.++||+|+||+||+|++..+|+.||||+++... ...+.+.+|++++++++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            5999999999999999999999899999999997543 22456788999988875           57899999988654


Q ss_pred             CCCCCceeeEEEeeccCCCHH-HHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCceEecCC
Q 043388          618 DSKGADFKALVFEYMENGSLE-DWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHD  695 (854)
Q Consensus       618 ~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~  695 (854)
                      ..   ...+++|+++..+... .......    ...+++..+..++.||+.||+|||+ .   +|+||||||+|||++.+
T Consensus        93 ~~---~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          93 GP---NGVHVVMVFEVLGENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             ET---TEEEEEEEECCCCEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEE
T ss_pred             cc---cceeeeeeeccccccccccccccc----ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeecc
Confidence            32   2456677766554433 3222222    1278889999999999999999998 5   99999999999999865


Q ss_pred             c-------ccccccccccccccCCCCCCcccccCCcccccCccccCCCCCCccchhHHHHHHHHHHHhCCCCCCCcccCC
Q 043388          696 M-------VAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVAPEYGMGSEASMTGDVYSFGILLLEMFTGRRPTDAAFTEG  768 (854)
Q Consensus       696 ~-------~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~pf~~~~~~~  768 (854)
                      +       ++.+|||.+........      ..+||+.|+|||++.+..++.++||||+||+++||++|+.||.......
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~  236 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDEHYT------NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  236 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCCC------SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             CcccccceeeEeecccccccccccc------cccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence            4       44459999886654332      2469999999999999999999999999999999999999997542211


Q ss_pred             c-----hHhHHhhh--cCCccccc-------ccCch-hhHHHhh----ccchhhHhhhhhHHHHHHHHHHHhhcccCCCC
Q 043388          769 L-----TLHEFVKM--TLPEKVIE-------IVDPS-LLMEVMA----NNSMIQEDRRARTQDCLNAITRTGVLCSMESP  829 (854)
Q Consensus       769 ~-----~~~~~~~~--~~~~~~~~-------~~d~~-~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  829 (854)
                      .     ........  ..+.....       ..+.. .......    ...................+.+++.+|++.||
T Consensus       237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP  316 (362)
T d1q8ya_         237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  316 (362)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence            0     11111110  00000000       00000 0000000    00000111112234557788999999999999


Q ss_pred             CCCCCHHHHHH
Q 043388          830 FERMEMRDVVA  840 (854)
Q Consensus       830 ~~RPs~~evl~  840 (854)
                      .+|||++|+++
T Consensus       317 ~~Rpta~e~L~  327 (362)
T d1q8ya_         317 RKRADAGGLVN  327 (362)
T ss_dssp             TTCBCHHHHHT
T ss_pred             hHCcCHHHHhc
Confidence            99999999976

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=1.4e-30  Score=275.97  Aligned_cols=253  Identities=27%  Similarity=0.417  Sum_probs=191.6

Q ss_pred             CCCCeeecccccccc--cCCcCccCCCCCcEEeccc-ccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCc
Q 043388           40 SALGMLLIRWNSLGG--QIPTTLGLLRNLVYLNVAE-NQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK  116 (854)
Q Consensus        40 ~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  116 (854)
                      .+++.|+|++|.+++  .+|..++.+++|++|+|++ |+++|.+|.+|+++++|++|+|++|+|+ .++...+..+++|+
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~-~~~~~~~~~~~~L~  128 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS-GAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCE-EECCGGGGGCTTCC
T ss_pred             EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccc-ccccccccchhhhc
Confidence            367888888888876  4778888888888888886 7888888888888888888888888887 45545556666666


Q ss_pred             EEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCC
Q 043388          117 ELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTAN  196 (854)
Q Consensus       117 ~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~  196 (854)
                      .++++.|.+.                 ..+|..|.++++|+++++++|.+++..|..+..+..+                
T Consensus       129 ~l~l~~N~~~-----------------~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l----------------  175 (313)
T d1ogqa_         129 TLDFSYNALS-----------------GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL----------------  175 (313)
T ss_dssp             EEECCSSEEE-----------------SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT----------------
T ss_pred             cccccccccc-----------------ccCchhhccCcccceeecccccccccccccccccccc----------------
Confidence            6665555432                 3456777777777777777777776666655444332                


Q ss_pred             ChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCC
Q 043388          197 DLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDG  276 (854)
Q Consensus       197 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  276 (854)
                                   ++.+++++|++++..|..+..+  ....+++++|.+.+.+|..+..+++|+.+++++|.+++.+| .
T Consensus       176 -------------~~~l~~~~n~l~~~~~~~~~~l--~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~  239 (313)
T d1ogqa_         176 -------------FTSMTISRNRLTGKIPPTFANL--NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-K  239 (313)
T ss_dssp             -------------CCEEECCSSEEEEECCGGGGGC--CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-G
T ss_pred             -------------cccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccc-c
Confidence                         3556666666666677777666  35568888888888888888888888888888888886554 5


Q ss_pred             ccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCc-ccC
Q 043388          277 VGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNK-LTG  343 (854)
Q Consensus       277 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~-l~~  343 (854)
                      +..+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+ +.|
T Consensus       240 ~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g  306 (313)
T d1ogqa_         240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEES
T ss_pred             cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccC
Confidence            77888888888888888888888888888888888888888888874 5778888888888887 444

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=4e-31  Score=280.11  Aligned_cols=257  Identities=28%  Similarity=0.434  Sum_probs=176.7

Q ss_pred             CCCeEecccccccCCCCCChhhhhhccCCCCCcEEEccc-CcCcccCChhhhhhcccccEEEccCCcccccCCccccccc
Q 043388          179 NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCD-NQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLV  257 (854)
Q Consensus       179 ~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~  257 (854)
                      +++.|+|++|.++..    ...+..+.++++|++|+|++ |+++|.+|.++.++. +|+.|+|++|++++..+..+..+.
T Consensus        51 ~v~~L~L~~~~l~g~----~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~-~L~~L~Ls~N~l~~~~~~~~~~~~  125 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKP----YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT-QLHYLYITHTNVSGAIPDFLSQIK  125 (313)
T ss_dssp             CEEEEEEECCCCSSC----EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCT-TCSEEEEEEECCEEECCGGGGGCT
T ss_pred             EEEEEECCCCCCCCC----CCCChHHhcCcccccccccccccccccccccccccc-ccchhhhccccccccccccccchh
Confidence            566666666665421    12233455666666666654 556555666666554 566666666666655555566666


Q ss_pred             cCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCcccc-chhccccceecccCCCCCcCCCCCccccc
Q 043388          258 NLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKL-ADLALSFNNLQGNIPSSLGNCQNLKGFDA  336 (854)
Q Consensus       258 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  336 (854)
                      +|+.+++++|++.+..|..|..+++|+.+++++|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++
T Consensus       126 ~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l  204 (313)
T d1ogqa_         126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDL  204 (313)
T ss_dssp             TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEEC
T ss_pred             hhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccc
Confidence            66666666666655556566666666666666666665556555555554 555556666665555555554333 3555


Q ss_pred             CCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEc
Q 043388          337 SHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNV  416 (854)
Q Consensus       337 s~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  416 (854)
                      ++|...+                         .+|..++.       +.+|+.+++++|.+++.+| .++.+++|+.|+|
T Consensus       205 ~~~~~~~-------------------------~~~~~~~~-------~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~L  251 (313)
T d1ogqa_         205 SRNMLEG-------------------------DASVLFGS-------DKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDL  251 (313)
T ss_dssp             CSSEEEE-------------------------CCGGGCCT-------TSCCSEEECCSSEECCBGG-GCCCCTTCCEEEC
T ss_pred             ccccccc-------------------------cccccccc-------ccccccccccccccccccc-ccccccccccccC
Confidence            5555544                         44444444       4568999999999997655 6889999999999


Q ss_pred             cCcccccccchhhcCccCCCeeecccccCcccCCCCccccCcccccccccccccCCcc
Q 043388          417 SSNNLSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVNVKLCGGID  474 (854)
Q Consensus       417 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~  474 (854)
                      ++|+++|.+|..|+++++|++|||++|+|+|.+|..+.+++...+++.+|..+||.|.
T Consensus       252 s~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl  309 (313)
T d1ogqa_         252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             CSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             ccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC
Confidence            9999999999999999999999999999999999988889999999999999999763

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=7e-29  Score=271.19  Aligned_cols=342  Identities=25%  Similarity=0.308  Sum_probs=207.5

Q ss_pred             cCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCcee
Q 043388           14 SLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFI   93 (854)
Q Consensus        14 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L   93 (854)
                      .+.+|++|++++|.|+. + +.++.+++|++|+|++|+|++. | .|+.+++|++|+|++|+|+++.|  ++++++|+.|
T Consensus        42 ~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L  115 (384)
T d2omza2          42 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGL  115 (384)
T ss_dssp             HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccccccc--cccccccccc
Confidence            44455666666666552 2 2355556666666666666532 2 25556666666666666654322  5556666666


Q ss_pred             eecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcC
Q 043388           94 YLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID  173 (854)
Q Consensus        94 ~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~  173 (854)
                      ++++|.++ .++.  ......+..+....+.+..+..                 ..................+     ..
T Consensus       116 ~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~l~~~~~-----------------~~~~~~~~~~~~~~~~~~~-----~~  170 (384)
T d2omza2         116 TLFNNQIT-DIDP--LKNLTNLNRLELSSNTISDISA-----------------LSGLTSLQQLSFGNQVTDL-----KP  170 (384)
T ss_dssp             ECCSSCCC-CCGG--GTTCTTCSEEEEEEEEECCCGG-----------------GTTCTTCSEEEEEESCCCC-----GG
T ss_pred             cccccccc-cccc--cccccccccccccccccccccc-----------------ccccccccccccccccchh-----hh
Confidence            66666555 2222  1233344444444433332210                 0001111111111111111     12


Q ss_pred             ccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccc
Q 043388          174 FSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGI  253 (854)
Q Consensus       174 f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~  253 (854)
                      +.............|....        ...+..+++++.+++++|.+++..|.  ... ..++.|++++|.++.  .+.+
T Consensus       171 ~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~~~~l~l~~n~i~~~~~~--~~~-~~L~~L~l~~n~l~~--~~~l  237 (384)
T d2omza2         171 LANLTTLERLDISSNKVSD--------ISVLAKLTNLESLIATNNQISDITPL--GIL-TNLDELSLNGNQLKD--IGTL  237 (384)
T ss_dssp             GTTCTTCCEEECCSSCCCC--------CGGGGGCTTCSEEECCSSCCCCCGGG--GGC-TTCCEEECCSSCCCC--CGGG
T ss_pred             hcccccccccccccccccc--------ccccccccccceeeccCCccCCCCcc--ccc-CCCCEEECCCCCCCC--cchh
Confidence            3333444444444444321        12355667777777777777754432  222 367778888887764  2457


Q ss_pred             cccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcc
Q 043388          254 RNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKG  333 (854)
Q Consensus       254 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  333 (854)
                      ..+++|+.|++++|++++..+  +..+++|+.|++++|++++..  .+..++.++.+++++|.+++  ...+..+++++.
T Consensus       238 ~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~  311 (384)
T d2omza2         238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTY  311 (384)
T ss_dssp             GGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSE
T ss_pred             hcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCe
Confidence            778888888888888876543  777888888888888887543  26777888888888888874  345777888888


Q ss_pred             cccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCE
Q 043388          334 FDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKE  413 (854)
Q Consensus       334 L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  413 (854)
                      |++++|++++..|                           +..       +++|++|++++|+|++ ++ .++.+++|++
T Consensus       312 L~ls~n~l~~l~~---------------------------l~~-------l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~  355 (384)
T d2omza2         312 LTLYFNNISDISP---------------------------VSS-------LTKLQRLFFANNKVSD-VS-SLANLTNINW  355 (384)
T ss_dssp             EECCSSCCSCCGG---------------------------GGG-------CTTCCEEECCSSCCCC-CG-GGGGCTTCCE
T ss_pred             EECCCCCCCCCcc---------------------------ccc-------CCCCCEEECCCCCCCC-Ch-hHcCCCCCCE
Confidence            8888888874211                           111       4568999999999985 33 6889999999


Q ss_pred             EEccCcccccccchhhcCccCCCeeecccc
Q 043388          414 LNVSSNNLSGQIPEFLQNLSFLEFLNLSYN  443 (854)
Q Consensus       414 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  443 (854)
                      |+|++|+|++..|  +.++++|+.|+|++|
T Consensus       356 L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         356 LSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             EECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             EECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            9999999997655  889999999999998

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=5.9e-28  Score=263.74  Aligned_cols=357  Identities=24%  Similarity=0.348  Sum_probs=247.1

Q ss_pred             EecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeeccccc
Q 043388           21 LAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRF  100 (854)
Q Consensus        21 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  100 (854)
                      ..++.+.+++.+.  ...+.+|++|++++|.|+. + +.+..+++|++|+|++|+|+++.|  |+++++|++|++++|+|
T Consensus        27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i  100 (384)
T d2omza2          27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI  100 (384)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccc
Confidence            4566666665543  3466788888888888874 3 457788888888888888886433  88888888888888888


Q ss_pred             ccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCC
Q 043388          101 SGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNL  180 (854)
Q Consensus       101 ~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L  180 (854)
                      + .++.  +.++++|+.|+++.+.+..+                   ........+..+....|.+..............
T Consensus       101 ~-~i~~--l~~l~~L~~L~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  158 (384)
T d2omza2         101 A-DITP--LANLTNLTGLTLFNNQITDI-------------------DPLKNLTNLNRLELSSNTISDISALSGLTSLQQ  158 (384)
T ss_dssp             C-CCGG--GTTCTTCCEEECCSSCCCCC-------------------GGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSE
T ss_pred             c-cccc--cccccccccccccccccccc-------------------ccccccccccccccccccccccccccccccccc
Confidence            7 4543  56777777777766655433                   123345667777777777765554444333333


Q ss_pred             CeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCC
Q 043388          181 WWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLI  260 (854)
Q Consensus       181 ~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~  260 (854)
                      .........+           ..+.............|...  .+..+..+. .+..+++++|.+++..|  +...++|+
T Consensus       159 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~-~~~~l~l~~n~i~~~~~--~~~~~~L~  222 (384)
T d2omza2         159 LSFGNQVTDL-----------KPLANLTTLERLDISSNKVS--DISVLAKLT-NLESLIATNNQISDITP--LGILTNLD  222 (384)
T ss_dssp             EEEEESCCCC-----------GGGTTCTTCCEEECCSSCCC--CCGGGGGCT-TCSEEECCSSCCCCCGG--GGGCTTCC
T ss_pred             cccccccchh-----------hhhccccccccccccccccc--ccccccccc-ccceeeccCCccCCCCc--ccccCCCC
Confidence            3333332222           13444555666666666554  334445554 67888888888876544  45667888


Q ss_pred             eeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCc
Q 043388          261 ALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNK  340 (854)
Q Consensus       261 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~  340 (854)
                      .|++++|+++..  +.+..+++|+.|++++|.+++..+  +..+++|+.|++++|.+++..  .+..++.++.+++++|.
T Consensus       223 ~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~  296 (384)
T d2omza2         223 ELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQ  296 (384)
T ss_dssp             EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSC
T ss_pred             EEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccccccc
Confidence            888888888753  357778888888888888875443  777788888888888887432  36677778888888887


Q ss_pred             ccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcc
Q 043388          341 LTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNN  420 (854)
Q Consensus       341 l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  420 (854)
                      +++ ++                          .+..       +.+++.|++++|++++..  .+..+++|++|+|++|+
T Consensus       297 l~~-~~--------------------------~~~~-------~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~  340 (384)
T d2omza2         297 LED-IS--------------------------PISN-------LKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNK  340 (384)
T ss_dssp             CSC-CG--------------------------GGGG-------CTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSC
T ss_pred             ccc-cc--------------------------ccch-------hcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCC
Confidence            763 11                          1111       457899999999999754  38899999999999999


Q ss_pred             cccccchhhcCccCCCeeecccccCcccCCCCccccCccccccccc
Q 043388          421 LSGQIPEFLQNLSFLEFLNLSYNHLEGEVPTKGVFSNKTKISLQVN  466 (854)
Q Consensus       421 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n  466 (854)
                      |++ +| .+.++++|++|++++|++++..| ...+++...+.+.+|
T Consensus       341 l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         341 VSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred             CCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence            984 55 69999999999999999998765 334555555555554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=2.1e-27  Score=250.33  Aligned_cols=267  Identities=19%  Similarity=0.238  Sum_probs=163.6

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT   96 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~   96 (854)
                      ..+++|.++++++ .+|..+.  +++++|+|++|+|+.+.+.+|..+++|++|++++|.+..+.|.+|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            6778899998898 6777765  578999999999986666688889999999999999988888889999999999999


Q ss_pred             ccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcc--cCCcCc
Q 043388           97 VNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKG--KVSIDF  174 (854)
Q Consensus        97 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~--~~~~~f  174 (854)
                      +|+|+ .+|...+   +.|+.|++..|.+..+                 .+..+.....+..++...|....  ..+..|
T Consensus        88 ~n~l~-~l~~~~~---~~l~~L~~~~n~l~~l-----------------~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~  146 (305)
T d1xkua_          88 KNQLK-ELPEKMP---KTLQELRVHENEITKV-----------------RKSVFNGLNQMIVVELGTNPLKSSGIENGAF  146 (305)
T ss_dssp             SSCCS-BCCSSCC---TTCCEEECCSSCCCBB-----------------CHHHHTTCTTCCEEECCSSCCCGGGBCTTGG
T ss_pred             CCccC-cCccchh---hhhhhhhccccchhhh-----------------hhhhhhccccccccccccccccccCCCcccc
Confidence            99888 7775432   3455555555544432                 12335556666667766664432  233445


Q ss_pred             cccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccc
Q 043388          175 SSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIR  254 (854)
Q Consensus       175 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~  254 (854)
                      ..+++|+.+++++|.+..++..         .+++|+.|++++|.++                         +..+..|.
T Consensus       147 ~~l~~L~~l~l~~n~l~~l~~~---------~~~~L~~L~l~~n~~~-------------------------~~~~~~~~  192 (305)
T d1xkua_         147 QGMKKLSYIRIADTNITTIPQG---------LPPSLTELHLDGNKIT-------------------------KVDAASLK  192 (305)
T ss_dssp             GGCTTCCEEECCSSCCCSCCSS---------CCTTCSEEECTTSCCC-------------------------EECTGGGT
T ss_pred             ccccccCccccccCCccccCcc---------cCCccCEEECCCCcCC-------------------------CCChhHhh
Confidence            5556666666666655443321         1244555555555554                         44444445


Q ss_pred             ccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCC------CcCC
Q 043388          255 NLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSS------LGNC  328 (854)
Q Consensus       255 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~------~~~l  328 (854)
                      +++.++.|++++|+++++.+.+|.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+......      +..+
T Consensus       193 ~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~  271 (305)
T d1xkua_         193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK  271 (305)
T ss_dssp             TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTS
T ss_pred             ccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhccc
Confidence            5555555555555555554555555555555555555554 33444555555555555555555332222      2334


Q ss_pred             CCCcccccCCCccc
Q 043388          329 QNLKGFDASHNKLT  342 (854)
Q Consensus       329 ~~L~~L~ls~N~l~  342 (854)
                      .+|+.|++++|++.
T Consensus       272 ~~L~~L~L~~N~~~  285 (305)
T d1xkua_         272 ASYSGVSLFSNPVQ  285 (305)
T ss_dssp             CCCSEEECCSSSSC
T ss_pred             CCCCEEECCCCcCc
Confidence            55666666666653

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=3.9e-27  Score=248.23  Aligned_cols=278  Identities=21%  Similarity=0.289  Sum_probs=214.7

Q ss_pred             CCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEE
Q 043388           40 SALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY  119 (854)
Q Consensus        40 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~  119 (854)
                      ...+.++-++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|+++ .++...|.++++|++|+
T Consensus        10 c~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~-~i~~~~f~~l~~L~~L~   85 (305)
T d1xkua_          10 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLY   85 (305)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEE
T ss_pred             ecCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccc-ccchhhhhCCCccCEec
Confidence            36788899999999 6777764  78999999999999777778999999999999999998 78778888888888888


Q ss_pred             cccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChh
Q 043388          120 LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD  199 (854)
Q Consensus       120 l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~  199 (854)
                      +++|+++.+                  |..+  ...++.|++++|.+..+.+..|.....+..++...|........   
T Consensus        86 l~~n~l~~l------------------~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~---  142 (305)
T d1xkua_          86 LSKNQLKEL------------------PEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE---  142 (305)
T ss_dssp             CCSSCCSBC------------------CSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBC---
T ss_pred             ccCCccCcC------------------ccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCC---
Confidence            888877544                  3332  45788888888888887777777777777777777755322211   


Q ss_pred             hhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccC
Q 043388          200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGE  279 (854)
Q Consensus       200 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  279 (854)
                       ...+..+++|+.+++++|.+                         + .+|..+  +++|+.|++++|.+++..+..|.+
T Consensus       143 -~~~~~~l~~L~~l~l~~n~l-------------------------~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~  193 (305)
T d1xkua_         143 -NGAFQGMKKLSYIRIADTNI-------------------------T-TIPQGL--PPSLTELHLDGNKITKVDAASLKG  193 (305)
T ss_dssp             -TTGGGGCTTCCEEECCSSCC-------------------------C-SCCSSC--CTTCSEEECTTSCCCEECTGGGTT
T ss_pred             -ccccccccccCccccccCCc-------------------------c-ccCccc--CCccCEEECCCCcCCCCChhHhhc
Confidence             12344455555555555544                         4 233322  468999999999999999999999


Q ss_pred             cccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcc-------h
Q 043388          280 LQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLS-------I  352 (854)
Q Consensus       280 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-------~  352 (854)
                      ++.+++|++++|.+.+..+..+.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+ .++...+.       .
T Consensus       194 ~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~  271 (305)
T d1xkua_         194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKK  271 (305)
T ss_dssp             CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTS
T ss_pred             cccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhccc
Confidence            999999999999999998999999999999999999998 57889999999999999999998 55544332       2


Q ss_pred             hhhHHHHHhhcCCCC--CCcCccccc
Q 043388          353 TTLSVYLALAHNLLN--DSLPLQVGN  376 (854)
Q Consensus       353 ~~l~~~l~l~~n~l~--~~~p~~~~~  376 (854)
                      .++. .+++++|.+.  ...|..|..
T Consensus       272 ~~L~-~L~L~~N~~~~~~~~~~~f~~  296 (305)
T d1xkua_         272 ASYS-GVSLFSNPVQYWEIQPSTFRC  296 (305)
T ss_dssp             CCCS-EEECCSSSSCGGGSCGGGGTT
T ss_pred             CCCC-EEECCCCcCccCcCCHhHhcc
Confidence            2333 3789999875  344444444

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.6e-26  Score=238.85  Aligned_cols=268  Identities=19%  Similarity=0.179  Sum_probs=153.0

Q ss_pred             EEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeec-cc
Q 043388           20 TLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLT-VN   98 (854)
Q Consensus        20 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~N   98 (854)
                      ++++++++++ .+|..+.  +++++|+|++|+|+++.+.+|.++++|++|++++|+|..+.+..+.+++.++.++.. .|
T Consensus        15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~   91 (284)
T d1ozna_          15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (284)
T ss_dssp             EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence            4556666666 4555443  455666666666665555566666666666666666666666666666666665543 33


Q ss_pred             ccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccC
Q 043388           99 RFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLK  178 (854)
Q Consensus        99 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~  178 (854)
                      .++ .++...|.++++|++|++                                         ++|.+..+.+..+....
T Consensus        92 ~~~-~l~~~~~~~l~~L~~L~l-----------------------------------------~~n~~~~~~~~~~~~~~  129 (284)
T d1ozna_          92 QLR-SVDPATFHGLGRLHTLHL-----------------------------------------DRCGLQELGPGLFRGLA  129 (284)
T ss_dssp             TCC-CCCTTTTTTCTTCCEEEC-----------------------------------------TTSCCCCCCTTTTTTCT
T ss_pred             ccc-cccchhhcccccCCEEec-----------------------------------------CCcccccccccccchhc
Confidence            443 444444555544444444                                         44444444444444444


Q ss_pred             CCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccccccc
Q 043388          179 NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVN  258 (854)
Q Consensus       179 ~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~  258 (854)
                      +|+.+++++|+|+.++.+      +|..+++|+.|++++|++++..|..|..+. .|+.+++++|+++++.|..|.++++
T Consensus       130 ~L~~l~l~~N~l~~i~~~------~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~-~L~~l~l~~N~l~~i~~~~f~~l~~  202 (284)
T d1ozna_         130 ALQYLYLQDNALQALPDD------TFRDLGNLTHLFLHGNRISSVPERAFRGLH-SLDRLLLHQNRVAHVHPHAFRDLGR  202 (284)
T ss_dssp             TCCEEECCSSCCCCCCTT------TTTTCTTCCEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTT
T ss_pred             ccchhhhccccccccChh------HhccccchhhcccccCcccccchhhhcccc-ccchhhhhhccccccChhHhhhhhh
Confidence            444444444444433322      234444555555555555544444444443 5666666666666666777777777


Q ss_pred             CCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCC
Q 043388          259 LIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASH  338 (854)
Q Consensus       259 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  338 (854)
                      |++|++++|+++++.+.+|+.+++|++|+|++|++....+. ..-...++.+....+.+....|..+.+   ....+++.
T Consensus       203 L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~  278 (284)
T d1ozna_         203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAA  278 (284)
T ss_dssp             CCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCG
T ss_pred             cccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCH
Confidence            88888888888777777777788888888888877654321 111234666666666666556655543   34445555


Q ss_pred             CcccC
Q 043388          339 NKLTG  343 (854)
Q Consensus       339 N~l~~  343 (854)
                      +.++|
T Consensus       279 ~~l~g  283 (284)
T d1ozna_         279 NDLQG  283 (284)
T ss_dssp             GGSCC
T ss_pred             HHCCC
Confidence            55543

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=4e-26  Score=237.43  Aligned_cols=257  Identities=21%  Similarity=0.199  Sum_probs=173.9

Q ss_pred             cCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecc-cccCcccChhhhc
Q 043388            7 QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVA-ENQFSGMFPRWIC   85 (854)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~   85 (854)
                      ++|..+.  +++++|+|++|+|++..+.+|.++++|++|++++|+|..+.+..+..+..+..++.+ .|.++++.|.+|.
T Consensus        25 ~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~  102 (284)
T d1ozna_          25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH  102 (284)
T ss_dssp             SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTT
T ss_pred             ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence            6787765  489999999999997667789999999999999999999999999999999999865 6788888899999


Q ss_pred             CCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCc
Q 043388           86 NISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQ  165 (854)
Q Consensus        86 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~  165 (854)
                      ++++|++|+|++|.+. .++...|...++|+.++++.|+++.+                 .+..|..+++|++|+|++|+
T Consensus       103 ~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i-----------------~~~~f~~~~~L~~L~l~~N~  164 (284)
T d1ozna_         103 GLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQAL-----------------PDDTFRDLGNLTHLFLHGNR  164 (284)
T ss_dssp             TCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCC-----------------CTTTTTTCTTCCEEECCSSC
T ss_pred             ccccCCEEecCCcccc-cccccccchhcccchhhhcccccccc-----------------ChhHhccccchhhcccccCc
Confidence            9999999999999997 66666666666666666665555432                 23456666666666666666


Q ss_pred             CcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcc
Q 043388          166 FKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQI  245 (854)
Q Consensus       166 i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l  245 (854)
                      |+.+++..|.++++|+.+++++|+++.+                              .|..|..+. +++.|++++|.+
T Consensus       165 l~~l~~~~f~~l~~L~~l~l~~N~l~~i------------------------------~~~~f~~l~-~L~~L~l~~N~i  213 (284)
T d1ozna_         165 ISSVPERAFRGLHSLDRLLLHQNRVAHV------------------------------HPHAFRDLG-RLMTLYLFANNL  213 (284)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCEE------------------------------CTTTTTTCT-TCCEEECCSSCC
T ss_pred             ccccchhhhccccccchhhhhhcccccc------------------------------ChhHhhhhh-hccccccccccc
Confidence            6666666666666666666665555443                              344444433 344455555555


Q ss_pred             cccCCccccccccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceec
Q 043388          246 SGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQ  318 (854)
Q Consensus       246 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  318 (854)
                      ++..+..|.++++|++|+|++|++...-+ .-+-...++.+....+.+....|..+.+   ...++++.+.|+
T Consensus       214 ~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~  282 (284)
T d1ozna_         214 SALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQ  282 (284)
T ss_dssp             SCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSC
T ss_pred             ccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCC
Confidence            44455556666666666666666653221 1111223555566666666566655543   334444444444

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=8e-24  Score=217.30  Aligned_cols=198  Identities=23%  Similarity=0.209  Sum_probs=176.2

Q ss_pred             CCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhhhhccC
Q 043388          127 NLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTN  206 (854)
Q Consensus       127 ~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~  206 (854)
                      .+.+.+.++++|     +.+|..+.  ++|++|+|++|+|+++++..|.++++|++|+|++|+|+.++.        +..
T Consensus        11 ~~~~v~C~~~~L-----~~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~--------~~~   75 (266)
T d1p9ag_          11 SHLEVNCDKRNL-----TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--------DGT   75 (266)
T ss_dssp             TCCEEECTTSCC-----SSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--------CSC
T ss_pred             CCeEEEccCCCC-----CeeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc--------ccc
Confidence            334445666665     45676653  589999999999999999999999999999999999986543        567


Q ss_pred             CCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCcccCcee
Q 043388          207 CSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQL  286 (854)
Q Consensus       207 l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  286 (854)
                      +++|++|+|++|+++ ..|..+..++ .|+.|++++|.+....+..+..+.++++|++++|.++.+.+..+..+++|+.|
T Consensus        76 l~~L~~L~Ls~N~l~-~~~~~~~~l~-~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l  153 (266)
T d1p9ag_          76 LPVLGTLDLSHNQLQ-SLPLLGQTLP-ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL  153 (266)
T ss_dssp             CTTCCEEECCSSCCS-SCCCCTTTCT-TCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccccccccccccccc-cccccccccc-ccccccccccccceeeccccccccccccccccccccceeccccccccccchhc
Confidence            899999999999998 5677777776 79999999999998889999999999999999999999999999999999999


Q ss_pred             eCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCccc
Q 043388          287 YMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLT  342 (854)
Q Consensus       287 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  342 (854)
                      ++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus       154 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            99999999888889999999999999999999 78888889999999999999986

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2.4e-23  Score=213.71  Aligned_cols=199  Identities=24%  Similarity=0.214  Sum_probs=113.2

Q ss_pred             CCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEE
Q 043388           40 SALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY  119 (854)
Q Consensus        40 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~  119 (854)
                      +.+.+.+.++++|+ .+|..+.  ++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+ .+|.  |..+++|++|+
T Consensus        10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~--~~~l~~L~~L~   83 (266)
T d1p9ag_          10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV--DGTLPVLGTLD   83 (266)
T ss_dssp             TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC--CSCCTTCCEEE
T ss_pred             CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc--ccccccccccc
Confidence            34444455555555 3454442  45666666666666555566666666666666666665 4442  33444444444


Q ss_pred             cccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChh
Q 043388          120 LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD  199 (854)
Q Consensus       120 l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~  199 (854)
                      +++|+++                  .++..+.++++|+.|++++|++..+.+..+..+.++++|++++|.++.++..   
T Consensus        84 Ls~N~l~------------------~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~---  142 (266)
T d1p9ag_          84 LSHNQLQ------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG---  142 (266)
T ss_dssp             CCSSCCS------------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTT---
T ss_pred             ccccccc------------------ccccccccccccccccccccccceeeccccccccccccccccccccceeccc---
Confidence            4444332                  2345566666777777777777666666666666666666666655544332   


Q ss_pred             hhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccC
Q 043388          200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGE  279 (854)
Q Consensus       200 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  279 (854)
                         .+..+++|+.|++++                         |+|++..+..|..+++|++|+|++|+|+ .+|+.+..
T Consensus       143 ---~~~~l~~l~~l~l~~-------------------------N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~  193 (266)
T d1p9ag_         143 ---LLTPTPKLEKLSLAN-------------------------NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG  193 (266)
T ss_dssp             ---TTTTCTTCCEEECTT-------------------------SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTT
T ss_pred             ---cccccccchhccccc-------------------------ccccccCccccccccccceeecccCCCc-ccChhHCC
Confidence               233344444444444                         4444444555666666777777777766 34555556


Q ss_pred             cccCceeeCcccccc
Q 043388          280 LQHLQQLYMFRNFLQ  294 (854)
Q Consensus       280 l~~L~~L~L~~N~l~  294 (854)
                      +++|+.|+|++|.+.
T Consensus       194 ~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         194 SHLLPFAFLHGNPWL  208 (266)
T ss_dssp             TCCCSEEECCSCCBC
T ss_pred             CCCCCEEEecCCCCC
Confidence            677777777777654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=8.5e-24  Score=205.13  Aligned_cols=165  Identities=19%  Similarity=0.192  Sum_probs=122.4

Q ss_pred             ccccCccCCCcceEEEEeEECCCceEEEEEEeecccc------------------cchHHHHHHHHHHHhccCCCeeeEE
Q 043388          550 FASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQK------------------GAFRSFVAECEALRNIRHRNLIKII  611 (854)
Q Consensus       550 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~  611 (854)
                      +.+.++||+|+||+||+|++. +|+.||||+++....                  .......+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            356789999999999999987 788999998753210                  0112345688899999999999988


Q ss_pred             EEeeccCCCCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCceE
Q 043388          612 TICSSIDSKGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHCQPPIVHGDLKPSNVL  691 (854)
Q Consensus       612 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl  691 (854)
                      ++.         ..++||||++++.+.+             ++...+..++.|++.|++|||++   +|+||||||+|||
T Consensus        81 ~~~---------~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NIL  135 (191)
T d1zara2          81 AWE---------GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL  135 (191)
T ss_dssp             EEE---------TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred             Eec---------CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhhee
Confidence            763         1379999998755432             33344567999999999999999   9999999999999


Q ss_pred             ecCCcccccccccccccccCCCCCCcccccCCcccccC------ccccCCCCCCccchhHHHHHHHH
Q 043388          692 LDHDMVAHQNFSLSHQLDSASKTPSSSIGIKGTVGYVA------PEYGMGSEASMTGDVYSFGILLL  752 (854)
Q Consensus       692 l~~~~~~~~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDv~slGvvl~  752 (854)
                      +++++.+++|||.|.....+...           .|..      .|. ....|+.++||||..--+.
T Consensus       136 v~~~~~~liDFG~a~~~~~~~~~-----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         136 VSEEGIWIIDFPQSVEVGEEGWR-----------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             EETTEEEECCCTTCEETTSTTHH-----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             eeCCCEEEEECCCcccCCCCCcH-----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            99999888899998765432211           1111      111 1346788999999865543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=5.7e-20  Score=197.03  Aligned_cols=314  Identities=26%  Similarity=0.293  Sum_probs=194.9

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeee
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYL   95 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L   95 (854)
                      .++++|||++|.|+ .+|+.   .++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++. +++.   .+.|++|+|
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---ccccccccc
Confidence            47999999999999 68864   468999999999999 678764   589999999999984 3331   246999999


Q ss_pred             cccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcc
Q 043388           96 TVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS  175 (854)
Q Consensus        96 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~  175 (854)
                      ++|+|+ .+|.  +..+++|++|+++++.+...                  |.   ....+..+.+.++....  ...+.
T Consensus       106 ~~n~l~-~lp~--~~~l~~L~~L~l~~~~~~~~------------------~~---~~~~l~~l~~~~~~~~~--~~~l~  159 (353)
T d1jl5a_         106 SNNQLE-KLPE--LQNSSFLKIIDVDNNSLKKL------------------PD---LPPSLEFIAAGNNQLEE--LPELQ  159 (353)
T ss_dssp             CSSCCS-SCCC--CTTCTTCCEEECCSSCCSCC------------------CC---CCTTCCEEECCSSCCSS--CCCCT
T ss_pred             cccccc-cccc--hhhhccceeecccccccccc------------------cc---ccccccchhhccccccc--ccccc
Confidence            999998 8885  57889999999888776532                  11   13445556665555432  33455


Q ss_pred             ccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccc
Q 043388          176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRN  255 (854)
Q Consensus       176 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~  255 (854)
                      .++.++.|++++|.+......          ....+.+...++.+. .+|. +..+. .++.+++++|.... .+.   .
T Consensus       160 ~l~~l~~L~l~~n~~~~~~~~----------~~~~~~l~~~~~~~~-~~~~-~~~l~-~L~~l~l~~n~~~~-~~~---~  222 (353)
T d1jl5a_         160 NLPFLTAIYADNNSLKKLPDL----------PLSLESIVAGNNILE-ELPE-LQNLP-FLTTIYADNNLLKT-LPD---L  222 (353)
T ss_dssp             TCTTCCEEECCSSCCSSCCCC----------CTTCCEEECCSSCCS-SCCC-CTTCT-TCCEEECCSSCCSS-CCS---C
T ss_pred             ccccceecccccccccccccc----------ccccccccccccccc-cccc-ccccc-cccccccccccccc-ccc---c
Confidence            666666666666665433221          123345555555444 3332 23332 56666666666552 232   2


Q ss_pred             cccCCeeeccccccccCCCCCccCcccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccc
Q 043388          256 LVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFD  335 (854)
Q Consensus       256 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  335 (854)
                      ..++..+.+.+|.+... +.   ..+.+...++..|.+.+.. ..   .......++..|.+.+.    ...+++|++|+
T Consensus       223 ~~~l~~~~~~~~~~~~~-~~---~~~~l~~~~~~~~~~~~l~-~l---~~~~~~~~~~~~~~~~~----~~~~~~L~~L~  290 (353)
T d1jl5a_         223 PPSLEALNVRDNYLTDL-PE---LPQSLTFLDVSENIFSGLS-EL---PPNLYYLNASSNEIRSL----CDLPPSLEELN  290 (353)
T ss_dssp             CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSEES-CC---CTTCCEEECCSSCCSEE----CCCCTTCCEEE
T ss_pred             ccccccccccccccccc-cc---ccccccccccccccccccc-cc---cchhcccccccCccccc----cccCCCCCEEE
Confidence            34566666777766532 22   2344555666555554321 10   01233445555555532    23356788888


Q ss_pred             cCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEE
Q 043388          336 ASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELN  415 (854)
Q Consensus       336 ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  415 (854)
                      +++|+++ .+|..                                   +.+|+.|+|++|+|+ .+|..   +++|++|+
T Consensus       291 Ls~N~l~-~lp~~-----------------------------------~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~  330 (353)
T d1jl5a_         291 VSNNKLI-ELPAL-----------------------------------PPRLERLIASFNHLA-EVPEL---PQNLKQLH  330 (353)
T ss_dssp             CCSSCCS-CCCCC-----------------------------------CTTCCEEECCSSCCS-CCCCC---CTTCCEEE
T ss_pred             CCCCccC-ccccc-----------------------------------cCCCCEEECCCCcCC-ccccc---cCCCCEEE
Confidence            8888876 33321                                   234778888888887 45542   45788888


Q ss_pred             ccCcccccccchhhcCccCCCeeec
Q 043388          416 VSSNNLSGQIPEFLQNLSFLEFLNL  440 (854)
Q Consensus       416 Ls~N~l~~~~p~~~~~l~~L~~L~l  440 (854)
                      |++|+|+ .+|+..   .+|+.|.+
T Consensus       331 L~~N~L~-~lp~~~---~~L~~L~~  351 (353)
T d1jl5a_         331 VEYNPLR-EFPDIP---ESVEDLRM  351 (353)
T ss_dssp             CCSSCCS-SCCCCC---TTCCEEEC
T ss_pred             CcCCcCC-CCCccc---cccCeeEC
Confidence            8888887 566533   34555544

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=1.2e-19  Score=194.56  Aligned_cols=304  Identities=25%  Similarity=0.297  Sum_probs=185.3

Q ss_pred             CCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEE
Q 043388           40 SALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELY  119 (854)
Q Consensus        40 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~  119 (854)
                      .++++|+|++|.|+ .+|+.   +++|++|+|++|+|+ .+|+.   +.+|+.|++++|+++ .++.-    .++|++|+
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l----p~~L~~L~  104 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLG  104 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEE
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh----cccccccc
Confidence            36888888888888 56754   467888888888888 45654   457888888888887 55421    12355555


Q ss_pred             cccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChh
Q 043388          120 LTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLD  199 (854)
Q Consensus       120 l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~  199 (854)
                      +++|.+.                  .+|. ++.+++|++|++++|.+.....    ....+..+.+..+......     
T Consensus       105 L~~n~l~------------------~lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~~~-----  156 (353)
T d1jl5a_         105 VSNNQLE------------------KLPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEELP-----  156 (353)
T ss_dssp             CCSSCCS------------------SCCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSCC-----
T ss_pred             ccccccc------------------cccc-hhhhccceeecccccccccccc----ccccccchhhccccccccc-----
Confidence            5554443                  3443 5678888888888888875433    2456667777666554321     


Q ss_pred             hhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccC
Q 043388          200 FVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGE  279 (854)
Q Consensus       200 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  279 (854)
                         .+..++.++.|++++|.+. ..+....    ....+...++.+. ..+ .+..++.|+.+++++|..... +.   .
T Consensus       157 ---~l~~l~~l~~L~l~~n~~~-~~~~~~~----~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~-~~---~  222 (353)
T d1jl5a_         157 ---ELQNLPFLTAIYADNNSLK-KLPDLPL----SLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTL-PD---L  222 (353)
T ss_dssp             ---CCTTCTTCCEEECCSSCCS-SCCCCCT----TCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSC-CS---C
T ss_pred             ---cccccccceeccccccccc-ccccccc----ccccccccccccc-ccc-ccccccccccccccccccccc-cc---c
Confidence               3556777888888888776 3332211    2344555555554 222 355667777777777766532 22   3


Q ss_pred             cccCceeeCccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCccchhhcchhhhHHHH
Q 043388          280 LQHLQQLYMFRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYL  359 (854)
Q Consensus       280 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l  359 (854)
                      ..++..+.+.+|.+.. .+....   .+...++..|.+.+. +..   .......++..|.+.+ +              
T Consensus       223 ~~~l~~~~~~~~~~~~-~~~~~~---~l~~~~~~~~~~~~l-~~l---~~~~~~~~~~~~~~~~-~--------------  279 (353)
T d1jl5a_         223 PPSLEALNVRDNYLTD-LPELPQ---SLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-L--------------  279 (353)
T ss_dssp             CTTCCEEECCSSCCSC-CCCCCT---TCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-E--------------
T ss_pred             cccccccccccccccc-cccccc---ccccccccccccccc-ccc---cchhcccccccCcccc-c--------------
Confidence            3456666666666652 232222   233333333333211 000   0112223333333331 0              


Q ss_pred             HhhcCCCCCCcCccccccccccccccccceeeccCcccccCCCcccccCCCCCEEEccCcccccccchhhcCccCCCeee
Q 043388          360 ALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGVIPFSLGFMKSIKELNVSSNNLSGQIPEFLQNLSFLEFLN  439 (854)
Q Consensus       360 ~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  439 (854)
                                 +   .       .+++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +++|+.|+
T Consensus       280 -----------~---~-------~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~  330 (353)
T d1jl5a_         280 -----------C---D-------LPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLH  330 (353)
T ss_dssp             -----------C---C-------CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEE
T ss_pred             -----------c---c-------cCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEE
Confidence                       0   0       1356999999999999 55643   678999999999999 67753   46899999


Q ss_pred             cccccCcccCCC
Q 043388          440 LSYNHLEGEVPT  451 (854)
Q Consensus       440 ls~N~l~~~~p~  451 (854)
                      |++|+|+. +|.
T Consensus       331 L~~N~L~~-lp~  341 (353)
T d1jl5a_         331 VEYNPLRE-FPD  341 (353)
T ss_dssp             CCSSCCSS-CCC
T ss_pred             CcCCcCCC-CCc
Confidence            99999984 553

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=2.9e-20  Score=187.93  Aligned_cols=221  Identities=19%  Similarity=0.160  Sum_probs=127.2

Q ss_pred             CeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEccc
Q 043388           43 GMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTF  122 (854)
Q Consensus        43 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~  122 (854)
                      +.++.+++.++ .+|..+.  +++++|+|++|+|+++.+.+|.++++|++|+|++|.+...+|...|.+++++++|.+..
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            45666666666 5555442  46777777777777666667777777777777777776556666666666666666543


Q ss_pred             -CCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcC-ccccCCCCeEecccccccCCCCCChhh
Q 043388          123 -CSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSID-FSSLKNLWWLNLEQNNLGMGTANDLDF  200 (854)
Q Consensus       123 -n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~-f~~l~~L~~L~L~~N~l~~~~~~~~~~  200 (854)
                       |++..                 ..+..|.++++|++|++++|++....+.. +..+..|..+..+++.+..+       
T Consensus        88 ~n~l~~-----------------~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i-------  143 (242)
T d1xwdc1          88 ANNLLY-----------------INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI-------  143 (242)
T ss_dssp             CTTCCE-----------------ECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEE-------
T ss_pred             cccccc-----------------cccccccccccccccccchhhhcccccccccccccccccccccccccccc-------
Confidence             23322                 12455667777777777777776543322 22333444444444444333       


Q ss_pred             hhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCCccCc
Q 043388          201 VTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDGVGEL  280 (854)
Q Consensus       201 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  280 (854)
                                             .+..+..+...+..|++++|+++.+.+..|.....++.+++++|+|+.+.++.|.++
T Consensus       144 -----------------------~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l  200 (242)
T d1xwdc1         144 -----------------------ERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA  200 (242)
T ss_dssp             -----------------------CTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTS
T ss_pred             -----------------------cccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCC
Confidence                                   233333333345555555555554433333322223333456666665555566666


Q ss_pred             ccCceeeCccccccccCCccccCccccchhccc
Q 043388          281 QHLQQLYMFRNFLQGSIPPSLGNLTKLADLALS  313 (854)
Q Consensus       281 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  313 (854)
                      ++|++|+|++|+|+...+..|.++++|+.+++.
T Consensus       201 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             CCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             CCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            677777777766665445556666666666554

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=3.8e-20  Score=186.99  Aligned_cols=222  Identities=14%  Similarity=0.088  Sum_probs=168.8

Q ss_pred             CCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcc-cChhhhcCCCCCceeeec
Q 043388           18 LQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSG-MFPRWICNISSLEFIYLT   96 (854)
Q Consensus        18 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~   96 (854)
                      .++++++++.++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+.+ +.+.+|.+++++++|++.
T Consensus        10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            468999999999 7887664  589999999999997777789999999999999999876 456689999999999986


Q ss_pred             c-cccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcc
Q 043388           97 V-NRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS  175 (854)
Q Consensus        97 ~-N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~  175 (854)
                      . |++. .++.+.|.++++|++|+++.|++....                ....+..+..+..+..+++++..+.+..|.
T Consensus        87 ~~n~l~-~~~~~~~~~l~~L~~l~l~~~~l~~~~----------------~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~  149 (242)
T d1xwdc1          87 KANNLL-YINPEAFQNLPNLQYLLISNTGIKHLP----------------DVHKIHSLQKVLLDIQDNINIHTIERNSFV  149 (242)
T ss_dssp             CCTTCC-EECTTSEECCTTCCEEEEESCCCCSCC----------------CCTTTCBSSCEEEEEESCTTCCEECTTSST
T ss_pred             cccccc-ccccccccccccccccccchhhhcccc----------------cccccccccccccccccccccccccccccc
Confidence            4 6787 788889999999999999988876441                123455678888888999999988888877


Q ss_pred             ccC-CCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCcccc
Q 043388          176 SLK-NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIR  254 (854)
Q Consensus       176 ~l~-~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~  254 (854)
                      +++ .++.|++++|+++.+..                               ..+......+.+++++|+|+.+.+..|.
T Consensus       150 ~~~~~l~~L~l~~n~l~~i~~-------------------------------~~~~~~~l~~~~~l~~n~l~~l~~~~f~  198 (242)
T d1xwdc1         150 GLSFESVILWLNKNGIQEIHN-------------------------------CAFNGTQLDELNLSDNNNLEELPNDVFH  198 (242)
T ss_dssp             TSBSSCEEEECCSSCCCEECT-------------------------------TTTTTCCEEEEECTTCTTCCCCCTTTTT
T ss_pred             cccccceeeeccccccccccc-------------------------------ccccchhhhccccccccccccccHHHhc
Confidence            654 55566666665543332                               2222222233345566677755566688


Q ss_pred             ccccCCeeeccccccccCCCCCccCcccCceeeCcc
Q 043388          255 NLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYMFR  290 (854)
Q Consensus       255 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  290 (854)
                      ++++|++|+|++|+|+.+.+..|.++++|+.+++.+
T Consensus       199 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         199 GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             TSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             CCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            888899999999888877777788888888877644

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=2.4e-22  Score=224.23  Aligned_cols=110  Identities=20%  Similarity=0.199  Sum_probs=75.5

Q ss_pred             CCCCEEecccccccccC-CccccCcCCCCeeecccccccc----cCCcCccCCCCCcEEecccccCcccC----hhhhc-
Q 043388           16 LNLQTLAIDFNYLTGQL-PDFVGNLSALGMLLIRWNSLGG----QIPTTLGLLRNLVYLNVAENQFSGMF----PRWIC-   85 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~-   85 (854)
                      .+|++||+++|++++.. .+.++.++++++|+|++|.|+.    .+...+..+++|++|||++|.|+...    .+.+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            36788888888887532 3446777888888888888873    33455677888888888888886322    22232 


Q ss_pred             CCCCCceeeecccccccccC----cccccCCCCCcEEEcccCCCC
Q 043388           86 NISSLEFIYLTVNRFSGSLP----FDILVNLPNLKELYLTFCSLK  126 (854)
Q Consensus        86 ~l~~L~~L~L~~N~l~~~~~----~~~~~~l~~L~~L~l~~n~l~  126 (854)
                      ..++|++|+|++|+|+ ...    ...+..+++|++|++++|.+.
T Consensus        82 ~~~~L~~L~L~~n~it-~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLT-GAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TTCCCCEEECTTSCCB-GGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCCEEECCCCCcc-ccccccccchhhccccccccccccccch
Confidence            2347888888888886 322    134566777888888777653

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=6.8e-20  Score=182.93  Aligned_cols=75  Identities=20%  Similarity=0.274  Sum_probs=34.1

Q ss_pred             EecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeeccccc
Q 043388           21 LAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRF  100 (854)
Q Consensus        21 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  100 (854)
                      ++++.+++++..  .+..+.+|+.|++.+|+|+. ++ .+..+++|++|+|++|+|+++.|  |.++++|++|++++|.+
T Consensus        24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~   97 (227)
T d1h6ua2          24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL   97 (227)
T ss_dssp             HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred             HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence            444444444322  23444445555555555542 22 34445555555555555543322  44444555555554444


Q ss_pred             c
Q 043388          101 S  101 (854)
Q Consensus       101 ~  101 (854)
                      +
T Consensus        98 ~   98 (227)
T d1h6ua2          98 K   98 (227)
T ss_dssp             S
T ss_pred             c
Confidence            4

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=1.5e-19  Score=180.49  Aligned_cols=211  Identities=22%  Similarity=0.279  Sum_probs=158.3

Q ss_pred             cCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCc
Q 043388           37 GNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLK  116 (854)
Q Consensus        37 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  116 (854)
                      ..+.++..++++.+++++..  .++.+.+|++|++++|.|+++ + .++.+++|++|+|++|+|+ .++.  |..+++|+
T Consensus        16 ~~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~-~~~~--l~~l~~l~   88 (227)
T d1h6ua2          16 PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQIT-DLAP--LKNLTKIT   88 (227)
T ss_dssp             HHHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCC-CCGG--GTTCCSCC
T ss_pred             HHHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceee-cccc--cccccccc
Confidence            33445566778888887543  557788889999999988854 3 5888899999999999887 4432  67778888


Q ss_pred             EEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCC
Q 043388          117 ELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTAN  196 (854)
Q Consensus       117 ~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~  196 (854)
                      .++++.|.++++                   ..+.++++|+.+++++|++.++.  .+...+.++.+.++.+.+....  
T Consensus        89 ~l~~~~n~~~~i-------------------~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--  145 (227)
T d1h6ua2          89 ELELSGNPLKNV-------------------SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--  145 (227)
T ss_dssp             EEECCSCCCSCC-------------------GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--
T ss_pred             cccccccccccc-------------------ccccccccccccccccccccccc--hhccccchhhhhchhhhhchhh--
Confidence            888777766544                   24667888888888888887543  4667788888888888775322  


Q ss_pred             ChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCCCCC
Q 043388          197 DLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGIIPDG  276 (854)
Q Consensus       197 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  276 (854)
                            .+.++++|+.|++++|.+...  ..+..++ +|+.|++++|++++. + .|+++++|++|+|++|+|+++.|  
T Consensus       146 ------~~~~~~~L~~L~l~~n~~~~~--~~l~~l~-~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--  212 (227)
T d1h6ua2         146 ------PLAGLTNLQYLSIGNAQVSDL--TPLANLS-KLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--  212 (227)
T ss_dssp             ------GGGGCTTCCEEECCSSCCCCC--GGGTTCT-TCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--
T ss_pred             ------hhccccccccccccccccccc--hhhcccc-cceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--
Confidence                  356778888999988888733  2366665 788999999988853 2 38888999999999999987643  


Q ss_pred             ccCcccCceeeCcc
Q 043388          277 VGELQHLQQLYMFR  290 (854)
Q Consensus       277 ~~~l~~L~~L~L~~  290 (854)
                      ++++++|+.|++++
T Consensus       213 l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         213 LANTSNLFIVTLTN  226 (227)
T ss_dssp             GTTCTTCCEEEEEE
T ss_pred             cccCCCCCEEEeeC
Confidence            78899999998863

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=3.2e-19  Score=175.19  Aligned_cols=182  Identities=21%  Similarity=0.312  Sum_probs=112.1

Q ss_pred             CEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeeccc
Q 043388           19 QTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVN   98 (854)
Q Consensus        19 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N   98 (854)
                      ...++..+.+++.++.  ..+.+|+.|++++|.++. ++ .+..+++|++|+|++|+|+++.  .++++++|++|++++|
T Consensus        27 i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n  100 (210)
T d1h6ta2          27 IKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDEN  100 (210)
T ss_dssp             HHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSS
T ss_pred             HHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccc
Confidence            3445566666544432  345667777777777763 22 3666777777777777777533  2567777777777777


Q ss_pred             ccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccC
Q 043388           99 RFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLK  178 (854)
Q Consensus        99 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~  178 (854)
                      +|+ .+|  .+.++++|+.|+++.|.+..+                   ..+.++++|+.+++++|+++..  ..+..++
T Consensus       101 ~i~-~l~--~l~~l~~L~~L~l~~~~~~~~-------------------~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~  156 (210)
T d1h6ta2         101 KVK-DLS--SLKDLKKLKSLSLEHNGISDI-------------------NGLVHLPQLESLYLGNNKITDI--TVLSRLT  156 (210)
T ss_dssp             CCC-CGG--GGTTCTTCCEEECTTSCCCCC-------------------GGGGGCTTCCEEECCSSCCCCC--GGGGGCT
T ss_pred             ccc-ccc--ccccccccccccccccccccc-------------------cccccccccccccccccccccc--ccccccc
Confidence            776 555  256666666666666654332                   2455666677777777766543  2455666


Q ss_pred             CCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEcc
Q 043388          179 NLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIG  241 (854)
Q Consensus       179 ~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~  241 (854)
                      +|+++++++|+++.+.        .+.++++|++|+|++|+++ .+| .+..++ +|+.|+|+
T Consensus       157 ~L~~l~l~~n~l~~i~--------~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~-~L~~L~Ls  208 (210)
T d1h6ta2         157 KLDTLSLEDNQISDIV--------PLAGLTKLQNLYLSKNHIS-DLR-ALAGLK-NLDVLELF  208 (210)
T ss_dssp             TCSEEECCSSCCCCCG--------GGTTCTTCCEEECCSSCCC-BCG-GGTTCT-TCSEEEEE
T ss_pred             cccccccccccccccc--------cccCCCCCCEEECCCCCCC-CCh-hhcCCC-CCCEEEcc
Confidence            7777777777665432        2556667777777777766 344 455554 57777665

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=1.1e-18  Score=169.96  Aligned_cols=182  Identities=25%  Similarity=0.348  Sum_probs=134.4

Q ss_pred             CCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeee
Q 043388           16 LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYL   95 (854)
Q Consensus        16 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L   95 (854)
                      .++..+.++.+.+++.++  ...+.+++.|++++|.|+. + +.+..+++|++|+|++|+|+++.|  |+++++|++|++
T Consensus        18 ~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l   91 (199)
T d2omxa2          18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM   91 (199)
T ss_dssp             HHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             HHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccc
Confidence            344456777777775443  3467788889999988883 3 347888899999999998886543  888889999999


Q ss_pred             cccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcc
Q 043388           96 TVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS  175 (854)
Q Consensus        96 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~  175 (854)
                      ++|.+. .++.  |.++++|+.|+++.|....+                   +.+.++++|+.|++++|++..+.  .+.
T Consensus        92 ~~n~~~-~~~~--l~~l~~L~~L~l~~~~~~~~-------------------~~~~~l~~L~~L~l~~n~l~~~~--~l~  147 (199)
T d2omxa2          92 NNNQIA-DITP--LANLTNLTGLTLFNNQITDI-------------------DPLKNLTNLNRLELSSNTISDIS--ALS  147 (199)
T ss_dssp             CSSCCC-CCGG--GTTCTTCSEEECCSSCCCCC-------------------GGGTTCTTCSEEECCSSCCCCCG--GGT
T ss_pred             cccccc-cccc--cccccccccccccccccccc-------------------cccchhhhhHHhhhhhhhhcccc--ccc
Confidence            998887 6653  67778888887777665432                   34677888888888888887543  578


Q ss_pred             ccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEE
Q 043388          176 SLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQF  238 (854)
Q Consensus       176 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L  238 (854)
                      .+++|++|++++|+++.++        .+.++++|++|++++|++++ ++ .+..++ +|+.|
T Consensus       148 ~~~~L~~L~l~~n~l~~l~--------~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~-~L~~L  199 (199)
T d2omxa2         148 GLTSLQQLNFSSNQVTDLK--------PLANLTTLERLDISSNKVSD-IS-VLAKLT-NLESL  199 (199)
T ss_dssp             TCTTCSEEECCSSCCCCCG--------GGTTCTTCCEEECCSSCCCC-CG-GGGGCT-TCSEE
T ss_pred             ccccccccccccccccCCc--------cccCCCCCCEEECCCCCCCC-Cc-cccCCC-CCCcC
Confidence            8888888888888887543        36788889999999998873 44 456654 56544

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=2e-21  Score=216.54  Aligned_cols=364  Identities=17%  Similarity=0.163  Sum_probs=215.4

Q ss_pred             CCCCeeecccccccccC-CcCccCCCCCcEEecccccCcc----cChhhhcCCCCCceeeecccccccccC-----cccc
Q 043388           40 SALGMLLIRWNSLGGQI-PTTLGLLRNLVYLNVAENQFSG----MFPRWICNISSLEFIYLTVNRFSGSLP-----FDIL  109 (854)
Q Consensus        40 ~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~  109 (854)
                      .+|+.||++.|+|++.. ...+..+++|++|+|++|.|+.    .++.++..+++|++|+|++|+|+ ...     ....
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~-~~~~~~l~~~l~   80 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG-DVGVHCVLQGLQ   80 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH-HHHHHHHHHTTC
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC-hHHHHHHHHHHh
Confidence            46899999999998532 4456778999999999999984    34567789999999999999986 221     1111


Q ss_pred             cCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCcc-----ccCCCCeEe
Q 043388          110 VNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFS-----SLKNLWWLN  184 (854)
Q Consensus       110 ~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~-----~l~~L~~L~  184 (854)
                      ...++|++|++++|             .++......++..+..+++|++|+|++|+|+......+.     .......+.
T Consensus        81 ~~~~~L~~L~L~~n-------------~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~  147 (460)
T d1z7xw1          81 TPSCKIQKLSLQNC-------------CLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQ  147 (460)
T ss_dssp             STTCCCCEEECTTS-------------CCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred             cCCCCCCEEECCCC-------------Cccccccccccchhhccccccccccccccchhhhhhhhhhccccccccccccc
Confidence            12234555555554             443333344667788899999999999998754322221     122233444


Q ss_pred             cccccccCCCCCChhhhhhccCCCCCcEEEcccCcCccc----CChhhhhhcccccEEEccCCccccc----CCcccccc
Q 043388          185 LEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGE----LPHSIANLSSTMIQFRIGGNQISGT----IPSGIRNL  256 (854)
Q Consensus       185 L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~~L~~L~l~~N~l~~~----~~~~~~~l  256 (854)
                      .....+....  .......+.....++.++++++.+...    ....+.........+.+..+.+...    ....+...
T Consensus       148 ~~~~~~~~~~--~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~  225 (460)
T d1z7xw1         148 LEYCSLSAAS--CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK  225 (460)
T ss_dssp             CTTSCCBGGG--HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHC
T ss_pred             ccccccchhh--hcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccccccccc
Confidence            4444332111  112233455667788888888776522    1112222223455677777765422    11234456


Q ss_pred             ccCCeeecccccccc-----CCCCCccCcccCceeeCccccccccC----CccccCccccchhccccceecccCCCC---
Q 043388          257 VNLIALTIEVNQLHG-----IIPDGVGELQHLQQLYMFRNFLQGSI----PPSLGNLTKLADLALSFNNLQGNIPSS---  324 (854)
Q Consensus       257 ~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~---  324 (854)
                      +.++.+++++|++..     ..+..+.....++.+++++|.+....    ...+...+.++.+++++|.++......   
T Consensus       226 ~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~  305 (460)
T d1z7xw1         226 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE  305 (460)
T ss_dssp             TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred             ccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence            778888888887642     12233445667888888888776432    223455677888888888876322211   


Q ss_pred             --CcCCCCCcccccCCCcccCccchhhcchhhhHHHHHhhcCCCCCCcCccccccccccccccccceeeccCcccccC--
Q 043388          325 --LGNCQNLKGFDASHNKLTGAIPQQVLSITTLSVYLALAHNLLNDSLPLQVGNLKNLVITCVSLEYLDISSNSFHGV--  400 (854)
Q Consensus       325 --~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~l~~n~l~~~~p~~~~~l~~l~~~~~~L~~L~Ls~N~l~~~--  400 (854)
                        ......|+.+++++|.++......+.   ..                         ...+.+|++|+|++|+|+..  
T Consensus       306 ~l~~~~~~L~~l~l~~~~l~~~~~~~l~---~~-------------------------~~~~~~L~~L~Ls~N~i~~~g~  357 (460)
T d1z7xw1         306 TLLEPGCQLESLWVKSCSFTAACCSHFS---SV-------------------------LAQNRFLLELQISNNRLEDAGV  357 (460)
T ss_dssp             HHTSTTCCCCEEECTTSCCBGGGHHHHH---HH-------------------------HHHCSSCCEEECCSSBCHHHHH
T ss_pred             cccccccccccccccccchhhhhhhhcc---cc-------------------------cccccchhhhheeeecccCccc
Confidence              12345678888888877632111111   10                         00133577777777776532  


Q ss_pred             --CCcccc-cCCCCCEEEccCccccc----ccchhhcCccCCCeeecccccCcc
Q 043388          401 --IPFSLG-FMKSIKELNVSSNNLSG----QIPEFLQNLSFLEFLNLSYNHLEG  447 (854)
Q Consensus       401 --~p~~~~-~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~  447 (854)
                        ++..+. ..+.|++|+|++|+|+.    .+++.+..+++|++|||++|+++.
T Consensus       358 ~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         358 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             HHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             chhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence              122222 34557777777777763    244455666777777777777653

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.77  E-value=1.9e-19  Score=174.24  Aligned_cols=130  Identities=25%  Similarity=0.324  Sum_probs=88.8

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeecccccccc-cCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeee
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGG-QIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYL   95 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L   95 (854)
                      +.+++++++++++ .+|..+.  +++++|+|++|+|+. ..+..|+.+++|++|+|++|.+.++.+++|..+++|++|+|
T Consensus         9 ~~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L   85 (192)
T d1w8aa_           9 EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL   85 (192)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             cCCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence            3467888888888 6776654  578888888888864 44566777888888888888888777778888888888888


Q ss_pred             cccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCc
Q 043388           96 TVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFK  167 (854)
Q Consensus        96 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~  167 (854)
                      ++|+|+ .+|.++|.++++|++|+|++|+|+.+                 .|++|..+++|++|+|++|.+.
T Consensus        86 s~N~l~-~l~~~~F~~l~~L~~L~L~~N~l~~i-----------------~~~~f~~l~~L~~l~L~~N~~~  139 (192)
T d1w8aa_          86 GENKIK-EISNKMFLGLHQLKTLNLYDNQISCV-----------------MPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             CSCCCC-EECSSSSTTCTTCCEEECCSSCCCEE-----------------CTTSSTTCTTCCEEECTTCCBC
T ss_pred             cccccc-ccCHHHHhCCCcccccccCCcccccc-----------------CHHHhcCCcccccccccccccc
Confidence            888887 66666666665555555555555433                 1344555555555555555554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=8e-19  Score=170.85  Aligned_cols=183  Identities=23%  Similarity=0.306  Sum_probs=128.9

Q ss_pred             cCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEE
Q 043388           39 LSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKEL  118 (854)
Q Consensus        39 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  118 (854)
                      +.+...+.++.+.+++.++  ...+.+|++|++++|.|+.+  +.++.+++|++|+|++|+|+ .++.  |.++++|++|
T Consensus        17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~-~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT-DITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCcccccccc-Cccc--ccCCcccccc
Confidence            3445566777777775433  34677888888888888753  34777888888888888887 4543  6777777777


Q ss_pred             EcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCCh
Q 043388          119 YLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDL  198 (854)
Q Consensus       119 ~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~  198 (854)
                      +++.|.+..+                  + .+.++++|+.|++++|++..+.  .+..+++|+.|++++|++..++    
T Consensus        90 ~l~~n~~~~~------------------~-~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~~~----  144 (199)
T d2omxa2          90 LMNNNQIADI------------------T-PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISDIS----  144 (199)
T ss_dssp             ECCSSCCCCC------------------G-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG----
T ss_pred             cccccccccc------------------c-cccccccccccccccccccccc--ccchhhhhHHhhhhhhhhcccc----
Confidence            7777765433                  2 3677888888888888887543  4677888888888888775432    


Q ss_pred             hhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCee
Q 043388          199 DFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIAL  262 (854)
Q Consensus       199 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  262 (854)
                          .+..+++|+.|++++|++++ ++ .+.+++ +|+.|++++|+|+.+  +.++++++|++|
T Consensus       145 ----~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~-~L~~L~ls~N~i~~i--~~l~~L~~L~~L  199 (199)
T d2omxa2         145 ----ALSGLTSLQQLNFSSNQVTD-LK-PLANLT-TLERLDISSNKVSDI--SVLAKLTNLESL  199 (199)
T ss_dssp             ----GGTTCTTCSEEECCSSCCCC-CG-GGTTCT-TCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred             ----cccccccccccccccccccC-Cc-cccCCC-CCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence                36677888888888888874 33 366665 688888888888743  357777777765

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=1.3e-18  Score=168.15  Aligned_cols=131  Identities=20%  Similarity=0.281  Sum_probs=116.7

Q ss_pred             CcEEEcccCcCcccCChhhhhhcccccEEEccCCccccc-CCccccccccCCeeeccccccccCCCCCccCcccCceeeC
Q 043388          210 LKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGT-IPSGIRNLVNLIALTIEVNQLHGIIPDGVGELQHLQQLYM  288 (854)
Q Consensus       210 L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  288 (854)
                      .+++++++|+++ .+|..+.   +.+++|+|++|+|++. .+..|.++++|+.|+|++|++..+.++.|..+++|++|+|
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L   85 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL   85 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCEEEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence            457888888888 6776553   4788999999999764 4667899999999999999999999999999999999999


Q ss_pred             ccccccccCCccccCccccchhccccceecccCCCCCcCCCCCcccccCCCcccCc
Q 043388          289 FRNFLQGSIPPSLGNLTKLADLALSFNNLQGNIPSSLGNCQNLKGFDASHNKLTGA  344 (854)
Q Consensus       289 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  344 (854)
                      ++|+|+...|.+|.++++|+.|+|++|+|+++.+.+|..+++|++|+|++|.+...
T Consensus        86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_          86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence            99999988888999999999999999999998899999999999999999999754

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=5.1e-18  Score=166.49  Aligned_cols=184  Identities=23%  Similarity=0.274  Sum_probs=117.4

Q ss_pred             CCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcc
Q 043388           42 LGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT  121 (854)
Q Consensus        42 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~  121 (854)
                      ....+++.+.+++.++.  ..+.+|++|++++|.++++.  .+..+++|++|+|++|+|+ .++.  +..+++|++|+++
T Consensus        26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~-~l~~--~~~l~~L~~L~l~   98 (210)
T d1h6ta2          26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLT-DIKP--LANLKNLGWLFLD   98 (210)
T ss_dssp             HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECC
T ss_pred             HHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCcccc-Cccc--cccCccccccccc
Confidence            33445666666644432  34667777777777777432  3667777777777777776 4442  4566666666666


Q ss_pred             cCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhhh
Q 043388          122 FCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFV  201 (854)
Q Consensus       122 ~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~  201 (854)
                      +|+++.+                  | .+.++++|+.|++++|.+..+  ..+..+++|+++++++|.++...       
T Consensus        99 ~n~i~~l------------------~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~~-------  150 (210)
T d1h6ta2          99 ENKVKDL------------------S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDIT-------  150 (210)
T ss_dssp             SSCCCCG------------------G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCCG-------
T ss_pred             ccccccc------------------c-ccccccccccccccccccccc--ccccccccccccccccccccccc-------
Confidence            6655432                  3 466677777777777777643  34667777777777777765322       


Q ss_pred             hhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccc
Q 043388          202 TLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEV  266 (854)
Q Consensus       202 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  266 (854)
                       .+..+++|+++++++|++++ ++ .+.+++ +|+.|++++|+|+. +| .|.++++|++|+|++
T Consensus       151 -~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~-~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         151 -VLSRLTKLDTLSLEDNQISD-IV-PLAGLT-KLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             -GGGGCTTCSEEECCSSCCCC-CG-GGTTCT-TCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             -cccccccccccccccccccc-cc-cccCCC-CCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence             24566777777777777763 33 255554 67777777777764 33 477777777777753

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=2.4e-16  Score=146.65  Aligned_cols=129  Identities=20%  Similarity=0.176  Sum_probs=73.5

Q ss_pred             ccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCC
Q 043388           36 VGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNL  115 (854)
Q Consensus        36 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  115 (854)
                      |.+...+++|+|++|+|+ .++..+..+++|++|+|++|+|+.+  +.|..+++|++|+|++|+|+ .+|..+|..+++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L   89 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDL   89 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhccccccc-CCCcccccccccc
Confidence            445555666666666666 3355555566666666666666643  23566666666666666665 5555555556666


Q ss_pred             cEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCC---cCccccCCCCeEe
Q 043388          116 KELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS---IDFSSLKNLWWLN  184 (854)
Q Consensus       116 ~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~---~~f~~l~~L~~L~  184 (854)
                      ++|++++|+++.+.               .+ ..+..+++|++|++++|.++..+.   ..+..+++|++||
T Consensus        90 ~~L~L~~N~i~~~~---------------~l-~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLVELG---------------DL-DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSCCCCCGG---------------GG-GGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             ccceeccccccccc---------------cc-cccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            66665555554431               11 245566677777777776654431   2344455555554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=2.9e-16  Score=146.12  Aligned_cols=133  Identities=17%  Similarity=0.128  Sum_probs=111.7

Q ss_pred             hhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCC
Q 043388           11 EIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSL   90 (854)
Q Consensus        11 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L   90 (854)
                      .|.+...+++|||++|+|+ .++..+..+++|++|+|++|+|+. ++ .|..+++|++|+|++|+|+++.+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            3678889999999999999 678778889999999999999994 43 58999999999999999998877888899999


Q ss_pred             ceeeecccccccccCc-ccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEec
Q 043388           91 EFIYLTVNRFSGSLPF-DILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDL  161 (854)
Q Consensus        91 ~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~L  161 (854)
                      ++|+|++|+|+ .++. ..+..+++|++|++++|.+..+.              ..-+..+..+++|++||-
T Consensus        90 ~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~--------------~~r~~~i~~lp~L~~LD~  146 (162)
T d1a9na_          90 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKK--------------HYRLYVIYKVPQVRVLDF  146 (162)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGST--------------THHHHHHHHCTTCSEETT
T ss_pred             ccceecccccc-ccccccccccccccchhhcCCCcccccc--------------chHHHHHHHCCCcCeeCC
Confidence            99999999998 6764 56788899999998888775441              001235788999999883

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.60  E-value=1.4e-17  Score=177.47  Aligned_cols=263  Identities=14%  Similarity=0.142  Sum_probs=160.0

Q ss_pred             CchhhhcCCCCCEEecccccccc----cCCccccCcCCCCeeeccccccccc----------CCcCccCCCCCcEEeccc
Q 043388            8 IPEEIGSLLNLQTLAIDFNYLTG----QLPDFVGNLSALGMLLIRWNSLGGQ----------IPTTLGLLRNLVYLNVAE   73 (854)
Q Consensus         8 ~p~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~----------~~~~~~~l~~L~~L~Ls~   73 (854)
                      +...+.....|++|+|++|.|..    .+...+...++|+.|+++++.....          +...+...++|++|+|++
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~  102 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  102 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence            55677888899999999998853    2445577788999999988765421          223355678899999999


Q ss_pred             ccCccc----ChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEcc--cCCCCCCceeeccCccCCCCCCCCCC
Q 043388           74 NQFSGM----FPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLT--FCSLKNLWWLNLEQNNLGMGTASSIP  147 (854)
Q Consensus        74 N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~--~n~l~~L~~L~L~~N~l~~~~~~~~p  147 (854)
                      |.++..    +...+...++|++|++++|.++.. ....+..  .|..+...  .-....|+.+++++|.++......+.
T Consensus       103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~-~~~~l~~--~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~  179 (344)
T d2ca6a1         103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ-AGAKIAR--ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA  179 (344)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHH-HHHHHHH--HHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHH
T ss_pred             cccccccccchhhhhcccccchheeccccccccc-ccccccc--cccccccccccccCcccceeeccccccccccccccc
Confidence            988764    344556788899999999887511 1000100  00000000  01223445555555555444444455


Q ss_pred             ccccCCCCCCEEecCCCcCccc-----CCcCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCcc
Q 043388          148 DSLSNASNLERLDLSGNQFKGK-----VSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFGG  222 (854)
Q Consensus       148 ~~~~~l~~L~~L~Ls~N~i~~~-----~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~  222 (854)
                      ..+...++|++|+|++|+|...     ....+...++|+.|+|++|.++.....  .+...+..+++|++|+|++|.|++
T Consensus       180 ~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~--~L~~~l~~~~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS--ALAIALKSWPNLRELGLNDCLLSA  257 (344)
T ss_dssp             HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH--HHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             chhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccc--cccccccccccchhhhhhcCccCc
Confidence            6677788899999999988642     334567788888888888887532211  234556778888888888888875


Q ss_pred             cCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccccCC----CCCc-cCcccCceeeCcccccc
Q 043388          223 ELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLHGII----PDGV-GELQHLQQLYMFRNFLQ  294 (854)
Q Consensus       223 ~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~-~~l~~L~~L~L~~N~l~  294 (854)
                      .....+......                   ...+.|++|++++|+|+...    ...+ .++++|+.|+|++|++.
T Consensus       258 ~g~~~l~~~l~~-------------------~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         258 RGAAAVVDAFSK-------------------LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             HHHHHHHHHHHT-------------------CSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             hhhHHHHHHhhh-------------------ccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            433333321100                   01234666666666654321    1112 13556777777777765

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.60  E-value=1.7e-15  Score=133.64  Aligned_cols=104  Identities=27%  Similarity=0.294  Sum_probs=90.2

Q ss_pred             CEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeeccc
Q 043388           19 QTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVN   98 (854)
Q Consensus        19 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N   98 (854)
                      ++|+|++|+|+ .++ .++.+++|++|++++|+|+ .+|..|+.+++|++|++++|+|+++ | .|..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence            58999999998 555 4899999999999999998 6788899999999999999999954 4 4899999999999999


Q ss_pred             ccccccCc-ccccCCCCCcEEEcccCCCCCC
Q 043388           99 RFSGSLPF-DILVNLPNLKELYLTFCSLKNL  128 (854)
Q Consensus        99 ~l~~~~~~-~~~~~l~~L~~L~l~~n~l~~L  128 (854)
                      +|+ .+|. ..|..+++|++|++++|.+...
T Consensus        76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             CCC-SSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             ccC-CCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            998 6663 5688889999999888887654

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.58  E-value=3.5e-15  Score=131.67  Aligned_cols=104  Identities=23%  Similarity=0.306  Sum_probs=65.4

Q ss_pred             CeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeeecccccccccCcccccCCCCCcEEEccc
Q 043388           43 GMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTF  122 (854)
Q Consensus        43 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~  122 (854)
                      ++|+|++|+|+ .++ .++.+++|++|+|++|+|+ .+|+.|+.+++|++|++++|+|+ .+|.  |..+++|++|++++
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~--~~~l~~L~~L~l~~   74 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQELLLCN   74 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECCS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc--cccccccCeEECCC
Confidence            46778888887 444 3777788888888888887 35666777778888888888776 5542  45555555555555


Q ss_pred             CCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcc
Q 043388          123 CSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKG  168 (854)
Q Consensus       123 n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~  168 (854)
                      |+++.+.               . ...+.++++|++|++++|+|+.
T Consensus        75 N~i~~~~---------------~-~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          75 NRLQQSA---------------A-IQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             SCCCSSS---------------T-TGGGGGCTTCCEEECTTSGGGG
T ss_pred             CccCCCC---------------C-chhhcCCCCCCEEECCCCcCCc
Confidence            5544331               0 1335555566666666665553

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=1.6e-15  Score=155.84  Aligned_cols=256  Identities=18%  Similarity=0.215  Sum_probs=127.6

Q ss_pred             CEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCccc-ChhhhcCCCCCceeeecc
Q 043388           19 QTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGM-FPRWICNISSLEFIYLTV   97 (854)
Q Consensus        19 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~   97 (854)
                      ++|||+++.+.......+-. .....+.++...+.... .......+|++|||++|.+++. ++..+.++++|++|+|++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            57888888775322222211 23456666666665332 3334456788888888887643 345567788888888888


Q ss_pred             cccccccCcccccCCCCCcEEEcccC-CCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCC-cCcccC-CcCc
Q 043388           98 NRFSGSLPFDILVNLPNLKELYLTFC-SLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGN-QFKGKV-SIDF  174 (854)
Q Consensus        98 N~l~~~~~~~~~~~l~~L~~L~l~~n-~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N-~i~~~~-~~~f  174 (854)
                      +.+++..+ ..+..+++|++|++++| .++.                ..+...+.++++|++|+++++ +++... ...+
T Consensus        81 ~~l~~~~~-~~l~~~~~L~~L~Ls~c~~itd----------------~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~  143 (284)
T d2astb2          81 LRLSDPIV-NTLAKNSNLVRLNLSGCSGFSE----------------FALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV  143 (284)
T ss_dssp             CBCCHHHH-HHHTTCTTCSEEECTTCBSCCH----------------HHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH
T ss_pred             cCCCcHHH-HHHhcCCCCcCccccccccccc----------------cccchhhHHHHhccccccccccccccccchhhh
Confidence            87763322 23455566666666553 2210                011122344566666666664 332111 1111


Q ss_pred             cc-cCCCCeEeccccc--ccCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCC-cccccCC
Q 043388          175 SS-LKNLWWLNLEQNN--LGMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGN-QISGTIP  250 (854)
Q Consensus       175 ~~-l~~L~~L~L~~N~--l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N-~l~~~~~  250 (854)
                      .. .++|+.|++++..  ++     +..+...+.++++                         |++|++++| .+++...
T Consensus       144 ~~~~~~L~~L~l~~~~~~i~-----~~~l~~l~~~~~~-------------------------L~~L~L~~~~~itd~~~  193 (284)
T d2astb2         144 AHVSETITQLNLSGYRKNLQ-----KSDLSTLVRRCPN-------------------------LVHLDLSDSVMLKNDCF  193 (284)
T ss_dssp             HHSCTTCCEEECCSCGGGSC-----HHHHHHHHHHCTT-------------------------CSEEECTTCTTCCGGGG
T ss_pred             cccccccchhhhcccccccc-----ccccccccccccc-------------------------ccccccccccCCCchhh
Confidence            11 2345555554321  11     0011112233344                         444444443 2343444


Q ss_pred             ccccccccCCeeecccc-ccccCCCCCccCcccCceeeCccccccccCCccccCc-cccchhccccceecccCCCCCcC
Q 043388          251 SGIRNLVNLIALTIEVN-QLHGIIPDGVGELQHLQQLYMFRNFLQGSIPPSLGNL-TKLADLALSFNNLQGNIPSSLGN  327 (854)
Q Consensus       251 ~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~  327 (854)
                      ..+.++++|++|+|++| .+++.....++.+++|+.|+++++ ++   ...+..+ ..+..|.+..++++...++.+++
T Consensus       194 ~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~---d~~l~~l~~~lp~L~i~~~~ls~~~~~~~~~  268 (284)
T d2astb2         194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN  268 (284)
T ss_dssp             GGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             hhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC---HHHHHHHHHhCccccccCccCCCCCCCccCc
Confidence            45555666666666663 455444445566666666666665 22   1112111 23444455666666555555444

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=4.3e-15  Score=152.62  Aligned_cols=235  Identities=17%  Similarity=0.168  Sum_probs=142.3

Q ss_pred             CCCEEecccccccccCCccccCcCCCCeeeccccccccc-CCcCccCCCCCcEEecccccCcccChhhhcCCCCCceeee
Q 043388           17 NLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQ-IPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIYL   95 (854)
Q Consensus        17 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L   95 (854)
                      .+..+.++.+.+.. ..........|++||+++|.++.. ++..+..+++|++|+|++|.+++..+.+++.+++|++|+|
T Consensus        24 ~~~~lrl~~~~~~~-~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L  102 (284)
T d2astb2          24 GVIAFRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL  102 (284)
T ss_dssp             TCSEEECTTCEECS-CCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred             cceEeecccccccc-chhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccc
Confidence            45677777777763 333444557899999999988743 4556788999999999999998888888999999999999


Q ss_pred             ccc-ccccccCcccccCCCCCcEEEcccCC-CCCCceeeccCccCCCCCCCCCCccccC-CCCCCEEecCCC--cCcccC
Q 043388           96 TVN-RFSGSLPFDILVNLPNLKELYLTFCS-LKNLWWLNLEQNNLGMGTASSIPDSLSN-ASNLERLDLSGN--QFKGKV  170 (854)
Q Consensus        96 ~~N-~l~~~~~~~~~~~l~~L~~L~l~~n~-l~~L~~L~L~~N~l~~~~~~~~p~~~~~-l~~L~~L~Ls~N--~i~~~~  170 (854)
                      +++ .+++.--..++.++++|++|++++|. ++.                ..++..+.. .++|+.|+++++  .++...
T Consensus       103 s~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~----------------~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~  166 (284)
T d2astb2         103 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE----------------KHVQVAVAHVSETITQLNLSGYRKNLQKSD  166 (284)
T ss_dssp             TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH----------------HHHHHHHHHSCTTCCEEECCSCGGGSCHHH
T ss_pred             cccccccccccchhhHHHHhcccccccccccccc----------------ccchhhhcccccccchhhhccccccccccc
Confidence            984 56521112235678889999888763 210                001112222 356777777654  233211


Q ss_pred             -CcCccccCCCCeEeccccc-ccCCCCCChhhhhhccCCCCCcEEEccc-CcCcccCChhhhhhcccccEEEccCCcccc
Q 043388          171 -SIDFSSLKNLWWLNLEQNN-LGMGTANDLDFVTLLTNCSSLKALSLCD-NQFGGELPHSIANLSSTMIQFRIGGNQISG  247 (854)
Q Consensus       171 -~~~f~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~  247 (854)
                       ...+..+++|++|++++|. ++.      +.+..+..+++|++|+|++ +.+++.....+..++ +|+.|++.++ ++ 
T Consensus       167 l~~l~~~~~~L~~L~L~~~~~itd------~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~-~L~~L~l~~~-~~-  237 (284)
T d2astb2         167 LSTLVRRCPNLVHLDLSDSVMLKN------DCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP-TLKTLQVFGI-VP-  237 (284)
T ss_dssp             HHHHHHHCTTCSEEECTTCTTCCG------GGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCT-TCCEEECTTS-SC-
T ss_pred             ccccccccccccccccccccCCCc------hhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCC-CCCEEeeeCC-CC-
Confidence             1123456667777776653 331      1223455666777777776 355555555555554 6777777665 22 


Q ss_pred             cCCcccccc-ccCCeeeccccccccCCCCCccC
Q 043388          248 TIPSGIRNL-VNLIALTIEVNQLHGIIPDGVGE  279 (854)
Q Consensus       248 ~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~  279 (854)
                        ...+..+ ..+..|.+..+.++.+.+..++.
T Consensus       238 --d~~l~~l~~~lp~L~i~~~~ls~~~~~~~~~  268 (284)
T d2astb2         238 --DGTLQLLKEALPHLQINCSHFTTIARPTIGN  268 (284)
T ss_dssp             --TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             --HHHHHHHHHhCccccccCccCCCCCCCccCc
Confidence              1222221 22444555666776665555544

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.52  E-value=1.1e-16  Score=170.43  Aligned_cols=249  Identities=16%  Similarity=0.204  Sum_probs=127.7

Q ss_pred             cCccCCCCCcEEecccccCccc----ChhhhcCCCCCceeeecccccccccCc----------ccccCCCCCcEEEcccC
Q 043388           58 TTLGLLRNLVYLNVAENQFSGM----FPRWICNISSLEFIYLTVNRFSGSLPF----------DILVNLPNLKELYLTFC  123 (854)
Q Consensus        58 ~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~----------~~~~~l~~L~~L~l~~n  123 (854)
                      ..+.....|++|+|++|.|...    +...+...++|+.|+++++.+. .+..          ..+...++|++|+    
T Consensus        25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~-~~~~~~~~~~~~l~~~l~~~~~L~~L~----   99 (344)
T d2ca6a1          25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG-RVKDEIPEALRLLLQALLKCPKLHTVR----   99 (344)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTT-SCGGGSHHHHHHHHHHHTTCTTCCEEE----
T ss_pred             HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCccc-ccccccchHHHHHHHHHhhCCCccccc----
Confidence            3445556666666666665432    2233445556666666655432 1111          1112223333333    


Q ss_pred             CCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCCcCc-------------cccCCCCeEecccccc
Q 043388          124 SLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVSIDF-------------SSLKNLWWLNLEQNNL  190 (854)
Q Consensus       124 ~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~~~f-------------~~l~~L~~L~L~~N~l  190 (854)
                               |++|.++......+...+...++|++|++++|.+.......+             ...+.|+.|++++|.+
T Consensus       100 ---------L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i  170 (344)
T d2ca6a1         100 ---------LSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL  170 (344)
T ss_dssp             ---------CCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCC
T ss_pred             ---------ccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccc
Confidence                     333333322223344555566777777777776642211111             2234455555555554


Q ss_pred             cCCCCCChhhhhhccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCcccccCCccccccccCCeeeccccccc
Q 043388          191 GMGTANDLDFVTLLTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQISGTIPSGIRNLVNLIALTIEVNQLH  270 (854)
Q Consensus       191 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  270 (854)
                      +.....  .+...+..+++|+.|+|++|+++..   .+.                 ..+...+..+++|+.|+|++|+++
T Consensus       171 ~~~~~~--~l~~~l~~~~~L~~L~L~~n~i~~~---g~~-----------------~~l~~~l~~~~~L~~L~Ls~N~i~  228 (344)
T d2ca6a1         171 ENGSMK--EWAKTFQSHRLLHTVKMVQNGIRPE---GIE-----------------HLLLEGLAYCQELKVLDLQDNTFT  228 (344)
T ss_dssp             TGGGHH--HHHHHHHHCTTCCEEECCSSCCCHH---HHH-----------------HHHHTTGGGCTTCCEEECCSSCCH
T ss_pred             cccccc--cccchhhhhhhhccccccccccccc---ccc-----------------cchhhhhcchhhhccccccccccc
Confidence            322111  2223334444555555555554411   000                 012234556677777777777765


Q ss_pred             cC----CCCCccCcccCceeeCccccccccCCcc----ccC--ccccchhccccceecccC----CCCCc-CCCCCcccc
Q 043388          271 GI----IPDGVGELQHLQQLYMFRNFLQGSIPPS----LGN--LTKLADLALSFNNLQGNI----PSSLG-NCQNLKGFD  335 (854)
Q Consensus       271 ~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~----~~~--l~~L~~L~L~~N~l~~~~----~~~~~-~l~~L~~L~  335 (854)
                      ..    +...+..+++|++|+|++|.|++.....    +..  .+.|+.|++++|.|+...    ...+. ++++|+.|+
T Consensus       229 ~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~  308 (344)
T d2ca6a1         229 HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE  308 (344)
T ss_dssp             HHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEE
T ss_pred             ccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEE
Confidence            32    2234566777888888888776542222    222  356888888888876422    22332 467899999


Q ss_pred             cCCCccc
Q 043388          336 ASHNKLT  342 (854)
Q Consensus       336 ls~N~l~  342 (854)
                      +++|++.
T Consensus       309 l~~N~~~  315 (344)
T d2ca6a1         309 LNGNRFS  315 (344)
T ss_dssp             CTTSBSC
T ss_pred             CCCCcCC
Confidence            9999986

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.45  E-value=1.2e-15  Score=147.18  Aligned_cols=132  Identities=22%  Similarity=0.282  Sum_probs=80.7

Q ss_pred             CCCEEecccc--cccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCceee
Q 043388           17 NLQTLAIDFN--YLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFIY   94 (854)
Q Consensus        17 ~L~~L~L~~n--~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~   94 (854)
                      .++.++++++  .++ .++.+++.+++|++|+|++|+|+. ++ .|..+++|++|+|++|+|+. +|..+..+++|++|+
T Consensus        24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~   99 (198)
T d1m9la_          24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELW   99 (198)
T ss_dssp             TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEE
T ss_pred             ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccc-ccccccccccccccc
Confidence            3445555543  233 455567777777777777777773 33 47777777777777777773 455555556677777


Q ss_pred             ecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCCcCcccCC
Q 043388           95 LTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGNQFKGKVS  171 (854)
Q Consensus        95 L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~~  171 (854)
                      +++|+|+ .++  .+..+++|+.|++++|+++++.               . ...|.++++|++|+|++|++....+
T Consensus       100 l~~N~i~-~l~--~~~~l~~L~~L~L~~N~i~~~~---------------~-~~~l~~l~~L~~L~L~~N~l~~~~~  157 (198)
T d1m9la_         100 ISYNQIA-SLS--GIEKLVNLRVLYMSNNKITNWG---------------E-IDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             CSEEECC-CHH--HHHHHHHSSEEEESEEECCCHH---------------H-HHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred             ccccccc-ccc--cccccccccccccccchhcccc---------------c-cccccCCCccceeecCCCccccCcc
Confidence            7777776 443  2455555555555555554331               0 0346667777777777777665443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.41  E-value=3.9e-15  Score=143.50  Aligned_cols=115  Identities=21%  Similarity=0.297  Sum_probs=99.4

Q ss_pred             cCchhhhcCCCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccChhhhcC
Q 043388            7 QIPEEIGSLLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICN   86 (854)
Q Consensus         7 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~   86 (854)
                      .+|..|..|++|++|+|++|+|+ .++ .++.+++|++|+|++|+|+ .+|..+..+++|++|++++|+|+.+  +.+.+
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~  113 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK  113 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred             hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence            35678999999999999999999 455 5999999999999999998 5677777778999999999999954  45889


Q ss_pred             CCCCceeeecccccccccCc-ccccCCCCCcEEEcccCCCCC
Q 043388           87 ISSLEFIYLTVNRFSGSLPF-DILVNLPNLKELYLTFCSLKN  127 (854)
Q Consensus        87 l~~L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~l~~n~l~~  127 (854)
                      +++|++|+|++|+|+ .++. ..|..+++|+.|++++|.+..
T Consensus       114 l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~  154 (198)
T d1m9la_         114 LVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             HHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred             cccccccccccchhc-cccccccccCCCccceeecCCCcccc
Confidence            999999999999998 6654 568899999999999887653

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=1.7e-13  Score=126.13  Aligned_cols=108  Identities=19%  Similarity=0.116  Sum_probs=86.9

Q ss_pred             CCCCCEEecccccccccCCccccCcCCCCeeecccc-cccccCCcCccCCCCCcEEecccccCcccChhhhcCCCCCcee
Q 043388           15 LLNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWN-SLGGQIPTTLGLLRNLVYLNVAENQFSGMFPRWICNISSLEFI   93 (854)
Q Consensus        15 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L   93 (854)
                      ....++++++++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.|++|.++++|++|
T Consensus         7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L   85 (156)
T d2ifga3           7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL   85 (156)
T ss_dssp             CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred             cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence            345677888888888 67788888888888888766 4887777788888889999999898888888888888888888


Q ss_pred             eecccccccccCcccccCCCCCcEEEcccCCC
Q 043388           94 YLTVNRFSGSLPFDILVNLPNLKELYLTFCSL  125 (854)
Q Consensus        94 ~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l  125 (854)
                      +|++|+|+ .+|.++|..+ +|+.|+|++|.+
T Consensus        86 ~Ls~N~l~-~l~~~~~~~~-~l~~L~L~~Np~  115 (156)
T d2ifga3          86 NLSFNALE-SLSWKTVQGL-SLQELVLSGNPL  115 (156)
T ss_dssp             ECCSSCCS-CCCSTTTCSC-CCCEEECCSSCC
T ss_pred             eccCCCCc-ccChhhhccc-cccccccCCCcc
Confidence            88888888 8888877655 477777766655

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=1.7e-12  Score=119.34  Aligned_cols=109  Identities=17%  Similarity=0.169  Sum_probs=83.8

Q ss_pred             CCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCCC-cCcccCCcCccccCCCCeEecccccccCCCCCChhhhhh
Q 043388          125 LKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSGN-QFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDFVTL  203 (854)
Q Consensus       125 l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~N-~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~  203 (854)
                      ....+.++++++.+     ..+|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.++.+      +
T Consensus         7 c~~~~~l~c~~~~~-----~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~------~   75 (156)
T d2ifga3           7 PHGSSGLRCTRDGA-----LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD------A   75 (156)
T ss_dssp             CSSSSCEECCSSCC-----CTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT------G
T ss_pred             cCCCCeEEecCCCC-----ccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccc------c
Confidence            33445566666666     456788888999999999766 59988888999999999999999999877664      6


Q ss_pred             ccCCCCCcEEEcccCcCcccCChhhhhhcccccEEEccCCccc
Q 043388          204 LTNCSSLKALSLCDNQFGGELPHSIANLSSTMIQFRIGGNQIS  246 (854)
Q Consensus       204 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~L~~L~l~~N~l~  246 (854)
                      |.++++|++|+|++|+|+ .+|....... .++.|+|++|.+.
T Consensus        76 f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          76 FHFTPRLSRLNLSFNALE-SLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             GGSCSCCCEEECCSSCCS-CCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             ccccccccceeccCCCCc-ccChhhhccc-cccccccCCCccc
Confidence            788889999999999998 5555544443 4777777777764

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.70  E-value=8.8e-10  Score=101.57  Aligned_cols=68  Identities=25%  Similarity=0.263  Sum_probs=39.6

Q ss_pred             CccccCCCCCCEEecCCCcCcccCCcCccccCCCCeEecccccccCCCCCChhh-hhhccCCCCCcEEE
Q 043388          147 PDSLSNASNLERLDLSGNQFKGKVSIDFSSLKNLWWLNLEQNNLGMGTANDLDF-VTLLTNCSSLKALS  214 (854)
Q Consensus       147 p~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~-~~~~~~l~~L~~L~  214 (854)
                      +..+..+++|+.|+|++|+|+.+.+..+....+|+.|++++|.+.....+..++ ...+..+++|+.||
T Consensus        84 ~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          84 SSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             GTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             HHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            344556677777777777777665544445556777777777765443332221 22355667777664

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.63  E-value=1.9e-09  Score=99.25  Aligned_cols=141  Identities=17%  Similarity=0.079  Sum_probs=93.5

Q ss_pred             CchhhhcC--CCCCEEecccccccccCCccccCcCCCCeeecccccccccCCcCccCCCCCcEEecccccCcccC--hhh
Q 043388            8 IPEEIGSL--LNLQTLAIDFNYLTGQLPDFVGNLSALGMLLIRWNSLGGQIPTTLGLLRNLVYLNVAENQFSGMF--PRW   83 (854)
Q Consensus         8 ~p~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~   83 (854)
                      ++..+...  ...+.||++++...    ..+..+..+..|+..+|.+. .++..+..+++|++|+|++|+|+.+.  +..
T Consensus        12 l~~~l~~~~~~~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~   86 (162)
T d1koha1          12 LKLIMSKRYDGSQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSI   86 (162)
T ss_dssp             HHHHHHTTBCSSSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTH
T ss_pred             HHHHHHhhcchhhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHH
Confidence            34444443  34566777765532    23556666777777777665 56667778999999999999999653  466


Q ss_pred             hcCCCCCceeeecccccccccCcccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEEecCC
Q 043388           84 ICNISSLEFIYLTVNRFSGSLPFDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERLDLSG  163 (854)
Q Consensus        84 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L~Ls~  163 (854)
                      +..+++|+.|+|++|+|+ +++.-.+....+|++|++++|.+.....-+.          ......+..+|+|+.||  +
T Consensus        87 ~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~----------~y~~~i~~~~P~L~~LD--g  153 (162)
T d1koha1          87 VQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQS----------TYISAIRERFPKLLRLD--G  153 (162)
T ss_dssp             HHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHH----------HHHHHHHTTSTTCCEET--T
T ss_pred             HhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccch----------hHHHHHHHHCCCCCEEC--c
Confidence            889999999999999998 7776555555667777777766643210000          00112356688888876  4


Q ss_pred             CcC
Q 043388          164 NQF  166 (854)
Q Consensus       164 N~i  166 (854)
                      +++
T Consensus       154 ~~v  156 (162)
T d1koha1         154 HEL  156 (162)
T ss_dssp             EEC
T ss_pred             CCC
Confidence            444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=2.6e-07  Score=92.37  Aligned_cols=148  Identities=18%  Similarity=0.161  Sum_probs=102.6

Q ss_pred             HHHHHHHhhccccCccCCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCC
Q 043388          541 AELSKATSEFASSNMIGQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDS  619 (854)
Q Consensus       541 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  619 (854)
                      .++....+.|+..+..+-++.+.||+...  ++..+++|+...........+.+|...+..+. +--+.+++.+....+ 
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~-   83 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG-   83 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC-
Confidence            45677778888877765556679999864  45557788886554444456788998888773 434667777765443 


Q ss_pred             CCCceeeEEEeeccCCCHHHHhhhcCCcccccccCHHHHHHHHHHHHHHHHHHHhcC-----------------------
Q 043388          620 KGADFKALVFEYMENGSLEDWLHQSNDHLEVCKLTLIQRVNIAIDVASAIEYLHHHC-----------------------  676 (854)
Q Consensus       620 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~-----------------------  676 (854)
                          ..++||++++|.++.+......           ....++.++++.++.||+..                       
T Consensus        84 ----~~~lv~~~l~G~~~~~~~~~~~-----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (263)
T d1j7la_          84 ----WSNLLMSEADGVLCSEEYEDEQ-----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN  148 (263)
T ss_dssp             ----EEEEEEECCSSEEHHHHTTTCS-----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred             ----ceEEEEEecccccccccccccc-----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence                6799999999988866543211           12335566667777777532                       


Q ss_pred             ---------------------------------CCCeEeecCCCCceEecCCccc-cccccccc
Q 043388          677 ---------------------------------QPPIVHGDLKPSNVLLDHDMVA-HQNFSLSH  706 (854)
Q Consensus       677 ---------------------------------~~~ivH~Dlkp~NIll~~~~~~-~~Dfg~~~  706 (854)
                                                       .+.++|+|+.|.||+++++.+. +|||+.+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                             1138999999999999988765 67998654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.87  E-value=5.4e-06  Score=82.02  Aligned_cols=75  Identities=11%  Similarity=0.028  Sum_probs=50.7

Q ss_pred             ccCCCc-ceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccC--CCeeeEEEEeeccCCCCCceeeEEEee
Q 043388          555 MIGQGS-FGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH--RNLIKIITICSSIDSKGADFKALVFEY  631 (854)
Q Consensus       555 ~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~  631 (854)
                      .+..|. .+.||+.... ++..+++|.......   ..+.+|+..++.+..  -.+.+++++..+.+     ..++||+|
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~-----~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAG-----RDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSS-----CEEEEEEC
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeeccccc-----ceEEEEEe
Confidence            344554 3689999876 566688898754432   346778888887743  33567777765443     57899999


Q ss_pred             ccCCCHH
Q 043388          632 MENGSLE  638 (854)
Q Consensus       632 ~~~gsL~  638 (854)
                      ++|.++.
T Consensus        88 i~G~~~~   94 (255)
T d1nd4a_          88 VPGQDLL   94 (255)
T ss_dssp             CSSEETT
T ss_pred             eeccccc
Confidence            9886653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.84  E-value=2.4e-05  Score=82.41  Aligned_cols=77  Identities=14%  Similarity=0.092  Sum_probs=50.3

Q ss_pred             cCccCCCcceEEEEeEECCCceEEEEEEeecc----c---ccchHHHHHHHHHHHhcc-C--CCeeeEEEEeeccCCCCC
Q 043388          553 SNMIGQGSFGSVYKGILGGEEMIVAVKVINLK----Q---KGAFRSFVAECEALRNIR-H--RNLIKIITICSSIDSKGA  622 (854)
Q Consensus       553 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~  622 (854)
                      .+.||.|....||++....+++.|+||.-...    .   .....+...|++.++.+. +  ..+.+++.+..+      
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~------  104 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE------  104 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT------
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC------
Confidence            34689999999999998777888999975421    1   112345667888888773 2  356677766432      


Q ss_pred             ceeeEEEeeccCCC
Q 043388          623 DFKALVFEYMENGS  636 (854)
Q Consensus       623 ~~~~lv~e~~~~gs  636 (854)
                       ..++|||++++..
T Consensus       105 -~~~lvmE~L~~~~  117 (392)
T d2pula1         105 -MAVTVMEDLSHLK  117 (392)
T ss_dssp             -TTEEEECCCTTSE
T ss_pred             -CCEEEEeccCCcc
Confidence             2479999997654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.81  E-value=1.8e-06  Score=79.12  Aligned_cols=72  Identities=14%  Similarity=0.143  Sum_probs=40.5

Q ss_pred             ccccCCCCCCEEecCCCcCcccCCc----CccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcccCcCc
Q 043388          148 DSLSNASNLERLDLSGNQFKGKVSI----DFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQFG  221 (854)
Q Consensus       148 ~~~~~l~~L~~L~Ls~N~i~~~~~~----~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  221 (854)
                      ..+...++|++|+|++|.+......    .+...+.|++|+|++|.|+....  ..+..++...++|++|++++|.+.
T Consensus        38 ~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~--~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          38 EAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL--ARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH--HHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             HHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHH--HHHHHHHHhCCcCCEEECCCCcCC
Confidence            3455556677777777766532222    23345666666666666653221  133445666667777777766554

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.72  E-value=4.8e-06  Score=76.24  Aligned_cols=124  Identities=10%  Similarity=0.118  Sum_probs=82.8

Q ss_pred             hcCCCCCceeeeccc-ccccccC---cccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCCCCEE
Q 043388           84 ICNISSLEFIYLTVN-RFSGSLP---FDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASNLERL  159 (854)
Q Consensus        84 ~~~l~~L~~L~L~~N-~l~~~~~---~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~L~~L  159 (854)
                      ..+.++|++|+|+++ .++..--   ...+...++|++|++++             |.++......+...+...+.|++|
T Consensus        11 ~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~-------------n~l~~~~~~~la~~L~~n~~L~~L   77 (167)
T d1pgva_          11 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLAN-------------TAISDSEARGLIELIETSPSLRVL   77 (167)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTT-------------SCCBHHHHTTHHHHHHHCSSCCEE
T ss_pred             HhCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccc-------------cccchhHHHHHhhhhhhcccccce
Confidence            346689999999974 4542110   11233444555555554             444444445566677788999999


Q ss_pred             ecCCCcCcccCC----cCccccCCCCeEecccccccCCCCC-ChhhhhhccCCCCCcEEEcccCcC
Q 043388          160 DLSGNQFKGKVS----IDFSSLKNLWWLNLEQNNLGMGTAN-DLDFVTLLTNCSSLKALSLCDNQF  220 (854)
Q Consensus       160 ~Ls~N~i~~~~~----~~f~~l~~L~~L~L~~N~l~~~~~~-~~~~~~~~~~l~~L~~L~L~~N~l  220 (854)
                      +|++|.|+....    ..+...+.|++|+|++|.+..+... ...+..++...++|+.|+++.+..
T Consensus        78 ~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          78 NVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             ECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             eeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence            999999985432    3466678899999999987655432 234566777889999999987754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.34  E-value=0.00016  Score=73.74  Aligned_cols=99  Identities=12%  Similarity=0.054  Sum_probs=56.2

Q ss_pred             CCcccHHHHHHHHhhcccc---CccCCCc-ceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccCCCe--e
Q 043388          535 FPMISYAELSKATSEFASS---NMIGQGS-FGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL--I  608 (854)
Q Consensus       535 ~~~~~~~~~~~~~~~~~~~---~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v  608 (854)
                      +...+++.+..+.+.+-..   +...=++ --.||++... +|..|++|+.+.... ..+++..|...+..|....+  +
T Consensus         5 f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~   82 (325)
T d1zyla1           5 FQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVA   82 (325)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             ccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCC
Confidence            4456677777777655321   1111122 2379999887 778899999875433 34667889999888843322  2


Q ss_pred             eEEEEeeccCCCCCceeeEEEeeccCC
Q 043388          609 KIITICSSIDSKGADFKALVFEYMENG  635 (854)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~lv~e~~~~g  635 (854)
                      ..+..............+.++++++|.
T Consensus        83 ~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          83 APVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             CceecCCCeeeeeeeEEEEEEeecCCc
Confidence            211110000001122568899998764

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.05  E-value=6e-05  Score=68.63  Aligned_cols=125  Identities=17%  Similarity=0.151  Sum_probs=55.3

Q ss_pred             ChhhhcCCCCCceeeecc-cccccccC---cccccCCCCCcEEEcccCCCCCCceeeccCccCCCCCCCCCCccccCCCC
Q 043388           80 FPRWICNISSLEFIYLTV-NRFSGSLP---FDILVNLPNLKELYLTFCSLKNLWWLNLEQNNLGMGTASSIPDSLSNASN  155 (854)
Q Consensus        80 ~p~~~~~l~~L~~L~L~~-N~l~~~~~---~~~~~~l~~L~~L~l~~n~l~~L~~L~L~~N~l~~~~~~~~p~~~~~l~~  155 (854)
                      +.....+.++|++|+|++ |.|+...-   ...+...++|++|++++|.+.             ......+-..+...++
T Consensus         9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~-------------~~~~~~L~~~l~~~~~   75 (166)
T d1io0a_           9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN-------------DPVAFALAEMLKVNNT   75 (166)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC-------------HHHHHHHHHHHHHCSS
T ss_pred             HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc-------------HHHHHHHHHHHhhccc
Confidence            344445667778888776 44541110   011223344444444443332             2222223344455566


Q ss_pred             CCEEecCCCcCcccC----CcCccccCCCCeEec--ccccccCCCCCChhhhhhccCCCCCcEEEcccCc
Q 043388          156 LERLDLSGNQFKGKV----SIDFSSLKNLWWLNL--EQNNLGMGTANDLDFVTLLTNCSSLKALSLCDNQ  219 (854)
Q Consensus       156 L~~L~Ls~N~i~~~~----~~~f~~l~~L~~L~L--~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~  219 (854)
                      ++.|++++|.+....    ...+...++|+.++|  ++|.++....  ..+..++...++|+.|+++.+.
T Consensus        76 l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~--~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          76 LKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE--MEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             CCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH--HHHHHHHHHCSSCCEEECCCSS
T ss_pred             chhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH--HHHHHHHHhCCCcCEEeCcCCC
Confidence            666666666654221    123444455554333  3344422111  1223344455555555555443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.04  E-value=3.4e-05  Score=70.30  Aligned_cols=74  Identities=20%  Similarity=0.275  Sum_probs=41.9

Q ss_pred             CCccccCCCCCCEEecCCCcCcccCC----cCccccCCCCeEecccccccCCCCCChhhhhhccCCCCCcEEEcc--cCc
Q 043388          146 IPDSLSNASNLERLDLSGNQFKGKVS----IDFSSLKNLWWLNLEQNNLGMGTANDLDFVTLLTNCSSLKALSLC--DNQ  219 (854)
Q Consensus       146 ~p~~~~~l~~L~~L~Ls~N~i~~~~~----~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~--~N~  219 (854)
                      +-.++...++|++|+|++|+++....    ..+...+.++.+++++|.++....  ..+...+...++|+.++|+  +|.
T Consensus        38 l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~--~~l~~~l~~~~~L~~l~L~l~~n~  115 (166)
T d1io0a_          38 CAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI--LALVEALQSNTSLIELRIDNQSQP  115 (166)
T ss_dssp             HHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH--HHHHHGGGGCSSCCEEECCCCSSC
T ss_pred             HHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhH--HHHHHHHHhCccccEEeeccCCCc
Confidence            34456667777788888877764322    234555667777777776643221  1334455666666654443  444


Q ss_pred             Cc
Q 043388          220 FG  221 (854)
Q Consensus       220 l~  221 (854)
                      +.
T Consensus       116 i~  117 (166)
T d1io0a_         116 LG  117 (166)
T ss_dssp             CC
T ss_pred             Cc
Confidence            44

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.18  E-value=0.0053  Score=61.75  Aligned_cols=63  Identities=8%  Similarity=0.087  Sum_probs=40.6

Q ss_pred             ccHHHHHHHHhhccccCcc-----CCCcceEEEEeEECCCceEEEEEEeecccccchHHHHHHHHHHHhccC
Q 043388          538 ISYAELSKATSEFASSNMI-----GQGSFGSVYKGILGGEEMIVAVKVINLKQKGAFRSFVAECEALRNIRH  604 (854)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  604 (854)
                      .+.+++.....+|.+++..     ..|---+.|+.+.. +| .+++|++....  ..+.+..|++++..+..
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~   70 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAA   70 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhh
Confidence            4678888888899775544     35555778999876 34 48899986432  22455677888888743

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.97  E-value=0.0094  Score=61.95  Aligned_cols=73  Identities=21%  Similarity=0.162  Sum_probs=50.0

Q ss_pred             CccCCCcceEEEEeEECC-------CceEEEEEEeecccccchHHHHHHHHHHHhcc-CCCeeeEEEEeeccCCCCCcee
Q 043388          554 NMIGQGSFGSVYKGILGG-------EEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSIDSKGADFK  625 (854)
Q Consensus       554 ~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  625 (854)
                      +.|+.|-.-.+|++....       ....|.+++.- ... ......+|..+++.+. +.-..++++++..         
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---------  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG---------  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT---------
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---------
Confidence            568888889999998753       23567777764 222 2345668999999884 4334577777631         


Q ss_pred             eEEEeeccCCCH
Q 043388          626 ALVFEYMENGSL  637 (854)
Q Consensus       626 ~lv~e~~~~gsL  637 (854)
                      .+||||++|.++
T Consensus       117 g~I~efi~g~~l  128 (395)
T d1nw1a_         117 GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEECCCCEEEC
T ss_pred             ceEEEEeccccC
Confidence            589999987544